Citrus Sinensis ID: 044561
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 614 | 2.2.26 [Sep-21-2011] | |||||||
| O80939 | 675 | L-type lectin-domain cont | yes | no | 0.946 | 0.860 | 0.533 | 1e-180 | |
| Q9M345 | 677 | L-type lectin-domain cont | no | no | 0.952 | 0.864 | 0.541 | 1e-179 | |
| Q9SZD5 | 669 | L-type lectin-domain cont | no | no | 0.944 | 0.866 | 0.532 | 1e-178 | |
| Q9FIF1 | 674 | Probable L-type lectin-do | no | no | 0.977 | 0.890 | 0.525 | 1e-175 | |
| Q9LSR9 | 657 | L-type lectin-domain cont | no | no | 0.929 | 0.869 | 0.529 | 1e-174 | |
| Q9M1G4 | 674 | Probable L-type lectin-do | no | no | 0.957 | 0.872 | 0.524 | 1e-173 | |
| Q9FIF0 | 694 | Putative L-type lectin-do | no | no | 0.986 | 0.873 | 0.496 | 1e-170 | |
| O04534 | 666 | Putative L-type lectin-do | no | no | 0.933 | 0.860 | 0.506 | 1e-169 | |
| Q9LSR8 | 766 | L-type lectin-domain cont | no | no | 0.936 | 0.750 | 0.513 | 1e-169 | |
| O81291 | 669 | L-type lectin-domain cont | no | no | 0.965 | 0.886 | 0.503 | 1e-168 |
| >sp|O80939|LRK41_ARATH L-type lectin-domain containing receptor kinase IV.1 OS=Arabidopsis thaliana GN=LECRK41 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 630 bits (1626), Expect = e-180, Method: Compositional matrix adjust.
Identities = 323/605 (53%), Positives = 431/605 (71%), Gaps = 24/605 (3%)
Query: 24 AQDVNQFIYHGFNEDAQLQRDGLASVHSNGLLQLTNTVSPQQEGHAFYRLPIKFNTSSSE 83
+Q +N +GFN L G+ +V NGLL+LTNT + Q+ GHAFY PI+F S +
Sbjct: 22 SQSLNFAYNNGFNPPTDLSIQGITTVTPNGLLKLTNT-TVQKTGHAFYTKPIRFKDSPNG 80
Query: 84 SLS-FSSNFVFAI----------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNH 132
++S FS++FVFAI G+AFV++P+ L +PS+Y+GLFN +NNG TNH
Sbjct: 81 TVSSFSTSFVFAIHSQIAILSGHGIAFVVAPNASL--PYGNPSQYIGLFNLANNGNETNH 138
Query: 133 ILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGDPIQI 192
+ A+ELDT+ + +F+D +DNHVGID+NSL S +S+PA Y+ D +G K L LI P+Q+
Sbjct: 139 VFAVELDTILSTEFNDTNDNHVGIDINSLKSVQSSPAGYW-DEKGQFKNLTLISRKPMQV 197
Query: 193 WISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLKSSHYVL 252
W+ YDG ++VT+AP + KPT+PL++ +LS +LL+ MYVGFS++TGS+ S HY+L
Sbjct: 198 WVDYDGRTNKIDVTMAPFNEDKPTRPLVTAVRDLSSVLLQDMYVGFSSATGSVLSEHYIL 257
Query: 253 GWSFNRSGPALNLDISSLPRLPHLPRPRAKANDKPQLKLVISVSLIAILVVLITIGAAVY 312
GWSF + A L +S LP+LP R K I + LI++ ++ I Y
Sbjct: 258 GWSFGLNEKAPPLALSRLPKLPRFEPKRISEFYK------IGMPLISLFLIFSFIFLVCY 311
Query: 313 IVRNKR-YEEVYEDWEREYGPQRFTYKDLYKATKGFKDKDVIGRGGFGKVYRGVL-ASNV 370
IVR +R + E E+WE+E+G RF +KDLY ATKGFK+K ++G GGFG VY+GV+ + +
Sbjct: 312 IVRRRRKFAEELEEWEKEFGKNRFRFKDLYYATKGFKEKGLLGTGGFGSVYKGVMPGTKL 371
Query: 371 QIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDK 430
+IAVK+VSH+S+QG+KEFVAE+VS+GR+ HRNLV L GYCRR+GE LLVYDYMPNGSLDK
Sbjct: 372 EIAVKRVSHESRQGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLDK 431
Query: 431 ILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDF 490
L+ + LNW QR ++I GVASGL YLHE+WEQVV+HRD+K +NVLLD +LNG+LGDF
Sbjct: 432 YLYNTPEVTLNWKQRIKVILGVASGLFYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDF 491
Query: 491 GLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVE-Q 549
GLARLYDH + PQTT +VGT GY+ PE RTG+A+ +TDV+AFG F+LEVA GRRP+E Q
Sbjct: 492 GLARLYDHGSDPQTTHVVGTLGYLAPEHTRTGRATMATDVFAFGAFLLEVACGRRPIEFQ 551
Query: 550 QGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNM 609
Q + ET LVDWV W KG I A D + C+EK++E+VLKLGL CSH P ARP+M
Sbjct: 552 QETDETFLLVDWVFGLWNKGDILAAKDPNMGSECDEKEVEMVLKLGLLCSHSDPRARPSM 611
Query: 610 RQVMQ 614
RQV+
Sbjct: 612 RQVLH 616
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9M345|LRK42_ARATH L-type lectin-domain containing receptor kinase IV.2 OS=Arabidopsis thaliana GN=LECRK42 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 629 bits (1622), Expect = e-179, Method: Compositional matrix adjust.
Identities = 337/622 (54%), Positives = 436/622 (70%), Gaps = 37/622 (5%)
Query: 11 CVLLCASFIFSALAQDVNQFIYHGFN---EDAQLQRDGLASVHSNGLLQLTNTVSPQQEG 67
C ++ +S +Q++N F Y+GF+ D LQ GLA+V NGLL+LTNT S Q+ G
Sbjct: 15 CQIMISS------SQNLN-FTYNGFHPPLTDISLQ--GLATVTPNGLLKLTNT-SVQKTG 64
Query: 68 HAFYRLPIKFNTSSSESLS-FSSNFVFAI----------GMAFVISPSKDLGKAEASPSE 116
HAF I+F S + ++S FS+ FVFAI G+AFV++P+ LG A PS+
Sbjct: 65 HAFCTERIRFKDSQNGNVSSFSTTFVFAIHSQIPTLSGHGIAFVVAPT--LGLPFALPSQ 122
Query: 117 YLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDRE 176
Y+GLFN SNNG TNHI A+E DT+Q+ +F D +DNHVGID+N L S + A Y D +
Sbjct: 123 YIGLFNISNNGNDTNHIFAVEFDTIQSSEFGDPNDNHVGIDLNGLRSANYSTAGYRDDHD 182
Query: 177 GMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYV 236
+ L LI IQ+WI YD ++VT+AP KP KPL+S +LS ILLE MYV
Sbjct: 183 KF-QNLSLISRKRIQVWIDYDNRSHRIDVTVAPFDSDKPRKPLVSYVRDLSSILLEDMYV 241
Query: 237 GFSASTGSLKSSHYVLGWSFNRSGPALNLDISSLPRLPHLPRPRAKANDKPQLKLVISVS 296
GFS++TGS+ S H+++GWSF +G A L +S LP+LP R K + L IS+S
Sbjct: 242 GFSSATGSVLSEHFLVGWSFRLNGEAPMLSLSKLPKLPRFEPRRISEFYKIGMPL-ISLS 300
Query: 297 LIAILVVLITIGAAVYIVR-NKRYEEVYEDWEREYGPQRFTYKDLYKATKGFKDKDVIGR 355
LI ++ L A YIVR K+YEE +DWE E+G RF +K+LY ATKGFK+KD++G
Sbjct: 301 LIFSIIFL-----AFYIVRRKKKYEEELDDWETEFGKNRFRFKELYHATKGFKEKDLLGS 355
Query: 356 GGFGKVYRGVL-ASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKG 414
GGFG+VYRG+L + +++AVK+VSHDSKQG+KEFVAE+VS+GR+ HRNLV L GYCRR+G
Sbjct: 356 GGFGRVYRGILPTTKLEVAVKRVSHDSKQGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRG 415
Query: 415 EFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKP 474
E LLVYDYMPNGSLDK L+ N + L+W QR II+GVASGL YLHE+WEQVV+HRD+K
Sbjct: 416 ELLLVYDYMPNGSLDKYLYNNPETTLDWKQRSTIIKGVASGLFYLHEEWEQVVIHRDVKA 475
Query: 475 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFG 534
+NVLLDAD NG+LGDFGLARLYDH + PQTT +VGT GY+ PE RTG+A+T+TDVYAFG
Sbjct: 476 SNVLLDADFNGRLGDFGLARLYDHGSDPQTTHVVGTLGYLAPEHSRTGRATTTTDVYAFG 535
Query: 535 VFMLEVASGRRPVE-QQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEE-KQMELVL 592
F+LEV SGRRP+E S +T LV+WV W +G I +A D +L + +++E+VL
Sbjct: 536 AFLLEVVSGRRPIEFHSASDDTFLLVEWVFSLWLRGNIMEAKDPKLGSSGYDLEEVEMVL 595
Query: 593 KLGLFCSHPKPEARPNMRQVMQ 614
KLGL CSH P ARP+MRQV+Q
Sbjct: 596 KLGLLCSHSDPRARPSMRQVLQ 617
|
Required during pollen development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SZD5|LRK59_ARATH L-type lectin-domain containing receptor kinase V.9 OS=Arabidopsis thaliana GN=LECRK59 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 624 bits (1610), Expect = e-178, Method: Compositional matrix adjust.
Identities = 324/609 (53%), Positives = 431/609 (70%), Gaps = 29/609 (4%)
Query: 22 ALAQ-DVNQFIYHGFNEDAQLQRDGLASVHSNGLLQLTNTVSPQQEGHAFYRLPIKFNTS 80
AL+Q + +F ++G+ D G+A +S GL++LTN+ S GH FY P++F S
Sbjct: 19 ALSQSEEGEFGFNGYLYD----NSGIAITNSKGLMKLTNS-SEFSYGHVFYNSPVRFKNS 73
Query: 81 SSESLS-FSSNFVFAI----------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQS 129
+ ++S FS+ FVFAI G+AFVISP+K G +S S+YLGLFN +NNG
Sbjct: 74 PNGTVSSFSTTFVFAIVSNVNALDGHGLAFVISPTK--GLPYSSSSQYLGLFNLTNNGDP 131
Query: 130 TNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGDP 189
+NHI+A+E DT QN +FDD+D+NHVGID+NSL S +++ A Y+ D +G K + LI P
Sbjct: 132 SNHIVAVEFDTFQNQEFDDMDNNHVGIDINSLSSEKASTAGYYEDDDGTFKNIRLINQKP 191
Query: 190 IQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLKSSH 249
IQ WI YD + + LNVT+ P+ +PKP PLLS +LS L ++MYVGF+++TG L+SSH
Sbjct: 192 IQAWIEYDSSRRQLNVTIHPIHLPKPKIPLLSLTKDLSPYLFDSMYVGFTSATGRLRSSH 251
Query: 250 YVLGWSFNRSGPALNLDISSLPRLPHLPRPRAKANDKPQLKLVISVSLIAILVVLITIGA 309
Y+LGW+F +G A N+DIS RLP LPR + K L + +S++ +AILV L TI
Sbjct: 252 YILGWTFKLNGTASNIDIS---RLPKLPRDSRSTSVKKILAISLSLTSLAILVFL-TISY 307
Query: 310 AVYIVRNKRYEEVYEDWEREYGPQRFTYKDLYKATKGFKDKDVIGRGGFGKVYRGVLA-S 368
+++ R K+ EV EDWE ++GP RF YKDLY ATKGF++ +++G+GGFGKVY+G L+ S
Sbjct: 308 MLFLKR-KKLMEVLEDWEVQFGPHRFAYKDLYIATKGFRNSELLGKGGFGKVYKGTLSTS 366
Query: 369 NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSL 428
N+ IAVKKVSHDS+QG++EFVAE+ ++GRLRH NLV+L GYCRRKGE LVYD MP GSL
Sbjct: 367 NMDIAVKKVSHDSRQGMREFVAEIATIGRLRHPNLVRLLGYCRRKGELYLVYDCMPKGSL 426
Query: 429 DKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLG 488
DK L+ + L+W QRF+II+ VASGL YLH W QV++HRDIKPANVLLD +NGKLG
Sbjct: 427 DKFLYHQPEQSLDWSQRFKIIKDVASGLCYLHHQWVQVIIHRDIKPANVLLDDSMNGKLG 486
Query: 489 DFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVE 548
DFGLA+L +H PQT+ + GTFGY+ PEL RTGKASTS+DV+AFG+ MLE+ GRRPV
Sbjct: 487 DFGLAKLCEHGFDPQTSNVAGTFGYISPELSRTGKASTSSDVFAFGILMLEITCGRRPVL 546
Query: 549 QQGSMET-VNLVDWVCDCWKKGAIRDASDSRLEGICE--EKQMELVLKLGLFCSHPKPEA 605
+ S + + L DWV DCW+ I D R++ + E+Q+ LVLKLGLFCSHP
Sbjct: 547 PRASSPSEMVLTDWVLDCWEDD-ILQVVDERVKQDDKYLEEQVALVLKLGLFCSHPVAAV 605
Query: 606 RPNMRQVMQ 614
RP+M V+Q
Sbjct: 606 RPSMSSVIQ 614
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIF1|LRK21_ARATH Probable L-type lectin-domain containing receptor kinase II.1 OS=Arabidopsis thaliana GN=LECRK21 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 615 bits (1587), Expect = e-175, Method: Compositional matrix adjust.
Identities = 334/636 (52%), Positives = 428/636 (67%), Gaps = 36/636 (5%)
Query: 1 MGAAPRSFCFCVLLCASFIFSALAQDVNQFIYHGFNEDAQLQRDGLASVHSNGLLQLTNT 60
M S F +++ F AQ+ + F+Y+ F +A L+ DG+A+ + +G L LTN
Sbjct: 1 MAGVLGSVVFWLIIGIHVTFLVFAQEGDHFVYYDF-RNADLELDGMANTN-HGPLHLTNN 58
Query: 61 VSPQQEGHAFYRLPIKFNTSSSESLSFSSNFVFAI----------GMAFVISPSKDLGKA 110
+ GHAFY +PIKF SS S SFS+ FVFAI GMAFV+SP+KDL ++
Sbjct: 59 TN-TGTGHAFYNIPIKFTASSLSSFSFSTEFVFAIFPLQKSTYGHGMAFVVSPTKDL-RS 116
Query: 111 EASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAA 170
S + LG+FN +N+ ++ HI A+ELDT QN + D N VGID+NS++S ESA A+
Sbjct: 117 NGSANSNLGIFNRANDNKTATHIFAVELDTNQNSESFDKGGNDVGIDINSIVSVESADAS 176
Query: 171 YFSDREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKP-----------L 219
YF+ R+G N +L L G I +WI YDG EK+LNVTLAP+ PKP P L
Sbjct: 177 YFNARKGKNISLPLASGKSILVWIDYDGIEKVLNVTLAPVQTPKPDSPYFSSFIKPKVPL 236
Query: 220 LSRAINLSHILLETMYVGFSASTGSLKSSHYVLGWSFNRSGPALNLDISSLPRLPHLPRP 279
LSR+INLS I ETMYVGFS STGS+KS+ Y+LGWSF + G A +LDIS L P P P
Sbjct: 237 LSRSINLSEIFTETMYVGFSGSTGSIKSNQYILGWSFKQGGKAESLDISRLSNPP--PSP 294
Query: 280 RAKANDKPQLKLVISVSLIAILVVLITIGAAVYIVRNKRYEEVYEDWEREYGPQRFTYKD 339
+ + LK V+ ++ I +T+G VY+ + K+Y EV E WE+EY PQR++++
Sbjct: 295 K-----RFPLKEVLGATISTI--AFLTLGGIVYLYKKKKYAEVLEQWEKEYSPQRYSFRI 347
Query: 340 LYKATKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLR 399
LYKATKGF++ ++G GGFGKVY+G+L S QIAVK+V HD++QG+K++VAE+ SMGRLR
Sbjct: 348 LYKATKGFRENQLLGAGGFGKVYKGILPSGTQIAVKRVYHDAEQGMKQYVAEIASMGRLR 407
Query: 400 HRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKIL-HTNIKPCLNWYQRFRIIRGVASGLLY 458
H+NLV L GYCRRKGE LLVYDYMPNGSLD L H N L W QR II+GVAS LLY
Sbjct: 408 HKNLVHLLGYCRRKGELLLVYDYMPNGSLDDYLFHKNKLKDLTWSQRVNIIKGVASALLY 467
Query: 459 LHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPEL 518
LHE+WEQVVLHRDIK +N+LLDADLNGKLGDFGLAR +D + T++VGT GYM PEL
Sbjct: 468 LHEEWEQVVLHRDIKASNILLDADLNGKLGDFGLARFHDRGVNLEATRVVGTIGYMAPEL 527
Query: 519 MRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSR 578
G +T TDVYAFG F+LEV GRRPV+ E V LV WV C K+ A+ D DS+
Sbjct: 528 TAMGVTTTCTDVYAFGAFILEVVCGRRPVDPDAPREQVILVKWVASCGKRDALTDTVDSK 587
Query: 579 LEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
L E + +L+LKLG+ CS PE RP+MRQ++Q
Sbjct: 588 LIDFKVE-EAKLLLKLGMLCSQINPENRPSMRQILQ 622
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LSR9|LRK18_ARATH L-type lectin-domain containing receptor kinase I.8 OS=Arabidopsis thaliana GN=LECRK18 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 612 bits (1578), Expect = e-174, Method: Compositional matrix adjust.
Identities = 319/602 (52%), Positives = 424/602 (70%), Gaps = 31/602 (5%)
Query: 24 AQDVNQFIYHGFNEDAQLQRDGLASVHSNGLLQLTNTVSPQQEGHAFYRLPIKFNTSSSE 83
+Q F ++GF + L DG+A + GLL+LT+T S Q++GHAF+R P+ FN SSE
Sbjct: 22 SQQETGFSFNGFRQ-GDLHVDGVAQILPGGLLRLTDT-SEQKKGHAFFRQPLVFN--SSE 77
Query: 84 SLSFSSNFVFAI----------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHI 133
LSFS++FV A+ G+AF +SPS DL A+A+ +YLGLFN + N ++HI
Sbjct: 78 PLSFSTHFVCAMVRKPGVTGGNGIAFFLSPSMDLTNADAT--QYLGLFNTTTNRSPSSHI 135
Query: 134 LAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGDPIQIW 193
AIELDTVQ+ +FDDID+NHVGIDVNSL S ESAPA+YFSD++G+NK++ L+ GD IQ+W
Sbjct: 136 FAIELDTVQSAEFDDIDNNHVGIDVNSLTSVESAPASYFSDKKGLNKSISLLSGDSIQVW 195
Query: 194 ISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLKSSHYVLG 253
+ +DG +LNV+LAP+ I KP++ L+SR++NLS ++ + M+VGFSA+TG L ++HY+LG
Sbjct: 196 VDFDGT--VLNVSLAPLGIRKPSQSLISRSMNLSEVIQDRMFVGFSAATGQLANNHYILG 253
Query: 254 WSFNRSGPAL-NLDISSLPRLPHLPRPRAKANDKPQLKLVISVSLIAILVVLITIGAAVY 312
WSF+RS +L +LDIS LP++PH P+ K + L L++ ++ +L+ Y
Sbjct: 254 WSFSRSKASLQSLDISKLPQVPH---PKMKTSLLLILLLIVLGIILLVLL------VGAY 304
Query: 313 IVRNKRYEEVYEDWEREYGPQRFTYKDLYKATKGFKDKDVIGRGGFGKVYRGVLASNVQI 372
+ R +Y EV E+WE+EYGP R++YK LYKATKGF +G+GGFG+VY+G L I
Sbjct: 305 LYRRNKYAEVREEWEKEYGPHRYSYKSLYKATKGFHKDGFLGKGGFGEVYKGTLPQE-DI 363
Query: 373 AVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKIL 432
AVK+ SH ++G+K+FVAE+ SMG L HRNLV L GYCRRKGEFLLV YMPNGSLD+ L
Sbjct: 364 AVKRFSHHGERGMKQFVAEIASMGCLDHRNLVPLFGYCRRKGEFLLVSKYMPNGSLDQFL 423
Query: 433 HTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGL 492
N +P L W +R I++G+AS L YLH + QVVLHRDIK +NV+LD D GKLGDFG+
Sbjct: 424 FHNREPSLTWSKRLGILKGIASALKYLHTEATQVVLHRDIKASNVMLDTDFTGKLGDFGM 483
Query: 493 ARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGS 552
AR +DH P TT VGT GYM PEL G AST TDVYAFG +LEV GRRPVE
Sbjct: 484 ARFHDHGANPTTTGAVGTVGYMGPELTSMG-ASTKTDVYAFGALILEVTCGRRPVEPNLP 542
Query: 553 METVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQV 612
+E LV WVCDCWK+ + A D +L G Q+E+VLKLGL C++ PE+RP+M +V
Sbjct: 543 IEKQLLVKWVCDCWKRKDLISARDPKLSGEL-IPQIEMVLKLGLLCTNLVPESRPDMVKV 601
Query: 613 MQ 614
+Q
Sbjct: 602 VQ 603
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M1G4|LRK15_ARATH Probable L-type lectin-domain containing receptor kinase I.5 OS=Arabidopsis thaliana GN=LECRK15 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 607 bits (1566), Expect = e-173, Method: Compositional matrix adjust.
Identities = 325/620 (52%), Positives = 431/620 (69%), Gaps = 32/620 (5%)
Query: 10 FCVLLCASF---IFSALAQDVNQFIYHGFNEDAQLQRDGLASVHSNGLLQLTNTVSPQQE 66
F + L +SF FS ++D + F+++GF + + L DG A++ NGLLQL S Q
Sbjct: 6 FLIWLISSFHLISFSTSSKDTS-FVFNGFGQ-SNLALDGSATLLPNGLLQLAKD-SQHQM 62
Query: 67 GHAFYRLPIKFNTSSSESLSFSSNFVFAI----------GMAFVISPSKDLGKAEASPSE 116
GHAF + PI F SSS+ LSFS++FV A+ G+ FVISP+ D +A+ P+
Sbjct: 63 GHAFIKKPIDF--SSSKPLSFSTHFVCALVPKPGFEGGHGITFVISPTVDFTRAQ--PTR 118
Query: 117 YLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDRE 176
Y+G+FNAS NG ++H+ A+ELDTV+N DF + ++NH+GIDVN+ IS ESAPA+YFS
Sbjct: 119 YMGIFNASTNGSPSSHLFAVELDTVRNPDFRETNNNHIGIDVNNPISVESAPASYFSKTA 178
Query: 177 GMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHIL-LETMY 235
N ++ L G PIQ+W+ Y G +LNV++AP+ KP+ PLLSR++NLS I ++
Sbjct: 179 QKNVSINLSSGKPIQVWVDYHG--NVLNVSVAPLEAEKPSLPLLSRSMNLSEIFSRRRLF 236
Query: 236 VGFSASTGSLKSSHYVLGWSF--NRSGPALNLDISSLPRLPHLPRPRAKANDKPQLKLVI 293
VGF+A+TG+ S HY+LGWSF NR L LD S +LP +PRPRA+ + K Q L+I
Sbjct: 237 VGFAAATGTSISYHYLLGWSFSTNRELSQL-LDFS---KLPQVPRPRAE-HKKVQFALII 291
Query: 294 SVSLIAILVVLITIGAAVYIVRNKRYEEVYEDWEREYGPQRFTYKDLYKATKGFKDKDVI 353
++ +I +VV+ + A VY R K+Y EV E WE++YG RF+YK LY ATKGF +
Sbjct: 292 ALPVILAIVVMAVL-AGVYYHRKKKYAEVSEPWEKKYGTHRFSYKSLYIATKGFHKDRFL 350
Query: 354 GRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRK 413
GRGGFG+VYRG L N +AVK+VSHD +QG+K+FVAE+VSM L+HRNLV L GYCRRK
Sbjct: 351 GRGGFGEVYRGDLPLNKTVAVKRVSHDGEQGMKQFVAEVVSMKSLKHRNLVPLLGYCRRK 410
Query: 414 GEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK 473
GE LLV +YMPNGSLD+ L + P L+W QRF I++G+AS L YLH + EQVVLHRDIK
Sbjct: 411 GELLLVSEYMPNGSLDQHLFDDQSPVLSWSQRFVILKGIASALFYLHTEAEQVVLHRDIK 470
Query: 474 PANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAF 533
+NV+LDA+LNG+LGDFG+AR +DH TT VGT GYM PEL+ G AST TDVYAF
Sbjct: 471 ASNVMLDAELNGRLGDFGMARFHDHGGNAATTAAVGTVGYMAPELITMG-ASTITDVYAF 529
Query: 534 GVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLK 593
GVF+LEVA GR+PVE +E L+ WVC+CWKK ++ DA D RL +++ELV+K
Sbjct: 530 GVFLLEVACGRKPVEFGVQVEKRFLIKWVCECWKKDSLLDAKDPRLGEEFVPEEVELVMK 589
Query: 594 LGLFCSHPKPEARPNMRQVM 613
LGL C++ PE+RP M QV+
Sbjct: 590 LGLLCTNIVPESRPAMGQVV 609
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIF0|LRK22_ARATH Putative L-type lectin-domain containing receptor kinase II.2 OS=Arabidopsis thaliana GN=LECRK22 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 599 bits (1544), Expect = e-170, Method: Compositional matrix adjust.
Identities = 323/650 (49%), Positives = 432/650 (66%), Gaps = 44/650 (6%)
Query: 1 MGAAPRSFCFCVLLCASFIFSALAQDVNQFIYHGFNEDAQLQRDGLASVHSNGLLQLTNT 60
M RS F +++C + LAQD ++F+YH F++ A L DG+AS+ +G L LTN
Sbjct: 1 MAGVLRSLRFWMIICVQVLSLVLAQDRDEFVYHDFSQ-ADLHLDGMASI-DDGRLHLTNN 58
Query: 61 VSPQQEGHAFYRLPIKFNTSSSESLSFSSNFVFAI--------GMAFVISPSKDLGKAEA 112
+ + GHAF+++P+ F TS S SLSFS+ FVFAI GMAFV++P D+ +
Sbjct: 59 TT-KSTGHAFWKIPMNFTTSPSSSLSFSTEFVFAIFPLLGDGQGMAFVVAPFMDI-RYSG 116
Query: 113 SPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYF 172
+ YLGLFN N+ ++ NHILA+ELDT + + + DNHVGID+NS+IS +SA A+YF
Sbjct: 117 DAASYLGLFNRKNDNKTENHILAVELDTNSSPEAIEDSDNHVGIDINSIISEDSANASYF 176
Query: 173 SDREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPT-----------KPLLS 221
S EG N + L I +WI Y+G EKLLNVT+AP+ PKP KPLLS
Sbjct: 177 SGTEGKNISFRLASEKSILVWIDYNGTEKLLNVTVAPVPTPKPALPYLSSSIKPRKPLLS 236
Query: 222 RAINLSHILLETMYVGFSASTGSLKSSHYVLGWSFNRSGPALNLDISSL----------- 270
R IN+S I TM+VGFS STG++KS Y+LGWSF + G A +LD+S +
Sbjct: 237 RFINISEIFNGTMFVGFSGSTGTVKSDQYILGWSFKKGGQAESLDLSKILDPPNRPPPPS 296
Query: 271 -----PRLPHLPRPRAKANDKPQLKLVISVSLIAILVVLITIGAAVYIVRNKRYEEVYED 325
P P P + K + + ++V+ IA L++L G +Y+ + K+Y EV E
Sbjct: 297 SPPPPPPPPPTPPTSRSKDSKNIIIICVTVTSIAFLLML---GGFLYLYKKKKYAEVLEH 353
Query: 326 WEREYGPQRFTYKDLYKATKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGI 385
WE EY PQR+++++LYKA +GF++ ++G GGFGKVY+G L S QIAVK+V H+++QG+
Sbjct: 354 WENEYSPQRYSFRNLYKAIRGFRENRLLGAGGFGKVYKGELPSGTQIAVKRVYHNAEQGM 413
Query: 386 KEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKIL-HTNIKPCLNWYQ 444
K++ AE+ SMGRLRH+NLV+L GYCRRKGE LLVYDYMPNGSLD L + N L W Q
Sbjct: 414 KQYAAEIASMGRLRHKNLVQLLGYCRRKGELLLVYDYMPNGSLDDYLFNKNKLKDLTWSQ 473
Query: 445 RFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT 504
R II+GVAS LLYLHE+WEQVVLHRDIK +N+LLDADLNG+LGDFGLAR +D Q
Sbjct: 474 RVNIIKGVASALLYLHEEWEQVVLHRDIKASNILLDADLNGRLGDFGLARFHDRGENLQA 533
Query: 505 TKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCD 564
T++VGT GYM PEL G A+T TD+YAFG F+LEV GRRPVE E ++L+ WV
Sbjct: 534 TRVVGTIGYMAPELTAMGVATTKTDIYAFGSFILEVVCGRRPVEPDRPPEQMHLLKWVAT 593
Query: 565 CWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
C K+ + D DS+L G + K+ +L+LKLG+ CS PE+RP+MR ++Q
Sbjct: 594 CGKRDTLMDVVDSKL-GDFKAKEAKLLLKLGMLCSQSNPESRPSMRHIIQ 642
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O04534|LRK51_ARATH Putative L-type lectin-domain containing receptor kinase V.1 OS=Arabidopsis thaliana GN=LECRK51 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 597 bits (1538), Expect = e-169, Method: Compositional matrix adjust.
Identities = 300/592 (50%), Positives = 408/592 (68%), Gaps = 19/592 (3%)
Query: 35 FNEDAQLQRDGLASVHSNGLLQLTNTVSPQQEGHAFYRLPIKFNTSSSESLS-FSSNFVF 93
FN + G A +++NGL++LTN+ +PQ G FY ++F S + ++S FS+ FVF
Sbjct: 28 FNTSGNMYTSGSAYINNNGLIRLTNS-TPQTTGQVFYNDQLRFKNSVNGTVSSFSTTFVF 86
Query: 94 AI----------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQN 143
+I G+AFVI P++DL + P+ YLGLFN SN G NHI+A+ELDT +
Sbjct: 87 SIEFHNGIYGGYGIAFVICPTRDL--SPTFPTTYLGLFNRSNMGDPKNHIVAVELDTKVD 144
Query: 144 LDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGDPIQIWISYDGAEKLL 203
F+D D NHVGID+N+L+S A A Y+ D G ++L L G P+QIWI YD +K +
Sbjct: 145 QQFEDKDANHVGIDINTLVSDTVALAGYYMD-NGTFRSLLLNSGQPMQIWIEYDSKQKQI 203
Query: 204 NVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLKSSHYVLGWSFNRSGPAL 263
NVTL P+ +PKP PLLS +LS LLE MYVGF+++TG L +SHY+LGW+F +G
Sbjct: 204 NVTLHPLYVPKPKIPLLSLEKDLSPYLLELMYVGFTSTTGDLTASHYILGWTFKMNGTTP 263
Query: 264 NLDISSLPRLPHLPRPRAKANDKPQLKLVISVSLIAILVVLITIGAAVYIVRNKRYEEVY 323
++D S LP++P +P ++ P L IS+++ +++++I + ++ K+ EV
Sbjct: 264 DIDPSRLPKIPRYNQPWIQS---PNGILTISLTVSGVIILIILSLSLWLFLKRKKLLEVL 320
Query: 324 EDWEREYGPQRFTYKDLYKATKGFKDKDVIGRGGFGKVYRGVL-ASNVQIAVKKVSHDSK 382
EDWE ++GP RF +KDL+ ATKGFKD +V+G+GGFGKVY+G L SNV+IAVK VSHDS+
Sbjct: 321 EDWEVQFGPHRFAFKDLHIATKGFKDTEVLGKGGFGKVYKGTLPVSNVEIAVKMVSHDSR 380
Query: 383 QGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNW 442
QG++EF+AE+ ++GRLRH NLV+L+GYCR KGE LVYD M GSLDK L+ L+W
Sbjct: 381 QGMREFIAEIATIGRLRHPNLVRLQGYCRHKGELYLVYDCMAKGSLDKFLYHQQTGNLDW 440
Query: 443 YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 502
QRF+II+ VASGL YLH+ W QV++HRDIKPAN+LLDA++N KLGDFGLA+L DH T P
Sbjct: 441 SQRFKIIKDVASGLYYLHQQWVQVIIHRDIKPANILLDANMNAKLGDFGLAKLCDHGTDP 500
Query: 503 QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWV 562
QT+ + GT GY+ PEL RTGKAST +DV+AFG+ MLE+A GR+P+ + S + L DWV
Sbjct: 501 QTSHVAGTLGYISPELSRTGKASTRSDVFAFGIVMLEIACGRKPILPRASQREMVLTDWV 560
Query: 563 CDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+CW+ I D ++ E+Q LVLKLGLFCSHP RPNM V+Q
Sbjct: 561 LECWENEDIMQVLDHKIGQEYVEEQAALVLKLGLFCSHPVAAIRPNMSSVIQ 612
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LSR8|LRK19_ARATH L-type lectin-domain containing receptor kinase I.9 OS=Arabidopsis thaliana GN=LECRK19 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 595 bits (1535), Expect = e-169, Method: Compositional matrix adjust.
Identities = 309/602 (51%), Positives = 414/602 (68%), Gaps = 27/602 (4%)
Query: 25 QDVNQFIYHGFNEDAQLQRDGLASVHSNGLLQLTNTVSPQQEGHAFYRLPIKFNTSSSES 84
Q F+Y F + L D A V +GLLQLTN S Q GHAF++ PI+F SSS
Sbjct: 22 QQETSFVYESFLDRQNLYLDKSAIVLPSGLLQLTNA-SEHQMGHAFHKKPIEF--SSSGP 78
Query: 85 LSFSSNFVFAI----------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHIL 134
LSFS++FV A+ G+ FV+SPS D AE++ YLG+FNAS NG S+ H+L
Sbjct: 79 LSFSTHFVCALVPKPGFEGGHGIVFVLSPSMDFTHAEST--RYLGIFNASTNGSSSYHVL 136
Query: 135 AIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGDPIQIWI 194
A+ELDT+ N DF DID NHVGIDVNS IS A A+Y+SD +G N+++ L+ G+PIQ+W+
Sbjct: 137 AVELDTIWNPDFKDIDHNHVGIDVNSPISVAIASASYYSDMKGSNESINLLSGNPIQVWV 196
Query: 195 SYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHIL--LETMYVGFSASTGSLKSSHYVL 252
Y+G LLNV++AP+ + KPT+PLLS INL+ + +++ GFSA+TG+ S Y+L
Sbjct: 197 DYEGT--LLNVSVAPLEVQKPTRPLLSHPINLTELFPNRSSLFAGFSAATGTAISDQYIL 254
Query: 253 GWSFN-RSGPALNLDISSLPRLPHLPRPRAKANDKPQLKLVISVSLIAILVVLITIGAAV 311
WSF+ G LDIS LP +PH PRA L +++ V L AILV+ + G +
Sbjct: 255 WWSFSIDRGSLQRLDISKLPEVPH---PRAPHKKVSTLIILLPVCL-AILVLAVLAG--L 308
Query: 312 YIVRNKRYEEVYEDWEREYGPQRFTYKDLYKATKGFKDKDVIGRGGFGKVYRGVLASNVQ 371
Y R ++Y EV E WE+E+ RF+Y+ L+KATKGF + +G+GGFG+VYRG L +
Sbjct: 309 YFRRRRKYSEVSETWEKEFDAHRFSYRSLFKATKGFSKDEFLGKGGFGEVYRGNLPQGRE 368
Query: 372 IAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKI 431
IAVK+VSH+ +G+K+FVAE+VSM L+HRNLV L GYCRRK E LLV +YMPNGSLD+
Sbjct: 369 IAVKRVSHNGDEGVKQFVAEVVSMRCLKHRNLVPLFGYCRRKRELLLVSEYMPNGSLDEH 428
Query: 432 LHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFG 491
L + KP L+W QR +++G+AS L YLH +QVVLHRD+K +N++LDA+ +G+LGDFG
Sbjct: 429 LFDDQKPVLSWSQRLVVVKGIASALWYLHTGADQVVLHRDVKASNIMLDAEFHGRLGDFG 488
Query: 492 LARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQG 551
+AR ++H TT VGT GYM PEL+ G AST TDVYAFGVFMLEV GRRPVE Q
Sbjct: 489 MARFHEHGGNAATTAAVGTVGYMAPELITMG-ASTGTDVYAFGVFMLEVTCGRRPVEPQL 547
Query: 552 SMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQ 611
+E +++ WVC+CWKK ++ DA+D RL G +++E+V+KLGL CS+ PE+RP M Q
Sbjct: 548 QVEKRHMIKWVCECWKKDSLLDATDPRLGGKFVAEEVEMVMKLGLLCSNIVPESRPTMEQ 607
Query: 612 VM 613
V+
Sbjct: 608 VV 609
|
May be involved in protein-protein interactions with RGD motif-containing proteins as potential ligands. Plays probably a structural and signaling role at the plant cell surfaces. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81291|LRK44_ARATH L-type lectin-domain containing receptor kinase IV.4 OS=Arabidopsis thaliana GN=LECRK44 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 593 bits (1530), Expect = e-168, Method: Compositional matrix adjust.
Identities = 313/622 (50%), Positives = 431/622 (69%), Gaps = 29/622 (4%)
Query: 12 VLLCASFIFSAL--AQDVNQFIYHGFNED-AQLQRDGLASVHSNGLLQLTNTVSPQQEGH 68
+ SF + +L + + F Y+GF + G+A++ NGLL+LTNT + Q GH
Sbjct: 8 TIFFLSFFWQSLKSSSQIIDFTYNGFRPPPTDISILGIATITPNGLLKLTNT-TMQSTGH 66
Query: 69 AFYRLPIKFNTSSSESLS-FSSNFVFAI--------GMAFVISPSKDLGKAEASPSEYLG 119
AFY PI+F S + ++S FS+ FVFAI GMAFVI+P+ L SP +YLG
Sbjct: 67 AFYTKPIRFKDSPNGTVSSFSTTFVFAIHSQIPIAHGMAFVIAPNPRL--PFGSPLQYLG 124
Query: 120 LFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMN 179
LFN +NNG NH+ A+ELDT+ N++F+D ++NHVGID+NSL S +S+PA Y+ + + +
Sbjct: 125 LFNVTNNGNVRNHVFAVELDTIMNIEFNDTNNNHVGIDINSLNSVKSSPAGYWDENDQFH 184
Query: 180 KTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFS 239
L LI +Q+W+ +DG L++VT+AP KP KPL+S +LS +LL+ M+VGFS
Sbjct: 185 N-LTLISSKRMQVWVDFDGPTHLIDVTMAPFGEVKPRKPLVSIVRDLSSVLLQDMFVGFS 243
Query: 240 ASTGSLKSSHYVLGWSFNRSGPALNLDISSLPRLPHLP-RP----RAKANDKPQLKLVIS 294
++TG++ S +VLGWSF +G A L +S LPRLP +P R N P + L++
Sbjct: 244 SATGNIVSEIFVLGWSFGVNGEAQPLALSKLPRLPVWDLKPTRVYRFYKNWVPLISLLLI 303
Query: 295 VSLIAILVVLITIGAAVYIVRNKRYEEVYEDWEREYGPQRFTYKDLYKATKGFKDKDVIG 354
L+ I +V + R +++ E EDWE E+G R +KDLY ATKGFKDK+++G
Sbjct: 304 PFLLIIFLVRFIMK------RRRKFAEEVEDWETEFGKNRLRFKDLYYATKGFKDKNILG 357
Query: 355 RGGFGKVYRGVL-ASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRK 413
GGFG VY+G++ + +IAVK+VS++S+QG+KEFVAE+VS+G++ HRNLV L GYCRR+
Sbjct: 358 SGGFGSVYKGIMPKTKKEIAVKRVSNESRQGLKEFVAEIVSIGQMSHRNLVPLVGYCRRR 417
Query: 414 GEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK 473
E LLVYDYMPNGSLDK L+ + + L+W QRF++I GVAS L YLHE+WEQVV+HRD+K
Sbjct: 418 DELLLVYDYMPNGSLDKYLYNSPEVTLDWKQRFKVINGVASALFYLHEEWEQVVIHRDVK 477
Query: 474 PANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAF 533
+NVLLDA+LNG+LGDFGLA+L DH + PQTT++VGT+GY+ P+ +RTG+A+T+TDV+AF
Sbjct: 478 ASNVLLDAELNGRLGDFGLAQLCDHGSDPQTTRVVGTWGYLAPDHIRTGRATTTTDVFAF 537
Query: 534 GVFMLEVASGRRPVE-QQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVL 592
GV +LEVA GRRP+E S E V LVDWV W + I DA D L ++K++E+VL
Sbjct: 538 GVLLLEVACGRRPIEINNQSGERVVLVDWVFRFWMEANILDAKDPNLGSEYDQKEVEMVL 597
Query: 593 KLGLFCSHPKPEARPNMRQVMQ 614
KLGL CSH P ARP MRQV+Q
Sbjct: 598 KLGLLCSHSDPLARPTMRQVLQ 619
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 614 | ||||||
| 225434861 | 675 | PREDICTED: L-type lectin-domain containi | 0.983 | 0.894 | 0.614 | 0.0 | |
| 224106419 | 607 | predicted protein [Populus trichocarpa] | 0.947 | 0.958 | 0.607 | 0.0 | |
| 255559006 | 667 | kinase, putative [Ricinus communis] gi|2 | 0.970 | 0.893 | 0.603 | 0.0 | |
| 224106425 | 674 | predicted protein [Populus trichocarpa] | 0.982 | 0.894 | 0.621 | 0.0 | |
| 224106407 | 675 | predicted protein [Populus trichocarpa] | 0.983 | 0.894 | 0.585 | 0.0 | |
| 255559000 | 670 | kinase, putative [Ricinus communis] gi|2 | 0.967 | 0.886 | 0.598 | 0.0 | |
| 255558978 | 662 | kinase, putative [Ricinus communis] gi|2 | 0.964 | 0.894 | 0.582 | 0.0 | |
| 224059452 | 599 | predicted protein [Populus trichocarpa] | 0.934 | 0.958 | 0.624 | 0.0 | |
| 359481749 | 1258 | PREDICTED: L-type lectin-domain containi | 0.942 | 0.460 | 0.575 | 0.0 | |
| 255559002 | 667 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.925 | 0.851 | 0.571 | 0.0 |
| >gi|225434861|ref|XP_002280641.1| PREDICTED: L-type lectin-domain containing receptor kinase IV.2 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 756 bits (1953), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/627 (61%), Positives = 475/627 (75%), Gaps = 23/627 (3%)
Query: 1 MGAAPRSFCFCVLLCASFIFSALAQDVNQFIYHGFNEDAQLQRDGLASVHSNGLLQLTNT 60
M S F ++L S ALA++ QFI++GF + A L G+A +H NGLLQLTNT
Sbjct: 1 MATTVTSLHFLIILFTSVKLLALAEEEAQFIHNGF-QGASLHLGGIAKIHPNGLLQLTNT 59
Query: 61 VSPQQEGHAFYRLPIKFNTSS--SESLSFSSNFVFAI----------GMAFVISPSKDLG 108
S QQ G AF+ LP+KFNTSS S SLSFS+ F FAI G+ F I+PS D
Sbjct: 60 -SKQQIGRAFFPLPLKFNTSSGDSRSLSFSTIFAFAIVPEWQALGGHGIVFTIAPSMDFP 118
Query: 109 KAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAP 168
A AS +YLGLFN +NNG S+NH+ A+ELDT+ + D D D NHVG+DVNSL S SAP
Sbjct: 119 GAVAS--QYLGLFNVTNNGNSSNHVFAVELDTILSPDLKDTDGNHVGVDVNSLDSEVSAP 176
Query: 169 AAYFSDREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSH 228
YFS++EG NK+LELI G +Q+WI YD +KL+NVT+AP+ PKP+ PLLS INLS
Sbjct: 177 VTYFSNKEGKNKSLELISGKAMQVWIDYDDVQKLINVTVAPLKSPKPSMPLLSTPINLSS 236
Query: 229 ILLETMYVGFSASTGSLKSSHYVLGWSFNRSGPALNLDISSLPRLPHLPRPRAKANDKPQ 288
I LE+MYVGFS++TG++ S HY+LGWSFNRSG A +L+IS LP LP PR K ++
Sbjct: 237 IFLESMYVGFSSATGAMASDHYILGWSFNRSGEAQSLEISELPSLP----PRKK--ERKT 290
Query: 289 LKLVISVSLIAILVVLITIGAAVYIVRNKRYEEVYEDWEREYGPQRFTYKDLYKATKGFK 348
L +++ +SL +++VL+ + A YI+R ++EE+ E+WE EYGPQRF+YKDLYKATKGFK
Sbjct: 291 LVVIVLLSLTTLVIVLVVLMGAGYIIRKLKFEELREEWEGEYGPQRFSYKDLYKATKGFK 350
Query: 349 DKDVIGRGGFGKVYRGVL-ASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLR 407
DK+++G GGFGKVYRG L +SN++IAVKKVSHDSKQG++EFVAE+ SMGRLRHRNLV+L
Sbjct: 351 DKELLGAGGFGKVYRGRLPSSNLEIAVKKVSHDSKQGMREFVAEIASMGRLRHRNLVQLL 410
Query: 408 GYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVV 467
GYCRR+GE LLVYD+MPNGSLDK L ++ P L W QR+ I+RGVAS LLYLHE+WEQVV
Sbjct: 411 GYCRRRGELLLVYDHMPNGSLDKFLFSDENPILTWPQRYHILRGVASSLLYLHEEWEQVV 470
Query: 468 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTS 527
LHRD+K +NVLLDA+LNG+LGDFGLA+LYDHDT PQTT +VGT GY+ PEL RTGKA++S
Sbjct: 471 LHRDVKASNVLLDANLNGRLGDFGLAKLYDHDTNPQTTHVVGTVGYLAPELTRTGKATSS 530
Query: 528 TDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQ 587
TDV+AFG FMLE A GRRPVE QG E L+DWV +CWK+GAI SD RLEG ++
Sbjct: 531 TDVFAFGAFMLETACGRRPVELQGYPEGGVLLDWVLECWKRGAILLTSDPRLEGHYVAEE 590
Query: 588 MELVLKLGLFCSHPKPEARPNMRQVMQ 614
MELVLKLGL CS P P RP+MRQVMQ
Sbjct: 591 MELVLKLGLLCSSPIPAVRPSMRQVMQ 617
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224106419|ref|XP_002314159.1| predicted protein [Populus trichocarpa] gi|222850567|gb|EEE88114.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 751 bits (1939), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 368/606 (60%), Positives = 464/606 (76%), Gaps = 24/606 (3%)
Query: 23 LAQDVNQFIYHGFNEDAQLQRDGLASVHSNGLLQLTNTVSPQQEGHAFYRLPIKFNTS-- 80
LAQ+ NQFIYHGF A L +A +H NGLL+LTNT S QQ G AF+ P +FNTS
Sbjct: 1 LAQEENQFIYHGFT-GANLLLSEIAKIHPNGLLELTNT-SKQQIGRAFFPFPFQFNTSLF 58
Query: 81 -SSESLSFSSNFVFAI----------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQS 129
+S SLSFS+ F F++ GMAF ISPS D A A+ +Y G+ N++++G
Sbjct: 59 NNSRSLSFSTQFAFSMVPELPTLGGQGMAFAISPSVDFTGAVAA--QYFGILNSTSDGLP 116
Query: 130 TNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGDP 189
+NH+LA+ELDTVQ+ D DI+++HVGIDVNSLIS ESAP YFSD E NK+L LI G
Sbjct: 117 SNHLLAVELDTVQSQDLKDINESHVGIDVNSLISIESAPVTYFSDEEKENKSLTLISGHA 176
Query: 190 IQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLKSSH 249
+ +WI YD E LLNVT+AP++ KPT PLLS ++LS ++L +MYVGFS+STG++ S++
Sbjct: 177 MHVWIDYDEVEMLLNVTVAPVTRTKPTLPLLSTPLDLSSVMLNSMYVGFSSSTGAMASNN 236
Query: 250 YVLGWSFNRSGPALNLDISSLPRLPHLPRPRAKANDKPQLKLVISVSLIAILVVLITIGA 309
Y+LGWSFNR G A +LD+S LP LP R K+ KPQL++V+ I +++L+ I
Sbjct: 237 YILGWSFNRGGQAQSLDVSKLPTLP----TRRKSRKKPQLRIVVPT--ITAIILLVAISG 290
Query: 310 AVYIVRNKRYEEVYEDWEREYGPQRFTYKDLYKATKGFKDKDVIGRGGFGKVYRGVL-AS 368
V+I+R K+YEE+ EDWE+EYGPQR +YKDLYKATKGF DK+++G GGFGKVYRGVL +S
Sbjct: 291 DVFIIRRKKYEELREDWEQEYGPQRISYKDLYKATKGFTDKELLGCGGFGKVYRGVLPSS 350
Query: 369 NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSL 428
N+Q+AVKKVSHDS+QG KEFVAE+VSMGRLRHRNLV+L GYCRRKGE LLVYDYMPNGSL
Sbjct: 351 NMQVAVKKVSHDSRQGTKEFVAEIVSMGRLRHRNLVQLFGYCRRKGELLLVYDYMPNGSL 410
Query: 429 DKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLG 488
DK+L N P LNW +R++IIRGVAS LLYLHE+WEQVVLHRD+K +NVLLDADLNG+LG
Sbjct: 411 DKLLFRNETPSLNWGRRYQIIRGVASALLYLHEEWEQVVLHRDVKASNVLLDADLNGRLG 470
Query: 489 DFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVE 548
DFGLA+ +DH + PQTTK+VGT GY+ PE+ RTGK++T +DV++FG FMLEVA GR+PVE
Sbjct: 471 DFGLAKFHDHGSTPQTTKVVGTVGYLAPEITRTGKSTTCSDVFSFGTFMLEVACGRKPVE 530
Query: 549 QQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPN 608
+ E V LVDWV +CW +GAI D R+EG E++ME+VLKLGL C+H P ARP+
Sbjct: 531 SERPPEEVVLVDWVLECWNRGAILGTVDPRIEGNHVEEEMEVVLKLGLLCTHRTPAARPS 590
Query: 609 MRQVMQ 614
MRQ +Q
Sbjct: 591 MRQTVQ 596
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255559006|ref|XP_002520526.1| kinase, putative [Ricinus communis] gi|223540368|gb|EEF41939.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 748 bits (1932), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 378/626 (60%), Positives = 474/626 (75%), Gaps = 30/626 (4%)
Query: 8 FCFCVLLCASFIFS---ALAQDVNQFIYHGFNEDAQLQRDGLASVHSNGLLQLTNTVSPQ 64
F +L F+ S A AQ+ +QFIY+GFN A L +G A++H NGLL+LTNT S Q
Sbjct: 5 FISLSILFTLFVHSKPLAFAQEADQFIYNGFN-GANLSLNGAANIHPNGLLELTNT-SHQ 62
Query: 65 QEGHAFYRLPIKFNTSSSES-----LSFSSNFVFAI----------GMAFVISPSKDLGK 109
Q GHAF+ P+ FN+S S + +SFS+NFVFA+ G+AF ISPS +
Sbjct: 63 QIGHAFFPFPLHFNSSLSNNSRTSLVSFSTNFVFAMVPESPGLDGHGLAFAISPSLEFKG 122
Query: 110 AEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPA 169
A A+ +YLGLFN++ G S+NH+LAIELDTV+N +F DID NHVG+DVN+L S +S A
Sbjct: 123 AIAT--QYLGLFNSTTIGLSSNHLLAIELDTVKNPEFGDIDGNHVGVDVNNLTSIQSVSA 180
Query: 170 AYFSDREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHI 229
+YFS+ E NK+LEL G P+Q+WI YD EKLLNVTLAP+ KP KPLLS I+LS +
Sbjct: 181 SYFSETEEKNKSLELTSGRPMQMWIDYDEMEKLLNVTLAPIERMKPEKPLLSTNIDLSAL 240
Query: 230 LLETMYVGFSASTGSLKSSHYVLGWSFNRSGPALNLDISSLPRLPHLPRPRAKANDKPQL 289
LLE+MYVGFSASTGS+ S+HY+LGWSFNRSG A +LD S LP LP + R K L
Sbjct: 241 LLESMYVGFSASTGSVSSNHYILGWSFNRSGQAQSLDPSKLPSLPQERKSRGK------L 294
Query: 290 KLVISVSLIAILVVLITIGAAVYIVRNKRYEEVYEDWEREYGPQRFTYKDLYKATKGFKD 349
+ I + L+ ++V+L+TI A +YI+R KRYEE+ EDWE++YGPQRF+YKDLYKATKGFKD
Sbjct: 295 AMKIMLPLVIVIVLLMTISATIYIMR-KRYEEIREDWEQQYGPQRFSYKDLYKATKGFKD 353
Query: 350 KDVIGRGGFGKVYRGVL-ASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRG 408
K+++G GGFGKVYRG L +SNV++AVKKVSHDS+QG+KEFVAE+ SMGRLRHRNLV+L G
Sbjct: 354 KELLGCGGFGKVYRGTLPSSNVEVAVKKVSHDSRQGMKEFVAEIASMGRLRHRNLVQLLG 413
Query: 409 YCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVL 468
YCRRKGE LVYD+MPNGSLDK L +N KP ++W +R++II+GVAS L YLHE+WEQVVL
Sbjct: 414 YCRRKGELFLVYDHMPNGSLDKFLFSNEKPNIDWVRRYQIIKGVASALYYLHEEWEQVVL 473
Query: 469 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTST 528
HRD+K +NVLLDADLNG+LGDFGLA+LYDH + PQTT +VGT GY+ PEL TGKA+TS+
Sbjct: 474 HRDVKASNVLLDADLNGRLGDFGLAKLYDHGSTPQTTHVVGTLGYLAPELTTTGKATTSS 533
Query: 529 DVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQM 588
DV+AFG+FMLEVA GR+PV+ + E V LVDWV +CW++G I D RLE ++
Sbjct: 534 DVFAFGIFMLEVACGRKPVKSERPPEEVILVDWVLECWERGNILGTIDPRLEDSYVAEET 593
Query: 589 ELVLKLGLFCSHPKPEARPNMRQVMQ 614
ELVLKLGL + P ARP +RQVMQ
Sbjct: 594 ELVLKLGLLSTQRIPTARPTIRQVMQ 619
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224106425|ref|XP_002314160.1| predicted protein [Populus trichocarpa] gi|222850568|gb|EEE88115.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 745 bits (1923), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 390/628 (62%), Positives = 478/628 (76%), Gaps = 25/628 (3%)
Query: 1 MGAAPRSFCFCVLLCASFIFSALAQDVNQFIYHGFNEDAQLQRDGLASVHSNGLLQLTNT 60
M A RS F + L S ALAQ+VNQFIYHGF A L +G+AS+H NGLL+LTNT
Sbjct: 1 MEALLRSLHFLLALFISLKHLALAQEVNQFIYHGFT-GANLSLNGIASIHPNGLLELTNT 59
Query: 61 VSPQQEGHAFYRLPIKFNTS---SSESLSFSSNFVFAI----------GMAFVISPSKDL 107
S QQ GHAF+ P F +S +S SLSFS+NFVFA+ G+A ISPS +
Sbjct: 60 -SKQQIGHAFFPFPFHFKSSFPNNSRSLSFSTNFVFAMVPETPTRGGHGIALAISPSTEF 118
Query: 108 GKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESA 167
A A+ +YLGLFN++ G S+NH+LAIELD V++ +F DI DNHVGIDVN+L S +SA
Sbjct: 119 KGATAT--QYLGLFNSTTVGLSSNHLLAIELDAVRSPEFRDIGDNHVGIDVNNLTSIQSA 176
Query: 168 PAAYFSDREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLS 227
PA+YFS E N++L+LI GDP+Q+WI YD E LLNVTLAP+SI KP KPLLS INLS
Sbjct: 177 PASYFSKHERENESLQLISGDPMQVWIDYDEMENLLNVTLAPVSIMKPQKPLLSTPINLS 236
Query: 228 HILLETMYVGFSASTGSLKSSHYVLGWSFNRSGPALNLDISSLPRLPHLPRPRAKANDKP 287
++LE+MYVGFS+STGS+ S HY+LGWSFN+SG A +LD S LP LP P + +KP
Sbjct: 237 LVVLESMYVGFSSSTGSVSSHHYILGWSFNKSGQAQSLDTSKLPSLP----PERNSTNKP 292
Query: 288 QLKLVISVSLIAILVVLITIGAAVYIVRNKRYEEVYEDWEREYGPQRFTYKDLYKATKGF 347
L+++I LI + V+LI A +YI+R KRYEEV+EDWE++YGPQRF YKDLYKATKGF
Sbjct: 293 YLRIMIP--LITVSVLLIASFATMYIMR-KRYEEVHEDWEQQYGPQRFRYKDLYKATKGF 349
Query: 348 KDKDVIGRGGFGKVYRGVL-ASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKL 406
K K ++G GGFG+VYRG L +S V+IAVKK++HDS QG+KEFVAE+ +MGRLRHRNLV+L
Sbjct: 350 KVKGLLGYGGFGRVYRGELRSSKVEIAVKKITHDSNQGMKEFVAEIATMGRLRHRNLVQL 409
Query: 407 RGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQV 466
GYCRRKGE LLVYDYMPNGSLDK L +KP LNW QR++IIRGVAS LLYLHE+WEQV
Sbjct: 410 LGYCRRKGELLLVYDYMPNGSLDKFLFCKVKPNLNWAQRYQIIRGVASALLYLHEEWEQV 469
Query: 467 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKAST 526
VLHRD+K +NVLLDADLNG+LGDFGLA+ +DH + PQTT +VGT GY+ PE+ RTGK++T
Sbjct: 470 VLHRDVKASNVLLDADLNGRLGDFGLAKFHDHGSTPQTTNVVGTVGYLAPEITRTGKSTT 529
Query: 527 STDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEK 586
+DV++FG FMLEVA GR+PVE + E V LVDWV +CWK+GAI D R EG E+
Sbjct: 530 CSDVFSFGTFMLEVACGRKPVESERPPEEVVLVDWVLECWKRGAILGTVDPRFEGNHVEE 589
Query: 587 QMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+MELVLKLGL C+H P ARP+MRQ MQ
Sbjct: 590 EMELVLKLGLLCTHRTPAARPSMRQAMQ 617
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224106407|ref|XP_002314156.1| predicted protein [Populus trichocarpa] gi|222850564|gb|EEE88111.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 737 bits (1902), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 368/628 (58%), Positives = 461/628 (73%), Gaps = 24/628 (3%)
Query: 1 MGAAPRSFCFCVLLCASFIFSALAQDVNQFIYHGFNEDAQLQRDGLASVHSNGLLQLTNT 60
M A+ ++ F + L S ALAQ+ N FIYHGF A L +A +H NGLL+LTNT
Sbjct: 1 MIASFKTLHFLLGLFVSLKLLALAQEENHFIYHGFT-GANLLLSEIAKIHPNGLLELTNT 59
Query: 61 VSPQQEGHAFYRLPIKFNTS---SSESLSFSSNFVFAI----------GMAFVISPSKDL 107
PQ G AF P +FNTS +S SLSFS+ F FA+ GMAF ISPS D
Sbjct: 60 SKPQI-GRAFLPFPFQFNTSLFNNSRSLSFSTQFAFAMVPELPTHGGQGMAFTISPSVDF 118
Query: 108 GKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESA 167
A A+ +Y G+ N++ +G +NH+LA+ELDTVQ+ D DI+++HVGID+NSLIS ESA
Sbjct: 119 TGAVAA--QYFGILNSTTDGLPSNHLLAVELDTVQSQDLKDINESHVGIDLNSLISIESA 176
Query: 168 PAAYFSDREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLS 227
P YFSD E NK+L LI G + +WI YD EKLLNVT+AP++ KPT PLLS+ ++LS
Sbjct: 177 PVTYFSDEENENKSLTLISGHVMHVWIDYDEVEKLLNVTVAPITRTKPTLPLLSKPLDLS 236
Query: 228 HILLETMYVGFSASTGSLKSSHYVLGWSFNRSGPALNLDISSLPRLPHLPRPRAKANDKP 287
++L++MYVGFSASTG++ SSHY+LGWSFNR G A +LD+S LP LP P+ K+ KP
Sbjct: 237 SVMLDSMYVGFSASTGAVASSHYILGWSFNRGGQAQSLDVSKLPSLP----PQRKSRKKP 292
Query: 288 QLKLVISVSLIAILVVLITIGAAVYIVRNKRYEEVYEDWEREYGPQRFTYKDLYKATKGF 347
L +I V I +++L+ I A I+R K+YEE+ EDWE+EYGPQRF+YKDLYKAT GF
Sbjct: 293 YL--IILVPTITAIILLVAISGAASIIRRKKYEELREDWEQEYGPQRFSYKDLYKATTGF 350
Query: 348 KDKDVIGRGGFGKVYRGVL-ASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKL 406
D+ ++G GGFGKVYRGVL +SN+Q+A+KKVSHDSKQG K+FVAE+ SMGRLRHRNLV+L
Sbjct: 351 TDRKLLGSGGFGKVYRGVLPSSNMQVAIKKVSHDSKQGTKQFVAEIASMGRLRHRNLVQL 410
Query: 407 RGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQV 466
GYCRRKGE LLVYDYMPNGSLDK+L N P LNW QR++++RGVAS LLYLHE+WEQV
Sbjct: 411 LGYCRRKGELLLVYDYMPNGSLDKLLFRNDTPSLNWVQRYQVLRGVASALLYLHEEWEQV 470
Query: 467 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKAST 526
VLHRD+K +N+LLD D NG+LGDFGLA+ YD PQTT +VGT GY+ PE+ RTG+A+T
Sbjct: 471 VLHRDVKASNILLDDDFNGRLGDFGLAKFYDRGANPQTTCVVGTVGYIAPEVTRTGRATT 530
Query: 527 STDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEK 586
S+DV+AFG FMLE+A GR+P+E + S E + LVDWV D WK G I D RLEG +
Sbjct: 531 SSDVFAFGTFMLEMACGRKPLEPEQSAEKMILVDWVLDSWKIGDILRTGDPRLEGNYVVE 590
Query: 587 QMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+MELVLKLGL C P ARP+MRQ+ Q
Sbjct: 591 EMELVLKLGLLCCFSTPHARPSMRQIGQ 618
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255559000|ref|XP_002520523.1| kinase, putative [Ricinus communis] gi|223540365|gb|EEF41936.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 736 bits (1899), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 372/622 (59%), Positives = 466/622 (74%), Gaps = 28/622 (4%)
Query: 8 FCFCVLLCASFI-FSALAQDVNQFIYHGFNEDAQLQRDGLASVHSNGLLQLTNTVSPQQE 66
VLL + F+ S AQD NQFIYHGFNE + L +G+A +H NGLL+LTN +S Q
Sbjct: 7 LLLIVLLNSVFLKHSGFAQDRNQFIYHGFNE-SNLNLNGIAKIHPNGLLELTN-ISYYQI 64
Query: 67 GHAFYRLPIKFNTSS---SESLSFSSNFVFAI----------GMAFVISPSKDLGKAEAS 113
G AF+ P+KF+ SS +ESLSFS++FVFAI G+ F ISP+ + A
Sbjct: 65 GRAFFPFPLKFDKSSPKNAESLSFSTSFVFAIDPEIPTLGGHGLVFTISPTVEFIGALGI 124
Query: 114 PSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFS 173
+YLGLFN+S NG+ +NH+ A+ELDT+ DF DI+DNHVGIDVN LIS+ SA A YFS
Sbjct: 125 --QYLGLFNSSTNGRDSNHVFAVELDTIWTPDFRDINDNHVGIDVNGLISNASASATYFS 182
Query: 174 DREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLET 233
D + NK+LELI P+Q+WI YD EKLLNVTLAP++ KP KPLLS I+LS +LL++
Sbjct: 183 DNQ--NKSLELISRSPMQVWIDYDAVEKLLNVTLAPITSKKPEKPLLSTTIDLSIVLLDS 240
Query: 234 MYVGFSASTGSLKSSHYVLGWSFNRSGPALNLDISSLPRLPHLPRPRAKANDKPQLKLVI 293
MYVGFS+STGS+ S HY+LGWSFNRSGPA +LD+S LP LP P+ K N L I
Sbjct: 241 MYVGFSSSTGSMASYHYILGWSFNRSGPAQSLDMSKLPSLPPKPKSGKKPN------LRI 294
Query: 294 SVSLIAILVVLITIGAAVYIVRNKRYEEVYEDWEREYGPQRFTYKDLYKATKGFKDKDVI 353
+ LI +VLITI AVYI R K+YEE++EDWE+EYGPQRF+Y+DLY+ATKGF+DK+++
Sbjct: 295 MIPLITASIVLITIFGAVYIKR-KKYEELHEDWEQEYGPQRFSYRDLYRATKGFQDKELL 353
Query: 354 GRGGFGKVYRGVL-ASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRR 412
G GGFGKVY+GVL +SN Q+AVK+ SH S+QG+KEFVAE+ SMGRLRHRNLV+L GYCRR
Sbjct: 354 GSGGFGKVYKGVLPSSNTQVAVKQFSHGSQQGMKEFVAEIASMGRLRHRNLVQLLGYCRR 413
Query: 413 KGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 472
K E LLVYDYMPNGSLD+ L N LNW QR +I++GVAS LLYLHE+W+QVVLHRD+
Sbjct: 414 KRELLLVYDYMPNGSLDRFLFQNDTLNLNWVQRLQILKGVASALLYLHEEWDQVVLHRDV 473
Query: 473 KPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYA 532
K +NV+LDA+L G+LGDFGLA+ YDH ++PQTT++VGT GY+ PE+ RTG+ +TS+DV+A
Sbjct: 474 KASNVMLDAELKGRLGDFGLAKFYDHGSLPQTTRVVGTIGYLAPEISRTGRFTTSSDVFA 533
Query: 533 FGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVL 592
FG +LEVA GR+ +E + V LVDWV +CWKKG I D SD L+G ++ME VL
Sbjct: 534 FGTLILEVACGRKTIEPERPPREVILVDWVLECWKKGVILDTSDPELQGKYMAEEMEFVL 593
Query: 593 KLGLFCSHPKPEARPNMRQVMQ 614
KLGL C+HP P RP MRQVMQ
Sbjct: 594 KLGLLCAHPAPAVRPTMRQVMQ 615
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255558978|ref|XP_002520512.1| kinase, putative [Ricinus communis] gi|223540354|gb|EEF41925.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 736 bits (1899), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 359/616 (58%), Positives = 464/616 (75%), Gaps = 24/616 (3%)
Query: 14 LCASFIFSALAQDVNQFIYHGFNEDAQLQRDGLASVHSNGLLQLTNTVSPQQEGHAFYRL 73
L S A AQ++NQFIY+GF + A L G+A++H NGLL+LTNT S Q G AF+ L
Sbjct: 10 LFVSLKLLASAQEINQFIYNGF-QGANLSLSGIATIHPNGLLELTNT-SYQMIGRAFFPL 67
Query: 74 PIKFNTSSS----ESLSFSSNFVFAI----------GMAFVISPSKDLGKAEASPSEYLG 119
P +FNTSSS +LSFS+NFVFA+ G+AF ISPSK + A+ +YLG
Sbjct: 68 PFRFNTSSSNNFQSALSFSTNFVFAMVPELPTHGGHGIAFAISPSKLCVGSMAT--QYLG 125
Query: 120 LFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMN 179
L N++ +G S+NH+ A+ELD+ ++ D +D++ NHVGID+NSL S+ESAP Y+ D+EG N
Sbjct: 126 LLNSTTDGLSSNHLFAVELDSAKSPDLEDMNANHVGIDINSLKSNESAPVTYYLDKEGRN 185
Query: 180 KTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFS 239
+TLEL GDP+Q+WI Y EKLLNVT+AP+ + KP++PLLS+++NLS +LLE+MYVGFS
Sbjct: 186 QTLELNSGDPMQVWIDYKEEEKLLNVTVAPIGVSKPSRPLLSKSLNLSQVLLESMYVGFS 245
Query: 240 ASTGSLKSSHYVLGWSFNRSGPALNLDISSLPRLPHLPRPRAKANDKPQLKLVISVSLIA 299
A+TGS+ S HY+LGWSFN+SG + LD S LP LP L + R K L+L+I +++
Sbjct: 246 AATGSVSSRHYILGWSFNKSGESQTLDPSKLPSLPSLAKSR-----KLNLRLIILLAVTL 300
Query: 300 ILVVLITIGAAVYIVRNKRYEEVYEDWEREYGPQRFTYKDLYKATKGFKDKDVIGRGGFG 359
+ +++T +R KRYEE+ EDWE+ YGPQRF+Y+ LYKAT+ F+DKD++G GGFG
Sbjct: 301 TVTIIVTAVLGTMFIRRKRYEEIREDWEKAYGPQRFSYEVLYKATRDFRDKDLLGAGGFG 360
Query: 360 KVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLL 418
KVYRG+L+S N Q+AVKK+SH+S QG+KEF+AE+ SMGRLRHRNLV+L GYCRRKGE LL
Sbjct: 361 KVYRGILSSCNTQVAVKKISHNSAQGMKEFIAEIASMGRLRHRNLVQLLGYCRRKGELLL 420
Query: 419 VYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVL 478
VY+YMPNGSLDK L + + LNW QR RIIRGVASGLLYLH DWEQVVLHRD+K +NVL
Sbjct: 421 VYEYMPNGSLDKFLFSKKEAKLNWDQRHRIIRGVASGLLYLHHDWEQVVLHRDVKASNVL 480
Query: 479 LDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFML 538
LDA+ N +LGDFGLA+ YDH T PQTT +VGT GY+ PEL++TGK +TS+DV+AFG FML
Sbjct: 481 LDANFNARLGDFGLAKFYDHGTNPQTTCVVGTVGYLAPELIKTGKPTTSSDVFAFGNFML 540
Query: 539 EVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFC 598
E+A GR+P E + E L DWV +CWK+G I +SD RLEG ++MELVLKLGL C
Sbjct: 541 EIACGRKPFEPKCLPEETILADWVLECWKRGDILSSSDPRLEGNYVVQEMELVLKLGLLC 600
Query: 599 SHPKPEARPNMRQVMQ 614
+H P ARP+MRQV+
Sbjct: 601 AHSTPAARPDMRQVVN 616
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224059452|ref|XP_002299853.1| predicted protein [Populus trichocarpa] gi|222847111|gb|EEE84658.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 712 bits (1839), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/599 (62%), Positives = 463/599 (77%), Gaps = 25/599 (4%)
Query: 29 QFIYHGFNEDAQLQRDGLASVHSNGLLQLTNTVSPQQEGHAFYRLPIKFNTSS--SESLS 86
QF Y+GF + A L DG+AS+H NGLL+LTN S QQ GHAF+ P FNTSS S SLS
Sbjct: 1 QFFYNGF-KGANLSLDGIASIHPNGLLELTN-ASKQQIGHAFFPFPFHFNTSSNNSRSLS 58
Query: 87 FSSNFVFAI----------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILAI 136
FS+NFVFA+ G+AF ISPS D A A+ +YLGLFN++ G S+NH+LAI
Sbjct: 59 FSTNFVFAMVPESPMRGGHGIAFTISPSTDFNGATAT--QYLGLFNSTTIGLSSNHLLAI 116
Query: 137 ELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGDPIQIWISY 196
ELD +++ +F DI+DNHVGIDVN+L S +SAPA+YFS+ G N+ L+LI GDP+Q+WI Y
Sbjct: 117 ELDAIRSPEFGDINDNHVGIDVNNLTSIQSAPASYFSEHGG-NEILQLISGDPMQVWIDY 175
Query: 197 DGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLKSSHYVLGWSF 256
D +KLL+VTLAP+S+ KP KPLLS I+LS +LL++MYVGFS+STGS+ S HY+LGWSF
Sbjct: 176 DEMDKLLDVTLAPVSVTKPRKPLLSTTIDLSQVLLDSMYVGFSSSTGSVSSHHYILGWSF 235
Query: 257 NRSGPALNLDISSLPRLPHLPRPRAKANDKPQLKLVISVSLIAILVVLITIGAAVYIVRN 316
N+SG A +L S LP LP P +++KP L++VI LI + V+LI A + I+RN
Sbjct: 236 NKSGQAQSLGTSKLPSLP----PERNSSNKPDLRIVIP--LITVSVLLIASFATMCIMRN 289
Query: 317 KRYEEVYEDWEREYGPQRFTYKDLYKATKGFKDKDVIGRGGFGKVYRGVL-ASNVQIAVK 375
K YEEV EDWE++YGPQRF YKDLYKATKGFKDK+++G GGFG+VYRG L +S V+IAVK
Sbjct: 290 K-YEEVREDWEQQYGPQRFRYKDLYKATKGFKDKELLGTGGFGRVYRGELRSSKVEIAVK 348
Query: 376 KVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTN 435
K+SH S QG+KEFVAE+ SMGRLRHRNLV+L GYCRRKGE LLVYDYMPNGSLDK L N
Sbjct: 349 KISHGSNQGMKEFVAEIASMGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKFLFCN 408
Query: 436 IKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARL 495
KP L+W +R++I+RGV S LLYLHE+W+QVVLHRD+K +NVLLD DLNG+LGDFGLA+
Sbjct: 409 EKPNLDWPRRYQILRGVGSALLYLHEEWQQVVLHRDVKASNVLLDGDLNGRLGDFGLAKF 468
Query: 496 YDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMET 555
+DH + PQTT +VGT GY+ PE+ RTGKA+TS+DV+AFG FMLEV GRRPVE + E
Sbjct: 469 HDHGSTPQTTNVVGTVGYLAPEITRTGKATTSSDVFAFGTFMLEVVCGRRPVESERPPEE 528
Query: 556 VNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
V LVDWV +CWK+GAI D RL E K++ELVLKLGL C+H P ARP+MRQV+Q
Sbjct: 529 VVLVDWVLECWKRGAILGTVDPRLNVNYEVKEVELVLKLGLLCTHRTPAARPSMRQVVQ 587
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359481749|ref|XP_003632669.1| PREDICTED: L-type lectin-domain containing receptor kinase IV.2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 681 bits (1756), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 347/603 (57%), Positives = 439/603 (72%), Gaps = 24/603 (3%)
Query: 24 AQDVNQFIYHGFNEDAQLQRDGLASVHSNGLLQLTNTVSPQQEGHAFYRLPIKF-NTSSS 82
+DV+ F Y+GF A L DGLA NGLL LTN + Q+ GHAFY P++F N+S++
Sbjct: 609 GEDVS-FTYNGFQTAANLSLDGLAQFTPNGLLILTNR-TKQETGHAFYSHPMRFKNSSNA 666
Query: 83 ESLSFSSNFVFAI----------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNH 132
+ SFS+ FVFAI G+AFVI+P++ G A PS++LGLF+ +NNG STNH
Sbjct: 667 PAFSFSTTFVFAIHPQYPTLSGHGIAFVIAPTR--GLPGALPSQHLGLFSDANNGNSTNH 724
Query: 133 ILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGDPIQI 192
I+A+ELDT+QN + DI+DNHVGID+N L S ++APA YF+ + G K L LI G P+Q+
Sbjct: 725 IVAVELDTIQNEELGDINDNHVGIDINGLKSDKAAPAGYFASKNGDFKNLSLISGRPMQV 784
Query: 193 WISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLKSSHYVL 252
W+ Y+ EK ++V LAP+S+ KP PLLS +LS IL TMYVGFS+STGS+ +SHY+L
Sbjct: 785 WVDYNALEKQIDVRLAPVSVDKPDIPLLSLPRDLSLILNNTMYVGFSSSTGSVLTSHYLL 844
Query: 253 GWSFNRSGPALNLDISSLPRLPHLPRPRAKANDKPQLKLVISVSLIAILVVLITIGAAVY 312
GWSF +G A L IS LP+LP + + A L ++ VS++A++ GA
Sbjct: 845 GWSFKMNGQAQPLAISQLPKLPRIGGQKKSAFLTSGLPVICVVSILAVMS-----GAVYL 899
Query: 313 IVRNKRYEEVYEDWEREYGPQRFTYKDLYKATKGFKDKDVIGRGGFGKVYRGVL-ASNVQ 371
I R K++ E EDWE +YGP RF YKDLY ATKGFKDK+++G GGFG+VYRGVL S ++
Sbjct: 900 IRRKKKFAEELEDWELDYGPHRFKYKDLYFATKGFKDKELLGSGGFGRVYRGVLPTSKLE 959
Query: 372 IAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKI 431
IAVKK+SH+S+QG+KEFVAE+VS+GRLRHRN+V L GYCRRKGE LLVYDYMPNGSLDK
Sbjct: 960 IAVKKISHESRQGMKEFVAEIVSIGRLRHRNIVSLLGYCRRKGELLLVYDYMPNGSLDKY 1019
Query: 432 LHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFG 491
L+ K LNW QRFR+++GVASGL YLH +WEQVV+HRD+K +NVLLD +LNG+LGDFG
Sbjct: 1020 LYDQPKVTLNWNQRFRVLKGVASGLSYLHGEWEQVVVHRDVKASNVLLDGELNGRLGDFG 1079
Query: 492 LARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQG 551
LARLYDH T PQTT +VGT GY+ PE RTGKA+T TDVYAFG F+LEVA GRRP+
Sbjct: 1080 LARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTRTDVYAFGAFLLEVACGRRPI---A 1136
Query: 552 SMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQ 611
ME + LVDWV W +G I ASD +L ++MELVLKLGL CSH +P ARP+M Q
Sbjct: 1137 PMEDLILVDWVFFFWNRGEILQASDPKLGVDYNAEEMELVLKLGLMCSHSEPNARPSMPQ 1196
Query: 612 VMQ 614
V+Q
Sbjct: 1197 VVQ 1199
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255559002|ref|XP_002520524.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223540366|gb|EEF41937.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 678 bits (1749), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 350/612 (57%), Positives = 446/612 (72%), Gaps = 44/612 (7%)
Query: 13 LLCASFIFS---ALAQDVNQFIYHGFNEDAQLQRDGLASVHSNGLLQLTNTVSPQQEGHA 69
+L +F+FS + AQD NQFIYHGFNE + L GLA+VH NGLL+LTN ++ + G A
Sbjct: 4 VLLITFVFSKHLSFAQDQNQFIYHGFNE-SNLNLSGLANVHPNGLLELTN-ITYLKVGRA 61
Query: 70 FYRLPIKFNTSSSESLSFSSNFVFAI----------------GMAFVISPSKDLGKAEAS 113
F++LP+KFN SS FS+NFVFAI G AF ISPS + A A+
Sbjct: 62 FFQLPLKFNKSS-----FSTNFVFAIDPERLPLGETPGLGGHGFAFTISPSMEFPGALAT 116
Query: 114 PSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFS 173
+Y GLFN+++NG +NH++AIE DT+Q LD DI++NHVGIDVN + S+ SAPAAYFS
Sbjct: 117 --QYFGLFNSTSNGLFSNHLVAIEFDTIQTLDCGDINNNHVGIDVNGVTSNVSAPAAYFS 174
Query: 174 DREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLET 233
D+E K L LI G P+Q+WI YD + +LN+TLAP+++ KP KPLLS I+LS ILL++
Sbjct: 175 DKE--YKNLTLISGKPMQVWIDYDEVQMILNITLAPITVMKPEKPLLSTTIDLSLILLDS 232
Query: 234 MYVGFSASTGSLKSSHYVLGWSFNRSGPALNLDISSLPRLPHLPRPRAKANDKPQL---- 289
MYVGFS+STGS+ S HY+LGWSFN+SGPA +LD S LP LP P + P
Sbjct: 233 MYVGFSSSTGSMASYHYILGWSFNKSGPAQSLDTSKLPSLPLAPPSPSLPVTPPAPPPSL 292
Query: 290 ---------KLVISVSLIAILVVLITIGAAVYIVRNKRYEEVYEDWEREYGPQRFTYKDL 340
KL+I+ S I VVLI I +YI++ K++EE+ EDWE+EYGPQRF+Y+DL
Sbjct: 293 PAPPSHPPKKLIITASSIVAGVVLIAIFGTLYILKRKKFEELREDWEKEYGPQRFSYRDL 352
Query: 341 YKATKGFKDKDVIGRGGFGKVYRGVL-ASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLR 399
YKATK FKDK+++G GGFGKVYRGVL +SN Q+AVKK SHDS+QG+KEF+AE+VSMGRLR
Sbjct: 353 YKATKAFKDKELLGFGGFGKVYRGVLPSSNTQVAVKKFSHDSQQGMKEFIAEIVSMGRLR 412
Query: 400 HRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYL 459
HRNLV+L GYCRRKGE LLVYDYMPNGSLDK L N P LNW QR++I+RGVAS LLYL
Sbjct: 413 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKFLFQNDTPNLNWVQRYQILRGVASALLYL 472
Query: 460 HEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELM 519
HE+WEQVVLHRD+K +NV+LDADL+G+LGDFGLA+ +D + PQT +VGT GY+ PE+
Sbjct: 473 HEEWEQVVLHRDVKASNVMLDADLSGRLGDFGLAKFHDRGSAPQTICVVGTVGYLAPEVS 532
Query: 520 RTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRL 579
RTG+ +T +DV++FG MLE+A GR+ +E Q V LVDWV + WK G + + SD RL
Sbjct: 533 RTGRVTTGSDVFSFGTLMLEMACGRKTIEPQKPAGEVILVDWVLESWKNGVLLEISDPRL 592
Query: 580 EGICEEKQMELV 591
EG ++MEL+
Sbjct: 593 EGKYMMEEMELL 604
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 614 | ||||||
| TAIR|locus:2040681 | 675 | RLK "receptor lectin kinase" [ | 0.491 | 0.447 | 0.632 | 6.5e-164 | |
| TAIR|locus:2084375 | 677 | AT3G53810 [Arabidopsis thalian | 0.493 | 0.447 | 0.638 | 2.3e-159 | |
| TAIR|locus:2168509 | 674 | AT5G59260 [Arabidopsis thalian | 0.967 | 0.881 | 0.503 | 1.7e-155 | |
| TAIR|locus:2119936 | 669 | AT4G29050 [Arabidopsis thalian | 0.967 | 0.887 | 0.493 | 1.1e-153 | |
| TAIR|locus:2133239 | 669 | AT4G02420 [Arabidopsis thalian | 0.488 | 0.448 | 0.602 | 4.5e-152 | |
| TAIR|locus:2144025 | 657 | AT5G60280 [Arabidopsis thalian | 0.929 | 0.869 | 0.504 | 2e-150 | |
| TAIR|locus:2085587 | 669 | AT3G45440 [Arabidopsis thalian | 0.954 | 0.875 | 0.480 | 2.1e-148 | |
| TAIR|locus:2078332 | 682 | AT3G45330 [Arabidopsis thalian | 0.957 | 0.862 | 0.501 | 3.4e-148 | |
| TAIR|locus:2133229 | 674 | LPK1 "lectin-like protein kina | 0.493 | 0.449 | 0.617 | 5.9e-148 | |
| TAIR|locus:2020608 | 666 | AT1G70110 [Arabidopsis thalian | 0.933 | 0.860 | 0.488 | 1e-146 |
| TAIR|locus:2040681 RLK "receptor lectin kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1038 (370.5 bits), Expect = 6.5e-164, Sum P(2) = 6.5e-164
Identities = 193/305 (63%), Positives = 242/305 (79%)
Query: 312 YIVRNKR-YEEVYEDWEREYGPQRFTYKDLYKATKGFKDKDVIGRGGFGKVYRGVL-ASN 369
YIVR +R + E E+WE+E+G RF +KDLY ATKGFK+K ++G GGFG VY+GV+ +
Sbjct: 311 YIVRRRRKFAEELEEWEKEFGKNRFRFKDLYYATKGFKEKGLLGTGGFGSVYKGVMPGTK 370
Query: 370 VQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLD 429
++IAVK+VSH+S+QG+KEFVAE+VS+GR+ HRNLV L GYCRR+GE LLVYDYMPNGSLD
Sbjct: 371 LEIAVKRVSHESRQGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLD 430
Query: 430 KILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGD 489
K L+ + LNW QR ++I GVASGL YLHE+WEQVV+HRD+K +NVLLD +LNG+LGD
Sbjct: 431 KYLYNTPEVTLNWKQRIKVILGVASGLFYLHEEWEQVVIHRDVKASNVLLDGELNGRLGD 490
Query: 490 FGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVE- 548
FGLARLYDH + PQTT +VGT GY+ PE RTG+A+ +TDV+AFG F+LEVA GRRP+E
Sbjct: 491 FGLARLYDHGSDPQTTHVVGTLGYLAPEHTRTGRATMATDVFAFGAFLLEVACGRRPIEF 550
Query: 549 QQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPN 608
QQ + ET LVDWV W KG I A D + C+EK++E+VLKLGL CSH P ARP+
Sbjct: 551 QQETDETFLLVDWVFGLWNKGDILAAKDPNMGSECDEKEVEMVLKLGLLCSHSDPRARPS 610
Query: 609 MRQVM 613
MRQV+
Sbjct: 611 MRQVL 615
|
|
| TAIR|locus:2084375 AT3G53810 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1046 (373.3 bits), Expect = 2.3e-159, Sum P(2) = 2.3e-159
Identities = 196/307 (63%), Positives = 245/307 (79%)
Query: 312 YIVRNKR-YEEVYEDWEREYGPQRFTYKDLYKATKGFKDKDVIGRGGFGKVYRGVL-ASN 369
YIVR K+ YEE +DWE E+G RF +K+LY ATKGFK+KD++G GGFG+VYRG+L +
Sbjct: 311 YIVRRKKKYEEELDDWETEFGKNRFRFKELYHATKGFKEKDLLGSGGFGRVYRGILPTTK 370
Query: 370 VQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLD 429
+++AVK+VSHDSKQG+KEFVAE+VS+GR+ HRNLV L GYCRR+GE LLVYDYMPNGSLD
Sbjct: 371 LEVAVKRVSHDSKQGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLD 430
Query: 430 KILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGD 489
K L+ N + L+W QR II+GVASGL YLHE+WEQVV+HRD+K +NVLLDAD NG+LGD
Sbjct: 431 KYLYNNPETTLDWKQRSTIIKGVASGLFYLHEEWEQVVIHRDVKASNVLLDADFNGRLGD 490
Query: 490 FGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVE- 548
FGLARLYDH + PQTT +VGT GY+ PE RTG+A+T+TDVYAFG F+LEV SGRRP+E
Sbjct: 491 FGLARLYDHGSDPQTTHVVGTLGYLAPEHSRTGRATTTTDVYAFGAFLLEVVSGRRPIEF 550
Query: 549 QQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEE-KQMELVLKLGLFCSHPKPEARP 607
S +T LV+WV W +G I +A D +L + +++E+VLKLGL CSH P ARP
Sbjct: 551 HSASDDTFLLVEWVFSLWLRGNIMEAKDPKLGSSGYDLEEVEMVLKLGLLCSHSDPRARP 610
Query: 608 NMRQVMQ 614
+MRQV+Q
Sbjct: 611 SMRQVLQ 617
|
|
| TAIR|locus:2168509 AT5G59260 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1516 (538.7 bits), Expect = 1.7e-155, P = 1.7e-155
Identities = 317/630 (50%), Positives = 405/630 (64%)
Query: 7 SFCFCVLLCASFIFSALAQDVNQFIYHGFNEDAQLQRDGLASVHSNGLLQLTNTVSPQQE 66
S F +++ F AQ+ + F+Y+ F +A L+ DG+A+ + +G L LTN +
Sbjct: 7 SVVFWLIIGIHVTFLVFAQEGDHFVYYDFR-NADLELDGMANTN-HGPLHLTNNTNTGT- 63
Query: 67 GHAFYRLPIKFNTXXXXXXXXXXNFVFAI----------GMAFVISPSKDLGKAEASPSE 116
GHAFY +PIKF FVFAI GMAFV+SP+KDL ++ S +
Sbjct: 64 GHAFYNIPIKFTASSLSSFSFSTEFVFAIFPLQKSTYGHGMAFVVSPTKDL-RSNGSANS 122
Query: 117 YLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDRE 176
LG+FN +N+ ++ HI A+ELDT QN + D N VGID+NS++S ESA A+YF+ R+
Sbjct: 123 NLGIFNRANDNKTATHIFAVELDTNQNSESFDKGGNDVGIDINSIVSVESADASYFNARK 182
Query: 177 GMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKP-----------LLSRAIN 225
G N +L L G I +WI YDG EK+LNVTLAP+ PKP P LLSR+IN
Sbjct: 183 GKNISLPLASGKSILVWIDYDGIEKVLNVTLAPVQTPKPDSPYFSSFIKPKVPLLSRSIN 242
Query: 226 LSHILLETMYVGFSASTGSLKSSHYVLGWSFNRSGPALNLDISSXXXXXXXXXXXAKAND 285
LS I ETMYVGFS STGS+KS+ Y+LGWSF + G A +LDIS +
Sbjct: 243 LSEIFTETMYVGFSGSTGSIKSNQYILGWSFKQGGKAESLDISRLSN--------PPPSP 294
Query: 286 KPQXXXXXXXXXXXXXXXXXXXXXXXYIVRNKRYEEVYEDWEREYGPQRFTYKDLYKATK 345
K + Y+ + K+Y EV E WE+EY PQR++++ LYKATK
Sbjct: 295 K-RFPLKEVLGATISTIAFLTLGGIVYLYKKKKYAEVLEQWEKEYSPQRYSFRILYKATK 353
Query: 346 GFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVK 405
GF++ ++G GGFGKVY+G+L S QIAVK+V HD++QG+K++VAE+ SMGRLRH+NLV
Sbjct: 354 GFRENQLLGAGGFGKVYKGILPSGTQIAVKRVYHDAEQGMKQYVAEIASMGRLRHKNLVH 413
Query: 406 LRGYCRRKGEFLLVYDYMPNGSLDKIL-HTNIKPCLNWYQRFRIIRGVASGLLYLHEDWE 464
L GYCRRKGE LLVYDYMPNGSLD L H N L W QR II+GVAS LLYLHE+WE
Sbjct: 414 LLGYCRRKGELLLVYDYMPNGSLDDYLFHKNKLKDLTWSQRVNIIKGVASALLYLHEEWE 473
Query: 465 QVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKA 524
QVVLHRDIK +N+LLDADLNGKLGDFGLAR +D + T++VGT GYM PEL G
Sbjct: 474 QVVLHRDIKASNILLDADLNGKLGDFGLARFHDRGVNLEATRVVGTIGYMAPELTAMGVT 533
Query: 525 STSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICE 584
+T TDVYAFG F+LEV GRRPV+ E V LV WV C K+ A+ D DS+L
Sbjct: 534 TTCTDVYAFGAFILEVVCGRRPVDPDAPREQVILVKWVASCGKRDALTDTVDSKLIDFKV 593
Query: 585 EKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
E + +L+LKLG+ CS PE RP+MRQ++Q
Sbjct: 594 E-EAKLLLKLGMLCSQINPENRPSMRQILQ 622
|
|
| TAIR|locus:2119936 AT4G29050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1499 (532.7 bits), Expect = 1.1e-153, P = 1.1e-153
Identities = 308/624 (49%), Positives = 413/624 (66%)
Query: 8 FCFCVLLCASFIFS-ALAQ-DVNQFIYHGFNEDAQLQRDGLASVHSNGLLQLTNTVSPQQ 65
F +LL F + AL+Q + +F ++G+ D G+A +S GL++LTN+ S
Sbjct: 4 FVLVLLLVLQFFSNKALSQSEEGEFGFNGYLYD----NSGIAITNSKGLMKLTNS-SEFS 58
Query: 66 EGHAFYRLPIKF-NTXXXXXXXXXXNFVFAI----------GMAFVISPSKDLGKAEASP 114
GH FY P++F N+ FVFAI G+AFVISP+K G +S
Sbjct: 59 YGHVFYNSPVRFKNSPNGTVSSFSTTFVFAIVSNVNALDGHGLAFVISPTK--GLPYSSS 116
Query: 115 SEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSD 174
S+YLGLFN +NNG +NHI+A+E DT QN +FDD+D+NHVGID+NSL S +++ A Y+ D
Sbjct: 117 SQYLGLFNLTNNGDPSNHIVAVEFDTFQNQEFDDMDNNHVGIDINSLSSEKASTAGYYED 176
Query: 175 REGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETM 234
+G K + LI PIQ WI YD + + LNVT+ P+ +PKP PLLS +LS L ++M
Sbjct: 177 DDGTFKNIRLINQKPIQAWIEYDSSRRQLNVTIHPIHLPKPKIPLLSLTKDLSPYLFDSM 236
Query: 235 YVGFSASTGSLKSSHYVLGWSFNRSGPALNLDISSXXXXXXXXXXXAKANDKPQXXXXXX 294
YVGF+++TG L+SSHY+LGW+F +G A N+DIS +++ +
Sbjct: 237 YVGFTSATGRLRSSHYILGWTFKLNGTASNIDISRLPKLPRD----SRSTSVKKILAISL 292
Query: 295 XXXXXXXXXXXXXXXXXYIVRNKRYEEVYEDWEREYGPQRFTYKDLYKATKGFKDKDVIG 354
++ R K+ EV EDWE ++GP RF YKDLY ATKGF++ +++G
Sbjct: 293 SLTSLAILVFLTISYMLFLKR-KKLMEVLEDWEVQFGPHRFAYKDLYIATKGFRNSELLG 351
Query: 355 RGGFGKVYRGVLA-SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRK 413
+GGFGKVY+G L+ SN+ IAVKKVSHDS+QG++EFVAE+ ++GRLRH NLV+L GYCRRK
Sbjct: 352 KGGFGKVYKGTLSTSNMDIAVKKVSHDSRQGMREFVAEIATIGRLRHPNLVRLLGYCRRK 411
Query: 414 GEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK 473
GE LVYD MP GSLDK L+ + L+W QRF+II+ VASGL YLH W QV++HRDIK
Sbjct: 412 GELYLVYDCMPKGSLDKFLYHQPEQSLDWSQRFKIIKDVASGLCYLHHQWVQVIIHRDIK 471
Query: 474 PANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAF 533
PANVLLD +NGKLGDFGLA+L +H PQT+ + GTFGY+ PEL RTGKASTS+DV+AF
Sbjct: 472 PANVLLDDSMNGKLGDFGLAKLCEHGFDPQTSNVAGTFGYISPELSRTGKASTSSDVFAF 531
Query: 534 GVFMLEVASGRRPVEQQGSMET-VNLVDWVCDCWKKGAIRDASDSRLEGICE--EKQMEL 590
G+ MLE+ GRRPV + S + + L DWV DCW+ ++ D R++ + E+Q+ L
Sbjct: 532 GILMLEITCGRRPVLPRASSPSEMVLTDWVLDCWEDDILQ-VVDERVKQDDKYLEEQVAL 590
Query: 591 VLKLGLFCSHPKPEARPNMRQVMQ 614
VLKLGLFCSHP RP+M V+Q
Sbjct: 591 VLKLGLFCSHPVAAVRPSMSSVIQ 614
|
|
| TAIR|locus:2133239 AT4G02420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 981 (350.4 bits), Expect = 4.5e-152, Sum P(2) = 4.5e-152
Identities = 182/302 (60%), Positives = 238/302 (78%)
Query: 315 RNKRYEEVYEDWEREYGPQRFTYKDLYKATKGFKDKDVIGRGGFGKVYRGVLA-SNVQIA 373
R +++ E EDWE E+G R +KDLY ATKGFKDK+++G GGFG VY+G++ + +IA
Sbjct: 318 RRRKFAEEVEDWETEFGKNRLRFKDLYYATKGFKDKNILGSGGFGSVYKGIMPKTKKEIA 377
Query: 374 VKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILH 433
VK+VS++S+QG+KEFVAE+VS+G++ HRNLV L GYCRR+ E LLVYDYMPNGSLDK L+
Sbjct: 378 VKRVSNESRQGLKEFVAEIVSIGQMSHRNLVPLVGYCRRRDELLLVYDYMPNGSLDKYLY 437
Query: 434 TNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLA 493
+ + L+W QRF++I GVAS L YLHE+WEQVV+HRD+K +NVLLDA+LNG+LGDFGLA
Sbjct: 438 NSPEVTLDWKQRFKVINGVASALFYLHEEWEQVVIHRDVKASNVLLDAELNGRLGDFGLA 497
Query: 494 RLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVE-QQGS 552
+L DH + PQTT++VGT+GY+ P+ +RTG+A+T+TDV+AFGV +LEVA GRRP+E S
Sbjct: 498 QLCDHGSDPQTTRVVGTWGYLAPDHIRTGRATTTTDVFAFGVLLLEVACGRRPIEINNQS 557
Query: 553 METVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQV 612
E V LVDWV W + I DA D L ++K++E+VLKLGL CSH P ARP MRQV
Sbjct: 558 GERVVLVDWVFRFWMEANILDAKDPNLGSEYDQKEVEMVLKLGLLCSHSDPLARPTMRQV 617
Query: 613 MQ 614
+Q
Sbjct: 618 LQ 619
|
|
| TAIR|locus:2144025 AT5G60280 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1468 (521.8 bits), Expect = 2.0e-150, P = 2.0e-150
Identities = 304/602 (50%), Positives = 401/602 (66%)
Query: 24 AQDVNQFIYHGFNEDAQLQRDGLASVHSNGLLQLTNTVSPQQEGHAFYRLPIKFNTXXXX 83
+Q F ++GF + L DG+A + GLL+LT+T S Q++GHAF+R P+ FN+
Sbjct: 22 SQQETGFSFNGFRQ-GDLHVDGVAQILPGGLLRLTDT-SEQKKGHAFFRQPLVFNSSEPL 79
Query: 84 XXXXXXNFVFAI----------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHI 133
+FV A+ G+AF +SPS DL A+A+ +YLGLFN + N ++HI
Sbjct: 80 SFST--HFVCAMVRKPGVTGGNGIAFFLSPSMDLTNADAT--QYLGLFNTTTNRSPSSHI 135
Query: 134 LAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGDPIQIW 193
AIELDTVQ+ +FDDID+NHVGIDVNSL S ESAPA+YFSD++G+NK++ L+ GD IQ+W
Sbjct: 136 FAIELDTVQSAEFDDIDNNHVGIDVNSLTSVESAPASYFSDKKGLNKSISLLSGDSIQVW 195
Query: 194 ISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLKSSHYVLG 253
+ +DG +LNV+LAP+ I KP++ L+SR++NLS ++ + M+VGFSA+TG L ++HY+LG
Sbjct: 196 VDFDGT--VLNVSLAPLGIRKPSQSLISRSMNLSEVIQDRMFVGFSAATGQLANNHYILG 253
Query: 254 WSFNRSGPAL-NLDISSXXXXXXXXXXXAKANDKPQXXXXXXXXXXXXXXXXXXXXXXXY 312
WSF+RS +L +LDIS + K + Y
Sbjct: 254 WSFSRSKASLQSLDISKLPQV---------PHPKMKTSLLLILLLIVLGIILLVLLVGAY 304
Query: 313 IVRNKRYEEVYEDWEREYGPQRFTYKDLYKATKGFKDKDVIGRGGFGKVYRGVLASNVQI 372
+ R +Y EV E+WE+EYGP R++YK LYKATKGF +G+GGFG+VY+G L I
Sbjct: 305 LYRRNKYAEVREEWEKEYGPHRYSYKSLYKATKGFHKDGFLGKGGFGEVYKGTLPQE-DI 363
Query: 373 AVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKIL 432
AVK+ SH ++G+K+FVAE+ SMG L HRNLV L GYCRRKGEFLLV YMPNGSLD+ L
Sbjct: 364 AVKRFSHHGERGMKQFVAEIASMGCLDHRNLVPLFGYCRRKGEFLLVSKYMPNGSLDQFL 423
Query: 433 HTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGL 492
N +P L W +R I++G+AS L YLH + QVVLHRDIK +NV+LD D GKLGDFG+
Sbjct: 424 FHNREPSLTWSKRLGILKGIASALKYLHTEATQVVLHRDIKASNVMLDTDFTGKLGDFGM 483
Query: 493 ARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGS 552
AR +DH P TT VGT GYM PEL G AST TDVYAFG +LEV GRRPVE
Sbjct: 484 ARFHDHGANPTTTGAVGTVGYMGPELTSMG-ASTKTDVYAFGALILEVTCGRRPVEPNLP 542
Query: 553 METVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQV 612
+E LV WVCDCWK+ + A D +L G Q+E+VLKLGL C++ PE+RP+M +V
Sbjct: 543 IEKQLLVKWVCDCWKRKDLISARDPKLSGELIP-QIEMVLKLGLLCTNLVPESRPDMVKV 601
Query: 613 MQ 614
+Q
Sbjct: 602 VQ 603
|
|
| TAIR|locus:2085587 AT3G45440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1449 (515.1 bits), Expect = 2.1e-148, P = 2.1e-148
Identities = 296/616 (48%), Positives = 404/616 (65%)
Query: 10 FCV-LLCASFIFSALAQDVNQFIYHGFNEDAQLQRDGLASVHSNGLLQLTNTVSPQQEGH 68
FC+ L+C S +Q +FI++GF + A L DG+A + NGLLQLT+ S Q+ GH
Sbjct: 12 FCLHLICIS------SQQETEFIFNGFGQ-ADLYTDGVAKILPNGLLQLTDG-SGQKMGH 63
Query: 69 AFYRLPIKFNTXXXXXXXXXX--------NFVFAIGMAFVISPSKDLGKAEASPSEYLGL 120
AF++ P +F + F+ G+AFV+S S DL +A+A+ ++LGL
Sbjct: 64 AFFKKPFEFKSPRSFSFSTHFVCALVPKPGFIGGHGIAFVLSASMDLTQADAT--QFLGL 121
Query: 121 FNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNK 180
FN S G ++H++A+ELDT + +FDDID NHVGIDVNSL+S S PAAYFS+ +G NK
Sbjct: 122 FNISTQGSPSSHLVAVELDTALSAEFDDIDANHVGIDVNSLMSIASTPAAYFSEIDGENK 181
Query: 181 TLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLET-MYVGFS 239
+++L+ GDPIQ+W+ Y G +LNVTLAP+ I KP++PLLSR+INLS + ++GFS
Sbjct: 182 SIKLLSGDPIQVWVDYGG--NVLNVTLAPLKIQKPSRPLLSRSINLSETFPDRKFFLGFS 239
Query: 240 ASTGSLKSSHYVLGWSFNRSGPALN-LDISSXXXXXXXXXXXAKANDKPQXXXXXXXXXX 298
+TG+L S Y+LGWS +R+ +L LD++ AK N P
Sbjct: 240 GATGTLISYQYILGWSLSRNKVSLQTLDVTKLPRVPRHR---AK-NKGPSVVLIVLLILL 295
Query: 299 XXXXXXXXXXXXXYIVRNKRYEEVYEDWEREYGPQRFTYKDLYKATKGFKDKDVIGRGGF 358
Y+ R ++Y E+ E+WE+EYGP RF+YKDLY AT GF ++G+GGF
Sbjct: 296 AIIVFLALGAA--YVYRRRKYAEIREEWEKEYGPHRFSYKDLYIATNGFNKDGLLGKGGF 353
Query: 359 GKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLL 418
GKVY+G L S QIAVK+VSHD+++G+K+FVAE+VSMG L+H+N+V L GYCRRKGE LL
Sbjct: 354 GKVYKGTLPSKGQIAVKRVSHDAEEGMKQFVAEIVSMGNLKHKNMVPLLGYCRRKGELLL 413
Query: 419 VYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVL 478
V +YMPNGSLD+ L + KP +W +R II+ +A+ L Y+H QVVLHRDIK +NV+
Sbjct: 414 VSEYMPNGSLDQYLFNDEKPPFSWRRRLLIIKDIATALNYMHTGAPQVVLHRDIKASNVM 473
Query: 479 LDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFML 538
LD + NG+LGDFG+AR +DH P TT VGT GYM PEL G A T+TDVY FG F+L
Sbjct: 474 LDTEFNGRLGDFGMARFHDHGKDPATTAAVGTIGYMAPELATVG-ACTATDVYGFGAFLL 532
Query: 539 EVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFC 598
EV GRRPVE S E +V WVC+CWK ++ A D R+ G +++E+VLKLGL C
Sbjct: 533 EVTCGRRPVEPGLSAERWYIVKWVCECWKMASLLGARDPRMRGEISAEEVEMVLKLGLLC 592
Query: 599 SHPKPEARPNMRQVMQ 614
++ P+ RP+M ++Q
Sbjct: 593 TNGVPDLRPSMEDIVQ 608
|
|
| TAIR|locus:2078332 AT3G45330 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1447 (514.4 bits), Expect = 3.4e-148, P = 3.4e-148
Identities = 309/616 (50%), Positives = 398/616 (64%)
Query: 13 LLCASFIFSALAQDVNQFIYHGFNED-AQLQRDGLASVHSNGLLQLTNTVSPQQEGHAFY 71
L+C + S +Q FIY+GFN+D L DG A +GLLQLTN + QQ+GHAF+
Sbjct: 13 LICFVNLISFSSQQDLSFIYNGFNQDQTNLNLDGSAKFLQDGLLQLTNATT-QQKGHAFF 71
Query: 72 RLPIKFNTXXXXXXXXXXNFVFAI----------GMAFVISPSKDLGKAEASPSEYLGLF 121
P +F + +FV A+ G+AFV+S S DL +A P++YLGLF
Sbjct: 72 NRPFEFGSASSQSPSFSTHFVCALVPKPGVDGGHGIAFVLSSSMDL--TQADPTQYLGLF 129
Query: 122 NASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKT 181
N S NG ++H+LAIELDTVQ+ +FDD D NHVGID NSL S ESA A+Y+SD+EG NK+
Sbjct: 130 NISTNGSPSSHLLAIELDTVQSAEFDDRDKNHVGIDENSLQSVESASASYYSDKEGKNKS 189
Query: 182 LELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETM-YVGFSA 240
L+L+ GDPIQ+WI Y+ + LLNVTLAP+ KP+KPLLS INL+ I + ++GFSA
Sbjct: 190 LKLLSGDPIQVWIDYE--DTLLNVTLAPLKTQKPSKPLLSITINLTAIFPDRKAFIGFSA 247
Query: 241 STGSLKSSHYVLGWSFNRSGPAL-NLDISSXXXXXXXXXXXAKANDKPQXXX-XXXXXXX 298
+TGSL S Y+LGWSF+R+ L +LDIS KP+
Sbjct: 248 ATGSLISYQYILGWSFSRNRALLQSLDISKLPT--------VPRPKKPEKTSPLLIVLLI 299
Query: 299 XXXXXXXXXXXXXYIVRNKRYEEVYEDWEREYGPQRFTYKDLYKATKGFKDKDVIGRGGF 358
Y+ R K+Y EV E WE+ YGP R++YK LYKAT+GF +GRGGF
Sbjct: 300 ILAIIVMVVVGGFYLYRRKKYAEVREPWEKPYGPLRYSYKSLYKATRGFNKDGRLGRGGF 359
Query: 359 GKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLL 418
G+VY+G L IAVK++SHD++QG+K+FVAE+V+MG L+H+NLV L GYCRRKGE LL
Sbjct: 360 GEVYKGTLPILGDIAVKRLSHDAEQGMKQFVAEVVTMGSLQHKNLVPLLGYCRRKGELLL 419
Query: 419 VYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVL 478
V YM GS+D+ L KP L+W QR I+R +AS L YLH QVVLHRDIK +NV+
Sbjct: 420 VSKYMEGGSVDQYLFHGDKPPLSWSQRVSILRDIASALCYLHTGASQVVLHRDIKASNVM 479
Query: 479 LDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFML 538
L+ +L G LGDFG+AR DH + T VGT GYM EL TG ST TDVYAFG FML
Sbjct: 480 LNGNLQGFLGDFGMARFDDHGSNLSATAAVGTIGYMALELTSTG-TSTRTDVYAFGAFML 538
Query: 539 EVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFC 598
EV GRRP + +E +LV WVC+CW++G++ +A D+RL G ++E+VLKLGL C
Sbjct: 539 EVTCGRRPFDPAMPVEKRHLVKWVCECWREGSLVNAVDTRLRGKFVPGEVEMVLKLGLLC 598
Query: 599 SHPKPEARPNMRQVMQ 614
+ PEARPNM QV+Q
Sbjct: 599 TSIIPEARPNMEQVVQ 614
|
|
| TAIR|locus:2133229 LPK1 "lectin-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 995 (355.3 bits), Expect = 5.9e-148, Sum P(2) = 5.9e-148
Identities = 189/306 (61%), Positives = 244/306 (79%)
Query: 312 YIVRNKR-YEEVYEDWEREYGPQRFTYKDLYKATKGFKDKDVIGRGGFGKVYRGVL-ASN 369
+IVR +R + E +EDWE E+G R +KDLY ATKGFKDKD++G GGFG+VYRGV+ +
Sbjct: 319 FIVRRRRKFAEEFEDWETEFGKNRLRFKDLYYATKGFKDKDLLGSGGFGRVYRGVMPTTK 378
Query: 370 VQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLD 429
+IAVK+VS++S+QG+KEFVAE+VS+GR+ HRNLV L GYCRR+ E LLVYDYMPNGSLD
Sbjct: 379 KEIAVKRVSNESRQGLKEFVAEIVSIGRMSHRNLVPLLGYCRRRDELLLVYDYMPNGSLD 438
Query: 430 KILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGD 489
K L+ + L+W QRF +I GVASGL YLHE+WEQVV+HRDIK +NVLLDA+ NG+LGD
Sbjct: 439 KYLYDCPEVTLDWKQRFNVIIGVASGLFYLHEEWEQVVIHRDIKASNVLLDAEYNGRLGD 498
Query: 490 FGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQ 549
FGLARL DH + PQTT++VGT+GY+ P+ +RTG+A+T+TDV+AFGV +LEVA GRRP+E
Sbjct: 499 FGLARLCDHGSDPQTTRVVGTWGYLAPDHVRTGRATTATDVFAFGVLLLEVACGRRPIEI 558
Query: 550 Q-GSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPN 608
+ S E+V LVD V W +G I DA+D L + +++++E VLKLGL CSH P+ RP
Sbjct: 559 EIESDESVLLVDSVFGFWIEGNILDATDPNLGSVYDQREVETVLKLGLLCSHSDPQVRPT 618
Query: 609 MRQVMQ 614
MRQV+Q
Sbjct: 619 MRQVLQ 624
|
|
| TAIR|locus:2020608 AT1G70110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1433 (509.5 bits), Expect = 1.0e-146, P = 1.0e-146
Identities = 289/592 (48%), Positives = 382/592 (64%)
Query: 35 FNEDAQLQRDGLASVHSNGLLQLTNTVSPQQEGHAFYRLPIKF-NTXXXXXXXXXXNFVF 93
FN + G A +++NGL++LTN+ +PQ G FY ++F N+ FVF
Sbjct: 28 FNTSGNMYTSGSAYINNNGLIRLTNS-TPQTTGQVFYNDQLRFKNSVNGTVSSFSTTFVF 86
Query: 94 AI----------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQN 143
+I G+AFVI P++DL + P+ YLGLFN SN G NHI+A+ELDT +
Sbjct: 87 SIEFHNGIYGGYGIAFVICPTRDL--SPTFPTTYLGLFNRSNMGDPKNHIVAVELDTKVD 144
Query: 144 LDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGDPIQIWISYDGAEKLL 203
F+D D NHVGID+N+L+S A A Y+ D G ++L L G P+QIWI YD +K +
Sbjct: 145 QQFEDKDANHVGIDINTLVSDTVALAGYYMDN-GTFRSLLLNSGQPMQIWIEYDSKQKQI 203
Query: 204 NVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLKSSHYVLGWSFNRSGPAL 263
NVTL P+ +PKP PLLS +LS LLE MYVGF+++TG L +SHY+LGW+F +G
Sbjct: 204 NVTLHPLYVPKPKIPLLSLEKDLSPYLLELMYVGFTSTTGDLTASHYILGWTFKMNGTTP 263
Query: 264 NLDISSXXXXXXXXXXXAKANDKPQXXXXXXXXXXXXXXXXXXXXXXXYIVRNKRYEEVY 323
++D S ++ P ++ K+ EV
Sbjct: 264 DIDPSRLPKIPRYNQPWIQS---PNGILTISLTVSGVIILIILSLSLWLFLKRKKLLEVL 320
Query: 324 EDWEREYGPQRFTYKDLYKATKGFKDKDVIGRGGFGKVYRGVL-ASNVQIAVKKVSHDSK 382
EDWE ++GP RF +KDL+ ATKGFKD +V+G+GGFGKVY+G L SNV+IAVK VSHDS+
Sbjct: 321 EDWEVQFGPHRFAFKDLHIATKGFKDTEVLGKGGFGKVYKGTLPVSNVEIAVKMVSHDSR 380
Query: 383 QGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNW 442
QG++EF+AE+ ++GRLRH NLV+L+GYCR KGE LVYD M GSLDK L+ L+W
Sbjct: 381 QGMREFIAEIATIGRLRHPNLVRLQGYCRHKGELYLVYDCMAKGSLDKFLYHQQTGNLDW 440
Query: 443 YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 502
QRF+II+ VASGL YLH+ W QV++HRDIKPAN+LLDA++N KLGDFGLA+L DH T P
Sbjct: 441 SQRFKIIKDVASGLYYLHQQWVQVIIHRDIKPANILLDANMNAKLGDFGLAKLCDHGTDP 500
Query: 503 QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWV 562
QT+ + GT GY+ PEL RTGKAST +DV+AFG+ MLE+A GR+P+ + S + L DWV
Sbjct: 501 QTSHVAGTLGYISPELSRTGKASTRSDVFAFGIVMLEIACGRKPILPRASQREMVLTDWV 560
Query: 563 CDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+CW+ I D ++ E+Q LVLKLGLFCSHP RPNM V+Q
Sbjct: 561 LECWENEDIMQVLDHKIGQEYVEEQAALVLKLGLFCSHPVAAIRPNMSSVIQ 612
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O80939 | LRK41_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5338 | 0.9462 | 0.8607 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 614 | |||
| cd06899 | 236 | cd06899, lectin_legume_LecRK_Arcelin_ConA, legume | 8e-99 | |
| pfam00139 | 231 | pfam00139, Lectin_legB, Legume lectin domain | 3e-96 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-49 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-49 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-48 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-48 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-47 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-46 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-45 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-39 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-34 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-34 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-33 | |
| cd01951 | 223 | cd01951, lectin_L-type, legume lectins | 9e-33 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-32 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-32 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-32 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-30 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-28 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-28 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-28 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-27 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-27 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-27 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-27 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-26 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-26 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-26 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-26 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-25 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-25 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-25 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-25 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-25 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-25 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-24 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-24 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-24 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-24 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-24 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-24 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-24 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-24 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 9e-24 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-23 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-23 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-22 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-22 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-22 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 9e-22 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-21 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-21 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-21 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-21 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-21 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-21 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-20 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-20 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-20 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-20 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-20 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-19 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-19 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-19 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-19 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-19 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-19 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-19 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 7e-19 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 9e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-18 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-18 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-18 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-18 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-18 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-18 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-17 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-17 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-17 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 7e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 9e-17 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-16 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-16 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-16 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-16 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-16 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-16 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 8e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 8e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 9e-16 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-15 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-15 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-15 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-15 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-15 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-15 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-15 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-15 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-15 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 8e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-15 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 9e-15 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 9e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-14 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 9e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 9e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-13 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-13 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-13 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-13 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-13 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-13 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-13 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-13 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 9e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-12 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-12 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-12 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-12 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-12 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 9e-12 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 9e-12 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 8e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-10 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-10 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 8e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 8e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 9e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 3e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 5e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.001 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 0.001 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.001 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.002 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.002 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.002 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.002 |
| >gnl|CDD|173887 cd06899, lectin_legume_LecRK_Arcelin_ConA, legume lectins, lectin-like receptor kinases, arcelin, concanavalinA, and alpha-amylase inhibitor | Back alignment and domain information |
|---|
Score = 300 bits (771), Expect = 8e-99
Identities = 115/245 (46%), Positives = 153/245 (62%), Gaps = 23/245 (9%)
Query: 29 QFIYHGFNED-AQLQRDGLASVHSNGLLQLTNTVSP-QQEGHAFYRLPIKF-NTSSSESL 85
F ++GF+ D + L G A++ SNG LQLTN SP G A Y P++ ++++ +
Sbjct: 2 SFNFNGFSSDQSNLTLQGDATISSNGALQLTNDTSPASSVGRALYSKPVRLWDSTTGKVA 61
Query: 86 SFSSNFVFAI----------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILA 135
SFS++F F+I G+AF ++P+ L AS YLGLFN+SNNG S+NHI+A
Sbjct: 62 SFSTSFSFSITPPNPSLGGDGLAFFLAPTDSL--PPASSGGYLGLFNSSNNGNSSNHIVA 119
Query: 136 IELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGDPIQIWIS 195
+E DT QN +F D DDNHVGIDVNSL S A Y+ D G +L G P+Q WI
Sbjct: 120 VEFDTFQNPEFGDPDDNHVGIDVNSL---VSVKAGYWDDDGG-----KLKSGKPMQAWID 171
Query: 196 YDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLKSSHYVLGWS 255
YD + K L+VTLA + KP KPLLS ++LS +L E +YVGFSASTG L HY+L WS
Sbjct: 172 YDSSSKRLSVTLAYSGVAKPKKPLLSYPVDLSKVLPEEVYVGFSASTGLLTELHYILSWS 231
Query: 256 FNRSG 260
F+ +G
Sbjct: 232 FSSNG 236
|
This alignment model includes the legume lectins (also known as agglutinins), the arcelin (also known as phytohemagglutinin-L) family of lectin-like defense proteins, the LecRK family of lectin-like receptor kinases, concanavalinA (ConA), and an alpha-amylase inhibitor. Arcelin is a major seed glycoprotein discovered in kidney beans (Phaseolus vulgaris) that has insecticidal properties and protects the seeds from predation by larvae of various bruchids. Arcelin is devoid of monosaccharide binding properties and lacks a key metal-binding loop that is present in other members of this family. Phytohaemagglutinin (PHA) is a lectin found in plants, especially beans, that affects cell metabolism by inducing mitosis and by altering the permeability of the cell membrane to various proteins. PHA agglutinates most mammalian red blood cell types by binding glycans on the cell surface. Medically, PHA is used as a mitogen to trigger cell division in T-lymphocytes and to activate latent HIV-1 from human peripheral lymphocytes. Plant L-type lectins are primarily found in the seeds of leguminous plants where they constitute about 10% of the total soluble protein of the seed extracts. They are synthesized during seed development several weeks after flowering and transported to the vacuole where they become condensed into specialized vesicles called protein bodies. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. Length = 236 |
| >gnl|CDD|215744 pfam00139, Lectin_legB, Legume lectin domain | Back alignment and domain information |
|---|
Score = 293 bits (753), Expect = 3e-96
Identities = 119/241 (49%), Positives = 153/241 (63%), Gaps = 25/241 (10%)
Query: 29 QFIYHGFNEDAQLQRDGLASVHSNGLLQLTNTVSPQQEGHAFYRLPIKF-NTSSSESLSF 87
F Y+GF+ + L G A+V NGLLQLTN V+ G A Y PI+ ++S+ + SF
Sbjct: 4 SFNYNGFSNVSNLTLQGDATVLPNGLLQLTN-VTNNSAGRALYSKPIRLWDSSTGKVASF 62
Query: 88 SSNFVFAI-----------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILAI 136
S++FVFAI G+AF ++PS A S YLGLFN+SNNG S+NHI+A+
Sbjct: 63 STSFVFAIKNIPKSTNGGDGLAFFLAPSGTQPGA--SSGGYLGLFNSSNNGNSSNHIVAV 120
Query: 137 ELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGDPIQIWISY 196
E DT N +F+DIDDNHVGIDVNS+IS S A+ L+L G PIQ+WI Y
Sbjct: 121 EFDTFLNPEFNDIDDNHVGIDVNSIISVASESAS--------FVPLDLNSGKPIQVWIDY 172
Query: 197 DGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLKSSHYVLGWSF 256
DG+ K L+VTLA KP +PLLS +++LS +L E +YVGFSASTG SHYVL WSF
Sbjct: 173 DGSSKRLSVTLAY--PNKPKRPLLSASVDLSTVLPEWVYVGFSASTGGATESHYVLSWSF 230
Query: 257 N 257
+
Sbjct: 231 S 231
|
Length = 231 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 2e-49
Identities = 72/275 (26%), Positives = 122/275 (44%), Gaps = 26/275 (9%)
Query: 347 FKDKDVIGRGGFGKVYRGVLASNVQI-AVKKV--SHDSKQGIKEFVAELVSMGRLRHRNL 403
++ +G G FG VY+ +I AVK + + + + E+ + RL H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 404 VKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDW 463
V+L K LV +Y G L L L+ + +I + GL YLH +
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG--PLSEDEAKKIALQILRGLEYLHSNG 118
Query: 464 EQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGK 523
++HRD+KP N+LLD + K+ DFGLA+ + T VGT YM PE++ G
Sbjct: 119 ---IIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFVGTPWYMAPEVLLGGN 174
Query: 524 -ASTSTDVYAFGVFMLEVASGRRPVEQQGS---METVNLVDWVCDCWKKGAIRDASDSRL 579
DV++ GV + E+ +G+ P + ++ + + G + + +
Sbjct: 175 GYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRI--------LGPPLEFDEPKW 226
Query: 580 EGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
EE + +L+ K C + P RP +++Q
Sbjct: 227 SSGSEEAK-DLIKK----CLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 170 bits (434), Expect = 5e-49
Identities = 72/270 (26%), Positives = 122/270 (45%), Gaps = 22/270 (8%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKE-FVAELVSMGRLRHRNLV 404
++ + +G G FGKVY + +A+K + + +E + E+ + +L+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 405 KLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWE 464
+L + + LV +Y G L +L + + + +R + S L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARF--YLRQILSALEYLHSKG- 117
Query: 465 QVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKA 524
++HRD+KP N+LLD D + KL DFGLAR D + T VGT YM PE++
Sbjct: 118 --IVHRDLKPENILLDEDGHVKLADFGLARQLDPGE--KLTTFVGTPEYMAPEVLLGKGY 173
Query: 525 STSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICE 584
+ D+++ GV + E+ +G+ P + + +KK E
Sbjct: 174 GKAVDIWSLGVILYELLTGKPPFPGDDQLLEL---------FKKIGKPKPPFPPPEWDIS 224
Query: 585 EKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+ +L+ KL L PE R + +Q
Sbjct: 225 PEAKDLIRKL-L---VKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 2e-48
Identities = 84/274 (30%), Positives = 135/274 (49%), Gaps = 30/274 (10%)
Query: 350 KDVIGRGGFGKVYRGVL-----ASNVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNL 403
+G G FG+VY+G L V++AVK + D S+Q I+EF+ E M +L H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 404 VKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDW 463
VKL G C + ++V +YMP G L L N L+ +A G+ YL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES-- 121
Query: 464 EQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTI-PQTTKLVGTFGYMDPELMRT 521
+ + HRD+ N L+ +L K+ DFGL+R LYD D + KL +M PE ++
Sbjct: 122 KNFI-HRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLKE 178
Query: 522 GKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580
GK ++ +DV++FGV + E+ + G P M +++++ KKG +
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEEP---YPGMSNAEVLEYL----KKGYRLPKPPN--- 228
Query: 581 GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
C + +L+L+ C PE RP ++++
Sbjct: 229 --CPPELYKLMLQ----CWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 6e-48
Identities = 81/273 (29%), Positives = 134/273 (49%), Gaps = 29/273 (10%)
Query: 350 KDVIGRGGFGKVYRGVL-----ASNVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNL 403
+G G FG+VY+G L V++AVK + D S+Q I+EF+ E M +L H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 404 VKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDW 463
VKL G C + +V +YM G L L N +P L+ +A G+ YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKN-RPKLSLSDLLSFALQIARGMEYLES-- 120
Query: 464 EQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMDPELMRTG 522
+ + HRD+ N L+ +L K+ DFGL+R LYD D + + +M PE ++ G
Sbjct: 121 KNFI-HRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR-WMAPESLKEG 178
Query: 523 KASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEG 581
K ++ +DV++FGV + E+ + G +P M +++++ K G +
Sbjct: 179 KFTSKSDVWSFGVLLWEIFTLGEQP---YPGMSNEEVLEYL----KNGYRLPQPPN---- 227
Query: 582 ICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
C + +L+L+ C PE RP ++++
Sbjct: 228 -CPPELYDLMLQ----CWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 3e-47
Identities = 65/191 (34%), Positives = 100/191 (52%), Gaps = 9/191 (4%)
Query: 353 IGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKE-FVAELVSMGRLRHRNLVKLRGYC 410
+G GGFG VY + ++A+K + + + E + E+ + +L H N+VKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 411 RRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHR 470
+ LV +Y GSL +L N L+ + RI+ + GL YLH ++HR
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLH---SNGIIHR 116
Query: 471 DIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMR-TGKASTST 528
D+KP N+LLD+D KL DFGL++L D +VGT YM PE++ G S +
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDK-SLLKTIVGTPAYMAPEVLLGKGYYSEKS 175
Query: 529 DVYAFGVFMLE 539
D+++ GV + E
Sbjct: 176 DIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 7e-46
Identities = 76/273 (27%), Positives = 132/273 (48%), Gaps = 32/273 (11%)
Query: 352 VIGRGGFGKVYRGVL-----ASNVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVK 405
+G G FG+VY+G L + ++AVK + S++ +EF+ E M +L H N+V+
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 406 LRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQ 465
L G C + +V +YMP G L L + L ++ +A G+ YL +
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLRKH-GEKLTLKDLLQMALQIAKGMEYLE---SK 121
Query: 466 VVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMDPELMRTGKA 524
+HRD+ N L+ +L K+ DFGL+R +Y+ D + +M PE ++ GK
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKF 181
Query: 525 STSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEG-- 581
++ +DV++FGV + E+ + G +P + E + L+ + G RL
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELL-------EDGY-------RLPRPE 227
Query: 582 ICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
C ++ EL+L+ C PE RP ++++
Sbjct: 228 NCPDELYELMLQ----CWAYDPEDRPTFSELVE 256
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 2e-45
Identities = 79/278 (28%), Positives = 129/278 (46%), Gaps = 37/278 (13%)
Query: 351 DVIGRGGFGKVYRGVL----ASNVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVK 405
+G G FG+VY+G L ++AVK + D S++ K+F+ E M +L H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 406 LRGYCRRKGEFLLVYDYMPNGSLDKIL-------HTNIKPCLNWYQRFRIIRGVASGLLY 458
L G C + LV +YM G L L + K L+ +A G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 459 LHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMDPE 517
L + +HRD+ N L+ DL K+ DFGL+R +YD D + T +M PE
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 518 LMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASD 576
++ G ++ +DV++FGV + E+ + G P + +++++ +KG
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATPY---PGLSNEEVLEYL----RKG------- 223
Query: 577 SRLE--GICEEKQMELVLKLGLFCSHPKPEARPNMRQV 612
RL C ++ EL+L C PE RP ++
Sbjct: 224 YRLPKPEYCPDELYELMLS----CWQLDPEDRPTFSEL 257
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 3e-39
Identities = 66/207 (31%), Positives = 110/207 (53%), Gaps = 23/207 (11%)
Query: 352 VIGRGGFGKVYRGVLASNVQ-IAVKKV--SHDSKQGIKEFVAELVSMGRLRHRNLVKLRG 408
++GRG FG VY + + +AVK V S DS++ ++ E+ + L+H N+V+ G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 409 YCR-RKGEFLLVY-DYMPNGSLDKILHTNIKPCLNWYQRFR--IIRGVA----SGLLYLH 460
R + L ++ +Y+ GSL +L + + +IR GL YLH
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLLKK--------FGKLPEPVIRKYTRQILEGLAYLH 118
Query: 461 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMDPELM 519
++HRDIK AN+L+D+D KL DFG A+ L D +T T + GT +M PE++
Sbjct: 119 S---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 520 RTGKASTSTDVYAFGVFMLEVASGRRP 546
R + + D+++ G ++E+A+G+ P
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 2e-34
Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 11/204 (5%)
Query: 347 FKDKDVIGRGGFGKVYRGVLASNVQI-AVKKVS--HDSKQGIKEFVAELVSMGRLRHRNL 403
++ D+IGRG FG VY+G+ A+K++S ++ +K + E+ + L+H N+
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61
Query: 404 VKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDW 463
VK G ++ +Y NGSL +I+ + V GL YLHE
Sbjct: 62 VKYIGSIETSDSLYIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHE-- 117
Query: 464 EQVVLHRDIKPANVLLDADLNGKLGDFGLA-RLYDHDTIPQTTKLVGTFGYMDPELMRTG 522
Q V+HRDIK AN+L D KL DFG+A +L D +VGT +M PE++
Sbjct: 118 -QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS--KDDASVVGTPYWMAPEVIEMS 174
Query: 523 KASTSTDVYAFGVFMLEVASGRRP 546
AST++D+++ G ++E+ +G P
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 7e-34
Identities = 82/268 (30%), Positives = 120/268 (44%), Gaps = 30/268 (11%)
Query: 350 KDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGY 409
IG+G FG V G ++AVK + DS + F+AE M LRH NLV+L G
Sbjct: 11 GATIGKGEFGDVMLGDYRGQ-KVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGV 68
Query: 410 CRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLH 469
+ +V +YM GSL L + + + Q+ V G+ YL E+ +H
Sbjct: 69 VLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVH 125
Query: 470 RDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVGTFGYMDPELMRTGKASTS 527
RD+ NVL+ DL K+ DFGLA+ D+ K + PE +R K ST
Sbjct: 126 RDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK------WTAPEALREKKFSTK 179
Query: 528 TDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEK 586
+DV++FG+ + E+ S GR P + + V V +KG R+E E
Sbjct: 180 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHV-------EKG-------YRME--APEG 223
Query: 587 QMELVLKLGLFCSHPKPEARPNMRQVMQ 614
V K+ C P RP +Q+ +
Sbjct: 224 CPPEVYKVMKDCWELDPAKRPTFKQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 4e-33
Identities = 64/211 (30%), Positives = 113/211 (53%), Gaps = 9/211 (4%)
Query: 347 FKDKDVIGRGGFGKVYRG-VLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVK 405
F+ + IG+GGFG+VY+ + ++A+K + +SK+ ++ + E+ + + +H N+VK
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 406 LRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQ 465
G +K E +V ++ GSL +L + + L Q + + + GL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQT-LTESQIAYVCKELLKGLEYLH---SN 117
Query: 466 VVLHRDIKPANVLLDADLNGKLGDFGLA-RLYDHDTIPQTTKLVGTFGYMDPELMRTGKA 524
++HRDIK AN+LL +D KL DFGL+ +L D +VGT +M PE++
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSD---TKARNTMVGTPYWMAPEVINGKPY 174
Query: 525 STSTDVYAFGVFMLEVASGRRPVEQQGSMET 555
D+++ G+ +E+A G+ P + M+
Sbjct: 175 DYKADIWSLGITAIELAEGKPPYSELPPMKA 205
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173886 cd01951, lectin_L-type, legume lectins | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 9e-33
Identities = 63/248 (25%), Positives = 99/248 (39%), Gaps = 34/248 (13%)
Query: 17 SFIFSALAQDVNQFIYHGFNEDAQLQRDGLASVHSNGLLQLTNTVSPQQEGHAFYRLPIK 76
S FS + + N A L D +G+L+LT + Q G A+Y+ PI
Sbjct: 2 SLNFSNFSNNNQSNWQ--LNGSATLTTD-------SGVLRLTP-DTGNQAGSAWYKTPID 51
Query: 77 FNTSSSESLSF--SSNFVF-AIGMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHI 133
+ + + F + A G+AFV+ LG +
Sbjct: 52 LSKDFTTTFKFYLGTKGTNGADGIAFVLQNDPAGALGGGGGGGGLG-------YGGIGNS 104
Query: 134 LAIELDTVQNLDFDDIDDNHVGIDVNSLISHE----SAPAAYFSDREGMNKTLELIIGDP 189
+A+E DT +N D +D + NH+ IDVN ++ S +A + G+ +
Sbjct: 105 VAVEFDTYKNDDNNDPNGNHISIDVNGNGNNTALATSLGSASLPNGTGLGNEHTV----- 159
Query: 190 IQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLKSSH 249
I+YD L V L S T ++ ++L + Y GF+ASTG L + H
Sbjct: 160 ---RITYDPTTNTLTVYLDNGSTL--TSLDITIPVDLIQLGPTKAYFGFTASTGGLTNLH 214
Query: 250 YVLGWSFN 257
+L WSF
Sbjct: 215 DILNWSFT 222
|
The L-type (legume-type) lectins are a highly diverse family of carbohydrate binding proteins that generally display no enzymatic activity toward the sugars they bind. This family includes arcelin, concanavalinA, the lectin-like receptor kinases, the ERGIC-53/VIP36/EMP46 type1 transmembrane proteins, and an alpha-amylase inhibitor. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. Length = 223 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 2e-32
Identities = 78/284 (27%), Positives = 132/284 (46%), Gaps = 25/284 (8%)
Query: 346 GFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRH-R 401
++ +G G FG+VY +A+K ++ + ++ F+ E+ + L H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 402 NLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNI-KPCLNWYQRFRIIRGVASGLLYLH 460
N+VKL + + +G LV +Y+ GSL+ +L K L+ + I+ + S L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 461 EDWEQVVLHRDIKPANVLLDADLN-GKLGDFGLARLYDHDTIPQ-----TTKLVGTFGYM 514
+ ++HRDIKP N+LLD D KL DFGLA+L + VGT GYM
Sbjct: 119 S---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 515 DPEL---MRTGKASTSTDVYAFGVFMLEVASGRRPVE-QQGSMETVNLVDWVCDCWKKGA 570
PE+ + AS+S+D+++ G+ + E+ +G P E ++ S T + + +
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235
Query: 571 IRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
S S E I + +L+ K P+ R + +
Sbjct: 236 ASPLSPSNPELI-SKAASDLLKK----LLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 5e-32
Identities = 66/224 (29%), Positives = 111/224 (49%), Gaps = 13/224 (5%)
Query: 347 FKDKDVIGRGGFGKVYRGVL-ASNVQIAVKK--VSHDSKQGIKEFVAELVSMGRLRHRNL 403
+ V+G+G G VY+ + A+KK V D + K+ + EL ++ +
Sbjct: 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEF-RKQLLRELKTLRSCESPYV 61
Query: 404 VKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRF--RIIRGVASGLLYLHE 461
VK G ++GE +V +YM GSL + +K + I R + GL YLH
Sbjct: 62 VKCYGAFYKEGEISIVLEYMDGGSLADL----LKKVGKIPEPVLAYIARQILKGLDYLHT 117
Query: 462 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRT 521
+ HRDIKP+N+L+++ K+ DFG++++ + +T+ Q VGT YM PE ++
Sbjct: 118 KRHII--HRDIKPSNLLINSKGEVKIADFGISKVLE-NTLDQCNTFVGTVTYMSPERIQG 174
Query: 522 GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDC 565
S + D+++ G+ +LE A G+ P G L+ +CD
Sbjct: 175 ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG 218
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 6e-32
Identities = 69/280 (24%), Positives = 127/280 (45%), Gaps = 39/280 (13%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKV--SHDSKQGIKEFVAELVSMGRLRHRNL 403
++ IG+G FGKVY + +K++ S+ S++ ++ + E+ + +L H N+
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 404 VKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPC--------LNW-YQRFRIIRGVAS 454
+K KG+ +V +Y G L + + K L+W Q +
Sbjct: 62 IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ-------LCL 114
Query: 455 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYM 514
L YLH + +LHRDIKP N+ L ++ KLGDFG++++ T +VGT Y+
Sbjct: 115 ALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT-VVGTPYYL 170
Query: 515 DPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDA 574
PEL + + +D+++ G + E+ + + P E + ++ L + + I
Sbjct: 171 SPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE-NLL--ELALKILKG-QYPPIPSQ 226
Query: 575 SDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
S L + + L+ PE RP++ Q++Q
Sbjct: 227 YSSELRNLV--SSL---LQ-------KDPEERPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 5e-30
Identities = 72/208 (34%), Positives = 111/208 (53%), Gaps = 23/208 (11%)
Query: 352 VIGRGGFGKVYRGVLASN----VQIAVK--KVSHDSKQGIKEFVAELVSMGRLRHRNLVK 405
VIG G FG+V RG L + +A+K K KQ + +F+ E MG+ H N+++
Sbjct: 11 VIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL-DFLTEASIMGQFDHPNIIR 69
Query: 406 LRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQ 465
L G + +++ +YM NGSLDK L N Q ++RG+ASG+ YL E
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLREN-DGKFTVGQLVGMLRGIASGMKYLS---EM 125
Query: 466 VVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFG------YMDPELM 519
+HRD+ N+L++++L K+ DFGL+R + TTK G + PE +
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK-----GGKIPIRWTAPEAI 180
Query: 520 RTGKASTSTDVYAFGVFMLEVAS-GRRP 546
K ++++DV++FG+ M EV S G RP
Sbjct: 181 AYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 7e-29
Identities = 66/216 (30%), Positives = 101/216 (46%), Gaps = 24/216 (11%)
Query: 347 FKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKE---FVAELVSMGRLRHRNL 403
++ + IG+G FG V + S+ +I V K KE V+E+ + L+H N+
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 404 VKLRGYCRR-----KGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRF------RIIRGV 452
V+ Y R +V +Y G L ++ I+ C + RI+ +
Sbjct: 62 VR---YYDRIIDRSNQTLYIVMEYCEGGDLAQL----IQKCKKERKYIEEEFIWRILTQL 114
Query: 453 ASGLLYLH--EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT 510
L H D VLHRD+KPAN+ LDA+ N KLGDFGLA++ HD+ T VGT
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT-YVGT 173
Query: 511 FGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRP 546
YM PE + +D+++ G + E+ + P
Sbjct: 174 PYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 62/210 (29%), Positives = 105/210 (50%), Gaps = 7/210 (3%)
Query: 353 IGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRR 412
+G G FG+V+ G+ + V++A+K + D ++F E+ ++ RLRH++L+ L C
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 413 KGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 472
++ + M GSL L + L + VA G+ YL EQ +HRD+
Sbjct: 74 GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDL 130
Query: 473 KPANVLLDADLNGKLGDFGLARLYDHDT-IPQTTKLVGTFGYMDPELMRTGKASTSTDVY 531
N+L+ DL K+ DFGLARL D + K+ + + PE G ST +DV+
Sbjct: 131 AARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTFSTKSDVW 188
Query: 532 AFGVFMLEVAS-GRRPVEQQGSMETVNLVD 560
+FG+ + E+ + G+ P + E + +
Sbjct: 189 SFGILLYEMFTYGQVPYPGMNNHEVYDQIT 218
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 6e-28
Identities = 74/212 (34%), Positives = 114/212 (53%), Gaps = 24/212 (11%)
Query: 353 IGRGGFGKVYRGV-LASNVQIAVKKVS-HDSKQG-IKEFVAELVSMGRLRHRNLVKLRGY 409
IG G FGKVY V L + +AVK++ D+ IKE E+ + L+H NLVK G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 410 CRRKGEFLLVYDYMPNGSLDKIL-HTNIKPCLNWYQRF--RIIRGVASGLLYLHEDWEQV 466
+ + + +Y G+L+++L H I + + + +++ G+A YLH
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLEHGRILD-EHVIRVYTLQLLEGLA----YLHS---HG 119
Query: 467 VLHRDIKPANVLLDADLNG--KLGDFGLA-RLYDHDTIPQTT--KLVGTFGYMDPELMRT 521
++HRDIKPAN+ LD NG KLGDFG A +L ++ T L GT YM PE++
Sbjct: 120 IVHRDIKPANIFLDH--NGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177
Query: 522 GKAS---TSTDVYAFGVFMLEVASGRRPVEQQ 550
GK + D+++ G +LE+A+G+RP +
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 7e-28
Identities = 66/226 (29%), Positives = 92/226 (40%), Gaps = 53/226 (23%)
Query: 346 GFKDKDVIGRGGFGKVYRGVLASNVQ-------IAVK---KVSHDSKQGIKEFVAELVSM 395
F+ VIG+G FGKV VQ A+K K K ++ + E +
Sbjct: 1 HFELLRVIGKGAFGKVC------IVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRIL 54
Query: 396 GRLRHRNLVKLRGYCRRKGEFL-LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGV-- 452
L H LV L Y + E + LV D + G L R+ + + V
Sbjct: 55 QELNHPFLVNLW-YSFQDEENMYLVVDLLLGGDL----------------RYHLSQKVKF 97
Query: 453 ------------ASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500
L YLH + ++HRDIKP N+LLD + + DF +A DT
Sbjct: 98 SEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154
Query: 501 IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRP 546
TT GT GYM PE++ S + D ++ GV E G+RP
Sbjct: 155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 61/224 (27%), Positives = 110/224 (49%), Gaps = 10/224 (4%)
Query: 345 KGFKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGI-KEFVAELVSMGRLRHRN 402
+ +G G G V + + + +AVK + + + I K+ + EL + +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60
Query: 403 LVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHED 462
+V G G+ + +YM GSLDKIL + +I V GL YLHE
Sbjct: 61 IVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGR-IPERILGKIAVAVLKGLTYLHEK 119
Query: 463 WEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTG 522
+ ++HRD+KP+N+L+++ KL DFG++ +++ +T VGT YM PE ++
Sbjct: 120 HK--IIHRDVKPSNILVNSRGQIKLCDFGVSG-QLVNSLAKT--FVGTSSYMAPERIQGN 174
Query: 523 KASTSTDVYAFGVFMLEVASGRRPV--EQQGSMETVNLVDWVCD 564
S +D+++ G+ ++E+A+GR P E L+ ++ +
Sbjct: 175 DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN 218
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 71/220 (32%), Positives = 123/220 (55%), Gaps = 17/220 (7%)
Query: 350 KDVIGRGGFGKVYRGVLA----SNVQIAVK--KVSHDSKQGIKEFVAELVSMGRLRHRNL 403
+ VIG G FG+V+RG+L V +A+K K + KQ ++F++E MG+ H N+
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR-QDFLSEASIMGQFSHHNI 68
Query: 404 VKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDW 463
++L G + +++ +YM NG+LDK L + + YQ ++RG+A+G+ YL
Sbjct: 69 IRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGE-FSSYQLVGMLRGIAAGMKYLS--- 124
Query: 464 EQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFG--YMDPELMRT 521
+ +HRD+ N+L++++L K+ DFGL+R+ + D T G + PE +
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184
Query: 522 GKASTSTDVYAFGVFMLEVAS-GRRP---VEQQGSMETVN 557
K ++++DV++FG+ M EV S G RP + M+ +N
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN 224
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 3e-27
Identities = 74/249 (29%), Positives = 125/249 (50%), Gaps = 33/249 (13%)
Query: 348 KDKDVIGRGGFGKVYRGVLA------SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHR 401
K ++VIG G FG+V RG L V I K + KQ ++F++E MG+ H
Sbjct: 7 KIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQR-RDFLSEASIMGQFDHP 65
Query: 402 NLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHE 461
N++ L G + +++ ++M NG+LD L N Q ++RG+A+G+ YL
Sbjct: 66 NIIHLEGVVTKSRPVMIITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLS- 123
Query: 462 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVG---TFGYMDPE 517
E +HRD+ N+L++++L K+ DFGL+R + DT P T +G + PE
Sbjct: 124 --EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE 181
Query: 518 LMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVD---------------- 560
+ K ++++DV+++G+ M EV S G RP + + +N ++
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTALH 241
Query: 561 -WVCDCWKK 568
+ DCW+K
Sbjct: 242 QLMLDCWQK 250
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 61/205 (29%), Positives = 105/205 (51%), Gaps = 16/205 (7%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHD-SKQGI-KEFVAELVSMGRLRHRNL 403
++ + +G G +G VY+ + +A+KK+ D ++GI + E+ + L+H N+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60
Query: 404 VKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPC-LNWYQR--FRIIRGVASGLLYLH 460
VKL + + LV++Y L K L P N + ++++RG+A Y H
Sbjct: 61 VKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLA----YCH 115
Query: 461 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPE-LM 519
+LHRD+KP N+L++ D KL DFGLAR + T ++V T Y PE L+
Sbjct: 116 SHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILL 171
Query: 520 RTGKASTSTDVYAFGVFMLEVASGR 544
+ ST+ D+++ G E+ +G+
Sbjct: 172 GSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 66/230 (28%), Positives = 109/230 (47%), Gaps = 41/230 (17%)
Query: 347 FKDKDVIGRGGFGKVYRGVL-ASNVQIAVKKVSHDSKQGIKEFVAELV-----SMGRL-R 399
FK +IG G F V +N + A+K + D +Q IKE + V + RL
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKIL--DKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 400 HRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLL-- 457
H ++KL + + V +Y PNG L + + L+ + R A+ +L
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKY--GSLD----EKCTRFYAAEILLA 114
Query: 458 --YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL-------- 507
YLH + ++HRD+KP N+LLD D++ K+ DFG A++ D ++ P++ K
Sbjct: 115 LEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171
Query: 508 -----------VGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRP 546
VGT Y+ PEL+ A S+D++A G + ++ +G+ P
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-26
Identities = 107/404 (26%), Positives = 183/404 (45%), Gaps = 46/404 (11%)
Query: 224 INLSHILLETMYVGFSASTGSLKSSHYVLGWSFNRSGPALNLDISSLPRLPHLPRPRAKA 283
+N+SH L GSL S+ L + N S A N+D+ LP P +
Sbjct: 576 VNISHNHLH----------GSLPSTGAFL--AINASAVAGNIDLCGGDTTSGLP-PCKRV 622
Query: 284 NDKPQLKLVISVSLIAILVVLITIGAAVYIVRNKRYEEV----YED--WEREYGPQR--- 334
P I+ +L A LV+ + V+I R + E+ ED WE ++ +
Sbjct: 623 RKTPSWWFYITCTLGAFLVLALVAFGFVFI-RGRNNLELKRVENEDGTWELQFFDSKVSK 681
Query: 335 -FTYKDLYKATKGFKDKDVIGRGGFGKVYRGVLASN-VQIAVKKVSHDSKQGIKEFVAEL 392
T D+ + K +++VI RG G Y+G N +Q VK+++ D +A+
Sbjct: 682 SITINDILSSLK---EENVISRGKKGASYKGKSIKNGMQFVVKEIN-DVNSIPSSEIAD- 736
Query: 393 VSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGV 452
MG+L+H N+VKL G CR + L+++Y+ +L ++L L+W +R +I G+
Sbjct: 737 --MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGI 789
Query: 453 ASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFG 512
A L +LH V+ ++ P +++D L L L D TK +
Sbjct: 790 AKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL-RLSLPGLLCTD-----TKCFISSA 843
Query: 513 YMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIR 572
Y+ PE T + +D+Y FG+ ++E+ +G+ P + + + ++V+W C+ +
Sbjct: 844 YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG-SIVEWARYCYSDCHLD 902
Query: 573 DASDSRLEGICEEKQMELV--LKLGLFCSHPKPEARPNMRQVMQ 614
D + G Q E+V + L L C+ P ARP V++
Sbjct: 903 MWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLK 946
|
Length = 968 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 70/234 (29%), Positives = 105/234 (44%), Gaps = 22/234 (9%)
Query: 353 IGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRR 412
+G G FG+V+ G+ + +AVK + + K+F+AE M +LRH L++L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 413 KGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 472
+ +V + M GSL + L L Q + VASG+ YL Q +HRD+
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDL 129
Query: 473 KPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYA 532
NVL+ + K+ DFGLAR+ D + PE + S +DV++
Sbjct: 130 AARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWS 189
Query: 533 FGVFMLE-VASGRRP------------VEQQGSMET-----VNLVDWVCDCWKK 568
FG+ + E V GR P V+Q M L D + DCWK+
Sbjct: 190 FGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLDCWKE 243
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 72/259 (27%), Positives = 118/259 (45%), Gaps = 45/259 (17%)
Query: 350 KDVIGRGGFGKVYRGVLA------SNVQIAVKKVSHDSKQGIKE-FVAELVSMGRLRHRN 402
K +G G FGKV+ G +AVK + + ++ F E + +H N
Sbjct: 10 KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHEN 69
Query: 403 LVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTN-------IKPC-----LNWYQRFRIIR 450
+VK G C ++V++YM +G L+K L ++ P L Q +I
Sbjct: 70 IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129
Query: 451 GVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LY--DHDTIPQTTKL 507
+ASG++YL Q +HRD+ N L+ DL K+GDFG++R +Y D+ + T L
Sbjct: 130 QIASGMVYLA---SQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML 186
Query: 508 VGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVD------ 560
+M PE + K +T +DV++FGV + E+ + G++P + E + +
Sbjct: 187 --PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQ 244
Query: 561 -------WVCD----CWKK 568
V D CWK+
Sbjct: 245 RPRTCPSEVYDIMLGCWKR 263
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 77/266 (28%), Positives = 118/266 (44%), Gaps = 30/266 (11%)
Query: 353 IGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRR 412
+G G FG V+ G + +A+K + + +F+ E M +L H NLV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 413 KGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 472
+ +V +YM NG L L K L + V + YL +HRD+
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRER-KGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDL 126
Query: 473 KPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDV 530
N L+ D K+ DFGLAR L D T Q TK + PE+ + S+ +DV
Sbjct: 127 AARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKF--PVKWAPPEVFDYSRFSSKSDV 184
Query: 531 YAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE--GICEEKQ 587
++FGV M EV S G+ P E+ + E V V ++ RL + +
Sbjct: 185 WSFGVLMWEVFSEGKMPYERFSNSEVVESV--------------SAGYRLYRPKLAPTEV 230
Query: 588 MELVLKLGLFCSHPKPEARPNMRQVM 613
++ C H KPE RP ++++
Sbjct: 231 YTIMYS----CWHEKPEDRPAFKKLL 252
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 65/212 (30%), Positives = 109/212 (51%), Gaps = 9/212 (4%)
Query: 347 FKDKDVIGRGGFGKVYRGVLASNVQIAVKK---VSHDSKQGIKEFVAELVSMGRLRHRNL 403
F+ + IG+G FG V++ V ++ ++ K +S +++ +E + E + +L +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 404 VKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDW 463
++ KG+ +V +Y NG L K+L L Q +R + GL +LH
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS-- 119
Query: 464 EQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGK 523
+ +LHRDIK N+ LDA N K+GD G+A+L +T T +VGT Y+ PEL
Sbjct: 120 -KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-IVGTPYYLSPELCEDKP 177
Query: 524 ASTSTDVYAFGVFMLEVASGRRP--VEQQGSM 553
+ +DV+A GV + E +G+ P QG++
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPFDANNQGAL 209
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 71/243 (29%), Positives = 122/243 (50%), Gaps = 31/243 (12%)
Query: 352 VIGRGGFGKVYRGVLA----SNVQIAVK--KVSHDSKQGIKEFVAELVSMGRLRHRNLVK 405
VIG G FG+V G L + +A+K K + KQ ++F++E MG+ H N++
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR-RDFLSEASIMGQFDHPNIIH 69
Query: 406 LRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQ 465
L G + ++V +YM NGSLD L + Q ++RG+ASG+ YL +
Sbjct: 70 LEGVVTKSKPVMIVTEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLS---DM 125
Query: 466 VVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFG--YMDPELMRTGK 523
+HRD+ N+L++++L K+ DFGL+R+ + D T G + PE + K
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 185
Query: 524 ASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVD-----------------WVCDC 565
++++DV+++G+ M EV S G RP + + + + ++ + DC
Sbjct: 186 FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQLMLDC 245
Query: 566 WKK 568
W+K
Sbjct: 246 WQK 248
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 29/220 (13%)
Query: 348 KDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKL 406
++ V+G+G +G VY L++ V+IA+K++ + ++ E+ L+HRN+V+
Sbjct: 11 GERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQY 70
Query: 407 RGYCRRKGEFLLVYDYMPNGSLDKILHTNIKP------CLNWYQRFRIIRGVASGLLYLH 460
G G F + + +P GSL +L + P + +Y + + GL YLH
Sbjct: 71 LGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYT-----KQILEGLKYLH 125
Query: 461 EDWEQVVLHRDIKPANVLLDADLNG--KLGDFG----LARLYDHDTIPQTTKLVGTFGYM 514
+ ++HRDIK NVL++ +G K+ DFG LA + P T GT YM
Sbjct: 126 ---DNQIVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAGIN-----PCTETFTGTLQYM 176
Query: 515 DPELMRTGKA--STSTDVYAFGVFMLEVASGRRPVEQQGS 552
PE++ G D+++ G ++E+A+G+ P + G
Sbjct: 177 APEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE 216
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 76/261 (29%), Positives = 116/261 (44%), Gaps = 31/261 (11%)
Query: 353 IGRGGFGKVYRGVLASNVQIAVKKVSHDSKQG---IKEFVAELVSMGRLRHRNLVKLRGY 409
+G G FG+V+ G ++AVK + K G + F+ E M +LRH LV+L
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTL----KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 410 CRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLH 469
C + +V +YM GSL L + L Q + +A G+ YL + +H
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIH 126
Query: 470 RDIKPANVLLDADLNGKLGDFGLARLY--DHDTIPQTTKLVGTFGYMDPELMRTGKASTS 527
RD+ N+L+ +L K+ DFGLARL D T + K + PE G+ +
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF--PIKWTAPEAANYGRFTIK 184
Query: 528 TDVYAFGVFMLE-VASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEK 586
+DV++FG+ + E V GR P + E + V+ R R C E+
Sbjct: 185 SDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE-----------RGYRMPRPPN-CPEE 232
Query: 587 QMELVLKLGLFCSHPKPEARP 607
+L+L+ C PE RP
Sbjct: 233 LYDLMLQ----CWDKDPEERP 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 68/208 (32%), Positives = 103/208 (49%), Gaps = 21/208 (10%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVK 405
+K+ + IG G G+VY+ A+ ++A+KK+ KQ + + E++ M +H N+V
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVD 79
Query: 406 LRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQ 465
E +V +YM GSL I+ N +N Q + R V GL YLH Q
Sbjct: 80 YYDSYLVGDELWVVMEYMDGGSLTDIITQNFVR-MNEPQIAYVCREVLQGLEYLHS---Q 135
Query: 466 VVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTK-------LVGTFGYMDPEL 518
V+HRDIK N+LL D + KL DFG A Q TK +VGT +M PE+
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFA--------AQLTKEKSKRNSVVGTPYWMAPEV 187
Query: 519 MRTGKASTSTDVYAFGVFMLEVASGRRP 546
++ D+++ G+ +E+A G P
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 9e-25
Identities = 77/267 (28%), Positives = 128/267 (47%), Gaps = 22/267 (8%)
Query: 350 KDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRG 408
K +G G +G+VY GV ++ +AVK + D+ + ++EF+ E M ++H NLV+L G
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 409 YCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVL 468
C R+ F ++ ++M G+L L + +N + ++S + YL ++ +
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFI 126
Query: 469 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTST 528
HRD+ N L+ + K+ DFGL+RL DT + PE + K S +
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 186
Query: 529 DVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQ 587
DV+AFGV + E+A+ G P ++L V + +KG + R EG C K
Sbjct: 187 DVWAFGVLLWEIATYGMSP------YPGIDLSQ-VYELLEKGYRME----RPEG-CPPKV 234
Query: 588 MELVLKLGLFCSHPKPEARPNMRQVMQ 614
EL+ C P RP+ ++ Q
Sbjct: 235 YELMRA----CWQWNPSDRPSFAEIHQ 257
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 16/205 (7%)
Query: 353 IGRGGFGKVYRGVLASN-----VQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKL 406
+G G FGKV Q+AVK ++H +Q +F E+ + L H N+VK
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 407 RGYCRRKGE--FLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWE 464
+G C + G L+ +Y+P+GSL L + + +N + + G+ YL
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICKGMDYLGS--- 127
Query: 465 QVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVG---TFGYMDPELMRT 521
Q +HRD+ N+L++++ K+ DFGLA++ D K G F Y PE +RT
Sbjct: 128 QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYA-PECLRT 186
Query: 522 GKASTSTDVYAFGVFMLEVASGRRP 546
K S+++DV++FGV + E+ + P
Sbjct: 187 SKFSSASDVWSFGVTLYELFTYGDP 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 74/232 (31%), Positives = 118/232 (50%), Gaps = 46/232 (19%)
Query: 351 DVIGRGGFGKVYRGVLASNVQ----IAVKKVS--------HDSKQG--IKEFVAELVSMG 396
++IG+G +G+VY LA NV +AVK+V HDS+Q +K +E+ ++
Sbjct: 7 ELIGKGTYGRVY---LALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLK 63
Query: 397 RLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFR------IIR 450
L H N+V+ G+ + + +Y+P GS I CL Y RF
Sbjct: 64 DLDHLNIVQYLGFETTEEYLSIFLEYVPGGS--------IGSCLRTYGRFEEQLVRFFTE 115
Query: 451 GVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR----LYDHDTIPQTTK 506
V GL YLH + +LHRD+K N+L+DAD K+ DFG+++ +YD+D Q
Sbjct: 116 QVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDND---QNMS 169
Query: 507 LVGTFGYMDPELMRTGKASTS--TDVYAFGVFMLEVASGRRP---VEQQGSM 553
+ G+ +M PE++ + S D+++ G +LE+ +GRRP E +M
Sbjct: 170 MQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM 221
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 25/205 (12%)
Query: 353 IGRGGFGKVYRGV-LASNVQIAVKKVS-HDSKQGIKEFVA-ELVSMGRLRHRNLVKLRGY 409
IG G +G+VY+ + +A+KK+ + K+G E+ + +LRH N+V+L+
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 410 C--RRKGEFLLVYDYMP---NGSLD----KILHTNIKPCLNWYQRFRIIRGVASGLLYLH 460
+ KG +V++YM G LD K + IK ++ + GL YLH
Sbjct: 67 VTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIK---------CYMKQLLEGLQYLH 117
Query: 461 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPE-LM 519
+LHRDIK +N+L++ D KL DFGLAR Y T V T Y PE L+
Sbjct: 118 S---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLL 174
Query: 520 RTGKASTSTDVYAFGVFMLEVASGR 544
+ D+++ G + E+ G+
Sbjct: 175 GATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 28/212 (13%)
Query: 353 IGRGGFGKVYRGV-LASNVQIAVKKVS-----HDSKQGIKEFVAELVSMGRLRHRNLVKL 406
+G G FG VY G+ L AVK+VS ++ +K+ E+ + +L+H N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 407 RGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFR------IIRGVASGLLYLH 460
G R + + + +P GSL K+L Y F R + GL YLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKK--------YGSFPEPVIRLYTRQILLGLEYLH 119
Query: 461 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTK-LVGTFGYMDPE-L 518
+ + +HRDIK AN+L+D + KL DFG+A+ K G+ +M PE +
Sbjct: 120 D---RNTVHRDIKGANILVDTNGVVKLADFGMAK---QVVEFSFAKSFKGSPYWMAPEVI 173
Query: 519 MRTGKASTSTDVYAFGVFMLEVASGRRPVEQQ 550
+ G + D+++ G +LE+A+G+ P Q
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEMATGKPPWSQL 205
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 9/204 (4%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVK 405
++ IG G +G VY+ +A+ +A+K + + + E+ + RH N+V
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64
Query: 406 LRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQ 465
G R+ + +V +Y GSL I P L+ Q + R GL YLHE
Sbjct: 65 YFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP-LSELQIAYVCRETLKGLAYLHE---T 120
Query: 466 VVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELM---RTG 522
+HRDIK AN+LL D + KL DFG++ TI + +GT +M PE+ R G
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQLTA-TIAKRKSFIGTPYWMAPEVAAVERKG 179
Query: 523 KASTSTDVYAFGVFMLEVASGRRP 546
D++A G+ +E+A + P
Sbjct: 180 GYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 62/226 (27%), Positives = 96/226 (42%), Gaps = 40/226 (17%)
Query: 353 IGRGGFGKVYRGVLASNVQI----AVKKVSHDSKQGIKEFVAELVSMG------RLRHRN 402
+G+G FGKV L A+K + K+ I + ++ R+ H
Sbjct: 1 LGKGSFGKVL---LVRKKDTGKLYAMKVLK---KKKIIKRKEVEHTLTERNILSRINHPF 54
Query: 403 LVKLRGYCRRKGEFL-LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVA-------- 453
+VKL Y + E L LV +Y P G L L + R A
Sbjct: 55 IVKLH-YAFQTEEKLYLVLEYAPGGELFSHL----------SKEGRFSEERARFYAAEIV 103
Query: 454 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 513
L YLH +++RD+KP N+LLDAD + KL DFGLA+ + +T GT Y
Sbjct: 104 LALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGTPEY 159
Query: 514 MDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLV 559
+ PE++ + D ++ GV + E+ +G+ P + E +
Sbjct: 160 LAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI 205
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 83/276 (30%), Positives = 125/276 (45%), Gaps = 36/276 (13%)
Query: 345 KGFKDKDVIGRGGFGKV----YRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRH 400
K K IG+G FG V YRG ++AVK + +D+ + F+AE M +LRH
Sbjct: 6 KELKLLQTIGKGEFGDVMLGDYRGN-----KVAVKCIKNDATA--QAFLAEASVMTQLRH 58
Query: 401 RNLVKLRGY-CRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYL 459
NLV+L G KG +V +YM GSL L + + L + V + YL
Sbjct: 59 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 118
Query: 460 HEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELM 519
+ +HRD+ NVL+ D K+ DFGL + + + T KL + PE +
Sbjct: 119 EAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKL--PVKWTAPEAL 171
Query: 520 RTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSR 578
R K ST +DV++FG+ + E+ S GR P + + V V+ KG DA D
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-------KGYKMDAPDG- 223
Query: 579 LEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
C +++ + C H RP+ Q+ +
Sbjct: 224 ----CPPVVYDVMKQ----CWHLDAATRPSFLQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 32/207 (15%)
Query: 353 IGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVA--ELVSMGRLRHRNLVKLRGY 409
IG G +G VY+ + +A+KK+ + A E+ + L H N++KL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 410 CRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQR-----------FRIIRGVASGLLY 458
R KG+ LV+++M T++ + QR +++++G+A +
Sbjct: 67 FRHKGDLYLVFEFM---------DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLA----F 113
Query: 459 LHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPEL 518
H +LHRD+KP N+L++ + KL DFGLAR + P T V T Y PEL
Sbjct: 114 CHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY-VVTRWYRAPEL 169
Query: 519 MRTGKA-STSTDVYAFGVFMLEVASGR 544
+ K ST D+++ G E+ S R
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 9e-24
Identities = 69/266 (25%), Positives = 120/266 (45%), Gaps = 25/266 (9%)
Query: 353 IGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKE-FVAELVSMGRLRHRNLVKLRGYCR 411
IG+G FG VY+GVL N ++AVK +K F+ E + + H N+VKL G C
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 412 RKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 471
+K +V + +P GSL L K L + ++ A+G+ YL + +HRD
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRD 118
Query: 472 IKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF--GYMDPELMRTGKASTSTD 529
+ N L+ + K+ DFG++R + I + + + PE + G+ ++ +D
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR-EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESD 177
Query: 530 VYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQM 588
V+++G+ + E S G P + +T ++ S R+ +
Sbjct: 178 VWSYGILLWETFSLGDTPYPGMSNQQTRERIE--------------SGYRMP--APQLCP 221
Query: 589 ELVLKLGLFCSHPKPEARPNMRQVMQ 614
E + +L L C PE RP+ ++
Sbjct: 222 EEIYRLMLQCWAYDPENRPSFSEIYN 247
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 62/198 (31%), Positives = 98/198 (49%), Gaps = 13/198 (6%)
Query: 353 IGRGGFGKVYR-GVLASNVQIAVKKVSHDSKQ-GIKEFVA-ELVSMGRLRHRNLVKLRGY 409
IG G G V++ + +A+KKV+ + GI E+ ++ +H +VKL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 410 CRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLH 469
F+LV +YMP L ++L +P L Q +R + G+ Y+H + ++H
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRDEERP-LPEAQVKSYMRMLLKGVAYMHAN---GIMH 122
Query: 470 RDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELM---RTGKAST 526
RD+KPAN+L+ AD K+ DFGLARL+ + + V T Y PEL+ R K
Sbjct: 123 RDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGAR--KYDP 180
Query: 527 STDVYAFGVFMLEVASGR 544
D++A G E+ +G
Sbjct: 181 GVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 4e-23
Identities = 75/273 (27%), Positives = 119/273 (43%), Gaps = 40/273 (14%)
Query: 353 IGRGGFGKVYRGVL----ASNVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLR 407
+G G FG V +GV V++AVK + + G KEF+ E M +L H +V+L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 408 GYCRRKGE-FLLVYDYMPNGSLDKIL----HTNIKPCLNWYQRFRIIRGVASGLLYLHED 462
G C KGE +LV + P G L K L + + VA G+ YL
Sbjct: 63 GVC--KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ------VAMGMAYLES- 113
Query: 463 WEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF--GYMDPELMR 520
+ +HRD+ NVLL K+ DFG++R + G + + PE +
Sbjct: 114 --KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECIN 171
Query: 521 TGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRL 579
GK S+ +DV+++GV + E S G +P + E + +++ S RL
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE--------------SGERL 217
Query: 580 EGICEEKQMELVLKLGLFCSHPKPEARPNMRQV 612
E+ + + + L C +PE RP ++
Sbjct: 218 P--RPEECPQEIYSIMLSCWKYRPEDRPTFSEL 248
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 6e-23
Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 6/205 (2%)
Query: 353 IGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRR 412
IG G FG V+ G ++A+K + + ++F+ E M +L H LV+L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 413 KGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 472
+ LV+++M +G L L + + + V G+ YL V+HRD+
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDL 126
Query: 473 KPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYA 532
N L+ + K+ DFG+ R D +T + PE+ K S+ +DV++
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWS 186
Query: 533 FGVFMLEVAS-GRRPVEQQGSMETV 556
FGV M EV S G+ P E + + E V
Sbjct: 187 FGVLMWEVFSEGKTPYENRSNSEVV 211
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 1e-22
Identities = 65/207 (31%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 353 IGRGGFGKVYRGV-LASN---VQIAVKKVSHDSKQGI-KEFVAELVSMGRLRHRNLVKLR 407
+G G FG V RG S + +AVK + D I +F+ E M L H NL++L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 408 GYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIR---GVASGLLYLHEDWE 464
G ++V + P GSL L K L + + +A+G+ YL
Sbjct: 63 GVVLTH-PLMMVTELAPLGSLLDRLR---KDALGHFLISTLCDYAVQIANGMRYLES--- 115
Query: 465 QVVLHRDIKPANVLLDADLNGKLGDFGLARLY----DHDTIPQTTKLVGTFGYMDPELMR 520
+ +HRD+ N+LL +D K+GDFGL R DH + + K+ F + PE +R
Sbjct: 116 KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESLR 173
Query: 521 TGKASTSTDVYAFGVFMLEVAS-GRRP 546
T S ++DV+ FGV + E+ + G P
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 1e-22
Identities = 53/201 (26%), Positives = 99/201 (49%), Gaps = 8/201 (3%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVK 405
F + +G G +G VY+ + + +A+K V + ++E + E+ + + +VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK 62
Query: 406 LRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQ 465
G + + +V +Y GS+ I+ K L + I+ GL YLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKT-LTEEEIAAILYQTLKGLEYLHS---N 118
Query: 466 VVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKAS 525
+HRDIK N+LL+ + KL DFG++ DT+ + ++GT +M PE+++ +
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQLT-DTMAKRNTVIGTPFWMAPEVIQEIGYN 177
Query: 526 TSTDVYAFGVFMLEVASGRRP 546
D+++ G+ +E+A G+ P
Sbjct: 178 NKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 4e-22
Identities = 81/265 (30%), Positives = 118/265 (44%), Gaps = 28/265 (10%)
Query: 353 IGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRR 412
+G G FG V G +A+K + S EF+ E M +L H LV+L G C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 413 KGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 472
+ +V +YM NG L L + K Q + + V G+ YL + +HRD+
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKR-FQPSQLLEMCKDVCEGMAYLE---SKQFIHRDL 126
Query: 473 KPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT---FGYMDPELMRTGKASTSTD 529
N L+D K+ DFGL+R D + T VG+ + PE++ K S+ +D
Sbjct: 127 AARNCLVDDQGCVKVSDFGLSRYVLDD---EYTSSVGSKFPVRWSPPEVLLYSKFSSKSD 183
Query: 530 VYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQM 588
V+AFGV M EV S G+ P E+ + ETV V + RL
Sbjct: 184 VWAFGVLMWEVYSLGKMPYERFNNSETVEKV--------------SQGLRLYR--PHLAS 227
Query: 589 ELVLKLGLFCSHPKPEARPNMRQVM 613
E V + C H K E RP +Q++
Sbjct: 228 EKVYAIMYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 4e-22
Identities = 76/278 (27%), Positives = 126/278 (45%), Gaps = 25/278 (8%)
Query: 344 TKGFKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVS----HDSKQGIKEFVAELVSMGRL 398
FK + IG+G F VY+ + L +A+KKV D+K ++ + E+ + +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKAR-QDCLKEIDLLKQL 59
Query: 399 RHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDK-ILHT-NIKPCLNWYQRFRIIRGVASGL 456
H N++K E +V + G L + I H K + ++ + S L
Sbjct: 60 DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119
Query: 457 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDP 516
++H + ++HRDIKPANV + A KLGD GL R + T LVGT YM P
Sbjct: 120 EHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSP 175
Query: 517 ELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASD 576
E + + +D+++ G + E+A+ + P + +NL +C +K
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFY----GDKMNLYS-LCKKIEKCDYPPLPA 230
Query: 577 SRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
E+ +LV + C +P PE RP++ V+Q
Sbjct: 231 DHY----SEELRDLVSR----CINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 6e-22
Identities = 67/209 (32%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 339 DLYKATKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRL 398
+L K T G ++IG G FG V +G ++AVK + D + F+ E M +L
Sbjct: 4 NLQKLTLG----EIIGEGEFGAVLQGEYTGQ-KVAVKNIKCDVTA--QAFLEETAVMTKL 56
Query: 399 RHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLY 458
H+NLV+L G G ++ V + M G+L L T + ++ Q + VA G+ Y
Sbjct: 57 HHKNLVRLLGVILHNGLYI-VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEY 115
Query: 459 LHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPEL 518
L + ++HRD+ N+L+ D K+ DFGLAR+ +KL + PE
Sbjct: 116 LES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--DNSKL--PVKWTAPEA 168
Query: 519 MRTGKASTSTDVYAFGVFMLEVAS-GRRP 546
++ K S+ +DV+++GV + EV S GR P
Sbjct: 169 LKHKKFSSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 9e-22
Identities = 78/281 (27%), Positives = 125/281 (44%), Gaps = 51/281 (18%)
Query: 352 VIGRGGFGKVYRGV---LASNVQIAVK-KVSHD--SKQGIKEFVAELVSMGRLRHRNLVK 405
V+G G FG VY+GV V+I V KV + S + KE + E M + H ++V+
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 406 LRGYCRRKGEFLLVYDYMPNGSLDKILH---TNIKP--CLNWYQRFRIIRGVASGLLYLH 460
L G C + L+ MP G L + NI LNW +A G+ YL
Sbjct: 74 LLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYLE 126
Query: 461 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFG-----YMD 515
E + ++HRD+ NVL+ + K+ DFGLA+L D D + G +M
Sbjct: 127 E---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD----EKEYHAEGGKVPIKWMA 179
Query: 516 PELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDA 574
E + + +DV+++GV + E+ + G +P E + V+ + D +KG
Sbjct: 180 LESILHRIYTHKSDVWSYGVTVWELMTFGAKP------YEGIPAVE-IPDLLEKG----- 227
Query: 575 SDSRLE--GICEEKQMELVLKLGLFCSHPKPEARPNMRQVM 613
RL IC +++K C E+RP ++++
Sbjct: 228 --ERLPQPPICTIDVYMVLVK----CWMIDAESRPTFKELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 9e-22
Identities = 73/273 (26%), Positives = 124/273 (45%), Gaps = 38/273 (13%)
Query: 353 IGRGGFGKVYRGVLASNV------QIAVKKVSHDSKQG-IKEFVAELVSMGRLRHRNLVK 405
+G+G FG VY G+ V ++A+K V+ ++ EF+ E M ++V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 406 LRGYCRRKGEFLLVYDYMPNGSLDKIL--------HTNIKPCLNWYQRFRIIRGVASGLL 457
L G L+V + M G L L + + ++ +A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 458 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMDP 516
YL + +HRD+ N ++ DL K+GDFG+ R +Y+ D + K + +M P
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 517 ELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQG-SMETVNLVDWVCDCWKKGAIRDA 574
E ++ G +T +DV++FGV + E+A+ +P QG S E V + +V D G D
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY--QGLSNEEV--LKFVID----GGHLDL 242
Query: 575 SDSRLEGICEEKQMELVLKLGLFCSHPKPEARP 607
++ C +K +L+L C P+ RP
Sbjct: 243 PEN-----CPDK----LLELMRMCWQYNPKMRP 266
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 1e-21
Identities = 68/253 (26%), Positives = 116/253 (45%), Gaps = 27/253 (10%)
Query: 353 IGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRR 412
+G+G FG+V+ G ++A+K + + + F+ E M +LRH LV+L
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 413 KGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 472
+ +V +YM GSL L + L Q + +ASG+ Y+ +HRD+
Sbjct: 73 E-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 128
Query: 473 KPANVLLDADLNGKLGDFGLARLYDHD--TIPQTTKLVGTFGYMDPELMRTGKASTSTDV 530
+ AN+L+ +L K+ DFGLARL + + T Q K + PE G+ + +DV
Sbjct: 129 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDV 186
Query: 531 YAFGVFMLEVAS-GRRPVEQQGSMETVNLV-----------------DWVCDCWKKGAIR 572
++FG+ + E+ + GR P + E ++ V D +C CW+K
Sbjct: 187 WSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEE 246
Query: 573 DASDSRLEGICEE 585
+ L+ E+
Sbjct: 247 RPTFEYLQAFLED 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 65/218 (29%), Positives = 105/218 (48%), Gaps = 28/218 (12%)
Query: 353 IGRGGFGKVYRGVL--------ASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLV 404
+G G FGKVY+G L A++V I K + + K +EF E M L+H N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQ-QEFRQEAELMSDLQHPNIV 71
Query: 405 KLRGYCRRKGEFLLVYDYMPNGSLDKIL--------------HTNIKPCLNWYQRFRIIR 450
L G C ++ ++++Y+ +G L + L +K L+ I
Sbjct: 72 CLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131
Query: 451 GVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARL-YDHDTIPQTTKLVG 509
+A+G+ YL +HRD+ N L+ L K+ DFGL+R Y D +K +
Sbjct: 132 QIAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188
Query: 510 TFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRP 546
+M PE + GK +T +D+++FGV + E+ S G +P
Sbjct: 189 PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 2e-21
Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 22/213 (10%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSH--DSKQGIKEFVAELVSMGRLRHRNL 403
++ IG G +G V V + ++A+KK+S+ D K + E+ + LRH N+
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61
Query: 404 VKLR-----GYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRF--RIIRGVASGL 456
+ L + +V + M L K++ + + Q F +I+RG L
Sbjct: 62 IGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRG----L 116
Query: 457 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD--TIPQTTKLVGTFGYM 514
YLH V+HRD+KP+N+L++++ + K+ DFGLAR D D T+ V T Y
Sbjct: 117 KYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR 173
Query: 515 DPELMRTGKA-STSTDVYAFGVFMLEVASGRRP 546
PEL+ + + + D+++ G E+ R+P
Sbjct: 174 APELLLSSSRYTKAIDIWSVGCIFAELL-TRKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 3e-21
Identities = 66/220 (30%), Positives = 114/220 (51%), Gaps = 15/220 (6%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQ----GIKEFVAELVSMGRLRHR 401
++ ++IGRG +G VYRG + + +A+K ++ D+ I+ VA L + + +
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 402 NLVKLRGYCRRKGEFL-LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLH 460
N+ K G KG L ++ +Y GS+ ++ + IIR V L Y+H
Sbjct: 63 NITKYYG-SYLKGPRLWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIH 118
Query: 461 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMR 520
+ V+HRDIK AN+L+ N KL DFG+A L + ++ ++T VGT +M PE++
Sbjct: 119 KVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-FVGTPYWMAPEVIT 174
Query: 521 TGKA-STSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLV 559
GK T D+++ G+ + E+A+G P + + L+
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI 214
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 5e-21
Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 30/215 (13%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKE---FVA--ELVSMGRLRH 400
++ +G G + VY+ + +A+KK+ ++ K+ F A E+ + L+H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 401 RNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILH--------TNIKPCLNWYQRFRIIRGV 452
N++ L K LV+++M L+K++ +IK ++ +RG+
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIK---SYMLM--TLRGL 115
Query: 453 ASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFG 512
YLH +W +LHRD+KP N+L+ +D KL DFGLAR + T ++V T
Sbjct: 116 E----YLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRW 167
Query: 513 YMDPELMRTGKA-STSTDVYAFGVFMLEVASGRRP 546
Y PEL+ + D+++ G E+ R P
Sbjct: 168 YRAPELLFGARHYGVGVDMWSVGCIFAELLL-RVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 6e-21
Identities = 64/208 (30%), Positives = 111/208 (53%), Gaps = 21/208 (10%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEF-VAELVSMGRLRHRNLV 404
FK + +G G + VY+G + +A+K++ D+++G + E+ M L+H N+V
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 405 KLRGYCRRKGEFLLVYDYMPNGSLDKILHTN-----IKPCLNWYQRFRIIRGVASGLLYL 459
+L + + +LV++YM + L K + T+ + P +++++G+A +
Sbjct: 62 RLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIA----FC 116
Query: 460 HEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT--KLVGTFGYMDPE 517
HE+ VLHRD+KP N+L++ KL DFGLAR + IP T V T Y P+
Sbjct: 117 HEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFG---IPVNTFSNEVVTLWYRAPD 170
Query: 518 -LMRTGKASTSTDVYAFGVFMLEVASGR 544
L+ + STS D+++ G M E+ +GR
Sbjct: 171 VLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 1e-20
Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 34/215 (15%)
Query: 352 VIGRGGFGKVY--RGVLASNVQIAVKKVSH------DSKQGIKEFVAELVSMGRLRHRNL 403
+G G F Y R V + +AVK+V++ + ++ ++ E+ M RL H ++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTL-MAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 404 VKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRF------RIIRGVASGLL 457
+++ G F L ++M GS+ +L Y F + GL
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSK--------YGAFKEAVIINYTEQLLRGLS 117
Query: 458 YLHEDWEQVVLHRDIKPANVLLDA---DLNGKLGDFGLA-RLYDHDTIPQTTK--LVGTF 511
YLHE+ Q++ HRD+K AN+L+D+ L ++ DFG A RL T + L+GT
Sbjct: 118 YLHEN--QII-HRDVKGANLLIDSTGQRL--RIADFGAAARLAAKGTGAGEFQGQLLGTI 172
Query: 512 GYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRP 546
+M PE++R + S DV++ G ++E+A+ + P
Sbjct: 173 AFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 1e-20
Identities = 59/200 (29%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 353 IGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKE---FVAELVSMGRLRHRNLVKLRGY 409
+G G FG+V+ G + ++A+K + KQG F+AE M +L+H LV+L
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSL----KQGSMSPEAFLAEANLMKQLQHPRLVRLYAV 69
Query: 410 CRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLH 469
++ ++ +YM NGSL L T L + + +A G+ ++ + +H
Sbjct: 70 VTQE-PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIH 125
Query: 470 RDIKPANVLLDADLNGKLGDFGLARLYDHD--TIPQTTKLVGTFGYMDPELMRTGKASTS 527
RD++ AN+L+ L K+ DFGLARL + + T + K + PE + G +
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF--PIKWTAPEAINYGTFTIK 183
Query: 528 TDVYAFGVFMLEVAS-GRRP 546
+DV++FG+ + E+ + GR P
Sbjct: 184 SDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 76/294 (25%), Positives = 138/294 (46%), Gaps = 46/294 (15%)
Query: 348 KDKDVI-----GRGGFGKVYRGVLAS------NVQIAVKKVSHDSKQGIKEFVAELVSMG 396
K +D++ G G FGKV+ + + +AVK + + K+F E +
Sbjct: 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLT 62
Query: 397 RLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTN--------------IKPCLNW 442
L+H ++VK G C ++V++YM +G L+K L + K L
Sbjct: 63 NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 122
Query: 443 YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTI 501
Q I +ASG++YL Q +HRD+ N L+ A+L K+GDFG++R +Y D
Sbjct: 123 SQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY 179
Query: 502 PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVD 560
+ +M PE + K +T +DV++FGV + E+ + G++P Q + E
Sbjct: 180 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE------ 233
Query: 561 WVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
V +C +G + + +C ++ +++L C +P+ R N++++ +
Sbjct: 234 -VIECITQGRVLERPR-----VCPKEVYDIMLG----CWQREPQQRLNIKEIYK 277
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 2e-20
Identities = 74/282 (26%), Positives = 129/282 (45%), Gaps = 38/282 (13%)
Query: 350 KDVIGRGGFGKVYRGVL------ASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNL 403
K +G G FGKV+ + +AVK + S K+F E + L+H ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69
Query: 404 VKLRGYCRRKGEFLLVYDYMPNGSLDKILHT-----------NIKPCLNWYQRFRIIRGV 452
VK G C ++V++YM +G L+K L N L Q I + +
Sbjct: 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 453 ASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTF 511
A+G++YL Q +HRD+ N L+ +L K+GDFG++R +Y D +
Sbjct: 130 AAGMVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186
Query: 512 GYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGA 570
+M PE + K +T +DV++ GV + E+ + G++P Q + E V +C +G
Sbjct: 187 RWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VIECITQGR 239
Query: 571 IRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQV 612
+ + C ++ +L+L C +P R N++++
Sbjct: 240 VLQRPRT-----CPKEVYDLMLG----CWQREPHMRLNIKEI 272
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 63/216 (29%), Positives = 103/216 (47%), Gaps = 20/216 (9%)
Query: 351 DVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQ-GIKEFVAELVSMGRLRHRNLVKLRG 408
+VIG G VY + L +N ++A+K++ + Q + E E+ +M + H N+VK
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 409 YCRRKGEFLLVYDYMPNGSLDKILHTNIK------PCLNWYQRFRIIRGVASGLLYLHED 462
E LV Y+ GSL I+ ++ + +++ V GL YLH
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIA-----TVLKEVLKGLEYLHS- 120
Query: 463 WEQVVLHRDIKPANVLLDADLNGKLGDFGL-ARLYDHDTIPQTTK--LVGTFGYMDPELM 519
+HRDIK N+LL D + K+ DFG+ A L D + + VGT +M PE+M
Sbjct: 121 --NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178
Query: 520 RTGKASTS-TDVYAFGVFMLEVASGRRPVEQQGSME 554
D+++FG+ +E+A+G P + M+
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK 214
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 4e-20
Identities = 75/282 (26%), Positives = 117/282 (41%), Gaps = 40/282 (14%)
Query: 352 VIGRGGFGKVYRGVL------ASNVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLV 404
+G G FG+VY G+ A +Q+AVK + S+Q +F+ E + M + H+N+V
Sbjct: 13 ALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIV 72
Query: 405 KLRGYCRRKGEFLLVYDYMPNGSLDKIL-----HTNIKPCLNWYQRFRIIRGVASGLLYL 459
+L G + ++ + M G L L L R VA G YL
Sbjct: 73 RLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL 132
Query: 460 HEDWEQVVLHRDIKPANVLLDADLNG---KLGDFGLAR-LYDHDTIPQTTKLVGTFGYMD 515
E+ +HRDI N LL G K+ DFG+AR +Y + + + +M
Sbjct: 133 EENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMP 189
Query: 516 PELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDA 574
PE G ++ TDV++FGV + E+ S G P + + E + V
Sbjct: 190 PEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV--------------T 235
Query: 575 SDSRLEGI--CEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
RL+ C V ++ C PE RPN +++
Sbjct: 236 GGGRLDPPKGCPGP----VYRIMTDCWQHTPEDRPNFATILE 273
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 6e-20
Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 22/208 (10%)
Query: 353 IGRGGFGKVYRGVL---ASNVQIAVKKVSHDSKQ--GIKEFVAELVSMGR-LRHRNLVKL 406
IGRG +G+VY+ + A+KK D +Q GI + +++ R L+H N+V L
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 407 RGYC--RRKGEFLLVYDYMPNGSLDKILH---TNIKPCLNWYQRFRIIRGVASGLLYLHE 461
L++DY + L +I+ + + ++ + +G+ YLH
Sbjct: 68 VEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS 126
Query: 462 DWEQVVLHRDIKPANVLL--DADLNG--KLGDFGLARLYDHDTIPQTT--KLVGTFGYMD 515
+W VLHRD+KPAN+L+ + G K+GD GLARL++ P +V T Y
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRA 183
Query: 516 PELMRTGKASTST-DVYAFGVFMLEVAS 542
PEL+ + T D++A G E+ +
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 6e-20
Identities = 74/217 (34%), Positives = 107/217 (49%), Gaps = 19/217 (8%)
Query: 345 KGFKDKDVIGRGGFGKVY--RGVLASNVQIAVKKVSHDSKQGIKEF---VAELVSMGRLR 399
K F D IG G FG VY R V + V +A+KK+S+ KQ +++ + E+ + +LR
Sbjct: 15 KLFTDLREIGHGSFGAVYFARDVRTNEV-VAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR 73
Query: 400 HRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYL 459
H N ++ +G R+ LV +Y GS IL + KP L + I G GL YL
Sbjct: 74 HPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKP-LQEVEIAAICHGALQGLAYL 131
Query: 460 HEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPEL- 518
H +HRDIK N+LL KL DFG A L P + VGT +M PE+
Sbjct: 132 HS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVS----PANS-FVGTPYWMAPEVI 183
Query: 519 --MRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSM 553
M G+ DV++ G+ +E+A + P+ +M
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 350 KDVIGRGGFGKVYRGVLAS----NVQIAVKKVSHDSKQGIKE-FVAELVSMGRLRHRNLV 404
IG G FG VY+GV S + +AVK + + ++E F+ E M + H ++V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 405 KLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIR---GVASGLLYLHE 461
KL G ++ V + P G L L N +I +++ L YL
Sbjct: 71 KLIGVITENPVWI-VMELAPLGELRSYLQVN----KYSLDLASLILYSYQLSTALAYLES 125
Query: 462 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRT 521
+ +HRDI NVL+ + KLGDFGL+R + ++ + +K +M PE +
Sbjct: 126 ---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF 182
Query: 522 GKASTSTDVYAFGVFMLEVAS-GRRP 546
+ ++++DV+ FGV M E+ G +P
Sbjct: 183 RRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 62/216 (28%), Positives = 92/216 (42%), Gaps = 32/216 (14%)
Query: 353 IGRGGFGKVYRGVLASNVQI-AVKKVSHDSKQGI-KEFVAELVSMGRLRHRNLVKLRGYC 410
+G G G V + L + I A+K ++ D + K+ + EL + +VK G
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68
Query: 411 --RRKGEFLLVYDYMPNGSLDKIL--------HTNIKPCLNWYQRFRIIRGVASGLLYLH 460
+ +Y GSLD I K +I V GL YLH
Sbjct: 69 LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG------KIAESVLKGLSYLH 122
Query: 461 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFG----YMDP 516
+ ++HRDIKP+N+LL KL DFG++ L GTF YM P
Sbjct: 123 S---RKIIHRDIKPSNILLTRKGQVKLCDFGVSG-------ELVNSLAGTFTGTSFYMAP 172
Query: 517 ELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGS 552
E ++ S ++DV++ G+ +LEVA R P +G
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGE 208
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 1e-19
Identities = 82/285 (28%), Positives = 126/285 (44%), Gaps = 49/285 (17%)
Query: 353 IGRGGFGKVYRGVL-------ASNVQIAVK---KVSHDSKQGIKEFVAELVSMGRLRHRN 402
+G G FG+VY G + +++AVK K + D ++ KEF+ E M H N
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK--KEFLKEAHLMSNFNHPN 60
Query: 403 LVKLRGYCRRKGEFLLVYDYMPNGSLDKILH-----TNIKPCLNWYQRFRIIRGVASGLL 457
+VKL G C ++ + M G L L P L + I VA G +
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 458 YLHEDWEQV-VLHRDIKPANVLL-----DADLNGKLGDFGLAR-LYDHDTIPQTTKLVGT 510
YL EQ+ +HRD+ N L+ DAD K+GDFGLAR +Y D + + +
Sbjct: 121 YL----EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 511 FGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKG 569
+M PE + GK +T +DV++FGV M E+ + G++P + E + V
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV---------- 226
Query: 570 AIRDASDSRLEG--ICEEKQMELVLKLGLFCSHPKPEARPNMRQV 612
+ RL+ C +K +L+ C P RP ++
Sbjct: 227 ----TAGGRLQKPENCPDKIYQLMTN----CWAQDPSERPTFDRI 263
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 1e-19
Identities = 66/269 (24%), Positives = 120/269 (44%), Gaps = 34/269 (12%)
Query: 353 IGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRR 412
+G G FG V+ G + +++A+K ++ + ++F+ E M +L H LV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSE-EDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 413 KGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFR------IIRGVASGLLYLHEDWEQV 466
+ +V ++M NG L L + + + V G+ YL +
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQR-------QGKLSKDMLLSMCQDVCEGMEYLERN---S 120
Query: 467 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKAST 526
+HRD+ N L+ + K+ DFG+ R D ++ + PE+ K S+
Sbjct: 121 FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSS 180
Query: 527 STDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEE 585
+DV++FGV M EV + G+ P E++ + E V ++ + RL +
Sbjct: 181 KSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI--------------SRGFRLYR--PK 224
Query: 586 KQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
V ++ C H KPE RP ++++
Sbjct: 225 LASMTVYEVMYSCWHEKPEGRPTFAELLR 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 68/219 (31%), Positives = 107/219 (48%), Gaps = 17/219 (7%)
Query: 345 KGFKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQG---IKEFVAELVSMGRLRH 400
K F D IG G FG VY + ++ +A+KK+S+ KQ ++ + E+ + +LRH
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 401 RNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLH 460
N ++ RG R+ LV +Y GS +L + KP L + + G GL YLH
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKP-LQEVEIAAVTHGALQGLAYLH 132
Query: 461 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPEL-- 518
++HRD+K N+LL KLGDFG A + + VGT +M PE+
Sbjct: 133 S---HNMIHRDVKAGNILLSEPGLVKLGDFGSASI-----MAPANXFVGTPYWMAPEVIL 184
Query: 519 -MRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETV 556
M G+ DV++ G+ +E+A + P+ +M +
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (221), Expect = 2e-19
Identities = 60/200 (30%), Positives = 97/200 (48%), Gaps = 18/200 (9%)
Query: 353 IGRGGFGKVYRGVLASNVQI-AVKKVSHDSKQGIKEF-----VAELVSMGRL-RHRNLVK 405
+G G FG VY ++ A+KK+ K+ + + E+ S+ +L H N+VK
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM----KKKFYSWEECMNLREVKSLRKLNEHPNIVK 62
Query: 406 LRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQ 465
L+ R E V++YM G+L +++ + II + GL ++H+
Sbjct: 63 LKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK---H 118
Query: 466 VVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPE-LMRTGKA 524
HRD+KP N+L+ K+ DFGLAR + + P T V T Y PE L+R+
Sbjct: 119 GFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTRWYRAPEILLRSTSY 176
Query: 525 STSTDVYAFGVFMLEVASGR 544
S+ D++A G M E+ + R
Sbjct: 177 SSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 23/209 (11%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLV 404
F + IG+G FG+VY+ + +N +A+K + + ++ I++ E+ + + R +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 405 KLRGYCRRKGEFL-LVYDYMPNGSLDKILHTNIKPCLNWYQRFR------IIRGVASGLL 457
K G KG L ++ +Y GS +L KP + I+R V GL
Sbjct: 63 KYYG-SFLKGSKLWIIMEYCGGGSCLDLL----KPG-----KLDETYIAFILREVLLGLE 112
Query: 458 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPE 517
YLHE + +HRDIK AN+LL + + KL DFG++ + T VGT +M PE
Sbjct: 113 YLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT-FVGTPFWMAPE 168
Query: 518 LMRTGKASTSTDVYAFGVFMLEVASGRRP 546
+++ D+++ G+ +E+A G P
Sbjct: 169 VIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 66/249 (26%), Positives = 118/249 (47%), Gaps = 31/249 (12%)
Query: 345 KGFKDKDVIGRGGFGKVYRGVLA----SNVQIAVKKV---SHDSKQGIKEFVAELVSMGR 397
K K + ++G G FG++ RG L + +A+ + D ++ + F+AE +++G+
Sbjct: 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQR--RGFLAEALTLGQ 62
Query: 398 LRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLL 457
H N+V+L G R ++V +YM NG+LD L + + L Q ++ G+ASG+
Sbjct: 63 FDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMK 121
Query: 458 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPE 517
YL E +H+ + VL+++DL K+ F + + I T + PE
Sbjct: 122 YLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPE 178
Query: 518 LMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVD---------------- 560
++ S+++DV++FG+ M EV S G RP + + V+
Sbjct: 179 AIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLH 238
Query: 561 -WVCDCWKK 568
+ DCW+K
Sbjct: 239 QLMLDCWQK 247
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 70/299 (23%), Positives = 122/299 (40%), Gaps = 58/299 (19%)
Query: 352 VIGRGGFGKVYRG-VLASNVQIAVK--KVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRG 408
V+G G +G V + A+ +A+K K S D + K + E+ + +LRH N+V L+
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 409 YCRRKGEFLLVYDYMPNGSLDKILHTN--------IKPCLNWYQRFRIIRGVASGLLYLH 460
RRKG LV++Y+ L+ +L + ++ + +++++ +A Y H
Sbjct: 68 AFRRKGRLYLVFEYVERTLLE-LLEASPGGLPPDAVRSYI-----WQLLQAIA----YCH 117
Query: 461 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELM- 519
++HRDIKP N+L+ KL DFG AR T V T Y PEL+
Sbjct: 118 S---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLV 174
Query: 520 ---RTGKASTSTDVYAFGVFMLEVASGRRPV---------------------EQQGSMET 555
GK DV+A G M E+ G P+ + +
Sbjct: 175 GDTNYGKP---VDVWAIGCIMAELLDG-EPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS 230
Query: 556 VNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
N + + + + ++ + R G ++ + C P+ R +++Q
Sbjct: 231 SNPR-FAGVAFPEPSQPESLERRYPGKVSSPALDFLKA----CLRMDPKERLTCDELLQ 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 6e-19
Identities = 72/231 (31%), Positives = 109/231 (47%), Gaps = 46/231 (19%)
Query: 353 IGRGGFGKVYRGV-LASNVQIAVKKVS-HDSKQG--IKEFVAELVSMGRLRHRNLVKL-- 406
+G G FG+VY+ + + +A+KK+ H+ K G I E+ + +L+H N+V L
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITAL-REIKILKKLKHPNVVPLID 74
Query: 407 ------RGYCRRKGEFLLVYDYMP---NGSLD----KILHTNIKPCLNWYQRFRIIRGVA 453
R++G +V YM +G L+ K+ + IK C + +
Sbjct: 75 MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIK-C--------YMLQLL 125
Query: 454 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT--------- 504
G+ YLHE +LHRDIK AN+L+D K+ DFGLAR YD P
Sbjct: 126 EGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYD-GPPPNPKGGGGGGTR 181
Query: 505 --TKLVGTFGYMDPEL-MRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGS 552
T LV T Y PEL + + +T+ D++ G E+ + RRP+ Q S
Sbjct: 182 KYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFT-RRPILQGKS 231
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 7e-19
Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 30/218 (13%)
Query: 350 KDVIGRGGFGKV----------YRGVLASN-----VQIAVKKVSHD-SKQGIKEFVAELV 393
K+ +G G FG+V + G A V +AVK + D +K +F+ E+
Sbjct: 10 KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIK 69
Query: 394 SMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKIL----------HTNIKPCLNWY 443
M RL++ N+++L G C ++ +YM NG L++ L H N P ++
Sbjct: 70 IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIA 129
Query: 444 QRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIP 502
+ +ASG+ YL +HRD+ N L+ K+ DFG++R LY D
Sbjct: 130 NLLYMAVQIASGMKYLA---SLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYR 186
Query: 503 QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEV 540
+ V +M E + GK +T++DV+AFGV + E+
Sbjct: 187 IQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 87.5 bits (216), Expect = 8e-19
Identities = 70/220 (31%), Positives = 106/220 (48%), Gaps = 19/220 (8%)
Query: 345 KGFKDKDVIGRGGFGKVY--RGVLASNVQIAVKKVSHDSKQGI---KEFVAELVSMGRLR 399
K F D IG G FG VY R V + V +A+KK+S+ KQ ++ + E+ + R++
Sbjct: 25 KLFTDLREIGHGSFGAVYFARDVRTNEV-VAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK 83
Query: 400 HRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYL 459
H N ++ +G R+ LV +Y GS +L + KP L + I G GL YL
Sbjct: 84 HPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKP-LQEVEIAAITHGALQGLAYL 141
Query: 460 HEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPEL- 518
H ++HRDIK N+LL KL DFG A + VGT +M PE+
Sbjct: 142 HS---HNMIHRDIKAGNILLTEPGQVKLADFGSASI-----ASPANSFVGTPYWMAPEVI 193
Query: 519 --MRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETV 556
M G+ DV++ G+ +E+A + P+ +M +
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 233
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 9e-19
Identities = 69/236 (29%), Positives = 108/236 (45%), Gaps = 27/236 (11%)
Query: 353 IGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRR 412
+G G FG+V+ G N ++AVK + + + F+ E M +LRH LV+L
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 413 KGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 472
+ +V +YM GSL L L + VA+G+ Y+ +HRD+
Sbjct: 73 E-PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDL 128
Query: 473 KPANVLLDADLNGKLGDFGLARLYDHD--TIPQTTKLVGTFGYMDPELMRTGKASTSTDV 530
+ AN+L+ L K+ DFGLARL + + T Q K + PE G+ + +DV
Sbjct: 129 RSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDV 186
Query: 531 YAFGVFMLE-VASGRRP------------VEQQGSMET-----VNLVDWVCDCWKK 568
++FG+ + E V GR P VE+ M ++L + + CWKK
Sbjct: 187 WSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKK 242
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 63/233 (27%), Positives = 115/233 (49%), Gaps = 34/233 (14%)
Query: 353 IGRGGFGKVYRGVLAS------NVQIAVKKVSHDSKQGIKEFV--AELVSMGRLRHRNLV 404
+G G FGKV+ + + +AVK + S+ ++F AEL+++ L+H+++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTV--LQHQHIV 70
Query: 405 KLRGYCRRKGEFLLVYDYMPNGSLDKILHTN-----------IKPC--LNWYQRFRIIRG 451
+ G C L+V++YM +G L++ L ++ L Q I
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 452 VASGLLY---LHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKL 507
+ASG++Y LH +HRD+ N L+ L K+GDFG++R +Y D +
Sbjct: 131 IASGMVYLASLH------FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 184
Query: 508 VGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLV 559
+ +M PE + K +T +D+++FGV + E+ + G++P Q + E + +
Sbjct: 185 MLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 1e-18
Identities = 74/270 (27%), Positives = 127/270 (47%), Gaps = 30/270 (11%)
Query: 351 DVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIK-EFVAELVSMGRLRHRNLVKLRGY 409
+++G+G FG+V++G L +AVK D Q +K +F++E + + H N+VKL G
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 410 CRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLH 469
C ++ +V + +P G L K L Q + A+G+ YL + +H
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKK-KDELKTKQLVKFALDAAAGMAYLE---SKNCIH 116
Query: 470 RDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT-FGYMDPELMRTGKASTST 528
RD+ N L+ + K+ DFG++R D D I ++ L + PE + G+ S+ +
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQED-DGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 529 DVYAFGVFMLEVAS-GRRP---VEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICE 584
DV+++G+ + E S G P + Q + E V +KG R+ C
Sbjct: 176 DVWSYGILLWETFSLGVCPYPGMTNQQAREQV----------EKG-------YRMS--CP 216
Query: 585 EKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+K + V K+ C KPE RP ++ +
Sbjct: 217 QKCPDDVYKVMQRCWDYKPENRPKFSELQK 246
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 80/276 (28%), Positives = 126/276 (45%), Gaps = 40/276 (14%)
Query: 352 VIGRGGFGKVYRGVLASN----VQIAVKKVSH--DSKQGIKEFVAELVSMGRLRHRNLVK 405
VIG+G FG VY G L + + AVK ++ D ++ +++F+ E + M H N++
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEE-VEQFLKEGIIMKDFSHPNVLS 60
Query: 406 LRGYC-RRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRG--VASGLLYLHED 462
L G C +G L+V YM +G L + N + I G VA G+ YL
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDL---RNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS- 116
Query: 463 WEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYD--HDTIPQTTKLVGTFGYMDPELM 519
+ +HRD+ N +LD K+ DFGLAR +YD + ++ T +M E +
Sbjct: 117 --KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL 174
Query: 520 RTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSR 578
+T K +T +DV++FGV + E+ + G P S + + R
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL--------------LQGRR 220
Query: 579 L--EGICEEKQMELVLKLGLFCSHPKPEARPNMRQV 612
L C + E++L C HPKPE RP ++
Sbjct: 221 LLQPEYCPDPLYEVMLS----CWHPKPEMRPTFSEL 252
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 62/213 (29%), Positives = 104/213 (48%), Gaps = 27/213 (12%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGI-KEFVAELVSMGRLRHRNLV 404
+++ IG G +G V + V++A+KK+S Q + + E+ + R +H N++
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENII 66
Query: 405 KL------RGYCRRKGEFLLVYDYMPNGSLDKILHT----NIKPCLNWYQRFRIIRGVAS 454
+ + + +V + M L K++ T N YQ I+RG
Sbjct: 67 GILDIIRPPSFESFN-DVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQ---ILRG--- 118
Query: 455 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYD--HDTIPQTTKLVGTFG 512
L Y+H VLHRD+KP+N+LL+ + + K+ DFGLAR+ D HD T+ V T
Sbjct: 119 -LKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174
Query: 513 YMDPELMRTGKA-STSTDVYAFGVFMLEVASGR 544
Y PE+M K + + D+++ G + E+ S R
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 2e-18
Identities = 65/214 (30%), Positives = 107/214 (50%), Gaps = 31/214 (14%)
Query: 353 IGRGGFGKVYRGVLASNVQIAVKKV---SHDSKQGIKEFVAELVSMGRLRHRNLVKLRGY 409
IG G G VY+ + ++ KV +H+ ++ E+ + + H N+VK
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTV-RRQICREIEILRDVNHPNVVKCHDM 140
Query: 410 CRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRF--RIIRGVASGLLYLHEDWEQVV 467
GE ++ ++M GSL+ T+I ++F + R + SG+ YLH + +
Sbjct: 141 FDHNGEIQVLLEFMDGGSLEG---THI-----ADEQFLADVARQILSGIAYLHR---RHI 189
Query: 468 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRT------ 521
+HRDIKP+N+L+++ N K+ DFG++R+ P + VGT YM PE + T
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS-VGTIAYMSPERINTDLNHGA 248
Query: 522 --GKASTSTDVYAFGVFMLEVASGRRP--VEQQG 551
G A D+++ GV +LE GR P V +QG
Sbjct: 249 YDGYAG---DIWSLGVSILEFYLGRFPFGVGRQG 279
|
Length = 353 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 3e-18
Identities = 70/220 (31%), Positives = 110/220 (50%), Gaps = 32/220 (14%)
Query: 344 TKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSK---------QGIKEFVAELVS 394
TKG +V+G+G +G VY G+ IAVK+V D+ + ++E V L S
Sbjct: 3 TKG----EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKS 58
Query: 395 MGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILH---TNIKPCLNWYQRFRIIRG 451
L+H N+V+ G C + +++P GS+ IL+ +P Y + +I+ G
Sbjct: 59 ---LKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK-QILDG 114
Query: 452 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR----LYDHDTIPQTTKL 507
VA YLH + V+HRDIK NV+L + KL DFG AR + H T K
Sbjct: 115 VA----YLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS 167
Query: 508 V-GTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRP 546
+ GT +M PE++ +D+++ G + E+A+G+ P
Sbjct: 168 MHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 26/209 (12%)
Query: 353 IGRGGFGKVYRGV-LASNVQIAVKKVS-HDSKQGIKEF----VAELVSMGRLRHRNLVKL 406
IG G +G VY+ L + +A+KKV S++GI +A L + H N+V+L
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 407 RGYC---RRKGEFL--LVYDYMPNGSLDKILHTNIKPC----LNWYQRFRIIRGVASGLL 457
C R E LV++++ D+ L T + C L ++R + G+
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHV-----DQDLATYLSKCPKPGLPPETIKDLMRQLLRGVD 121
Query: 458 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPE 517
+LH ++HRD+KP N+L+ +D K+ DFGLAR+Y + T +V T Y PE
Sbjct: 122 FLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEM--ALTSVVVTLWYRAPE 176
Query: 518 LMRTGKASTSTDVYAFGVFMLEVASGRRP 546
++ +T D+++ G E+ RRP
Sbjct: 177 VLLQSSYATPVDMWSVGCIFAELFR-RRP 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 4e-18
Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 13/202 (6%)
Query: 353 IGRGGFGKVYRGV-LASNVQIAVKKV-----SHDSKQGIKEFVAELVSMGRLRHRNLVKL 406
+G+G FG+VY + + ++AVK+V S ++K+ + E+ + L+H +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 407 RGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQV 466
G R + +YMP GS+ L L + R + G+ YLH + +
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSN---M 124
Query: 467 VLHRDIKPANVLLDADLNGKLGDFGLA-RLYD-HDTIPQTTKLVGTFGYMDPELMRTGKA 524
++HRDIK AN+L D+ N KLGDFG + RL + + GT +M PE++
Sbjct: 125 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGY 184
Query: 525 STSTDVYAFGVFMLEVASGRRP 546
DV++ G ++E+ + + P
Sbjct: 185 GRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 5e-18
Identities = 73/238 (30%), Positives = 117/238 (49%), Gaps = 41/238 (17%)
Query: 351 DVIGRGGFGKVYRGV-LASNVQIAVKKVSHDS-KQGIK-EFVAELVSMGRLRHRNLVKLR 407
IG G +G+VY+ + +A+KKV D+ K+G + E+ + +L HRN+V L+
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLK 72
Query: 408 ----------GYCRRKGEFLLVYDYMPN---GSLDKIL----HTNIKPCLNWYQRFRIIR 450
+ + KG F LV++YM + G L+ L +IK ++
Sbjct: 73 EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK---------SFMK 123
Query: 451 GVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT 510
+ GL Y H+ + LHRDIK +N+LL+ KL DFGLARLY+ + T V T
Sbjct: 124 QLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVIT 180
Query: 511 FGYMDPELM----RTGKASTSTDVYAFGVFMLEVASGRRPVEQQGS-METVNLVDWVC 563
Y PEL+ R G A DV++ G + E+ + ++P+ Q + + L+ +C
Sbjct: 181 LWYRPPELLLGEERYGPA---IDVWSCGCILGELFT-KKPIFQANQELAQLELISRLC 234
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 6e-18
Identities = 59/218 (27%), Positives = 100/218 (45%), Gaps = 26/218 (11%)
Query: 347 FKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRL-RHRNLVK 405
F+ +VIG G +GKVY+ Q+ K+ + +E E + + H N+
Sbjct: 8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIAT 67
Query: 406 LRGYCRRKG------EFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFR------IIRGVA 453
G +K + LV + GS+ + +K +R + I+R
Sbjct: 68 FYGAFIKKNPPGNDDQLWLVMELCGGGSVTDL----VKGLRKKGKRLKEEWIAYILRETL 123
Query: 454 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 513
GL YLHE+ V+HRDIK N+LL + KL DFG++ D T+ + +GT +
Sbjct: 124 RGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDS-TLGRRNTFIGTPYW 179
Query: 514 MDPELMRTGKASTST-----DVYAFGVFMLEVASGRRP 546
M PE++ + ++ DV++ G+ +E+A G+ P
Sbjct: 180 MAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 7e-18
Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 9/203 (4%)
Query: 353 IGRGGFGKVYR-GVLASNVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKLRG 408
+G+GGFG+V V A+ A KK+ ++G + + E + ++ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 409 YCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVL 468
K + LV M G L ++ +P + + GL +LH+ + ++
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---RRIV 117
Query: 469 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTST 528
+RD+KP NVLLD N ++ D GLA + + GT GYM PE+++ S
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSV 175
Query: 529 DVYAFGVFMLEVASGRRPVEQQG 551
D +A G + E+ +GR P Q+
Sbjct: 176 DWFALGCTLYEMIAGRSPFRQRK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-17
Identities = 61/236 (25%), Positives = 110/236 (46%), Gaps = 22/236 (9%)
Query: 353 IGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRR 412
+G G FG+V+ G ++ ++AVK + + ++ F+ E M L+H LV+L +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 413 KGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 472
+ ++ +YM GSL L ++ + + +A G+ Y+ + +HRD+
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDL 129
Query: 473 KPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYA 532
+ ANVL+ L K+ DFGLAR+ + + + PE + G + +DV++
Sbjct: 130 RAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 189
Query: 533 FGVFMLEVAS-GRRPVE-----------QQG----SMET--VNLVDWVCDCWKKGA 570
FG+ + E+ + G+ P Q+G ME L D + CWK+ A
Sbjct: 190 FGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTCWKEKA 245
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 61/225 (27%), Positives = 98/225 (43%), Gaps = 19/225 (8%)
Query: 351 DVIGRGGFGKVYRG---VLASNVQIAVKKVSHDSK-QGIKEFVAELVSMGRLRHRNLVKL 406
D IG G FGKV G S ++ VK++ + F+ E+ L H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 407 RGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQR---FRIIRGVASGLLYLHEDW 463
G C +LLV ++ P G L L +N Q+ R+ VASGLL+LH+
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA- 119
Query: 464 EQVVLHRDIKPANVLLDADLNGKLGDFGLA-RLYDHDTIPQTTKLVGTFGYMDPELM--- 519
+H D+ N L ADL+ K+GD+GLA Y D ++ PEL+
Sbjct: 120 --DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 520 ----RTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLV 559
+ +++++ GV M E+ + +P + + V
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV 222
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 50/200 (25%), Positives = 98/200 (49%), Gaps = 11/200 (5%)
Query: 353 IGRGGFGKVYRGVLASNVQIAVKKVSH-DSKQGIKEFVAELVSMGRLRHRNLVKLRGYCR 411
+G G FGKVY+ A K+ +S++ +++F+ E+ + +H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 412 RKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 471
+ + ++ ++ G+LD I+ + R+ + R + L +LH V+HRD
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRY-VCRQMLEALNFLHS---HKVIHRD 128
Query: 472 IKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTS---- 527
+K N+LL D + KL DFG++ + T+ + +GT +M PE++ +
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAK-NKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDY 187
Query: 528 -TDVYAFGVFMLEVASGRRP 546
D+++ G+ ++E+A P
Sbjct: 188 KADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 353 IGRGGFGKVYRGVLA----SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRG 408
IG G G V +A + Q+AVKK+ +Q + E+V M +H N+V++
Sbjct: 27 IGEGSTGIV---CIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYS 83
Query: 409 YCRRKGEFLLVYDYMPNGSL-DKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVV 467
E +V +++ G+L D + HT + N Q + V L +LH Q V
Sbjct: 84 SYLVGDELWVVMEFLEGGALTDIVTHTRM----NEEQIATVCLAVLKALSFLHA---QGV 136
Query: 468 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTS 527
+HRDIK ++LL +D KL DFG + +P+ LVGT +M PE++ T
Sbjct: 137 IHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE-VPRRKSLVGTPYWMAPEVISRLPYGTE 195
Query: 528 TDVYAFGVFMLEVASGRRP 546
D+++ G+ ++E+ G P
Sbjct: 196 VDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 70/225 (31%), Positives = 113/225 (50%), Gaps = 29/225 (12%)
Query: 335 FTYKDLYKATKGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKV-SHDSKQGIKEFVAEL 392
FT +DL KD IGRG FG V + + S +AVK++ S ++ K + +L
Sbjct: 1 FTAEDL-------KDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDL 53
Query: 393 -VSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLD---KILHTNIKPCLNWYQRFRI 448
V M +VK G R+G+ + + M + SLD K ++ +K + I
Sbjct: 54 DVVMRSSDCPYIVKFYGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPE----EI 108
Query: 449 IRGVA----SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT 504
+ +A L YL E+ + ++HRD+KP+N+LLD + N KL DFG++ D+I +
Sbjct: 109 LGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISG-QLVDSIAK- 164
Query: 505 TKLVGTFGYMDPELMRTGKAS---TSTDVYAFGVFMLEVASGRRP 546
T+ G YM PE + +DV++ G+ + EVA+G+ P
Sbjct: 165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 75/275 (27%), Positives = 124/275 (45%), Gaps = 25/275 (9%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVS----HDSKQGIKEFVAELVSMGRLRHR 401
F+ + IGRG F +VYR L +A+KKV D+K ++ V E+ + +L H
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAK-ARQDCVKEIDLLKQLNHP 62
Query: 402 NLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQR--FRIIRGVASGLLYL 459
N++K E +V + G L +++ K +R ++ + S + ++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 460 HEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELM 519
H + V+HRDIKPANV + A KLGD GL R + T + LVGT YM PE +
Sbjct: 123 HS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPERI 178
Query: 520 RTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRL 579
+ +D+++ G + E+A+ + P M +L + C
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGD-KMNLFSLCQKIEQC------------DY 225
Query: 580 EGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+ E E + +L C +P P+ RP++ V Q
Sbjct: 226 PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 68/270 (25%), Positives = 124/270 (45%), Gaps = 25/270 (9%)
Query: 347 FKDKDVIGRGGFGKVYRGVLASNVQIAVKKVS--HDSKQGIKEFVAELVSMGRLRHRNLV 404
F + IG+G FG+V++G+ ++ K+ +++ I++ E+ + + +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 405 KLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWE 464
K G + + ++ +Y+ GS +L L+ Q I+R + GL YLH + +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHSEKK 122
Query: 465 QVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKA 524
+HRDIK ANVLL KL DFG+A DT + VGT +M PE+++
Sbjct: 123 ---IHRDIKAANVLLSEHGEVKLADFGVAGQLT-DTQIKRNTFVGTPFWMAPEVIKQSAY 178
Query: 525 STSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICE 584
+ D+++ G+ +E+A G P + M+ + L I + LEG
Sbjct: 179 DSKADIWSLGITAIELAKGEPPHSELHPMKVLFL------------IPKNNPPTLEGNYS 226
Query: 585 EKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+ E V C + +P RP +++++
Sbjct: 227 KPLKEFVEA----CLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 24/215 (11%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSH--DSKQGIKEFVAELVSMGRLRHRNL 403
+K + IG G +G V + S ++A+KK+ H D K + EL + +H N+
Sbjct: 7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNI 66
Query: 404 VKLRGYCRRKGE----FLLVYDYMPNGSLDKILHTNIKPCLNWYQRF---RIIRGVASGL 456
+ +R R G +V D M + L I+H++ +P + R+ +++RG L
Sbjct: 67 IAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSD-QPLTEEHIRYFLYQLLRG----L 120
Query: 457 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT---TKLVGTFGY 513
Y+H V+HRD+KP+N+L++ D ++GDFG+AR T+ V T Y
Sbjct: 121 KYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWY 177
Query: 514 MDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPV 547
PEL+ + + +T+ D+++ G E+ GRR +
Sbjct: 178 RAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 3e-17
Identities = 66/205 (32%), Positives = 98/205 (47%), Gaps = 18/205 (8%)
Query: 347 FKDKDVIGRGGFGKV--YRGVLASN---VQIAVKKVSHDSKQGIKE-FVAELVSMGRLRH 400
K V+G G FGKV Y A++ +AVK + + Q + E+ + L H
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYH 65
Query: 401 RNLVKLRGYCRRKGE--FLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLY 458
N+VK +G C +G L+ +Y+P GSL L + LN Q + + G+ Y
Sbjct: 66 ENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAY 122
Query: 459 LHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVG---TFGYMD 515
LH Q +HRD+ NVLLD D K+GDFGLA+ + G F Y
Sbjct: 123 LHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA- 178
Query: 516 PELMRTGKASTSTDVYAFGVFMLEV 540
E ++ K S ++DV++FGV + E+
Sbjct: 179 VECLKENKFSYASDVWSFGVTLYEL 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 3e-17
Identities = 66/217 (30%), Positives = 102/217 (47%), Gaps = 21/217 (9%)
Query: 353 IGRGGFGKVYR-GVLASNVQIAVKKVS--HDSKQGIKEFV-AELVSMGRLRHRNLVKLRG 408
+G GGFG+V V + N A+K V H + G +E + +E + H +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 409 YCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQ-RFRIIRGVASGLLYLHEDWEQVV 467
+ K ++ +Y G L IL + Y RF I V YLH + +
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGL--FDEYTARF-YIACVVLAFEYLHN---RGI 114
Query: 468 LHRDIKPANVLLDADLNG--KLGDFGLAR-LYDHDTIPQTTKLVGTFGYMDPELMRTGKA 524
++RD+KP N+LLD+ NG KL DFG A+ L +T GT Y+ PE++
Sbjct: 115 IYRDLKPENLLLDS--NGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGY 169
Query: 525 STSTDVYAFGVFMLEVASGRRPV--EQQGSMETVNLV 559
S D ++ G+ + E+ +GR P + + ME N +
Sbjct: 170 DFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDI 206
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 4e-17
Identities = 70/266 (26%), Positives = 116/266 (43%), Gaps = 24/266 (9%)
Query: 353 IGRGGFGKVYRGVL-ASNVQIAVKKVSHDSKQGIK-EFVAELVSMGRLRHRNLVKLRGYC 410
IGRG FG+V+ G L A N +AVK +K +F+ E + + H N+V+L G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 411 RRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHR 470
+K +V + + G L T P L + +++ A+G+ YL + +HR
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLES---KHCIHR 118
Query: 471 DIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT-FGYMDPELMRTGKASTSTD 529
D+ N L+ K+ DFG++R + T + + PE + G+ S+ +D
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESD 178
Query: 530 VYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQM 588
V++FG+ + E S G P + +T R+A + + C E
Sbjct: 179 VWSFGILLWEAFSLGAVPYANLSNQQT----------------REAIEQGVRLPCPELCP 222
Query: 589 ELVLKLGLFCSHPKPEARPNMRQVMQ 614
+ V +L C P RP+ V Q
Sbjct: 223 DAVYRLMERCWEYDPGQRPSFSTVHQ 248
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 5e-17
Identities = 69/270 (25%), Positives = 120/270 (44%), Gaps = 25/270 (9%)
Query: 347 FKDKDVIGRGGFGKVYRGVLASNVQIAVKKVS--HDSKQGIKEFVAELVSMGRLRHRNLV 404
F + IG+G FG+VY+G+ ++ K+ +++ I++ E+ + + +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 405 KLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWE 464
+ G + + ++ +Y+ GS +L P Y I+R + GL YLH + +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPG--PLEETYIA-TILREILKGLDYLHSERK 122
Query: 465 QVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKA 524
+HRDIK ANVLL + KL DFG+A I + T VGT +M PE+++
Sbjct: 123 ---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIKQSAY 178
Query: 525 STSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICE 584
D+++ G+ +E+A G P M + L I S LEG
Sbjct: 179 DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL------------IPKNSPPTLEGQYS 226
Query: 585 EKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+ E V C + P RP +++++
Sbjct: 227 KPFKEFVEA----CLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 72/248 (29%), Positives = 118/248 (47%), Gaps = 40/248 (16%)
Query: 336 TYKDLYKATKGFKDKDVIGRGGFGKVYRGVLASNVQI-AVKKVSHDS-KQGIK-EFVAEL 392
Y+ L K IG+G FG+V++ QI A+KKV ++ K+G + E+
Sbjct: 13 KYEKLAK----------IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREI 62
Query: 393 VSMGRLRHRNLVKLRGYCRR--------KGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQ 444
+ L+H N+V L CR KG F LV+++ + L +L +N +
Sbjct: 63 KILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLL-SNKNVKFTLSE 120
Query: 445 RFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT 504
++++ + +GL Y+H + +LHRD+K AN+L+ D KL DFGLAR + +
Sbjct: 121 IKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKP 177
Query: 505 TKL---VGTFGYMDPELM----RTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMET-- 555
+ V T Y PEL+ G D++ G M E+ + R P+ QG+ E
Sbjct: 178 NRYTNRVVTLWYRPPELLLGERDYGPP---IDMWGAGCIMAEMWT-RSPI-MQGNTEQHQ 232
Query: 556 VNLVDWVC 563
+ L+ +C
Sbjct: 233 LTLISQLC 240
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 5e-17
Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 9/215 (4%)
Query: 347 FKDKDVIGRGGFGKVYRGVLASNVQI-AVKKVS-HDSKQGIKEFVAELVSMGRLRHRNLV 404
F + IG+G FG+V++G+ Q+ A+K + +++ I++ E+ + + +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 405 KLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWE 464
K G + + ++ +Y+ GS +L P + +Q +++ + GL YLH + +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAG--P-FDEFQIATMLKEILKGLDYLHSEKK 122
Query: 465 QVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKA 524
+HRDIK ANVLL + KL DFG+A I + T VGT +M PE+++
Sbjct: 123 ---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIQQSAY 178
Query: 525 STSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLV 559
+ D+++ G+ +E+A G P M + L+
Sbjct: 179 DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI 213
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 6e-17
Identities = 66/217 (30%), Positives = 102/217 (47%), Gaps = 17/217 (7%)
Query: 347 FKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSKQ---GIKEFVAELVSMGRLRHRN 402
F IG G FG VY + +N +AVKK+S+ KQ ++ + E+ + +L+H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 403 LVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHED 462
++ +G ++ LV +Y GS +L + KP L + I G GL YLH
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKP-LQEVEIAAITHGALQGLAYLHS- 139
Query: 463 WEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPEL---M 519
++HRDIK N+LL KL DFG A VGT +M PE+ M
Sbjct: 140 --HNMIHRDIKAGNILLTEPGQVKLADFGSASK-----SSPANSFVGTPYWMAPEVILAM 192
Query: 520 RTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETV 556
G+ DV++ G+ +E+A + P+ +M +
Sbjct: 193 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 229
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 6e-17
Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 29/206 (14%)
Query: 353 IGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGI-KEFVAELVSMGRLRHRNLVKLRGYC 410
+G G G V + + + +A K V +K + K+ + EL M R +V G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 411 RRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRF---------RIIRGVASGLLYLHE 461
+ + ++M GSLD+I Y++ +I V GL YL+
Sbjct: 73 LNENNICMCMEFMDCGSLDRI-----------YKKGGPIPVEILGKIAVAVVEGLTYLYN 121
Query: 462 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLA-RLYDHDTIPQTTKLVGTFGYMDPELMR 520
++HRDIKP+N+L+++ KL DFG++ L + +I T VGT YM PE ++
Sbjct: 122 --VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN--SIADT--FVGTSTYMSPERIQ 175
Query: 521 TGKASTSTDVYAFGVFMLEVASGRRP 546
GK + +DV++ G+ ++E+A G+ P
Sbjct: 176 GGKYTVKSDVWSLGISIIELALGKFP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 6e-17
Identities = 61/256 (23%), Positives = 121/256 (47%), Gaps = 22/256 (8%)
Query: 353 IGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRR 412
+G G FG+V+ + ++AVK + S ++ F+AE M L+H LVKL +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72
Query: 413 KGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 472
+ +++ ++M GSL L ++ + +A G+ ++ + + +HRD+
Sbjct: 73 EPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDL 128
Query: 473 KPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYA 532
+ AN+L+ A L K+ DFGLAR+ + + + PE + G + +DV++
Sbjct: 129 RAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 188
Query: 533 FGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELV 591
FG+ ++E+ + GR P + E + ++ +G ++ C E+ ++
Sbjct: 189 FGILLMEIVTYGRIPYPGMSNPEVIRALE-------RGYRMPRPEN-----CPEELYNIM 236
Query: 592 LKLGLFCSHPKPEARP 607
++ C +PE RP
Sbjct: 237 MR----CWKNRPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 6e-17
Identities = 57/201 (28%), Positives = 100/201 (49%), Gaps = 8/201 (3%)
Query: 352 VIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVA---ELVSMGRLRHRNLVKLRG 408
IG G FGK+Y S+ + V K +K +KE A E++ + +++H N+V
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 409 YCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVL 468
+ G +V +Y G L K ++ + Q ++ GL ++H+ + +L
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD---RKIL 123
Query: 469 HRDIKPANVLLDAD-LNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTS 527
HRDIK N+ L + + KLGDFG+AR + D++ VGT Y+ PE+ + +
Sbjct: 124 HRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYTCVGTPYYLSPEICQNRPYNNK 182
Query: 528 TDVYAFGVFMLEVASGRRPVE 548
TD+++ G + E+ + + P E
Sbjct: 183 TDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 7e-17
Identities = 75/273 (27%), Positives = 120/273 (43%), Gaps = 25/273 (9%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVS----HDSKQGIKEFVAELVSMGRLRHR 401
F+ + IGRG F +VYR L V +A+KKV D+K + + E+ + +L H
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAK-ARADCIKEIDLLKQLNHP 62
Query: 402 NLVKLRGYCRRKGEFLLVYDYMPNGSLDKILH--TNIKPCLNWYQRFRIIRGVASGLLYL 459
N++K E +V + G L +++ K + ++ + S L ++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 460 HEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELM 519
H + V+HRDIKPANV + A KLGD GL R + T + LVGT YM PE +
Sbjct: 123 HS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPERI 178
Query: 520 RTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRL 579
+ +D+++ G + E+A+ + P M +L + C D L
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGD-KMNLYSLCKKIEQCDYPPLPSDHYSEEL 237
Query: 580 EGICEEKQMELVLKLGLFCSHPKPEARPNMRQV 612
+L C +P PE RP++ V
Sbjct: 238 R------------QLVNMCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 9e-17
Identities = 60/218 (27%), Positives = 100/218 (45%), Gaps = 31/218 (14%)
Query: 353 IGRGGFGKVYR----GVLASNVQ--IAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVK 405
IG+G FG+V++ G+L +AVK + + S +F E M H N+VK
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 406 LRGYCRRKGEFLLVYDYMPNGSLDKILHTNI--------------------KPCLNWYQR 445
L G C L+++YM G L++ L L+ ++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 446 FRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQT 504
I + VA+G+ YL E+ +HRD+ N L+ ++ K+ DFGL+R +Y D +
Sbjct: 133 LCIAKQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 505 TKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS 542
+M PE + + +T +DV+A+GV + E+ S
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 64/279 (22%), Positives = 111/279 (39%), Gaps = 35/279 (12%)
Query: 352 VIGRGGFGKVYRGVLASNVQ------IAVKKVSH-DSKQGIKEFVAELVSMGRLRHRNLV 404
+GRG FG+V+ + + VK + + EF EL +L H+N+V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 405 KLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIK-------PCLNWYQRFRIIRGVASGLL 457
+L G CR ++ +Y G L + L P L+ Q+ + +A G+
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 458 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMDP 516
+L +HRD+ N L+ + K+ L++ +Y+ + L+ ++ P
Sbjct: 132 HLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLRWLAP 187
Query: 517 ELMRTGKASTSTDVYAFGVFMLEV-ASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDAS 575
E ++ ST +DV++FGV M EV G P E +N
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLN---------------RLQ 232
Query: 576 DSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+LE E + KL C P+ RP+ +++
Sbjct: 233 AGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVS 271
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 64/193 (33%), Positives = 96/193 (49%), Gaps = 12/193 (6%)
Query: 353 IGRGGFGKVYRGV-LASNVQIAVKKVSHD-SKQGIK-EFVAELVSMGRLRHRNLVKLRGY 409
IG G +G VYR S +A+KKV D + GI + E+ + LRH N+V+L+
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74
Query: 410 C--RRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVV 467
+ LV +Y L +L P + Q ++ + GL YLHE++ +
Sbjct: 75 VVGKHLDSIFLVMEYCEQ-DLASLLDNMPTP-FSESQVKCLMLQLLRGLQYLHENF---I 129
Query: 468 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPE-LMRTGKAST 526
+HRD+K +N+LL K+ DFGLAR Y P T K+V T Y PE L+ +T
Sbjct: 130 IHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPELLLGCTTYTT 188
Query: 527 STDVYAFGVFMLE 539
+ D++A G + E
Sbjct: 189 AIDMWAVGCILAE 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 58/217 (26%), Positives = 107/217 (49%), Gaps = 10/217 (4%)
Query: 345 KGFKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVA-ELVSMGRLRHRN 402
K + + IG+G G VY + +A+ ++A+K+++ +Q KE + E++ M +H N
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNL-QQQPKKELIINEILVMRENKHPN 77
Query: 403 LVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHED 462
+V E +V +Y+ GSL ++ + C++ Q + R L +LH +
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSN 134
Query: 463 WEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTG 522
V+HRDIK N+LL D + KL DFG + ++T +VGT +M PE++
Sbjct: 135 Q---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRK 190
Query: 523 KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLV 559
D+++ G+ +E+ G P + + + L+
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 64/205 (31%), Positives = 99/205 (48%), Gaps = 28/205 (13%)
Query: 352 VIGRGGFGKVYRGVLASNVQI-AVKKV--SHDSKQGIKEFVAELVSMGRLRHRNLVKLRG 408
++G G +G V + QI A+KK S D K K + E+ + +LRH NLV L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 409 YCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQR--FRIIRGVASGLLYLHEDWEQV 466
RRK LV++++ + LD + + ++ F+I+RG+ + H
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIE----FCH---SHN 120
Query: 467 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI--PQT--TKLVGTFGYMDPELM--- 519
++HRDIKP N+L+ KL DFG AR T+ P T V T Y PEL+
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFAR-----TLAAPGEVYTDYVATRWYRAPELLVGD 175
Query: 520 -RTGKASTSTDVYAFGVFMLEVASG 543
+ G+A D++A G + E+ +G
Sbjct: 176 TKYGRA---VDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 2e-16
Identities = 59/215 (27%), Positives = 108/215 (50%), Gaps = 19/215 (8%)
Query: 352 VIGRGGFGK--VYRGVLASNVQIAVKKV--SHDSKQGIKEFVAELVSMGRLRHRNLVKLR 407
V+G+G FG+ +YR + + K+V + S++ ++ + E+V + L+H N++
Sbjct: 7 VLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 408 GYCRRKGEFLLVYDYMPNGSL-DKILHTNIK----PCLNWYQRFRIIRGVASGLLYLHED 462
+ L+ +Y G+L DKI+ + + WY F+I+ V+ Y+H+
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYL-FQIVSAVS----YIHK- 119
Query: 463 WEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTG 522
+LHRDIK N+ L KLGDFG++++ + T +VGT YM PEL +
Sbjct: 120 --AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELCQGV 176
Query: 523 KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVN 557
K + +D++A G + E+ + +R + + V
Sbjct: 177 KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVV 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 3e-16
Identities = 74/284 (26%), Positives = 120/284 (42%), Gaps = 47/284 (16%)
Query: 346 GFKDKDVIGRGGFGKVYR-GVLASNVQIAVKKV--SHDSKQGIKEFVAELVSMGRLRHRN 402
FK +G+G +G VY+ L+ N A+K+V S++ ++ V E+ + + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 403 LVKLRGYCRRKGEFLL------VYDYMPNGSLDKIL------HTNIKPCLNWYQRFRIIR 450
++ K FL V +Y P G L K + I W RI
Sbjct: 61 II------SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW----RIFI 110
Query: 451 GVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT 510
+ GL LHE Q +LHRD+K AN+LL A+ K+GD G++++ +GT
Sbjct: 111 QLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQIGT 164
Query: 511 FGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGA 570
YM PE+ + S +D+++ G + E+A+ P E + SM+ + V K
Sbjct: 165 PHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR-SMQDLRYK--VQRG-KYPP 220
Query: 571 IRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
I L+ KP+ RPN +++
Sbjct: 221 IPPIYSQDLQNFIR------------SMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 59/198 (29%), Positives = 100/198 (50%), Gaps = 15/198 (7%)
Query: 353 IGRGGFGKVYR---GVLASNVQ--IAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLR 407
+G+G FG V L N +AVKK+ H + + +++F E+ + L+H N+VK +
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 408 GYCRRKG--EFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQ 465
G C G LV +Y+P GSL L + + L+ + + G+ YL +
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLG---SK 127
Query: 466 VVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVG---TFGYMDPELMRTG 522
+HRD+ N+L++++ K+GDFGL ++ D + G F Y PE +
Sbjct: 128 RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA-PESLTES 186
Query: 523 KASTSTDVYAFGVFMLEV 540
K S ++DV++FGV + E+
Sbjct: 187 KFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 3e-16
Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 10/211 (4%)
Query: 353 IGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRR 412
+G+G FG+V+ G ++A+K + + + F+ E M +LRH LV L
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 413 KGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 472
+ +V ++M GSL L L Q + +A G+ Y+ +HRD+
Sbjct: 73 E-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDL 128
Query: 473 KPANVLLDADLNGKLGDFGLARLYDHD--TIPQTTKLVGTFGYMDPELMRTGKASTSTDV 530
+ AN+L+ +L K+ DFGLARL + + T Q K + PE G+ + +DV
Sbjct: 129 RAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDV 186
Query: 531 YAFGVFMLE-VASGRRPVEQQGSMETVNLVD 560
++FG+ + E V GR P + E + V+
Sbjct: 187 WSFGILLTELVTKGRVPYPGMVNREVLEQVE 217
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 4e-16
Identities = 58/214 (27%), Positives = 104/214 (48%), Gaps = 30/214 (14%)
Query: 351 DVIGRGGFGKVYRGVLASN---VQIAVKKV-SHDSKQGIKEFVAELVSMGRL-RHRNLVK 405
DVIG G FG+V + + + + A+K++ + SK ++F EL + +L H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 406 LRGYCRRKGEFLLVYDYMPNGSL------DKILHTN--------IKPCLNWYQRFRIIRG 451
L G C +G L +Y P+G+L ++L T+ L+ Q
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 452 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR---LYDHDTIPQTTKLV 508
VA G+ YL + + +HRD+ N+L+ + K+ DFGL+R +Y T+ +
Sbjct: 121 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL---- 173
Query: 509 GTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS 542
+M E + +T++DV+++GV + E+ S
Sbjct: 174 -PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 54/179 (30%), Positives = 89/179 (49%), Gaps = 7/179 (3%)
Query: 368 SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGS 427
S Q+AVK + +Q + E+V M +H+N+V++ E ++ +++ G+
Sbjct: 45 SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104
Query: 428 LDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKL 487
L I+ + + LN Q + V L YLH Q V+HRDIK ++LL D KL
Sbjct: 105 LTDIV-SQTR--LNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKL 158
Query: 488 GDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRP 546
DFG D +P+ LVGT +M PE++ T D+++ G+ ++E+ G P
Sbjct: 159 SDFGFCAQISKD-VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 4e-16
Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 21/218 (9%)
Query: 352 VIGRGGFGKVYRGVLASNV----QIAVKKVSHD--SKQGIKEFVA---ELVSMGRLRHRN 402
++G+G FG+VY L +V ++A K+V D S + KE A E+ + L+H
Sbjct: 9 LLGQGAFGRVY---LCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHER 65
Query: 403 LVKLRGYCRRKGE--FLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLH 460
+V+ G R + E + +YMP GS+ L L + R + G+ YLH
Sbjct: 66 IVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKA--YGALTESVTRKYTRQILEGMSYLH 123
Query: 461 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT--TKLVGTFGYMDPEL 518
+ +++HRDIK AN+L D+ N KLGDFG ++ + T + GT +M PE+
Sbjct: 124 SN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180
Query: 519 MRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETV 556
+ DV++ G ++E+ + + P + +M +
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI 218
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 4e-16
Identities = 56/204 (27%), Positives = 85/204 (41%), Gaps = 21/204 (10%)
Query: 353 IGRGGFGKVYRGVLASNVQI-------AVKKVSHDSKQGIKEFVAELVSMGRLRHR-NLV 404
I +G FG VY LA +KK +K + AE M +
Sbjct: 4 ISKGAFGSVY---LAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 405 KLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWE 464
KL + K LV +Y+ G ++ T +W +++ I V G+ LH+
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQY--IAEVVLGVEDLHQRG- 117
Query: 465 QVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKA 524
++HRDIKP N+L+D + KL DFGL+R + K VGT Y+ PE +
Sbjct: 118 --IIHRDIKPENLLIDQTGHLKLTDFGLSRN-----GLENKKFVGTPDYLAPETILGVGD 170
Query: 525 STSTDVYAFGVFMLEVASGRRPVE 548
+D ++ G + E G P
Sbjct: 171 DKMSDWWSLGCVIFEFLFGYPPFH 194
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 26/205 (12%)
Query: 353 IGRGGFGKVYRGV-LASNVQIAVKKVSHDSK-QGIKEF-VAELVSMGRLRHRNLVKLRGY 409
IG G +G VY+ +N IA+KK+ + + +G+ + E+ + ++H N+V+L+
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 410 CRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQR------FRIIRGVASGLLYLHEDW 463
+ LV++Y+ LD H + P R ++I+RG+A Y H
Sbjct: 70 VHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA----YCHS-- 120
Query: 464 EQVVLHRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIP--QTTKLVGTFGYMDPELMR 520
VLHRD+KP N+L+D N KL DFGLAR + IP T V T Y PE++
Sbjct: 121 -HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG---IPVRTFTHEVVTLWYRAPEILL 176
Query: 521 TGKA-STSTDVYAFGVFMLEVASGR 544
+ ST D+++ G E+ + +
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 5e-16
Identities = 65/222 (29%), Positives = 112/222 (50%), Gaps = 20/222 (9%)
Query: 350 KDVIGRGGFGKVYRG-VLASNVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLR 407
++++G G G VY+ L + +AVK + D + + K+ ++EL + + ++
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 408 GYCRRKGEFLLVYDYMPNGSLDKILHTNI-KPCLNWYQRFRIIRGVASGLLYLHEDWEQV 466
G + + ++M GSLD ++ I + L RI V GL YL W
Sbjct: 66 GAFFVENRISICTEFMDGGSLD--VYRKIPEHVLG-----RIAVAVVKGLTYL---WSLK 115
Query: 467 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKAST 526
+LHRD+KP+N+L++ KL DFG++ ++I +T VGT YM PE + +
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQL-VNSIAKT--YVGTNAYMAPERISGEQYGI 172
Query: 527 STDVYAFGVFMLEVASGRRPVEQ----QGSMETVNLVDWVCD 564
+DV++ G+ +E+A GR P Q QGS+ + L+ + D
Sbjct: 173 HSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD 214
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 6e-16
Identities = 64/212 (30%), Positives = 108/212 (50%), Gaps = 33/212 (15%)
Query: 353 IGRGGFGKVYRGV-LASNVQIAVKKVSH--DSKQGIKEFVAELVSMGRLRHRNLVKLRGY 409
IGRG +G V +N ++A+KK+++ D++ K + E+ + L H N++ ++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 410 CR--RKGEF---LLVYDYMPNGSLDKILHTNIKP--------CLNWYQRFRIIRGVASGL 456
+ F +VY+ M D LH I+ C Y ++++RG L
Sbjct: 73 MPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQTLSDDHC--QYFLYQLLRG----L 121
Query: 457 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDP 516
Y+H VLHRD+KP+N+LL+A+ + K+ DFGLAR + T+ V T Y P
Sbjct: 122 KYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-EKGDFMTEYVVTRWYRAP 177
Query: 517 E-LMRTGKASTSTDVYAFGVFMLEVASGRRPV 547
E L+ + +T+ DV++ G E+ GR+P+
Sbjct: 178 ELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 6e-16
Identities = 62/230 (26%), Positives = 108/230 (46%), Gaps = 26/230 (11%)
Query: 353 IGRGGFGKVYRGVL----ASNVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKL 406
+G FGK+Y+G L + Q+ K D + Q EF E M L H N+V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 407 RGYCRRKGEFLLVYDYMPNGSLDKIL-----HTNI----------KPCLNWYQRFRIIRG 451
G ++ ++++Y+ G L + L H+++ K L+ I
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 452 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGT 510
+A+G+ YL + +H+D+ N+L+ L+ K+ D GL+R +Y D K +
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 511 FGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLV 559
+M PE + GK S+ +D+++FGV + E+ S G +P + E + +V
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV 239
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 8e-16
Identities = 60/227 (26%), Positives = 112/227 (49%), Gaps = 34/227 (14%)
Query: 352 VIGRGGFGKVYRGVLASNVQI-AVKKVSHDS---------KQGIKEFVAELVSMGRLRHR 401
+IG G FG VY G+ AS+ ++ AVK+V S + + E+ + L+H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 402 NLVKLRGYCRRKGEFLLVY-DYMPNGSLDKILHTNIKPCLNWYQRFR------IIRGVAS 454
N+V+ G + L ++ +Y+P GS+ +L N Y F +R +
Sbjct: 67 NIVQYLG-SSLDADHLNIFLEYVPGGSVAALL--------NNYGAFEETLVRNFVRQILK 117
Query: 455 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTK-----LVG 509
GL YLH + ++HRDIK AN+L+D K+ DFG+++ + +++ T L G
Sbjct: 118 GLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQG 174
Query: 510 TFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETV 556
+ +M PE+++ + D+++ G ++E+ +G+ P ++ +
Sbjct: 175 SVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI 221
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 8e-16
Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 30/215 (13%)
Query: 350 KDVIGRGGFGKVYRGVLASN---VQIAVKKV-SHDSKQGIKEFVAELVSMGRL-RHRNLV 404
+DVIG G FG+V R ++ + + A+K + S+ ++F EL + +L H N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 405 KLRGYCRRKGEFLLVYDYMPNGSL------DKILHTN--------IKPCLNWYQRFRIIR 450
L G C +G + +Y P G+L ++L T+ L Q +
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 451 GVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR---LYDHDTIPQTTKL 507
VA+G+ YL E + +HRD+ NVL+ +L K+ DFGL+R +Y T+ +
Sbjct: 127 DVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRL--- 180
Query: 508 VGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS 542
+M E + +T +DV++FGV + E+ S
Sbjct: 181 --PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 9e-16
Identities = 66/216 (30%), Positives = 109/216 (50%), Gaps = 17/216 (7%)
Query: 352 VIGRGGFGKVYRGVLA-SNVQIAVKKVSHD--SKQGIKEFVA---ELVSMGRLRHRNLVK 405
++GRG FG+VY A + ++AVK+V D S++ KE A E+ + LRH +V+
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 406 LRGYCRRKGE---FLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHED 462
G C R E + +YMP GS+ L N +R+ R + G+ YLH +
Sbjct: 69 YYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRY--TRQILQGVSYLHSN 125
Query: 463 WEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT--TKLVGTFGYMDPELMR 520
+++HRDIK AN+L D+ N KLGDFG ++ + T + GT +M PE++
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVIS 182
Query: 521 TGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETV 556
DV++ ++E+ + + P + +M +
Sbjct: 183 GEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI 218
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 9e-16
Identities = 55/180 (30%), Positives = 88/180 (48%), Gaps = 9/180 (5%)
Query: 368 SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGS 427
+ Q+AVKK+ +Q + E+V M H N+V + E +V +++ G+
Sbjct: 46 TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105
Query: 428 L-DKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGK 486
L D + HT +N Q + V L YLH Q V+HRDIK ++LL +D K
Sbjct: 106 LTDIVTHTR----MNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIK 158
Query: 487 LGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRP 546
L DFG + +P+ LVGT +M PE++ T D+++ G+ ++E+ G P
Sbjct: 159 LSDFGFCAQVSKE-VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 9e-16
Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 15/215 (6%)
Query: 352 VIGRGGFGKVYRGVLA-SNVQIAVKKVSHD--SKQGIKEFVA---ELVSMGRLRHRNLVK 405
++G+G FG+VY A + ++AVK+V D S + KE A E+ + L H +V+
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 406 LRGYCRRKGEFLL--VYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDW 463
G R E L ++MP GS+ L + N +++ R + G+ YLH +
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYT--RQILEGVSYLHSN- 125
Query: 464 EQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT--TKLVGTFGYMDPELMRT 521
+++HRDIK AN+L D+ N KLGDFG ++ + T + GT +M PE++
Sbjct: 126 --MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183
Query: 522 GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETV 556
D+++ G ++E+ + + P + +M +
Sbjct: 184 EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI 218
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 57/206 (27%), Positives = 103/206 (50%), Gaps = 15/206 (7%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIK-EFVAELVSMGRLRHRNLV 404
F+ +G G G V + + S + +A K + + K I+ + + EL + +V
Sbjct: 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIV 62
Query: 405 KLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIK---PCLNWYQRFRIIRGVASGLLYLHE 461
G GE + ++M GSLD++L + L +I V GL YL E
Sbjct: 63 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILG-----KISIAVLRGLTYLRE 117
Query: 462 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRT 521
+ ++HRD+KP+N+L+++ KL DFG++ D++ + VGT YM PE ++
Sbjct: 118 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANS--FVGTRSYMSPERLQG 172
Query: 522 GKASTSTDVYAFGVFMLEVASGRRPV 547
+ +D+++ G+ ++E+A GR P+
Sbjct: 173 THYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 77/290 (26%), Positives = 119/290 (41%), Gaps = 59/290 (20%)
Query: 353 IGRGGFGKVYRGVLASNV---QIAVKKV-SHDSKQGIKEFVAELVSMGRLRHRNLVKLRG 408
IG G FGKV G + S Q+ VK++ S Q +F+ E L+H NL++ G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 409 YCRRKGEFLLVYDYMPNGSLDKILHT-----NIKPCLNWYQRFRIIRGVASGLLYLHEDW 463
C +LLV ++ P G L L + + P QR +A GLL+LH++
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMAC--EIALGLLHLHKN- 119
Query: 464 EQVVLHRDIKPANVLLDADLNGKLGDFGLARL-YDHDTIPQTTKLVGTFGYMDPEL---- 518
+H D+ N LL ADL K+GD+GL+ Y D +L ++ PEL
Sbjct: 120 --NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 519 ---MRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDA 574
+ + ++V++ GV + E+ G +P + +
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT--------------- 222
Query: 575 SDSRLEGICEEKQMEL---VLKLGL---------FCSHPKPEARPNMRQV 612
E+Q++L LKL L FC PE RP+ +V
Sbjct: 223 --------VREQQLKLPKPRLKLPLSDRWYEVMQFCWLQ-PEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 77.5 bits (190), Expect = 2e-15
Identities = 55/216 (25%), Positives = 106/216 (49%), Gaps = 8/216 (3%)
Query: 345 KGFKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNL 403
K + + IG+G G V+ + +A+ ++A+K+++ + + + E++ M L++ N+
Sbjct: 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNI 78
Query: 404 VKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDW 463
V E +V +Y+ GSL ++ + C++ Q + R L +LH +
Sbjct: 79 VNFLDSFLVGDELFVVMEYLAGGSLTDVV---TETCMDEAQIAAVCRECLQALEFLHANQ 135
Query: 464 EQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGK 523
V+HRDIK NVLL D + KL DFG + ++T +VGT +M PE++
Sbjct: 136 ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKA 191
Query: 524 ASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLV 559
D+++ G+ +E+ G P + + + L+
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 45/215 (20%)
Query: 351 DVIGRGGFGKVYRGVLASNVQ-IAVKKVSHDSKQG-----IKEFVAELVSMGR-LRHRNL 403
D +G G + VY+G Q +A+K++ + ++G I+E S+ + L+H N+
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIRE-----ASLLKDLKHANI 65
Query: 404 VKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQR-----------FRIIRGV 452
V L K LV++Y+ T++K ++ F+++RG+
Sbjct: 66 VTLHDIIHTKKTLTLVFEYL---------DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGL 116
Query: 453 ASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT--KLVGT 510
A Y H+ + VLHRD+KP N+L+ KL DFGLAR ++P T V T
Sbjct: 117 A----YCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARA---KSVPSKTYSNEVVT 166
Query: 511 FGYMDPE-LMRTGKASTSTDVYAFGVFMLEVASGR 544
Y P+ L+ + + STS D++ G E+A+GR
Sbjct: 167 LWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 59/217 (27%), Positives = 104/217 (47%), Gaps = 34/217 (15%)
Query: 350 KDVIGRGGFGKVYRGVLASN---VQIAVKKVS-HDSKQGIKEFVAELVSMGRL-RHRNLV 404
+DVIG G FG+V + + + + A+K++ + SK ++F EL + +L H N++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 405 KLRGYCRRKGEFLLVYDYMPNGSL------DKILHTN--------IKPCLNWYQRFRIIR 450
L G C +G L +Y P+G+L ++L T+ L+ Q
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 451 GVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT 510
VA G+ YL + + +HRD+ N+L+ + K+ DFGL+R Q + T
Sbjct: 132 DVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKT 181
Query: 511 FG-----YMDPELMRTGKASTSTDVYAFGVFMLEVAS 542
G +M E + +T++DV+++GV + E+ S
Sbjct: 182 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 61/225 (27%), Positives = 105/225 (46%), Gaps = 16/225 (7%)
Query: 347 FKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRL-RHRNLVK 405
F+ +V+G G +G+VY+G Q+A KV ++ +E E+ + + HRN+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 406 LRGYCRRKG------EFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYL 459
G +K + LV ++ GS+ ++ L I R + GL +L
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL 137
Query: 460 HEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELM 519
H V+HRDIK NVLL + KL DFG++ D T+ + +GT +M PE++
Sbjct: 138 HA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR-TVGRRNTFIGTPYWMAPEVI 193
Query: 520 RTGKASTST-----DVYAFGVFMLEVASGRRPVEQQGSMETVNLV 559
+ +T D+++ G+ +E+A G P+ M + L+
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI 238
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 67/280 (23%), Positives = 127/280 (45%), Gaps = 40/280 (14%)
Query: 353 IGRGGFGKVYRGVLASNVQ------IAVKKVSHDSKQGIK-EFVAELVSMGRLRHRNLVK 405
+G+G FG VY G+ V+ +A+K V+ + + EF+ E M ++V+
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 406 LRGYCRRKGEFLLVYDYMPNGSLDKILHT----------NIKPCLNWYQRFRIIRGVASG 455
L G + L++ + M G L L + P L + ++ +A G
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLK--KMIQMAGEIADG 131
Query: 456 LLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYM 514
+ YL+ + +HRD+ N ++ D K+GDFG+ R +Y+ D + K + +M
Sbjct: 132 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 515 DPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRD 573
PE ++ G +T +DV++FGV + E+A+ +P + + + + V +G + D
Sbjct: 189 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV-------MEGGLLD 241
Query: 574 ASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVM 613
D+ C + EL+ C P+ RP+ +++
Sbjct: 242 KPDN-----CPDMLFELM----RMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 61/211 (28%), Positives = 104/211 (49%), Gaps = 34/211 (16%)
Query: 353 IGRGGFGKVYRGVLASNVQI-AVKKVSHDSK-QGIKEF-VAELVSMGRLRHRNLVKLRGY 409
IG G +G V++ +I A+K+V D +G+ + E+ + L+H+N+V+L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 410 CRRKGEFLLVYDYMP----------NGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYL 459
+ LV++Y NG +D +K + F++++G+A +
Sbjct: 68 LHSDKKLTLVFEYCDQDLKKYFDSCNGDID---PEIVKSFM-----FQLLKGLA----FC 115
Query: 460 HEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP--QTTKLVGTFGYMDPE 517
H VLHRD+KP N+L++ + KL DFGLAR + IP + V T Y P+
Sbjct: 116 HS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFG---IPVRCYSAEVVTLWYRPPD 169
Query: 518 LMRTGKA-STSTDVYAFGVFMLEVASGRRPV 547
++ K STS D+++ G E+A+ RP+
Sbjct: 170 VLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 39/223 (17%)
Query: 353 IGRGGFGKVYRGV-LASNVQIAVKKV--------SHDSKQGIKE----FVA--ELVSMGR 397
+G G +GKV + + +A+KKV +Q + F EL M
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 398 LRHRNLVKLRG-YCRRKGEFL-LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASG 455
++H N++ L Y +G+F+ LV D M L K++ I+ L Q I+ + +G
Sbjct: 77 IKHENIMGLVDVYV--EGDFINLVMDIM-ASDLKKVVDRKIR--LTESQVKCILLQILNG 131
Query: 456 LLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT----------- 504
L LH+ + +HRD+ PAN+ +++ K+ DFGLAR Y + T
Sbjct: 132 LNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188
Query: 505 --TKLVGTFGYMDPE-LMRTGKASTSTDVYAFGVFMLEVASGR 544
T V T Y PE LM K + D+++ G E+ +G+
Sbjct: 189 EMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 21/213 (9%)
Query: 352 VIGRGGFGKVYRGVL----ASNVQIAVK--KVSHDSKQGIKEFVAELVSMGRLRHRNLVK 405
++G G FG V G L S +++AVK K+ + I+EF++E M H N++K
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 406 LRGYC---RRKGEF---LLVYDYMPNGSLDKIL---HTNIKPCLNWYQRF-RIIRGVASG 455
L G C + +++ +M +G L L P Q + + +A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 456 LLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYM 514
+ YL + +HRD+ N +L D+ + DFGL++ +Y D Q ++
Sbjct: 126 MEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 515 DPELMRTGKASTSTDVYAFGVFMLEVAS-GRRP 546
E + ++ +DV+AFGV M E+A+ G+ P
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 59/215 (27%), Positives = 104/215 (48%), Gaps = 21/215 (9%)
Query: 353 IGRGGFGKVYR------GVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKL 406
+G G FGKVY+ G LA A K + S++ +++++ E+ + H +VKL
Sbjct: 20 LGDGAFGKVYKAKNKETGALA-----AAKVIETKSEEELEDYMVEIEILATCNHPYIVKL 74
Query: 407 RGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQV 466
G G+ ++ ++ P G++D I+ + L Q I R + L YLH
Sbjct: 75 LGAFYWDGKLWIMIEFCPGGAVDAIM-LELDRGLTEPQIQVICRQMLEALQYLHS---MK 130
Query: 467 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPEL-----MRT 521
++HRD+K NVLL D + KL DFG++ + T+ + +GT +M PE+ M+
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSA-KNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189
Query: 522 GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETV 556
D+++ G+ ++E+A P + M +
Sbjct: 190 TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL 224
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 5e-15
Identities = 65/227 (28%), Positives = 101/227 (44%), Gaps = 35/227 (15%)
Query: 352 VIGRGGFGKVYRGVLASNV---------QIAVKKVSHDSKQGIKEFVAELVSMGRLRHRN 402
V+G G FG R +L +V +I + K S + KE V + +++H N
Sbjct: 7 VVGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVL----LAKMKHPN 59
Query: 403 LVKLRGYCRRKGEFLLVYDYMPNGSL-DKILHTNIK-----PCLNWYQRFRIIRGVASGL 456
+V + G +V +Y G L KI K L W+ + + G+
Sbjct: 60 IVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ------MCLGV 113
Query: 457 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDP 516
++HE + VLHRDIK N+ L + KLGDFG ARL T VGT Y+ P
Sbjct: 114 QHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT-YVGTPYYVPP 169
Query: 517 ELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVC 563
E+ + +D+++ G + E+ + + P Q S + NL+ VC
Sbjct: 170 EIWENMPYNNKSDIWSLGCILYELCTLKHPF-QANSWK--NLILKVC 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 62/205 (30%), Positives = 102/205 (49%), Gaps = 25/205 (12%)
Query: 351 DVIGRGGFGKVYRG--VLASNVQIAVKKVSHDSKQGIK-EFVAELVSMGRLRHRNLVKLR 407
+ +G G + V++G L N+ +A+K++ + ++G + E+ + L+H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 408 GYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQR-------FRIIRGVASGLLYLH 460
LV++Y LDK L + C N ++I+RG+A Y H
Sbjct: 71 DIVHTDKSLTLVFEY-----LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLA----YCH 121
Query: 461 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPE-LM 519
+ VLHRD+KP N+L++ KL DFGLAR T + ++V T Y P+ L+
Sbjct: 122 R---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLL 177
Query: 520 RTGKASTSTDVYAFGVFMLEVASGR 544
+ + ST D++ G E+ASGR
Sbjct: 178 GSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 6e-15
Identities = 53/208 (25%), Positives = 102/208 (49%), Gaps = 8/208 (3%)
Query: 353 IGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCR 411
IG+G G VY + +A+ ++A+K+++ + + + E++ M ++ N+V
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 412 RKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 471
E +V +Y+ GSL ++ + C++ Q + R L +LH + V+HRD
Sbjct: 87 VGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALDFLHSNQ---VIHRD 140
Query: 472 IKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVY 531
IK N+LL D + KL DFG + ++T +VGT +M PE++ D++
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 532 AFGVFMLEVASGRRPVEQQGSMETVNLV 559
+ G+ +E+ G P + + + L+
Sbjct: 200 SLGIMAIEMVEGEPPYLNENPLRALYLI 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 6e-15
Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 15/204 (7%)
Query: 352 VIGRGGFGKVY--RGVLASNV----QIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVK 405
V+GRG FG V+ R + QI V++++ D + + E + L H N+++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQN---ECQVLKLLSHPNIIE 63
Query: 406 LRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQ 465
++V +Y P G+L + + K C + I+ LL LH +
Sbjct: 64 YYENFLEDKALMIVMEYAPGGTLAEYIQ---KRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 466 VVLHRDIKPANVLLDADLN-GKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKA 524
++LHRD+K N+LLD K+GDFG++++ + T +VGT Y+ PEL
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYISPELCEGKPY 178
Query: 525 STSTDVYAFGVFMLEVASGRRPVE 548
+ +D++A G + E+AS +R E
Sbjct: 179 NQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 6e-15
Identities = 59/209 (28%), Positives = 100/209 (47%), Gaps = 10/209 (4%)
Query: 353 IGRGGFGKVYRGVLASNVQ-IAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCR 411
IG G G V + S+ + +AVKK+ +Q + E+V M +H N+V++
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 412 RKGEFLLVYDYMPNGSL-DKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHR 470
E +V +++ G+L D + HT +N Q + V L LH Q V+HR
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLKALSVLHA---QGVIHR 140
Query: 471 DIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDV 530
DIK ++LL D KL DFG + +P+ LVGT +M PEL+ D+
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKE-VPRRKSLVGTPYWMAPELISRLPYGPEVDI 199
Query: 531 YAFGVFMLEVASGRRPVEQQGSMETVNLV 559
++ G+ ++E+ G P + ++ + ++
Sbjct: 200 WSLGIMVIEMVDGEPPYFNEPPLKAMKMI 228
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 7e-15
Identities = 61/223 (27%), Positives = 107/223 (47%), Gaps = 47/223 (21%)
Query: 353 IGRGGFGKVYRGV-LASNVQIAVKKVSHDSK-QGIKEF-VAELVSMGRLRHRNLVKLRGY 409
IG G +G VY+G + +A+KK+ +S+ +G+ + E+ + L+H N+V L+
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 410 CRRKGEFLLVYDYM------------PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLL 457
++ L+++++ +D L +K L YQ + G+L
Sbjct: 68 LMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAEL---VKSYL--YQ-------ILQGIL 115
Query: 458 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLA-------RLYDHDTIPQTTKLVGT 510
+ H + VLHRD+KP N+L+D KL DFGLA R+Y H+ + T
Sbjct: 116 FCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV--------T 164
Query: 511 FGYMDPE-LMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGS 552
Y PE L+ + + ST D+++ G E+A+ ++P+ S
Sbjct: 165 LWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPLFHGDS 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 7e-15
Identities = 63/207 (30%), Positives = 103/207 (49%), Gaps = 14/207 (6%)
Query: 353 IGRGGFGKVYRGVL-ASNVQIAVKKVSHDSKQGIKEFVAELVS---MGRLRHRNLVKLRG 408
+G+GGFG+V + A+ A KK++ + K + +V + ++ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 409 YCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVA---SGLLYLHEDWEQ 465
+ K + LV M G L ++ N+ + R A SGL +LH+ +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIY-NVDEENPGFPEPRACFYTAQIISGLEHLHQ---R 116
Query: 466 VVLHRDIKPANVLLDADLNGKLGDFGLA-RLYDHDTIPQTTKLVGTFGYMDPELMRTGKA 524
+++RD+KP NVLLD D N ++ D GLA L D + +T GT G+M PEL++ +
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTKGYAGTPGFMAPELLQGEEY 174
Query: 525 STSTDVYAFGVFMLEVASGRRPVEQQG 551
S D +A GV + E+ + R P +G
Sbjct: 175 DFSVDYFALGVTLYEMIAARGPFRARG 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 8e-15
Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 10/199 (5%)
Query: 353 IGRGGFGKVYRGVLASNVQIA-VKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCR 411
IG G +G VY+ + ++A +K + + + E++ M +H N+V G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 412 RKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 471
R+ + + ++ GSL I H + L+ Q + R GL YLH + +HRD
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYH--VTGPLSESQIAYVSRETLQGLYYLHSKGK---MHRD 131
Query: 472 IKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELM---RTGKASTST 528
IK AN+LL + + KL DFG++ TI + +GT +M PE+ R G +
Sbjct: 132 IKGANILLTDNGHVKLADFGVSAQITA-TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLC 190
Query: 529 DVYAFGVFMLEVASGRRPV 547
D++A G+ +E+A + P+
Sbjct: 191 DIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 8e-15
Identities = 64/211 (30%), Positives = 103/211 (48%), Gaps = 36/211 (17%)
Query: 353 IGRGGFGKVYRGV-LASNVQIAVKKVSHDS-KQGIKEFVAELVSMGR-LRHRNLVKLRGY 409
IG G +G VY+ + +A+KK+ ++ +G+ +S+ + L H N+V+L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 410 CRRKGEFLLVYDYM-----------PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLY 458
+ + LV++++ P LD L IK L YQ +++G+A Y
Sbjct: 67 VHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPL---IKSYL--YQ---LLQGIA----Y 114
Query: 459 LHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP--QTTKLVGTFGYMDP 516
H VLHRD+KP N+L+D + KL DFGLAR + +P T V T Y P
Sbjct: 115 CHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFG---VPVRTYTHEVVTLWYRAP 168
Query: 517 ELMRTGKA-STSTDVYAFGVFMLEVASGRRP 546
E++ + ST D+++ G E+ + RRP
Sbjct: 169 EILLGSRQYSTPVDIWSIGCIFAEMVN-RRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 9e-15
Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 29/207 (14%)
Query: 351 DVIGRGGFGKVYRG--VLASNVQIAVKKVSHDSKQGIK-EFVAELVSMGRLRHRNLVKLR 407
D +G G + VY+G L N+ +A+K++ + ++G + E+ + L+H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 408 GYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQR-------FRIIRGVASGLLYLH 460
+ LV++Y LDK L + C N F+++RG+ Y H
Sbjct: 71 DIIHTEKSLTLVFEY-----LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLN----YCH 121
Query: 461 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT--KLVGTFGYMDPE- 517
+ VLHRD+KP N+L++ KL DFGLAR +IP T V T Y P+
Sbjct: 122 R---RKVLHRDLKPQNLLINERGELKLADFGLARA---KSIPTKTYSNEVVTLWYRPPDI 175
Query: 518 LMRTGKASTSTDVYAFGVFMLEVASGR 544
L+ + ST D++ G E+++GR
Sbjct: 176 LLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 9e-15
Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 353 IGRGGFGKVYRGVLASNVQ----IAVKKVSHDSKQG---IKEFVAELVSMGRLRHRNLVK 405
I +G +G+V+ LA A+K + + + + E + + + +VK
Sbjct: 1 ISKGAYGRVF---LAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57
Query: 406 LRGYCRRKGE--FLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDW 463
L Y +G+ LV +Y+P G L +L N+ L+ I + L YLH +
Sbjct: 58 L--YYSFQGKKNLYLVMEYLPGGDLASLLE-NVG-SLDEDVARIYIAEIVLALEYLHSNG 113
Query: 464 EQVVLHRDIKPANVLLDADLNGKLGDFGLAR-------LYDHDTIPQTTKLVGTFGYMDP 516
++HRD+KP N+L+D++ + KL DFGL++ + +D + ++VGT Y+ P
Sbjct: 114 ---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170
Query: 517 ELMRTGKASTSTDVYAFGVFMLEVASGRRP 546
E++ S + D ++ G + E G P
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 61/218 (27%), Positives = 110/218 (50%), Gaps = 20/218 (9%)
Query: 352 VIGRGGFGKVY--RGVLASNV-QIAVKKVSHDSKQGIKEFV---AELVSMGRLRHRNLVK 405
V+G+G FGKV+ R + + Q+ KV + +++ V E + + H +VK
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 406 LRGYCRRKGEFLLVYDYMPNGSLDKILHTNI---KPCLNWYQRFRIIRGVASGLLYLHED 462
L + +G+ L+ D++ G L L + + + +Y + +A L +LH
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFY-----LAELALALDHLHS- 116
Query: 463 WEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMDPELMRT 521
+++RD+KP N+LLD + + KL DFGL++ DH+ + GT YM PE++
Sbjct: 117 --LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNR 172
Query: 522 GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLV 559
+ S D ++FGV M E+ +G P + + ET+ ++
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 69/229 (30%), Positives = 112/229 (48%), Gaps = 27/229 (11%)
Query: 347 FKDKDVIGRGGFGKVYRGVL---ASNVQIAVKKVSHDSKQGIK---EFVAELVSMGRLRH 400
K V+G G FG VY+G+ V+I V + G K EF+ E + M + H
Sbjct: 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH 68
Query: 401 RNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHT---NI--KPCLNWYQRFRIIRGVASG 455
+LV+L G C LV MP+G L +H NI + LNW + +A G
Sbjct: 69 PHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKG 121
Query: 456 LLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT---KLVGTFG 512
++YL E + ++HRD+ NVL+ + + K+ DFGLARL + D K+
Sbjct: 122 MMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM--PIK 176
Query: 513 YMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVD 560
+M E + K + +DV+++GV + E+ + G +P + + E +L++
Sbjct: 177 WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 26/211 (12%)
Query: 353 IGRGGFGKVYRGVL------ASNVQIAVKKVSHD-SKQGIKEFVAELVSMGRL-RHRNLV 404
+G G FG+V + +AVK + D +++ + + V+E+ M + +H+N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 405 KLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKP-CLNWYQRFRIIRG------------ 451
L G C ++G +V +Y +G+L L P R
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 452 -VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVG 509
VA G+ +L + +HRD+ NVL+ D K+ DFGLAR ++ D +TT
Sbjct: 140 QVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRL 196
Query: 510 TFGYMDPELMRTGKASTSTDVYAFGVFMLEV 540
+M PE + + +DV++FGV + E+
Sbjct: 197 PVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 227
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 30/207 (14%)
Query: 352 VIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQG--IKEFVAELVSMGR-LRHRNLVKLRG 408
V+G G +G V + +I K DS++ +KE + M R L+ N+V+L+
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 409 YCRRKGEFLLVYDY-----------MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLL 457
RR+G+ LV++Y MPNG + + + I +++I+ +
Sbjct: 68 AFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYI---------YQLIKAIH---- 114
Query: 458 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPE 517
+ H++ ++HRDIKP N+L+ + KL DFG AR + T+ V T Y PE
Sbjct: 115 WCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPE 171
Query: 518 LMRTGKASTSTDVYAFGVFMLEVASGR 544
L+ + D+++ G + E++ G+
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 64/221 (28%), Positives = 102/221 (46%), Gaps = 34/221 (15%)
Query: 353 IGRGGFGKVYRGVL-----ASNVQIAVKKVSHDSKQGI--KEFVAELVSMGRLRHRNLVK 405
+G FGKVY+G L Q K D +G +EF E + RL+H N+V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 406 LRGYCRRKGEFLLVYDYMPNGSLDKIL-----HTNI---------KPCLNWYQRFRIIRG 451
L G ++ +++ Y + L + L H+++ K L I+
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 452 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGT 510
+A+G+ +L V+H+D+ NVL+ LN K+ D GL R +Y D KL+G
Sbjct: 133 IAAGMEFLSS---HHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYY----KLMGN 185
Query: 511 ----FGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRP 546
+M PE + GK S +D++++GV + EV S G +P
Sbjct: 186 SLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 79/296 (26%), Positives = 126/296 (42%), Gaps = 54/296 (18%)
Query: 353 IGRGGFGKVYRGVLASNVQ--IAVKKVS-HDSKQG-----IKEFVAELVSMGRLRHRNLV 404
IG G +GKV++ N +A+K+V ++G I+E VA L + H N+V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE-VAVLRHLETFEHPNVV 67
Query: 405 KLRGYCR-----RKGEFLLVYDYMPNG---SLDKILHTNIKPCL---NWYQRFRIIRGVA 453
+L C R+ + LV++++ LDK+ + +Q R
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR------ 121
Query: 454 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 513
GL +LH V+HRD+KP N+L+ + KL DFGLAR+Y T +V T Y
Sbjct: 122 -GLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVVTLWY 175
Query: 514 MDPELMRTGKASTSTDVYAFGVFMLEVASGRRP-------VEQQGSMETVNLV----DWV 562
PE++ +T D+++ G E+ R+P V+Q G + V + DW
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234
Query: 563 CDCWKKGAIRDASDSR----LEGIC---EEKQMELVLKLGLFCSHPKPEARPNMRQ 611
D R A S+ +E +E +L+LK F + A +
Sbjct: 235 RDV---ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 2e-14
Identities = 62/227 (27%), Positives = 107/227 (47%), Gaps = 20/227 (8%)
Query: 347 FKDKDVIGRGGFGKVYRGVLASNVQIA---VKKVSHDSKQGIKEFVAELVSMGRLRHRNL 403
F+ +++G G +G+VY+G Q+A V V+ D ++ IK+ + L HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSH--HRNI 65
Query: 404 VKLRGYCRRKG------EFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLL 457
G +K + LV ++ GS+ ++ L I R + GL
Sbjct: 66 ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 125
Query: 458 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPE 517
+LH+ V+HRDIK NVLL + KL DFG++ D T+ + +GT +M PE
Sbjct: 126 HLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR-TVGRRNTFIGTPYWMAPE 181
Query: 518 LMRTGKASTST-----DVYAFGVFMLEVASGRRPVEQQGSMETVNLV 559
++ + +T D+++ G+ +E+A G P+ M + L+
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 228
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 62/232 (26%), Positives = 110/232 (47%), Gaps = 41/232 (17%)
Query: 347 FKDKDVIGRGGFGKVYRGVLAS-----------NVQ------IAVKKVSHD-SKQGIKEF 388
FK+K +G G FG+V+ + + NV+ +AVK + D +K +F
Sbjct: 9 FKEK--LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDF 66
Query: 389 VAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNI------------ 436
+ E+ + RL+ N+++L G C + ++ +YM NG L++ L ++
Sbjct: 67 LKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126
Query: 437 -----KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFG 491
P +++ + +ASG+ YL +HRD+ N L+ +L K+ DFG
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLATRNCLVGENLTIKIADFG 183
Query: 492 LAR-LYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS 542
++R LY D + V +M E + GK +T++DV+AFGV + E+
Sbjct: 184 MSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 29/222 (13%)
Query: 352 VIGRGGFGKVYRGVL---ASNVQIAVK-KVSHD--SKQGIKEFVAELVSMGRLRHRNLVK 405
++G G FG V++G+ +++I V K D +Q +E +++MG L H +V+
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 406 LRGYCRRKGEFLLVYDYMPNGSLDKILHTN---IKP--CLNWYQRFRIIRGVASGLLYLH 460
L G C LV P GSL + + + P LNW + +A G+ YL
Sbjct: 74 LLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMYYLE 126
Query: 461 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMDPELM 519
E ++HR++ N+LL +D ++ DFG+A LY D ++ +M E +
Sbjct: 127 E---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 520 RTGKASTSTDVYAFGVFMLEVAS-------GRRPVEQQGSME 554
G+ + +DV+++GV + E+ S G RP E +E
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 2e-14
Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 49/208 (23%)
Query: 353 IGRGGFGKVYRGVLASNVQI-AVKKV------SHDSKQGIKE--FVAELVSMGRLRHRNL 403
+G+G +G V++ + ++ A+KK+ + D+++ +E F+ EL H N+
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGD-----HPNI 69
Query: 404 VKLRGYCRRKG--EFLLVYDYMPNGSLDKILHTNIKPCL--------NWYQRFRIIRGVA 453
VKL + + + LV++YM + LH I+ + YQ + ++
Sbjct: 70 VKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRYIMYQLLKALK--- 121
Query: 454 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR----LYDHDTIPQTTKLVG 509
Y+H V+HRD+KP+N+LL++D KL DFGLAR L ++ P T V
Sbjct: 122 ----YIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 510 TFGYMDPELMRTGKASTSTDVYAFGVFM 537
T Y PE++ ST Y GV M
Sbjct: 175 TRWYRAPEILL---GSTR---YTKGVDM 196
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 58/204 (28%), Positives = 101/204 (49%), Gaps = 11/204 (5%)
Query: 347 FKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSH-DSKQGIK-EFVAELVSMGRLRHRNLV 404
F+ +G G G V++ + I +K+ H + K I+ + + EL + +V
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 405 KLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWE 464
G GE + ++M GSLD++L + + I V GL YL E +
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI--AVIKGLTYLRE--K 122
Query: 465 QVVLHRDIKPANVLLDADLNGKLGDFGLA-RLYDHDTIPQTTKLVGTFGYMDPELMRTGK 523
++HRD+KP+N+L+++ KL DFG++ +L D VGT YM PE ++
Sbjct: 123 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGTH 178
Query: 524 ASTSTDVYAFGVFMLEVASGRRPV 547
S +D+++ G+ ++E+A GR P+
Sbjct: 179 YSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 2e-14
Identities = 53/211 (25%), Positives = 102/211 (48%), Gaps = 14/211 (6%)
Query: 353 IGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCR 411
IG+G G VY + +A+ ++A+++++ + + + E++ M ++ N+V
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 412 RKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 471
E +V +Y+ GSL ++ + C++ Q + R L +LH + V+HRD
Sbjct: 88 VGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRD 141
Query: 472 IKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTK---LVGTFGYMDPELMRTGKASTST 528
IK N+LL D + KL DFG P+ +K +VGT +M PE++
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCA----QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 529 DVYAFGVFMLEVASGRRPVEQQGSMETVNLV 559
D+++ G+ +E+ G P + + + L+
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLI 228
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 353 IGRGGFGKVYRGVLASNVQI-AVKKVSHD-SKQGIKEFVAEL-VSMGRLRHRNLVKLRGY 409
+GRG +G V + I AVK++ + Q K + +L +SM + V G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 410 CRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRF--RIIRGVASGLLYLHEDWEQVV 467
R+G+ + + M + SLDK L + +I + L YLH V
Sbjct: 69 LFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--V 125
Query: 468 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPEL----MRTGK 523
+HRD+KP+NVL++ + KL DFG++ Y D++ +T G YM PE +
Sbjct: 126 IHRDVKPSNVLINRNGQVKLCDFGISG-YLVDSVAKTID-AGCKPYMAPERINPELNQKG 183
Query: 524 ASTSTDVYAFGVFMLEVASGRRPVEQQGSM 553
+DV++ G+ M+E+A+GR P + +
Sbjct: 184 YDVKSDVWSLGITMIELATGRFPYDSWKTP 213
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 68/216 (31%), Positives = 106/216 (49%), Gaps = 25/216 (11%)
Query: 347 FKDKDVIGRGGFGKVYR-GVLASNVQIAVKKVSHDSKQGIKEFVAELVSMG------RLR 399
F+ V+G+GGFG+V V A+ A KK+ K+ IK+ E +++ ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLE---KKRIKKRKGESMALNEKQILEKVN 58
Query: 400 HRNLVKLRGYCRRKGEFLLVYDYMPNGSLD-KILHTNIKPCLNWYQRFRIIRGVAS---G 455
R +V L K LV M G L I H ++ R + A G
Sbjct: 59 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAG----FEEGRAVFYAAEICCG 114
Query: 456 LLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTK-LVGTFGYM 514
L LH+ E++V +RD+KP N+LLD + ++ D GLA H QT K VGT GYM
Sbjct: 115 LEDLHQ--ERIV-YRDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGRVGTVGYM 168
Query: 515 DPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQ 550
PE+++ + + S D +A G + E+ +G+ P +Q+
Sbjct: 169 APEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 61/209 (29%), Positives = 107/209 (51%), Gaps = 23/209 (11%)
Query: 347 FKDKDVIGRGGFGKVYRGVLASNVQ----IAVKKVSHDSK-QGIKEF-VAELVSMGRLRH 400
F+ + IG G +G VY+ A N +A+KK+ D++ +G+ + E+ + L H
Sbjct: 2 FQKVEKIGEGTYGVVYK---ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 58
Query: 401 RNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILH----TNIKPCLNWYQRFRIIRGVASGL 456
N+VKL + + LV++++ + L K + + I L F++++G+A
Sbjct: 59 PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLA--- 114
Query: 457 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDP 516
+ H VLHRD+KP N+L++ + KL DFGLAR + T ++V T Y P
Sbjct: 115 -FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAP 169
Query: 517 ELMRTGK-ASTSTDVYAFGVFMLEVASGR 544
E++ K ST+ D+++ G E+ + R
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 72/279 (25%), Positives = 127/279 (45%), Gaps = 36/279 (12%)
Query: 353 IGRGGFGKVYRGVLAS------NVQIAVKKVSHDS--KQGIKEFVAELVSMGRLRHRNLV 404
+G+G FG VY G ++AVK V+ + ++ I EF+ E M ++V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHHVV 72
Query: 405 KLRGYCRRKGEFLLVYDYMPNGSLDKILHT--------NIKPCLNWYQRFRIIRGVASGL 456
+L G + L+V + M +G L L + +P + ++ +A G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 457 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMD 515
YL+ + +HRD+ N ++ D K+GDFG+ R +Y+ D + K + +M
Sbjct: 133 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189
Query: 516 PELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDAS 575
PE ++ G +TS+D+++FGV + E+ S Q S E V + +V D G D
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV--LKFVMD----GGYLDQP 243
Query: 576 DSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
D+ C E+ +L+ C P+ RP +++
Sbjct: 244 DN-----CPERVTDLM----RMCWQFNPKMRPTFLEIVN 273
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 16/209 (7%)
Query: 347 FKDKDV-----IGRGGFGKVYRGVLASNVQIAVKKVSH-DSKQGIK-EFVAELVSMGRLR 399
KD D +G G G V + + I +K+ H + K I+ + + EL +
Sbjct: 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN 61
Query: 400 HRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYL 459
+V G GE + ++M GSLD++L + + I V GL YL
Sbjct: 62 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSI--AVLRGLAYL 119
Query: 460 HEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLA-RLYDHDTIPQTTKLVGTFGYMDPEL 518
E + ++HRD+KP+N+L+++ KL DFG++ +L D VGT YM PE
Sbjct: 120 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPER 173
Query: 519 MRTGKASTSTDVYAFGVFMLEVASGRRPV 547
++ S +D+++ G+ ++E+A GR P+
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 16/202 (7%)
Query: 352 VIGRGGFGKVYRGVL------ASNVQIAVKKVSHDSKQGIKE-FVAELVSMGRL-RHRNL 403
+G G FGKV + +++AVK + + +E ++EL M L H N+
Sbjct: 42 TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENI 101
Query: 404 VKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDW 463
V L G C G L++ +Y G L L + L VA G+ +L
Sbjct: 102 VNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS-- 159
Query: 464 EQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT---IPQTTKLVGTFGYMDPELMR 520
+ +HRD+ NVLL K+ DFGLAR +D+ + +L +M PE +
Sbjct: 160 -KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL--PVKWMAPESIF 216
Query: 521 TGKASTSTDVYAFGVFMLEVAS 542
+ +DV+++G+ + E+ S
Sbjct: 217 NCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 6e-14
Identities = 57/200 (28%), Positives = 99/200 (49%), Gaps = 26/200 (13%)
Query: 353 IGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQ------GIKEFVAELVSMGRLRHRNLVK 405
I G +G VYR + +A+KK+ + ++ ++E L +L+H N+V
Sbjct: 13 IEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILL----KLQHPNIVT 68
Query: 406 LR----GYCRRKGEFLLVYDYMPNGSLD-KILHTNIKPCLNWYQRFRIIRGVASGLLYLH 460
++ G K +V +Y+ + D K L +K + ++ + SG+ +LH
Sbjct: 69 VKEVVVGSNLDK--IYMVMEYVEH---DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH 123
Query: 461 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPE-LM 519
++W +LHRD+K +N+LL+ K+ DFGLAR Y + T+LV T Y PE L+
Sbjct: 124 DNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG-SPLKPYTQLVVTLWYRAPELLL 179
Query: 520 RTGKASTSTDVYAFGVFMLE 539
+ ST+ D+++ G E
Sbjct: 180 GAKEYSTAIDMWSVGCIFAE 199
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 7e-14
Identities = 63/211 (29%), Positives = 107/211 (50%), Gaps = 26/211 (12%)
Query: 351 DVIGRGGFGKVYRGVL--ASNVQIAVKKVS---HDSKQGIKEFVAELVSMGRLRHRNLVK 405
D +G+G +G VY+ VL + V +A+K++ +SK + + EL + + +V
Sbjct: 7 DELGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESK--FNQIIMELDILHKAVSPYIVD 63
Query: 406 LRGYCRRKGEFLLVYDYMPNGSLDKI----LHTNIKPCLNWYQRFRIIRGVASGLLYLHE 461
G +G + +YM GSLDK+ + T P RI V GL +L E
Sbjct: 64 FYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIP---EDVLRRITYAVVKGLKFLKE 120
Query: 462 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRT 521
+ ++HRD+KP NVL++ + KL DFG++ ++ +T +G YM PE +++
Sbjct: 121 EHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA-SLAKTN--IGCQSYMAPERIKS 175
Query: 522 GKA------STSTDVYAFGVFMLEVASGRRP 546
G + +DV++ G+ +LE+A GR P
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 8e-14
Identities = 68/249 (27%), Positives = 96/249 (38%), Gaps = 57/249 (22%)
Query: 351 DVIGRGGFGKVY-------RGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNL 403
VIGRG FG+V+ V A +++ K Q I AE + +
Sbjct: 7 KVIGRGAFGEVWLVRDKDTGQVYA--MKVLRKSDMIKRNQ-IAHVRAERDILADADSPWI 63
Query: 404 VKLRGYCRRKGEFL-LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRG------VASGL 456
VKL Y + E L LV +YMP G L +N R + +A +
Sbjct: 64 VKLY-YSFQDEEHLYLVMEYMPGGDL-----------MNLLIRKDVFPEETARFYIAELV 111
Query: 457 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLA------------RLYDHDTIPQT 504
L L + +HRDIKP N+L+DAD + KL DFGL H+ + +
Sbjct: 112 LALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171
Query: 505 TKL----------------VGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVE 548
L VGT Y+ PE++R D ++ GV + E+ G P
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFY 231
Query: 549 QQGSMETVN 557
ET N
Sbjct: 232 SDTLQETYN 240
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 9e-14
Identities = 60/219 (27%), Positives = 104/219 (47%), Gaps = 28/219 (12%)
Query: 353 IGRGGFGKVYRGVLASNV----QIAVKKV--SHDSKQGIKEFVAELVSMGRLRHRNLVKL 406
IG G FGK +L + Q +K++ S S + +E E+ + ++H N+V+
Sbjct: 8 IGEGSFGK---AILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 407 RGYCRRKGEFLLVYDYMPNGSLDKILHTNI------KPCLNWYQRFRIIRGVASGLLYLH 460
+ G +V DY G L K ++ L+W+ + + L ++H
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQ------ICLALKHVH 118
Query: 461 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMR 520
+ + +LHRDIK N+ L D KLGDFG+AR+ + T+ +GT Y+ PE+
Sbjct: 119 D---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVL-NSTVELARTCIGTPYYLSPEICE 174
Query: 521 TGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLV 559
+ +D++A G + E+ + + E G+M+ NLV
Sbjct: 175 NRPYNNKSDIWALGCVLYEMCTLKHAFE-AGNMK--NLV 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 9e-14
Identities = 55/210 (26%), Positives = 103/210 (49%), Gaps = 11/210 (5%)
Query: 353 IGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCR 411
+G G FGKVY+ + V A K + S++ +++++ E+ + H N+VKL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 412 RKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 471
+ ++ ++ G++D ++ +P L Q + + L YLHE+ ++HRD
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERP-LTEPQIRVVCKQTLEALNYLHEN---KIIHRD 128
Query: 472 IKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELM--RTGKAST--- 526
+K N+L D + KL DFG++ + TI + +GT +M PE++ T K
Sbjct: 129 LKAGNILFTLDGDIKLADFGVSA-KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDY 187
Query: 527 STDVYAFGVFMLEVASGRRPVEQQGSMETV 556
DV++ G+ ++E+A P + M +
Sbjct: 188 KADVWSLGITLIEMAQIEPPHHELNPMRVL 217
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 63/200 (31%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 353 IGRGGFGKVYRGVLASNV--QIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKLR 407
+G+GGFG+V V N A KK+ K G K + E + ++ +V L
Sbjct: 1 LGKGGFGEVC-AVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59
Query: 408 GYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVV 467
K LV M G L ++ + L + + G+L+LH +
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDI 116
Query: 468 LHRDIKPANVLLDADLNGKLGDFGLA-RLYDHDTIPQTTKLVGTFGYMDPELMRTGKAST 526
++RD+KP NVLLD N +L D GLA L D TI T+ GT GYM PE+++ S
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMAPEILKEEPYSY 173
Query: 527 STDVYAFGVFMLEVASGRRP 546
D +A G + E+ +GR P
Sbjct: 174 PVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 37/209 (17%)
Query: 353 IGRGGFGKVYRGVLASNVQ-IAVKKVSHDSKQGIKEFVA--ELVSMGRLRHRNLVKLRGY 409
+G G + VY+G+ N Q +A+K +S +++G+ F A E + L+H N+V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLKHANIVLLHDI 71
Query: 410 CRRKGEFLLVYDYM-----------PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLY 458
K V++YM P G LH P F+++RG+A Y
Sbjct: 72 IHTKETLTFVFEYMHTDLAQYMIQHPGG-----LH----PYNVRLFMFQLLRGLA----Y 118
Query: 459 LHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT--KLVGTFGYMDP 516
+H Q +LHRD+KP N+L+ KL DFGLAR +IP T V T Y P
Sbjct: 119 IHG---QHILHRDLKPQNLLISYLGELKLADFGLAR---AKSIPSQTYSSEVVTLWYRPP 172
Query: 517 E-LMRTGKASTSTDVYAFGVFMLEVASGR 544
+ L+ S++ D++ G +E+ G+
Sbjct: 173 DVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 58/220 (26%), Positives = 94/220 (42%), Gaps = 41/220 (18%)
Query: 352 VIGRGGFGKV----YRG--------VLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLR 399
V+G+G FGKV +G VL +V + V + K V L +
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDV--ECTMTEKR-VLALAG----K 54
Query: 400 HRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRG------VA 453
H L +L + K V +Y+ G L + RF R +
Sbjct: 55 HPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR--------SGRFDEPRARFYAAEIV 106
Query: 454 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVGTF 511
GL +LHE + +++RD+K NVLLD++ + K+ DFG+ + + T T+ GT
Sbjct: 107 LGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT---TSTFCGTP 160
Query: 512 GYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQG 551
Y+ PE++ + D +A GV + E+ +G+ P E
Sbjct: 161 DYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 62/232 (26%), Positives = 99/232 (42%), Gaps = 32/232 (13%)
Query: 345 KGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHD-------------SKQGIKEFVAE 391
K F K ++GRG FG VQ+ +K + D +++ + F E
Sbjct: 1 KDFDVKSLVGRGHFG---------EVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEE 51
Query: 392 LVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRG 451
+ + +L+ + K LV +Y P G L +L+ +F +
Sbjct: 52 RDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYL--- 108
Query: 452 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 511
A +L +H + +HRDIKP NVL+D + KL DFG A + + + VGT
Sbjct: 109 -AELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTP 167
Query: 512 GYMDPELMRT----GKAS--TSTDVYAFGVFMLEVASGRRPVEQQGSMETVN 557
Y+ PE++ T GK + D ++ GV E+ GR P + S +T N
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYN 219
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 1e-13
Identities = 50/181 (27%), Positives = 76/181 (41%), Gaps = 12/181 (6%)
Query: 367 ASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNG 426
++ VK V+ G K E+ + + HR ++ L R K +V MP
Sbjct: 117 EQRKKVIVKAVT-----GGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMV---MPKY 168
Query: 427 SLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGK 486
D + + L Q I R + L YLH + ++HRD+K N+ LD N
Sbjct: 169 KCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAV 225
Query: 487 LGDFGLA-RLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRR 545
LGDFG A +L H PQ GT PEL+ TD+++ G+ + E++
Sbjct: 226 LGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNV 285
Query: 546 P 546
Sbjct: 286 T 286
|
Length = 392 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 60/199 (30%), Positives = 99/199 (49%), Gaps = 16/199 (8%)
Query: 353 IGRGGFGKVY------RGVLASNVQIAVKKVSHDSKQG-IKEFVAELVSMGRLRHRNLVK 405
+G G FGKV G + Q+AVK + +S I + E+ + L H N+VK
Sbjct: 12 LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 406 LRGYCRRKGE--FLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDW 463
+G C G L+ +++P+GSL + L N K +N Q+ + + G+ YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGS-- 127
Query: 464 EQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTK--LVGTFGYMDPELMRT 521
+ +HRD+ NVL++++ K+GDFGL + + D T K L + PE +
Sbjct: 128 -RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186
Query: 522 GKASTSTDVYAFGVFMLEV 540
K ++DV++FGV + E+
Sbjct: 187 SKFYIASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 60/222 (27%), Positives = 102/222 (45%), Gaps = 33/222 (14%)
Query: 347 FKDKDVIGRGGFGKVY----RGVLA-------------SNVQIAVKKVSHDS-KQGIKEF 388
FK+K +G G FG+V+ G+ V +AVK + D+ K +F
Sbjct: 9 FKEK--LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDF 66
Query: 389 VAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKIL---------HTNIKPC 439
+ E+ M RL+ N+++L C ++ +YM NG L++ L
Sbjct: 67 LKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVT 126
Query: 440 LNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDH 498
+++ + +ASG+ YL +HRD+ N L+ + K+ DFG++R LY
Sbjct: 127 ISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSG 183
Query: 499 DTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEV 540
D + V +M E + GK +T++DV+AFGV + E+
Sbjct: 184 DYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEI 225
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 68/209 (32%), Positives = 98/209 (46%), Gaps = 25/209 (11%)
Query: 352 VIGRGGFGKVYRGVLASNVQIAVKKVS-----HDSKQ----GIKEFVAELVSMGRLRHRN 402
VIGRG + KV L N QI KV HD + ++ V E S
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPF---- 57
Query: 403 LVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCL-NWYQRFRIIRGVASGLLYLHE 461
LV L + LV +Y+ G L + H + L + RF + L +LHE
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDL--MFHMQRQRKLPEEHARFYAAE-ICIALNFLHE 114
Query: 462 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVGTFGYMDPELM 519
+ +++RD+K NVLLDAD + KL D+G+ + L DT T+ GT Y+ PE++
Sbjct: 115 ---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT---TSTFCGTPNYIAPEIL 168
Query: 520 RTGKASTSTDVYAFGVFMLEVASGRRPVE 548
R + S D +A GV M E+ +GR P +
Sbjct: 169 RGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 17/212 (8%)
Query: 347 FKDKDVIGRGGFGKVYR-GVLASNVQIAVKKVSHDSKQGIKEFVAELVSMG------RLR 399
F+ V+G+GGFG+V V A+ A KK+ K+ IK+ E +++ ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLE---KKRIKKRKGEAMALNEKQILEKVN 58
Query: 400 HRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYL 459
R +V L K LV M G L ++ P + + + GL L
Sbjct: 59 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDL 118
Query: 460 HEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLA-RLYDHDTIPQTTKLVGTFGYMDPEL 518
H + +++RD+KP N+LLD + ++ D GLA + + +TI VGT GYM PE+
Sbjct: 119 HR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR---VGTVGYMAPEV 172
Query: 519 MRTGKASTSTDVYAFGVFMLEVASGRRPVEQQ 550
++ + + S D + G + E+ G+ P Q+
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGKSPFRQR 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 18/210 (8%)
Query: 341 YKATKGFKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGI--KEFVAELVSMGR 397
++ T + D +G G FG V + +A+KK+ + K EL +
Sbjct: 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKH 65
Query: 398 LRHRNLVKLRG-YCRRKGEFLLVYDYMPNGSLDKILHTN-IKPCLNWYQRFRIIRGVASG 455
LRH N++ L + + V + + L ++L + ++ Y ++I+RG
Sbjct: 66 LRHENIISLSDIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQYFLYQILRG---- 120
Query: 456 LLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMD 515
L Y+H V+HRD+KP+N+L++ + + K+ DFGLAR+ D PQ T V T Y
Sbjct: 121 LKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQD----PQMTGYVSTRYYRA 173
Query: 516 PELMRT-GKASTSTDVYAFGVFMLEVASGR 544
PE+M T K D+++ G E+ G+
Sbjct: 174 PEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 3e-13
Identities = 53/197 (26%), Positives = 93/197 (47%), Gaps = 21/197 (10%)
Query: 355 RGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCR--- 411
R G +G IA K+V S+ I + E++++GRL H N++K+ R
Sbjct: 179 RRGVNSTNQGKPKCERLIA-KRVKAGSRAAI-QLENEILALGRLNHENILKIEEILRSEA 236
Query: 412 ------RKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQ 465
+K +F L Y +M + + D +P L Q I++ + + Y+H+ +
Sbjct: 237 NTYMITQKYDFDL-YSFMYDEAFD----WKDRPLL--KQTRAIMKQLLCAVEYIHD---K 286
Query: 466 VVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKAS 525
++HRDIK N+ L+ D LGDFG A ++ + VGT PE++
Sbjct: 287 KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYC 346
Query: 526 TSTDVYAFGVFMLEVAS 542
TD+++ G+ +L++ S
Sbjct: 347 EITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 61/199 (30%), Positives = 93/199 (46%), Gaps = 18/199 (9%)
Query: 353 IGRGGFGKVYRGVLASNVQI-AVKKV--SHDSKQGIKEFVAELVSMGRLRHRNLVKLRGY 409
IG G +G V++ QI A+KK S D K + E+ + +L+H NLV L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 410 CRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLH 469
RRK + LV++Y + L++ L N + + + +II + + H+ +H
Sbjct: 69 FRRKRKLHLVFEYCDHTVLNE-LEKNPRG-VPEHLIKKIIWQTLQAVNFCHK---HNCIH 123
Query: 470 RDIKPANVLLDADLNGKLGDFGLARL---YDHDTIPQTTKLVGTFGYMDPELMRTG--KA 524
RD+KP N+L+ KL DFG AR+ D T V T Y PEL+ G +
Sbjct: 124 RDVKPENILITKQGQIKLCDFGFARILTGPGDD----YTDYVATRWYRAPELL-VGDTQY 178
Query: 525 STSTDVYAFGVFMLEVASG 543
DV+A G E+ +G
Sbjct: 179 GPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 59/205 (28%), Positives = 104/205 (50%), Gaps = 25/205 (12%)
Query: 351 DVIGRGGFGKVYRG--VLASNVQIAVKKVSHDSKQGIK-EFVAELVSMGRLRHRNLVKLR 407
D +G G + V++G L N+ +A+K++ + ++G + E+ + L+H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLH 69
Query: 408 GYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQ-------RFRIIRGVASGLLYLH 460
+ LV++Y LD L + C N F+++RG++ Y H
Sbjct: 70 DIIHTERCLTLVFEY-----LDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLS----YCH 120
Query: 461 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPE-LM 519
+ + +LHRD+KP N+L++ KL DFGLAR T + ++V T Y P+ L+
Sbjct: 121 K---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLL 176
Query: 520 RTGKASTSTDVYAFGVFMLEVASGR 544
+ + ST D++ G + E+A+GR
Sbjct: 177 GSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 32/215 (14%)
Query: 353 IGRGGFGKVYR----GVLASN----VQIAVKKVSHD-SKQGIKEFVAELVSMGRL-RHRN 402
+G G FG+V R G+ S V +AVK + + + + + + ++E+ M + +H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 403 LVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIR------------ 450
++ L G C ++G ++ +Y G+L + L P ++ F I +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDY--TFDITKVPEEQLSFKDLV 137
Query: 451 ----GVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTT 505
VA G+ YL + +HRD+ NVL+ D K+ DFGLAR ++D D +T+
Sbjct: 138 SCAYQVARGMEYLES---RRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194
Query: 506 KLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEV 540
+M PE + + +DV++FG+ M E+
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 57/211 (27%), Positives = 110/211 (52%), Gaps = 20/211 (9%)
Query: 353 IGRGGFGKVYRGVLASN---VQIAVK--KVSHDSKQGIKEFVAELVSMGRLRHRNLVKLR 407
+G G FG V G L + +++AVK K++ ++ +++F++E V M H N+++L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 408 GYCRRKGEF------LLVYDYMPNGSLDK-ILHTNIKPC---LNWYQRFRIIRGVASGLL 457
G C + E +++ +M +G L +L++ + C L + + +ASG+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 458 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLA-RLYDHDTIPQTTKLVGTFGYMDP 516
YL + +HRD+ N +L+ ++N + DFGL+ ++Y+ D Q ++
Sbjct: 127 YLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 517 ELMRTGKASTSTDVYAFGVFMLEVAS-GRRP 546
E + +T +DV++FGV M E+A+ G+ P
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 5e-13
Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 25/215 (11%)
Query: 352 VIGRGGFGKVYRGVLASNVQIAVKKV-----SHDSKQ----GIKEFVAELVSMGRLRHRN 402
VIGRG + KV L +I KV +D + ++ V E S H
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETAS----NHPF 57
Query: 403 LVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCL-NWYQRFRIIRGVASGLLYLHE 461
LV L + + V +++ G L + H + L + RF ++ L +LHE
Sbjct: 58 LVGLHSCFQTESRLFFVIEFVSGGDL--MFHMQRQRKLPEEHARFYSAE-ISLALNFLHE 114
Query: 462 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVGTFGYMDPELM 519
+ +++RD+K NVLLDA+ + KL D+G+ + + DT T+ GT Y+ PE++
Sbjct: 115 ---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT---TSTFCGTPNYIAPEIL 168
Query: 520 RTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSME 554
R S D +A GV M E+ +GR P + G +
Sbjct: 169 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSD 203
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 54/193 (27%), Positives = 89/193 (46%), Gaps = 16/193 (8%)
Query: 370 VQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSL 428
V +AVK + D S ++F+ E+ + RL N+ +L G C ++ +YM NG L
Sbjct: 47 VLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106
Query: 429 DKIL--HTNIKPCLNWYQRF-------RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL 479
++ L H L + + +ASG+ YL +HRD+ N L+
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLV 163
Query: 480 DADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFML 538
+ K+ DFG++R LY D + +M E + GK +T +DV+AFGV +
Sbjct: 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLW 223
Query: 539 EVAS--GRRPVEQ 549
E+ + +P E
Sbjct: 224 EILTLCREQPYEH 236
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 7e-13
Identities = 60/218 (27%), Positives = 102/218 (46%), Gaps = 38/218 (17%)
Query: 353 IGRGGFGKVYRGVLAS-----------NVQIAVKKVSHD-SKQGIKEFVAELVSMGRL-R 399
+G G FG+V V+A V +AVK + D +++ + + V+E+ M + +
Sbjct: 23 LGEGCFGQV---VMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 79
Query: 400 HRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIR--------- 450
H+N++ L G C + G ++ +Y G+L + L P + + + I R
Sbjct: 80 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY--SYDIARVPDEQMTFK 137
Query: 451 -------GVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIP 502
VA G+ YL Q +HRD+ NVL+ + K+ DFGLAR + + D
Sbjct: 138 DLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYK 194
Query: 503 QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEV 540
+TT +M PE + + +DV++FGV M E+
Sbjct: 195 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 8e-13
Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 16/202 (7%)
Query: 353 IGRGGFGKVYRGVLASNVQI----AVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRG 408
+G G +G VY+ A N+ AVK + + E+ + +H N+V G
Sbjct: 17 VGSGTYGDVYK---ARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFG 73
Query: 409 YCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVL 468
+ + + +Y GSL I H + L+ Q + R GL YLH + +
Sbjct: 74 SYLSREKLWICMEYCGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLAYLHSKGK---M 128
Query: 469 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELM---RTGKAS 525
HRDIK AN+LL + + KL DFG+A TI + +GT +M PE+ + G +
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAAKITA-TIAKRKSFIGTPYWMAPEVAAVEKNGGYN 187
Query: 526 TSTDVYAFGVFMLEVASGRRPV 547
D++A G+ +E+A + P+
Sbjct: 188 QLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 9e-13
Identities = 70/243 (28%), Positives = 98/243 (40%), Gaps = 71/243 (29%)
Query: 353 IGRGGFGKVYRGVLASNV----QIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVK 405
IG+GG G+VY LA + ++A+KK+ D + K F+ E L H +V
Sbjct: 10 IGKGGMGEVY---LAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 406 LRGYCRRKGEFLLVYDYMP----------------NGSLDKILH--TNIKPCLNWYQRFR 447
+ C VY MP SL K L T++ L
Sbjct: 67 VYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFL------S 117
Query: 448 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLG-----DFGLAR-------- 494
I + + + Y+H + VLHRD+KP N+LL G G D+G A
Sbjct: 118 IFHKICATIEYVHS---KGVLHRDLKPDNILL-----GLFGEVVILDWGAAIFKKLEEED 169
Query: 495 -----------LYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASG 543
Y TIP K+VGT YM PE + AS STD+YA GV + ++ +
Sbjct: 170 LLDIDVDERNICYSSMTIP--GKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTL 227
Query: 544 RRP 546
P
Sbjct: 228 SFP 230
|
Length = 932 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 67/293 (22%), Positives = 122/293 (41%), Gaps = 52/293 (17%)
Query: 352 VIGRGGFGKVYRGV------LASNVQIAVKKVSHDSKQG-IKEFVAELVSMGRLRHRNLV 404
+G G FGKV + A +AVK + ++ +++ ++E + ++ H +++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 405 KLRGYCRRKGEFLLVYDYMPNGSLDKIL-----------------------HTNIKPCLN 441
KL G C + G LL+ +Y GSL L + + + L
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA-LT 125
Query: 442 WYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDT 500
++ G+ YL E ++HRD+ NVL+ K+ DFGL+R +Y+ D+
Sbjct: 126 MGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182
Query: 501 IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLV 559
+ +K +M E + +T +DV++FGV + E+ + G P NL+
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLL 242
Query: 560 DWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQV 612
K G + ++ C E+ L+L C +P+ RP +
Sbjct: 243 -------KTGYRMERPEN-----CSEEMYNLMLT----CWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 61/202 (30%), Positives = 98/202 (48%), Gaps = 14/202 (6%)
Query: 353 IGRGGFGKVYRGVL---ASNVQIAVKKVSHDSK-QGIK-EFVAELVSMGRLRHRNLVKLR 407
+G G FG V +G+ S +AVK + +D+ +K E + E M +L + +V++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 408 GYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVV 467
G C + ++LV + G L+K L N + ++ V+ G+ YL E
Sbjct: 63 GICEAES-WMLVMELAELGPLNKFLQKNKH--VTEKNITELVHQVSMGMKYLEE---TNF 116
Query: 468 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF--GYMDPELMRTGKAS 525
+HRD+ NVLL K+ DFGL++ D K G + + PE M K S
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176
Query: 526 TSTDVYAFGVFMLEVAS-GRRP 546
+ +DV++FGV M E S G++P
Sbjct: 177 SKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 21/210 (10%)
Query: 347 FKDKDVIGRGGFGKVYR-GVLASNVQIAVKKVSHDSKQGIKEFVAELVSMG------RLR 399
F+ V+G+GGFG+V V A+ A K++ K+ IK+ E +++ ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLE---KKRIKKRKGESMALNEKQILEKVN 58
Query: 400 HRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYL 459
+ +V L K LV M G L ++ P + + GL L
Sbjct: 59 SQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDL 118
Query: 460 HEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL---VGTFGYMDP 516
H + ++RD+KP N+LLD + ++ D GLA IP+ + VGT GYM P
Sbjct: 119 HR---ENTVYRDLKPENILLDDYGHIRISDLGLAV-----KIPEGESIRGRVGTVGYMAP 170
Query: 517 ELMRTGKASTSTDVYAFGVFMLEVASGRRP 546
E++ + + S D + G + E+ G+ P
Sbjct: 171 EVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 22/222 (9%)
Query: 353 IGRGGFGKV----YRGVLASNVQIAVKKVSH--DSKQGIKEFVAELVSMGRLR-HRNLVK 405
+G+G +G V + +A+KK+++ K K + EL + R H+N+
Sbjct: 8 LGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITC 66
Query: 406 LRGY-CRRKGEFLLVYDYMP--NGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHED 462
L G F +Y Y L +I+ + +Q F I + GL Y+H
Sbjct: 67 LYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSF--IYQILCGLKYIHS- 123
Query: 463 WEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT---TKLVGTFGYMDPELM 519
VLHRD+KP N+L++AD K+ DFGLAR + + T+ V T Y PE+M
Sbjct: 124 --ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIM 181
Query: 520 RTGKA-STSTDVYAFGVFMLEVASGRRPV-EQQGSMETVNLV 559
+ ++ + + DV++ G + E+ GR+PV + + ++ +N +
Sbjct: 182 LSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYVDQLNQI 222
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (168), Expect = 1e-12
Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 347 FKDKDVIGRGGFGKVYRGVLASNVQI-AVKKVSHD----SKQGIKEFVAELVSMGRLRHR 401
F+ +G G FG+V + + A+K +S KQ ++ + E + +RH
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIRHP 61
Query: 402 NLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHE 461
LV L G + LV +Y+P G L L + + RF + V L YLH
Sbjct: 62 FLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPV-ARFYAAQ-VVLALEYLHS 119
Query: 462 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRT 521
+++RD+KP N+LLD+D K+ DFG A+ T T L GT Y+ PE++ +
Sbjct: 120 ---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT--YT--LCGTPEYLAPEIILS 172
Query: 522 ---GKASTSTDVYAFGVFMLEVASGRRP 546
GKA D +A G+ + E+ +G P
Sbjct: 173 KGYGKAV---DWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 39/215 (18%)
Query: 353 IGRGGFGKVYRGVLASN-------VQIAVKKVSHDSKQGIKEFVA--ELVS-MGRLRHRN 402
+G+G F +Y+GVL V V ++ +A E S M +L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 403 LVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHED 462
LVKL G C R E ++V +Y+ G LD LH K ++ + + + + +AS L YL
Sbjct: 63 LVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHRE-KNNVSLHWKLDVAKQLASALHYLE-- 118
Query: 463 WEQVVLHRDIKPANVLL-DADLNG------KLGDFG-----LARLYDHDTIPQTTKLVGT 510
++ ++H ++ N+L+ LN KL D G L+R + IP
Sbjct: 119 -DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP-------- 169
Query: 511 FGYMDPELMRTGKASTST--DVYAFGVFMLEVASG 543
++ PE +R G+AS + D ++FG +LE+ S
Sbjct: 170 --WIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-12
Identities = 54/192 (28%), Positives = 95/192 (49%), Gaps = 20/192 (10%)
Query: 371 QIAVKKVSHDSKQG---IKEFVAELVSMGRLRHRNLVKL--RGYCRRKGEFLLVYDYMPN 425
++A+K + D+ + F E RL H N+V L G G V++Y+P
Sbjct: 5 EVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAP-PGLLFAVFEYVPG 63
Query: 426 GSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL---DAD 482
+L ++L + L + R++ V L H Q ++HRD+KP N+++
Sbjct: 64 RTLREVLAAD--GALPAGETGRLMLQVLDALACAHN---QGIVHRDLKPQNIMVSQTGVR 118
Query: 483 LNGKLGDFGLARL------YDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVF 536
+ K+ DFG+ L D T+ +TT+++GT Y PE +R + ++D+YA+G+
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLI 178
Query: 537 MLEVASGRRPVE 548
LE +G+R V+
Sbjct: 179 FLECLTGQRVVQ 190
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 72/291 (24%), Positives = 131/291 (45%), Gaps = 51/291 (17%)
Query: 353 IGRGGFGKVYRGVLASNVQI-----------AVKKVSHD-SKQGIKEFVAELVSMGRL-R 399
+G G FG+V V+A + I AVK + D + + + + V+E+ M + +
Sbjct: 20 LGEGCFGQV---VMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK 76
Query: 400 HRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNW-YQRFRIIR-------- 450
H+N++ L G C + G ++ +Y G+L + L P +++ + ++
Sbjct: 77 HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 451 -----GVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQT 504
VA G+ YL Q +HRD+ NVL+ D K+ DFGLAR +++ D +T
Sbjct: 137 VSCAYQVARGMEYLAS---QKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193
Query: 505 TKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVC 563
T +M PE + + +DV++FGV + E+ + G P E L+
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL---- 249
Query: 564 DCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
K+G D + C ++ ++++ C H P RP +Q+++
Sbjct: 250 ---KEGHRMDKPAN-----CTH-ELYMIMRE---CWHAVPSQRPTFKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 58/223 (26%), Positives = 101/223 (45%), Gaps = 48/223 (21%)
Query: 353 IGRGGFGKVYRGVLASNV-----------QIAVKKVSHD-SKQGIKEFVAELVSMGRL-R 399
+G G FG+V V+A + ++AVK + D +++ + + ++E+ M + +
Sbjct: 26 LGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82
Query: 400 HRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNW----------------- 442
H+N++ L G C + G ++ +Y G+L + L P + +
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 443 ----YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 498
YQ VA G+ YL + +HRD+ NVL+ D K+ DFGLAR H
Sbjct: 143 VSCAYQ-------VARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 192
Query: 499 -DTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEV 540
D +TT +M PE + + +DV++FGV + E+
Sbjct: 193 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 65/269 (24%), Positives = 122/269 (45%), Gaps = 28/269 (10%)
Query: 353 IGRGGFGKVYRGVL---ASNVQIAVKKVSHDSKQGIK-EFVAELVSMGRLRHRNLVKLRG 408
+G G FG V +GV + +A+K + +++++ ++ E + E M +L + +V++ G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 409 YCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVL 468
C + +LV + G L+K L K + ++ V+ G+ YL + +
Sbjct: 63 VCEAEA-LMLVMEMASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEG---KNFV 117
Query: 469 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF--GYMDPELMRTGKAST 526
HRD+ NVLL K+ DFGL++ D + G + + PE + K S+
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177
Query: 527 STDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEE 585
+DV+++G+ M E S G++P ++ E ++ ++ RL+ C
Sbjct: 178 RSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE--------------QGKRLD--CPA 221
Query: 586 KQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+ + L C K E RPN +V +
Sbjct: 222 ECPPEMYALMKDCWIYKWEDRPNFAKVEE 250
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 38/115 (33%), Positives = 65/115 (56%), Gaps = 8/115 (6%)
Query: 446 FRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT 505
++I+RG L YLH +LHRDIKP N+L++++ K+ DFGLAR+ + D T
Sbjct: 110 YQILRG----LKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMT 162
Query: 506 KLVGTFGYMDPE-LMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLV 559
+ V T Y PE LM + +++ D+++ G E+ R + Q ++ ++L+
Sbjct: 163 QEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI 217
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 353 IGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQG------IKEFVAELVSMGRLRHRNLVK 405
IG G +G VY+ S +A+K V + + ++E VA L + H N+V+
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVRE-VALLKRLEAFDHPNIVR 66
Query: 406 LRGYCR-----RKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLH 460
L C R+ + LV++++ + L L P L ++R GL +LH
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH 125
Query: 461 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMR 520
+ ++HRD+KP N+L+ + KL DFGLAR+Y T +V T Y PE++
Sbjct: 126 AN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQM--ALTPVVVTLWYRAPEVLL 180
Query: 521 TGKASTSTDVYAFGVFMLEVASGRRPV 547
+T D+++ G E+ R+P+
Sbjct: 181 QSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 62/203 (30%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 352 VIGRGGFGKVYRGVLASNVQIAVKKVSHDS----KQGIKEFVAEL-VSMGRLRHRNLVKL 406
VIG+G FGKV S+ KV K+ +AE V + L+H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 407 RGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPC-LNWYQRFRIIRGVASGLLYLHEDWEQ 465
+ + V DY+ G L H + C L RF VAS + YLH
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYAAE-VASAIGYLHS---L 115
Query: 466 VVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVGTFGYMDPELMRTGK 523
+++RD+KP N+LLD+ + L DFGL + + +T T+ GT Y+ PE++R
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET---TSTFCGTPEYLAPEVLRKEP 172
Query: 524 ASTSTDVYAFGVFMLEVASGRRP 546
+ D + G + E+ G P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 68/236 (28%), Positives = 103/236 (43%), Gaps = 34/236 (14%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVK 405
+ D +G G G V+ V + ++AVKK+ Q +K + E+ + RL H N+VK
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66
Query: 406 -----------LRGYCRRKGEFLLVY---DYMPNGSLDKILHTNIKPC----LNWYQRFR 447
L E VY +YM L +L L YQ R
Sbjct: 67 VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLSEEHARLFMYQLLR 125
Query: 448 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA-DLNGKLGDFGLARLYDHDTIPQ--T 504
GL Y+H VLHRD+KPANV ++ DL K+GDFGLAR+ D +
Sbjct: 126 -------GLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYL 175
Query: 505 TKLVGTFGYMDPELMRTGKAST-STDVYAFGVFMLEVASGRRPVEQQGSMETVNLV 559
++ + T Y P L+ + T + D++A G E+ +G+ +E + L+
Sbjct: 176 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI 231
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 59/231 (25%), Positives = 103/231 (44%), Gaps = 26/231 (11%)
Query: 346 GFKDKDVIGRGGFGKVYRGVL-----ASNVQIAVKKVS-HDSKQGIKEFVAELVSMGRLR 399
D++ G FG+++ G+L ++ VK V H S+ + + E + L
Sbjct: 7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLS 66
Query: 400 HRNLVKLRGYCRRKGEFLLV-YDYMPNGSLDKILH------TNIKPCLNWYQRFRIIRGV 452
H+N++ + C GE V Y YM G+L L N L+ Q + +
Sbjct: 67 HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126
Query: 453 ASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT-- 510
A G+ YLH+ + V+H+DI N ++D +L K+ D L+R D P +G
Sbjct: 127 ACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSR----DLFPMDYHCLGDNE 179
Query: 511 ---FGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVN 557
+M E + + S+++DV++FGV + E+ + G+ P + E
Sbjct: 180 NRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAA 230
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 5e-12
Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 14/198 (7%)
Query: 352 VIGRGGFGKV----YRGVLASNVQIAVKKVS--HDSKQGIKEFVAELVSMGRLRHRNLVK 405
V+G+G +G+V +R Q +KK++ + S++ K E + +L+H N+V
Sbjct: 7 VVGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVA 63
Query: 406 LR-GYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWE 464
R + G +V + G L L L Q +A L YLHE
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE--- 120
Query: 465 QVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKA 524
+ +LHRD+K NV L K+GD G+AR+ ++ +T L+GT YM PEL
Sbjct: 121 KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST-LIGTPYYMSPELFSNKPY 179
Query: 525 STSTDVYAFGVFMLEVAS 542
+ +DV+A G + E+A+
Sbjct: 180 NYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 7e-12
Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 25/211 (11%)
Query: 352 VIGRGGFGKVYRGVLASNVQI-AVKKVSHD---SKQGIKEFVAE--LVSMGRLRHRNLVK 405
V+G+G FGKV L + ++ AVK + D ++ + E ++S+ R H L +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQ 60
Query: 406 LRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRG------VASGLLYL 459
L C + + L NG D + H I+ +RF R + S L++L
Sbjct: 61 LY-CCFQTPDRLFFVMEFVNGG-DLMFH--IQKS----RRFDEARARFYAAEITSALMFL 112
Query: 460 HEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELM 519
H+ + +++RD+K NVLLD + + KL DFG+ + + T+ GT Y+ PE++
Sbjct: 113 HD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TTSTFCGTPDYIAPEIL 168
Query: 520 RTGKASTSTDVYAFGVFMLEVASGRRPVEQQ 550
+ S D +A GV + E+ G P E +
Sbjct: 169 QEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 7e-12
Identities = 73/266 (27%), Positives = 119/266 (44%), Gaps = 34/266 (12%)
Query: 352 VIGRGGFGKVYRGVL-ASNVQIAVKKVSHDSKQGIKEFVAELVSMGRL----RHRNLVKL 406
++G+G FGKV+ L +N A+K + D + +V L H L L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 407 RGYC--RRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRG------VASGLLY 458
YC + K V +Y+ G L + H I+ C +F + R + GL +
Sbjct: 62 --YCTFQTKENLFFVMEYLNGGDL--MFH--IQSC----HKFDLPRATFYAAEIICGLQF 111
Query: 459 LHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR---LYDHDTIPQTTKLVGTFGYMD 515
LH + +++RD+K N+LLD D + K+ DFG+ + L D +T GT Y+
Sbjct: 112 LHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD----AKTCTFCGTPDYIA 164
Query: 516 PELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDAS 575
PE++ K +TS D ++FGV + E+ G+ P E + C+ + R+A
Sbjct: 165 PEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAK 224
Query: 576 DSRLEGICEEKQMELVLKLGLFCSHP 601
D ++ E + L +K G HP
Sbjct: 225 DILVKLFVREPERRLGVK-GDIRQHP 249
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 67/215 (31%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 352 VIGRGGFGKVYRGVLASNVQI----AVKKVSHDSKQGI-----KEFVAELVSMGRLRHRN 402
VIGRG + KV L +I VKK + + I ++ V E S H
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS----NHPF 57
Query: 403 LVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCL-NWYQRFRIIRGVASGLLYLHE 461
LV L + + V +Y+ G L + H + L + RF ++ L YLHE
Sbjct: 58 LVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAE-ISLALNYLHE 114
Query: 462 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVGTFGYMDPELM 519
+ +++RD+K NVLLD++ + KL D+G+ + L DT T+ GT Y+ PE++
Sbjct: 115 ---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNYIAPEIL 168
Query: 520 RTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSME 554
R S D +A GV M E+ +GR P + GS +
Sbjct: 169 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 203
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 7e-12
Identities = 62/209 (29%), Positives = 93/209 (44%), Gaps = 29/209 (13%)
Query: 352 VIGRGGFGKVYRGVLASNVQ----IAVKKVSHDS---KQGIKEFVAEL-VSMGRLRHRNL 403
VIG+G FGKV LA + AVK + + K+ K +AE V + ++H L
Sbjct: 2 VIGKGSFGKVL---LAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFL 58
Query: 404 VKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRG------VASGLL 457
V L + + V DY+ G L H L + F R +AS L
Sbjct: 59 VGLHYSFQTADKLYFVLDYVNGGEL--FFH------LQRERSFPEPRARFYAAEIASALG 110
Query: 458 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPE 517
YLH +++RD+KP N+LLD+ + L DFGL + + T+ GT Y+ PE
Sbjct: 111 YLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPE 166
Query: 518 LMRTGKASTSTDVYAFGVFMLEVASGRRP 546
++R + D + G + E+ G P
Sbjct: 167 VLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 9e-12
Identities = 38/100 (38%), Positives = 56/100 (56%), Gaps = 10/100 (10%)
Query: 452 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLA-RLYDHDTIPQTTKLVGT 510
+ L YL E + V+HRD+KP+N+LLDA N KL DFG++ RL D T+ G
Sbjct: 123 IVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA---KTRSAGC 177
Query: 511 FGYMDPELM----RTGKASTSTDVYAFGVFMLEVASGRRP 546
YM PE + K DV++ G+ ++E+A+G+ P
Sbjct: 178 AAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 9e-12
Identities = 63/224 (28%), Positives = 94/224 (41%), Gaps = 25/224 (11%)
Query: 347 FKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKL 406
F+ VIGRG FG+V + +I K+ + K + + R V +
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILN------KWEMLKRAETACFREERNVLV 56
Query: 407 RGYCR----------RKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGL 456
G C+ + LV DY G L +L RF I A +
Sbjct: 57 NGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYI----AEMV 112
Query: 457 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDP 516
L +H + +HRDIKP NVLLD + + +L DFG + D Q++ VGT Y+ P
Sbjct: 113 LAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISP 172
Query: 517 ELMRT-----GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMET 555
E+++ GK D ++ GV M E+ G P + +ET
Sbjct: 173 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET 216
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 62/221 (28%), Positives = 106/221 (47%), Gaps = 40/221 (18%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVAELVSMGR-------L 398
+K ++VIG+G +G V + + ++A+KK+ + E V++ + R L
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI-----NDVFEHVSDATRILREIKLLRLL 56
Query: 399 RHRNLVKLRGYC-----RRKGEFLLVYDYMPNGSLDKILHTNIKP----CLNWYQRF--R 447
RH ++V+++ R + +V++ M + LH IK +Q F +
Sbjct: 57 RHPDIVEIKHIMLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLTPEHHQFFLYQ 111
Query: 448 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT--T 505
++R L Y+H V HRD+KP N+L +AD K+ DFGLAR+ +DT T
Sbjct: 112 LLRA----LKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 164
Query: 506 KLVGTFGYMDPELMRT--GKASTSTDVYAFGVFMLEVASGR 544
V T Y PEL + K + + D+++ G EV +G+
Sbjct: 165 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 25/215 (11%)
Query: 352 VIGRGGFGKVYRGVL----ASNVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVK 405
++G+G FG V L S ++AVK + D S I+EF+ E M H N++K
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 406 LRG---YCRRKGEF---LLVYDYMPNGSL------DKILHTNIKPCLNWYQRFRIIRGVA 453
L G R KG +++ +M +G L +I L RF I +A
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI--DIA 123
Query: 454 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFG 512
SG+ YL + +HRD+ N +L+ ++ + DFGL++ +Y D Q
Sbjct: 124 SGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK 180
Query: 513 YMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRP 546
++ E + +T +DV+AFGV M E+ + G+ P
Sbjct: 181 WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 56/210 (26%), Positives = 90/210 (42%), Gaps = 30/210 (14%)
Query: 352 VIGRGGFGKVYRGVLASNVQI----AVKK---VSHDSKQGIKEFVAELVSMGRLRHRNLV 404
V+GRG FGKV ++ A+KK ++ D + + + RH LV
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65
Query: 405 KLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRG------VASGLLY 458
L + + V +Y G L +HT+ F R V GL Y
Sbjct: 66 NLFACFQTEDHVCFVMEYAAGGDLMMHIHTD---------VFSEPRAVFYAACVVLGLQY 116
Query: 459 LHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVGTFGYMDP 516
LHE+ +++RD+K N+LLD + K+ DFGL + + D T+ GT ++ P
Sbjct: 117 LHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR---TSTFCGTPEFLAP 170
Query: 517 ELMRTGKASTSTDVYAFGVFMLEVASGRRP 546
E++ + + D + GV + E+ G P
Sbjct: 171 EVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 53/199 (26%), Positives = 89/199 (44%), Gaps = 12/199 (6%)
Query: 353 IGRGGFGKVYRGVLASNVQI----AVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRG 408
IG+G FGKV + +I ++K S+ + +AE + ++ +V L+
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 409 YCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQ-RFRIIRGVASGLLYLHEDWEQVV 467
+ + LV ++ G L H + + + RF A L L + V
Sbjct: 61 SFQSPEKLYLVLAFINGGEL--FHHLQREGRFDLSRARFYT----AELLCALENLHKFNV 114
Query: 468 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTS 527
++RD+KP N+LLD + L DFGL +L D +T GT Y+ PEL+ + +
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCGTPEYLAPELLLGHGYTKA 173
Query: 528 TDVYAFGVFMLEVASGRRP 546
D + GV + E+ +G P
Sbjct: 174 VDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 21/214 (9%)
Query: 347 FKDKDVIGRGGFGKVYR-GVLASNVQIAVKKVSHDSKQGIKEFVAELVSMG------RLR 399
F+ V+G+GGFG+V V A+ A KK+ K+ IK+ E +++ ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLE---KKRIKKRKGEAMALNEKRILEKVN 58
Query: 400 HRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYL 459
R +V L K LV M G L ++ P + + + GL L
Sbjct: 59 SRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDL 118
Query: 460 HEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL---VGTFGYMDP 516
E++V +RD+KP N+LLD + ++ D GLA IP+ + VGT GYM P
Sbjct: 119 QR--ERIV-YRDLKPENILLDDRGHIRISDLGLAV-----QIPEGETVRGRVGTVGYMAP 170
Query: 517 ELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQ 550
E++ K + S D + G + E+ G+ P ++
Sbjct: 171 EVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKR 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 61/203 (30%), Positives = 98/203 (48%), Gaps = 27/203 (13%)
Query: 353 IGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVA--ELVSMGRLRHRNLVKLRGYC 410
+G G + VY+G N ++ KV ++ F A E + L+H N+V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 411 RRKGEFLLVYDYMPNG---SLDKI---LH-TNIKPCLNWYQRFRIIRGVASGLLYLHEDW 463
K LV++Y+ +DK LH N+K L F+++RG++ Y+H+ +
Sbjct: 73 HTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFL-----FQLLRGLS----YIHQRY 123
Query: 464 EQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT--KLVGTFGYMDPE-LMR 520
+LHRD+KP N+L+ KL DFGLAR ++P T V T Y P+ L+
Sbjct: 124 ---ILHRDLKPQNLLISDTGELKLADFGLARA---KSVPSHTYSNEVVTLWYRPPDVLLG 177
Query: 521 TGKASTSTDVYAFGVFMLEVASG 543
+ + ST D++ G +E+ G
Sbjct: 178 STEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 62/245 (25%), Positives = 108/245 (44%), Gaps = 25/245 (10%)
Query: 329 EYGPQRFTYKDLYKATKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEF 388
Y + L T ++ + IG+G +GKVY+ + +A K+ +E
Sbjct: 6 PYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEI 65
Query: 389 VAELVSMGRL-RHRNLVKLRGYCRRK-----GEFLLVYDYMPNGSLDKILHTNIKPCLNW 442
AE + L H N+VK G + G+ LV + GS+ ++ +K L
Sbjct: 66 EAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTEL----VKGLLIC 121
Query: 443 YQRFR------IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 496
QR I+ G GL +LH + ++HRD+K N+LL + KL DFG++
Sbjct: 122 GQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQL 178
Query: 497 DHDTIPQTTKLVGTFGYMDPELMRTGKASTST-----DVYAFGVFMLEVASGRRPVEQQG 551
+ + T VGT +M PE++ + + DV++ G+ +E+ G P+
Sbjct: 179 TSTRLRRNTS-VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH 237
Query: 552 SMETV 556
++T+
Sbjct: 238 PVKTL 242
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 6e-11
Identities = 63/207 (30%), Positives = 96/207 (46%), Gaps = 24/207 (11%)
Query: 353 IGRGGFGKVYRGVLASNVQI-AVKKVSHD---SKQGIKEFVAE---LVSMGRLRHRNLVK 405
IG+G FG+VY+ +I A+K +S +K+ + + E LV +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 406 LRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRG---VASGLLYLHED 462
L+ + + LV DYM G L H L RF R +A +L L
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGEL--FWH------LQKEGRFSEDRAKFYIAELVLALEHL 112
Query: 463 WEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVGTFGYMDPELMR 520
+ +++RD+KP N+LLDA + L DFGL++ L D+ T T GT Y+ PE++
Sbjct: 113 HKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT---TNTFCGTTEYLAPEVLL 169
Query: 521 TGKASTS-TDVYAFGVFMLEVASGRRP 546
K T D ++ GV + E+ G P
Sbjct: 170 DEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 8e-11
Identities = 59/224 (26%), Positives = 97/224 (43%), Gaps = 34/224 (15%)
Query: 353 IGRGGFGKVYRGVLASNVQIAVKKVSHD-------------SKQGIKEFVAELVSMGRLR 399
+G+GG+G+V+ +A KK + + ++ + E + +
Sbjct: 9 VGQGGYGQVF---------LAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK 59
Query: 400 HRNLVKLRGYCRRKGEFL-LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLY 458
LVKL Y + E+L L +Y+P G +L N+ + RF + + +
Sbjct: 60 SEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLL-NNLGVLSEDHARFYMAEMFEA-VDA 116
Query: 459 LHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPEL 518
LHE +HRD+KP N L+DA + KL DFGL++ + +VG+ YM PE+
Sbjct: 117 LHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYMAPEV 169
Query: 519 MRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMET-VNLVDW 561
+R + D ++ G + E G P ET NL W
Sbjct: 170 LRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW 213
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 8e-11
Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 28/213 (13%)
Query: 352 VIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYC- 410
+IGRGGFG+VY A ++ K K+ IK E +++ +LV G C
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCL--DKKRIKMKQGETLALNERIMLSLVS-TGDCP 57
Query: 411 ---------RRKGEFLLVYDYMPNGSLDKILHTN---IKPCLNWYQRFRIIRGVASGLLY 458
+ + D M G L L + + + +Y I+ GL +
Sbjct: 58 FIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIIL-----GLEH 112
Query: 459 LHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPEL 518
+H + V++RD+KPAN+LLD + ++ D GLA + P + VGT GYM PE+
Sbjct: 113 MHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHAS--VGTHGYMAPEV 166
Query: 519 MRTGKA-STSTDVYAFGVFMLEVASGRRPVEQQ 550
++ G A +S D ++ G + ++ G P Q
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQH 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 15/202 (7%)
Query: 352 VIGRGGFGKVYRGVL-ASNVQIAVKKVSHDSKQGIKEFVAELVS--MGRLRHRNLVKLRG 408
V+G+G FGKV L AVK + D + +V + L N
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 409 YC--RRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQV 466
YC + K V +++ G L + H K + Y+ + GL +LH
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDL--MFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG--- 116
Query: 467 VLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVGTFGYMDPELMRTGKA 524
+++RD+K NV+LD D + K+ DFG+ + ++ + + + GT Y+ PE+++ K
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN---RASTFCGTPDYIAPEILQGLKY 173
Query: 525 STSTDVYAFGVFMLEVASGRRP 546
+ S D ++FGV + E+ G+ P
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 64/238 (26%), Positives = 114/238 (47%), Gaps = 53/238 (22%)
Query: 343 ATKGFKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHR 401
K +K ++IG G FG VY + + ++ ++A+KKV D + +E L+ M L H
Sbjct: 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRE----LLIMKNLNHI 119
Query: 402 NLVKLRGY----CRRKGE---FL-LVYDYMPNGSLDKILHTNIKPCLNWYQR-------- 445
N++ L+ Y C +K E FL +V +++P + +H +K Y R
Sbjct: 120 NIIFLKDYYYTECFKKNEKNIFLNVVMEFIP-----QTVHKYMK----HYARNNHALPLF 170
Query: 446 ------FRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG-KLGDFGLARLYDH 498
+++ R +A Y+H + + HRD+KP N+L+D + + KL DFG A+ +
Sbjct: 171 LVKLYSYQLCRALA----YIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAK--NL 221
Query: 499 DTIPQTTKLVGTFGYMDPELMR-TGKASTSTDVYAFGVFMLE------VASGRRPVEQ 549
++ + + Y PELM +T D+++ G + E + SG+ V+Q
Sbjct: 222 LAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ 279
|
Length = 440 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 36/99 (36%), Positives = 57/99 (57%), Gaps = 8/99 (8%)
Query: 452 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVG 509
V L++LH V++RD+K N+LLDA+ + KL DFG+ + + + T TT G
Sbjct: 105 VTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT---TTTFCG 158
Query: 510 TFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVE 548
T Y+ PE+++ + S D +A GV M E+ +G+ P E
Sbjct: 159 TPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 65/277 (23%), Positives = 124/277 (44%), Gaps = 34/277 (12%)
Query: 351 DVIGRGGFGKVYRGVLASNVQ--IAVKKVS----------HDSKQGIKEFVAEL-VSMGR 397
+ +G G FG VY+ +N Q +A+K+++ + + I + V+E+ + +
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 398 LRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQR--FRIIRGVASG 455
LRH N+V+ +V D + L + ++ + + + + I +
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125
Query: 456 LLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMD 515
L YLH+ E+ ++HRD+ P N++L D + DFGLA+ ++ + T +VGT Y
Sbjct: 126 LRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES--KLTSVVGTILYSC 181
Query: 516 PELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDAS 575
PE+++ DV+AFG + ++ + +P +M ++ I +A
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCT-LQPPFYSTNMLSLAT-----------KIVEAV 229
Query: 576 DSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQV 612
L + + V+ C P EARP++ QV
Sbjct: 230 YEPLPEGMYSEDVTDVIT---SCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 59/216 (27%), Positives = 105/216 (48%), Gaps = 19/216 (8%)
Query: 338 KDLYKATKGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSKQGI--KEFVAELVS 394
K +++ + +++ +G G +G V + +++AVKK+S + I K EL
Sbjct: 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 69
Query: 395 MGRLRHRNLVKLRGY---CRRKGEFLLVY--DYMPNGSLDKILHTNIKPCLNWYQRFRII 449
+ ++H N++ L R EF VY ++ L+ I+ + + + +F +I
Sbjct: 70 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQF-LI 126
Query: 450 RGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVG 509
+ GL Y+H ++HRD+KP+N+ ++ D K+ DFGLAR T + T V
Sbjct: 127 YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVA 179
Query: 510 TFGYMDPELMRTGKASTST-DVYAFGVFMLEVASGR 544
T Y PE+M T D+++ G M E+ +GR
Sbjct: 180 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 29/217 (13%)
Query: 352 VIGRGGFGKVYRGVL-ASNVQIAVKKVSHDSKQGIKEFVAELVSMGRL----RHRNLVKL 406
V+G+G FGKV L +N A+K + D + +V L H L L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 407 RGYC--RRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRG------VASGLLY 458
+C + K V +Y+ G L + H I+ RF R + GL +
Sbjct: 62 --FCTFQTKEHLFFVMEYLNGGDL--MFH--IQSSG----RFDEARARFYAAEIICGLQF 111
Query: 459 LHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARL-YDHDTIPQTTKLVGTFGYMDPE 517
LH+ +++RD+K NVLLD D + K+ DFG+ + + + + + GT Y+ PE
Sbjct: 112 LHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--KASTFCGTPDYIAPE 166
Query: 518 LMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSME 554
+++ K + S D ++FGV + E+ G+ P + E
Sbjct: 167 ILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 33/98 (33%), Positives = 59/98 (60%), Gaps = 6/98 (6%)
Query: 452 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTK-LVGT 510
+A GL +LH + +++RD+K NV+LDA+ + K+ DFG+ + ++ +TT+ GT
Sbjct: 110 IAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGT 164
Query: 511 FGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVE 548
Y+ PE++ S D +AFGV + E+ +G+ P +
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 28/87 (32%), Positives = 47/87 (54%), Gaps = 2/87 (2%)
Query: 467 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKA-- 524
+++RDIK N+LLD++ + L DFGL++ + + + GT YM PE++R G
Sbjct: 126 IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGH 185
Query: 525 STSTDVYAFGVFMLEVASGRRPVEQQG 551
+ D ++ GV E+ +G P G
Sbjct: 186 DKAVDWWSLGVLTFELLTGASPFTVDG 212
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 29/209 (13%)
Query: 352 VIGRGGFGKVYRGVLASN--------VQIAVKKVSHDSKQGIKEFVAEL-VSMGRLRHRN 402
VIG+G FGKV +LA V++ KK+ + K+ K +AE V + ++H
Sbjct: 2 VIGKGSFGKV---LLAKRKLDGKCYAVKVLQKKIVLNRKEQ-KHIMAERNVLLKNVKHPF 57
Query: 403 LVKLRGYCRRKGEFLLVYDYMPNGSLDKILH---TNIKPCLNWYQRFRIIRGVASGLLYL 459
LV L + + V D++ G L L + +P +Y +AS L YL
Sbjct: 58 LVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFY-----AAEIASALGYL 112
Query: 460 HEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVGTFGYMDPE 517
H +++RD+KP N+LLD+ + L DFGL + + DT TT GT Y+ PE
Sbjct: 113 HS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT---TTTFCGTPEYLAPE 166
Query: 518 LMRTGKASTSTDVYAFGVFMLEVASGRRP 546
++R + D + G + E+ G P
Sbjct: 167 VIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 4e-10
Identities = 64/235 (27%), Positives = 106/235 (45%), Gaps = 48/235 (20%)
Query: 353 IGRGGFGKVYRGVLASNVQ--IAVKKVSHDSKQGIKE-----FVAELVSMGRLRHRNLVK 405
IG G FG+V+ V Q K +S+ +G+KE V E+ M L+H+N+V+
Sbjct: 21 IGNGRFGEVFL-VKHKRTQEFFCWKAISY---RGLKEREKSQLVIEVNVMRELKHKNIVR 76
Query: 406 L--RGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFR------IIRGVASGLL 457
R + + ++ ++ G L + NI+ C + + I R + L
Sbjct: 77 YIDRFLNKANQKLYILMEFCDAGDLSR----NIQKCYKMFGKIEEHAIVDITRQLLHALA 132
Query: 458 YLHEDWE----QVVLHRDIKPANVLLDA-------------DLNG----KLGDFGLARLY 496
Y H + + VLHRD+KP N+ L +LNG K+GDFGL++
Sbjct: 133 YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI 192
Query: 497 DHDTIPQTTKLVGTFGYMDPELM--RTGKASTSTDVYAFGVFMLEVASGRRPVEQ 549
+++ + VGT Y PEL+ T +D++A G + E+ SG+ P +
Sbjct: 193 GIESMAHSC--VGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245
|
Length = 1021 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 66/226 (29%), Positives = 106/226 (46%), Gaps = 31/226 (13%)
Query: 352 VIGRGGFGKVYRGVLA---SNVQIAVK-KV--SHDSKQGIKEFVAELVSMGRLRHRNLVK 405
V+G G FG VY+G+ NV+I V KV + S + KE + E M + + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 406 LRGYCRRKGEFLLVYDYMPNGSLDKILHTN-----IKPCLNWYQRFRIIRGVASGLLYLH 460
L G C LV MP G L + N + LNW + +A G+ YL
Sbjct: 74 LLGICL-TSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLE 126
Query: 461 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFG-----YMD 515
E ++HRD+ NVL+ + + K+ DFGLARL D D T+ G +M
Sbjct: 127 E---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID----ETEYHADGGKVPIKWMA 179
Query: 516 PELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVD 560
E + + + +DV+++GV + E+ + G +P + + E +L++
Sbjct: 180 LESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 60/240 (25%), Positives = 99/240 (41%), Gaps = 51/240 (21%)
Query: 337 YKDLYKATKGFKDK-------DVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFV 389
Y+ + + + + K VIGRG FG+V + V H S Q K +
Sbjct: 28 YEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEV-------------QLVRHKSSQ--KVYA 72
Query: 390 AELVSMGRLRHRN-------------------LVKLRGYCRRKGEFLLVYDYMPNGSLDK 430
+L+S + R+ +V+L + +V +YMP G L
Sbjct: 73 MKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN 132
Query: 431 ILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDF 490
++ +N W + + A +L L ++HRD+KP N+LLD + KL DF
Sbjct: 133 LM-SNYDVPEKWAKFY-----TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADF 186
Query: 491 GLARLYDHDTIPQTTKLVGTFGYMDPELMRT----GKASTSTDVYAFGVFMLEVASGRRP 546
G D + + VGT Y+ PE++++ G D ++ GVF+ E+ G P
Sbjct: 187 GTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 33/93 (35%), Positives = 48/93 (51%), Gaps = 5/93 (5%)
Query: 468 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMR-----TG 522
+HRDIKP NVLLD + + +L DFG D Q+ VGT Y+ PE+++ G
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKG 183
Query: 523 KASTSTDVYAFGVFMLEVASGRRPVEQQGSMET 555
+ D ++ GV M E+ G P + +ET
Sbjct: 184 RYGPECDWWSLGVCMYEMLYGETPFYAESLVET 216
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 36/104 (34%), Positives = 60/104 (57%), Gaps = 6/104 (5%)
Query: 452 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTK-LVGT 510
+A GL +LH + +++RD+K NV+LD++ + K+ DFG+ + D + TTK GT
Sbjct: 110 IAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGT 164
Query: 511 FGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSME 554
Y+ PE++ S D +AFGV + E+ +G+ P E + E
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 6e-10
Identities = 34/99 (34%), Positives = 56/99 (56%), Gaps = 7/99 (7%)
Query: 455 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYM 514
GL ++H + V++RD+KPAN+LLD + ++ D GLA + P + VGT GYM
Sbjct: 109 GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHAS--VGTHGYM 162
Query: 515 DPELMRTGKA-STSTDVYAFGVFMLEVASGRRPVEQQGS 552
PE+++ G A +S D ++ G + ++ G P Q +
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 16/218 (7%)
Query: 338 KDLYKATKGFKDKDVIGRGGFGKV--YRGVLASNVQIAVKKVSHDS--KQGIKEFVAELV 393
+DL + ++ VIGRG FG+V R V A+K +S K+ F E
Sbjct: 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKV-YAMKLLSKFEMIKRSDSAFFWEER 94
Query: 394 SMGRLRHRNLVKLRGYCRRKGEFL-LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGV 452
+ + V Y + +L +V +YMP G L ++ P + RF
Sbjct: 95 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVP--EKWARFY----T 148
Query: 453 ASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFG 512
A +L L +HRD+KP N+LLD + KL DFG + + + + VGT
Sbjct: 149 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 208
Query: 513 YMDPELMRT----GKASTSTDVYAFGVFMLEVASGRRP 546
Y+ PE++++ G D ++ GVF+ E+ G P
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 6e-10
Identities = 37/104 (35%), Positives = 61/104 (58%), Gaps = 6/104 (5%)
Query: 456 LLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH---DTIPQTTKLVGTFG 512
LL +H + ++HRDIK AN+LL ++ KLGDFG +++Y D + +T GT
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT--FCGTPY 210
Query: 513 YMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETV 556
Y+ PE+ R S D+++ GV + E+ + +RP + + +ME V
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE-NMEEV 253
|
Length = 496 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 7e-10
Identities = 70/241 (29%), Positives = 105/241 (43%), Gaps = 31/241 (12%)
Query: 317 KRYEEVYEDWEREYGPQRFTYKDLYKATKGFKDKDVIGRGGFGKVYRGVLASNVQI-AVK 375
RYE+ E L + F VIGRG FG+V S+ Q+ A+K
Sbjct: 26 SRYEKAAEK-----------ITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMK 74
Query: 376 KVSHDSKQGIKE-----FVAELVSMGRLRHRNLVKLRGYCRRKGEFL-LVYDYMPNGSLD 429
+S + IK F E M +V+L Y + ++L +V +YMP G L
Sbjct: 75 LLSKF--EMIKRSDSAFFWEERDIMAHANSEWIVQLH-YAFQDDKYLYMVMEYMPGGDLV 131
Query: 430 KILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGD 489
++ +N W RF V L +H +HRD+KP N+LLD + KL D
Sbjct: 132 NLM-SNYDIPEKW-ARFYTAE-VVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLAD 185
Query: 490 FGLARLYDHDTIPQTTKLVGTFGYMDPELMRT----GKASTSTDVYAFGVFMLEVASGRR 545
FG D + + + VGT Y+ PE++++ G D ++ GVF+ E+ G
Sbjct: 186 FGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 245
Query: 546 P 546
P
Sbjct: 246 P 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 7e-10
Identities = 62/222 (27%), Positives = 97/222 (43%), Gaps = 55/222 (24%)
Query: 353 IGRGGFGKVYRGVLASNVQIAVKKVSHDSKQ-GIKEFVAELVSMG---------RLRHRN 402
+GRG +G VY+ A +K D + +K+ +SM L+H N
Sbjct: 9 VGRGTYGHVYK---------AKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPN 59
Query: 403 LVKLR----GYCRRKGEFLLVYDYMPNG-----SLDKILHTNIKPCLNWYQRFRIIRGVA 453
++ L+ + RK L++DY + + N KP ++ RG+
Sbjct: 60 VISLQKVFLSHADRK--VWLLFDYAEHDLWHIIKFHRASKANKKPV-------QLPRGMV 110
Query: 454 SGLLY--------LHEDWEQVVLHRDIKPANVLL--DADLNG--KLGDFGLARLYDHDTI 501
LLY LH +W VLHRD+KPAN+L+ + G K+ D G ARL++
Sbjct: 111 KSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 167
Query: 502 P--QTTKLVGTFGYMDPELMRTGKAST-STDVYAFGVFMLEV 540
P +V TF Y PEL+ + T + D++A G E+
Sbjct: 168 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 8e-10
Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 41/215 (19%)
Query: 353 IGRGGFGKVYRGVLASNVQIAVKKVSHDSKQ-GIKEFVAELVSMG---------RLRHRN 402
+GRG +G VY+ A +K D K+ +K+ +SM L+H N
Sbjct: 9 VGRGTYGHVYK---------AKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPN 59
Query: 403 LVKLR----GYCRRKGEFLLVYDYMPNG-----SLDKILHTNIKPC-LNWYQRFRIIRGV 452
++ L+ + RK L++DY + + N KP L ++ +
Sbjct: 60 VIALQKVFLSHSDRK--VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQI 117
Query: 453 ASGLLYLHEDWEQVVLHRDIKPANVLL--DADLNG--KLGDFGLARLYDHDTIP--QTTK 506
G+ YLH +W VLHRD+KPAN+L+ + G K+ D G ARL++ P
Sbjct: 118 LDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174
Query: 507 LVGTFGYMDPELMRTGKAST-STDVYAFGVFMLEV 540
+V TF Y PEL+ + T + D++A G E+
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 61/229 (26%), Positives = 98/229 (42%), Gaps = 52/229 (22%)
Query: 352 VIGRGGFGKVYRGVLASNVQIAVKKVS-HDSKQGIKEFVAELVSMGRLRHRNLV---KLR 407
V+G G +GKV+ V+KVS HDS +L +M L+ +V K
Sbjct: 7 VLGTGAYGKVF----------LVRKVSGHDS--------GKLYAMKVLKKATIVQKAKTT 48
Query: 408 GYCR---------RKGEFL--------------LVYDYMPNGSLDKILHTNIKPCLNWYQ 444
+ R R+ FL L+ DY+ G L L + Q
Sbjct: 49 EHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQ 108
Query: 445 RFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT 504
+ + L +LH+ +++RDIK N+LLD++ + L DFGL++ + D + +
Sbjct: 109 IY--SGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERA 163
Query: 505 TKLVGTFGYMDPELMRTGKA--STSTDVYAFGVFMLEVASGRRPVEQQG 551
GT YM P+++R G + D ++ GV M E+ +G P G
Sbjct: 164 YSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDG 212
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 13/209 (6%)
Query: 352 VIGRGGFGKVYRGVLASN-----VQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKL 406
VIG+G FGKV + V++ KK K+ V + ++H LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 407 RGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPC-LNWYQRFRIIRGVASGLLYLHEDWEQ 465
+ + V DY+ G L H + C L RF +AS L YLH
Sbjct: 62 HFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAE-IASALGYLHS---L 115
Query: 466 VVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKAS 525
+++RD+KP N+LLD+ + L DFGL + + + T+ GT Y+ PE++
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPEVLHKQPYD 174
Query: 526 TSTDVYAFGVFMLEVASGRRPVEQQGSME 554
+ D + G + E+ G P + + E
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRNTAE 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 59/221 (26%), Positives = 92/221 (41%), Gaps = 28/221 (12%)
Query: 352 VIGRGGFGKVY------------RGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLR 399
++G+G FGKV +L V IA +V+H + E + R
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHT--------LTESRVLKNTR 53
Query: 400 HRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRG-VASGLLY 458
H L L+ + K V +Y+ G L H + + + R R + S L Y
Sbjct: 54 HPFLTSLKYSFQTKDRLCFVMEYVNGGEL--FFHLSRERVFS-EDRTRFYGAEIVSALDY 110
Query: 459 LHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPEL 518
LH +++RD+K N++LD D + K+ DFGL + D T GT Y+ PE+
Sbjct: 111 LHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPEV 166
Query: 519 MRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLV 559
+ + D + GV M E+ GR P Q + L+
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 207
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 47/171 (27%), Positives = 81/171 (47%), Gaps = 2/171 (1%)
Query: 390 AELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRII 449
+EL + H +VK + + LL+ +Y G L+K + +K L +Q + +
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLP-FQEYEVG 172
Query: 450 RGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY-DHDTIPQTTKLV 508
+L L E + ++HRD+K AN+ L KLGDFG ++ Y D ++ +
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFC 232
Query: 509 GTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLV 559
GT Y+ PEL + S D+++ GV + E+ + RP + E + V
Sbjct: 233 GTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQV 283
|
Length = 478 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 22/202 (10%)
Query: 353 IGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGI--KEFVAELVSMGRLRHRNLVKLRGY 409
+G G +G V + + ++A+KK+S + I K EL + ++H N++ L
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 410 ------CRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDW 463
+F LV YM L KI+ + Y ++++ G L Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHPLSEDKVQYLVYQMLCG----LKYIHS-- 135
Query: 464 EQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGK 523
++HRD+KP N+ ++ D K+ DFGLAR D + T V T Y PE++
Sbjct: 136 -AGIIHRDLKPGNLAVNEDCELKILDFGLARHAD----AEMTGYVVTRWYRAPEVILNWM 190
Query: 524 ASTST-DVYAFGVFMLEVASGR 544
T D+++ G M E+ +G+
Sbjct: 191 HYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 61/229 (26%), Positives = 108/229 (47%), Gaps = 27/229 (11%)
Query: 347 FKDKDVIGRGGFGKVYRGVL---ASNVQI--AVKKVSH-DSKQGIKEFVAELVSMGRLRH 400
FK V+G G FG VY+G+ V+I A+K++ S + KE + E M + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 401 RNLVKLRGYCRRKGEFLLVYDYMPNGSL-DKILHTNIKPC----LNWYQRFRIIRGVASG 455
++ +L G C L+ MP G L D + LNW + +A G
Sbjct: 69 PHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 121
Query: 456 LLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI---PQTTKLVGTFG 512
+ YL E + ++HRD+ NVL+ + K+ DFGLA+L D + K+ +
Sbjct: 122 MNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178
Query: 513 YMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVD 560
++ L R + +DV+++GV + E+ + G +P + + E ++++
Sbjct: 179 ALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 225
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 42/152 (27%), Positives = 73/152 (48%), Gaps = 13/152 (8%)
Query: 397 RLRHRNLVKLRGYCRRKGEFLL--VYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVAS 454
+ H +++L + + L + +Y+P G L L N N F +
Sbjct: 57 EVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLR-NSGRFSNSTGLFYASE-IVC 112
Query: 455 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYM 514
L YLH + +++RD+KP N+LLD + + KL DFG A+ +T L GT Y+
Sbjct: 113 ALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK----KLRDRTWTLCGTPEYL 165
Query: 515 DPELMRTGKASTSTDVYAFGVFMLEVASGRRP 546
PE++++ + + D +A G+ + E+ G P
Sbjct: 166 APEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 60/212 (28%), Positives = 88/212 (41%), Gaps = 28/212 (13%)
Query: 352 VIGRGGFGKVY------------RGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLR 399
++G+G FGKV +L V IA +V+H V E + R
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT--------VTESRVLQNTR 53
Query: 400 HRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRG-VASGLLY 458
H L L+ + V +Y G L H + + +R R + S L Y
Sbjct: 54 HPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFT-EERARFYGAEIVSALEY 110
Query: 459 LHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPEL 518
LH + V++RDIK N++LD D + K+ DFGL + D T GT Y+ PE+
Sbjct: 111 LHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEV 166
Query: 519 MRTGKASTSTDVYAFGVFMLEVASGRRPVEQQ 550
+ + D + GV M E+ GR P Q
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 11/213 (5%)
Query: 352 VIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRL----RHRNLVKLR 407
++G+G FGKV + + K+ K+ VA ++ R+ RH L L+
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 408 GYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRG-VASGLLYLHEDWEQV 466
+ V +Y G L H + + + R R + S L YLH E+
Sbjct: 62 YSFQTHDRLCFVMEYANGGEL--FFHLSRERVFS-EDRARFYGAEIVSALDYLHS--EKN 116
Query: 467 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKAST 526
V++RD+K N++LD D + K+ DFGL + D T GT Y+ PE++
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDYGR 175
Query: 527 STDVYAFGVFMLEVASGRRPVEQQGSMETVNLV 559
+ D + GV M E+ GR P Q + L+
Sbjct: 176 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 208
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 5e-09
Identities = 52/203 (25%), Positives = 96/203 (47%), Gaps = 16/203 (7%)
Query: 353 IGRGGFGKVYRGV---LASNVQI----AVKKVSHDSKQGIKEFVAELVS-MGRLRHRNLV 404
+G+G F K+++G+ + ++ + KV S + E E S M +L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 405 KLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWE 464
G C E ++V +Y+ GSLD L N K +N + + + +A L +L +
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKN-KNLINISWKLEVAKQLAWALHFLE---D 118
Query: 465 QVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD---TIPQTTKLVGTFGYMDPELMRT 521
+ + H ++ NVLL + + K G+ +L D T+ L+ ++ PE +
Sbjct: 119 KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECIEN 178
Query: 522 GKA-STSTDVYAFGVFMLEVASG 543
+ S + D ++FG + E+ SG
Sbjct: 179 PQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 59/213 (27%), Positives = 103/213 (48%), Gaps = 21/213 (9%)
Query: 341 YKATKGFKDKDVIGRGGFGKV---YRGVLASNVQIAVKKVSH--DSKQGIKEFVAELVSM 395
+ K ++ IG G G V + VL NV AVKK+S ++ K ELV +
Sbjct: 17 FTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINV--AVKKLSRPFQNQTHAKRAYRELVLL 74
Query: 396 GRLRHRNLVKLRG-YCRRKG--EFLLVYDYMP--NGSLDKILHTNIKPCLNWYQRFRIIR 450
+ H+N++ L + +K EF VY M + +L +++H + Y ++++
Sbjct: 75 KCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQML- 133
Query: 451 GVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT 510
G+ +LH ++HRD+KP+N+++ +D K+ DFGLAR + + T V T
Sbjct: 134 ---CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM--MTPYVVT 185
Query: 511 FGYMDPELMRTGKASTSTDVYAFGVFMLEVASG 543
Y PE++ + D+++ G M E+ G
Sbjct: 186 RYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 57/215 (26%), Positives = 88/215 (40%), Gaps = 34/215 (15%)
Query: 352 VIGRGGFGKVY------------RGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLR 399
++G+G FGKV +L V IA +V+H + E + R
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHT--------LTESRVLQNTR 53
Query: 400 HRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQ-RFRIIRG-VASGLL 457
H L L+ + V +Y G L ++ + + R R + S L
Sbjct: 54 HPFLTALKYSFQTHDRLCFVMEYANGGEL----FFHLSRERVFSEDRARFYGAEIVSALG 109
Query: 458 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVGTFGYMD 515
YLH V++RD+K N++LD D + K+ DFGL + + D T GT Y+
Sbjct: 110 YLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTPEYLA 163
Query: 516 PELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQ 550
PE++ + D + GV M E+ GR P Q
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 56/218 (25%), Positives = 103/218 (47%), Gaps = 23/218 (10%)
Query: 338 KDLYKATKGFKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSH--DSKQGIKEFVAELVS 394
K +++ ++D +G G +G V + + ++A+KK+ S+ K EL
Sbjct: 8 KTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRL 67
Query: 395 MGRLRHRNLVKLRGY------CRRKGEFLLVYDYMPNGSLDKIL-HTNIKPCLNWYQRFR 447
+ ++H N++ L R +F LV +M L K++ H + + ++
Sbjct: 68 LKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQ 126
Query: 448 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 507
+++G L Y+H ++HRD+KP N+ ++ D K+ DFGLAR D + T
Sbjct: 127 MLKG----LKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTD----SEMTGY 175
Query: 508 VGTFGYMDPELMRTGKASTST-DVYAFGVFMLEVASGR 544
V T Y PE++ T T D+++ G M E+ +G+
Sbjct: 176 VVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 62/225 (27%), Positives = 99/225 (44%), Gaps = 37/225 (16%)
Query: 352 VIGRGGFGKVY--RGVLASNV-QIAVKKVSHDSKQGIKEFVAELVSMGR--LRHRN---- 402
V+G G +GKV+ R V + ++ KV + K E R L H
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66
Query: 403 LVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQR-------FRIIRG-VAS 454
LV L + + + L+ DY+ G + L YQR R G +
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGEMFTHL----------YQRDNFSEDEVRFYSGEIIL 116
Query: 455 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYM 514
L +LH+ +++RDIK N+LLD++ + L DFGL++ + + +T GT YM
Sbjct: 117 ALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYM 173
Query: 515 DPELMRT----GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMET 555
PE++R GKA D ++ G+ + E+ +G P +G T
Sbjct: 174 APEIIRGKGGHGKA---VDWWSLGILIFELLTGASPFTLEGERNT 215
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 61/218 (27%), Positives = 106/218 (48%), Gaps = 22/218 (10%)
Query: 352 VIGRGGFGKVY--RGVLASNV-QIAVKKVSHDSK-----QGIKEFVAELVSMGRLRHRNL 403
V+G+GG+GKV+ R V ++ +I KV + + AE + ++H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 404 VKLRGYCRRKGEFLLVYDYMPNGSLDKILHTN---IKPCLNWYQRFRIIRGVASGLLYLH 460
V L + G+ L+ +Y+ G L L ++ +Y + ++ L +LH
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFY-----LSEISLALEHLH 117
Query: 461 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPE-LM 519
+ Q +++RD+KP N+LLDA + KL DFGL + H+ T GT YM PE LM
Sbjct: 118 Q---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGTIEYMAPEILM 173
Query: 520 RTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVN 557
R+G + D ++ G M ++ +G P + +T++
Sbjct: 174 RSGHGK-AVDWWSLGALMYDMLTGAPPFTAENRKKTID 210
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 30/97 (30%), Positives = 57/97 (58%), Gaps = 4/97 (4%)
Query: 452 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 511
++ GL +LH + +++RD+K NV+LD++ + K+ DFG+ + + D + T GT
Sbjct: 110 ISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV-TTRTFCGTP 165
Query: 512 GYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVE 548
Y+ PE++ S D +A+GV + E+ +G+ P +
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (135), Expect = 2e-08
Identities = 58/220 (26%), Positives = 90/220 (40%), Gaps = 23/220 (10%)
Query: 333 QRFTYKDLYKATKGFKDKDVIGRGGFGKVYRGVL---ASNVQIAVKKVSHDSKQGIKEFV 389
K + K +I G FGKV VL + K + + I+ V
Sbjct: 7 SELV--QFLKNCEIVKKLKLI-DGKFGKVS--VLKHKPTQKLFVQKIIKAKNFNAIEPMV 61
Query: 390 AELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRII 449
+L M + N +KL +L+ DY+ +G L +L K L+ + +II
Sbjct: 62 HQL--MKD--NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK--LSEAEVKKII 115
Query: 450 RGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLV 508
R + L LH+ ++H DIK NVL D + L D+GL + I +
Sbjct: 116 RQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCK-----IIGTPSCYD 167
Query: 509 GTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVE 548
GT Y PE ++ S D +A GV E+ +G+ P +
Sbjct: 168 GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFK 207
|
Length = 267 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 5/93 (5%)
Query: 468 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRT-----G 522
+HRDIKP N+L+D + + +L DFG D Q++ VGT Y+ PE+++ G
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKG 183
Query: 523 KASTSTDVYAFGVFMLEVASGRRPVEQQGSMET 555
K D ++ GV M E+ G P + +ET
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETPFYAESLVET 216
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 34/150 (22%), Positives = 67/150 (44%), Gaps = 7/150 (4%)
Query: 391 ELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIR 450
E + + + H ++++++ +V + + L L +P L Q I +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRP-LPIDQALIIEK 164
Query: 451 GVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT 510
+ GL YLH Q ++HRD+K N+ ++ +GD G A+ P L GT
Sbjct: 165 QILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--PAFLGLAGT 219
Query: 511 FGYMDPELMRTGKASTSTDVYAFGVFMLEV 540
PE++ K ++ D+++ G+ + E+
Sbjct: 220 VETNAPEVLARDKYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 50/223 (22%), Positives = 92/223 (41%), Gaps = 32/223 (14%)
Query: 340 LYKATKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHD--SKQGIKEFVAELVSMGR 397
L K F+D + + +N +AVKK++ D SK+ +K E+++ +
Sbjct: 3 LTLIGKCFED------LMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQ 55
Query: 398 LRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLL 457
L+H N++ E +V M GS + +L T+ L I++ V + L
Sbjct: 56 LQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALD 115
Query: 458 YLHEDWEQVVLHRDIKPANVLLDADLNGKL-----------GDFGLARLYDHDTIPQTTK 506
Y+H + + HR +K +++LL D L ++D
Sbjct: 116 YIHS--KGFI-HRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF-----PKS 167
Query: 507 LVGTFGYMDPELMR---TGKASTSTDVYAFGVFMLEVASGRRP 546
V ++ PE+++ G S D+Y+ G+ E+A+G P
Sbjct: 168 SVKNLPWLSPEVLQQNLQGYNEKS-DIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 29/208 (13%)
Query: 353 IGRGGFGKVYRGVLASNVQIA---VK--KVSHDSKQGIKEFVAELVSMGRLRHRNLVKLR 407
IG G FGKV + ++ +A VK K + SK+ EF+ + L+H N+++
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQ-NEFLQQGDPYRILQHPNILQCL 61
Query: 408 GYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQR-------FRIIRGVASGLLYLH 460
G C +LLV++Y G L L W++R R+ +A+G+ ++H
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQE-----QWHRRNSQLLLLQRMACEIAAGVTHMH 116
Query: 461 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLA-RLYDHDTIPQTTKLVGTFGYMDPELM 519
+ LH D+ N L +DL K+GD+G+ Y D I ++ PEL+
Sbjct: 117 K---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELV 173
Query: 520 --RTGKASTS-----TDVYAFGVFMLEV 540
G T+ ++V+A GV + E+
Sbjct: 174 GEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 3e-08
Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 17/208 (8%)
Query: 341 YKATKGFKDKDVIGRGGFGKV---YRGVLASNVQIAVKKVSH--DSKQGIKEFVAELVSM 395
+ K +++ IG G G V Y VL NV A+KK+S ++ K ELV M
Sbjct: 13 FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYRELVLM 70
Query: 396 GRLRHRNLVKLRG-YCRRKG--EFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGV 452
+ H+N++ L + +K EF VY M +D L I+ L+ + ++ +
Sbjct: 71 KCVNHKNIISLLNVFTPQKSLEEFQDVYLVME--LMDANLCQVIQMELDHERMSYLLYQM 128
Query: 453 ASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFG 512
G+ +LH ++HRD+KP+N+++ +D K+ DFGLAR T T V T
Sbjct: 129 LCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY 183
Query: 513 YMDPELMRTGKASTSTDVYAFGVFMLEV 540
Y PE++ + D+++ G M E+
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEM 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 31/207 (14%)
Query: 353 IGRGGFGKVYRGVLA-SNVQIAVKKVSH--DSKQGIKEFVAELVSMGRLRHRNLVKLRG- 408
+G G +G+V + ++A+KK+S S K EL + + H N++ L
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82
Query: 409 YCRRKG--EFLLVYDYMP--NGSLDKILHT------NIKPCLNWYQRFRIIRGVASGLLY 458
+ +F VY L+ I+ +I+ + YQ I+RG L Y
Sbjct: 83 FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLV--YQ---ILRG----LKY 133
Query: 459 LHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPEL 518
+H ++HRD+KP+N+ ++ D K+ DFGLAR D + T V T Y PE+
Sbjct: 134 IHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEI 186
Query: 519 MRTGKASTST-DVYAFGVFMLEVASGR 544
M T D+++ G M E+ +G+
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 9/90 (10%)
Query: 458 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT-KLVGTFGYMDP 516
YLH + +++RD+KP N+LLD + K+ DFG A+ +P T L GT Y+ P
Sbjct: 133 YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEYLAP 184
Query: 517 ELMRTGKASTSTDVYAFGVFMLEVASGRRP 546
E++++ + D + GV + E +G P
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 26/205 (12%)
Query: 353 IGRGGFGKVYRGVLASNVQ-----IAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLV 404
+G G FG+V +LA+ +A+K+ ++ + +E + + H V
Sbjct: 38 LGTGSFGRV---ILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCV 94
Query: 405 KLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGV--ASGLLYLHED 462
L G + + LV +++ G L N +RF G A+ ++ + E
Sbjct: 95 NLYGSFKDESYLYLVLEFVIGGEFFTFLRRN--------KRFPNDVGCFYAAQIVLIFEY 146
Query: 463 WEQV-VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRT 521
+ + +++RD+KP N+LLD D K+ DFG A++ D +T L GT Y+ PE++
Sbjct: 147 LQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD----TRTYTLCGTPEYIAPEILLN 202
Query: 522 GKASTSTDVYAFGVFMLEVASGRRP 546
+ D + G+F+ E+ G P
Sbjct: 203 VGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 6e-08
Identities = 46/153 (30%), Positives = 72/153 (47%), Gaps = 21/153 (13%)
Query: 353 IGRGGFGKVYRGVLASNVQI----AVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRG 408
I RG FGKVY G +N ++ VKK +K + + AE ++ + +V L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 409 YCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRF------RIIRGVASGLLYLHED 462
+ LV +Y+ G + +LH Y F + I VA L YLH
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHI--------YGYFDEEMAVKYISEVALALDYLHR- 122
Query: 463 WEQVVLHRDIKPANVLLDADLNGKLGDFGLARL 495
++HRD+KP N+L+ + + KL DFGL+++
Sbjct: 123 --HGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 8e-08
Identities = 61/226 (26%), Positives = 101/226 (44%), Gaps = 31/226 (13%)
Query: 351 DVIGRGGFGKVYRGVLASNVQIAVKKV---SHDSKQGIKEFVAELVSMGRLR-HRNLVKL 406
+ IG+G +GKV++ + N A K+ HD + I+ AE + L H N+VK
Sbjct: 24 ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIE---AEYNILKALSDHPNVVKF 80
Query: 407 RGYCRRKG-----EFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFR------IIRGVASG 455
G +K + LV + GS+ + +K L +R I+ G
Sbjct: 81 YGMYYKKDVKNGDQLWLVLELCNGGSVTDL----VKGFLKRGERMEEPIIAYILHEALMG 136
Query: 456 LLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMD 515
L +LH + +HRD+K N+LL + KL DFG++ + + T VGT +M
Sbjct: 137 LQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS-VGTPFWMA 192
Query: 516 PELMRTGKASTST-----DVYAFGVFMLEVASGRRPVEQQGSMETV 556
PE++ + ST DV++ G+ +E+ G P+ M +
Sbjct: 193 PEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL 238
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 17/212 (8%)
Query: 341 YKATKGFKDKDVIGRGGFGKV---YRGVLASNVQIAVKKVSH--DSKQGIKEFVAELVSM 395
+ K +++ IG G G V Y +L NV A+KK+S ++ K ELV M
Sbjct: 20 FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAYRELVLM 77
Query: 396 GRLRHRNLVKLRG-YCRRKG--EFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGV 452
+ H+N++ L + +K EF VY M +D L I+ L+ + ++ +
Sbjct: 78 KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME--LMDANLCQVIQMELDHERMSYLLYQM 135
Query: 453 ASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFG 512
G+ +LH ++HRD+KP+N+++ +D K+ DFGLAR T T V T
Sbjct: 136 LCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY 190
Query: 513 YMDPELMRTGKASTSTDVYAFGVFMLEVASGR 544
Y PE++ + D+++ G M E+ G
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 53/211 (25%), Positives = 91/211 (43%), Gaps = 43/211 (20%)
Query: 353 IGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEF-VAELVS------------MGRLR 399
+G+G FG VY + K V+ + + +KE V EL + +L
Sbjct: 8 LGKGSFGTVY-------LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 400 HRNLVKLRGYCRRKGEFLLVYDYMPNGSLD----------KILHTNIKPCLNWYQRFRII 449
H +VK + F ++ +Y LD K L N W+ + +
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSEN--QVCEWFIQLLL- 117
Query: 450 RGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVG 509
G+ Y+H+ + +LHRD+K N+ L +L K+GDFG++RL + T G
Sbjct: 118 -----GVHYMHQ---RRILHRDLKAKNIFLKNNLL-KIGDFGVSRLL-MGSCDLATTFTG 167
Query: 510 TFGYMDPELMRTGKASTSTDVYAFGVFMLEV 540
T YM PE ++ + +D+++ G + E+
Sbjct: 168 TPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 57/217 (26%), Positives = 100/217 (46%), Gaps = 21/217 (9%)
Query: 338 KDLYKATKGFKDKDVIGRGGFGKVYRGVLASNVQ-IAVKKVSHDSKQGI--KEFVAELVS 394
K +++ + +++ +G G +G V Q +AVKK+S + I + EL
Sbjct: 8 KTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRL 67
Query: 395 MGRLRHRNLVKL------RGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRI 448
+ ++H N++ L E LV + M L+ I+ + + + +F +
Sbjct: 68 LKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIV--KCQKLSDEHVQF-L 123
Query: 449 IRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLV 508
I + GL Y+H ++HRD+KP+NV ++ D ++ DFGLAR D + T V
Sbjct: 124 IYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADD----EMTGYV 176
Query: 509 GTFGYMDPELMRTGKASTST-DVYAFGVFMLEVASGR 544
T Y PE+M T D+++ G M E+ G+
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 1e-07
Identities = 54/206 (26%), Positives = 86/206 (41%), Gaps = 34/206 (16%)
Query: 353 IGRGGFGKVYRG-VLASNVQIAVK--KVSHDSKQGIKEFVAELVSMGRLR-HRNLVKLRG 408
IG G F +V + + A+K K S + + E+ ++ RL H N+++L
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL-REIQALRRLSPHPNILRLI- 64
Query: 409 YCRRKGEFLLVYDYMPNGSLDKILH---TNI-------KPCLNWYQRFRIIRGVASGLLY 458
E L +D G L + N+ K L + + + L +
Sbjct: 65 ------EVL--FD-RKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDH 115
Query: 459 LHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMDPE 517
+H + + HRDIKP N+L+ D+ KL DFG R +Y P T+ + T Y PE
Sbjct: 116 MHRNG---IFHRDIKPENILIKDDI-LKLADFGSCRGIYSK---PPYTEYISTRWYRAPE 168
Query: 518 LMRT-GKASTSTDVYAFGVFMLEVAS 542
+ T G D++A G E+ S
Sbjct: 169 CLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 62/229 (27%), Positives = 105/229 (45%), Gaps = 24/229 (10%)
Query: 334 RFTYKDLYKATKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELV 393
R T +Y +KD D + K + +L KV S + I E
Sbjct: 5 RGTRTQIYAGILNYKDDDEDDGYSYEKEIKVIL---------KVLDPSHRDISLAFFETA 55
Query: 394 SMGR-LRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGV 452
SM R + H+++V L G C R E ++V +++ G LD +H L +F++ + +
Sbjct: 56 SMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDV-LTTPWKFKVAKQL 114
Query: 453 ASGLLYLHEDWEQVVLHRDIKPANVLLDAD-LNGKLGDFGLARLYDHDTIPQTT----KL 507
AS L YL ED + V H ++ N+LL + ++G+ G F +L D IP T +
Sbjct: 115 ASALSYL-EDKDLV--HGNVCTKNILLAREGIDGECGPF--IKLSD-PGIPITVLSRQEC 168
Query: 508 VGTFGYMDPELMRTGKA-STSTDVYAFGVFMLEVA-SGRRPVEQQGSME 554
V ++ PE + K S + D ++FG + E+ +G P++ + E
Sbjct: 169 VERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE 217
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 6e-07
Identities = 60/247 (24%), Positives = 94/247 (38%), Gaps = 65/247 (26%)
Query: 347 FKDKDVIGRGGFGKVY----RG--------VLASNVQIAVKKVSH-DSKQGIKEFVAELV 393
FK ++G+G G+V+ +G VL I KV ++Q I
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEI-------- 54
Query: 394 SMGRLRHRNLVKLRGYCRRKGE--FLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRG 451
+ L H L L Y + E LV DY P G L ++L CL + R
Sbjct: 55 -LATLDHPFLPTL--YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCL----SEEVARF 107
Query: 452 VAS----GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP----- 502
A+ L YLH +++RD+KP N+LL + L DF L++ D + P
Sbjct: 108 YAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKAL 164
Query: 503 -----------------------QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLE 539
++ VGT Y+ PE++ ++ D + G+ + E
Sbjct: 165 RKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYE 224
Query: 540 VASGRRP 546
+ G P
Sbjct: 225 MLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 51/224 (22%), Positives = 95/224 (42%), Gaps = 45/224 (20%)
Query: 347 FKDKDVIGRGGFGKVYRGVLASNVQ-IAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVK 405
++ + IG G +GKVY+ + + +A+KK + + E + LR +L++
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE-------EGIPPTALREISLLQ 55
Query: 406 LRGYC---------------RRKGEFLLVYDYMPNGSLDKIL-------HTNIKPCLNWY 443
+ K LV++Y+ + L K + +
Sbjct: 56 MLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKS 114
Query: 444 QRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIP 502
+++++GVA + H+ V+HRD+KP N+L+D K+ D GL R + +IP
Sbjct: 115 FMYQLLKGVA----HCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF---SIP 164
Query: 503 --QTTKLVGTFGYMDPE-LMRTGKASTSTDVYAFGVFMLEVASG 543
T + T Y PE L+ + ST D+++ G E++
Sbjct: 165 VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 52/204 (25%), Positives = 78/204 (38%), Gaps = 52/204 (25%)
Query: 403 LVKLRGYCRRKGEFLLVYDYMPNGSLDKIL-HTNIKPCLNWYQRFRIIRGVASGLLYLHE 461
+VKL + K V DY+P G + +L I RF I + + +H+
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFE--EDLARFYIAE-LTCAIESVHK 119
Query: 462 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLA---------------------------R 494
+HRDIKP N+L+D D + KL DFGL
Sbjct: 120 ---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176
Query: 495 LYDHDTIPQTT---------------KLVGTFGYMDPE-LMRTGKASTSTDVYAFGVFML 538
+ D LVGT Y+ PE L+RTG + D ++ GV +
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILY 235
Query: 539 EVASGRRPVEQQGSMET-VNLVDW 561
E+ G+ P ET + +++W
Sbjct: 236 EMLVGQPPFLADTPAETQLKVINW 259
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 70/265 (26%), Positives = 105/265 (39%), Gaps = 86/265 (32%)
Query: 352 VIGRGGFGKVYRGVLA--SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRH----RNL-- 403
VIGRG FG+V R V + A+KK+ +E++ ++ H R++
Sbjct: 8 VIGRGAFGEV-RLVQKKDTGHIYAMKKLRK----------SEMLEKEQVAHVRAERDILA 56
Query: 404 -------VKLRGYCRRKGEFL-LVYDYMPNGSLDKILHTNIKPCLNWYQ-------RFRI 448
VKL Y + +L L+ +Y+P G + +L +K RF I
Sbjct: 57 EADNPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLL---MK-----KDTFTEEETRFYI 107
Query: 449 IRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGL------------ARLY 496
A +L + + +HRDIKP N+LLDA + KL DFGL R+
Sbjct: 108 ----AETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRIL 163
Query: 497 DHDTI---------PQTTK----------------LVGTFGYMDPE-LMRTGKASTSTDV 530
H P ++K VGT Y+ PE ++TG + D
Sbjct: 164 SHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDW 222
Query: 531 YAFGVFMLEVASGRRPVEQQGSMET 555
++ GV M E+ G P ET
Sbjct: 223 WSLGVIMYEMLVGYPPFCSDNPQET 247
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 345 KGFKDKDVIGRGGFGKV---YRGVLASNVQIAVKKVSH------DSKQGIKEFVAELVSM 395
K +++ IG G G V Y V NV A+KK+S +K+ +E V M
Sbjct: 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNV--AIKKLSRPFQNVTHAKRAYRELVL----M 69
Query: 396 GRLRHRNLVKLRGYC---RRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGV 452
+ H+N++ L + EF VY M +D L I+ L+ + ++ +
Sbjct: 70 KLVNHKNIIGLLNVFTPQKSLEEFQDVYLVME--LMDANLCQVIQMDLDHERMSYLLYQM 127
Query: 453 ASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFG 512
G+ +LH ++HRD+KP+N+++ +D K+ DFGLAR + T V T
Sbjct: 128 LCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRY 182
Query: 513 YMDPELMRTGKASTSTDVYAFGVFMLEVASGR 544
Y PE++ + D+++ G M E+ G
Sbjct: 183 YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 28/97 (28%), Positives = 46/97 (47%), Gaps = 3/97 (3%)
Query: 448 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 507
I R V + YLHE+ ++HRDIK N+ ++ + LGDFG A +
Sbjct: 187 IERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGW 243
Query: 508 VGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGR 544
GT PEL+ + D+++ G+ + E+A+
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 31/125 (24%), Positives = 58/125 (46%), Gaps = 6/125 (4%)
Query: 420 YDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL 479
Y + + +L + L VA G+ +L + +HRD+ NVLL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLL 270
Query: 480 DADLNGKLGDFGLAR--LYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFM 537
K+ DFGLAR ++D + + + + + +M PE + +T +DV+++G+ +
Sbjct: 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFL-PVKWMAPESIFDNLYTTLSDVWSYGILL 329
Query: 538 LEVAS 542
E+ S
Sbjct: 330 WEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 5e-05
Identities = 42/144 (29%), Positives = 70/144 (48%), Gaps = 16/144 (11%)
Query: 414 GEFLLVYD-YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 472
G +L V +M GS + +L T ++ I+ G GL YLH++ +HR+I
Sbjct: 71 GSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNI 127
Query: 473 KPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFG--------YMDPELMRTGKA 524
K +++L+ D G + GL+ LY Q K+V F ++ PEL+R
Sbjct: 128 KASHILISGD--GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLY 185
Query: 525 --STSTDVYAFGVFMLEVASGRRP 546
+ +D+Y+ G+ E+A+GR P
Sbjct: 186 GYNVKSDIYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 64/259 (24%), Positives = 98/259 (37%), Gaps = 54/259 (20%)
Query: 347 FKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKL 406
F+ VIGRG FG+V I K+ + KE VA + R LV+
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHI----RAERDILVEA 58
Query: 407 RGYC--------RRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLY 458
G + K L+ +++P G + +L Q + +A +L
Sbjct: 59 DGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFY-----IAETVLA 113
Query: 459 LHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGL-------------------------- 492
+ + +HRDIKP N+LLDA + KL DFGL
Sbjct: 114 IDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSF 173
Query: 493 --------ARLYDHDTIPQTTKLVGTFGYMDPEL-MRTGKASTSTDVYAFGVFMLEVASG 543
A + + VGT Y+ PE+ M+TG + D ++ GV M E+ G
Sbjct: 174 QNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIG 232
Query: 544 RRPVEQQGSMETV-NLVDW 561
P + ET +++W
Sbjct: 233 YPPFCSETPQETYRKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 8e-05
Identities = 42/142 (29%), Positives = 63/142 (44%), Gaps = 49/142 (34%)
Query: 468 LHRDIKPANVLLDADLNGKLGDFGL---------ARLY---DH---DTI--------PQT 504
+HRDIKP N+L+D D + KL DFGL ++ Y DH D++ P
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 505 TK-----------------------LVGTFGYMDPE-LMRTGKASTSTDVYAFGVFMLEV 540
+ LVGT Y+ PE L+RTG D ++ GV + E+
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYEM 241
Query: 541 ASGRRPVEQQGSMET-VNLVDW 561
G+ P Q +ET + +++W
Sbjct: 242 LVGQPPFLAQTPLETQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 9e-05
Identities = 61/258 (23%), Positives = 99/258 (38%), Gaps = 52/258 (20%)
Query: 347 FKDKDVIGRGGFGKVYRGVLASNV-----QIAVKKVSHDSKQGIKEFVAELVSMGRLRHR 401
F+ VIGRG FG+V R V + ++K K+ + AE +
Sbjct: 3 FESLKVIGRGAFGEV-RLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 402 NLVKLRGYCRRKGEFLLVYDYMPNGSLDKIL---HTNIKPCLNWYQRFRIIRGVASGLLY 458
+VK+ + K L+ +++P G + +L T + +Y +A +L
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFY--------IAETVLA 113
Query: 459 LHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLA------------RLYDHDTIPQTT- 505
+ + +HRDIKP N+LLD+ + KL DFGL R +H T
Sbjct: 114 IDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTF 173
Query: 506 ---------------------KLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGR 544
VGT Y+ PE+ + D ++ GV M E+ G
Sbjct: 174 QNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233
Query: 545 RPVEQQGSMETV-NLVDW 561
P + ET +++W
Sbjct: 234 PPFCSETPQETYKKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 44/166 (26%), Positives = 75/166 (45%), Gaps = 22/166 (13%)
Query: 452 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LY-DHDTIPQTTKLVG 509
VA G+ +L + +HRD+ N+LL + K+ DFGLAR +Y D D + + + +
Sbjct: 183 VARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL- 238
Query: 510 TFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKK 568
+M PE + +T +DV++FGV + E+ S G P V + + C K
Sbjct: 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP------YPGVQINEEFCQRLKD 292
Query: 569 GAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
G A ++ I ++ L C P+ RP +++
Sbjct: 293 GTRMRAPENATPEI---------YRIMLACWQGDPKERPTFSALVE 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 52/207 (25%), Positives = 80/207 (38%), Gaps = 54/207 (26%)
Query: 403 LVKLRGYCRRKGEFLLVYDYMPNGSLDKIL-HTNIKPCLNWYQRFRIIRGVASGLLYLHE 461
+VKL + K V DY+P G + +L + P RF I A L +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFP--EVLARFYI----AELTLAIES 116
Query: 462 DWEQVVLHRDIKPANVLLDADLNGKLGDFGL--------------------------ARL 495
+ +HRDIKP N+L+D D + KL DFGL + L
Sbjct: 117 VHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDL 176
Query: 496 YDH----------DTIPQTTK----------LVGTFGYMDPELMRTGKASTSTDVYAFGV 535
+D T+ Q LVGT Y+ PE++ + D ++ GV
Sbjct: 177 WDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236
Query: 536 FMLEVASGRRPVEQQGSMET-VNLVDW 561
+ E+ G+ P ET + +++W
Sbjct: 237 ILFEMLVGQPPFLAPTPTETQLKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 44/166 (26%), Positives = 74/166 (44%), Gaps = 22/166 (13%)
Query: 452 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LY-DHDTIPQTTKLVG 509
VA G+ +L + +HRD+ N+LL + K+ DFGLAR +Y D D + + +
Sbjct: 188 VAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL- 243
Query: 510 TFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKK 568
+M PE + + +DV++FGV + E+ S G P V + + C K+
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP------YPGVKIDEEFCRRLKE 297
Query: 569 GAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
G A D + + L C H +P RP ++++
Sbjct: 298 GTRMRAPDYTTPEMYQTM---------LDCWHGEPSQRPTFSELVE 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 63/266 (23%), Positives = 109/266 (40%), Gaps = 43/266 (16%)
Query: 345 KGFKDKDVIGRGGFGKVYRGVLASNVQI---AVKKVSHDSKQGI------------KEFV 389
K +K +IG GGFG VY AS+ I AV K+ + + I + +
Sbjct: 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKI 71
Query: 390 AELVSMGRLRHRNLVKLRG-----YCRRKGEFLLVYDYMPNGS--LDKILHTNIKPCLNW 442
A ++ + H + K G CR F+L+ + N +I N K +
Sbjct: 72 ALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKN-KKLIK- 129
Query: 443 YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY----DH 498
I++ + + L Y+HE + H DIKP N+++D + G + D+G+A + H
Sbjct: 130 ----NIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKH 182
Query: 499 DTIPQTTKLV--GTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETV 556
+ K + GT Y + + D+ + G ML+ A + +G
Sbjct: 183 IEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWA--GIKLPWKGFGHNG 240
Query: 557 NLVDWV-CDCWK---KGAIRDASDSR 578
NL+ CD K +G I+ + ++
Sbjct: 241 NLIHAAKCDFIKRLHEGKIKIKNANK 266
|
Length = 294 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 32/123 (26%), Positives = 57/123 (46%), Gaps = 6/123 (4%)
Query: 420 YDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL 479
Y + N P L++ VA+G+ +L + +HRD+ NVL+
Sbjct: 216 YLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLI 272
Query: 480 DADLNGKLGDFGLAR--LYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFM 537
K+ DFGLAR + D + I + + + +M PE + +T +DV++FG+ +
Sbjct: 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFL-PLKWMAPESIFNNLYTTLSDVWSFGILL 331
Query: 538 LEV 540
E+
Sbjct: 332 WEI 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 5e-04
Identities = 45/177 (25%), Positives = 80/177 (45%), Gaps = 36/177 (20%)
Query: 395 MGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTN-IKPCLNWYQRFRIIRGVA 453
M ++ H +L + G C R E ++V +++ +G LD L + + W + + + +A
Sbjct: 70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQLA 127
Query: 454 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNG-------KLGDFG-----LARLYDHDTI 501
S L YL ED + ++H ++ N+LL KL D G L+R + I
Sbjct: 128 SALSYL-ED--KNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVERI 184
Query: 502 PQTTKLVGTFGYMDPELMRTGKA-STSTDVYAFGVFMLEVA-------SGRRPVEQQ 550
P ++ PE + G + ST+ D ++FG +LE+ R P E++
Sbjct: 185 P----------WIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE 231
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 42/147 (28%), Positives = 64/147 (43%), Gaps = 19/147 (12%)
Query: 312 YIVRNKRYEEVYEDWEREY---GPQRFTYKDLYKATKGFKDKDVIGR----GGFGKVYRG 364
Y +R K E V D EY P + Y ++ + D V+GR G FG+V
Sbjct: 1 YEIRWKVIESVSSD-GHEYIYVDPMQLPYDSAWEMPR---DNLVLGRTLGSGAFGRVVEA 56
Query: 365 VL------ASNVQIAVKKVSHDSKQGIKE-FVAELVSMGRL-RHRNLVKLRGYCRRKGEF 416
S +++AVK + ++ K+ ++EL M L H N+V L G C + G
Sbjct: 57 TAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116
Query: 417 LLVYDYMPNGSLDKILHTNIKPCLNWY 443
++ +Y G L LH N L +Y
Sbjct: 117 YIITEYCRYGDLVDYLHRNKHTFLQYY 143
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 36/195 (18%), Positives = 79/195 (40%), Gaps = 22/195 (11%)
Query: 375 KKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGY--------CRRKGEFLLVYDYMPNG 426
KK K I E+ ++ R+ N++K+ G+ R L+ +Y G
Sbjct: 52 KKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPR----LSLILEYCTRG 107
Query: 427 SLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGK 486
L ++L L++ + + GL L++ + ++++ + L+ + K
Sbjct: 108 YLREVLDKEKD--LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLK 163
Query: 487 LGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRT--GKASTSTDVYAFGVFMLEVASGR 544
+ GL ++ K V Y +++ + + D+Y+ GV + E+ +G+
Sbjct: 164 IICHGLEKILSSPPF----KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219
Query: 545 RPVEQQGSMETVNLV 559
P E + E +L+
Sbjct: 220 IPFENLTTKEIYDLI 234
|
Length = 283 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 15/26 (57%), Positives = 20/26 (76%)
Query: 468 LHRDIKPANVLLDADLNGKLGDFGLA 493
+HRDIKP N+L+D + KL DFGL+
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 9/111 (8%)
Query: 440 LNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD 499
L+ R VA G+ +L + +HRD+ NVLL K+ DFGLAR +D
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265
Query: 500 T---IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRP 546
+ + +L +M PE + + +DV+++G+ + E+ S G+ P
Sbjct: 266 SNYVVKGNARL--PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 31/93 (33%), Positives = 51/93 (54%), Gaps = 6/93 (6%)
Query: 452 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LY-DHDTIPQTTKLVG 509
VA G+ +L + +HRD+ N+LL + K+ DFGLAR +Y D D + + +
Sbjct: 182 VARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL- 237
Query: 510 TFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS 542
+M PE + +T +DV++FGV + E+ S
Sbjct: 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 4/93 (4%)
Query: 450 RGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD-TIPQTTKLV 508
R + S + Y+H + ++HRDIK NVL++ + LGDFG A + P +
Sbjct: 267 RQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIA 323
Query: 509 GTFGYMDPELMRTGKASTSTDVYAFGVFMLEVA 541
GT PE++ + S D+++ G+ + E A
Sbjct: 324 GTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAA 356
|
Length = 461 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 37/157 (23%), Positives = 68/157 (43%), Gaps = 15/157 (9%)
Query: 400 HRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYL 459
H N+V R E +V +M GS ++ T+ ++ I++GV L Y+
Sbjct: 58 HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYI 117
Query: 460 HEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFG------- 512
H +HR +K +++L+ D GK+ GL Q ++V F
Sbjct: 118 HH---MGYVHRSVKASHILISVD--GKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVL 172
Query: 513 -YMDPELMRTGKA--STSTDVYAFGVFMLEVASGRRP 546
++ PE+++ +D+Y+ G+ E+A+G P
Sbjct: 173 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 34/105 (32%), Positives = 50/105 (47%), Gaps = 17/105 (16%)
Query: 456 LLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR---------LYDH----DTIP 502
L YLH ++HRD+KP N+L+ + + KL DFGL++ LY+ DT
Sbjct: 114 LEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 503 QTTKLV-GTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRP 546
K V GT Y+ PE++ D +A G+ + E G P
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 614 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06899 | 236 | lectin_legume_LecRK_Arcelin_ConA legume lectins, l | 100.0 | |
| PF00139 | 236 | Lectin_legB: Legume lectin domain; InterPro: IPR00 | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd01951 | 223 | lectin_L-type legume lectins. The L-type (legume-t | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.82 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| cd07308 | 218 | lectin_leg-like legume-like lectins: ERGIC-53, ERG | 99.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.79 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.76 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.72 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.7 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.69 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.69 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.69 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.68 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.68 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.68 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.66 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.61 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.6 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.56 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.54 | |
| cd06901 | 248 | lectin_VIP36_VIPL VIP36 and VIPL type 1 transmembr | 99.52 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.52 | |
| cd06902 | 225 | lectin_ERGIC-53_ERGL ERGIC-53 and ERGL type 1 tran | 99.44 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.41 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.4 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.32 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.23 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.21 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.19 | |
| cd06903 | 215 | lectin_EMP46_EMP47 EMP46 and EMP47 type 1 transmem | 99.16 | |
| PF03388 | 229 | Lectin_leg-like: Legume-like lectin family; InterP | 99.11 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.09 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.04 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.04 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.93 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.9 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.75 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.74 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.72 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.71 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.56 | |
| KOG3839 | 351 | consensus Lectin VIP36, involved in the transport | 98.49 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.4 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.36 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.33 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.32 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.3 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.17 | |
| KOG3838 | 497 | consensus Mannose lectin ERGIC-53, involved in gly | 98.11 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.06 | |
| cd06900 | 255 | lectin_VcfQ VcfQ bacterial pilus biogenesis protei | 98.03 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.02 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.99 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.97 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.92 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.84 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.81 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.8 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.5 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.39 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.3 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.25 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.23 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.22 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.14 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.08 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.05 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.01 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.82 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.65 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.56 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.5 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.39 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.34 | |
| PLN02236 | 344 | choline kinase | 96.12 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.0 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.96 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.55 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.53 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.19 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.47 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 94.42 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-57 Score=473.48 Aligned_cols=283 Identities=46% Similarity=0.822 Sum_probs=253.5
Q ss_pred CCcccCHHHHHHHhcCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEE
Q 044561 331 GPQRFTYKDLYKATKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYC 410 (614)
Q Consensus 331 ~~~~~~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~ 410 (614)
..+.|+++++..||++|...+.||+|+||.||+|.+.++..||||++.....+..++|.+|+.++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45679999999999999999999999999999999999999999988766543256799999999999999999999999
Q ss_pred eecC-eEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEee
Q 044561 411 RRKG-EFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGD 489 (614)
Q Consensus 411 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~D 489 (614)
.+.+ +.+||||||++|||.++|+......++|.+|++|+.++|+||+|||+.+.++||||||||+|||||+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9999 599999999999999999986543799999999999999999999998888999999999999999999999999
Q ss_pred eccccccCC-CCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhc
Q 044561 490 FGLARLYDH-DTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKK 568 (614)
Q Consensus 490 fGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~ 568 (614)
||+|+.... ........ .||.+|+|||++..+..+.|+|||||||+|+||+||++|.+.........+++|++..+.+
T Consensus 221 FGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred ccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 999976544 22111111 7999999999999999999999999999999999999999866555566699999999999
Q ss_pred CCcccccccccc-CcCcH-HHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 569 GAIRDASDSRLE-GICEE-KQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 569 ~~~~~~~d~~l~-~~~~~-~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+.+.+++|+++. +..+. ++++.+.+++++|++++|++||+|.||++
T Consensus 300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 999999999997 55554 78999999999999999999999999863
|
|
| >cd06899 lectin_legume_LecRK_Arcelin_ConA legume lectins, lectin-like receptor kinases, arcelin, concanavalinA, and alpha-amylase inhibitor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-53 Score=416.92 Aligned_cols=221 Identities=49% Similarity=0.794 Sum_probs=200.4
Q ss_pred ceEEeCCCCC-CCCceEecceeEcCCCcEEecCCC--CCCceeeEeeCCceeecCCC-CCceeeeeeeEEee--------
Q 044561 28 NQFIYHGFNE-DAQLQRDGLASVHSNGLLQLTNTV--SPQQEGHAFYRLPIKFNTSS-SESLSFSSNFVFAI-------- 95 (614)
Q Consensus 28 ~~f~~~~f~~-~~~~~~~g~a~~~~~g~l~Lt~~~--~~~~~G~~~y~~pv~l~~~~-~~~~sF~t~F~f~i-------- 95 (614)
++|+|++|.. ..++.++|+|.+..+|.|+||++. . .++|||||++||+||+.. +.++||+|+|+|.|
T Consensus 1 ~~f~f~~f~~~~~~l~l~G~A~~~~~~~i~LT~~~~~~-~~~G~v~y~~pi~l~~~~~~~~~sFst~F~F~i~~~~~~~~ 79 (236)
T cd06899 1 LSFNFNGFSSDQSNLTLQGDATISSNGALQLTNDTSPA-SSVGRALYSKPVRLWDSTTGKVASFSTSFSFSITPPNPSLG 79 (236)
T ss_pred CceecCCCCCCCCCEEEecceEcCCCCeEEecCCCCCC-cceEEEEeCCCEEeecCCCCCceeEEEEEEEEEEcCCCCCC
Confidence 4799999986 578999999999778999999987 5 899999999999999987 88999999999999
Q ss_pred --eeEEEEcCCCCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeeEecCCCcccccccCcccc
Q 044561 96 --GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFS 173 (614)
Q Consensus 96 --G~aF~l~p~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~ 173 (614)
||||+|+|....+ .+..|++|||++.++.+.+.+++|||||||++|.+++||++||||||+|++.|..+..+..
T Consensus 80 gdGlAF~i~~~~~~~--~~~~G~~lG~~~~~~~~~~~~~~vAVEFDT~~n~~~~D~~~nHigIdvn~~~S~~~~~~~~-- 155 (236)
T cd06899 80 GDGLAFFLAPTDSLP--PASSGGYLGLFNSSNNGNSSNHIVAVEFDTFQNPEFGDPDDNHVGIDVNSLVSVKAGYWDD-- 155 (236)
T ss_pred CCeEEEEEecCCCCC--CCCCcceeeeecCCCCCCcccceEEEEeecccCcccCCCCCCeEEEEcCCcccceeecccc--
Confidence 9999999987554 4689999999999887778899999999999999889999999999999998887766542
Q ss_pred CccCCCccccccCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcccccccccccccccCCCccceeeEec
Q 044561 174 DREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLKSSHYVLG 253 (614)
Q Consensus 174 ~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastg~~~~~h~i~s 253 (614)
..++|.+|+.++|||+||+.+++|+|+|.+.+..+|..|+++..+||+.+|+++||||||||||...|.|+|++
T Consensus 156 ------~~~~l~~g~~~~v~I~Y~~~~~~L~V~l~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFSasTG~~~~~h~i~s 229 (236)
T cd06899 156 ------DGGKLKSGKPMQAWIDYDSSSKRLSVTLAYSGVAKPKKPLLSYPVDLSKVLPEEVYVGFSASTGLLTELHYILS 229 (236)
T ss_pred ------ccccccCCCeEEEEEEEcCCCCEEEEEEEeCCCCCCcCCEEEEeccHHHhCCCceEEEEEeEcCCCcceEEEEE
Confidence 22457899999999999999999999999877678889999999999999999999999999999999999999
Q ss_pred cccccC
Q 044561 254 WSFNRS 259 (614)
Q Consensus 254 Wsf~~~ 259 (614)
|+|+++
T Consensus 230 WsF~s~ 235 (236)
T cd06899 230 WSFSSN 235 (236)
T ss_pred EEEEcC
Confidence 999864
|
This alignment model includes the legume lectins (also known as agglutinins), the arcelin (also known as phytohemagglutinin-L) family of lectin-like defense proteins, the LecRK family of lectin-like receptor kinases, concanavalinA (ConA), and an alpha-amylase inhibitor. Arcelin is a major seed glycoprotein discovered in kidney beans (Phaseolus vulgaris) that has insecticidal properties and protects the seeds from predation by larvae of various bruchids. Arcelin is devoid of monosaccharide binding properties and lacks a key metal-binding loop that is present in other members of this family. Phytohaemagglutinin (PHA) is a lectin found in plants, especially beans, that affects cell metabolism by inducing mitosis and by altering the permeability of the cell membrane to various proteins. PHA agglutinates most mammalian red blood cell types by bindin |
| >PF00139 Lectin_legB: Legume lectin domain; InterPro: IPR001220 Legume lectins are one of the largest lectin families with more than 70 lectins reported | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-51 Score=407.66 Aligned_cols=222 Identities=44% Similarity=0.743 Sum_probs=196.5
Q ss_pred ceEEeCCCCCCCCceEecceeEcCCCcEEecCCCCCCceeeEeeCCceeecCCC-CCceeeeeeeEEee-----------
Q 044561 28 NQFIYHGFNEDAQLQRDGLASVHSNGLLQLTNTVSPQQEGHAFYRLPIKFNTSS-SESLSFSSNFVFAI----------- 95 (614)
Q Consensus 28 ~~f~~~~f~~~~~~~~~g~a~~~~~g~l~Lt~~~~~~~~G~~~y~~pv~l~~~~-~~~~sF~t~F~f~i----------- 95 (614)
.+|+|++|....+++++|+|.+..+|+|+||++....++|||||++||+|||.. +.++||+|+|+|.|
T Consensus 2 ~~F~~~~F~~~~~~~l~G~A~~~~~~~l~LT~~~~~~~~G~~~y~~pi~l~d~~~~~~~sF~t~F~f~i~~~~~~~~~~~ 81 (236)
T PF00139_consen 2 VSFSFPSFSNSSNLTLNGDASISSNGSLQLTPDSTNNQAGRAWYNNPIQLWDSTTGNVASFSTSFSFSITNGPGSSNNGG 81 (236)
T ss_dssp EEEEESSBTTGTTEEEEETEEEETTSEEESSTBETSSEEEEEEESSEEESBETTTTEBEEEEEEEEEEEEESSSSSSS-B
T ss_pred ceEEcCCCCCCCceEEEeeEEeccCCeEEcCCCCCCCcEEEEEECCcEEEeCCCCcceeeeeeEEEEEEeccCCCCccCC
Confidence 589999995458999999999966999999986544799999999999999998 77899999999999
Q ss_pred -eeEEEEcCCCCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeeEecCCCcccccccCccccC
Q 044561 96 -GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSD 174 (614)
Q Consensus 96 -G~aF~l~p~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~ 174 (614)
||||+|+|....+ .++.|++||+++.++.+.+.+++|||||||++|++++||++||||||+|++.|..+.++.++.
T Consensus 82 dGlAFvi~~~~~~~--~~~~g~~lG~~~~~~~~~~~~~~vAVEFDT~~N~~~~d~~~nHIgI~~n~~~s~~~~~~~~~~- 158 (236)
T PF00139_consen 82 DGLAFVIQPDPNLP--GGSSGGYLGLFNSSTDGNGINNSVAVEFDTYKNPEYNDPDDNHIGIDVNSVVSNKTASAGYYS- 158 (236)
T ss_dssp EEEEEEEEETTSST--TTSSGGGTTTSSSSSTTGGGGCEEEEEEETSTCGGGTTTSSSEEEEEESSSSESEEEE----E-
T ss_pred CceEEEEecCcccc--cCCCCCccCccccccCCCccCcEEEEEEeeeecccccccCCCEEEEECCCCcccccccccccc-
Confidence 9999999988544 567999999999888777789999999999999999999999999999999999887776552
Q ss_pred ccCCCccccccCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcccccccccccccccCCCccceeeEecc
Q 044561 175 REGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLKSSHYVLGW 254 (614)
Q Consensus 175 ~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastg~~~~~h~i~sW 254 (614)
....++.+|+.++|||+||+.+++|+|++.... .+|..|+++..+||+.+++++||||||||||...|.|.|++|
T Consensus 159 ----~~~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~~l~~~vdL~~~l~~~v~vGFsasTG~~~~~h~I~sW 233 (236)
T PF00139_consen 159 ----SPSFSLSDGKWHTVWIDYDASTKRLSVYLDDNS-SKPSSPVLSVNVDLSAVLPEQVYVGFSASTGGSYQTHDILSW 233 (236)
T ss_dssp ----EEEHHHGTTSEEEEEEEEETTTTEEEEEEEETT-TTSEEEEEEEE--HHHHSCSEEEEEEEEEESSSSEEEEEEEE
T ss_pred ----cccccccCCcEEEEEEEEcCCccEEEEEEeccc-CCCcceeEEEEEchHHhcCCCcEEEEEeecCCCcceEEEEEE
Confidence 245688999999999999999999999999874 578889999999999999999999999999999999999999
Q ss_pred ccc
Q 044561 255 SFN 257 (614)
Q Consensus 255 sf~ 257 (614)
+|+
T Consensus 234 ~F~ 236 (236)
T PF00139_consen 234 SFS 236 (236)
T ss_dssp EEE
T ss_pred EeC
Confidence 995
|
Leguminous plant lectins resemble each other in their physicochemical properties although they differ in their carbohydrate specificities. They consist of two or four subunits with relative molecular mass of 30 kDa and each subunit has one carbohydrate-binding site. The interaction with sugars requires tightly bound calcium and manganese ions. The structural similarities of these lectins are reported by the primary structural analyses and X-ray crystallographic studies. X-ray studies have shown that the folding of the polypeptide chains in the region of the carbohydrate-binding sites is also similar, despite differences in the primary sequences. The carbohydrate-binding sites of these lectins consist of two conserved amino acids on beta pleated sheets. One of these loops contains transition metals, calcium and manganese, which keep the amino acid residues of the sugar-binding site at the required positions. Amino acid sequences of this loop play an important role in the carbohydrate-binding specificities of these lectins. These lectins bind either glucose/mannose or galactose. The exact function of legume lectins is not known but they may be involved in the attachment of nitrogen-fixing bacteria to legumes and in the protection against pathogens. Some legume lectins are proteolytically processed to produce two chains, beta (which corresponds to the N-terminal) and alpha (C-terminal) (IPR000985 from INTERPRO). The lectin concanavalin A (conA) from jack bean is exceptional in that the two chains are transposed and ligated (by formation of a new peptide bond). The N terminus of mature conA thus corresponds to that of the alpha chain and the C terminus to the beta chain.; GO: 0005488 binding; PDB: 1VLN_B 2GDF_C 2JE9_C 2JEC_C 1DGL_B 2P37_B 2CWM_A 2P34_D 2OW4_A 3IPV_B .... |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-47 Score=391.92 Aligned_cols=246 Identities=32% Similarity=0.527 Sum_probs=203.4
Q ss_pred CcceeeeeCcEEEEEEEEecCcEEEEEEeecCChh--hHHHHHHHHHHhcccCCCceeEEeeEEeecC-eEEEEEEecCC
Q 044561 349 DKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQ--GIKEFVAELVSMGRLRHRNLVKLRGYCRRKG-EFLLVYDYMPN 425 (614)
Q Consensus 349 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~lV~E~~~~ 425 (614)
..+.||+|+||+||+|.+++...||||++...... ..++|.+|+.+|.+++|||||+++|+|.+.. .+++|||||++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 34559999999999999987666999999765322 2669999999999999999999999999887 79999999999
Q ss_pred CCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCc-eEecCcCCCCeEEcCCC-CEEEeeeccccccCCCCCCc
Q 044561 426 GSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQV-VLHRDIKPANVLLDADL-NGKLGDFGLARLYDHDTIPQ 503 (614)
Q Consensus 426 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivHrDikp~NIll~~~~-~~kl~DfGla~~~~~~~~~~ 503 (614)
|+|.++++...+..+++..+++++.|||+||.|||+ .+ ||||||||+|||++.++ ++||+|||+++...... ..
T Consensus 125 GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~ 200 (362)
T KOG0192|consen 125 GSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-TS 200 (362)
T ss_pred CcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-cc
Confidence 999999988545669999999999999999999996 55 99999999999999997 99999999998766532 22
Q ss_pred ccccccCCCccchhhhc--CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccC
Q 044561 504 TTKLVGTFGYMDPELMR--TGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEG 581 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~--~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~ 581 (614)
.+...||+.|||||++. ...++.|+||||||+++|||+||+.||...... .....+.. .+. +.
T Consensus 201 ~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~---~~~~~v~~---~~~---------Rp 265 (362)
T KOG0192|consen 201 MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV---QVASAVVV---GGL---------RP 265 (362)
T ss_pred ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHh---cCC---------CC
Confidence 34468999999999999 568999999999999999999999999876542 12222211 111 11
Q ss_pred cCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHh
Q 044561 582 ICEEKQMELVLKLGLFCSHPKPEARPNMRQVM 613 (614)
Q Consensus 582 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 613 (614)
..+..+...+..++.+||+.||++||++.|++
T Consensus 266 ~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~ 297 (362)
T KOG0192|consen 266 PIPKECPPHLSSLMERCWLVDPSRRPSFLEIV 297 (362)
T ss_pred CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHH
Confidence 22222445677778889999999999999986
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=390.21 Aligned_cols=245 Identities=33% Similarity=0.516 Sum_probs=211.8
Q ss_pred CcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecCCCCc
Q 044561 349 DKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSL 428 (614)
Q Consensus 349 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 428 (614)
..+.||+|.||.||.|.++....||+|.+..... ..+.|.+|+++|++|+|+|||+++|+|..++.+|||||||++|||
T Consensus 210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsL 288 (468)
T KOG0197|consen 210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSL 288 (468)
T ss_pred HHHHhcCCccceEEEEEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcH
Confidence 3567999999999999999988999999977533 346789999999999999999999999999999999999999999
Q ss_pred chhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcccccc
Q 044561 429 DKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLV 508 (614)
Q Consensus 429 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 508 (614)
.++|+...+..+...+.+.++.|||+||+||++ +++|||||.++|||++++..+||+|||||+...++.........
T Consensus 289 l~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~k 365 (468)
T KOG0197|consen 289 LDYLRTREGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGK 365 (468)
T ss_pred HHHhhhcCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCC
Confidence 999998667779999999999999999999995 89999999999999999999999999999976666544444445
Q ss_pred cCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcHHH
Q 044561 509 GTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQ 587 (614)
Q Consensus 509 gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~ 587 (614)
-+..|.|||.+..++++.|||||||||+||||+| |+.|+.++...+.+..+ .+|. +-..+..+
T Consensus 366 fPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~l-------e~Gy---------Rlp~P~~C 429 (468)
T KOG0197|consen 366 FPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELL-------ERGY---------RLPRPEGC 429 (468)
T ss_pred CCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHH-------hccC---------cCCCCCCC
Confidence 5789999999999999999999999999999999 99999988776554433 2222 11234455
Q ss_pred HHHHHHHHHHcCCCCCCCCCCHHHHh
Q 044561 588 MELVLKLGLFCSHPKPEARPNMRQVM 613 (614)
Q Consensus 588 ~~~l~~l~~~cl~~dP~~RPs~~evl 613 (614)
...+.++|..||+.+|++|||+..+.
T Consensus 430 P~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 430 PDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred CHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 66788899999999999999998653
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=366.80 Aligned_cols=254 Identities=29% Similarity=0.425 Sum_probs=212.0
Q ss_pred cCHHHHHHHhcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEee
Q 044561 335 FTYKDLYKATKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRR 412 (614)
Q Consensus 335 ~~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 412 (614)
++..|+.. .+.||+|..|+|||+.++. +.-+|+|.+... +....+++.+|++++++.+||+||+++|.|..
T Consensus 76 i~~~dle~-------~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 76 ISLSDLER-------LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred cCHHHhhh-------hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 45555543 5789999999999999986 677899999544 44456789999999999999999999999999
Q ss_pred cC-eEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeec
Q 044561 413 KG-EFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFG 491 (614)
Q Consensus 413 ~~-~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfG 491 (614)
.+ .+.++||||++|||++++... +.+++...-+|+.+|++||.|||+ ++.||||||||+|||+++.|.+||||||
T Consensus 149 ~~~~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFG 224 (364)
T KOG0581|consen 149 NGEEISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFG 224 (364)
T ss_pred CCceEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEecccc
Confidence 98 599999999999999999864 449999999999999999999996 4899999999999999999999999999
Q ss_pred cccccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCC--CccccccHHHHHHHhhhcC
Q 044561 492 LARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQ--GSMETVNLVDWVCDCWKKG 569 (614)
Q Consensus 492 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~--~~~~~~~l~~~v~~~~~~~ 569 (614)
.+....+. .....+||..|||||.+.+..|+.++||||||+.++|+++|+.|+... .......+..++...
T Consensus 225 VS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~---- 297 (364)
T KOG0581|consen 225 VSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDE---- 297 (364)
T ss_pred ccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC----
Confidence 99877655 345579999999999999999999999999999999999999999764 223344444444331
Q ss_pred CccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 570 AIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 570 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
. .+++... .....+..++..|++.||.+|||++|+++
T Consensus 298 p-----pP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 298 P-----PPRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred C-----CCCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1 1222221 23456778888999999999999999975
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=383.41 Aligned_cols=247 Identities=27% Similarity=0.461 Sum_probs=211.2
Q ss_pred cCCCCcceeeeeCcEEEEEEEE-ecCcEEEEEEeecC---ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVL-ASNVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
+.|+..+.||+|||+.||+++. ..|..||+|.+.+. .....+...+||++.++|+|||||++++++++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688899999999999999998 56999999999774 3345577889999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
|+|++++|..+++. ++.+++.++..++.||+.||.|||+ .+|+|||||..|++|++++++||+|||||.....+.
T Consensus 98 ELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 99999999999984 5669999999999999999999995 899999999999999999999999999999887654
Q ss_pred CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
. ...+.|||+-|+|||++.....+..+||||+||+||-|+.|++||+...-.+...-+. . .+-.+
T Consensus 173 E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik-------~------~~Y~~- 237 (592)
T KOG0575|consen 173 E-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK-------L------NEYSM- 237 (592)
T ss_pred c-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH-------h------cCccc-
Confidence 3 3445799999999999998899999999999999999999999998765544443321 1 11111
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+........+|+.++|++||.+|||+.+||+
T Consensus 238 ---P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 238 ---PSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ---ccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 2223334566777799999999999999984
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-45 Score=363.00 Aligned_cols=203 Identities=26% Similarity=0.486 Sum_probs=183.9
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 421 (614)
.+|...+.||+|+|++||+|+++. +..||||++... .+...+....|+.+|+.++|||||++++++..++.+|||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 467777889999999999999875 889999999877 56667778999999999999999999999999999999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCC------CCEEEeeeccccc
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDAD------LNGKLGDFGLARL 495 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~------~~~kl~DfGla~~ 495 (614)
||.+|+|.++++... .+++.....++.|||.||++|| +++||||||||+||||+.. -.+||+|||+|+.
T Consensus 90 yC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred eCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 999999999998854 5999999999999999999999 5999999999999999765 4589999999998
Q ss_pred cCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccc
Q 044561 496 YDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSME 554 (614)
Q Consensus 496 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~ 554 (614)
...+. ...+.+|++.|||||++..++|+.|+|+||.|+++||+++|+.||+.....|
T Consensus 165 L~~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e 221 (429)
T KOG0595|consen 165 LQPGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE 221 (429)
T ss_pred CCchh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence 87654 3455799999999999999999999999999999999999999998766544
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=388.86 Aligned_cols=250 Identities=30% Similarity=0.525 Sum_probs=213.3
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEe------cCcEEEEEEeecCChh-hHHHHHHHHHHhcccCCCceeEEeeEEeecCeE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLA------SNVQIAVKKVSHDSKQ-GIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEF 416 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 416 (614)
+.+....+.||+|+||+||+|... +...||||.++..... ...+|.+|++++..++|||||+|+|.|.+++.+
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 445666788999999999999853 2466999999887655 778999999999999999999999999999999
Q ss_pred EEEEEecCCCCcchhcccCC------------CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCC
Q 044561 417 LLVYDYMPNGSLDKILHTNI------------KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLN 484 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~ 484 (614)
++|+|||..|+|.++|.... +..|+..+.+.||.|||.||.||.+ +.+|||||..+|+|+.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceE
Confidence 99999999999999996432 2338899999999999999999995 89999999999999999999
Q ss_pred EEEeeeccccccCC-CCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHH
Q 044561 485 GKLGDFGLARLYDH-DTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWV 562 (614)
Q Consensus 485 ~kl~DfGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v 562 (614)
+||+||||++..-. +.........-+++||+||.+..+++|.+||||||||+|||+++ |+.|+.+..+.|.+
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI------ 715 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI------ 715 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH------
Confidence 99999999986433 22222223455789999999999999999999999999999999 99999988776544
Q ss_pred HHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q 044561 563 CDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQV 612 (614)
Q Consensus 563 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev 612 (614)
+..++|.+.. +++.+...+..||..||+.+|++||+++||
T Consensus 716 -e~i~~g~lL~---------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 716 -ECIRAGQLLS---------CPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred -HHHHcCCccc---------CCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 3445555433 566677789999999999999999999997
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-45 Score=345.83 Aligned_cols=249 Identities=26% Similarity=0.422 Sum_probs=206.6
Q ss_pred CCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeE-EeecCe-EEEEE
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGY-CRRKGE-FLLVY 420 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~-~~~~~~-~~lV~ 420 (614)
+|++.++||.|.||+|||+... ++..+|.|++..+ +.+....+..|+.+|++|+|||||+++++ +.+.++ ++|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 3566788999999999999864 6888999998754 44556778999999999999999999994 555555 89999
Q ss_pred EecCCCCcchhccc--CCCCCcChhHHHHHHHHhHhhchhhhccCCC-ceEecCcCCCCeEEcCCCCEEEeeeccccccC
Q 044561 421 DYMPNGSLDKILHT--NIKPCLNWYQRFRIIRGVASGLLYLHEDWEQ-VVLHRDIKPANVLLDADLNGKLGDFGLARLYD 497 (614)
Q Consensus 421 E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDikp~NIll~~~~~~kl~DfGla~~~~ 497 (614)
|||..|+|...++. ..+..+++..+++++.|++.||.++|+.+.+ .|+||||||.||+|+.+|.+||+||||++.+.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 99999999999864 3456699999999999999999999985533 48999999999999999999999999999987
Q ss_pred CCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccc
Q 044561 498 HDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDS 577 (614)
Q Consensus 498 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~ 577 (614)
.... .....+|||.||+||.+.+..|+.|+||||+||++|||+.-+.||.+.. ....++.+..|.....-
T Consensus 180 s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n-------~~~L~~KI~qgd~~~~p-- 249 (375)
T KOG0591|consen 180 SKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN-------LLSLCKKIEQGDYPPLP-- 249 (375)
T ss_pred chhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc-------HHHHHHHHHcCCCCCCc--
Confidence 6542 2345799999999999999999999999999999999999999998752 22345555555443321
Q ss_pred cccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHH
Q 044561 578 RLEGICEEKQMELVLKLGLFCSHPKPEARPNMR 610 (614)
Q Consensus 578 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 610 (614)
+....+.|..++..|+.+||+.||+.-
T Consensus 250 ------~~~YS~~l~~li~~ci~vd~~~RP~t~ 276 (375)
T KOG0591|consen 250 ------DEHYSTDLRELINMCIAVDPEQRPDTV 276 (375)
T ss_pred ------HHHhhhHHHHHHHHHccCCcccCCCcc
Confidence 234456677788889999999999843
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=354.66 Aligned_cols=251 Identities=24% Similarity=0.377 Sum_probs=204.0
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChh-------hHHHHHHHHHHhcccCCCceeEEeeEEeecCeE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQ-------GIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEF 416 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 416 (614)
+.|...+.||+|+||.|-+|..+. ++.||||.+.+.... ......+|+++|++|+|||||++++++...+..
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 456778899999999999999765 899999999764211 122356999999999999999999999999999
Q ss_pred EEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCC---CCEEEeeeccc
Q 044561 417 LLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDAD---LNGKLGDFGLA 493 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~---~~~kl~DfGla 493 (614)
|+||||+++|.|.+.+-.+. .+.+..-..+++|++.|+.|||+ ++|+||||||+|||+..+ ..+||+|||+|
T Consensus 252 YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred EEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccchh
Confidence 99999999999999987643 47788888999999999999995 999999999999999765 77999999999
Q ss_pred cccCCCCCCcccccccCCCccchhhhcCCC---CCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCC
Q 044561 494 RLYDHDTIPQTTKLVGTFGYMDPELMRTGK---ASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGA 570 (614)
Q Consensus 494 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~ 570 (614)
+..+... .+.+.|||+.|.|||++.++. +..+.|+||+||+||-++||.+||........ +. +...+|+
T Consensus 327 K~~g~~s--fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s--l~----eQI~~G~ 398 (475)
T KOG0615|consen 327 KVSGEGS--FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS--LK----EQILKGR 398 (475)
T ss_pred hccccce--ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc--HH----HHHhcCc
Confidence 9887443 566789999999999998754 34588999999999999999999976543321 11 1122332
Q ss_pred ccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 571 IRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 571 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
... ......+..++.+.|+.+||..||++|||+.|+|+
T Consensus 399 y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 399 YAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred ccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 221 11223445677889999999999999999999985
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=337.94 Aligned_cols=263 Identities=22% Similarity=0.309 Sum_probs=210.3
Q ss_pred CCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC--hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS--KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
.|+...++|+|+||.|||++.++ |+.||||++...+ ....+-.++|+.+|++++|+|+|.++.+|..+..++||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 46667789999999999999987 8999999996543 33445678999999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 502 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 502 (614)
|+..-|+++=+. ...++.....+++.|++.|+.|+| ++++|||||||+|||++.++.+||||||+|+.... ...
T Consensus 83 ~dhTvL~eLe~~--p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd 156 (396)
T KOG0593|consen 83 CDHTVLHELERY--PNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGD 156 (396)
T ss_pred cchHHHHHHHhc--cCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcC-Ccc
Confidence 987666554333 234899999999999999999999 58999999999999999999999999999998774 223
Q ss_pred cccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHH--------hhhcC-Ccc
Q 044561 503 QTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCD--------CWKKG-AIR 572 (614)
Q Consensus 503 ~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~--------~~~~~-~~~ 572 (614)
..+..+.|.+|.|||++.+ -+|...+||||.||++.||++|.+-|++..+-+++.++..... .+..+ .+.
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 4567789999999999887 6899999999999999999999999998887777666543321 11111 111
Q ss_pred ccc-----cccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 573 DAS-----DSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 573 ~~~-----d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+. +++-....-......++.++..|++.||.+|++-.|+++
T Consensus 237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 111 111111111223346899999999999999999999874
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=354.16 Aligned_cols=263 Identities=27% Similarity=0.367 Sum_probs=216.0
Q ss_pred CCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC--hhhHHHHHHHHHHhcccCCCceeEEeeEEeec--CeEEEEEE
Q 044561 347 FKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS--KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRK--GEFLLVYD 421 (614)
Q Consensus 347 f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~E 421 (614)
|+..++||+|.||.||||+... +..||+|++..+. .....-..+||.+|++|+||||++|.+...+. +.+|||+|
T Consensus 119 feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFe 198 (560)
T KOG0600|consen 119 FEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFE 198 (560)
T ss_pred HHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEe
Confidence 4456789999999999999764 8899999998765 33455678999999999999999999998776 78999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCC
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI 501 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~ 501 (614)
||++ +|.-++... .-.++..++..+++|++.||.|||+ ++|+|||||.+|||||.+|.+||+|||||+++.....
T Consensus 199 YMdh-DL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 199 YMDH-DLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS 273 (560)
T ss_pred cccc-hhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence 9965 677776653 3459999999999999999999994 9999999999999999999999999999999887776
Q ss_pred CcccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcc-----ccc
Q 044561 502 PQTTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIR-----DAS 575 (614)
Q Consensus 502 ~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~-----~~~ 575 (614)
...+..+-|.+|.|||++.+. .|+.+.|+||.||||.||+.|++.+.+..+.+++..+...+.-..+..+. .+.
T Consensus 274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~ 353 (560)
T KOG0600|consen 274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHAT 353 (560)
T ss_pred cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCccc
Confidence 667888899999999998764 79999999999999999999999999999888888887776554444333 111
Q ss_pred cccccCcCcHH-------HHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 576 DSRLEGICEEK-------QMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 576 d~~l~~~~~~~-------~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
-.+....+... .....+.|+..+|..||.+|.|+.++|+
T Consensus 354 ~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 354 IFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 11111111111 1234677888899999999999999875
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=377.42 Aligned_cols=260 Identities=31% Similarity=0.557 Sum_probs=222.4
Q ss_pred ccCHHHHHHHhcCC---------CCcceeeeeCcEEEEEEEEec----CcEEEEEEeecC-ChhhHHHHHHHHHHhcccC
Q 044561 334 RFTYKDLYKATKGF---------KDKDVIGRGGFGKVYRGVLAS----NVQIAVKKVSHD-SKQGIKEFVAELVSMGRLR 399 (614)
Q Consensus 334 ~~~~~el~~~~~~f---------~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~ 399 (614)
.++|+|-.+|...| ++.++||.|.||.||+|.++- ...||||.++.. .+....+|+.|..||.++.
T Consensus 609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd 688 (996)
T KOG0196|consen 609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD 688 (996)
T ss_pred CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC
Confidence 47888877776554 567899999999999999863 456999999876 4556789999999999999
Q ss_pred CCceeEEeeEEeecCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEE
Q 044561 400 HRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL 479 (614)
Q Consensus 400 H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll 479 (614)
||||++|.|+........||.|||+||+|+.+|+.+.. .+++.|+..++++||.||.||. +.++|||||.++|||+
T Consensus 689 HPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILV 764 (996)
T KOG0196|consen 689 HPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILV 764 (996)
T ss_pred CCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheee
Confidence 99999999999999999999999999999999998764 4999999999999999999999 5999999999999999
Q ss_pred cCCCCEEEeeeccccccCCCCCCccccccc--CCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccc
Q 044561 480 DADLNGKLGDFGLARLYDHDTIPQTTKLVG--TFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETV 556 (614)
Q Consensus 480 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~ 556 (614)
+.+..+|++||||++....+.....+..-| +.+|.|||.+...++|.++||||||++|||+++ |.+||..+.+.+.+
T Consensus 765 NsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVI 844 (996)
T KOG0196|consen 765 NSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI 844 (996)
T ss_pred ccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHH
Confidence 999999999999999886665333343333 469999999999999999999999999999998 99999988776655
Q ss_pred cHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHh
Q 044561 557 NLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVM 613 (614)
Q Consensus 557 ~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 613 (614)
..++ +| -+| -.+.++...|.+||+.||++|-.+||.+.||+
T Consensus 845 kaIe-------~g-------yRL--PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV 885 (996)
T KOG0196|consen 845 KAIE-------QG-------YRL--PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIV 885 (996)
T ss_pred HHHH-------hc-------cCC--CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHH
Confidence 4432 11 112 23455667899999999999999999999986
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=341.38 Aligned_cols=242 Identities=26% Similarity=0.357 Sum_probs=200.6
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC---ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLV 419 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 419 (614)
.++|+..++||+|+||+||.++.++ ++.+|+|.+++. .....+...+|..+|.+++||.||+++-.+.+.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 4678999999999999999999876 788999998765 334567788999999999999999999999999999999
Q ss_pred EEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCC
Q 044561 420 YDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD 499 (614)
Q Consensus 420 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~ 499 (614)
+||+.||.|..+|++. ..+++..+..++.+|+.||.||| +.+||||||||+|||||++|+++|+||||++..-..
T Consensus 104 ld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 9999999999999874 34999999999999999999999 599999999999999999999999999999865443
Q ss_pred CCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccc
Q 044561 500 TIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRL 579 (614)
Q Consensus 500 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 579 (614)
. ..+...+||+.|||||++....|+.++|.||+|+++|||++|.+||...+..+.... ..++++.. .
T Consensus 179 ~-~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~-------I~~~k~~~-----~ 245 (357)
T KOG0598|consen 179 G-DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDK-------ILKGKLPL-----P 245 (357)
T ss_pred C-CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHH-------HhcCcCCC-----C
Confidence 2 234557999999999999999999999999999999999999999987654433222 22222111 1
Q ss_pred cCcCcHHHHHHHHHHHHHcCCCCCCCCC
Q 044561 580 EGICEEKQMELVLKLGLFCSHPKPEARP 607 (614)
Q Consensus 580 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP 607 (614)
..-.+ .....++...+..||++|.
T Consensus 246 p~~ls----~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 246 PGYLS----EEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CccCC----HHHHHHHHHHhccCHHHhc
Confidence 11122 2344555568999999996
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=353.59 Aligned_cols=262 Identities=24% Similarity=0.335 Sum_probs=214.8
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhH-HHHHHHHHHhcccC-CCceeEEeeEEeecC-eEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGI-KEFVAELVSMGRLR-HRNLVKLRGYCRRKG-EFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~-~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~-~~~lV~ 420 (614)
++|...++||.|.||.||+|+.+. +..||||++++...... ..=++|++.|++|+ ||||+++.+.+.+.+ .+++||
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf 89 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF 89 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence 456677889999999999999765 88899999977643321 23368999999998 999999999998887 999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
||| ..+|.++++.+ +..+++.++..|+.||++||+|+| +.|+.|||+||+|||+..+..+||+||||||......
T Consensus 90 E~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp 164 (538)
T KOG0661|consen 90 EFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKP 164 (538)
T ss_pred Hhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccccCC
Confidence 999 57999999987 677999999999999999999999 6999999999999999999999999999999876543
Q ss_pred CCcccccccCCCccchhhh-cCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccc------
Q 044561 501 IPQTTKLVGTFGYMDPELM-RTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRD------ 573 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~-~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~------ 573 (614)
..+..+.|.+|.|||++ +.+.|+.+.||||+||+++|+.+-++-|.+..+.+++.-+-.|.....+..+.+
T Consensus 165 --PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~ 242 (538)
T KOG0661|consen 165 --PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLAS 242 (538)
T ss_pred --CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHH
Confidence 56778999999999976 567899999999999999999999999998877666555544443333322222
Q ss_pred --------cccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 574 --------ASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 574 --------~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.....+....+. ......+|+..|+..||.+|||+.|++|
T Consensus 243 ~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~ 290 (538)
T KOG0661|consen 243 AMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQ 290 (538)
T ss_pred HhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence 111122222222 5567888889999999999999999986
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=340.55 Aligned_cols=252 Identities=27% Similarity=0.459 Sum_probs=203.1
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecC--eEEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKG--EFLLVYD 421 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV~E 421 (614)
.++...+.||+|.||.||++...+ +...|||.+........+.+.+|+.+|++++|||||+.+|...... .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 346667899999999999999876 8889999997764444677899999999999999999999854444 6999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcC-CCCEEEeeeccccccCC--
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA-DLNGKLGDFGLARLYDH-- 498 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~-~~~~kl~DfGla~~~~~-- 498 (614)
|+++|||.+++..... .+++..+..+.+||++||.|||+ ++||||||||+|||++. ++.+||+|||++.....
T Consensus 97 y~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred ccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999988655 69999999999999999999995 99999999999999999 79999999999987663
Q ss_pred CCCCcccccccCCCccchhhhcCCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccc
Q 044561 499 DTIPQTTKLVGTFGYMDPELMRTGK-ASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDS 577 (614)
Q Consensus 499 ~~~~~~~~~~gt~~y~aPE~~~~~~-~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~ 577 (614)
..........||+.|||||++..+. ...++||||+||++.||+||+.||... .....++.....++..+
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~P----- 242 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSLP----- 242 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCCC-----
Confidence 2222344578999999999998643 345999999999999999999999753 11222222222222122
Q ss_pred cccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 578 RLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 578 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.++........+++.+|+..||++|||+.++|+
T Consensus 243 ----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~ 275 (313)
T KOG0198|consen 243 ----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLE 275 (313)
T ss_pred ----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 223334455677777899999999999999984
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=343.61 Aligned_cols=257 Identities=27% Similarity=0.422 Sum_probs=211.2
Q ss_pred cCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCCh-hhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSK-QGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
+...++++||+|.||.|..+....+..||||+++.+.. ...++|.+|+++|.+++||||++++|+|..++.+++++|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 44567889999999999999998889999999987754 44589999999999999999999999999999999999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccC-CCCCC
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYD-HDTIP 502 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~-~~~~~ 502 (614)
++|+|.++|.++..+.+.-....+|+.|||+||+||.+ .++|||||.++|||+|.++++||+|||+++..- .+...
T Consensus 618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 99999999998765556777788899999999999996 899999999999999999999999999998543 33333
Q ss_pred cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHH--cCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 503 QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVA--SGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 503 ~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~--tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
...+.+-+.+|||||.+..+++|.++|||+||+++||++ |...||.....++.. +........+.....
T Consensus 695 vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv---en~~~~~~~~~~~~~------ 765 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV---ENAGEFFRDQGRQVV------ 765 (807)
T ss_pred eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH---HhhhhhcCCCCccee------
Confidence 444567789999999999999999999999999999986 588899876654433 222232222211111
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHh
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARPNMRQVM 613 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 613 (614)
-..+.-+...+.++++.||..+.++||++.++.
T Consensus 766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh 798 (807)
T KOG1094|consen 766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLH 798 (807)
T ss_pred ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHH
Confidence 112233445677889999999999999999874
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=378.18 Aligned_cols=251 Identities=32% Similarity=0.535 Sum_probs=209.7
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec--C----cEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS--N----VQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFL 417 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~--~----~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 417 (614)
+..+..+.||+|.||.||+|...+ + ..||+|.+... +.+...+|++|..+|++++|||||+++|.|.+.+..+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 345566789999999999999865 3 34899999766 5667789999999999999999999999999999999
Q ss_pred EEEEecCCCCcchhcccCC-----CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecc
Q 044561 418 LVYDYMPNGSLDKILHTNI-----KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGL 492 (614)
Q Consensus 418 lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGl 492 (614)
+++|||++|+|..+|++.. ...++..+.+.++.|||+|+.||+ ++..|||||.++|+||++...+||+||||
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccch
Confidence 9999999999999998751 345899999999999999999999 48999999999999999999999999999
Q ss_pred cccc-CCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCC
Q 044561 493 ARLY-DHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGA 570 (614)
Q Consensus 493 a~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~ 570 (614)
|+.+ +.+.........-+..|||||.+..+.++.|+|||||||++||++| |..||....+.+.+..+ .+.|
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~------~~gg- 921 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDV------LEGG- 921 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHH------HhCC-
Confidence 9943 3333333333345679999999999999999999999999999999 99999887665543321 1222
Q ss_pred ccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 571 IRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 571 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
++. .+..+.+.+.+||.+||+.+|++||++..|++
T Consensus 922 -------RL~--~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 922 -------RLD--PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred -------ccC--CCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 221 24455667889999999999999999999874
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=348.07 Aligned_cols=249 Identities=25% Similarity=0.414 Sum_probs=210.6
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
..|....+||+|+.|.||.+.... ++.||||++........+-+.+|+.+|+..+|+|||+++..+..+++++.|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 346667889999999999998654 8889999998776666677899999999999999999999999999999999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCc
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 503 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 503 (614)
++|+|.+.+.... +++.++..|++++++||+||| .++|+|||||.+|||++.+|.+||+|||+|..+..... .
T Consensus 353 ~ggsLTDvVt~~~---~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-K 425 (550)
T KOG0578|consen 353 EGGSLTDVVTKTR---MTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-K 425 (550)
T ss_pred CCCchhhhhhccc---ccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC-c
Confidence 9999999987643 999999999999999999999 49999999999999999999999999999988776554 3
Q ss_pred ccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcC
Q 044561 504 TTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGIC 583 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 583 (614)
....+||+.|||||+.....|.+|.||||||++++||+-|.+||-...+-..+.++ -..|. ++ + ..
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI------a~ng~-P~-----l--k~ 491 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATNGT-PK-----L--KN 491 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH------hhcCC-CC-----c--CC
Confidence 45579999999999999999999999999999999999999999764433222222 11111 11 1 12
Q ss_pred cHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 584 EEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 584 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+.....+.++..+||..|+++||+++|+|+
T Consensus 492 ~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 492 PEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred ccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 3334456788888999999999999999985
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=331.38 Aligned_cols=260 Identities=25% Similarity=0.394 Sum_probs=208.3
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
+.|+..+.||.|..++||+|+.. .+..||||++..+. ....+.+.+|+..|+.++||||++++..|..+..+|+||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 56888999999999999999975 48899999997653 33468899999999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccc-cCCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARL-YDHDTI 501 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~-~~~~~~ 501 (614)
|.+||+.++++......+++..+..|++++++||.||| +++.||||||+.||||+++|.+||+|||.+-. .+++..
T Consensus 106 Ma~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R 182 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDR 182 (516)
T ss_pred hcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccCce
Confidence 99999999998877777999999999999999999999 59999999999999999999999999998644 333321
Q ss_pred --CcccccccCCCccchhhhcC--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccc
Q 044561 502 --PQTTKLVGTFGYMDPELMRT--GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDS 577 (614)
Q Consensus 502 --~~~~~~~gt~~y~aPE~~~~--~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~ 577 (614)
......+||++|||||++.. ..|+.|+||||||+...||++|..||....+.+.+ . .. -++..+...-.
T Consensus 183 ~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL--l---~t--Lqn~pp~~~t~ 255 (516)
T KOG0582|consen 183 QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL--L---LT--LQNDPPTLLTS 255 (516)
T ss_pred eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH--H---HH--hcCCCCCcccc
Confidence 11145689999999999643 36899999999999999999999999876543322 1 11 12222211111
Q ss_pred cccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 578 RLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 578 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+..+-.......+.+++..|+..||++|||+.++++
T Consensus 256 ~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 256 GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 1111111112235778888899999999999999875
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=335.12 Aligned_cols=256 Identities=29% Similarity=0.425 Sum_probs=192.8
Q ss_pred cCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhc--ccCCCceeEEeeEEeecC----eEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMG--RLRHRNLVKLRGYCRRKG----EFLL 418 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~--~l~H~niv~l~g~~~~~~----~~~l 418 (614)
...+..++||+|+||.||||++++ +.||||++....+ +.|.+|-++.+ .++|+||+++++.-.... +++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~~~k---qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLDN-RLVAVKIFPEQEK---QSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhccC-ceeEEEecCHHHH---HHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 445567889999999999999964 7899999965544 45666655554 568999999999876655 8999
Q ss_pred EEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccC------CCceEecCcCCCCeEEcCCCCEEEeeecc
Q 044561 419 VYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDW------EQVVLHRDIKPANVLLDADLNGKLGDFGL 492 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~ivHrDikp~NIll~~~~~~kl~DfGl 492 (614)
|+||.++|||.++|..+. ++|....+|+..+++||+|||++. +++|+|||||++|||+.+|+++.|+||||
T Consensus 286 Vt~fh~kGsL~dyL~~nt---isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKANT---ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred EeeeccCCcHHHHHHhcc---ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 999999999999998754 999999999999999999999874 77899999999999999999999999999
Q ss_pred ccccCCCCCC-cccccccCCCccchhhhcCC------CCCcchhHHHHHHHHHHHHcCCCCCCCCCcccc-c--------
Q 044561 493 ARLYDHDTIP-QTTKLVGTFGYMDPELMRTG------KASTSTDVYAFGVFMLEVASGRRPVEQQGSMET-V-------- 556 (614)
Q Consensus 493 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~------~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~-~-------- 556 (614)
|..+..+... .....+||.+|||||++.+. ..-.+.||||+|++||||++...-+.....++. .
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 9887754422 23347999999999999653 223579999999999999996654432111110 0
Q ss_pred -cHHHHHHHhhhcCCccccccccccC-cCcHHHHHHHHHHHHHcCCCCCCCCCCHHH
Q 044561 557 -NLVDWVCDCWKKGAIRDASDSRLEG-ICEEKQMELVLKLGLFCSHPKPEARPNMRQ 611 (614)
Q Consensus 557 -~l~~~v~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 611 (614)
--++.+++..-..+ ..+.+.. ......+..+.+.+..||++||+.|.|+.=
T Consensus 443 hPt~e~mq~~VV~kK----~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~C 495 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKK----QRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGC 495 (534)
T ss_pred CCCHHHHHHHHHhhc----cCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHH
Confidence 01122222221111 1122211 112245778999999999999999999853
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=313.57 Aligned_cols=263 Identities=22% Similarity=0.330 Sum_probs=212.9
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChh--hHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQ--GIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 421 (614)
++|...+.||+|.||.||+|+... |+.||||+++..+.. .....++|++.|+.++|+||+.+++++.+.+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 356777899999999999999765 899999999865332 24567899999999999999999999999999999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCC
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI 501 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~ 501 (614)
||+ .+|...++.+. ..++..++..++.++++|++|||+ ..|+||||||.|+|++++|.+||+|||+++.+.....
T Consensus 82 fm~-tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred ecc-ccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 995 68998888754 468999999999999999999994 8999999999999999999999999999999876553
Q ss_pred CcccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccc-----
Q 044561 502 PQTTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDAS----- 575 (614)
Q Consensus 502 ~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~----- 575 (614)
.. +..+-|.+|.|||++.+. .|+...||||.||++.||+-|.+-|.+.++-+++..+-.......+..+++..
T Consensus 157 ~~-~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 157 IQ-THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred cc-ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence 33 334789999999998764 78999999999999999999998888877766665554443333333333321
Q ss_pred -------cccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 576 -------DSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 576 -------d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+.+...+ ......+++|+..|+..||.+|+|+.|+++
T Consensus 236 ~~~~~~P~~~~~~lf-~aas~d~ldLl~~m~~ynP~~Rita~qaL~ 280 (318)
T KOG0659|consen 236 VKIQQFPKPPLNNLF-PAASSDALDLLSKMLTYNPKKRITASQALK 280 (318)
T ss_pred HHHhcCCCCcccccc-ccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence 11111111 123345688999999999999999999985
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=334.24 Aligned_cols=253 Identities=17% Similarity=0.310 Sum_probs=200.3
Q ss_pred cccCHHHHHHHhcCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChh---hHHHHHHHHHHhcccCCCceeEEeeE
Q 044561 333 QRFTYKDLYKATKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQ---GIKEFVAELVSMGRLRHRNLVKLRGY 409 (614)
Q Consensus 333 ~~~~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~ 409 (614)
+.++.+++ +......||+|++|.||+|.+ ++..||+|++...... ..+.+.+|+.++++++||||++++|+
T Consensus 13 ~~i~~~~i-----~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~ 86 (283)
T PHA02988 13 KCIESDDI-----DKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGF 86 (283)
T ss_pred eecCHHHc-----CCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeee
Confidence 33455555 233346799999999999998 5788999998765332 25778899999999999999999999
Q ss_pred Eee----cCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCE
Q 044561 410 CRR----KGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG 485 (614)
Q Consensus 410 ~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~ 485 (614)
+.+ ....++||||+++|+|.+++... ..+++.+...++.+++.||.|||+ ..+++||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~ 162 (283)
T PHA02988 87 IIDIVDDLPRLSLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKL 162 (283)
T ss_pred EEecccCCCceEEEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcE
Confidence 876 35789999999999999999764 358999999999999999999995 3578899999999999999999
Q ss_pred EEeeeccccccCCCCCCcccccccCCCccchhhhcC--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHH
Q 044561 486 KLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRT--GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVC 563 (614)
Q Consensus 486 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~ 563 (614)
||+|||+++...... ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||......+.. ..+.
T Consensus 163 kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~---~~i~ 235 (283)
T PHA02988 163 KIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIY---DLII 235 (283)
T ss_pred EEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHH---HHHH
Confidence 999999998654322 23468899999999976 68899999999999999999999999865433221 1111
Q ss_pred HhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 564 DCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 564 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
. .+. ...+ +....+.+.+++.+||+.||++|||+.|+++
T Consensus 236 ~---~~~-----~~~~----~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 236 N---KNN-----SLKL----PLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred h---cCC-----CCCC----CCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 1 110 0111 1123345778888999999999999999974
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=344.09 Aligned_cols=253 Identities=26% Similarity=0.416 Sum_probs=197.8
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEe------cCcEEEEEEeecCC-hhhHHHHHHHHHHhccc-CCCceeEEeeEEeec-C
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLA------SNVQIAVKKVSHDS-KQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRK-G 414 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~-~ 414 (614)
.++|+..+.||+|+||.||+|... .+..||+|++.... ....+.+.+|+.++.++ +||||++++++|... +
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 356888899999999999999752 24579999987543 33456789999999999 899999999998765 4
Q ss_pred eEEEEEEecCCCCcchhcccCC----------------------------------------------------------
Q 044561 415 EFLLVYDYMPNGSLDKILHTNI---------------------------------------------------------- 436 (614)
Q Consensus 415 ~~~lV~E~~~~gsL~~~l~~~~---------------------------------------------------------- 436 (614)
.+++||||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 6899999999999999886421
Q ss_pred --CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCC-CcccccccCCCc
Q 044561 437 --KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGY 513 (614)
Q Consensus 437 --~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y 513 (614)
...+++.++..++.||++||.|||+ ++|+||||||+|||++.++.+||+|||+++....... .......++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 1247888999999999999999995 8999999999999999999999999999986543221 112234567889
Q ss_pred cchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHH
Q 044561 514 MDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVL 592 (614)
Q Consensus 514 ~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 592 (614)
+|||++.+..++.++|||||||++|||++ |+.||......+. .......+... .... .....+.
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~------~~~~~~~~~~~-----~~~~----~~~~~l~ 307 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE------FCQRLKDGTRM-----RAPE----NATPEIY 307 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH------HHHHHhcCCCC-----CCCC----CCCHHHH
Confidence 99999998899999999999999999997 9999976443221 11112222111 1111 2234577
Q ss_pred HHHHHcCCCCCCCCCCHHHHhC
Q 044561 593 KLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 593 ~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+++.+||+.||++|||+.|+++
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHH
Confidence 8899999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=333.05 Aligned_cols=251 Identities=25% Similarity=0.329 Sum_probs=201.4
Q ss_pred CCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEE
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 421 (614)
.|+..+.||+|+||.||++... ++..||+|.+.... ......+.+|+.++++++|+|++++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3677889999999999999976 48899999986542 2234567899999999999999999999999999999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCC
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI 501 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~ 501 (614)
|+++|+|..++.......+++.++..++.|++.||.|||+ .+|+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 9999999988865444568999999999999999999994 899999999999999999999999999998754332
Q ss_pred CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccC
Q 044561 502 PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEG 581 (614)
Q Consensus 502 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~ 581 (614)
......||..|+|||++.+..++.++|||||||++|||++|+.||...........+ ........ .
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~---~~~~~~~~----------~ 222 (285)
T cd05631 157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV---DRRVKEDQ----------E 222 (285)
T ss_pred -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHH---HHHhhccc----------c
Confidence 223457899999999999989999999999999999999999999865432211111 11111100 0
Q ss_pred cCcHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHhC
Q 044561 582 ICEEKQMELVLKLGLFCSHPKPEARPN-----MRQVMQ 614 (614)
Q Consensus 582 ~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 614 (614)
.++......+..|+.+||+.||++||+ +.++++
T Consensus 223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 111222345677888899999999997 788764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=350.45 Aligned_cols=249 Identities=31% Similarity=0.455 Sum_probs=201.7
Q ss_pred CCCCcceeeeeCcEEEEEEEEecC-----cEEEEEEeec---CChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEE
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLASN-----VQIAVKKVSH---DSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFL 417 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~~-----~~vavK~~~~---~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 417 (614)
+....++||+|+||.||+|+++.. ..||||.... ..+...++|.+|.++|++++|||||+++|++..+..++
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 334458899999999999998642 2289999885 34777899999999999999999999999999999999
Q ss_pred EEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccC
Q 044561 418 LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYD 497 (614)
Q Consensus 418 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~ 497 (614)
+|||+|+||+|+++|+++.. .++..++..++.+.|.||+|||+ ++++||||.++|+|++.++.+||+||||++.-.
T Consensus 238 ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred EEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence 99999999999999998653 59999999999999999999994 899999999999999999999999999988654
Q ss_pred CCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCcccccc
Q 044561 498 HDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASD 576 (614)
Q Consensus 498 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 576 (614)
.... ......-+..|+|||.+..+.++.++|||||||++||+++ |..||.+....+.. .++. ..+.
T Consensus 314 ~~~~-~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~---~kI~---~~~~------ 380 (474)
T KOG0194|consen 314 QYVM-KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVK---AKIV---KNGY------ 380 (474)
T ss_pred ceee-ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHH---HHHH---hcCc------
Confidence 1111 1111235679999999999999999999999999999999 88899876543221 2221 1111
Q ss_pred ccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 577 SRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 577 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+...+......+..++.+||..+|++||+|.++.+
T Consensus 381 ---r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 381 ---RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred ---cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 11122234455666777899999999999999863
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=344.76 Aligned_cols=252 Identities=28% Similarity=0.455 Sum_probs=201.9
Q ss_pred HhcCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 343 ATKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 343 ~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
..+.+...+.||+|.||+||+|.|.+ .||||.+..+ ..+..+.|.+|+..+++-+|.||+-+.|||...+. .||.
T Consensus 390 p~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiT 466 (678)
T KOG0193|consen 390 PPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIIT 466 (678)
T ss_pred CHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeee
Confidence 33455667889999999999999965 4889988765 55678899999999999999999999999998877 9999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
.+|++.+|..+|+... ..|+..+.+.|++|||+||.|||. ++|||||||..||+++++++|||+||||+.......
T Consensus 467 qwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~ 542 (678)
T KOG0193|consen 467 QWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWS 542 (678)
T ss_pred hhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeeeeeec
Confidence 9999999999999764 459999999999999999999995 899999999999999999999999999997543221
Q ss_pred -CCcccccccCCCccchhhhcCC---CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccc
Q 044561 501 -IPQTTKLVGTFGYMDPELMRTG---KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASD 576 (614)
Q Consensus 501 -~~~~~~~~gt~~y~aPE~~~~~---~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 576 (614)
........|...|||||+++.+ +|+..+||||||+++|||+||..||.....+..+-.+ .+|.+. .|
T Consensus 543 g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmV-------GrG~l~--pd 613 (678)
T KOG0193|consen 543 GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMV-------GRGYLM--PD 613 (678)
T ss_pred cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEe-------cccccC--cc
Confidence 1122334578899999998754 6899999999999999999999999844333222111 122111 11
Q ss_pred ccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHh
Q 044561 577 SRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVM 613 (614)
Q Consensus 577 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 613 (614)
... ....+.+.+.+|+..||..++++||.+.+|+
T Consensus 614 ~s~---~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il 647 (678)
T KOG0193|consen 614 LSK---IRSNCPKAMKRLLSDCWKFDREERPLFPQLL 647 (678)
T ss_pred chh---hhccCHHHHHHHHHHHHhcCcccCccHHHHH
Confidence 111 1233445677777789999999999999987
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=381.54 Aligned_cols=255 Identities=27% Similarity=0.540 Sum_probs=210.9
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
...++..+.||+|+||.||+|+.. ++..||+|++....... .+|++.+++++||||++++|+|.+.+..++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc----HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 346778889999999999999985 58899999986543221 3468889999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 502 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 502 (614)
|++|+|.++++. ++|.++.+++.|+|+||+|||+.+.++|+||||||+||+++.++.+++. +|........
T Consensus 765 ~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~--- 835 (968)
T PLN00113 765 IEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--- 835 (968)
T ss_pred CCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---
Confidence 999999999963 8999999999999999999997667899999999999999999988876 6665433221
Q ss_pred cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccC-
Q 044561 503 QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEG- 581 (614)
Q Consensus 503 ~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~- 581 (614)
....+|..|+|||++.+..++.++|||||||++|||++|+.|++... ......++|+...+.........|+.+..
T Consensus 836 --~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (968)
T PLN00113 836 --TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARYCYSDCHLDMWIDPSIRGD 912 (968)
T ss_pred --CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc-CCCCcHHHHHHHhcCccchhheeCccccCC
Confidence 22367899999999999999999999999999999999999995432 23345667777666555566666766643
Q ss_pred -cCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 582 -ICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 582 -~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+.+++..+.+++.+||+.||++||||+||++
T Consensus 913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 946 (968)
T PLN00113 913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLK 946 (968)
T ss_pred CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHH
Confidence 245567778899999999999999999999974
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=331.43 Aligned_cols=265 Identities=21% Similarity=0.307 Sum_probs=203.9
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC--hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS--KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 421 (614)
++|+..+.||+|+||.||+++.+. +..+|+|++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 368888999999999999999875 7889999987542 3345678899999999999999999999999999999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCC
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI 501 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~ 501 (614)
|++++.+..+... ...+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 81 YVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 9998877655433 2358999999999999999999994 8999999999999999999999999999987654333
Q ss_pred CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHH--------Hhh-hcCCcc
Q 044561 502 PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVC--------DCW-KKGAIR 572 (614)
Q Consensus 502 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~--------~~~-~~~~~~ 572 (614)
.......|++.|+|||++.+..++.++|||||||++|||++|+.||......+....+.... +.+ ......
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 33344578999999999988889999999999999999999999998654433222111110 000 000000
Q ss_pred cccccccc------CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 573 DASDSRLE------GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 573 ~~~d~~l~------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
....+... ..........+.+++.+|+++||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000 0001112345888999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=339.81 Aligned_cols=250 Identities=24% Similarity=0.369 Sum_probs=203.8
Q ss_pred HhcCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecC----Ch-hhHHHHHHHHHHhcccC-CCceeEEeeEEeecCe
Q 044561 343 ATKGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHD----SK-QGIKEFVAELVSMGRLR-HRNLVKLRGYCRRKGE 415 (614)
Q Consensus 343 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~ 415 (614)
...+|...+.||+|.||+|+.|... .+..||+|.+... .. ...+.+.+|+.+++.++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 3467889999999999999999876 4799999976553 11 23455668999999999 9999999999999999
Q ss_pred EEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCC-CCEEEeeecccc
Q 044561 416 FLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDAD-LNGKLGDFGLAR 494 (614)
Q Consensus 416 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~-~~~kl~DfGla~ 494 (614)
+++||||+.+|+|.+++.. ...+.+.+..+++.|+++|++|||+ ++|+||||||+|||+|.+ +++||+|||++.
T Consensus 95 ~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred EEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 9999999999999999987 3458899999999999999999995 899999999999999999 999999999999
Q ss_pred ccCCCCCCcccccccCCCccchhhhcCCC-CC-cchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcc
Q 044561 495 LYDHDTIPQTTKLVGTFGYMDPELMRTGK-AS-TSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIR 572 (614)
Q Consensus 495 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t-~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~ 572 (614)
... .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+......... ...++..
T Consensus 170 ~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~-------ki~~~~~- 240 (370)
T KOG0583|consen 170 ISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYR-------KIRKGEF- 240 (370)
T ss_pred ccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHH-------HHhcCCc-
Confidence 874 2222455679999999999999876 74 88999999999999999999998743222111 1122111
Q ss_pred ccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 573 DASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 573 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+...+. ...+..|+.+|+.+||.+|+++.+|++
T Consensus 241 -----~~p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 241 -----KIPSYLL---SPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred -----cCCCCcC---CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 1112221 345677788899999999999999873
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=334.62 Aligned_cols=248 Identities=24% Similarity=0.364 Sum_probs=203.6
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC---ChhhHHHHHHHHHHhccc-CCCceeEEeeEEeecCeEEE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD---SKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGEFLL 418 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 418 (614)
.++|...+.||+|+|++|++|+.++ +.++|||++.+. .+...+-...|-..|.+| .||.|++|+-.+.++..+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 4578889999999999999999876 889999998654 122233456788888888 89999999999999999999
Q ss_pred EEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCC
Q 044561 419 VYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 498 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~ 498 (614)
|+||+++|+|.++|++. +.|++.....++.+|+.||+|||+ .+||||||||+|||||++|++||.|||-|+.+..
T Consensus 152 vLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 99999999999999885 459999999999999999999995 9999999999999999999999999999987653
Q ss_pred CCCC----------c--ccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhh
Q 044561 499 DTIP----------Q--TTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCW 566 (614)
Q Consensus 499 ~~~~----------~--~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~ 566 (614)
.... . ....+||..|.+||++..+..+..+|+|+|||++|+|+.|++||...++-- ..+.+.+
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl---iFqkI~~-- 301 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL---IFQKIQA-- 301 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH---HHHHHHH--
Confidence 2211 1 134799999999999999999999999999999999999999998755321 1122221
Q ss_pred hcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHh
Q 044561 567 KKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVM 613 (614)
Q Consensus 567 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 613 (614)
++-.+...++ +.+..|+.+.|..||.+|++..||-
T Consensus 302 --------l~y~fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk 336 (604)
T KOG0592|consen 302 --------LDYEFPEGFP----EDARDLIKKLLVRDPSDRLTSQQIK 336 (604)
T ss_pred --------hcccCCCCCC----HHHHHHHHHHHccCccccccHHHHh
Confidence 2233333444 4556666678999999999999875
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=334.85 Aligned_cols=200 Identities=26% Similarity=0.405 Sum_probs=176.1
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
++|+..+.||+|+||.||+++... +..+|+|.+.... ....+++.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 578889999999999999999875 7788999887653 34456799999999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 502 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 502 (614)
+++|+|.+++... ..+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++.+||+|||++.......
T Consensus 85 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 158 (331)
T cd06649 85 MDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 158 (331)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc--
Confidence 9999999999764 348899999999999999999996 3469999999999999999999999999987654322
Q ss_pred cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Q 044561 503 QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQG 551 (614)
Q Consensus 503 ~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~ 551 (614)
.....||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 159 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 206 (331)
T cd06649 159 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD 206 (331)
T ss_pred -cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 233578999999999998889999999999999999999999997543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=327.27 Aligned_cols=247 Identities=32% Similarity=0.575 Sum_probs=192.9
Q ss_pred CcceeeeeCcEEEEEEEEe-----cCcEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 349 DKDVIGRGGFGKVYRGVLA-----SNVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 349 ~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
..+.||+|.||.||+|.+. .+..|+||.+... ..+..+++.+|++.+++++||||++++|+|...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3578999999999999998 2567999999654 344578999999999999999999999999988889999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC-C
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT-I 501 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~-~ 501 (614)
+++|+|.++|.......+++.++..|+.||++||.|||+ .+++|+||+++||++++++.+||+|||++....... .
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred ccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence 999999999998755669999999999999999999995 789999999999999999999999999998763222 1
Q ss_pred CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 502 PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 502 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
...........|+|||.+....++.++||||||+++|||++ |+.|+......+ .... ..++....
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~---~~~~----~~~~~~~~------- 225 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE---IIEK----LKQGQRLP------- 225 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH---HHHH----HHTTEETT-------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccc----ccccccce-------
Confidence 12233456789999999998889999999999999999999 788886553222 1111 12221111
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+......+.+++.+||+.||++|||+.+|++
T Consensus 226 --~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 226 --IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp --SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred --eccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11122345678888899999999999999974
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=324.86 Aligned_cols=250 Identities=27% Similarity=0.455 Sum_probs=199.8
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe----cCcEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA----SNVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLV 419 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 419 (614)
++|+..+.||+|+||.||+|.++ .+..+|+|.+.... ....+.+.+|+..+++++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46788899999999999999864 25679999987653 33456789999999999999999999999999999999
Q ss_pred EEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCC
Q 044561 420 YDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD 499 (614)
Q Consensus 420 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~ 499 (614)
|||+++|+|.+++.... ..+++.+++.++.|++.||+||| +++++||||||+||+++.++.+|++|||.+......
T Consensus 85 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 85 TEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999987642 35899999999999999999999 589999999999999999999999999987654332
Q ss_pred CCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCcccccccc
Q 044561 500 TIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSR 578 (614)
Q Consensus 500 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~ 578 (614)
.........++..|+|||.+....++.++|||||||++||+++ |+.||......+. .. ...++... .
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~---~~----~~~~~~~~-----~ 228 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV---IK----AVEDGFRL-----P 228 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HH----HHHCCCCC-----C
Confidence 2111222345678999999998999999999999999999775 9999976543321 11 11121111 1
Q ss_pred ccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 579 LEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 579 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
. +......+.+++..||+++|++||++.||++
T Consensus 229 ~----~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 229 A----PRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred C----CCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 1 1223345778888999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=329.49 Aligned_cols=258 Identities=24% Similarity=0.400 Sum_probs=198.9
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-----------------CcEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-----------------NVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKL 406 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l 406 (614)
.+|...+.||+|+||.||++.+++ +..||+|.+... ......++.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 467788999999999999998643 236899988764 34455689999999999999999999
Q ss_pred eeEEeecCeEEEEEEecCCCCcchhcccCC-----------------CCCcChhHHHHHHHHhHhhchhhhccCCCceEe
Q 044561 407 RGYCRRKGEFLLVYDYMPNGSLDKILHTNI-----------------KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLH 469 (614)
Q Consensus 407 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH 469 (614)
++++...+..++||||+++|+|.+++.... ...+++.++.+++.||+.||.|||+ .+|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccc
Confidence 999999999999999999999999885421 1247888999999999999999995 89999
Q ss_pred cCcCCCCeEEcCCCCEEEeeeccccccCCCCC-CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc--CCCC
Q 044561 470 RDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS--GRRP 546 (614)
Q Consensus 470 rDikp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t--g~~p 546 (614)
|||||+|||++.++.+||+|||+++....... .......++..|+|||++..+.++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999986543321 11223456789999999988899999999999999999986 5667
Q ss_pred CCCCCccccccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 547 VEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 547 ~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
|......+. ...+........... . . ..+......+.+++.+||+.||++|||+.||.+
T Consensus 242 ~~~~~~~~~---~~~~~~~~~~~~~~~-~-~----~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 242 YGELTDEQV---IENAGEFFRDQGRQV-Y-L----FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CCcCCHHHH---HHHHHHHhhhccccc-c-c----cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 765433222 222222211111000 0 0 011122346788899999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=336.74 Aligned_cols=246 Identities=27% Similarity=0.387 Sum_probs=205.2
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 421 (614)
++|...+.||+|.||.||||+.+. .+.||+|.+.+. .+...+...+|++++++++||||+.++++++...++++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 467778899999999999999886 677899988664 44557788999999999999999999999999999999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCC
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI 501 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~ 501 (614)
|+.+ +|..+|... ..++++++..|+.++.+||.|||+ .+|+|||+||.|||++..+.+|+||||+|+....+..
T Consensus 82 ~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~ 155 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS 155 (808)
T ss_pred hhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccCce
Confidence 9966 999999874 459999999999999999999995 8999999999999999999999999999998776542
Q ss_pred CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccC
Q 044561 502 PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEG 581 (614)
Q Consensus 502 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~ 581 (614)
..+...||+.|||||++.++.|+..+|+||+||++||++.|++||.... ...++.. +.. |+-.
T Consensus 156 -vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s---i~~Lv~~----I~~-------d~v~-- 218 (808)
T KOG0597|consen 156 -VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS---ITQLVKS----ILK-------DPVK-- 218 (808)
T ss_pred -eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH---HHHHHHH----Hhc-------CCCC--
Confidence 3455789999999999999999999999999999999999999996532 2222221 111 1111
Q ss_pred cCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 582 ICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 582 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+.........+....+..||.+|.+..++++
T Consensus 219 -~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 219 -PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred -CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 12234445666677789999999999988763
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=337.18 Aligned_cols=252 Identities=22% Similarity=0.311 Sum_probs=203.1
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
++|+..+.||+|+||.||+|+... ++.||+|++.... ....+.+.+|+.++..++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 368889999999999999999875 7889999987542 234567889999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
||+++|+|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 999999999999753 358999999999999999999994 8999999999999999999999999999986543
Q ss_pred CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+. .+. ..+.. +..
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~----~~~-~~~~~---~~~- 222 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK----YWK-ETLQR---PVY- 222 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHH----hcc-ccccC---CCC-
Confidence 2234579999999999998899999999999999999999999997654433222111 010 00000 000
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..........+.+++.+|+..+|++||++.|+++
T Consensus 223 ~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~ 256 (333)
T cd05600 223 DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKN 256 (333)
T ss_pred CccccccCHHHHHHHHHHhhChhhhcCCHHHHHh
Confidence 0000122345677888899999999999999974
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=330.39 Aligned_cols=248 Identities=26% Similarity=0.476 Sum_probs=212.3
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
..|+..+.||+|.||.||||.... ++.||+|.+..+. +...+++.+|+.++.+++++||.+++|.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 346667899999999999999876 7889999997653 44567889999999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 502 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 502 (614)
|.+|++.+.|.... .+++..+.-|++++..||.|||+ ++.+|||||+.|||+..+|.+||+|||++-........
T Consensus 93 ~~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred hcCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence 99999999998643 35888888999999999999995 89999999999999999999999999999877665544
Q ss_pred cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCc
Q 044561 503 QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGI 582 (614)
Q Consensus 503 ~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 582 (614)
. .+.+||+.|||||++....|+.|+||||||++.+||++|.+|+....+...+.++ .+-..|.+.+.
T Consensus 168 r-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI------------pk~~PP~L~~~ 234 (467)
T KOG0201|consen 168 R-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI------------PKSAPPRLDGD 234 (467)
T ss_pred c-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec------------cCCCCCccccc
Confidence 4 6679999999999999889999999999999999999999999877664444332 34445555543
Q ss_pred CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 583 CEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 583 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+. ..+.+++..|++.||+.||++.++++
T Consensus 235 ~S----~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 235 FS----PPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred cC----HHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 33 35777888899999999999999985
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=329.81 Aligned_cols=244 Identities=20% Similarity=0.270 Sum_probs=200.1
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
++|+..+.||+|+||.||++..+. ++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 367888999999999999999874 7889999986542 234566889999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
||+++|+|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 81 EYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence 999999999998764 358999999999999999999995 89999999999999999999999999999865432
Q ss_pred CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. . ....+.. .+.
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~---~----~i~~~~~------~~~ 218 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIY---E----KILAGKL------EFP 218 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---H----HHHhCCc------CCC
Confidence 22357899999999999888999999999999999999999999765432211 1 1111111 111
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHhC
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARPN-----MRQVMQ 614 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 614 (614)
... ...+.+++.+|++.||.+||+ +.|+++
T Consensus 219 ~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 219 RHL----DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred ccC----CHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 112 235677888899999999995 888764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=326.94 Aligned_cols=264 Identities=24% Similarity=0.331 Sum_probs=196.0
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe--cCcEEEEEEeecCC--hhhHHHHHHHHHHhccc---CCCceeEEeeEEe-----e
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA--SNVQIAVKKVSHDS--KQGIKEFVAELVSMGRL---RHRNLVKLRGYCR-----R 412 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~-----~ 412 (614)
++|+..+.||+|+||.||+|+.. ++..+|+|++.... ......+.+|+.+++.+ +||||++++++|. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888899999999999999874 36779999886532 22233455666666554 7999999999985 3
Q ss_pred cCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecc
Q 044561 413 KGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGL 492 (614)
Q Consensus 413 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGl 492 (614)
...+++||||++ ++|.+++.......+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456899999996 689999876555568999999999999999999994 8999999999999999999999999999
Q ss_pred ccccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcc
Q 044561 493 ARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIR 572 (614)
Q Consensus 493 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~ 572 (614)
++...... ......||+.|+|||.+....++.++|||||||++|||++|+.||......+....+...........+.
T Consensus 157 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 157 ARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred eEeccCCc--ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 98665432 2344578999999999988889999999999999999999999998755433222211110000000000
Q ss_pred c-------ccccccc---CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 573 D-------ASDSRLE---GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 573 ~-------~~d~~l~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
. ....... .....+..+.+.+++.+|++.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0 0000000 0001112345678899999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=320.91 Aligned_cols=249 Identities=27% Similarity=0.455 Sum_probs=201.1
Q ss_pred cCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecC
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMP 424 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 424 (614)
++|+..+.||+|+||.||++.++++..+++|.+.... ...+++.+|+.++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 3577788999999999999999888889999876443 234678899999999999999999999999999999999999
Q ss_pred CCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcc
Q 044561 425 NGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT 504 (614)
Q Consensus 425 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 504 (614)
+|+|.+++.... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||+++..........
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 83 NGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 999999987543 35899999999999999999999 48999999999999999999999999999986543332222
Q ss_pred cccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcC
Q 044561 505 TKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGIC 583 (614)
Q Consensus 505 ~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 583 (614)
....++..|+|||.+....++.++||||||+++|||++ |+.||......+. ...+. ++... ..+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~---~~~i~----~~~~~--~~~------ 223 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV---VEMIS----RGFRL--YRP------ 223 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHH----CCCCC--CCC------
Confidence 22345678999999988889999999999999999999 8999976543222 12111 11110 011
Q ss_pred cHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 584 EEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 584 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
......+.+++.+||+++|++||++.++++
T Consensus 224 -~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 224 -KLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred -CCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 112245788999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=326.11 Aligned_cols=264 Identities=21% Similarity=0.284 Sum_probs=200.4
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
++|+..+.||+|+||.||+|..+. +..||+|.+.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 468888999999999999999864 7889999986543 22345678999999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 502 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 502 (614)
++ ++|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~- 158 (288)
T cd07871 85 LD-SDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK- 158 (288)
T ss_pred CC-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence 97 58988886542 347899999999999999999995 8999999999999999999999999999976543221
Q ss_pred cccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccc--------
Q 044561 503 QTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRD-------- 573 (614)
Q Consensus 503 ~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~-------- 573 (614)
......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+...........+..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 1233468999999998865 5689999999999999999999999987654443332211111000000000
Q ss_pred -cccccccCc----CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 574 -ASDSRLEGI----CEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 574 -~~d~~l~~~----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
...+..... ........+.+|+.+|++.||.+|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000110000 00011234678888999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=321.61 Aligned_cols=250 Identities=28% Similarity=0.452 Sum_probs=202.6
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
.+|...+.||+|+||.||+|..++ +..+++|.+..+ ....+++.+|++.+++++|+||++++++|...+..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 346778899999999999999875 778999988654 334577899999999999999999999999999999999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCc
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 503 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 503 (614)
++++|.+++.......+++..++.++.|+++||+|||+ .+++||||||+||++++++.+||+|||++..........
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 99999999976555568999999999999999999994 899999999999999999999999999998765433222
Q ss_pred ccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCc
Q 044561 504 TTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGI 582 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 582 (614)
.....++..|+|||.+.+..++.++|||||||++|||++ |..|+......+. .+....+. .. .
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-------~~~~~~~~-----~~----~ 225 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-------YELLEKGY-----RM----E 225 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHHCCC-----CC----C
Confidence 222334678999999988899999999999999999998 9999875433221 11111111 01 1
Q ss_pred CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 583 CEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 583 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+......+.+++.+||+.||++||++.++++
T Consensus 226 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 226 RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 11122345778888999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=321.56 Aligned_cols=250 Identities=24% Similarity=0.421 Sum_probs=203.8
Q ss_pred cCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecC
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMP 424 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 424 (614)
++|+..++||+|+||.||+|...++..+++|.+..... ..+.+.+|+.++++++|+||+++++.+...+..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 46788899999999999999988888899998865433 35788999999999999999999999999999999999999
Q ss_pred CCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcc
Q 044561 425 NGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT 504 (614)
Q Consensus 425 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 504 (614)
+++|.+++.......+++.++..++.|+++||+|||+ .+++||||||+||+++.++.+||+|||++...........
T Consensus 85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05072 85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR 161 (261)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCceecc
Confidence 9999999976555568999999999999999999994 8999999999999999999999999999987654332222
Q ss_pred cccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcC
Q 044561 505 TKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGIC 583 (614)
Q Consensus 505 ~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 583 (614)
....++..|+|||++..+.++.++|||||||++|||++ |+.||......+. ...+. .+... +. ...
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~~~----~~~~~----~~-~~~- 228 (261)
T cd05072 162 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV---MSALQ----RGYRM----PR-MEN- 228 (261)
T ss_pred CCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH---HHHHH----cCCCC----CC-CCC-
Confidence 33346778999999988889999999999999999998 9999976443221 11111 11100 11 111
Q ss_pred cHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 584 EEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 584 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
....+.+++.+|++++|++||++.++++
T Consensus 229 ---~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 229 ---CPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred ---CCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 2245778888999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=333.88 Aligned_cols=241 Identities=24% Similarity=0.297 Sum_probs=195.8
Q ss_pred ceeeeeCcEEEEEEEEec-CcEEEEEEeecC---ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecCCC
Q 044561 351 DVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNG 426 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 426 (614)
+.||+|+||.||+++.+. +..+|+|.+... .......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999999764 888999998754 2334466789999999999999999999999999999999999999
Q ss_pred CcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcccc
Q 044561 427 SLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTK 506 (614)
Q Consensus 427 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 506 (614)
+|.+++... ..+++.++..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~ 154 (323)
T cd05571 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKT 154 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccccc
Confidence 999988764 358999999999999999999994 899999999999999999999999999987532221 12334
Q ss_pred cccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcHH
Q 044561 507 LVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEK 586 (614)
Q Consensus 507 ~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~ 586 (614)
.+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. .. ...+. ..+.. .
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~---~~----~~~~~------~~~p~----~ 217 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF---EL----ILMEE------IRFPR----T 217 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHH---HH----HHcCC------CCCCC----C
Confidence 57999999999999889999999999999999999999999764332211 11 11111 11111 2
Q ss_pred HHHHHHHHHHHcCCCCCCCCC-----CHHHHhC
Q 044561 587 QMELVLKLGLFCSHPKPEARP-----NMRQVMQ 614 (614)
Q Consensus 587 ~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 614 (614)
....+.+++.+||+.||++|| ++.++++
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 218 LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 234567788889999999999 7988874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=307.75 Aligned_cols=199 Identities=26% Similarity=0.401 Sum_probs=180.9
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCCh---hhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSK---QGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
++|+..+.||.|+||.|..++.+. +..+|+|.+.+..- .+.+...+|..+|+.+.||.++++++.|.+.+.+|+||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 457778999999999999999876 77899999977643 33455678999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
||.++|.|.++|++.. .+++..+..++.||+.||+|||+ ..|++||+||+|||+|.+|.+||.|||+|+....
T Consensus 124 eyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~-- 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG-- 196 (355)
T ss_pred eccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecC--
Confidence 9999999999998754 49999999999999999999995 8999999999999999999999999999997654
Q ss_pred CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCc
Q 044561 501 IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGS 552 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~ 552 (614)
.+.+.|||+.|+|||++..+.+..++|.|||||++|||++|.+||.....
T Consensus 197 --rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 197 --RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred --cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 35678999999999999999999999999999999999999999987665
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=334.79 Aligned_cols=243 Identities=20% Similarity=0.287 Sum_probs=200.1
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
++|+..+.||+|+||.||+|+.+. ++.+|+|.+.... ....+.+.+|+.++++++||||+++++++..++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 467888999999999999999875 7889999987542 234567889999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
||+++|+|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 98 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 98 EFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred cCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 999999999998764 348899999999999999999995 899999999999999999999999999998664322
Q ss_pred CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+. .+...++.. .+.
T Consensus 173 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-------~~~i~~~~~------~~p 235 (329)
T PTZ00263 173 ----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI-------YEKILAGRL------KFP 235 (329)
T ss_pred ----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH-------HHHHhcCCc------CCC
Confidence 235799999999999988899999999999999999999999975433211 111122211 111
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHh
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARPN-----MRQVM 613 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl 613 (614)
..++ ..+.+++.+||+.||++||+ +.+++
T Consensus 236 ~~~~----~~~~~li~~~L~~dP~~R~~~~~~~~~~ll 269 (329)
T PTZ00263 236 NWFD----GRARDLVKGLLQTDHTKRLGTLKGGVADVK 269 (329)
T ss_pred CCCC----HHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 1122 34677888899999999997 67776
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=335.94 Aligned_cols=236 Identities=27% Similarity=0.509 Sum_probs=194.5
Q ss_pred CcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecCCCCc
Q 044561 349 DKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSL 428 (614)
Q Consensus 349 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 428 (614)
..+.||+|+.|.||.|++. ++.||||+++.-. ..+|+-|++|+|+||+.+.|+|....-+|||||||+.|-|
T Consensus 128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 4578999999999999995 5679999985432 2578889999999999999999999999999999999999
Q ss_pred chhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcccccc
Q 044561 429 DKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLV 508 (614)
Q Consensus 429 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 508 (614)
...|+.. ..++-.....+.++||.||.|||. ..|||||||.-||||..+-.+||+|||-++....-. .....+
T Consensus 200 ~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S--TkMSFa 272 (904)
T KOG4721|consen 200 YEVLKAG--RPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS--TKMSFA 272 (904)
T ss_pred HHHHhcc--CccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhhh--hhhhhh
Confidence 9999874 458888899999999999999994 899999999999999999999999999998665431 233468
Q ss_pred cCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcHHHH
Q 044561 509 GTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQM 588 (614)
Q Consensus 509 gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~ 588 (614)
||..|||||++++.+.++|+||||||||||||+||..||..-+...++ |.-|. ..+.-..+..+.
T Consensus 273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII---------wGVGs------NsL~LpvPstcP 337 (904)
T KOG4721|consen 273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII---------WGVGS------NSLHLPVPSTCP 337 (904)
T ss_pred hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE---------EeccC------CcccccCcccCc
Confidence 999999999999999999999999999999999999999754332221 11111 111111334444
Q ss_pred HHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 589 ELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 589 ~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+-+.-|+.+||+..|.+|||++||+.
T Consensus 338 ~GfklL~Kqcw~sKpRNRPSFrqil~ 363 (904)
T KOG4721|consen 338 DGFKLLLKQCWNSKPRNRPSFRQILL 363 (904)
T ss_pred hHHHHHHHHHHhcCCCCCccHHHHHH
Confidence 55666777899999999999999973
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=338.06 Aligned_cols=248 Identities=27% Similarity=0.435 Sum_probs=211.9
Q ss_pred CCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecC
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMP 424 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 424 (614)
++.+.++||-|.||.||.|+|+. ...||||.++.+. ...++|++|..+|+.++|||+|+|+|+|..+..+|||.|||.
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~ 346 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC 346 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence 45667899999999999999987 6779999987654 356899999999999999999999999999999999999999
Q ss_pred CCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcc
Q 044561 425 NGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT 504 (614)
Q Consensus 425 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 504 (614)
.|+|.++|....+..++-...+.++.||++||.||. ++.+|||||.++|+|+.++..+|++||||++++..+....-
T Consensus 347 yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAH 423 (1157)
T KOG4278|consen 347 YGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAH 423 (1157)
T ss_pred CccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceecc
Confidence 999999999887878888999999999999999999 69999999999999999999999999999999877653222
Q ss_pred cccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcC
Q 044561 505 TKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGIC 583 (614)
Q Consensus 505 ~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 583 (614)
.-..-++.|.|||.+....++.|+|||+|||+|||+.| |..||.+-+... |.++.++| .+.+-
T Consensus 424 AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq-------VY~LLEkg---------yRM~~ 487 (1157)
T KOG4278|consen 424 AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYGLLEKG---------YRMDG 487 (1157)
T ss_pred cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH-------HHHHHhcc---------ccccC
Confidence 22233678999999998999999999999999999999 899998754322 22333332 22234
Q ss_pred cHHHHHHHHHHHHHcCCCCCCCCCCHHHHh
Q 044561 584 EEKQMELVLKLGLFCSHPKPEARPNMRQVM 613 (614)
Q Consensus 584 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 613 (614)
++.+...+.+||++||+.+|.+||+++|+-
T Consensus 488 PeGCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 488 PEGCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred CCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 556677899999999999999999999874
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=329.75 Aligned_cols=200 Identities=26% Similarity=0.422 Sum_probs=175.1
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
++|+..+.||+|+||.||++.... +..+|+|.+... .....+.+.+|++++++++|+||++++++|...+..++||||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence 678889999999999999999874 777888887654 333456789999999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 502 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 502 (614)
+++|+|.+++... ..+++.....++.|++.||.|||+ ..+|+||||||+|||+++++.+||+|||++.......
T Consensus 85 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-- 158 (333)
T cd06650 85 MDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 158 (333)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc--
Confidence 9999999999763 348899999999999999999996 3579999999999999999999999999997653321
Q ss_pred cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Q 044561 503 QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQG 551 (614)
Q Consensus 503 ~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~ 551 (614)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 159 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 206 (333)
T cd06650 159 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206 (333)
T ss_pred -cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence 233468999999999998889999999999999999999999997543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=319.26 Aligned_cols=251 Identities=27% Similarity=0.427 Sum_probs=203.3
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
.++|+..+.||+|++|.||+|..+++..|++|.+.... ...+++.+|+.++++++|||++++++++...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 35688889999999999999998778889999986543 33567899999999999999999999999999999999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCc
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 503 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 503 (614)
++++|.+++.......+++.++..++.|++.||.||| +.+++||||||+||++++++.+||+|||++..........
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA 160 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence 9999999997655456899999999999999999999 4899999999999999999999999999998765332211
Q ss_pred ccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCc
Q 044561 504 TTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGI 582 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 582 (614)
......+..|+|||.+....++.++||||||++++||++ |+.||......+... ....+... .
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-------~~~~~~~~---------~ 224 (261)
T cd05068 161 REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQ-------QVDQGYRM---------P 224 (261)
T ss_pred cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH-------HHHcCCCC---------C
Confidence 121223458999999988889999999999999999999 999997544322111 11111000 0
Q ss_pred CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 583 CEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 583 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+......+.+++.+|++.+|++||++.++++
T Consensus 225 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 225 CPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 11123356788899999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=320.35 Aligned_cols=251 Identities=29% Similarity=0.487 Sum_probs=207.4
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
..+|+..+.||+|+||.||+|...++..+++|.+.........++.+|+.+++.++|+||+++++++...+..++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 34577888999999999999999888899999998776656678899999999999999999999999999999999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCc
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 503 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 503 (614)
++++|.+++.......+++.++..++.|++.||.|||+ ++++||||||+||++++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~- 160 (261)
T cd05148 85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL- 160 (261)
T ss_pred ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCcccc-
Confidence 99999999987655678999999999999999999994 89999999999999999999999999999866443221
Q ss_pred ccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCc
Q 044561 504 TTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGI 582 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 582 (614)
.....++..|+|||.+....++.++||||||+++++|++ |+.||......+.. ..+. .+.. ..
T Consensus 161 ~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~---~~~~----~~~~---------~~ 224 (261)
T cd05148 161 SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVY---DQIT----AGYR---------MP 224 (261)
T ss_pred ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHH---HHHH----hCCc---------CC
Confidence 123345678999999988889999999999999999998 89999765432222 1111 1100 01
Q ss_pred CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 583 CEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 583 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+....+.+.+++.+||+.||++|||++++++
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 225 CPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 11223356778889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=311.27 Aligned_cols=264 Identities=22% Similarity=0.281 Sum_probs=210.4
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChh-h-HHHHHHHHHHhcccCCCceeEEeeEEee--cCeEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQ-G-IKEFVAELVSMGRLRHRNLVKLRGYCRR--KGEFLLV 419 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV 419 (614)
++|+..+.|++|.||.||+|+.+. ++.||+|+++.+.+. + --.-++||.+|.+++|||||.+..+... -+.+|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 356778899999999999999875 888999999876432 2 1245799999999999999999988754 3579999
Q ss_pred EEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCC
Q 044561 420 YDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD 499 (614)
Q Consensus 420 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~ 499 (614)
||||++ +|..++..-. +.+...+...++.|+++|++||| ...|+|||||++|+|+...|.+||+|||||+.++..
T Consensus 156 Me~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred HHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 999964 8888887653 56889999999999999999999 589999999999999999999999999999998876
Q ss_pred CCCcccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccc
Q 044561 500 TIPQTTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSR 578 (614)
Q Consensus 500 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~ 578 (614)
. ...+..+-|.+|.|||++.+. .|+++.|+||+|||+.||+++++-|.+..+.++++.+-.......+..++......
T Consensus 231 ~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 231 L-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred c-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 3 345667889999999998764 68999999999999999999999999888777666664444333333333222211
Q ss_pred --------------ccCcCcHH-HHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 579 --------------LEGICEEK-QMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 579 --------------l~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+++.+... ..+.-.+|+...+..||.+|.|+.|.|+
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 12222221 2345567777789999999999999875
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=332.54 Aligned_cols=262 Identities=24% Similarity=0.365 Sum_probs=195.3
Q ss_pred CCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeec-----CeEE
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRK-----GEFL 417 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~~ 417 (614)
+|+..+.||+|+||.||+|+.+. +..||+|++... ......++.+|+.++++++||||+++++++... ..++
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 46778999999999999999764 889999998643 233456788999999999999999999987543 3589
Q ss_pred EEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccC
Q 044561 418 LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYD 497 (614)
Q Consensus 418 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~ 497 (614)
+|||||+ ++|.+++... ..+++..+..++.||++||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELME-SDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCC-CCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 9999995 6898888654 348999999999999999999995 899999999999999999999999999998643
Q ss_pred CCCC--CcccccccCCCccchhhhcC--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHH--------Hh
Q 044561 498 HDTI--PQTTKLVGTFGYMDPELMRT--GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVC--------DC 565 (614)
Q Consensus 498 ~~~~--~~~~~~~gt~~y~aPE~~~~--~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~--------~~ 565 (614)
.... .......||+.|+|||++.. ..++.++|||||||++|||++|+.||......+....+.... ..
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 2221 11234578999999999865 678999999999999999999999997654322211111000 00
Q ss_pred hhcCCcccc-------ccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 566 WKKGAIRDA-------SDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 566 ~~~~~~~~~-------~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+......+. ....+...++ .....+.+++.+||+.||++|||+.|+++
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFP-NADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcC-CCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000000 0000000000 11234678889999999999999999985
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=318.81 Aligned_cols=260 Identities=26% Similarity=0.367 Sum_probs=198.7
Q ss_pred HhcCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeec----CeEEE
Q 044561 343 ATKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRK----GEFLL 418 (614)
Q Consensus 343 ~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~----~~~~l 418 (614)
..++....+.||+|.||.||+|.++ |+.||||++...++....+ ..|+..-.-|+|+||+.+++.-..+ .+++|
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE~SWfr-EtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDERSWFR-ETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred hhheeEEEEEecCccccceeecccc-CCceEEEEecccchhhhhh-HHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 3456778899999999999999996 6679999997665543322 2566666677999999999976544 37899
Q ss_pred EEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhcc-----CCCceEecCcCCCCeEEcCCCCEEEeeeccc
Q 044561 419 VYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHED-----WEQVVLHRDIKPANVLLDADLNGKLGDFGLA 493 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivHrDikp~NIll~~~~~~kl~DfGla 493 (614)
|.+|.++|||.++|..+ .++-...++++..+|.||+|||.+ .++.|.|||||+.|||+.+++.+.|+|+|||
T Consensus 287 vTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA 363 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 363 (513)
T ss_pred eeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence 99999999999999874 499999999999999999999965 3788999999999999999999999999999
Q ss_pred cccCCCC---CCcccccccCCCccchhhhcCC------CCCcchhHHHHHHHHHHHHcC----------CCCCCCCCccc
Q 044561 494 RLYDHDT---IPQTTKLVGTFGYMDPELMRTG------KASTSTDVYAFGVFMLEVASG----------RRPVEQQGSME 554 (614)
Q Consensus 494 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~------~~t~~~Dv~S~Gvll~el~tg----------~~p~~~~~~~~ 554 (614)
...+... ....+..+||.+|||||++.+. ..-..+||||||+++||++.. +.||....+.+
T Consensus 364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D 443 (513)
T KOG2052|consen 364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD 443 (513)
T ss_pred EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC
Confidence 8766543 1234557999999999998653 223579999999999999862 46775443322
Q ss_pred cccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q 044561 555 TVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQV 612 (614)
Q Consensus 555 ~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev 612 (614)
.- .+.+.+..-..++....+. ...+.+.+..+.+++..||..||..|.|+-.|
T Consensus 444 Ps--~eeMrkVVCv~~~RP~ipn---rW~s~~~l~~m~klMkeCW~~Np~aRltALri 496 (513)
T KOG2052|consen 444 PS--FEEMRKVVCVQKLRPNIPN---RWKSDPALRVMAKLMKECWYANPAARLTALRI 496 (513)
T ss_pred CC--HHHHhcceeecccCCCCCc---ccccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence 21 1222222222222222222 33456788899999999999999999987554
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=330.72 Aligned_cols=241 Identities=24% Similarity=0.311 Sum_probs=195.8
Q ss_pred ceeeeeCcEEEEEEEEec-CcEEEEEEeecC---ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecCCC
Q 044561 351 DVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNG 426 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 426 (614)
+.||+|+||.||++..+. +..+|+|++... .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999999764 888999999754 2334567889999999999999999999999999999999999999
Q ss_pred CcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcccc
Q 044561 427 SLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTK 506 (614)
Q Consensus 427 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 506 (614)
+|..++... ..+++.++..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~ 154 (328)
T cd05593 81 ELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKT 154 (328)
T ss_pred CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccccc
Confidence 999888653 358999999999999999999994 899999999999999999999999999987533221 12234
Q ss_pred cccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcHH
Q 044561 507 LVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEK 586 (614)
Q Consensus 507 ~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~ 586 (614)
..||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... ...+ +..+...+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~-------~~~~------~~~~p~~~--- 218 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL-------ILME------DIKFPRTL--- 218 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHH-------hccC------CccCCCCC---
Confidence 5799999999999988999999999999999999999999976443221111 1111 11111222
Q ss_pred HHHHHHHHHHHcCCCCCCCCC-----CHHHHhC
Q 044561 587 QMELVLKLGLFCSHPKPEARP-----NMRQVMQ 614 (614)
Q Consensus 587 ~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 614 (614)
...+.+++.+|++.||++|| ++.|+++
T Consensus 219 -~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 219 -SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred -CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 23466778889999999997 8888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=338.22 Aligned_cols=253 Identities=24% Similarity=0.343 Sum_probs=197.7
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEe------cCcEEEEEEeecCC-hhhHHHHHHHHHHhccc-CCCceeEEeeEEeecCe
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLA------SNVQIAVKKVSHDS-KQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGE 415 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 415 (614)
.++|+..+.||+|+||.||+|+.. .+..||+|++.... ....+.+.+|+.+++.+ +||||++++++|...+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 346788899999999999999742 25679999986543 33456788999999999 89999999999999999
Q ss_pred EEEEEEecCCCCcchhcccCC-----------------------------------------------------------
Q 044561 416 FLLVYDYMPNGSLDKILHTNI----------------------------------------------------------- 436 (614)
Q Consensus 416 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 436 (614)
.++|||||++|+|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999998886421
Q ss_pred --------------CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCC
Q 044561 437 --------------KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 502 (614)
Q Consensus 437 --------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 502 (614)
...+++.++..++.||++||.|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 1247889999999999999999995 89999999999999999999999999999865433211
Q ss_pred -cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 503 -QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 503 -~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
......++..|+|||.+.+..++.++|||||||++|||++ |..||....... ..... ..++.... ..
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~----~~~~~~~~-----~~ 339 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKM----IKEGYRML-----SP 339 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHH----HHhCccCC-----CC
Confidence 1122345678999999999999999999999999999998 888986543221 11111 11111100 00
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
. .....+.+++.+||++||++|||+.||++
T Consensus 340 ~----~~~~~l~~li~~cl~~dP~~RPs~~eil~ 369 (375)
T cd05104 340 E----CAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369 (375)
T ss_pred C----CCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 1 11235778888999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=317.64 Aligned_cols=249 Identities=31% Similarity=0.459 Sum_probs=200.4
Q ss_pred cCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecC
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMP 424 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 424 (614)
++|+..+.||+|+||.||+|..+++..+|+|.+..... ..+++.+|+.++++++||||++++++|...+..+++|||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 35677889999999999999988777899998875432 34678999999999999999999999999999999999999
Q ss_pred CCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcc
Q 044561 425 NGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT 504 (614)
Q Consensus 425 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 504 (614)
+|+|.+++..... .+++.+++.++.||+.||.||| +.+++|+||||+||+++.++.+||+|||+++..........
T Consensus 83 ~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 83 NGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred CCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 9999999876433 5899999999999999999999 48999999999999999999999999999876544322222
Q ss_pred cccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcC
Q 044561 505 TKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGIC 583 (614)
Q Consensus 505 ~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 583 (614)
....++..|+|||.+....++.++||||||+++|||++ |+.||......+.. ... ..+.... .
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~---~~~----~~~~~~~-----~---- 222 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETV---EKV----SQGLRLY-----R---- 222 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHH---HHH----hcCCCCC-----C----
Confidence 22345678999999988889999999999999999998 99998754432211 111 1111110 0
Q ss_pred cHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 584 EEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 584 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+......+.+++.+||++||++||++.++++
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~ 253 (256)
T cd05113 223 PHLASEKVYAIMYSCWHEKAEERPTFQQLLS 253 (256)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 1112356788888999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=330.16 Aligned_cols=241 Identities=25% Similarity=0.309 Sum_probs=195.1
Q ss_pred ceeeeeCcEEEEEEEEec-CcEEEEEEeecC---ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecCCC
Q 044561 351 DVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNG 426 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 426 (614)
+.||+|+||.||++..+. +..||+|.+... .......+.+|+.+++.++||||+++++++...+.+++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 469999999999999764 888999998754 2334566788999999999999999999999999999999999999
Q ss_pred CcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcccc
Q 044561 427 SLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTK 506 (614)
Q Consensus 427 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 506 (614)
+|..++... ..+++.++..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++....... .....
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 154 (323)
T cd05595 81 ELFFHLSRE--RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKT 154 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccccc
Confidence 999888764 358999999999999999999995 899999999999999999999999999987532221 12233
Q ss_pred cccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcHH
Q 044561 507 LVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEK 586 (614)
Q Consensus 507 ~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~ 586 (614)
..||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... ...+. ..+...+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~-------~~~~~------~~~p~~~--- 218 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL-------ILMEE------IRFPRTL--- 218 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHH-------HhcCC------CCCCCCC---
Confidence 5799999999999988999999999999999999999999976543221111 11111 1111222
Q ss_pred HHHHHHHHHHHcCCCCCCCCC-----CHHHHhC
Q 044561 587 QMELVLKLGLFCSHPKPEARP-----NMRQVMQ 614 (614)
Q Consensus 587 ~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 614 (614)
...+.+++.+||+.||++|| ++.++++
T Consensus 219 -~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 219 -SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred -CHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 33566788889999999998 8888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=328.26 Aligned_cols=238 Identities=24% Similarity=0.302 Sum_probs=193.2
Q ss_pred eeeeCcEEEEEEEEec-CcEEEEEEeecC---ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecCCCCc
Q 044561 353 IGRGGFGKVYRGVLAS-NVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSL 428 (614)
Q Consensus 353 lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 428 (614)
||+|+||.||++...+ +..+|+|++... .......+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 6999999999999875 778999998653 334456788999999999999999999999999999999999999999
Q ss_pred chhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcccccc
Q 044561 429 DKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLV 508 (614)
Q Consensus 429 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 508 (614)
.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... .......
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 154 (312)
T cd05585 81 FHHLQRE--GRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFC 154 (312)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccccc
Confidence 9998764 348999999999999999999994 899999999999999999999999999998543222 1234457
Q ss_pred cCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcHHHH
Q 044561 509 GTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQM 588 (614)
Q Consensus 509 gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~ 588 (614)
||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. +....+. ..+... ..
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~-------~~~~~~~------~~~~~~----~~ 217 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMY-------RKILQEP------LRFPDG----FD 217 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHH-------HHHHcCC------CCCCCc----CC
Confidence 999999999999889999999999999999999999999764332211 1111111 111112 22
Q ss_pred HHHHHHHHHcCCCCCCCCCC---HHHHh
Q 044561 589 ELVLKLGLFCSHPKPEARPN---MRQVM 613 (614)
Q Consensus 589 ~~l~~l~~~cl~~dP~~RPs---~~evl 613 (614)
..+.+++.+||+.||++||+ +.|++
T Consensus 218 ~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 218 RDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 45677788899999999975 67765
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=325.61 Aligned_cols=246 Identities=25% Similarity=0.327 Sum_probs=201.0
Q ss_pred HhcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEE
Q 044561 343 ATKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLL 418 (614)
Q Consensus 343 ~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 418 (614)
..++|+....||+|+||.||.++.++ |..+|+|++++.. +...+...+|-.+|...++|+||+|+-.+.+...+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 34689999999999999999999887 8889999998764 4456678899999999999999999999999999999
Q ss_pred EEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCC
Q 044561 419 VYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 498 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~ 498 (614)
||||.|||++..+|... ..|++.....++.+.+.|+.-|| +.++|||||||+|+|||..|++||+||||+.-+..
T Consensus 219 iMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence 99999999999999873 56999999999999999999999 69999999999999999999999999999853211
Q ss_pred ----------------------CCCC-----cc-------------------cccccCCCccchhhhcCCCCCcchhHHH
Q 044561 499 ----------------------DTIP-----QT-------------------TKLVGTFGYMDPELMRTGKASTSTDVYA 532 (614)
Q Consensus 499 ----------------------~~~~-----~~-------------------~~~~gt~~y~aPE~~~~~~~t~~~Dv~S 532 (614)
...+ .. ...+|||.|||||++.+..|+..+|.||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 0000 00 1237999999999999999999999999
Q ss_pred HHHHHHHHHcCCCCCCCCCccccccHH-HHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCC
Q 044561 533 FGVFMLEVASGRRPVEQQGSMETVNLV-DWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPN 608 (614)
Q Consensus 533 ~Gvll~el~tg~~p~~~~~~~~~~~l~-~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs 608 (614)
+|||||||+.|-+||...++.+....+ .|..... .-.+.. ......+|+.+|+. ||++|.-
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~------fP~~~~--------~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK------FPEEVD--------LSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc------CCCcCc--------ccHHHHHHHHHHhc-CHHHhcC
Confidence 999999999999999988776654333 3322211 111111 11456667777887 9999975
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=301.33 Aligned_cols=247 Identities=27% Similarity=0.389 Sum_probs=209.2
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
++|+..+.||+|.||.||.|+.+. +..||+|.+.+.. .+...++.+|+++.+.|+||||+++++++.+....||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 568889999999999999999875 7789999987652 233467889999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
||.++|+|...|.......+++.....++.|+|.||.|+| .++|+||||||+|+|++..+..||+|||.+.....+
T Consensus 102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~- 177 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSN- 177 (281)
T ss_pred EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecCCC-
Confidence 9999999999999766667999999999999999999999 599999999999999999999999999998765422
Q ss_pred CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
...+.+||..|++||...+..++...|+|++|++.+|++.|.+||+.....+...-+. + .+..++
T Consensus 178 --kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~---k-------~~~~~p--- 242 (281)
T KOG0580|consen 178 --KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIR---K-------VDLKFP--- 242 (281)
T ss_pred --CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHH---H-------ccccCC---
Confidence 3456799999999999999999999999999999999999999998776544432221 1 111112
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
......+.+++..|+..+|.+|.+..|+++
T Consensus 243 ----~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 243 ----STISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred ----cccChhHHHHHHHHhccCccccccHHHHhh
Confidence 222334667778899999999999999874
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=320.68 Aligned_cols=251 Identities=28% Similarity=0.491 Sum_probs=202.3
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-C-----cEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-N-----VQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFL 417 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 417 (614)
++|+..+.||+|+||.||+|.... + ..+++|.+.... .....++.+|+..+++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 357778899999999999998754 2 568999886543 344567899999999999999999999999999999
Q ss_pred EEEEecCCCCcchhcccCCC--------------CCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCC
Q 044561 418 LVYDYMPNGSLDKILHTNIK--------------PCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADL 483 (614)
Q Consensus 418 lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~ 483 (614)
++|||+++++|.+++..... ..+++.+++.++.|++.||.|||+ .+++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCC
Confidence 99999999999999865321 458899999999999999999994 8999999999999999999
Q ss_pred CEEEeeeccccccCCCC-CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHH
Q 044561 484 NGKLGDFGLARLYDHDT-IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDW 561 (614)
Q Consensus 484 ~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~ 561 (614)
.+||+|||+++...... ........+++.|+|||.+.++.++.++|||||||++|||++ |+.||......+..
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~----- 236 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI----- 236 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-----
Confidence 99999999998653322 122333456889999999988899999999999999999998 99999765433221
Q ss_pred HHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 562 VCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 562 v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+.++.... .+......+.+|+.+||+.||++||++.||++
T Consensus 237 --~~i~~~~~~~---------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~ 278 (283)
T cd05048 237 --EMIRSRQLLP---------CPEDCPARVYALMIECWNEIPARRPRFKDIHT 278 (283)
T ss_pred --HHHHcCCcCC---------CcccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1122222111 12233466888889999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=331.98 Aligned_cols=244 Identities=22% Similarity=0.310 Sum_probs=199.5
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec--CcEEEEEEeecC---ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS--NVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLV 419 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 419 (614)
++|+..+.||+|+||.||+|..+. +..+|+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 468889999999999999998764 357999998653 223456788999999999999999999999999999999
Q ss_pred EEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCC
Q 044561 420 YDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD 499 (614)
Q Consensus 420 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~ 499 (614)
|||+++|+|.+++..+ ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++++||+|||++......
T Consensus 110 ~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 9999999999999764 348999999999999999999994 89999999999999999999999999999865432
Q ss_pred CCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccc
Q 044561 500 TIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRL 579 (614)
Q Consensus 500 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 579 (614)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......... +....+.. .+
T Consensus 185 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~-------~~i~~~~~------~~ 247 (340)
T PTZ00426 185 ----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIY-------QKILEGII------YF 247 (340)
T ss_pred ----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHH-------HHHhcCCC------CC
Confidence 23457999999999999888999999999999999999999999764432111 11111111 11
Q ss_pred cCcCcHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHhC
Q 044561 580 EGICEEKQMELVLKLGLFCSHPKPEARP-----NMRQVMQ 614 (614)
Q Consensus 580 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 614 (614)
....+ ..+..++.+|++.||++|+ ++.|+++
T Consensus 248 p~~~~----~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 248 PKFLD----NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred CCCCC----HHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 11222 3456778889999999995 8988864
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=313.08 Aligned_cols=249 Identities=28% Similarity=0.427 Sum_probs=205.3
Q ss_pred CCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
+|+..+.||+|++|.||++..+. +..+++|.+... .....+++.+|++++++++|||++++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 46778899999999999999864 788999988643 344567889999999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 502 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 502 (614)
+++++|.+++.......+++.++..++.|++.||.|||+ .+++||||||+||++++++.+||+|||++.........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 999999999987545669999999999999999999994 89999999999999999999999999998866543321
Q ss_pred cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCc
Q 044561 503 QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGI 582 (614)
Q Consensus 503 ~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 582 (614)
.....|++.|+|||+..+..++.++|+||||++++||++|+.||......+ ... ...++....
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~----~~~~~~~~~--------- 220 (256)
T cd08529 158 -ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---LIL----KIIRGVFPP--------- 220 (256)
T ss_pred -hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHH----HHHcCCCCC---------
Confidence 233468899999999998889999999999999999999999997654221 111 111111111
Q ss_pred CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 583 CEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 583 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
........+.+++.+||+.+|++||++.++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 221 VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred CccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 11123456788889999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=342.95 Aligned_cols=250 Identities=22% Similarity=0.295 Sum_probs=202.7
Q ss_pred CCCCcceeeeeCcEEEEEEEEec--CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS--NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
.|...+.||+|+||.||++.... +..|++|++..........+.+|+.+++.++||||+++++++...+..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 37888999999999999998653 5678888876666666677889999999999999999999999999999999999
Q ss_pred CCCCcchhcccC--CCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCC
Q 044561 424 PNGSLDKILHTN--IKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI 501 (614)
Q Consensus 424 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~ 501 (614)
++|+|.+++... ....+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988642 23458899999999999999999995 8999999999999999999999999999987654321
Q ss_pred -CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 502 -PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 502 -~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ..+ ..+.... .
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~---~~~----~~~~~~~-----~- 291 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIM---QQV----LYGKYDP-----F- 291 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHH----HhCCCCC-----C-
Confidence 1234457999999999999889999999999999999999999999754332211 111 1111110 1
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+......+.+++.+||+.||++||++.++++
T Consensus 292 ---~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 292 ---PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ---CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1112245778888899999999999999874
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=316.18 Aligned_cols=266 Identities=24% Similarity=0.362 Sum_probs=210.8
Q ss_pred HHhcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEee--cCChhhHHHHHHHHHHhcccCCCceeEEeeEEee-----c
Q 044561 342 KATKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVS--HDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRR-----K 413 (614)
Q Consensus 342 ~~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~--~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-----~ 413 (614)
.....|...+.||+|+||.|+.+..+. +..||+|++. .......++-.+|+++++.++|+||+.+.+.... -
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 344556667889999999999999875 8999999998 4456667888999999999999999999998765 3
Q ss_pred CeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccc
Q 044561 414 GEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLA 493 (614)
Q Consensus 414 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla 493 (614)
+..|+|+|+| ..+|.+.++.+ +.|+......++.|+++||.|+|+ .+|+||||||+|++++.+...||+|||||
T Consensus 99 ~DvYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred ceeEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccce
Confidence 5799999999 67899998874 349999999999999999999996 89999999999999999999999999999
Q ss_pred cccCCC-CCCcccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCc
Q 044561 494 RLYDHD-TIPQTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAI 571 (614)
Q Consensus 494 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~ 571 (614)
+..+.. .....+..+.|.+|.|||++.. ..|+.+.||||.||++.||++|++-|.+.+..+++.++..+.....+..+
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL 252 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence 987643 1223466789999999998754 58999999999999999999999999988776666665433322221111
Q ss_pred ccccccc---------------ccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 572 RDASDSR---------------LEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 572 ~~~~d~~---------------l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+..+. +...++ ..-...++|..+||..||.+|+|+.|+|+
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 1111000 001111 12234677778899999999999999874
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=319.45 Aligned_cols=251 Identities=25% Similarity=0.326 Sum_probs=201.6
Q ss_pred CCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEE
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 421 (614)
+|+..+.||+|+||.||++... ++..||+|++.... ......+.+|+.+++.++||||+++++.+..++.+++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4677899999999999999976 47889999986542 2233557889999999999999999999999999999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCC
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI 501 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~ 501 (614)
|+++|+|.+++.......+++..+..++.|++.||.|||+ .+++||||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 9999999988865444569999999999999999999995 8999999999999999999999999999987543321
Q ss_pred CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccC
Q 044561 502 PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEG 581 (614)
Q Consensus 502 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~ 581 (614)
.....|+..|+|||++.+..++.++||||+||++|||++|+.||.......... .+......+. .
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~---~~~~~~~~~~----------~ 222 (285)
T cd05605 158 --IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKRE---EVERRVKEDQ----------E 222 (285)
T ss_pred --cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHH---HHHHHhhhcc----------c
Confidence 223478999999999988889999999999999999999999997644322111 1111111110 1
Q ss_pred cCcHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHhC
Q 044561 582 ICEEKQMELVLKLGLFCSHPKPEARP-----NMRQVMQ 614 (614)
Q Consensus 582 ~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 614 (614)
..+......+.+++..|++.||++|| ++.++++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 223 EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 11222344577888899999999999 8888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd01951 lectin_L-type legume lectins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=305.27 Aligned_cols=195 Identities=30% Similarity=0.463 Sum_probs=162.7
Q ss_pred CCceEecceeEcC-CCcEEecCCCCCCceeeEeeCCceeecCCCCCceeeeeeeEEee---------eeEEEEcCCCCCC
Q 044561 39 AQLQRDGLASVHS-NGLLQLTNTVSPQQEGHAFYRLPIKFNTSSSESLSFSSNFVFAI---------GMAFVISPSKDLG 108 (614)
Q Consensus 39 ~~~~~~g~a~~~~-~g~l~Lt~~~~~~~~G~~~y~~pv~l~~~~~~~~sF~t~F~f~i---------G~aF~l~p~~~~~ 108 (614)
.++.++|+|.+.+ ++.|+||++.. .++|++||++||++|. +|+|+|+|.| ||||+|+|....+
T Consensus 14 ~~~~~~G~A~~~~~~~~l~Lt~~~~-~~~G~~~~~~~i~~~~------~F~~~F~f~i~~~~~~~gdG~aF~l~~~~~~~ 86 (223)
T cd01951 14 SNWQLNGSATLTTDSGVLRLTPDTG-NQAGSAWYKTPIDLSK------DFTTTFKFYLGTKGTNGADGIAFVLQNDPAGA 86 (223)
T ss_pred hhcEEcccEEecCCCCEEEECCCCC-CcEEEEEECCcEeccC------CEEEEEEEEEeCCCCCCCCcEEEEEecCCCCc
Confidence 5899999999975 78999999876 8999999999999984 5999999999 9999999976543
Q ss_pred CCCCCCC--CcccccccCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeeEecCCCcccc--cccCccccCccCCCccccc
Q 044561 109 KAEASPS--EYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHE--SAPAAYFSDREGMNKTLEL 184 (614)
Q Consensus 109 ~~~~~~g--~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~--~~~~~~~~~~~~~~~~~~l 184 (614)
.+.+| ++||+ .+.++.+||||||++|.+++||+.||||||+|+..+.. ..+..+.. .+...
T Consensus 87 --~~~~g~~~~lG~-------~~~~~~~aVefDT~~N~~~~dp~~~higi~~n~~~~~~~~~~~~~~~~------~~~~~ 151 (223)
T cd01951 87 --LGGGGGGGGLGY-------GGIGNSVAVEFDTYKNDDNNDPNGNHISIDVNGNGNNTALATSLGSAS------LPNGT 151 (223)
T ss_pred --cccCCCCCccCc-------cccCCeEEEEEeccccCCCCCCCCCEEEEEcCCCCCCcccccccceee------CCCcc
Confidence 34444 88886 45568899999999999888999999999999987541 11112111 11122
Q ss_pred cCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcccccccccccccccCCCccceeeEeccccc
Q 044561 185 IIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLKSSHYVLGWSFN 257 (614)
Q Consensus 185 ~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastg~~~~~h~i~sWsf~ 257 (614)
.+|+.++|||+||+.+++|+|++..... |..|.++.++||+..++++||||||||||...+.|.|++|+|+
T Consensus 152 ~~g~~~~v~I~Y~~~~~~L~v~l~~~~~--~~~~~l~~~~~l~~~~~~~~yvGFTAsTG~~~~~h~V~~wsf~ 222 (223)
T cd01951 152 GLGNEHTVRITYDPTTNTLTVYLDNGST--LTSLDITIPVDLIQLGPTKAYFGFTASTGGLTNLHDILNWSFT 222 (223)
T ss_pred CCCCEEEEEEEEeCCCCEEEEEECCCCc--cccccEEEeeeecccCCCcEEEEEEcccCCCcceeEEEEEEec
Confidence 2399999999999999999999986543 6678999999999999999999999999999999999999996
|
The L-type (legume-type) lectins are a highly diverse family of carbohydrate binding proteins that generally display no enzymatic activity toward the sugars they bind. This family includes arcelin, concanavalinA, the lectin-like receptor kinases, the ERGIC-53/VIP36/EMP46 type1 transmembrane proteins, and an alpha-amylase inhibitor. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=335.52 Aligned_cols=252 Identities=25% Similarity=0.389 Sum_probs=197.1
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec------CcEEEEEEeecCC-hhhHHHHHHHHHHhccc-CCCceeEEeeEEeecCeE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS------NVQIAVKKVSHDS-KQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGEF 416 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 416 (614)
++|+..+.||+|+||.||+++... +..||+|++.... ......+.+|+.+++.+ +|+||++++++|...+..
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 468889999999999999998532 3579999997543 33456788999999999 899999999999999999
Q ss_pred EEEEEecCCCCcchhcccCC------------------------------------------------------------
Q 044561 417 LLVYDYMPNGSLDKILHTNI------------------------------------------------------------ 436 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~~------------------------------------------------------------ 436 (614)
++|||||++|+|.+++....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 99999999999999875321
Q ss_pred --------CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCC-ccccc
Q 044561 437 --------KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP-QTTKL 507 (614)
Q Consensus 437 --------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~ 507 (614)
...+++.++.+++.||++||.|||+ ++|+||||||+|||+++++.+||+|||+++........ .....
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 1247888999999999999999995 89999999999999999999999999999865433211 11223
Q ss_pred ccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcHH
Q 044561 508 VGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEK 586 (614)
Q Consensus 508 ~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~ 586 (614)
.++..|+|||++....++.++|||||||++|||++ |+.||......+.. .+....+. .......
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~------~~~~~~~~-----~~~~~~~---- 339 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKF------YKMVKRGY-----QMSRPDF---- 339 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHH------HHHHHccc-----CccCCCC----
Confidence 45678999999988899999999999999999997 99999764332211 11111110 0001111
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 587 QMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 587 ~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
....+.+++.+||+.||++|||+.+|++
T Consensus 340 ~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 340 APPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1245778888999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=315.36 Aligned_cols=248 Identities=28% Similarity=0.429 Sum_probs=198.7
Q ss_pred CCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecCC
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPN 425 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 425 (614)
+|+..+.||+|+||.||++.++++..+++|.+..... ...++.+|++++++++||||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 4677889999999999999987777899998864332 335688999999999999999999999999999999999999
Q ss_pred CCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCccc
Q 044561 426 GSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT 505 (614)
Q Consensus 426 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 505 (614)
++|.+++..+. ..+++..+..++.|++.||.|||+ .+++||||||+||++++++.+||+|||+++...........
T Consensus 84 ~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 84 GCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence 99999987643 358999999999999999999994 89999999999999999999999999999765433211112
Q ss_pred ccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCc
Q 044561 506 KLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICE 584 (614)
Q Consensus 506 ~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 584 (614)
...++..|+|||.+....++.++||||||+++|||++ |+.||......+.. .. ...+. .... +
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~~----~~~~~-----~~~~----~ 223 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV---ES----VSAGY-----RLYR----P 223 (256)
T ss_pred CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH---HH----HHcCC-----cCCC----C
Confidence 2234567999999998889999999999999999999 89998754432211 11 11110 0111 1
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 585 EKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 585 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
......+.+++.+||+.+|++|||+.|+++
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~ 253 (256)
T cd05059 224 KLAPTEVYTIMYSCWHEKPEDRPAFKKLLS 253 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 113446888999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=319.79 Aligned_cols=263 Identities=20% Similarity=0.301 Sum_probs=197.6
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCCh-hhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSK-QGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 421 (614)
.++|+..+.||+|+||.||+|+.+ ++..+|+|++..... .....+.+|+.+++.++||||+++++++......++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 367888999999999999999987 478899999875432 223467789999999999999999999999999999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCC
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI 501 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~ 501 (614)
|++ ++|.+++... ...+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++........
T Consensus 84 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 158 (303)
T cd07869 84 YVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH 158 (303)
T ss_pred CCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc
Confidence 995 6787777653 3458899999999999999999995 8999999999999999999999999999875433221
Q ss_pred CcccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhh---cCCcc-----
Q 044561 502 PQTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWK---KGAIR----- 572 (614)
Q Consensus 502 ~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~---~~~~~----- 572 (614)
......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ......+..... ...+.
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 159 -TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI--QDQLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred -cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhCCCChhhccchhhc
Confidence 2233568999999999865 45789999999999999999999999764321 111111111110 00000
Q ss_pred -ccccccccCcCcH---------HHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 573 -DASDSRLEGICEE---------KQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 573 -~~~d~~l~~~~~~---------~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
...........+. .....+.+|+.+|++.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000000000000 01234678888999999999999999984
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=332.19 Aligned_cols=243 Identities=25% Similarity=0.370 Sum_probs=201.8
Q ss_pred HhcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhccc-CCCceeEEeeEEeecCeEE
Q 044561 343 ATKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGEFL 417 (614)
Q Consensus 343 ~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 417 (614)
..++|...++||+|.||+|+++..+. ++.+|||.++++. +...+....|-.++... +||.+++++..+..++++|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 34678899999999999999999986 7789999998763 44456667777777666 5999999999999999999
Q ss_pred EEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccC
Q 044561 418 LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYD 497 (614)
Q Consensus 418 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~ 497 (614)
.||||+.||++..+.+. ..+++..+..++..|+.||+||| +++|||||||.+|||||.+|++||+||||++..-
T Consensus 446 fvmey~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEEEecCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccC
Confidence 99999999995544443 45999999999999999999999 5999999999999999999999999999998643
Q ss_pred CCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccc
Q 044561 498 HDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDS 577 (614)
Q Consensus 498 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~ 577 (614)
... ..+.+.+||+.|||||++.+..|+.++|.|||||+||||+.|..||++++++|..+.+. ..|.
T Consensus 520 ~~g-~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~-------------~d~~ 585 (694)
T KOG0694|consen 520 GQG-DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV-------------NDEV 585 (694)
T ss_pred CCC-CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh-------------cCCC
Confidence 222 25677899999999999999999999999999999999999999999887766554331 1122
Q ss_pred cccCcCcHHHHHHHHHHHHHcCCCCCCCCCCH
Q 044561 578 RLEGICEEKQMELVLKLGLFCSHPKPEARPNM 609 (614)
Q Consensus 578 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 609 (614)
. ++.........++.+++..||++|.-+
T Consensus 586 ~----yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 586 R----YPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred C----CCCcccHHHHHHHHHHhccCcccccCC
Confidence 2 233334455666677899999999876
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=329.43 Aligned_cols=245 Identities=25% Similarity=0.408 Sum_probs=191.2
Q ss_pred CCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecC
Q 044561 347 FKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMP 424 (614)
Q Consensus 347 f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 424 (614)
|+..+.||+|+||.||+|+... ++.||+|.+.... ....+.+.+|+++++.++|+||+++++++...+.+++||||++
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 3446789999999999999764 7899999986543 3345678999999999999999999999999999999999999
Q ss_pred CCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcc
Q 044561 425 NGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT 504 (614)
Q Consensus 425 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 504 (614)
+|+|.... ..++..+..++.||+.||.|||+ .+|+||||||+|||+++++.+||+|||+++....... ..
T Consensus 156 ~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~ 225 (353)
T PLN00034 156 GGSLEGTH------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-PC 225 (353)
T ss_pred CCcccccc------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc-cc
Confidence 99987532 25677888999999999999994 8999999999999999999999999999987643321 22
Q ss_pred cccccCCCccchhhhcC-----CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccc
Q 044561 505 TKLVGTFGYMDPELMRT-----GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRL 579 (614)
Q Consensus 505 ~~~~gt~~y~aPE~~~~-----~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 579 (614)
....||..|+|||++.. ...+.++|||||||++|||++|+.||......+...+...+. ... ...
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~----~~~-----~~~- 295 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC----MSQ-----PPE- 295 (353)
T ss_pred cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh----ccC-----CCC-
Confidence 34579999999998743 234568999999999999999999997433222111111110 000 011
Q ss_pred cCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 580 EGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 580 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
........+.+++.+||+.||++||++.|+++
T Consensus 296 ---~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 296 ---APATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred ---CCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11122345778888999999999999999985
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=326.62 Aligned_cols=251 Identities=22% Similarity=0.300 Sum_probs=198.1
Q ss_pred CCCCcceeeeeCcEEEEEEEEe----cCcEEEEEEeecC----ChhhHHHHHHHHHHhccc-CCCceeEEeeEEeecCeE
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLA----SNVQIAVKKVSHD----SKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGEF 416 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 416 (614)
+|+..+.||+|+||.||+++.. .+..+|+|.+... .....+.+..|+.+++.+ +|+||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4777899999999999998863 4788999998653 223345678899999999 599999999999999999
Q ss_pred EEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecccccc
Q 044561 417 LLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 496 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~ 496 (614)
++||||+++|+|.+++... ..+++.++..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 9999999999999998763 348999999999999999999994 89999999999999999999999999999865
Q ss_pred CCCCCCcccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccc
Q 044561 497 DHDTIPQTTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDAS 575 (614)
Q Consensus 497 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~ 575 (614)
............||+.|+|||++.+. .++.++|||||||++|||++|+.||.......... .+...... .
T Consensus 156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~---~~~~~~~~------~ 226 (332)
T cd05614 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS---EVSRRILK------C 226 (332)
T ss_pred cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH---HHHHHHhc------C
Confidence 44333334456799999999998765 47889999999999999999999997543322111 11111111 1
Q ss_pred cccccCcCcHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHhC
Q 044561 576 DSRLEGICEEKQMELVLKLGLFCSHPKPEARP-----NMRQVMQ 614 (614)
Q Consensus 576 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 614 (614)
++.+.... ...+.+++.+|++.||++|| ++.++++
T Consensus 227 ~~~~~~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 227 DPPFPSFI----GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCCCCCCC----CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 11222222 23466778889999999999 7778763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=314.05 Aligned_cols=248 Identities=27% Similarity=0.466 Sum_probs=199.5
Q ss_pred cCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecC
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMP 424 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 424 (614)
++|+..+.||+|+||.||+|..+++..+++|.+..... ..+.+.+|+.++++++|+|++++++++. .+..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 35777889999999999999988888899999876433 3467899999999999999999999875 456899999999
Q ss_pred CCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcc
Q 044561 425 NGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT 504 (614)
Q Consensus 425 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 504 (614)
+++|.+++.......+++.++..++.|++.||.|||+ .+++||||||+||++++++.+||+|||++...........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccc
Confidence 9999999976544568999999999999999999995 8999999999999999999999999999987654332222
Q ss_pred cccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcC
Q 044561 505 TKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGIC 583 (614)
Q Consensus 505 ~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 583 (614)
....++..|+|||.+....++.++|+||||+++|||++ |+.||......+. .+.. ..+... ..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~---~~~~----~~~~~~---------~~ 224 (260)
T cd05070 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREV---LEQV----ERGYRM---------PC 224 (260)
T ss_pred cCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH---HHHH----HcCCCC---------CC
Confidence 22345678999999988889999999999999999999 8999975433221 1111 111000 11
Q ss_pred cHHHHHHHHHHHHHcCCCCCCCCCCHHHHh
Q 044561 584 EEKQMELVLKLGLFCSHPKPEARPNMRQVM 613 (614)
Q Consensus 584 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 613 (614)
+......+.+++.+|++++|++|||+.++.
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~ 254 (260)
T cd05070 225 PQDCPISLHELMLQCWKKDPEERPTFEYLQ 254 (260)
T ss_pred CCcCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 122334688899999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=327.78 Aligned_cols=203 Identities=26% Similarity=0.343 Sum_probs=175.8
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
++|+..+.||+|+||+||++.... +..+|+|++.... ......+.+|+.++.+++|+||+++++.+.+...+++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 468889999999999999999765 7889999987542 233456788999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
|||++|+|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 81 EFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred cCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 999999999999764 358999999999999999999994 899999999999999999999999999987543211
Q ss_pred C----------------------------------CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCC
Q 044561 501 I----------------------------------PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRP 546 (614)
Q Consensus 501 ~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p 546 (614)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 0 001235799999999999988999999999999999999999999
Q ss_pred CCCCCc
Q 044561 547 VEQQGS 552 (614)
Q Consensus 547 ~~~~~~ 552 (614)
|.....
T Consensus 236 f~~~~~ 241 (363)
T cd05628 236 FCSETP 241 (363)
T ss_pred CCCCCH
Confidence 976543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=330.38 Aligned_cols=262 Identities=23% Similarity=0.311 Sum_probs=199.5
Q ss_pred CCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecC-----eEE
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKG-----EFL 417 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~ 417 (614)
+|+..+.||+|+||.||++... ++..||+|++... .....+++.+|+.+++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999975 4889999998653 3334567889999999999999999999998776 799
Q ss_pred EEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccC
Q 044561 418 LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYD 497 (614)
Q Consensus 418 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~ 497 (614)
+|+||+. ++|.+.+... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999996 5787777553 358999999999999999999994 899999999999999999999999999998665
Q ss_pred CCCCCcccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHH--------------
Q 044561 498 HDTIPQTTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWV-------------- 562 (614)
Q Consensus 498 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v-------------- 562 (614)
...........++..|+|||++.+. .++.++|||||||++|||++|+.||......+....+...
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 4333333445688999999998764 4789999999999999999999999866543332222110
Q ss_pred --HHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 563 --CDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 563 --~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
................+ ........+.+.+|+.+|++.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 235 GARAHILRGPHKPPSLPVL-YTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HHHHHHHhCCCCCCchHHh-cccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 00000000000000000 0011112345778889999999999999999974
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=328.70 Aligned_cols=242 Identities=25% Similarity=0.316 Sum_probs=195.1
Q ss_pred ceeeeeCcEEEEEEEEec-CcEEEEEEeecC---ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecCCC
Q 044561 351 DVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNG 426 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 426 (614)
+.||+|+||.||++.... +..+|+|.+... ......++..|+.+++.++||||+++++++...+.+++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999999764 788999998754 2334567788999999999999999999999999999999999999
Q ss_pred CcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcccc
Q 044561 427 SLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTK 506 (614)
Q Consensus 427 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 506 (614)
+|..++... ..+++.++..++.||+.||.|||+ ..+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 155 (325)
T cd05594 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMKT 155 (325)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-ccccc
Confidence 999888653 358999999999999999999995 3799999999999999999999999999987533222 12234
Q ss_pred cccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcHH
Q 044561 507 LVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEK 586 (614)
Q Consensus 507 ~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~ 586 (614)
..||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ..+. ..+....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i-------~~~~------~~~p~~~--- 219 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI-------LMEE------IRFPRTL--- 219 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH-------hcCC------CCCCCCC---
Confidence 57999999999999889999999999999999999999999765432221111 1111 1111122
Q ss_pred HHHHHHHHHHHcCCCCCCCCC-----CHHHHhC
Q 044561 587 QMELVLKLGLFCSHPKPEARP-----NMRQVMQ 614 (614)
Q Consensus 587 ~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 614 (614)
...+.+++.+|++.||++|+ ++.++++
T Consensus 220 -~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 220 -SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred -CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 23466788889999999996 8998874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=324.83 Aligned_cols=239 Identities=23% Similarity=0.344 Sum_probs=189.3
Q ss_pred ceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhcc-cCCCceeEEeeEEeecCeEEEEEEecCC
Q 044561 351 DVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGR-LRHRNLVKLRGYCRRKGEFLLVYDYMPN 425 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~~~~~~lV~E~~~~ 425 (614)
+.||+|+||.||+|..++ +..||+|.+.... ....+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999875 7789999987542 2334455666666664 4899999999999999999999999999
Q ss_pred CCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCccc
Q 044561 426 GSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT 505 (614)
Q Consensus 426 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 505 (614)
|+|..++... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~ 154 (316)
T cd05592 81 GDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAS 154 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccc
Confidence 9999988764 348999999999999999999995 899999999999999999999999999997643322 2234
Q ss_pred ccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcH
Q 044561 506 KLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEE 585 (614)
Q Consensus 506 ~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~ 585 (614)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... .... .+.+...+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~-------i~~~------~~~~~~~~-- 219 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDS-------ILND------RPHFPRWI-- 219 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHH-------HHcC------CCCCCCCC--
Confidence 45799999999999988899999999999999999999999976543222111 1111 01111122
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCHH-HH
Q 044561 586 KQMELVLKLGLFCSHPKPEARPNMR-QV 612 (614)
Q Consensus 586 ~~~~~l~~l~~~cl~~dP~~RPs~~-ev 612 (614)
...+.+++.+||+.||++||++. ++
T Consensus 220 --~~~~~~ll~~~l~~~P~~R~~~~~~l 245 (316)
T cd05592 220 --SKEAKDCLSKLFERDPTKRLGVDGDI 245 (316)
T ss_pred --CHHHHHHHHHHccCCHHHcCCChHHH
Confidence 23456777889999999999975 44
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=332.55 Aligned_cols=251 Identities=27% Similarity=0.354 Sum_probs=201.7
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
++|+..+.||+|+||.||+|... ++..||+|++.... ......+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888899999999999999987 48899999987542 234567889999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
||+++++|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999999999765 458999999999999999999995 899999999999999999999999999998654432
Q ss_pred ----------------------------CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCc
Q 044561 501 ----------------------------IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGS 552 (614)
Q Consensus 501 ----------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~ 552 (614)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 1122345799999999999999999999999999999999999999976543
Q ss_pred cccccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCC-HHHHhC
Q 044561 553 METVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPN-MRQVMQ 614 (614)
Q Consensus 553 ~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~evl~ 614 (614)
.+.... +.. +. ..+. -+.. .. ....+..++..|+. ||++||+ +.|+++
T Consensus 236 ~~~~~~---i~~-~~-~~~~---~p~~-~~----~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 236 QETYNK---IIN-WK-ESLR---FPPD-PP----VSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred HHHHHH---Hhc-cC-Cccc---CCCC-CC----CCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 221111 111 00 0000 0000 01 23456677778997 9999999 999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=330.36 Aligned_cols=258 Identities=17% Similarity=0.214 Sum_probs=195.5
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
.+|+..+.||+|+||.||++.... ++.||+|+... ..+.+|+.++++++||||+++++++......++|+|++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 568899999999999999999865 78899996532 34678999999999999999999999999999999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCc
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 503 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 503 (614)
. ++|..++... ..+++.+++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.........
T Consensus 166 ~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~ 239 (391)
T PHA03212 166 K-TDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239 (391)
T ss_pred C-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence 5 7888887653 348999999999999999999995 899999999999999999999999999997543322223
Q ss_pred ccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccc----cccHHHHHHHhhhc--CCc------
Q 044561 504 TTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSME----TVNLVDWVCDCWKK--GAI------ 571 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~----~~~l~~~v~~~~~~--~~~------ 571 (614)
.....||+.|+|||++....++.++|||||||++|||++|+.|+......+ .......+...... ...
T Consensus 240 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~ 319 (391)
T PHA03212 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQA 319 (391)
T ss_pred cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhH
Confidence 344679999999999998899999999999999999999998875432111 00111111111000 000
Q ss_pred --cc---------cccccccCc--CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 572 --RD---------ASDSRLEGI--CEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 572 --~~---------~~d~~l~~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.. ...+..... ........+..|+.+||+.||++|||+.|+++
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 320 NLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00 000000000 00122346788899999999999999999985
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=315.62 Aligned_cols=260 Identities=25% Similarity=0.346 Sum_probs=202.5
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecC-----eEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKG-----EFLL 418 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~l 418 (614)
-.|...+++|.|+||.||+|++.. +..||||++..+.+-. -+|+++|+.++|||||+++-++.... ...|
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 346667899999999999999876 6899999998765422 47999999999999999999875432 3469
Q ss_pred EEEecCCCCcchhcccC--CCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCC-CCEEEeeeccccc
Q 044561 419 VYDYMPNGSLDKILHTN--IKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDAD-LNGKLGDFGLARL 495 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~-~~~kl~DfGla~~ 495 (614)
||||||. +|.+.++.. .+..++...+.-+..||.+||.|||+ .+|+||||||+|+|+|.+ |.+||||||-|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999975 788887641 23458888889999999999999995 899999999999999987 9999999999998
Q ss_pred cCCCCCCcccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcc--
Q 044561 496 YDHDTIPQTTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIR-- 572 (614)
Q Consensus 496 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~-- 572 (614)
...+.. ......|..|.|||++.+. .|+.+.||||.||++.||+-|++-|.+.+..+++.++-.+.....+..+.
T Consensus 176 L~~~ep--niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 176 LVKGEP--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred eccCCC--ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 876653 3445678999999998764 79999999999999999999999999877766665554443322222111
Q ss_pred -----cccccccc-----CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 573 -----DASDSRLE-----GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 573 -----~~~d~~l~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+...+.+. ...........++|+.+++..+|.+|.++.|++.
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 11112221 1122233445777888899999999999999874
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=313.55 Aligned_cols=249 Identities=27% Similarity=0.453 Sum_probs=200.4
Q ss_pred cCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecC
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMP 424 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 424 (614)
.+|+..+.||+|+||.||+|..++...+++|++..... ..+++.+|+++++.++||||+++++.+. .+..++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 45788899999999999999987777899999875332 3467899999999999999999999874 456899999999
Q ss_pred CCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcc
Q 044561 425 NGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT 504 (614)
Q Consensus 425 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 504 (614)
+|+|.+++.......+++.++..++.|++.||.|||+ .+++||||||+||++++++.+||+|||++...........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~ 160 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 160 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccccccc
Confidence 9999999976544568999999999999999999994 8999999999999999999999999999987654432222
Q ss_pred cccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcC
Q 044561 505 TKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGIC 583 (614)
Q Consensus 505 ~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 583 (614)
....++..|+|||+.....++.++||||||+++|||++ |+.||......+... ....+.. ...
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~-------~~~~~~~---------~~~ 224 (262)
T cd05071 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD-------QVERGYR---------MPC 224 (262)
T ss_pred cCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHH-------HHhcCCC---------CCC
Confidence 23356778999999988889999999999999999999 888887554322111 1111100 011
Q ss_pred cHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 584 EEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 584 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+....+.+++.+|+++||++||++.++++
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 225 PPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred ccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 2234456788999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=314.93 Aligned_cols=243 Identities=24% Similarity=0.421 Sum_probs=207.6
Q ss_pred CCCCcceeeeeCcEEEEEEEE-ecCcEEEEEEeecC---ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEE
Q 044561 346 GFKDKDVIGRGGFGKVYRGVL-ASNVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 421 (614)
+|+..+.||+|.||+|-++.. ..|+.||||.++++ +++++-.+.+|+++|+.|+||||++++.+++.++.+.||||
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME 133 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME 133 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence 456677899999999999997 45999999999765 56666778899999999999999999999999999999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCC
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI 501 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~ 501 (614)
|..+|.|.+++... +.|++.+...++.||.+|+.|+| +.+++|||||.+|||+|.|+++||+||||+.++....
T Consensus 134 YaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k- 207 (668)
T KOG0611|consen 134 YASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK- 207 (668)
T ss_pred ecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhcccc-
Confidence 99999999999874 45999999999999999999999 6999999999999999999999999999999887765
Q ss_pred CcccccccCCCccchhhhcCCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 502 PQTTKLVGTFGYMDPELMRTGKA-STSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 502 ~~~~~~~gt~~y~aPE~~~~~~~-t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
-.++.||++.|.+||++.+.+| .+..|.||||++||-|+.|..||++.+....+. .+..|...+-
T Consensus 208 -fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvr-------QIs~GaYrEP------ 273 (668)
T KOG0611|consen 208 -FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVR-------QISRGAYREP------ 273 (668)
T ss_pred -HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHH-------HhhcccccCC------
Confidence 3456799999999999998887 689999999999999999999998865433221 1223332221
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHh
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARPNMRQVM 613 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 613 (614)
+......-|+.||+..||++|-|+.+|.
T Consensus 274 -----~~PSdA~gLIRwmLmVNP~RRATieDiA 301 (668)
T KOG0611|consen 274 -----ETPSDASGLIRWMLMVNPERRATIEDIA 301 (668)
T ss_pred -----CCCchHHHHHHHHHhcCcccchhHHHHh
Confidence 1223356688899999999999998874
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=323.83 Aligned_cols=247 Identities=26% Similarity=0.350 Sum_probs=194.6
Q ss_pred ceeeeeCcEEEEEEEEec-CcEEEEEEeecC---ChhhHHHHHHHHHHhccc-CCCceeEEeeEEeecCeEEEEEEecCC
Q 044561 351 DVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD---SKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGEFLLVYDYMPN 425 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 425 (614)
+.||+|+||.||++..+. ++.+|+|.+... .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 469999999999999875 788999998754 333455677888888776 799999999999999999999999999
Q ss_pred CCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCccc
Q 044561 426 GSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT 505 (614)
Q Consensus 426 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 505 (614)
|+|..++... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~ 154 (329)
T cd05618 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTS 154 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Cccc
Confidence 9999888654 358999999999999999999995 899999999999999999999999999987533221 1223
Q ss_pred ccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccc--cccHHHHHHHhhhcCCccccccccccCcC
Q 044561 506 KLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSME--TVNLVDWVCDCWKKGAIRDASDSRLEGIC 583 (614)
Q Consensus 506 ~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~--~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 583 (614)
...||..|+|||++.+..++.++|||||||++|||++|+.||....... ......++.+....+.. .+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~~p~-- 226 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------RIPR-- 226 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------CCCC--
Confidence 4579999999999999899999999999999999999999996422111 11122233333222211 1111
Q ss_pred cHHHHHHHHHHHHHcCCCCCCCCCC------HHHHh
Q 044561 584 EEKQMELVLKLGLFCSHPKPEARPN------MRQVM 613 (614)
Q Consensus 584 ~~~~~~~l~~l~~~cl~~dP~~RPs------~~evl 613 (614)
.....+..++.+||+.||++||+ +.+++
T Consensus 227 --~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05618 227 --SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQ 260 (329)
T ss_pred --CCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHh
Confidence 22345677888899999999998 46665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=313.30 Aligned_cols=250 Identities=30% Similarity=0.490 Sum_probs=200.8
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec----CcEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS----NVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLV 419 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 419 (614)
++|+..+.||+|+||.||+|.++. ...+++|.+.... .....+|.+|+.++++++||||+++++++...+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 468889999999999999999853 3578999886543 34456789999999999999999999999999999999
Q ss_pred EEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCC
Q 044561 420 YDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD 499 (614)
Q Consensus 420 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~ 499 (614)
|||+++++|.+++.... ..+++.++..++.|++.||.||| +.+|+||||||+||++++++.+||+|||++......
T Consensus 84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 84 TEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999987643 35899999999999999999999 489999999999999999999999999999877522
Q ss_pred CCC-cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccc
Q 044561 500 TIP-QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDS 577 (614)
Q Consensus 500 ~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~ 577 (614)
... ......++..|+|||.+....++.++||||||+++|||++ |..||......+ ....+ .++....
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~----~~~~~~~---- 228 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VIKAV----EDGYRLP---- 228 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HHHHH----HcCCCCC----
Confidence 211 1122345678999999998889999999999999999998 999986543322 11111 1111000
Q ss_pred cccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 578 RLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 578 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+......+.+++.+|++.+|++||++.||++
T Consensus 229 -----~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~ 260 (266)
T cd05033 229 -----PPMDCPSALYQLMLDCWQKDRNERPTFSQIVS 260 (266)
T ss_pred -----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 01122345788999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=332.57 Aligned_cols=253 Identities=23% Similarity=0.272 Sum_probs=200.3
Q ss_pred HhcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC---ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEE
Q 044561 343 ATKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLL 418 (614)
Q Consensus 343 ~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 418 (614)
..++|+..+.||+|+||.||+++.+. +..+|+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 34678889999999999999999865 788999998653 22334557889999999999999999999999999999
Q ss_pred EEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCC
Q 044561 419 VYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 498 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~ 498 (614)
||||+++|+|.+++... .++...+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 121 v~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999998653 37888899999999999999995 8999999999999999999999999999987654
Q ss_pred CCCCcccccccCCCccchhhhcCC----CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccc
Q 044561 499 DTIPQTTKLVGTFGYMDPELMRTG----KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDA 574 (614)
Q Consensus 499 ~~~~~~~~~~gt~~y~aPE~~~~~----~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~ 574 (614)
.........+||+.|+|||++... .++.++|||||||++|||++|+.||......+... +........
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~------~i~~~~~~~-- 266 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS------KIMDHKNSL-- 266 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHH------HHHcCCCcC--
Confidence 433233446799999999998653 47899999999999999999999997654322111 111100000
Q ss_pred ccccccCcCcHHHHHHHHHHHHHcCCCCCCC--CCCHHHHhC
Q 044561 575 SDSRLEGICEEKQMELVLKLGLFCSHPKPEA--RPNMRQVMQ 614 (614)
Q Consensus 575 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~ 614 (614)
..... ......+.+++.+|++.+|++ ||++.|+++
T Consensus 267 ---~~~~~--~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 267 ---TFPDD--IEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred ---CCCCc--CCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 00110 012345667788899999987 999999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=324.01 Aligned_cols=248 Identities=25% Similarity=0.337 Sum_probs=196.0
Q ss_pred ceeeeeCcEEEEEEEEec-CcEEEEEEeecC---ChhhHHHHHHHHHHhccc-CCCceeEEeeEEeecCeEEEEEEecCC
Q 044561 351 DVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD---SKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGEFLLVYDYMPN 425 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 425 (614)
+.||+|+||.||+++.+. +..||+|.+... .....+.+..|..++.++ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 469999999999999875 788999999754 233456678899999888 799999999999999999999999999
Q ss_pred CCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCccc
Q 044561 426 GSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT 505 (614)
Q Consensus 426 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 505 (614)
|+|..++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~ 154 (329)
T cd05588 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTS 154 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCC-Cccc
Confidence 9999888654 359999999999999999999994 899999999999999999999999999987432211 1233
Q ss_pred ccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccc--cccHHHHHHHhhhcCCccccccccccCcC
Q 044561 506 KLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSME--TVNLVDWVCDCWKKGAIRDASDSRLEGIC 583 (614)
Q Consensus 506 ~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~--~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 583 (614)
...||+.|+|||++.+..++.++|+|||||++|||++|+.||+.....+ .....++..+...++.. .+...+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~p~~~ 228 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------RIPRSL 228 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------CCCCCC
Confidence 4579999999999998899999999999999999999999997433221 11122233333222211 111222
Q ss_pred cHHHHHHHHHHHHHcCCCCCCCCCC------HHHHhC
Q 044561 584 EEKQMELVLKLGLFCSHPKPEARPN------MRQVMQ 614 (614)
Q Consensus 584 ~~~~~~~l~~l~~~cl~~dP~~RPs------~~evl~ 614 (614)
...+.+++.+|++.||++||+ +.++++
T Consensus 229 ----~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 229 ----SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred ----CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 234677888899999999997 677763
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=317.13 Aligned_cols=251 Identities=28% Similarity=0.469 Sum_probs=202.2
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec------CcEEEEEEeecCChh-hHHHHHHHHHHhcccCCCceeEEeeEEeecCeEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS------NVQIAVKKVSHDSKQ-GIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFL 417 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 417 (614)
.+|...+.||+|+||.||+|...+ +..+++|.+...... ..+.+.+|++++++++|+|++++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457778899999999999998743 467999998765444 5678999999999999999999999999999999
Q ss_pred EEEEecCCCCcchhcccCC------------CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCE
Q 044561 418 LVYDYMPNGSLDKILHTNI------------KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG 485 (614)
Q Consensus 418 lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~ 485 (614)
+||||+++++|.+++.... ...+++.++..++.|++.|+.|||+ .+++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCeE
Confidence 9999999999999986532 2458899999999999999999994 899999999999999999999
Q ss_pred EEeeeccccccCCCCC-CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHH
Q 044561 486 KLGDFGLARLYDHDTI-PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVC 563 (614)
Q Consensus 486 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~ 563 (614)
||+|||++........ .......+++.|+|||++..+.++.++|||||||++|||++ |+.||......+. .+
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~---~~--- 235 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV---IE--- 235 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---HH---
Confidence 9999999976433221 11223356788999999999999999999999999999998 9999876543321 11
Q ss_pred HhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 564 DCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 564 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
....+..... +......+.+++.+||+.||++||++.||++
T Consensus 236 -~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 236 -CITQGRLLQR---------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred -HHHcCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 1122222111 1122345788888999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=330.88 Aligned_cols=253 Identities=24% Similarity=0.352 Sum_probs=195.3
Q ss_pred CCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC---ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEE
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 421 (614)
.|+..+.||+|+||+||+|+... +..+|+|++... .....+.+.+|+.++++++||||+++++++.+.+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 57788999999999999999765 788999999754 23445678899999999999999999999999999999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCC
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI 501 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~ 501 (614)
|+++|+|.+++... ..+++..+..++.||+.||.||| ..+|+||||||+|||++.++++||+|||++........
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 99999999998764 34889999999999999999999 48999999999999999999999999999764321000
Q ss_pred ----------------------------------------------CcccccccCCCccchhhhcCCCCCcchhHHHHHH
Q 044561 502 ----------------------------------------------PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGV 535 (614)
Q Consensus 502 ----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gv 535 (614)
......+||+.|+|||++....++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 0012347999999999998888999999999999
Q ss_pred HHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 536 FMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 536 ll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
++|||++|+.||......+... .+.. + ..... . + ....++.+....+.++ .|+.++|..||++.|+++
T Consensus 237 il~elltG~~Pf~~~~~~~~~~---~i~~-~-~~~~~-~--~-~~~~~s~~~~dli~~l--l~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQL---KVIN-W-ENTLH-I--P-PQVKLSPEAVDLITKL--CCSAEERLGRNGADDIKA 304 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHHH---HHHc-c-ccccC-C--C-CCCCCCHHHHHHHHHH--ccCcccccCCCCHHHHhc
Confidence 9999999999997654322111 0100 0 00000 0 0 0112333333333332 367778888999999874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=331.25 Aligned_cols=251 Identities=25% Similarity=0.319 Sum_probs=197.3
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC---ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
++|+..+.||+|+||.||+++... +..||+|++... .....+.+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 468889999999999999999865 788999999753 2334566788999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
||+++|+|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 81 E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 81 EYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 999999999998764 358999999999999999999994 899999999999999999999999999987543211
Q ss_pred CC-------------------------------------cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcC
Q 044561 501 IP-------------------------------------QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASG 543 (614)
Q Consensus 501 ~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg 543 (614)
.. .....+||+.|+|||++....++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 00 01124699999999999988999999999999999999999
Q ss_pred CCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCC---HHHHhC
Q 044561 544 RRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPN---MRQVMQ 614 (614)
Q Consensus 544 ~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~evl~ 614 (614)
+.||......+.. ..+.. +. ..+. . ... ..++ +.+.+++.+|+. +|.+|++ +.|+++
T Consensus 236 ~~Pf~~~~~~~~~---~~i~~-~~-~~~~-~-~~~--~~~s----~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 236 YPPFCSDNPQETY---RKIIN-WK-ETLQ-F-PDE--VPLS----PEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCHHHHH---HHHHc-CC-CccC-C-CCC--CCCC----HHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 9999765432211 11111 00 0000 0 000 0122 345556666886 9999998 988874
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=323.90 Aligned_cols=241 Identities=22% Similarity=0.308 Sum_probs=193.0
Q ss_pred CCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC---ChhhHHHHHHHHHHhcccCC-CceeEEeeEEeecCeEEEEE
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRH-RNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~ 420 (614)
+|+..+.||+|+||.||+|+.++ +..||+|++... .....+.+..|..++..++| ++|+++++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 47778999999999999999875 678999998754 23345677889999999876 45888999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
||+++|+|.+++... ..+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 81 EYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 999999999998764 348899999999999999999994 899999999999999999999999999987532211
Q ss_pred CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||......+.. ..+ .+.. ..+.
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~---~~i----~~~~------~~~~ 221 (324)
T cd05587 156 -KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF---QSI----MEHN------VSYP 221 (324)
T ss_pred -CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH---HHH----HcCC------CCCC
Confidence 1223457999999999999888999999999999999999999999765432221 111 1111 1111
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCCCH
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARPNM 609 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 609 (614)
... ...+.+++.+|++.||++||+.
T Consensus 222 ~~~----~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 222 KSL----SKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCC----CHHHHHHHHHHhhcCHHHcCCC
Confidence 122 2356778888999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=311.24 Aligned_cols=249 Identities=26% Similarity=0.447 Sum_probs=199.8
Q ss_pred cCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecC
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMP 424 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 424 (614)
++|...+.||+|++|.||++..+++..+++|++..... ..+.+.+|+.++++++|+|++++++++. .+..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 35777889999999999999988777899998765432 3467889999999999999999999875 456899999999
Q ss_pred CCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcc
Q 044561 425 NGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT 504 (614)
Q Consensus 425 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 504 (614)
+++|.+++.......+++..+..++.|++.||.||| +.+++||||||+||++++++.+||+|||++...........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence 999999997655556899999999999999999999 48999999999999999999999999999986644332222
Q ss_pred cccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcC
Q 044561 505 TKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGIC 583 (614)
Q Consensus 505 ~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 583 (614)
....++..|+|||......++.++||||||+++|||++ |+.||......+.. .+. ..+... ..
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~---~~~----~~~~~~---------~~ 224 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL---EQV----ERGYRM---------PC 224 (260)
T ss_pred CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHH----HcCCCC---------CC
Confidence 23346778999999988899999999999999999999 89999764432211 111 111100 11
Q ss_pred cHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 584 EEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 584 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+......+.+++.+||++||++||++.+|++
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 225 PQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred CcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1223456788888999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=323.50 Aligned_cols=243 Identities=24% Similarity=0.349 Sum_probs=192.0
Q ss_pred CCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHH---HhcccCCCceeEEeeEEeecCeEEEE
Q 044561 347 FKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELV---SMGRLRHRNLVKLRGYCRRKGEFLLV 419 (614)
Q Consensus 347 f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~---~l~~l~H~niv~l~g~~~~~~~~~lV 419 (614)
|+..+.||+|+||.||++..+. +..||+|++.... ....+.+.+|+. .++.++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 5567899999999999999865 7889999997542 223345555654 45677899999999999999999999
Q ss_pred EEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCC
Q 044561 420 YDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD 499 (614)
Q Consensus 420 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~ 499 (614)
|||+++++|..++.. ..+++.++..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++......
T Consensus 81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 999999999988864 349999999999999999999994 89999999999999999999999999998753322
Q ss_pred CCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccc
Q 044561 500 TIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRL 579 (614)
Q Consensus 500 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 579 (614)
. ......+|++.|+|||.+.+..++.++|||||||++|||++|+.||......+... ....+. ...
T Consensus 155 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~-------~i~~~~------~~~ 220 (324)
T cd05589 155 G-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD-------SIVNDE------VRY 220 (324)
T ss_pred C-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHH-------HHHhCC------CCC
Confidence 2 12334579999999999998899999999999999999999999997654322211 111111 111
Q ss_pred cCcCcHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHh
Q 044561 580 EGICEEKQMELVLKLGLFCSHPKPEARP-----NMRQVM 613 (614)
Q Consensus 580 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl 613 (614)
...+ ...+.+++.+||+.||++|| ++.+++
T Consensus 221 p~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~ 255 (324)
T cd05589 221 PRFL----SREAISIMRRLLRRNPERRLGSGEKDAEDVK 255 (324)
T ss_pred CCCC----CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHh
Confidence 1122 34467788889999999999 466655
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=324.81 Aligned_cols=241 Identities=25% Similarity=0.378 Sum_probs=193.3
Q ss_pred ceeeeeCcEEEEEEEEe----cCcEEEEEEeecC----ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 351 DVIGRGGFGKVYRGVLA----SNVQIAVKKVSHD----SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
+.||+|+||.||+++.. .+..+|+|.+... .......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999863 4678999998753 223345678899999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 502 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 502 (614)
+++++|.+++... ..+.+..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 155 (323)
T cd05584 82 LSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-T 155 (323)
T ss_pred CCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-C
Confidence 9999999998764 347888999999999999999995 899999999999999999999999999987543222 1
Q ss_pred cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCc
Q 044561 503 QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGI 582 (614)
Q Consensus 503 ~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 582 (614)
......||+.|+|||++....++.++|||||||++|||++|+.||......+.. .....+.. .+...
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~-------~~~~~~~~------~~~~~ 222 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTI-------DKILKGKL------NLPPY 222 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHH-------HHHHcCCC------CCCCC
Confidence 233457999999999998888999999999999999999999999765432211 11111111 11112
Q ss_pred CcHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHhC
Q 044561 583 CEEKQMELVLKLGLFCSHPKPEARP-----NMRQVMQ 614 (614)
Q Consensus 583 ~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 614 (614)
. ...+.+++.+|++.||++|| ++.++++
T Consensus 223 ~----~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 223 L----TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred C----CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 2 23567788889999999999 7877753
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=315.37 Aligned_cols=244 Identities=26% Similarity=0.338 Sum_probs=192.6
Q ss_pred eeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecCCCCc
Q 044561 353 IGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSL 428 (614)
Q Consensus 353 lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 428 (614)
||+|+||.||++..+. +..+|+|++.... ....+.+..|++++++++||||+++.+++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 6999999999999865 8899999986432 12234556799999999999999999999999999999999999999
Q ss_pred chhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcccccc
Q 044561 429 DKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLV 508 (614)
Q Consensus 429 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 508 (614)
.+++.......+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++....... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence 998876555568999999999999999999994 899999999999999999999999999998665432 223356
Q ss_pred cCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcHHHH
Q 044561 509 GTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQM 588 (614)
Q Consensus 509 gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~ 588 (614)
|+..|+|||++.+..++.++||||+||++|||++|+.||........ ........ ...... .. ... ..
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~-~~~~~~----~~-~~~----~~ 223 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRT-LEDEVK----FE-HQN----FT 223 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHh-hccccc----cc-ccc----CC
Confidence 89999999999988899999999999999999999999975432111 11111111 111110 00 011 23
Q ss_pred HHHHHHHHHcCCCCCCCCCCHHHHh
Q 044561 589 ELVLKLGLFCSHPKPEARPNMRQVM 613 (614)
Q Consensus 589 ~~l~~l~~~cl~~dP~~RPs~~evl 613 (614)
..+.+++.+||+.||++||+++|++
T Consensus 224 ~~~~~li~~~L~~~P~~R~~~~~~~ 248 (277)
T cd05607 224 EESKDICRLFLAKKPEDRLGSREKN 248 (277)
T ss_pred HHHHHHHHHHhccCHhhCCCCccch
Confidence 3467888889999999999996544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=329.15 Aligned_cols=252 Identities=24% Similarity=0.296 Sum_probs=200.3
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
++|+..+.||+|+||.||++..+. +..+|+|++.... ....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 468889999999999999999864 7889999987542 234567889999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
||+++|+|.+++... ...+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 81 EYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 999999999999764 2358999999999999999999994 899999999999999999999999999998765443
Q ss_pred CCcccccccCCCccchhhhc------CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccc
Q 044561 501 IPQTTKLVGTFGYMDPELMR------TGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDA 574 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~------~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~ 574 (614)
........||+.|+|||++. ...++.++|||||||++|||++|+.||......+... +..........
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~------~i~~~~~~~~~ 230 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYN------NIMNFQRFLKF 230 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHH------HHHcCCCccCC
Confidence 33333457899999999986 4567899999999999999999999997654322111 11111111111
Q ss_pred ccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 575 SDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 575 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+ .......+..|+..|++ +|++||++.++++
T Consensus 231 ~~-------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 231 PE-------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CC-------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 00 00122345667777997 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=323.97 Aligned_cols=236 Identities=22% Similarity=0.330 Sum_probs=190.5
Q ss_pred ceeeeeCcEEEEEEEEec-CcEEEEEEeecC---ChhhHHHHHHHHHHhccc-CCCceeEEeeEEeecCeEEEEEEecCC
Q 044561 351 DVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD---SKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGEFLLVYDYMPN 425 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 425 (614)
+.||+|+||.||+++.+. +..||+|.+... .....+.+..|..++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999875 788999998753 223456677888888776 699999999999999999999999999
Q ss_pred CCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCccc
Q 044561 426 GSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT 505 (614)
Q Consensus 426 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 505 (614)
|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~ 154 (320)
T cd05590 81 GDLMFHIQKS--RRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTS 154 (320)
T ss_pred chHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cccc
Confidence 9999988764 34899999999999999999999 4899999999999999999999999999987543222 1233
Q ss_pred ccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcH
Q 044561 506 KLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEE 585 (614)
Q Consensus 506 ~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~ 585 (614)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+... ....+.. .....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~-------~i~~~~~------~~~~~--- 218 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFE-------AILNDEV------VYPTW--- 218 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHH-------HHhcCCC------CCCCC---
Confidence 4579999999999998889999999999999999999999997654332211 1111111 01111
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCH
Q 044561 586 KQMELVLKLGLFCSHPKPEARPNM 609 (614)
Q Consensus 586 ~~~~~l~~l~~~cl~~dP~~RPs~ 609 (614)
....+.+++.+|++.||++||++
T Consensus 219 -~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 219 -LSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred -CCHHHHHHHHHHcccCHHHCCCC
Confidence 23356778888999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=308.74 Aligned_cols=244 Identities=26% Similarity=0.462 Sum_probs=197.0
Q ss_pred ceeeeeCcEEEEEEEEecCcEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecCCCCcc
Q 044561 351 DVIGRGGFGKVYRGVLASNVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLD 429 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 429 (614)
++||+|+||.||+|...++..+++|.+.... ......+.+|+.++++++||||++++++|...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3699999999999998888899999987654 333457889999999999999999999999999999999999999999
Q ss_pred hhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCccccccc
Q 044561 430 KILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVG 509 (614)
Q Consensus 430 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~g 509 (614)
+++.... ..+++.++..++.|++.+|.||| ..+++||||||+||+++.++.+||+|||++...............+
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 81 SFLRKKK-DELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 9986543 45899999999999999999999 4899999999999999999999999999997654433222222344
Q ss_pred CCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcHHHH
Q 044561 510 TFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQM 588 (614)
Q Consensus 510 t~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~ 588 (614)
+..|+|||++..+.++.++||||||+++||+++ |..||......+.. .....+.... .+....
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~-------~~~~~~~~~~---------~~~~~~ 220 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAR-------EQVEKGYRMS---------CPQKCP 220 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH-------HHHHcCCCCC---------CCCCCC
Confidence 678999999998899999999999999999998 99999754332211 1111111111 111223
Q ss_pred HHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 589 ELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 589 ~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+.+++.+|++.+|++||++.|+++
T Consensus 221 ~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 221 DDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHHH
Confidence 56788899999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=310.33 Aligned_cols=250 Identities=24% Similarity=0.397 Sum_probs=200.7
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC-----hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS-----KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLL 418 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 418 (614)
++|+..+.||+|++|.||++...+ +..+++|.+.... ....+.+.+|+.++++++||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 578889999999999999999754 7889999886432 2234578899999999999999999999999999999
Q ss_pred EEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCC
Q 044561 419 VYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 498 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~ 498 (614)
|+||+++++|.+++... ..+++..+..++.|++.||.||| +.+++||||+|+||++++++++||+|||++.....
T Consensus 82 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 99999999999998763 34889999999999999999999 48999999999999999999999999999976543
Q ss_pred CCCCcc--cccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccc
Q 044561 499 DTIPQT--TKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASD 576 (614)
Q Consensus 499 ~~~~~~--~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 576 (614)
...... ....++..|+|||.+.+..++.++||||||+++|||++|+.||......+. .. ....... .
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~---~~~~~~~-----~ 225 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA---IF---KIATQPT-----N 225 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH---HH---HHhccCC-----C
Confidence 221111 234678899999999988899999999999999999999999865432211 11 1111100 1
Q ss_pred ccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 577 SRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 577 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.. .+......+..++.+||+.+|++|||+.|+++
T Consensus 226 ~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 226 PQ----LPSHVSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred CC----CCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 11 12223345677888999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=329.74 Aligned_cols=244 Identities=24% Similarity=0.350 Sum_probs=203.6
Q ss_pred CCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 347 FKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 347 f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
|+..+.||+|+-|.|-.|+... |+.+|||.+.+.. ......+.+|+.+|+-+.|||++++++++++..++|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 5667889999999999999865 8999999997652 23345678999999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 502 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 502 (614)
+++|-|.++|-.. +.+++.+..++++||+.|+.|+|. .+|+|||+||+|+|||.++++||+|||||.+-..+..
T Consensus 94 v~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl- 167 (786)
T KOG0588|consen 94 VPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL- 167 (786)
T ss_pred cCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCCcc-
Confidence 9999999998763 459999999999999999999994 8999999999999999999999999999987665553
Q ss_pred cccccccCCCccchhhhcCCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccC
Q 044561 503 QTTKLVGTFGYMDPELMRTGKA-STSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEG 581 (614)
Q Consensus 503 ~~~~~~gt~~y~aPE~~~~~~~-t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~ 581 (614)
..+.||++.|.|||++.+.+| ..++||||.||||+.|++|+.||++++. ..+.. ...+|.+.- ..
T Consensus 168 -LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi---r~LLl----KV~~G~f~M------Ps 233 (786)
T KOG0588|consen 168 -LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI---RVLLL----KVQRGVFEM------PS 233 (786)
T ss_pred -ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH---HHHHH----HHHcCcccC------CC
Confidence 345699999999999999887 6899999999999999999999985332 22322 233333321 12
Q ss_pred cCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 582 ICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 582 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+. .+..|+.+|+..||++|.|++||++
T Consensus 234 ~Is~----eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 234 NISS----EAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred cCCH----HHHHHHHHHhccCccccccHHHHhh
Confidence 2333 3455666799999999999999975
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=335.28 Aligned_cols=261 Identities=23% Similarity=0.338 Sum_probs=193.8
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeec--------C
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRK--------G 414 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--------~ 414 (614)
.++|+..+.||+|+||.||+|+..+ +..||+|++..... ...+|+.+++.++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ----YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 4578899999999999999999865 78899999865432 234799999999999999999876432 2
Q ss_pred eEEEEEEecCCCCcchhccc--CCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCC-CEEEeeec
Q 044561 415 EFLLVYDYMPNGSLDKILHT--NIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADL-NGKLGDFG 491 (614)
Q Consensus 415 ~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~-~~kl~DfG 491 (614)
.+++||||+++ +|.+++.. .....+++..+..++.||+.||.|||+ .+|+||||||+|||++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 46799999974 67666643 223468999999999999999999995 8999999999999999665 69999999
Q ss_pred cccccCCCCCCcccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhh----
Q 044561 492 LARLYDHDTIPQTTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCW---- 566 (614)
Q Consensus 492 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~---- 566 (614)
+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|++||.+....+....+..+....
T Consensus 217 la~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~ 294 (440)
T PTZ00036 217 SAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQ 294 (440)
T ss_pred cchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 998665432 22335789999999998654 68999999999999999999999998765443322221111000
Q ss_pred --------hcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 567 --------KKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 567 --------~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..-.+.......+...++......+.+|+.+||+.||++|||+.|+++
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 295 LKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 000011111111111122223356788899999999999999999975
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=329.73 Aligned_cols=255 Identities=23% Similarity=0.271 Sum_probs=198.3
Q ss_pred HHHhcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC---ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeE
Q 044561 341 YKATKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEF 416 (614)
Q Consensus 341 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 416 (614)
....++|+..+.||+|+||.||+++.+. +..+|+|.+... .....+.+.+|+.+++.++||||+++++++..++.+
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 3345679999999999999999999875 778999998642 223345678899999999999999999999999999
Q ss_pred EEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecccccc
Q 044561 417 LLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 496 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~ 496 (614)
++||||+++|+|.+++... .+++.++..++.||+.||.|||+ ++|+||||||+|||+++++.+||+|||++...
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceec
Confidence 9999999999999998653 38889999999999999999994 89999999999999999999999999999876
Q ss_pred CCCCCCcccccccCCCccchhhhcCC----CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcc
Q 044561 497 DHDTIPQTTKLVGTFGYMDPELMRTG----KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIR 572 (614)
Q Consensus 497 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~ 572 (614)
............||+.|+|||++... .++.++||||+||++|||++|+.||......+... +........
T Consensus 193 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~------~i~~~~~~~ 266 (370)
T cd05621 193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYS------KIMDHKNSL 266 (370)
T ss_pred ccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHH------HHHhCCccc
Confidence 54332233456799999999998653 37889999999999999999999997654322111 111110000
Q ss_pred ccccccccCcCcHHHHHHHHHHHHHcCCCCCCC--CCCHHHHhC
Q 044561 573 DASDSRLEGICEEKQMELVLKLGLFCSHPKPEA--RPNMRQVMQ 614 (614)
Q Consensus 573 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~ 614 (614)
. ... .......+..++..|+..++.+ ||++.|+++
T Consensus 267 ~-----~p~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~ 303 (370)
T cd05621 267 N-----FPE--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ 303 (370)
T ss_pred C-----CCC--cccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence 0 111 0112334556667788755543 899999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=315.26 Aligned_cols=253 Identities=24% Similarity=0.440 Sum_probs=199.8
Q ss_pred HhcCCCCcceeeeeCcEEEEEEEEec------CcEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCe
Q 044561 343 ATKGFKDKDVIGRGGFGKVYRGVLAS------NVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGE 415 (614)
Q Consensus 343 ~~~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 415 (614)
++++|+..+.||+|+||.||+|..++ +..+|+|++... ......++.+|+.+++.++||||+++++++...+.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 35678889999999999999998642 456999988643 23345678999999999999999999999999999
Q ss_pred EEEEEEecCCCCcchhcccCC--------CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEE
Q 044561 416 FLLVYDYMPNGSLDKILHTNI--------KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKL 487 (614)
Q Consensus 416 ~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl 487 (614)
.++||||+++++|.+++.... ...+++.++..++.|++.||.|||+ .+++||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEE
Confidence 999999999999999986422 1246788999999999999999994 89999999999999999999999
Q ss_pred eeeccccccCCCCCC-cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHh
Q 044561 488 GDFGLARLYDHDTIP-QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDC 565 (614)
Q Consensus 488 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~ 565 (614)
+|||+++........ ......++..|+|||.+..+.++.++|||||||++|||++ |..||......+.. . .
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~---~----~ 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL---R----F 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH---H----H
Confidence 999998765432211 1122345778999999998889999999999999999999 78888754432211 1 1
Q ss_pred hhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 566 WKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 566 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..++.... .+......+.+++.+|++.||++|||+.|+++
T Consensus 234 ~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 273 (277)
T cd05062 234 VMEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 273 (277)
T ss_pred HHcCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11111111 11122345788999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=310.02 Aligned_cols=252 Identities=27% Similarity=0.460 Sum_probs=200.8
Q ss_pred CCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHH--HHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 347 FKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIK--EFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 347 f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~--~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
|+..+.||+|+||+||+++... +..+|+|.+......... ...+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 4567899999999999999876 568999999877544332 3456999999999999999999999999999999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCc
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 503 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 503 (614)
++++|.+++.. ...+++.++..++.|+++||.+||+ .+++||||||+||++++++.++|+|||.+.... .....
T Consensus 81 ~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQK--NKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNEN 154 (260)
T ss_dssp TTEBHHHHHHH--HSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSE
T ss_pred ccccccccccc--ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-ccccc
Confidence 99999999983 3458999999999999999999995 899999999999999999999999999997642 22223
Q ss_pred ccccccCCCccchhhhc-CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCc
Q 044561 504 TTKLVGTFGYMDPELMR-TGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGI 582 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~-~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 582 (614)
.....++..|+|||++. ...++.++||||+|+++++|++|+.|+......+............ ......
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~--------~~~~~~-- 224 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRP--------LPSSSQ-- 224 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTH--------HHHHTT--
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccc--------cccccc--
Confidence 44567899999999998 7889999999999999999999999998652222222221111100 000000
Q ss_pred CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 583 CEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 583 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
........+.+++.+||+.||++||++.++++
T Consensus 225 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 225 QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00001267888899999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=321.78 Aligned_cols=249 Identities=25% Similarity=0.408 Sum_probs=196.2
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-Cc----EEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NV----QIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLL 418 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 418 (614)
.+|+..+.||+|+||.||+|++.. +. .||+|.+... .....+++.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 468889999999999999999753 33 3899998654 344567889999999999999999999999764 5789
Q ss_pred EEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCC
Q 044561 419 VYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 498 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~ 498 (614)
++||+++|+|.+++.... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccccC
Confidence 999999999999997643 348899999999999999999995 8999999999999999999999999999987654
Q ss_pred CCCCc-ccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCcccccc
Q 044561 499 DTIPQ-TTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASD 576 (614)
Q Consensus 499 ~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 576 (614)
..... .....++..|+|||++....++.++||||||+++|||++ |+.||......+.. .....+....
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-------~~~~~~~~~~--- 231 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-------SILEKGERLP--- 231 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-------HHHhCCCCCC---
Confidence 33211 112234678999999998899999999999999999997 99999754322211 1111111000
Q ss_pred ccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 577 SRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 577 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
....+ ...+.+++.+||+.+|++||++.++++
T Consensus 232 --~~~~~----~~~~~~li~~cl~~~p~~Rps~~~l~~ 263 (316)
T cd05108 232 --QPPIC----TIDVYMIMVKCWMIDADSRPKFRELII 263 (316)
T ss_pred --CCCCC----CHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 01112 234677888999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=323.74 Aligned_cols=241 Identities=24% Similarity=0.345 Sum_probs=193.2
Q ss_pred ceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhccc-CCCceeEEeeEEeecCeEEEEEEecCC
Q 044561 351 DVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGEFLLVYDYMPN 425 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 425 (614)
+.||+|+||.||+|+.++ ++.+|+|.+.... ....+.+..|..++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 469999999999999875 7889999987542 33445677888888765 799999999999999999999999999
Q ss_pred CCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCccc
Q 044561 426 GSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT 505 (614)
Q Consensus 426 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 505 (614)
|+|...+... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++........ ...
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~ 154 (321)
T cd05591 81 GDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTT 154 (321)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCc-ccc
Confidence 9999888754 348999999999999999999994 8999999999999999999999999999875432221 223
Q ss_pred ccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcH
Q 044561 506 KLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEE 585 (614)
Q Consensus 506 ~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~ 585 (614)
...||+.|+|||++....++.++|||||||++|||++|+.||......+.. .. ...+.. .....++
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~---~~----i~~~~~------~~p~~~~- 220 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF---ES----ILHDDV------LYPVWLS- 220 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHH---HH----HHcCCC------CCCCCCC-
Confidence 457899999999999889999999999999999999999999765433221 11 111111 1111122
Q ss_pred HHHHHHHHHHHHcCCCCCCCCC-------CHHHHhC
Q 044561 586 KQMELVLKLGLFCSHPKPEARP-------NMRQVMQ 614 (614)
Q Consensus 586 ~~~~~l~~l~~~cl~~dP~~RP-------s~~evl~ 614 (614)
..+.+++.+|++.||++|| ++.++++
T Consensus 221 ---~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 221 ---KEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred ---HHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 3466778889999999999 7888763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=310.85 Aligned_cols=248 Identities=27% Similarity=0.454 Sum_probs=201.2
Q ss_pred cCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecC
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMP 424 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 424 (614)
++|+..++||+|+||.||+|..+++..+|+|.+..... ...++.+|+.++++++|+|++++++++. .+..+++|||++
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME 83 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence 46788899999999999999988889999999875443 3467889999999999999999999864 567899999999
Q ss_pred CCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcc
Q 044561 425 NGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT 504 (614)
Q Consensus 425 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 504 (614)
+++|.+++.......+++.++..++.|++.||.||| +.+++||||||+||++++++.++|+|||++...........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05067 84 NGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccc
Confidence 999999987655556899999999999999999999 48999999999999999999999999999987653332222
Q ss_pred cccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcC
Q 044561 505 TKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGIC 583 (614)
Q Consensus 505 ~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 583 (614)
....++..|+|||.+....++.++||||||++++||++ |+.||......+.. .. ...+.... .
T Consensus 161 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~---~~----~~~~~~~~-----~---- 224 (260)
T cd05067 161 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI---QN----LERGYRMP-----R---- 224 (260)
T ss_pred cCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHH---HH----HHcCCCCC-----C----
Confidence 23346778999999988889999999999999999999 99999765433221 11 11111111 1
Q ss_pred cHHHHHHHHHHHHHcCCCCCCCCCCHHHHh
Q 044561 584 EEKQMELVLKLGLFCSHPKPEARPNMRQVM 613 (614)
Q Consensus 584 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 613 (614)
+......+.+++.+|++.+|++||++.+++
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~ 254 (260)
T cd05067 225 PDNCPEELYELMRLCWKEKPEERPTFEYLR 254 (260)
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 111234588889999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=330.18 Aligned_cols=253 Identities=27% Similarity=0.405 Sum_probs=198.8
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec------CcEEEEEEeecCC-hhhHHHHHHHHHHhcccC-CCceeEEeeEEeecCe
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS------NVQIAVKKVSHDS-KQGIKEFVAELVSMGRLR-HRNLVKLRGYCRRKGE 415 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~ 415 (614)
.++|...+.||+|+||.||+|+... +..||+|++.... ....+.+.+|+.+++++. ||||++++++|.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 4578888999999999999998632 3469999997543 334567899999999996 9999999999999999
Q ss_pred EEEEEEecCCCCcchhcccCC-----------------------------------------------------------
Q 044561 416 FLLVYDYMPNGSLDKILHTNI----------------------------------------------------------- 436 (614)
Q Consensus 416 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 436 (614)
.+||||||++|+|.+++..+.
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 999999999999998876421
Q ss_pred -----------------------------------CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcC
Q 044561 437 -----------------------------------KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA 481 (614)
Q Consensus 437 -----------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~ 481 (614)
...+++.++..++.|+++||.|||+ .+|+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeC
Confidence 1247888899999999999999994 89999999999999999
Q ss_pred CCCEEEeeeccccccCCCCC-CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHH
Q 044561 482 DLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLV 559 (614)
Q Consensus 482 ~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~ 559 (614)
++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||......+..
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~--- 349 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF--- 349 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH---
Confidence 99999999999986543221 12223456788999999988889999999999999999997 99998754322111
Q ss_pred HHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 560 DWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 560 ~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
......+... . .+......+.+++.+||+.||++||++.+|.+
T Consensus 350 ---~~~~~~~~~~-----~----~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 350 ---YNKIKSGYRM-----A----KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred ---HHHHhcCCCC-----C----CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 1111111100 0 11223356788889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=339.50 Aligned_cols=255 Identities=23% Similarity=0.314 Sum_probs=203.0
Q ss_pred HHHhcCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecC---
Q 044561 341 YKATKGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKG--- 414 (614)
Q Consensus 341 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--- 414 (614)
....++|...+.||+|+||+||+++.. ++..||+|++... .......+.+|+..+..++|+|++++...+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 344578999999999999999999875 4889999998654 3445667889999999999999999988765332
Q ss_pred -----eEEEEEEecCCCCcchhcccCC--CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEE
Q 044561 415 -----EFLLVYDYMPNGSLDKILHTNI--KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKL 487 (614)
Q Consensus 415 -----~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl 487 (614)
.+++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEE
Confidence 3789999999999999986532 3458899999999999999999995 89999999999999999999999
Q ss_pred eeeccccccCCCCC-CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhh
Q 044561 488 GDFGLARLYDHDTI-PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCW 566 (614)
Q Consensus 488 ~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~ 566 (614)
+|||+++....... .......||+.|+|||++....++.++|||||||++|||++|+.||......+.. ...
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~-------~~~ 257 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVM-------HKT 257 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH-------HHH
Confidence 99999987643221 1233467999999999999989999999999999999999999999764332211 111
Q ss_pred hcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 567 KKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 567 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+.... + +......+..++.+||+.||++||++.++++
T Consensus 258 ~~~~~~~-----~----~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 258 LAGRYDP-----L----PPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred hcCCCCC-----C----CCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 1111111 1 1122345778888899999999999999873
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=316.48 Aligned_cols=260 Identities=22% Similarity=0.342 Sum_probs=200.5
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
++|+..+.||+|+||.||++.... +..+++|.+... ......++.+|++++++++||||+++++.|..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 368889999999999999999765 677888887654 333456788999999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 502 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 502 (614)
+++++|.+++... ..+++..+..++.|+++||.|||+ ..+++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 154 (308)
T cd06615 81 MDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 154 (308)
T ss_pred cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence 9999999999764 448899999999999999999996 3689999999999999999999999999987553322
Q ss_pred cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcc----------
Q 044561 503 QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIR---------- 572 (614)
Q Consensus 503 ~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~---------- 572 (614)
.....++..|+|||.+.+..++.++|+||||+++|||++|+.||......... .+...........
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 155 -ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE---AMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred -cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH---HhhcCccccccccCCcccccCCC
Confidence 23357889999999998888999999999999999999999998654321111 1000000000000
Q ss_pred ----------ccccccc---cCcC-cHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 573 ----------DASDSRL---EGIC-EEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 573 ----------~~~d~~l---~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+..+... .... .......+.+++.+|++.||++||++.||++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 286 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTK 286 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000000 0000 0012235788999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=310.37 Aligned_cols=251 Identities=28% Similarity=0.472 Sum_probs=203.5
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
.++|...+.||+|+||.||++..+++..+++|.+..... ..+++.+|+.++++++|+|++++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 357888899999999999999988888899998875433 3467899999999999999999999999989999999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCc
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 503 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 503 (614)
++++|.+++.......+++.++..++.|++.|+.|||+ .+++|+||||+||++++++.+||+|||++..........
T Consensus 84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (261)
T cd05034 84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA 160 (261)
T ss_pred CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhhhh
Confidence 99999999987655569999999999999999999994 899999999999999999999999999998765432222
Q ss_pred ccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCc
Q 044561 504 TTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGI 582 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 582 (614)
.....++..|+|||.+.+..++.++|+||||++++|+++ |+.||......+.. +. ...+. . ..
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~---~~----~~~~~-~----~~---- 224 (261)
T cd05034 161 REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVL---EQ----VERGY-R----MP---- 224 (261)
T ss_pred hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HH----HHcCC-C----CC----
Confidence 222234678999999998889999999999999999998 99999654332211 11 11110 0 00
Q ss_pred CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 583 CEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 583 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+......+.+++.+|++.+|++||+++++++
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 225 RPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 01112346788899999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=339.40 Aligned_cols=249 Identities=24% Similarity=0.344 Sum_probs=204.7
Q ss_pred CCCCcceeeeeCcEEEEEEEEecC-cEEEEEEeecCChhhHHHHHHHHHHhcccC-CCceeEEeeE-Eee------cCeE
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLASN-VQIAVKKVSHDSKQGIKEFVAELVSMGRLR-HRNLVKLRGY-CRR------KGEF 416 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~-~~~------~~~~ 416 (614)
+.++.+.|.+|||+.||.+....+ .++|+|++...+++..+.+.+|+++|++|+ |+|||.+++. ... .-++
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev 117 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV 117 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence 345678899999999999999875 999999998889999999999999999997 9999999993 221 2378
Q ss_pred EEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecccccc
Q 044561 417 LLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 496 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~ 496 (614)
+|.||||++|+|-+++..+....|++.++++|+.|+++|+++||.. +.+|||||||-+||||..+++.||||||-+.-.
T Consensus 118 llLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~ 196 (738)
T KOG1989|consen 118 LLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTK 196 (738)
T ss_pred EeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence 9999999999999999977666699999999999999999999964 788999999999999999999999999998643
Q ss_pred CCCC-CC-------cccccccCCCccchhhhc---CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHh
Q 044561 497 DHDT-IP-------QTTKLVGTFGYMDPELMR---TGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDC 565 (614)
Q Consensus 497 ~~~~-~~-------~~~~~~gt~~y~aPE~~~---~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~ 565 (614)
-... .. ..-...-|+.|.|||.+. +...++|+|||+|||+||-||....||+..+.-.++
T Consensus 197 ~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIl--------- 267 (738)
T KOG1989|consen 197 ILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAIL--------- 267 (738)
T ss_pred cCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEE---------
Confidence 3221 10 111124589999999864 567899999999999999999999999876443222
Q ss_pred hhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 566 WKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 566 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+....--........+..|+..||++||++||++-||++
T Consensus 268 ----------ng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~ 306 (738)
T KOG1989|consen 268 ----------NGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLE 306 (738)
T ss_pred ----------eccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHH
Confidence 122111112456778889999999999999999999873
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=314.87 Aligned_cols=251 Identities=25% Similarity=0.413 Sum_probs=198.6
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-----cCcEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-----SNVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLL 418 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 418 (614)
++|+..+.||+|+||.||+|... .+..+++|.+... ..+...++.+|+.++++++||||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 45777889999999999999852 3577999998753 34455788999999999999999999999999999999
Q ss_pred EEEecCCCCcchhcccCC---------------CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCC
Q 044561 419 VYDYMPNGSLDKILHTNI---------------KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADL 483 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~ 483 (614)
||||+++++|.+++.... ...+++.+...++.|++.||.|||+ ++++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence 999999999999985321 2347899999999999999999994 8999999999999999999
Q ss_pred CEEEeeeccccccCCCCC-CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHH
Q 044561 484 NGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDW 561 (614)
Q Consensus 484 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~ 561 (614)
.+||+|||++........ .......++..|+|||.+....++.++||||||+++|||++ |..||......+.. +
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~---~- 237 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI---E- 237 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH---H-
Confidence 999999999976543221 11223345778999999988889999999999999999998 99998654332211 1
Q ss_pred HHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 562 VCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 562 v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
....+.... .... ....+.+++.+|+++||++||++.+|++
T Consensus 238 ---~~~~~~~~~-----~~~~----~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 278 (283)
T cd05090 238 ---MVRKRQLLP-----CSED----CPPRMYSLMTECWQEGPSRRPRFKDIHT 278 (283)
T ss_pred ---HHHcCCcCC-----CCCC----CCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 111111111 1112 2345777888999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=316.55 Aligned_cols=251 Identities=29% Similarity=0.486 Sum_probs=202.6
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe------cCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA------SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLL 418 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 418 (614)
.+|...+.||+|+||.||+|+.. ++..+++|.+........+.+.+|+.++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 34677789999999999999853 245688999877776667789999999999999999999999999999999
Q ss_pred EEEecCCCCcchhcccCC--------------CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCC
Q 044561 419 VYDYMPNGSLDKILHTNI--------------KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLN 484 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~ 484 (614)
||||+++++|.+++.... ...+++.+++.++.||+.||.||| .++|+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCc
Confidence 999999999999986532 234899999999999999999999 489999999999999999999
Q ss_pred EEEeeeccccccCCCCC-CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHH
Q 044561 485 GKLGDFGLARLYDHDTI-PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWV 562 (614)
Q Consensus 485 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v 562 (614)
+||+|||++........ .......++..|+|||.+....++.++||||||+++|||++ |+.||......+.
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~------- 234 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV------- 234 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------
Confidence 99999999976543221 11233456788999999988889999999999999999998 9999876543321
Q ss_pred HHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 563 CDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 563 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+....+..... .......+.+++.+||+.||++||++++|++
T Consensus 235 ~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 235 IECITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHHHhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 112222222211 1112345778899999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=306.86 Aligned_cols=264 Identities=23% Similarity=0.320 Sum_probs=207.5
Q ss_pred CCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChh--hHHHHHHHHHHhcccCCCc-eeEEeeEEeecC------e
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQ--GIKEFVAELVSMGRLRHRN-LVKLRGYCRRKG------E 415 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~------~ 415 (614)
.|...++||+|.||+||+|+.+. |..||+|++..+.++ .-....+|+.++++++|+| |+++.+++...+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 45556779999999999999865 889999999876542 3345689999999999999 999999998877 8
Q ss_pred EEEEEEecCCCCcchhcccCCC--CCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccc
Q 044561 416 FLLVYDYMPNGSLDKILHTNIK--PCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLA 493 (614)
Q Consensus 416 ~~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla 493 (614)
+++|+||+ ..+|..++..... ..++...+..++.||+.||+|||+ .+|+||||||+|||++++|.+||+|||+|
T Consensus 92 l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccchH
Confidence 99999999 5689999876543 357778899999999999999995 89999999999999999999999999999
Q ss_pred cccCCCCCCcccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcc
Q 044561 494 RLYDHDTIPQTTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIR 572 (614)
Q Consensus 494 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~ 572 (614)
+...-+.. ..+..++|..|.|||++.+. .|+...||||+||++.||++++.-|.+..+.+++..+-.+.....+..++
T Consensus 168 ra~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp 246 (323)
T KOG0594|consen 168 RAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP 246 (323)
T ss_pred HHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence 97654332 24556899999999999876 78999999999999999999999998877655554444333333333333
Q ss_pred ccc---cc--cccCcC-----cH---HHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 573 DAS---DS--RLEGIC-----EE---KQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 573 ~~~---d~--~l~~~~-----~~---~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
... +- ...... .. .......+++.+|++.+|.+|.|++.+++
T Consensus 247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~ 301 (323)
T KOG0594|consen 247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALT 301 (323)
T ss_pred CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhc
Confidence 222 11 111110 01 11135778888899999999999998874
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=320.72 Aligned_cols=240 Identities=23% Similarity=0.361 Sum_probs=190.9
Q ss_pred ceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhcc-cCCCceeEEeeEEeecCeEEEEEEecCC
Q 044561 351 DVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGR-LRHRNLVKLRGYCRRKGEFLLVYDYMPN 425 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~~~~~~lV~E~~~~ 425 (614)
+.||+|+||.||+|...+ +..||+|.+.... ....+.+..|..++.. ++||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999875 7889999987542 2234556677777775 4899999999999999999999999999
Q ss_pred CCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCccc
Q 044561 426 GSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT 505 (614)
Q Consensus 426 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 505 (614)
|+|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++....... ....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (316)
T cd05619 81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTC 154 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Ccee
Confidence 9999998753 348899999999999999999994 899999999999999999999999999987532221 1223
Q ss_pred ccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcH
Q 044561 506 KLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEE 585 (614)
Q Consensus 506 ~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~ 585 (614)
...||..|+|||++.+..++.++|||||||++|||++|+.||......+... .+ ..+. +......
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~---~i----~~~~------~~~~~~~-- 219 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQ---SI----RMDN------PCYPRWL-- 219 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHH---HH----HhCC------CCCCccC--
Confidence 4578999999999998889999999999999999999999997654322211 11 1111 1111112
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCHH-HHh
Q 044561 586 KQMELVLKLGLFCSHPKPEARPNMR-QVM 613 (614)
Q Consensus 586 ~~~~~l~~l~~~cl~~dP~~RPs~~-evl 613 (614)
...+.+++.+|++.||++||++. +++
T Consensus 220 --~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 220 --TREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred --CHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 23466778889999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=313.83 Aligned_cols=245 Identities=26% Similarity=0.340 Sum_probs=194.0
Q ss_pred eeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecCCCCc
Q 044561 353 IGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSL 428 (614)
Q Consensus 353 lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 428 (614)
||+|+||+||++.... ++.+|+|++.... ....+.+..|+.++++++|+||+++.+++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 6999999999999764 7889999987542 22345678899999999999999999999999999999999999999
Q ss_pred chhcccC--CCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcccc
Q 044561 429 DKILHTN--IKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTK 506 (614)
Q Consensus 429 ~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 506 (614)
..++... ....+++.++..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 8887532 23458999999999999999999995 8999999999999999999999999999976544322 2233
Q ss_pred cccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcHH
Q 044561 507 LVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEK 586 (614)
Q Consensus 507 ~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~ 586 (614)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||......... .........+. . ..+..
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~------~----~~~~~ 223 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN---KELKQRILNDS------V----TYPDK 223 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH---HHHHHhhcccC------C----CCccc
Confidence 57899999999999999999999999999999999999999754322111 00111110100 0 11222
Q ss_pred HHHHHHHHHHHcCCCCCCCCC-----CHHHHhC
Q 044561 587 QMELVLKLGLFCSHPKPEARP-----NMRQVMQ 614 (614)
Q Consensus 587 ~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 614 (614)
....+.+++.+|++.||++|| ++.++++
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 334577888889999999999 6777763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=321.91 Aligned_cols=241 Identities=22% Similarity=0.334 Sum_probs=193.1
Q ss_pred CCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhccc-CCCceeEEeeEEeecCeEEEEE
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 420 (614)
+|+..+.||+|+||.||+|+.+. +..+|+|.+.... ....+.+..|..++..+ +|++|+++++++...+.+++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 47778999999999999999875 6789999987542 22344567788887776 5899999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
||+++|+|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+|||+++++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 81 EYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 999999999988764 348999999999999999999994 899999999999999999999999999997543222
Q ss_pred CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
. ......||+.|+|||++....++.++|||||||++|||++|+.||......+.. ..+. +... .
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~---~~i~----~~~~------~-- 219 (323)
T cd05616 156 V-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF---QSIM----EHNV------A-- 219 (323)
T ss_pred C-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHH---HHHH----hCCC------C--
Confidence 1 223457999999999999999999999999999999999999999765432221 1111 1111 1
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCCCH
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARPNM 609 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 609 (614)
++......+..++.+|++.||++|++.
T Consensus 220 --~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 220 --YPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred --CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 111223456778888999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=315.24 Aligned_cols=249 Identities=23% Similarity=0.396 Sum_probs=202.7
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
++|+..+.||+|+||.||+|+.. ++..+++|.+........+.+.+|+.+++.++|+|++++++.+......++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 47888899999999999999975 47889999998765555677889999999999999999999999999999999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCc
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 503 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 503 (614)
++++|.+++... .+++.++..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++........ .
T Consensus 100 ~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~ 172 (296)
T cd06654 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (296)
T ss_pred CCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhcccccc-c
Confidence 999999998643 48899999999999999999995 8999999999999999999999999999876543321 1
Q ss_pred ccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcC
Q 044561 504 TTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGIC 583 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 583 (614)
.....+++.|+|||.+....++.++|||||||++|||++|+.||......+.. . .....+ .... ..
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~--~----~~~~~~-~~~~-------~~ 238 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--Y----LIATNG-TPEL-------QN 238 (296)
T ss_pred cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH--H----HHhcCC-CCCC-------CC
Confidence 23346889999999998888899999999999999999999999754432111 0 111111 0000 01
Q ss_pred cHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 584 EEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 584 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+......+.+++.+||..||++||++.++++
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred ccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 1223345778889999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=310.03 Aligned_cols=252 Identities=25% Similarity=0.382 Sum_probs=200.6
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
++|+..+.||+|+||.||+|+.. ++..+++|++........+.+.+|+.++++++||||+++++++..++..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 46888899999999999999975 47889999987665555667889999999999999999999999999999999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCc
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 503 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 503 (614)
++++|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++........ .
T Consensus 89 ~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~ 162 (267)
T cd06646 89 GGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-K 162 (267)
T ss_pred CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeeccccc-c
Confidence 999999998753 358999999999999999999994 8999999999999999999999999999986643221 1
Q ss_pred ccccccCCCccchhhhc---CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 504 TTKLVGTFGYMDPELMR---TGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~---~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
.....++..|+|||.+. ...++.++|||||||+++||++|+.|+......+..... ..... ..+...
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~-------~~~~~---~~~~~~ 232 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-------SKSNF---QPPKLK 232 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee-------ecCCC---CCCCCc
Confidence 23346889999999874 345788999999999999999999998644322111100 00000 111111
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
. .......+.+++.+||+.+|++||++.++++
T Consensus 233 ~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 264 (267)
T cd06646 233 D--KTKWSSTFHNFVKISLTKNPKKRPTAERLLT 264 (267)
T ss_pred c--ccccCHHHHHHHHHHhhCChhhCcCHHHHhc
Confidence 0 1112346778889999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=312.90 Aligned_cols=252 Identities=24% Similarity=0.376 Sum_probs=198.7
Q ss_pred HhcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhccc-CCCceeEEeeEEeec------C
Q 044561 343 ATKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRK------G 414 (614)
Q Consensus 343 ~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~------~ 414 (614)
++..|+..+.||+|+||.||+|...+ ++.+|+|++..... ...++.+|+.+++++ +|+|++++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 45667888899999999999999865 78899998865433 345778899999998 699999999998753 4
Q ss_pred eEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecccc
Q 044561 415 EFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR 494 (614)
Q Consensus 415 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~ 494 (614)
.++++|||+++++|.+++.......+++..+..++.|++.||.|||+ ++|+||||||+||++++++.+||+|||++.
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 68999999999999999987545568999999999999999999995 899999999999999999999999999998
Q ss_pred ccCCCCCCcccccccCCCccchhhhc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcC
Q 044561 495 LYDHDTIPQTTKLVGTFGYMDPELMR-----TGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKG 569 (614)
Q Consensus 495 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~ 569 (614)
...... .......|+..|+|||++. ...++.++|||||||++|||++|+.||.......... .. ...
T Consensus 160 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~------~~-~~~ 231 (272)
T cd06637 160 QLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF------LI-PRN 231 (272)
T ss_pred eccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH------HH-hcC
Confidence 654322 1233457899999999986 3357889999999999999999999996433211111 00 111
Q ss_pred CccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 570 AIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 570 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
...... .......+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 232 PAPRLK--------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCCCCC--------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 111111 1112345778888999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=315.49 Aligned_cols=250 Identities=28% Similarity=0.493 Sum_probs=201.3
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe------cCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA------SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLL 418 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 418 (614)
.+|...+.||+|+||.||++... ++..+++|.+........+.+.+|+.++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46788899999999999999852 245689999887766677789999999999999999999999999999999
Q ss_pred EEEecCCCCcchhcccCC-----------CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEE
Q 044561 419 VYDYMPNGSLDKILHTNI-----------KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKL 487 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl 487 (614)
||||+++++|.+++.... ...+++.++..++.|++.||+||| +.+++||||||+||++++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEe
Confidence 999999999999986432 234899999999999999999999 489999999999999999999999
Q ss_pred eeeccccccCCCCC-CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHh
Q 044561 488 GDFGLARLYDHDTI-PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDC 565 (614)
Q Consensus 488 ~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~ 565 (614)
+|||+++....... .......++..|+|||.+....++.++|||||||+++||++ |+.||......+.. +.
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~-------~~ 234 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI-------EC 234 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HH
Confidence 99999986543221 11223345778999999988889999999999999999998 89998655432211 11
Q ss_pred hhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHh
Q 044561 566 WKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVM 613 (614)
Q Consensus 566 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 613 (614)
...+.... ....+ ...+.+++.+||++||.+|||+.|++
T Consensus 235 i~~~~~~~-----~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~v~ 273 (288)
T cd05093 235 ITQGRVLQ-----RPRTC----PKEVYDLMLGCWQREPHMRLNIKEIH 273 (288)
T ss_pred HHcCCcCC-----CCCCC----CHHHHHHHHHHccCChhhCCCHHHHH
Confidence 22222111 11112 23578889999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=319.29 Aligned_cols=264 Identities=21% Similarity=0.312 Sum_probs=199.5
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCCh-hhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSK-QGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
++|...+.||+|+||.||+|+.+. +..+|+|++..... .....+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 468888999999999999999864 77899999875432 2334677899999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 502 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 502 (614)
+++ +|.+++... ...+++.++..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++........
T Consensus 86 ~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 159 (309)
T cd07872 86 LDK-DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK- 159 (309)
T ss_pred CCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence 974 788877654 2348899999999999999999994 8999999999999999999999999999976543221
Q ss_pred cccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccc------c
Q 044561 503 QTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDA------S 575 (614)
Q Consensus 503 ~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~------~ 575 (614)
......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+..+....+...........+... .
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 1223467899999998865 46789999999999999999999999876554433333221111000000000 0
Q ss_pred cccccCc-------CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 576 DSRLEGI-------CEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 576 d~~l~~~-------~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+...... ........+.+++.+|++.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0000000 00112334678888999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=309.90 Aligned_cols=250 Identities=25% Similarity=0.364 Sum_probs=197.4
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
++|+..+.||+|+||.||+|+.. .+..+|+|.+... .....+++.+|++++++++|||++++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 35777889999999999999975 4788999998755 334456789999999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 502 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 502 (614)
+++++|..+. .+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-- 149 (279)
T cd06619 81 MDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-- 149 (279)
T ss_pred CCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence 9999997542 36788899999999999999994 899999999999999999999999999997654332
Q ss_pred cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCc
Q 044561 503 QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGI 582 (614)
Q Consensus 503 ~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 582 (614)
.....|+..|+|||++.+..++.++|+||||+++|||++|+.||......+.........+...... .+.+.
T Consensus 150 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~-- 221 (279)
T cd06619 150 -AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVLP-- 221 (279)
T ss_pred -ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCCC--
Confidence 2335789999999999888899999999999999999999999965332221111111111111111 11111
Q ss_pred CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 583 CEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 583 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.......+.+++.+|++.||++||++.|+++
T Consensus 222 -~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 222 -VGQFSEKFVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred -CCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 1112235778888999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=320.24 Aligned_cols=243 Identities=26% Similarity=0.328 Sum_probs=193.7
Q ss_pred ceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhccc-CCCceeEEeeEEeecCeEEEEEEecCC
Q 044561 351 DVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGEFLLVYDYMPN 425 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 425 (614)
+.||+|+||.||++.... +..+|+|.+.... ....+.+..|+.++.++ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999865 7889999997642 23456678899998888 699999999999999999999999999
Q ss_pred CCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCccc
Q 044561 426 GSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT 505 (614)
Q Consensus 426 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 505 (614)
|+|..++... ..+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....... ....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (327)
T cd05617 81 GDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTS 154 (327)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Ccee
Confidence 9999888653 349999999999999999999995 899999999999999999999999999987532211 1233
Q ss_pred ccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcH
Q 044561 506 KLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEE 585 (614)
Q Consensus 506 ~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~ 585 (614)
..+||+.|+|||++.+..++.++|||||||++|||++|+.||............++..+....... .+....+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~~p~~~~- 227 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI------RIPRFLS- 227 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC------CCCCCCC-
Confidence 457999999999999989999999999999999999999999754333333333333333322211 1111222
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCH
Q 044561 586 KQMELVLKLGLFCSHPKPEARPNM 609 (614)
Q Consensus 586 ~~~~~l~~l~~~cl~~dP~~RPs~ 609 (614)
..+.+++.+|++.||++||++
T Consensus 228 ---~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 228 ---VKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred ---HHHHHHHHHHhccCHHHcCCC
Confidence 345677788999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=312.15 Aligned_cols=250 Identities=24% Similarity=0.339 Sum_probs=199.6
Q ss_pred CCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 347 FKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 347 f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
|+..+.||+|+||.||++.... ++.+|+|++.... ....+.+.+|+.++++++|+|++++++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 6677899999999999999875 7889999986542 22345678899999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 502 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 502 (614)
+++++|.+++.......+++.++..++.|++.||.|||+ .+|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence 999999999865444568999999999999999999994 899999999999999999999999999987654322
Q ss_pred cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCc
Q 044561 503 QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGI 582 (614)
Q Consensus 503 ~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 582 (614)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||.................... ......
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~---------~~~~~~ 227 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ---------EEYSEK 227 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh---------hhcCcc
Confidence 11234789999999999988999999999999999999999999976433211111111111000 111112
Q ss_pred CcHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHhC
Q 044561 583 CEEKQMELVLKLGLFCSHPKPEARPN-----MRQVMQ 614 (614)
Q Consensus 583 ~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 614 (614)
+ ...+.+++.+||+.||++||| +.|+++
T Consensus 228 ~----~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 228 F----SPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred C----CHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 2 234677888899999999999 888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=320.69 Aligned_cols=241 Identities=24% Similarity=0.343 Sum_probs=193.7
Q ss_pred ceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhccc-CCCceeEEeeEEeecCeEEEEEEecCC
Q 044561 351 DVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGEFLLVYDYMPN 425 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 425 (614)
+.||+|+||.||++..+. +..+|+|.+.... ....+.+..|..++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999875 7789999987542 23445677888888877 699999999999999999999999999
Q ss_pred CCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCccc
Q 044561 426 GSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT 505 (614)
Q Consensus 426 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 505 (614)
|+|..++... ..+++.++..++.|++.||.|||+ .+|+||||||+||++++++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (318)
T cd05570 81 GDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTS 154 (318)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cccc
Confidence 9999888764 348999999999999999999994 899999999999999999999999999987532221 1223
Q ss_pred ccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcH
Q 044561 506 KLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEE 585 (614)
Q Consensus 506 ~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~ 585 (614)
..+|++.|+|||++.+..++.++|||||||++|||++|+.||......+.. .....+.. ....
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~-------~~i~~~~~------~~~~---- 217 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF-------QSILEDEV------RYPR---- 217 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHH-------HHHHcCCC------CCCC----
Confidence 357899999999999989999999999999999999999999754432211 11111111 1111
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCH-----HHHhC
Q 044561 586 KQMELVLKLGLFCSHPKPEARPNM-----RQVMQ 614 (614)
Q Consensus 586 ~~~~~l~~l~~~cl~~dP~~RPs~-----~evl~ 614 (614)
.....+.+++.+||+.||++||++ .++++
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 218 WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 123456788889999999999999 87763
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=320.95 Aligned_cols=240 Identities=22% Similarity=0.342 Sum_probs=190.7
Q ss_pred ceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhcc-cCCCceeEEeeEEeecCeEEEEEEecCC
Q 044561 351 DVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGR-LRHRNLVKLRGYCRRKGEFLLVYDYMPN 425 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~~~~~~lV~E~~~~ 425 (614)
+.||+|+||.||+|+.+. +..||+|.+.... ....+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 469999999999999875 7889999987542 2234556677777765 4899999999999999999999999999
Q ss_pred CCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCccc
Q 044561 426 GSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT 505 (614)
Q Consensus 426 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 505 (614)
|+|..++... ..+++.++..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (316)
T cd05620 81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRAS 154 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Ccee
Confidence 9999988764 348899999999999999999994 899999999999999999999999999987532221 1234
Q ss_pred ccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcH
Q 044561 506 KLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEE 585 (614)
Q Consensus 506 ~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~ 585 (614)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. +....+ .+.+....+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~-------~~~~~~------~~~~~~~~~- 220 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELF-------ESIRVD------TPHYPRWIT- 220 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhC------CCCCCCCCC-
Confidence 467999999999999889999999999999999999999999765432211 111111 111111222
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCHH-HHh
Q 044561 586 KQMELVLKLGLFCSHPKPEARPNMR-QVM 613 (614)
Q Consensus 586 ~~~~~l~~l~~~cl~~dP~~RPs~~-evl 613 (614)
..+.+++.+|++.||++||++. +++
T Consensus 221 ---~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 221 ---KESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred ---HHHHHHHHHHccCCHHHcCCChHHHH
Confidence 3466778889999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=314.39 Aligned_cols=263 Identities=24% Similarity=0.304 Sum_probs=194.2
Q ss_pred CCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCCh--hhHHHHHHHHHHhccc---CCCceeEEeeEEee-----cC
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSK--QGIKEFVAELVSMGRL---RHRNLVKLRGYCRR-----KG 414 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~-----~~ 414 (614)
+|+..+.||+|+||.||+|..+. +..+|+|.+..... .....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 47778899999999999999875 78899998865321 1223445666666554 79999999998764 34
Q ss_pred eEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecccc
Q 044561 415 EFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR 494 (614)
Q Consensus 415 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~ 494 (614)
..+++|||++ ++|.+++.......+++.++..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++.
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 6899999997 588888876555568999999999999999999995 899999999999999999999999999998
Q ss_pred ccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccc-
Q 044561 495 LYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRD- 573 (614)
Q Consensus 495 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~- 573 (614)
...... ......+|..|+|||++.+..++.++||||+||++|||++|++||......+....+...........+..
T Consensus 157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 157 IYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 765332 22335689999999999888899999999999999999999999976543322211111000000000000
Q ss_pred ------cccccc---cCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 574 ------ASDSRL---EGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 574 ------~~d~~l---~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
...+.. ...+.....+.+.+++.+|+++||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000 00111123345778888999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=307.77 Aligned_cols=244 Identities=27% Similarity=0.467 Sum_probs=193.5
Q ss_pred ceeeeeCcEEEEEEEEe-cCcEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecCCCCc
Q 044561 351 DVIGRGGFGKVYRGVLA-SNVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSL 428 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 428 (614)
+.||+|+||.||+|... ++..+++|.+... .......+.+|++++++++||||++++++|...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999986 4888999987654 344556799999999999999999999999999999999999999999
Q ss_pred chhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcc-ccc
Q 044561 429 DKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT-TKL 507 (614)
Q Consensus 429 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~-~~~ 507 (614)
.+++... ...+++.++..++.|+++||.||| +.+++||||||+||+++.++.+||+|||++........... ...
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 81 LTFLRTE-GPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 9998653 235899999999999999999999 48999999999999999999999999999876443221111 111
Q ss_pred ccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcHH
Q 044561 508 VGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEK 586 (614)
Q Consensus 508 ~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~ 586 (614)
..+..|+|||.+..+.++.++||||||+++|||++ |..||......+.. .....+. ....+..
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~-------~~~~~~~---------~~~~~~~ 220 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTR-------EAIEQGV---------RLPCPEL 220 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHH-------HHHHcCC---------CCCCccc
Confidence 23457999999998889999999999999999998 88888654322111 1111110 0011222
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 587 QMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 587 ~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
....+.+++.+|++++|++|||+.||++
T Consensus 221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 221 CPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 2346788889999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=324.02 Aligned_cols=250 Identities=23% Similarity=0.362 Sum_probs=210.7
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCe-EEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGE-FLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-~~lV~ 420 (614)
++|...+++|+|+||.++..+.+. +..+++|++... .....+...+|+.++++++|||||.+.+.+.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 457778899999999999988764 778999998654 33334567899999999999999999999999888 99999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
+||+||+|.+.+.......++++.+..++.|++.|+.||| +..|+|||||+.||+++.+..+||+|||+|+......
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 9999999999998876677999999999999999999999 4899999999999999999999999999999887664
Q ss_pred CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
. ....++||+.||.||++.+.+|..|+|||||||++|||++-+++|...+... ++..+.+. . .
T Consensus 161 ~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---Li~ki~~~----~----~----- 223 (426)
T KOG0589|consen 161 S-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---LILKINRG----L----Y----- 223 (426)
T ss_pred h-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---HHHHHhhc----c----C-----
Confidence 2 2345799999999999999999999999999999999999999998765433 22222111 1 1
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.-.+......+..++..|+..+|+.||++.++|.
T Consensus 224 ~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~ 257 (426)
T KOG0589|consen 224 SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLR 257 (426)
T ss_pred CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhh
Confidence 1123444556778888899999999999999974
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=327.43 Aligned_cols=259 Identities=23% Similarity=0.273 Sum_probs=201.2
Q ss_pred HHHHHHHhcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC---ChhhHHHHHHHHHHhcccCCCceeEEeeEEee
Q 044561 337 YKDLYKATKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRR 412 (614)
Q Consensus 337 ~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 412 (614)
..++....++|+..+.||+|+||.||++..+. +..+|+|.+... .....+.+.+|+.+++.++||||+++++.+..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 44555566899999999999999999999875 778999998643 22334567889999999999999999999999
Q ss_pred cCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecc
Q 044561 413 KGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGL 492 (614)
Q Consensus 413 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGl 492 (614)
.+.+++||||+++|+|.+++... .++...+..++.||+.||.|||+ ++|+||||||+|||++.++++||+|||+
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 99999999999999999998653 37888899999999999999994 8999999999999999999999999999
Q ss_pred ccccCCCCCCcccccccCCCccchhhhcCC----CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhc
Q 044561 493 ARLYDHDTIPQTTKLVGTFGYMDPELMRTG----KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKK 568 (614)
Q Consensus 493 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~ 568 (614)
+...............||+.|+|||++... .++.++|||||||++|||++|+.||......+.. ......
T Consensus 189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~------~~i~~~ 262 (371)
T cd05622 189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY------SKIMNH 262 (371)
T ss_pred eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHH------HHHHcC
Confidence 987654433333456799999999998653 3789999999999999999999999765432211 111111
Q ss_pred CCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCC--CCCHHHHhC
Q 044561 569 GAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEA--RPNMRQVMQ 614 (614)
Q Consensus 569 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~ 614 (614)
.......+ .......+..++.+|+..++.+ ||++.|+++
T Consensus 263 ~~~~~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~ 303 (371)
T cd05622 263 KNSLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 303 (371)
T ss_pred CCcccCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhc
Confidence 11011100 1112344666777899844433 789998864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=311.17 Aligned_cols=249 Identities=23% Similarity=0.316 Sum_probs=198.6
Q ss_pred CCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 347 FKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 347 f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
|+..+.||+|+||+||++.... ++.+|+|.+.... ......+.+|+.+++.++|+|++++.+.+..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 5667889999999999999864 7889999986542 22345578899999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 502 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 502 (614)
+++++|.+++.......+++..+..++.|++.||.|||+ .+|+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-- 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence 999999988876444569999999999999999999994 899999999999999999999999999997654322
Q ss_pred cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCc
Q 044561 503 QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGI 582 (614)
Q Consensus 503 ~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 582 (614)
......|+..|+|||++.+..++.++|+||||+++|||++|+.||...........+ .....++. ...
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~---~~~~~~~~------~~~--- 224 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV---DRRVLETE------EVY--- 224 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHhhhccc------ccc---
Confidence 223357899999999998888999999999999999999999999764432221111 11111110 011
Q ss_pred CcHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHh
Q 044561 583 CEEKQMELVLKLGLFCSHPKPEARPN-----MRQVM 613 (614)
Q Consensus 583 ~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl 613 (614)
.......+.+++..|++.||++||+ +.+++
T Consensus 225 -~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~ 259 (285)
T cd05632 225 -SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVK 259 (285)
T ss_pred -CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHH
Confidence 1122334677888899999999999 55665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=315.07 Aligned_cols=257 Identities=23% Similarity=0.386 Sum_probs=197.2
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-----cCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEee--cCeEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-----SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRR--KGEFL 417 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~ 417 (614)
++|+..+.||+|+||.||++..+ .+..|++|++........+.+.+|++++++++|||++++.+++.. ...++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46778899999999999999853 367899999987777777889999999999999999999998754 34689
Q ss_pred EEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccC
Q 044561 418 LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYD 497 (614)
Q Consensus 418 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~ 497 (614)
+||||+++++|.+++... ...+++..+..++.|++.||.|||+ .+++||||||+||++++++.+||+|||++....
T Consensus 84 lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 999999999999998754 2358999999999999999999994 899999999999999999999999999998764
Q ss_pred CCCCCc--ccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccc--------c-ccHHHHHHHhh
Q 044561 498 HDTIPQ--TTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSME--------T-VNLVDWVCDCW 566 (614)
Q Consensus 498 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~--------~-~~l~~~v~~~~ 566 (614)
...... .....++..|+|||++.+..++.++||||||++++||++|..|+....... . ........+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 332111 111223456999999988889999999999999999999887754321100 0 00000011111
Q ss_pred hcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 567 KKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 567 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+. ....+......+.+++.+||+++|++|||+.||++
T Consensus 240 ~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 240 KNNG---------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred hcCC---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 1100 00011122346888899999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=308.13 Aligned_cols=256 Identities=26% Similarity=0.438 Sum_probs=203.2
Q ss_pred HHHHhcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEE
Q 044561 340 LYKATKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLL 418 (614)
Q Consensus 340 l~~~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 418 (614)
+..+++.+.....||+|+||.||+|...+ +..+++|.+........+.+.+|+.++++++|+||+++++++...+..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 34566777778899999999999999764 77899999887777777889999999999999999999999999999999
Q ss_pred EEEecCCCCcchhcccCCCCCc--ChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcC-CCCEEEeeeccccc
Q 044561 419 VYDYMPNGSLDKILHTNIKPCL--NWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA-DLNGKLGDFGLARL 495 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~-~~~~kl~DfGla~~ 495 (614)
|+||+++++|.+++.... ..+ ++..+..++.||+.||.|||+ .+|+||||||+||+++. ++.+||+|||++..
T Consensus 83 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 83 FMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 999999999999987642 224 788889999999999999994 89999999999999976 67999999999876
Q ss_pred cCCCCCCcccccccCCCccchhhhcCCC--CCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccc
Q 044561 496 YDHDTIPQTTKLVGTFGYMDPELMRTGK--ASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRD 573 (614)
Q Consensus 496 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~ 573 (614)
...... ......++..|+|||++.... ++.++||||||+++|||++|+.||......... .+......
T Consensus 159 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~~~~~~~~------ 228 (268)
T cd06624 159 LAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---MFKVGMFK------ 228 (268)
T ss_pred cccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---Hhhhhhhc------
Confidence 543221 222346789999999986543 788999999999999999999998653321111 01000000
Q ss_pred cccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 574 ASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 574 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+. .+....+.+..++.+|++++|++|||+.|+++
T Consensus 229 -~~~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 229 -IHPE----IPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred -cCCC----CCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0111 12223345778888999999999999999974
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=307.56 Aligned_cols=253 Identities=27% Similarity=0.412 Sum_probs=202.2
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecC---ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
.+|+..+.||+|+||.||+|+.. ++..+++|++... .......+.+|+.+++.++|||++++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46888899999999999999976 4788999987542 3344567889999999999999999999999999999999
Q ss_pred EecCCCCcchhcccC--CCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCC
Q 044561 421 DYMPNGSLDKILHTN--IKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 498 (614)
Q Consensus 421 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~ 498 (614)
||+++++|.+++... ....+++.++..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999888532 2345889999999999999999999 48999999999999999999999999999887654
Q ss_pred CCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccc
Q 044561 499 DTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSR 578 (614)
Q Consensus 499 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~ 578 (614)
... ......++..|+|||.+.+..++.++|+||||+++|||++|+.||...... ..... +........
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-~~~~~----~~~~~~~~~------ 226 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LFSLC----QKIEQCDYP------ 226 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc-HHHHH----HHHhcCCCC------
Confidence 321 122346888999999998888899999999999999999999998653321 11111 111111111
Q ss_pred ccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 579 LEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 579 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..........+.+++.+||+.+|++||++.+|++
T Consensus 227 --~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 227 --PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred --CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 1112233456788889999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=313.36 Aligned_cols=261 Identities=26% Similarity=0.373 Sum_probs=196.0
Q ss_pred CCCcceeeeeCcEEEEEEEE-----ecCcEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeec--CeEEE
Q 044561 347 FKDKDVIGRGGFGKVYRGVL-----ASNVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRK--GEFLL 418 (614)
Q Consensus 347 f~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~l 418 (614)
|+..+.||+|+||+||++.. .++..+|+|.+.... ....+.+.+|+.++++++||||++++++|... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37788999999999988753 246789999987653 34457788999999999999999999998654 46899
Q ss_pred EEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCC
Q 044561 419 VYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 498 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~ 498 (614)
+|||+++++|.+++... .+++.++..++.|++.||.|||+ .+++||||||+||++++++.+||+|||+++....
T Consensus 86 v~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 99999999999998753 39999999999999999999994 8999999999999999999999999999986654
Q ss_pred CCCC--cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccc
Q 044561 499 DTIP--QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASD 576 (614)
Q Consensus 499 ~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 576 (614)
.... ......++..|+|||.+....++.++||||||++++||++|+.|+...... ................+.+..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-FEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch-hhhhhcccccccchhhhhhhhh
Confidence 3211 112224566799999998888999999999999999999999998643221 0001100000000001111111
Q ss_pred ccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 577 SRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 577 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.......+......+.+++.+||+++|++|||+.+|++
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 11111122233456888899999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=305.82 Aligned_cols=249 Identities=22% Similarity=0.362 Sum_probs=202.3
Q ss_pred CCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
+|+..+.||+|+||.||++.... +..+++|.+... .....+.+.+|+.++++++|+|++++++.+..++.++++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 46778999999999999999864 788999988653 3445577889999999999999999999999999999999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCc
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 503 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 503 (614)
++++|.+++.......+++.....++.|++.||.||| +.+++|+||||+||++++++.++|+|||++........ .
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~ 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence 9999999887654556899999999999999999999 48999999999999999999999999999976643321 2
Q ss_pred ccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcC
Q 044561 504 TTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGIC 583 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 583 (614)
.....|+..|+|||++....++.++|+||||+++|+|++|+.||........ . .. ...+.... +
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~---~---~~-~~~~~~~~-----~---- 220 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL---I---LK-VCQGSYKP-----L---- 220 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH---H---HH-HhcCCCCC-----C----
Confidence 2335688999999999888899999999999999999999999975432211 1 11 11121111 1
Q ss_pred cHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 584 EEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 584 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+......+.+++.+||+.||++||++.+++.
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 221 PSHYSYELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred CcccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence 1112235678888999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=323.40 Aligned_cols=236 Identities=25% Similarity=0.342 Sum_probs=190.7
Q ss_pred ceeeeeCcEEEEEEEEe----cCcEEEEEEeecCC--hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecC
Q 044561 351 DVIGRGGFGKVYRGVLA----SNVQIAVKKVSHDS--KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMP 424 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 424 (614)
+.||+|+||.||++... .+..+|+|++.... ......+..|++++++++||||+++++++...+.+|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 57999999999998752 47889999987543 2234567789999999999999999999999999999999999
Q ss_pred CCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcc
Q 044561 425 NGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT 504 (614)
Q Consensus 425 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 504 (614)
+|+|.+++... ..+++.++..++.||++||.|||+ .+|+||||||+||+++.++.+||+|||++....... ...
T Consensus 82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~ 155 (318)
T cd05582 82 GGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKA 155 (318)
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cce
Confidence 99999998764 358999999999999999999995 899999999999999999999999999997654332 123
Q ss_pred cccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCc
Q 044561 505 TKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICE 584 (614)
Q Consensus 505 ~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 584 (614)
....||+.|+|||.+....++.++|||||||++|||++|+.||......+.. ..+ .+... .+...+
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~---~~i----~~~~~------~~p~~~- 221 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM---TMI----LKAKL------GMPQFL- 221 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHH---HHH----HcCCC------CCCCCC-
Confidence 3457899999999998888899999999999999999999999764432211 111 11111 111122
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCH
Q 044561 585 EKQMELVLKLGLFCSHPKPEARPNM 609 (614)
Q Consensus 585 ~~~~~~l~~l~~~cl~~dP~~RPs~ 609 (614)
...+.+++.+||+.||++||++
T Consensus 222 ---~~~~~~li~~~l~~~P~~R~~a 243 (318)
T cd05582 222 ---SPEAQSLLRALFKRNPANRLGA 243 (318)
T ss_pred ---CHHHHHHHHHHhhcCHhHcCCC
Confidence 2346678888999999999994
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=311.73 Aligned_cols=252 Identities=27% Similarity=0.438 Sum_probs=198.8
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec------CcEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS------NVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEF 416 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 416 (614)
+++|+..+.||+|++|.||+|.+.+ +..+++|.+.... ......+.+|+.++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4668888999999999999999864 4568888876543 34456789999999999999999999999999999
Q ss_pred EEEEEecCCCCcchhcccCC-----CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCC---CEEEe
Q 044561 417 LLVYDYMPNGSLDKILHTNI-----KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADL---NGKLG 488 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~---~~kl~ 488 (614)
++||||+++++|.+++.... ...+++.++.+++.||+.||.|||+ .+++||||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEec
Confidence 99999999999999986542 1358999999999999999999995 8999999999999998765 59999
Q ss_pred eeccccccCCCCCC-cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhh
Q 044561 489 DFGLARLYDHDTIP-QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCW 566 (614)
Q Consensus 489 DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~ 566 (614)
|||+++........ .......+..|+|||++.+..++.++|||||||++|||++ |+.||......+.... .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~-------~ 234 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF-------V 234 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-------H
Confidence 99999866332211 1122234568999999998899999999999999999997 9999976544322111 1
Q ss_pred hcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 567 KKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 567 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+... ..+......+.+++.+|++.+|++||++.+|++
T Consensus 235 ~~~~~~---------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~ 273 (277)
T cd05036 235 TGGGRL---------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILE 273 (277)
T ss_pred HcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 111000 111122346778889999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=328.43 Aligned_cols=202 Identities=25% Similarity=0.356 Sum_probs=173.2
Q ss_pred CCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEE
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 421 (614)
.|+..+.||+|+||.||+|+... +..+|+|++.... ....+.+.+|+.++++++||||+++++.+.+.+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 57788999999999999999765 7889999986542 3345678899999999999999999999999999999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC-
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT- 500 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~- 500 (614)
||++|+|.+++... ..+++.....++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 99999999998764 348889999999999999999995 899999999999999999999999999975321000
Q ss_pred ---------------------------------------------CCcccccccCCCccchhhhcCCCCCcchhHHHHHH
Q 044561 501 ---------------------------------------------IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGV 535 (614)
Q Consensus 501 ---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gv 535 (614)
.......+||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00012246999999999999889999999999999
Q ss_pred HHHHHHcCCCCCCCCCc
Q 044561 536 FMLEVASGRRPVEQQGS 552 (614)
Q Consensus 536 ll~el~tg~~p~~~~~~ 552 (614)
++|||++|+.||.....
T Consensus 237 il~elltG~~Pf~~~~~ 253 (382)
T cd05625 237 ILYEMLVGQPPFLAQTP 253 (382)
T ss_pred HHHHHHhCCCCCCCCCH
Confidence 99999999999976543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=327.97 Aligned_cols=251 Identities=22% Similarity=0.283 Sum_probs=194.0
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
++|+..+.||+|+||.||++.... +..||+|++.... ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 367888999999999999998764 7889999986532 334567889999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
||+++|+|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 81 EFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 999999999998764 358899999999999999999994 899999999999999999999999999986332100
Q ss_pred C------------C----------------------------------cccccccCCCccchhhhcCCCCCcchhHHHHH
Q 044561 501 I------------P----------------------------------QTTKLVGTFGYMDPELMRTGKASTSTDVYAFG 534 (614)
Q Consensus 501 ~------------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~G 534 (614)
. . .....+||+.|+|||++....++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 0 0 00124699999999999988999999999999
Q ss_pred HHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCC---CCCHHH
Q 044561 535 VFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEA---RPNMRQ 611 (614)
Q Consensus 535 vll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~---RPs~~e 611 (614)
|++|||++|+.||......+.... +.. +. ..+ . +... ......+.+++.+|+. +|.+ |+++.|
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~---i~~-~~-~~~-~-----~p~~--~~~s~~~~dli~~lL~-~~~~r~~r~~~~~ 301 (377)
T cd05629 236 AIMFECLIGWPPFCSENSHETYRK---IIN-WR-ETL-Y-----FPDD--IHLSVEAEDLIRRLIT-NAENRLGRGGAHE 301 (377)
T ss_pred hhhhhhhcCCCCCCCCCHHHHHHH---HHc-cC-Ccc-C-----CCCC--CCCCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence 999999999999976543222111 110 00 000 0 0000 0112345566677887 6665 469999
Q ss_pred HhC
Q 044561 612 VMQ 614 (614)
Q Consensus 612 vl~ 614 (614)
+++
T Consensus 302 ~l~ 304 (377)
T cd05629 302 IKS 304 (377)
T ss_pred Hhc
Confidence 874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=312.04 Aligned_cols=251 Identities=27% Similarity=0.359 Sum_probs=197.4
Q ss_pred HHhcCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCChh--------------hHHHHHHHHHHhcccCCCceeEE
Q 044561 342 KATKGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSKQ--------------GIKEFVAELVSMGRLRHRNLVKL 406 (614)
Q Consensus 342 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--------------~~~~~~~Ei~~l~~l~H~niv~l 406 (614)
+..++|+..+.||+|.||.|-+|+.. ++..||+|.+.+.... ..++..+||.+|++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34577899999999999999999976 4888999999664211 23578899999999999999999
Q ss_pred eeEEee--cCeEEEEEEecCCCCcchhcccCCCCC-cChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCC
Q 044561 407 RGYCRR--KGEFLLVYDYMPNGSLDKILHTNIKPC-LNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADL 483 (614)
Q Consensus 407 ~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~ 483 (614)
+.+..+ .+.+|||+|||..|.+...=. ... +...++++++.++..||.|||. ++||||||||+|+||+++|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~---d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPP---DKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCC---CcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCC
Confidence 999865 468999999999888765432 233 8999999999999999999995 9999999999999999999
Q ss_pred CEEEeeeccccccCCCC----CCcccccccCCCccchhhhcCCC----CCcchhHHHHHHHHHHHHcCCCCCCCCCcccc
Q 044561 484 NGKLGDFGLARLYDHDT----IPQTTKLVGTFGYMDPELMRTGK----ASTSTDVYAFGVFMLEVASGRRPVEQQGSMET 555 (614)
Q Consensus 484 ~~kl~DfGla~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~----~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~ 555 (614)
++||+|||.+.....+. .......+||+.|+|||...++. .+.+.||||+||+||.|+.|+.||-.....+.
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l 327 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL 327 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence 99999999998663221 12234468999999999987643 36789999999999999999999976433221
Q ss_pred ccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHh
Q 044561 556 VNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVM 613 (614)
Q Consensus 556 ~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 613 (614)
.. ++....+.--...+.-+.+..|++++|.+||++|.+..+|.
T Consensus 328 ~~---------------KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik 370 (576)
T KOG0585|consen 328 FD---------------KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIK 370 (576)
T ss_pred HH---------------HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhhe
Confidence 11 11111121111123456788888999999999999998874
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=311.32 Aligned_cols=249 Identities=26% Similarity=0.426 Sum_probs=194.7
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-Cc----EEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NV----QIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLL 418 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 418 (614)
.+|+..+.||+|+||.||+|++.. +. .+++|.+.... .....++..|+..+++++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 356778899999999999999753 33 47778775443 334567888999999999999999999885 456789
Q ss_pred EEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCC
Q 044561 419 VYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 498 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~ 498 (614)
++||+++|+|.+++.... ..+++..+..++.||+.||.|||+ ++++||||||+||++++++.+||+|||+++....
T Consensus 86 i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 999999999999997643 458999999999999999999994 8899999999999999999999999999986543
Q ss_pred CCC-CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCcccccc
Q 044561 499 DTI-PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASD 576 (614)
Q Consensus 499 ~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 576 (614)
... .......++..|+|||.+..+.++.++||||||+++|||++ |+.||......+.. +...++.... .
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~-------~~~~~~~~~~--~ 232 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP-------DLLEKGERLA--Q 232 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-------HHHHCCCcCC--C
Confidence 221 12233457789999999988899999999999999999998 99999765432211 1112222111 1
Q ss_pred ccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 577 SRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 577 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+ ..++ ..+..++.+||..||++|||+.|+++
T Consensus 233 ~---~~~~----~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 233 P---QICT----IDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred C---CCCC----HHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1 1122 34566788899999999999999864
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=323.11 Aligned_cols=252 Identities=28% Similarity=0.424 Sum_probs=197.2
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec------CcEEEEEEeecCC-hhhHHHHHHHHHHhccc-CCCceeEEeeEEeec-Ce
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS------NVQIAVKKVSHDS-KQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRK-GE 415 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~-~~ 415 (614)
++|+..+.||+|+||.||+|...+ +..||+|++.... ....+.+..|+.++.++ +|+||++++++|... ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 467888999999999999997532 3679999987543 33456788899999999 899999999988654 57
Q ss_pred EEEEEEecCCCCcchhcccCC-----------------------------------------------------------
Q 044561 416 FLLVYDYMPNGSLDKILHTNI----------------------------------------------------------- 436 (614)
Q Consensus 416 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 436 (614)
++++|||+++++|.+++....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 899999999999999885421
Q ss_pred CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCC-CcccccccCCCccc
Q 044561 437 KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMD 515 (614)
Q Consensus 437 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~a 515 (614)
...++|.++..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++....... .......++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 1258999999999999999999994 8999999999999999999999999999987543321 12233456778999
Q ss_pred hhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHH
Q 044561 516 PELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKL 594 (614)
Q Consensus 516 PE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l 594 (614)
||++.+..++.++|||||||+++||++ |+.||......+. ..+....+.... .+......+.++
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~------~~~~~~~~~~~~---------~~~~~~~~~~~l 308 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE------FCRRLKEGTRMR---------APEYATPEIYSI 308 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH------HHHHHhccCCCC---------CCccCCHHHHHH
Confidence 999999999999999999999999998 9999975432221 111111111110 111223467888
Q ss_pred HHHcCCCCCCCCCCHHHHhC
Q 044561 595 GLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 595 ~~~cl~~dP~~RPs~~evl~ 614 (614)
+.+||+.+|++||++.||++
T Consensus 309 ~~~cl~~~p~~RPs~~ell~ 328 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVE 328 (337)
T ss_pred HHHHccCChhhCcCHHHHHH
Confidence 99999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=321.45 Aligned_cols=237 Identities=26% Similarity=0.322 Sum_probs=188.1
Q ss_pred ceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHH-HhcccCCCceeEEeeEEeecCeEEEEEEecCC
Q 044561 351 DVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELV-SMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPN 425 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 425 (614)
+.||+|+||+||+|+.+. ++.||+|++.... ....+++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 469999999999999864 8889999987542 223344555554 46789999999999999999999999999999
Q ss_pred CCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCccc
Q 044561 426 GSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT 505 (614)
Q Consensus 426 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 505 (614)
|+|..++..+ ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (323)
T cd05575 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTS 154 (323)
T ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cccc
Confidence 9999988764 358899999999999999999994 899999999999999999999999999987532221 1233
Q ss_pred ccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcH
Q 044561 506 KLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEE 585 (614)
Q Consensus 506 ~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~ 585 (614)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. +....+.. .+....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-------~~i~~~~~------~~~~~~-- 219 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMY-------DNILNKPL------RLKPNI-- 219 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHH-------HHHHcCCC------CCCCCC--
Confidence 457999999999999989999999999999999999999999764432211 11111111 111122
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCHH
Q 044561 586 KQMELVLKLGLFCSHPKPEARPNMR 610 (614)
Q Consensus 586 ~~~~~l~~l~~~cl~~dP~~RPs~~ 610 (614)
...+.+++.+|++.||++||+++
T Consensus 220 --~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 220 --SVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred --CHHHHHHHHHHhhcCHHhCCCCC
Confidence 34567788889999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=306.09 Aligned_cols=245 Identities=32% Similarity=0.471 Sum_probs=201.8
Q ss_pred cCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecC
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMP 424 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 424 (614)
++|+..+.||+|+||.||+|... ++.+++|.+..... ..+++.+|+.++++++|+|++++++++...+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 46778899999999999999875 67899999976654 56789999999999999999999999999999999999999
Q ss_pred CCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcc
Q 044561 425 NGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT 504 (614)
Q Consensus 425 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 504 (614)
+++|.+++.......+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~---- 156 (256)
T cd05039 84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ---- 156 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEccccccccccccc----
Confidence 9999999987655569999999999999999999994 899999999999999999999999999998664322
Q ss_pred cccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcC
Q 044561 505 TKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGIC 583 (614)
Q Consensus 505 ~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 583 (614)
.....+..|+|||.+..+.++.++||||||++++||++ |+.||......+. . .....+.... .
T Consensus 157 ~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~----~~~~~~~~~~---------~ 220 (256)
T cd05039 157 DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---V----PHVEKGYRME---------A 220 (256)
T ss_pred ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH---H----HHHhcCCCCC---------C
Confidence 12345678999999988889999999999999999997 9999875433221 1 1111111100 1
Q ss_pred cHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 584 EEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 584 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+......+.+++.+|++.+|++||++.|+++
T Consensus 221 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 221 PEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred ccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 1112356778888999999999999999873
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=312.31 Aligned_cols=250 Identities=25% Similarity=0.417 Sum_probs=197.1
Q ss_pred CCCCcceeeeeCcEEEEEEEEec------CcEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEE
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS------NVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLL 418 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 418 (614)
+|+..+.||+|+||.||+|+... ...+++|.+.... .....++.+|+.+++.++||||+++++.|...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 36778899999999999998642 2468888876543 3445678999999999999999999999999999999
Q ss_pred EEEecCCCCcchhcccCC----------------------CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCC
Q 044561 419 VYDYMPNGSLDKILHTNI----------------------KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN 476 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~N 476 (614)
++||+++++|.+++.... ...+++.+++.++.|++.||.||| +.+++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence 999999999999875421 134889999999999999999999 4899999999999
Q ss_pred eEEcCCCCEEEeeeccccccCCCCC-CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccc
Q 044561 477 VLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSME 554 (614)
Q Consensus 477 Ill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~ 554 (614)
|++++++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||++++||++ |+.||......+
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999976533221 11222345678999999988889999999999999999998 999997543322
Q ss_pred cccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 555 TVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 555 ~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+++...++... ..+......+.+++.+|++++|++||++.|+++
T Consensus 238 -------~~~~~~~~~~~---------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 238 -------LFNLLKTGYRM---------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred -------HHHHHhCCCCC---------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 11221211100 011122345778889999999999999999873
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=329.07 Aligned_cols=250 Identities=24% Similarity=0.298 Sum_probs=193.2
Q ss_pred CCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEE
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 421 (614)
+|+..+.||+|+||.||+++... +..+|+|.+.... ......+.+|+.++++++|+||+++++.+.+++.+++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 58888999999999999999765 7889999986532 2234567899999999999999999999999999999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC-
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT- 500 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~- 500 (614)
|+++|+|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 82 YIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 99999999999764 358889999999999999999994 899999999999999999999999999975321100
Q ss_pred -----------------------------------------CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHH
Q 044561 501 -----------------------------------------IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLE 539 (614)
Q Consensus 501 -----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~e 539 (614)
.......+||+.|+|||++....++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 000123479999999999998899999999999999999
Q ss_pred HHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCC---CHHHHhC
Q 044561 540 VASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARP---NMRQVMQ 614 (614)
Q Consensus 540 l~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP---s~~evl~ 614 (614)
|++|+.||......+.... +. .+.. . ........++.+ +.+++.+|+ .+|++|+ ++.|+++
T Consensus 237 ll~G~~Pf~~~~~~~~~~~---i~-~~~~-~----~~~~~~~~~s~~----~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 237 MLVGQPPFLADTPAETQLK---VI-NWET-T----LHIPSQAKLSRE----ASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred hhhCCCCCCCCCHHHHHHH---Hh-ccCc-c----ccCCCCCCCCHH----HHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 9999999976543322111 10 0100 0 000001123333 333444454 4999999 8898874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=315.69 Aligned_cols=252 Identities=25% Similarity=0.372 Sum_probs=200.3
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe------cCcEEEEEEeecCC-hhhHHHHHHHHHHhccc-CCCceeEEeeEEeecCeE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA------SNVQIAVKKVSHDS-KQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGEF 416 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 416 (614)
++|...+.||+|+||.||++... .+..+|+|++.... ....+.+.+|+.+++++ +||||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 46888899999999999999752 24578999887543 33456789999999999 799999999999999999
Q ss_pred EEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecccccc
Q 044561 417 LLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 496 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~ 496 (614)
++||||+++|+|.+++.......+++.++..++.|++.||.|||+ ++|+|+||||+||+++.++.+||+|||+++..
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~ 191 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLARDI 191 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCcccccc
Confidence 999999999999999976544458999999999999999999994 89999999999999999999999999999865
Q ss_pred CCCCCC-cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCcccc
Q 044561 497 DHDTIP-QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDA 574 (614)
Q Consensus 497 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~ 574 (614)
...... ......++..|+|||.+....++.++|||||||++|||++ |+.||......+.. . +....+...
T Consensus 192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~--~----~~~~~~~~~-- 263 (302)
T cd05055 192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF--Y----KLIKEGYRM-- 263 (302)
T ss_pred cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH--H----HHHHcCCcC--
Confidence 433211 1122345778999999998889999999999999999998 99998754432211 1 111111100
Q ss_pred ccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 575 SDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 575 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+....+.+.+++.+|++++|++|||+.|+++
T Consensus 264 -------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 264 -------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 011112346788899999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=304.23 Aligned_cols=249 Identities=24% Similarity=0.424 Sum_probs=203.5
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
++|+..+.||+|+||.||+|...+ +..+++|.+..... .+++.+|++++++++|+|++++++++......++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 568888999999999999999876 78899999875533 678999999999999999999999999999999999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCc
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 503 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 503 (614)
++++|.+++... ...+++..+..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||++........ .
T Consensus 81 ~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (256)
T cd06612 81 GAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-K 155 (256)
T ss_pred CCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-c
Confidence 999999998653 3458999999999999999999994 8999999999999999999999999999987654321 2
Q ss_pred ccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcC
Q 044561 504 TTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGIC 583 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 583 (614)
.....++..|+|||++.+..++.++||||||+++|||++|+.||......+....+ .... .+.+ ..
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~-------~~~~-----~~~~--~~ 221 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI-------PNKP-----PPTL--SD 221 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh-------ccCC-----CCCC--Cc
Confidence 23345788999999998888999999999999999999999999754332211100 0000 0001 01
Q ss_pred cHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 584 EEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 584 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+......+.+++.+|+++||++|||+.||++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 222 PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 1222345788888999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=310.91 Aligned_cols=251 Identities=26% Similarity=0.445 Sum_probs=200.0
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe------cCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA------SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLL 418 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 418 (614)
+++...+.||+|+||.||++... ++..+++|.+..........+.+|+++++.++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45677889999999999999743 245788998887777777889999999999999999999999999999999
Q ss_pred EEEecCCCCcchhcccCCC-------------CCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCE
Q 044561 419 VYDYMPNGSLDKILHTNIK-------------PCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG 485 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~ 485 (614)
+|||+++++|.+++..... ..+++.++..++.|++.||+||| +.+++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCE
Confidence 9999999999999865321 34889999999999999999999 4899999999999999999999
Q ss_pred EEeeeccccccCCCCC-CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHH
Q 044561 486 KLGDFGLARLYDHDTI-PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVC 563 (614)
Q Consensus 486 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~ 563 (614)
||+|||++........ .......+++.|+|||.+....++.++|||||||++|||++ |+.||......+... ..
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~---~~- 237 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE---CI- 237 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHH---HH-
Confidence 9999999975543221 11122345678999999988899999999999999999998 999986544332211 11
Q ss_pred HhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 564 DCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 564 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+... .....+ ...+.+++.+||+.||++||++.||++
T Consensus 238 ---~~~~~~-----~~~~~~----~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 238 ---TQGREL-----ERPRTC----PPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred ---HcCccC-----CCCCCC----CHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 111100 011112 245778888999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=315.10 Aligned_cols=253 Identities=26% Similarity=0.438 Sum_probs=201.0
Q ss_pred HhcCCCCcceeeeeCcEEEEEEEEec------CcEEEEEEeecC-ChhhHHHHHHHHHHhccc-CCCceeEEeeEEeecC
Q 044561 343 ATKGFKDKDVIGRGGFGKVYRGVLAS------NVQIAVKKVSHD-SKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKG 414 (614)
Q Consensus 343 ~~~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 414 (614)
..++|+..+.||+|+||.||++...+ ...+++|.+... ......++.+|+.+++++ +|+||+++++++...+
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 34567888999999999999998753 357899988754 334456788999999999 7999999999999999
Q ss_pred eEEEEEEecCCCCcchhcccC--------------CCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEc
Q 044561 415 EFLLVYDYMPNGSLDKILHTN--------------IKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD 480 (614)
Q Consensus 415 ~~~lV~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~ 480 (614)
..+++|||+++|+|.+++... ....+++..+++++.|++.||.|||+ .+|+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEc
Confidence 999999999999999998642 23458999999999999999999994 8999999999999999
Q ss_pred CCCCEEEeeeccccccCCCCC-CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccH
Q 044561 481 ADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNL 558 (614)
Q Consensus 481 ~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l 558 (614)
.++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||......+..
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-- 244 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF-- 244 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH--
Confidence 999999999999987654321 11222345678999999988889999999999999999998 99998754432221
Q ss_pred HHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 559 VDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 559 ~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+....+.... .+......+.+++.+|++.||++|||+.|+++
T Consensus 245 -----~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~ 286 (293)
T cd05053 245 -----KLLKEGYRME---------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVE 286 (293)
T ss_pred -----HHHHcCCcCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 1111111111 11122346778999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=307.53 Aligned_cols=253 Identities=28% Similarity=0.428 Sum_probs=201.5
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecC---ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
.+|+..+.||+|+||.||++... ++..+++|.+... ......++.+|+.+++.++|+||+++++++...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 35777889999999999999975 5889999987653 3334567889999999999999999999999999999999
Q ss_pred EecCCCCcchhcccC--CCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCC
Q 044561 421 DYMPNGSLDKILHTN--IKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 498 (614)
Q Consensus 421 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~ 498 (614)
||+++++|.+++... ....+++.++..++.|++.||.||| +++++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988642 2345899999999999999999999 48999999999999999999999999999876644
Q ss_pred CCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccc
Q 044561 499 DTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSR 578 (614)
Q Consensus 499 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~ 578 (614)
... ......++..|+|||.+.+..++.++|+||||+++|||++|..||...... ..... +..... ..+.
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~----~~~~~~-----~~~~ 227 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLC----KKIEQC-----DYPP 227 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-HHHHh----hhhhcC-----CCCC
Confidence 321 122346889999999998888999999999999999999999999654321 11111 111111 1111
Q ss_pred ccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 579 LEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 579 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
. ......+.+.+++.+||+.||++||||.+|++
T Consensus 228 ~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 228 L---PSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred C---CcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 1 11223446778888999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=302.83 Aligned_cols=249 Identities=26% Similarity=0.367 Sum_probs=201.8
Q ss_pred CCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEee-cCeEEEEEE
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRR-KGEFLLVYD 421 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV~E 421 (614)
+|+..+.||+|++|.||++..+. +..+++|++... .....+.+.+|++++++++|+|++++++.+.. .+.++++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 47788999999999999999765 678999998654 23445678899999999999999999998764 456899999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCC
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI 501 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~ 501 (614)
|+++++|.+++.......+++.++..++.+++.|+.||| +.+++||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 999999999998755556899999999999999999999 48999999999999999999999999999987643322
Q ss_pred CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccC
Q 044561 502 PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEG 581 (614)
Q Consensus 502 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~ 581 (614)
......+++.|+|||.+.+..++.++||||||++++||++|+.||......+. ... ...+.+..
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~------~~~-~~~~~~~~-------- 221 (257)
T cd08223 158 -MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL------VYR-IIEGKLPP-------- 221 (257)
T ss_pred -ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH------HHH-HHhcCCCC--------
Confidence 22345688999999999988899999999999999999999999975432211 111 11222111
Q ss_pred cCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 582 ICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 582 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+......+.+++.+|+++||++||++.++++
T Consensus 222 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 222 -MPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred -CccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 12223346778899999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=311.45 Aligned_cols=249 Identities=23% Similarity=0.412 Sum_probs=203.1
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
++|+..+.||+|+||.||++... ++..|++|.+........+.+.+|+.+++.++|+|++++++++...+..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 57888999999999999999975 58899999997665555677889999999999999999999999999999999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCc
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 503 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 503 (614)
++++|.+++... .+++.++..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++........ .
T Consensus 99 ~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~ 171 (297)
T cd06656 99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 171 (297)
T ss_pred CCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-C
Confidence 999999998653 48899999999999999999995 8999999999999999999999999999876543321 1
Q ss_pred ccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcC
Q 044561 504 TTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGIC 583 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 583 (614)
.....+++.|+|||.+.+..++.++|+|||||++|+|++|+.||......+..... ..+.... . ..
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~-------~~~~~~~-----~--~~ 237 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------ATNGTPE-----L--QN 237 (297)
T ss_pred cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee-------ccCCCCC-----C--CC
Confidence 23346889999999999888999999999999999999999999754432211100 0000000 0 01
Q ss_pred cHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 584 EEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 584 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+......+.+++.+||+.+|++||++.++++
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 238 PERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1222345677888999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=312.65 Aligned_cols=249 Identities=26% Similarity=0.434 Sum_probs=197.2
Q ss_pred CCCcceeeeeCcEEEEEEEEec------CcEEEEEEeecCChh-hHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEE
Q 044561 347 FKDKDVIGRGGFGKVYRGVLAS------NVQIAVKKVSHDSKQ-GIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLV 419 (614)
Q Consensus 347 f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 419 (614)
|+..+.||+|+||.||+|...+ +..+|+|++...... ..+.+.+|+.++++++||||+++++++...+..+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 5567789999999999998743 467999999765433 346688999999999999999999999999999999
Q ss_pred EEecCCCCcchhcccC--------------CCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCE
Q 044561 420 YDYMPNGSLDKILHTN--------------IKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG 485 (614)
Q Consensus 420 ~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~ 485 (614)
+||+++++|.+++... .+..+++..+..++.|++.||.|||+ .+|+||||||+||++++++.+
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCce
Confidence 9999999999998531 12348889999999999999999994 899999999999999999999
Q ss_pred EEeeeccccccCCCCC-CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHH
Q 044561 486 KLGDFGLARLYDHDTI-PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVC 563 (614)
Q Consensus 486 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~ 563 (614)
||+|||+++....... .......+++.|+|||.+..+.++.++|||||||++|||++ |..||......+. .+
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---~~--- 237 (283)
T cd05091 164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV---IE--- 237 (283)
T ss_pred EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH---
Confidence 9999999886543221 12233456789999999988889999999999999999998 8888865433221 11
Q ss_pred HhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 564 DCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 564 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
....+.... .+......+..++..|++.+|++||+++||++
T Consensus 238 -~i~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 238 -MIRNRQVLP---------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred -HHHcCCcCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 111211111 12223445778889999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=314.15 Aligned_cols=249 Identities=29% Similarity=0.454 Sum_probs=195.9
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-C--cEEEEEEeecC-ChhhHHHHHHHHHHhccc-CCCceeEEeeEEeecCeEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-N--VQIAVKKVSHD-SKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGEFLLV 419 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~--~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 419 (614)
++|+..+.||+|+||.||+|..++ + ..+++|.++.. .....+.+.+|+.++.++ +||||+++++++...+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 468888999999999999999865 3 34688877643 344567789999999999 799999999999999999999
Q ss_pred EEecCCCCcchhcccCC--------------CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCE
Q 044561 420 YDYMPNGSLDKILHTNI--------------KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG 485 (614)
Q Consensus 420 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~ 485 (614)
+||+++++|.+++.... ...+++.++..++.|++.||+|||+ .+|+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeE
Confidence 99999999999986532 1348899999999999999999994 899999999999999999999
Q ss_pred EEeeeccccccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHH
Q 044561 486 KLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCD 564 (614)
Q Consensus 486 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~ 564 (614)
||+|||++....... .......+..|+|||.+....++.++|||||||++|||++ |+.||......+.. +
T Consensus 159 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~-------~ 229 (297)
T cd05089 159 KIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY-------E 229 (297)
T ss_pred EECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-------H
Confidence 999999987433211 1111233567999999988889999999999999999997 99999765432211 1
Q ss_pred hhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 565 CWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 565 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
....+.. ... +......+.+++.+||+.+|.+||++.++++
T Consensus 230 ~~~~~~~-----~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 270 (297)
T cd05089 230 KLPQGYR-----MEK----PRNCDDEVYELMRQCWRDRPYERPPFAQISV 270 (297)
T ss_pred HHhcCCC-----CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1111110 011 1112345778888999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=322.80 Aligned_cols=263 Identities=22% Similarity=0.273 Sum_probs=197.9
Q ss_pred HHhcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeec-----
Q 044561 342 KATKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRK----- 413 (614)
Q Consensus 342 ~~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~----- 413 (614)
...++|+..+.||+|+||.||++.... +..+|+|++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 345789999999999999999998764 788999998754 333456788999999999999999999987543
Q ss_pred -CeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecc
Q 044561 414 -GEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGL 492 (614)
Q Consensus 414 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGl 492 (614)
...++||||+++ +|.+.+.. .+++..+..++.|+++||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCcc
Confidence 357999999964 66666643 3889999999999999999999 48999999999999999999999999999
Q ss_pred ccccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHH------------
Q 044561 493 ARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVD------------ 560 (614)
Q Consensus 493 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~------------ 560 (614)
++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||......+......
T Consensus 166 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (355)
T cd07874 166 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_pred cccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 98654332 2234578999999999998889999999999999999999999997654322211100
Q ss_pred ----HHHHhhhcC-Cc-----cccccccc---cCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 561 ----WVCDCWKKG-AI-----RDASDSRL---EGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 561 ----~v~~~~~~~-~~-----~~~~d~~l---~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+....... .. .......+ ...........+.+++.+|++.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence 000000000 00 00000000 00011112346788999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=315.62 Aligned_cols=203 Identities=27% Similarity=0.346 Sum_probs=174.5
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC---ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
++|+..+.||+|+||.||+++... +..+|+|.+... .....+.+.+|+.++..++|+||+++++++.+.+.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 468888999999999999999865 788999998642 2233456888999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
||+++|+|.+++... ...+++.++..++.||+.||.||| +++|+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 999999999999653 235889999999999999999999 4899999999999999999999999999997655433
Q ss_pred CCcccccccCCCccchhhhcC-----CCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Q 044561 501 IPQTTKLVGTFGYMDPELMRT-----GKASTSTDVYAFGVFMLEVASGRRPVEQQG 551 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~-----~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~ 551 (614)
........||+.|+|||++.. +.++.++|||||||++|||++|+.||....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~ 212 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC
Confidence 323334579999999999863 457889999999999999999999997643
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=322.65 Aligned_cols=262 Identities=23% Similarity=0.300 Sum_probs=196.3
Q ss_pred HhcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecC-----
Q 044561 343 ATKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKG----- 414 (614)
Q Consensus 343 ~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----- 414 (614)
..++|+..+.||+|+||.||++.... +..+|+|++... ......++.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 45789999999999999999999764 888999998653 3344567889999999999999999999886443
Q ss_pred -eEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccc
Q 044561 415 -EFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLA 493 (614)
Q Consensus 415 -~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla 493 (614)
..++||||+++ +|.+.+.. .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 57999999965 56665543 37889999999999999999994 89999999999999999999999999999
Q ss_pred cccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHH------------H-
Q 044561 494 RLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLV------------D- 560 (614)
Q Consensus 494 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~------------~- 560 (614)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+..... .
T Consensus 171 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (359)
T cd07876 171 RTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR 248 (359)
T ss_pred cccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence 7644322 223457899999999999889999999999999999999999999765432211100 0
Q ss_pred ---HHHHhhhc-CCccccc-ccccc-------CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 561 ---WVCDCWKK-GAIRDAS-DSRLE-------GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 561 ---~v~~~~~~-~~~~~~~-d~~l~-------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+...... ....... ..... ...+......+.+|+.+|++.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000 0000000 00000 0011112345778889999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=307.13 Aligned_cols=248 Identities=24% Similarity=0.414 Sum_probs=193.5
Q ss_pred CCcceeeeeCcEEEEEEEEecCc---EEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeec------CeE
Q 044561 348 KDKDVIGRGGFGKVYRGVLASNV---QIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRK------GEF 416 (614)
Q Consensus 348 ~~~~~lG~G~fg~Vy~~~~~~~~---~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~~ 416 (614)
...+.||+|+||.||+|++.+.. .+|+|.++.. .....+.+.+|+.+++.++|+||++++++|... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 45678999999999999986532 5899987654 345567889999999999999999999987532 257
Q ss_pred EEEEEecCCCCcchhcccC----CCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecc
Q 044561 417 LLVYDYMPNGSLDKILHTN----IKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGL 492 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGl 492 (614)
+++|||+++|+|.+++... ....+++..+..++.|++.||.|||+ .+|+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCc
Confidence 8999999999999887421 23458999999999999999999994 8999999999999999999999999999
Q ss_pred ccccCCCCCC-cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCC
Q 044561 493 ARLYDHDTIP-QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGA 570 (614)
Q Consensus 493 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~ 570 (614)
++........ ......+++.|+|||.+....++.++||||||+++|||++ |+.||......+ .. +....+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~----~~~~~~~ 231 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---IY----DYLRQGN 231 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHHHcCC
Confidence 9876543211 1122346778999999998889999999999999999999 888987543322 11 1122222
Q ss_pred ccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 571 IRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 571 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
... . +......+.+++.+||++||++|||+.++++
T Consensus 232 ~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~ 266 (272)
T cd05075 232 RLK-----Q----PPDCLDGLYSLMSSCWLLNPKDRPSFETLRC 266 (272)
T ss_pred CCC-----C----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 111 1 1122345788889999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=305.56 Aligned_cols=248 Identities=25% Similarity=0.457 Sum_probs=200.4
Q ss_pred cCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecC
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMP 424 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 424 (614)
++|+..+.||+|+||.||++...++..+++|.+.... ...+.+.+|++++++++|+|++++.+.+.. ...+++|||++
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA 83 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence 5688889999999999999998777889999887543 345678899999999999999999999877 77899999999
Q ss_pred CCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcc
Q 044561 425 NGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT 504 (614)
Q Consensus 425 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 504 (614)
+++|.+++.......+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++...........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (260)
T cd05073 84 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR 160 (260)
T ss_pred CCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCcccc
Confidence 9999999977555568999999999999999999994 8999999999999999999999999999976544332222
Q ss_pred cccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcC
Q 044561 505 TKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGIC 583 (614)
Q Consensus 505 ~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 583 (614)
....++..|+|||++..+.++.++|+||||++++|+++ |+.||......+. ..+ ...+.... .
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~----~~~~~~~~---------~ 224 (260)
T cd05073 161 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV---IRA----LERGYRMP---------R 224 (260)
T ss_pred cCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH---HHH----HhCCCCCC---------C
Confidence 23345678999999988889999999999999999999 9999976443221 111 11111111 0
Q ss_pred cHHHHHHHHHHHHHcCCCCCCCCCCHHHHh
Q 044561 584 EEKQMELVLKLGLFCSHPKPEARPNMRQVM 613 (614)
Q Consensus 584 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 613 (614)
.......+.+++.+|++++|++||++.+++
T Consensus 225 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~ 254 (260)
T cd05073 225 PENCPEELYNIMMRCWKNRPEERPTFEYIQ 254 (260)
T ss_pred cccCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 112234577888899999999999999886
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=306.39 Aligned_cols=250 Identities=29% Similarity=0.527 Sum_probs=198.7
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-C---cEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-N---VQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLV 419 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 419 (614)
.+|+..+.||+|+||.||+|.... + ..+++|++... .....+++.+|++++++++|+|++++.+++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 467778999999999999999863 2 36899988755 344456789999999999999999999999999999999
Q ss_pred EEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCC
Q 044561 420 YDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD 499 (614)
Q Consensus 420 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~ 499 (614)
|||+++++|.+++.... ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 85 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 85 TEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999987643 458999999999999999999994 89999999999999999999999999999766433
Q ss_pred CCCccc--ccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCcccccc
Q 044561 500 TIPQTT--KLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASD 576 (614)
Q Consensus 500 ~~~~~~--~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 576 (614)
...... ....+..|+|||++....++.++|||||||++|||++ |+.||......+.. .....+...
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~-------~~i~~~~~~---- 229 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVM-------KAINDGFRL---- 229 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHH-------HHHhcCCCC----
Confidence 211111 1223457999999988889999999999999999997 99999654332211 111111100
Q ss_pred ccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 577 SRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 577 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+ ...+....+.+++.+|++.+|++||++.+|++
T Consensus 230 ~-----~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 230 P-----APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred C-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0 11122345788999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=334.67 Aligned_cols=263 Identities=24% Similarity=0.326 Sum_probs=193.7
Q ss_pred HHhcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccC------CCceeEEeeEEeec-
Q 044561 342 KATKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLR------HRNLVKLRGYCRRK- 413 (614)
Q Consensus 342 ~~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~------H~niv~l~g~~~~~- 413 (614)
..+.+|+..+.||+|+||+||+|.... +..||||++..... ..+++..|+.++.+++ |.+++++++++...
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~ 204 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET 204 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence 445789999999999999999999865 77899999865322 2344555666666554 45689999988754
Q ss_pred CeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCC----------
Q 044561 414 GEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADL---------- 483 (614)
Q Consensus 414 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~---------- 483 (614)
+++++|||++ +++|.+++... ..+++.++..|+.||+.||.|||+ +.+|+||||||+|||++.++
T Consensus 205 ~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 205 GHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred ceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCcccccccccc
Confidence 5789999998 77888888653 359999999999999999999995 35999999999999998765
Q ss_pred ------CEEEeeeccccccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcccccc
Q 044561 484 ------NGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVN 557 (614)
Q Consensus 484 ------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~ 557 (614)
.+||+|||++..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+...
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 355 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH 355 (467)
T ss_pred cCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 499999998864322 2344689999999999999999999999999999999999999998765544333
Q ss_pred HHHHHHHh-----------------hhc-CCcccccccc-c---c---CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q 044561 558 LVDWVCDC-----------------WKK-GAIRDASDSR-L---E---GICEEKQMELVLKLGLFCSHPKPEARPNMRQV 612 (614)
Q Consensus 558 l~~~v~~~-----------------~~~-~~~~~~~d~~-l---~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev 612 (614)
.+...... +.. +.+....++. + . ..........+.+|+.+||+.||++|||+.|+
T Consensus 356 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~ 435 (467)
T PTZ00284 356 LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQM 435 (467)
T ss_pred HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHH
Confidence 33221100 000 0000000000 0 0 00000112457789999999999999999999
Q ss_pred hC
Q 044561 613 MQ 614 (614)
Q Consensus 613 l~ 614 (614)
++
T Consensus 436 L~ 437 (467)
T PTZ00284 436 TT 437 (467)
T ss_pred hc
Confidence 85
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=308.31 Aligned_cols=249 Identities=22% Similarity=0.349 Sum_probs=197.9
Q ss_pred CCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecCC
Q 044561 347 FKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPN 425 (614)
Q Consensus 347 f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 425 (614)
|+..+.||+|+||.||+|.... +..+++|.+........+.+.+|+++++.++|||++++++++..++..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 3456779999999999999876 677888888776666778899999999999999999999999999999999999999
Q ss_pred CCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCccc
Q 044561 426 GSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT 505 (614)
Q Consensus 426 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 505 (614)
++|..++... ...+++..+..++.|+++||.|||+ .+++||||||+||+++.++.+||+|||++....... ....
T Consensus 87 ~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~ 161 (282)
T cd06643 87 GAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRD 161 (282)
T ss_pred CcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEccccccccccccc-cccc
Confidence 9999887653 2458999999999999999999995 899999999999999999999999999987653322 1223
Q ss_pred ccccCCCccchhhhc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 506 KLVGTFGYMDPELMR-----TGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 506 ~~~gt~~y~aPE~~~-----~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
...++..|+|||++. ...++.++|||||||++|||++|+.||......+.. .... ........
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~------~~~~-~~~~~~~~----- 229 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL------LKIA-KSEPPTLA----- 229 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHH------HHHh-hcCCCCCC-----
Confidence 346899999999974 345778999999999999999999998754322211 1111 11100100
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+......+.+++.+||+.||++||++.++++
T Consensus 230 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 230 --QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred --CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01112245778888999999999999999975
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=304.58 Aligned_cols=250 Identities=26% Similarity=0.433 Sum_probs=200.0
Q ss_pred CCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCC------hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEE
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDS------KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLV 419 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 419 (614)
+|+..+.||+|+||.||+|...++..+|+|.+.... ....+.+.+|+.++++++|+||++++++|.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 467788999999999999998778899999886432 22345688999999999999999999999999999999
Q ss_pred EEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCC
Q 044561 420 YDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD 499 (614)
Q Consensus 420 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~ 499 (614)
|||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 81 MEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 9999999999999764 348899999999999999999994 88999999999999999999999999998764321
Q ss_pred -----CCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccc
Q 044561 500 -----TIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDA 574 (614)
Q Consensus 500 -----~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~ 574 (614)
.........++..|+|||.+.+..++.++||||||++++||++|+.||......+.... ... ..+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~---~~~--~~~~---- 226 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFY---IGA--HRGL---- 226 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHH---hhh--ccCC----
Confidence 11112334688999999999888899999999999999999999999975432211100 000 0011
Q ss_pred ccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 575 SDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 575 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+.+.. .....+..++.+||+++|++||++.|+++
T Consensus 227 -~~~~~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 -MPRLPD----SFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -CCCCCC----CCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 111212 22345677888899999999999999974
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=318.68 Aligned_cols=237 Identities=26% Similarity=0.340 Sum_probs=186.9
Q ss_pred ceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHH-HhcccCCCceeEEeeEEeecCeEEEEEEecCC
Q 044561 351 DVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELV-SMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPN 425 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 425 (614)
++||+|+||.||+|+... +..+|+|.+.... .....++.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999865 7889999986542 222344555554 57889999999999999999999999999999
Q ss_pred CCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCccc
Q 044561 426 GSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT 505 (614)
Q Consensus 426 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 505 (614)
|+|..++... ..+++.++..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (321)
T cd05603 81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTS 154 (321)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cccc
Confidence 9998888653 348888999999999999999994 899999999999999999999999999987532221 1233
Q ss_pred ccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcH
Q 044561 506 KLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEE 585 (614)
Q Consensus 506 ~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~ 585 (614)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||...+..+. .+.+ ..+.. . .+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i----~~~~~------~----~~~ 217 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM---YDNI----LHKPL------Q----LPG 217 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH---HHHH----hcCCC------C----CCC
Confidence 45789999999999988899999999999999999999999976532211 1111 11110 1 111
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCHH
Q 044561 586 KQMELVLKLGLFCSHPKPEARPNMR 610 (614)
Q Consensus 586 ~~~~~l~~l~~~cl~~dP~~RPs~~ 610 (614)
.....+.+++.+|++.||.+||+..
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 218 GKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCHHHHHHHHHHccCCHhhcCCCC
Confidence 2234567788889999999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=309.38 Aligned_cols=263 Identities=23% Similarity=0.328 Sum_probs=196.3
Q ss_pred CCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC--hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS--KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
+|+..+.||+|++|.||+|+.+. +..|++|++.... ....+.+.+|+.++++++|||++++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 46778899999999999999864 8889999886442 22346788999999999999999999999999999999999
Q ss_pred cCCCCcchhcccCC-CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCC
Q 044561 423 MPNGSLDKILHTNI-KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI 501 (614)
Q Consensus 423 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~ 501 (614)
++ ++|.+++.... ...+++.++..++.|+++||.|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 68888876533 2568999999999999999999994 8999999999999999999999999999976543221
Q ss_pred CcccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCC----------
Q 044561 502 PQTTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGA---------- 570 (614)
Q Consensus 502 ~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~---------- 570 (614)
......+++.|+|||.+.+. .++.++|||||||+++||++|+.||......+.............+..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 157 -VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred -cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence 12234678899999988654 578999999999999999999999976443221110000000000000
Q ss_pred ---ccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 571 ---IRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 571 ---~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
........+.. ........+.+++.+|++.||++|||+.+|++
T Consensus 236 ~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 236 KNTFPKWKKGSLRS-AVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HhhccccCcchhHH-hcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000 00012245668888999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=316.69 Aligned_cols=241 Identities=22% Similarity=0.319 Sum_probs=192.4
Q ss_pred CCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhcccC-CCceeEEeeEEeecCeEEEEE
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRLR-HRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 420 (614)
+|+..+.||+|+||.||++..+. +..||+|++.... ....+.+..|..++..+. |++|+++.+++...+.+++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 36778899999999999999765 7889999987542 233456778888888875 577888999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
||+++|+|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 81 EYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 999999999998764 348999999999999999999994 899999999999999999999999999987543222
Q ss_pred CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
. ......||+.|+|||++....++.++|||||||++|||++|+.||......+. ...+. ++.. ...
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~---~~~i~----~~~~------~~p 221 (323)
T cd05615 156 V-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL---FQSIM----EHNV------SYP 221 (323)
T ss_pred c-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH---HHHHH----hCCC------CCC
Confidence 1 22345689999999999988899999999999999999999999976543221 11111 1111 111
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCCCH
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARPNM 609 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 609 (614)
.. ....+.+++.+|++.+|++|++.
T Consensus 222 ~~----~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 222 KS----LSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred cc----CCHHHHHHHHHHcccCHhhCCCC
Confidence 11 23456778888999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=304.79 Aligned_cols=249 Identities=28% Similarity=0.472 Sum_probs=199.6
Q ss_pred cCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecC
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMP 424 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 424 (614)
.+|+..+.||+|+||.||++.+..+..+++|.+..... ...++.+|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 35677789999999999999987778899998865432 23578899999999999999999999999999999999999
Q ss_pred CCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcc
Q 044561 425 NGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT 504 (614)
Q Consensus 425 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 504 (614)
+++|.+++.... ..+++..+..++.|++.|+.|||+ .+++||||||+||+++.++.+||+|||++...........
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 83 HGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 999999987543 358899999999999999999994 8999999999999999999999999999876543322112
Q ss_pred cccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcC
Q 044561 505 TKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGIC 583 (614)
Q Consensus 505 ~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 583 (614)
....++.+|+|||.+..+.++.++||||||+++|||++ |+.||......+. .. ...++. ....+.
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---~~----~~~~~~--~~~~~~----- 224 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV---VE----TINAGF--RLYKPR----- 224 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH---HH----HHhCCC--CCCCCC-----
Confidence 22235678999999988889999999999999999998 9999875433221 11 111110 001111
Q ss_pred cHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 584 EEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 584 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
...+.+.+++.+||+.+|++|||+.|+++
T Consensus 225 --~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~ 253 (256)
T cd05112 225 --LASQSVYELMQHCWKERPEDRPSFSLLLH 253 (256)
T ss_pred --CCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 12356888999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=304.08 Aligned_cols=242 Identities=26% Similarity=0.417 Sum_probs=191.1
Q ss_pred eeeeeCcEEEEEEEEe---cCcEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecCCCC
Q 044561 352 VIGRGGFGKVYRGVLA---SNVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGS 427 (614)
Q Consensus 352 ~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 427 (614)
.||+|+||.||+|.+. .+..+|+|.+.... ....+++.+|+.++++++||||++++++|. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999875 24568999887653 334567899999999999999999999885 457899999999999
Q ss_pred cchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCc--cc
Q 044561 428 LDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ--TT 505 (614)
Q Consensus 428 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~--~~ 505 (614)
|.+++... ...+++.++.+++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.......... ..
T Consensus 81 L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 81 LNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 99998753 3458999999999999999999994 899999999999999999999999999998654332111 11
Q ss_pred ccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCc
Q 044561 506 KLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICE 584 (614)
Q Consensus 506 ~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 584 (614)
...++..|+|||.+....++.++||||||+++||+++ |+.||......+.. .....+... .++
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~~~~---------~~~ 220 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM-------SFIEQGKRL---------DCP 220 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH-------HHHHCCCCC---------CCC
Confidence 1233578999999988889999999999999999996 99999765432211 111122111 112
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 585 EKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 585 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
....+.+.+++.+||..+|++||++.+|.+
T Consensus 221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 221 AECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 223456778888999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=305.00 Aligned_cols=241 Identities=27% Similarity=0.397 Sum_probs=191.0
Q ss_pred eeeeeCcEEEEEEEEe---cCcEEEEEEeecCC--hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecCCC
Q 044561 352 VIGRGGFGKVYRGVLA---SNVQIAVKKVSHDS--KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNG 426 (614)
Q Consensus 352 ~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 426 (614)
.||+|+||.||+|.++ ++..+|+|++.... ....+++.+|+.+++.++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999764 36789999886543 334678899999999999999999999885 45678999999999
Q ss_pred CcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCc--c
Q 044561 427 SLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ--T 504 (614)
Q Consensus 427 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~--~ 504 (614)
+|.+++... ..+++..+..++.|++.||.||| +++++||||||+||+++.++.+||+|||+++......... .
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 81 PLNKFLQKN--KHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 999998753 35899999999999999999999 4899999999999999999999999999998765433211 1
Q ss_pred cccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcC
Q 044561 505 TKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGIC 583 (614)
Q Consensus 505 ~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 583 (614)
....++..|+|||.+....++.++|+|||||++|||++ |+.||......+. ... ..++.... ....
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~----i~~~~~~~-----~~~~- 222 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV---TQM----IESGERME-----CPQR- 222 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH----HHCCCCCC-----CCCC-
Confidence 22234678999999988889999999999999999998 9999976433221 111 12211111 1112
Q ss_pred cHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 584 EEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 584 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
....+.+++.+||++||++||++.+|.+
T Consensus 223 ---~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 223 ---CPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred ---CCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 2345778888999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=305.68 Aligned_cols=249 Identities=26% Similarity=0.455 Sum_probs=196.1
Q ss_pred CCCcceeeeeCcEEEEEEEEec----CcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCe-----
Q 044561 347 FKDKDVIGRGGFGKVYRGVLAS----NVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGE----- 415 (614)
Q Consensus 347 f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~----- 415 (614)
|+..+.||+|+||.||+|.... +..+|+|++... .......+.+|+..++.++|||++++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567899999999999999753 367999998754 33445788999999999999999999999876554
Q ss_pred -EEEEEEecCCCCcchhcccC----CCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeee
Q 044561 416 -FLLVYDYMPNGSLDKILHTN----IKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDF 490 (614)
Q Consensus 416 -~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~Df 490 (614)
.++++||+++|+|..++... ....+++..+..++.|++.||.|||+ .+++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence 79999999999999988542 23458999999999999999999994 89999999999999999999999999
Q ss_pred ccccccCCCCCC-cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhc
Q 044561 491 GLARLYDHDTIP-QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKK 568 (614)
Q Consensus 491 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~ 568 (614)
|+++........ ......++..|+|||.+....++.++|||||||++|||++ |..||......+ ..+++ ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~~~----~~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYDYL----RH 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----Hc
Confidence 999865433211 1222345678999999988889999999999999999999 888986544322 12222 11
Q ss_pred CCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 569 GAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 569 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+.... .+......+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~ 267 (273)
T cd05035 231 GNRLK---------QPEDCLDELYDLMYSCWRADPKDRPTFTKLRE 267 (273)
T ss_pred CCCCC---------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11111 11223446788888999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=304.00 Aligned_cols=245 Identities=27% Similarity=0.423 Sum_probs=197.6
Q ss_pred ceeeeeCcEEEEEEEEec--C--cEEEEEEeecCCh-hhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecCC
Q 044561 351 DVIGRGGFGKVYRGVLAS--N--VQIAVKKVSHDSK-QGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPN 425 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 425 (614)
+.||+|++|.||+|.+.. + ..+|+|.+..... ...+.+.+|+..+++++||||+++++.+.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999754 2 3589999987765 667889999999999999999999999988 899999999999
Q ss_pred CCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCC--c
Q 044561 426 GSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP--Q 503 (614)
Q Consensus 426 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~--~ 503 (614)
++|.+++.......+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++......... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999997754356899999999999999999999 489999999999999999999999999999876542211 1
Q ss_pred ccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCc
Q 044561 504 TTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGI 582 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 582 (614)
.....++..|+|||.+....++.++|||||||++|||++ |+.||......+.... ... .+....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~---~~~---~~~~~~--------- 221 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKK---IDK---EGERLE--------- 221 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---HHh---cCCcCC---------
Confidence 123456789999999998899999999999999999998 9999965433322111 111 110000
Q ss_pred CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 583 CEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 583 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+......+.+++.+|++.+|++||++.++++
T Consensus 222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 222 RPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred CCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 11122346778889999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=312.14 Aligned_cols=264 Identities=22% Similarity=0.311 Sum_probs=198.6
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
++|...+.||+|+||.||+|+.+. +..||+|.+.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 468888999999999999999864 7889999986543 22335677899999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 502 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 502 (614)
++ ++|.+++... ...+++..+..++.|+++||.|||+ .+|+||||||+||++++++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 159 (301)
T cd07873 86 LD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 159 (301)
T ss_pred cc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence 97 6888888654 3358899999999999999999994 8999999999999999999999999999976543221
Q ss_pred cccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccc------
Q 044561 503 QTTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDAS------ 575 (614)
Q Consensus 503 ~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~------ 575 (614)
......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...+..+....+...........+....
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence 12234578899999988653 57889999999999999999999997654432221111100000000000000
Q ss_pred ---cccccCcC----cHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 576 ---DSRLEGIC----EEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 576 ---d~~l~~~~----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+.....+ .......+.+|+.+|+++||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 01110000 0112335678889999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=311.39 Aligned_cols=258 Identities=24% Similarity=0.390 Sum_probs=198.1
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec---------------CcEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEee
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS---------------NVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRG 408 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g 408 (614)
.+|+..+.||+|+||.||++...+ ...||+|.+... .......+.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 468888999999999999987643 234899988765 3344567899999999999999999999
Q ss_pred EEeecCeEEEEEEecCCCCcchhcccCC----------CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeE
Q 044561 409 YCRRKGEFLLVYDYMPNGSLDKILHTNI----------KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVL 478 (614)
Q Consensus 409 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIl 478 (614)
++...+..++||||+++++|.+++.... ...+++.+++.++.|++.||.|||+ .+++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEE
Confidence 9999999999999999999999885432 1247899999999999999999994 89999999999999
Q ss_pred EcCCCCEEEeeeccccccCCCCC-CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc--CCCCCCCCCcccc
Q 044561 479 LDADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS--GRRPVEQQGSMET 555 (614)
Q Consensus 479 l~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t--g~~p~~~~~~~~~ 555 (614)
+++++.+||+|||++........ .......++..|+|||.+..+.++.++|||||||+++||++ |..||......+.
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 99999999999999976543221 11222345778999999988899999999999999999998 5667765433222
Q ss_pred ccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 556 VNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 556 ~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
. ....+.+......... ..+......+.+++.+|++.||++|||+.+|++
T Consensus 242 ~---~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 242 I---ENTGEFFRNQGRQIYL------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred H---HHHHHhhhhccccccC------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 1 1111111111000000 001112346889999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=302.56 Aligned_cols=253 Identities=28% Similarity=0.437 Sum_probs=203.5
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecC---ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
++|+..+.||+|+||.||+|... ++..+++|.+... .....+.+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999987 5888999988632 2334567899999999999999999999999999999999
Q ss_pred EecCCCCcchhcccC--CCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCC
Q 044561 421 DYMPNGSLDKILHTN--IKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 498 (614)
Q Consensus 421 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~ 498 (614)
||+++++|.+++... ....+++.++..++.++++||.|||+ .+++||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999988642 23458999999999999999999994 8999999999999999999999999999876544
Q ss_pred CCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccc
Q 044561 499 DTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSR 578 (614)
Q Consensus 499 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~ 578 (614)
... ......++..|+|||.+.+..++.++|+||||+++|||++|+.||..... ...+. .+....+....
T Consensus 159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~-~~~~~~~~~~~----- 227 (267)
T cd08224 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSL-CKKIEKCDYPP----- 227 (267)
T ss_pred CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHH-HhhhhcCCCCC-----
Confidence 321 12334688899999999888899999999999999999999999864331 11111 11111111111
Q ss_pred ccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 579 LEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 579 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.........+.+++.+||+++|++|||+.+|++
T Consensus 228 ---~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 228 ---LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred ---CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 111133456788889999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=306.27 Aligned_cols=247 Identities=27% Similarity=0.449 Sum_probs=201.9
Q ss_pred CCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
+|+..+.||.|++|.||+|.... +..+++|.+.... ......+.+|+.+++.++|+|++++.+++.+....++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 56778889999999999999875 7889999987653 444567889999999999999999999999999999999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCc
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 503 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 503 (614)
++++|.+++... .+++.++..++.|++.||.|||+ ++++||||+|+||++++++.++|+|||++....... ..
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~ 154 (274)
T cd06609 82 GGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SK 154 (274)
T ss_pred CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccc-cc
Confidence 999999998764 58999999999999999999994 899999999999999999999999999998765432 12
Q ss_pred ccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcC
Q 044561 504 TTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGIC 583 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 583 (614)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||......+.. .....+.. +.+...
T Consensus 155 ~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~-------~~~~~~~~-----~~~~~~- 221 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL-------FLIPKNNP-----PSLEGN- 221 (274)
T ss_pred cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHH-------HHhhhcCC-----CCCccc-
Confidence 23346888999999999888999999999999999999999999754322111 11111111 111111
Q ss_pred cHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 584 EEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 584 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.....+.+++.+|++.+|++||+++++++
T Consensus 222 --~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 222 --KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred --ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 02335677888899999999999999974
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=303.75 Aligned_cols=244 Identities=31% Similarity=0.443 Sum_probs=196.0
Q ss_pred cCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEe-ecCeEEEEEEec
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCR-RKGEFLLVYDYM 423 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~-~~~~~~lV~E~~ 423 (614)
++|+..+.||+|+||.||++..+ +..+++|...... ..+.+.+|+.++++++|+|++++++++. ..+..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46788899999999999999765 6678999886543 3467889999999999999999999764 456789999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCc
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 503 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 503 (614)
++++|.+++.......+++..+..++.|++.||.|||+ ++++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 99999999987655568999999999999999999994 899999999999999999999999999987544322
Q ss_pred ccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCc
Q 044561 504 TTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGI 582 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 582 (614)
....++..|+|||++....++.++|||||||++|||++ |+.||......+ ....+. .+... .
T Consensus 157 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~~~~~----~~~~~-----~---- 219 (256)
T cd05082 157 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVE----KGYKM-----D---- 219 (256)
T ss_pred -CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHh----cCCCC-----C----
Confidence 22345678999999998889999999999999999997 999986543221 111111 11111 1
Q ss_pred CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 583 CEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 583 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
........+.+++.+|++.+|++|||+.++++
T Consensus 220 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 220 APDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 11122346778888999999999999999863
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=301.15 Aligned_cols=249 Identities=22% Similarity=0.352 Sum_probs=203.8
Q ss_pred CCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
+|+..+.||+|+||.||.++... +..+++|++... .....+++.+|+.++++++|+||+++++++.+.+.++++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 47788999999999999998764 788999987654 345567889999999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 502 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 502 (614)
+++++|.+++.......+++.++..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 999999999987544568999999999999999999994 7999999999999999999999999999986644332
Q ss_pred cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCc
Q 044561 503 QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGI 582 (614)
Q Consensus 503 ~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 582 (614)
......++..|+|||.+.+..++.++||||||+++|||++|+.||......+.. ... ..+.....
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~------~~~-~~~~~~~~-------- 221 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLV------VKI-VQGNYTPV-------- 221 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHH------HHH-HcCCCCCC--------
Confidence 223456899999999998888899999999999999999999999754332211 111 12221111
Q ss_pred CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 583 CEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 583 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+......+.+++.+||+++|++||++.++++
T Consensus 222 -~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~ 252 (256)
T cd08221 222 -VSVYSSELISLVHSLLQQDPEKRPTADEVLD 252 (256)
T ss_pred -ccccCHHHHHHHHHHcccCcccCCCHHHHhh
Confidence 1122345777888899999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=308.18 Aligned_cols=251 Identities=26% Similarity=0.456 Sum_probs=200.9
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec------CcEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS------NVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFL 417 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 417 (614)
++|...+.||+|+||.||+|..++ +..+++|.+.... ......+.+|+.+++.++||||+++++++......+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 467788999999999999998753 3679999986543 344567889999999999999999999999999999
Q ss_pred EEEEecCCCCcchhcccCC--------CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEee
Q 044561 418 LVYDYMPNGSLDKILHTNI--------KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGD 489 (614)
Q Consensus 418 lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~D 489 (614)
+||||+++|+|.+++.... ...+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEECC
Confidence 9999999999999986422 234789999999999999999999 48999999999999999999999999
Q ss_pred eccccccCCCCC-CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhh
Q 044561 490 FGLARLYDHDTI-PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWK 567 (614)
Q Consensus 490 fGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~ 567 (614)
||+++....... .......++..|+|||.+..+.++.++|||||||++||+++ |+.||......+.. .+. .
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~---~~~----~ 235 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVL---KFV----I 235 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHH---HHH----h
Confidence 999876543321 12233456789999999988889999999999999999998 99998754432221 111 1
Q ss_pred cCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 568 KGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 568 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+.... ....+ ...+.+++.+||+.+|++|||+.|+++
T Consensus 236 ~~~~~~-----~~~~~----~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 236 DGGHLD-----LPENC----PDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred cCCCCC-----CCCCC----CHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 111111 11112 446788899999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=320.45 Aligned_cols=248 Identities=28% Similarity=0.483 Sum_probs=209.5
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-----CcEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-----NVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLL 418 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 418 (614)
+.....++||+|-||.||+|++.+ .-.||||..+.+ .....+.|++|..+|++++||||++++|.|.+. ..+|
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeE
Confidence 344567789999999999999643 345899999875 344567899999999999999999999999764 6899
Q ss_pred EEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCC
Q 044561 419 VYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 498 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~ 498 (614)
|||.++.|.|..+|+.+. ..|+......++.||+.+|+|||+ ...|||||..+|||+.+.-.+||+||||++..+.
T Consensus 468 vmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred EEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 999999999999998864 459999999999999999999996 8999999999999999999999999999999887
Q ss_pred CCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccc
Q 044561 499 DTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDS 577 (614)
Q Consensus 499 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~ 577 (614)
+.....+...-+..|||||.+.-.+++.++|||.|||+|||++. |..||.+-.+.+.+..+ ++|.
T Consensus 544 ~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i-------EnGe------- 609 (974)
T KOG4257|consen 544 DAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI-------ENGE------- 609 (974)
T ss_pred cchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe-------cCCC-------
Confidence 76655555566889999999999999999999999999999987 99999886665543222 2221
Q ss_pred cccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHh
Q 044561 578 RLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVM 613 (614)
Q Consensus 578 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 613 (614)
++ -+++.+...|..|+.+||..+|.+||.+.|+.
T Consensus 610 Rl--P~P~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 610 RL--PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred CC--CCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 11 24555667888999999999999999999874
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=310.79 Aligned_cols=259 Identities=24% Similarity=0.392 Sum_probs=202.2
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-----------------CcEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-----------------NVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVK 405 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~ 405 (614)
.++|+..+.||+|+||.||++...+ +..+++|++.... ....+++.+|+.++++++|||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3568888999999999999998653 2457899887553 445678899999999999999999
Q ss_pred EeeEEeecCeEEEEEEecCCCCcchhcccCC---------CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCC
Q 044561 406 LRGYCRRKGEFLLVYDYMPNGSLDKILHTNI---------KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN 476 (614)
Q Consensus 406 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~N 476 (614)
++++|..++..+++|||+++++|.+++.... ...+++..++.++.|++.||.|||+ .+++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhc
Confidence 9999999999999999999999999987543 1258999999999999999999994 899999999999
Q ss_pred eEEcCCCCEEEeeeccccccCCCC-CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc--CCCCCCCCCcc
Q 044561 477 VLLDADLNGKLGDFGLARLYDHDT-IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS--GRRPVEQQGSM 553 (614)
Q Consensus 477 Ill~~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t--g~~p~~~~~~~ 553 (614)
|+++.++.++|+|||+++...... ........++..|+|||.+..+.++.++|||||||++|||++ +..|+......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 999999999999999997654322 112233456789999999988889999999999999999998 67777654322
Q ss_pred ccccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 554 ETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 554 ~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+ ........+..+......+ .+......+.+++.+|++.||++|||+.||++
T Consensus 241 ~---~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 241 Q---VIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred H---HHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 2 1222222222211111111 11112346888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=309.68 Aligned_cols=252 Identities=25% Similarity=0.428 Sum_probs=198.0
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec------CcEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS------NVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEF 416 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 416 (614)
.++|+..+.||+|+||.||+|..++ +..||+|.+.... ......+.+|+..++.++||||+++++++...+..
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 4678889999999999999997642 4578999876543 23345688999999999999999999999999999
Q ss_pred EEEEEecCCCCcchhcccCC--------CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEe
Q 044561 417 LLVYDYMPNGSLDKILHTNI--------KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLG 488 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~ 488 (614)
++||||+++|+|.+++.... ...+++..+..++.|++.||.||| +++|+||||||+||++++++.+||+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEEC
Confidence 99999999999999996421 234577888999999999999999 4899999999999999999999999
Q ss_pred eeccccccCCCCC-CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhh
Q 044561 489 DFGLARLYDHDTI-PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCW 566 (614)
Q Consensus 489 DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~ 566 (614)
|||+++....... .......++..|+|||.+..+.++.++|||||||++|||++ |..||......+.. . ..
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~---~----~~ 234 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL---K----FV 234 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---H----HH
Confidence 9999986543221 11222345678999999998889999999999999999998 78888654332211 1 11
Q ss_pred hcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 567 KKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 567 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+.... .+......+.+++.+|++.||++|||+.++++
T Consensus 235 ~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 273 (288)
T cd05061 235 MDGGYLD---------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVN 273 (288)
T ss_pred HcCCCCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1111111 11122356888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=310.80 Aligned_cols=249 Identities=23% Similarity=0.426 Sum_probs=202.6
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
++|+..+.||.|++|.||+|... +++.+++|.+........+.+.+|+.+++.++|||++++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 45888899999999999999875 48899999997665555678889999999999999999999999999999999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCc
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 503 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 503 (614)
++++|.+++... .+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........ .
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~ 171 (296)
T cd06655 99 AGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-K 171 (296)
T ss_pred CCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcccccc-c
Confidence 999999988653 48999999999999999999995 8999999999999999999999999999876543321 1
Q ss_pred ccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcC
Q 044561 504 TTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGIC 583 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 583 (614)
.....++..|+|||.+.+..++.++|||||||++|||++|+.||......+... ... ........ .
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~---~~~----~~~~~~~~-------~ 237 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY---LIA----TNGTPELQ-------N 237 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHH----hcCCcccC-------C
Confidence 233468899999999988889999999999999999999999997654322111 111 11000000 1
Q ss_pred cHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 584 EEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 584 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+......+.+++.+||..||++||++.++++
T Consensus 238 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 238 PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred cccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 1112235677888999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=324.32 Aligned_cols=252 Identities=26% Similarity=0.412 Sum_probs=197.9
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec------CcEEEEEEeecCC-hhhHHHHHHHHHHhcccC-CCceeEEeeEEeecCeE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS------NVQIAVKKVSHDS-KQGIKEFVAELVSMGRLR-HRNLVKLRGYCRRKGEF 416 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~ 416 (614)
++|...+.||+|+||.||+|++.+ +..||+|++.... ....+.+.+|+.++.++. ||||++++++|...+..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 456778899999999999998642 4579999997653 333457889999999997 99999999999999999
Q ss_pred EEEEEecCCCCcchhcccCC------------------------------------------------------------
Q 044561 417 LLVYDYMPNGSLDKILHTNI------------------------------------------------------------ 436 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~~------------------------------------------------------------ 436 (614)
++||||+++|+|.++++.+.
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 99999999999999986431
Q ss_pred ------------------------------------CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEc
Q 044561 437 ------------------------------------KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD 480 (614)
Q Consensus 437 ------------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~ 480 (614)
...+++.++..++.|++.||.|||+ ++++||||||+|||++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEEEe
Confidence 1246788889999999999999994 8999999999999999
Q ss_pred CCCCEEEeeeccccccCCCCC-CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccH
Q 044561 481 ADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNL 558 (614)
Q Consensus 481 ~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l 558 (614)
+++.+||+|||+++....... .......++..|+|||.+....++.++||||||+++|||++ |+.||......+..
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~-- 351 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF-- 351 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH--
Confidence 999999999999986533221 12223457889999999988889999999999999999998 89998654322211
Q ss_pred HHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 559 VDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 559 ~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+....+... . .+......+.+++.+||+.+|++||+++||++
T Consensus 352 ----~~~~~~~~~~-----~----~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~ 394 (401)
T cd05107 352 ----YNAIKRGYRM-----A----KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVH 394 (401)
T ss_pred ----HHHHHcCCCC-----C----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1111111100 0 11112346778888999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=319.02 Aligned_cols=237 Identities=25% Similarity=0.295 Sum_probs=187.8
Q ss_pred ceeeeeCcEEEEEEEEec-CcEEEEEEeecC---ChhhHHHHHHHHH-HhcccCCCceeEEeeEEeecCeEEEEEEecCC
Q 044561 351 DVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD---SKQGIKEFVAELV-SMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPN 425 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 425 (614)
+.||+|+||+||+++... +..+|+|++... .....+++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 469999999999999764 888999998654 2233445566655 46779999999999999999999999999999
Q ss_pred CCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCccc
Q 044561 426 GSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT 505 (614)
Q Consensus 426 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 505 (614)
|+|..++... ..+++.++..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~ 154 (325)
T cd05604 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTT 154 (325)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCcc
Confidence 9999888653 358999999999999999999994 899999999999999999999999999987532221 1233
Q ss_pred ccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcH
Q 044561 506 KLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEE 585 (614)
Q Consensus 506 ~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~ 585 (614)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. +....+.+ .+....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~-------~~~~~~~~------~~~~~~-- 219 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMY-------DNILHKPL------VLRPGA-- 219 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHH-------HHHHcCCc------cCCCCC--
Confidence 457999999999999989999999999999999999999999765432211 11111111 111112
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCHH
Q 044561 586 KQMELVLKLGLFCSHPKPEARPNMR 610 (614)
Q Consensus 586 ~~~~~l~~l~~~cl~~dP~~RPs~~ 610 (614)
...+.+++.+|++.||++||+++
T Consensus 220 --~~~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 220 --SLTAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred --CHHHHHHHHHHhccCHHhcCCCC
Confidence 23466778889999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=319.71 Aligned_cols=262 Identities=22% Similarity=0.258 Sum_probs=197.4
Q ss_pred HhcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeec------
Q 044561 343 ATKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRK------ 413 (614)
Q Consensus 343 ~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------ 413 (614)
..++|+..+.||+|+||.||++.... +..+|+|++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 45689999999999999999999764 788999998754 334456788999999999999999999987543
Q ss_pred CeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccc
Q 044561 414 GEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLA 493 (614)
Q Consensus 414 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla 493 (614)
...++||||+++ +|.+.+.. .+++.++..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 357999999964 67666643 37889999999999999999994 89999999999999999999999999999
Q ss_pred cccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHH--------HHH-
Q 044561 494 RLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDW--------VCD- 564 (614)
Q Consensus 494 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~--------v~~- 564 (614)
+...... ......+|..|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.. ...
T Consensus 174 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (364)
T cd07875 174 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251 (364)
T ss_pred cccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 8654432 22335789999999999998999999999999999999999999976543322111100 000
Q ss_pred -------hhh-cCCccccc----cccc----cCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 565 -------CWK-KGAIRDAS----DSRL----EGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 565 -------~~~-~~~~~~~~----d~~l----~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
... ........ .+.. ...........+.+++.+|++.||++|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000 00000000 0000 00011112345788899999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=304.74 Aligned_cols=237 Identities=24% Similarity=0.420 Sum_probs=187.0
Q ss_pred ceeeeeCcEEEEEEEEec-------------CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEE
Q 044561 351 DVIGRGGFGKVYRGVLAS-------------NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFL 417 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 417 (614)
+.||+|+||.||+|+... ...+++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998642 2357888876655555667889999999999999999999999999999
Q ss_pred EEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCC-------EEEeee
Q 044561 418 LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLN-------GKLGDF 490 (614)
Q Consensus 418 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~-------~kl~Df 490 (614)
+||||+++|+|+.++.... ..+++.++.+++.||++||.|||+ ++|+||||||+|||++.++. +|++||
T Consensus 81 lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999999886532 358999999999999999999994 89999999999999987664 899999
Q ss_pred ccccccCCCCCCcccccccCCCccchhhhc-CCCCCcchhHHHHHHHHHHHH-cCCCCCCCCCccccccHHHHHHHhhhc
Q 044561 491 GLARLYDHDTIPQTTKLVGTFGYMDPELMR-TGKASTSTDVYAFGVFMLEVA-SGRRPVEQQGSMETVNLVDWVCDCWKK 568 (614)
Q Consensus 491 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~~~Dv~S~Gvll~el~-tg~~p~~~~~~~~~~~l~~~v~~~~~~ 568 (614)
|++...... ....++..|+|||.+. ...++.++|||||||++|||+ .|+.|+......+.. ... .
T Consensus 157 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-------~~~-~ 223 (262)
T cd05077 157 GIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-------RFY-E 223 (262)
T ss_pred CCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-------HHH-h
Confidence 998754322 2245788999999886 456899999999999999998 588887643322111 111 1
Q ss_pred CCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 569 GAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 569 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+... ... .....+.+++.+||+.||++||++++|++
T Consensus 224 ~~~~------~~~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~ 259 (262)
T cd05077 224 GQCM------LVT----PSCKELADLMTHCMNYDPNQRPFFRAIMR 259 (262)
T ss_pred cCcc------CCC----CChHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1110 000 11245678888999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=301.35 Aligned_cols=253 Identities=26% Similarity=0.410 Sum_probs=205.4
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
++|+..+.||+|+||.||++.... +..+++|.+........+.+.+|+.++++++|||++++++.+...+.++++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 568888999999999999999864 7789999998776666788999999999999999999999999999999999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCc
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 503 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 503 (614)
++++|.+++... ...+++.++..++.|++.||.||| +.+++|+||||+||++++++.+||+|||++........ .
T Consensus 83 ~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~ 157 (262)
T cd06613 83 GGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-K 157 (262)
T ss_pred CCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhhh-c
Confidence 999999998764 245899999999999999999999 48999999999999999999999999999876543221 2
Q ss_pred ccccccCCCccchhhhcCC---CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 504 TTKLVGTFGYMDPELMRTG---KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~~~---~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
.....++..|+|||.+... .++.++|+||||+++|||++|+.|+......+.... ...... ....+.
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~-------~~~~~~---~~~~~~ 227 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL-------ISKSNF---PPPKLK 227 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------HHhccC---CCcccc
Confidence 2334688899999998766 789999999999999999999999975443222111 011100 001111
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
........+.+++.+||+.+|++|||+.+|++
T Consensus 228 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 228 --DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred --chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 12223456888999999999999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=313.68 Aligned_cols=249 Identities=28% Similarity=0.452 Sum_probs=195.3
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-Cc--EEEEEEeecC-ChhhHHHHHHHHHHhccc-CCCceeEEeeEEeecCeEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NV--QIAVKKVSHD-SKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGEFLLV 419 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 419 (614)
++|+..+.||+|+||.||+|.++. +. .+++|++... .....+++.+|+.++.++ +|+||+++++++..++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 467888999999999999999764 33 4577776543 344567888999999999 899999999999999999999
Q ss_pred EEecCCCCcchhcccCC--------------CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCE
Q 044561 420 YDYMPNGSLDKILHTNI--------------KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG 485 (614)
Q Consensus 420 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~ 485 (614)
|||+++++|.+++.... ...+++.+++.++.|++.||.||| +.+++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCcE
Confidence 99999999999986432 235889999999999999999999 4899999999999999999999
Q ss_pred EEeeeccccccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHH
Q 044561 486 KLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCD 564 (614)
Q Consensus 486 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~ 564 (614)
||+|||++....... ......++..|+|||.+....++.++|||||||+++||++ |..||......+.. .
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~---- 234 (303)
T cd05088 164 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY---E---- 234 (303)
T ss_pred EeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHH---H----
Confidence 999999986432111 1122234668999999988888999999999999999998 99999754432211 1
Q ss_pred hhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 565 CWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 565 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
....+. .... +......+.+++.+|++.+|++||++.++++
T Consensus 235 ~~~~~~-----~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 275 (303)
T cd05088 235 KLPQGY-----RLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILV 275 (303)
T ss_pred HHhcCC-----cCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 111110 0001 1112335778889999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=303.44 Aligned_cols=247 Identities=23% Similarity=0.438 Sum_probs=198.2
Q ss_pred CCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCCh---------hhHHHHHHHHHHhcccCCCceeEEeeEEeecCeE
Q 044561 347 FKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSK---------QGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEF 416 (614)
Q Consensus 347 f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 416 (614)
|...+.||+|++|.||+|.... +..+++|.+..... ...+.+.+|+.++++++||||+++++++...+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 5667899999999999999764 78899998865422 1235688999999999999999999999999999
Q ss_pred EEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecccccc
Q 044561 417 LLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 496 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~ 496 (614)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||+++..
T Consensus 82 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred EEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 9999999999999999764 348899999999999999999994 89999999999999999999999999999876
Q ss_pred CCCCC-----CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCc
Q 044561 497 DHDTI-----PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAI 571 (614)
Q Consensus 497 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~ 571 (614)
..... .......|+..|+|||.+....++.++|+||||+++|||++|+.||......+. + ... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~---~~~-~~--- 226 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA---I---FKI-GE--- 226 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH---H---HHH-hc---
Confidence 53211 111224578899999999888899999999999999999999999975432111 1 110 01
Q ss_pred cccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 572 RDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 572 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
...+.+ +....+.+..++.+||++||++||++.||++
T Consensus 227 --~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 --NASPEI----PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred --cCCCcC----CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 111111 2223355777888999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=312.54 Aligned_cols=251 Identities=26% Similarity=0.423 Sum_probs=198.6
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe--------cCcEEEEEEeecC-ChhhHHHHHHHHHHhccc-CCCceeEEeeEEeecC
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA--------SNVQIAVKKVSHD-SKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKG 414 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 414 (614)
.+|...+.||+|+||.||+++.. ++..+++|.+... .....+++.+|+.+++.+ +||||+++++++...+
T Consensus 15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 94 (304)
T cd05101 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 94 (304)
T ss_pred HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCC
Confidence 46778899999999999999742 2346899988654 344567889999999999 8999999999999999
Q ss_pred eEEEEEEecCCCCcchhcccCC--------------CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEc
Q 044561 415 EFLLVYDYMPNGSLDKILHTNI--------------KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD 480 (614)
Q Consensus 415 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~ 480 (614)
..+++|||+++|+|.+++.... ...+++.++..++.||++||.|||+ .+++||||||+||+++
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nili~ 171 (304)
T cd05101 95 PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLVT 171 (304)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEEEc
Confidence 9999999999999999987532 2357889999999999999999994 8999999999999999
Q ss_pred CCCCEEEeeeccccccCCCCCC-cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccH
Q 044561 481 ADLNGKLGDFGLARLYDHDTIP-QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNL 558 (614)
Q Consensus 481 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l 558 (614)
.++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..|+......+..
T Consensus 172 ~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-- 249 (304)
T cd05101 172 ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF-- 249 (304)
T ss_pred CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH--
Confidence 9999999999999876443211 1222345678999999988889999999999999999998 78888654322211
Q ss_pred HHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 559 VDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 559 ~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+....+.... .+......+.+++.+||+++|++|||+.|+++
T Consensus 250 -----~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~ 291 (304)
T cd05101 250 -----KLLKEGHRMD---------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291 (304)
T ss_pred -----HHHHcCCcCC---------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 1111111110 11123456778888999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=307.50 Aligned_cols=251 Identities=25% Similarity=0.376 Sum_probs=200.7
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
+.|+..+.||+|+||.||+|.... +..+++|.+........+.+.+|+.+++.++|+|++++++.+..++.+++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 457778899999999999999875 7889999998777777788999999999999999999999999999999999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCc
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 503 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 503 (614)
++++|..++.... ..+++.++..++.|++.+|.||| +.+++||||||+||+++.++.+||+|||++....... ..
T Consensus 92 ~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~ 166 (292)
T cd06644 92 PGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QR 166 (292)
T ss_pred CCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceeccccc-cc
Confidence 9999988876532 35899999999999999999999 4899999999999999999999999999987543322 11
Q ss_pred ccccccCCCccchhhhc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccc
Q 044561 504 TTKLVGTFGYMDPELMR-----TGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSR 578 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~-----~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~ 578 (614)
.....++..|+|||++. ...++.++|||||||++|||++|+.||......+. ..+. .......
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~~-~~~~~~~----- 234 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKI-AKSEPPT----- 234 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH------HHHH-hcCCCcc-----
Confidence 23346888999999874 34568899999999999999999999865432111 1111 1111111
Q ss_pred ccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 579 LEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 579 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.. .+......+..++.+||+.||++||++.|+++
T Consensus 235 ~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 235 LS--QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred CC--CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00 11122335677888899999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=306.39 Aligned_cols=264 Identities=23% Similarity=0.310 Sum_probs=201.0
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC--hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS--KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 421 (614)
++|+..+.||+|+||.||+|+.+. +..+++|++.... ....+.+.+|+.++++++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 357788899999999999999875 7889999886542 2234567899999999999999999999999999999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCC
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI 501 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~ 501 (614)
|+++++|..++... ..+++.++..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 81 YCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred ccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 99999888877543 348999999999999999999995 8999999999999999999999999999987654321
Q ss_pred CcccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHH--------HhhhcCCcc
Q 044561 502 PQTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVC--------DCWKKGAIR 572 (614)
Q Consensus 502 ~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~--------~~~~~~~~~ 572 (614)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+......... ..+..+...
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence 2223457889999999875 457899999999999999999999997655433221111000 000000000
Q ss_pred -ccccccccCcCc-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 573 -DASDSRLEGICE-----EKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 573 -~~~d~~l~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
....+......+ ......+.+++.+|++++|++||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000000000000 112356788999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=312.91 Aligned_cols=251 Identities=25% Similarity=0.416 Sum_probs=197.7
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec--------CcEEEEEEeecC-ChhhHHHHHHHHHHhccc-CCCceeEEeeEEeecC
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS--------NVQIAVKKVSHD-SKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKG 414 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 414 (614)
++|...+.||+|+||.||++...+ ...+|+|.+... ......++.+|+.+++.+ +||||++++++|...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 468888999999999999998632 246899988754 234556788999999999 7999999999999999
Q ss_pred eEEEEEEecCCCCcchhcccCC--------------CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEc
Q 044561 415 EFLLVYDYMPNGSLDKILHTNI--------------KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD 480 (614)
Q Consensus 415 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~ 480 (614)
..++||||+++|+|.+++.... ...+++.++++++.|++.||+||| +.+++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEEc
Confidence 9999999999999999997532 134899999999999999999999 48999999999999999
Q ss_pred CCCCEEEeeeccccccCCCCC-CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccH
Q 044561 481 ADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNL 558 (614)
Q Consensus 481 ~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l 558 (614)
.++.+||+|||++........ .......++..|+|||.+.+..++.++|||||||++|||++ |+.||......+..
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~-- 252 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF-- 252 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH--
Confidence 999999999999876543221 11122234568999999988889999999999999999998 88888654322111
Q ss_pred HHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 559 VDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 559 ~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+....+... ..+......+.+++.+|++.+|++||++.+|++
T Consensus 253 -----~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 294 (307)
T cd05098 253 -----KLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294 (307)
T ss_pred -----HHHHcCCCC---------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 111111111 111222346778888999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=307.77 Aligned_cols=252 Identities=23% Similarity=0.367 Sum_probs=199.9
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-----CcEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEee-cCeE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-----NVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRR-KGEF 416 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~ 416 (614)
.++|+..+.||+|+||.||+|...+ +..|++|++... .....+.+.+|+.++++++|+|++++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678888999999999999999876 677899988654 34456778999999999999999999999876 4678
Q ss_pred EEEEEecCCCCcchhcccCCC------CCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeee
Q 044561 417 LLVYDYMPNGSLDKILHTNIK------PCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDF 490 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~Df 490 (614)
++++||+++++|.+++..... ..+++.++..++.|++.||.||| +.+++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCC
Confidence 999999999999999865321 45899999999999999999999 489999999999999999999999999
Q ss_pred ccccccCCCCCC-cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhc
Q 044561 491 GLARLYDHDTIP-QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKK 568 (614)
Q Consensus 491 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~ 568 (614)
|+++.+...... ......++..|+|||++....++.++||||||+++||+++ |+.||......+ ...++. .
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~----~ 234 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYLK----D 234 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHHHH----c
Confidence 999865432211 1122345678999999988889999999999999999999 999997543322 111111 1
Q ss_pred CCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 569 GAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 569 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+.. ...... ....+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~-----~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 235 GYR-----LAQPIN----CPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCC-----CCCCCc----CCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 110 000111 2245778899999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=322.96 Aligned_cols=245 Identities=30% Similarity=0.509 Sum_probs=205.3
Q ss_pred ceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecCCCCcc
Q 044561 351 DVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLD 429 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 429 (614)
-+||+|.||+||.|+..+ ...+|||.+.....+..+-+..|+...+.|+|+|||+++|.|.+.+.+-+.||.+|||||.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 479999999999999876 6678999998777667777889999999999999999999999999999999999999999
Q ss_pred hhcccCCCCCc--ChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEc-CCCCEEEeeeccccccCCCCCCcccc
Q 044561 430 KILHTNIKPCL--NWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD-ADLNGKLGDFGLARLYDHDTIPQTTK 506 (614)
Q Consensus 430 ~~l~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~ 506 (614)
++|...- +++ ++.++-.+.+||++||.||| ++.|||||||-+|||++ -.|.+||+|||-++....- .+.+.+
T Consensus 661 sLLrskW-GPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~TET 735 (1226)
T KOG4279|consen 661 SLLRSKW-GPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCTET 735 (1226)
T ss_pred HHHHhcc-CCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccC-Cccccc
Confidence 9998754 335 77888899999999999999 58999999999999995 4789999999999876532 345566
Q ss_pred cccCCCccchhhhcCC--CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCc
Q 044561 507 LVGTFGYMDPELMRTG--KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICE 584 (614)
Q Consensus 507 ~~gt~~y~aPE~~~~~--~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 584 (614)
..||..|||||++..+ .|..++|||||||.+.||.||++||...+.+...- ++-|.. +.-...+
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM--------FkVGmy------KvHP~iP 801 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM--------FKVGMY------KVHPPIP 801 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh--------hhhcce------ecCCCCc
Confidence 7899999999999876 48899999999999999999999997665543211 111111 1123356
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 585 EKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 585 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
++.......++++|..+||.+||+++++|+
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 667778888899999999999999999875
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=305.20 Aligned_cols=252 Identities=25% Similarity=0.394 Sum_probs=199.8
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
++|+..+.||+|+||.||+|+..+ +..+++|.+..........+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 356677889999999999999764 7889999987766555667889999999999999999999999999999999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCc
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 503 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 503 (614)
++++|.+++... ..+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++....... ..
T Consensus 89 ~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~ 162 (267)
T cd06645 89 GGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AK 162 (267)
T ss_pred CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-cc
Confidence 999999998754 358999999999999999999994 899999999999999999999999999987654322 12
Q ss_pred ccccccCCCccchhhhc---CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 504 TTKLVGTFGYMDPELMR---TGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~---~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
.....|+..|+|||.+. ...++.++|+|||||++|||++|+.||........... . ...... .+...
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~------~-~~~~~~---~~~~~ 232 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL------M-TKSNFQ---PPKLK 232 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHh------h-hccCCC---CCccc
Confidence 23457899999999874 45688999999999999999999999865433221111 0 011100 11111
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.. ....+.+.+++.+|++.+|++||++.+|++
T Consensus 233 ~~--~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 233 DK--MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred cc--CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 00 011234677888899999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=322.10 Aligned_cols=203 Identities=27% Similarity=0.348 Sum_probs=175.4
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC---ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
++|+..+.||+|+||.||++..+. +..+|+|++... .......+.+|+.++.+++|+||+++++.+.+.+.+++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 367888999999999999999875 788999998653 2334567788999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
||+++|+|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 81 EFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred eCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 999999999998764 348999999999999999999994 899999999999999999999999999987543211
Q ss_pred C----------------------------------CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCC
Q 044561 501 I----------------------------------PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRP 546 (614)
Q Consensus 501 ~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p 546 (614)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 0 011234799999999999998999999999999999999999999
Q ss_pred CCCCCc
Q 044561 547 VEQQGS 552 (614)
Q Consensus 547 ~~~~~~ 552 (614)
|.....
T Consensus 236 f~~~~~ 241 (360)
T cd05627 236 FCSETP 241 (360)
T ss_pred CCCCCH
Confidence 976544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=306.80 Aligned_cols=254 Identities=25% Similarity=0.363 Sum_probs=202.3
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
++|+..+.||+|+||+||++.... +..+++|.+.... ....+.+.+|+++++.++||||+++++++...+.+++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 456677899999999999999764 7788999876543 34567889999999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 502 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 502 (614)
+++++|.+++... ..+++..+..++.+++.+|.|||+ ..+++||||||+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-- 158 (284)
T cd06620 85 MDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-- 158 (284)
T ss_pred CCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence 9999999988763 358999999999999999999996 3689999999999999999999999999987543322
Q ss_pred cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccc-----cccHHHHHHHhhhcCCccccccc
Q 044561 503 QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSME-----TVNLVDWVCDCWKKGAIRDASDS 577 (614)
Q Consensus 503 ~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~-----~~~l~~~v~~~~~~~~~~~~~d~ 577 (614)
.....|+..|+|||++.+..++.++|+|||||++|||++|+.||......+ .....++....... . .+
T Consensus 159 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-----~~ 231 (284)
T cd06620 159 -ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE-P-----PP 231 (284)
T ss_pred -cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc-c-----CC
Confidence 223478999999999988889999999999999999999999997544321 11111222221111 0 01
Q ss_pred cccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 578 RLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 578 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+. .......+.+++.+|+++||++|||+.|+++
T Consensus 232 ~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~ 265 (284)
T cd06620 232 RLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCA 265 (284)
T ss_pred CCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 111 1113345778888999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=312.54 Aligned_cols=256 Identities=20% Similarity=0.290 Sum_probs=193.7
Q ss_pred Ccceeeee--CcEEEEEEEEec-CcEEEEEEeecCC--hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 349 DKDVIGRG--GFGKVYRGVLAS-NVQIAVKKVSHDS--KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 349 ~~~~lG~G--~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
..++||+| +|++||++..+. +..||+|++.... ....+.+.+|+.+++.++||||++++++|..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35679999 789999999865 7889999987542 334456778999999999999999999999999999999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCC-CCCC
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH-DTIP 502 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~-~~~~ 502 (614)
++|+|.+++.......+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++++||+.+..... ....
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 99999999976544558999999999999999999994 8999999999999999999999999986543221 1100
Q ss_pred -----cccccccCCCccchhhhcC--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccc
Q 044561 503 -----QTTKLVGTFGYMDPELMRT--GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDAS 575 (614)
Q Consensus 503 -----~~~~~~gt~~y~aPE~~~~--~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~ 575 (614)
......++..|+|||++.. ..++.++|||||||++|||++|+.||......+.. ... ..+......
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~-----~~~~~~~~~ 231 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEK-----LNGTVPCLL 231 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH--HHH-----hcCCccccc
Confidence 0112356778999999875 45889999999999999999999999754321110 000 001110000
Q ss_pred c-------------------ccc-----------------cCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 576 D-------------------SRL-----------------EGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 576 d-------------------~~l-----------------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+ ... ...........+.+++.+|++.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0 000 00011222346788999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=301.95 Aligned_cols=242 Identities=29% Similarity=0.458 Sum_probs=192.3
Q ss_pred ceeeeeCcEEEEEEEEec-C---cEEEEEEeecCCh-hhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecCC
Q 044561 351 DVIGRGGFGKVYRGVLAS-N---VQIAVKKVSHDSK-QGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPN 425 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~-~---~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 425 (614)
+.||+|+||.||+|++.. + ..+++|.+..... ...+++.+|+.+++++.|+|++++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999998643 2 6799999876543 34567899999999999999999999876 4568999999999
Q ss_pred CCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcc-
Q 044561 426 GSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT- 504 (614)
Q Consensus 426 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~- 504 (614)
|+|.+++.... .+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 99999997653 58999999999999999999994 8999999999999999999999999999986644332111
Q ss_pred -cccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCc
Q 044561 505 -TKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGI 582 (614)
Q Consensus 505 -~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 582 (614)
....++..|+|||.+....++.++||||||+++|||++ |+.||......+ ...++.. +... .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~~~~----~~~~---------~ 218 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAMLES----GERL---------P 218 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHHc----CCcC---------C
Confidence 11223568999999988899999999999999999998 999997654322 2222211 1100 0
Q ss_pred CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 583 CEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 583 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+......+.+++.+|++++|++||++.++++
T Consensus 219 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 219 RPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 11122346778899999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=307.07 Aligned_cols=251 Identities=25% Similarity=0.423 Sum_probs=199.8
Q ss_pred CCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
+|+..+.||+|+||.||++..+ .+..+|+|.+... ......++.+|+.++++++|+||+++++.+...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5677889999999999999987 4888999988754 3344578899999999999999999999999999999999999
Q ss_pred CCCCcchhcccCC-CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCC
Q 044561 424 PNGSLDKILHTNI-KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 502 (614)
Q Consensus 424 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 502 (614)
++++|..++.... ...+++..+..++.|++.||.|||+ +.+++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 157 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-- 157 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc--
Confidence 9999999887532 2358999999999999999999996 3689999999999999999999999999987654322
Q ss_pred cccccccCCCccchhhhcCCC------CCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccc
Q 044561 503 QTTKLVGTFGYMDPELMRTGK------ASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASD 576 (614)
Q Consensus 503 ~~~~~~gt~~y~aPE~~~~~~------~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 576 (614)
.....++..|+|||.+.+.. ++.++|+|||||++|||++|+.||............ .....+..
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~----~~~~~~~~----- 227 (286)
T cd06622 158 -AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQL----SAIVDGDP----- 227 (286)
T ss_pred -cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHH----HHHhhcCC-----
Confidence 22346788999999985543 488999999999999999999999754322211111 11111111
Q ss_pred ccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 577 SRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 577 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+. .+......+..++.+|++.+|++||++.++++
T Consensus 228 ~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 228 PT----LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred CC----CCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 11 12223455778888999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=301.23 Aligned_cols=249 Identities=23% Similarity=0.356 Sum_probs=202.9
Q ss_pred CCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
+|+..+.||+|+||.+|++.... ++.+++|++... .....+++.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 47788999999999999999764 788999998653 334456889999999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 502 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 502 (614)
+++++|.+++.......+++.++..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 999999999876544458999999999999999999994 8999999999999999999999999999986644321
Q ss_pred cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCc
Q 044561 503 QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGI 582 (614)
Q Consensus 503 ~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 582 (614)
......|++.|+|||++.+...+.++|+|||||+++||++|+.||......+. +.+. ..+....
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~------~~~~-~~~~~~~--------- 220 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL------VLKI-IRGSYPP--------- 220 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH------HHHH-hcCCCCC---------
Confidence 12234688899999999888899999999999999999999999975432221 1111 1111111
Q ss_pred CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 583 CEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 583 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+......+.+++.+|++.+|++||++.+|++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 221 VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11122345778888999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=313.80 Aligned_cols=203 Identities=27% Similarity=0.347 Sum_probs=173.8
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC---ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
++|+..+.||+|+||.||+++.+. +..+|+|.+... .......+.+|+.++..++|+||+++++.+.+.+.+++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 368888999999999999999876 677999988643 2223345788999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
||+++|+|.+++.... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred eccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 9999999999997632 348999999999999999999994 899999999999999999999999999997654333
Q ss_pred CCcccccccCCCccchhhhc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Q 044561 501 IPQTTKLVGTFGYMDPELMR-----TGKASTSTDVYAFGVFMLEVASGRRPVEQQG 551 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~-----~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~ 551 (614)
........||+.|+|||++. ...++.++|||||||++|||++|+.||....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~ 212 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC
Confidence 22333457999999999986 3467899999999999999999999997654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=300.86 Aligned_cols=245 Identities=30% Similarity=0.509 Sum_probs=199.8
Q ss_pred ceeeeeCcEEEEEEEEec----CcEEEEEEeecCChh-hHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecCC
Q 044561 351 DVIGRGGFGKVYRGVLAS----NVQIAVKKVSHDSKQ-GIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPN 425 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 425 (614)
+.||+|+||.||++.... +..+++|.+...... ..+.+.+|+..++.++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999864 778999998766443 367889999999999999999999999999999999999999
Q ss_pred CCcchhcccCC-------CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCC
Q 044561 426 GSLDKILHTNI-------KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 498 (614)
Q Consensus 426 gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~ 498 (614)
++|.+++.... ...+++.++..++.|+++||.||| +.+++||||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999998742 256999999999999999999999 48999999999999999999999999999987654
Q ss_pred CCC-CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCcccccc
Q 044561 499 DTI-PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASD 576 (614)
Q Consensus 499 ~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 576 (614)
... .......++..|+|||.+....++.++||||+|++++||++ |+.||......+. . +....+...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~----~~~~~~~~~---- 226 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV---L----EYLRKGYRL---- 226 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH---H----HHHHcCCCC----
Confidence 321 12233467889999999988889999999999999999999 6999976533221 1 111111110
Q ss_pred ccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 577 SRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 577 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+......+.+++.+|++.+|++|||+.|+++
T Consensus 227 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~ 259 (262)
T cd00192 227 -----PKPEYCPDELYELMLSCWQLDPEDRPTFSELVE 259 (262)
T ss_pred -----CCCccCChHHHHHHHHHccCCcccCcCHHHHHH
Confidence 111222456778888999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=302.06 Aligned_cols=249 Identities=24% Similarity=0.429 Sum_probs=194.1
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC-----hhhHHHHHHHHHHhcccCCCceeEEeeEEee--cCeE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS-----KQGIKEFVAELVSMGRLRHRNLVKLRGYCRR--KGEF 416 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~ 416 (614)
.+|+..+.||+|+||.||++...+ +..+++|++.... .+..+.+.+|+.++++++||||+++++++.. .+..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 468889999999999999999865 7889999886432 2344678899999999999999999998865 3678
Q ss_pred EEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecccccc
Q 044561 417 LLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 496 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~ 496 (614)
++++||+++++|.+++.... .+++.....++.|++.||.||| ..+++||||||+||+++.++.+||+|||+++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 99999999999999987643 4889999999999999999999 489999999999999999999999999998765
Q ss_pred CCCCC--CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccc
Q 044561 497 DHDTI--PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDA 574 (614)
Q Consensus 497 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~ 574 (614)
..... .......++..|+|||.+.+..++.++|||||||++|||++|+.||......+. +.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~------~~~~~~~~----- 225 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA------IFKIATQP----- 225 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH------HHHHhcCC-----
Confidence 43211 111234588899999999888899999999999999999999999975432111 11111110
Q ss_pred ccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 575 SDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 575 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+.+ +....+.+..++ +||..+|++||+++||++
T Consensus 226 ~~~~~----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 TNPQL----PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCCCC----chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 11222 111222333443 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=302.55 Aligned_cols=246 Identities=24% Similarity=0.443 Sum_probs=202.2
Q ss_pred CCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
.|+..+.||+|+||.||+|.... +..+|+|.+... .......+.+|+.+++.++|+||+++++.+...+..++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 45667889999999999999865 788999988754 3455678899999999999999999999999999999999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCc
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 503 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 503 (614)
++++|.+++..+ .+++.+...++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........ .
T Consensus 85 ~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06640 85 GGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred CCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-c
Confidence 999999998653 48899999999999999999994 8999999999999999999999999999976544321 2
Q ss_pred ccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcC
Q 044561 504 TTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGIC 583 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 583 (614)
.....++..|+|||.+.+..++.++|+|||||++|||++|+.|+......+.... ...+. ....
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~-------~~~~~---------~~~~ 221 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL-------IPKNN---------PPTL 221 (277)
T ss_pred cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh-------hhcCC---------CCCC
Confidence 2334678899999999888899999999999999999999999975443221111 01110 1122
Q ss_pred cHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 584 EEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 584 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.......+.+++.+||+.+|++||++.++++
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06640 222 TGEFSKPFKEFIDACLNKDPSFRPTAKELLK 252 (277)
T ss_pred chhhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence 3344566888999999999999999999974
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=306.85 Aligned_cols=251 Identities=23% Similarity=0.356 Sum_probs=202.2
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
++|+..+.||+|+||.||++..+. +..+++|.+........+.+.+|++++++++|||++++++.+...+..++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 457778899999999999999864 7889999998777777788999999999999999999999999999999999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCc
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 503 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 503 (614)
++++|.+++.... ..+++.++..++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++........ .
T Consensus 85 ~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~ 159 (280)
T cd06611 85 DGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-K 159 (280)
T ss_pred CCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhccccc-c
Confidence 9999999987643 358999999999999999999994 8999999999999999999999999999876543221 2
Q ss_pred ccccccCCCccchhhhc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccc
Q 044561 504 TTKLVGTFGYMDPELMR-----TGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSR 578 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~-----~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~ 578 (614)
.....++..|+|||.+. ...++.++|+||||+++|||++|+.||......+.. . ....+......
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~------~-~~~~~~~~~~~--- 229 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL------L-KILKSEPPTLD--- 229 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH------H-HHhcCCCCCcC---
Confidence 23346899999999875 345678999999999999999999999764332211 1 11111111110
Q ss_pred ccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 579 LEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 579 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+......+.+++..||+.+|++||++.++++
T Consensus 230 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 230 ----QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred ----CcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 01112235677888899999999999999985
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=302.98 Aligned_cols=249 Identities=27% Similarity=0.409 Sum_probs=188.8
Q ss_pred ceeeeeCcEEEEEEEEec---CcEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecCCC
Q 044561 351 DVIGRGGFGKVYRGVLAS---NVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNG 426 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 426 (614)
+.||+|+||.||+|...+ +..+++|++.... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999998754 3568999886553 334457889999999999999999999999999999999999999
Q ss_pred CcchhcccCC---CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCC-
Q 044561 427 SLDKILHTNI---KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP- 502 (614)
Q Consensus 427 sL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~- 502 (614)
+|.+++.... ....++..+..++.|++.||.|||+ .+++||||||+||+++.++++||+|||++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999987532 2246778888999999999999995 89999999999999999999999999999754433211
Q ss_pred cccccccCCCccchhhhcCC-------CCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCcccc
Q 044561 503 QTTKLVGTFGYMDPELMRTG-------KASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDA 574 (614)
Q Consensus 503 ~~~~~~gt~~y~aPE~~~~~-------~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~ 574 (614)
......++..|+|||++... .++.++|+||||+++|||++ |+.||......+.. ... ..+.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~---~~~----~~~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL---TYT----VREQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH---HHH----hhcccCCC
Confidence 12234578889999998642 35789999999999999996 99999754433221 111 11111222
Q ss_pred ccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 575 SDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 575 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.++.+.... .+.+.+++..|+ .+|++|||+.||++
T Consensus 231 ~~~~~~~~~----~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 231 PKPRLKLPL----SDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CCCccCCCC----ChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 222222222 223556777798 58999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=294.49 Aligned_cols=251 Identities=25% Similarity=0.391 Sum_probs=204.3
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC-----h---hhHHHHHHHHHHhccc-CCCceeEEeeEEeec
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS-----K---QGIKEFVAELVSMGRL-RHRNLVKLRGYCRRK 413 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-----~---~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 413 (614)
...|..++.||.|..+.|-++..+. +.+.|+|++.... + .-.+.-.+|+.+|+++ .||+|+++.++++..
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 3567888999999999999998765 7889999885431 1 1223446799999998 599999999999999
Q ss_pred CeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccc
Q 044561 414 GEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLA 493 (614)
Q Consensus 414 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla 493 (614)
..+++|+|.|+.|.|.++|... ..++++...+|++|+.+|+.||| .+.||||||||+|||+|++.++||+|||++
T Consensus 96 sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred chhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEecccee
Confidence 9999999999999999999763 45999999999999999999999 489999999999999999999999999999
Q ss_pred cccCCCCCCcccccccCCCccchhhhc------CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhh
Q 044561 494 RLYDHDTIPQTTKLVGTFGYMDPELMR------TGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWK 567 (614)
Q Consensus 494 ~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~ 567 (614)
+.+..+. .....|||++|+|||.+. ...|+...|+|+.||+||.|+.|.+||.....- .+....-
T Consensus 171 ~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm-------lMLR~Im 241 (411)
T KOG0599|consen 171 CQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM-------LMLRMIM 241 (411)
T ss_pred eccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH-------HHHHHHH
Confidence 9887665 566789999999999874 346889999999999999999999999754221 1222233
Q ss_pred cCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 568 KGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 568 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+|... +..++ ..+....+..|+.+|++.||.+|.|++|+|+
T Consensus 242 eGkyq-F~spe-----Wadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 242 EGKYQ-FRSPE-----WADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred hcccc-cCCcc-----hhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 33321 11111 2233456788889999999999999999874
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=304.80 Aligned_cols=250 Identities=28% Similarity=0.479 Sum_probs=198.4
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec----CcEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS----NVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLV 419 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 419 (614)
.+|+..+.||+|+||.||+|.... +..+++|.+.... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 457788999999999999998752 3468999886543 33456889999999999999999999999999999999
Q ss_pred EEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCC
Q 044561 420 YDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD 499 (614)
Q Consensus 420 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~ 499 (614)
|||+++++|.+++.... ..+++.++..++.|++.||.||| +++++||||||+||+++.++.+||+|||++......
T Consensus 84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 84 TEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999997643 45899999999999999999999 489999999999999999999999999999876543
Q ss_pred CCCcc--cccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCcccccc
Q 044561 500 TIPQT--TKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASD 576 (614)
Q Consensus 500 ~~~~~--~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 576 (614)
..... ....++..|+|||.+....++.++|+||||++++|+++ |+.||......+. ...+. ++.-
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~---~~~~~----~~~~----- 227 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV---IKAIE----EGYR----- 227 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH---HHHHh----CCCc-----
Confidence 22111 11223568999999988889999999999999999886 9999976443221 11111 1100
Q ss_pred ccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 577 SRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 577 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
... .......+.+++.+|++.+|++||+|.++++
T Consensus 228 ~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 228 LPA----PMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred CCC----CCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 000 1112345678888999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=316.52 Aligned_cols=237 Identities=25% Similarity=0.330 Sum_probs=186.8
Q ss_pred ceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHH-HhcccCCCceeEEeeEEeecCeEEEEEEecCC
Q 044561 351 DVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELV-SMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPN 425 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 425 (614)
+.||+|+||.||+++.+. +..+|+|.+.... .....++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 469999999999999875 6789999987532 222334445544 56788999999999999999999999999999
Q ss_pred CCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCccc
Q 044561 426 GSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT 505 (614)
Q Consensus 426 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 505 (614)
|+|.+++... ..+.+.+...++.||++||.|||+ .+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~ 154 (325)
T cd05602 81 GELFYHLQRE--RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTS 154 (325)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCcc
Confidence 9999998763 347888888999999999999995 899999999999999999999999999997543222 1233
Q ss_pred ccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcH
Q 044561 506 KLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEE 585 (614)
Q Consensus 506 ~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~ 585 (614)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ..+ ..... .+...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i----~~~~~------~~~~~--- 218 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY---DNI----LNKPL------QLKPN--- 218 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHH---HHH----HhCCc------CCCCC---
Confidence 457999999999999989999999999999999999999999765432211 111 11111 11111
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCHH
Q 044561 586 KQMELVLKLGLFCSHPKPEARPNMR 610 (614)
Q Consensus 586 ~~~~~l~~l~~~cl~~dP~~RPs~~ 610 (614)
....+.+++.+|++.||.+||++.
T Consensus 219 -~~~~~~~li~~~l~~~p~~R~~~~ 242 (325)
T cd05602 219 -ITNSARHLLEGLLQKDRTKRLGAK 242 (325)
T ss_pred -CCHHHHHHHHHHcccCHHHCCCCC
Confidence 233466777889999999999876
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=308.67 Aligned_cols=258 Identities=24% Similarity=0.403 Sum_probs=198.4
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-----------------CcEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-----------------NVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKL 406 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l 406 (614)
++|+..+.||+|+||.||++...+ ...+|+|.+... ......++.+|+.++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 468889999999999999986432 345899988754 34455789999999999999999999
Q ss_pred eeEEeecCeEEEEEEecCCCCcchhcccCCC---------CCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCe
Q 044561 407 RGYCRRKGEFLLVYDYMPNGSLDKILHTNIK---------PCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 477 (614)
Q Consensus 407 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NI 477 (614)
++++...+..++||||+++++|.+++..... ..+++.++..++.|++.||.|||+ .+++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheE
Confidence 9999999999999999999999999865321 247788999999999999999995 8999999999999
Q ss_pred EEcCCCCEEEeeeccccccCCCCC-CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc--CCCCCCCCCccc
Q 044561 478 LLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS--GRRPVEQQGSME 554 (614)
Q Consensus 478 ll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t--g~~p~~~~~~~~ 554 (614)
+++.++.+||+|||++........ .......++..|++||....+.++.++|||||||++|||++ |..||......+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999986543321 11222345678999999888889999999999999999998 778886544332
Q ss_pred cccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 555 TVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 555 ~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
... ...+.+........ .+. +......+.+++.+||+.||++||++.||++
T Consensus 242 ~~~---~~~~~~~~~~~~~~-~~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 242 VIE---NTGEFFRDQGRQVY-LPK-----PALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHH---HHHHHHhhcccccc-CCC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 221 11111111110000 010 1112356788999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=307.36 Aligned_cols=245 Identities=26% Similarity=0.451 Sum_probs=198.4
Q ss_pred CCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecC
Q 044561 347 FKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMP 424 (614)
Q Consensus 347 f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 424 (614)
|+..+.||+|+||.||+|.... +..+|+|.+.... ....+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 4456779999999999998765 7789999886543 3455678999999999999999999999999999999999999
Q ss_pred CCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcc
Q 044561 425 NGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT 504 (614)
Q Consensus 425 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 504 (614)
+++|.+++.. ..+++..+..++.|+++|+.||| +++++|+||+|+||++++++.+||+|||++........ ..
T Consensus 86 ~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~ 158 (277)
T cd06642 86 GGSALDLLKP---GPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KR 158 (277)
T ss_pred CCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcch-hh
Confidence 9999998864 34899999999999999999999 48999999999999999999999999999976554321 12
Q ss_pred cccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCc
Q 044561 505 TKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICE 584 (614)
Q Consensus 505 ~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 584 (614)
....++..|+|||++.+..++.++||||||++++||++|+.|+......+... ....+. .+.+ .
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-------~~~~~~-----~~~~----~ 222 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF-------LIPKNS-----PPTL----E 222 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh-------hhhcCC-----CCCC----C
Confidence 23467889999999998889999999999999999999999986543221110 011111 1111 2
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 585 EKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 585 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
......+.+++.+|++.+|++||++.++++
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 223 GQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 223445778888999999999999999974
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=307.11 Aligned_cols=236 Identities=23% Similarity=0.374 Sum_probs=185.9
Q ss_pred eeeeeCcEEEEEEEEec-------------------------CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEE
Q 044561 352 VIGRGGFGKVYRGVLAS-------------------------NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKL 406 (614)
Q Consensus 352 ~lG~G~fg~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l 406 (614)
.||+|+||.||+|.+.. ...|++|.+.........++.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999998531 13478888876555556778899999999999999999
Q ss_pred eeEEeecCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCC---
Q 044561 407 RGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADL--- 483 (614)
Q Consensus 407 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~--- 483 (614)
+++|...+..++||||+++|+|+.++... ...+++..+..++.|+++||.|||+ ++|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999998653 3458999999999999999999994 8999999999999997654
Q ss_pred ----CEEEeeeccccccCCCCCCcccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHH-cCCCCCCCCCcccccc
Q 044561 484 ----NGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVA-SGRRPVEQQGSMETVN 557 (614)
Q Consensus 484 ----~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~-tg~~p~~~~~~~~~~~ 557 (614)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||......+...
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred CccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 3799999988643221 12357788999998865 56899999999999999995 6999987654332211
Q ss_pred HHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 558 LVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 558 l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.... .. .+... ....+..++.+||+.+|++|||+.+|++
T Consensus 233 ---~~~~---~~--------~~~~~----~~~~~~~li~~cl~~~p~~Rps~~~il~ 271 (274)
T cd05076 233 ---FYEK---KH--------RLPEP----SCKELATLISQCLTYEPTQRPSFRTILR 271 (274)
T ss_pred ---HHHh---cc--------CCCCC----CChHHHHHHHHHcccChhhCcCHHHHHH
Confidence 1100 00 01111 1234778888999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=308.10 Aligned_cols=264 Identities=26% Similarity=0.372 Sum_probs=202.9
Q ss_pred CCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
+|+..+.||+|+||.||+|..++ +..|++|++... .....+.+.+|++++++++|+||+++++++...+..++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 57888999999999999999875 788999988643 233456789999999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 502 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 502 (614)
++++.+..+.... ..+++.++..++.||+.||.|||+ .+++||||+|+||++++++.+||+|||++.........
T Consensus 82 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 82 VERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred CCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence 9987777665442 348999999999999999999994 89999999999999999999999999999876654432
Q ss_pred cccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHh--------hhc-C---
Q 044561 503 QTTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDC--------WKK-G--- 569 (614)
Q Consensus 503 ~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~--------~~~-~--- 569 (614)
......++..|+|||++.+. .++.++||||||+++|||++|+.||......+........+.. +.. .
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence 33445788999999999887 7899999999999999999999999765433221111111100 000 0
Q ss_pred --Ccccccccc-ccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 570 --AIRDASDSR-LEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 570 --~~~~~~d~~-l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
......+.. ....++......+.+++.+||+++|++||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000000000 000111122466889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=300.05 Aligned_cols=247 Identities=26% Similarity=0.441 Sum_probs=200.4
Q ss_pred CCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCC-----hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEE
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDS-----KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLV 419 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 419 (614)
+|+..+.||+|++|.||+|... ++..+++|.+.... .+..+.+.+|+.++++++|+|++++++++.....++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667789999999999999987 58889999886543 34567889999999999999999999999999999999
Q ss_pred EEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCC
Q 044561 420 YDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD 499 (614)
Q Consensus 420 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~ 499 (614)
|||+++++|.+++... ..+++.++..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 81 LELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 9999999999998764 348899999999999999999995 89999999999999999999999999998865443
Q ss_pred CCCcccccccCCCccchhhhcCCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccc
Q 044561 500 TIPQTTKLVGTFGYMDPELMRTGK-ASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSR 578 (614)
Q Consensus 500 ~~~~~~~~~gt~~y~aPE~~~~~~-~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~ 578 (614)
. ......++..|++||.+.... ++.++|+||||+++|||++|+.||......+ .............
T Consensus 156 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~------~~~~~~~~~~~~~----- 222 (258)
T cd06632 156 S--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA------AVFKIGRSKELPP----- 222 (258)
T ss_pred c--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH------HHHHHHhcccCCC-----
Confidence 3 223456889999999987766 8999999999999999999999996543211 1111111111111
Q ss_pred ccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 579 LEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 579 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+......+.+++.+||+.+|++||++.++++
T Consensus 223 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 223 ----IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ----cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 11122345677888899999999999999974
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=338.31 Aligned_cols=251 Identities=24% Similarity=0.327 Sum_probs=196.1
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC---ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
.+|+..+.||+|+||.||+|+... ++.||+|++... .....+++.+|+.++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 468888999999999999999865 888999998754 2334567899999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCC---------CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeec
Q 044561 421 DYMPNGSLDKILHTNI---------KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFG 491 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfG 491 (614)
||+++|+|.+++.... ...+++.+++.++.||++||.|||+ ++|+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999886311 1336678889999999999999995 899999999999999999999999999
Q ss_pred cccccCCCC-----------------CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccc
Q 044561 492 LARLYDHDT-----------------IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSME 554 (614)
Q Consensus 492 la~~~~~~~-----------------~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~ 554 (614)
+++...... .......+||+.|+|||++.+..++.++|||||||+++||++|+.||......+
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 998652110 011123579999999999999999999999999999999999999997533221
Q ss_pred cccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q 044561 555 TVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQV 612 (614)
Q Consensus 555 ~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev 612 (614)
... . .......+ .. ...+....+.+++.+|++.||++||+..+.
T Consensus 239 i~~------~----~~i~~P~~--~~--p~~~iP~~L~~LI~rcL~~DP~kR~ss~ee 282 (932)
T PRK13184 239 ISY------R----DVILSPIE--VA--PYREIPPFLSQIAMKALAVDPAERYSSVQE 282 (932)
T ss_pred hhh------h----hhccChhh--cc--ccccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 110 0 00000000 00 001223456778889999999999765543
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=310.54 Aligned_cols=252 Identities=25% Similarity=0.371 Sum_probs=203.7
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCCh---hhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSK---QGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
++|+..+.||+|++|.||++...+ +..+++|.+..... ...+.+.+|++.++.++|+||+++++.+...+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 367888999999999999999876 88899999876532 35567899999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
||+++++|.+++.......+++..+..++.|+++||.|||+ .+++||||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 99999999999876555669999999999999999999994 899999999999999999999999999987553221
Q ss_pred CC----------------------------cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCc
Q 044561 501 IP----------------------------QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGS 552 (614)
Q Consensus 501 ~~----------------------------~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~ 552 (614)
.. ......|+..|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 10 11124688899999999988899999999999999999999999976543
Q ss_pred cccccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCC----HHHHhC
Q 044561 553 METVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPN----MRQVMQ 614 (614)
Q Consensus 553 ~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs----~~evl~ 614 (614)
.+... +...+ .. .... .......+.+++.+|++.||++||| +.|+++
T Consensus 238 ~~~~~------~~~~~-~~------~~~~--~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 238 DETFS------NILKK-EV------TFPG--SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHHHH------HHhcC-Cc------cCCC--ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 22111 11110 00 0100 1113456888888999999999999 888874
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=304.25 Aligned_cols=243 Identities=28% Similarity=0.458 Sum_probs=190.4
Q ss_pred ceeeeeCcEEEEEEEEec-Cc--EEEEEEeecC-ChhhHHHHHHHHHHhccc-CCCceeEEeeEEeecCeEEEEEEecCC
Q 044561 351 DVIGRGGFGKVYRGVLAS-NV--QIAVKKVSHD-SKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGEFLLVYDYMPN 425 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 425 (614)
+.||+|+||.||+|.+++ +. .+++|.+... .....+.+.+|+.++.++ +||||++++++|...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999865 33 4688887643 344556889999999999 799999999999999999999999999
Q ss_pred CCcchhcccCC--------------CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeec
Q 044561 426 GSLDKILHTNI--------------KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFG 491 (614)
Q Consensus 426 gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfG 491 (614)
|+|.+++.... ...+++.++..++.|++.||+|||+ .+++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence 99999986532 1347899999999999999999994 899999999999999999999999999
Q ss_pred cccccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCC
Q 044561 492 LARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGA 570 (614)
Q Consensus 492 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~ 570 (614)
++....... .......+..|+|||++....++.++||||||++++||++ |+.||......+... ....+.
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~-------~~~~~~ 228 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE-------KLPQGY 228 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHH-------HHhCCC
Confidence 986432211 1112234567999999988889999999999999999997 999996543322111 111111
Q ss_pred ccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 571 IRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 571 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+ . +......+.+++.+|++.||.+|||+.++++
T Consensus 229 ~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 229 RLE-----K----PLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CCC-----C----CCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 000 1 1112345778899999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=310.96 Aligned_cols=196 Identities=26% Similarity=0.406 Sum_probs=160.2
Q ss_pred cceeeeeCcEEEEEEEEe---cCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEee--cCeEEEEEEecC
Q 044561 350 KDVIGRGGFGKVYRGVLA---SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRR--KGEFLLVYDYMP 424 (614)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~ 424 (614)
.++||+|+||.||+|+.+ .+..+|+|.+..... ...+.+|+.++++++||||+++++++.. ....+++|||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 457999999999999975 357899998865432 2456789999999999999999998854 456899999995
Q ss_pred CCCcchhcccC-------CCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEE----cCCCCEEEeeeccc
Q 044561 425 NGSLDKILHTN-------IKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL----DADLNGKLGDFGLA 493 (614)
Q Consensus 425 ~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll----~~~~~~kl~DfGla 493 (614)
++|.+++... ....+++..+..++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5787776422 12348899999999999999999995 899999999999999 45678999999999
Q ss_pred cccCCCCC--CcccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Q 044561 494 RLYDHDTI--PQTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQG 551 (614)
Q Consensus 494 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~ 551 (614)
+....... .......||+.|+|||++.+ ..++.++||||+||+++||++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 87654321 12334678999999999876 458999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=299.87 Aligned_cols=255 Identities=26% Similarity=0.417 Sum_probs=204.1
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
++|+..+.||+|+||.||+|...+ +..+++|++.... ....+.+.+|++.++.++|+|++++++.+...+..++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 468889999999999999999764 7789999886543 33567889999999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCC-CCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCC
Q 044561 423 MPNGSLDKILHTNIK-PCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI 501 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~ 501 (614)
+++++|.+++..... ..+++.....++.|++.||.||| +.+++||||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999976432 56899999999999999999999 48999999999999999999999999999876654332
Q ss_pred C---cccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccc
Q 044561 502 P---QTTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDS 577 (614)
Q Consensus 502 ~---~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~ 577 (614)
. ......|+..|+|||.+... .++.++|+||||++++||++|+.||......+.. . +.... ..+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~--~----~~~~~------~~~ 225 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL--M----LTLQN------DPP 225 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhH--H----HHhcC------CCC
Confidence 2 22334688999999998876 7899999999999999999999999755432211 1 11111 011
Q ss_pred cccCcC-cHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 578 RLEGIC-EEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 578 ~l~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+.... .....+.+.+++.+|++.||++||++.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 111111 1123355778888999999999999999975
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=304.94 Aligned_cols=252 Identities=23% Similarity=0.394 Sum_probs=200.3
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec------CcEEEEEEeecCChh-hHHHHHHHHHHhcccCCCceeEEeeEEeecCeEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS------NVQIAVKKVSHDSKQ-GIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFL 417 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 417 (614)
++|+..+.||+|+||.||+|+.+. ...+++|.+...... ..+++.+|+.++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 567888999999999999999642 356888888655443 5678999999999999999999999999999999
Q ss_pred EEEEecCCCCcchhcccCCC-------CCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeee
Q 044561 418 LVYDYMPNGSLDKILHTNIK-------PCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDF 490 (614)
Q Consensus 418 lV~E~~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~Df 490 (614)
+||||+++|+|.+++..... ..+++.++..++.|++.||.|||+ .+|+||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999976431 258999999999999999999994 89999999999999999999999999
Q ss_pred ccccccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcC
Q 044561 491 GLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKG 569 (614)
Q Consensus 491 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~ 569 (614)
|++...............++..|+|||.+....++.++||||||++++||++ |..||......+ .+. ....+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~----~~~~~ 234 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLN----RLQAG 234 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHH----HHHcC
Confidence 9987543332222333456778999999988888999999999999999999 788886433221 111 11111
Q ss_pred CccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 570 AIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 570 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
...... .. .....+.+++.+|++.+|++||++.|+++
T Consensus 235 ~~~~~~----~~----~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~ 271 (275)
T cd05046 235 KLELPV----PE----GCPSRLYKLMTRCWAVNPKDRPSFSELVS 271 (275)
T ss_pred CcCCCC----CC----CCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 111110 11 12346788899999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=288.94 Aligned_cols=256 Identities=25% Similarity=0.315 Sum_probs=202.7
Q ss_pred HhcCCCCcceeeeeCcEEEEEEEE-ecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeec-----CeE
Q 044561 343 ATKGFKDKDVIGRGGFGKVYRGVL-ASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRK-----GEF 416 (614)
Q Consensus 343 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~ 416 (614)
..++|.+.+.||+|||+.||.++. .++..+|+|++.-.+.++.+..++|++..++++|||++++++++..+ .+.
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 346788999999999999999984 45778999999988888889999999999999999999999987544 359
Q ss_pred EEEEEecCCCCcchhcccC--CCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecccc
Q 044561 417 LLVYDYMPNGSLDKILHTN--IKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR 494 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~ 494 (614)
||+++|...|||.+.+... .+..+++.+.++|+.+|++||.+||+. ..+++||||||.|||+.+.+.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 9999999999999998653 234699999999999999999999964 4569999999999999999999999999887
Q ss_pred ccCCCC--------CCcccccccCCCccchhhhc---CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHH
Q 044561 495 LYDHDT--------IPQTTKLVGTFGYMDPELMR---TGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVC 563 (614)
Q Consensus 495 ~~~~~~--------~~~~~~~~gt~~y~aPE~~~---~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~ 563 (614)
...-.- .........|..|.|||++. +...++++|||||||++|+|+.|..||+..-.
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~----------- 246 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ----------- 246 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-----------
Confidence 543211 01112235689999999885 34578999999999999999999999974321
Q ss_pred HhhhcCCcccc-ccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHh
Q 044561 564 DCWKKGAIRDA-SDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVM 613 (614)
Q Consensus 564 ~~~~~~~~~~~-~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 613 (614)
.-|.+.-+ ....+.-.-+....+.+.+++.+|++.||.+||++.+++
T Consensus 247 ---~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll 294 (302)
T KOG2345|consen 247 ---QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELL 294 (302)
T ss_pred ---cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHH
Confidence 01111111 111221111122567789999999999999999999986
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=300.18 Aligned_cols=248 Identities=24% Similarity=0.398 Sum_probs=201.2
Q ss_pred CCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
+|+..+.||+|+||.||++.... +..+++|.+... .....+.+.+|+.++++++|||++++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 46778999999999999999864 788999998654 334467889999999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCC-CCEEEeeeccccccCCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDAD-LNGKLGDFGLARLYDHDTI 501 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~-~~~kl~DfGla~~~~~~~~ 501 (614)
+++++|.+++.......+++..+..++.+++.+|.|||+ ++++||||||+||+++.+ +.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS- 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence 999999999987555568999999999999999999994 899999999999999865 457999999998765432
Q ss_pred CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccC
Q 044561 502 PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEG 581 (614)
Q Consensus 502 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~ 581 (614)
......++..|+|||.+....++.++||||||+++|+|++|+.||........ .... ..+....
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~----~~~~~~~-------- 220 (256)
T cd08220 157 -KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL---VLKI----MSGTFAP-------- 220 (256)
T ss_pred -cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH---HHHH----HhcCCCC--------
Confidence 22335688999999999888889999999999999999999999976443221 1111 1111111
Q ss_pred cCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 582 ICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 582 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+......+..++.+||+++|++|||+.|+++
T Consensus 221 -~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 221 -ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred -CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11112345778888999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=318.81 Aligned_cols=258 Identities=22% Similarity=0.337 Sum_probs=195.6
Q ss_pred HHhcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC--hhhHHHHHHHHHHhcccCCCceeEEeeEEeec-----
Q 044561 342 KATKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS--KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRK----- 413 (614)
Q Consensus 342 ~~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~----- 413 (614)
...++|+..+.||+|+||.||+|.... +..||+|++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 445678889999999999999999764 7889999987542 23446678999999999999999999987533
Q ss_pred -CeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecc
Q 044561 414 -GEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGL 492 (614)
Q Consensus 414 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGl 492 (614)
...++++|++ +++|.+++.. ..+++.++..++.||+.||.|||+ .+|+||||||+|||+++++.+||+|||+
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCcc
Confidence 4579999998 7889888754 248999999999999999999995 8999999999999999999999999999
Q ss_pred ccccCCCCCCcccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhc---
Q 044561 493 ARLYDHDTIPQTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKK--- 568 (614)
Q Consensus 493 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~--- 568 (614)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.... ..+....
T Consensus 165 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---~~~~~~~~~~ 237 (343)
T cd07878 165 ARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKR---IMEVVGTPSP 237 (343)
T ss_pred ceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHH---HHHHhCCCCH
Confidence 9865432 233578999999999876 4689999999999999999999999976443221111 1110000
Q ss_pred --------C-------CccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 569 --------G-------AIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 569 --------~-------~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
. .+.......+.... ......+.+++.+|++.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 238 EVLKKISSEHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HHHHhcchhhHHHHhhccccccchhHHHhc-cCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 00000000000000 001224678889999999999999999974
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=315.09 Aligned_cols=203 Identities=28% Similarity=0.347 Sum_probs=174.7
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC---ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
++|+..+.||+|+||.||+++.+. +..+|+|.+... .......+.+|..++..++|+||+++++++...+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 368888999999999999999875 778999998653 2223455788999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
||+++|+|.+++.... ..+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||++.......
T Consensus 81 Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred eCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999999997632 35889999999999999999999 4899999999999999999999999999998765443
Q ss_pred CCcccccccCCCccchhhhcC-----CCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Q 044561 501 IPQTTKLVGTFGYMDPELMRT-----GKASTSTDVYAFGVFMLEVASGRRPVEQQG 551 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~-----~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~ 551 (614)
........||+.|+|||++.. +.++.++|||||||++|||++|+.||....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 212 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC
Confidence 323334579999999999875 467889999999999999999999997544
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=305.13 Aligned_cols=249 Identities=27% Similarity=0.401 Sum_probs=195.5
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-Cc----EEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NV----QIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLL 418 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 418 (614)
++|+..+.||+|+||.||+|.+.. +. .||+|.+... .....+++.+|+.+++.++|+||++++++|.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 567888999999999999998653 33 4799988654 34446778999999999999999999999975 45789
Q ss_pred EEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCC
Q 044561 419 VYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 498 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~ 498 (614)
++||+++|+|.+++..+. ..+++.+++.++.|++.||.|||+ ++++||||||+|||++.++.+||+|||+++....
T Consensus 86 ~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 86 VTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 999999999999987643 358999999999999999999995 8999999999999999999999999999987653
Q ss_pred CCCC-cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCcccccc
Q 044561 499 DTIP-QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASD 576 (614)
Q Consensus 499 ~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 576 (614)
.... ......++..|+|||.+.+..++.++|||||||++|||++ |..||......+. ..+ ...+....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~----~~~~~~~~--- 231 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI---PDL----LEKGERLP--- 231 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHH----HHCCCcCC---
Confidence 3211 1112234678999999988889999999999999999998 8999865433221 111 11111111
Q ss_pred ccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 577 SRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 577 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
. +......+.+++.+||+.||++||++.++++
T Consensus 232 --~----~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 232 --Q----PPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred --C----CccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 1112345778888999999999999999873
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=309.21 Aligned_cols=264 Identities=25% Similarity=0.374 Sum_probs=200.2
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC--hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS--KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 421 (614)
++|+..+.||+|+||.||+|..++ +..+|+|++.... ....+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 357788999999999999999875 7889999876432 2235678899999999999999999999999999999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCC
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI 501 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~ 501 (614)
|+++++|..+.... ..+++.++..++.|+++||.|||+ .+++||||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 81 FVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred cCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 99999998876543 348999999999999999999995 899999999999999999999999999998654433
Q ss_pred CcccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHh--------hhcCCc-
Q 044561 502 PQTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDC--------WKKGAI- 571 (614)
Q Consensus 502 ~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~--------~~~~~~- 571 (614)
.......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+........... +.....
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence 22233567899999998865 45788999999999999999999999754432211111110000 000000
Q ss_pred cccccccccC-----cCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 572 RDASDSRLEG-----ICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 572 ~~~~d~~l~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.....+.... .........+.+++.+||+.+|++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000000000 001122456888999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=310.69 Aligned_cols=251 Identities=25% Similarity=0.433 Sum_probs=196.7
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe--------cCcEEEEEEeecC-ChhhHHHHHHHHHHhccc-CCCceeEEeeEEeecC
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA--------SNVQIAVKKVSHD-SKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKG 414 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 414 (614)
.+|...+.||+|+||.||+++.. ....+++|.+... ......++.+|+.+++++ +||||++++++|...+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 45778899999999999999752 2346888988754 334567788999999999 6999999999999999
Q ss_pred eEEEEEEecCCCCcchhcccCC--------------CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEc
Q 044561 415 EFLLVYDYMPNGSLDKILHTNI--------------KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD 480 (614)
Q Consensus 415 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~ 480 (614)
..+++|||+++|+|.+++.... ...+++.++..++.|++.||.||| +.+++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEEc
Confidence 9999999999999999986532 235899999999999999999999 48999999999999999
Q ss_pred CCCCEEEeeeccccccCCCCC-CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccH
Q 044561 481 ADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNL 558 (614)
Q Consensus 481 ~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l 558 (614)
.++.+||+|||+++....... .......++..|+|||.+.++.++.++||||||+++|||++ |+.||......+...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~- 247 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK- 247 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH-
Confidence 999999999999986543221 11222234567999999988889999999999999999999 889986543322111
Q ss_pred HHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 559 VDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 559 ~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
....+.... .+......+.+++.+|++.||++|||+.|+++
T Consensus 248 ------~~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 248 ------LLREGHRMD---------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred ------HHHcCCCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 111111111 11112335667888999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=303.84 Aligned_cols=249 Identities=29% Similarity=0.514 Sum_probs=197.3
Q ss_pred CCCCcceeeeeCcEEEEEEEEec-C---cEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS-N---VQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
.|+..+.||+|+||.||+|.... + ..|++|.+... .....++|..|+.++++++||||+++.+++..++..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46678899999999999999764 2 35999998765 3445678999999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
||+++++|.+++.... ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 85 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 85 EFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred ecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999987643 458999999999999999999994 899999999999999999999999999987654332
Q ss_pred CCc-cc-ccc--cCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccc
Q 044561 501 IPQ-TT-KLV--GTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDAS 575 (614)
Q Consensus 501 ~~~-~~-~~~--gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~ 575 (614)
... .. ... .+..|+|||.+....++.++|||||||++||+++ |+.||......+ ...++...+ ...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~i~~~~---~~~--- 231 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINAIEQDY---RLP--- 231 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHHHHcCC---cCC---
Confidence 111 11 111 2457999999998899999999999999999886 999997544322 122221110 000
Q ss_pred cccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 576 DSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 576 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+.+....+.+++.+||+.+|++||++.+|++
T Consensus 232 -------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 232 -------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred -------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01122345778888999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=306.09 Aligned_cols=261 Identities=25% Similarity=0.308 Sum_probs=202.3
Q ss_pred CCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCC--hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDS--KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
+|+..+.||+|+||.||+|+.. ++..+++|++.... ....+.+.+|+.++++++|||++++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4677889999999999999986 48889999987654 33456789999999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 502 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 502 (614)
+ +++|.+++.... ..+++.++..++.||++||.|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 9 999999987543 459999999999999999999995 89999999999999999999999999999876544322
Q ss_pred cccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCC---cc------
Q 044561 503 QTTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGA---IR------ 572 (614)
Q Consensus 503 ~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~---~~------ 572 (614)
......++..|+|||.+.+. .++.++||||+|++++||++|++||......+. ..++........ ..
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ---LAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH---HHHHHHHcCCCChHHHhhccCcc
Confidence 23445789999999988654 468999999999999999999888865443221 112221111000 00
Q ss_pred ---cccccccc----CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 573 ---DASDSRLE----GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 573 ---~~~d~~l~----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
....+.-. .....+..+.+.+++.+|++++|++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00000000 0001122367888899999999999999999974
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=298.67 Aligned_cols=249 Identities=31% Similarity=0.529 Sum_probs=200.5
Q ss_pred CCCcceeeeeCcEEEEEEEEec-C----cEEEEEEeecCChh-hHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 347 FKDKDVIGRGGFGKVYRGVLAS-N----VQIAVKKVSHDSKQ-GIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 347 f~~~~~lG~G~fg~Vy~~~~~~-~----~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
|+..+.||.|+||.||+++..+ + ..+++|.+...... ..+.+.+|+..++.++|+|++++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3456889999999999999875 3 77999999765443 5678999999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
||+++++|.+++.......+++.++..++.|++.||.||| +.+++||||||+||++++++.++|+|||++.......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 9999999999997654333899999999999999999999 4899999999999999999999999999998765542
Q ss_pred CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRL 579 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 579 (614)
........++..|+|||.+....++.++||||+|++++||++ |+.||......+.. ..+ ..+....
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~---~~~----~~~~~~~------ 224 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVL---EYL----KKGYRLP------ 224 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHH----hcCCCCC------
Confidence 222212336789999999988889999999999999999998 78888653322211 111 1111111
Q ss_pred cCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 580 EGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 580 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
........+.+++.+|++.||++|||+.|+++
T Consensus 225 ---~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 225 ---KPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred ---CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 01113345777888999999999999999974
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=306.82 Aligned_cols=252 Identities=26% Similarity=0.441 Sum_probs=200.0
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEe------cCcEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLA------SNVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEF 416 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 416 (614)
.++|+..+.||+|+||.||++..+ ++..+++|.+.... ....+++.+|+.++++++|||+++++++|...+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 356888899999999999999864 35778999887543 34557789999999999999999999999999999
Q ss_pred EEEEEecCCCCcchhcccCC--------------------CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCC
Q 044561 417 LLVYDYMPNGSLDKILHTNI--------------------KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN 476 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~N 476 (614)
+++|||+++|+|.+++.... ...+++.+++.++.|++.||.|||+ ++++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhh
Confidence 99999999999999986421 1247889999999999999999994 899999999999
Q ss_pred eEEcCCCCEEEeeeccccccCCCCC-CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccc
Q 044561 477 VLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSME 554 (614)
Q Consensus 477 Ill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~ 554 (614)
|+++.++.+||+|||++........ ........+..|+|||.+....++.++|||||||++|||++ |..||......+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999876543221 11222345678999999988899999999999999999997 888886543322
Q ss_pred cccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 555 TVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 555 ~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.. .....+.... .+......+.+++.+|++.||++|||+.|+++
T Consensus 241 ~~-------~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 241 VI-------YYVRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HH-------HHHhcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 11 1112222111 11122356788999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=313.75 Aligned_cols=250 Identities=25% Similarity=0.323 Sum_probs=210.5
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChh---hHHHHHHHHHHhcccC-CCceeEEeeEEeecCeEEE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQ---GIKEFVAELVSMGRLR-HRNLVKLRGYCRRKGEFLL 418 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~l 418 (614)
...|+..+.||.|.||.||+++.+. +..+|+|.+.+.... ..+...+|+.+|+++. ||||+++.+.++....+++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 3467777899999999999999887 899999999776433 3468899999999998 9999999999999999999
Q ss_pred EEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCC----CCEEEeeecccc
Q 044561 419 VYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDAD----LNGKLGDFGLAR 494 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~----~~~kl~DfGla~ 494 (614)
|||+|.+|.|.+.+... .+++.....++.|++.++.|||+ .+|+||||||+|+|+... +.+|++|||++.
T Consensus 114 vmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 99999999999998775 29999999999999999999995 999999999999999643 479999999999
Q ss_pred ccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccc
Q 044561 495 LYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDA 574 (614)
Q Consensus 495 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~ 574 (614)
.... .......+||+.|+|||++....|+.++||||+|+++|.|++|..||......+.... ...+..
T Consensus 188 ~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~-------i~~~~~--- 255 (382)
T KOG0032|consen 188 FIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLA-------ILRGDF--- 255 (382)
T ss_pred EccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHH-------HHcCCC---
Confidence 8876 3356678999999999999989999999999999999999999999988765443321 122222
Q ss_pred ccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 575 SDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 575 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+....-....+.+..++..|+..||.+|+|+.++|+
T Consensus 256 ---~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 256 ---DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred ---CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 1222222233456777888899999999999999985
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=306.64 Aligned_cols=261 Identities=22% Similarity=0.314 Sum_probs=201.7
Q ss_pred cCHHHHHHHhcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhccc-CCCceeEEeeEEe-
Q 044561 335 FTYKDLYKATKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRL-RHRNLVKLRGYCR- 411 (614)
Q Consensus 335 ~~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~- 411 (614)
+.++++..+.++|+..+.||+|+||.||++.... +..+++|.+..... ...++.+|+.+++++ +|||++++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 4455666778899999999999999999999865 77899998765322 235678899999999 6999999999874
Q ss_pred ----ecCeEEEEEEecCCCCcchhcccC--CCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCE
Q 044561 412 ----RKGEFLLVYDYMPNGSLDKILHTN--IKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG 485 (614)
Q Consensus 412 ----~~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~ 485 (614)
.++..++||||+++++|.+++... ....+++..+..++.|+++||.|||+ .+++||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCE
Confidence 345789999999999999887532 23458899999999999999999994 899999999999999999999
Q ss_pred EEeeeccccccCCCCCCcccccccCCCccchhhhcC-----CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHH
Q 044561 486 KLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRT-----GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVD 560 (614)
Q Consensus 486 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~ 560 (614)
||+|||++........ ......|+..|+|||++.. ..++.++||||+||++|||++|+.|+......+..
T Consensus 164 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~---- 238 (286)
T cd06638 164 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL---- 238 (286)
T ss_pred EEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH----
Confidence 9999999986543321 2233468999999998753 45788999999999999999999999754322111
Q ss_pred HHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 561 WVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 561 ~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.. ...+......++ . .....+..++.+||+.||++|||+.||++
T Consensus 239 --~~-~~~~~~~~~~~~---~----~~~~~~~~li~~~l~~~p~~Rps~~ell~ 282 (286)
T cd06638 239 --FK-IPRNPPPTLHQP---E----LWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282 (286)
T ss_pred --hh-ccccCCCcccCC---C----CcCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00 011110111111 1 11235778888999999999999999985
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=321.03 Aligned_cols=259 Identities=22% Similarity=0.252 Sum_probs=196.3
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec---CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS---NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 421 (614)
.+|...+.||+|+||.||++...+ +..|++|.+... +...+|+.++++++||||+++++++...+..++|||
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 457888999999999999998643 567888887643 234579999999999999999999999999999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC-
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT- 500 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~- 500 (614)
++. ++|.+++.. ...+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 167 ~~~-~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 167 KYK-CDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred hcC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 995 688888843 3459999999999999999999994 899999999999999999999999999997655432
Q ss_pred CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccc-----
Q 044561 501 IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDAS----- 575 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~----- 575 (614)
........||+.|+|||++....++.++|||||||++|||++|+.||..............+.+...........
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 320 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN 320 (392)
T ss_pred cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence 222334679999999999998899999999999999999999999997654332222222222211110000000
Q ss_pred --------cccccCc--C-----cHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 576 --------DSRLEGI--C-----EEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 576 --------d~~l~~~--~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
....+.. . .......+..++.+|+..||++|||+.|+++
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 0000000 0 0011234667788899999999999999974
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=301.32 Aligned_cols=235 Identities=26% Similarity=0.461 Sum_probs=187.3
Q ss_pred ceeeeeCcEEEEEEEEecCc-----------EEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEE
Q 044561 351 DVIGRGGFGKVYRGVLASNV-----------QIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLV 419 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 419 (614)
+.||+|+||.||+|...+.. .+++|.+...... ...+.+|+.++++++|||+++++++|.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999987533 4677776554433 6788999999999999999999999988 788999
Q ss_pred EEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCC-------CEEEeeecc
Q 044561 420 YDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADL-------NGKLGDFGL 492 (614)
Q Consensus 420 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~-------~~kl~DfGl 492 (614)
|||+++|+|.+++..... .+++..+..++.||+.||.|||+ ++|+||||||+||+++.++ .+||+|||+
T Consensus 79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999976432 58999999999999999999994 8999999999999999888 799999999
Q ss_pred ccccCCCCCCcccccccCCCccchhhhcCC--CCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcC
Q 044561 493 ARLYDHDTIPQTTKLVGTFGYMDPELMRTG--KASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKG 569 (614)
Q Consensus 493 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~ 569 (614)
+..... .....++..|+|||++... .++.++||||||+++|||++ |..|+......+.. .+ +...
T Consensus 155 a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~---~~----~~~~ 222 (259)
T cd05037 155 PITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE---RF----YQDQ 222 (259)
T ss_pred cccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH---HH----HhcC
Confidence 986543 1223567789999998776 78999999999999999999 57777554322111 11 1100
Q ss_pred CccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 570 AIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 570 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.. . +......+.+++.+||+.+|++|||+.+|++
T Consensus 223 ~~-------~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 223 HR-------L----PMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CC-------C----CCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00 0 0001156788899999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=316.06 Aligned_cols=193 Identities=20% Similarity=0.299 Sum_probs=164.7
Q ss_pred HhcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEE
Q 044561 343 ATKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 343 ~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 421 (614)
...+|+..+.||+|+||.||+|.... +..||+|..... ....|+.++++++||||+++++++...+..++|+|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 34579999999999999999999875 677888875332 23468999999999999999999999999999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCC
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI 501 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~ 501 (614)
|+ .++|.+++... ...+++.++..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 138 ~~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 211 (357)
T PHA03209 138 HY-SSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP- 211 (357)
T ss_pred cc-CCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCc-
Confidence 99 46888887654 3458999999999999999999995 899999999999999999999999999997543221
Q ss_pred CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCC
Q 044561 502 PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVE 548 (614)
Q Consensus 502 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~ 548 (614)
......||..|+|||++.+..++.++|||||||++|||+++..|+.
T Consensus 212 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 212 -AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred -ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 2234578999999999998899999999999999999998666553
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=321.67 Aligned_cols=194 Identities=25% Similarity=0.290 Sum_probs=167.3
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
..+|...+.||+|+||.||++.... ++.||+|.... ..+.+|+.++++++|+||+++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4578889999999999999999875 78899996432 3456899999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCC-
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI- 501 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~- 501 (614)
+ .++|..++.... ..++|.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 242 ~-~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 242 Y-RSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 9 478888876542 359999999999999999999994 8999999999999999999999999999986543321
Q ss_pred CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCC
Q 044561 502 PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVE 548 (614)
Q Consensus 502 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~ 548 (614)
.......||..|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 11234579999999999998899999999999999999999887654
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=302.98 Aligned_cols=249 Identities=26% Similarity=0.410 Sum_probs=197.8
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec----CcEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS----NVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLV 419 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 419 (614)
++|...+.||+|+||.||+|...+ ...+++|...... ....+.+.+|+.++++++|||+++++++|.. +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457778899999999999998754 2468889887654 4556789999999999999999999999875 457899
Q ss_pred EEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCC
Q 044561 420 YDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD 499 (614)
Q Consensus 420 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~ 499 (614)
|||+++|+|.+++.... ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 85 MELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 99999999999997643 358999999999999999999994 89999999999999999999999999999866544
Q ss_pred CCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCcccccccc
Q 044561 500 TIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSR 578 (614)
Q Consensus 500 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~ 578 (614)
.........++..|+|||.+....++.++||||||++++|+++ |+.||......+.. .+. ..+... .
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~---~~~----~~~~~~-----~ 228 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI---GRI----ENGERL-----P 228 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHH----HcCCcC-----C
Confidence 3222223345568999999988889999999999999999986 99999765433221 111 111111 0
Q ss_pred ccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 579 LEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 579 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.... ....+.+++.+|+.++|++|||+.++++
T Consensus 229 ~~~~----~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 229 MPPN----CPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred CCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1112 2345777888999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=304.71 Aligned_cols=260 Identities=24% Similarity=0.384 Sum_probs=204.8
Q ss_pred cCHHHHHHHhcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhccc-CCCceeEEeeEEee
Q 044561 335 FTYKDLYKATKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRR 412 (614)
Q Consensus 335 ~~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~ 412 (614)
.++.++..+...|+..+.||+|+||.||+|.... ++.+++|.+..... ...++..|+.+++++ +|+|++++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 4667777778889999999999999999999865 78889998865533 345678899999988 69999999999853
Q ss_pred ------cCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEE
Q 044561 413 ------KGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGK 486 (614)
Q Consensus 413 ------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~k 486 (614)
....+++|||+++|+|.+++.......+++..+..++.|+++||.|||+ .+++||||||+||++++++.++
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEE
Confidence 4678999999999999999876555568899999999999999999995 8999999999999999999999
Q ss_pred EeeeccccccCCCCCCcccccccCCCccchhhhc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHH
Q 044561 487 LGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMR-----TGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDW 561 (614)
Q Consensus 487 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~ 561 (614)
|+|||++........ ......|+..|+|||.+. ...++.++|||||||++|||++|+.||......+.....
T Consensus 162 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~-- 238 (282)
T cd06636 162 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI-- 238 (282)
T ss_pred EeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhH--
Confidence 999999876543221 223356899999999875 345788999999999999999999999654322211100
Q ss_pred HHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 562 VCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 562 v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
... ....+ ........+.+++.+||+.||++||++.|+++
T Consensus 239 -----~~~-----~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 239 -----PRN-----PPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -----hhC-----CCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000 01111 11122346788888999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=306.03 Aligned_cols=261 Identities=25% Similarity=0.351 Sum_probs=203.5
Q ss_pred cCHHHHHHHhcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhccc-CCCceeEEeeEEee
Q 044561 335 FTYKDLYKATKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRR 412 (614)
Q Consensus 335 ~~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~ 412 (614)
++..++..++++|+..+.||+|+||.||++...+ +..+++|.+..... ...++.+|+.+++++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 4556666778899999999999999999999864 78899998865432 235677899999998 79999999999875
Q ss_pred c-----CeEEEEEEecCCCCcchhcccC--CCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCE
Q 044561 413 K-----GEFLLVYDYMPNGSLDKILHTN--IKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG 485 (614)
Q Consensus 413 ~-----~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~ 485 (614)
. +..++||||+++++|.++++.. ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCE
Confidence 4 3689999999999999988632 23458999999999999999999994 899999999999999999999
Q ss_pred EEeeeccccccCCCCCCcccccccCCCccchhhhcCC-----CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHH
Q 044561 486 KLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTG-----KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVD 560 (614)
Q Consensus 486 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~ 560 (614)
||+|||++........ ......|+..|+|||.+... .++.++|||||||++|||++|+.||......+..
T Consensus 168 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~---- 242 (291)
T cd06639 168 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL---- 242 (291)
T ss_pred EEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH----
Confidence 9999999886543221 12234688999999998643 3688999999999999999999999754332211
Q ss_pred HHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 561 WVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 561 ~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+ +.++......+ ..+....+..++.+|++.+|++||++.|+++
T Consensus 243 --~~-~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 243 --FK-IPRNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred --HH-HhcCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11 11111111111 1122345788899999999999999999975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=300.66 Aligned_cols=249 Identities=25% Similarity=0.411 Sum_probs=197.6
Q ss_pred CCCCcceeeeeCcEEEEEEEEec--CcEEEEEEeecC----------ChhhHHHHHHHHHHhcc-cCCCceeEEeeEEee
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS--NVQIAVKKVSHD----------SKQGIKEFVAELVSMGR-LRHRNLVKLRGYCRR 412 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~ 412 (614)
+|+..+.||+|+||.||+|..+. +..+++|.+... ......++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 46778899999999999999876 677999987532 22345667889988865 799999999999999
Q ss_pred cCeEEEEEEecCCCCcchhccc--CCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeee
Q 044561 413 KGEFLLVYDYMPNGSLDKILHT--NIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDF 490 (614)
Q Consensus 413 ~~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~Df 490 (614)
.+..+++|||+++++|.+++.. .....+++.+++.++.|++.||.|||+ ..+++||||+|+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999988753 223458999999999999999999995 368999999999999999999999999
Q ss_pred ccccccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCC
Q 044561 491 GLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGA 570 (614)
Q Consensus 491 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~ 570 (614)
|++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||........ .. ...++.
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~---~~----~~~~~~ 229 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL---AT----KIVEAV 229 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH---HH----HHhhcc
Confidence 9998765433 23345688999999999988899999999999999999999999865432211 11 111111
Q ss_pred ccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHh
Q 044561 571 IRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVM 613 (614)
Q Consensus 571 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 613 (614)
..... .......+.+++.+||+.||++||++.|+.
T Consensus 230 ~~~~~--------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~ 264 (269)
T cd08528 230 YEPLP--------EGMYSEDVTDVITSCLTPDAEARPDIIQVS 264 (269)
T ss_pred CCcCC--------cccCCHHHHHHHHHHCCCCCccCCCHHHHH
Confidence 11110 111234577888899999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=297.85 Aligned_cols=244 Identities=27% Similarity=0.446 Sum_probs=196.3
Q ss_pred ceeeeeCcEEEEEEEEecCcEEEEEEeecCChh-hHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecCCCCcc
Q 044561 351 DVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQ-GIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLD 429 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 429 (614)
++||+|+||.||++..+++..+++|++...... ..+.+.+|++++++++|+||+++++++...+..++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999877889999998765433 5678999999999999999999999999999999999999999999
Q ss_pred hhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcc-cccc
Q 044561 430 KILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT-TKLV 508 (614)
Q Consensus 430 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~-~~~~ 508 (614)
+++.... ..+++..+..++.+++.+|.||| +++++||||||+||+++.++.+||+|||++........... ....
T Consensus 81 ~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 81 TFLRKKK-NRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 9986542 35889999999999999999999 48999999999999999999999999999986543221111 1223
Q ss_pred cCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcHHH
Q 044561 509 GTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQ 587 (614)
Q Consensus 509 gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~ 587 (614)
.+..|+|||.+.++.++.++|+||||++++||++ |..||......+... ....+. ....+...
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~-------~~~~~~---------~~~~~~~~ 220 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRE-------RIESGY---------RMPAPQLC 220 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHH-------HHhcCC---------CCCCCccC
Confidence 4567999999988889999999999999999999 888886554322111 111110 00111223
Q ss_pred HHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 588 MELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 588 ~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
...+.+++.+|++.+|++|||+.|+++
T Consensus 221 ~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 221 PEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 346888899999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=301.19 Aligned_cols=253 Identities=26% Similarity=0.429 Sum_probs=197.5
Q ss_pred CCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCCh----------hhHHHHHHHHHHhcccCCCceeEEeeEEeecC
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSK----------QGIKEFVAELVSMGRLRHRNLVKLRGYCRRKG 414 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 414 (614)
+|...+.||+|+||.||+|.... +..+|+|.+..... ...+.+.+|+.++++++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 35667899999999999998764 78899998754211 12346788999999999999999999999999
Q ss_pred eEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecccc
Q 044561 415 EFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR 494 (614)
Q Consensus 415 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~ 494 (614)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.+||+|||++.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 999999999999999998764 358999999999999999999995 899999999999999999999999999997
Q ss_pred ccCCCCC-CcccccccCCCccchhhhcCCC--CCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCc
Q 044561 495 LYDHDTI-PQTTKLVGTFGYMDPELMRTGK--ASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAI 571 (614)
Q Consensus 495 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~ 571 (614)
....... .......++..|+|||.+.... ++.++|+||||+++||+++|+.||......+ ...+.... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~-~~ 229 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA------AMFKLGNK-RS 229 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH------HHHHhhcc-cc
Confidence 6543221 1223346889999999987654 7899999999999999999999986432211 11111111 11
Q ss_pred cccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 572 RDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 572 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
....+..... .....+.+++.+|++++|++||++.+|++
T Consensus 230 ~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 230 APPIPPDVSM----NLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred CCcCCccccc----cCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 1111111111 22356777888899999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=300.30 Aligned_cols=248 Identities=25% Similarity=0.393 Sum_probs=185.8
Q ss_pred eeeeeCcEEEEEEEEec---CcEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecCCCC
Q 044561 352 VIGRGGFGKVYRGVLAS---NVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGS 427 (614)
Q Consensus 352 ~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 427 (614)
.||+|+||.||+|...+ ...+++|.+... .......+.+|+..++.++|+||+++++.|...+..++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999998654 346788877544 33445678899999999999999999999999999999999999999
Q ss_pred cchhcccCCC---CCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCC-Cc
Q 044561 428 LDKILHTNIK---PCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQ 503 (614)
Q Consensus 428 L~~~l~~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~-~~ 503 (614)
|.+++..... ...++.....++.||+.||+|||+ ++|+||||||+||++++++.+||+|||++........ ..
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999876432 235678889999999999999994 8999999999999999999999999999875433211 11
Q ss_pred ccccccCCCccchhhhcC-------CCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccc
Q 044561 504 TTKLVGTFGYMDPELMRT-------GKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDAS 575 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~~-------~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~ 575 (614)
.....++..|+|||++.. ..++.++|||||||++|||++ |+.||......+. .. .....+ .....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~---~~---~~~~~~-~~~~~ 231 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV---LK---QVVREQ-DIKLP 231 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH---HH---HHhhcc-CccCC
Confidence 123356778999998743 356889999999999999999 7888865433221 11 111111 11222
Q ss_pred cccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 576 DSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 576 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
++.+...+ ...+.+++..|+ .||++|||+.||++
T Consensus 232 ~~~~~~~~----~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 232 KPQLDLKY----SDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred CCcccccC----CHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 22222222 234455666688 59999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=299.77 Aligned_cols=244 Identities=29% Similarity=0.473 Sum_probs=188.0
Q ss_pred ceeeeeCcEEEEEEEEec----CcEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEe-ecCeEEEEEEecC
Q 044561 351 DVIGRGGFGKVYRGVLAS----NVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCR-RKGEFLLVYDYMP 424 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~-~~~~~~lV~E~~~ 424 (614)
+.||+|+||.||+|.+.+ ...+|+|++... .....+.+.+|+.+++.++|||+++++++|. .++..++++||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998643 356899988543 3445678889999999999999999999876 4556899999999
Q ss_pred CCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCC---
Q 044561 425 NGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI--- 501 (614)
Q Consensus 425 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~--- 501 (614)
+|+|.+++.... ..+++..+..++.|+++||.||| +.+++||||||+|||+++++.+||+|||+++.......
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 81 HGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 999999997643 34678888999999999999999 48999999999999999999999999999975533211
Q ss_pred CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcC-CCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 502 PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASG-RRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 502 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg-~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
.......++..|+|||.+....++.++||||||+++|||++| ..|+...... .....+. .+... ..
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~~~~~----~~~~~-----~~- 223 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DITVYLL----QGRRL-----LQ- 223 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHh----cCCCC-----CC-
Confidence 111233457789999999888899999999999999999995 5566543221 1222211 11100 00
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+......+.+++.+||+++|++||++.||++
T Consensus 224 ---~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 224 ---PEYCPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred ---CCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1112345778899999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=305.22 Aligned_cols=237 Identities=23% Similarity=0.412 Sum_probs=187.5
Q ss_pred ceeeeeCcEEEEEEEEec--------CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 351 DVIGRGGFGKVYRGVLAS--------NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
+.||+|+||.||+|..+. ...+++|.+........+++.+|+.+++.++|||++++++++...+..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998753 234788887666556667889999999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCC--------EEEeeecccc
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLN--------GKLGDFGLAR 494 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~--------~kl~DfGla~ 494 (614)
+++|+|.+++..+. ..+++..+..++.||+.||.||| +.+|+||||||+||+++.++. +|++|||++.
T Consensus 81 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 81 VKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999999997653 35899999999999999999999 489999999999999987765 5899999886
Q ss_pred ccCCCCCCcccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCC-CCCCCCCccccccHHHHHHHhhhcCCcc
Q 044561 495 LYDHDTIPQTTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGR-RPVEQQGSMETVNLVDWVCDCWKKGAIR 572 (614)
Q Consensus 495 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~-~p~~~~~~~~~~~l~~~v~~~~~~~~~~ 572 (614)
.... .....++..|+|||++.+. .++.++||||||+++|||++|. .|+......... . .... .
T Consensus 157 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~---~----~~~~-~-- 221 (258)
T cd05078 157 TVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL---Q----FYED-R-- 221 (258)
T ss_pred ccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH---H----HHHc-c--
Confidence 5432 2234678899999999764 5799999999999999999985 555433221111 0 0010 0
Q ss_pred ccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 573 DASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 573 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+ +......+.+++.+||+.||++|||++++++
T Consensus 222 ----~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 255 (258)
T cd05078 222 ----HQL----PAPKWTELANLINQCMDYEPDFRPSFRAIIR 255 (258)
T ss_pred ----ccC----CCCCcHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 011 1112245778888999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=307.51 Aligned_cols=195 Identities=26% Similarity=0.411 Sum_probs=159.3
Q ss_pred cceeeeeCcEEEEEEEEec---CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEee--cCeEEEEEEecC
Q 044561 350 KDVIGRGGFGKVYRGVLAS---NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRR--KGEFLLVYDYMP 424 (614)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~ 424 (614)
..+||+|+||.||+|+.++ +..+|+|.+..... ...+.+|+.++++++||||+++++++.. ....++|+||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 3579999999999999754 46799998865432 2457789999999999999999998853 567899999996
Q ss_pred CCCcchhcccC-------CCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEE----cCCCCEEEeeeccc
Q 044561 425 NGSLDKILHTN-------IKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL----DADLNGKLGDFGLA 493 (614)
Q Consensus 425 ~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll----~~~~~~kl~DfGla 493 (614)
++|.+++... ....+++..+..++.|++.||.|||+ .+|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 4676665421 12358899999999999999999995 899999999999999 56678999999999
Q ss_pred cccCCCCC--CcccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCC
Q 044561 494 RLYDHDTI--PQTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQ 550 (614)
Q Consensus 494 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~ 550 (614)
+....... .......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 87654322 12234578999999999876 45799999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=314.92 Aligned_cols=252 Identities=26% Similarity=0.404 Sum_probs=194.7
Q ss_pred cCCCCcceeeeeCcEEEEEEEE------ecCcEEEEEEeecCC-hhhHHHHHHHHHHhccc-CCCceeEEeeEEeec-Ce
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVL------ASNVQIAVKKVSHDS-KQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRK-GE 415 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~-~~ 415 (614)
++|+..+.||+|+||.||+|.. ..++.||||++.... ......+.+|+.++.++ +||||++++++|... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 4688899999999999999974 236789999997543 33456788999999999 689999999988654 56
Q ss_pred EEEEEEecCCCCcchhcccCC-----------------------------------------------------------
Q 044561 416 FLLVYDYMPNGSLDKILHTNI----------------------------------------------------------- 436 (614)
Q Consensus 416 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 436 (614)
.+++|||+++|+|.+++....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 899999999999999886421
Q ss_pred ------CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCC-Cccccccc
Q 044561 437 ------KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVG 509 (614)
Q Consensus 437 ------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~g 509 (614)
...+++.++..++.|+++||.|||+ .+|+||||||+||+++.++.+||+|||++........ .......+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 1237888999999999999999994 8999999999999999999999999999976532211 11222345
Q ss_pred CCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcHHHH
Q 044561 510 TFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQM 588 (614)
Q Consensus 510 t~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~ 588 (614)
+..|+|||.+....++.++||||||+++|||++ |..||......+. ......++.... ..... .
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~------~~~~~~~~~~~~-----~~~~~----~ 308 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGTRMR-----APDYT----T 308 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH------HHHHHhccCCCC-----CCCCC----C
Confidence 678999999988889999999999999999997 9999865432211 111111221111 11111 2
Q ss_pred HHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 589 ELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 589 ~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+.+++..||++||++|||+.||++
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~ 334 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVE 334 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHH
Confidence 35778888999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=304.71 Aligned_cols=262 Identities=24% Similarity=0.345 Sum_probs=196.5
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCChh-hHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSKQ-GIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
++|+..+.||+|++|.||+|..+ ++..|++|.+...... ....+.+|++++++++|+||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 56888899999999999999986 4788999998654322 234567899999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 502 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 502 (614)
++ ++|.+++.... ..+++.....++.|+++||.|||+ .+++||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~- 158 (291)
T cd07844 85 LD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK- 158 (291)
T ss_pred CC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence 97 58998887543 358999999999999999999994 8999999999999999999999999999875432221
Q ss_pred cccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhc---CCcccc----
Q 044561 503 QTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKK---GAIRDA---- 574 (614)
Q Consensus 503 ~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~---~~~~~~---- 574 (614)
......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||....... .......+.... ......
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE--DQLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHhcCCCChhhhhhhhhcc
Confidence 1122356889999998865 457899999999999999999999996543111 111111111100 000000
Q ss_pred ----------ccccccCcCc-HHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 575 ----------SDSRLEGICE-EKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 575 ----------~d~~l~~~~~-~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
....+..... ......+.+++.+|++++|++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000000000 001255678889999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=307.87 Aligned_cols=257 Identities=25% Similarity=0.385 Sum_probs=197.6
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-----cCcEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeec--CeE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-----SNVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRK--GEF 416 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 416 (614)
+.|+..+.||+|+||.||.+.+. .+..+++|.+.... ....+.+.+|+.++++++|||++++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 34677889999999999999852 36789999987553 44456789999999999999999999998775 568
Q ss_pred EEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecccccc
Q 044561 417 LLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 496 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~ 496 (614)
++||||+++++|.+++.... ..+++.++..++.|++.||.||| +++++||||||+||+++.++.+||+|||+++..
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCcccccc
Confidence 99999999999999986543 35899999999999999999999 489999999999999999999999999999866
Q ss_pred CCCCCC--cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcc--------ccccHHHHHHHhh
Q 044561 497 DHDTIP--QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSM--------ETVNLVDWVCDCW 566 (614)
Q Consensus 497 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~--------~~~~l~~~v~~~~ 566 (614)
...... ......++..|+|||.+.+..++.++||||||+++|||++++.|....... .............
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL 239 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence 543211 122345677899999998888999999999999999999988765321100 0000011111111
Q ss_pred hcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 567 KKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 567 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+.... .+......+.+++.+|++.||++||++.++++
T Consensus 240 ~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 278 (284)
T cd05079 240 EEGKRLP---------RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278 (284)
T ss_pred HcCccCC---------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1111100 11123456888999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=292.78 Aligned_cols=251 Identities=24% Similarity=0.353 Sum_probs=200.7
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
+++|+..+.||+|.|+.||++.... |+++|+|.+... +..+.+++.+|+.+.+.|+||||+++.....+.+..|||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 3456777899999999999998754 888888877533 3446788899999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcC---CCCEEEeeeccccccC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA---DLNGKLGDFGLARLYD 497 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~---~~~~kl~DfGla~~~~ 497 (614)
|+|.|+.|..-+-.+ ...++...-..++||+++|.|+|+ ++|||||+||+|+++.+ ..-+||+|||+|....
T Consensus 90 e~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred ecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999997766543 347788888999999999999995 89999999999999954 3458999999999887
Q ss_pred CCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccc
Q 044561 498 HDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDS 577 (614)
Q Consensus 498 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~ 577 (614)
.+. ...-.+||++|||||+++..+|+..+|||+.||+|+-|+.|++||.+.+.......+ ..|... .++
T Consensus 165 ~g~--~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I-------~~g~yd--~~~ 233 (355)
T KOG0033|consen 165 DGE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQI-------KAGAYD--YPS 233 (355)
T ss_pred Ccc--ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHH-------hccccC--CCC
Confidence 332 334458999999999999999999999999999999999999999875543322221 222111 122
Q ss_pred cccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 578 RLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 578 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+-.... .+....|+.+|+..||.+|.|+.|.|+
T Consensus 234 ~~w~~i----s~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 234 PEWDTV----TPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred cccCcC----CHHHHHHHHHHhccChhhhccHHHHhC
Confidence 122222 234667778899999999999999874
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=298.39 Aligned_cols=252 Identities=24% Similarity=0.416 Sum_probs=200.5
Q ss_pred CCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCC------hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEE
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDS------KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLL 418 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 418 (614)
+|+..+.||+|++|.||++... ++..+++|.+.... ....+.+.+|+..+++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4677889999999999999875 47889999886532 2245678999999999999999999999999999999
Q ss_pred EEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCC-CEEEeeeccccccC
Q 044561 419 VYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADL-NGKLGDFGLARLYD 497 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~-~~kl~DfGla~~~~ 497 (614)
|+||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++ .+||+|||++....
T Consensus 81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 99999999999998753 358899999999999999999994 8999999999999998876 59999999987665
Q ss_pred CCCC---CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccc
Q 044561 498 HDTI---PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDA 574 (614)
Q Consensus 498 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~ 574 (614)
.... .......++..|+|||.+.+..++.++|+||+|++++||++|+.||........... ..+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~----- 227 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL---IFKIASAT----- 227 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH---HHHHhccC-----
Confidence 4321 112234688999999999888899999999999999999999999965432221111 11110000
Q ss_pred ccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 575 SDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 575 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.....+......+.+++.+|++.+|++||++.|+++
T Consensus 228 ----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 228 ----TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ----CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 011223334456778889999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=295.97 Aligned_cols=251 Identities=27% Similarity=0.446 Sum_probs=206.6
Q ss_pred CCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCCh-hhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSK-QGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
+|+..+.||+|++|.||+++... +..+++|++..... ...+.+.+|+..+.+++|+|++++++++...+..++||||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 57788999999999999999876 88999999876644 45678999999999999999999999999999999999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCc
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 503 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 503 (614)
++++|.+++... ..+++..+..++.|+++||.|||+ ..+++||||+|+||+++.++.++|+|||++.........
T Consensus 82 ~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~--~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~- 156 (264)
T cd06623 82 DGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ- 156 (264)
T ss_pred CCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhc--cCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc-
Confidence 999999999764 458999999999999999999993 289999999999999999999999999999876543322
Q ss_pred ccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcC
Q 044561 504 TTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGIC 583 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 583 (614)
.....++..|+|||.+.+..++.++|+||||+++|||++|+.||......+......++. .... +. .
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~----~~~~-----~~----~ 223 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC----DGPP-----PS----L 223 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh----cCCC-----CC----C
Confidence 224468899999999998889999999999999999999999997654322222222221 1111 11 1
Q ss_pred cHH-HHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 584 EEK-QMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 584 ~~~-~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+.. ....+..++.+|++++|++||++.|+++
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 224 PAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred CcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 111 3456778888899999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=307.24 Aligned_cols=244 Identities=25% Similarity=0.375 Sum_probs=197.4
Q ss_pred cceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecCCCCc
Q 044561 350 KDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSL 428 (614)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 428 (614)
...||+|+||.||++.... +..+++|++........+.+.+|+..++.++|+|++++++.+...+..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 4569999999999999764 788999998776666667889999999999999999999999999999999999999999
Q ss_pred chhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcccccc
Q 044561 429 DKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLV 508 (614)
Q Consensus 429 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 508 (614)
.+++... .+++.++..++.||+.||.|||+ .+|+||||||+||++++++.+||+|||++........ ......
T Consensus 107 ~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~ 179 (292)
T cd06658 107 TDIVTHT---RMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSLV 179 (292)
T ss_pred HHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCceee
Confidence 9988542 48999999999999999999995 7999999999999999999999999999876543321 223356
Q ss_pred cCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcHHHH
Q 044561 509 GTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQM 588 (614)
Q Consensus 509 gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~ 588 (614)
|+..|+|||.+....++.++||||||++++||++|+.||......+.... + .. ...+.+.. .....
T Consensus 180 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~---~----~~-----~~~~~~~~--~~~~~ 245 (292)
T cd06658 180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR---I----RD-----NLPPRVKD--SHKVS 245 (292)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---H----Hh-----cCCCcccc--ccccC
Confidence 89999999999888899999999999999999999999975433221111 1 10 01111111 11123
Q ss_pred HHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 589 ELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 589 ~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+..++.+|+..||++|||+.|+++
T Consensus 246 ~~~~~li~~~l~~~P~~Rpt~~~il~ 271 (292)
T cd06658 246 SVLRGFLDLMLVREPSQRATAQELLQ 271 (292)
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhh
Confidence 34667778899999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=321.25 Aligned_cols=247 Identities=26% Similarity=0.383 Sum_probs=206.1
Q ss_pred CCCcceeeeeCcEEEEEEEEec----CcEEEEEEeecCChh-hHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEE
Q 044561 347 FKDKDVIGRGGFGKVYRGVLAS----NVQIAVKKVSHDSKQ-GIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 347 f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 421 (614)
.+..++||+|.||.|++|.|+. ...||||++..+... ...+|++|+.+|.+|+|+|+++|+|...+ ..+.+|+|
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 3445789999999999999864 345899999887655 78899999999999999999999999987 77899999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCC
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI 501 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~ 501 (614)
+++.|||.+.|++..+..|-......++.|||.||.||.+ +++|||||..+|+|+-....+||+||||.+.+.....
T Consensus 191 LaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred hcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 9999999999998667789999999999999999999995 8999999999999999999999999999997765431
Q ss_pred C-cc-cccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCcccccccc
Q 044561 502 P-QT-TKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSR 578 (614)
Q Consensus 502 ~-~~-~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~ 578 (614)
. .+ ...--...|+|||.++..+++.++|||+|||.+|||++ |..||.+......+..+ |..
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~i----------------D~~ 331 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNI----------------DAG 331 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhc----------------ccc
Confidence 1 11 11223568999999999999999999999999999999 88899775544333322 111
Q ss_pred ccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHh
Q 044561 579 LEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVM 613 (614)
Q Consensus 579 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 613 (614)
-+-..+..+.+.+.+++..||.++|++|||+..|.
T Consensus 332 erLpRPk~csedIY~imk~cWah~paDRptFsair 366 (1039)
T KOG0199|consen 332 ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIR 366 (1039)
T ss_pred ccCCCCCCChHHHHHHHHHhccCCccccccHHHHH
Confidence 11123556778899999999999999999998874
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=297.30 Aligned_cols=251 Identities=30% Similarity=0.470 Sum_probs=200.7
Q ss_pred CCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCCh--hhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSK--QGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
+|+..+.||+|+||.||+|... ++..+++|.+..... ...+++.+|+.+++.++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4677899999999999999976 478899999876544 3678899999999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 502 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 502 (614)
+++++|.+++... ..+++..+..++.++++||.|||+ .+++|+||+|+||++++++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 9999999998764 348899999999999999999994 89999999999999999999999999999876543322
Q ss_pred cc---cccccCCCccchhhhcCCC---CCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccc
Q 044561 503 QT---TKLVGTFGYMDPELMRTGK---ASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASD 576 (614)
Q Consensus 503 ~~---~~~~gt~~y~aPE~~~~~~---~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 576 (614)
.. ....++..|+|||++.... ++.++||||||++++|+++|+.||........ ..... ..+. .
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~--~~~~~----~~~~-----~ 224 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ--IMFHV----GAGH-----K 224 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH--HHHHH----hcCC-----C
Confidence 11 1346788999999998766 88999999999999999999999975432111 11000 0011 1
Q ss_pred ccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 577 SRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 577 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+.+.... .....+.+++.+|++.+|++||++.|+++
T Consensus 225 ~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 225 PPIPDSL--QLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCccc--ccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111111 11345667888999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=297.06 Aligned_cols=249 Identities=23% Similarity=0.384 Sum_probs=195.5
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC-----ChhhHHHHHHHHHHhcccCCCceeEEeeEEeec--CeE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD-----SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRK--GEF 416 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 416 (614)
++|+..+.||+|+||.||+|...+ +..|++|.+... .....+.+.+|+.++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 468889999999999999999865 788999987532 123456788999999999999999999988663 568
Q ss_pred EEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecccccc
Q 044561 417 LLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 496 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~ 496 (614)
+++|||+++++|.+++... ..+++....+++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++...
T Consensus 82 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 8999999999999998753 347889999999999999999995 89999999999999999999999999998765
Q ss_pred CCCCC--CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccc
Q 044561 497 DHDTI--PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDA 574 (614)
Q Consensus 497 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~ 574 (614)
..... .......++..|+|||.+.+..++.++||||||+++|||++|+.||........ . .+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---~---~~~~~~~----- 225 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA---I---FKIATQP----- 225 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH---H---HHHhcCC-----
Confidence 43211 112334688999999999888899999999999999999999999965322111 1 1111000
Q ss_pred ccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 575 SDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 575 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
. ....+......+..++.+|+. +|++||++.||++
T Consensus 226 ~----~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 T----NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred C----CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0 111233334456667777884 9999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=304.16 Aligned_cols=260 Identities=22% Similarity=0.305 Sum_probs=199.0
Q ss_pred CCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCChh-----hHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEE
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSKQ-----GIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLV 419 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 419 (614)
+|+..+.||+|+||.||+|..+ ++..|++|++...... ....+..|++++++++|+||+++++++...+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3677789999999999999976 4889999999765322 345677899999999999999999999999999999
Q ss_pred EEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCC
Q 044561 420 YDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD 499 (614)
Q Consensus 420 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~ 499 (614)
|||+ +++|.+++.... ..+++..+..++.||++||.|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999 999999997643 359999999999999999999994 89999999999999999999999999999876543
Q ss_pred CCCcccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhc---------C
Q 044561 500 TIPQTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKK---------G 569 (614)
Q Consensus 500 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~---------~ 569 (614)
.. ......++..|+|||.+.+ ..++.++|||||||+++||++|..||......+... ........ .
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 156 NR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLG---KIFEALGTPTEENWPGVT 231 (298)
T ss_pred Cc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHH---HHHHHcCCCchhhhhhcc
Confidence 21 2223356788999998854 467899999999999999999988876544322111 11111000 0
Q ss_pred CccccccccccCcC-----cHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 570 AIRDASDSRLEGIC-----EEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 570 ~~~~~~d~~l~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.............. .......+.+++.+||++||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 00000000000001 1122456788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=307.01 Aligned_cols=244 Identities=25% Similarity=0.369 Sum_probs=197.0
Q ss_pred cceeeeeCcEEEEEEEEe-cCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecCCCCc
Q 044561 350 KDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSL 428 (614)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 428 (614)
...||+|+||.||++... ++..+++|.+........+.+.+|+.+++.++|||++++++.+..++..++|+||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 456999999999999976 4888999998765555567788999999999999999999999999999999999999999
Q ss_pred chhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcccccc
Q 044561 429 DKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLV 508 (614)
Q Consensus 429 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 508 (614)
..++.. ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........ ......
T Consensus 106 ~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~ 178 (297)
T cd06659 106 TDIVSQ---TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLV 178 (297)
T ss_pred HHHHhh---cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-ccccee
Confidence 998754 348999999999999999999994 8999999999999999999999999999876543321 223357
Q ss_pred cCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcHHHH
Q 044561 509 GTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQM 588 (614)
Q Consensus 509 gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~ 588 (614)
|+..|+|||++....++.++|||||||+++||++|+.||......+.. ..+. ..... ... ......
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~---~~~~----~~~~~-----~~~--~~~~~~ 244 (297)
T cd06659 179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM---KRLR----DSPPP-----KLK--NAHKIS 244 (297)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHh----ccCCC-----Ccc--ccCCCC
Confidence 899999999998888999999999999999999999999754432221 1111 11000 000 001112
Q ss_pred HHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 589 ELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 589 ~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+.+++.+|++.+|++||++.++++
T Consensus 245 ~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 245 PVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 34677888899999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=303.25 Aligned_cols=249 Identities=24% Similarity=0.426 Sum_probs=202.4
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
.+|+..+.||+|+||.||++... ++..+++|.+........+.+.+|+.++++++|||++++++.+...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 57888899999999999999875 47889999987655555677899999999999999999999999999999999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCc
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 503 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 503 (614)
++++|.+++... .+++.++..++.|++.||.||| +++++||||||+||+++.++.+||+|||++........ .
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~ 171 (293)
T cd06647 99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 171 (293)
T ss_pred CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-c
Confidence 999999998653 3889999999999999999999 48999999999999999999999999999876543321 2
Q ss_pred ccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcC
Q 044561 504 TTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGIC 583 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 583 (614)
.....+++.|+|||.+..+.++.++|+||||+++||+++|+.||......+..... ...+ .. .. ..
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~------~~~~-~~-----~~--~~ 237 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATNG-TP-----EL--QN 237 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh------hcCC-CC-----CC--CC
Confidence 23346888999999998888999999999999999999999999765432221110 0000 00 00 01
Q ss_pred cHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 584 EEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 584 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.......+..++.+||+.+|++||++.++++
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 268 (293)
T cd06647 238 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 268 (293)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1223345778889999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=302.61 Aligned_cols=263 Identities=26% Similarity=0.367 Sum_probs=201.0
Q ss_pred CCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC--hhhHHHHHHHHHHhcccCCCceeEEeeEEeec--CeEEEEEE
Q 044561 347 FKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS--KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRK--GEFLLVYD 421 (614)
Q Consensus 347 f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~E 421 (614)
|+..+.||+|++|.||+|+..+ +..+++|++.... ....+.+.+|+.++++++|+|++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 4567889999999999999875 7889999997653 33446788999999999999999999999888 89999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCC
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI 501 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~ 501 (614)
|++ ++|.+++.... ..+++.++..++.|+++||.|||+ .+++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred ccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 997 48888886542 458999999999999999999994 8999999999999999999999999999987655432
Q ss_pred CcccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccc------
Q 044561 502 PQTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDA------ 574 (614)
Q Consensus 502 ~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~------ 574 (614)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+...+...........
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF 235 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence 23344467889999997764 45789999999999999999999999765543322222111110000000000
Q ss_pred --------ccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 575 --------SDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 575 --------~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
....+...+...+...+.+++.+|++.+|++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0001111111112456888999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=299.24 Aligned_cols=257 Identities=26% Similarity=0.367 Sum_probs=200.7
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeec--CeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRK--GEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 420 (614)
++|...+.||.|++|.||++.... +..+++|.+.... .....++.+|++++++++||||++++++|... +.+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 357788999999999999999865 7889999887543 34567789999999999999999999988653 4789999
Q ss_pred EecCCCCcchhccc--CCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCC
Q 044561 421 DYMPNGSLDKILHT--NIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 498 (614)
Q Consensus 421 E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~ 498 (614)
||+++++|.+++.. .....+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999988753 223458899999999999999999994 8999999999999999999999999999875543
Q ss_pred CCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCc--cccccHHHHHHHhhhcCCcccccc
Q 044561 499 DTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGS--METVNLVDWVCDCWKKGAIRDASD 576 (614)
Q Consensus 499 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~--~~~~~l~~~v~~~~~~~~~~~~~d 576 (614)
.. .....++..|+|||.+.+..++.++||||||+++|||++|+.||..... ........+... .......+
T Consensus 158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 230 (287)
T cd06621 158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----MPNPELKD 230 (287)
T ss_pred cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----CCchhhcc
Confidence 22 1234578899999999988999999999999999999999999976532 111122222111 11111111
Q ss_pred ccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 577 SRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 577 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
. .. ......+.+.+++.+|++.+|++|||+.|+++
T Consensus 231 ~-~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 231 E-PG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred C-CC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 1 10 01123456789999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=304.90 Aligned_cols=257 Identities=26% Similarity=0.412 Sum_probs=199.6
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-----cCcEEEEEEeecCChh-hHHHHHHHHHHhcccCCCceeEEeeEEee--cCeE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-----SNVQIAVKKVSHDSKQ-GIKEFVAELVSMGRLRHRNLVKLRGYCRR--KGEF 416 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~ 416 (614)
+.|+..+.||+|+||.||++.+. .+..+|+|.+...... ..+++.+|+++++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 34666789999999999999864 2578999998766543 56789999999999999999999999887 5679
Q ss_pred EEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecccccc
Q 044561 417 LLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 496 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~ 496 (614)
+++|||+++++|.+++.... ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 99999999999999997643 359999999999999999999994 89999999999999999999999999999876
Q ss_pred CCCCCC--cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccc--------cHHHHHHHhh
Q 044561 497 DHDTIP--QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETV--------NLVDWVCDCW 566 (614)
Q Consensus 497 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~--------~l~~~v~~~~ 566 (614)
...... ......++..|+|||.+.+..++.++||||||++++||++|+.|+......... .......+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence 532211 111234556799999998888999999999999999999999998643221100 0011111111
Q ss_pred hcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 567 KKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 567 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+. ....+......+.+++.+||+++|++|||+.||++
T Consensus 240 ~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 240 KEGE---------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HcCC---------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1111 00011122356888999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=310.43 Aligned_cols=251 Identities=27% Similarity=0.423 Sum_probs=197.2
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec--------CcEEEEEEeecC-ChhhHHHHHHHHHHhccc-CCCceeEEeeEEeecC
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS--------NVQIAVKKVSHD-SKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKG 414 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 414 (614)
.+|+..+.||+|+||.||++...+ ...+++|.+... .....+++.+|+.+++++ +||||++++++|...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 357788999999999999997532 236899987654 344567899999999999 7999999999999999
Q ss_pred eEEEEEEecCCCCcchhcccCC--------------CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEc
Q 044561 415 EFLLVYDYMPNGSLDKILHTNI--------------KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD 480 (614)
Q Consensus 415 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~ 480 (614)
..+++|||+++|+|.+++.... ...+++.++..++.|++.||.|||+ .+++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEc
Confidence 9999999999999999986532 2348899999999999999999994 8999999999999999
Q ss_pred CCCCEEEeeeccccccCCCCCC-cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccH
Q 044561 481 ADLNGKLGDFGLARLYDHDTIP-QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNL 558 (614)
Q Consensus 481 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l 558 (614)
.++.+||+|||+++........ ......++..|+|||.+....++.++||||||+++|||++ |..||......+..
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-- 246 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF-- 246 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH--
Confidence 9999999999999865432211 1222234567999999988889999999999999999998 88888654332211
Q ss_pred HHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 559 VDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 559 ~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.....+.... .+......+.+++.+|++.+|++||++.|+++
T Consensus 247 -----~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~ 288 (334)
T cd05100 247 -----KLLKEGHRMD---------KPANCTHELYMIMRECWHAVPSQRPTFKQLVE 288 (334)
T ss_pred -----HHHHcCCCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 1111111111 11122345778889999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=304.14 Aligned_cols=260 Identities=23% Similarity=0.335 Sum_probs=197.9
Q ss_pred CCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC--hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS--KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
+|+..+.||+|++|.||+|+... +..+++|++.... ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 47788999999999999999864 7889999886543 22345788999999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 502 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 502 (614)
++ ++|.+++.......+++.++..++.|++.||+|||+ .+++||||+|+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence 95 689888876555669999999999999999999994 8999999999999999999999999999876543321
Q ss_pred cccccccCCCccchhhhcCCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhc-------------
Q 044561 503 QTTKLVGTFGYMDPELMRTGK-ASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKK------------- 568 (614)
Q Consensus 503 ~~~~~~gt~~y~aPE~~~~~~-~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~------------- 568 (614)
......++..|+|||.+.+.. ++.++||||||+++|||++|+.||......+.. .... +....
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL--FRIF-RTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHH-HHhCCCChhhhhhhhHHH
Confidence 123345788999999886644 588999999999999999999999764432211 1100 00000
Q ss_pred ---CCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 569 ---GAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 569 ---~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..........+... .......+.+++.+|++.||++||+++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 233 DYKPSFPKWARQDFSKV-VPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHhhcccccccCHHHH-cccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000000000 0111234677888999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=303.08 Aligned_cols=264 Identities=22% Similarity=0.288 Sum_probs=200.0
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCCh--hhHHHHHHHHHHhcccCCCceeEEeeEEeec--CeEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSK--QGIKEFVAELVSMGRLRHRNLVKLRGYCRRK--GEFLLV 419 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV 419 (614)
++|+..+.||+|+||.||+|..+. +..+++|.+..... .....+.+|+.++++++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 467788899999999999999875 78899999875432 2234567899999999999999999998877 899999
Q ss_pred EEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCC
Q 044561 420 YDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD 499 (614)
Q Consensus 420 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~ 499 (614)
|||++ ++|.+++.... ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 85 ~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 85 MEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred ehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 99997 58988886543 358999999999999999999995 89999999999999999999999999999876543
Q ss_pred CCCcccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHH--------HHHhh----
Q 044561 500 TIPQTTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDW--------VCDCW---- 566 (614)
Q Consensus 500 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~--------v~~~~---- 566 (614)
. .......++..|+|||.+.+. .++.++|+||||++++||++|+.||......+....+.. .|..+
T Consensus 160 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 160 L-KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred c-cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 2 122334578899999988754 468999999999999999999999976543322211100 01000
Q ss_pred --hcCCccccccccccCcCcHH-HHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 567 --KKGAIRDASDSRLEGICEEK-QMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 567 --~~~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
............+...++.. ..+.+.+++.+|++.+|++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00111111111122222222 2455778888999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=300.45 Aligned_cols=245 Identities=29% Similarity=0.485 Sum_probs=193.4
Q ss_pred ceeeeeCcEEEEEEEEec-------CcEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 351 DVIGRGGFGKVYRGVLAS-------NVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
+.||+|+||.||+|+.++ +..+++|.+.... .....++.+|+.+++.++||||++++++|...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999999754 2568889876543 34467889999999999999999999999999999999999
Q ss_pred cCCCCcchhcccCC-----CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCC-----CEEEeeecc
Q 044561 423 MPNGSLDKILHTNI-----KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADL-----NGKLGDFGL 492 (614)
Q Consensus 423 ~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~-----~~kl~DfGl 492 (614)
+++++|.+++.... ...+++.++..++.|++.||.|||+ .+++|+||||+||+++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999986532 2348899999999999999999994 8899999999999999887 899999999
Q ss_pred ccccCCCCC-CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCC
Q 044561 493 ARLYDHDTI-PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGA 570 (614)
Q Consensus 493 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~ 570 (614)
+........ .......++..|+|||.+.++.++.++||||||+++|||++ |+.||......+ ....+ ..+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~~~----~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQHV----TAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHHHH----hcCC
Confidence 976543221 11222345778999999999999999999999999999998 999987543322 11111 1111
Q ss_pred ccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 571 IRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 571 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.. ..+......+.+++.+||.++|++||++.+|++
T Consensus 231 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 231 RL---------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred cc---------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 00 011223456788999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=299.22 Aligned_cols=247 Identities=27% Similarity=0.474 Sum_probs=198.0
Q ss_pred CCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecC-ChhhHHHHHHHHHHhcccC---CCceeEEeeEEeecCeEEEEE
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHD-SKQGIKEFVAELVSMGRLR---HRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV~ 420 (614)
.|+..+.||+|+||.||+|... ++..+++|.+... .....+++.+|+.++++++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 3667788999999999999975 4888999988654 3344567889999998886 999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
||+++++|.+++... .+++.....++.|++.||.||| +.+++||||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred ecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 999999999998653 5899999999999999999999 4899999999999999999999999999998765433
Q ss_pred CCcccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRL 579 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 579 (614)
. ......|+..|+|||.+.++ .++.++|+||||+++|||++|+.||......+... ..... ..+.+
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~-------~~~~~-----~~~~~ 222 (277)
T cd06917 156 S-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM-------LIPKS-----KPPRL 222 (277)
T ss_pred c-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh-------ccccC-----CCCCC
Confidence 2 22334689999999998754 46899999999999999999999997543221111 00111 11111
Q ss_pred cCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 580 EGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 580 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
... .....+.+++.+|++.||++||++.|+++
T Consensus 223 ~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 223 EDN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred Ccc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 111 13345778888999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=298.85 Aligned_cols=253 Identities=26% Similarity=0.384 Sum_probs=199.9
Q ss_pred HhcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhccc-CCCceeEEeeEEeecC------
Q 044561 343 ATKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKG------ 414 (614)
Q Consensus 343 ~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~------ 414 (614)
++++|+..+.||+|++|.||+|..+. +..+++|.+..... ..+++.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 45789999999999999999999864 77899998876544 346789999999999 6999999999997644
Q ss_pred eEEEEEEecCCCCcchhcccCC--CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecc
Q 044561 415 EFLLVYDYMPNGSLDKILHTNI--KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGL 492 (614)
Q Consensus 415 ~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGl 492 (614)
.+++||||+++++|.+++.... ...+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999999886532 3568999999999999999999994 8999999999999999999999999999
Q ss_pred ccccCCCCCCcccccccCCCccchhhhcC-----CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhh
Q 044561 493 ARLYDHDTIPQTTKLVGTFGYMDPELMRT-----GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWK 567 (614)
Q Consensus 493 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~ 567 (614)
+....... .......++..|+|||.+.. ..++.++||||||++++||++|+.||......+.. .+ ..
T Consensus 160 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~------~~-~~ 231 (275)
T cd06608 160 SAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL------FK-IP 231 (275)
T ss_pred ceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHH------HH-hh
Confidence 87654322 12233468899999998753 34678999999999999999999999643322111 11 11
Q ss_pred cCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 568 KGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 568 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
++... .+. .+....+.+.+++.+|+..||++|||+.|+++
T Consensus 232 ~~~~~-----~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 RNPPP-----TLK--SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ccCCC-----CCC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11111 111 11223456778899999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=297.94 Aligned_cols=243 Identities=29% Similarity=0.476 Sum_probs=194.8
Q ss_pred cCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecC
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMP 424 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 424 (614)
++|+..+.||+|+||.||++.. .+..+++|.+..... .+.+.+|+.++++++|||++++++++... ..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~--~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVT--AQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcch--HHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 3577889999999999999975 567799999865432 35788999999999999999999998654 5799999999
Q ss_pred CCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcc
Q 044561 425 NGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT 504 (614)
Q Consensus 425 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 504 (614)
+++|.+++.......+++.++..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---- 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---- 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence 999999998755556899999999999999999999 4899999999999999999999999999987643321
Q ss_pred cccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcC
Q 044561 505 TKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGIC 583 (614)
Q Consensus 505 ~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 583 (614)
.....+..|+|||.+.++.++.++|+||||+++|||++ |+.||......+. .....++.... .
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-------~~~~~~~~~~~---------~ 218 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV-------KECVEKGYRME---------P 218 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH-------HHHHhCCCCCC---------C
Confidence 12234568999999988899999999999999999998 9999876543221 11111211111 1
Q ss_pred cHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 584 EEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 584 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.......+.+++.+||+.+|++||++.++++
T Consensus 219 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 219 PEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1122345778888999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=295.41 Aligned_cols=252 Identities=25% Similarity=0.422 Sum_probs=202.2
Q ss_pred CCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEee--cCeEEEEE
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRR--KGEFLLVY 420 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~ 420 (614)
+|+..+.||+|+||.||++.... +..+++|.+... .....+++.+|++++++++|+|++++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 46778899999999999999764 788999988643 34455678899999999999999999998754 45689999
Q ss_pred EecCCCCcchhcccC--CCCCcChhHHHHHHHHhHhhchhhhccC--CCceEecCcCCCCeEEcCCCCEEEeeecccccc
Q 044561 421 DYMPNGSLDKILHTN--IKPCLNWYQRFRIIRGVASGLLYLHEDW--EQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 496 (614)
Q Consensus 421 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~ 496 (614)
||+++++|.+++... ....+++.++..++.|++.||.|||... ..+++|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998653 2346899999999999999999999332 488999999999999999999999999999876
Q ss_pred CCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccc
Q 044561 497 DHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASD 576 (614)
Q Consensus 497 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 576 (614)
...... .....++..|+|||.+....++.++|+||||+++++|++|+.||......+ .. +....+...
T Consensus 161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~----~~~~~~~~~---- 228 (265)
T cd08217 161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LA----SKIKEGKFR---- 228 (265)
T ss_pred cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---HH----HHHhcCCCC----
Confidence 554321 233468999999999988889999999999999999999999997654221 11 111222211
Q ss_pred ccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 577 SRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 577 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+......+.+++.+|++.+|++||++.+|++
T Consensus 229 -----~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 229 -----RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred -----CCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 122233456788889999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=336.63 Aligned_cols=255 Identities=22% Similarity=0.330 Sum_probs=197.7
Q ss_pred HHhcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEee--cCeE
Q 044561 342 KATKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRR--KGEF 416 (614)
Q Consensus 342 ~~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~ 416 (614)
....+|...+.||+|+||.||++.... +..+++|.+... .......+..|+.++++++||||+++++++.. ...+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 344689999999999999999999876 667888887643 33445778999999999999999999998754 3578
Q ss_pred EEEEEecCCCCcchhcccCC--CCCcChhHHHHHHHHhHhhchhhhccC----CCceEecCcCCCCeEEcC---------
Q 044561 417 LLVYDYMPNGSLDKILHTNI--KPCLNWYQRFRIIRGVASGLLYLHEDW----EQVVLHRDIKPANVLLDA--------- 481 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~----~~~ivHrDikp~NIll~~--------- 481 (614)
||||||+++|+|.++|.... ...+++..++.|+.||+.||.|||+.. ..+||||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 99999999999999987532 245999999999999999999999632 146999999999999964
Q ss_pred --------CCCEEEeeeccccccCCCCCCcccccccCCCccchhhhcC--CCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Q 044561 482 --------DLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRT--GKASTSTDVYAFGVFMLEVASGRRPVEQQG 551 (614)
Q Consensus 482 --------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~ 551 (614)
...+||+|||++....... ......||+.|+|||++.. ..++.++|||||||+||||++|+.||....
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 3348999999998664432 2234579999999999854 458899999999999999999999997543
Q ss_pred ccccccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 552 SMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 552 ~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+ .+......+.. ..+ .. ....+..|+..||+.+|++||++.|+++
T Consensus 248 ~~~------qli~~lk~~p~-----lpi-~~----~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 248 NFS------QLISELKRGPD-----LPI-KG----KSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred cHH------HHHHHHhcCCC-----CCc-CC----CCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 221 11111111110 000 11 1245778888999999999999999974
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=296.70 Aligned_cols=245 Identities=26% Similarity=0.460 Sum_probs=198.0
Q ss_pred CCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecC
Q 044561 347 FKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMP 424 (614)
Q Consensus 347 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 424 (614)
|+..+.||+|+||.||+|... ++..+|+|.+.... ....+.+.+|+..+++++||||+++++++..++..++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 556788999999999999875 47889999876442 3445678899999999999999999999999999999999999
Q ss_pred CCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcc
Q 044561 425 NGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT 504 (614)
Q Consensus 425 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 504 (614)
+++|.+++... .+++..+..++.|++.++.||| +.+++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 86 ~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~~ 158 (277)
T cd06641 86 GGSALDLLEPG---PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KR 158 (277)
T ss_pred CCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccchh-hh
Confidence 99999998643 4899999999999999999999 48999999999999999999999999999876543321 12
Q ss_pred cccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCc
Q 044561 505 TKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICE 584 (614)
Q Consensus 505 ~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 584 (614)
....++..|+|||.+.+...+.++|+|||||++|||++|..|+........ .. . ...+.. +.+.
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~---~-~~~~~~-----~~~~---- 222 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV---LF---L-IPKNNP-----PTLE---- 222 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH---HH---H-HhcCCC-----CCCC----
Confidence 234678899999999888889999999999999999999999865332111 11 1 111111 1111
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 585 EKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 585 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
......+.+++.+|++.+|++||++.++++
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 223 GNYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 122345677888899999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=298.05 Aligned_cols=253 Identities=25% Similarity=0.388 Sum_probs=202.1
Q ss_pred CCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
+|+..+.||+|++|.||++..+. ++.+++|++.... ....+++.+|++++++++||||+++++.+...+.+++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 56777899999999999999874 7889999887653 345577899999999999999999999999999999999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCc
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 503 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 503 (614)
++++|.+++.... ..+++..+..++.|+++||.|||+ ..+++||||||+||++++++.+||+|||.+........
T Consensus 82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 156 (265)
T cd06605 82 DGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-- 156 (265)
T ss_pred CCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh--
Confidence 9999999987643 458899999999999999999994 28999999999999999999999999999876543221
Q ss_pred ccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcC
Q 044561 504 TTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGIC 583 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 583 (614)
....++..|+|||.+.+..++.++||||||+++++|++|+.||....... ....+.+... ..+.. +.+.
T Consensus 157 -~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~-~~~~~-----~~~~--- 225 (265)
T cd06605 157 -KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYI-VNEPP-----PRLP--- 225 (265)
T ss_pred -hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHH-hcCCC-----CCCC---
Confidence 11568889999999988899999999999999999999999996543211 1111111111 11111 1111
Q ss_pred cHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 584 EEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 584 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.......+.+++.+|+..||++|||+.|+++
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 226 SGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred hhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 1113345778888999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=313.98 Aligned_cols=240 Identities=24% Similarity=0.318 Sum_probs=186.1
Q ss_pred eeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhccc---CCCceeEEeeEEeecCeEEEEEEecCC
Q 044561 353 IGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRL---RHRNLVKLRGYCRRKGEFLLVYDYMPN 425 (614)
Q Consensus 353 lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~~~~~lV~E~~~~ 425 (614)
||+|+||+||+|+.+. +..||+|++.... ......+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 6999999999999865 8899999986532 22233455666666655 699999999999999999999999999
Q ss_pred CCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCccc
Q 044561 426 GSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT 505 (614)
Q Consensus 426 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 505 (614)
|+|..++... ..+++..+..++.||++||.|||+ ++|+||||||+|||++.++.+||+|||++....... ....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~ 154 (330)
T cd05586 81 GELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTN 154 (330)
T ss_pred ChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCcc
Confidence 9999988763 358999999999999999999995 899999999999999999999999999987543222 1233
Q ss_pred ccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCc
Q 044561 506 KLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICE 584 (614)
Q Consensus 506 ~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 584 (614)
..+||..|+|||.+.+. .++.++|||||||++|||++|+.||......+. .+....+.. ++...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~-------~~~i~~~~~------~~~~~-- 219 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM-------YRNIAFGKV------RFPKN-- 219 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH-------HHHHHcCCC------CCCCc--
Confidence 45799999999998754 479999999999999999999999976433221 111111111 11110
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCC----CHHHHhC
Q 044561 585 EKQMELVLKLGLFCSHPKPEARP----NMRQVMQ 614 (614)
Q Consensus 585 ~~~~~~l~~l~~~cl~~dP~~RP----s~~evl~ 614 (614)
.....+.+++.+||+.||++|| ++.|+++
T Consensus 220 -~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 220 -VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 1123456778889999999998 5666653
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=297.54 Aligned_cols=248 Identities=24% Similarity=0.382 Sum_probs=185.9
Q ss_pred eeeeeCcEEEEEEEEecC---cEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecCCCC
Q 044561 352 VIGRGGFGKVYRGVLASN---VQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGS 427 (614)
Q Consensus 352 ~lG~G~fg~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 427 (614)
.||+|+||.||+|...++ ..+++|.+.... ....+.+.+|+..++.++||||+++++.|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999986543 345667665443 3455789999999999999999999999999999999999999999
Q ss_pred cchhcccCC--CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCC-CCCcc
Q 044561 428 LDKILHTNI--KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD-TIPQT 504 (614)
Q Consensus 428 L~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~-~~~~~ 504 (614)
|.+++.... ...+++..+..++.||+.||.|||+ .+++||||||+|||++.++.+||+|||++...... .....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999997532 2346777888999999999999994 89999999999999999999999999998643221 11122
Q ss_pred cccccCCCccchhhhcC-------CCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCcccccc
Q 044561 505 TKLVGTFGYMDPELMRT-------GKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASD 576 (614)
Q Consensus 505 ~~~~gt~~y~aPE~~~~-------~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 576 (614)
....++..|+|||++.. ..++.++||||||+++|||++ |..||......+.. .... .+......+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~------~~~~-~~~~~~~~~ 231 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVL------NHVI-KDQQVKLFK 231 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHH------HHHH-hhcccccCC
Confidence 34567889999998753 245789999999999999997 56787654332211 1111 122223333
Q ss_pred ccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 577 SRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 577 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+.+...++ ..+.+++..|| .+|++||++.||++
T Consensus 232 ~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 232 PQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred CccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 44333333 34555666798 67999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=302.46 Aligned_cols=267 Identities=26% Similarity=0.368 Sum_probs=199.6
Q ss_pred HHhcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC--hhhHHHHHHHHHHhcccCCCceeEEeeEEeecC----
Q 044561 342 KATKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS--KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKG---- 414 (614)
Q Consensus 342 ~~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~---- 414 (614)
...++|+..+.||+|+||.||+|..+. +..+++|++.... ......+.+|++++++++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 345678889999999999999999875 7889999987543 223356778999999999999999999987654
Q ss_pred ------eEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEe
Q 044561 415 ------EFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLG 488 (614)
Q Consensus 415 ------~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~ 488 (614)
.+++|+||+++ +|...+... ...+++.++..++.|++.||.|||+ .+|+||||||+||++++++.+||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeC
Confidence 79999999975 676666553 3458999999999999999999994 899999999999999999999999
Q ss_pred eeccccccCCCCCCcccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhh
Q 044561 489 DFGLARLYDHDTIPQTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWK 567 (614)
Q Consensus 489 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~ 567 (614)
|||++...............++..|+|||.+.+ ..++.++|||||||+++||++|+.||......+....+........
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 238 (302)
T cd07864 159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238 (302)
T ss_pred cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 999998765443222233456788999998865 3578999999999999999999999976543332222221111110
Q ss_pred cCCccccc--------cc------cccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 568 KGAIRDAS--------DS------RLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 568 ~~~~~~~~--------d~------~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
........ +. ....... .....+.+++.+||+.||++||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFS-FIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hhhcccccccccccccccccccccchhhhcC-CCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00011100 00 0000000 12345788888999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=296.29 Aligned_cols=248 Identities=23% Similarity=0.300 Sum_probs=205.8
Q ss_pred CCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 347 FKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 347 f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
|+..+.||+|.-|+||.+.+++ +..+|+|.+.+.. ++...+...|-+||+.++||.++.|++.++.+...||+|||
T Consensus 79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~mey 158 (459)
T KOG0610|consen 79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEY 158 (459)
T ss_pred HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEec
Confidence 4456789999999999999987 5789999997763 44456678899999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCC---
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD--- 499 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~--- 499 (614)
|+||+|..+++++....+++..+..++.+++-||+||| -.|||+|||||+||||.++|++-|+||.|+......
T Consensus 159 CpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~ 235 (459)
T KOG0610|consen 159 CPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTL 235 (459)
T ss_pred CCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCCCee
Confidence 99999999999988889999999999999999999999 499999999999999999999999999987532110
Q ss_pred -------------------------------C---------------------CCcccccccCCCccchhhhcCCCCCcc
Q 044561 500 -------------------------------T---------------------IPQTTKLVGTFGYMDPELMRTGKASTS 527 (614)
Q Consensus 500 -------------------------------~---------------------~~~~~~~~gt~~y~aPE~~~~~~~t~~ 527 (614)
. .......+||-.|+|||++.+...+.+
T Consensus 236 ~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsA 315 (459)
T KOG0610|consen 236 VKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSA 315 (459)
T ss_pred eccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCch
Confidence 0 001123579999999999999999999
Q ss_pred hhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCC
Q 044561 528 TDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARP 607 (614)
Q Consensus 528 ~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP 607 (614)
+|.|+|||++|||+.|+.||.+.+..+.+..+- . .+.++.+. ......+.+|+.+.|.+||++|.
T Consensus 316 VDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv-----~--------~~l~Fp~~--~~vs~~akDLIr~LLvKdP~kRl 380 (459)
T KOG0610|consen 316 VDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIV-----G--------QPLKFPEE--PEVSSAAKDLIRKLLVKDPSKRL 380 (459)
T ss_pred hhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHh-----c--------CCCcCCCC--CcchhHHHHHHHHHhccChhhhh
Confidence 999999999999999999999988877664431 0 01111111 13345677888889999999998
Q ss_pred C----HHHH
Q 044561 608 N----MRQV 612 (614)
Q Consensus 608 s----~~ev 612 (614)
. +.||
T Consensus 381 g~~rGA~eI 389 (459)
T KOG0610|consen 381 GSKRGAAEI 389 (459)
T ss_pred ccccchHHh
Confidence 7 5555
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=301.47 Aligned_cols=261 Identities=23% Similarity=0.317 Sum_probs=194.6
Q ss_pred CCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC--hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS--KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
+|+..+.||+|+||.||+|+.+. +..+++|++.... ......+.+|+.++++++|||++++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 36778899999999999999864 8889999986542 22235678899999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 502 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 502 (614)
++ ++|.+++... ...+++.++..++.||++||.|||+ .+++||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 154 (284)
T cd07839 81 CD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR- 154 (284)
T ss_pred CC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence 96 5787777643 2458999999999999999999994 8999999999999999999999999999986543221
Q ss_pred cccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCC------ccccc
Q 044561 503 QTTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGA------IRDAS 575 (614)
Q Consensus 503 ~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~------~~~~~ 575 (614)
......++..|+|||.+.+. .++.++|||||||++|||++|+.|+......+ .......+...... .....
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCChHHhHHhhhcc
Confidence 12234678899999998764 46899999999999999999999864432211 11111111000000 00000
Q ss_pred cc----cccC-----cCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 576 DS----RLEG-----ICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 576 d~----~l~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+. .... .......+.+.+++.+|++.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00 0000 001112356778889999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=314.70 Aligned_cols=260 Identities=19% Similarity=0.285 Sum_probs=209.0
Q ss_pred CCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccC-C-----CceeEEeeEEeecCeEEE
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLR-H-----RNLVKLRGYCRRKGEFLL 418 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H-----~niv~l~g~~~~~~~~~l 418 (614)
+|.+.+.||+|.||.|-||.... ++.||||+++.... -..+...|+.+|..|+ | -|+|++++++..++++||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 67889999999999999999876 88999999976543 3456678999999886 4 589999999999999999
Q ss_pred EEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCC--CCEEEeeecccccc
Q 044561 419 VYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDAD--LNGKLGDFGLARLY 496 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~--~~~kl~DfGla~~~ 496 (614)
|+|.+ ..+|.++|+.+....++...+..|+.||+.||..|| +.+|||+||||+||||.+- ..+||+|||.++..
T Consensus 266 VfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99999 679999999988888999999999999999999999 5999999999999999653 46999999999876
Q ss_pred CCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHH--------hh--
Q 044561 497 DHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCD--------CW-- 566 (614)
Q Consensus 497 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~--------~~-- 566 (614)
.... ...+.+..|.|||++.+.+|+.+.||||||||+.||++|.+-|.+.++.+++..+..+.. ..
T Consensus 342 ~q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~ 417 (586)
T KOG0667|consen 342 SQRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKK 417 (586)
T ss_pred CCcc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence 5432 256778899999999999999999999999999999999988988877766655533221 10
Q ss_pred -----hc-CCcccc----------------------cccc-cc-------CcCcHHHHHHHHHHHHHcCCCCCCCCCCHH
Q 044561 567 -----KK-GAIRDA----------------------SDSR-LE-------GICEEKQMELVLKLGLFCSHPKPEARPNMR 610 (614)
Q Consensus 567 -----~~-~~~~~~----------------------~d~~-l~-------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 610 (614)
.+ ...... .+.. .. .......-+.+.+++.+|+..||.+|+|..
T Consensus 418 ~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~ 497 (586)
T KOG0667|consen 418 AHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPA 497 (586)
T ss_pred cceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHH
Confidence 00 000000 0000 00 011113345678999999999999999999
Q ss_pred HHhC
Q 044561 611 QVMQ 614 (614)
Q Consensus 611 evl~ 614 (614)
|+++
T Consensus 498 qal~ 501 (586)
T KOG0667|consen 498 QALN 501 (586)
T ss_pred HHhc
Confidence 9875
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=298.62 Aligned_cols=248 Identities=24% Similarity=0.351 Sum_probs=200.6
Q ss_pred CCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecC
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMP 424 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 424 (614)
.|...+.||+|++|.||++... ++..+++|++........+.+.+|+.+++.++|||++++++++...+..++++||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 3455679999999999999975 478899999876665566778999999999999999999999999999999999999
Q ss_pred CCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcc
Q 044561 425 NGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT 504 (614)
Q Consensus 425 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 504 (614)
+++|.+++.. ..+++.++..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++........ ..
T Consensus 100 ~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~ 172 (285)
T cd06648 100 GGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RR 172 (285)
T ss_pred CCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-cc
Confidence 9999999876 348999999999999999999995 8999999999999999999999999998876543321 22
Q ss_pred cccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCc
Q 044561 505 TKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICE 584 (614)
Q Consensus 505 ~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 584 (614)
....|+..|+|||.+.+..++.++||||||++++||++|+.||......+. .... ..+.. +.... .
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~---~~~~----~~~~~-----~~~~~--~ 238 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA---MKRI----RDNLP-----PKLKN--L 238 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH---HHHH----HhcCC-----CCCcc--c
Confidence 334689999999999888899999999999999999999999865432211 1111 11110 11110 1
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 585 EKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 585 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
......+.+++.+||+.+|++||++.++++
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 239 HKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 112346888899999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=301.50 Aligned_cols=253 Identities=28% Similarity=0.401 Sum_probs=194.4
Q ss_pred CCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC-hhhHHHHHHHHHHhcccC-CCceeEEeeEEeecCeEEEEEEe
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS-KQGIKEFVAELVSMGRLR-HRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
+|...+.||+|+||.||++.... +..+|+|++.... ......+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 34456789999999999999865 7889999987543 344567889999999996 99999999999999999999999
Q ss_pred cCCCCcchhc---ccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCC
Q 044561 423 MPNGSLDKIL---HTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD 499 (614)
Q Consensus 423 ~~~gsL~~~l---~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~ 499 (614)
++ ++|.++. .......+++..+..++.+++.||.|||+ +.+++||||||+||+++.++.+||+|||++......
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 85 4554433 22233568999999999999999999996 368999999999999999999999999999765433
Q ss_pred CCCcccccccCCCccchhhhcCC---CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccc
Q 044561 500 TIPQTTKLVGTFGYMDPELMRTG---KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASD 576 (614)
Q Consensus 500 ~~~~~~~~~gt~~y~aPE~~~~~---~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 576 (614)
. ......|+..|+|||.+... .++.++|||||||++|||++|+.||..... ....+.+... +. .
T Consensus 162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~-~~-----~ 228 (288)
T cd06616 162 I--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVK-GD-----P 228 (288)
T ss_pred C--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcC-CC-----C
Confidence 2 12233688999999998765 689999999999999999999999965431 1111111111 11 1
Q ss_pred ccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 577 SRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 577 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+.+...........+.+++.+|+++||++|||+.+|++
T Consensus 229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 229 PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11211111223456788899999999999999999974
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=300.08 Aligned_cols=244 Identities=24% Similarity=0.333 Sum_probs=199.9
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
++|+..+.||+|+||.||++.... ++.+++|.+.... ....+.+.+|++++++++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 367788999999999999999875 7889999886532 234567889999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 999999999998764 458999999999999999999994 89999999999999999999999999999876543
Q ss_pred CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
.....+++.|+|||.+.+...+.++||||||++++||++|+.||......+. .+....+.. .+.
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~~------~~~ 218 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI-------YEKILEGKV------RFP 218 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHhcCCc------cCC
Confidence 2334688999999999888889999999999999999999999975442111 111111111 111
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHhC
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARP-----NMRQVMQ 614 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 614 (614)
... ...+..++.+||..||++|| +++|+++
T Consensus 219 ~~~----~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 219 SFF----SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ccC----CHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 112 34566788889999999999 7777763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=288.92 Aligned_cols=248 Identities=28% Similarity=0.474 Sum_probs=204.2
Q ss_pred CCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecCC
Q 044561 347 FKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPN 425 (614)
Q Consensus 347 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 425 (614)
|+..+.||+|++|.||++... ++..+++|++........+++.+|+..+++++|+|++++++++...+..++++||+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 667789999999999999987 4788999999877655678899999999999999999999999999999999999999
Q ss_pred CCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCccc
Q 044561 426 GSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT 505 (614)
Q Consensus 426 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 505 (614)
++|.+++.... ..+++..+..++.|++.+|.||| ..+++||||+|+||++++++.++|+|||.+........ ..
T Consensus 82 ~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~ 155 (253)
T cd05122 82 GSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RN 155 (253)
T ss_pred CcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--cc
Confidence 99999987643 45899999999999999999999 48999999999999999999999999999987655432 33
Q ss_pred ccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcH
Q 044561 506 KLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEE 585 (614)
Q Consensus 506 ~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~ 585 (614)
...++..|++||.+....++.++|+||||+++++|++|+.|+......+.... ............ .
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-------~~~~~~~~~~~~-------~ 221 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK-------IATNGPPGLRNP-------E 221 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH-------HHhcCCCCcCcc-------c
Confidence 45788999999999888899999999999999999999999975432221111 011111111110 0
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 586 KQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 586 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.....+.+++.+|++.||++|||+.|+++
T Consensus 222 ~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 222 KWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 01345778888999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=298.26 Aligned_cols=249 Identities=27% Similarity=0.434 Sum_probs=196.0
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-Cc----EEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NV----QIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLL 418 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 418 (614)
.+|+..+.||+|+||.||+|..+. +. .+++|...... .....++.+|+.++++++|||+++++++|.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 456778899999999999999754 32 58888876553 3455788999999999999999999999987 78999
Q ss_pred EEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCC
Q 044561 419 VYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 498 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~ 498 (614)
||||+++|+|.+++..+. ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++....
T Consensus 86 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 999999999999997643 348999999999999999999995 8999999999999999999999999999987653
Q ss_pred CCCCc-ccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCcccccc
Q 044561 499 DTIPQ-TTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASD 576 (614)
Q Consensus 499 ~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 576 (614)
..... .....++..|+|||.+....++.++|+||||++++|+++ |+.||......+. ...+ ..+... .
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~----~~~~~~--~- 231 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI---PDLL----EKGERL--P- 231 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHH---HHHH----hCCCCC--C-
Confidence 32111 111223568999999988889999999999999999998 9999976433221 1111 111100 0
Q ss_pred ccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 577 SRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 577 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
....++ ..+..++.+||..||++||++.++++
T Consensus 232 --~~~~~~----~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 232 --QPPICT----IDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred --CCCCCC----HHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 011122 34677788899999999999999863
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=298.70 Aligned_cols=251 Identities=25% Similarity=0.347 Sum_probs=192.3
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC-hhhHHHHHHHHHH-hcccCCCceeEEeeEEeecCeEEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS-KQGIKEFVAELVS-MGRLRHRNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~Ei~~-l~~l~H~niv~l~g~~~~~~~~~lV~E 421 (614)
++|+..+.||+|+||.||+++.+. +..||+|++.... .....++..|+.. ++.++|||++++++++...+..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 367888999999999999999875 8899999987643 2334456666665 566789999999999999999999999
Q ss_pred ecCCCCcchhcccC--CCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCC
Q 044561 422 YMPNGSLDKILHTN--IKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD 499 (614)
Q Consensus 422 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~ 499 (614)
|++ |+|.+++... ....+++..+..++.|++.||.|||+ ..+++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh--cCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 7888777542 23468999999999999999999995 238999999999999999999999999999865432
Q ss_pred CCCcccccccCCCccchhhhcC----CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccc
Q 044561 500 TIPQTTKLVGTFGYMDPELMRT----GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDAS 575 (614)
Q Consensus 500 ~~~~~~~~~gt~~y~aPE~~~~----~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~ 575 (614)
. ..+...++..|+|||.+.. ..++.++|+|||||++|||++|+.||...... .... .... .+..
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~---~~~~-~~~~---- 225 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP--FQQL---KQVV-EEPS---- 225 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC--HHHH---HHHH-hcCC----
Confidence 2 1223468889999998854 45688999999999999999999999643211 1111 1111 1111
Q ss_pred cccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 576 DSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 576 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+.+. .....+.+..++.+||..+|++||++.++++
T Consensus 226 -~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 226 -PQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -CCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111 1112345778888999999999999999974
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=295.40 Aligned_cols=249 Identities=23% Similarity=0.382 Sum_probs=200.3
Q ss_pred CCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC--hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS--KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
+|+..+.||+|+||.||++..+. +..+++|.+.... ....+.+.+|+.+++.++|+|++++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 46778899999999999999875 7889999986542 23445778999999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCC-CEEEeeeccccccCCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADL-NGKLGDFGLARLYDHDTI 501 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~-~~kl~DfGla~~~~~~~~ 501 (614)
+++++|.+++.......+++..+..++.|+++||.|||+ .+++|+||||+||++++++ .+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 999999999876554568999999999999999999995 8999999999999999885 469999999976653321
Q ss_pred CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccC
Q 044561 502 PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEG 581 (614)
Q Consensus 502 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~ 581 (614)
......|++.|+|||.+....++.++|+||||++++||++|+.||...... +++.... .+.....
T Consensus 158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~-~~~~~~~------- 222 (257)
T cd08225 158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QLVLKIC-QGYFAPI------- 222 (257)
T ss_pred -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHh-cccCCCC-------
Confidence 222346889999999998888999999999999999999999998654322 1222211 1111111
Q ss_pred cCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 582 ICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 582 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.......+.+++.+|++.+|++|||+.|+++
T Consensus 223 --~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 223 --SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred --CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1112245777888899999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=300.71 Aligned_cols=245 Identities=29% Similarity=0.451 Sum_probs=195.3
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
+.|+..+.||+|+||.||+|.... +..|++|++.... ....+++.+|+.+++.++|||++++.++|...+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 457788899999999999999864 8889999886432 334467889999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
||++ |+|.+++... ...+++.++..++.|++.||.|||+ .+++||||+|+||+++.++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 95 EYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred HhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 9996 6777766543 2358999999999999999999995 89999999999999999999999999998765432
Q ss_pred CCcccccccCCCccchhhhc---CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMR---TGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDS 577 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~---~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~ 577 (614)
....++..|+|||.+. .+.++.++||||||+++|||++|+.||.......... .. ..+.. +
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~------~~-~~~~~-----~ 232 (307)
T cd06607 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HI-AQNDS-----P 232 (307)
T ss_pred ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH------HH-hcCCC-----C
Confidence 2346788999999874 4568899999999999999999999987543222110 00 00000 1
Q ss_pred cccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 578 RLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 578 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+ ......+.+..++.+||+.||++||++.+|++
T Consensus 233 ~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 233 TL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred CC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 11 11223456888899999999999999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=301.45 Aligned_cols=249 Identities=21% Similarity=0.242 Sum_probs=196.3
Q ss_pred CCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEE
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 421 (614)
+|+..+.||+|+||.||++.... +..|++|.+.... ....+.+.+|+.+++.++||||+++++.+..++..++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 67888999999999999999875 7889999887553 2345678899999999999999999999999999999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC-
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT- 500 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~- 500 (614)
|+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 82 YVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred cCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 99999999999764 358999999999999999999994 899999999999999999999999999986421110
Q ss_pred -------------CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhh
Q 044561 501 -------------IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWK 567 (614)
Q Consensus 501 -------------~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~ 567 (614)
........++..|+|||.+....++.++|+||||+++|||++|+.||.+....+.. ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~-------~~~~ 229 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF-------GQVI 229 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHH
Confidence 00111245788999999998888999999999999999999999999754332211 1111
Q ss_pred cCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCC---HHHHh
Q 044561 568 KGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPN---MRQVM 613 (614)
Q Consensus 568 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~evl 613 (614)
.+... .+.... .....+..++.+|+++||++||+ +.|++
T Consensus 230 ~~~~~---~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll 271 (305)
T cd05609 230 SDDIE---WPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVK 271 (305)
T ss_pred hcccC---CCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHH
Confidence 11110 111111 12334678888999999999998 55555
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=303.35 Aligned_cols=249 Identities=27% Similarity=0.459 Sum_probs=193.8
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-Cc----EEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NV----QIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLL 418 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 418 (614)
++|+..+.||+|+||.||+|++.. +. .+++|.+.... .....++.+|+.+++.++||||++++++|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 457778899999999999998753 33 46888876543 23345788999999999999999999998754 5679
Q ss_pred EEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCC
Q 044561 419 VYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 498 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~ 498 (614)
++||+++|+|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccC
Confidence 999999999999987642 348899999999999999999994 8999999999999999999999999999986653
Q ss_pred CCCC-cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCcccccc
Q 044561 499 DTIP-QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASD 576 (614)
Q Consensus 499 ~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 576 (614)
.... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. .+++ ..+....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~---~~~~----~~~~~~~--- 231 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI---PDLL----EKGERLP--- 231 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH----HCCCCCC---
Confidence 3211 1222345778999999988889999999999999999997 9999865432221 1111 1111110
Q ss_pred ccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 577 SRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 577 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
....+ ...+..++..||..+|++||++.++++
T Consensus 232 --~~~~~----~~~~~~li~~c~~~~p~~Rp~~~~l~~ 263 (303)
T cd05110 232 --QPPIC----TIDVYMVMVKCWMIDADSRPKFKELAA 263 (303)
T ss_pred --CCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01112 235677888899999999999999863
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=299.76 Aligned_cols=262 Identities=23% Similarity=0.319 Sum_probs=196.5
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCC--hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDS--KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 421 (614)
++|+..+.||+|++|.||+|..+ +++.+++|++.... ....+.+.+|++++++++|||++++++++...+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999987 47889999886542 2334678899999999999999999999999999999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcC-CCCEEEeeeccccccCCCC
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA-DLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~-~~~~kl~DfGla~~~~~~~ 500 (614)
|++ ++|.+++.......+++.....++.||+.||.|||+ ++++||||+|+||+++. ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 995 578887765444446888889999999999999994 89999999999999985 5578999999997654322
Q ss_pred CCcccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcC---Ccc----
Q 044561 501 IPQTTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKG---AIR---- 572 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~---~~~---- 572 (614)
.......+++.|+|||.+.+. .++.++||||||+++|||++|+.||......+.... ........ .+.
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 158 -RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFK---IFRILGTPNEETWPGVTS 233 (294)
T ss_pred -cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCCChhhcccccc
Confidence 122334678899999988664 578999999999999999999999976543322111 11111000 000
Q ss_pred --ccc--cccccCc----CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 573 --DAS--DSRLEGI----CEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 573 --~~~--d~~l~~~----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
... -+..... ......+.+.+++.+|++.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 0000000 01112345778888999999999999999975
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=297.44 Aligned_cols=252 Identities=28% Similarity=0.435 Sum_probs=204.4
Q ss_pred HhcCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEE
Q 044561 343 ATKGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 343 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 421 (614)
.++.|+..+.||+|++|.||+|..+ ++..+++|.+..... ..+.+.+|++.+++++|+|++++++.+...+..++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4566788889999999999999987 478899999976655 56778899999999999999999999999999999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCC
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI 501 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~ 501 (614)
|+++++|.+++.... ..+++.++..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++........
T Consensus 96 ~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 96 YMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred ccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 999999999998753 369999999999999999999994 8999999999999999999999999999875543221
Q ss_pred CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccC
Q 044561 502 PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEG 581 (614)
Q Consensus 502 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~ 581 (614)
......++..|++||.+.+..++.++|+||||+++|||++|+.||......+.. . . ..........+
T Consensus 172 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~---~---~-~~~~~~~~~~~----- 238 (286)
T cd06614 172 -KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL---F---L-ITTKGIPPLKN----- 238 (286)
T ss_pred -hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH---H---H-HHhcCCCCCcc-----
Confidence 122345788999999998888999999999999999999999998654332111 1 0 01111111111
Q ss_pred cCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 582 ICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 582 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.......+..++.+|++.+|.+||++.++++
T Consensus 239 --~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 239 --PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred --hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1112345778899999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=297.27 Aligned_cols=264 Identities=21% Similarity=0.302 Sum_probs=196.4
Q ss_pred HhcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChh-hHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 343 ATKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQ-GIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 343 ~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
++++|...+.||+|+||.||+|.... +..+++|.+...... ....+.+|+.+++.++|+||+++.+++..++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 45788999999999999999999764 888999998654332 2346778999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
||++ ++|.+++.... ..+++.++..++.|++.||.|||+ .+|+||||||+||+++.++++||+|||+++......
T Consensus 83 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 83 EYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred eccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 9995 67777665432 347888999999999999999995 799999999999999999999999999987543322
Q ss_pred CCcccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcC---------C
Q 044561 501 IPQTTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKG---------A 570 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~---------~ 570 (614)
. ......++..|+|||.+.+. .++.++||||||+++|||++|+.||...... .......+...... .
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07870 158 Q-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEKIWTVLGVPTEDTWPGVSK 234 (291)
T ss_pred C-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHHHHHHcCCCChhhhhhhhh
Confidence 1 12233578899999998653 5788999999999999999999999754321 11111111111000 0
Q ss_pred ccccccccc----cCcC-----cHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 571 IRDASDSRL----EGIC-----EEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 571 ~~~~~d~~l----~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+........ .... .......+.+++.+|++.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000 0000 0011345678888999999999999999974
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=314.12 Aligned_cols=245 Identities=24% Similarity=0.426 Sum_probs=194.8
Q ss_pred CCcceeeeeCcEEEEEEEEec-CcEEEEEEee----cCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecC--eEEEEE
Q 044561 348 KDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVS----HDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKG--EFLLVY 420 (614)
Q Consensus 348 ~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~----~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV~ 420 (614)
+...+||+|+|-+||||.+.. |.+||=..++ ..+....+.|..|+.+|+.|+||||++++.++.+.. .+-+|.
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 456789999999999999864 6666532221 123445688999999999999999999999987655 488999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCC-CCEEEeeeccccccCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDAD-LNGKLGDFGLARLYDHD 499 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~-~~~kl~DfGla~~~~~~ 499 (614)
|.|..|+|..|+++..+ ++...+.+|++||++||.|||+. .++|+|||||.+||+|+.+ |.+||+|+|||......
T Consensus 123 EL~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ecccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 99999999999987543 88889999999999999999986 7899999999999999765 89999999999987665
Q ss_pred CCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccc
Q 044561 500 TIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRL 579 (614)
Q Consensus 500 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 579 (614)
. ...+.|||.|||||++. ..|.+..||||||++|+||+|+..||..-.+..++ ...|........+.++.|+
T Consensus 200 ~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQI--YKKV~SGiKP~sl~kV~dP-- 271 (632)
T KOG0584|consen 200 H---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQI--YKKVTSGIKPAALSKVKDP-- 271 (632)
T ss_pred c---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHH--HHHHHcCCCHHHhhccCCH--
Confidence 4 23379999999999987 68999999999999999999999999653332211 1122222222222333232
Q ss_pred cCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 580 EGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 580 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+.+++.+|+.. .++|||++|+|+
T Consensus 272 ----------evr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 272 ----------EVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ----------HHHHHHHHHhcC-chhccCHHHHhh
Confidence 366778889999 999999999985
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=299.74 Aligned_cols=260 Identities=23% Similarity=0.324 Sum_probs=197.5
Q ss_pred CCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCC--hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 347 FKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDS--KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 347 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
|+..+.||+|++|.||+|..+ ++..+++|++.... ....+.+.+|+..+++++|||++++++++...+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566788999999999999976 48899999987543 223457889999999999999999999999999999999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCc
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 503 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 503 (614)
+ ++|.+++.......+++.++..++.|+++||.|||+ ++++||||+|+||+++.++.++|+|||++........ .
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~ 155 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-T 155 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-c
Confidence 5 689999876544568999999999999999999995 8999999999999999999999999999976543321 1
Q ss_pred ccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcC-------------
Q 044561 504 TTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKG------------- 569 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~------------- 569 (614)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||......+.. ...+.......
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQL--FRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhCCCChHHhhhhhhchhh
Confidence 2223568899999987654 5689999999999999999999999765432211 11110000000
Q ss_pred --CccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 570 --AIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 570 --~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
........... .........+.+++.+|+++||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 234 KPTFPKWARQDLS-KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhcccccccchh-hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000000000 011112245778899999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=299.86 Aligned_cols=247 Identities=25% Similarity=0.318 Sum_probs=202.5
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC---ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
+.|+.-++||+||||.||.++.+. |..+|.|++.+. .+++....++|-.++.+++.+.||.+--.++.++.++||+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 468888999999999999999876 888999988553 3455667789999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
..|.||+|.-+|.+...+.+++..+..++.+|+.||.+|| +..||+||+||+|||+|+.|+++|+|+|||..+..+.
T Consensus 265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK 341 (591)
T ss_pred EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence 9999999999999877778999999999999999999999 5899999999999999999999999999999877665
Q ss_pred CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
.. ...+||.+|||||++.++.|+...|.||+||++|||+.|+.||...........++ +...+ ...
T Consensus 342 ~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvd---rr~~~------~~~--- 407 (591)
T KOG0986|consen 342 PI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVD---RRTLE------DPE--- 407 (591)
T ss_pred cc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHH---HHHhc------chh---
Confidence 32 23389999999999999999999999999999999999999997654322211111 11100 111
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCCCH
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARPNM 609 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 609 (614)
.+++.-.+....+....|+.||++|.--
T Consensus 408 -ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 408 -EYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred -hcccccCHHHHHHHHHHHccCHHHhccC
Confidence 1223333445555556789999999654
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=301.30 Aligned_cols=265 Identities=23% Similarity=0.329 Sum_probs=196.0
Q ss_pred CCCCcceeeeeCcEEEEEEEEec---CcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeec--CeEE
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS---NVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRK--GEFL 417 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~ 417 (614)
+|+..+.||+|+||.||+|+... +..+|+|.+.... ....+.+.+|+.++++++||||+++++++... +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 36778899999999999999864 6889999997743 33446678899999999999999999999888 8899
Q ss_pred EEEEecCCCCcchhcccC---CCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcC----CCCEEEeee
Q 044561 418 LVYDYMPNGSLDKILHTN---IKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA----DLNGKLGDF 490 (614)
Q Consensus 418 lV~E~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~----~~~~kl~Df 490 (614)
+||||+++ +|.+++... ....+++..+..++.|++.||.|||+ .+|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 666665422 12358899999999999999999995 89999999999999999 999999999
Q ss_pred ccccccCCCCC--CcccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccc------cHHHH
Q 044561 491 GLARLYDHDTI--PQTTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETV------NLVDW 561 (614)
Q Consensus 491 Gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~------~l~~~ 561 (614)
|++........ .......++..|+|||.+.+. .++.++||||||++++||++|+.||......... .....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986644322 122334678999999988664 5789999999999999999999999765432200 00111
Q ss_pred HHHhhhcC------------Ccccccc---------ccccCcCcH--HHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 562 VCDCWKKG------------AIRDASD---------SRLEGICEE--KQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 562 v~~~~~~~------------~~~~~~d---------~~l~~~~~~--~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+.+..... ......+ ..+....+. .....+.+++.+|+++||++|||+.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11111000 0000000 000000011 22345788999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=307.85 Aligned_cols=261 Identities=23% Similarity=0.336 Sum_probs=195.3
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEeec-----CeE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRK-----GEF 416 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~ 416 (614)
+++|+..+.||+|+||.||+|+... +..||+|++... .......+.+|+.++++++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 4678999999999999999999764 888999998643 233456788999999999999999999987644 358
Q ss_pred EEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecccccc
Q 044561 417 LLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 496 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~ 496 (614)
++++||++ ++|.+++.. ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 84 ~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeec
Confidence 99999996 577777754 348999999999999999999995 89999999999999999999999999999765
Q ss_pred CCCCCC--cccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcC---C
Q 044561 497 DHDTIP--QTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKG---A 570 (614)
Q Consensus 497 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~---~ 570 (614)
...... ......|+..|+|||.+.+ ..++.++|||||||+++||++|+.||........ ...+.+..... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~~~~~~~~~~~~~~~ 233 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---LNLILGVLGTPSQED 233 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCCHHH
Confidence 432211 1123468999999998754 4688999999999999999999999975432211 11111111100 0
Q ss_pred cccccccc-------c--cCc-----CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 571 IRDASDSR-------L--EGI-----CEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 571 ~~~~~d~~-------l--~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+....+.. . ... ........+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~ 291 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALA 291 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00000000 0 000 00112345788999999999999999999974
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=300.90 Aligned_cols=265 Identities=24% Similarity=0.344 Sum_probs=196.8
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC--hhhHHHHHHHHHHhcccCCCceeEEeeEEeecC-------
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS--KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKG------- 414 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------- 414 (614)
++|+..+.||+|+||.||+|..+. +..+|+|++.... ......+.+|+.++++++||||++++++|...+
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 468889999999999999999865 8889999886542 222345678999999999999999999987654
Q ss_pred -eEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccc
Q 044561 415 -EFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLA 493 (614)
Q Consensus 415 -~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla 493 (614)
..++||||++ ++|.+.+... ...+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 4599999996 5787777653 2358999999999999999999995 79999999999999999999999999999
Q ss_pred cccCCCCCC---cccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcC
Q 044561 494 RLYDHDTIP---QTTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKG 569 (614)
Q Consensus 494 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~ 569 (614)
......... ......++..|+|||.+.+. .++.++||||||++++||++|+.||......+....+..++......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 866433211 12234578899999988654 46889999999999999999999997655443333333322211111
Q ss_pred Cccccccc------cccCcC---------cHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 570 AIRDASDS------RLEGIC---------EEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 570 ~~~~~~d~------~l~~~~---------~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
......+. ...... .......+.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 11110000 000000 0001234678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=286.47 Aligned_cols=250 Identities=27% Similarity=0.423 Sum_probs=204.8
Q ss_pred CCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCCh--hhHHHHHHHHHHhcccCCCceeEEeeEEeec--CeEEEEE
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSK--QGIKEFVAELVSMGRLRHRNLVKLRGYCRRK--GEFLLVY 420 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 420 (614)
+|+..+.||+|++|.||+|..+ ++..+++|.+..... ...+.+.+|+..+++++|+||+++++.+... +..++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3677889999999999999987 488899999876542 4567889999999999999999999999988 8999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
||+++++|.+++.... .+++.++..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||.+.......
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999987643 69999999999999999999995 899999999999999999999999999998766543
Q ss_pred CC-cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccc
Q 044561 501 IP-QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRL 579 (614)
Q Consensus 501 ~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 579 (614)
.. ......++..|+|||.+.....+.++||||||+++++|++|+.||..... ...........+.
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~--------- 221 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAALYKIGSSGE--------- 221 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHHhccccCC---------
Confidence 21 12335688999999999888899999999999999999999999976541 1111111111011
Q ss_pred cCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 580 EGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 580 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
....+......+.+++.+|++.||++||++.|+++
T Consensus 222 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 222 PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11122223466888889999999999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=298.12 Aligned_cols=262 Identities=20% Similarity=0.264 Sum_probs=194.4
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC--hhhHHHHHHHHHHhcccC-CCceeEEeeEEeecCe-----
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS--KQGIKEFVAELVSMGRLR-HRNLVKLRGYCRRKGE----- 415 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~----- 415 (614)
++|+..+.||+|+||.||+|.... +..||+|++.... ......+.+|+.+++.++ |||++++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 367888999999999999999864 7889999876543 223457888999999995 6999999999877665
Q ss_pred EEEEEEecCCCCcchhcccCC---CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcC-CCCEEEeeec
Q 044561 416 FLLVYDYMPNGSLDKILHTNI---KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA-DLNGKLGDFG 491 (614)
Q Consensus 416 ~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~-~~~~kl~DfG 491 (614)
.++||||+++ +|.+++.... ...+++.++..++.||++||.|||+ ++++||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 7888876432 2358999999999999999999994 89999999999999998 8999999999
Q ss_pred cccccCCCCCCcccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCC
Q 044561 492 LARLYDHDTIPQTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGA 570 (614)
Q Consensus 492 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~ 570 (614)
++........ ......+++.|+|||.+.+ ..++.++||||||+++|||++|..||......+.... +........
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~---~~~~~~~~~ 232 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLH---IFKLLGTPT 232 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH---HHHHhCCCC
Confidence 9986543221 1223356889999998865 4578999999999999999999999976543221111 111100000
Q ss_pred ---cccccc-------cccc----CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 571 ---IRDASD-------SRLE----GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 571 ---~~~~~d-------~~l~----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
...... +... ..........+.+++.+|+++||++||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000 0000 0000122345788899999999999999999974
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=293.66 Aligned_cols=248 Identities=26% Similarity=0.315 Sum_probs=202.9
Q ss_pred CCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEE
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 421 (614)
+|+..+.||+|+||.||++..+. +..+++|.+.... ....+.+.+|++++++++||||+++++.+......++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 47788999999999999999874 8889999987542 2456788999999999999999999999999999999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCC
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI 501 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~ 501 (614)
|+++++|.+++... ..+++.++..++.|+++||.|||+ .+++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999999999764 458999999999999999999994 899999999999999999999999999988654432
Q ss_pred CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccC
Q 044561 502 PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEG 581 (614)
Q Consensus 502 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~ 581 (614)
......|+..|+|||.+....++.++|+||||+++|+|++|+.||....... ..+....... . ..
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~------~----~~ 219 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET------A----DV 219 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc------c----cc
Confidence 2233568889999999988889999999999999999999999997654321 1111111111 0 01
Q ss_pred cCcHHHHHHHHHHHHHcCCCCCCCCCCH--HHHhC
Q 044561 582 ICEEKQMELVLKLGLFCSHPKPEARPNM--RQVMQ 614 (614)
Q Consensus 582 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~--~evl~ 614 (614)
..+......+.+++.+||+.||.+||++ +|+++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 220 LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred cCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 1122223567788889999999999999 88763
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=316.69 Aligned_cols=246 Identities=28% Similarity=0.455 Sum_probs=201.9
Q ss_pred CCCcceeeeeCcEEEEEEEEe-c----CcEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 347 FKDKDVIGRGGFGKVYRGVLA-S----NVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 347 f~~~~~lG~G~fg~Vy~~~~~-~----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
.+..++||+|+||+||||.+- + +.+||+|.+... ..+...+++.|+..|.+++|||+++|+|+|.... +.||.
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 455789999999999999973 2 346888887654 4556789999999999999999999999998776 88999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
+|||.|+|.++++.+ +..+--...+.+..|||+||.||| ++.+|||||..+|||+.+-..+||.|||+++....+.
T Consensus 777 q~mP~G~LlDyvr~h-r~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREH-RDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HhcccchHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 999999999999875 456888999999999999999999 5999999999999999999999999999999887654
Q ss_pred CCccc-ccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCcccccccc
Q 044561 501 IPQTT-KLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSR 578 (614)
Q Consensus 501 ~~~~~-~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~ 578 (614)
..-.. ...-.+.|||-|.+....++.++|||||||.+||++| |..|+++....|.-++. +.|. +
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dll-------e~ge-------R 918 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLL-------EKGE-------R 918 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHH-------hccc-------c
Confidence 32211 1123568999999999999999999999999999999 99999887665544433 2221 1
Q ss_pred ccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHh
Q 044561 579 LEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVM 613 (614)
Q Consensus 579 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 613 (614)
+. .++.+...+..++.+||..|++.||+++++.
T Consensus 919 Ls--qPpiCtiDVy~~mvkCwmid~~~rp~fkel~ 951 (1177)
T KOG1025|consen 919 LS--QPPICTIDVYMVMVKCWMIDADSRPTFKELA 951 (1177)
T ss_pred CC--CCCCccHHHHHHHHHHhccCcccCccHHHHH
Confidence 21 2333445677777889999999999999874
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=300.60 Aligned_cols=265 Identities=26% Similarity=0.341 Sum_probs=196.4
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCCh--hhHHHHHHHHHHhcccCCCceeEEeeEEeec--CeEEE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSK--QGIKEFVAELVSMGRLRHRNLVKLRGYCRRK--GEFLL 418 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~l 418 (614)
.++|+..+.||+|+||.||+|..+. +..||+|++..... .....+.+|+.++++++|+|++++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 3578889999999999999999865 88899999865432 2233567899999999999999999998654 56899
Q ss_pred EEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCC
Q 044561 419 VYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 498 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~ 498 (614)
||||++ ++|.+++... ...+++.++..++.|+++||.|||+ .+++||||||+||++++++.+||+|||++.....
T Consensus 86 v~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 86 VMEYCE-QDLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEecCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 999996 5788887653 2458999999999999999999995 8999999999999999999999999999987654
Q ss_pred CCCCcccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccc--
Q 044561 499 DTIPQTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDAS-- 575 (614)
Q Consensus 499 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~-- 575 (614)
... ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||...+..+....+................
T Consensus 161 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07845 161 PAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL 239 (309)
T ss_pred ccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence 321 1223345788999999865 457899999999999999999999997655433322221110000000000000
Q ss_pred ----cccccCc----Cc---HHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 576 ----DSRLEGI----CE---EKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 576 ----d~~l~~~----~~---~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
...+... .. ......+.+++.+|+++||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000 00 011345677889999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=304.99 Aligned_cols=263 Identities=22% Similarity=0.291 Sum_probs=198.6
Q ss_pred HHhcCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeec-----
Q 044561 342 KATKGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRK----- 413 (614)
Q Consensus 342 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~----- 413 (614)
...++|+..+.||+|+||.||++... ++..+|+|++... .....+++.+|+.++++++|+||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 34578999999999999999999976 4889999998643 334456778899999999999999999987543
Q ss_pred -CeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecc
Q 044561 414 -GEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGL 492 (614)
Q Consensus 414 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGl 492 (614)
...++||||++ ++|.+.+... +++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCcc
Confidence 35799999995 5888877542 8889999999999999999995 8999999999999999999999999999
Q ss_pred ccccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHH---------H--
Q 044561 493 ARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVD---------W-- 561 (614)
Q Consensus 493 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~---------~-- 561 (614)
++...... ......++..|+|||.+.+..++.++|||||||++++|++|+.||...+..+....+. +
T Consensus 165 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 165 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242 (353)
T ss_pred ceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 98765432 1233467899999999998899999999999999999999999997654322111100 0
Q ss_pred ----HHH-hhhcC------Cccccccccc----cCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 562 ----VCD-CWKKG------AIRDASDSRL----EGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 562 ----v~~-~~~~~------~~~~~~d~~l----~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
... ..... .+.+...... ...........+.+++.+|++.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000 00000 0000000000 00011123456788999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=295.29 Aligned_cols=257 Identities=22% Similarity=0.252 Sum_probs=193.1
Q ss_pred CCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC-hhhHHHHHHHHHHhcccC-CCceeEEeeEEeec--CeEEEEEE
Q 044561 347 FKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS-KQGIKEFVAELVSMGRLR-HRNLVKLRGYCRRK--GEFLLVYD 421 (614)
Q Consensus 347 f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~--~~~~lV~E 421 (614)
|+..+.||+|+||.||+|.... +..+|+|++.... ........+|+..+.++. |+|++++++++.+. +.+++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 4567889999999999999764 7889999886542 222234457888888885 99999999999887 89999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCC
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI 501 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~ 501 (614)
|++ ++|.+.+.... ..+++.++..++.|++.||.|||+ .+++||||||+||+++. +.+||+|||++.......
T Consensus 81 ~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~- 153 (282)
T cd07831 81 LMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP- 153 (282)
T ss_pred cCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCC-
Confidence 996 58877776532 458999999999999999999995 89999999999999999 999999999998664332
Q ss_pred CcccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhh-----------hcC
Q 044561 502 PQTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCW-----------KKG 569 (614)
Q Consensus 502 ~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~-----------~~~ 569 (614)
......++..|+|||.+.. +.++.++|||||||++|||++|+.||...+..+.. .+..+.. ...
T Consensus 154 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07831 154 -PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQI---AKIHDVLGTPDAEVLKKFRKS 229 (282)
T ss_pred -CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHH---HHHHHHcCCCCHHHHHhhccc
Confidence 1223467889999997654 55789999999999999999999999765433221 1111111 110
Q ss_pred CccccccccccC----cCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 570 AIRDASDSRLEG----ICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 570 ~~~~~~d~~l~~----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.......+.... .........+.+++.+||+++|++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 001100000000 001123567889999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=293.55 Aligned_cols=249 Identities=27% Similarity=0.437 Sum_probs=192.9
Q ss_pred CCCcceeeeeCcEEEEEEEEec----CcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecC------
Q 044561 347 FKDKDVIGRGGFGKVYRGVLAS----NVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKG------ 414 (614)
Q Consensus 347 f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 414 (614)
|+..+.||+|+||.||+|.+.. +..+|+|.+... .....+++.+|++++++++|||++++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 4567889999999999998642 578999988654 3445677899999999999999999999886532
Q ss_pred eEEEEEEecCCCCcchhcccC----CCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeee
Q 044561 415 EFLLVYDYMPNGSLDKILHTN----IKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDF 490 (614)
Q Consensus 415 ~~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~Df 490 (614)
..++++||+++|+|..++... ....+++....+++.|++.||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence 347899999999998887432 12247889999999999999999995 89999999999999999999999999
Q ss_pred ccccccCCCCC-CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhc
Q 044561 491 GLARLYDHDTI-PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKK 568 (614)
Q Consensus 491 Gla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~ 568 (614)
|+++....... .......++..|++||.+....++.++|||||||++|||++ |+.||......+ ...+.. .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~~~~----~ 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNYLI----K 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHHHHH----c
Confidence 99986543321 11222345678999999988889999999999999999999 888886543322 111111 1
Q ss_pred CCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 569 GAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 569 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+... .. +......+.+++.+|++++|++|||+.|+++
T Consensus 231 ~~~~-----~~----~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 231 GNRL-----KQ----PPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred CCcC-----CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1100 00 1122346888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=294.51 Aligned_cols=263 Identities=25% Similarity=0.367 Sum_probs=199.3
Q ss_pred CCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChh-hHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQ-GIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
+|+..+.||+|++|.||+|+.+. +..+++|++...... ..+.+.+|+.++++++|+|++++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 47788999999999999999864 788999998765332 3456778999999999999999999999999999999999
Q ss_pred CCCCcchhcccCC-CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCC
Q 044561 424 PNGSLDKILHTNI-KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 502 (614)
Q Consensus 424 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 502 (614)
++ +|.+++.... ...+++.++..++.|++.||.|||+ .+++||||||+||++++++.+||+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 84 8888776533 3458999999999999999999995 8999999999999999999999999999976543221
Q ss_pred cccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHH--------HHhhhc-----
Q 044561 503 QTTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWV--------CDCWKK----- 568 (614)
Q Consensus 503 ~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v--------~~~~~~----- 568 (614)
......++..|++||.+.+. .++.++||||||+++|||++|+.||......+....+... ++.+..
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 12234678899999988654 5688999999999999999999999765543322211100 000000
Q ss_pred CCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 569 GAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 569 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.......+... ..........+.+++.+|++.||++||++.|+++
T Consensus 236 ~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 236 PTFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred ccccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000000 0011122356778889999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=295.47 Aligned_cols=258 Identities=25% Similarity=0.338 Sum_probs=200.0
Q ss_pred CCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCCh--hhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 347 FKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSK--QGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 347 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
|+..+.||+|++|.||++..+ ++..+++|++..... .....+.+|+.++++++|+||+++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456788999999999999986 478899998865533 24567889999999999999999999999999999999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCc
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 503 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 503 (614)
++ +|.+++.... ..+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||.+....... ..
T Consensus 81 ~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~ 154 (283)
T cd05118 81 DT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP 154 (283)
T ss_pred CC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence 75 8888876643 458999999999999999999994 899999999999999999999999999998765433 12
Q ss_pred ccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhc---CCcccccc---
Q 044561 504 TTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKK---GAIRDASD--- 576 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~---~~~~~~~d--- 576 (614)
.....++..|+|||.+.+. .++.++|+||||+++++|++|+.||......+.... ..+.... ..+....+
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFK---IFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHcCCCchHhcccchhhhh
Confidence 2334678899999998776 789999999999999999999999976544322211 1111100 00000000
Q ss_pred -----------ccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 577 -----------SRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 577 -----------~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
... ..........+.+++.+||++||.+||++.++++
T Consensus 232 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 232 NYKFSFPKKAGMPL-PKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhccccccCH-HHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000 0111233567889999999999999999999974
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=298.14 Aligned_cols=243 Identities=28% Similarity=0.451 Sum_probs=193.0
Q ss_pred CCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC---ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 347 FKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 347 f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
|+..+.||+|+||.||+++... +..+++|++... .....+.+.+|+.++++++|||+++++++|..++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 5667889999999999999764 788999998643 233446788999999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 502 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 502 (614)
++ |+|.+.+... ...+++.++..++.|++.||.|||+ .+++||||+|+||+++.++.+||+|||++.....
T Consensus 107 ~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---- 177 (317)
T cd06635 107 CL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---- 177 (317)
T ss_pred CC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCC----
Confidence 96 5777776543 3458999999999999999999994 8999999999999999999999999999875433
Q ss_pred cccccccCCCccchhhhc---CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccc
Q 044561 503 QTTKLVGTFGYMDPELMR---TGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRL 579 (614)
Q Consensus 503 ~~~~~~gt~~y~aPE~~~---~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 579 (614)
.....++..|+|||.+. .+.++.++|||||||++|||++|+.||......+.... ...+....
T Consensus 178 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~-------~~~~~~~~------ 243 (317)
T cd06635 178 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-------IAQNESPT------ 243 (317)
T ss_pred -cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHH-------HHhccCCC------
Confidence 22346888999999874 45688999999999999999999999865432211110 11111000
Q ss_pred cCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 580 EGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 580 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.........+.+++.+|++.+|++||++.++++
T Consensus 244 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 276 (317)
T cd06635 244 --LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLK 276 (317)
T ss_pred --CCCccccHHHHHHHHHHccCCcccCcCHHHHHh
Confidence 011123345788889999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=292.88 Aligned_cols=259 Identities=24% Similarity=0.341 Sum_probs=195.8
Q ss_pred CCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC--hhhHHHHHHHHHHhccc---CCCceeEEeeEEeecCe-----
Q 044561 347 FKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS--KQGIKEFVAELVSMGRL---RHRNLVKLRGYCRRKGE----- 415 (614)
Q Consensus 347 f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~~~----- 415 (614)
|+..+.||+|+||.||+|+.+. +..+++|++.... ......+.+|+.+++++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5667899999999999999875 8899999987432 22234566777666555 69999999999988776
Q ss_pred EEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccc
Q 044561 416 FLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARL 495 (614)
Q Consensus 416 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~ 495 (614)
.+++|||++ ++|.+++.......+++.++..++.|+++||.|||+ .+++|+||+|+||+++.++.+||+|||++..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 999999996 589888876544469999999999999999999995 8999999999999999999999999999987
Q ss_pred cCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhh-cCC--cc
Q 044561 496 YDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWK-KGA--IR 572 (614)
Q Consensus 496 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~-~~~--~~ 572 (614)
...... .....++..|+|||.+.+..++.++|+|||||++|||++|+.||......+....+ .+... .+. ..
T Consensus 157 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 231 (287)
T cd07838 157 YSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKI---FDVIGLPSEEEWP 231 (287)
T ss_pred ccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHH---HHHcCCCChHhcC
Confidence 654331 22335788999999999888999999999999999999999998765443322111 11100 000 00
Q ss_pred -------cccccccc---CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 573 -------DASDSRLE---GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 573 -------~~~d~~l~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
........ ..........+.+++.+||+.||++||++.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000000 1111223456788999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=308.89 Aligned_cols=243 Identities=29% Similarity=0.458 Sum_probs=200.4
Q ss_pred CCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChh---hHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 347 FKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQ---GIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 347 f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
|...+.||.|+||.||-++... ...||||++....++ .+.+++.|+..|++++|||++.+.|++..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 4455679999999999999865 677999999866444 457899999999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 502 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 502 (614)
| -||-.+++.-. ++++-+.++..|..+.++||+|||+ .+.||||||+.|||+++.|.+||+|||.|.....
T Consensus 108 C-lGSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---- 178 (948)
T KOG0577|consen 108 C-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP---- 178 (948)
T ss_pred H-hccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCc----
Confidence 9 57777777553 4568999999999999999999996 8999999999999999999999999999987653
Q ss_pred cccccccCCCccchhhhc---CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccc
Q 044561 503 QTTKLVGTFGYMDPELMR---TGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRL 579 (614)
Q Consensus 503 ~~~~~~gt~~y~aPE~~~---~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 579 (614)
....+||+.|||||++. .+.|+-++||||+|++..||.-.++|+..++-...+..+ ..+. .|-+
T Consensus 179 -AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHI-------AQNe-----sPtL 245 (948)
T KOG0577|consen 179 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-------AQNE-----SPTL 245 (948)
T ss_pred -hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHH-------HhcC-----CCCC
Confidence 34569999999999874 578999999999999999999999998876543322211 1111 1112
Q ss_pred cCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 580 EGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 580 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
. ..+-...+..++..|++.-|.+|||..++++
T Consensus 246 q---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 246 Q---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred C---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 1 2334556788888999999999999999874
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=287.58 Aligned_cols=249 Identities=25% Similarity=0.409 Sum_probs=204.0
Q ss_pred CCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC--hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS--KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
+|+..+.||+|+||.||++.... +..+++|++.... ....+++.+|++.+++++|+|++++.+.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 46778899999999999999864 7889999987653 35567789999999999999999999999999999999999
Q ss_pred cCCCCcchhcccCC--CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 423 MPNGSLDKILHTNI--KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 423 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
+++++|.+++.... ...+++.++..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999987643 3569999999999999999999995 799999999999999999999999999998765543
Q ss_pred CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
.......|++.|+|||......++.++|+||+|+++++|++|+.||......+.. .......... +.
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~~-----~~ 224 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELA-------LKILKGQYPP-----IP 224 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHH-------HHHhcCCCCC-----CC
Confidence 1223347889999999998888999999999999999999999999755422111 1111111111 11
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
. .....+.+++.+|++.+|++||++.|+++
T Consensus 225 ~----~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 225 S----QYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred C----CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1 22345777888999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=289.85 Aligned_cols=242 Identities=26% Similarity=0.348 Sum_probs=195.9
Q ss_pred eeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecCCCCc
Q 044561 353 IGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSL 428 (614)
Q Consensus 353 lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 428 (614)
||+|++|.||+++... +..+++|.+.... ....+.+.+|+.++++++||||+++++.+.+++..++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6899999999999875 7889999986542 23456789999999999999999999999999999999999999999
Q ss_pred chhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcccccc
Q 044561 429 DKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLV 508 (614)
Q Consensus 429 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 508 (614)
.+++... ..+++.++..++.|+++||.|||+ .+++|+||+|+||+++.++.+||+|||++....... ......
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~ 153 (262)
T cd05572 81 WTILRDR--GLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFC 153 (262)
T ss_pred HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccccc
Confidence 9999764 348999999999999999999994 899999999999999999999999999998765432 223346
Q ss_pred cCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcHHHH
Q 044561 509 GTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQM 588 (614)
Q Consensus 509 gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~ 588 (614)
++..|++||.+....++.++|+||||+++|||++|+.||....... .... .... .+.. ....+....
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~---~~~~-~~~~--------~~~~~~~~~ 220 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-MEIY---NDIL-KGNG--------KLEFPNYID 220 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-HHHH---HHHh-ccCC--------CCCCCcccC
Confidence 8899999999988889999999999999999999999997654211 1111 1111 0000 011111124
Q ss_pred HHHHHHHHHcCCCCCCCCCC-----HHHHhC
Q 044561 589 ELVLKLGLFCSHPKPEARPN-----MRQVMQ 614 (614)
Q Consensus 589 ~~l~~l~~~cl~~dP~~RPs-----~~evl~ 614 (614)
..+.+++.+||+.+|++||+ ++|+++
T Consensus 221 ~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 221 KAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 56788888999999999999 888764
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=292.52 Aligned_cols=247 Identities=26% Similarity=0.440 Sum_probs=206.3
Q ss_pred CCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecCC
Q 044561 347 FKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPN 425 (614)
Q Consensus 347 f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 425 (614)
|...++||+|+||.|||+..+. |..+|+|++..++ ..+++..|+.++.+++.|++|+++|.+.....+++|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 5567789999999999999876 8899999987664 467899999999999999999999999999999999999999
Q ss_pred CCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCccc
Q 044561 426 GSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT 505 (614)
Q Consensus 426 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 505 (614)
||+.+.++.+ +++|.+.++..++++-++||+|||. ..-+|||||+.|||++.+|.+||+|||.|-.+... .....
T Consensus 113 GSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-MAKRN 187 (502)
T KOG0574|consen 113 GSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-MAKRN 187 (502)
T ss_pred CcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhh-HHhhC
Confidence 9999999875 4579999999999999999999994 78899999999999999999999999999765433 23445
Q ss_pred ccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcH
Q 044561 506 KLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEE 585 (614)
Q Consensus 506 ~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~ 585 (614)
++.||+.|||||++..-.|..++||||+|+...||.-|++||..-.+...+..+ +-...+.++ .++
T Consensus 188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI------------PT~PPPTF~--KPE 253 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI------------PTKPPPTFK--KPE 253 (502)
T ss_pred ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec------------cCCCCCCCC--ChH
Confidence 679999999999999989999999999999999999999999754332211110 001111111 233
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 586 KQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 586 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.-.....+++.+|+-.+|++|-|+.+++|
T Consensus 254 ~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 254 EWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred hhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 34556788899999999999999999875
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=320.42 Aligned_cols=199 Identities=24% Similarity=0.372 Sum_probs=159.5
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec--CcEEEEE------------------EeecCChhhHHHHHHHHHHhcccCCCce
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS--NVQIAVK------------------KVSHDSKQGIKEFVAELVSMGRLRHRNL 403 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~Ei~~l~~l~H~ni 403 (614)
.++|+..+.||+|+||+||++..+. +...+.| ++. ........+.+|+.++++++||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCCc
Confidence 4678999999999999999987643 1111211 111 122334568899999999999999
Q ss_pred eEEeeEEeecCeEEEEEEecCCCCcchhcccCC---CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEc
Q 044561 404 VKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNI---KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD 480 (614)
Q Consensus 404 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~ 480 (614)
+++++++...+..|+|+|++. ++|.+++.... .......+...++.||+.||.|||+ ++|+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEC
Confidence 999999999999999999984 56766664322 1123456677899999999999995 8999999999999999
Q ss_pred CCCCEEEeeeccccccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCC
Q 044561 481 ADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPV 547 (614)
Q Consensus 481 ~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~ 547 (614)
.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|..++
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 9999999999999876554333334467999999999999889999999999999999999987644
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=304.89 Aligned_cols=263 Identities=23% Similarity=0.350 Sum_probs=197.7
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeec-----Ce
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRK-----GE 415 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~ 415 (614)
.++|+..+.||+|+||.||+++... +..|++|++... .....+.+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 4578889999999999999999764 788999998653 333456678899999999999999999987644 35
Q ss_pred EEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccc
Q 044561 416 FLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARL 495 (614)
Q Consensus 416 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~ 495 (614)
.++||||+. ++|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++..
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 899999995 7888888654 359999999999999999999995 8999999999999999999999999999986
Q ss_pred cCCCCCCcccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHh--------h
Q 044561 496 YDHDTIPQTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDC--------W 566 (614)
Q Consensus 496 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~--------~ 566 (614)
..... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||......+.......+... .
T Consensus 158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 158 TSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred cCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 64432 12233467889999998765 46889999999999999999999999765432221111111000 0
Q ss_pred hcCCcc-------ccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 567 KKGAIR-------DASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 567 ~~~~~~-------~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+... ...+.... .........+.+++.+|++++|++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~ 290 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALA 290 (337)
T ss_pred CchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHc
Confidence 000000 00000000 001123456788999999999999999999974
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=287.30 Aligned_cols=247 Identities=26% Similarity=0.403 Sum_probs=202.5
Q ss_pred CCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
+|+..+.||+|+||.||+++.+. +..+++|++... ......++.+|++++++++|+||+++.+++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 46778899999999999998764 778999998754 234456788999999999999999999999999999999999
Q ss_pred cCCCCcchhcccCC--CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 423 MPNGSLDKILHTNI--KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 423 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
+++++|.+++.... ...+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 99999999986522 2458999999999999999999994 899999999999999999999999999998765542
Q ss_pred CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
.....++..|++||.+.+..++.++|+||||++++||++|+.||......+. . .....+....
T Consensus 158 ---~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~---~----~~~~~~~~~~------- 220 (256)
T cd08530 158 ---AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL---R----YKVQRGKYPP------- 220 (256)
T ss_pred ---cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---H----HHHhcCCCCC-------
Confidence 2234678899999999888899999999999999999999999976543211 1 1111222111
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+......+..++.+|++.+|++||++.|+++
T Consensus 221 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 221 --IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred --CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 12233456888999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=285.67 Aligned_cols=247 Identities=30% Similarity=0.470 Sum_probs=202.4
Q ss_pred CCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCCh--hhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSK--QGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
+|+..+.||+|++|.||+++... +..+++|.+..... ...+.+.+|++++++++|+|++++++++...+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 36778899999999999998764 78899999977654 4567899999999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 502 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 502 (614)
+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 9999999998764 458999999999999999999994 89999999999999999999999999999876544321
Q ss_pred cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCc
Q 044561 503 QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGI 582 (614)
Q Consensus 503 ~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 582 (614)
.....++..|+|||......++.++||||+|+++++|++|+.|+........ .+... .... +.+
T Consensus 156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~------~~~~~-~~~~-----~~~--- 219 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA------LFRIV-QDDH-----PPL--- 219 (254)
T ss_pred -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH------HHHHh-ccCC-----CCC---
Confidence 2334688999999999887889999999999999999999999875432111 11111 1111 111
Q ss_pred CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 583 CEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 583 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+....+.+..++.+|++.+|++||++.|+++
T Consensus 220 -~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 220 -PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1122346778888999999999999999974
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=291.96 Aligned_cols=243 Identities=25% Similarity=0.326 Sum_probs=192.7
Q ss_pred eeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecCCCCc
Q 044561 353 IGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSL 428 (614)
Q Consensus 353 lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 428 (614)
||+|+||+||++..+. +..+++|.+.... ......+.+|++++++++|||++++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 6899999999998764 7889999886532 22345677899999999999999999999999999999999999999
Q ss_pred chhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcccccc
Q 044561 429 DKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLV 508 (614)
Q Consensus 429 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 508 (614)
.+++.......+++.++..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||++....... ......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccccc
Confidence 999977554569999999999999999999994 899999999999999999999999999987654322 223346
Q ss_pred cCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcHHHH
Q 044561 509 GTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQM 588 (614)
Q Consensus 509 gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~ 588 (614)
++..|+|||.+.+..++.++||||||+++++|++|+.||.......... ...+.. .. ..... +....
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~----~~--~~~~~----~~~~~ 222 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE---ELKRRT----LE--MAVEY----PDKFS 222 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH---HHHhcc----cc--ccccC----CccCC
Confidence 7889999999988889999999999999999999999997544311111 111100 00 01111 11223
Q ss_pred HHHHHHHHHcCCCCCCCCC-----CHHHHh
Q 044561 589 ELVLKLGLFCSHPKPEARP-----NMRQVM 613 (614)
Q Consensus 589 ~~l~~l~~~cl~~dP~~RP-----s~~evl 613 (614)
..+.+++.+||+.||++|| ++.+++
T Consensus 223 ~~~~~li~~~l~~~p~~R~~~~~~~~~~ll 252 (277)
T cd05577 223 PEAKDLCEALLQKDPEKRLGCRGGSADEVR 252 (277)
T ss_pred HHHHHHHHHHccCChhHccCCCcccHHHHH
Confidence 4567888889999999999 666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=292.27 Aligned_cols=241 Identities=24% Similarity=0.329 Sum_probs=185.4
Q ss_pred eeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHH---hcccCCCceeEEeeEEeecCeEEEEEEecC
Q 044561 352 VIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVS---MGRLRHRNLVKLRGYCRRKGEFLLVYDYMP 424 (614)
Q Consensus 352 ~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~---l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 424 (614)
.||+|+||.||++...+ +..+|+|.+.... ......+.+|..+ +...+|||++++++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999999865 7889999886532 1222333444433 334579999999999999999999999999
Q ss_pred CCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcc
Q 044561 425 NGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT 504 (614)
Q Consensus 425 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 504 (614)
+++|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+||++++++.+||+|||++....... .
T Consensus 81 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~ 152 (279)
T cd05633 81 GGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P 152 (279)
T ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---c
Confidence 99999988754 359999999999999999999995 899999999999999999999999999987554322 2
Q ss_pred cccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcC
Q 044561 505 TKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGIC 583 (614)
Q Consensus 505 ~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 583 (614)
....|+..|+|||.+.+ ..++.++||||+||+++||++|+.||..........+ ..... .....+
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~----~~~~~------~~~~~~---- 218 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTL------TVNVEL---- 218 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHH----HHHhh------cCCcCC----
Confidence 23468999999999864 4578999999999999999999999975433221111 11100 011111
Q ss_pred cHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHhC
Q 044561 584 EEKQMELVLKLGLFCSHPKPEARP-----NMRQVMQ 614 (614)
Q Consensus 584 ~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 614 (614)
+......+.+++.+|++.||++|| +++|+++
T Consensus 219 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 219 PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 222334577788889999999999 5999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=305.07 Aligned_cols=265 Identities=25% Similarity=0.364 Sum_probs=198.5
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC--hhhHHHHHHHHHHhcccCCCceeEEeeEEee----cCeE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS--KQGIKEFVAELVSMGRLRHRNLVKLRGYCRR----KGEF 416 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~ 416 (614)
..+|+..+.||+|+||.||+|..+. +..|++|++.... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 3678888999999999999999765 8899999987642 2345677889999999999999999998753 3578
Q ss_pred EEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecccccc
Q 044561 417 LLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 496 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~ 496 (614)
++||||+. ++|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+||++++++.+||+|||++...
T Consensus 84 ~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 99999995 6899888654 348999999999999999999994 89999999999999999999999999999765
Q ss_pred CCCCCC---cccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHH--------HH
Q 044561 497 DHDTIP---QTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWV--------CD 564 (614)
Q Consensus 497 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v--------~~ 564 (614)
...... ......++..|+|||.+.. ..++.++|||||||++|||++|+.||...+.......+... .+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 433211 1123478899999998865 46889999999999999999999999765433222111100 00
Q ss_pred hhhcCCcccccc---cccc---CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 565 CWKKGAIRDASD---SRLE---GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 565 ~~~~~~~~~~~d---~~l~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
........+..+ .... ..........+..++.+|++.+|++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 000000000000 0000 0001122456888999999999999999999874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=298.60 Aligned_cols=259 Identities=20% Similarity=0.310 Sum_probs=193.2
Q ss_pred ceeeee--CcEEEEEEEEe-cCcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecCC
Q 044561 351 DVIGRG--GFGKVYRGVLA-SNVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPN 425 (614)
Q Consensus 351 ~~lG~G--~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 425 (614)
..||+| +||+||++... .+..||+|.+... .....+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 99999999986 4889999998653 333457788999999999999999999999999999999999999
Q ss_pred CCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCc--
Q 044561 426 GSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ-- 503 (614)
Q Consensus 426 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~-- 503 (614)
++|.+++.......+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+|++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 999999886544568999999999999999999994 899999999999999999999999998654322111100
Q ss_pred ----ccccccCCCccchhhhcCC--CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHh------------
Q 044561 504 ----TTKLVGTFGYMDPELMRTG--KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDC------------ 565 (614)
Q Consensus 504 ----~~~~~gt~~y~aPE~~~~~--~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~------------ 565 (614)
.....++..|+|||++.+. .++.++|||||||+++||++|+.||......+.. .......
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML--LQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH--HHHhcCCCCCCccccccch
Confidence 1112346679999998763 4789999999999999999999999764332211 0000000
Q ss_pred --------------------hhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 566 --------------------WKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 566 --------------------~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
...+......+..+...........+.+|+.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0000000111111111222334567889999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=295.15 Aligned_cols=244 Identities=25% Similarity=0.359 Sum_probs=196.3
Q ss_pred cceeeeeCcEEEEEEEEe-cCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecCCCCc
Q 044561 350 KDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSL 428 (614)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 428 (614)
...||+|+||.||++..+ ++..+++|++........+.+.+|+.+++.++|+|++++++.+...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 357999999999999986 4888999998766555667789999999999999999999999999999999999999999
Q ss_pred chhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcccccc
Q 044561 429 DKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLV 508 (614)
Q Consensus 429 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 508 (614)
.+++... .+++.....++.|++.||.|||+ .+++||||+|+||++++++.++|+|||++....... .......
T Consensus 105 ~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~ 177 (292)
T cd06657 105 TDIVTHT---RMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLV 177 (292)
T ss_pred HHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccccc
Confidence 9987543 38999999999999999999995 899999999999999999999999999987654332 1223346
Q ss_pred cCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcHHHH
Q 044561 509 GTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQM 588 (614)
Q Consensus 509 gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~ 588 (614)
++..|+|||.+....++.++|+||+|+++|||++|+.||......+... ...... .+.+.. .....
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~---~~~~~~---------~~~~~~--~~~~~ 243 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK---MIRDNL---------PPKLKN--LHKVS 243 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHhhC---------CcccCC--cccCC
Confidence 8899999999988888999999999999999999999997543322111 111100 111100 01122
Q ss_pred HHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 589 ELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 589 ~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+.+++.+|++.+|.+||++.++++
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 34667788899999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=304.45 Aligned_cols=263 Identities=24% Similarity=0.372 Sum_probs=196.7
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC--ChhhHHHHHHHHHHhccc-CCCceeEEeeEEeec--CeEE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD--SKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRK--GEFL 417 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~--~~~~ 417 (614)
.++|+..+.||+|+||.||+|.... +..+++|++... .......+.+|+.+++++ +||||++++++|... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 4567888899999999999999864 788999988542 233445677899999999 999999999998653 4689
Q ss_pred EEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccC
Q 044561 418 LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYD 497 (614)
Q Consensus 418 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~ 497 (614)
+||||++ ++|..++... .+++.++..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++....
T Consensus 86 lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred EEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 9999997 5898888654 58899999999999999999994 899999999999999999999999999998654
Q ss_pred CCCC----CcccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHH--------
Q 044561 498 HDTI----PQTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCD-------- 564 (614)
Q Consensus 498 ~~~~----~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~-------- 564 (614)
.... .......|+..|+|||.+.. ..++.++||||||+++|||++|+.||......+..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 3321 22334578999999998754 4578899999999999999999999976543322111110000
Q ss_pred hhhcCCcccccc-------ccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 565 CWKKGAIRDASD-------SRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 565 ~~~~~~~~~~~d-------~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+.........+ ....... ......+.+++.+|++.||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~P~~Rps~~~il~ 294 (337)
T cd07852 239 SIKSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTAEEALE 294 (337)
T ss_pred HHHhhhHHHhhhhcccccccchhhhc-cCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence 000000000000 0000000 112356788899999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=294.61 Aligned_cols=261 Identities=25% Similarity=0.337 Sum_probs=197.7
Q ss_pred CCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCCh-hhHHHHHHHHHHhcccC-CCceeEEeeEEeecCeEEEEEEec
Q 044561 347 FKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSK-QGIKEFVAELVSMGRLR-HRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 347 f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
|+..+.||+|++|.||+|+..+ +..+++|++..... .......+|+..+++++ |+|++++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 4567889999999999999875 77899998865432 22234567999999999 999999999999999999999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCc
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 503 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 503 (614)
+|+|.+++.......+++.++..++.|++.+|.|||+ .+++|+||+|+||+++.++.++|+|||++....... .
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--~ 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--P 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCC--C
Confidence 8899998876544568999999999999999999995 899999999999999999999999999998665432 2
Q ss_pred ccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHH----------HHHHhhhcCCcc
Q 044561 504 TTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVD----------WVCDCWKKGAIR 572 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~----------~v~~~~~~~~~~ 572 (614)
.....++..|+|||.+.. ..++.++|+||||++++||++|+.||......+...... |...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 233467889999998754 457899999999999999999999997654332221110 000000000000
Q ss_pred cccc----ccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 573 DASD----SRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 573 ~~~d----~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.... ..+....+ .....+.+++.+|++.+|++||+++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~-~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 235 FRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccHHHHcc-cCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000 00000011 11356889999999999999999999974
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=285.72 Aligned_cols=248 Identities=22% Similarity=0.265 Sum_probs=189.1
Q ss_pred HHHHHhcCCCCccee--eeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhccc-CCCceeEEeeEEeecC
Q 044561 339 DLYKATKGFKDKDVI--GRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKG 414 (614)
Q Consensus 339 el~~~~~~f~~~~~l--G~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 414 (614)
+.....++|+..+.+ |+|+||.||++..+. +..+++|.+........ |+.....+ +|||++++++++...+
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCC
Confidence 333444566666665 999999999999765 77788888765322111 22222112 7999999999999999
Q ss_pred eEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCC-CEEEeeeccc
Q 044561 415 EFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADL-NGKLGDFGLA 493 (614)
Q Consensus 415 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~-~~kl~DfGla 493 (614)
..++||||+++++|.+++..+. .+++.++..++.|+++||.|||+ .+++||||||+||+++.++ .++|+|||++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 9999999999999999997653 69999999999999999999995 8899999999999999998 9999999998
Q ss_pred cccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccc
Q 044561 494 RLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRD 573 (614)
Q Consensus 494 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~ 573 (614)
....... ...++..|+|||++....++.++||||||++++||++|+.||..... +......+.... ...
T Consensus 158 ~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~--~~~--- 226 (267)
T PHA03390 158 KIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED-EELDLESLLKRQ--QKK--- 226 (267)
T ss_pred eecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc-chhhHHHHHHhh--ccc---
Confidence 7654322 23688999999999988899999999999999999999999974432 222222221111 000
Q ss_pred cccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCC-HHHHhC
Q 044561 574 ASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPN-MRQVMQ 614 (614)
Q Consensus 574 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~evl~ 614 (614)
.. ........+.+++.+|++++|++||+ +.|+++
T Consensus 227 ---~~----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 227 ---LP----FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ---CC----cccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 00 11123345777888899999999996 699875
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=289.53 Aligned_cols=242 Identities=24% Similarity=0.372 Sum_probs=195.3
Q ss_pred eeeeCcEEEEEEEEec-CcEEEEEEeecCCh---hhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecCCCCc
Q 044561 353 IGRGGFGKVYRGVLAS-NVQIAVKKVSHDSK---QGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSL 428 (614)
Q Consensus 353 lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 428 (614)
||+|+||.||+++... +..+++|.+..... ...+.+.+|+.++++++|||++++++.+..++..+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999875 88999999865533 4567789999999999999999999999999999999999999999
Q ss_pred chhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCC-------
Q 044561 429 DKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI------- 501 (614)
Q Consensus 429 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~------- 501 (614)
.+++.... .+++..+..++.|+++||.||| +.+++||||+|+||++++++.+||+|||++........
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99987643 5899999999999999999999 48999999999999999999999999999876543321
Q ss_pred CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccC
Q 044561 502 PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEG 581 (614)
Q Consensus 502 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~ 581 (614)
.......++..|++||.......+.++||||||++++||++|+.||......+... . ...+... ...
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~------~-~~~~~~~------~~~ 222 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQ------N-ILNGKIE------WPE 222 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH------H-HhcCCcC------CCc
Confidence 12233567889999999988889999999999999999999999997654322111 1 1111111 000
Q ss_pred cCcHHHHHHHHHHHHHcCCCCCCCCCCH---HHHhC
Q 044561 582 ICEEKQMELVLKLGLFCSHPKPEARPNM---RQVMQ 614 (614)
Q Consensus 582 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~---~evl~ 614 (614)
.. .....+..++.+|++.+|++|||+ .++++
T Consensus 223 ~~--~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 223 DV--EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred cc--cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 00 024567788889999999999999 77764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=323.81 Aligned_cols=254 Identities=26% Similarity=0.436 Sum_probs=197.9
Q ss_pred HHhcCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEee-------
Q 044561 342 KATKGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRR------- 412 (614)
Q Consensus 342 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~------- 412 (614)
....+|++.+.||+||||.|||++.+ ||+.+|||++... +........+|+..+.+|+|||+|+++..+.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 34567889999999999999999987 6999999999765 44556778999999999999999998864311
Q ss_pred --------------------------------------------------------------------------------
Q 044561 413 -------------------------------------------------------------------------------- 412 (614)
Q Consensus 413 -------------------------------------------------------------------------------- 412 (614)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ------------------------c--------CeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhh
Q 044561 413 ------------------------K--------GEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLH 460 (614)
Q Consensus 413 ------------------------~--------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH 460 (614)
+ -.+||-||||+...|.+++..+.... .-...++++.+|++||.|+|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHH
Confidence 0 13689999999988888887754211 46778899999999999999
Q ss_pred ccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccC-----------------CCCCCcccccccCCCccchhhhcCC-
Q 044561 461 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYD-----------------HDTIPQTTKLVGTFGYMDPELMRTG- 522 (614)
Q Consensus 461 ~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~- 522 (614)
+++||||||||.||++|++..+||+|||+|.... .......+..+||.-|+|||++.+.
T Consensus 715 ---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 ---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred ---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 4899999999999999999999999999998621 0111234567899999999998754
Q ss_pred --CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCC
Q 044561 523 --KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSH 600 (614)
Q Consensus 523 --~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~ 600 (614)
+|+.|+|+||+|+|++||+. ||... .|.. .+....+.+.++.- ..+..+.+..-.+++.+|++
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts--MERa----~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~ 856 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTS--MERA----SILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLS 856 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCch--HHHH----HHHHhcccCCCCCC------cccccccchHHHHHHHHHhc
Confidence 59999999999999999984 45432 1111 22333445555443 22334445556788899999
Q ss_pred CCCCCCCCHHHHhC
Q 044561 601 PKPEARPNMRQVMQ 614 (614)
Q Consensus 601 ~dP~~RPs~~evl~ 614 (614)
+||.+|||+.|+|+
T Consensus 857 hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 857 HDPSKRPTATELLN 870 (1351)
T ss_pred CCCccCCCHHHHhh
Confidence 99999999999984
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=295.93 Aligned_cols=259 Identities=20% Similarity=0.300 Sum_probs=192.6
Q ss_pred cceeeeeCcEEEEEEEEecCcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecCCCC
Q 044561 350 KDVIGRGGFGKVYRGVLASNVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGS 427 (614)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 427 (614)
.+.+|.|+++.||++.. ++..+|+|++... .....+.+.+|+.+++.++|+||+++++++...+..+++|||+++|+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34455566666666655 5888999998765 44566789999999999999999999999999999999999999999
Q ss_pred cchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCC------
Q 044561 428 LDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI------ 501 (614)
Q Consensus 428 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~------ 501 (614)
|.+++.......+++.....++.|+++||.|||+ .+|+||||||+||+++.++.+||+|||.+........
T Consensus 86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 9999986544568999999999999999999994 8999999999999999999999999998865432111
Q ss_pred CcccccccCCCccchhhhcC--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhh----hcC------
Q 044561 502 PQTTKLVGTFGYMDPELMRT--GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCW----KKG------ 569 (614)
Q Consensus 502 ~~~~~~~gt~~y~aPE~~~~--~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~----~~~------ 569 (614)
.......++..|+|||++.. ..++.++|||||||++|||++|+.||........ ..+...... ...
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYPLYE 240 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchhhhc
Confidence 11123457788999999865 3578999999999999999999999975432211 111111000 000
Q ss_pred -Cccc----cccccc----cCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 570 -AIRD----ASDSRL----EGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 570 -~~~~----~~d~~l----~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.... ..++.. ...........+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 0000 000000 01112223356788999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=302.37 Aligned_cols=263 Identities=24% Similarity=0.305 Sum_probs=201.4
Q ss_pred CCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC--hhhHHHHHHHHHHhcccCCCceeEEeeEEeecC-----eEE
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS--KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKG-----EFL 417 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~ 417 (614)
+|+..+.||+|++|.||+|+... +..+++|++.... ....+.+.+|+.+++.++|+||+++.+++...+ .++
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 46778899999999999999865 8889999987643 344577899999999999999999999988775 789
Q ss_pred EEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccC
Q 044561 418 LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYD 497 (614)
Q Consensus 418 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~ 497 (614)
++|||++ ++|.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++....
T Consensus 81 lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999997 58888887643 69999999999999999999995 899999999999999999999999999998765
Q ss_pred CCCC--CcccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCC----
Q 044561 498 HDTI--PQTTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGA---- 570 (614)
Q Consensus 498 ~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~---- 570 (614)
.... .......++..|+|||.+.+. .++.++|+||||+++++|++|+.||......+....+...........
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 5431 123334678899999999877 789999999999999999999999976654332222111100000000
Q ss_pred ----cccccc---ccc---cCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 571 ----IRDASD---SRL---EGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 571 ----~~~~~d---~~l---~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+... ..- ...........+.+++.+||+.+|++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 000000 000 00001112345788899999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=292.05 Aligned_cols=251 Identities=24% Similarity=0.369 Sum_probs=192.8
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC-hhhHHHHHHHHHHhcccC-CCceeEEeeEEeecCeEEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS-KQGIKEFVAELVSMGRLR-HRNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 421 (614)
++|+..+.||+|+||.||+|..+. +..+|+|.+.... .....++..|+.++.+.. |+||++++++|......+++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 457788999999999999999876 8889999987543 334456777887776664 9999999999999999999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCC
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI 501 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~ 501 (614)
|++ ++|.+++... ...+++.++..++.|++.||.|||+ ..+|+||||+|+||++++++.+||+|||++........
T Consensus 95 ~~~-~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 95 LMS-TCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred ccC-cCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 985 5777766543 2368999999999999999999996 35899999999999999999999999999976543321
Q ss_pred CcccccccCCCccchhhhcCCC----CCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccc
Q 044561 502 PQTTKLVGTFGYMDPELMRTGK----ASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDS 577 (614)
Q Consensus 502 ~~~~~~~gt~~y~aPE~~~~~~----~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~ 577 (614)
.....++..|+|||.+.... ++.++||||||+++|||++|+.||...... ..... .... +........
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~---~~~~-~~~~~~~~~ 242 (296)
T cd06618 171 --KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVLT---KILQ-EEPPSLPPN 242 (296)
T ss_pred --ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHHH---HHhc-CCCCCCCCC
Confidence 12335788999999987543 788999999999999999999999643221 11111 1111 111111000
Q ss_pred cccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 578 RLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 578 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
. ...+.+.+++.+||+.||++||++.++++
T Consensus 243 ---~----~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 272 (296)
T cd06618 243 ---E----GFSPDFCSFVDLCLTKDHRKRPKYRELLQ 272 (296)
T ss_pred ---C----CCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 12345788888999999999999999974
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=285.33 Aligned_cols=249 Identities=24% Similarity=0.402 Sum_probs=196.0
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC-----ChhhHHHHHHHHHHhcccCCCceeEEeeEEeec--CeE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD-----SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRK--GEF 416 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 416 (614)
.+|+..+.||+|+||.||+|.... +..+++|.+... ..+..+.+.+|+.++++++|+||+++++++.+. +.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 468889999999999999999765 888999987532 233456788999999999999999999998654 568
Q ss_pred EEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecccccc
Q 044561 417 LLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 496 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~ 496 (614)
++++||+++++|.+++... ..+++.....++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 9999999999999998753 348899999999999999999994 89999999999999999999999999999865
Q ss_pred CCCCC--CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccc
Q 044561 497 DHDTI--PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDA 574 (614)
Q Consensus 497 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~ 574 (614)
..... .......++..|+|||++.+..++.++|+|||||+++||++|+.||......+. +.+....+
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~----- 225 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA------IFKIATQP----- 225 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH------HHHHHcCC-----
Confidence 43211 112234688999999999888889999999999999999999999965422211 11111110
Q ss_pred ccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 575 SDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 575 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+ ..+....+.+..++.+|++ +|.+||+..++++
T Consensus 226 ~~~----~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 226 TKP----MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCC----CCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 011 1222333557777788999 5799999998864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=282.55 Aligned_cols=259 Identities=22% Similarity=0.367 Sum_probs=204.5
Q ss_pred CHHHHHHHhcCCCCcceeeeeCcEEEEEEEE-ecCcEEEEEEeecCChhhHHHHHHHHHHhcccC-CCceeEEeeEEeec
Q 044561 336 TYKDLYKATKGFKDKDVIGRGGFGKVYRGVL-ASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLR-HRNLVKLRGYCRRK 413 (614)
Q Consensus 336 ~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~ 413 (614)
+++|+++.|. +.||+|+|+.|-.++. ..+.++|||++.+.......+..+|++++.+.+ |+||++|+.|++++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 5778888775 6799999999999884 568999999999888888889999999999985 99999999999999
Q ss_pred CeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCC---EEEeee
Q 044561 414 GEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLN---GKLGDF 490 (614)
Q Consensus 414 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~---~kl~Df 490 (614)
..+|||||.|.+|+|..++++. ..+++.++.++.++|+.||.+|| +++|.|||+||+|||..+-.+ +|||||
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred ceEEEEEecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeecc
Confidence 9999999999999999999874 45999999999999999999999 599999999999999976544 799999
Q ss_pred ccccccCC--C----CCCcccccccCCCccchhhhc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccc---
Q 044561 491 GLARLYDH--D----TIPQTTKLVGTFGYMDPELMR-----TGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETV--- 556 (614)
Q Consensus 491 Gla~~~~~--~----~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~--- 556 (614)
.|...... + ..+...+.+|+..|||||+.. .-.|..++|.|||||++|-|++|.+||.+....+-.
T Consensus 224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr 303 (463)
T KOG0607|consen 224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR 303 (463)
T ss_pred ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC
Confidence 98764321 1 123345578999999999863 235789999999999999999999999876542211
Q ss_pred ----c-HHHHHHHhhhcCCccccccccccCcCcHHH----HHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 557 ----N-LVDWVCDCWKKGAIRDASDSRLEGICEEKQ----MELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 557 ----~-l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~----~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
. -.....+.+.+|.. ++++++ .....+|+...+-.|+.+|.++.++++
T Consensus 304 Ge~Cr~CQ~~LFesIQEGkY----------eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 304 GEVCRVCQNKLFESIQEGKY----------EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCccHHHHHHHHHHHhccCC----------cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 0 00111122222221 122222 234556666678899999999988864
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=301.28 Aligned_cols=259 Identities=23% Similarity=0.325 Sum_probs=191.3
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeec------C
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRK------G 414 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~ 414 (614)
..+|...+.||+|+||.||+|+.. ++..+|+|++... .......+.+|+.+++.++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 367888999999999999999975 4889999998653 222345678999999999999999999998654 3
Q ss_pred eEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecccc
Q 044561 415 EFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR 494 (614)
Q Consensus 415 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~ 494 (614)
..++|+||+. .+|..++. ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++
T Consensus 94 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred eEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 5699999996 46666542 248899999999999999999994 899999999999999999999999999987
Q ss_pred ccCCCCCCcccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHH--------HHh
Q 044561 495 LYDHDTIPQTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWV--------CDC 565 (614)
Q Consensus 495 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v--------~~~ 565 (614)
..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+... .+.
T Consensus 166 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07879 166 HADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK 241 (342)
T ss_pred CCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 65332 223467889999999876 46889999999999999999999999764432211111100 000
Q ss_pred hhcCCcccccc--cccc-CcC---cHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 566 WKKGAIRDASD--SRLE-GIC---EEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 566 ~~~~~~~~~~d--~~l~-~~~---~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
........... +... ... .......+.+++.+||+.||++||++.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296 (342)
T ss_pred hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00000000000 0000 000 0012235678899999999999999999974
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=299.91 Aligned_cols=268 Identities=23% Similarity=0.326 Sum_probs=200.3
Q ss_pred cCHHHHHHHhcCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEe
Q 044561 335 FTYKDLYKATKGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCR 411 (614)
Q Consensus 335 ~~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~ 411 (614)
...+++...+++|...+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.++++++||||+++.+++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 345667778899999999999999999999875 4888999998754 2333567889999999999999999999875
Q ss_pred ec------CeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCE
Q 044561 412 RK------GEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG 485 (614)
Q Consensus 412 ~~------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~ 485 (614)
.. ...+++++++ +++|.+++... .+++..+..++.|+++||.|||+ .+|+||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCE
Confidence 43 3478888887 78998887643 48999999999999999999994 899999999999999999999
Q ss_pred EEeeeccccccCCCCCCcccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHH---
Q 044561 486 KLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDW--- 561 (614)
Q Consensus 486 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~--- 561 (614)
||+|||++...... .....++..|+|||.+.+ ..++.++|||||||+++||++|+.||......+....+..
T Consensus 160 kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (345)
T cd07877 160 KILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 235 (345)
T ss_pred EEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 99999998765432 233467889999998866 4678899999999999999999999975443222111100
Q ss_pred -----HHHhhhcCC-------ccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 562 -----VCDCWKKGA-------IRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 562 -----v~~~~~~~~-------~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
......... +......... .........+.+++.+|+++||++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 236 TPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred CCCHHHHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 000000000 0000000000 000011234678888999999999999999874
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=292.92 Aligned_cols=243 Identities=29% Similarity=0.449 Sum_probs=192.6
Q ss_pred CCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC---ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 347 FKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 347 f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
|+..+.||+|+||.||+|+... +..+++|.+... .....+++.+|+++++.++|+|++++.+++......++||||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 5556789999999999999864 778999988642 334456788999999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 502 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 502 (614)
+. |+|.+++... ...+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 97 ~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 97 CL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred cC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 96 6787776543 2348999999999999999999994 89999999999999999999999999998765432
Q ss_pred cccccccCCCccchhhhc---CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccc
Q 044561 503 QTTKLVGTFGYMDPELMR---TGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRL 579 (614)
Q Consensus 503 ~~~~~~gt~~y~aPE~~~---~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 579 (614)
....++..|+|||.+. .+.++.++|||||||++|||++|+.|+......+... ....+.... .
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-------~~~~~~~~~-----~ 234 (308)
T cd06634 169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-------HIAQNESPA-----L 234 (308)
T ss_pred --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH-------HHhhcCCCC-----c
Confidence 2346788999999874 3567889999999999999999999986543221111 111111111 1
Q ss_pred cCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 580 EGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 580 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
........+..++.+||+.+|++||++.++++
T Consensus 235 ---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~ 266 (308)
T cd06634 235 ---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (308)
T ss_pred ---CcccccHHHHHHHHHHhhCCcccCCCHHHHhh
Confidence 11123345778888999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=290.59 Aligned_cols=248 Identities=25% Similarity=0.370 Sum_probs=201.3
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecC---ChhhHHHHHHHHHHhcccC-CCceeEEeeEEeecCeEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHD---SKQGIKEFVAELVSMGRLR-HRNLVKLRGYCRRKGEFLLV 419 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV 419 (614)
++|...+.||+|+||.||++... ++..+++|.+... .....+.+.+|+.++++++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36788899999999999999987 4888999988653 2334567889999999998 99999999999999999999
Q ss_pred EEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCC
Q 044561 420 YDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD 499 (614)
Q Consensus 420 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~ 499 (614)
|||+++++|.+++.... .+++.++..++.|++.||.|||+ .+++|+||+|+||+++.+++++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 81 LEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 99999999999997643 59999999999999999999994 89999999999999999999999999998865433
Q ss_pred CC-------------------CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHH
Q 044561 500 TI-------------------PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVD 560 (614)
Q Consensus 500 ~~-------------------~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~ 560 (614)
.. .......++..|+|||......++.++|+||||++++|+++|+.||........ ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~ 232 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT---FQ 232 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH---HH
Confidence 21 122234678899999999888899999999999999999999999976542111 11
Q ss_pred HHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCH----HHHhC
Q 044561 561 WVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNM----RQVMQ 614 (614)
Q Consensus 561 ~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~----~evl~ 614 (614)
... .. .. ..+....+.+.+++.+|++.+|++||++ .|+++
T Consensus 233 ~~~----~~------~~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 233 KIL----KL------EY----SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHH----hc------CC----CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 111 00 00 1111224457788889999999999999 88874
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=318.48 Aligned_cols=252 Identities=26% Similarity=0.437 Sum_probs=202.5
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec--------CcEEEEEEeecC-ChhhHHHHHHHHHHhccc-CCCceeEEeeEEeecC
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS--------NVQIAVKKVSHD-SKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKG 414 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 414 (614)
++....+.||+|.||.|++|.... ...||||.++.. .....+.+..|+++|+.+ +|+|++.++|+|..++
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 444556699999999999998642 356899998755 335667899999999998 5999999999999999
Q ss_pred eEEEEEEecCCCCcchhcccCC------------C--CCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEc
Q 044561 415 EFLLVYDYMPNGSLDKILHTNI------------K--PCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD 480 (614)
Q Consensus 415 ~~~lV~E~~~~gsL~~~l~~~~------------~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~ 480 (614)
..++|.||+++|+|.++|+.+. . ..++..+.+.++.|||.||+||++ .++|||||.++|||+.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLIT 452 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEec
Confidence 9999999999999999998654 0 238899999999999999999995 8899999999999999
Q ss_pred CCCCEEEeeeccccccCCCCCCcccccc--cCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcccccc
Q 044561 481 ADLNGKLGDFGLARLYDHDTIPQTTKLV--GTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVN 557 (614)
Q Consensus 481 ~~~~~kl~DfGla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~ 557 (614)
++..+||+|||+++...+........-. -+..|||||.+....++.++||||||++||||++ |..||.+....+
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~--- 529 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE--- 529 (609)
T ss_pred CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH---
Confidence 9999999999999976554433322222 3456999999999999999999999999999999 889997632111
Q ss_pred HHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 558 LVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 558 l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+.+..++|.-.+ .+..+...+..+|..||+.+|++||++.|+.+
T Consensus 530 ---~l~~~l~~G~r~~---------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 530 ---ELLEFLKEGNRME---------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred ---HHHHHHhcCCCCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 1123334443322 23334556778899999999999999999863
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=296.54 Aligned_cols=259 Identities=23% Similarity=0.307 Sum_probs=194.7
Q ss_pred CCC-CcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCChhh--------------HHHHHHHHHHhcccCCCceeEEeeE
Q 044561 346 GFK-DKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSKQG--------------IKEFVAELVSMGRLRHRNLVKLRGY 409 (614)
Q Consensus 346 ~f~-~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~Ei~~l~~l~H~niv~l~g~ 409 (614)
+|. ..+.||+|+||.||+|..+ .++.||+|++....... ...+.+|+++++.++|+||++++++
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 443 3567999999999999976 48899999986542211 1247789999999999999999999
Q ss_pred EeecCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEee
Q 044561 410 CRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGD 489 (614)
Q Consensus 410 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~D 489 (614)
+..++..++||||++ |+|.+++... ..+++.....++.|++.||.||| +.+++||||+|+||+++.++.+||+|
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~d 162 (335)
T PTZ00024 89 YVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIAD 162 (335)
T ss_pred EecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECC
Confidence 999999999999996 6898888653 34899999999999999999999 48999999999999999999999999
Q ss_pred eccccccCCCC-------------CCcccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcccc
Q 044561 490 FGLARLYDHDT-------------IPQTTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSMET 555 (614)
Q Consensus 490 fGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~ 555 (614)
||++....... ........++..|+|||.+.+. .++.++|+|||||++|||++|+.||...+..+.
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~ 242 (335)
T PTZ00024 163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ 242 (335)
T ss_pred ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99997654111 0111223568899999998764 468999999999999999999999976554332
Q ss_pred ccHHHHHHHhhhcCC---ccccc------------cccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 556 VNLVDWVCDCWKKGA---IRDAS------------DSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 556 ~~l~~~v~~~~~~~~---~~~~~------------d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
. ..+........ +.... ....... .......+.+++.+|++.+|++|||+.|+++
T Consensus 243 ~---~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 243 L---GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTI-FPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred H---HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHh-CcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 2 22222111110 11000 0001000 0112345778889999999999999999974
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=299.05 Aligned_cols=246 Identities=24% Similarity=0.327 Sum_probs=203.3
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC--hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS--KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 421 (614)
..|.+...||+|.|++|..++... +.+||+|.+.+.. ......+.+|+++|+.++|||||+++.+...+..+|+|||
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e 135 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME 135 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence 467888999999999999999865 8999999987653 3334558899999999999999999999999999999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCC
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI 501 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~ 501 (614)
|+.+|.+.+++.++.+ +.......++.|+.++++||| .+.|||||||++||||+.++++||+|||++..+..+.
T Consensus 136 ya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~- 209 (596)
T KOG0586|consen 136 YASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL- 209 (596)
T ss_pred eccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeecccc-
Confidence 9999999999988654 666888899999999999999 4899999999999999999999999999999887554
Q ss_pred CcccccccCCCccchhhhcCCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 502 PQTTKLVGTFGYMDPELMRTGKA-STSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 502 ~~~~~~~gt~~y~aPE~~~~~~~-t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
.....+|++.|.|||++.+.++ .+++|+||+|+++|-|++|..||++..-.+...- ++-.+++
T Consensus 210 -~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~r---------------vl~gk~r 273 (596)
T KOG0586|consen 210 -MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPR---------------VLRGKYR 273 (596)
T ss_pred -cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccch---------------heeeeec
Confidence 4456799999999999988766 7899999999999999999999987553322110 1111111
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+.-......+++++++-.+|.+|+++.++++
T Consensus 274 --Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 274 --IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred --ccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 11112233455666789999999999999874
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=283.13 Aligned_cols=240 Identities=25% Similarity=0.292 Sum_probs=186.6
Q ss_pred ceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHH-hcccCCCceeEEeeEEeecCeEEEEEEecCC
Q 044561 351 DVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVS-MGRLRHRNLVKLRGYCRRKGEFLLVYDYMPN 425 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~-l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 425 (614)
+.||+|+||.||+|.... ++.+|+|.+.... ......+..|..+ ....+|+|++++++++..++.+++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 468999999999999864 7889999986543 2223344555444 4456899999999999999999999999999
Q ss_pred CCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCccc
Q 044561 426 GSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT 505 (614)
Q Consensus 426 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 505 (614)
++|.+++... ..+++.++..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||++..... ..
T Consensus 82 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~ 151 (260)
T cd05611 82 GDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NK 151 (260)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc-----cc
Confidence 9999999764 348899999999999999999995 8999999999999999999999999999875433 22
Q ss_pred ccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcH
Q 044561 506 KLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEE 585 (614)
Q Consensus 506 ~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~ 585 (614)
...++..|+|||.+.+..++.++||||||+++|||++|..||......+.. .....+... ..... ..
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~--~~~~~----~~ 218 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVF-------DNILSRRIN--WPEEV----KE 218 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHH-------HHHHhcccC--CCCcc----cc
Confidence 346788999999998888899999999999999999999999754432211 111111110 00111 11
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCH---HHHh
Q 044561 586 KQMELVLKLGLFCSHPKPEARPNM---RQVM 613 (614)
Q Consensus 586 ~~~~~l~~l~~~cl~~dP~~RPs~---~evl 613 (614)
.....+.+++.+|++.||++||++ .|++
T Consensus 219 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 219 FCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred cCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 223557888889999999999966 5654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=287.92 Aligned_cols=250 Identities=22% Similarity=0.333 Sum_probs=195.0
Q ss_pred CCCCcceeeeeCcEEEEEEEEe----cCcEEEEEEeecCC----hhhHHHHHHHHHHhccc-CCCceeEEeeEEeecCeE
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLA----SNVQIAVKKVSHDS----KQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGEF 416 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 416 (614)
+|+..+.||+|+||.||++... ++..+|+|++.... ....+.+.+|+.+++++ +|+||+++++.+..++..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 3677889999999999999863 57889999987532 22346678899999999 599999999999999999
Q ss_pred EEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecccccc
Q 044561 417 LLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 496 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~ 496 (614)
++||||+++++|.+++... ..+++..+..++.|++.||.||| +.+++||||+|+|||++.++.+||+|||++...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 81 HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 9999999999999998764 34889999999999999999999 489999999999999999999999999999876
Q ss_pred CCCCCCcccccccCCCccchhhhcCC--CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccc
Q 044561 497 DHDTIPQTTKLVGTFGYMDPELMRTG--KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDA 574 (614)
Q Consensus 497 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~ 574 (614)
............|+..|+|||.+... .++.++||||||+++|||++|+.||........ ...........
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~------ 227 (290)
T cd05613 156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRILKS------ 227 (290)
T ss_pred ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHhhcc------
Confidence 54433333345689999999998653 467899999999999999999999964322111 11111111110
Q ss_pred ccccccCcCcHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHh
Q 044561 575 SDSRLEGICEEKQMELVLKLGLFCSHPKPEARP-----NMRQVM 613 (614)
Q Consensus 575 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl 613 (614)
.+. .+......+..++.+|++.||++|| ++.+++
T Consensus 228 -~~~----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~ 266 (290)
T cd05613 228 -EPP----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIK 266 (290)
T ss_pred -CCC----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHH
Confidence 011 1112234567888889999999997 667665
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=289.34 Aligned_cols=243 Identities=27% Similarity=0.441 Sum_probs=191.3
Q ss_pred CCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC---ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 347 FKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 347 f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
|...+.||+|+||.||+|+... +..+++|++... .....+.+.+|+.++++++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 4455779999999999999764 788999998653 233446788999999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 502 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 502 (614)
++ |+|.+++... ...+++.++..++.|++.+|.|||+ .+++||||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 103 CL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred CC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 95 5777776543 2458999999999999999999995 8999999999999999999999999999864322
Q ss_pred cccccccCCCccchhhhc---CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccc
Q 044561 503 QTTKLVGTFGYMDPELMR---TGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRL 579 (614)
Q Consensus 503 ~~~~~~gt~~y~aPE~~~---~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 579 (614)
.....|+..|+|||++. .+.++.++||||||+++|||++|+.|+......... ... . ........
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~---~~~---~-~~~~~~~~---- 241 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---YHI---A-QNDSPTLQ---- 241 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH---HHH---H-hcCCCCCC----
Confidence 23356889999999974 456888999999999999999999998764322211 111 1 11111111
Q ss_pred cCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 580 EGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 580 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.......+..++.+||+.+|++||++.++++
T Consensus 242 ----~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 242 ----SNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred ----ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111234677888999999999999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=306.00 Aligned_cols=256 Identities=29% Similarity=0.388 Sum_probs=196.5
Q ss_pred CCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeecC------eEEE
Q 044561 347 FKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKG------EFLL 418 (614)
Q Consensus 347 f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------~~~l 418 (614)
+...+.||+|+||.||+|+.+. |+.||||.+.... ....+...+|++++++++|+|||++.+.=++.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 4456789999999999999765 9999999987643 333456678999999999999999999765443 5789
Q ss_pred EEEecCCCCcchhcccCC-CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEc--CCC--CEEEeeeccc
Q 044561 419 VYDYMPNGSLDKILHTNI-KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD--ADL--NGKLGDFGLA 493 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~--~~~--~~kl~DfGla 493 (614)
|||||.+|||...|.... ...|++.+.+.++.+++.||.||| +.+|+||||||.||++- ++| .-||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 999999999999998754 346999999999999999999999 58999999999999993 334 3699999999
Q ss_pred cccCCCCCCcccccccCCCccchhhhc-CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcc
Q 044561 494 RLYDHDTIPQTTKLVGTFGYMDPELMR-TGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIR 572 (614)
Q Consensus 494 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~ 572 (614)
+..+.+. ..+..+||..|++||++. .+.|+..+|.|||||++||.+||..||.....+.....+.|....-......
T Consensus 172 rel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~ 249 (732)
T KOG4250|consen 172 RELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA 249 (732)
T ss_pred ccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence 9887765 567789999999999998 4889999999999999999999999998665544333333433222221111
Q ss_pred cccccccc------------CcCcHHHHHHHHHHHHHcCCCCCCCCC
Q 044561 573 DASDSRLE------------GICEEKQMELVLKLGLFCSHPKPEARP 607 (614)
Q Consensus 573 ~~~d~~l~------------~~~~~~~~~~l~~l~~~cl~~dP~~RP 607 (614)
-..+++.. -........++-+....++..+|++|-
T Consensus 250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 11111111 112334445566666667777777776
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=293.23 Aligned_cols=266 Identities=25% Similarity=0.329 Sum_probs=195.1
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCCh--hhHHHHHHHHHHhcccCCCceeEEeeEEeec-------
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSK--QGIKEFVAELVSMGRLRHRNLVKLRGYCRRK------- 413 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------- 413 (614)
.++|+..+.||+|+||.||+|..+. +..+++|++..... .....+.+|+++++.++||||+++++.+...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 4678899999999999999999864 78899998865432 2234567899999999999999999987443
Q ss_pred -CeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecc
Q 044561 414 -GEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGL 492 (614)
Q Consensus 414 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGl 492 (614)
..+++|+||+.+ +|...+... ...+++.++..++.|+++||.|||+ .+++||||||+||++++++.+||+|||+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCcc
Confidence 357999999964 676666543 3459999999999999999999995 8999999999999999999999999999
Q ss_pred ccccCCCCC----------CcccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHH
Q 044561 493 ARLYDHDTI----------PQTTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDW 561 (614)
Q Consensus 493 a~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~ 561 (614)
+........ ...+...+++.|+|||.+.+. .++.++||||||++++||++|+.||......+....+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 986543221 111234678889999987654 578999999999999999999999976554332222211
Q ss_pred HHHhhhcCC------ccccccccccCcCc-------HHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 562 VCDCWKKGA------IRDASDSRLEGICE-------EKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 562 v~~~~~~~~------~~~~~d~~l~~~~~-------~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+....... +....+.......+ ....+.+.+++.+|++.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 111100000 00100000000000 112246788999999999999999999974
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=297.55 Aligned_cols=250 Identities=25% Similarity=0.380 Sum_probs=199.1
Q ss_pred cCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeec--CChhhHHHHHHHHHHhcccC-CCceeEEeeEEeecCeEEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSH--DSKQGIKEFVAELVSMGRLR-HRNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 421 (614)
+.|++.++||+||.+.||++...+.+.+|+|++.. .+.+...-|.+|+..|.+|+ |.+|++|++|-..++.+|+|||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 45788899999999999999988888899988754 35667788999999999995 9999999999999999999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCC
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI 501 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~ 501 (614)
|= ..+|..+|++.......| .+..+..|++.++.++| +.+|||.||||.|.|+- .|.+||+|||.|..+..+..
T Consensus 441 ~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 441 CG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred cc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEE-eeeEEeeeechhcccCcccc
Confidence 85 678999998866554455 77789999999999999 58999999999999984 57899999999998776542
Q ss_pred -CcccccccCCCccchhhhcCC-----------CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcC
Q 044561 502 -PQTTKLVGTFGYMDPELMRTG-----------KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKG 569 (614)
Q Consensus 502 -~~~~~~~gt~~y~aPE~~~~~-----------~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~ 569 (614)
......+||+-||+||.+... +.+.++||||+||+||+|+.|+.||..-. +...
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n~~a--------- 580 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----NQIA--------- 580 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----HHHH---------
Confidence 233456999999999988532 35689999999999999999999996421 1111
Q ss_pred CccccccccccCcCcHHH-HHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 570 AIRDASDSRLEGICEEKQ-MELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 570 ~~~~~~d~~l~~~~~~~~-~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
++..+.|+.-.-+++.-- -..+..++..||..||.+||+..|+|+
T Consensus 581 Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 581 KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 123344443221111110 111788888999999999999999985
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=289.52 Aligned_cols=245 Identities=20% Similarity=0.341 Sum_probs=208.1
Q ss_pred CCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCC--hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDS--KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
-|...+.||+|.|..|-.++.- .|..||||.+.+.. .-....+.+|+.-|+-++|||||+|+.+......+|||.|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 3666788999999999888864 58999999997653 33445788999999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEE-cCCCCEEEeeeccccccCCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL-DADLNGKLGDFGLARLYDHDTI 501 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll-~~~~~~kl~DfGla~~~~~~~~ 501 (614)
-.+|+|.+++.+.. ..+.+....+++.||+.|+.|+| +..+|||||||+||.+ ..-|-+||.|||++..+..+.
T Consensus 99 GD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~- 173 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK- 173 (864)
T ss_pred cCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc-
Confidence 99999999997764 44999999999999999999999 6899999999999877 567889999999998877665
Q ss_pred CcccccccCCCccchhhhcCCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 502 PQTTKLVGTFGYMDPELMRTGKA-STSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 502 ~~~~~~~gt~~y~aPE~~~~~~~-t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
..++.+|+..|-|||++.+..| -++.|||||||+||-|+||+.||+..+..|.+.. ++|.+..
T Consensus 174 -kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTm---------------ImDCKYt 237 (864)
T KOG4717|consen 174 -KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTM---------------IMDCKYT 237 (864)
T ss_pred -hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhh---------------hhccccc
Confidence 5566799999999999998877 4689999999999999999999988776665432 3444332
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHh
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARPNMRQVM 613 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 613 (614)
.+.........|+..|+..||++|-+..||.
T Consensus 238 --vPshvS~eCrdLI~sMLvRdPkkRAslEeI~ 268 (864)
T KOG4717|consen 238 --VPSHVSKECRDLIQSMLVRDPKKRASLEEIV 268 (864)
T ss_pred --CchhhhHHHHHHHHHHHhcCchhhccHHHHh
Confidence 3445556677888889999999999999985
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=288.14 Aligned_cols=253 Identities=21% Similarity=0.274 Sum_probs=180.2
Q ss_pred cCCCCcceeeeeCcEEEEEEEEecC----cEEEEEEeecCChhh-----------HHHHHHHHHHhcccCCCceeEEeeE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLASN----VQIAVKKVSHDSKQG-----------IKEFVAELVSMGRLRHRNLVKLRGY 409 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~~----~~vavK~~~~~~~~~-----------~~~~~~Ei~~l~~l~H~niv~l~g~ 409 (614)
++|+..++||+|+||.||+|...++ ..+++|......... ......+...+..++|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5788999999999999999997654 345555433222111 0112334455677899999999997
Q ss_pred EeecC----eEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCE
Q 044561 410 CRRKG----EFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG 485 (614)
Q Consensus 410 ~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~ 485 (614)
+.... ..++++|++. .++.+.+... ...++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCcE
Confidence 65543 3467788763 3565555432 235788899999999999999994 899999999999999999999
Q ss_pred EEeeeccccccCCCCC------CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHH
Q 044561 486 KLGDFGLARLYDHDTI------PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLV 559 (614)
Q Consensus 486 kl~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~ 559 (614)
||+|||+++....... .......||+.|+|||++.+..++.++|||||||+++||++|+.||............
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~ 245 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence 9999999986542211 1122346999999999999999999999999999999999999999865332211111
Q ss_pred -H-HHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 560 -D-WVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 560 -~-~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
. ...+...++.. .. ..+ ...+.+++..|+..+|++||++.++++
T Consensus 246 ~~~~~~~~~~~~~~------~~-~~~----~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 246 AKCDFIKRLHEGKI------KI-KNA----NKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred hHHHHHHHhhhhhh------cc-CCC----CHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 0 01111111111 00 111 345777888899999999999999874
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=284.57 Aligned_cols=241 Identities=24% Similarity=0.317 Sum_probs=185.9
Q ss_pred eeeeeCcEEEEEEEEec-CcEEEEEEeecCCh---hhHHHHHHHH---HHhcccCCCceeEEeeEEeecCeEEEEEEecC
Q 044561 352 VIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSK---QGIKEFVAEL---VSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMP 424 (614)
Q Consensus 352 ~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~Ei---~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 424 (614)
.||+|+||.||++.... ++.||+|.+..... .....+..|. ..++...|||++++.+++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999999765 78899999865421 2222233443 34455689999999999999999999999999
Q ss_pred CCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcc
Q 044561 425 NGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT 504 (614)
Q Consensus 425 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 504 (614)
+++|.+++... ..+++.++..++.|++.||.|||+ .+++||||||+||++++++.+||+|||++....... .
T Consensus 81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~ 152 (278)
T cd05606 81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P 152 (278)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---C
Confidence 99999988653 459999999999999999999995 899999999999999999999999999987554322 2
Q ss_pred cccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcC
Q 044561 505 TKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGIC 583 (614)
Q Consensus 505 ~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 583 (614)
....|+..|+|||.+.++ .++.++||||+|++++||++|+.||........... ..... ..+..+....
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~------~~~~~~~~~~ 222 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTL------TMAVELPDSF 222 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH----HHHhh------ccCCCCCCcC
Confidence 234789999999998754 588999999999999999999999976432221111 11100 0111122222
Q ss_pred cHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHhC
Q 044561 584 EEKQMELVLKLGLFCSHPKPEARP-----NMRQVMQ 614 (614)
Q Consensus 584 ~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 614 (614)
...+.+++.+|+..+|++|| ++.++++
T Consensus 223 ----s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 223 ----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred ----CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 34577778889999999999 9999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=295.08 Aligned_cols=265 Identities=22% Similarity=0.306 Sum_probs=198.3
Q ss_pred HHHHHhcCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEee-cC
Q 044561 339 DLYKATKGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRR-KG 414 (614)
Q Consensus 339 el~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~ 414 (614)
++..++++|+..+.||+|+||.||++... ++..+++|++... .....+.+.+|+.++++++|||++++.+++.. .+
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 45567889999999999999999999976 4888999988543 22345677899999999999999999998865 56
Q ss_pred eEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecccc
Q 044561 415 EFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR 494 (614)
Q Consensus 415 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~ 494 (614)
..++++||+ +++|.+++... .+++.....++.|+++||.|||+ .+++||||+|+||++++++.+||+|||++.
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred cEEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 789999999 56888887643 37888889999999999999994 899999999999999999999999999987
Q ss_pred ccCCCCCCcccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHH--------HHHh
Q 044561 495 LYDHDTIPQTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDW--------VCDC 565 (614)
Q Consensus 495 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~--------v~~~ 565 (614)
..... .....++..|+|||.+.+ ..++.++||||||++++||++|+.||.............. +.+.
T Consensus 157 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 157 IQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred ccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 54332 223467889999998766 5689999999999999999999999976543211111000 0000
Q ss_pred hhcCCccccc-cccccCcCcH-----HHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 566 WKKGAIRDAS-DSRLEGICEE-----KQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 566 ~~~~~~~~~~-d~~l~~~~~~-----~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
...+...+.. .-......+. .....+.+++.+|++++|++||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000 0000000011 12356788899999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=298.22 Aligned_cols=263 Identities=24% Similarity=0.321 Sum_probs=193.6
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeec----------
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRK---------- 413 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~---------- 413 (614)
.+|...+.||+|+||.||+|.... +..|++|++........+.+.+|++++++++||||+++++.+...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 578889999999999999999865 788999999776666677889999999999999999999766543
Q ss_pred ----CeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcC-CCCEEEe
Q 044561 414 ----GEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA-DLNGKLG 488 (614)
Q Consensus 414 ----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~-~~~~kl~ 488 (614)
...++||||++ ++|.+++... .+++.++..++.||++||.||| +.+++||||||+||+++. ++.+||+
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEEC
Confidence 35799999997 5888887543 4889999999999999999999 489999999999999974 5678999
Q ss_pred eeccccccCCCCCC--cccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHh
Q 044561 489 DFGLARLYDHDTIP--QTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDC 565 (614)
Q Consensus 489 DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~ 565 (614)
|||+++........ ......++..|+|||.+.. ..++.++|||||||++|||++|+.||......+...........
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99999765432111 1123467889999998754 45788999999999999999999999765432221111000000
Q ss_pred hh---cCCc----ccccc--cccc----CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 566 WK---KGAI----RDASD--SRLE----GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 566 ~~---~~~~----~~~~d--~~l~----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.. .... ..... .... ..........+.+++.+|+++||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00 0000 00000 0000 0000112345778889999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=286.61 Aligned_cols=261 Identities=24% Similarity=0.331 Sum_probs=199.3
Q ss_pred CCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC--hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 347 FKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS--KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 347 f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
|+..+.||+|++|.||+|+... ++.+++|.+.... ....+.+..|+.++++++|+|++++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 4556789999999999999875 8889999987653 334567789999999999999999999999999999999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCc
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 503 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 503 (614)
+ ++|.+++.... ..+++.++..++.|++.||.|||+ .+|+||||+|+||++++++.+||+|||++........ .
T Consensus 81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 154 (282)
T cd07829 81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-T 154 (282)
T ss_pred C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-c
Confidence 7 58999987642 359999999999999999999995 8999999999999999999999999999986654321 2
Q ss_pred ccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHH--------HHHhhh-----cC
Q 044561 504 TTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDW--------VCDCWK-----KG 569 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~--------v~~~~~-----~~ 569 (614)
.....++..|+|||.+.+. .++.++||||||++++||++|+.||......+....+.. .|..+. ..
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 2234567889999998776 789999999999999999999999976543322211110 000000 00
Q ss_pred CccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 570 AIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 570 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.............. ......+.+++.+||..||++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 235 TFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00010000000000 011346888999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=301.18 Aligned_cols=249 Identities=22% Similarity=0.356 Sum_probs=199.8
Q ss_pred CCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecCC
Q 044561 347 FKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPN 425 (614)
Q Consensus 347 f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 425 (614)
+.+...||.|+||+||+++.++ +...|.|.+...+....++|+-||.+|..++||+||+|++.|..++.+++..|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 3445679999999999999886 444577888888888899999999999999999999999999999999999999999
Q ss_pred CCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCccc
Q 044561 426 GSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT 505 (614)
Q Consensus 426 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 505 (614)
|-.+.++-.- ...|++.++.-+++|++.||.|||+ +.|||||||+.|||++-+|.++|+|||.+-...... ....
T Consensus 114 GAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~-qkRD 188 (1187)
T KOG0579|consen 114 GAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR-QKRD 188 (1187)
T ss_pred chHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchhHH-hhhc
Confidence 9999987653 3459999999999999999999995 899999999999999999999999999975433221 2334
Q ss_pred ccccCCCccchhhh-----cCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 506 KLVGTFGYMDPELM-----RTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 506 ~~~gt~~y~aPE~~-----~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
...||+.|||||++ ...+|..++||||||+.|.||..+.+|-...++. . |.-...+..-+-++.
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM------R-VllKiaKSePPTLlq---- 257 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM------R-VLLKIAKSEPPTLLQ---- 257 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH------H-HHHHHhhcCCCcccC----
Confidence 56899999999986 3568999999999999999999999996543321 1 111112211122221
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+..-...+.++...|+..||..||++.|+++
T Consensus 258 ---PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 258 ---PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred ---cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 1222334566677799999999999999985
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=285.59 Aligned_cols=249 Identities=22% Similarity=0.301 Sum_probs=193.2
Q ss_pred CCCCcceeeeeCcEEEEEEEEe----cCcEEEEEEeecCC----hhhHHHHHHHHHHhccc-CCCceeEEeeEEeecCeE
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLA----SNVQIAVKKVSHDS----KQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGEF 416 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 416 (614)
+|+..+.||+|++|.||+++.. ++..+++|.+.... ....+.+.+|+.++.++ +|||++++++.+...+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 3667889999999999999853 36789999886532 22345688999999999 599999999999999999
Q ss_pred EEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecccccc
Q 044561 417 LLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 496 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~ 496 (614)
++||||+++|+|.+++... ..+++..+..++.|++++|.|||+ .+++||||||+||+++.++.++|+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 9999999999999998753 348899999999999999999994 89999999999999999999999999998765
Q ss_pred CCCCCCcccccccCCCccchhhhcCCC--CCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccc
Q 044561 497 DHDTIPQTTKLVGTFGYMDPELMRTGK--ASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDA 574 (614)
Q Consensus 497 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~ 574 (614)
............|+..|+|||.+.+.. .+.++||||||++++||++|+.||........ ... ..+.....
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~-~~~~~~~~----- 227 (288)
T cd05583 156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSE-ISRRILKS----- 227 (288)
T ss_pred ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHH-HHHHHHcc-----
Confidence 443322233356889999999987654 78899999999999999999999964322111 111 11111110
Q ss_pred ccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q 044561 575 SDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQV 612 (614)
Q Consensus 575 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev 612 (614)
.......+ ...+.+++.+|++.||++|||++++
T Consensus 228 -~~~~~~~~----~~~l~~li~~~l~~~p~~R~t~~~~ 260 (288)
T cd05583 228 -KPPFPKTM----SAEARDFIQKLLEKDPKKRLGANGA 260 (288)
T ss_pred -CCCCCccc----CHHHHHHHHHHhcCCHhhccCcchH
Confidence 11111122 2346778888999999999997654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=293.99 Aligned_cols=261 Identities=21% Similarity=0.314 Sum_probs=195.5
Q ss_pred HHhcCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecC----
Q 044561 342 KATKGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKG---- 414 (614)
Q Consensus 342 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~---- 414 (614)
...++|+..+.||+|+||.||++... ++..||+|++... .....+.+.+|+.++++++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 34567889999999999999999976 4888999998543 2334467889999999999999999999886543
Q ss_pred --eEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecc
Q 044561 415 --EFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGL 492 (614)
Q Consensus 415 --~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGl 492 (614)
..++||||+ +++|.+++.. ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg~ 164 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGL 164 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence 469999999 7789888764 34899999999999999999999 48999999999999999999999999999
Q ss_pred ccccCCCCCCcccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHH--------HHH
Q 044561 493 ARLYDHDTIPQTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVD--------WVC 563 (614)
Q Consensus 493 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~--------~v~ 563 (614)
+....... ....++..|+|||.+.+ ..++.++|+||||+++++|++|+.||............. ...
T Consensus 165 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (343)
T cd07880 165 ARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV 240 (343)
T ss_pred ccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 98654322 23467889999999875 458899999999999999999999997544321110000 000
Q ss_pred HhhhcCC-------ccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 564 DCWKKGA-------IRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 564 ~~~~~~~-------~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+.+.... +.......+. .........+..++.+|++.||++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 241 QKLQSEDAKNYVKKLPRFRKKDFR-SLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HhhcchhHHHHHHhccccCcchHH-HhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000 0000000000 001112234778899999999999999999874
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=280.99 Aligned_cols=248 Identities=22% Similarity=0.324 Sum_probs=191.6
Q ss_pred CCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC-----ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEE
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD-----SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLV 419 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 419 (614)
+|...+.||+|+||.||++.... +..+++|.++.. ......++..|+.++++++|||++++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 46778899999999999998764 333444444321 222334567899999999999999999999999999999
Q ss_pred EEecCCCCcchhccc--CCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccC
Q 044561 420 YDYMPNGSLDKILHT--NIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYD 497 (614)
Q Consensus 420 ~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~ 497 (614)
|||+++++|.+++.. .....+++.++..++.|+++||.|||+ .+++|+||||+||+++. +.+||+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998864 223468999999999999999999994 89999999999999975 569999999987654
Q ss_pred CCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccc
Q 044561 498 HDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDS 577 (614)
Q Consensus 498 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~ 577 (614)
.... ......|+..|+|||.+....++.++|+||||+++|+|++|+.||......+ .... ...+...
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~------~~~~-~~~~~~~----- 223 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS------VVLR-IVEGPTP----- 223 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHH-HHcCCCC-----
Confidence 3321 2223467889999999988888999999999999999999999996432211 1111 1111111
Q ss_pred cccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 578 RLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 578 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
. .+......+.+++.+|++.+|++||++.|+++
T Consensus 224 ~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 224 S----LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred C----CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1 12233456778889999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=292.10 Aligned_cols=262 Identities=24% Similarity=0.308 Sum_probs=191.5
Q ss_pred CCCCcceeeeeCcEEEEEEEEec---CcEEEEEEeecC--ChhhHHHHHHHHHHhccc-CCCceeEEeeEEeec----Ce
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS---NVQIAVKKVSHD--SKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRK----GE 415 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~----~~ 415 (614)
+|+..+.||+|+||.||++.... +..+|+|++... .....+.+.+|+.+++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 46778899999999999999763 668999988643 222356778899999999 599999999975432 45
Q ss_pred EEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccc
Q 044561 416 FLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARL 495 (614)
Q Consensus 416 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~ 495 (614)
.++++||+. ++|.+++... ..+++..+..++.||+.||.|||+ .+++||||||+||+++.++.+||+|||++..
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 789999985 6898888653 358999999999999999999994 8999999999999999999999999999986
Q ss_pred cCCCCC---CcccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHH--------
Q 044561 496 YDHDTI---PQTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVC-------- 563 (614)
Q Consensus 496 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~-------- 563 (614)
...... .......|+..|+|||.+.+ ..++.++|+||+|+++++|++|+.||......+....+....
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL 234 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 543221 11233578999999998765 468999999999999999999999997644322111110000
Q ss_pred HhhhcCCc-------cccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 564 DCWKKGAI-------RDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 564 ~~~~~~~~-------~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+..... .......+.. ........+.+++.+|++.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000 0000000000 00112345788899999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=297.68 Aligned_cols=262 Identities=22% Similarity=0.317 Sum_probs=197.1
Q ss_pred HHhcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCe---
Q 044561 342 KATKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGE--- 415 (614)
Q Consensus 342 ~~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~--- 415 (614)
...++|+..+.||+|++|.||+|+... +..+++|++... .....+.+.+|+.++++++|+|++++.+++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 345678889999999999999999865 788999988653 23344667889999999999999999998766554
Q ss_pred ---EEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecc
Q 044561 416 ---FLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGL 492 (614)
Q Consensus 416 ---~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGl 492 (614)
.++|+||+ +++|.+++.. ..+++.++..++.|+++||.|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEccccc
Confidence 89999999 6799888865 348999999999999999999995 8999999999999999999999999999
Q ss_pred ccccCCCCCCcccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHH--------HH
Q 044561 493 ARLYDHDTIPQTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDW--------VC 563 (614)
Q Consensus 493 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~--------v~ 563 (614)
+...... .....++..|+|||.+.+ ..++.++||||||++++||++|+.||......+....+.. .+
T Consensus 165 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 240 (343)
T cd07851 165 ARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL 240 (343)
T ss_pred ccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence 9865432 233467889999999865 3678999999999999999999999976543222111100 00
Q ss_pred HhhhcCCcccccc---ccccCcCc---HHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 564 DCWKKGAIRDASD---SRLEGICE---EKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 564 ~~~~~~~~~~~~d---~~l~~~~~---~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+.......... ......+. ......+.+++.+|+++||++|||+.||++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0000000000000 00000000 012456888999999999999999999974
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=270.44 Aligned_cols=246 Identities=24% Similarity=0.363 Sum_probs=194.3
Q ss_pred CcceeeeeCcEEEEEEEEec-CcEEEEEEeecC-ChhhHHHHHHHHHHhcccC-CCceeEEeeEEeecCeEEEEEEecCC
Q 044561 349 DKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD-SKQGIKEFVAELVSMGRLR-HRNLVKLRGYCRRKGEFLLVYDYMPN 425 (614)
Q Consensus 349 ~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~ 425 (614)
....||+|..|.|+++..+. +...|||.+... +++..++++..+.++...+ +|.||+.+|++......++.||.| .
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s 174 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-S 174 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-H
Confidence 35669999999999999876 788999998765 5666788888888877665 899999999999999999999999 4
Q ss_pred CCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCccc
Q 044561 426 GSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT 505 (614)
Q Consensus 426 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 505 (614)
..++.++... .+++++.-+-++...+.+||.||.+ +.+|+|||+||+|||+|+.|++||||||.+-.+-... ..+
T Consensus 175 ~C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk--Aht 249 (391)
T KOG0983|consen 175 TCAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--AHT 249 (391)
T ss_pred HHHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccc--ccc
Confidence 5667766653 4558888888999999999999998 7999999999999999999999999999997654433 234
Q ss_pred ccccCCCccchhhhcC---CCCCcchhHHHHHHHHHHHHcCCCCCCCCCc-cccccHHHHHHHhhhcCCccccccccccC
Q 044561 506 KLVGTFGYMDPELMRT---GKASTSTDVYAFGVFMLEVASGRRPVEQQGS-METVNLVDWVCDCWKKGAIRDASDSRLEG 581 (614)
Q Consensus 506 ~~~gt~~y~aPE~~~~---~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~-~~~~~l~~~v~~~~~~~~~~~~~d~~l~~ 581 (614)
+.+|.+.|||||.+.- .+|..++||||||+.++||+||+.||..... .+.+ ..+.+ . ..+.+..
T Consensus 250 rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~l---tkvln-----~----ePP~L~~ 317 (391)
T KOG0983|consen 250 RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVL---TKVLN-----E----EPPLLPG 317 (391)
T ss_pred cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHH---HHHHh-----c----CCCCCCc
Confidence 5689999999999853 4788999999999999999999999986432 2222 11111 1 1122221
Q ss_pred cCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 582 ICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 582 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.. .-.....+++..||..|+.+||...++|+
T Consensus 318 ~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 318 HM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred cc--CcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 11 02335666777799999999999999885
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=274.80 Aligned_cols=240 Identities=24% Similarity=0.298 Sum_probs=195.5
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
++|+..++||+|.||+|-.++.+. +..+|+|+++++- +.....-+.|-.+|+..+||.+..+.-.+...+.+|+||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 567888999999999999999875 7889999998763 333344567888999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
||..+|.|.-+|... ..+++.....+-..|..||.|||+ ++||+||||.+|.|+|.+|++||.||||++.--..
T Consensus 248 eyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~- 321 (516)
T KOG0690|consen 248 EYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY- 321 (516)
T ss_pred EEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhcccc-
Confidence 999999999999763 458888888899999999999996 89999999999999999999999999999753222
Q ss_pred CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
...+...|||+.|+|||++....|..+.|.|.+||+||||+|||.||...+......++- .-|-++.
T Consensus 322 g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl-------------~ed~kFP 388 (516)
T KOG0690|consen 322 GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL-------------MEDLKFP 388 (516)
T ss_pred cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH-------------hhhccCC
Confidence 224566899999999999999999999999999999999999999998776654443331 1122222
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCC
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARP 607 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RP 607 (614)
.....+ ...|....+..||.+|.
T Consensus 389 r~ls~e----AktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 389 RTLSPE----AKTLLSGLLKKDPKKRL 411 (516)
T ss_pred ccCCHH----HHHHHHHHhhcChHhhc
Confidence 223332 33444457889999995
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=276.32 Aligned_cols=238 Identities=26% Similarity=0.361 Sum_probs=193.9
Q ss_pred eeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecCCCCc
Q 044561 353 IGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSL 428 (614)
Q Consensus 353 lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 428 (614)
||+|+||.||++...+ +..+++|.+.... ......+..|+.++++++|+|++++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6899999999999875 7889999886543 22456788999999999999999999999999999999999999999
Q ss_pred chhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcccccc
Q 044561 429 DKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLV 508 (614)
Q Consensus 429 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 508 (614)
.+++.... .+++..+..++.|+++||.|||+ .+++|+||+|+||+++.++.++|+|||++....... .......
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~ 154 (250)
T cd05123 81 FSHLSKEG--RFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFC 154 (250)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCc
Confidence 99997643 48999999999999999999994 899999999999999999999999999998765432 1233456
Q ss_pred cCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcHHHH
Q 044561 509 GTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQM 588 (614)
Q Consensus 509 gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~ 588 (614)
++..|++||...+...+.++|+||||+++|||++|+.||......+ ....+ .++. ..+ +....
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~~~~----~~~~------~~~----~~~~~ 217 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE---IYEKI----LKDP------LRF----PEFLS 217 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHH----hcCC------CCC----CCCCC
Confidence 8889999999988888999999999999999999999997544311 11111 1111 111 11113
Q ss_pred HHHHHHHHHcCCCCCCCCCCH---HHHh
Q 044561 589 ELVLKLGLFCSHPKPEARPNM---RQVM 613 (614)
Q Consensus 589 ~~l~~l~~~cl~~dP~~RPs~---~evl 613 (614)
..+.+++.+|+..||++||++ .+++
T Consensus 218 ~~l~~~i~~~l~~~p~~R~~~~~~~~l~ 245 (250)
T cd05123 218 PEARDLISGLLQKDPTKRLGSGGAEEIK 245 (250)
T ss_pred HHHHHHHHHHhcCCHhhCCCcccHHHHH
Confidence 456778888999999999999 7765
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=323.42 Aligned_cols=251 Identities=28% Similarity=0.417 Sum_probs=200.3
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
+-++.....||.|.||.||.|...+ |.-.|+|-+.-. .....+...+|+.++..++|||+|+++|+-.+++..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 4456677899999999999999766 777888877543 3445567789999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
|||++|+|.+.+.... ..++.....+..|++.|+.||| +.+||||||||.||+|+.+|.+|++|||.|..+....
T Consensus 1314 EyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred HHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCch
Confidence 9999999999997642 2566666678899999999999 5999999999999999999999999999998776543
Q ss_pred ---CCcccccccCCCccchhhhcCC---CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccc
Q 044561 501 ---IPQTTKLVGTFGYMDPELMRTG---KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDA 574 (614)
Q Consensus 501 ---~~~~~~~~gt~~y~aPE~~~~~---~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~ 574 (614)
........||+-|||||++.+. ...-+.||||+|||++||+||++||...+..-. +...| ..|..+.
T Consensus 1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a--IMy~V----~~gh~Pq- 1461 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA--IMYHV----AAGHKPQ- 1461 (1509)
T ss_pred hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH--HHhHH----hccCCCC-
Confidence 1223456899999999998653 356789999999999999999999986654321 11111 1222222
Q ss_pred ccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 575 SDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 575 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+++.....-.+++..|+..||++|.++.|+++
T Consensus 1462 --------~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1462 --------IPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred --------CchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 23334455667788899999999999988874
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=273.86 Aligned_cols=250 Identities=25% Similarity=0.332 Sum_probs=193.6
Q ss_pred cceeeeeCcEEEEEEEEec-CcEEEEEEeecCCh-hhHHHHHHHHHHhccc-CCCceeEEeeEEeecCeEEEEEEecCCC
Q 044561 350 KDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSK-QGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGEFLLVYDYMPNG 426 (614)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~g 426 (614)
...||.|+||+|+|-..+. |+..|||+++.... ...++++.|.+...+- ++||||+++|.+-.++..++.||.| ..
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~ 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DI 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hh
Confidence 4569999999999998875 89999999986643 5567888888766554 7999999999999999999999999 56
Q ss_pred Ccchhcc---cCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCc
Q 044561 427 SLDKILH---TNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 503 (614)
Q Consensus 427 sL~~~l~---~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 503 (614)
||+.+.+ .-.+..+++.-+-.|......||.||.+ +..|||||+||+|||+|..|.+||||||.+-...... .
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si--A 223 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI--A 223 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHHH--H
Confidence 7776643 2234458888888899999999999998 6899999999999999999999999999987654432 3
Q ss_pred ccccccCCCccchhhhcCC--CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccC
Q 044561 504 TTKLVGTFGYMDPELMRTG--KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEG 581 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~~~--~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~ 581 (614)
.+.-+|...|||||.+... .|..++||||||++|+|++||+.|+..... ..+.++... .|..+.+..+.-
T Consensus 224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv-~gdpp~l~~~~~-- 295 (361)
T KOG1006|consen 224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVV-IGDPPILLFDKE-- 295 (361)
T ss_pred hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHH-cCCCCeecCccc--
Confidence 3455889999999998642 488999999999999999999999976543 222222222 222222211110
Q ss_pred cCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 582 ICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 582 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+....+.+++..|+..|-..||+..++.+
T Consensus 296 --~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 296 --CVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred --ccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 1112335677788899999999999988763
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=274.89 Aligned_cols=258 Identities=22% Similarity=0.334 Sum_probs=205.8
Q ss_pred HHHHHHHhcCCCCcceeeeeCcEEEEEEEEec------CcEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeE
Q 044561 337 YKDLYKATKGFKDKDVIGRGGFGKVYRGVLAS------NVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGY 409 (614)
Q Consensus 337 ~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~ 409 (614)
.+++.....+++...++-+|.||.||+|.|.+ .++|.+|.++.. +.-+...++.|--.+..+.|||+.++.+.
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 45566666778888899999999999997643 455777877644 55567789999999999999999999999
Q ss_pred Eeec-CeEEEEEEecCCCCcchhccc------CCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCC
Q 044561 410 CRRK-GEFLLVYDYMPNGSLDKILHT------NIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDAD 482 (614)
Q Consensus 410 ~~~~-~~~~lV~E~~~~gsL~~~l~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~ 482 (614)
+.+. ...+.+|.++.-|+|..+|.. +..+.++-.+...++.|++.|++||| +.++||.||..+|++||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhh
Confidence 8765 567999999999999999972 22356888899999999999999999 5999999999999999999
Q ss_pred CCEEEeeeccccccCCCC-CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHH
Q 044561 483 LNGKLGDFGLARLYDHDT-IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVD 560 (614)
Q Consensus 483 ~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~ 560 (614)
.++||+|=.|++..-... .........+..||+||.+.+..|+.++|||||||+||||+| |+.|+..-++.|....
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y-- 510 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY-- 510 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH--
Confidence 999999999998653322 111222235678999999999999999999999999999998 9999987666554322
Q ss_pred HHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHh
Q 044561 561 WVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVM 613 (614)
Q Consensus 561 ~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 613 (614)
.++|. ++.+ +-.+...|..++.-||..+|++||++.|++
T Consensus 511 -----lkdGy-------RlaQ--P~NCPDeLf~vMacCWallpeeRPsf~Qlv 549 (563)
T KOG1024|consen 511 -----LKDGY-------RLAQ--PFNCPDELFTVMACCWALLPEERPSFSQLV 549 (563)
T ss_pred -----Hhccc-------eecC--CCCCcHHHHHHHHHHHhcCcccCCCHHHHH
Confidence 12221 2221 223456788888899999999999999986
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-32 Score=306.55 Aligned_cols=145 Identities=31% Similarity=0.442 Sum_probs=130.4
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
++|...+.||+|+||.||+|.... +..||+|++.... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 578889999999999999999874 8889999986542 334567889999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecccc
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR 494 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~ 494 (614)
||+++++|.+++... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999998753 348899999999999999999995 799999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.4e-33 Score=267.03 Aligned_cols=266 Identities=26% Similarity=0.336 Sum_probs=195.5
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-----CcEEEEEEeecCChh--hHHHHHHHHHHhcccCCCceeEEeeEEee-cCeE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-----NVQIAVKKVSHDSKQ--GIKEFVAELVSMGRLRHRNLVKLRGYCRR-KGEF 416 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~ 416 (614)
..|+....||+|.||.||+++-++ +..+|+|+++.+.+. ......+|+.+++.++|||++.+..++.. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 457788899999999999996533 236899999766332 12356789999999999999999998876 7889
Q ss_pred EEEEEecCCCCcchhcccCC---CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCC----CCEEEee
Q 044561 417 LLVYDYMPNGSLDKILHTNI---KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDAD----LNGKLGD 489 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~----~~~kl~D 489 (614)
+|++||.++ +|...++... ...++......|++||+.|+.|||+ +-|+||||||.|||+..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeec
Confidence 999999965 7888776422 2458889999999999999999996 679999999999999877 9999999
Q ss_pred eccccccCCCCCC--cccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCc------cccccHHH
Q 044561 490 FGLARLYDHDTIP--QTTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGS------METVNLVD 560 (614)
Q Consensus 490 fGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~------~~~~~l~~ 560 (614)
+|+++.+...-.+ ....++-|.+|.|||++.+. .||.+.||||.||++.||++-.+-|.+... +-..+.++
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 9999998765432 34556789999999998875 689999999999999999998887765321 11122233
Q ss_pred HHHHhh---hcCCccccc----------ccc--ccCcCc-HHH-------HHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 561 WVCDCW---KKGAIRDAS----------DSR--LEGICE-EKQ-------MELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 561 ~v~~~~---~~~~~~~~~----------d~~--l~~~~~-~~~-------~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+.+.. ...+++.+. |-+ ....+. ... ....++|..+++..||.+|.|+.|.++
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle 336 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE 336 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence 222221 111111111 000 000000 000 012567777899999999999999875
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-32 Score=268.06 Aligned_cols=219 Identities=19% Similarity=0.156 Sum_probs=174.3
Q ss_pred eCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecCCCCcchhccc
Q 044561 356 GGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHT 434 (614)
Q Consensus 356 G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~ 434 (614)
|.+|.||+++.+. ++.+|+|++..... +..|...+....|||++++++++...+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh-----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 8899999999865 78899999876532 23444555556799999999999999999999999999999999876
Q ss_pred CCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcccccccCCCcc
Q 044561 435 NIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYM 514 (614)
Q Consensus 435 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~ 514 (614)
. ..+++..+..++.|+++||.||| +++++||||||+||+++.++.++++|||++....... ....++..|+
T Consensus 79 ~--~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y~ 149 (237)
T cd05576 79 F--LNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMYC 149 (237)
T ss_pred h--cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCcccc
Confidence 4 34899999999999999999999 5899999999999999999999999999886554321 2234577899
Q ss_pred chhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHH
Q 044561 515 DPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKL 594 (614)
Q Consensus 515 aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l 594 (614)
|||......++.++|+||+|++++||++|+.|+....... . ......+... ....+.++
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~-----~~~~~~~~~~----~~~~~~~l 208 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------N-----THTTLNIPEW----VSEEARSL 208 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------c-----cccccCCccc----CCHHHHHH
Confidence 9999988888999999999999999999998875321100 0 0000011111 23456778
Q ss_pred HHHcCCCCCCCCCCH
Q 044561 595 GLFCSHPKPEARPNM 609 (614)
Q Consensus 595 ~~~cl~~dP~~RPs~ 609 (614)
+.+|++.||++||++
T Consensus 209 i~~~l~~dp~~R~~~ 223 (237)
T cd05576 209 LQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHccCCHHHhcCC
Confidence 888999999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=242.30 Aligned_cols=262 Identities=23% Similarity=0.307 Sum_probs=201.6
Q ss_pred CCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCCh--hhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 347 FKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSK--QGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 347 f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
|+..++||+|.||+|+||+.++ ++.||+|++..++. .--...++|+.+++.++|+|||++++....++.+-+|+|||
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c 83 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence 4556789999999999999776 77899999976532 22456789999999999999999999999999999999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCc
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 503 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 503 (614)
..+|..+...- .+.++.+....++.|+++||.++|+ ..+.|||+||.|.||+.+|..|++|||+++.++-.. .-
T Consensus 84 -dqdlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipv-rc 157 (292)
T KOG0662|consen 84 -DQDLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-RC 157 (292)
T ss_pred -hHHHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCce-Ee
Confidence 45677776543 3458889999999999999999996 899999999999999999999999999999776432 12
Q ss_pred ccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccc---ccc
Q 044561 504 TTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDAS---DSR 578 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~---d~~ 578 (614)
....+-|.+|.+|+++.+. -|+...|+||-||++.|+.. |++-|++.+..+++..+-|+.....+..++.+. |-.
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 2334678999999998875 47899999999999999997 677777777777666666666665555544332 222
Q ss_pred ccCcCcHH-----HH----HHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 579 LEGICEEK-----QM----ELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 579 l~~~~~~~-----~~----~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.-..++.. .. ..=..|....+.-+|.+|.++.+.+|
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 22221110 01 11123333455669999999998875
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=262.53 Aligned_cols=238 Identities=29% Similarity=0.394 Sum_probs=193.4
Q ss_pred CcEEEEEEEEec-CcEEEEEEeecCChhh-HHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecCCCCcchhccc
Q 044561 357 GFGKVYRGVLAS-NVQIAVKKVSHDSKQG-IKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHT 434 (614)
Q Consensus 357 ~fg~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~ 434 (614)
+||.||+|+..+ +..+++|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999976 8889999997765544 68899999999999999999999999999999999999999999999876
Q ss_pred CCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcccccccCCCcc
Q 044561 435 NIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYM 514 (614)
Q Consensus 435 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~ 514 (614)
... +++.++..++.+++.++.|||+ .+++|+||+|+||++++++.++|+|||.+....... ......++..|+
T Consensus 81 ~~~--~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~ 153 (244)
T smart00220 81 RGR--LSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYM 153 (244)
T ss_pred ccC--CCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCC
Confidence 433 8899999999999999999994 799999999999999999999999999998765542 233456888999
Q ss_pred chhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHH
Q 044561 515 DPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKL 594 (614)
Q Consensus 515 aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l 594 (614)
+||.+....++.++||||||+++++|++|..||......+ ...+ ....+..... .........+.++
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--~~~~----~~~~~~~~~~-------~~~~~~~~~~~~~ 220 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL--ELFK----KIGKPKPPFP-------PPEWKISPEAKDL 220 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HHHH----HHhccCCCCc-------cccccCCHHHHHH
Confidence 9999988888999999999999999999999997532211 1111 1111111100 0000023467788
Q ss_pred HHHcCCCCCCCCCCHHHHhC
Q 044561 595 GLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 595 ~~~cl~~dP~~RPs~~evl~ 614 (614)
+.+|+..+|++||++.++++
T Consensus 221 i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 221 IRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHccCCchhccCHHHHhh
Confidence 89999999999999999975
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-33 Score=264.08 Aligned_cols=262 Identities=27% Similarity=0.450 Sum_probs=206.9
Q ss_pred CCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC-hhh-HHHHHHHHHHhcccCCCceeEEeeEEeec--------Ce
Q 044561 347 FKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS-KQG-IKEFVAELVSMGRLRHRNLVKLRGYCRRK--------GE 415 (614)
Q Consensus 347 f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--------~~ 415 (614)
|....+||+|.||.||+++.+. ++.||+|++..++ +.+ -...++|+.+|..++|+|++.++..|... ..
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 4445679999999999999865 7778888775532 222 34568999999999999999999988543 45
Q ss_pred EEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccc
Q 044561 416 FLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARL 495 (614)
Q Consensus 416 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~ 495 (614)
+|+|+++|++ +|.-+|... ...++..++.++++++..||.|+| ...|+|||+||.|+||+.++.+||+|||+++.
T Consensus 99 ~ylVf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred eeeeHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 8999999964 677777653 345889999999999999999999 58999999999999999999999999999976
Q ss_pred cCCC---CCCcccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCc
Q 044561 496 YDHD---TIPQTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAI 571 (614)
Q Consensus 496 ~~~~---~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~ 571 (614)
+... ..+..+..+-|.+|.+||.+.+ ..++++.|||.-||+|.||+++.+-+.+..+...+.++...+..+.+.-+
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW 253 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW 253 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence 6432 2334556677999999998875 57899999999999999999999999988888888888777766666555
Q ss_pred cccccccccCcC-----c-------HHHH------HHHHHHHHHcCCCCCCCCCCHHHHh
Q 044561 572 RDASDSRLEGIC-----E-------EKQM------ELVLKLGLFCSHPKPEARPNMRQVM 613 (614)
Q Consensus 572 ~~~~d~~l~~~~-----~-------~~~~------~~l~~l~~~cl~~dP~~RPs~~evl 613 (614)
++...-.+.... + ++.+ ...+.|+..++..||.+||.+.+++
T Consensus 254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~al 313 (376)
T KOG0669|consen 254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQAL 313 (376)
T ss_pred CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhh
Confidence 544332221111 0 1111 2467788889999999999999986
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=292.84 Aligned_cols=259 Identities=19% Similarity=0.224 Sum_probs=168.4
Q ss_pred HhcCCCCcceeeeeCcEEEEEEEEec-----CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeE------Ee
Q 044561 343 ATKGFKDKDVIGRGGFGKVYRGVLAS-----NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGY------CR 411 (614)
Q Consensus 343 ~~~~f~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~------~~ 411 (614)
..++|+..+.||+|+||.||+|++.+ +..||+|++...... +....| .++...+.++..++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 45789999999999999999999864 578999987643321 111111 1111222222222111 34
Q ss_pred ecCeEEEEEEecCCCCcchhcccCCCC------------------CcChhHHHHHHHHhHhhchhhhccCCCceEecCcC
Q 044561 412 RKGEFLLVYDYMPNGSLDKILHTNIKP------------------CLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK 473 (614)
Q Consensus 412 ~~~~~~lV~E~~~~gsL~~~l~~~~~~------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik 473 (614)
.....++||||+++++|.+++...... ......+..++.|++.||.|||+ ++|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCC
Confidence 567899999999999999988653210 11233456799999999999995 899999999
Q ss_pred CCCeEEcC-CCCEEEeeeccccccCCCCCCcccccccCCCccchhhhcCC----------------------CCCcchhH
Q 044561 474 PANVLLDA-DLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTG----------------------KASTSTDV 530 (614)
Q Consensus 474 p~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~t~~~Dv 530 (614)
|+|||++. ++.+||+|||+++..............+++.|+|||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 58999999999986654433334456889999999965322 23456799
Q ss_pred HHHHHHHHHHHcCCCCCCCCCcc-------ccccHHHHHHHhhhcCCccccccccccCcCc--HHHHHHHHHHHHHcCCC
Q 044561 531 YAFGVFMLEVASGRRPVEQQGSM-------ETVNLVDWVCDCWKKGAIRDASDSRLEGICE--EKQMELVLKLGLFCSHP 601 (614)
Q Consensus 531 ~S~Gvll~el~tg~~p~~~~~~~-------~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~--~~~~~~l~~l~~~cl~~ 601 (614)
|||||++|||+++..|.+..... .......|.... .....+.+...++ ........+|+.+|++.
T Consensus 363 wSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLV------EPRASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhh------ccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence 99999999999977664321000 000011111000 0000000000000 00112345788899999
Q ss_pred CCCCCCCHHHHhC
Q 044561 602 KPEARPNMRQVMQ 614 (614)
Q Consensus 602 dP~~RPs~~evl~ 614 (614)
||++|||+.|+++
T Consensus 437 dP~kR~ta~e~L~ 449 (566)
T PLN03225 437 KGRQRISAKAALA 449 (566)
T ss_pred CcccCCCHHHHhC
Confidence 9999999999985
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=284.53 Aligned_cols=260 Identities=22% Similarity=0.301 Sum_probs=178.4
Q ss_pred hcCCCCcceeeeeCcEEEEEEEE-----------------ecCcEEEEEEeecCChhhHHHHH--------------HHH
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVL-----------------ASNVQIAVKKVSHDSKQGIKEFV--------------AEL 392 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~~~--------------~Ei 392 (614)
.++|+..++||+|+||.||+|.+ .+++.||||++........++|. .|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 56899999999999999999974 23467999998765443333333 466
Q ss_pred HHhcccCCCce-----eEEeeEEee--------cCeEEEEEEecCCCCcchhcccCC----------------------C
Q 044561 393 VSMGRLRHRNL-----VKLRGYCRR--------KGEFLLVYDYMPNGSLDKILHTNI----------------------K 437 (614)
Q Consensus 393 ~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~----------------------~ 437 (614)
.++.+++|.++ ++++++|.. ++..+|||||+++++|.++++... .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 67777766554 677888753 357899999999999999886421 1
Q ss_pred CCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcccccccCCCccchh
Q 044561 438 PCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPE 517 (614)
Q Consensus 438 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE 517 (614)
..++|..+..++.|++++|.|||+ .+|+||||||+|||++.++.+||+|||++...............+|+.|+|||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 235678889999999999999994 89999999999999999999999999999765443222222234578999999
Q ss_pred hhcCCCC----------------------CcchhHHHHHHHHHHHHcCCC-CCCCCCccc-cccHHHHH---HHhhhcCC
Q 044561 518 LMRTGKA----------------------STSTDVYAFGVFMLEVASGRR-PVEQQGSME-TVNLVDWV---CDCWKKGA 570 (614)
Q Consensus 518 ~~~~~~~----------------------t~~~Dv~S~Gvll~el~tg~~-p~~~~~~~~-~~~l~~~v---~~~~~~~~ 570 (614)
.+..... ..+.||||+||+++||++|.. |+....... ........ |..+....
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~ 460 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK 460 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence 8754321 234799999999999999875 664321110 00001111 11111111
Q ss_pred ccccccccccCcCcHHHHHHHHHHHHHcCCCCC---CCCCCHHHHhC
Q 044561 571 IRDASDSRLEGICEEKQMELVLKLGLFCSHPKP---EARPNMRQVMQ 614 (614)
Q Consensus 571 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP---~~RPs~~evl~ 614 (614)
. +-...... .+...+|+.+|+..+| .+|+|+.|+|+
T Consensus 461 ~----~~~~~d~~----s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 461 Y----DFSLLDRN----KEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred C----Cccccccc----ChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 1 11111112 2345556666777654 78999999985
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-32 Score=260.32 Aligned_cols=253 Identities=21% Similarity=0.271 Sum_probs=194.6
Q ss_pred HhcCCCCc-ceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhccc-CCCceeEEeeEEee----cCe
Q 044561 343 ATKGFKDK-DVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRR----KGE 415 (614)
Q Consensus 343 ~~~~f~~~-~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~----~~~ 415 (614)
.+++|++. ++||-|-.|+|-.+..+. ++.+|+|.+.... ...+|++..-.. .|||||++++++.. ..-
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP-----KARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH-----HHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 34445443 579999999999999875 7888999886443 335677765544 69999999998754 356
Q ss_pred EEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcC---CCCEEEeeecc
Q 044561 416 FLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA---DLNGKLGDFGL 492 (614)
Q Consensus 416 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~---~~~~kl~DfGl 492 (614)
+++|||.|+||.|.+.++.+....+++.++-.|++||+.|+.|||+ .+|.||||||+|+|... |-.+||+|||+
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEeccccc
Confidence 8899999999999999998888889999999999999999999995 89999999999999965 45689999999
Q ss_pred ccccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcc
Q 044561 493 ARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIR 572 (614)
Q Consensus 493 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~ 572 (614)
|+...... ...+.+-|+.|.|||++...+|...+|+||+||+||-|+||.+||....... +.--+...+..|..
T Consensus 211 AK~t~~~~--~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---ispgMk~rI~~gqy- 284 (400)
T KOG0604|consen 211 AKETQEPG--DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---ISPGMKRRIRTGQY- 284 (400)
T ss_pred ccccCCCc--cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---CChhHHhHhhccCc-
Confidence 99765432 3455688999999999999999999999999999999999999997543211 11011111111110
Q ss_pred ccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 573 DASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 573 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
++-+++ .....+...+++..+|..+|.+|.|+.|++.
T Consensus 285 ~FP~pE-----Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 285 EFPEPE-----WSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred cCCChh-----HhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 111111 1223456777888899999999999999873
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=282.85 Aligned_cols=238 Identities=21% Similarity=0.282 Sum_probs=189.3
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhccc-CCCceeEEeeEEeecCeEEEEEE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 421 (614)
+..|.....+|.|+|+.|-++.... ++..++|++.....+ -.+|+.++... +||||+++.+.+.+..+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~----~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD----NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccccc----cccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 4567777789999999999998765 788999999766222 24566555444 79999999999999999999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEE-cCCCCEEEeeeccccccCCCC
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL-DADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll-~~~~~~kl~DfGla~~~~~~~ 500 (614)
++.++-|.+.+..... +. .++..|+.+|+.++.|||+ +++|||||||+|||+ ++.++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred hccccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 9999887776655332 22 7777899999999999995 999999999999999 58999999999999876654
Q ss_pred CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
....+-|..|.|||++....+++++|+||||++||+|++|+.||...... . ........+...
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~----ei~~~i~~~~~s-------- 532 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--I----EIHTRIQMPKFS-------- 532 (612)
T ss_pred ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--H----HHHHhhcCCccc--------
Confidence 23346688999999999999999999999999999999999999765433 1 112222222222
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHh
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARPNMRQVM 613 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 613 (614)
....+...+|+.+||+.||.+||+|.|+.
T Consensus 533 ----~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~ 561 (612)
T KOG0603|consen 533 ----ECVSDEAKDLLQQLLQVDPALRLGADEIG 561 (612)
T ss_pred ----cccCHHHHHHHHHhccCChhhCcChhhhc
Confidence 22334566777889999999999999985
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=285.75 Aligned_cols=260 Identities=25% Similarity=0.380 Sum_probs=210.1
Q ss_pred CHHHHHHHhcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhccc-CCCceeEEeeEEee-
Q 044561 336 TYKDLYKATKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRR- 412 (614)
Q Consensus 336 ~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~- 412 (614)
.++.+-..+..|++.+.||+|.+|.||+++... ++..|+|+...+.+. .++...|.++++.. .|||++.++|++..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 344445556788999999999999999999765 777788877655443 35677889999887 69999999998853
Q ss_pred ----cCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEe
Q 044561 413 ----KGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLG 488 (614)
Q Consensus 413 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~ 488 (614)
+++++||||||.+||.-++++.-....+.|..+..|+..++.|+.+|| +..++|||||-.|||++.++.+||+
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEe
Confidence 468999999999999999998765667999999999999999999999 5899999999999999999999999
Q ss_pred eeccccccCCCCCCcccccccCCCccchhhhc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHH
Q 044561 489 DFGLARLYDHDTIPQTTKLVGTFGYMDPELMR-----TGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVC 563 (614)
Q Consensus 489 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~ 563 (614)
|||++...+.... ...+..||+.|||||++. ...|+..+|+||||++..||.-|.+|+..+-+...+-+
T Consensus 166 DFGvSaQldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~----- 239 (953)
T KOG0587|consen 166 DFGVSAQLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL----- 239 (953)
T ss_pred eeeeeeeeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc-----
Confidence 9999988775543 344568999999999884 23577899999999999999999999876544322211
Q ss_pred HhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 564 DCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 564 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+...-.+.+. -+..-.+.+..++..|+..|-++||++.++++
T Consensus 240 -------IpRNPPPkLk--rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 240 -------IPRNPPPKLK--RPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred -------CCCCCCcccc--chhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 1122222222 24555677888999999999999999999875
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=301.88 Aligned_cols=215 Identities=31% Similarity=0.358 Sum_probs=189.2
Q ss_pred CHHHHHHHhcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC---ChhhHHHHHHHHHHhcccCCCceeEEeeEEe
Q 044561 336 TYKDLYKATKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKLRGYCR 411 (614)
Q Consensus 336 ~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~ 411 (614)
...++.-..++|.+.++||+|+||.|..++.+. +..+|.|++.+. .+....-|..|-.+|..-+.+=|+++.-.+.
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 456666777889999999999999999999876 777899998763 3344567888999998888999999999999
Q ss_pred ecCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeec
Q 044561 412 RKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFG 491 (614)
Q Consensus 412 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfG 491 (614)
+..++|+|||||+||+|-.+|.+.. .+++..+..++..|.-||.-|| +.|+|||||||+|||||..|++||+|||
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccch
Confidence 9999999999999999999998754 5899999999999999999999 5999999999999999999999999999
Q ss_pred cccccCCCCCCcccccccCCCccchhhhcC-----CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcccc
Q 044561 492 LARLYDHDTIPQTTKLVGTFGYMDPELMRT-----GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMET 555 (614)
Q Consensus 492 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~ 555 (614)
-|-.++.+..-.....+|||.|++||++.. +.|...+|.||+||++|||+.|..||....-.+.
T Consensus 221 sClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveT 289 (1317)
T KOG0612|consen 221 SCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVET 289 (1317)
T ss_pred hHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHH
Confidence 998888666666777899999999999863 5789999999999999999999999976544433
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=276.39 Aligned_cols=194 Identities=27% Similarity=0.453 Sum_probs=171.4
Q ss_pred cceeeeeCcEEEEEEEEec-CcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecCCC
Q 044561 350 KDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNG 426 (614)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 426 (614)
.++||+|.||+||-|+.+. |+.||||.+.+. ......++.+|+.+|.+++||.||.+..-|+..+..+.|||.+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 5889999999999999865 999999998654 3445578899999999999999999999999999999999999 56
Q ss_pred CcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCC---CCEEEeeeccccccCCCCCCc
Q 044561 427 SLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDAD---LNGKLGDFGLARLYDHDTIPQ 503 (614)
Q Consensus 427 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~---~~~kl~DfGla~~~~~~~~~~ 503 (614)
+..+.+-..+.+.|++..-..++.||+.||.||| .++|+|+||||+|||+.+. .++||||||.|+.+.....+
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR- 723 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR- 723 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchhhhh-
Confidence 6555555555677999999999999999999999 5999999999999999654 57999999999998876533
Q ss_pred ccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCC
Q 044561 504 TTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQ 549 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~ 549 (614)
..++||+.|+|||+++++.|...-|+||.||++|--++|..||..
T Consensus 724 -rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE 768 (888)
T KOG4236|consen 724 -RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE 768 (888)
T ss_pred -hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC
Confidence 446999999999999999999999999999999999999999964
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=265.71 Aligned_cols=241 Identities=22% Similarity=0.321 Sum_probs=188.8
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCCh---hhHHHHHHHHHHhccc-CCCceeEEeeEEeecCeEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSK---QGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGEFLLV 419 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 419 (614)
.+|....+||+|+||+|-.+..++ .+.+|||+++++-- ...+--..|-.+|.-. +-|.++++..++..-+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 468888999999999999999876 66789999877521 1122223455555544 578899999999999999999
Q ss_pred EEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCC
Q 044561 420 YDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD 499 (614)
Q Consensus 420 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~ 499 (614)
|||+.+|+|-.++++-. .+.+..+..++.+||-||-+|| .++|++||||.+|||+|.+|++||.|||+++.--.+
T Consensus 429 MEyvnGGDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred EEEecCchhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecccccccccC
Confidence 99999999999988743 4888899999999999999999 499999999999999999999999999999853322
Q ss_pred CCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccc
Q 044561 500 TIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRL 579 (614)
Q Consensus 500 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 579 (614)
. ..+.+.+||+.|+|||++...+|..++|.|||||+||||+.|++||++.++.+....+ .+ ...
T Consensus 504 ~-~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI---~e------------hnv 567 (683)
T KOG0696|consen 504 G-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI---ME------------HNV 567 (683)
T ss_pred C-cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---HH------------ccC
Confidence 2 2345679999999999999999999999999999999999999999987765543222 11 111
Q ss_pred cCcCcHHHHHHHHHHHHHcCCCCCCCCCC
Q 044561 580 EGICEEKQMELVLKLGLFCSHPKPEARPN 608 (614)
Q Consensus 580 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs 608 (614)
.++.....+...+....+...|.+|.-
T Consensus 568 --syPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 568 --SYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred --cCcccccHHHHHHHHHHhhcCCccccC
Confidence 122233334444555567788888753
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=265.65 Aligned_cols=262 Identities=19% Similarity=0.290 Sum_probs=206.6
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCC--C----ceeEEeeEEeecCeE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRH--R----NLVKLRGYCRRKGEF 416 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H--~----niv~l~g~~~~~~~~ 416 (614)
+++|.+...+|+|.||.|-++.... +..||+|+++.-.+ ..+...-|++++.++.+ | -++++.+|+.-.++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 6788999999999999999998776 68899998865433 23445678999999832 3 288899999999999
Q ss_pred EEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcC---------------
Q 044561 417 LLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA--------------- 481 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~--------------- 481 (614)
+||+|.+ |-|+.++|..+.-.+++..++..|++|+++++++|| +.+++|-||||+|||+.+
T Consensus 167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCccce
Confidence 9999998 669999999988888999999999999999999999 489999999999999932
Q ss_pred -----CCCEEEeeeccccccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccc
Q 044561 482 -----DLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETV 556 (614)
Q Consensus 482 -----~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~ 556 (614)
+..+|++|||-|....... ...+.|..|.|||++.+-..+..+||||+||||.|+.+|..-|+..++.|.+
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHL 318 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHL 318 (415)
T ss_pred eccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHH
Confidence 3458999999998755433 4568899999999999999999999999999999999999999877665644
Q ss_pred cHHHHHHH--------------hhhcCCcc-----------ccccccc----cCcCcHHHHHHHHHHHHHcCCCCCCCCC
Q 044561 557 NLVDWVCD--------------CWKKGAIR-----------DASDSRL----EGICEEKQMELVLKLGLFCSHPKPEARP 607 (614)
Q Consensus 557 ~l~~~v~~--------------~~~~~~~~-----------~~~d~~l----~~~~~~~~~~~l~~l~~~cl~~dP~~RP 607 (614)
...+.+.+ ....+.+. .+.++.. .......+...|.+|+..|+..||.+|+
T Consensus 319 aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~Ri 398 (415)
T KOG0671|consen 319 AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRI 398 (415)
T ss_pred HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccc
Confidence 44433221 11122111 0111000 0112344556799999999999999999
Q ss_pred CHHHHhC
Q 044561 608 NMRQVMQ 614 (614)
Q Consensus 608 s~~evl~ 614 (614)
|++|+++
T Consensus 399 Tl~EAL~ 405 (415)
T KOG0671|consen 399 TLREALS 405 (415)
T ss_pred cHHHHhc
Confidence 9999974
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-32 Score=274.63 Aligned_cols=242 Identities=24% Similarity=0.312 Sum_probs=201.8
Q ss_pred cCCCCcceeeeeCcEEEEEEEEecCc-EEEEEEeecC---ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLASNV-QIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~~~-~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
.+++....||-|+||.|-....+... .+|+|.+++. +....+....|-.+|.+.+.|.||+++..+.+....|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34556678999999999998876533 3677776543 3445567789999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
|-|-||.|+..|.++ +.++......++..+.+|+.|||+ ++||+|||||+|.|+|.+|-+||.|||+|+.+..+.
T Consensus 500 EaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 500 EACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred HhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 999999999999874 559999999999999999999994 999999999999999999999999999999887765
Q ss_pred CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
.+.+.+||+.|.|||++.++....++|.||||++++||++|++||.+.++....+++-.-.+.+
T Consensus 575 --KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i-------------- 638 (732)
T KOG0614|consen 575 --KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI-------------- 638 (732)
T ss_pred --ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh--------------
Confidence 5667899999999999999999999999999999999999999999887776666653221211
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCCC
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARPN 608 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs 608 (614)
.++.........|+.+.+..+|.+|.-
T Consensus 639 -~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 639 -EFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred -hcccccchhHHHHHHHHHhcCcHhhhc
Confidence 123333344556666678889999865
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=240.58 Aligned_cols=197 Identities=29% Similarity=0.400 Sum_probs=166.5
Q ss_pred cceeeeeCcEEEEEEEEe-cCcEEEEEEeecC-ChhhHHHHHHHHHHhccc-CCCceeEEeeEEeecCeEEEEEEecCCC
Q 044561 350 KDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHD-SKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGEFLLVYDYMPNG 426 (614)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~g 426 (614)
.+.||+|++|.|-+-++. .|...|+|++... +.+..++.+.|+.+..+. .+|.+|.++|...+.+..++.||.| ..
T Consensus 51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~t 129 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DT 129 (282)
T ss_pred hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hh
Confidence 456999999999888875 4888999999765 455667888999876654 7999999999999999999999999 57
Q ss_pred Ccchhccc--CCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcc
Q 044561 427 SLDKILHT--NIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT 504 (614)
Q Consensus 427 sL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 504 (614)
||+.+-.+ .....+++..+=+|+..+.+||.|||+ +..++|||+||+|||++.+|++|+||||.+-.+.+.- ..
T Consensus 130 Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi--Ak 205 (282)
T KOG0984|consen 130 SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI--AK 205 (282)
T ss_pred hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhh--HH
Confidence 88877543 123558899999999999999999999 7999999999999999999999999999997665433 23
Q ss_pred cccccCCCccchhhhcC----CCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Q 044561 505 TKLVGTFGYMDPELMRT----GKASTSTDVYAFGVFMLEVASGRRPVEQQG 551 (614)
Q Consensus 505 ~~~~gt~~y~aPE~~~~----~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~ 551 (614)
+...|...|||||.+.. ..|+-++||||||+.+.||++++.||+...
T Consensus 206 t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 206 TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 33578899999998753 478999999999999999999999998654
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-31 Score=281.68 Aligned_cols=244 Identities=24% Similarity=0.406 Sum_probs=187.2
Q ss_pred CCCcceeeeeCcEE-EEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhccc-CCCceeEEeeEEeecCeEEEEEEecC
Q 044561 347 FKDKDVIGRGGFGK-VYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGEFLLVYDYMP 424 (614)
Q Consensus 347 f~~~~~lG~G~fg~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~ 424 (614)
|...+++|.|+.|+ ||+|.. +++.||||++-.+. ..-..+|+..++.- +||||+++++.-.++...||..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 56677899999886 699998 47799999985442 34457899999888 5999999999888899999999999
Q ss_pred CCCcchhcccC--CCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcC---C--CCEEEeeeccccccC
Q 044561 425 NGSLDKILHTN--IKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA---D--LNGKLGDFGLARLYD 497 (614)
Q Consensus 425 ~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~---~--~~~kl~DfGla~~~~ 497 (614)
..+|.+++... ......-...+.+..|+++||++||+ .+||||||||.||||+. + ..++|+|||+++...
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 67999999873 11112224567889999999999996 89999999999999976 2 568999999999887
Q ss_pred CCCC--CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcC-CCCCCCCCccccccHHHHHHHhhhcCCcccc
Q 044561 498 HDTI--PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASG-RRPVEQQGSMETVNLVDWVCDCWKKGAIRDA 574 (614)
Q Consensus 498 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg-~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~ 574 (614)
.+.. .......||.+|+|||++....-+.++||||+||++|.+++| ..||...-..+ .+.+ .+...-
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-~NIl--------~~~~~L- 732 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-ANIL--------TGNYTL- 732 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-hhhh--------cCccce-
Confidence 6542 234456899999999999998888999999999999999995 88997543221 1111 000000
Q ss_pred ccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 575 SDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 575 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+. ...++ ...+|+.+|++++|..||++.+|+.
T Consensus 733 --~~L~--~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 733 --VHLE--PLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred --eeec--cCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 0011 11111 6778888999999999999999974
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-30 Score=266.40 Aligned_cols=240 Identities=25% Similarity=0.347 Sum_probs=193.6
Q ss_pred CCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEE
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 421 (614)
-|...+.||-|+||+|.++...| ...+|.|.+.+.+ ++......+|-.||.....+=+|+|+-.+.+++.+|+|||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 47778889999999999998766 5568999887653 4455667889999999999999999999999999999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCC---
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH--- 498 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~--- 498 (614)
|++||++-.+|.+. +.+++..+..++.++..|+++.| +.|.|||||||+|||||.+|++||.|||||.-+..
T Consensus 710 YIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred ccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceeccc
Confidence 99999999988763 45888888899999999999999 79999999999999999999999999999864311
Q ss_pred ------CC-CC-------------------------------cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHH
Q 044561 499 ------DT-IP-------------------------------QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEV 540 (614)
Q Consensus 499 ------~~-~~-------------------------------~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el 540 (614)
+. .. .....+||..|+|||++....++..+|.||.||+|+||
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence 00 00 00124799999999999988999999999999999999
Q ss_pred HcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCC
Q 044561 541 ASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPK 602 (614)
Q Consensus 541 ~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~d 602 (614)
+.|+.||....+.+....+ -.+...++-...+....++...+.+| |+..|
T Consensus 865 ~~g~~pf~~~tp~~tq~kv---------~nw~~~l~~~~~~~ls~e~~~li~kL---c~sad 914 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGETQYKV---------INWRNFLHIPYQGNLSKEALDLIQKL---CCSAD 914 (1034)
T ss_pred hhCCCCccCCCCCcceeee---------eehhhccccccccccCHHHHHHHHHH---hcChh
Confidence 9999999877665543221 12233444444566677777777776 76644
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-31 Score=249.73 Aligned_cols=262 Identities=25% Similarity=0.393 Sum_probs=199.9
Q ss_pred CCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeec-----CeEE
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRK-----GEFL 417 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~~ 417 (614)
+.+..+.||.|+||.||...+. +++.|+.|++..- +....+.+.+|++++..++|.|++..++..... .++|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 4566789999999999999875 5889999998654 334567889999999999999999988876543 3678
Q ss_pred EEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccC
Q 044561 418 LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYD 497 (614)
Q Consensus 418 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~ 497 (614)
.+.|.| ..+|.+++-. .+.++-..+.-+..||++||.|||+ .+|.||||||.|.|+++|...||||||+++..+
T Consensus 134 V~TELm-QSDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 134 VLTELM-QSDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHH-Hhhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccc
Confidence 899998 5678777765 3458888999999999999999996 899999999999999999999999999999887
Q ss_pred CCCCCcccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHH------------HH
Q 044561 498 HDTIPQTTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWV------------CD 564 (614)
Q Consensus 498 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v------------~~ 564 (614)
.+....++..+-|..|.|||++.+. .|+.+.||||.||++.||+..+.-|...++.+.+.++... ++
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence 7766666767789999999998875 6899999999999999999999999877776666555322 11
Q ss_pred hhh----cCCccccccccccCcCc-HHHHHHHHHHHHHcCCCCCCCCCCHHHHh
Q 044561 565 CWK----KGAIRDASDSRLEGICE-EKQMELVLKLGLFCSHPKPEARPNMRQVM 613 (614)
Q Consensus 565 ~~~----~~~~~~~~d~~l~~~~~-~~~~~~l~~l~~~cl~~dP~~RPs~~evl 613 (614)
.-+ ++....-.-+.+-.... ...-...+.+.++++++||.+|.+..+.+
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~ 341 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEAL 341 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhc
Confidence 111 11111111111111111 11112234455668999999999988765
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-30 Score=260.50 Aligned_cols=254 Identities=27% Similarity=0.390 Sum_probs=192.8
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC-------hhhHHHHHHHHHHhcccCCCceeEEeeEEee-cCe
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS-------KQGIKEFVAELVSMGRLRHRNLVKLRGYCRR-KGE 415 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~ 415 (614)
++|-..++||+|||+.|||+..-. .+-||||+-.... ....+...+|..+.+.|.||.||++++++.- .+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 345567789999999999999654 6667887653221 1223456789999999999999999999864 467
Q ss_pred EEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEc---CCCCEEEeeecc
Q 044561 416 FLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD---ADLNGKLGDFGL 492 (614)
Q Consensus 416 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~---~~~~~kl~DfGl 492 (614)
+|-|.|||++.+|+-+|+.+ ..+++.++..|+.||..||.||.+. +.+|||-||||.|||+. ..|.+||.||||
T Consensus 543 FCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred ceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 89999999999999999874 4589999999999999999999964 78999999999999994 457899999999
Q ss_pred ccccCCCCC------CcccccccCCCccchhhhcCC----CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHH
Q 044561 493 ARLYDHDTI------PQTTKLVGTFGYMDPELMRTG----KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWV 562 (614)
Q Consensus 493 a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~----~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v 562 (614)
++.++.+.. ..+...+||.+|++||++.-+ +.+.|+||||.||++|..+.|+.||........
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd------- 692 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD------- 692 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH-------
Confidence 998875432 233456899999999987543 578899999999999999999999976433221
Q ss_pred HHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q 044561 563 CDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQV 612 (614)
Q Consensus 563 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev 612 (614)
...++.+..+..-.+... .........++.+|++.--++|....|+
T Consensus 693 --ILqeNTIlkAtEVqFP~K--PvVsseAkaFIRRCLaYRKeDR~DV~qL 738 (775)
T KOG1151|consen 693 --ILQENTILKATEVQFPPK--PVVSSEAKAFIRRCLAYRKEDRIDVQQL 738 (775)
T ss_pred --HHhhhchhcceeccCCCC--CccCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence 122333333333322211 0112234566777998888888776665
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=245.54 Aligned_cols=247 Identities=25% Similarity=0.331 Sum_probs=192.3
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC---ChhhHHHHHHHHHHhccc-CCCceeEEeeEEeecCeEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD---SKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGEFLLV 419 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 419 (614)
.+|...++||.|+|.+|-.++++. .+.+|+|.++++ ..+...-...|-.+..+. +||.+|.+..++..+..+++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 568889999999999999999876 677888888654 334445555666665554 799999999999999999999
Q ss_pred EEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCC
Q 044561 420 YDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD 499 (614)
Q Consensus 420 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~ 499 (614)
.||+++|+|--+++.. ..++++.+..+...|.-||.||| +++|++||||.+|||+|.+|++||.|+|+++.--.+
T Consensus 330 ieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred EEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence 9999999998888764 34999999999999999999999 499999999999999999999999999999853322
Q ss_pred CCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCC--CccccccHHHHHHHhhhcCCccccccc
Q 044561 500 TIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQ--GSMETVNLVDWVCDCWKKGAIRDASDS 577 (614)
Q Consensus 500 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~--~~~~~~~l~~~v~~~~~~~~~~~~~d~ 577 (614)
. ..+.+.+||+.|+|||++++..|....|.|++||+|+||+.||.||+-- ++++ .+--++..+..-+..+.
T Consensus 405 g-d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d-~ntedylfqvilekqir----- 477 (593)
T KOG0695|consen 405 G-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPD-MNTEDYLFQVILEKQIR----- 477 (593)
T ss_pred C-cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcc-cchhHHHHHHHhhhccc-----
Confidence 2 2456689999999999999999999999999999999999999999732 2222 22333443333222211
Q ss_pred cccCcCcHHHHHHHHHHHHHcCCCCCCCCCC
Q 044561 578 RLEGICEEKQMELVLKLGLFCSHPKPEARPN 608 (614)
Q Consensus 578 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs 608 (614)
+ +.....+...+...-++.||.+|.-
T Consensus 478 -i----prslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 478 -I----PRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred -c----cceeehhhHHHHHHhhcCCcHHhcC
Confidence 1 1112223334455578999988853
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-28 Score=231.52 Aligned_cols=209 Identities=33% Similarity=0.564 Sum_probs=182.6
Q ss_pred eeeeCcEEEEEEEEec-CcEEEEEEeecCChh-hHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecCCCCcch
Q 044561 353 IGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQ-GIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDK 430 (614)
Q Consensus 353 lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~ 430 (614)
||+|.+|.||++...+ +..+++|++...... ..+.+.+|+..++.++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999875 888999998766443 45678999999999999999999999999999999999999999999
Q ss_pred hcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcC-CCCEEEeeeccccccCCCCCCccccccc
Q 044561 431 ILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA-DLNGKLGDFGLARLYDHDTIPQTTKLVG 509 (614)
Q Consensus 431 ~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~~g 509 (614)
++.... ..+++..+..++.++++++.+||+ .+++|+||+|.||+++. ++.++|+|||.+........ ......+
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~ 155 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVG 155 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccC
Confidence 987642 358999999999999999999995 79999999999999999 89999999999986654321 1233467
Q ss_pred CCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcHHHH
Q 044561 510 TFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQM 588 (614)
Q Consensus 510 t~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~ 588 (614)
...|++||..... ..+.+.|+|++|+++++|
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 8899999999877 788999999999999999
Q ss_pred HHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 589 ELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 589 ~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+.+++..|++.||++||++.++++
T Consensus 188 ~~~~~~l~~~l~~~p~~R~~~~~l~~ 213 (215)
T cd00180 188 PELKDLIRKMLQKDPEKRPSAKEILE 213 (215)
T ss_pred HHHHHHHHHHhhCCcccCcCHHHHhh
Confidence 45777888899999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=231.75 Aligned_cols=254 Identities=20% Similarity=0.304 Sum_probs=192.3
Q ss_pred hcCCCCcceeeeeCcEEEEEEEE-ecCcEEEEEEeecCChhhHHHHHHHHHHhcccC-CCceeEEeeEEeec--CeEEEE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVL-ASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLR-HRNLVKLRGYCRRK--GEFLLV 419 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~--~~~~lV 419 (614)
.++|+..+++|.|.++.|+.|.. .++++++||.++.-. .+.+.+|+.+|..|. ||||+++++...+. ....||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 45678889999999999999985 457888899886543 367789999999997 99999999998764 567899
Q ss_pred EEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCC-CCEEEeeeccccccCC
Q 044561 420 YDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDAD-LNGKLGDFGLARLYDH 498 (614)
Q Consensus 420 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~-~~~kl~DfGla~~~~~ 498 (614)
+||+.+.+...+.. .|+...+...+.++++||.|+|| +||.|||+||.|+|||.. ...+|+|+|||.++..
T Consensus 114 FE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 99998887766653 38888999999999999999996 999999999999999864 5699999999999876
Q ss_pred CCCCcccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCC-CCccccccHHHHHH----------H--
Q 044561 499 DTIPQTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQ-QGSMETVNLVDWVC----------D-- 564 (614)
Q Consensus 499 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~-~~~~~~~~l~~~v~----------~-- 564 (614)
+. .....+.+..|--||++.. ..|...-|+|||||++.+|+..+.||.. .++.+++.-+..+. +
T Consensus 186 ~~--eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~ 263 (338)
T KOG0668|consen 186 GK--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ 263 (338)
T ss_pred Cc--eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence 64 2334466778899999875 4578899999999999999999999853 34444333222221 1
Q ss_pred ------------hhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 565 ------------CWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 565 ------------~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
...+..+..++.+.-..... ...++++...+..|-++|||++|++.
T Consensus 264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~----peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVS----PEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred cCCChhHhhHhhccccccHHHhCCccccccCC----hHHHHHHHHHHhhccccccchHHHhc
Confidence 01111111111111111111 34566777789999999999999873
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-27 Score=231.34 Aligned_cols=199 Identities=31% Similarity=0.476 Sum_probs=173.9
Q ss_pred CCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChh-hHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecC
Q 044561 347 FKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQ-GIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMP 424 (614)
Q Consensus 347 f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 424 (614)
|+..+.||+|++|.||++...+ +..+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567889999999999999876 788999999876554 67788999999999999999999999999999999999999
Q ss_pred CCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcc
Q 044561 425 NGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT 504 (614)
Q Consensus 425 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 504 (614)
+++|.+++...... +++..+..++.+++.++.+||+ .+++|+||+|+||+++.++.++|+|||.+...........
T Consensus 81 ~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred CCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence 99999998764322 7899999999999999999994 7999999999999999999999999999987655431122
Q ss_pred cccccCCCccchhhh-cCCCCCcchhHHHHHHHHHHHHcCCCCCCC
Q 044561 505 TKLVGTFGYMDPELM-RTGKASTSTDVYAFGVFMLEVASGRRPVEQ 549 (614)
Q Consensus 505 ~~~~gt~~y~aPE~~-~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~ 549 (614)
....++..|++||.+ ....++.++|+|+||++++||++|+.||..
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 345678899999998 666778899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-28 Score=251.30 Aligned_cols=197 Identities=24% Similarity=0.397 Sum_probs=169.0
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhh-----HHHHHHHHHHhcccC---CCceeEEeeEEe
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQG-----IKEFVAELVSMGRLR---HRNLVKLRGYCR 411 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~-----~~~~~~Ei~~l~~l~---H~niv~l~g~~~ 411 (614)
..+|...+.+|+|+||.|+.|.++. ...|++|.+.++. +.+ .-..-.|+++|..++ |+||+|++++++
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 3467888999999999999999886 5678888886642 111 123457999999997 999999999999
Q ss_pred ecCeEEEEEEec-CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeee
Q 044561 412 RKGEFLLVYDYM-PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDF 490 (614)
Q Consensus 412 ~~~~~~lV~E~~-~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~Df 490 (614)
+.+.+||+||-. ++-+|.+++... +.+++.+...|++||+.|+++|| .++|||||||-+||.++.+|-+||+||
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeec
Confidence 999999999986 455788888763 45999999999999999999999 499999999999999999999999999
Q ss_pred ccccccCCCCCCcccccccCCCccchhhhcCCCC-CcchhHHHHHHHHHHHHcCCCCCC
Q 044561 491 GLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKA-STSTDVYAFGVFMLEVASGRRPVE 548 (614)
Q Consensus 491 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~~Dv~S~Gvll~el~tg~~p~~ 548 (614)
|-+.....+. ....+||..|.|||++.+.+| ...-|||++|++||.++....||.
T Consensus 715 gsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9998776654 455789999999999998877 667899999999999999888874
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=235.24 Aligned_cols=131 Identities=24% Similarity=0.352 Sum_probs=111.8
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccC-----C---CceeEEeeEEeec--
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLR-----H---RNLVKLRGYCRRK-- 413 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----H---~niv~l~g~~~~~-- 413 (614)
.+|...++||.|.|++||++.... .+-||+|+.+.. ....+..+.||++|++++ | .+||+|+++|...
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 568889999999999999999765 667888877543 334456788999999883 2 4699999999764
Q ss_pred --CeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEE
Q 044561 414 --GEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL 479 (614)
Q Consensus 414 --~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll 479 (614)
.+.++|+|+. |-+|..+|....-+.++...+.+|++||+.||.|||. +-+|||-||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence 5899999999 7789999887777779999999999999999999998 5799999999999999
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.8e-28 Score=234.21 Aligned_cols=259 Identities=24% Similarity=0.281 Sum_probs=194.5
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeec------Ce
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRK------GE 415 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~ 415 (614)
.+|.....+|.|.- .|..+... .++.|++|+.... .....++..+|+..+..++|+|+++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45556677888887 56555543 3788999998654 344567788999999999999999999988643 46
Q ss_pred EEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccc
Q 044561 416 FLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARL 495 (614)
Q Consensus 416 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~ 495 (614)
.|+|||+| ..+|...+... ++-..+..|..|++.|+.|||+ .+|+||||||+||++..+..+||.|||+++.
T Consensus 96 ~y~v~e~m-~~nl~~vi~~e----lDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVILME----LDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHHhh-hhHHHHHHHHh----cchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhcc
Confidence 89999999 67888888732 6778889999999999999995 8999999999999999999999999999987
Q ss_pred cCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHH------------
Q 044561 496 YDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVC------------ 563 (614)
Q Consensus 496 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~------------ 563 (614)
.+.. -..+..+.|..|.|||++.+-.+.+.+||||.||++.||++|+.-|.+.+.-+....+....
T Consensus 168 e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 168 EDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred cCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence 6554 24566788999999999988889999999999999999999999887655433322221111
Q ss_pred ----Hhhh------cCCccc-cccccccCc--CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 564 ----DCWK------KGAIRD-ASDSRLEGI--CEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 564 ----~~~~------~~~~~~-~~d~~l~~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
...+ .-.+.+ +.|...... .+.-....+..++.+||-.||++|.|++++|+
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 0000 000011 111111111 11122345677788899999999999999985
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-27 Score=251.80 Aligned_cols=252 Identities=26% Similarity=0.384 Sum_probs=201.6
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
.+|.....+|+|.||.|||++.+. +...|+|.++.+.....+-..+|+-+++..+||||+.++|.+...+.+++.||||
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc 94 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC 94 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence 467778899999999999999765 7888999998887777788889999999999999999999999999999999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCc
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 503 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 503 (614)
.+|+|.+.-+. ..++++.++..+++...+||+|||+ ++-+|||||-.||++++.|.+|++|||.+-.+...-. .
T Consensus 95 gggslQdiy~~--TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~-K 168 (829)
T KOG0576|consen 95 GGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA-K 168 (829)
T ss_pred CCCcccceeee--cccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhhhh-h
Confidence 99999998775 4569999999999999999999995 8889999999999999999999999999876654322 3
Q ss_pred ccccccCCCccchhhh---cCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 504 TTKLVGTFGYMDPELM---RTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~---~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
.....||+.|||||+. +.+.|...+|||+.|+...|+.--++|....-+..... ...+. ....+.+.
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~-------LmTkS---~~qpp~lk 238 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALF-------LMTKS---GFQPPTLK 238 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHH-------Hhhcc---CCCCCccc
Confidence 3446899999999976 35678999999999999999987777754322211111 11110 01111121
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
. ...-.+.+-.++..|+..+|++||++..+|+
T Consensus 239 D--k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 239 D--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred C--CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1 1122345777788899999999999987764
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.1e-28 Score=245.79 Aligned_cols=282 Identities=21% Similarity=0.247 Sum_probs=216.0
Q ss_pred hhhhhhccCCcccCHHHHHHHhcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccC--
Q 044561 323 YEDWEREYGPQRFTYKDLYKATKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLR-- 399 (614)
Q Consensus 323 ~~~~~~~~~~~~~~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-- 399 (614)
.+.|....|--+..+.|+.. ..|......|+|-|++|.+|.... +..||||++.....- .+.=+.|+++|++|+
T Consensus 412 ~DNWdDaEGYYrv~igE~LD--~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~A 488 (752)
T KOG0670|consen 412 QDNWDDAEGYYRVRIGELLD--SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDA 488 (752)
T ss_pred ccCcccccceEEEehhhhhc--ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhcc
Confidence 34455555555556666554 678888899999999999999865 789999999876443 244478999999995
Q ss_pred ----CCceeEEeeEEeecCeEEEEEEecCCCCcchhcccCC-CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCC
Q 044561 400 ----HRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNI-KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKP 474 (614)
Q Consensus 400 ----H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp 474 (614)
--|+++++-.|...+++|||+|-+ ..+|.+.|++.. ...|.......++.|+.-||..|. +-+|+|.||||
T Consensus 489 D~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKP 564 (752)
T KOG0670|consen 489 DPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKP 564 (752)
T ss_pred CchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCc
Confidence 357899999999999999999987 678999998643 345888999999999999999999 58999999999
Q ss_pred CCeEEcCCC-CEEEeeeccccccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcc
Q 044561 475 ANVLLDADL-NGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSM 553 (614)
Q Consensus 475 ~NIll~~~~-~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~ 553 (614)
.|||+++.. .+||||||-|........ +...-+..|.|||++.+-.|....|+||.||+||||.||+.-|++..+.
T Consensus 565 DNiLVNE~k~iLKLCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN 641 (752)
T KOG0670|consen 565 DNILVNESKNILKLCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNN 641 (752)
T ss_pred cceEeccCcceeeeccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcH
Confidence 999998764 579999999987766543 3334567899999999999999999999999999999999999998887
Q ss_pred ccccHHHHHHHh-----hhcCCcc---------------------------ccccc------cccC--cCc---HHHHHH
Q 044561 554 ETVNLVDWVCDC-----WKKGAIR---------------------------DASDS------RLEG--ICE---EKQMEL 590 (614)
Q Consensus 554 ~~~~l~~~v~~~-----~~~~~~~---------------------------~~~d~------~l~~--~~~---~~~~~~ 590 (614)
.++.+...+... +.+|.+. ..+.| .+.+ .++ ......
T Consensus 642 ~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~ 721 (752)
T KOG0670|consen 642 QMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQ 721 (752)
T ss_pred HHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHH
Confidence 766554322211 1111110 00001 1111 122 234566
Q ss_pred HHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 591 VLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 591 l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+..|...|+..||++|.|..|+|+
T Consensus 722 ~rdLLdkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 722 LRDLLDKMLILDPEKRITVNQALK 745 (752)
T ss_pred HHHHHHHHhccChhhcCCHHHHhc
Confidence 888999999999999999999875
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-26 Score=218.17 Aligned_cols=247 Identities=22% Similarity=0.351 Sum_probs=186.8
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhccc-CCCceeEEeeE-EeecCeEEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRL-RHRNLVKLRGY-CRRKGEFLLVYD 421 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~-~~~~~~~~lV~E 421 (614)
+.|.+.+.+|+|.||.+-.+..+. ++.+++|-+... ....++|.+|...--.| .|.||+.-++. +...+.+++++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 457778899999999999999886 677888877554 33468899998765556 58999987764 667788999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEE-cC-CCCEEEeeeccccccCCC
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL-DA-DLNGKLGDFGLARLYDHD 499 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll-~~-~~~~kl~DfGla~~~~~~ 499 (614)
|+|.|+|.+-+..+ .+.+....+++.|+++|+.|+|+ .++||||||.+|||| +. .-++||||||+.+..+..
T Consensus 103 ~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 103 FAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred cCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence 99999999988653 37788888999999999999996 899999999999999 33 347999999998865432
Q ss_pred CCCcccccccCCCccchhhhcCC-----CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccc
Q 044561 500 TIPQTTKLVGTFGYMDPELMRTG-----KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDA 574 (614)
Q Consensus 500 ~~~~~~~~~gt~~y~aPE~~~~~-----~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~ 574 (614)
- ...--+..|.+||..... ...+.+|+|.||++++.+++|+.||+.... .....|-|..|..+.....
T Consensus 177 V----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~---~d~~Y~~~~~w~~rk~~~~ 249 (378)
T KOG1345|consen 177 V----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI---MDKPYWEWEQWLKRKNPAL 249 (378)
T ss_pred e----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc---cCchHHHHHHHhcccCccC
Confidence 2 112235578899976432 357789999999999999999999985433 3344667777777666532
Q ss_pred ccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHH
Q 044561 575 SDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQ 611 (614)
Q Consensus 575 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 611 (614)
. +.-..+.+ .++++..+-+.++|++|-...+
T Consensus 250 P--~~F~~fs~----~a~r~Fkk~lt~~~~drcki~~ 280 (378)
T KOG1345|consen 250 P--KKFNPFSE----KALRLFKKSLTPRFKDRCKIWT 280 (378)
T ss_pred c--hhhcccCH----HHHHHHHHhcCCcccccchhHH
Confidence 2 22222344 4555556689999999954444
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-26 Score=267.37 Aligned_cols=196 Identities=17% Similarity=0.262 Sum_probs=139.0
Q ss_pred cccCC-CceeEEeeEE-------eecCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCce
Q 044561 396 GRLRH-RNLVKLRGYC-------RRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVV 467 (614)
Q Consensus 396 ~~l~H-~niv~l~g~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 467 (614)
+.++| +||++++++| .+...+++++|++ +++|.++|... ...+++.++..++.||++||.|||+ ++|
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~gI 101 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHS---QGI 101 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 34556 6888888887 2334678889987 66999999754 3459999999999999999999994 899
Q ss_pred EecCcCCCCeEEcCC-------------------CCEEEeeeccccccCCCC---------------CCcccccccCCCc
Q 044561 468 LHRDIKPANVLLDAD-------------------LNGKLGDFGLARLYDHDT---------------IPQTTKLVGTFGY 513 (614)
Q Consensus 468 vHrDikp~NIll~~~-------------------~~~kl~DfGla~~~~~~~---------------~~~~~~~~gt~~y 513 (614)
+||||||+||||+.. +.+|++|||+++...... .......+||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 999999999999654 445666666665321100 0001124688999
Q ss_pred cchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHH
Q 044561 514 MDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLK 593 (614)
Q Consensus 514 ~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 593 (614)
||||++.+..++.++|||||||+||||++|..|+..... ..... .... .++... ........
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~~~~~----~~~~----~~~~~~-----~~~~~~~~ 243 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----TMSSL----RHRV----LPPQIL-----LNWPKEAS 243 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----HHHHH----HHhh----cChhhh-----hcCHHHHH
Confidence 999999999999999999999999999999888643110 11000 0000 111110 11223456
Q ss_pred HHHHcCCCCCCCCCCHHHHhC
Q 044561 594 LGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 594 l~~~cl~~dP~~RPs~~evl~ 614 (614)
++.+||+++|.+||+|.||++
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHhCCCChhhCcChHHHhh
Confidence 778899999999999999975
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.5e-25 Score=221.07 Aligned_cols=199 Identities=29% Similarity=0.477 Sum_probs=165.4
Q ss_pred HHhcCCCCcceeeeeCcEEEEEEEEec----CcEEEEEEeecCChhhHHHHHHHHHHhcccC-CCceeEEeeEEeecCeE
Q 044561 342 KATKGFKDKDVIGRGGFGKVYRGVLAS----NVQIAVKKVSHDSKQGIKEFVAELVSMGRLR-HRNLVKLRGYCRRKGEF 416 (614)
Q Consensus 342 ~~~~~f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~ 416 (614)
...+.|...++||+|.|++||++.+.. ...||+|.+...+. .....+|++.|..+. +.||+++.+++...+..
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 345678889999999999999998643 57799999876543 356789999999994 99999999999999999
Q ss_pred EEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCC-CCEEEeeeccccc
Q 044561 417 LLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDAD-LNGKLGDFGLARL 495 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~-~~~kl~DfGla~~ 495 (614)
.+|+||+++-...++... ++..++..++..+..||.++| .++||||||||+|+|.+.. +.-.|.|||||..
T Consensus 111 ~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred EEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHHH
Confidence 999999999988888765 778899999999999999999 5999999999999999764 6679999999973
Q ss_pred cCCCC--------------C----------------C-------------cccccccCCCccchhhhcC-CCCCcchhHH
Q 044561 496 YDHDT--------------I----------------P-------------QTTKLVGTFGYMDPELMRT-GKASTSTDVY 531 (614)
Q Consensus 496 ~~~~~--------------~----------------~-------------~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~ 531 (614)
.+... . + .....+||+||.|||++.. +.-++++|||
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 21100 0 0 0012469999999999865 4568899999
Q ss_pred HHHHHHHHHHcCCCCCCCC
Q 044561 532 AFGVFMLEVASGRRPVEQQ 550 (614)
Q Consensus 532 S~Gvll~el~tg~~p~~~~ 550 (614)
|-|++++-+++++.||...
T Consensus 263 s~GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKA 281 (418)
T ss_pred eccceeehhhccccccccC
Confidence 9999999999999999654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.4e-24 Score=202.93 Aligned_cols=162 Identities=20% Similarity=0.219 Sum_probs=121.3
Q ss_pred CCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCccc
Q 044561 426 GSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT 505 (614)
Q Consensus 426 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 505 (614)
|+|.+++... ...+++.+++.++.|+++||.|||+ ++ ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----- 63 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----- 63 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc-----
Confidence 6889998754 3459999999999999999999996 33 999999999999999 99998765432
Q ss_pred ccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcH
Q 044561 506 KLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEE 585 (614)
Q Consensus 506 ~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~ 585 (614)
..||+.|+|||++.+..++.++|||||||++|||++|+.||....... .....+....... ++.. .....
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~------~~~~-~~~~~ 133 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPAD------DPRD-RSNLE 133 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhccC------Cccc-cccHH
Confidence 268999999999999999999999999999999999999996533211 1111111111110 0000 00112
Q ss_pred HHHH--HHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 586 KQME--LVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 586 ~~~~--~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.... .+.+++.+||+.||++||++.|+++
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~ 164 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRREAANHYLA 164 (176)
T ss_pred HHHhhhhHHHHHHHHHhcccccccCHHHHHH
Confidence 2222 5889999999999999999999874
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.9e-23 Score=213.46 Aligned_cols=165 Identities=21% Similarity=0.234 Sum_probs=128.6
Q ss_pred HHhcCCCCcceeeeeCcEEEEEEEEe--cCcEEEEEEeecC-----ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecC
Q 044561 342 KATKGFKDKDVIGRGGFGKVYRGVLA--SNVQIAVKKVSHD-----SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKG 414 (614)
Q Consensus 342 ~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 414 (614)
....+|...+.||+|+||+||+|..+ ++..+|||++... .....+.+.+|++++++++|+|+++.+.. .+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence 34567999999999999999999875 3666799987533 22345678999999999999999853322 24
Q ss_pred eEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCc-CCCCeEEcCCCCEEEeeeccc
Q 044561 415 EFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI-KPANVLLDADLNGKLGDFGLA 493 (614)
Q Consensus 415 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDi-kp~NIll~~~~~~kl~DfGla 493 (614)
..++||||+++++|... .. .. ...++.+++++|.|||+ ++|+|||| ||+|||++.++++||+|||++
T Consensus 92 ~~~LVmE~~~G~~L~~~-~~-----~~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA-RP-----HG---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred CcEEEEEccCCCCHHHh-Cc-----cc---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 68999999999999632 11 11 14678899999999995 89999999 999999999999999999999
Q ss_pred cccCCCCC-------CcccccccCCCccchhhhcC
Q 044561 494 RLYDHDTI-------PQTTKLVGTFGYMDPELMRT 521 (614)
Q Consensus 494 ~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~ 521 (614)
+....... ...+...+++.|+|||.+..
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 87654321 11235678889999998854
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-23 Score=199.79 Aligned_cols=238 Identities=20% Similarity=0.360 Sum_probs=182.5
Q ss_pred ceeeeeCcEEEEEEEEecCcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecCCCCc
Q 044561 351 DVIGRGGFGKVYRGVLASNVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSL 428 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 428 (614)
-+|.+...|+.|+|+++++. +++|++... .....++|..|.-.++-+.||||+.++|.|....++.++..|||.|||
T Consensus 196 tkl~e~hsgelwrgrwqgnd-ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQGND-IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hhhccCCCcccccccccCcc-hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 35888899999999997653 455655432 333456789999999999999999999999999999999999999999
Q ss_pred chhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEe--eeccccccCCCCCCcccc
Q 044561 429 DKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLG--DFGLARLYDHDTIPQTTK 506 (614)
Q Consensus 429 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~--DfGla~~~~~~~~~~~~~ 506 (614)
...|+.......+-.|..+++.++|+|++|||+- ++-|----+.+..+++|++.+++|. |--++.. ...
T Consensus 275 ynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfq--------e~g 345 (448)
T KOG0195|consen 275 YNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ--------EVG 345 (448)
T ss_pred HHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeee--------ccc
Confidence 9999987777788899999999999999999984 4444455688999999999998874 3222211 111
Q ss_pred cccCCCccchhhhcCCCC---CcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcC
Q 044561 507 LVGTFGYMDPELMRTGKA---STSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGIC 583 (614)
Q Consensus 507 ~~gt~~y~aPE~~~~~~~---t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 583 (614)
..-.+.||+||.++.++- -.++|+|||.+++|||.|...||....+.|..-.+ .-+.++-.+
T Consensus 346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki---------------aleglrv~i 410 (448)
T KOG0195|consen 346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI---------------ALEGLRVHI 410 (448)
T ss_pred cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh---------------hhccccccC
Confidence 233678999999976543 35799999999999999999999876655433211 112223334
Q ss_pred cHHHHHHHHHHHHHcCCCCCCCCCCHHHHh
Q 044561 584 EEKQMELVLKLGLFCSHPKPEARPNMRQVM 613 (614)
Q Consensus 584 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 613 (614)
+......+.+|+.-|++.||.+||.+..|+
T Consensus 411 ppgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 411 PPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred CCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 444455667777779999999999998764
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=8e-21 Score=195.14 Aligned_cols=258 Identities=28% Similarity=0.407 Sum_probs=194.6
Q ss_pred CCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChh---hHHHHHHHHHHhcccCCC-ceeEEeeEEeecCeEEEEEEe
Q 044561 347 FKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQ---GIKEFVAELVSMGRLRHR-NLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 347 f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~H~-niv~l~g~~~~~~~~~lV~E~ 422 (614)
|...+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 556788999999999999987 67888888665332 467899999999999988 799999999777778999999
Q ss_pred cCCCCcchhcccCCC-CCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCC-CEEEeeeccccccCCCC
Q 044561 423 MPNGSLDKILHTNIK-PCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADL-NGKLGDFGLARLYDHDT 500 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~-~~kl~DfGla~~~~~~~ 500 (614)
+.++++.+++..... ..+.......++.|++.++.|+|+ .+++|||+||+||+++... .++++|||.++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999977665422 258899999999999999999994 7899999999999999998 79999999998554433
Q ss_pred CC-----cccccccCCCccchhhhcC---CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcc
Q 044561 501 IP-----QTTKLVGTFGYMDPELMRT---GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIR 572 (614)
Q Consensus 501 ~~-----~~~~~~gt~~y~aPE~~~~---~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~ 572 (614)
.. ......|+..|+|||.+.. ..+....|+||+|++++++++|+.|+...... .......+........
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc
Confidence 21 2355689999999999987 57899999999999999999999997654321 0011111111111111
Q ss_pred ccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHh
Q 044561 573 DASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVM 613 (614)
Q Consensus 573 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 613 (614)
.................+.+++..|+..+|..|.++.+..
T Consensus 234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~ 273 (384)
T COG0515 234 -SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273 (384)
T ss_pred -ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHh
Confidence 0000111111122234567777789999999999987654
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.5e-21 Score=201.58 Aligned_cols=203 Identities=25% Similarity=0.289 Sum_probs=165.8
Q ss_pred CCCCcceeeeeCcEEEEEEEEecC--cEEEEEEeecCChhhHHHHHHHHHHhcccCC----CceeEEeeEE-eecCeEEE
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLASN--VQIAVKKVSHDSKQGIKEFVAELVSMGRLRH----RNLVKLRGYC-RRKGEFLL 418 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H----~niv~l~g~~-~~~~~~~l 418 (614)
+|+..+.||+|+||.||++..... ..+|+|............+..|..++..+.. +++.++++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 788999999999999999997663 4678887765533332366778888887763 5888888888 47778899
Q ss_pred EEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCC-----CCEEEeeeccc
Q 044561 419 VYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDAD-----LNGKLGDFGLA 493 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~-----~~~kl~DfGla 493 (614)
||+.+ +.+|.++........++..+.+.|+.|++.+|.+|| +.+++||||||.|+++... ..+.|.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99998 889999886655567999999999999999999999 4999999999999999754 46899999999
Q ss_pred c--ccCCCC-----CCc--ccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCc
Q 044561 494 R--LYDHDT-----IPQ--TTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGS 552 (614)
Q Consensus 494 ~--~~~~~~-----~~~--~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~ 552 (614)
+ .+.... .+. .....||..|.++....+...+.+.|+||++.++.|+..|..||.....
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 8 332111 111 1234699999999999999999999999999999999999999976543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.4e-22 Score=221.57 Aligned_cols=253 Identities=19% Similarity=0.232 Sum_probs=186.0
Q ss_pred CCcceeeeeCcEEEEEEEEec-CcEEEEEEe-----ecCChh-hHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 348 KDKDVIGRGGFGKVYRGVLAS-NVQIAVKKV-----SHDSKQ-GIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 348 ~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~-----~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
...+++|.|++|.|+..+... ......|.. ...... ....+..|+.+-..++|+|++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 457889999999877776543 222333322 122222 2223677888889999999998888887777777779
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
|||++ +|..++... ..+...++..+++|+..|+.|||+ .+|.|||+|++|++++.++.+||+|||.+.....+.
T Consensus 401 E~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred hcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 99999 999998764 348889999999999999999995 999999999999999999999999999998665433
Q ss_pred C---CcccccccCCCccchhhhcCCCCCc-chhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccc
Q 044561 501 I---PQTTKLVGTFGYMDPELMRTGKAST-STDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASD 576 (614)
Q Consensus 501 ~---~~~~~~~gt~~y~aPE~~~~~~~t~-~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 576 (614)
. ......+|+..|+|||.+....|.+ ..||||.|+++..|.+|+.||......+... . .. .+. .....
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-~---~~---~~~-~~~~~ 546 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-K---TN---NYS-DQRNI 546 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-h---hh---ccc-ccccc
Confidence 2 3445578999999999999888865 6899999999999999999997654433321 0 00 000 00000
Q ss_pred ccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 577 SRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 577 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..-..............++.+|+++||.+|-|+.+|++
T Consensus 547 ~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 547 FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00001122333445677788899999999999999985
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.6e-20 Score=197.58 Aligned_cols=209 Identities=26% Similarity=0.432 Sum_probs=158.1
Q ss_pred hcccCCCceeEEeeEEeecCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCC
Q 044561 395 MGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKP 474 (614)
Q Consensus 395 l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp 474 (614)
|+.+.|.|+.+++|.|.++...+.|.+||+.|+|.+.+... ...++|.....++++|+.||.|||+ .+-..|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeeeecc
Confidence 46789999999999999999999999999999999999874 3459999999999999999999996 23349999999
Q ss_pred CCeEEcCCCCEEEeeeccccccCCC-CCCcccccccCCCccchhhhcCC-------CCCcchhHHHHHHHHHHHHcCCCC
Q 044561 475 ANVLLDADLNGKLGDFGLARLYDHD-TIPQTTKLVGTFGYMDPELMRTG-------KASTSTDVYAFGVFMLEVASGRRP 546 (614)
Q Consensus 475 ~NIll~~~~~~kl~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~t~~~Dv~S~Gvll~el~tg~~p 546 (614)
+|+++|..+.+||.|||+....... .........-...|.|||.+... ..+.+.||||||++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9999999999999999998776421 11111122345679999998763 147789999999999999999999
Q ss_pred CCCCCcccc-ccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHh
Q 044561 547 VEQQGSMET-VNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVM 613 (614)
Q Consensus 547 ~~~~~~~~~-~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 613 (614)
|+.....+. ..++.++.+ ......-+.+.... +..+.+..++..||..+|++||++.+|-
T Consensus 158 ~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred cccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHH
Confidence 986443322 233333322 11111122221110 2333688889999999999999999873
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.1e-21 Score=214.82 Aligned_cols=246 Identities=21% Similarity=0.232 Sum_probs=178.9
Q ss_pred CCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCC-hhhHHHHHHHHHH--hcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDS-KQGIKEFVAELVS--MGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~--l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
++...+.||++.|=+|.+|+.+.|. |+||.+-+.. .-..+.|.++++- ...++|||.+++..+-......|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 4667788999999999999998887 8888875543 4445555554443 4445899999999987777888999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccc--cCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARL--YDHDT 500 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~--~~~~~ 500 (614)
. .-+|.+.|.. ++.+...+...|+.|++.||..+| +.+|+|||||.+||||++-.-+.|+||.--+. ...+.
T Consensus 103 v-khnLyDRlST--RPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 103 V-KHNLYDRLST--RPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred H-hhhhhhhhcc--chHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 8 4578888866 566889999999999999999999 69999999999999999999999999986542 22222
Q ss_pred CCcccc----cccCCCccchhhhcCC-----------CCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHH
Q 044561 501 IPQTTK----LVGTFGYMDPELMRTG-----------KASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCD 564 (614)
Q Consensus 501 ~~~~~~----~~gt~~y~aPE~~~~~-----------~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~ 564 (614)
....+. ...-.+|+|||.+... ..+++.||||+||++.||++ |++||.-. .+..
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~a---- 246 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLA---- 246 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHh----
Confidence 212111 1233479999987531 26789999999999999999 67777521 1111
Q ss_pred hhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 565 CWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 565 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
++.|. .......+.+.- ...+..|++.|++.||++|.|+.+.|+
T Consensus 247 -Yr~~~-~~~~e~~Le~Ie----d~~~Rnlil~Mi~rdPs~RlSAedyL~ 290 (1431)
T KOG1240|consen 247 -YRSGN-ADDPEQLLEKIE----DVSLRNLILSMIQRDPSKRLSAEDYLQ 290 (1431)
T ss_pred -HhccC-ccCHHHHHHhCc----CccHHHHHHHHHccCchhccCHHHHHH
Confidence 12221 111111111111 124677888899999999999999875
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.5e-20 Score=175.71 Aligned_cols=142 Identities=16% Similarity=0.102 Sum_probs=108.0
Q ss_pred cceeeeeCcEEEEEEEEecCcEEEEEEeecCChh--h-------H-----------------HHHHHHHHHhcccCCCce
Q 044561 350 KDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQ--G-------I-----------------KEFVAELVSMGRLRHRNL 403 (614)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~Ei~~l~~l~H~ni 403 (614)
...||+|+||.||+|...+|+.||+|++...... . . .....|+..+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999888999999998754211 0 0 122348999999987776
Q ss_pred eEEeeEEeecCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCC
Q 044561 404 VKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADL 483 (614)
Q Consensus 404 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~ 483 (614)
.....+.. ...+|||||++++++...+.. ...++..+...++.|++.+|.|||+ ..+|+||||||+|||++ ++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H--~~giiHrDlkP~NIli~-~~ 154 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQ--DCRLVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEE-CC
Confidence 43322211 223899999998877655332 2358899999999999999999932 47999999999999998 47
Q ss_pred CEEEeeeccccccCC
Q 044561 484 NGKLGDFGLARLYDH 498 (614)
Q Consensus 484 ~~kl~DfGla~~~~~ 498 (614)
.++|+|||++...++
T Consensus 155 ~v~LiDFG~a~~~~~ 169 (190)
T cd05147 155 KLYIIDVSQSVEHDH 169 (190)
T ss_pred cEEEEEccccccCCC
Confidence 899999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd07308 lectin_leg-like legume-like lectins: ERGIC-53, ERGL, VIP36, VIPL, EMP46, and EMP47 | Back alignment and domain information |
|---|
Probab=99.81 E-value=1e-18 Score=171.28 Aligned_cols=176 Identities=25% Similarity=0.285 Sum_probs=125.5
Q ss_pred CCceEecceeEcCCCcEEecCCCCCCceeeEeeCCceeecCCCCCceeeeeeeEEee---------eeEEEEcCCCCCCC
Q 044561 39 AQLQRDGLASVHSNGLLQLTNTVSPQQEGHAFYRLPIKFNTSSSESLSFSSNFVFAI---------GMAFVISPSKDLGK 109 (614)
Q Consensus 39 ~~~~~~g~a~~~~~g~l~Lt~~~~~~~~G~~~y~~pv~l~~~~~~~~sF~t~F~f~i---------G~aF~l~p~~~~~~ 109 (614)
.++.+.|+|.+. ++.|+||++.. .+.|++||+.|+++. +|+|+|+|.| ||||+++|...
T Consensus 20 ~~w~~~G~a~~~-~~~i~LT~~~~-~~~G~~~~~~pi~~~-------~F~~~f~F~i~~~~~~~gdG~af~~~~~~~--- 87 (218)
T cd07308 20 GNWTVGGSTVIT-KNYIRLTPDVP-SQSGSLWSRVPIPAK-------DFEIEVEFSIHGGSGLGGDGFAFWYTEEPG--- 87 (218)
T ss_pred CCeEEcCCeEEe-CCEEEeCCCCC-CCEeEEEeCCCccCC-------CEEEEEEEEEeCCCCCCCCEEEEEEECCCC---
Confidence 579999999997 89999999876 799999999999983 5999999999 99999998543
Q ss_pred CCCCCCCcccccccCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeeEecC-CCcc-----------cccccCccccCccC
Q 044561 110 AEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVN-SLIS-----------HESAPAAYFSDREG 177 (614)
Q Consensus 110 ~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~n-s~~s-----------~~~~~~~~~~~~~~ 177 (614)
..|+.+|.-+ ..+-+||||||+.|. +-..++|.+-+| +..+ .....+.+
T Consensus 88 ---~~g~~~G~~~-------~~~Glai~fdt~~n~---~~~~p~i~~~~Ndg~~~~~~~~d~~~~~~~~c~~~~------ 148 (218)
T cd07308 88 ---SDGPLFGGPD-------KFKGLAIFFDTYDND---GKGFPSISVFLNDGTKSYDYETDGEKLELASCSLKF------ 148 (218)
T ss_pred ---CCCcccccCC-------CCCEEEEEEEcCCCC---CCCCCeEEEEEeCCCceecccCCCccccccceeEec------
Confidence 2344555422 235599999999985 223344544333 1111 11222211
Q ss_pred CCccccccCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcccccccccccccccCCCccceeeEeccccc
Q 044561 178 MNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLKSSHYVLGWSFN 257 (614)
Q Consensus 178 ~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastg~~~~~h~i~sWsf~ 257 (614)
..++++++++|.|+ .+.|.|.+... .+........++.- .+|+..|+||||+||...+.|.|++|.+.
T Consensus 149 ------~~~~~~~~~~I~y~--~~~l~v~i~~~---~~~~~~~c~~~~~~-~l~~~~y~G~sA~tg~~~d~~dIls~~~~ 216 (218)
T cd07308 149 ------RNSNAPTTLRISYL--NNTLKVDITYS---EGNNWKECFTVEDV-ILPSQGYFGFSAQTGDLSDNHDILSVHTY 216 (218)
T ss_pred ------ccCCCCeEEEEEEE--CCEEEEEEeCC---CCCCccEEEEcCCc-ccCCCCEEEEEeccCCCcCcEEEEEEEee
Confidence 11267999999999 78899999643 12222333333322 46789999999999999999999999764
|
The legume-like (leg-like) lectins are eukaryotic intracellular sugar transport proteins with a carbohydrate recognition domain similar to that of the legume lectins. This domain binds high-mannose-type oligosaccharides for transport from the endoplasmic reticulum to the Golgi complex. These leg-like lectins include ERGIC-53, ERGL, VIP36, VIPL, EMP46, EMP47, and the UIP5 (ULP1-interacting protein 5) precursor protein. Leg-like lectins have different intracellular distributions and dynamics in the endoplasmic reticulum-Golgi system of the secretory pathway and interact with N-glycans of glycoproteins in a calcium-dependent manner, suggesting a role in glycoprotein sorting and trafficking. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "ba |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.6e-19 Score=176.71 Aligned_cols=231 Identities=21% Similarity=0.245 Sum_probs=152.7
Q ss_pred CCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhcccC----------CCceeEEeeEE--
Q 044561 347 FKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRLR----------HRNLVKLRGYC-- 410 (614)
Q Consensus 347 f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~----------H~niv~l~g~~-- 410 (614)
+...+.||.|+++.||.++..+ ++++++|...... ....+++.+|.-....+. |-.++..++..
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 4557889999999999999987 8899999886443 334667777765555532 22222222222
Q ss_pred -------eec---C-----eEEEEEEecCCCCcchhccc---C--CCCCcChhHHHHHHHHhHhhchhhhccCCCceEec
Q 044561 411 -------RRK---G-----EFLLVYDYMPNGSLDKILHT---N--IKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHR 470 (614)
Q Consensus 411 -------~~~---~-----~~~lV~E~~~~gsL~~~l~~---~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHr 470 (614)
... . ..+++|+-+ .++|.+++.. . ....+....++.+..|+++.+++||+ .+++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEec
Confidence 111 1 236788887 6788877542 1 12235666778888999999999995 899999
Q ss_pred CcCCCCeEEcCCCCEEEeeeccccccCCCCCCcccccccCCCccchhhhcC--------CCCCcchhHHHHHHHHHHHHc
Q 044561 471 DIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRT--------GKASTSTDVYAFGVFMLEVAS 542 (614)
Q Consensus 471 Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~~~Dv~S~Gvll~el~t 542 (614)
||+|+|++++.+|.++|+||+.....+..... ...+..|.+||.... -.++.+.|.|++|+++|.|+|
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 99999999999999999999887755432211 234578999997643 247889999999999999999
Q ss_pred CCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCC
Q 044561 543 GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEAR 606 (614)
Q Consensus 543 g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~R 606 (614)
|+.||.......... ..-+.|. +..+.+..|+..++++||++|
T Consensus 246 ~~lPf~~~~~~~~~~--------------------~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPE--------------------WDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSG--------------------GGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCcccccc--------------------ccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999997653321111 0223466 777889999999999999988
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.8e-20 Score=176.94 Aligned_cols=171 Identities=13% Similarity=0.168 Sum_probs=131.3
Q ss_pred HhcCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhh---HHH------HHHHHHHhcccCCCceeEEeeEEeec
Q 044561 343 ATKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQG---IKE------FVAELVSMGRLRHRNLVKLRGYCRRK 413 (614)
Q Consensus 343 ~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~---~~~------~~~Ei~~l~~l~H~niv~l~g~~~~~ 413 (614)
...+|+..+++|.|+||.||.... ++..+++|.+....... ... +.+|+..+.+++|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 457899999999999999999655 56689999986542221 122 67899999999999999998875532
Q ss_pred --------CeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCE
Q 044561 414 --------GEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG 485 (614)
Q Consensus 414 --------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~ 485 (614)
+..+|+|||++|.+|.++.. ++. ....+++.++..|| +.+++|||+||+||+++.++ +
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-E
Confidence 35899999999999987632 222 24568999999999 58999999999999999988 9
Q ss_pred EEeeeccccccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHH
Q 044561 486 KLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVA 541 (614)
Q Consensus 486 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~ 541 (614)
+|+|||.......+... ..+.....+..++|+|+||+.+.-+.
T Consensus 174 ~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 99999988755332211 11333445667999999999886553
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.2e-19 Score=170.66 Aligned_cols=203 Identities=25% Similarity=0.332 Sum_probs=166.8
Q ss_pred hcCCCCcceeeeeCcEEEEEEEE-ecCcEEEEEEeecCChhhHHHHHHHHHHhcccCC-CceeEEeeEEeecCeEEEEEE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVL-ASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRH-RNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~E 421 (614)
...|...++||+|+||.+|.|.. .+|.+||+|.-+...++ .++..|..+.+.|++ ..|..+..+..++..-.+|||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 35688899999999999999985 45999999987665443 456778888888875 677778888888889999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcC---CCCEEEeeeccccccCC
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA---DLNGKLGDFGLARLYDH 498 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~---~~~~kl~DfGla~~~~~ 498 (614)
.. +-||.+++.-..+ .++..+.+-++-|++.-++|+| .++.+||||||+|.|..- ..++.++||||++.+..
T Consensus 92 LL-GPsLEdLfnfC~R-~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSR-RFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred cc-CccHHHHHHHHhh-hhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 98 8899998875433 3888999999999999999999 599999999999999954 45688999999987643
Q ss_pred CC------CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcc
Q 044561 499 DT------IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSM 553 (614)
Q Consensus 499 ~~------~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~ 553 (614)
.. ........||.+|.+-....+..-+...|+-|+|.+|...--|..||++....
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA 227 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence 21 22345578999999887776667788999999999999999999999876543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.5e-19 Score=168.73 Aligned_cols=141 Identities=18% Similarity=0.164 Sum_probs=110.6
Q ss_pred cceeeeeCcEEEEEEEEecCcEEEEEEeecCChh--------------------------hHHHHHHHHHHhcccCCCce
Q 044561 350 KDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQ--------------------------GIKEFVAELVSMGRLRHRNL 403 (614)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~Ei~~l~~l~H~ni 403 (614)
...||+|++|.||+|...+|+.||||.+...... ....+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999999878999999998764211 01223578899999999887
Q ss_pred eEEeeEEeecCeEEEEEEecCCCCcchh-cccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCC
Q 044561 404 VKLRGYCRRKGEFLLVYDYMPNGSLDKI-LHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDAD 482 (614)
Q Consensus 404 v~l~g~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~ 482 (614)
.....+... ..+|||||++++++... +.. ..++..+...++.|++.++.+||+ +.+|+||||||+||+++ +
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~-~ 153 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH-D 153 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-C
Confidence 544333322 24899999998865443 332 347788899999999999999995 38999999999999999 8
Q ss_pred CCEEEeeeccccccCC
Q 044561 483 LNGKLGDFGLARLYDH 498 (614)
Q Consensus 483 ~~~kl~DfGla~~~~~ 498 (614)
+.++|+|||++....+
T Consensus 154 ~~~~liDFG~a~~~~~ 169 (190)
T cd05145 154 GKPYIIDVSQAVELDH 169 (190)
T ss_pred CCEEEEEcccceecCC
Confidence 9999999999986654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.2e-18 Score=163.97 Aligned_cols=187 Identities=17% Similarity=0.083 Sum_probs=140.6
Q ss_pred CCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChh----hHHHHHHHHHHhcccC-CCceeEEeeEEeecCeEEEEEEe
Q 044561 348 KDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQ----GIKEFVAELVSMGRLR-HRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 348 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
.....|++|+||+||.+.- ++.+++.+.+.....- ....+.+|+++|++|. |+++.+++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4567899999999996655 5777777777655431 1235789999999995 5889999886 446999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCc-CCCCeEEcCCCCEEEeeeccccccCCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI-KPANVLLDADLNGKLGDFGLARLYDHDTI 501 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDi-kp~NIll~~~~~~kl~DfGla~~~~~~~~ 501 (614)
+++.+|.+.+.. ....++.|++++|.++| ..+|+|||| ||+|||++.++.++|+|||++........
T Consensus 80 I~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 80 LAGAAMYQRPPR---------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred ecCccHHhhhhh---------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 999888654321 11357789999999999 489999999 79999999999999999999986544321
Q ss_pred C----c--------ccccccCCCccchhhhcCC-CCC-cchhHHHHHHHHHHHHcCCCCCCCCC
Q 044561 502 P----Q--------TTKLVGTFGYMDPELMRTG-KAS-TSTDVYAFGVFMLEVASGRRPVEQQG 551 (614)
Q Consensus 502 ~----~--------~~~~~gt~~y~aPE~~~~~-~~t-~~~Dv~S~Gvll~el~tg~~p~~~~~ 551 (614)
. . ......++.|++|+...-- ..+ ...+.++-|+-+|.++|++.+...+.
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 0 1122467888998854321 223 56889999999999999999876544
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.2e-18 Score=168.99 Aligned_cols=200 Identities=22% Similarity=0.300 Sum_probs=164.6
Q ss_pred CCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCChhhHHHHHHHHHHhccc-CCCceeEEeeEEeecCeEEEEEEec
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
.|+..++||+|.||..+.|+.- .++.||||.-...++. -++..|....+.| ..++|.+.+-+-.++.+-.||+|..
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A--PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA--PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCCc--chHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 5788899999999999999843 5889999976554432 3556677776666 4789999888888888889999998
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcC-----CCCEEEeeeccccccCC
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA-----DLNGKLGDFGLARLYDH 498 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~-----~~~~kl~DfGla~~~~~ 498 (614)
+-||+++..-.. ..++..+..-+|.|++.-++|+|+ +.+|.|||||+|.||.. ...+.|+|||+|+.+..
T Consensus 107 -GPSLEDLFD~Cg-R~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 107 -GPSLEDLFDLCG-RRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred -CcCHHHHHHHhc-CcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 889998876443 349999999999999999999995 89999999999999954 34589999999998754
Q ss_pred CCC------CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCc
Q 044561 499 DTI------PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGS 552 (614)
Q Consensus 499 ~~~------~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~ 552 (614)
... .......||.+||+-....+.+-+.+.|+-|+|-+++..+-|..||.+...
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 321 223346799999998888888889999999999999999999999987543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.6e-18 Score=165.39 Aligned_cols=137 Identities=20% Similarity=0.269 Sum_probs=107.3
Q ss_pred CCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhccc-----CCCceeEEeeEEeecC---e-EE
Q 044561 347 FKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRL-----RHRNLVKLRGYCRRKG---E-FL 417 (614)
Q Consensus 347 f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-----~H~niv~l~g~~~~~~---~-~~ 417 (614)
....+.||+|+||.||. .......+||++........+++.+|+.+++.+ .||||++++|++.++. . +.
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34567899999999996 444333478888765455567889999999999 5799999999998863 4 34
Q ss_pred EEEEe--cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhc-hhhhccCCCceEecCcCCCCeEEcC----CCCEEEeee
Q 044561 418 LVYDY--MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGL-LYLHEDWEQVVLHRDIKPANVLLDA----DLNGKLGDF 490 (614)
Q Consensus 418 lV~E~--~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivHrDikp~NIll~~----~~~~kl~Df 490 (614)
+|+|| +++|+|.+++.+. .+++. ..++.+++.++ .|||+ .+|+||||||+|||++. +.+++|+|+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 78999 6689999999653 25554 35678888787 89994 89999999999999974 347999995
Q ss_pred ccc
Q 044561 491 GLA 493 (614)
Q Consensus 491 Gla 493 (614)
+-+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.7e-19 Score=186.74 Aligned_cols=186 Identities=26% Similarity=0.371 Sum_probs=151.3
Q ss_pred eeeeeCcEEEEEEEE----ecCcEEEEEEeecCChhh--HHHHHHHHHHhcccC-CCceeEEeeEEeecCeEEEEEEecC
Q 044561 352 VIGRGGFGKVYRGVL----ASNVQIAVKKVSHDSKQG--IKEFVAELVSMGRLR-HRNLVKLRGYCRRKGEFLLVYDYMP 424 (614)
Q Consensus 352 ~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~~~~--~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~ 424 (614)
.+|+|.||.|+.+.. +.+..++.|...+..... ......|-.++..++ ||.++++.-.+..++..+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 378999999987653 225556776665432110 113345667777776 9999999999999999999999999
Q ss_pred CCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcc
Q 044561 425 NGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT 504 (614)
Q Consensus 425 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 504 (614)
+|.|...+.... .++..........++-++.++| +.+|+|||+|++||+++.+|++|+.|||+++..-....
T Consensus 81 gg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEV--MFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--- 152 (612)
T ss_pred cchhhhccccCC--chHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh---
Confidence 999998887643 3667777777888999999999 59999999999999999999999999999986544332
Q ss_pred cccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCC
Q 044561 505 TKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQ 549 (614)
Q Consensus 505 ~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~ 549 (614)
.+||..|||||++. ....+.|.||||++++||++|..||..
T Consensus 153 --~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 --ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred --cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 28999999999998 567899999999999999999999976
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.70 E-value=6.9e-17 Score=179.62 Aligned_cols=141 Identities=19% Similarity=0.268 Sum_probs=113.4
Q ss_pred HHhcCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecC-------ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecC
Q 044561 342 KATKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHD-------SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKG 414 (614)
Q Consensus 342 ~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~-------~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 414 (614)
.....|...+.||+|+||.||+|.+.+...++.++.... .....+.+.+|+++++.++|++++....++....
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 334455678899999999999998865443332222221 1122356889999999999999998888887777
Q ss_pred eEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecccc
Q 044561 415 EFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR 494 (614)
Q Consensus 415 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~ 494 (614)
..++||||+++++|.+++. ....++.+++++|.||| +.+++||||||+|||+ +++.++|+|||+++
T Consensus 410 ~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred CCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 8899999999999998874 35678999999999999 4899999999999999 67899999999998
Q ss_pred cc
Q 044561 495 LY 496 (614)
Q Consensus 495 ~~ 496 (614)
..
T Consensus 476 ~~ 477 (535)
T PRK09605 476 YS 477 (535)
T ss_pred cC
Confidence 54
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.69 E-value=9.6e-17 Score=159.10 Aligned_cols=143 Identities=17% Similarity=0.130 Sum_probs=110.7
Q ss_pred CCCCcceeeeeCcEEEEEEE--EecCcEEEEEEeecCChh------------------------hHHHHHHHHHHhcccC
Q 044561 346 GFKDKDVIGRGGFGKVYRGV--LASNVQIAVKKVSHDSKQ------------------------GIKEFVAELVSMGRLR 399 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~Ei~~l~~l~ 399 (614)
.|+..+.||+|+||.||+|. ..++..||+|.+...... ....+..|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46778899999999999998 456899999998754210 1123568999999997
Q ss_pred CC--ceeEEeeEEeecCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCc-eEecCcCCCC
Q 044561 400 HR--NLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQV-VLHRDIKPAN 476 (614)
Q Consensus 400 H~--niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivHrDikp~N 476 (614)
+. .+.+++++ ...++||||+++.+|....... ..+...+...++.|++.++.+||+ .+ ++||||||+|
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~N 179 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYN 179 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhh
Confidence 53 34444443 2348999999998887765332 235566778999999999999995 78 9999999999
Q ss_pred eEEcCCCCEEEeeeccccccCC
Q 044561 477 VLLDADLNGKLGDFGLARLYDH 498 (614)
Q Consensus 477 Ill~~~~~~kl~DfGla~~~~~ 498 (614)
|+++ +++++|+|||++...+.
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred EEEE-CCCEEEEEChhhhccCC
Confidence 9999 88999999999875443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.2e-16 Score=160.11 Aligned_cols=190 Identities=22% Similarity=0.297 Sum_probs=134.8
Q ss_pred CCCceeEEeeEEee---------------------------cCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHH
Q 044561 399 RHRNLVKLRGYCRR---------------------------KGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRG 451 (614)
Q Consensus 399 ~H~niv~l~g~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ 451 (614)
+|||||++++++.+ ...+|+||..+ ..+|..++..+. .+.....-|+.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC---CchHHHHHHHHH
Confidence 69999998886632 34689999988 458999887654 566677788999
Q ss_pred hHhhchhhhccCCCceEecCcCCCCeEE--cCC--CCEEEeeeccccccCCCC-----CCcccccccCCCccchhhhcCC
Q 044561 452 VASGLLYLHEDWEQVVLHRDIKPANVLL--DAD--LNGKLGDFGLARLYDHDT-----IPQTTKLVGTFGYMDPELMRTG 522 (614)
Q Consensus 452 ia~gL~yLH~~~~~~ivHrDikp~NIll--~~~--~~~kl~DfGla~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~ 522 (614)
+++|+.||| +++|.|||+|++|||+ |++ -...|+|||++-..+... ....-..-|.-.-||||+....
T Consensus 350 lLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 999999999 6999999999999999 333 346899999886443311 1122234577788999998643
Q ss_pred C------CCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHH
Q 044561 523 K------ASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGL 596 (614)
Q Consensus 523 ~------~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~ 596 (614)
+ ...|+|.|+.|.+.||++....||...++. .++.. .+++..++. +...++ ..+.+|+.
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L~~r-----~Yqe~qLPa-----lp~~vp----p~~rqlV~ 491 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LLDTR-----TYQESQLPA-----LPSRVP----PVARQLVF 491 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-eechh-----hhhhhhCCC-----CcccCC----hHHHHHHH
Confidence 2 246899999999999999999999764321 11111 122222222 222233 34566666
Q ss_pred HcCCCCCCCCCCHH
Q 044561 597 FCSHPKPEARPNMR 610 (614)
Q Consensus 597 ~cl~~dP~~RPs~~ 610 (614)
..+++||.+|||.+
T Consensus 492 ~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 492 DLLKRDPSKRVSPN 505 (598)
T ss_pred HHhcCCccccCCcc
Confidence 78999999999975
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.69 E-value=8.6e-18 Score=175.17 Aligned_cols=123 Identities=28% Similarity=0.474 Sum_probs=108.1
Q ss_pred CeEEEEEEecCCCCcchhcccC-CCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecc
Q 044561 414 GEFLLVYDYMPNGSLDKILHTN-IKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGL 492 (614)
Q Consensus 414 ~~~~lV~E~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGl 492 (614)
..+|+.|++|...+|.++|..+ .....++.....++.|++.|+.| ++.+|||+||.||+...+..+||+|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence 3589999999999999999743 33457889999999999999999 6889999999999999999999999999
Q ss_pred ccccCCCC-----CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc
Q 044561 493 ARLYDHDT-----IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS 542 (614)
Q Consensus 493 a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t 542 (614)
........ ....+..+||..||+||.+.+..|+.|+||||||++|+|++.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 87765544 234456789999999999999999999999999999999986
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.8e-16 Score=153.32 Aligned_cols=145 Identities=17% Similarity=0.157 Sum_probs=111.5
Q ss_pred HHHHHhcCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChh----------------------hHHHHHHHHHHhc
Q 044561 339 DLYKATKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQ----------------------GIKEFVAELVSMG 396 (614)
Q Consensus 339 el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~Ei~~l~ 396 (614)
++......|...+.||+|+||.||++...+++.+|||++...... ....+..|+..+.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 333333346777899999999999999888999999987543200 1123567888888
Q ss_pred ccCCCc--eeEEeeEEeecCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCC
Q 044561 397 RLRHRN--LVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKP 474 (614)
Q Consensus 397 ~l~H~n--iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp 474 (614)
.+.|++ +.+.++. ...++||||+++++|...... .....++.+++.++.++|+ .+++||||||
T Consensus 89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p 153 (198)
T cd05144 89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYK---HGIIHGDLSE 153 (198)
T ss_pred HHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCc
Confidence 888774 4444442 345899999999998775431 3456788999999999994 8999999999
Q ss_pred CCeEEcCCCCEEEeeeccccccCC
Q 044561 475 ANVLLDADLNGKLGDFGLARLYDH 498 (614)
Q Consensus 475 ~NIll~~~~~~kl~DfGla~~~~~ 498 (614)
+||++++++.++|+|||++.....
T Consensus 154 ~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred ccEEEcCCCcEEEEECCccccCCC
Confidence 999999999999999999975544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.1e-16 Score=156.10 Aligned_cols=134 Identities=22% Similarity=0.315 Sum_probs=112.7
Q ss_pred ceeeeeCcEEEEEEEEecCcEEEEEEeecCCh--------hhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 351 DVIGRGGFGKVYRGVLASNVQIAVKKVSHDSK--------QGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
+.||+|++|.||+|.. .+..+++|+...... .....+.+|+.++..++|+++.....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 566788887653221 1224578899999999999988877777777888999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccc
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARL 495 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~ 495 (614)
+++++|.+++.... + ++..++.+++.+|.+|| ..+++|||++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG-----M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999886531 2 88899999999999999 48999999999999999 78999999999875
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.8e-17 Score=184.12 Aligned_cols=198 Identities=21% Similarity=0.201 Sum_probs=156.1
Q ss_pred HHHhcCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccC---CCceeEEeeEEeecCeEE
Q 044561 341 YKATKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLR---HRNLVKLRGYCRRKGEFL 417 (614)
Q Consensus 341 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~ 417 (614)
..-.+.|.+.+.||+|+||+||+|...++..+|+|.-+..+.. +|.--.+++.+|+ -+.|..+...+.-.+.-+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 3344568888999999999999999988999999987665432 2333334444444 233444444444567789
Q ss_pred EEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcC-------CCCEEEeee
Q 044561 418 LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA-------DLNGKLGDF 490 (614)
Q Consensus 418 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~-------~~~~kl~Df 490 (614)
||+||.+.|+|.++++. .+.++|.....++.|++.-+.+|| ..+|||+||||+|.||.. +.-++|+||
T Consensus 771 lv~ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred eeeeccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEec
Confidence 99999999999999984 456999999999999999999999 589999999999999942 345899999
Q ss_pred ccccccCCC-CCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCC
Q 044561 491 GLARLYDHD-TIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRP 546 (614)
Q Consensus 491 Gla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p 546 (614)
|.+..+.-- ........++|-.+-.+|...+...+.+.|.|.++-+++-|+.|+.-
T Consensus 846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 998654321 11244557889999999999999999999999999999999998754
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.5e-16 Score=152.23 Aligned_cols=130 Identities=19% Similarity=0.288 Sum_probs=105.9
Q ss_pred eeeeeCcEEEEEEEEecCcEEEEEEeecCC--------hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 352 VIGRGGFGKVYRGVLASNVQIAVKKVSHDS--------KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 352 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
.||+|+||.||+|.+ ++..+++|...... ....+++.+|+++++.++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 45678888864321 112356788999999999887665555556667779999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccc
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARL 495 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~ 495 (614)
++++|.+++.... . .++.+++.+|.+|| ..+++|||++|.||+++ ++.+++.|||++..
T Consensus 80 ~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN---D------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH---H------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998875421 1 78999999999999 48999999999999999 89999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.6e-16 Score=172.24 Aligned_cols=173 Identities=25% Similarity=0.335 Sum_probs=124.2
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
.+|...+.|-.|++|.||..+++. .+.+|. ++.++..- .+- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~li-----lRn--ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLI-----LRN--ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhh-cccccchh-----hhc--cccccCCccee-------------------
Confidence 568888999999999999998876 555676 44332211 110 22233334333
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC---
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT--- 500 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~--- 500 (614)
|+-...++... .++... +.+++|||+ .+|+|||+||+|.+|+.-|++|+.|||+.+......
T Consensus 136 --gDc~tllk~~g--~lPvdm--------vla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 --GDCATLLKNIG--PLPVDM--------VLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred --chhhhhcccCC--CCcchh--------hHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 33333443321 233222 678999995 899999999999999999999999999987532110
Q ss_pred -----C------CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHH
Q 044561 501 -----I------PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLV 559 (614)
Q Consensus 501 -----~------~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~ 559 (614)
. -....++||+.|+|||++.-..|...+|+|++|+++||.+-|+.||.++.++|.+..+
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~v 270 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV 270 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhh
Confidence 0 0123358999999999999889999999999999999999999999998776655433
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.7e-15 Score=134.99 Aligned_cols=135 Identities=19% Similarity=0.165 Sum_probs=114.6
Q ss_pred CcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCC--CceeEEeeEEeecCeEEEEEEecCCC
Q 044561 349 DKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRH--RNLVKLRGYCRRKGEFLLVYDYMPNG 426 (614)
Q Consensus 349 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~lV~E~~~~g 426 (614)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+..++.++| .++.+++++....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35679999999999999865 6789998865543 4678899999999976 58999999888888999999999888
Q ss_pred CcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccc
Q 044561 427 SLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARL 495 (614)
Q Consensus 427 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~ 495 (614)
.+..+ +......++.++++++.+||.....+++|+|++|+||++++.+.+++.|||.+..
T Consensus 79 ~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77654 4567778899999999999964445899999999999999999999999998874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.3e-14 Score=138.75 Aligned_cols=138 Identities=21% Similarity=0.211 Sum_probs=98.1
Q ss_pred cceeeeeCcEEEEEEEEecCcEEEEEEeecCChh--hHHHH----------------------HHHHHHhcccCCCc--e
Q 044561 350 KDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQ--GIKEF----------------------VAELVSMGRLRHRN--L 403 (614)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~----------------------~~Ei~~l~~l~H~n--i 403 (614)
.+.||+|+||.||+|...+++.||||.+...... ....+ ..|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888899999988654221 11111 24555555554332 3
Q ss_pred eEEeeEEeecCeEEEEEEecCCCCcchh-cccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCC
Q 044561 404 VKLRGYCRRKGEFLLVYDYMPNGSLDKI-LHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDAD 482 (614)
Q Consensus 404 v~l~g~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~ 482 (614)
.+.++. ...++||||++++.+... +.... .. .+...++.+++.++.++|+ +.+|+||||||+||+++ +
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD-D 150 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-C
Confidence 334432 245899999998654322 22111 11 6678899999999999994 38999999999999999 8
Q ss_pred CCEEEeeeccccccCC
Q 044561 483 LNGKLGDFGLARLYDH 498 (614)
Q Consensus 483 ~~~kl~DfGla~~~~~ 498 (614)
+.++|+|||.+.....
T Consensus 151 ~~~~liDfg~a~~~~~ 166 (187)
T cd05119 151 GKVYIIDVPQAVEIDH 166 (187)
T ss_pred CcEEEEECcccccccC
Confidence 9999999999975544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.3e-15 Score=169.31 Aligned_cols=255 Identities=24% Similarity=0.289 Sum_probs=187.3
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec--CcEEEEEEeecCC--hhhHHHHHHHHHHhcccC-CCceeEEeeEEeecCeEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS--NVQIAVKKVSHDS--KQGIKEFVAELVSMGRLR-HRNLVKLRGYCRRKGEFLLV 419 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV 419 (614)
..|...+.||+|.|+.|-...... ...+++|.+.... ....+....|..+-..+. |+|++++++.....+..++.
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 456667789999999998877644 4456677665543 233344456777777776 99999999999999999999
Q ss_pred EEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCC-CEEEeeeccccccCC
Q 044561 420 YDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADL-NGKLGDFGLARLYDH 498 (614)
Q Consensus 420 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~-~~kl~DfGla~~~~~ 498 (614)
.+|..++++...+........+....-.++.|+..++.|+|. +.++.||||||+|.+++..+ ..|++|||+|..+..
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999998843222246667777899999999999995 48999999999999999999 999999999987765
Q ss_pred --CCCCccccccc-CCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccc
Q 044561 499 --DTIPQTTKLVG-TFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDA 574 (614)
Q Consensus 499 --~~~~~~~~~~g-t~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~ 574 (614)
+........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+......+.. ...|.... +.
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~~~---~~---- 249 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKSNK---GR---- 249 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeecccc---cc----
Confidence 33333445678 9999999998774 4577899999999999999999998765433211 11111000 00
Q ss_pred ccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHh
Q 044561 575 SDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVM 613 (614)
Q Consensus 575 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 613 (614)
........ ......++...|+..+|..|.+.+++-
T Consensus 250 ~~~~~~~~----~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 250 FTQLPWNS----ISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred cccCcccc----CChhhhhcccccccCCchhcccccccc
Confidence 00111111 223345555668889999999988763
|
|
| >cd06901 lectin_VIP36_VIPL VIP36 and VIPL type 1 transmembrane proteins, lectin domain | Back alignment and domain information |
|---|
Probab=99.52 E-value=4.4e-13 Score=132.32 Aligned_cols=186 Identities=19% Similarity=0.167 Sum_probs=114.4
Q ss_pred CCceEecceeEcCCCcEEecCCCCCCceeeEeeCCceeecCCCCCceeeeeeeEEee----------eeEEEEcCCCCCC
Q 044561 39 AQLQRDGLASVHSNGLLQLTNTVSPQQEGHAFYRLPIKFNTSSSESLSFSSNFVFAI----------GMAFVISPSKDLG 108 (614)
Q Consensus 39 ~~~~~~g~a~~~~~g~l~Lt~~~~~~~~G~~~y~~pv~l~~~~~~~~sF~t~F~f~i----------G~aF~l~p~~~~~ 108 (614)
+++.+.|+|.+. ++.|+||++.+ .+.|++||+.|+++. +|+++|+|.| ||||+++....
T Consensus 20 ~~w~~~G~a~v~-~~~IrLTp~~~-~~~G~~w~~~p~~~~-------~F~~~f~F~I~~~~~~~~GdGlAfw~t~~~~-- 88 (248)
T cd06901 20 PLWDFLGSTMVT-SQYIRLTPDHQ-SKQGSIWNRVPCYLR-------DWEMHVHFKVHGSGKNLFGDGFAIWYTKERM-- 88 (248)
T ss_pred CCEEEcceEEEc-CCeEEECCCCC-CCEEEEeccCCccCC-------CEEEEEEEEEeCCCCCCCCCEEEEEEEcCCC--
Confidence 689999999997 67999999877 689999999999983 4999999999 99999997542
Q ss_pred CCCCCCCCcccccccCCCCCCCCcEEEEEeeccCCCCCC-CCCCCeeeEec-CCCcccccccCccccCccC-CCcc--cc
Q 044561 109 KAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFD-DIDDNHVGIDV-NSLISHESAPAAYFSDREG-MNKT--LE 183 (614)
Q Consensus 109 ~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~-d~~~~Hvgid~-ns~~s~~~~~~~~~~~~~~-~~~~--~~ 183 (614)
..|..+|-.+. -+ . +||-|||+.|.+-. ....+-|-+-+ ++...-.. ..|.+. .+.. ..
T Consensus 89 ----~~G~~fG~~~~---f~---G-l~I~~Dt~~n~~~~~~~~~P~i~~~~NDGt~~yd~-----~~Dg~~~~~~~C~~~ 152 (248)
T cd06901 89 ----QPGPVFGSKDN---FH---G-LAIFFDTYSNQNGEHEHVHPYISAMVNNGSLSYDH-----DRDGTHTELAGCSAP 152 (248)
T ss_pred ----ccCcccccCCC---Cc---e-EEEEEECCCCCCCcccCCCceEEEEEcCCCeeecc-----cCCCchhhcCceeee
Confidence 22333443221 11 1 89999999985310 01122232222 22111000 000000 0000 01
Q ss_pred -ccCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcccccccccccccccCCCccceeeEeccccc
Q 044561 184 -LIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLKSSHYVLGWSFN 257 (614)
Q Consensus 184 -l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastg~~~~~h~i~sWsf~ 257 (614)
-..+.+.+++|.|... .|.|.+...+. .. ...-..+ -.-.||...|+||||+||...+.|.|++-.+.
T Consensus 153 ~rn~~~~t~~rI~Y~~~--~l~v~vd~~~~--~~-w~~Cf~~-~~v~LP~~~yfGiSA~Tg~~sd~hdIlsv~~~ 221 (248)
T cd06901 153 FRNKDHDTFVAIRYSKG--RLTVMTDIDGK--NE-WKECFDV-TGVRLPTGYYFGASAATGDLSDNHDIISMKLY 221 (248)
T ss_pred ccCCCCCeEEEEEEECC--eEEEEEecCCC--Cc-eeeeEEe-CCeecCCCCEEEEEecCCCCCCcEEEEEEEEe
Confidence 1345567899999964 57777753221 11 0111111 12236777999999999999999999985554
|
The vesicular integral protein of 36 kDa (VIP36) is a type 1 transmembrane protein of the mammalian early secretory pathway that acts as a cargo receptor transporting high mannose type glycoproteins between the Golgi and the endoplasmic reticulum (ER). Lectins of the early secretory pathway are involved in the selective transport of newly synthesized glycoproteins from the ER to the ER-Golgi intermediate compartment (ERGIC). The most prominent cycling lectin is the mannose-binding type1 membrane protein ERGIC-53, which functions as a cargo receptor to facilitate export of glycoproteins from the ER. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded she |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.52 E-value=6.3e-14 Score=139.22 Aligned_cols=135 Identities=19% Similarity=0.180 Sum_probs=105.0
Q ss_pred cceee-eeCcEEEEEEEEecCcEEEEEEeecCC-------------hhhHHHHHHHHHHhcccCCCce--eEEeeEEeec
Q 044561 350 KDVIG-RGGFGKVYRGVLASNVQIAVKKVSHDS-------------KQGIKEFVAELVSMGRLRHRNL--VKLRGYCRRK 413 (614)
Q Consensus 350 ~~~lG-~G~fg~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~Ei~~l~~l~H~ni--v~l~g~~~~~ 413 (614)
...|| .||.|+||+.... +..+++|++.... ......+.+|+.++.+++|+++ ++.++++..+
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45788 8999999999875 6678888875421 1223567889999999998875 6777765443
Q ss_pred C----eEEEEEEecCC-CCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEe
Q 044561 414 G----EFLLVYDYMPN-GSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLG 488 (614)
Q Consensus 414 ~----~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~ 488 (614)
. ..++|+|++++ .+|.+++... .++.. .+.+|+.+|.+|| ..+|+||||||.|||++.++.++|+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEE
Confidence 2 23599999997 6888887642 24433 3578999999999 5899999999999999999999999
Q ss_pred eeccccc
Q 044561 489 DFGLARL 495 (614)
Q Consensus 489 DfGla~~ 495 (614)
|||.+..
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9998875
|
|
| >cd06902 lectin_ERGIC-53_ERGL ERGIC-53 and ERGL type 1 transmembrane proteins, N-terminal lectin domain | Back alignment and domain information |
|---|
Probab=99.44 E-value=8.5e-12 Score=121.64 Aligned_cols=186 Identities=19% Similarity=0.245 Sum_probs=121.1
Q ss_pred CCceEecceeEcCCCcEEecCCCCCCceeeEeeCCceeecCCCCCceeeeeeeEEee---------eeEEEEcCCCCCCC
Q 044561 39 AQLQRDGLASVHSNGLLQLTNTVSPQQEGHAFYRLPIKFNTSSSESLSFSSNFVFAI---------GMAFVISPSKDLGK 109 (614)
Q Consensus 39 ~~~~~~g~a~~~~~g~l~Lt~~~~~~~~G~~~y~~pv~l~~~~~~~~sF~t~F~f~i---------G~aF~l~p~~~~~~ 109 (614)
+...+.|+|.+. ++.|+||++.+ .+.|.+|.+.|++. + +|+.+|+|.| ||||.++....
T Consensus 22 ~~W~~~G~t~~~-~~~IrLTp~~~-~~~G~iw~~~~~~~-~------~w~ie~~Fri~g~~~~~gdG~a~W~t~~~~--- 89 (225)
T cd06902 22 PFWSHGGDAIAS-LEQVRLTPSLR-SKKGSVWTKNPFSF-E------NWEVEVTFRVTGRGRIGADGLAIWYTKERG--- 89 (225)
T ss_pred CceEecccEEec-CCEEEECCCCC-CCEEEEeeCCCcCC-C------CEEEEEEEEEecCCCCCCCEEEEEEECCCC---
Confidence 568899999986 88999999766 78999999999984 3 3999999999 89999996532
Q ss_pred CCCCCCCcccccccCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeeEecC-CCcccccccCccccCcc-CCCcc--ccc-
Q 044561 110 AEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVN-SLISHESAPAAYFSDRE-GMNKT--LEL- 184 (614)
Q Consensus 110 ~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~n-s~~s~~~~~~~~~~~~~-~~~~~--~~l- 184 (614)
..|..+|..+.- .=+||.|||+.|.+ ..+.+.|-+-+| +...-... .|.. ..+.. ...
T Consensus 90 ---~~G~~~G~~~~f-------~Gl~I~~Dt~~n~~--~~~~p~i~~~~NDGt~~yd~~-----~D~~~~~~~~C~~~~r 152 (225)
T cd06902 90 ---EEGPVFGSSDKW-------NGVGIFFDSFDNDG--KKNNPAILVVGNDGTKSYDHQ-----NDGLTQALGSCLRDFR 152 (225)
T ss_pred ---CCCCccCCCCcc-------cEEEEEEECCCCCC--CCCCcEEEEEECCCCeecccc-----CCCcccccceEEEecc
Confidence 234445542221 11799999998853 233345644443 21111100 0000 00000 011
Q ss_pred cCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcc-cccccccccccccCCCccceeeEeccccc
Q 044561 185 IIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSH-ILLETMYVGFSASTGSLKSSHYVLGWSFN 257 (614)
Q Consensus 185 ~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~-~l~~~~~vGFsastg~~~~~h~i~sWsf~ 257 (614)
....+.+++|.|.. ..|.|.+..... +.......-+++.. .||...|+||||+||...+.|.|++|++.
T Consensus 153 n~~~p~~~rI~Y~~--~~l~V~~d~~~~--~~~~~~~~Cf~~~~v~LP~~~yfGiSA~Tg~l~d~hDIls~~~~ 222 (225)
T cd06902 153 NKPYPVRAKITYYQ--NVLTVSINNGFT--PNKDDYELCTRVENMVLPPNGYFGVSAATGGLADDHDVLSFLTF 222 (225)
T ss_pred CCCCCeEEEEEEEC--CeEEEEEeCCcC--CCCCcccEEEecCCeeCCCCCEEEEEecCCCCCCcEeEEEEEEe
Confidence 23568999999997 568888863221 11111222233333 46788999999999999999999999886
|
ERGIC-53 and ERGL, N-terminal carbohydrate recognition domain. ERGIC-53 and ERGL are eukaryotic mannose-binding type 1 transmembrane proteins of the early secretory pathway that transport newly synthesized glycoproteins from the endoplasmic reticulum (ER) to the ER-Golgi intermediate compartment (ERGIC). ERGIC-53 and ERGL have an N-terminal lectin-like carbohydrate recognition domain (represented by this alignment model) as well as a C-terminal transmembrane domain. ERGIC-53 functions as a 'cargo receptor' to facilitate the export of glycoproteins with different characteristics from the ER, while the ERGIC-53-like protein (ERGL) which may act as a regulator of ERGIC-53. In mammals, ERGIC-53 forms a complex with MCFD2 (multi-coagulation factor deficiency 2) which then recruits blood coagulation factors V and VIII. Mutations in either MCFD2 or ERGIC-53 cause a mild form of inherite |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.41 E-value=1e-12 Score=141.80 Aligned_cols=145 Identities=19% Similarity=0.243 Sum_probs=100.9
Q ss_pred CCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHH---------------------------------------
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIK--------------------------------------- 386 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~--------------------------------------- 386 (614)
.|+ .+.||+|++|.||+|++++|+.||||...........
T Consensus 119 ~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E 197 (437)
T TIGR01982 119 EFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE 197 (437)
T ss_pred hCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence 344 3689999999999999999999999998654211110
Q ss_pred -HHHHHHHHhccc----CCCceeEEeeEEe-ecCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHh-hchhh
Q 044561 387 -EFVAELVSMGRL----RHRNLVKLRGYCR-RKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVAS-GLLYL 459 (614)
Q Consensus 387 -~~~~Ei~~l~~l----~H~niv~l~g~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~-gL~yL 459 (614)
+|.+|...+.++ +|.+-+.+-..+. ..+..+|||||+++++|.++...... .. .+..++..++. .+..+
T Consensus 198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql 273 (437)
T TIGR01982 198 LDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQV 273 (437)
T ss_pred HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHH
Confidence 133454444444 2333333333332 23457999999999999987653211 12 34456666666 36677
Q ss_pred hccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCC
Q 044561 460 HEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 498 (614)
Q Consensus 460 H~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~ 498 (614)
| ..+++|+|+||.||+++.+++++++|||++...+.
T Consensus 274 ~---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 274 L---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred H---hCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 8 48999999999999999999999999999986653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.7e-13 Score=133.51 Aligned_cols=200 Identities=22% Similarity=0.322 Sum_probs=137.7
Q ss_pred HHhcccCCCceeEEeeEEeec-----CeEEEEEEecCCCCcchhcccCC--CCCcChhHHHHHHHHhHhhchhhhccCCC
Q 044561 393 VSMGRLRHRNLVKLRGYCRRK-----GEFLLVYDYMPNGSLDKILHTNI--KPCLNWYQRFRIIRGVASGLLYLHEDWEQ 465 (614)
Q Consensus 393 ~~l~~l~H~niv~l~g~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 465 (614)
..+-++.|.|||++..|+.+. ....++.|||..|+|..+|++.. ...+......+++-||..||.|||+ +.+
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence 445567899999999988654 45789999999999999997532 3457777788999999999999997 489
Q ss_pred ceEecCcCCCCeEEcCCCCEEEeeecccccc---CCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc
Q 044561 466 VVLHRDIKPANVLLDADLNGKLGDFGLARLY---DHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS 542 (614)
Q Consensus 466 ~ivHrDikp~NIll~~~~~~kl~DfGla~~~---~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t 542 (614)
+|+|+++..+-|++..++-+|++----.... ............+-++|.+||+-..-+.+.++|||+||+..+||.-
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 9999999999999999998887532111100 0000111223356789999998777777889999999999999998
Q ss_pred CCCCCCC-CCccccccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHh
Q 044561 543 GRRPVEQ-QGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVM 613 (614)
Q Consensus 543 g~~p~~~-~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 613 (614)
+...-.. ....+....+..+ +...-++.-++ ++..|++..|..||+|++++
T Consensus 278 lEiq~tnseS~~~~ee~ia~~--------i~~len~lqr~------------~i~kcl~~eP~~rp~ar~ll 329 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIANV--------IIGLENGLQRG------------SITKCLEGEPNGRPDARLLL 329 (458)
T ss_pred heeccCCCcceeehhhhhhhh--------eeeccCccccC------------cCcccccCCCCCCcchhhhh
Confidence 7764221 1111111111000 01111111111 23349999999999999876
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.3e-12 Score=137.45 Aligned_cols=246 Identities=23% Similarity=0.288 Sum_probs=177.2
Q ss_pred CCCCcceeee--eCcEEEEEEEE--e-cCcEEEEEEeecCC--hhhHHHHHHHHHHhcccC-CCceeEEeeEEeecCeEE
Q 044561 346 GFKDKDVIGR--GGFGKVYRGVL--A-SNVQIAVKKVSHDS--KQGIKEFVAELVSMGRLR-HRNLVKLRGYCRRKGEFL 417 (614)
Q Consensus 346 ~f~~~~~lG~--G~fg~Vy~~~~--~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~ 417 (614)
.|...+.+|. |.+|.||++.. . +...+|+|+-+... ......=.+|+....+++ |+|.++....+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4556778999 99999999987 4 36778888854332 233333356777777774 999999888999999999
Q ss_pred EEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHh----hchhhhccCCCceEecCcCCCCeEEcCC-CCEEEeeecc
Q 044561 418 LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVAS----GLLYLHEDWEQVVLHRDIKPANVLLDAD-LNGKLGDFGL 492 (614)
Q Consensus 418 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivHrDikp~NIll~~~-~~~kl~DfGl 492 (614)
+-.|+| +.+|..+.+... ..++....+.+..+..+ ||.++|+ ..++|-|+||.||++..+ ..++++|||+
T Consensus 195 iqtE~~-~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred eeeccc-cchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCcce
Confidence 999999 477877776532 33677777777777777 9999995 899999999999999999 8899999999
Q ss_pred ccccCCCCCCc----ccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhc
Q 044561 493 ARLYDHDTIPQ----TTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKK 568 (614)
Q Consensus 493 a~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~ 568 (614)
...+....... .....|...|++||..+ +.++.+.|+|++|.+.+|..++..+....... .| ...+.
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~W--~~~r~ 340 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS------SW--SQLRQ 340 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC------Cc--ccccc
Confidence 98876554221 12236778899999875 57799999999999999999987765432111 00 00011
Q ss_pred CCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHh
Q 044561 569 GAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVM 613 (614)
Q Consensus 569 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 613 (614)
+. ..+ ++.......+..+..+|++.+|-.|++.+.+.
T Consensus 341 ~~---ip~-----e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 341 GY---IPL-----EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred cc---Cch-----hhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 11 111 11111122334467779999999999988764
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.23 E-value=8.4e-12 Score=136.32 Aligned_cols=143 Identities=16% Similarity=0.166 Sum_probs=92.8
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhh----------------------------------HHH--
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQG----------------------------------IKE-- 387 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~----------------------------------~~~-- 387 (614)
..|+. +.||+|++|.||+|++++ |+.||||.....-... .+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45666 789999999999999988 9999999997542110 111
Q ss_pred ----HHHHHHHhcccC----CCceeEEeeEEee-cCeEEEEEEecCCCCcchhc--ccCC--CCCcChhHHHHHHHHhHh
Q 044561 388 ----FVAELVSMGRLR----HRNLVKLRGYCRR-KGEFLLVYDYMPNGSLDKIL--HTNI--KPCLNWYQRFRIIRGVAS 454 (614)
Q Consensus 388 ----~~~Ei~~l~~l~----H~niv~l~g~~~~-~~~~~lV~E~~~~gsL~~~l--~~~~--~~~l~~~~~~~i~~~ia~ 454 (614)
|.+|...+.+++ +.+.+.+-..+.+ ....+|||||++|+.+.++- .... ...+.......++.|+.
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif- 277 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF- 277 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-
Confidence 233333333332 3333333332222 34568999999999997742 2211 01133333333344443
Q ss_pred hchhhhccCCCceEecCcCCCCeEEcCCC----CEEEeeeccccccCC
Q 044561 455 GLLYLHEDWEQVVLHRDIKPANVLLDADL----NGKLGDFGLARLYDH 498 (614)
Q Consensus 455 gL~yLH~~~~~~ivHrDikp~NIll~~~~----~~kl~DfGla~~~~~ 498 (614)
..+++|+|+||.||+++.++ .+++.|||+....+.
T Consensus 278 ---------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 ---------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ---------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 36899999999999999988 999999999876644
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.21 E-value=6.9e-11 Score=127.29 Aligned_cols=164 Identities=17% Similarity=0.230 Sum_probs=127.3
Q ss_pred cCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecCCCCcchhcccCCCCCcChhHHHH
Q 044561 368 SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFR 447 (614)
Q Consensus 368 ~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ 447 (614)
++..|.|......+........+-++.++.++||||++++.....++.+|||+|-+ ..|..++.+ +.......
T Consensus 36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~-----l~~~~v~~ 108 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE-----LGKEEVCL 108 (690)
T ss_pred cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH-----hHHHHHHH
Confidence 47788888887766644556678889999999999999999999999999999987 356766665 33555666
Q ss_pred HHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcccccccCCCccchhhhcCCCCCcc
Q 044561 448 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTS 527 (614)
Q Consensus 448 i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~ 527 (614)
.+.||+.||.+||+ +.+++|++|.-+.|++++.|..||++|-++.....-.. .......-..|..|+.+.... ..
T Consensus 109 Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~--~s 183 (690)
T KOG1243|consen 109 GLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE--WS 183 (690)
T ss_pred HHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--cc
Confidence 78999999999997 68899999999999999999999999998865432221 111112223566777653322 46
Q ss_pred hhHHHHHHHHHHHHcC
Q 044561 528 TDVYAFGVFMLEVASG 543 (614)
Q Consensus 528 ~Dv~S~Gvll~el~tg 543 (614)
.|.|-|||+++|++.|
T Consensus 184 ~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 184 IDSWGLGCLIEELFNG 199 (690)
T ss_pred hhhhhHHHHHHHHhCc
Confidence 7999999999999999
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.19 E-value=5.3e-11 Score=111.67 Aligned_cols=131 Identities=21% Similarity=0.157 Sum_probs=94.7
Q ss_pred cceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCcee-EEeeEEeecCeEEEEEEecCCCCc
Q 044561 350 KDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLV-KLRGYCRRKGEFLLVYDYMPNGSL 428 (614)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~~gsL 428 (614)
.+.|+.|.++.||++... +..+++|....... ....+..|+..++.+.+.+++ +++.+. ....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 356889999999999865 66799998755432 123457888888888665544 444443 2335799999999887
Q ss_pred chhcccCCCCCcChhHHHHHHHHhHhhchhhhccC--CCceEecCcCCCCeEEcCCCCEEEeeeccccc
Q 044561 429 DKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDW--EQVVLHRDIKPANVLLDADLNGKLGDFGLARL 495 (614)
Q Consensus 429 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDikp~NIll~~~~~~kl~DfGla~~ 495 (614)
...- . ....++.+++++|..||+.. ..+++|+|++|.||+++ ++.++++||+.+..
T Consensus 79 ~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 6530 1 11245678999999999632 12369999999999999 67899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd06903 lectin_EMP46_EMP47 EMP46 and EMP47 type 1 transmembrane proteins, N-terminal lectin domain | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.6e-09 Score=104.88 Aligned_cols=176 Identities=16% Similarity=0.193 Sum_probs=111.9
Q ss_pred CCceEecceeEcCCCcEEecCCCCCCceeeEeeCCceeecCCCCCceeeeeeeEEee---------eeEEEEcCCCCCCC
Q 044561 39 AQLQRDGLASVHSNGLLQLTNTVSPQQEGHAFYRLPIKFNTSSSESLSFSSNFVFAI---------GMAFVISPSKDLGK 109 (614)
Q Consensus 39 ~~~~~~g~a~~~~~g~l~Lt~~~~~~~~G~~~y~~pv~l~~~~~~~~sF~t~F~f~i---------G~aF~l~p~~~~~~ 109 (614)
++..+.|+|.+. ++.|+||++ + ++.|.+|-+.|+++.+ +|+.+|+|.| ||||.++......
T Consensus 21 ~~W~~~G~t~v~-~~~IrLTp~-~-s~~G~iWs~~pl~~~~------~w~ie~~Fri~G~~~~~gdGla~W~t~~~~~~- 90 (215)
T cd06903 21 PNWQTSGNPKLE-SGRIILTPP-G-NQRGSLWLKKPLSLKD------EWTIEWTFRSTGPEGRSGGGLNFWLVKDGNAD- 90 (215)
T ss_pred CCeEEcCcEEee-CCeEEECCC-C-CceEeEeeCCcCCCCC------CEEEEEEEEecccCCcCCCEEEEEEECCCccc-
Confidence 578899999997 889999999 6 8999999999998863 3999999999 8999999654221
Q ss_pred CCCCCC-CcccccccCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeeEecCCCcccccccCccccCccCCCcc--c-ccc
Q 044561 110 AEASPS-EYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKT--L-ELI 185 (614)
Q Consensus 110 ~~~~~g-~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~~~~~~~~--~-~l~ 185 (614)
.| ..+|-.+. -+| +||.|||+.|. .| ..-++.-++...-.... |....+.. . -..
T Consensus 91 ----~g~~~fG~~~~-f~G------l~I~~Dt~~n~---~p--~i~~~~NDGt~~yd~~~-----d~~~~~g~C~~~~rn 149 (215)
T cd06903 91 ----VGTSSIYGPSK-FDG------LQLLIDNNGGS---GG--SLRGFLNDGSKDYKNED-----VDSLAFGSCLFAYQD 149 (215)
T ss_pred ----CCccccCCCCC-CcE------EEEEEECCCCC---Cc--eEEEEECCCCeeccccC-----CcccccceeeEeccC
Confidence 11 22222111 111 79999999873 12 11222222221110000 00000000 0 124
Q ss_pred CCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCccccc-ccccccccccCCCccceeeEeccc
Q 044561 186 IGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILL-ETMYVGFSASTGSLKSSHYVLGWS 255 (614)
Q Consensus 186 ~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~-~~~~vGFsastg~~~~~h~i~sWs 255 (614)
.+.+.+++|.|....+.|+|.+... .-..++ .-.|| .-.|+||||+||...+.|.|++-.
T Consensus 150 ~~~p~~iri~Y~~~~~~l~v~vd~~---------~Cf~~~-~v~lP~~~y~fGiSAaTg~~~d~hdIl~~~ 210 (215)
T cd06903 150 SGVPSTIRLSYDALNSLFKVQVDNR---------LCFQTD-KVQLPQGGYRFGITAANADNPESFEILKLK 210 (215)
T ss_pred CCCCEEEEEEEECCCCEEEEEECCC---------EEEecC-CeecCCCCCEEEEEEcCCCCCCcEEEEEEE
Confidence 5668999999998778999988421 111111 11255 456799999999999999998744
|
EMP46 and EMP47, N-terminal carbohydrate recognition domain. EMP46 and EMP47 are fungal type-I transmembrane proteins that cycle between the endoplasmic reticulum and the golgi apparatus and are thought to function as cargo receptors that transport newly synthesized glycoproteins. EMP47 is a receptor for EMP46 responsible for the selective transport of EMP46 by forming hetero-oligomerization between the two proteins. EMP46 and EMP47 have an N-terminal lectin-like carbohydrate recognition domain (represented by this alignment model) as well as a C-terminal transmembrane domain. EMP46 and EMP47 are 45% sequence-identical to one another and have sequence homology to a class of intracellular lectins defined by ERGIC-53 and VIP36. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat s |
| >PF03388 Lectin_leg-like: Legume-like lectin family; InterPro: IPR005052 Lectins are structurally diverse proteins that bind to specific carbohydrates | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.6e-09 Score=106.50 Aligned_cols=187 Identities=24% Similarity=0.305 Sum_probs=112.1
Q ss_pred CCceEecceeEcCCCcEEecCCCCCCceeeEeeCCceeecCCCCCceeeeeeeEEee----------eeEEEEcCCCCCC
Q 044561 39 AQLQRDGLASVHSNGLLQLTNTVSPQQEGHAFYRLPIKFNTSSSESLSFSSNFVFAI----------GMAFVISPSKDLG 108 (614)
Q Consensus 39 ~~~~~~g~a~~~~~g~l~Lt~~~~~~~~G~~~y~~pv~l~~~~~~~~sF~t~F~f~i----------G~aF~l~p~~~~~ 108 (614)
+...+.|+|.+. ++.|+||++.+ ++.|.+|.+.|++.. +|+.+|+|.| ||||.++....
T Consensus 22 ~~W~~~G~t~i~-~~~IrLTp~~~-~~~G~iws~~~~~~~-------~w~i~~~Fri~g~~~~~~g~G~a~W~t~~~~-- 90 (229)
T PF03388_consen 22 PNWDIGGSTVIT-DNFIRLTPDRQ-SQSGSIWSRKPIPFD-------NWEIEFTFRISGQEKGLGGDGMAFWYTKDPG-- 90 (229)
T ss_dssp TTEEEEET-EEE-SSEEEEE-SST-TEEEEEEESS-BEES-------EEEEEEEEEEESS-SSS-S-EEEEEEESSSS--
T ss_pred CCEEECCeEEec-CCEEEECCCcc-cCEEEEEEcCCCCcc-------CEEEEEEEEEeccccCcCCCeEEEEEEcCcc--
Confidence 468899999997 99999999887 899999999999983 3999999999 89999996542
Q ss_pred CCCCCCCCcccccccCCCCCCCCcEEEEEeeccCCCCCC-CCCCCeeeEecCCCcccccccCccccC-ccCCCcc--ccc
Q 044561 109 KAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFD-DIDDNHVGIDVNSLISHESAPAAYFSD-REGMNKT--LEL 184 (614)
Q Consensus 109 ~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~-d~~~~Hvgid~ns~~s~~~~~~~~~~~-~~~~~~~--~~l 184 (614)
..|..+|..+.- .| +||=||||.|.+-. ....+.|.+-+|- -+.......+ ....+.. ...
T Consensus 91 ----~~G~~fG~~~~f-~G------l~i~idt~~N~~~~~~~~~p~i~~~~ND----Gt~~~~~~~dg~~~~~~~C~~~~ 155 (229)
T PF03388_consen 91 ----SDGPVFGGPDKF-DG------LGIFIDTYDNDEGGHKRGFPYISAMLND----GTKSYDHDNDGKDQSLGSCSADY 155 (229)
T ss_dssp ----SSCSBTTB-SS--EE------EEEEEEES-TTCTTCTSTSSEEEEEEEE----SSS---GGGTTTTT-SEEEE---
T ss_pred ----ccccccCCCccc-ce------EEEEEEcccCCCcccccccceEEEEecC----CCccccccccCcccccccceecc
Confidence 245555532221 11 79999999986311 1123444444431 1111111111 0001110 111
Q ss_pred -cCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcccccccccccccccCCCccceeeEecc
Q 044561 185 -IIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLKSSHYVLGW 254 (614)
Q Consensus 185 -~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastg~~~~~h~i~sW 254 (614)
..+.+.+++|.|... .|.|.+...-.........-..++ .-.||+..|+|+||+||...+.|.|++-
T Consensus 156 rn~~~p~~~ri~Y~~~--~l~v~id~~~~~~~~~~~~Cf~~~-~v~LP~~~yfGvSA~Tg~~~d~hdi~s~ 223 (229)
T PF03388_consen 156 RNSDVPTRIRISYSKN--TLTVSIDSNYLKNQDDWELCFTTD-GVDLPEGYYFGVSAATGELSDNHDILSV 223 (229)
T ss_dssp BTESSEEEEEEEEETT--EEEEEEETSCCSECCTTEEEEEES-TEEGGSSBEEEEEEEESSSGGEEEEEEE
T ss_pred CcCCCCEEEEEEEECC--eEEEEEecccccCCcCCcEEEEcC-CeecCCCCEEEEEecCCCCCCcEEEEEE
Confidence 235578999999954 577777521011111112222222 1246788899999999999999999873
|
This family includes the VIP36 and ERGIC-53 lectins. These two proteins were the first members of the family of animal lectins similar to the leguminous plant lectins []. The alignment for this family is towards the N terminus, where the similarity of VIP36 and ERGIC-53 is greatest. Although they have been identified as a family of animal lectins, this alignment also includes yeast sequences[]. ERGIC-53 is a 53kDa protein, localised to the intermediate region between the endoplasmic reticulum and the Golgi apparatus (ER-Golgi-Intermediate Compartment, ERGIC). It was identified as a calcium-dependent, mannose-specific lectin []. Its dysfunction has been associated with combined factors V and VIII deficiency, suggesting an important and substrate-specific role for ERGIC-53 in the glycoprotein-secreting pathway [,]. The L-type lectin-like domain has an overall globular shape composed of a beta-sandwich of two major twisted antiparallel beta-sheets. The beta-sandwich comprises a major concave beta-sheet and a minor convex beta-sheet, in a variation of the jelly roll fold [, , , ]. ; GO: 0016020 membrane; PDB: 3A4U_A 3LCP_B 2A6Z_A 2A71_C 2A70_B 2A6Y_A 2A6X_A 2A6W_B 2A6V_B 2E6V_B .... |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.09 E-value=6e-10 Score=109.15 Aligned_cols=142 Identities=19% Similarity=0.210 Sum_probs=110.0
Q ss_pred ceeeeeCcEEEEEEEEecCcEEEEEEeecCCh-hhHHHHHHHHHHhcccCC--CceeEEeeEEeec---CeEEEEEEecC
Q 044561 351 DVIGRGGFGKVYRGVLASNVQIAVKKVSHDSK-QGIKEFVAELVSMGRLRH--RNLVKLRGYCRRK---GEFLLVYDYMP 424 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~---~~~~lV~E~~~ 424 (614)
+.|+.|..+.||++...++..+++|....... ....++..|.++++.+++ .++.+++.++... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999987667899998765432 134567889999998875 3457777777654 36789999999
Q ss_pred CCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhcc------------------------------------------
Q 044561 425 NGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHED------------------------------------------ 462 (614)
Q Consensus 425 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------ 462 (614)
+.++.+.+.. ..++..++..++.++++.|.+||+.
T Consensus 84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9988876642 2367777888888888888888842
Q ss_pred -----------CCCceEecCcCCCCeEEcC--CCCEEEeeeccccc
Q 044561 463 -----------WEQVVLHRDIKPANVLLDA--DLNGKLGDFGLARL 495 (614)
Q Consensus 463 -----------~~~~ivHrDikp~NIll~~--~~~~kl~DfGla~~ 495 (614)
....++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1356899999999999998 56689999998763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.6e-10 Score=123.45 Aligned_cols=246 Identities=20% Similarity=0.246 Sum_probs=168.0
Q ss_pred HHHHhcCCCCcceeeeeCcEEEEEEEEe--cCcEEEEEEeecCChhhHHH--HHHHHHHhccc-CCCceeEEeeEEeecC
Q 044561 340 LYKATKGFKDKDVIGRGGFGKVYRGVLA--SNVQIAVKKVSHDSKQGIKE--FVAELVSMGRL-RHRNLVKLRGYCRRKG 414 (614)
Q Consensus 340 l~~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~~~~~--~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 414 (614)
....+.+|.....||.|.|+.|++...+ ++..+++|.+.........+ -..|+.+...+ .|.+.+.....+..-.
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 3445567888999999999999998865 36778888876543222211 23455555555 4888888777676777
Q ss_pred eEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCC-CCEEEeeeccc
Q 044561 415 EFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDAD-LNGKLGDFGLA 493 (614)
Q Consensus 415 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~-~~~kl~DfGla 493 (614)
..|+--|||+++++...+.. ...++...++++..|++.++.++| .+.++|+|+||+||++..+ +..+++|||++
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred cccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhccccccc
Confidence 77899999999998766532 334788889999999999999999 4899999999999999886 88899999998
Q ss_pred cccCCCCCCcccccccCCCc-cchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcc
Q 044561 494 RLYDHDTIPQTTKLVGTFGY-MDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIR 572 (614)
Q Consensus 494 ~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~ 572 (614)
....-.. ......+..| .+|+......+..+.|++|||.-+.|.+++..--+....-- ....+...
T Consensus 415 t~~~~~~---~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~----------~i~~~~~p 481 (524)
T KOG0601|consen 415 TRLAFSS---GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL----------TIRSGDTP 481 (524)
T ss_pred cccceec---ccccccccccccchhhccccccccccccccccccccccccCcccCcccccce----------eeeccccc
Confidence 6422111 1111223334 36666667788999999999999999988775433211100 01111111
Q ss_pred ccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHh
Q 044561 573 DASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVM 613 (614)
Q Consensus 573 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 613 (614)
...+.. .+.+.+.+ .+..+++..||.+.+..
T Consensus 482 -----~~~~~~--~~~q~~~k---v~~~~~~~~~~l~~~l~ 512 (524)
T KOG0601|consen 482 -----NLPGLK--LQLQVLLK---VMINPDRKRRPSAVELS 512 (524)
T ss_pred -----CCCchH--Hhhhhhhh---hhcCCccccchhhhhhc
Confidence 111111 23333333 48899999999887653
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.04 E-value=2e-09 Score=102.60 Aligned_cols=138 Identities=18% Similarity=0.117 Sum_probs=98.5
Q ss_pred ceeeeeCcEEEEEEEEec-------CcEEEEEEeecCC-----h-----------------hhHHHHH----HHHHHhcc
Q 044561 351 DVIGRGGFGKVYRGVLAS-------NVQIAVKKVSHDS-----K-----------------QGIKEFV----AELVSMGR 397 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~-----~-----------------~~~~~~~----~Ei~~l~~ 397 (614)
..||.|.-+.||.|...+ +..+|||..+... . ...+.+. +|...|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998653 4789999875421 0 0112223 78888888
Q ss_pred cCC--CceeEEeeEEeecCeEEEEEEecCCCCcch-hcccCCCCCcChhHHHHHHHHhHhhchhh-hccCCCceEecCcC
Q 044561 398 LRH--RNLVKLRGYCRRKGEFLLVYDYMPNGSLDK-ILHTNIKPCLNWYQRFRIIRGVASGLLYL-HEDWEQVVLHRDIK 473 (614)
Q Consensus 398 l~H--~niv~l~g~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrDik 473 (614)
+.. -++.+++++ ..-+|||||+.+..+.. .+.. ..++..+...+..+++.+|..| | +.++||+||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence 853 455566654 45689999997654422 2222 1244556677889999999999 7 5899999999
Q ss_pred CCCeEEcCCCCEEEeeeccccccCCC
Q 044561 474 PANVLLDADLNGKLGDFGLARLYDHD 499 (614)
Q Consensus 474 p~NIll~~~~~~kl~DfGla~~~~~~ 499 (614)
+.|||++ ++.+.|+|||.+...+++
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~~hp 177 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEPTHP 177 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeCCCC
Confidence 9999997 468999999998766553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.93 E-value=5.7e-09 Score=95.89 Aligned_cols=143 Identities=19% Similarity=0.230 Sum_probs=102.9
Q ss_pred CcceeeeeCcEEEEEEEEecCcEEEEEE-eecC-------ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 349 DKDVIGRGGFGKVYRGVLASNVQIAVKK-VSHD-------SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 349 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~-~~~~-------~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
....+-||+-+.|+++.+.+ +...||. +.+. .+-..++..+|...+.+++--.|.-..-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~G-e~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSG-EAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccCC-ceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 56789999999999999864 4444443 3222 1223456788999999887555544444455555667899
Q ss_pred EecCC-CCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCC---EEEeeeccccc
Q 044561 421 DYMPN-GSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLN---GKLGDFGLARL 495 (614)
Q Consensus 421 E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~---~kl~DfGla~~ 495 (614)
||.++ .++.+++...............++..|-+.+.-|| ...|+|+||..+||++..++. +.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99976 36788876543333333444788899999999999 589999999999999976553 58999999864
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.90 E-value=5.5e-09 Score=96.47 Aligned_cols=131 Identities=21% Similarity=0.252 Sum_probs=97.5
Q ss_pred ceeeeeCcEEEEEEEEecCcEEEEEEe-ecCC-------hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 351 DVIGRGGFGKVYRGVLASNVQIAVKKV-SHDS-------KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~~~~vavK~~-~~~~-------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
..+++|+-+.+|.+.+.+. .+++|.- .+.- +-....-.+|..++.+++--.+.-.+-+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~-~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGL-PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccCc-ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 3578999999999977543 3455533 2211 11234457899999888755555545556677788899999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccc
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARL 495 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~ 495 (614)
.++..|.+.+... +..++..+-.-+.-|| +.+|+|+||.++||++..+. +.++||||+..
T Consensus 81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA---------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc---------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888764 2566777777788899 59999999999999997765 99999999974
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.75 E-value=5.1e-08 Score=102.33 Aligned_cols=168 Identities=17% Similarity=0.315 Sum_probs=127.9
Q ss_pred cEEEEEEEEe-cCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEee----cCeEEEEEEecCCC-Ccchh
Q 044561 358 FGKVYRGVLA-SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRR----KGEFLLVYDYMPNG-SLDKI 431 (614)
Q Consensus 358 fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV~E~~~~g-sL~~~ 431 (614)
-.+.||+..+ +|..+++|++..+..+.......-+++++++.|.|+|++..++.. +..+++||+|.|+. +|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3577898865 588899999954444443344566788999999999999998763 35789999999854 46554
Q ss_pred cccCC-------------CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCC
Q 044561 432 LHTNI-------------KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 498 (614)
Q Consensus 432 l~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~ 498 (614)
-..+. ....++..+|.++.|+..||.++|+ .|+.-+-|.+++|+++.+.+++|...|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 32211 2347789999999999999999995 8999999999999999999999999888776655
Q ss_pred CCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCC
Q 044561 499 DTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRP 546 (614)
Q Consensus 499 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p 546 (614)
+.. +| +. -..+-|.=.||.+++.|.||+..
T Consensus 446 d~~-------------~~--le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT-------------EP--LE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC-------------cc--hh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 431 11 11 13467888999999999999654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.74 E-value=7.6e-08 Score=91.47 Aligned_cols=127 Identities=20% Similarity=0.273 Sum_probs=83.9
Q ss_pred EEEEEEEecCcEEEEEEeecCC--------------h------------hhHHHHHHHHHHhcccCCC--ceeEEeeEEe
Q 044561 360 KVYRGVLASNVQIAVKKVSHDS--------------K------------QGIKEFVAELVSMGRLRHR--NLVKLRGYCR 411 (614)
Q Consensus 360 ~Vy~~~~~~~~~vavK~~~~~~--------------~------------~~~~~~~~Ei~~l~~l~H~--niv~l~g~~~ 411 (614)
.||.|...++..+|+|...... + .......+|...|.++... ++.+++.+-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899998889999999875421 0 0123456799999998765 455665442
Q ss_pred ecCeEEEEEEecC--CCCcchhcccCCCCCcChhHHHHHHHHhHhhchhh-hccCCCceEecCcCCCCeEEcCCCCEEEe
Q 044561 412 RKGEFLLVYDYMP--NGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYL-HEDWEQVVLHRDIKPANVLLDADLNGKLG 488 (614)
Q Consensus 412 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrDikp~NIll~~~~~~kl~ 488 (614)
.-+|||||++ +..+..+.... ++......++.+++..+..+ | +.+|+|+|+.+.||+++++ .+.|+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEE
Confidence 3369999998 55554433221 22456677788888866664 6 5899999999999999988 99999
Q ss_pred eeccccccCC
Q 044561 489 DFGLARLYDH 498 (614)
Q Consensus 489 DfGla~~~~~ 498 (614)
|||.+....+
T Consensus 149 Df~qav~~~~ 158 (188)
T PF01163_consen 149 DFGQAVDSSH 158 (188)
T ss_dssp -GTTEEETTS
T ss_pred ecCcceecCC
Confidence 9998875543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.1e-07 Score=95.82 Aligned_cols=141 Identities=17% Similarity=0.081 Sum_probs=99.0
Q ss_pred ceeeeeCcEEEEEEEEecCcEEEEEEeecCChh-hHH----------HHHHHHHHhcccCCCc--eeEEeeEEee-----
Q 044561 351 DVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQ-GIK----------EFVAELVSMGRLRHRN--LVKLRGYCRR----- 412 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~----------~~~~Ei~~l~~l~H~n--iv~l~g~~~~----- 412 (614)
+.+-+-....|.+..+ +|+.+.||+....... ..+ .+.+|...+.++...+ ..+++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4444444445667655 5668999977543311 112 3678888887774333 3344455433
Q ss_pred cCeEEEEEEecCCC-CcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcC-------CCC
Q 044561 413 KGEFLLVYDYMPNG-SLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA-------DLN 484 (614)
Q Consensus 413 ~~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~-------~~~ 484 (614)
...-+||+|++++. +|.+++........+...+..++.+++..+.-|| ..+|+|+|++++|||++. +..
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCce
Confidence 23578999999876 7888875422233556677899999999999999 599999999999999975 467
Q ss_pred EEEeeeccccc
Q 044561 485 GKLGDFGLARL 495 (614)
Q Consensus 485 ~kl~DfGla~~ 495 (614)
+.++||+.++.
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 89999998863
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.71 E-value=3.1e-09 Score=119.35 Aligned_cols=247 Identities=20% Similarity=0.205 Sum_probs=155.7
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC---ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
+++...+-+-+|.++.+.-+.-.. +.-.+.|..... ..+..+....+-.++-..+||-++...--+......+|++
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence 455556667778888887655332 211122221111 1111122222222222234455555444445567889999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccC---
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYD--- 497 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~--- 497 (614)
+|..+++|...|+... +.+.+-....+..+...++|||+ ..+.|||++|.|++...++..++.|||......
T Consensus 884 ~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~ 958 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP 958 (1205)
T ss_pred HHhccCCchhhhhcCC--CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCcccccccccccc
Confidence 9999999999988743 45555556667778899999995 558999999999999999999999998433211
Q ss_pred ----C--------------C----C-----CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Q 044561 498 ----H--------------D----T-----IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQ 550 (614)
Q Consensus 498 ----~--------------~----~-----~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~ 550 (614)
. . . ........||+.|++||.+.+.......|.|+.|++++|.++|..||...
T Consensus 959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence 0 0 0 01123457899999999999999999999999999999999999999765
Q ss_pred CccccccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHH
Q 044561 551 GSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMR 610 (614)
Q Consensus 551 ~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 610 (614)
....... ....+...- ..-+.........+....+..+|.+|-.|.
T Consensus 1039 tpq~~f~-------ni~~~~~~~-------p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1039 TPQQIFE-------NILNRDIPW-------PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred chhhhhh-------ccccCCCCC-------CCCccccChhhhhhhhhhhccCchhccCcc
Confidence 5433221 111111111 011122222344445556778888887665
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=3.4e-08 Score=107.31 Aligned_cols=150 Identities=19% Similarity=0.363 Sum_probs=100.5
Q ss_pred HHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCC--------CcccccccCCCccchhhhc
Q 044561 449 IRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI--------PQTTKLVGTFGYMDPELMR 520 (614)
Q Consensus 449 ~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~--------~~~~~~~gt~~y~aPE~~~ 520 (614)
+.+++.||.|+|. ..++||++|.|++|.++.++..||+.|+.+........ ...........|.|||++.
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 4456699999997 68999999999999999999999999998765433111 0111123456899999998
Q ss_pred CCCCCcchhHHHHHHHHHHHHcCCCC-CCCCCccccccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcC
Q 044561 521 TGKASTSTDVYAFGVFMLEVASGRRP-VEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCS 599 (614)
Q Consensus 521 ~~~~t~~~Dv~S~Gvll~el~tg~~p-~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl 599 (614)
....+.++|+||+|++++-+..|..+ +...+........ +...+.--.......+.+..+.|. +++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~---------~~~~~~~~~~~s~~~p~el~~~l~----k~l 249 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS---------RNLLNAGAFGYSNNLPSELRESLK----KLL 249 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh---------hcccccccccccccCcHHHHHHHH----HHh
Confidence 88889999999999999999955544 4333222222111 011111111111334444444444 479
Q ss_pred CCCCCCCCCHHHHh
Q 044561 600 HPKPEARPNMRQVM 613 (614)
Q Consensus 600 ~~dP~~RPs~~evl 613 (614)
..++..||++.++.
T Consensus 250 ~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLL 263 (700)
T ss_pred cCCcccCcchhhhh
Confidence 99999999887764
|
|
| >KOG3839 consensus Lectin VIP36, involved in the transport of glycoproteins carrying high mannose-type glycans [Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.9e-06 Score=85.40 Aligned_cols=182 Identities=21% Similarity=0.314 Sum_probs=118.9
Q ss_pred CCceEecceeEcCCCcEEecCCCCCCceeeEeeCCceeecCCCCCceeeeeeeEEee----------eeEEEEcCCCCCC
Q 044561 39 AQLQRDGLASVHSNGLLQLTNTVSPQQEGHAFYRLPIKFNTSSSESLSFSSNFVFAI----------GMAFVISPSKDLG 108 (614)
Q Consensus 39 ~~~~~~g~a~~~~~g~l~Lt~~~~~~~~G~~~y~~pv~l~~~~~~~~sF~t~F~f~i----------G~aF~l~p~~~~~ 108 (614)
.+..+.|.+.+. ..-++||.+.+ ++.|.+|=.+||-..+ |...+.|.+ |||+..+-....
T Consensus 72 ~~W~~~Gstvv~-~~~irLT~d~q-sk~GAv~n~~Pv~s~~-------wev~v~fkv~~~s~~lfgdG~Aiw~t~Er~q- 141 (351)
T KOG3839|consen 72 PNWNLSGSTVVT-SNYIRLTPDEQ-SKSGAVWNRQPVFSRD-------WEVLVHFKVHGQSKNLFGDGMAIWYTKERAQ- 141 (351)
T ss_pred cCccccccEEEE-eeeeecccccc-ccccccccCCCccccc-------eeEEEEEEEecCCCcccccceEEEeeccccc-
Confidence 568889999887 66799999988 8999999999997644 889999988 999999965432
Q ss_pred CCCCCCCCcccccccCCCCCCCCcEEEEEeeccCCCCCCCCCC--CeeeEecCCCcccccccCccccCccCCCc-----c
Q 044561 109 KAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDD--NHVGIDVNSLISHESAPAAYFSDREGMNK-----T 181 (614)
Q Consensus 109 ~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~--~Hvgid~ns~~s~~~~~~~~~~~~~~~~~-----~ 181 (614)
.|-.+|-++.= +-+||=.|||.|.+ +.+.. +-|.+.+| .-+++|+-+.++.-. .
T Consensus 142 -----~GPvFG~~dkF-------~GL~vfidtY~n~~-g~~~~v~P~isvmv~------~gs~sYD~~~Dg~~tel~gc~ 202 (351)
T KOG3839|consen 142 -----PGPVFGSKDKF-------TGLAVFIDTYGNHN-GPHEHVFPYISVMVN------IGSLSYDHSKDGTHTELAGCT 202 (351)
T ss_pred -----CCCCCCCcccc-------eeEEEEEeccCCcC-CCcccceeeEEEEec------cCCcccccCCCCCccccccce
Confidence 35555543331 33899999998852 12211 22233222 233444433332110 0
Q ss_pred ccccCCc-cEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCccc-ccccccccccccCCCccceeeEecccc
Q 044561 182 LELIIGD-PIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHI-LLETMYVGFSASTGSLKSSHYVLGWSF 256 (614)
Q Consensus 182 ~~l~~g~-~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~-l~~~~~vGFsastg~~~~~h~i~sWsf 256 (614)
..+.+.. .-.+-|.|+. ++|++..+..+ |. ....-.++..+ +|.--|+|+||+||.+...|.|.+-.+
T Consensus 203 a~~rn~~~dt~~~iry~~--~~l~~~~dl~~---~~--~~~~c~~~n~v~lp~g~~fg~SasTGdlSd~HdivS~kl 272 (351)
T KOG3839|consen 203 ANFRNLPHDTLVVIRYEK--KTLSISIDLEG---PN--EWIDCFSLNNVELPLGYFFGVSASTGDLSDSHDIVSLKL 272 (351)
T ss_pred eeeccCCCcceeEEEecC--CceEEEEecCC---Cc--eeeeeeeecceecccceEEeeeeccCccchhhHHHHhhh
Confidence 1112221 2347799997 77777775432 22 24445666664 677788999999999999999988544
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.40 E-value=2.5e-06 Score=87.70 Aligned_cols=193 Identities=20% Similarity=0.226 Sum_probs=128.9
Q ss_pred CCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEE------eecC-eEEEEE
Q 044561 348 KDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYC------RRKG-EFLLVY 420 (614)
Q Consensus 348 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~------~~~~-~~~lV~ 420 (614)
...+.||+|+-+.+|..-.- ...+.|++.........+..+|+. +.-.||-+-.=+.|= .+++ .+-+.|
T Consensus 14 ~~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~aqk~a~la--~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQAQKVAELA--ATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCCccccCCccceeeecchh--hchhheeecCCCchHHHHHHHHhc--cCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 45678999999999964322 123456665554333333333322 122455433312221 1222 266777
Q ss_pred EecCCCC-cchhccc----CCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccc
Q 044561 421 DYMPNGS-LDKILHT----NIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARL 495 (614)
Q Consensus 421 E~~~~gs-L~~~l~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~ 495 (614)
..+++.- ...++.. ..-+..+|.-.+++++.+|.+.+-|| +.+.+-+|+.++|+|+.+++.+.|.|-.--..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccceee
Confidence 7776542 2222221 11245899999999999999999999 48999999999999999999999998554433
Q ss_pred cCCCCCCcccccccCCCccchhhhc-----CCCCCcchhHHHHHHHHHHHHcC-CCCCCC
Q 044561 496 YDHDTIPQTTKLVGTFGYMDPELMR-----TGKASTSTDVYAFGVFMLEVASG-RRPVEQ 549 (614)
Q Consensus 496 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~~Dv~S~Gvll~el~tg-~~p~~~ 549 (614)
..++. .....+|...|++||.-. +..-+...|-|.+|+++++++.| +.||.+
T Consensus 167 ~~ng~--~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 167 NANGT--LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred ccCCc--eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence 33322 233457899999999764 33567889999999999999986 999975
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.36 E-value=2.1e-06 Score=84.26 Aligned_cols=137 Identities=18% Similarity=0.170 Sum_probs=94.9
Q ss_pred CCcceeeeeCcEEEEEEEEecCcEEEEEEeecCCh----------------------hhHHHHHHHHHHhcccCCC--ce
Q 044561 348 KDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSK----------------------QGIKEFVAELVSMGRLRHR--NL 403 (614)
Q Consensus 348 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~Ei~~l~~l~H~--ni 403 (614)
.....||.|.-+.||.|....+.++++|.-..... -......+|.+.|.+|.-. .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 34578999999999999999999999995432110 0122356788888888654 56
Q ss_pred eEEeeEEeecCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCC
Q 044561 404 VKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADL 483 (614)
Q Consensus 404 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~ 483 (614)
.+.+++ +.-.+||||.++-.|...- ++....-.++..|+.-+.-+- ..++||+|+.+-||+++++|
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg 239 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecCC
Confidence 666654 4457999999886665542 112222233333443333333 37899999999999999999
Q ss_pred CEEEeeeccccccCC
Q 044561 484 NGKLGDFGLARLYDH 498 (614)
Q Consensus 484 ~~kl~DfGla~~~~~ 498 (614)
.+.++||-.+...++
T Consensus 240 ~~~vIDwPQ~v~~~h 254 (304)
T COG0478 240 DIVVIDWPQAVPISH 254 (304)
T ss_pred CEEEEeCcccccCCC
Confidence 999999987765444
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.33 E-value=3.8e-06 Score=80.51 Aligned_cols=137 Identities=18% Similarity=0.145 Sum_probs=102.4
Q ss_pred eeeeCcEEEEEEEEecCcEEEEEEeecCC------hhhHHHHHHHHHHhcccCC--CceeEEeeEEe-ec----CeEEEE
Q 044561 353 IGRGGFGKVYRGVLASNVQIAVKKVSHDS------KQGIKEFVAELVSMGRLRH--RNLVKLRGYCR-RK----GEFLLV 419 (614)
Q Consensus 353 lG~G~fg~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~-~~----~~~~lV 419 (614)
-|.||-+-|++-.+.+. .+.+|+-...- ..+...|.+|+..+.++.. -.+.+.. ++. .+ -.-+||
T Consensus 26 ~~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 45688889998776544 68888875221 2255789999999988853 2244444 332 21 246899
Q ss_pred EEecCC-CCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCC--EEEeeecccc
Q 044561 420 YDYMPN-GSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLN--GKLGDFGLAR 494 (614)
Q Consensus 420 ~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~--~kl~DfGla~ 494 (614)
+|-+++ -+|.+++........+..++..++.++++.+.-|| ..++.|+|+.+.||+++.++. ++++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 997753 47888886654445677888899999999999999 599999999999999987777 9999998665
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.32 E-value=2.1e-06 Score=83.48 Aligned_cols=106 Identities=25% Similarity=0.338 Sum_probs=82.5
Q ss_pred HHHHHHHHHhcccCC--CceeEEeeEEeecC----eEEEEEEecCCC-CcchhcccCCCCCcChhHHHHHHHHhHhhchh
Q 044561 386 KEFVAELVSMGRLRH--RNLVKLRGYCRRKG----EFLLVYDYMPNG-SLDKILHTNIKPCLNWYQRFRIIRGVASGLLY 458 (614)
Q Consensus 386 ~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~----~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~y 458 (614)
....+|...+..+.. -...+.+++..... ..+||+|++++. +|.+++..... ++......++.+++..+.-
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK 133 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence 456778877777743 23445666655432 458999999874 79998876332 5667788999999999999
Q ss_pred hhccCCCceEecCcCCCCeEEcCCC---CEEEeeecccccc
Q 044561 459 LHEDWEQVVLHRDIKPANVLLDADL---NGKLGDFGLARLY 496 (614)
Q Consensus 459 LH~~~~~~ivHrDikp~NIll~~~~---~~kl~DfGla~~~ 496 (614)
|| ..+|+|+|+++.|||++.+. .+.++||+-++..
T Consensus 134 lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 134 LH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99 59999999999999999887 8999999987753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.30 E-value=4.6e-06 Score=91.03 Aligned_cols=141 Identities=20% Similarity=0.241 Sum_probs=90.8
Q ss_pred ceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhH------------------------------HH----------HHH
Q 044561 351 DVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGI------------------------------KE----------FVA 390 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~------------------------------~~----------~~~ 390 (614)
+.|+.++-|.||+|++++|+.||||+....-++.. ++ +..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 67999999999999999999999999876422111 11 223
Q ss_pred HHHHhccc----CCCceeEEeeEE-eecCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhc-hhhhccCC
Q 044561 391 ELVSMGRL----RHRNLVKLRGYC-RRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGL-LYLHEDWE 464 (614)
Q Consensus 391 Ei~~l~~l----~H~niv~l~g~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~ 464 (614)
|...+.++ ++..-+++=..| .-.+.-.|+|||++|-.+.+...... ..++...+ +..++++. ..+= .
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~i---a~~~~~~f~~q~~---~ 283 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKEL---AELLVRAFLRQLL---R 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHH---HHHHHHHHHHHHH---h
Confidence 33333333 122222222222 23456789999999999988843222 22443332 22222221 1111 3
Q ss_pred CceEecCcCCCCeEEcCCCCEEEeeeccccccCC
Q 044561 465 QVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 498 (614)
Q Consensus 465 ~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~ 498 (614)
.++.|.|..|.||+++.+++..+.|||+....+.
T Consensus 284 dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 5899999999999999999999999999876654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.5e-05 Score=78.62 Aligned_cols=138 Identities=14% Similarity=0.163 Sum_probs=83.1
Q ss_pred ceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCc--eeEEeeEEeecCeEEEEEEecCCCC-
Q 044561 351 DVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRN--LVKLRGYCRRKGEFLLVYDYMPNGS- 427 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~~~~~~~~~lV~E~~~~gs- 427 (614)
..||+|..+.||+. .+..+++|...... ......+|.+.++.+..-. +.+.++++...+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 56999999999984 24456777765433 2234578998888886433 4667777777778889999998863
Q ss_pred cchhc---------------------ccCCCCCcChhHHH-HHHHHh----------Hhh-chhhhc-cCCCceEecCcC
Q 044561 428 LDKIL---------------------HTNIKPCLNWYQRF-RIIRGV----------ASG-LLYLHE-DWEQVVLHRDIK 473 (614)
Q Consensus 428 L~~~l---------------------~~~~~~~l~~~~~~-~i~~~i----------a~g-L~yLH~-~~~~~ivHrDik 473 (614)
+...+ |.-.........+. .+..++ .+. ..+|.. .....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 22111 11000011111100 000000 000 111110 114567899999
Q ss_pred CCCeEEcCCCCEEEeeecccc
Q 044561 474 PANVLLDADLNGKLGDFGLAR 494 (614)
Q Consensus 474 p~NIll~~~~~~kl~DfGla~ 494 (614)
|.||++++++ +.++||+.+.
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCCC-cEEEechhcC
Confidence 9999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG3838 consensus Mannose lectin ERGIC-53, involved in glycoprotein traffic [Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=98.11 E-value=8.9e-05 Score=74.91 Aligned_cols=179 Identities=20% Similarity=0.345 Sum_probs=111.5
Q ss_pred ceEecceeEcCCCcEEecCCCCCCceeeEeeCCceeecCCCCCceeeeeeeEEee---------eeEEEEcCCCCCCCCC
Q 044561 41 LQRDGLASVHSNGLLQLTNTVSPQQEGHAFYRLPIKFNTSSSESLSFSSNFVFAI---------GMAFVISPSKDLGKAE 111 (614)
Q Consensus 41 ~~~~g~a~~~~~g~l~Lt~~~~~~~~G~~~y~~pv~l~~~~~~~~sF~t~F~f~i---------G~aF~l~p~~~~~~~~ 111 (614)
..--|||-.. .-.++|+++-. ++.|.+|-+..+.+-+ |..+-.|.+ |||+--+.....
T Consensus 56 W~~~GdAIas-~eqvRlaPSmr-srkGavWtka~~~fe~-------weVev~~rVtGrGRiGAdGlaiWYt~~~G~---- 122 (497)
T KOG3838|consen 56 WSHHGDAIAS-SEQVRLAPSMR-SRKGAVWTKASVPFEN-------WEVEVQFRVTGRGRIGADGLAIWYTRGRGH---- 122 (497)
T ss_pred eeecCccccc-ccceeeccccc-cccCceeecccCCccc-------ceEEEEEEecccccccCCceEEEEecCCCc----
Confidence 5567888764 77899998766 7889999998777743 778888888 999988753321
Q ss_pred CCCCCcccccccCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeeEecCC-CcccccccCccccCccCCCcc-----cccc
Q 044561 112 ASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNS-LISHESAPAAYFSDREGMNKT-----LELI 185 (614)
Q Consensus 112 ~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns-~~s~~~~~~~~~~~~~~~~~~-----~~l~ 185 (614)
-|.-+|-.+ ..+| +++=||+|.|. +--|.+-|.+-.|. -.+-.. ..+|..-. -+..
T Consensus 123 --~GpVfGg~d-~WnG------igiffDSfdnD--~qknnP~Is~~lndGt~~ydh-------~~DGasQ~LssCqrDFR 184 (497)
T KOG3838|consen 123 --VGPVFGGLD-SWNG------IGIFFDSFDND--GQKNNPAISVLLNDGTIPYDH-------PGDGASQGLSSCQRDFR 184 (497)
T ss_pred --ccccccccc-cccc------eEEEeeccccc--CCcCCccEEEEecCCcccccC-------CCccHHHHHHHhhHHhc
Confidence 122222111 1122 78999999985 33456666665542 111000 00110000 0111
Q ss_pred C-CccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcc-cccccccccccccCCCccceeeEeccc
Q 044561 186 I-GDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSH-ILLETMYVGFSASTGSLKSSHYVLGWS 255 (614)
Q Consensus 186 ~-g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~-~l~~~~~vGFsastg~~~~~h~i~sWs 255 (614)
| --+..|+|+|- .++|+|.+...-.+. ..+-+- ++... .||..-|+|.||+||...--|+|++..
T Consensus 185 NkPyPvRarItY~--~nvLtv~innGmtp~-d~yE~C--~rve~~~lp~nGyFGvSAATGgLADDHDVl~Fl 251 (497)
T KOG3838|consen 185 NKPYPVRARITYY--GNVLTVMINNGMTPS-DDYEFC--VRVENLLLPPNGYFGVSAATGGLADDHDVLSFL 251 (497)
T ss_pred cCCCCceEEEEEe--ccEEEEEEcCCCCCC-CCccee--EeccceeccCCCeeeeeecccccccccceeeeE
Confidence 1 12688999998 678999886432222 222233 33334 467889999999999999999999864
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.06 E-value=2.6e-05 Score=76.63 Aligned_cols=142 Identities=20% Similarity=0.226 Sum_probs=83.9
Q ss_pred cceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCC--ceeEEeeEEe---ecCeEEEEEEecC
Q 044561 350 KDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHR--NLVKLRGYCR---RKGEFLLVYDYMP 424 (614)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~--niv~l~g~~~---~~~~~~lV~E~~~ 424 (614)
.+.|+.|..+.||+....+ ..+++|..... .......+|..+++.+... .+.+++.++. .....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3579999999999999877 58888887554 4456677888888877533 3456666443 2345799999999
Q ss_pred CCCcch----------------hc---ccC--CCCCcChhH---------HHHH------------HHHhHh-hchhhhc
Q 044561 425 NGSLDK----------------IL---HTN--IKPCLNWYQ---------RFRI------------IRGVAS-GLLYLHE 461 (614)
Q Consensus 425 ~gsL~~----------------~l---~~~--~~~~l~~~~---------~~~i------------~~~ia~-gL~yLH~ 461 (614)
+..+.. .+ +.. ....+.+.. .... ...+.+ .+..++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988877 11 111 001111110 0000 011111 2222321
Q ss_pred ----cCCCceEecCcCCCCeEEc-CCCCEEEeeecccc
Q 044561 462 ----DWEQVVLHRDIKPANVLLD-ADLNGKLGDFGLAR 494 (614)
Q Consensus 462 ----~~~~~ivHrDikp~NIll~-~~~~~kl~DfGla~ 494 (614)
.....++|+|+.|.||+++ +++.+-|.||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1357899999999999999 66666799998765
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd06900 lectin_VcfQ VcfQ bacterial pilus biogenesis protein, lectin domain | Back alignment and domain information |
|---|
Probab=98.03 E-value=0.00032 Score=67.32 Aligned_cols=197 Identities=17% Similarity=0.147 Sum_probs=105.6
Q ss_pred eEcCCCcEEecCCCCCCceeeEeeCCceeecCCCCCceeeeeeeEEee---------eeEEEEcCCCCCCCCCCCCCCcc
Q 044561 48 SVHSNGLLQLTNTVSPQQEGHAFYRLPIKFNTSSSESLSFSSNFVFAI---------GMAFVISPSKDLGKAEASPSEYL 118 (614)
Q Consensus 48 ~~~~~g~l~Lt~~~~~~~~G~~~y~~pv~l~~~~~~~~sF~t~F~f~i---------G~aF~l~p~~~~~~~~~~~g~~l 118 (614)
.+. +|.||||+... ++.|-+.|.++++--+. + ...+|.... |+||||+-... ++..+..||-|
T Consensus 28 ~i~-~g~LRLT~~~~-nqata~~~~~~FPs~~n-~----v~veFd~yayg~~g~GADGia~vLsDasv-~p~~G~fGGsL 99 (255)
T cd06900 28 QVV-NNRLRLTDASG-NQATAVTLQRLFPSAGN-Y----VEVEFDYYAYGSGGNGADGVALVLSDASV-TPQAGAFGGSL 99 (255)
T ss_pred ccc-cCeEEeccCcc-CcceeEEEeeeeccCCC-e----EEEEEEEEEecCCCCCCceEEEEEeCCCc-CCcCCCcCccc
Confidence 444 79999999877 89999999998876432 1 345555544 99999994332 22367889999
Q ss_pred cccccCC-CCCCCCcEEEEEeeccCCCCC-CCCCCCeeeEecCCCc---ccc-cccCccccCccCCCccccccC----Cc
Q 044561 119 GLFNASN-NGQSTNHILAIELDTVQNLDF-DDIDDNHVGIDVNSLI---SHE-SAPAAYFSDREGMNKTLELII----GD 188 (614)
Q Consensus 119 Gl~~~~~-~~~~~~~~vaVEFDt~~n~~~-~d~~~~Hvgid~ns~~---s~~-~~~~~~~~~~~~~~~~~~l~~----g~ 188 (614)
|+--.+. ......-.++|-||-|-|... .+....-.|---++|. |.. +....|........+.++..+ ..
T Consensus 100 GYa~~~~~~~GfaGGwLGiGlDEyGNFsn~~eg~~~~~g~r~~sV~vRGsg~g~~gY~yl~gt~~~~~~id~~~~~~~~~ 179 (255)
T cd06900 100 GYAQRNDGVPGFAGGWLGIGLDEYGNFSNPNEGRNGFSGRRPQSVTVRGSGSGYTGYKYITGTGVLPPGIDNNSTSTPAP 179 (255)
T ss_pred ccccccCCCCccccceEEEEEeccccccCCCCCccCCcccccceEEEECCCCCCcCceEecccCCCCcccccCCCCCCCC
Confidence 9976542 222355789999999877321 1211111222222221 111 111112111110111111111 12
Q ss_pred cEEEEEEEeCC---CcEEEEEEeeCCCCCCCCCcee-ee-ccCc--ccccccccccccccCCCccceeeEec
Q 044561 189 PIQIWISYDGA---EKLLNVTLAPMSIPKPTKPLLS-RA-INLS--HILLETMYVGFSASTGSLKSSHYVLG 253 (614)
Q Consensus 189 ~~~~~I~Y~~~---~~~l~v~~~~~~~~~~~~~~ls-~~-~dl~--~~l~~~~~vGFsastg~~~~~h~i~s 253 (614)
.+.=+|.-|+. ...|+|.-+-.+-.. ..+++. .. ++.. ..+|+..+++|++|||...-.|.|-.
T Consensus 180 ~hrY~i~Ids~~~~~~~vsV~R~~~~gg~-~~~~I~~~d~~~~~~q~avP~~f~lS~TgSTGgstN~HEIdn 250 (255)
T cd06900 180 GHRYRITIDSTNGDNAWLSVERDIGNGGA-YFVVILTFDALAEQNQDAIPENFYLSFTGSTGGSTNTHEIDN 250 (255)
T ss_pred ceEEEEEEecCCCCceEEEEEEEccCCce-eEEeecceeeccccCCCCCCccEEEEEEecCCCcccceeecc
Confidence 24444444443 334555544221111 111221 11 2333 56789999999999999988998864
|
This family includes bacterial proteins homologous to the VcfQ (also known as MshQ) bacterial pilus biogenesis protein. VcfQ is encoded by the vcfQ gene of the type IV pilus gene cluster of Vibrio cholerae and is essential for type IV pilus assembly. VcfQ has a Laminin G-like domain as well as an L-type lectin domain. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.02 E-value=3.7e-05 Score=83.74 Aligned_cols=143 Identities=17% Similarity=0.208 Sum_probs=90.3
Q ss_pred cceeeeeCcEEEEEEEEecCcEEEEEEeecCChhh-------------------------------HHH------HHHHH
Q 044561 350 KDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQG-------------------------------IKE------FVAEL 392 (614)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-------------------------------~~~------~~~Ei 392 (614)
.+.||.-..|.||+|++++|+.||||.-...-+.. .+. |.+|.
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 36799999999999999999999999876542111 011 33333
Q ss_pred HHhcc----cCCCc---eeEEeeEE-eecCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCC
Q 044561 393 VSMGR----LRHRN---LVKLRGYC-RRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWE 464 (614)
Q Consensus 393 ~~l~~----l~H~n---iv~l~g~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 464 (614)
+-..+ ++|-+ -|++=.++ .-.....|+||||+|..+.+.-.-.. ..++...+..-+.+...-+-+ .
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~~l~~~~~~qIf-----~ 319 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK-RGISPHDILNKLVEAYLEQIF-----K 319 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH-cCCCHHHHHHHHHHHHHHHHH-----h
Confidence 32222 23444 11111222 22346789999999998887643221 224444444333333222222 3
Q ss_pred CceEecCcCCCCeEEcC----CCCEEEeeeccccccCC
Q 044561 465 QVVLHRDIKPANVLLDA----DLNGKLGDFGLARLYDH 498 (614)
Q Consensus 465 ~~ivHrDikp~NIll~~----~~~~kl~DfGla~~~~~ 498 (614)
.|.+|+|-.|.||+++. ++.+.+-|||+.....+
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 58999999999999984 67899999999876654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.99 E-value=8.6e-05 Score=72.37 Aligned_cols=156 Identities=17% Similarity=0.130 Sum_probs=100.9
Q ss_pred ccCHHHHHHHhcCCCCcce---eeeeCcEEEEEEEEecCcEEEEEEeecCChhhH------------------------H
Q 044561 334 RFTYKDLYKATKGFKDKDV---IGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGI------------------------K 386 (614)
Q Consensus 334 ~~~~~el~~~~~~f~~~~~---lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~------------------------~ 386 (614)
..+++.+.....+....+. |.+|.-+.||+|.-.++..+|+|++........ .
T Consensus 34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~ 113 (268)
T COG1718 34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA 113 (268)
T ss_pred hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence 3567777777776666655 556777789999988889999999875421110 0
Q ss_pred HHHHHHHHhcccC--CCceeEEeeEEeecCeEEEEEEecCCCC-cchhcccCCCCCcChhHHHHHHHHhHhhchhhhccC
Q 044561 387 EFVAELVSMGRLR--HRNLVKLRGYCRRKGEFLLVYDYMPNGS-LDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDW 463 (614)
Q Consensus 387 ~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~lV~E~~~~gs-L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 463 (614)
...+|..-|+++. +-.+.+.+++ .+-.|||||+.... -.-.|.. ..+...+...+..++++.+.-|-.
T Consensus 114 W~~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~~-- 184 (268)
T COG1718 114 WARKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLYK-- 184 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHHH--
Confidence 1234555555542 2223333332 23479999996441 1111221 113333566677777777777763
Q ss_pred CCceEecCcCCCCeEEcCCCCEEEeeeccccccCCC
Q 044561 464 EQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD 499 (614)
Q Consensus 464 ~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~ 499 (614)
..++||+||..-|||+. ++.+.|+|+|-+...+++
T Consensus 185 ~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~hp 219 (268)
T COG1718 185 EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDHP 219 (268)
T ss_pred hcCcccccchhhheEEE-CCeEEEEECccccccCCC
Confidence 47899999999999999 889999999998766653
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.97 E-value=7.8e-05 Score=71.87 Aligned_cols=137 Identities=14% Similarity=0.189 Sum_probs=89.4
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHH---------HHHHHHhcccC---CCceeEEeeEEe
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEF---------VAELVSMGRLR---HRNLVKLRGYCR 411 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~Ei~~l~~l~---H~niv~l~g~~~ 411 (614)
..+|+..+++-......|.+-.. ++..+++|..........+.| .+++..+.+++ -.....++..+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 45677777777777777776665 357788888766544333332 23344343342 223333333332
Q ss_pred -----ecCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEE
Q 044561 412 -----RKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGK 486 (614)
Q Consensus 412 -----~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~k 486 (614)
-....+|+|||++|..|.+... ++. .++..+++++.-|| +.|+.|+|+.|.|++++.++ ++
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~~-i~ 174 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNNG-IR 174 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECCc-EE
Confidence 2345679999999988876542 222 24566778899999 58999999999999998654 99
Q ss_pred Eeeeccccc
Q 044561 487 LGDFGLARL 495 (614)
Q Consensus 487 l~DfGla~~ 495 (614)
+.||+..+.
T Consensus 175 iID~~~k~~ 183 (229)
T PF06176_consen 175 IIDTQGKRM 183 (229)
T ss_pred EEECccccc
Confidence 999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.95 E-value=4.6e-05 Score=76.02 Aligned_cols=138 Identities=17% Similarity=0.141 Sum_probs=83.0
Q ss_pred eeeeCc-EEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccC-CCceeEEeeEEeecCeEEEEEEecCCCCcch
Q 044561 353 IGRGGF-GKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLR-HRNLVKLRGYCRRKGEFLLVYDYMPNGSLDK 430 (614)
Q Consensus 353 lG~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~ 430 (614)
|-.|.. ..||+.... +..+.+|+..... ..+..+|+.+++.+. +--+.+++++....+..++|||+++|.+|..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444554 788998764 4677778775443 234567888887773 3445677777776677899999999988764
Q ss_pred hc-------------------ccCC--CCCcC--hhHHHHHH-HH-------------------hHhhchhhh----ccC
Q 044561 431 IL-------------------HTNI--KPCLN--WYQRFRII-RG-------------------VASGLLYLH----EDW 463 (614)
Q Consensus 431 ~l-------------------~~~~--~~~l~--~~~~~~i~-~~-------------------ia~gL~yLH----~~~ 463 (614)
.. +.-. ...+. ........ .. +...+..|- +..
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 42 1100 00111 00011000 00 001111110 112
Q ss_pred CCceEecCcCCCCeEEcCCCCEEEeeecccc
Q 044561 464 EQVVLHRDIKPANVLLDADLNGKLGDFGLAR 494 (614)
Q Consensus 464 ~~~ivHrDikp~NIll~~~~~~kl~DfGla~ 494 (614)
...++|+|+.|.|||++++....|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 4669999999999999998778899999775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.92 E-value=1.4e-06 Score=93.94 Aligned_cols=181 Identities=18% Similarity=0.187 Sum_probs=132.8
Q ss_pred ceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCc-eeEEeeEEeecCeEEEEEEecCCC-Cc
Q 044561 351 DVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRN-LVKLRGYCRRKGEFLLVYDYMPNG-SL 428 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~lV~E~~~~g-sL 428 (614)
+-.++|+++++||.+-........+.+... ....-++++|.+++||| .+..++-+..+...+++++++..+ +-
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~ 322 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS 322 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence 457889999999977544444445555433 33356788999999999 777777788888899999999877 32
Q ss_pred chhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcccccc
Q 044561 429 DKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLV 508 (614)
Q Consensus 429 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 508 (614)
...... ..-.+...+...+...-.++++|||+ ..-+|+| ||+..+ +..|.+||+....+.... ......
T Consensus 323 ~~~~~~-se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t~~ 391 (829)
T KOG0576|consen 323 ALEMTV-SEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRTAI 391 (829)
T ss_pred cccCCh-hhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc--ccccCC
Confidence 222211 11235556666778888899999996 3357888 777755 678999999887666543 234467
Q ss_pred cCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCC
Q 044561 509 GTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPV 547 (614)
Q Consensus 509 gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~ 547 (614)
+|+.++|||+...+.+..+.|+|+.|+-..++.-|-+|-
T Consensus 392 ~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 392 GTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 899999999999999999999999998777777776664
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.84 E-value=4.4e-05 Score=72.80 Aligned_cols=102 Identities=27% Similarity=0.251 Sum_probs=81.7
Q ss_pred HHHHHhcccCC-CceeEEeeEEeecCeEEEEEEecCCCCcchh---cccCCCCCcChhHHHHHHHHhHhhchhhhccCCC
Q 044561 390 AELVSMGRLRH-RNLVKLRGYCRRKGEFLLVYDYMPNGSLDKI---LHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQ 465 (614)
Q Consensus 390 ~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~---l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 465 (614)
.|.-+++.+++ +++.+++|+|-+ ++|.||.+.+++... +.. -...+|..|.+|+.++++.+.+|++....
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~--~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQ--FLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccccccc--ccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 57778888876 699999999943 678999987766532 111 11268999999999999999999976556
Q ss_pred ceEecCcCCCCeEEcCCCCEEEeeeccccccC
Q 044561 466 VVLHRDIKPANVLLDADLNGKLGDFGLARLYD 497 (614)
Q Consensus 466 ~ivHrDikp~NIll~~~~~~kl~DfGla~~~~ 497 (614)
.+.-.|++++|+-+++++++|+.|...+...+
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 68899999999999999999999998775443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.0002 Score=68.67 Aligned_cols=130 Identities=20% Similarity=0.334 Sum_probs=87.8
Q ss_pred CCcceeeeeCcEEEEEEEEecCcEEEEEEeecCC----------------hhhHHHHHHHHHHhcccC------CCceeE
Q 044561 348 KDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDS----------------KQGIKEFVAELVSMGRLR------HRNLVK 405 (614)
Q Consensus 348 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~Ei~~l~~l~------H~niv~ 405 (614)
+....||+|+.-.||.-- ++...+||...... ....++..+|+.....+. +.+|.+
T Consensus 4 ~~~~~i~~G~~R~cy~HP--~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r 81 (199)
T PF10707_consen 4 SESDLIAQGGERDCYQHP--DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR 81 (199)
T ss_pred CCCcccccCCCceEEECC--CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence 345679999999999743 44456777776554 223455566665554444 889999
Q ss_pred EeeEEeecCeEEEEEEecCC--C----CcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEE
Q 044561 406 LRGYCRRKGEFLLVYDYMPN--G----SLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL 479 (614)
Q Consensus 406 l~g~~~~~~~~~lV~E~~~~--g----sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll 479 (614)
++|+.++...+.+|+|.+.+ | +|.+++... .++. ...+.+.++.+ ||- +..|+.+|++|+||++
T Consensus 82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~~~~L~~f~~---~l~---~~~Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-ELRQALDEFKR---YLL---DHHIVIRDLNPHNIVV 151 (199)
T ss_pred EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-HHHHHHHHHHH---HHH---HcCCeecCCCcccEEE
Confidence 99999999999999998743 2 466676443 2444 44444444443 444 3679999999999999
Q ss_pred cCCC----CEEEee
Q 044561 480 DADL----NGKLGD 489 (614)
Q Consensus 480 ~~~~----~~kl~D 489 (614)
.... .+.|+|
T Consensus 152 ~~~~~~~~~lvlID 165 (199)
T PF10707_consen 152 QRRDSGEFRLVLID 165 (199)
T ss_pred EecCCCceEEEEEe
Confidence 5432 466776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00016 Score=84.81 Aligned_cols=79 Identities=14% Similarity=0.246 Sum_probs=57.2
Q ss_pred cceeeeeCcEEEEEEEEecC---cEEEEEEeecCC-hhhHHHHHHHHHHhcccC-CCce--eEEeeEEeec---CeEEEE
Q 044561 350 KDVIGRGGFGKVYRGVLASN---VQIAVKKVSHDS-KQGIKEFVAELVSMGRLR-HRNL--VKLRGYCRRK---GEFLLV 419 (614)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-H~ni--v~l~g~~~~~---~~~~lV 419 (614)
.+.++.|.+..+|+....++ ..+++|+..... ......+.+|..+++.+. |.++ .+++.+|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46789999999999877653 356777654332 122346789999999885 6654 7888888764 467899
Q ss_pred EEecCCCCc
Q 044561 420 YDYMPNGSL 428 (614)
Q Consensus 420 ~E~~~~gsL 428 (614)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999987654
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00051 Score=68.10 Aligned_cols=74 Identities=15% Similarity=0.112 Sum_probs=44.5
Q ss_pred ceeeeeCcE-EEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCC---ceeEEeeEEeec---CeEEEEEEec
Q 044561 351 DVIGRGGFG-KVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHR---NLVKLRGYCRRK---GEFLLVYDYM 423 (614)
Q Consensus 351 ~~lG~G~fg-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~---niv~l~g~~~~~---~~~~lV~E~~ 423 (614)
+.|+.|+.. .||+. +..+++|..... .....+.+|.+.+..+... .+.+.++.+... +..+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 457777776 48875 234666654332 2234678888888777532 233444443332 2358899999
Q ss_pred CCCCcch
Q 044561 424 PNGSLDK 430 (614)
Q Consensus 424 ~~gsL~~ 430 (614)
+|.++.+
T Consensus 77 ~G~~l~~ 83 (235)
T cd05155 77 EGETATA 83 (235)
T ss_pred cCCCCCc
Confidence 9988753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0026 Score=65.48 Aligned_cols=79 Identities=10% Similarity=0.039 Sum_probs=56.4
Q ss_pred CCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCC---CceeEEeeEEee---cCeEEEEE
Q 044561 347 FKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRH---RNLVKLRGYCRR---KGEFLLVY 420 (614)
Q Consensus 347 f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H---~niv~l~g~~~~---~~~~~lV~ 420 (614)
....+.||.|..+.||+....++ .+.+|..+... ....+.+|...++.+.- -.+.+++++|.. .+..+|||
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQG-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred hheeeecCCccceeEEEEEcCCC-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 34456799999999999876555 35556543211 22467888888888743 467788888754 36789999
Q ss_pred EecCCCCc
Q 044561 421 DYMPNGSL 428 (614)
Q Consensus 421 E~~~~gsL 428 (614)
|+++++++
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99998765
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.00087 Score=67.36 Aligned_cols=137 Identities=15% Similarity=0.052 Sum_probs=76.1
Q ss_pred eeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCce-eEEeeEEeecCeEEEEEEecCCCCcchh
Q 044561 353 IGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNL-VKLRGYCRRKGEFLLVYDYMPNGSLDKI 431 (614)
Q Consensus 353 lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~~~gsL~~~ 431 (614)
+..|-...+|+.. .++..+++|..........-...+|..+++.+....+ .+++..+. -++||||++|..+...
T Consensus 4 ~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 4567778899887 3466777876544322211134678888877754333 33444332 2689999998776532
Q ss_pred -----------------cccCC--CCCcChhHH-HHHHHHhH---------hhchhhhc-----cCCCceEecCcCCCCe
Q 044561 432 -----------------LHTNI--KPCLNWYQR-FRIIRGVA---------SGLLYLHE-----DWEQVVLHRDIKPANV 477 (614)
Q Consensus 432 -----------------l~~~~--~~~l~~~~~-~~i~~~ia---------~gL~yLH~-----~~~~~ivHrDikp~NI 477 (614)
||... ...++...+ .....++. .-+..+-. .....++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 11111 111121111 11111111 11111111 1135689999999999
Q ss_pred EEcCCCCEEEeeeccccc
Q 044561 478 LLDADLNGKLGDFGLARL 495 (614)
Q Consensus 478 ll~~~~~~kl~DfGla~~ 495 (614)
++++++ +.|.||..+..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999877 78999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0013 Score=60.98 Aligned_cols=130 Identities=18% Similarity=0.201 Sum_probs=86.5
Q ss_pred CcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeE-EeeEEeecCeEEEEEEecCCCC
Q 044561 349 DKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVK-LRGYCRRKGEFLLVYDYMPNGS 427 (614)
Q Consensus 349 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~-l~g~~~~~~~~~lV~E~~~~gs 427 (614)
..+.|++|.+|.||+|.+.+. .+|+|.-..++.. ..+..|.+++..++-.++.+ ++.|- ...+.|||..|-+
T Consensus 26 v~~~L~KG~~s~Vyl~~~~~~-~~a~Kvrr~ds~r--~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~ 98 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWRGG-EVALKVRRRDSPR--RNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhcccccEEEEeeccCc-eEEEEEecCCcch--hhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcc
Confidence 356799999999999998644 7888887766543 56778888888887665543 33332 2345599998888
Q ss_pred cchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcC-CCCeEEcCCCCEEEeeeccccccC
Q 044561 428 LDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK-PANVLLDADLNGKLGDFGLARLYD 497 (614)
Q Consensus 428 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik-p~NIll~~~~~~kl~DfGla~~~~ 497 (614)
|.+.-... +-.+. ..+++.-.-|- ..+|-|+.|. |...++-.+..+.|+||.-|....
T Consensus 99 L~~~~~~~-----~rk~l----~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~ 157 (201)
T COG2112 99 LGKLEIGG-----DRKHL----LRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFKK 157 (201)
T ss_pred hhhhhhcc-----cHHHH----HHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhhcc
Confidence 87765431 22233 33444423333 4788888876 444555555599999999887443
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0019 Score=63.83 Aligned_cols=139 Identities=21% Similarity=0.223 Sum_probs=78.9
Q ss_pred ceeeeeCcEEEEEEEEec--CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCce-eEEeeEEeecCeEEEEEEecCCCC
Q 044561 351 DVIGRGGFGKVYRGVLAS--NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNL-VKLRGYCRRKGEFLLVYDYMPNGS 427 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~~~gs 427 (614)
+.|..|-...+|+....+ +..+++|........ .-.-.+|+.+++.+...++ .++++.+. + .++|||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCCc
Confidence 457778888999988664 567888866543221 1222467777777753333 34444332 2 37999999877
Q ss_pred cchh-----------------cccCC-C--------CCc-ChhHHHHHHHH----------------------hH---hh
Q 044561 428 LDKI-----------------LHTNI-K--------PCL-NWYQRFRIIRG----------------------VA---SG 455 (614)
Q Consensus 428 L~~~-----------------l~~~~-~--------~~l-~~~~~~~i~~~----------------------ia---~g 455 (614)
+... ++... . ... .|..+..+... +. ..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 6422 01100 0 001 12221121111 11 11
Q ss_pred ch-hhhc-cCCCceEecCcCCCCeEEcC-CCCEEEeeecccc
Q 044561 456 LL-YLHE-DWEQVVLHRDIKPANVLLDA-DLNGKLGDFGLAR 494 (614)
Q Consensus 456 L~-yLH~-~~~~~ivHrDikp~NIll~~-~~~~kl~DfGla~ 494 (614)
|. .+.. .....++|+|+.+.|||+++ +..+.++||..|.
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 11 1111 02467999999999999998 5789999998775
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0021 Score=61.34 Aligned_cols=125 Identities=27% Similarity=0.394 Sum_probs=87.7
Q ss_pred cCCCCcceeeeeCc-EEEEEEEEecCcEEEEEEeec---CC------------h------hhHHHHHHHHHHhcccC---
Q 044561 345 KGFKDKDVIGRGGF-GKVYRGVLASNVQIAVKKVSH---DS------------K------QGIKEFVAELVSMGRLR--- 399 (614)
Q Consensus 345 ~~f~~~~~lG~G~f-g~Vy~~~~~~~~~vavK~~~~---~~------------~------~~~~~~~~Ei~~l~~l~--- 399 (614)
..++..+.||.|.- |.|||.++. |..+|+|.+.. .. . .....|..|.....+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 56778899999999 999999985 55899999322 10 0 12235788988888775
Q ss_pred CCce--eEEeeEEeec------------------CeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhh
Q 044561 400 HRNL--VKLRGYCRRK------------------GEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYL 459 (614)
Q Consensus 400 H~ni--v~l~g~~~~~------------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL 459 (614)
+.++ |+.+||..-. ....||.||.+... .+...+ +.++.+-|.-+
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~~~----~~~~~~dl~~~ 180 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQIRD----IPQMLRDLKIL 180 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccchhH----HHHHHHHHHHH
Confidence 4566 9999997322 12467888775433 122223 44566667788
Q ss_pred hccCCCceEecCcCCCCeEEcCCCCEEEeeeccc
Q 044561 460 HEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLA 493 (614)
Q Consensus 460 H~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla 493 (614)
| +.+|+-+|+++.|.. .-||+|||.+
T Consensus 181 ~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 H---KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred H---HCCeeeccCcccccc-----CCEEEecccC
Confidence 8 699999999999975 4589999854
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0011 Score=76.76 Aligned_cols=193 Identities=17% Similarity=0.176 Sum_probs=125.9
Q ss_pred HHHHHHHhcccCCCceeEEeeEEeecCe----EEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccC
Q 044561 388 FVAELVSMGRLRHRNLVKLRGYCRRKGE----FLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDW 463 (614)
Q Consensus 388 ~~~Ei~~l~~l~H~niv~l~g~~~~~~~----~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 463 (614)
-.-|+..+.++.|+|++.++.|-.++.. ..+..|+|..-++...++.- ...+....+.+..++.+||.|+|+
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~~~~~~GL~~~h~-- 304 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV--GSIPLETLRILHQKLLEGLAYLHS-- 304 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc--cccCHHHHHHHHHHHhhhHHHHHH--
Confidence 3456778888899999999998765533 23456778888888877653 347888888899999999999996
Q ss_pred CCceEecCcCCC---CeEEcCCCCEEEe--eeccccccCCCCCCcccccccCCCccchhhhcCCCCCc--chhHHHHHHH
Q 044561 464 EQVVLHRDIKPA---NVLLDADLNGKLG--DFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKAST--STDVYAFGVF 536 (614)
Q Consensus 464 ~~~ivHrDikp~---NIll~~~~~~kl~--DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~--~~Dv~S~Gvl 536 (614)
....|.-+..+ +--.+.++...++ ||+.......... ......+..+.+||......+.. ..|+|++|..
T Consensus 305 -~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~--~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 305 -LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK--SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred -hccceeEEecccccccccCccceeecchhhhcccccCCCccc--chhhcCccccccccccccccchhhhhhHHHHHHHH
Confidence 33334333333 3334556666666 8887765543321 12223455678888776655544 4799999999
Q ss_pred HHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHh
Q 044561 537 MLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVM 613 (614)
Q Consensus 537 l~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 613 (614)
...+..|..+-..... +. .-+...+.. .+......|+..++++|++..+++
T Consensus 382 ~~~~~~~~~i~~~~~~------~~----------------~~l~~~~~~----~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKSAV------PV----------------SLLDVLSTS----ELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred HhhhhhcCcccccccc------hh----------------hhhccccch----hhhhhhhhhcchhhhhccchhhhh
Confidence 9999987765322110 00 000011111 234455569999999999998876
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0082 Score=62.37 Aligned_cols=140 Identities=18% Similarity=0.165 Sum_probs=75.0
Q ss_pred ceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhccc-----CCCceeEEe-e--EEeecCeEEEEEEe
Q 044561 351 DVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRL-----RHRNLVKLR-G--YCRRKGEFLLVYDY 422 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-----~H~niv~l~-g--~~~~~~~~~lV~E~ 422 (614)
+.|+.|....+|+....++ .+++|+....... ....|+..+..| ..|.+++-. | +....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~~~---~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFERLTAE---DLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEeccCChH---HhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 4567777789999876555 6788877522222 222333333333 233333211 1 12235668999999
Q ss_pred cCCCCcchh--------------cccCCC---------CCcCh-hHHHHH------------HHH-hHhhchhhhc----
Q 044561 423 MPNGSLDKI--------------LHTNIK---------PCLNW-YQRFRI------------IRG-VASGLLYLHE---- 461 (614)
Q Consensus 423 ~~~gsL~~~--------------l~~~~~---------~~l~~-~~~~~i------------~~~-ia~gL~yLH~---- 461 (614)
++|..+... ++.... ..+.| .+...- +.+ +...+..+..
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 988765321 111000 01112 111111 111 1111222221
Q ss_pred cCCCceEecCcCCCCeEEcCCCCEEEeeecccc
Q 044561 462 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR 494 (614)
Q Consensus 462 ~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~ 494 (614)
....+++|+|+.|.||+++.+...-|.||+.+.
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 134689999999999999976556899999876
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0049 Score=63.28 Aligned_cols=141 Identities=21% Similarity=0.180 Sum_probs=82.0
Q ss_pred cceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCc--eeEEeeE------EeecCeEEEEEE
Q 044561 350 KDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRN--LVKLRGY------CRRKGEFLLVYD 421 (614)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~------~~~~~~~~lV~E 421 (614)
.+.|..|....+|+....+ ..+++|...... ..+...|+.++..+.+.+ +.+++.. ....+..+++++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEKVS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCCCC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4567778778999987544 467888775422 234556666666664322 3444332 123456789999
Q ss_pred ecCCCCcchh--------------cccCC---C------CCcChhHHHH----------HHHHhHhhchhhhc----cCC
Q 044561 422 YMPNGSLDKI--------------LHTNI---K------PCLNWYQRFR----------IIRGVASGLLYLHE----DWE 464 (614)
Q Consensus 422 ~~~~gsL~~~--------------l~~~~---~------~~l~~~~~~~----------i~~~ia~gL~yLH~----~~~ 464 (614)
|++|..+... ++... . ....|..... ....+...+.++.. ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 9998876431 01100 0 0112222110 01112223333331 124
Q ss_pred CceEecCcCCCCeEEcCCCCEEEeeecccc
Q 044561 465 QVVLHRDIKPANVLLDADLNGKLGDFGLAR 494 (614)
Q Consensus 465 ~~ivHrDikp~NIll~~~~~~kl~DfGla~ 494 (614)
.+++|+|+.|.||+++++..+.|.||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 679999999999999998777899999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.0051 Score=65.46 Aligned_cols=76 Identities=14% Similarity=0.117 Sum_probs=52.6
Q ss_pred cceeeeeCcEEEEEEEEecC-cEEEEEEeecC-----C--hhhHHHHHHHHHHhcccC---CCceeEEeeEEeecCeEEE
Q 044561 350 KDVIGRGGFGKVYRGVLASN-VQIAVKKVSHD-----S--KQGIKEFVAELVSMGRLR---HRNLVKLRGYCRRKGEFLL 418 (614)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~-----~--~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~l 418 (614)
.+.||.|.+..||+....++ +.++||.-... . .-..+++..|.+.|..+. ..++.+++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 35689999999999998776 48999975321 1 123456667777777652 2456677766 3355789
Q ss_pred EEEecCCCC
Q 044561 419 VYDYMPNGS 427 (614)
Q Consensus 419 V~E~~~~gs 427 (614)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998644
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.005 Score=63.44 Aligned_cols=139 Identities=25% Similarity=0.299 Sum_probs=79.9
Q ss_pred ceeeeeCcEEEEEEEEec-------CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCce-eEEeeEEeecCeEEEEEEe
Q 044561 351 DVIGRGGFGKVYRGVLAS-------NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNL-VKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~ 422 (614)
+.+..|-...+|+....+ +..+++|....... ...+..+|..++..+....+ .++++.+. + .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhe
Confidence 446667777899888654 46788887655432 22344677777777643333 34555443 2 358999
Q ss_pred cCCCCcchh-c----------------ccCCCC-------Cc--ChhHHHHH--------------------------HH
Q 044561 423 MPNGSLDKI-L----------------HTNIKP-------CL--NWYQRFRI--------------------------IR 450 (614)
Q Consensus 423 ~~~gsL~~~-l----------------~~~~~~-------~l--~~~~~~~i--------------------------~~ 450 (614)
++|..+... + |..... .. -|..+..+ ..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 988877532 1 111000 00 01111110 11
Q ss_pred HhHhhchhhh------ccCCCceEecCcCCCCeEEcCC----CCEEEeeecccc
Q 044561 451 GVASGLLYLH------EDWEQVVLHRDIKPANVLLDAD----LNGKLGDFGLAR 494 (614)
Q Consensus 451 ~ia~gL~yLH------~~~~~~ivHrDikp~NIll~~~----~~~kl~DfGla~ 494 (614)
.+..-+..|. ......++|+|+.+.||+++++ +.++++||..+.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 1112222332 1235789999999999999985 889999999876
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.00078 Score=79.66 Aligned_cols=160 Identities=13% Similarity=0.017 Sum_probs=114.3
Q ss_pred HHHHHHHHhcccCCCceeEEeeEEe--ecCeEEEEEEecCCCCcchhcccCCC--CCcChhHHHHHHHHhHhhchhhhcc
Q 044561 387 EFVAELVSMGRLRHRNLVKLRGYCR--RKGEFLLVYDYMPNGSLDKILHTNIK--PCLNWYQRFRIIRGVASGLLYLHED 462 (614)
Q Consensus 387 ~~~~Ei~~l~~l~H~niv~l~g~~~--~~~~~~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~ 462 (614)
....|....++..|+++.....-.. +..+.+.+++|+..|.+.+.+-++.. +.++..-.....++......-+|+.
T Consensus 1275 mll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1275 MLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence 3445555666778998877655433 23467899999999999998876432 3344444444444434444444432
Q ss_pred --CCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHH
Q 044561 463 --WEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEV 540 (614)
Q Consensus 463 --~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el 540 (614)
...-.+|+++|+-|.+|..+-++|++++|+.+...+.. ......++++.|+.|++...-+++.++|+|..|+-+++.
T Consensus 1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~-sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL-SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred ccCCccchhhhhhhhccceecCCcccccccccccccCchH-hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence 23457899999999999999999999999998433322 122335678889999999888889999999999999999
Q ss_pred HcCCCCC
Q 044561 541 ASGRRPV 547 (614)
Q Consensus 541 ~tg~~p~ 547 (614)
.-|..+|
T Consensus 1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred hcccHHH
Confidence 8877765
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.56 E-value=0.029 Score=58.02 Aligned_cols=142 Identities=20% Similarity=0.164 Sum_probs=79.2
Q ss_pred cceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCC--ceeEEeeEE------eecCeEEEEEE
Q 044561 350 KDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHR--NLVKLRGYC------RRKGEFLLVYD 421 (614)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~--niv~l~g~~------~~~~~~~lV~E 421 (614)
.+.++.|....+|+....++ .+++|+...... ..+...|++++..|... .+.+++... ...+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45577777789998875444 577787644211 22334455555555321 233433321 22456789999
Q ss_pred ecCCCCcchh--------------cccCCCC----------CcChhHHHH------------HHHHhHhhchhhhc----
Q 044561 422 YMPNGSLDKI--------------LHTNIKP----------CLNWYQRFR------------IIRGVASGLLYLHE---- 461 (614)
Q Consensus 422 ~~~~gsL~~~--------------l~~~~~~----------~l~~~~~~~------------i~~~ia~gL~yLH~---- 461 (614)
|++|..+... ++..... .-.|..... ....+.+.+.++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 9988665321 1110000 011211110 01112233444431
Q ss_pred cCCCceEecCcCCCCeEEcCCCCEEEeeecccc
Q 044561 462 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR 494 (614)
Q Consensus 462 ~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~ 494 (614)
....+++|+|+.+.||+++.++...|.||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 235789999999999999998877899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.024 Score=57.64 Aligned_cols=32 Identities=31% Similarity=0.592 Sum_probs=26.4
Q ss_pred CCceEecCcCCCCeEEcCCCC-EEEeeeccccc
Q 044561 464 EQVVLHRDIKPANVLLDADLN-GKLGDFGLARL 495 (614)
Q Consensus 464 ~~~ivHrDikp~NIll~~~~~-~kl~DfGla~~ 495 (614)
...++|+|+++.||+++++++ .-|.||+.+..
T Consensus 184 ~~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 184 HTVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CCeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 356899999999999997555 46999998763
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.0036 Score=66.83 Aligned_cols=164 Identities=21% Similarity=0.305 Sum_probs=93.5
Q ss_pred HHHHHHHHHhcccCCCceeEEeeEEeec-CeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCC
Q 044561 386 KEFVAELVSMGRLRHRNLVKLRGYCRRK-GEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWE 464 (614)
Q Consensus 386 ~~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 464 (614)
.+++....+++.+.|+|+.+.+.+-... ....+|+|++ +.||.+.+..+. +.... ..+.+
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~---l~~~s------~~~~~--------- 87 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN---LKDES------LLAHG--------- 87 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc---cchhh------hcccc---------
Confidence 4556677888999999999999887644 3478999999 778888876542 11111 11111
Q ss_pred CceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCC
Q 044561 465 QVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGR 544 (614)
Q Consensus 465 ~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~ 544 (614)
+.| .||+ +++| -++. . | |- ...+|+||||+|.++.|+.-|.
T Consensus 88 --~~~-----~~~~-------~~td-~~~t---~--------------~--~~-----~~~pKsdVwsl~~i~~el~L~~ 128 (725)
T KOG1093|consen 88 --VLH-----LNII-------YITD-HFLT---K--------------Y--PS-----PIGPKSDVWSLGFIILELYLGI 128 (725)
T ss_pred --cce-----ehhh-------hccc-cccc---c--------------C--CC-----CCCcchhhhhHHHHHHHHHHhh
Confidence 111 1222 2222 0000 0 0 00 0114999999999999999998
Q ss_pred CCCCCCCccccccHHHHHHHhhhc-CCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHh
Q 044561 545 RPVEQQGSMETVNLVDWVCDCWKK-GAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVM 613 (614)
Q Consensus 545 ~p~~~~~~~~~~~l~~~v~~~~~~-~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 613 (614)
.-+......+....+ .+.... +......-+ ..+..++.+..+++...|+-..|..||...+..
T Consensus 129 ~l~~~~~~s~~l~~i---~k~~~~d~~~~~~a~e---~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~ 192 (725)
T KOG1093|consen 129 SLEAELTESEYLEIL---LKYYTDDQELLSTAME---HLIQLLADKKRLPLLKKCLWLEPIIRPLPMELS 192 (725)
T ss_pred HHHHHHHHHHHHHHH---HHhccCchhHHHHHHH---HHHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence 776543332222211 111110 000000000 123344556788889999999999999776654
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.028 Score=57.35 Aligned_cols=75 Identities=17% Similarity=0.251 Sum_probs=47.0
Q ss_pred CCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhccc---CCCceeEEeeEEeecCeEEEEEEecC
Q 044561 348 KDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRL---RHRNLVKLRGYCRRKGEFLLVYDYMP 424 (614)
Q Consensus 348 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~~~~~lV~E~~~ 424 (614)
+..+.++.|....+|+.. .++..+.||.-... ....|..|..-|+.| .--.+.+.+++....+..+|++||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~---~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNSES---GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEEGG---GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecChh---hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 445679999999999977 56778899987632 234567777777666 34557788888877777899999998
Q ss_pred CC
Q 044561 425 NG 426 (614)
Q Consensus 425 ~g 426 (614)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 77
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.029 Score=59.02 Aligned_cols=140 Identities=15% Similarity=0.179 Sum_probs=79.8
Q ss_pred ceeeeeCcEEEEEEEEec-----CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCcee-EEeeEEeecCeEEEEEEecC
Q 044561 351 DVIGRGGFGKVYRGVLAS-----NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLV-KLRGYCRRKGEFLLVYDYMP 424 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~ 424 (614)
+.+-.|-.-.+|+....+ +..+++|...........+ .+|..+++.+...++. ++++.+. .+ .|+||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~-~g---~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFP-NG---RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEEC-Cc---eEEEeeC
Confidence 345457777899987543 2567777765543322222 5788888877544444 4455443 22 5899998
Q ss_pred CCCcchh-----------------cccCC----CCCcChhHHHHHHHHhH-----------------hhchh----hhc-
Q 044561 425 NGSLDKI-----------------LHTNI----KPCLNWYQRFRIIRGVA-----------------SGLLY----LHE- 461 (614)
Q Consensus 425 ~gsL~~~-----------------l~~~~----~~~l~~~~~~~i~~~ia-----------------~gL~y----LH~- 461 (614)
+.+|... +|... .....|.++.++..++. ..+.. +..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7776421 11111 00122333333322211 11111 111
Q ss_pred cCCCceEecCcCCCCeEEcC-CCCEEEeeeccccc
Q 044561 462 DWEQVVLHRDIKPANVLLDA-DLNGKLGDFGLARL 495 (614)
Q Consensus 462 ~~~~~ivHrDikp~NIll~~-~~~~kl~DfGla~~ 495 (614)
.....++|+|+++.|||+++ ++.+.++||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 12457999999999999986 46899999988764
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.00 E-value=0.0061 Score=61.72 Aligned_cols=137 Identities=16% Similarity=0.114 Sum_probs=90.2
Q ss_pred CCCcceeeeeCcEEEEEEEEecCcEEEEEEeecC--C-------h---------hh----HHHHHHHHHHhcccCC--Cc
Q 044561 347 FKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHD--S-------K---------QG----IKEFVAELVSMGRLRH--RN 402 (614)
Q Consensus 347 f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~-------~---------~~----~~~~~~Ei~~l~~l~H--~n 402 (614)
+...++||-|.-+.||.+...+|.+.++|.-... + + .+ .-...+|...|+.|.. =-
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 5678899999999999999988888887742211 0 0 00 0113457777777642 12
Q ss_pred eeEEeeEEeecCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCC
Q 044561 403 LVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDAD 482 (614)
Q Consensus 403 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~ 482 (614)
+.+.+++ +.-++|||++.+-.|.+.-+- .+..+++.-+.++ +.-|. +.|+||+|..-=||+++++
T Consensus 174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~v-----~d~~~ly~~lm~~---Iv~la---~~GlIHgDFNEFNimv~dd 238 (465)
T KOG2268|consen 174 VPKPIDH----NRHCVVMELVDGYPLRQVRHV-----EDPPTLYDDLMGL---IVRLA---NHGLIHGDFNEFNIMVKDD 238 (465)
T ss_pred CCCcccc----cceeeHHHhhcccceeeeeec-----CChHHHHHHHHHH---HHHHH---HcCceecccchheeEEecC
Confidence 3344443 345789999988888765433 2233333333332 22333 4899999999999999999
Q ss_pred CCEEEeeeccccccCC
Q 044561 483 LNGKLGDFGLARLYDH 498 (614)
Q Consensus 483 ~~~kl~DfGla~~~~~ 498 (614)
..++++||--.....+
T Consensus 239 ~~i~vIDFPQmvS~sh 254 (465)
T KOG2268|consen 239 DKIVVIDFPQMVSTSH 254 (465)
T ss_pred CCEEEeechHhhccCC
Confidence 9999999986655444
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.96 E-value=0.063 Score=55.28 Aligned_cols=130 Identities=18% Similarity=0.206 Sum_probs=77.1
Q ss_pred EEEEEEEecCcEEEEEEee-cCChhhHHHHHHHHHHhcccC--CCceeEEeeEEeecC--eEEEEEEecCCCCcchhccc
Q 044561 360 KVYRGVLASNVQIAVKKVS-HDSKQGIKEFVAELVSMGRLR--HRNLVKLRGYCRRKG--EFLLVYDYMPNGSLDKILHT 434 (614)
Q Consensus 360 ~Vy~~~~~~~~~vavK~~~-~~~~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~--~~~lV~E~~~~gsL~~~l~~ 434 (614)
.+|..... ++++++.+-. ...........+|+.+++.+. ---..+.++.|.++. ..+.||+|+++..+.+.+..
T Consensus 40 ~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~ 118 (321)
T COG3173 40 DTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPP 118 (321)
T ss_pred ceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCc
Confidence 34443333 5556665221 122333445567777777664 233455677787766 77999999988554443322
Q ss_pred CCCCCcChhHHHHHH-HHhHhhchhhh--------------------------------------------------c--
Q 044561 435 NIKPCLNWYQRFRII-RGVASGLLYLH--------------------------------------------------E-- 461 (614)
Q Consensus 435 ~~~~~l~~~~~~~i~-~~ia~gL~yLH--------------------------------------------------~-- 461 (614)
... . .+++ ..+++.|.-|| +
T Consensus 119 ~~~---~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~ 191 (321)
T COG3173 119 ESL---G----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANR 191 (321)
T ss_pred ccc---h----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcC
Confidence 110 0 0111 13333333333 1
Q ss_pred ---cCCCceEecCcCCCCeEEcCCCCEEEeeeccccccC
Q 044561 462 ---DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYD 497 (614)
Q Consensus 462 ---~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~ 497 (614)
.....++|+|+++.|++++.+.-+=+.||+++..-+
T Consensus 192 p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 192 PPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred CCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 115679999999999999998889999999987544
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.55 E-value=0.061 Score=55.54 Aligned_cols=112 Identities=21% Similarity=0.251 Sum_probs=76.4
Q ss_pred CeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccc
Q 044561 414 GEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLA 493 (614)
Q Consensus 414 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla 493 (614)
...|++|++. +++|.. +. .-.|.+...++++.+.-+.-+.. +-+.-|||+.-.||||+ +|++.|+||-++
T Consensus 299 ~y~yl~~kdh-gt~is~-ik-----~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 299 LYLYLHFKDH-GTPISI-IK-----ADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred eEEEEEEecC-Cceeee-ee-----cccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeeee
Confidence 3567888875 445433 22 25689999999999888888876 67888999999999999 999999999999
Q ss_pred cccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCC
Q 044561 494 RLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRR 545 (614)
Q Consensus 494 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~ 545 (614)
+.-..... ... ...--|-.+. |.-+.+-|||-+ |--|+.|+.
T Consensus 369 Rl~~~q~~-isy-----~rldhp~lF~-G~dd~QFeIYrl---Mr~l~~g~w 410 (488)
T COG5072 369 RLSYSQGI-ISY-----NRLDHPDLFN-GVDDYQFEIYRL---MRRLLKGRW 410 (488)
T ss_pred ecccCCce-eec-----cccCchhhhc-CccceeeeHHHH---HHHHhcCcH
Confidence 95333221 111 1223455554 455777888864 334444543
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.53 E-value=0.04 Score=52.99 Aligned_cols=116 Identities=17% Similarity=0.159 Sum_probs=72.3
Q ss_pred CcEEEEEEEEecCcEEEEEEeecCChh-hHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecCCCCcchhcccC
Q 044561 357 GFGKVYRGVLASNVQIAVKKVSHDSKQ-GIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTN 435 (614)
Q Consensus 357 ~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~ 435 (614)
+..+.-+++-+-| ...+|++..-.-. ...-|..+..++.+++ .|+++..- ....+-++.|+|-.-
T Consensus 74 gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~--------- 139 (308)
T PF07387_consen 74 GNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKI--------- 139 (308)
T ss_pred CceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCc---------
Confidence 3344444443322 3456666544333 4456677888877664 46666632 334567889988321
Q ss_pred CCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccc
Q 044561 436 IKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLA 493 (614)
Q Consensus 436 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla 493 (614)
.....-.|..+ ++.|.-.|++ ..+.+|+|..|+|||-|.+|.+||.|-+..
T Consensus 140 -----~i~~~N~i~ag-i~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 140 -----KINFSNFITAG-IKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred -----ccchhHHHHHh-HHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhh
Confidence 11111122222 3567778865 588999999999999999999999997753
|
The function of this family is unknown. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.19 E-value=0.24 Score=52.85 Aligned_cols=80 Identities=16% Similarity=0.127 Sum_probs=50.8
Q ss_pred cceeeeeCcEEEEEEEEecCcEEEEEEeecC----Ch---hhHHHHHHHHHHhcccC---CCceeEEeeEEeecCeEEEE
Q 044561 350 KDVIGRGGFGKVYRGVLASNVQIAVKKVSHD----SK---QGIKEFVAELVSMGRLR---HRNLVKLRGYCRRKGEFLLV 419 (614)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~----~~---~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV 419 (614)
.+.||-|....||+.... +..++||+-... .. ....+-..|...|+.+. ..++.+++.+|. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 467899999999998764 456888876521 11 12233334455554442 357888888887 446788
Q ss_pred EEecCC--CCcchhc
Q 044561 420 YDYMPN--GSLDKIL 432 (614)
Q Consensus 420 ~E~~~~--gsL~~~l 432 (614)
||++++ ..+.+-+
T Consensus 114 ME~L~~~~~ilr~~L 128 (418)
T PLN02756 114 MRYLEPPHIILRKGL 128 (418)
T ss_pred EeecCCcceehhhhh
Confidence 999976 3454444
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.47 E-value=0.16 Score=53.02 Aligned_cols=141 Identities=17% Similarity=0.229 Sum_probs=78.3
Q ss_pred ceeeeeCcEEEEEEEEec----CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCcee-EEeeEEeecCeEEEEEEecCC
Q 044561 351 DVIGRGGFGKVYRGVLAS----NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLV-KLRGYCRRKGEFLLVYDYMPN 425 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~~ 425 (614)
+.|..|--..+|+....+ +..++++......... -.-.+|..+++.+...++. ++++++. .+ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~-IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV-IDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeE-echHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 345456677888887543 2367777765443322 1225688888877655553 4555542 22 58999977
Q ss_pred CCcchh-----------------cccCC----CCCcChhHHHHHHHHhH----------------------hhch----h
Q 044561 426 GSLDKI-----------------LHTNI----KPCLNWYQRFRIIRGVA----------------------SGLL----Y 458 (614)
Q Consensus 426 gsL~~~-----------------l~~~~----~~~l~~~~~~~i~~~ia----------------------~gL~----y 458 (614)
..|..- +|... ...--|..+.++..++. .-+. .
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 766321 11111 00112333333322221 1111 1
Q ss_pred hhc-cCCCceEecCcCCCCeEEcC-CCCEEEeeecccccc
Q 044561 459 LHE-DWEQVVLHRDIKPANVLLDA-DLNGKLGDFGLARLY 496 (614)
Q Consensus 459 LH~-~~~~~ivHrDikp~NIll~~-~~~~kl~DfGla~~~ 496 (614)
+.+ ......+|+|+.+.|||+++ ++.++++||..|...
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n 214 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS 214 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence 111 11346899999999999975 578999999988643
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.42 E-value=0.29 Score=50.85 Aligned_cols=144 Identities=15% Similarity=0.131 Sum_probs=91.1
Q ss_pred CcceeeeeCcEEEEEEEEecCcEEEEEEeecCC-----h----------------hh-----HHHHHHHHHHhcccCCCc
Q 044561 349 DKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDS-----K----------------QG-----IKEFVAELVSMGRLRHRN 402 (614)
Q Consensus 349 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-----~----------------~~-----~~~~~~Ei~~l~~l~H~n 402 (614)
+...|..|.-..||.+.-.+|..+|||+++..- + .. .-....|+.-|.+|+...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 445788999999999999999999999875421 0 00 011234555566654333
Q ss_pred eeEEeeEEeecCeEEEEEEecCCCCc-chhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcC
Q 044561 403 LVKLRGYCRRKGEFLLVYDYMPNGSL-DKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA 481 (614)
Q Consensus 403 iv~l~g~~~~~~~~~lV~E~~~~gsL-~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~ 481 (614)
|.-.- -..- ..-.|||+|+....- .-.|+. ..++...+..+-.+++.-|.-|.. +-.+||.||.--|+|+ .
T Consensus 228 IP~Pe-PIlL-k~hVLVM~FlGrdgw~aPkLKd---~~ls~~ka~~~Y~~~v~~MR~lY~--~c~LVHADLSEfN~Ly-h 299 (520)
T KOG2270|consen 228 IPCPE-PILL-KNHVLVMEFLGRDGWAAPKLKD---ASLSTSKARELYQQCVRIMRRLYQ--KCRLVHADLSEFNLLY-H 299 (520)
T ss_pred CCCCC-ceee-ecceEeeeeccCCCCcCccccc---ccCChHHHHHHHHHHHHHHHHHHH--HhceeccchhhhhheE-E
Confidence 21000 0000 123699999952211 111222 236666677777777777777765 4679999999999988 5
Q ss_pred CCCEEEeeeccccccCCCC
Q 044561 482 DLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 482 ~~~~kl~DfGla~~~~~~~ 500 (614)
+|.+.|+|-+-+...+++.
T Consensus 300 dG~lyiIDVSQSVE~DHP~ 318 (520)
T KOG2270|consen 300 DGKLYIIDVSQSVEHDHPH 318 (520)
T ss_pred CCEEEEEEccccccCCChh
Confidence 6789999998887666543
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 614 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-54 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-53 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-42 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-41 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-37 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-37 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-37 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-34 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-25 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-24 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-23 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-23 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-23 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-23 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-23 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-23 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-23 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-23 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-23 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-23 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-23 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-23 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-23 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-23 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-23 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-22 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-22 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-22 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-22 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-22 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-21 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-21 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-21 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-21 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-21 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-21 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-21 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-21 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-21 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-21 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-21 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-21 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-21 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-21 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-21 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-21 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-21 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-21 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-21 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-21 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-21 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-21 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-21 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-20 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-20 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-20 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-20 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-20 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-20 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-19 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-19 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-19 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-19 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-19 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-19 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-19 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-19 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-19 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-19 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-19 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-19 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-19 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-19 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-19 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-19 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-19 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-19 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-19 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-19 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-19 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-19 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-19 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-19 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-19 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-19 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-19 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-19 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 8e-19 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 8e-19 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-19 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 9e-19 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-18 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-18 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-18 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-18 | ||
| 2fmd_A | 240 | Structural Basis Of Carbohydrate Recognition By Bow | 3e-18 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-18 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-18 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-18 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 9e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 9e-18 | ||
| 3usu_B | 242 | Crystal Structure Of Butea Monosperma Seed Lectin L | 1e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-17 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-17 | ||
| 3usu_A | 256 | Crystal Structure Of Butea Monosperma Seed Lectin L | 1e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-17 | ||
| 1g8w_A | 233 | Improved Structure Of Phytohemagglutinin-L From The | 2e-17 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-17 | ||
| 1fat_A | 252 | Phytohemagglutinin-L Length = 252 | 3e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-17 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-17 | ||
| 3ipv_B | 239 | Crystal Structure Of Spatholobus Parviflorus Seed L | 7e-17 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 8e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-17 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-16 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-16 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-16 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-16 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-16 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-16 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-16 | ||
| 3ipv_A | 251 | Crystal Structure Of Spatholobus Parviflorus Seed L | 4e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-16 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-16 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-16 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-16 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 8e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-16 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-16 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-16 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-15 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-15 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-15 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-15 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-15 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-15 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-15 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-15 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-15 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-15 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-15 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-15 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-15 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-15 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-15 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-15 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-15 | ||
| 3ujo_A | 281 | Galactose-Specific Seed Lectin From Dolichos Lablab | 3e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-15 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-15 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-15 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-15 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-15 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-15 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-15 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-15 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-15 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-15 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-15 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-15 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-15 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-15 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-15 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 7e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 7e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 8e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 8e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 8e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 8e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-15 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 8e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 8e-15 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 8e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 9e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 9e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-14 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-14 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-14 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-14 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-14 | ||
| 1gnz_A | 257 | Lectin I-B4 From Griffonia Simplicifolia (Gs I-B4)m | 1e-14 | ||
| 1hql_A | 257 | The Xenograft Antigen In Complex With The B4 Isolec | 1e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-14 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-14 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-14 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 8e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-14 | ||
| 1wbl_A | 241 | Winged Bean Lectin Complexed With Methyl-Alpha-D-Ga | 8e-14 | ||
| 1wbf_A | 242 | Winged Bean Lectin, Saccharide Free Form Length = 2 | 9e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 9e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 9e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-13 | ||
| 2e7q_A | 237 | Crystal Structure Of Basic Winged Bean Lectin In Co | 3e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-13 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-13 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-13 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-13 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-13 | ||
| 1bjq_A | 253 | The Dolichos Biflorus Seed Lectin In Complex With A | 4e-13 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-13 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 7e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 7e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-13 | ||
| 1lul_A | 253 | Db58, A Legume Lectin From Dolichos Biflorus Length | 8e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 8e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 8e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-12 | ||
| 3zvx_A | 261 | Structure Of The Lectin From Platypodium Elegans In | 1e-12 | ||
| 1avb_A | 226 | Arcelin-1 From Phaseolus Vulgaris L Length = 226 | 1e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-12 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-12 | ||
| 2bqp_A | 234 | The Structure Of The Pea Lectin-D-Glucopyranose Com | 2e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-12 | ||
| 2sba_A | 253 | Soybean Agglutinin Complexed With 2,6-Pentasacchari | 2e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-12 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-12 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-12 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-12 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 8e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 9e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-11 | ||
| 1dbn_A | 239 | Maackia Amurensis Leukoagglutinin (Lectin) With Sia | 1e-11 | ||
| 1fny_A | 237 | Legume Lectin Of The Bark Of Robinia Pseudoacacia. | 1e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-11 | ||
| 1n47_A | 233 | Isolectin B4 From Vicia Villosa In Complex With The | 2e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-11 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-11 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-11 | ||
| 2pel_A | 236 | Peanut Lectin Length = 236 | 4e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-11 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-11 | ||
| 1bzw_A | 232 | Peanut Lectin Complexed With C-Lactose Length = 232 | 5e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-11 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 6e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 6e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 7e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-11 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 8e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 9e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-10 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-10 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-10 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-10 | ||
| 1uzy_A | 242 | Erythrina Crystagalli Lectin Length = 242 | 3e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-10 | ||
| 2eig_A | 234 | Lotus Tetragonolobus Seed Lectin (Isoform) Length = | 7e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 8e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 8e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 8e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 9e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-09 | ||
| 1gz9_A | 239 | High-Resolution Crystal Structure Of Erythrina Cris | 1e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-09 | ||
| 1qnw_A | 242 | Lectin Ii From Ulex Europaeus Length = 242 | 1e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-09 | ||
| 1gsl_A | 243 | Lectin (Fourth Isolated From (Griffonia Simplicifol | 1e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-09 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-09 | ||
| 3n35_A | 242 | Erythrina Corallodendron Lectin Mutant (Y106g) With | 2e-09 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-09 | ||
| 1fay_A | 238 | Winged Bean Acidic Lectin Complexed With Methyl-Alp | 2e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-09 | ||
| 1fyu_A | 255 | Crystal Structure Of Erythrina Corallodendron Lecti | 3e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-09 | ||
| 1sfy_A | 239 | Crystal Structure Of Recombinant Erythrina Corallod | 3e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-09 | ||
| 1lte_A | 239 | Structure Of A Legume Lectin With An Ordered N-Link | 3e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-09 | ||
| 1ax0_A | 239 | Erythrina Corallodendron Lectin In Complex With N-A | 4e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 8e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 8e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 8e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 8e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 9e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 9e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-08 | ||
| 2ovu_A | 237 | Crystal Strucure Of A Lectin From Canavalia Gladiat | 3e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-08 | ||
| 1qmo_E | 133 | Structure Of Fril, A Legume Lectin That Delays Hema | 3e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-08 | ||
| 2yz4_A | 237 | The Neutron Structure Of Concanavalin A At 2.2 Angs | 4e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-08 | ||
| 2ctv_A | 237 | High Resolution Crystallographic Studies Of Native | 4e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-08 | ||
| 3u4x_A | 236 | Crystal Structure Of A Lectin From Camptosema Pedic | 5e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 5e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-08 | ||
| 2d3p_A | 236 | Cratylia Floribunda Seed Lectin Crystallized At Bas | 6e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 6e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-08 | ||
| 1cn1_A | 237 | Crystal Structure Of Demetallized Concanavalin A. T | 6e-08 | ||
| 2cna_A | 237 | The Covalent And Three-Dimensional Structure Of Con | 6e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 7e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 7e-08 | ||
| 1ioa_A | 240 | Arcelin-5, A Lectin-Like Defense Protein From Phase | 8e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-08 | ||
| 1wuv_A | 237 | Crystal Structure Of Native Canavalia Gladiata Lect | 9e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-07 | ||
| 1mvq_A | 236 | Cratylia Mollis Lectin (Isoform 1) In Complex With | 1e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 1azd_A | 237 | Concanavalin From Canavalia Brasiliensis Length = 2 | 1e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-07 | ||
| 2cwm_A | 237 | Native Crystal Structure Of No Releasing Inductive | 1e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-07 | ||
| 2ow4_A | 237 | Crystal Structure Of A Lectin From Canavalia Mariti | 2e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-07 | ||
| 2jec_A | 239 | Crystal Structure Of Recombinant Dioclea Grandiflor | 2e-07 | ||
| 2je9_A | 239 | Crystal Structure Of Recombinant Dioclea Grandiflor | 2e-07 | ||
| 2gdf_A | 237 | Crystal Structure Of Dioclea Violacea Seed Lectin L | 2e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-07 | ||
| 3sh3_A | 237 | Crystal Structure Of A Pro-Inflammatory Lectin From | 2e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-07 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-07 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-07 | ||
| 2zbj_A | 237 | Crystal Structure Of Dioclea Rostrata Lectin Length | 3e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-07 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 4e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-07 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2FMD|A Chain A, Structural Basis Of Carbohydrate Recognition By Bowringia Milbraedii Seed Agglutinin Length = 240 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3USU|B Chain B, Crystal Structure Of Butea Monosperma Seed Lectin Length = 242 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3USU|A Chain A, Crystal Structure Of Butea Monosperma Seed Lectin Length = 256 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1G8W|A Chain A, Improved Structure Of Phytohemagglutinin-L From The Kidney Bean Length = 233 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1FAT|A Chain A, Phytohemagglutinin-L Length = 252 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3IPV|B Chain B, Crystal Structure Of Spatholobus Parviflorus Seed Lectin Length = 239 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3IPV|A Chain A, Crystal Structure Of Spatholobus Parviflorus Seed Lectin Length = 251 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3UJO|A Chain A, Galactose-Specific Seed Lectin From Dolichos Lablab In Complex With Adenine And Galactose Length = 281 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1GNZ|A Chain A, Lectin I-B4 From Griffonia Simplicifolia (Gs I-B4)metal Free Form Length = 257 | Back alignment and structure |
|
| >pdb|1HQL|A Chain A, The Xenograft Antigen In Complex With The B4 Isolectin Of Griffonia Simplicifolia Lectin-1 Length = 257 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1WBL|A Chain A, Winged Bean Lectin Complexed With Methyl-Alpha-D-Galactose Length = 241 | Back alignment and structure |
|
| >pdb|1WBF|A Chain A, Winged Bean Lectin, Saccharide Free Form Length = 242 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2E7Q|A Chain A, Crystal Structure Of Basic Winged Bean Lectin In Complex With B Blood Group Trisaccharide Length = 237 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1BJQ|A Chain A, The Dolichos Biflorus Seed Lectin In Complex With Adenine Length = 253 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1LUL|A Chain A, Db58, A Legume Lectin From Dolichos Biflorus Length = 253 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3ZVX|A Chain A, Structure Of The Lectin From Platypodium Elegans In Complex With A Trimannoside Length = 261 | Back alignment and structure |
|
| >pdb|1AVB|A Chain A, Arcelin-1 From Phaseolus Vulgaris L Length = 226 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2BQP|A Chain A, The Structure Of The Pea Lectin-D-Glucopyranose Complex Length = 234 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2SBA|A Chain A, Soybean Agglutinin Complexed With 2,6-Pentasaccharide Length = 253 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1DBN|A Chain A, Maackia Amurensis Leukoagglutinin (Lectin) With Sialyllactose Length = 239 | Back alignment and structure |
|
| >pdb|1FNY|A Chain A, Legume Lectin Of The Bark Of Robinia Pseudoacacia. Length = 237 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1N47|A Chain A, Isolectin B4 From Vicia Villosa In Complex With The Tn Antigen Length = 233 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2PEL|A Chain A, Peanut Lectin Length = 236 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1BZW|A Chain A, Peanut Lectin Complexed With C-Lactose Length = 232 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1UZY|A Chain A, Erythrina Crystagalli Lectin Length = 242 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2EIG|A Chain A, Lotus Tetragonolobus Seed Lectin (Isoform) Length = 234 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1GZ9|A Chain A, High-Resolution Crystal Structure Of Erythrina Cristagalli Lectin In Complex With 2'-Alpha-L-Fucosyllactose Length = 239 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1QNW|A Chain A, Lectin Ii From Ulex Europaeus Length = 242 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1GSL|A Chain A, Lectin (Fourth Isolated From (Griffonia Simplicifolia)) Complex With Y Human Blood Group Determinant Length = 243 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3N35|A Chain A, Erythrina Corallodendron Lectin Mutant (Y106g) With N- Acetylgalactosamine Length = 242 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1FAY|A Chain A, Winged Bean Acidic Lectin Complexed With Methyl-Alpha-D-Galactose (Monoclinic Form) Length = 238 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1FYU|A Chain A, Crystal Structure Of Erythrina Corallodendron Lectin In Hexagonal Crystal Form Length = 255 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1SFY|A Chain A, Crystal Structure Of Recombinant Erythrina Corallodandron Lectin Length = 239 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1LTE|A Chain A, Structure Of A Legume Lectin With An Ordered N-Linked Carbohydrate In Complex With Lactose Length = 239 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1AX0|A Chain A, Erythrina Corallodendron Lectin In Complex With N-Actylgalactosamine Length = 239 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2OVU|A Chain A, Crystal Strucure Of A Lectin From Canavalia Gladiata (Cgl) In Complex With Man1-2man-Ome Length = 237 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1QMO|E Chain E, Structure Of Fril, A Legume Lectin That Delays Hematopoietic Progenitor Maturation Length = 133 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2YZ4|A Chain A, The Neutron Structure Of Concanavalin A At 2.2 Angstroms Length = 237 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2CTV|A Chain A, High Resolution Crystallographic Studies Of Native Concanavalin A Using Rapid Laue Data Collection Methods And The Introduction Of A Monochromatic Large-Angle Oscillation Technique (Lot) Length = 237 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3U4X|A Chain A, Crystal Structure Of A Lectin From Camptosema Pedicellatum Seeds In Complex With 5-Bromo-4-Chloro-3-Indolyl-Alpha-D-Mannose Length = 236 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2D3P|A Chain A, Cratylia Floribunda Seed Lectin Crystallized At Basic Ph Length = 236 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1CN1|A Chain A, Crystal Structure Of Demetallized Concanavalin A. The Metal- Binding Region Length = 237 | Back alignment and structure |
|
| >pdb|2CNA|A Chain A, The Covalent And Three-Dimensional Structure Of Concanavalin A, Iv.Atomic Coordinates,Hydrogen Bonding,And Quaternary Structure Length = 237 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1IOA|A Chain A, Arcelin-5, A Lectin-Like Defense Protein From Phaseolus Vulgaris Length = 240 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1WUV|A Chain A, Crystal Structure Of Native Canavalia Gladiata Lectin (Cgl): A Tetrameric Cona-Like Lectin Length = 237 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1MVQ|A Chain A, Cratylia Mollis Lectin (Isoform 1) In Complex With Methyl-Alpha-D- Mannose Length = 236 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1AZD|A Chain A, Concanavalin From Canavalia Brasiliensis Length = 237 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2CWM|A Chain A, Native Crystal Structure Of No Releasing Inductive Lectin From Seeds Of The Canavalia Maritima (Conm) Length = 237 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2OW4|A Chain A, Crystal Structure Of A Lectin From Canavalia Maritima Seeds (Conm) In Complex With Man1-2man-Ome Length = 237 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2JEC|A Chain A, Crystal Structure Of Recombinant Dioclea Grandiflora Lectin Mutant E123a-H131n-K132q Complexed With 5-Bromo-4-Chloro-3- Indolyl-A-D-Mannose Length = 239 | Back alignment and structure |
|
| >pdb|2JE9|A Chain A, Crystal Structure Of Recombinant Dioclea Grandiflora Lectin Complexed With 5-Bromo-4-Chloro-3-Indolyl-A-D-Mannose Length = 239 | Back alignment and structure |
|
| >pdb|2GDF|A Chain A, Crystal Structure Of Dioclea Violacea Seed Lectin Length = 237 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3SH3|A Chain A, Crystal Structure Of A Pro-Inflammatory Lectin From The Seeds Of Dioclea Wilsonii Standl Length = 237 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2ZBJ|A Chain A, Crystal Structure Of Dioclea Rostrata Lectin Length = 237 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 363 bits (935), Expect = e-122
Identities = 115/297 (38%), Positives = 182/297 (61%), Gaps = 6/297 (2%)
Query: 324 EDWEREYG-PQRFTYKDLYKATKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSK 382
ED E G +RF+ ++L A+ F +K+++GRGGFGKVY+G LA +AVK++ +
Sbjct: 8 EDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERT 67
Query: 383 QGIK-EFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILH--TNIKPC 439
QG + +F E+ + HRNL++LRG+C E LLVY YM NGS+ L +P
Sbjct: 68 QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPP 127
Query: 440 LNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD 499
L+W +R RI G A GL YLH+ + ++HRD+K AN+LLD + +GDFGLA+L D+
Sbjct: 128 LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 187
Query: 500 TIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVE--QQGSMETVN 557
TT + GT G++ PE + TGK+S TDV+ +GV +LE+ +G+R + + + + V
Sbjct: 188 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 247
Query: 558 LVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
L+DWV K+ + D L+G +++++E ++++ L C+ P RP M +V++
Sbjct: 248 LLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 304
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 340 bits (875), Expect = e-113
Identities = 101/285 (35%), Positives = 152/285 (53%), Gaps = 6/285 (2%)
Query: 333 QRFTYKDLYKATKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAEL 392
R DL +AT F K +IG G FGKVY+GVL ++A+K+ + +S QGI+EF E+
Sbjct: 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86
Query: 393 VSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPC--LNWYQRFRIIR 450
++ RH +LV L G+C + E +L+Y YM NG+L + L+ + P ++W QR I
Sbjct: 87 ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 451 GVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY-DHDTIPQTTKLVG 509
G A GL YLH ++HRD+K N+LLD + K+ DFG+++ + D +T + G
Sbjct: 147 GAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKG 203
Query: 510 TFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKG 569
T GY+DPE G+ + +DVY+FGV + EV R + Q E VNL +W + G
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263
Query: 570 AIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+ D L + + + C E RP+M V+
Sbjct: 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLW 308
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 334 bits (859), Expect = e-111
Identities = 97/297 (32%), Positives = 160/297 (53%), Gaps = 21/297 (7%)
Query: 331 GPQRFTYKDLYKATKGFKDKD------VIGRGGFGKVYRGVLASNVQIAVKKVSH----D 380
F++ +L T F ++ +G GGFG VY+G + +N +AVKK++
Sbjct: 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDIT 69
Query: 381 SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILH-TNIKPC 439
+++ ++F E+ M + +H NLV+L G+ + LVY YMPNGSL L + P
Sbjct: 70 TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129
Query: 440 LNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH- 498
L+W+ R +I +G A+G+ +LHE+ + HRDIK AN+LLD K+ DFGLAR +
Sbjct: 130 LSWHMRCKIAQGAANGINFLHEN--HHI-HRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 499 DTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNL 558
T+++VGT YM PE + G+ + +D+Y+FGV +LE+ +G V++ E L
Sbjct: 187 AQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDE--HREPQLL 243
Query: 559 VDWVCDCWK-KGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+D + + I D D ++ + +E + + C H K RP++++V Q
Sbjct: 244 LDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 250 bits (641), Expect = 2e-78
Identities = 74/303 (24%), Positives = 126/303 (41%), Gaps = 28/303 (9%)
Query: 335 FTYKDLYKATKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVS 394
++LY + + +V RG FG V++ L N +AVK KQ + E+ S
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 395 MGRLRHRNLVKLRGYCRR----KGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIR 450
+ ++H N+++ G +R + L+ + GSL L N+ ++W + I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV---VSWNELCHIAE 128
Query: 451 GVASGLLYLHED-------WEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP- 502
+A GL YLHED + + HRDIK NVLL +L + DFGLA ++
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAG 188
Query: 503 QTTKLVGTFGYMDPELMRTG-----KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVN 557
T VGT YM PE++ A D+YA G+ + E+AS + +
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248
Query: 558 LVDWVCDCWKKGAIRDASDSRL------EGICEEKQMELVLKLGLFCSHPKPEARPNMRQ 611
+ + +++ + + + M ++ + C EAR +
Sbjct: 249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGC 308
Query: 612 VMQ 614
V +
Sbjct: 309 VGE 311
|
| >3ipv_A Lectin alpha chain; galactose binding, SEED lectin, hemagglutinin, legume lectin fungal, sugar binding protein; 2.04A {Spatholobus parviflorus} PDB: 3ipv_B 3usu_B* 3usu_A* Length = 251 | Back alignment and structure |
|---|
Score = 213 bits (542), Expect = 4e-65
Identities = 80/267 (29%), Positives = 122/267 (45%), Gaps = 40/267 (14%)
Query: 24 AQDVNQFIYHGFNED-AQLQRDGLASVHSNGLLQLTNTVS-----PQQEGHAFYRLPIKF 77
A++ F++ F L G A V G+LQLTN P G A Y PI
Sbjct: 1 AEET-SFVFSKFKPLEPNLILQGDALVTVAGVLQLTNVDKNGVPEPSSLGRATYSAPINI 59
Query: 78 -NTSSSESLSFSSNFVFAI----------GMAFVISPSKDLGKAEASPSEYLGLFNASNN 126
++++ SF+++F F I G+AF ++P S +LGLF+++ +
Sbjct: 60 WDSATGLVASFATSFRFTIYAPNIATIADGLAFFLAPVASAPD---SGGGFLGLFDSAVS 116
Query: 127 GQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELII 186
G ST +A+E DT +N F D H+G DVNS+ S ++ L
Sbjct: 117 G-STYQTVAVEFDTYENTVFTDPPYTHIGFDVNSISSIKTVK-------------WSLAN 162
Query: 187 GDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLK 246
G+ ++ I+Y+ A KLL +L S T +L+ ++LS +L E + VGFSA+TG+
Sbjct: 163 GEAAKVLITYNSAVKLLVASLVYPS--SKTSFILADIVDLSSVLPEWVRVGFSAATGASG 220
Query: 247 ---SSHYVLGWSFNRSGPALNLDISSL 270
+H V WSF SS
Sbjct: 221 GKIETHDVFSWSFASKLAGXXTKDSSF 247
|
| >1hql_A Lectin; xenograft antigen, sugar BI protein; HET: GLA MBG NAG; 2.20A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1gnz_A* Length = 257 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 2e-64
Identities = 72/267 (26%), Positives = 120/267 (44%), Gaps = 36/267 (13%)
Query: 29 QFIYHGFNEDAQ--LQRDGLASVHSNGLLQLTNTVS-----PQQEGHAFYRLPIKF-NTS 80
F + F D + + G A+ + G LQL T G A Y P++ +
Sbjct: 6 SFTFPNFWSDVEDSIIFQGDANT-TAGTLQLCKTNQYGTPLQWSAGRALYSDPVQLWDNK 64
Query: 81 SSESLSFSSNFVFAI---------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQ-ST 130
+ SF + F F + G+AF ++P EYLGLFN S Q S
Sbjct: 65 TESVASFYTEFTFFLKITGNGPADGLAFFLAPPDSDV---KDAGEYLGLFNKSTATQPSK 121
Query: 131 NHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGDPI 190
N ++A+E DT N +F + H+GI+VNS++S + + G
Sbjct: 122 NQVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVATKRWEDSD----------IFSGKIA 171
Query: 191 QIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLKS-SH 249
ISYDG+ ++L V +S P + +LS ++++ L E++ VG SASTG+ + +
Sbjct: 172 TARISYDGSAEILTVV---LSYPDGSDYILSHSVDMRQNLPESVRVGISASTGNNQFLTV 228
Query: 250 YVLGWSFNRSGPALNLDISSLPRLPHL 276
Y+L W F+ + + ++ + P +
Sbjct: 229 YILSWRFSSNLQSTSVKAAMEPEITRT 255
|
| >1v6i_A Agglutinin, PNA, galactose-binding lectin; open quaternary association, orthorhombic, carbohydrate specificity, protein crystallography; HET: GAL GLC; 2.15A {Arachis hypogaea} SCOP: b.29.1.1 PDB: 1bzw_A* 1v6j_A* 1v6k_A* 1v6l_A* 1v6m_A 1v6n_A 1v6o_A 2dva_A* 1cq9_A 1ciw_A* 1qf3_A* 1rir_A* 1rit_A* 2dh1_A 1cr7_A* 2dv9_A* 2dvb_A* 2dvd_A* 2dvf_A 2dvg_A* ... Length = 232 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 5e-64
Identities = 63/249 (25%), Positives = 111/249 (44%), Gaps = 34/249 (13%)
Query: 24 AQDVNQFIYHGFNE-DAQLQRDGLASVHSNGLLQLTNTVSPQQEGHAFYRLPIKF-NTSS 81
A+ V F ++ F+E + + G +V SNG +QLTN G Y +P++ ++++
Sbjct: 1 AETV-SFNFNSFSEGNPAINFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIWSSAT 59
Query: 82 SESLSFSSNFVFAI----------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTN 131
SF ++F F + G+ F I+P A + LG ++ +
Sbjct: 60 GNVASFLTSFSFEMKDIKDYDPADGIIFFIAPEDTQIPAGSIGGGTLG----VSDTKGAG 115
Query: 132 HILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGDPIQ 191
H + +E DT N +++D +HVGIDVNS+ S ++ P S G ++
Sbjct: 116 HFVGVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVPWNSVS-------------GAVVK 162
Query: 192 IWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLKSS-HY 250
+ + YD + K L+V + +++ ++L L E + GFSAS H
Sbjct: 163 VTVIYDSSTKTLSVAVTN---DNGDITTIAQVVDLKAKLPERVKFGFSASGSLGGRQIHL 219
Query: 251 VLGWSFNRS 259
+ WSF +
Sbjct: 220 IRSWSFTST 228
|
| >1fny_A BARK lectin, BARK agglutinin I,polypeptide A; legume lectin, jelly roll, sugar binding protein; 1.81A {Robinia pseudoacacia} SCOP: b.29.1.1 PDB: 1fnz_A* Length = 237 | Back alignment and structure |
|---|
Score = 207 bits (527), Expect = 5e-63
Identities = 71/253 (28%), Positives = 114/253 (45%), Gaps = 39/253 (15%)
Query: 29 QFIYHGFNED-AQLQRDGLASVHSNGLLQLTNTV----SPQQEGHAFYRLPIKF-NTSSS 82
F + F + L G A V S G+LQLTN V S + G A Y P + ++++
Sbjct: 5 SFSFPKFAPNQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWDSTTG 64
Query: 83 ESLSFSSNFVFAI----------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNH 132
SF ++F F I G+AF ++P LG+F +N
Sbjct: 65 NVASFVTSFTFIIQAPNPATTADGLAFFLAPVDTQP---LDLGGMLGIFK-DGYFNKSNQ 120
Query: 133 ILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGDPIQI 192
I+A+E DT N D+D H+GI+VNS+ S ++ P + + G+ +
Sbjct: 121 IVAVEFDTFSNGDWD-PKGRHLGINVNSIESIKTVPWNWTN-------------GEVANV 166
Query: 193 WISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGS---LKSSH 249
+ISY+ + K L +L S T ++ +++ +L E + GFSA+TG ++
Sbjct: 167 FISYEASTKSLTASLVYPS--LETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQTN 224
Query: 250 YVLGWSFNRSGPA 262
VL WSF + P
Sbjct: 225 DVLSWSFESNLPG 237
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 1e-61
Identities = 69/314 (21%), Positives = 115/314 (36%), Gaps = 39/314 (12%)
Query: 335 FTYKDLYKATKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVS 394
+ K ++IGRG +G VY+G L +AVK S ++Q +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK-NIYR 60
Query: 395 MGRLRHRNLVKLRGYCRR-----KGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRII 449
+ + H N+ + R + E+LLV +Y PNGSL K L + +W R+
Sbjct: 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLA 117
Query: 450 RGVASGLLYLHEDWEQ------VVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 503
V GL YLH + + + HRD+ NVL+ D + DFGL+ + + +
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177
Query: 504 -------TTKLVGTFGYMDPELMR-------TGKASTSTDVYAFGVFMLEVASGRRPVEQ 549
VGT YM PE++ A D+YA G+ E+ +
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237
Query: 550 QGSMETVNLV--DWVCDCWKKGAIRDA---SDSRLE----GICEEKQMELVLKLGLFCSH 600
S+ + V + ++ R + + + + C
Sbjct: 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWD 297
Query: 601 PKPEARPNMRQVMQ 614
EAR + +
Sbjct: 298 QDAEARLTAQXAEE 311
|
| >2fmd_A Lectin, agglutinin, BMA; legume lectin, beta sandwich, protein-carbohydrate complex, sugar binding protein; HET: MAN; 1.90A {Bowringia mildbraedii} Length = 240 | Back alignment and structure |
|---|
Score = 203 bits (517), Expect = 2e-61
Identities = 78/254 (30%), Positives = 112/254 (44%), Gaps = 34/254 (13%)
Query: 29 QFIYHGFNEDAQ-LQRDGLASVHSNGLLQLTNTV-----SPQQEGHAFYRLPIKFNTSSS 82
F + F Q L G ASV SN LQLT G A Y PI+ SSS
Sbjct: 5 CFTFTDFESGQQDLIFQGDASVGSNKALQLTKVDSKGNPQGGSVGRALYTAPIRLWQSSS 64
Query: 83 ESLSFSSNFVFAI----------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNH 132
SF + F F+I F+ SP + S LGLF +SNN S N
Sbjct: 65 LVASFETTFTFSISQGSSTPADALTFFIASPDTKI--PSGSGGRLLGLFGSSNNAGSDNG 122
Query: 133 ILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGDPIQI 192
++++E DT N D D + H+GIDVNS+ S ++ + + G
Sbjct: 123 VVSVEFDTYPNTDIGDPNYRHIGIDVNSIRSKAASKWDWQN-------------GKTATA 169
Query: 193 WISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLKSSHYVL 252
ISY+ A K L+V S P + ++S + L+++ + + VGFSA+TG ++ +L
Sbjct: 170 HISYNSASKRLSVVS---SYPNSSPVVVSFDVELNNVBPBWVRVGFSATTGQYTQTNNIL 226
Query: 253 GWSFNRSGPALNLD 266
WSF S +
Sbjct: 227 AWSFRSSLMGYQAN 240
|
| >2eig_A Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG binding protein; HET: NAG; 2.00A {Lotus tetragonolobus} Length = 234 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 3e-61
Identities = 60/247 (24%), Positives = 105/247 (42%), Gaps = 34/247 (13%)
Query: 30 FIYHGFNEDAQLQRDGLASVHSNGLLQLTN-TVSPQQEGHAFYRLPIKF-NTSSSESLSF 87
F Y F +D L G A + ++G L + + + HA Y P+ ++++ SF
Sbjct: 3 FNYTRFKDDGSLIFQGDAKIWTDGRLAMPTDPLVNRTTSHALYATPVPIWDSATGNVASF 62
Query: 88 SSNFVFAI----------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILAIE 137
++F F + G+ F ++P E P+ G +++ S N +A+E
Sbjct: 63 ITSFSFIVSNVQRYPPTDGVVFFLAPW----GTEIPPNSQGGYLGITDSSNSQNQFVAVE 118
Query: 138 LDTVQN-LDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGDPIQIWISY 196
D+ N D + +H+GIDVNS++S ++ + G + I Y
Sbjct: 119 FDSHPNVWDPKSLRSSHIGIDVNSIMSLKAVN-------------WNRVSGSLEKATIIY 165
Query: 197 DGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSAST-GSLKSSHYVLGWS 255
D K+L V + +S+ I+L +L E + VGFSA+T + H + WS
Sbjct: 166 DSDTKILTVVMTHQ---NGQITTISQEIDLKTVLPEKVSVGFSATTWNPERERHDIYSWS 222
Query: 256 FNRSGPA 262
F +
Sbjct: 223 FTSTLKE 229
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 2e-60
Identities = 77/270 (28%), Positives = 128/270 (47%), Gaps = 21/270 (7%)
Query: 348 KDKDVIGRGGFGKVYRGVLASNVQIAVKKV--SHDSKQGIKEFVAELVSMGRLRHRNLVK 405
K+ IG G FG V+R +AVK + + + EF+ E+ M RLRH N+V
Sbjct: 40 NIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98
Query: 406 LRGYCRRKGEFLLVYDYMPNGSLDKILH-TNIKPCLNWYQRFRIIRGVASGLLYLHEDWE 464
G + +V +Y+ GSL ++LH + + L+ +R + VA G+ YLH
Sbjct: 99 FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RN 157
Query: 465 QVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKA 524
++HR++K N+L+D K+ DFGL+RL T + GT +M PE++R +
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK-ASTFLSSKSAAGTPEWMAPEVLRDEPS 216
Query: 525 STSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICE 584
+ +DVY+FGV + E+A+ ++P + +V V K+ I + ++ I E
Sbjct: 217 NEKSDVYSFGVILWELATLQQPWGN---LNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIE 273
Query: 585 EKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
C +P RP+ +M
Sbjct: 274 G------------CWTNEPWKRPSFATIMD 291
|
| >1fx5_A UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HOMO-dimer, fucose specific lectin, SUG binding protein; HET: NAG FUC BMA MAN; 2.20A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1jxn_A* Length = 242 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 1e-59
Identities = 67/254 (26%), Positives = 110/254 (43%), Gaps = 36/254 (14%)
Query: 24 AQDVNQFIYHGFNEDAQ-LQRDGLASVHSNGLLQLTNT---VSPQQEGHAFYRLPIKF-N 78
+ D+ F + F+++ + L G ASV G+LQL + + G A Y PI N
Sbjct: 1 SDDL-SFKFKNFSQNGKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIWN 59
Query: 79 TSSSESLSFSSNFVFAI-----------GMAFVISPSKDLGKAEASPSEYLGLFNASNNG 127
++ E SF ++F F + G+ F ++P Y GLFN +
Sbjct: 60 CNTGELASFITSFSFFMETSANPKAATDGLTFFLAPPDSPL---RRAGGYFGLFNDTKCD 116
Query: 128 QSTNHILAIELDTVQNL-DFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELII 186
S+ +A+E DT+ + +F D H+GIDVN + S + +
Sbjct: 117 -SSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAERW-----------NKRYGL 164
Query: 187 GDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTG-SL 245
+ + I Y+ + K L +L S T ++ ++L IL E + VGFS ST
Sbjct: 165 NNVANVEIIYEASSKTLTASLTYPS--DQTSISVTSIVDLKEILPEWVSVGFSGSTYIGR 222
Query: 246 KSSHYVLGWSFNRS 259
+++H VL W F +
Sbjct: 223 QATHEVLNWYFTST 236
|
| >3zyr_A Lectin; sugar binding protein, N-glycan; HET: NAG BMA MAN GOL; 1.65A {Platypodium elegans} PDB: 3zvx_A* 1ukg_A* 1q8o_A* 1q8q_A* 1q8s_A* 1q8v_A* 1q8p_A* 2auy_A* 2gme_A 2gmm_A* 2gmp_A* 2gn3_A* 2gn7_A* 2gnb_A* 2gnd_A* 2gnm_A* 2gnt_A 2phf_A* 2phr_A* 2pht_A* ... Length = 261 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 2e-59
Identities = 70/264 (26%), Positives = 112/264 (42%), Gaps = 36/264 (13%)
Query: 18 FIFSALAQDVNQFIYHGFNED-AQLQRDGLASVHSNGLLQLTNTVS-----PQQEGHAFY 71
+ A + D F + F+ D L G A N +LQLT T S G +
Sbjct: 2 LLNRANSTDSLSFSFINFDRDERNLIFQGDAHTSRNNILQLTRTDSNGAPVRSTVGRILH 61
Query: 72 RLPIKF-NTSSSESLSFSSNFVFAI---------GMAFVISPSKDLGKAEASPSEYLGLF 121
++ S++ + + F F + G+AF I+P D S LGLF
Sbjct: 62 SAQVRLWEKSTNRVANLQTQFSFFLSSPLSNPADGIAFFIAPP-DTTIPSGSAGGLLGLF 120
Query: 122 NASNN-GQSTNHILAIELDTV--QNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGM 178
N +S N +LA+E DT QN + D + H+GIDVNS+ S +
Sbjct: 121 NPRTALNESANQVLAVEFDTFFAQNSNTWDPNYQHIGIDVNSIRSSKVVR---------- 170
Query: 179 NKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGF 238
E G + + ++Y+ + + ++V P + LS ++L+ IL E + VGF
Sbjct: 171 ---WERREGKTLNVLVTYNPSTRTIDVVAT---YPDGQRYQLSHVVDLTTILPEWVRVGF 224
Query: 239 SASTGSLKSSHYVLGWSFNRSGPA 262
SA++G +H + WSF +
Sbjct: 225 SAASGEQFQTHNLESWSFTSTLLY 248
|
| >1gzc_A Erythrina crista-galli lectin; carbohydrate, sugar binding protein, saccharide, protein-carbohydrate interactions, lactose, glycoprotein; HET: LAT; 1.58A {Erythrina crista-galli} SCOP: b.29.1.1 PDB: 1gz9_A* 1fyu_A* 1ax0_A* 1ax1_A* 1ax2_A* 1axy_A* 1axz_A* 1lte_A* 1sfy_A* 1v00_A* 1uzz_A 1uzy_A* 3n35_A* 3n36_A* 3n3h_A* Length = 239 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 2e-59
Identities = 68/254 (26%), Positives = 106/254 (41%), Gaps = 41/254 (16%)
Query: 29 QFIYHGFNEDAQ-LQRDGLASVHSNGLLQLTNTVS-----PQQEGHAFYRLPIKF-NTSS 81
F + F L G A + +G+LQLT G Y P+ ++++
Sbjct: 5 SFSFSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMWDSTT 64
Query: 82 SESLSFSSNFVFAI-----------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQST 130
SF + F F+I G+ F + P+K A YLG+FN S ++
Sbjct: 65 GTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSK---PAQGYGYLGVFNNSKQD-NS 120
Query: 131 NHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGDPI 190
LA+E DT N +D H+GIDVNS+ S ++ P +L G
Sbjct: 121 YQTLAVEFDTFSN-PWDPPQVPHIGIDVNSIRSIKTQP-------------FQLDNGQVA 166
Query: 191 QIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGS---LKS 247
+ I YD K+L+V L S ++ +++ +L + + VG S +TG+
Sbjct: 167 NVVIKYDAPSKILHVVLVYPS--SGAIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDAAE 224
Query: 248 SHYVLGWSFNRSGP 261
+H V WSF S P
Sbjct: 225 THDVYSWSFQASLP 238
|
| >1gsl_A Griffonia simplicifolia lectin 4; glycoprotein, manganese; HET: FUC GAL MAG NAG BMA; 2.00A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1lec_A* 1led_A* Length = 243 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 3e-59
Identities = 66/263 (25%), Positives = 106/263 (40%), Gaps = 40/263 (15%)
Query: 17 SFIFSALAQDVNQFIYHGFNEDAQLQRDGLASVHSNGLLQLTNTV-----SPQQEGHAFY 71
+F + + + Y N ++ G A+ G LQLT T G A Y
Sbjct: 5 NFTYP------DFWSYSLKNG-TEITFLGDATR-IPGALQLTKTDANGNPVRSSAGQASY 56
Query: 72 RLPIKFNTSSSESLSFSSNFVFAI---------GMAFVISPSKDLGKAEASPSEYLGLFN 122
P+ S+ ++ SF ++F F + G+AF ++P +LGLF
Sbjct: 57 SEPVFLWDSTGKAASFYTSFTFLLKNYGAPTADGLAFFLAPVDSSV---KDYGGFLGLFR 113
Query: 123 ASNN-GQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKT 181
S N ++A+E DT N D++D H+GIDVNS++S +
Sbjct: 114 HETAADPSKNQVVAVEFDTWINKDWNDPPYPHIGIDVNSIVSVATTRWENDD-------- 165
Query: 182 LELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSAS 241
I+YD K+L V +S +LS ++L+ +L + + +GFSA
Sbjct: 166 --AYGSSIATAHITYDARSKILTVL---LSYEHGRDYILSHVVDLAKVLPQKVRIGFSAG 220
Query: 242 TGSLKSSHYVLGWSFNRSGPALN 264
G Y+L W F + N
Sbjct: 221 VG-YDEVTYILSWHFFSTLDGTN 242
|
| >1qnw_A Chitin binding lectin, UEA-II; carbohydrate binding; HET: NAG; 2.35A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1dzq_A* 1qoo_A* 1qos_A* 1qot_A* Length = 242 | Back alignment and structure |
|---|
Score = 195 bits (496), Expect = 2e-58
Identities = 71/257 (27%), Positives = 123/257 (47%), Gaps = 35/257 (13%)
Query: 23 LAQDVNQFIYHGFNEDAQ-LQRDGLASVHSNGLLQLTNTVSP--QQEGHAFYRLPIKFNT 79
L+ D+ F + F + + + G ASV + G+LQ+T P G A Y PI+
Sbjct: 2 LSDDL-SFNFDKFVPNQKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIWD 60
Query: 80 SSSESLSF-SSNFVFAI---------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQS 129
S + ++ +++F F + G+AF ++P+ + S + GLF+ S++ +S
Sbjct: 61 SITGKVASFATSFSFVVKADKSDGVDGLAFFLAPANSQIPS-GSSAGMFGLFS-SSDSKS 118
Query: 130 TNHILAIELDTVQNLDFD--DIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIG 187
+N I+A+E DT ++ D D H+GIDVNS+ S ++ + + G
Sbjct: 119 SNQIIAVEFDTYFGKAYNPWDPDFKHIGIDVNSIKSIKTVKWDWRN-------------G 165
Query: 188 DPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLK- 246
+ + I+Y K L V L+ S T +++ +++L IL E + VGFS G+
Sbjct: 166 EVADVVITYRAPTKSLTVCLSYPS--DGTSNIITASVDLKAILPEWVSVGFSGGVGNAAE 223
Query: 247 -SSHYVLGWSFNRSGPA 262
+H VL W F + A
Sbjct: 224 FETHDVLSWYFTSNLEA 240
|
| >1fat_A Phytohemagglutinin-L; glycoprotein, plant defense protein, lectin; HET: NAG; 2.80A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1g8w_A* Length = 252 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 5e-58
Identities = 79/265 (29%), Positives = 126/265 (47%), Gaps = 46/265 (17%)
Query: 29 QFIYHGFNEDAQLQRDGLASVHSNGLLQLTNTVS-----PQQEGHAFYRLPIKF-NTSSS 82
F + FN + L ASV S+G L+LTN G AFY PI+ + ++
Sbjct: 5 YFNFQRFN-ETNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWDNTTG 63
Query: 83 ESLSFSSNFVFAI----------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNH 132
SF+++F F I G+AF + P +LGLF+ SN S H
Sbjct: 64 TVASFATSFTFNIQVPNNAGPADGLAFALVPVGSQP---KDKGGFLGLFDGSN---SNFH 117
Query: 133 ILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGDPIQI 192
+A+E DT+ N D+D + H+GIDVNS+ S ++ + + G+ ++
Sbjct: 118 TVAVEFDTLYNKDWDP-TERHIGIDVNSIRSIKTTRWDFVN-------------GENAEV 163
Query: 193 WISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLK---SSH 249
I+YD + LL +L S + T ++S ++L +L E + VGFSA+TG K ++
Sbjct: 164 LITYDSSTNLLVASLVYPS--QKTSFIVSDTVDLKSVLPEWVSVGFSATTGINKGNVETN 221
Query: 250 YVLGWSFNRS----GPALNLDISSL 270
VL WSF + L++++L
Sbjct: 222 DVLSWSFASKLSDETTSEGLNLANL 246
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 7e-58
Identities = 71/272 (26%), Positives = 117/272 (43%), Gaps = 29/272 (10%)
Query: 347 FKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKL 406
+ ++V+GRG FG V + +A+K++ +S+ K F+ EL + R+ H N+VKL
Sbjct: 10 IEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIVKL 66
Query: 407 RGYCRRKGEFLLVYDYMPNGSLDKILH-TNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQ 465
G C LV +Y GSL +LH P + G+ YLH +
Sbjct: 67 YGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK 124
Query: 466 VVLHRDIKPANVLLDADLN-GKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKA 524
++HRD+KP N+LL A K+ DFG A T G+ +M PE+
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT----HMTNNKGSAAWMAPEVFEGSNY 180
Query: 525 STSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGI-- 582
S DV+++G+ + EV + R+P + W + +R I
Sbjct: 181 SEKCDVFSWGIILWEVITRRKP--FDEIGGPAFRIMWAV----------HNGTRPPLIKN 228
Query: 583 CEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+ L+ + C P RP+M ++++
Sbjct: 229 LPKPIESLMTR----CWSKDPSQRPSMEEIVK 256
|
| >1wbf_A Protein (agglutinin); lectin (agglutinin), legume lectin, protein crystallography, group specificity, saccharide free form; HET: NAG; 2.30A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 2d3s_A* 2dtw_A* 1wbl_A* 2dty_A* 2du0_A* 2du1_A* 2e51_A* 2e53_A* 2zmk_A* 2zml_A* 2zmn_A* 2e7t_A* 2e7q_A* Length = 242 | Back alignment and structure |
|---|
Score = 193 bits (490), Expect = 1e-57
Identities = 71/259 (27%), Positives = 116/259 (44%), Gaps = 48/259 (18%)
Query: 30 FIYHGFNED-AQLQRDGLASVHSNGLLQLTNTV----SPQQEGHAFYRLPIKF-NTSSSE 83
F ++ F+++ QL+ A + SN +L+LT V + G A Y P++ ++++
Sbjct: 6 FNFNQFHQNEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDSTTGN 65
Query: 84 SLSFSSNFVFAI-----------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNH 132
SF + F F+I G+ F I+P Y G++N +
Sbjct: 66 VASFETRFSFSIRQPFPRPHPADGLVFFIAPPNTQ---TGEGGGYFGIYNPLSP----YP 118
Query: 133 ILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGDPIQI 192
+A+E DT +N D H+GIDVNS+IS ++ P L G +
Sbjct: 119 FVAVEFDTFRN--TWDPQIPHIGIDVNSVISTKTVP-------------FTLDNGGIANV 163
Query: 193 WISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLK------ 246
I YD + K+L+V L T ++ ++L +L E++ VGFSA+TG
Sbjct: 164 VIKYDASTKILHVVLVFP--SLGTIYTIADIVDLKQVLPESVNVGFSAATGDPSGKQRNA 221
Query: 247 -SSHYVLGWSFNRSGPALN 264
+H +L WSF+ S P N
Sbjct: 222 TETHDILSWSFSASLPGTN 240
|
| >1sbf_A Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {Glycine max} SCOP: b.29.1.1 PDB: 1sbd_A* 1sbe_A* 1g9f_A* 2sba_A* Length = 253 | Back alignment and structure |
|---|
Score = 193 bits (490), Expect = 2e-57
Identities = 77/268 (28%), Positives = 120/268 (44%), Gaps = 43/268 (16%)
Query: 24 AQDVNQFIYHGFNED-AQLQRDGLASVHSNGLLQLTN-----TVSPQQEGHAFYRLPIKF 77
A+ V F ++ F + G A V S+G LQL T P G A Y PI
Sbjct: 1 AETV-SFSWNKFVPKQPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHI 59
Query: 78 -NTSSSESLSFSSNFVFAI----------GMAFVISPSKDLGKAEASPSEYLGLFNASNN 126
+ + SF+++F F G+AF ++P + + YLGLFN
Sbjct: 60 WDKETGSVASFAASFNFTFYAPDTKRLADGLAFFLAPIDTK---PQTHAGYLGLFN---E 113
Query: 127 GQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELII 186
+S + ++A+E DT +N D + H+GI+VNS+ S ++ +L
Sbjct: 114 NESGDQVVAVEFDTFRN--SWDPPNPHIGINVNSIRSIKTTS-------------WDLAN 158
Query: 187 GDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSL- 245
++ I+YD + LL +L S + T +LS ++L L E + +GFSA+TG
Sbjct: 159 NKVAKVLITYDASTSLLVASLVYPS--QRTSNILSDVVDLKTSLPEWVRIGFSAATGLDI 216
Query: 246 -KSSHYVLGWSFNRSGPALNLDISSLPR 272
SH VL WSF + P + +I L
Sbjct: 217 PGESHDVLSWSFASNLPHASSNIDPLDL 244
|
| >1g7y_A Stem/LEAF lectin DB58; jelly roll fold, sugar binding protein; HET: NAG FUC FUL; 2.50A {Vigna unguiculata subsp} SCOP: b.29.1.1 PDB: 1lul_A 1lu1_A* 1bjq_A* 1lu2_A* Length = 253 | Back alignment and structure |
|---|
Score = 192 bits (488), Expect = 4e-57
Identities = 75/268 (27%), Positives = 120/268 (44%), Gaps = 45/268 (16%)
Query: 26 DVNQFIYHGFNEDAQLQRDGLASVHSNGLLQLTNTVS-----PQQEGHAFYRLPIKF-NT 79
D+ F + FN + G A+V S+ L +LT G AFY PI+ +
Sbjct: 2 DIQSFSFKNFN-SSSFILQGDATVSSSKL-RLTKVKGNGLPTLSSLGRAFYSSPIQIYDK 59
Query: 80 SSSESLSFSSNFVFAI----------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQS 129
S+ S++++F I G+AF + P S S +LG+F++ +
Sbjct: 60 STGAVASWATSFTANIFAPNKSSSADGIAFALVPVGSEP---KSNSGFLGVFDSDVYD-N 115
Query: 130 TNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGDP 189
+ +A+E DT N D+D H+GIDVNS+ S +A + G
Sbjct: 116 SAQTVAVEFDTFSNTDWD-PTSRHIGIDVNSIKSIRTASWGLAN-------------GQN 161
Query: 190 IQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGS---LK 246
+I I+Y+ A LL +L S + T ++S +++++ L E + +GFSA+TG
Sbjct: 162 AEILITYNAATSLLVASLVHPS--RRTSYIVSERVDITNELPEYVSIGFSATTGLSEGYT 219
Query: 247 SSHYVLGWSFNRS----GPALNLDISSL 270
+H VL WSF LDI+S
Sbjct: 220 ETHDVLSWSFASKLPDDSTTEPLDIASY 247
|
| >1n47_A Isolectin B4; cancer antigen, vicia villosa lectin, glycoprotein TN-bindin protein, carbohydrate recognition, sugar binding protein; HET: NAG FUC TNR; 2.70A {Vicia villosa} SCOP: b.29.1.1 Length = 233 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 2e-56
Identities = 67/250 (26%), Positives = 112/250 (44%), Gaps = 40/250 (16%)
Query: 29 QFIYHGFNED-AQLQRDGLASVHSNGLLQLTNTVS----PQQEGHAFYRLPIKFNTSSSE 83
F + FN + L A V+S G L+LT + P G A Y PI + +++
Sbjct: 5 SFSFTNFNPNQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIHDNTTL 64
Query: 84 SLSFSSNFVFAI----------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHI 133
+ SF+++F F + G+AF ++P + +LGLF + ++
Sbjct: 65 A-SFTTSFSFVMAAPAAAAVADGLAFFLAPPDTQP---QARGGFLGLFADRAHD-ASYQT 119
Query: 134 LAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGDPIQIW 193
+A+E DT N D + H+GID N + S ++ P +++ G+ I
Sbjct: 120 VAVEFDTYSN--AWDPNYTHIGIDTNGIESKKTTP-------------FDMVYGEKANIV 164
Query: 194 ISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGS---LKSSHY 250
I+Y + K L +L T +S ++L IL E + VGFSA+TG + +H
Sbjct: 165 ITYQASTKALAASLVFPV--SQTSYAVSARVDLRDILPEYVRVGFSATTGLNAGVVETHD 222
Query: 251 VLGWSFNRSG 260
++ WSF S
Sbjct: 223 IVSWSFAVSL 232
|
| >1dbn_A MAL, protein (leukoagglutinin); plant lectin, carbohydrate binding, sialyllactose, sugar BIN protein; HET: NAG SIA GAL BGC; 2.75A {Maackia amurensis} SCOP: b.29.1.1 Length = 239 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 5e-56
Identities = 73/256 (28%), Positives = 114/256 (44%), Gaps = 38/256 (14%)
Query: 24 AQDVNQFIYHGFNED-AQLQRDGLASVHSNGLLQLTNT----VSPQQEGHAFYRLPIKF- 77
+ ++ F + F + A L G ASV S G+LQLT G A Y P++
Sbjct: 1 SDEL-SFTINNFVPNEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIW 59
Query: 78 NTSSSESLSFSSNFVFAI----------GMAFVISPSKDLGKAEASPSEYLGLFNASNNG 127
++ SFS++F F + G+AF ++P D S S+YLGLFN ++N
Sbjct: 60 GNTTGSVASFSTSFTFVVKAPNPDITSDGLAFYLAPP-DSQIPSGSVSKYLGLFN-NSNS 117
Query: 128 QSTNHILAIELDTVQNLDFDDID--DNHVGIDVNSLISHESAPAAYFSDREGMNKTLELI 185
S+N I+A+E DT +D D H+GIDVN + S ++ + + L
Sbjct: 118 DSSNQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIESIKTVQWDWINGGVAFATITYLA 177
Query: 186 IGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTG-- 243
+ + Y T ++ +++L IL E + VGFSA+TG
Sbjct: 178 PNKTLIASLVYPS---------------NQTTFSVAASVDLKEILPEWVRVGFSAATGYP 222
Query: 244 SLKSSHYVLGWSFNRS 259
+ +H VL WSF +
Sbjct: 223 TEVETHDVLSWSFTST 238
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 1e-55
Identities = 72/282 (25%), Positives = 122/282 (43%), Gaps = 40/282 (14%)
Query: 348 KDKDVIGRGGFGKVYRGVLASNVQIAVKKV----SHDSKQGIKEFVAELVSMGRLRHRNL 403
+++IG GGFGKVYR ++AVK D Q I+ E L+H N+
Sbjct: 10 TLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNI 68
Query: 404 VKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDW 463
+ LRG C ++ LV ++ G L+++L + +A G+ YLH++
Sbjct: 69 IALRGVCLKEPNLCLVMEFARGGPLNRVLS---GKRIPPDILVNWAVQIARGMNYLHDEA 125
Query: 464 EQVVLHRDIKPANVLLDADLNG--------KLGDFGLARLYDHDTIPQTTKLVGTFGYMD 515
++HRD+K +N+L+ + K+ DFGLAR + T G + +M
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT---KMSAAGAYAWMA 182
Query: 516 PELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDAS 575
PE++R S +DV+++GV + E+ +G P + V +
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM-------------N 229
Query: 576 DSRLEGI---CEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
L I C E +L+ C +P P +RP+ ++
Sbjct: 230 KLALP-IPSTCPEPFAKLMED----CWNPDPHSRPSFTNILD 266
|
| >2bqp_A Protein (PEA lectin); D-glucopyranose complex, sugar binding protein; HET: GLC; 1.90A {Pisum sativum} SCOP: b.29.1.1 Length = 234 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 2e-55
Identities = 65/247 (26%), Positives = 105/247 (42%), Gaps = 35/247 (14%)
Query: 29 QFIYHGFNED-AQLQRDGLASVHSNGLLQLTNTVSPQQEGHAFYRLPIKF-NTSSSESLS 86
F+ F+ D L G + L LT G A Y PI + + +
Sbjct: 5 SFLITKFSPDQQNLIFQGDGYT-TKEKLTLTKA-VKNTVGRALYSSPIHIWDRETGNVAN 62
Query: 87 FSSNFVFAI----------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILAI 136
F ++F F I G F I+P + YLG+FN++ T +A+
Sbjct: 63 FVTSFTFVINAPNSYNVADGFTFFIAPVDTKP---QTGGGYLGVFNSAEYD-KTTQTVAV 118
Query: 137 ELDTVQNLDFDDID-DNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGDPIQIWIS 195
E DT N +D + D H+GIDVNS+ S + + G+ + I+
Sbjct: 119 EFDTFYNAAWDPSNRDRHIGIDVNSIKSVNTKSWKLQN-------------GEEANVVIA 165
Query: 196 YDGAEKLLNVTLAP---MSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLKSSHYVL 252
++ A +L V+L + T LS ++L ++ E + +GFSA+TG+ ++H VL
Sbjct: 166 FNAATNVLTVSLTYPNNSLEEEVTSYTLSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVL 225
Query: 253 GWSFNRS 259
WSF+
Sbjct: 226 SWSFHSE 232
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 2e-55
Identities = 57/279 (20%), Positives = 111/279 (39%), Gaps = 32/279 (11%)
Query: 350 KDVIGRGGFGKVYRGVL-ASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRG 408
+V+G+G FG+ + + + +K++ ++ + F+ E+ M L H N++K G
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 409 YCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVL 468
+ + +Y+ G+L I+ + W QR + +ASG+ YLH ++
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIKSMDSQ-YPWSQRVSFAKDIASGMAYLH---SMNII 130
Query: 469 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-------------PQTTKLVGTFGYMD 515
HRD+ N L+ + N + DFGLARL + + +VG +M
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 516 PELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDAS 575
PE++ DV++FG+ + E+ ++ + R
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-----VRGFLDRYCP 245
Query: 576 DSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+ C + ++ C PE RP+ ++
Sbjct: 246 PN-----CPPSFFPITVR----CCDLDPEKRPSFVKLEH 275
|
| >1f9k_A Acidic lectin; legume lectin, glycosylated protein, H-antigenic specificity agglutinin, sugar binding protein; HET: NAG MAN AMG; 3.00A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 1fay_A* Length = 238 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 4e-55
Identities = 74/262 (28%), Positives = 109/262 (41%), Gaps = 47/262 (17%)
Query: 26 DVNQFIYHGFNED-AQLQRDGLASVHSNGLLQLTNTVS-----PQQEGHAFYRLPIKF-N 78
+ F + F E+ +L AS+ SNG+L+LT + G A Y PIK +
Sbjct: 1 ETQSFNFDHFEENSKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWD 60
Query: 79 TSSSESLSFSSNFVFAI-----------GMAFVISPSKDLGKAEASPSEYLGLFNASNNG 127
+++ SF + F F I G+ F + P + LG+F
Sbjct: 61 STTGNVASFETRFSFNITQPYAYPEPADGLTFFMVPPNS---PQGEDGGNLGVFKPPEG- 116
Query: 128 QSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIG 187
++ A+E DT QN D H+GIDVNS++S ++ +L G
Sbjct: 117 ---DNAFAVEFDTFQN--TWDPQVPHIGIDVNSIVSSKTLH-------------FQLENG 158
Query: 188 DPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILL--ETMYVGFSASTGSL 245
+ I YD K+LNV LA S T LS ++L E + VG SA+TG
Sbjct: 159 GVANVVIKYDSPTKILNVVLAFHS--VGTVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQ 216
Query: 246 K---SSHYVLGWSFNRSGPALN 264
K +H ++ WSF S N
Sbjct: 217 KNAVETHEIISWSFTSSLQETN 238
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 9e-55
Identities = 65/283 (22%), Positives = 125/283 (44%), Gaps = 36/283 (12%)
Query: 347 FKDKDVIGRGGFGKVYRGVLASNVQ-IAVKKVSHDSKQG-------IKEFVAELVSMGRL 398
+ + IG+GGFG V++G L + +A+K + +G +EF E+ M L
Sbjct: 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 399 RHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLY 458
H N+VKL G +V +++P G L L P + W + R++ +A G+ Y
Sbjct: 81 NHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIEY 137
Query: 459 LHEDWEQVVLHRDIKPANVLLD-----ADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 513
+ + ++HRD++ N+ L A + K+ DFGL++ H + L+G F +
Sbjct: 138 MQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS----VSGLLGNFQW 192
Query: 514 MDPELM--RTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAI 571
M PE + + D Y+F + + + +G P ++ + + ++ + + + I
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-IKFINMIREEGLRPTI 251
Query: 572 RDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+ RL + E C P+ RP+ +++
Sbjct: 252 PEDCPPRLRNVIEL------------CWSGDPKKRPHFSYIVK 282
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 3e-54
Identities = 49/273 (17%), Positives = 103/273 (37%), Gaps = 36/273 (13%)
Query: 352 VIGRGGFGKVYRGVLASNVQIAVK--KVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGY 409
+ G++++G I VK KV S + ++F E + H N++ + G
Sbjct: 17 KLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75
Query: 410 CRR--KGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVV 467
C+ L+ +MP GSL +LH ++ Q + +A G+ +LH E ++
Sbjct: 76 CQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLI 134
Query: 468 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTS 527
+ +V++D D+ ++ + + Q+ + ++ PE ++ T+
Sbjct: 135 PRHALNSRSVMIDEDMTARISMADVKFSF------QSPGRMYAPAWVAPEALQKKPEDTN 188
Query: 528 T---DVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKG---AIRDASDSRLEG 581
D+++F V + E+ + P +ME V +G I +
Sbjct: 189 RRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVAL------EGLRPTIPPGISPHVSK 242
Query: 582 ICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+ + C + P RP ++
Sbjct: 243 LMKI------------CMNEDPAKRPKFDMIVP 263
|
| >1ioa_A Arcelin-5A, ARC5A; lectin-like proteins, plant defense proteins, lectin; HET: NAG FUC; 2.70A {Phaseolus vulgaris} SCOP: b.29.1.1 Length = 240 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 9e-54
Identities = 69/262 (26%), Positives = 106/262 (40%), Gaps = 46/262 (17%)
Query: 24 AQDVNQFIYHGFNEDAQLQRDGLASVHSNGLLQLTNTVS-----PQQEGHAFYRLPIKFN 78
A + F + F+ D +L G A++ S G LQLT S G AFY PI+
Sbjct: 1 ATET-SFNFPNFHTDDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIK 59
Query: 79 TSSSESLSFSSNFVFAI----------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQ 128
S++ + SF++NF F I G+AF + P E+LG+FN +NN +
Sbjct: 60 DSNNVA-SFNTNFTFIIRAKNQSISAYGLAFALVPVNSPP---QKKQEFLGIFN-TNNPE 114
Query: 129 STNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGD 188
+A+ +T +N D D N + VN G+
Sbjct: 115 PNARTVAVVFNTFKN--RIDFDKNFIKPYVNENCD------------------FHKYNGE 154
Query: 189 PIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGS---L 245
+ I+YD + L V L K +S ++L + E + VGFS ++G
Sbjct: 155 KTDVQITYDSSNNDLRVFLHFTV--SQVKCSVSATVHLEKEVDEWVSVGFSPTSGLTEDT 212
Query: 246 KSSHYVLGWSFNRSGPALNLDI 267
+H VL WSF+ +I
Sbjct: 213 TETHDVLSWSFSSKFRNKLSNI 234
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 9e-54
Identities = 70/304 (23%), Positives = 133/304 (43%), Gaps = 34/304 (11%)
Query: 315 RNKRYEEVYEDWEREYGPQRFTYKDLYKATKGFKDKDVIGRGGFGKVYRGVLASNVQIAV 374
+ + +DWE + IG G FG VY+G +V + +
Sbjct: 8 HHHGSRDAADDWEIPD-------GQI-------TVGQRIGSGSFGTVYKGKWHGDVAVKM 53
Query: 375 KKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHT 434
V+ + Q ++ F E+ + + RH N++ GY + +V + SL LH
Sbjct: 54 LNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHA 112
Query: 435 NIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR 494
+ + + I R A G+ YLH + ++HRD+K N+ L D K+GDFGLA
Sbjct: 113 S-ETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLAT 168
Query: 495 LYDHDTIPQT-TKLVGTFGYMDPELMRTGKASTST---DVYAFGVFMLEVASGRRPVEQQ 550
+ +L G+ +M PE++R ++ + DVYAFG+ + E+ +G+ P
Sbjct: 169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS-- 226
Query: 551 GSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMR 610
++ + + + +G++ S++ C ++ L+ + C K + RP+
Sbjct: 227 -NINNRDQIIEMVG---RGSLSP-DLSKVRSNCPKRMKRLMAE----CLKKKRDERPSFP 277
Query: 611 QVMQ 614
+++
Sbjct: 278 RILA 281
|
| >1avb_A Arcelin-1; lectin-like glycoprotein, plant defense, insecticidal activi lectin; HET: NAG; 1.90A {Phaseolus vulgaris} SCOP: b.29.1.1 Length = 226 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 3e-53
Identities = 72/247 (29%), Positives = 106/247 (42%), Gaps = 43/247 (17%)
Query: 29 QFIYHGFNEDAQLQRDGLASVHSNGLLQLTNTVSPQQE--GHAFYRLPIKF-NTSSSESL 85
F FN L G A+V S G L LTN +++ G AFY PI+ + +
Sbjct: 5 SFNVETFN-KTNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQINDRTIDNLA 63
Query: 86 SFSSNFVFAI----------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILA 135
SFS+NF F I G+AF + P YLGLFN +N H +A
Sbjct: 64 SFSTNFTFRINAKNIENSAYGLAFALVPVGSRP---KLKGRYLGLFNTTNYD-RDAHTVA 119
Query: 136 IELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGDPIQIWIS 195
+ DT N + IDVNS+ + + + G+ ++ I+
Sbjct: 120 VVFDT---------VSNRIEIDVNSIRPIATESCNFGHN-----------NGEKAEVRIT 159
Query: 196 YDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLK---SSHYVL 252
YD + L V+L S K +S + L + + + VGFSA++GS K +H VL
Sbjct: 160 YDSPKNDLRVSLLYPS--SEEKCHVSATVPLEKEVEDWVSVGFSATSGSKKETTETHNVL 217
Query: 253 GWSFNRS 259
WSF+ +
Sbjct: 218 SWSFSSN 224
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 1e-52
Identities = 59/280 (21%), Positives = 115/280 (41%), Gaps = 37/280 (13%)
Query: 350 KDVIGRGGFGKVYRGVLASNVQIAVK--KVSHDSKQGIKEFVAELVSMGRLRHRNLVKLR 407
++IG+G FG+VY G V A++ + D++ +K F E+++ + RH N+V
Sbjct: 38 GELIGKGRFGQVYHGRWHGEV--AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 408 GYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVV 467
G C ++ +L ++ + K L+ + +I + + G+ YLH + +
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVR-DAKIVLDVNKTRQIAQEIVKGMGYLH---AKGI 151
Query: 468 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP----QTTKLVGTFGYMDPELMRTGK 523
LH+D+K NV D + + DFGL + + G ++ PE++R
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 524 A---------STSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDA 574
S +DV+A G E+ + P + Q + + + G +
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG-------TGMKPNL 263
Query: 575 SDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
S ++ +++L C + E RP ++M
Sbjct: 264 SQIG----MGKEISDILLF----CWAFEQEERPTFTKLMD 295
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 8e-52
Identities = 74/320 (23%), Positives = 118/320 (36%), Gaps = 65/320 (20%)
Query: 333 QRFTYKDLYKATKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKV-SHDSKQGIKEFVAE 391
QR +D+ + +G+G +G+V+RG +AVK S D K +E E
Sbjct: 3 QRTVARDI-------TLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRE--TE 52
Query: 392 LVSMGRLRHRNLVKLRGYCRRKG----EFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFR 447
L + LRH N++ + L+ Y GSL L L+ R
Sbjct: 53 LYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT---LDTVSCLR 109
Query: 448 IIRGVASGLLYLHEDWEQ-----VVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 502
I+ +ASGL +LH + + HRD+K N+L+ + + D GLA ++ T
Sbjct: 110 IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQ 169
Query: 503 Q---TTKLVGTFGYMDPELMR------TGKASTSTDVYAFGVFMLEVASGRRP------- 546
VGT YM PE++ + D++AFG+ + EVA
Sbjct: 170 LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229
Query: 547 -------VEQQGSMETVNLVDWVCD-----CWKKGAIRDASDSRLEGICEEKQMELVLKL 594
V S E + VC D + + L + +E
Sbjct: 230 KPPFYDVVPNDPSFEDM--RKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKE--------- 278
Query: 595 GLFCSHPKPEARPNMRQVMQ 614
C + P AR ++ +
Sbjct: 279 ---CWYQNPSARLTALRIKK 295
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 3e-50
Identities = 66/304 (21%), Positives = 111/304 (36%), Gaps = 62/304 (20%)
Query: 351 DVIGRGGFGKVYRGVLASNVQIAVKKV-SHDSKQGIKEFVAELVSMGRLRHRNLVKLRGY 409
+ IG+G FG+V+RG ++AVK S + + +E AE+ LRH N++
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAA 104
Query: 410 CRRKG----EFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQ 465
+ + LV DY +GSL L+ + ++ ASGL +LH +
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 466 -----VVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT---TKLVGTFGYMDPE 517
+ HRD+K N+L+ + + D GLA +D T VGT YM PE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 518 LMR------TGKASTSTDVYAFGVFMLEVASGRRPVEQQGSME------------TVNLV 559
++ ++ D+YA G+ E+A + +
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 281
Query: 560 DWVC---------DCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMR 610
VC + W+ + + I E C + AR
Sbjct: 282 KVVCEQKLRPNIPNRWQS----CEALRVMAKIMRE------------CWYANGAARLTAL 325
Query: 611 QVMQ 614
++ +
Sbjct: 326 RIKK 329
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 5e-50
Identities = 66/306 (21%), Positives = 112/306 (36%), Gaps = 66/306 (21%)
Query: 351 DVIGRGGFGKVYRGVLASNVQIAVKKV-SHDSKQGIKEFVAELVSMGRLRHRNLVKLRGY 409
IG+G +G+V+ G ++AVK + + +E E+ +RH N++
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRE--TEIYQTVLMRHENILGFIAA 99
Query: 410 CRRKG----EFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHED--- 462
+ + L+ DY NGSL L + L+ ++ SGL +LH +
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 463 --WEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ---TTKLVGTFGYMDPE 517
+ + HRD+K N+L+ + + D GLA + DT VGT YM PE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216
Query: 518 L------MRTGKASTSTDVYAFGVFMLEVASGRRP--------------VEQQGSMETVN 557
+ ++ D+Y+FG+ + EVA V S E +
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDM- 275
Query: 558 LVDWVC---------DCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPN 608
+ VC + W D ++ + E C P +R
Sbjct: 276 -REIVCIKKLRPSFPNRWSS----DECLRQMGKLMTE------------CWAHNPASRLT 318
Query: 609 MRQVMQ 614
+V +
Sbjct: 319 ALRVKK 324
|
| >1dhk_B Bean lectin-like inhibitor, porcine pancreatic alpha-amylase; CO (hydrolase-inhibitor), complex (hydrolase-inhibitor) comple; HET: NAG; 1.85A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1viw_B* Length = 223 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 7e-50
Identities = 60/254 (23%), Positives = 101/254 (39%), Gaps = 41/254 (16%)
Query: 24 AQDVNQFIYHGFNEDAQLQRDGLASVHSNGLLQLTNTVSPQQEGHAFYRLPIKF-NTSSS 82
A + FI FN+ L G A+V SNG LQL+ S AFY PI+ ++++
Sbjct: 1 ATET-SFIIDAFNK-TNLILQGDATVSSNGNLQLSYN-SYDSMSRAFYSAPIQIRDSTTG 57
Query: 83 ESLSFSSNFVFAIGMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQ 142
SF +NF I + + + L +S + +E DT
Sbjct: 58 NVASFDTNFTMNI-----RTHRQANS------AVGLDFVLVPVQPESKGDTVTVEFDTFL 106
Query: 143 NLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGDPIQIWISYDGAEKL 202
+ + IDVN+ + D G ++ I+Y+ + K+
Sbjct: 107 S---------RISIDVNNNDIKSVPWDVHDYD------------GQNAEVRITYNSSTKV 145
Query: 203 LNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLK---SSHYVLGWSFNRS 259
+V+L+ S K +S + L + + + VGFSA++G+ + +H VL WSF+
Sbjct: 146 FSVSLSNPSTGKS--NNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDVLSWSFSSK 203
Query: 260 GPALNLDISSLPRL 273
L S +
Sbjct: 204 FINLKDQKSERSNI 217
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-42
Identities = 66/272 (24%), Positives = 111/272 (40%), Gaps = 30/272 (11%)
Query: 350 KDVIGRGGFGKVYRGVL-ASNVQIAVKKV-SHDSKQGIKEFVAELVSMGRLRHRNLVKLR 407
+ IGRG FG+V+ G L A N +AVK +F+ E + + H N+V+L
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 408 GYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVV 467
G C +K +V + + G L T L +++ A+G+ YL +
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLE---SKCC 234
Query: 468 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY--MDPELMRTGKAS 525
+HRD+ N L+ K+ DFG++R + L PE + G+ S
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGL-RQVPVKWTAPEALNYGRYS 293
Query: 526 TSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE--GI 582
+ +DV++FG+ + E S G P + +T V+ RL +
Sbjct: 294 SESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE--------------KGGRLPCPEL 339
Query: 583 CEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
C + L+ + C +P RP+ + Q
Sbjct: 340 CPDAVFRLMEQ----CWAYEPGQRPSFSTIYQ 367
|
| >2ltn_A PEA lectin, alpha chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1bqp_A* 1hkd_A 1ofs_A* 1rin_A* 1lof_C* 1len_A 1lem_A 1les_A* 2lal_A 1loe_A 1loa_A* 1loc_A* 1lod_A* 1lob_A 1lof_A* 1log_A* 1lgc_A* 1lgb_A* 2b7y_A* Length = 181 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-41
Identities = 49/192 (25%), Positives = 77/192 (40%), Gaps = 32/192 (16%)
Query: 29 QFIYHGFNED-AQLQRDGLASVHSNGLLQLTNTVSPQQEGHAFYRLPIKF-NTSSSESLS 86
F+ F+ D L G + L LT G A Y PI + + +
Sbjct: 5 SFLITKFSPDQQNLIFQGDGYT-TKEKLTLTKA-VKNTVGRALYSSPIHIWDRETGNVAN 62
Query: 87 FSSNFVFAI----------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILAI 136
F ++F F I G F I+P + YLG+FN++ T +A+
Sbjct: 63 FVTSFTFVINAPNSYNVADGFTFFIAPVDTKP---QTGGGYLGVFNSAEYD-KTTQTVAV 118
Query: 137 ELDTVQNLDFDDID-DNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGDPIQIWIS 195
E DT N +D + D H+GIDVNS+ S + +L G+ + I+
Sbjct: 119 EFDTFYNAAWDPSNRDRHIGIDVNSIKSVNTKS-------------WKLQNGEEANVVIA 165
Query: 196 YDGAEKLLNVTL 207
++ A +L V+L
Sbjct: 166 FNAATNVLTVSL 177
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 5e-39
Identities = 74/270 (27%), Positives = 112/270 (41%), Gaps = 30/270 (11%)
Query: 350 KDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGY 409
+G G FG V G +AVK + S EF E +M +L H LVK G
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-DEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 410 CRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLH 469
C ++ +V +Y+ NG L L ++ L Q + V G+ +L +H
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLE---SHQFIH 127
Query: 470 RDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY--MDPELMRTGKASTS 527
RD+ N L+D DL K+ DFG+ R D + + F PE+ K S+
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ--YVSSVGTKFPVKWSAPEVFHYFKYSSK 185
Query: 528 TDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE--GICE 584
+DV+AFG+ M EV S G+ P + + E V V RL +
Sbjct: 186 SDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS--------------QGHRLYRPHLAS 231
Query: 585 EKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+ +++ C H PE RP +Q++
Sbjct: 232 DTIYQIMYS----CWHELPEKRPTFQQLLS 257
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 6e-39
Identities = 71/269 (26%), Positives = 121/269 (44%), Gaps = 30/269 (11%)
Query: 351 DVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYC 410
+G+G FG+V+ G ++A+K + + + F+ E M +LRH LV+L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 411 RRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHR 470
+ +V +YM GSL L L Q + +ASG+ Y+ +HR
Sbjct: 249 SEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 304
Query: 471 DIKPANVLLDADLNGKLGDFGLARLYDHD--TIPQTTKLVGTFGYMDPELMRTGKASTST 528
D++ AN+L+ +L K+ DFGLARL + + T Q K + PE G+ + +
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKS 362
Query: 529 DVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE--GICEE 585
DV++FG+ + E+ + GR P + E ++ V+ +G R+ C E
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-------RG-------YRMPCPPECPE 408
Query: 586 KQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+L+ + C +PE RP +
Sbjct: 409 SLHDLMCQ----CWRKEPEERPTFEYLQA 433
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 7e-39
Identities = 70/270 (25%), Positives = 114/270 (42%), Gaps = 34/270 (12%)
Query: 350 KDVIGRGGFGKVYRGVLASNVQIAVK--KVSHDSKQGIKEFVAELVSMGRLRHRNLVKLR 407
IG G FG V+ G + ++A+K + S++ +F+ E M +L H LV+L
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLY 69
Query: 408 GYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVV 467
G C + LV ++M +G L L T + + V G+ YL E V
Sbjct: 70 GVCLEQAPICLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLE---EACV 125
Query: 468 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY--MDPELMRTGKAS 525
+HRD+ N L+ + K+ DFG+ R D T+ F PE+ + S
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWASPEVFSFSRYS 183
Query: 526 TSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEG--I 582
+ +DV++FGV M EV S G+ P E + + E V + + RL +
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS--------------TGFRLYKPRL 229
Query: 583 CEEKQMELVLKLGLFCSHPKPEARPNMRQV 612
+++ C +PE RP ++
Sbjct: 230 ASTHVYQIMNH----CWRERPEDRPAFSRL 255
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 8e-39
Identities = 72/268 (26%), Positives = 124/268 (46%), Gaps = 26/268 (9%)
Query: 351 DVIGRGGFGKVYRGVL-ASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGY 409
+G G +G+VY GV ++ +AVK + D+ + ++EF+ E M ++H NLV+L G
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 410 CRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLH 469
C R+ F ++ ++M G+L L + ++ + ++S + YL ++ +H
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 341
Query: 470 RDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTD 529
R++ N L+ + K+ DFGL+RL DT + PE + K S +D
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 401
Query: 530 VYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE--GICEEK 586
V+AFGV + E+A+ G P + L++ D R+E C EK
Sbjct: 402 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--------------KDYRMERPEGCPEK 447
Query: 587 QMELVLKLGLFCSHPKPEARPNMRQVMQ 614
EL+ C P RP+ ++ Q
Sbjct: 448 VYELMRA----CWQWNPSDRPSFAEIHQ 471
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-38
Identities = 71/269 (26%), Positives = 121/269 (44%), Gaps = 30/269 (11%)
Query: 351 DVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYC 410
+G+G FG+V+ G ++A+K + + + F+ E M +LRH LV+L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 411 RRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHR 470
+ +V +YM GSL L L Q + +ASG+ Y+ +HR
Sbjct: 332 SEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 387
Query: 471 DIKPANVLLDADLNGKLGDFGLARLYDHD--TIPQTTKLVGTFGYMDPELMRTGKASTST 528
D++ AN+L+ +L K+ DFGLARL + + T Q K + PE G+ + +
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKS 445
Query: 529 DVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE--GICEE 585
DV++FG+ + E+ + GR P + E ++ V+ +G R+ C E
Sbjct: 446 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-------RG-------YRMPCPPECPE 491
Query: 586 KQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+L+ + C +PE RP +
Sbjct: 492 SLHDLMCQ----CWRKEPEERPTFEYLQA 516
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-38
Identities = 61/206 (29%), Positives = 107/206 (51%), Gaps = 13/206 (6%)
Query: 348 KDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKL 406
D+ V+G+G +G VY G L++ V+IA+K++ + + E+ L+H+N+V+
Sbjct: 25 GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQY 84
Query: 407 RGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRII-RGVASGLLYLHEDWEQ 465
G G + + +P GSL +L + P + Q + + GL YLH +
Sbjct: 85 LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DN 141
Query: 466 VVLHRDIKPANVLLDADLNG--KLGDFGLA-RLYDHDTIPQTTKLVGTFGYMDPELMRTG 522
++HRDIK NVL++ +G K+ DFG + RL + +T GT YM PE++ G
Sbjct: 142 QIVHRDIKGDNVLINTY-SGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKG 198
Query: 523 K--ASTSTDVYAFGVFMLEVASGRRP 546
+ D+++ G ++E+A+G+ P
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-38
Identities = 71/268 (26%), Positives = 111/268 (41%), Gaps = 30/268 (11%)
Query: 350 KDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGY 409
+G G FG V G +A+K + S EF+ E M L H LV+L G
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 410 CRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLH 469
C ++ ++ +YM NG L L + Q + + V + YL + LH
Sbjct: 88 CTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLH 143
Query: 470 RDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY--MDPELMRTGKASTS 527
RD+ N L++ K+ DFGL+R D T+ + F PE++ K S+
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLMYSKFSSK 201
Query: 528 TDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE--GICE 584
+D++AFGV M E+ S G+ P E+ + ET + RL +
Sbjct: 202 SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA--------------QGLRLYRPHLAS 247
Query: 585 EKQMELVLKLGLFCSHPKPEARPNMRQV 612
EK ++ C H K + RP + +
Sbjct: 248 EKVYTIMYS----CWHEKADERPTFKIL 271
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 18/210 (8%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKV---SHDSKQGIKEFVAELVSMGRLRHRN 402
F+ + IGRG F +VYR L V +A+KKV + + + E+ + +L H N
Sbjct: 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 403 LVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRF------RIIRGVASGL 456
++K E +V + G L ++ IK + + + S L
Sbjct: 94 VIKYYASFIEDNELNIVLELADAGDLSRM----IKHFKKQKRLIPERTVWKYFVQLCSAL 149
Query: 457 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDP 516
++H + V+HRDIKPANV + A KLGD GL R + T + LVGT YM P
Sbjct: 150 EHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSP 205
Query: 517 ELMRTGKASTSTDVYAFGVFMLEVASGRRP 546
E + + +D+++ G + E+A+ + P
Sbjct: 206 ERIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-38
Identities = 84/300 (28%), Positives = 138/300 (46%), Gaps = 43/300 (14%)
Query: 335 FTYKDLYKATKGF---------KDKDVIGRGGFGKVYRGVLAS----NVQIAVK--KVSH 379
TY++ +A + F + +IG G G+V G L +V +A+K K +
Sbjct: 30 HTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY 89
Query: 380 DSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPC 439
+Q ++F++E MG+ H N+++L G R ++V +YM NGSLD L T+
Sbjct: 90 TERQ-RRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH-DGQ 147
Query: 440 LNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD 499
Q ++RGV +G+ YL + +HRD+ NVL+D++L K+ DFGL+R+ + D
Sbjct: 148 FTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204
Query: 500 TIPQTTKLVGTFGY--MDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETV 556
T G PE + S+++DV++FGV M EV + G RP + + +
Sbjct: 205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVI 264
Query: 557 NLVDWVCDCWKKGAIRDASDSRLEG--ICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+ V+ RL C +L+L C H RP Q++
Sbjct: 265 SSVE--------------EGYRLPAPMGCPHALHQLMLD----CWHKDRAQRPRFSQIVS 306
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 3e-38
Identities = 71/244 (29%), Positives = 121/244 (49%), Gaps = 23/244 (9%)
Query: 335 FTYKDLYKATKGFKD---------KDVIGRGGFGKVYRGVL----ASNVQIAVK--KVSH 379
T++D + F V+G G FG+V G L + +A+K KV +
Sbjct: 26 HTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY 85
Query: 380 DSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPC 439
KQ ++F+ E MG+ H N+++L G + ++V +YM NGSLD L +
Sbjct: 86 TEKQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQ 143
Query: 440 LNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD 499
Q ++RG+ASG+ YL + +HRD+ N+L++++L K+ DFGL R+ + D
Sbjct: 144 FTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200
Query: 500 TIPQTTKLVGTFGY--MDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETV 556
T G PE + K ++++DV+++G+ + EV S G RP + + + +
Sbjct: 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI 260
Query: 557 NLVD 560
VD
Sbjct: 261 KAVD 264
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 5e-38
Identities = 78/275 (28%), Positives = 118/275 (42%), Gaps = 36/275 (13%)
Query: 351 DVIGRGGFGKVYRGVL----ASNVQIAVK--KVSHDSKQGIKEFVAELVSMGRLRHRNLV 404
+VIGRG FG VY G L + AVK D + + +F+ E + M H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFSHPNVL 89
Query: 405 KLRGYC-RRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDW 463
L G C R +G L+V YM +G L + VA G+ YL
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLAS-- 146
Query: 464 EQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTF--GYMDPELMR 520
+ +HRD+ N +LD K+ DFGLAR +YD + K +M E ++
Sbjct: 147 -KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 205
Query: 521 TGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRL 579
T K +T +DV++FGV + E+ + G P + + + RL
Sbjct: 206 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL--------------QGRRL 251
Query: 580 E--GICEEKQMELVLKLGLFCSHPKPEARPNMRQV 612
C + E++LK C HPK E RP+ ++
Sbjct: 252 LQPEYCPDPLYEVMLK----CWHPKAEMRPSFSEL 282
|
| >1qmo_E Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 Length = 133 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 6e-38
Identities = 43/131 (32%), Positives = 60/131 (45%), Gaps = 16/131 (12%)
Query: 131 NHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGDPI 190
++++A+E DT N D+ D + H+GIDVNS+ S +A + + G
Sbjct: 1 SNVVAVEFDTYLNPDYGDPNYIHIGIDVNSIRSKVTAKWDWQN-------------GKIA 47
Query: 191 QIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLKSSHY 250
ISY+ K L+VT LS I L +L E + VG SASTG K +
Sbjct: 48 TAHISYNSVSKRLSVTSYY---AGSKPATLSYDIELHTVLPEWVRVGLSASTGQDKERNT 104
Query: 251 VLGWSFNRSGP 261
V WSF S
Sbjct: 105 VHSWSFTSSLW 115
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 6e-38
Identities = 50/203 (24%), Positives = 88/203 (43%), Gaps = 7/203 (3%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNL 403
+ IG G FGK Q +K+++ S + +E E+ + ++H N+
Sbjct: 26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85
Query: 404 VKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDW 463
V+ R G +V DY G L K ++ Q + L ++H+
Sbjct: 86 VQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD-- 143
Query: 464 EQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGK 523
+ +LHRDIK N+ L D +LGDFG+AR+ + +GT Y+ PE+
Sbjct: 144 -RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA-CIGTPYYLSPEICENKP 201
Query: 524 ASTSTDVYAFGVFMLEVASGRRP 546
+ +D++A G + E+ + +
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHA 224
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-37
Identities = 63/277 (22%), Positives = 115/277 (41%), Gaps = 31/277 (11%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVS--HDSKQGIKEFVAELVSMGRLRHRNL 403
K IGRG F VY+G+ + V++A ++ +K + F E + L+H N+
Sbjct: 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 87
Query: 404 VKLRGY----CRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYL 459
V+ + K +LV + M +G+L L + R + GL +L
Sbjct: 88 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFL 145
Query: 460 HEDWEQVVLHRDIKPANVLLDADLNG--KLGDFGLARLYDHDTIPQTTKLVGTFGYMDPE 517
H ++HRD+K N+ + G K+GD GLA L ++GT +M PE
Sbjct: 146 HTR-TPPIIHRDLKCDNIFITGP-TGSVKIGDLGLATLKRASF---AKAVIGTPEFMAPE 200
Query: 518 LMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDS 577
+ S DVYAFG+ MLE+A+ P + + + +++ +
Sbjct: 201 MYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQI---------YRR-VTSGVKPA 249
Query: 578 RLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+ + + E++ C + R +++ ++
Sbjct: 250 SFDKVAIPEVKEIIEG----CIRQNKDERYSIKDLLN 282
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-37
Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 10/215 (4%)
Query: 350 KDVIGRGGFGKVYRGVL-ASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRG 408
K +G G +G+VY GV ++ +AVK + D+ + ++EF+ E M ++H NLV+L G
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 409 YCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVL 468
C R+ F ++ ++M G+L L + ++ + ++S + YL ++ +
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFI 133
Query: 469 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY--MDPELMRTGKAST 526
HRD+ N L+ + K+ DFGL+RL DT F PE + K S
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG--AKFPIKWTAPESLAYNKFSI 191
Query: 527 STDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVD 560
+DV+AFGV + E+A+ G P + L++
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 226
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-37
Identities = 64/285 (22%), Positives = 125/285 (43%), Gaps = 47/285 (16%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVK 405
FK+ ++IG GGFG+V++ +K+V +++++ +E + ++ +L H N+V
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE--VKALA--KLDHVNIVH 68
Query: 406 LRGY---------------CRRKGEFL-LVYDYMPNGSLDKILHTNIKPCLNWYQRFRII 449
G R K + L + ++ G+L++ + L+ +
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 450 RGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVG 509
+ G+ Y+H + +++RD+KP+N+ L K+GDFGL +D + T+ G
Sbjct: 129 EQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG--KRTRSKG 183
Query: 510 TFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKG 569
T YM PE + + D+YA G+ + E+ ET + + G
Sbjct: 184 TLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA-----FETSKFFTDL----RDG 234
Query: 570 AIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
I D D + + + +++ L KPE RPN ++++
Sbjct: 235 IISDIFDKKEKTLL--QKL---LS-------KKPEDRPNTSEILR 267
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-37
Identities = 61/216 (28%), Positives = 108/216 (50%), Gaps = 14/216 (6%)
Query: 350 KDVIGRGGFGKVYRGVLASNVQIAVK--KVSHDSKQGIKEFVAELVSMGRLRHRNLVKLR 407
+ +G G FG+V+ G + ++AVK K S F+AE M +L+H+ LV+L
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRLY 74
Query: 408 GYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVV 467
++ ++ +YM NGSL L T L + + +A G+ ++ E +
Sbjct: 75 AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNY 130
Query: 468 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY--MDPELMRTGKAS 525
+HRD++ AN+L+ L+ K+ DFGLARL + + T + F PE + G +
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNE--YTAREGAKFPIKWTAPEAINYGTFT 188
Query: 526 TSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVD 560
+DV++FG+ + E+ + GR P + E + ++
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 4e-37
Identities = 83/369 (22%), Positives = 140/369 (37%), Gaps = 46/369 (12%)
Query: 267 ISSLPRLPHLPRPRAKANDKPQLKLVISVSLIAILVVLITIGAAVYIVRNKRYEEVYEDW 326
+S + + H + +++ + + + + + E +Y
Sbjct: 1 MSPIDPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQG 60
Query: 327 EREYGPQRFTYK-DLYKATKGF---------KDKDVIGRGGFGKVYRGVL----ASNVQI 372
+L +A + +VIGRG FG VY G L +
Sbjct: 61 ANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHC 120
Query: 373 AVK--KVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYC-RRKGEFLLVYDYMPNGSLD 429
AVK D + + +F+ E + M H N++ L G C R +G L+V YM +G L
Sbjct: 121 AVKSLNRITDIGE-VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 179
Query: 430 KILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGD 489
+ VA G+ +L + +HRD+ N +LD K+ D
Sbjct: 180 NFIRNE-THNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVAD 235
Query: 490 FGLAR-LYDHDTIPQTTKLVGTF--GYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRR 545
FGLAR +YD + K +M E ++T K +T +DV++FGV + E+ + G
Sbjct: 236 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 295
Query: 546 PVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE--GICEEKQMELVLKLGLFCSHPKP 603
P + + + RL C + E++LK C HPK
Sbjct: 296 PYPDVNTFDITVYLL--------------QGRRLLQPEYCPDPLYEVMLK----CWHPKA 337
Query: 604 EARPNMRQV 612
E RP+ ++
Sbjct: 338 EMRPSFSEL 346
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-37
Identities = 63/277 (22%), Positives = 118/277 (42%), Gaps = 39/277 (14%)
Query: 351 DVIGRGGFGKVYRGVLAS-----NVQIAVK--KVSHDSKQGIKEFVAELVSMGRLRHRNL 403
V+G G FG VY+G+ + +A+K + + K KE + E M + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNPHV 79
Query: 404 VKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDW 463
+L G C L+ MP G L + + K + +A G+ YL +
Sbjct: 80 CRLLGICLTS-TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLED-- 135
Query: 464 EQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT---FGYMDPELMR 520
+ ++HRD+ NVL+ + K+ DFGLA+L + + G +M E +
Sbjct: 136 -RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWMALESIL 192
Query: 521 TGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRL 579
+ +DV+++GV + E+ + G +P + + E ++++ KG RL
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-------KG-------ERL 238
Query: 580 E--GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
IC ++ K C ++RP R+++
Sbjct: 239 PQPPICTIDVYMIMRK----CWMIDADSRPKFRELII 271
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 6e-37
Identities = 74/269 (27%), Positives = 116/269 (43%), Gaps = 32/269 (11%)
Query: 350 KDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGY 409
IG+G FG V G ++AVK + +D+ + F+AE M +LRH NLV+L G
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 254
Query: 410 C-RRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVL 468
KG +V +YM GSL L + + L + V + YL +
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFV 311
Query: 469 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTST 528
HRD+ NVL+ D K+ DFGL + + + T KL + PE +R K ST +
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKL--PVKWTAPEALREKKFSTKS 367
Query: 529 DVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE--GICEE 585
DV++FG+ + E+ S GR P + + V V+ +++ C
Sbjct: 368 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE--------------KGYKMDAPDGCPP 413
Query: 586 KQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+++ C H RP Q+ +
Sbjct: 414 AVYDVMKN----CWHLDAATRPTFLQLRE 438
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 9e-37
Identities = 68/213 (31%), Positives = 102/213 (47%), Gaps = 12/213 (5%)
Query: 350 KDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGY 409
IG+G FG V G ++AVK + +D+ + F+AE M +LRH NLV+L G
Sbjct: 26 LQTIGKGEFGDVMLGD-YRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 82
Query: 410 C-RRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVL 468
KG +V +YM GSL L + + L + V + YL +
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFV 139
Query: 469 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTST 528
HRD+ NVL+ D K+ DFGL + + + T KL + PE +R K ST +
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKL--PVKWTAPEALREKKFSTKS 195
Query: 529 DVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVD 560
DV++FG+ + E+ S GR P + + V V+
Sbjct: 196 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 228
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 9e-37
Identities = 69/275 (25%), Positives = 117/275 (42%), Gaps = 34/275 (12%)
Query: 350 KDVIGRGGFGKVYRGVL---ASNVQIAVK--KVSHDSKQGIKEFVAELVSMGRLRHRNLV 404
+G G FG V +GV + +A+K K + +E + E M +L + +V
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD-TEEMMREAQIMHQLDNPYIV 73
Query: 405 KLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWE 464
+L G C+ + +LV + G L K L + + ++ V+ G+ YL E
Sbjct: 74 RLIGVCQAE-ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE--- 128
Query: 465 QVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF--GYMDPELMRTG 522
+ +HRD+ NVLL K+ DFGL++ D T + G + + PE +
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 188
Query: 523 KASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEG 581
K S+ +DV+++GV M E S G++P ++ E + ++ R+E
Sbjct: 189 KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE--------------QGKRMEC 234
Query: 582 --ICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
C + L+ C K E RP+ V Q
Sbjct: 235 PPECPPELYALMSD----CWIYKWEDRPDFLTVEQ 265
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 75/275 (27%), Positives = 131/275 (47%), Gaps = 35/275 (12%)
Query: 350 KDVIGRGGFGKVYRGVL-----ASNVQIAVK--KVSHDSKQGIKEFVAELVSMGRLRHRN 402
+ VIG G FG+VY+G+L V +A+K K + KQ +F+ E MG+ H N
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR-VDFLGEAGIMGQFSHHN 107
Query: 403 LVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHED 462
+++L G + +++ +YM NG+LDK L + Q ++RG+A+G+ YL
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLA-- 164
Query: 463 WEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY--MDPELMR 520
+HRD+ N+L++++L K+ DFGL+R+ + D T G PE +
Sbjct: 165 -NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223
Query: 521 TGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRL 579
K ++++DV++FG+ M EV + G RP + + E + ++ RL
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN--------------DGFRL 269
Query: 580 EG--ICEEKQMELVLKLGLFCSHPKPEARPNMRQV 612
C +L+++ C + RP +
Sbjct: 270 PTPMDCPSAIYQLMMQ----CWQQERARRPKFADI 300
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-36
Identities = 55/213 (25%), Positives = 104/213 (48%), Gaps = 10/213 (4%)
Query: 351 DVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYC 410
+G G FG+V+ + ++AVK + S + F+AE M L+H LVKL
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 411 RRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHR 470
++ ++ ++M GSL L ++ + +A G+ ++ + + +HR
Sbjct: 253 TKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHR 308
Query: 471 DIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY--MDPELMRTGKASTST 528
D++ AN+L+ A L K+ DFGLAR+ + + T + F PE + G + +
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDNE--YTAREGAKFPIKWTAPEAINFGSFTIKS 366
Query: 529 DVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVD 560
DV++FG+ ++E+ + GR P + E + ++
Sbjct: 367 DVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 8e-36
Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 14/217 (6%)
Query: 352 VIGRGGFGKVYRGVL---ASNVQIAVK--KVSHDSKQGIKEFVAELVSMGRLRHRNLVKL 406
+G G FG V +G +AVK K + E +AE M +L + +V++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 407 RGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQV 466
G C + ++LV + G L+K L N + ++ V+ G+ YL E E
Sbjct: 84 IGICEAES-WMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYL-E--ESN 137
Query: 467 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF--GYMDPELMRTGKA 524
+HRD+ NVLL K+ DFGL++ D + G + + PE + K
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 197
Query: 525 STSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVD 560
S+ +DV++FGV M E S G++P E +++
Sbjct: 198 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 234
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-35
Identities = 72/273 (26%), Positives = 119/273 (43%), Gaps = 35/273 (12%)
Query: 350 KDVIGRGGFGKVYRGVL----ASNVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLV 404
++G G FG+VY GV + +AVK D + ++F++E V M L H ++V
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 405 KLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWE 464
KL G + ++ + P G L L N K L + + YL
Sbjct: 77 KLIGIIEEE-PTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLES--- 131
Query: 465 QVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQT-TKLVGTFGYMDPELMRTG 522
+HRDI N+L+ + KLGDFGL+R + D D + T+L +M PE +
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPESINFR 189
Query: 523 KASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE- 580
+ +T++DV+ F V M E+ S G++P + + + +++ KG RL
Sbjct: 190 RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-------KG-------DRLPK 235
Query: 581 -GICEEKQMELVLKLGLFCSHPKPEARPNMRQV 612
+C L+ + C P RP ++
Sbjct: 236 PDLCPPVLYTLMTR----CWDYDPSDRPRFTEL 264
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 58/290 (20%), Positives = 116/290 (40%), Gaps = 59/290 (20%)
Query: 350 KDVIGRGGFGKVYRGVL--------ASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHR 401
+ +G+G F K+++GV ++ +K + + + F M +L H+
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 402 NLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHE 461
+LV G C E +LV +++ GSLD L N K C+N + + + +A+ + +L
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLE- 130
Query: 462 DWEQVVLHRDIKPANVLLDADLNG--------KLGDFGLAR-LYDHDTIPQTTKLVGTFG 512
E ++H ++ N+LL + + KL D G++ + D
Sbjct: 131 --ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------------I 176
Query: 513 Y------MDPELMRTGKA-STSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCD 564
+ PE + K + +TD ++FG + E+ S G +P+ S + +
Sbjct: 177 LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE---- 232
Query: 565 CWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+L + L+ C +P+ RP+ R +++
Sbjct: 233 ----------DRHQLPAPKAAELANLINN----CMDYEPDHRPSFRAIIR 268
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 16/210 (7%)
Query: 348 KDKDVIGRGGFGKVYRGVLA----SNVQIAVK--KVSHDSKQGIKEFVAELVSMGRLRHR 401
VIG+G FG VY G + +Q A+K + +Q ++ F+ E + M L H
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQ-VEAFLREGLLMRGLNHP 82
Query: 402 NLVKLRGYC-RRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLH 460
N++ L G +G ++ YM +G L + + + + VA G+ YL
Sbjct: 83 NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLA 141
Query: 461 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTF--GYMDPE 517
E Q +HRD+ N +LD K+ DFGLAR + D + + E
Sbjct: 142 E---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE 198
Query: 518 LMRTGKASTSTDVYAFGVFMLEVAS-GRRP 546
++T + +T +DV++FGV + E+ + G P
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 55/202 (27%), Positives = 100/202 (49%), Gaps = 13/202 (6%)
Query: 350 KDVIGRGGFGKVYRGVL-----ASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLV 404
+G+G FG V + +AVKK+ H +++ +++F E+ + L+H N+V
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 405 KLRGYCRRKGE--FLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHED 462
K +G C G L+ +Y+P GSL L + K ++ + + + G+ YL
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLG-- 131
Query: 463 WEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF--GYMDPELMR 520
+ +HRD+ N+L++ + K+GDFGL ++ D K G + PE +
Sbjct: 132 -TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190
Query: 521 TGKASTSTDVYAFGVFMLEVAS 542
K S ++DV++FGV + E+ +
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-35
Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 17/205 (8%)
Query: 351 DVIGRGGFGKVYRGVLAS----NVQIAVK--KVSHDSKQGIKEFVAELVSMGRLRHRNLV 404
IG G FG V++G+ S + +A+K K ++F+ E ++M + H ++V
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV-REKFLQEALTMRQFDHPHIV 79
Query: 405 KLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWE 464
KL G ++ + G L L K L+ +++ L YL
Sbjct: 80 KLIGVITEN-PVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLES--- 134
Query: 465 QVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQT-TKLVGTFGYMDPELMRTG 522
+ +HRDI NVL+ ++ KLGDFGL+R + D + KL +M PE +
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFR 192
Query: 523 KASTSTDVYAFGVFMLEVAS-GRRP 546
+ ++++DV+ FGV M E+ G +P
Sbjct: 193 RFTSASDVWMFGVCMWEILMHGVKP 217
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-35
Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 18/213 (8%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNL 403
++ IG G +G+ + + + K++ + ++ + V+E+ + L+H N+
Sbjct: 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 404 VKLRG--YCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRF------RIIRGVASG 455
V+ R +V +Y G L + I Q R++ +
Sbjct: 68 VRYYDRIIDRTNTTLYIVMEYCEGGDLASV----ITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 456 LLYLHE--DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 513
L H D VLHRD+KPANV LD N KLGDFGLAR+ +HDT VGT Y
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS-FAKTFVGTPYY 182
Query: 514 MDPELMRTGKASTSTDVYAFGVFMLEVASGRRP 546
M PE M + +D+++ G + E+ + P
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-35
Identities = 64/299 (21%), Positives = 118/299 (39%), Gaps = 48/299 (16%)
Query: 351 DVIGRGGFGKVYRGVLAS-----NVQIAVK--KVSHDSKQGIKEFVAELVSMGRLRHRNL 403
V+G G FG VY+G+ + +A+K + + K KE + E M + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNPHV 79
Query: 404 VKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDW 463
+L G C L+ MP G L + + K + +A G+ YL +
Sbjct: 80 CRLLGICLTS-TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLED-- 135
Query: 464 EQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT---FGYMDPELMR 520
+ ++HRD+ NVL+ + K+ DFGLA+L + + G +M E +
Sbjct: 136 -RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWMALESIL 192
Query: 521 TGKASTSTDVYAFGVFMLEVAS-GRRP------------VEQQGSME-----TVNLVDWV 562
+ +DV+++GV + E+ + G +P +E+ + T+++ +
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIM 252
Query: 563 CDCWKKGAIRDASD--------SRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVM 613
CW DA + + Q LV++ P P R +M
Sbjct: 253 VKCWMI----DADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALM 307
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-35
Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 14/205 (6%)
Query: 352 VIGRGGFGKVYRGVL-----ASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKL 406
+G+G FG V + +AVK++ H ++F E+ + L +VK
Sbjct: 30 QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 407 RGYCRRKGE--FLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWE 464
RG G LV +Y+P+G L L + + L+ + + G+ YL
Sbjct: 90 RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYLG---S 145
Query: 465 QVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF--GYMDPELMRTG 522
+ +HRD+ N+L++++ + K+ DFGLA+L D + G + PE +
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 205
Query: 523 KASTSTDVYAFGVFMLEVAS-GRRP 546
S +DV++FGV + E+ + +
Sbjct: 206 IFSRQSDVWSFGVVLYELFTYCDKS 230
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 9e-35
Identities = 55/202 (27%), Positives = 100/202 (49%), Gaps = 13/202 (6%)
Query: 350 KDVIGRGGFGKVYRGVL-----ASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLV 404
+G+G FG V + +AVKK+ H +++ +++F E+ + L+H N+V
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 405 KLRGYCRRKGE--FLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHED 462
K +G C G L+ +Y+P GSL L + K ++ + + + G+ YL
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLG-- 162
Query: 463 WEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF--GYMDPELMR 520
+ +HRD+ N+L++ + K+GDFGL ++ D K G + PE +
Sbjct: 163 -TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 221
Query: 521 TGKASTSTDVYAFGVFMLEVAS 542
K S ++DV++FGV + E+ +
Sbjct: 222 ESKFSVASDVWSFGVVLYELFT 243
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 1e-34
Identities = 70/271 (25%), Positives = 114/271 (42%), Gaps = 34/271 (12%)
Query: 350 KDVIGRGGFGKVYRGVL----ASNVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRN 402
+ +G G FG V RG V +AVK + D + + +F+ E+ +M L HRN
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 403 LVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHED 462
L++L G +V + P GSL L + + R VA G+ YL
Sbjct: 83 LIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLES- 139
Query: 463 WEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY--MDPELMR 520
+ +HRD+ N+LL K+GDFGL R + + + PE ++
Sbjct: 140 --KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 197
Query: 521 TGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRL 579
T S ++D + FGV + E+ + G+ P + ++ +D K+G RL
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID------KEGE-------RL 244
Query: 580 E--GICEEKQMELVLKLGLFCSHPKPEARPN 608
C + ++++ C KPE RP
Sbjct: 245 PRPEDCPQDIYNVMVQ----CWAHKPEDRPT 271
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 64/271 (23%), Positives = 111/271 (40%), Gaps = 39/271 (14%)
Query: 350 KDVIGRGGFGKVYRGVLAS-----NVQIAVK--KVSHDSKQGIKEFVAELVSMGRLRHRN 402
V+G G FG V++GV + + +K + + + ++++G L H +
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQS-FQAVTDHMLAIGSLDHAH 76
Query: 403 LVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHED 462
+V+L G C LV Y+P GSL + + + L +A G+ YL E
Sbjct: 77 IVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEE- 133
Query: 463 WEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT---FGYMDPELM 519
++HR++ NVLL + ++ DFG+A L D + +M E +
Sbjct: 134 --HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD--KQLLYSEAKTPIKWMALESI 189
Query: 520 RTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSR 578
GK + +DV+++GV + E+ + G P E +L++ KG R
Sbjct: 190 HFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-------KG-------ER 235
Query: 579 LE--GICEEKQMELVLKLGLFCSHPKPEARP 607
L IC +++K C RP
Sbjct: 236 LAQPQICTIDVYMVMVK----CWMIDENIRP 262
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-34
Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 28/212 (13%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVK 405
+ +GRG FG+V+R + Q AVKKV + + V ELV+ L +V
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVP 114
Query: 406 LRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFR------IIRGVASGLLYL 459
L G R + + + GSL +++ + GL YL
Sbjct: 115 LYGAVREGPWVNIFMELLEGGSLGQLIKQ--------MGCLPEDRALYYLGQALEGLEYL 166
Query: 460 HEDWEQVVLHRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTK----LVGTFGYM 514
H + +LH D+K NVLL +D + L DFG A D + ++ + GT +M
Sbjct: 167 HT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHM 223
Query: 515 DPELMRTGKASTSTDVYAFGVFMLEVASGRRP 546
PE++ D+++ ML + +G P
Sbjct: 224 APEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-34
Identities = 68/274 (24%), Positives = 116/274 (42%), Gaps = 32/274 (11%)
Query: 350 KDVIGRGGFGKVYRGVLAS---NVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVK 405
+G G FG V +GV + +A+K + K +E + E M +L + +V+
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 406 LRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQ 465
L G C+ + +LV + G L K L + + ++ V+ G+ YL E +
Sbjct: 401 LIGVCQAE-ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE---K 455
Query: 466 VVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY--MDPELMRTGK 523
+HR++ NVLL K+ DFGL++ D T + G + PE + K
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 524 ASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEG- 581
S+ +DV+++GV M E S G++P ++ E + ++ R+E
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE--------------QGKRMECP 561
Query: 582 -ICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
C + L+ C K E RP+ V Q
Sbjct: 562 PECPPELYALMSD----CWIYKWEDRPDFLTVEQ 591
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-34
Identities = 62/229 (27%), Positives = 102/229 (44%), Gaps = 16/229 (6%)
Query: 330 YGPQRFTYKDLYKATKGF-KDKDVIGRGGFGKVYRGVLA-----SNVQIAVKKV-SHDSK 382
+ T D K F K +G G FGKV + Q+AVK +
Sbjct: 5 SEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG 64
Query: 383 QGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGE--FLLVYDYMPNGSLDKILHTNIKPCL 440
I + E+ + L H N+VK +G C G L+ +++P+GSL + L N K +
Sbjct: 65 NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN-KNKI 123
Query: 441 NWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500
N Q+ + + G+ YL + +HRD+ NVL++++ K+GDFGL + + D
Sbjct: 124 NLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180
Query: 501 IPQTTKLVGTF--GYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRP 546
T K + PE + K ++DV++FGV + E+ +
Sbjct: 181 EYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSD 229
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 7e-34
Identities = 70/309 (22%), Positives = 123/309 (39%), Gaps = 40/309 (12%)
Query: 314 VRNKRYEEVYEDWEREYGPQRFTYKDLYKATKGFKDKDV-----IGRGGFGKVYRGVLAS 368
VR+ D E + TY + + + IG G FG V++G+ S
Sbjct: 354 VRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMS 413
Query: 369 ----NVQIAVK--KVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422
+ +A+K K ++F+ E ++M + H ++VKL G ++ +
Sbjct: 414 PENPAMAVAIKTCKNCTSDSV-REKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMEL 471
Query: 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDAD 482
G L L K L+ +++ L YL + +HRDI NVL+ ++
Sbjct: 472 CTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSN 527
Query: 483 LNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVA 541
KLGDFGL+R + D + + +M PE + + ++++DV+ FGV M E+
Sbjct: 528 DCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586
Query: 542 S-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE--GICEEKQMELVLKLGLFC 598
G +P + + + + ++ + RL C L+ K C
Sbjct: 587 MHGVKPFQGVKNNDVIGRIE--------------NGERLPMPPNCPPTLYSLMTK----C 628
Query: 599 SHPKPEARP 607
P RP
Sbjct: 629 WAYDPSRRP 637
|
| >1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... Length = 237 | Back alignment and structure |
|---|
Score = 128 bits (321), Expect = 9e-34
Identities = 38/129 (29%), Positives = 61/129 (47%), Gaps = 16/129 (12%)
Query: 131 NHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGDPI 190
+ I+A+ELDT N D D H+GID+ S+ S ++A + G
Sbjct: 2 DTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAK-------------WNMQNGKVG 48
Query: 191 QIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLKSSHY 250
I Y+ +K L+ ++ P +S ++L ++L E + VG SASTG K ++
Sbjct: 49 TAHIIYNSVDKRLSAVVSY---PNADSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNT 105
Query: 251 VLGWSFNRS 259
+L WSF
Sbjct: 106 ILSWSFTSK 114
|
| >1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... Length = 237 | Back alignment and structure |
|---|
Score = 75.7 bits (185), Expect = 1e-15
Identities = 36/134 (26%), Positives = 51/134 (38%), Gaps = 17/134 (12%)
Query: 6 RSFCFCVLLCASFIFSALAQDVNQFIYHGFNEDAQLQRDGLASVHSNGLLQLTNTVS--- 62
S+ F L ++ A + +D LQ D A+ ++G L+LT S
Sbjct: 107 LSWSFTSKLKSNSTHETNALHFMFNQFSKDQKDLILQGD--ATTGTDGNLELTRVSSNGS 164
Query: 63 --PQQEGHAFYRLPIKFNTSSSESLSFSSNFVFAI---------GMAFVISPSKDLGKAE 111
G A + P+ SS+ SF + F F I G+AF IS D
Sbjct: 165 PQGSSVGRALFYAPVHIWESSAVVASFEATFTFLIKSPDSHPADGIAFFISNI-DSSIPS 223
Query: 112 ASPSEYLGLFNASN 125
S LGLF +N
Sbjct: 224 GSTGRLLGLFPDAN 237
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 69/291 (23%), Positives = 124/291 (42%), Gaps = 54/291 (18%)
Query: 352 VIGRGGFGKVYRGVL------ASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVK 405
+G G FGKV+ + +AVK + S+ ++F E + L+H+++V+
Sbjct: 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 406 LRGYCRRKGEFLLVYDYMPNGSLDKIL-------------HTNIKPCLNWYQRFRIIRGV 452
G C L+V++YM +G L++ L L Q + V
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 453 ASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTF 511
A+G++YL +HRD+ N L+ L K+GDFG++R +Y D G
Sbjct: 168 AAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY---YRV--GGR 219
Query: 512 G-----YMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDC 565
+M PE + K +T +DV++FGV + E+ + G++P Q + E ++ +
Sbjct: 220 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI------ 273
Query: 566 WKKGAIRDASDSRLE--GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+G LE C + ++ C +P+ R +++ V
Sbjct: 274 -TQG-------RELERPRACPPEVYAIMRG----CWQREPQQRHSIKDVHA 312
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-33
Identities = 61/294 (20%), Positives = 110/294 (37%), Gaps = 47/294 (15%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQ-GIKEFVAELVSMGRLRHRNLV 404
F+ +GRGGFG V+ + A+K++ +++ ++ + E+ ++ +L H +V
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 405 KLRGY---------CRRKGEFLLVY---DYMPNGSL-DKILHTNIKPCLNWYQRFRIIRG 451
+ + + +Y +L D + I
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 452 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT------ 505
+A + +LH + ++HRD+KP+N+ D K+GDFGL D D QT
Sbjct: 127 IAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 506 -----KLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVD 560
VGT YM PE + S D+++ G+ + E+ P ME V
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YPFS--TQMERVRT-- 236
Query: 561 WVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+R+ L + +V + L P P RP +++
Sbjct: 237 -----LTD--VRNLKFPPLFTQKYPCEYVMVQDM-L---SPSPMERPEAINIIE 279
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-33
Identities = 61/264 (23%), Positives = 105/264 (39%), Gaps = 53/264 (20%)
Query: 350 KDVIGRGGFGKVYRGVL------ASNVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRN 402
+ +G FGKVY+G L +A+K + +EF E + RL+H N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 403 LVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTN--------------IKPCLNWYQRFRI 448
+V L G + +++ Y +G L + L +K L +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 449 IRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKL 507
+ +A+G+ YL V+H+D+ NVL+ LN K+ D GL R +Y D
Sbjct: 134 VAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN- 189
Query: 508 VGTFG-----YMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRP------------VEQ 549
+M PE + GK S +D++++GV + EV S G +P +
Sbjct: 190 ----SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRN 245
Query: 550 QGSME-----TVNLVDWVCDCWKK 568
+ + + + +CW +
Sbjct: 246 RQVLPCPDDCPAWVYALMIECWNE 269
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 56/219 (25%), Positives = 101/219 (46%), Gaps = 30/219 (13%)
Query: 350 KDVIGRGGFGKVYRGVL----ASNVQIAVK--KVSHDSKQGIKEFVAELVSMGRLRHRNL 403
++G G FG V G L +++++AVK K+ + S++ I+EF++E M H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 404 VKLRGYC-----RRKGEFLLVYDYMPNGSLDKIL----HTNIKPCLNWYQRFRIIRGVAS 454
++L G C + + +++ +M G L L + + + +A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 455 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFG- 512
G+ YL + LHRD+ N +L D+ + DFGL++ +Y D Q
Sbjct: 159 GMEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRI-----AK 210
Query: 513 ----YMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRP 546
++ E + ++ +DV+AFGV M E+A+ G P
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 57/217 (26%), Positives = 92/217 (42%), Gaps = 25/217 (11%)
Query: 350 KDVIGRGGFGKVYRGVL----ASNVQIAVK--KVSHDSKQGIKEFVAELVSMGRLRHRNL 403
++G+G FG V L S V++AVK K + I+EF+ E M H ++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 404 VKLRGYCRRKG------EFLLVYDYMPNGSLDKIL----HTNIKPCLNWYQRFRIIRGVA 453
KL G R +++ +M +G L L L R + +A
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 454 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTF- 511
G+ YL + +HRD+ N +L D+ + DFGL+R +Y D Q
Sbjct: 148 CGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCA--SKLP 202
Query: 512 -GYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRP 546
++ E + + +DV+AFGV M E+ + G+ P
Sbjct: 203 VKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 54/204 (26%), Positives = 85/204 (41%), Gaps = 12/204 (5%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHD--SKQGIKEFVAELVSMGRL-RHRN 402
F+ +G G +G+V++ AVK+ + +AE+ S ++ +H
Sbjct: 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118
Query: 403 LVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHED 462
V+L G L + SL + L Q + +R L +LH
Sbjct: 119 CVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGAS-LPEAQVWGYLRDTLLALAHLHS- 175
Query: 463 WEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTG 522
Q ++H D+KPAN+ L KLGDFGL + G YM PEL++ G
Sbjct: 176 --QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV--QEGDPRYMAPELLQ-G 230
Query: 523 KASTSTDVYAFGVFMLEVASGRRP 546
T+ DV++ G+ +LEVA
Sbjct: 231 SYGTAADVFSLGLTILEVACNMEL 254
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 70/282 (24%), Positives = 114/282 (40%), Gaps = 44/282 (15%)
Query: 352 VIGRGGFGKVYRGVL------ASNVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLV 404
+G G FG+VY G + S +Q+AVK + S+Q +F+ E + + + H+N+V
Sbjct: 37 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 405 KLRGYCRRKGEFLLVYDYMPNGSLDKIL-----HTNIKPCLNWYQRFRIIRGVASGLLYL 459
+ G + ++ + M G L L + L + R +A G YL
Sbjct: 97 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 460 HEDWEQVVLHRDIKPANVLLDA---DLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFG--Y 513
E +HRDI N LL K+GDFG+AR +Y + +
Sbjct: 157 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC--AMLPVKW 211
Query: 514 MDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIR 572
M PE G ++ TD ++FGV + E+ S G P + + E + V G
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV-------TSG--- 261
Query: 573 DASDSRLE--GICEEKQMELVLKLGLFCSHPKPEARPNMRQV 612
R++ C ++ + C +PE RPN +
Sbjct: 262 ----GRMDPPKNCPGPVYRIMTQ----CWQHQPEDRPNFAII 295
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-33
Identities = 71/316 (22%), Positives = 129/316 (40%), Gaps = 62/316 (19%)
Query: 321 EVYEDWEREYGPQRFTYKDLYKATKGFKDKDVIGRGGFGKVYRGVL------ASNVQIAV 374
+VY E E ++ T +G+G FG VY GV ++A+
Sbjct: 13 DVYVPDEWEVAREKITMSR------------ELGQGSFGMVYEGVAKGVVKDEPETRVAI 60
Query: 375 KKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKIL- 432
K V+ S + EF+ E M ++V+L G + L++ + M G L L
Sbjct: 61 KTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR 120
Query: 433 -------HTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG 485
+ + + + ++ +A G+ YL+ +HRD+ N ++ D
Sbjct: 121 SLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTV 177
Query: 486 KLGDFGLAR-LYDHDTIPQTTKLVGTFGY-----MDPELMRTGKASTSTDVYAFGVFMLE 539
K+GDFG+ R +Y+ D + K G M PE ++ G +T +DV++FGV + E
Sbjct: 178 KIGDFGMTRDIYETDYYRKGGK-----GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE 232
Query: 540 VAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE--GICEEKQMELVLKLGL 596
+A+ +P + + + + V +G L+ C + EL+
Sbjct: 233 IATLAEQPYQGLSNEQVLRFV-------MEG-------GLLDKPDNCPDMLFELMRM--- 275
Query: 597 FCSHPKPEARPNMRQV 612
C P+ RP+ ++
Sbjct: 276 -CWQYNPKMRPSFLEI 290
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-33
Identities = 57/291 (19%), Positives = 95/291 (32%), Gaps = 45/291 (15%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVK 405
+ +G GGF V L A+K++ +Q +E E H N+++
Sbjct: 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90
Query: 406 LRGYCRR----KGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRF------RIIRGVASG 455
L YC R K E L+ + G+L I+ + ++ G+ G
Sbjct: 91 LVAYCLRERGAKHEAWLLLPFFKRGTLWNE----IERLKDKGNFLTEDQILWLLLGICRG 146
Query: 456 LLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL-------- 507
L +H + HRD+KP N+LL + L D G L
Sbjct: 147 LEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQ 203
Query: 508 VGTFGYMDPELMRT---GKASTSTDVYAFGVFMLEVASGRRPVEQQG-SMETVNLVDWVC 563
T Y PEL TDV++ G + + G P + ++V L
Sbjct: 204 RCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA---- 259
Query: 564 DCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+ + R + +L P RP++ ++
Sbjct: 260 ---VQNQLSIPQSPRH-----SSALWQLLN---SMMTVDPHQRPHIPLLLS 299
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 9e-33
Identities = 69/300 (23%), Positives = 126/300 (42%), Gaps = 56/300 (18%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVK 405
F++ V+G+G FG+V + + A+KK+ H ++ + ++E++ + L H+ +V+
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVR 66
Query: 406 LRG------------YCRRKGEFL-LVYDYMPNGSL-DKILHTNIKPCLNWYQRFRIIRG 451
+K L + +Y NG+L D I N+ + +R+ R
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN--QQRDEYWRLFRQ 124
Query: 452 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT------- 504
+ L Y+H Q ++HRD+KP N+ +D N K+GDFGLA+
Sbjct: 125 ILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 505 ------TKLVGTFGYMDPELMR-TGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVN 557
T +GT Y+ E++ TG + D+Y+ G+ E+ ME VN
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFST-----GMERVN 236
Query: 558 LVDWVCDCWKKGAIRDAS---DSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+ KK +R S + + + +++ L + P RP R ++
Sbjct: 237 I-------LKK--LRSVSIEFPPDFDDNKMKVEKKIIRLL-I---DHDPNKRPGARTLLN 283
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 9e-33
Identities = 52/234 (22%), Positives = 99/234 (42%), Gaps = 27/234 (11%)
Query: 331 GPQRFTYKDLYKATKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHD--SKQGIKEF 388
G + ++ + + + IG GG KV++ + A+K V+ + Q + +
Sbjct: 14 GTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSY 73
Query: 389 VAELVSMGRLRHRNL--VKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRF 446
E+ + +L+ + ++L Y +V + N L+ L K ++ ++R
Sbjct: 74 RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKK--KKSIDPWERK 130
Query: 447 RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG--KLGDFGLARLYDHDTIPQT 504
+ + + +H + ++H D+KPAN L+ +G KL DFG+A DT
Sbjct: 131 SYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVV 184
Query: 505 TK-LVGTFGYMDPELMR-----------TGKASTSTDVYAFGVFMLEVASGRRP 546
VGT YM PE ++ K S +DV++ G + + G+ P
Sbjct: 185 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 74/286 (25%), Positives = 130/286 (45%), Gaps = 49/286 (17%)
Query: 353 IGRGGFGKVYRGVL------ASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKL 406
+G G FGKV+ + +AVK + + K+F E + L+H ++VK
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 407 RGYCRRKGEFLLVYDYMPNGSLDKILHTN--------------IKPCLNWYQRFRIIRGV 452
G C ++V++YM +G L+K L + K L Q I +
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 453 ASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTF 511
ASG++YL Q +HRD+ N L+ A+L K+GDFG++R +Y D
Sbjct: 143 ASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH--TML 197
Query: 512 --GYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKK 568
+M PE + K +T +DV++FGV + E+ + G++P Q + E + + +
Sbjct: 198 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI-------TQ 250
Query: 569 GAIRDASDSRLE--GICEEKQMELVLKLGLFCSHPKPEARPNMRQV 612
G LE +C ++ +++L C +P+ R N++++
Sbjct: 251 G-------RVLERPRVCPKEVYDVMLG----CWQREPQQRLNIKEI 285
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 71/282 (25%), Positives = 115/282 (40%), Gaps = 44/282 (15%)
Query: 352 VIGRGGFGKVYRGVL------ASNVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLV 404
+G G FG+VY G + S +Q+AVK + S+Q +F+ E + + + H+N+V
Sbjct: 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 405 KLRGYCRRKGEFLLVYDYMPNGSLDKIL-----HTNIKPCLNWYQRFRIIRGVASGLLYL 459
+ G + ++ + M G L L + L + R +A G YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 460 HEDWEQVVLHRDIKPANVLLDADLNG---KLGDFGLAR-LYDHDTIPQTTKLVGTFG--Y 513
E +HRDI N LL G K+GDFG+AR +Y + +
Sbjct: 198 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGC--AMLPVKW 252
Query: 514 MDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIR 572
M PE G ++ TD ++FGV + E+ S G P + + E + V G
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV-------TSG--- 302
Query: 573 DASDSRLE--GICEEKQMELVLKLGLFCSHPKPEARPNMRQV 612
R++ C ++ + C +PE RPN +
Sbjct: 303 ----GRMDPPKNCPGPVYRIMTQ----CWQHQPEDRPNFAII 336
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 51/220 (23%), Positives = 94/220 (42%), Gaps = 27/220 (12%)
Query: 345 KGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRN 402
+ + IG GG KV++ + A+K V+ + Q + + E+ + +L+ +
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 403 L--VKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLH 460
++L Y +V + N L+ L K ++ ++R + + + +H
Sbjct: 69 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIH 125
Query: 461 EDWEQVVLHRDIKPANVLLDADLNG--KLGDFGLARLYDHDTIPQTTK-LVGTFGYMDPE 517
+ ++H D+KPAN L+ +G KL DFG+A DT VGT YM PE
Sbjct: 126 ---QHGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179
Query: 518 LMR-----------TGKASTSTDVYAFGVFMLEVASGRRP 546
++ K S +DV++ G + + G+ P
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 17/208 (8%)
Query: 350 KDVIGRGGFGKVYRGVL-----ASNVQIAVKKV-SHDSKQGIKEFVAELVSMGRLRHRNL 403
+G G FGKV + +AVK + + Q + E+ + L H ++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 404 VKLRGYCRRKGE--FLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHE 461
+K +G C G LV +Y+P GSL L + + Q + + G+ YLH
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHA 152
Query: 462 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF--GYMDPELM 519
Q +HRD+ NVLLD D K+GDFGLA+ + G + PE +
Sbjct: 153 ---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 209
Query: 520 RTGKASTSTDVYAFGVFMLEVAS-GRRP 546
+ K ++DV++FGV + E+ +
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLTHCDSS 237
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 50/220 (22%), Positives = 93/220 (42%), Gaps = 27/220 (12%)
Query: 345 KGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRN 402
+ + IG GG KV++ + A+K V+ + Q + + E+ + +L+ +
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 403 L--VKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLH 460
++L Y +V + N L+ L K ++ ++R + + + +H
Sbjct: 116 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIH 172
Query: 461 EDWEQVVLHRDIKPANVLLDADLNG--KLGDFGLARLYDHDTIPQTTK-LVGTFGYMDPE 517
+ ++H D+KPAN L+ +G KL DFG+A DT VG YM PE
Sbjct: 173 ---QHGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226
Query: 518 LMR-----------TGKASTSTDVYAFGVFMLEVASGRRP 546
++ K S +DV++ G + + G+ P
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-32
Identities = 50/201 (24%), Positives = 96/201 (47%), Gaps = 11/201 (5%)
Query: 351 DVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVA----ELVSMGRLRHRNLVK 405
D +G GG VY N+++A+K + +E + E+ + +L H+N+V
Sbjct: 17 DKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 406 LRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQ 465
+ + LV +Y+ +L + + ++ L+ + G+ + H+
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAHD---M 130
Query: 466 VVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKAS 525
++HRDIKP N+L+D++ K+ DFG+A+ ++ QT ++GT Y PE +
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATD 190
Query: 526 TSTDVYAFGVFMLEVASGRRP 546
TD+Y+ G+ + E+ G P
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPP 211
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-32
Identities = 58/223 (26%), Positives = 98/223 (43%), Gaps = 37/223 (16%)
Query: 350 KDVIGRGGFGKVYRGVL---ASNVQIAVK--KVSHDSKQGIKEFVAELVSMGRL-RHRNL 403
+DVIG G FG+V + + + A+K K ++F EL + +L H N+
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD-HRDFAGELEVLCKLGHHPNI 88
Query: 404 VKLRGYCRRKGEFLLVYDYMPNGSLDKILHTN--------------IKPCLNWYQRFRII 449
+ L G C +G L +Y P+G+L L + L+ Q
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 450 RGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVG 509
VA G+ YL ++ +HRD+ N+L+ + K+ DFGL+R + + T
Sbjct: 149 ADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTM--- 200
Query: 510 TFG-----YMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRP 546
G +M E + +T++DV+++GV + E+ S G P
Sbjct: 201 --GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 54/201 (26%), Positives = 82/201 (40%), Gaps = 11/201 (5%)
Query: 351 DVIGRGGFGKVYRGV-LASNVQIAVK----KVSHDSKQGIKEFVAELVSMGRLRHRNLVK 405
++GRGG G VY +A+K +S D E + GRL+ ++V
Sbjct: 40 RLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDP-VFRTRMQREARTAGRLQEPHVVP 98
Query: 406 LRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQ 465
+ + G+ + + L +L L + I+R + S L H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHA---A 153
Query: 466 VVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKAS 525
HRD+KP N+L+ AD L DFG+A + + Q VGT YM PE A+
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHAT 213
Query: 526 TSTDVYAFGVFMLEVASGRRP 546
D+YA + E +G P
Sbjct: 214 YRADIYALTCVLYECLTGSPP 234
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 51/202 (25%), Positives = 98/202 (48%), Gaps = 10/202 (4%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVK 405
+ + IG+G G VY + +A+ ++A+++++ + + + E++ M ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 406 LRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQ 465
E +V +Y+ GSL ++ C++ Q + R L +LH
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---N 135
Query: 466 VVLHRDIKPANVLLDADLNGKLGDFGL-ARLYDHDTIPQTTKLVGTFGYMDPELMRTGKA 524
V+HRDIK N+LL D + KL DFG A++ + + +VGT +M PE++
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 525 STSTDVYAFGVFMLEVASGRRP 546
D+++ G+ +E+ G P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP 215
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 10/202 (4%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVK 405
IG G G V S Q+AVK + +Q + E+V M +H N+V+
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 406 LRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQ 465
+ E ++ +++ G+L I+ LN Q + V L YLH Q
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHA---Q 160
Query: 466 VVLHRDIKPANVLLDADLNGKLGDFGL-ARLYDHDTIPQTTKLVGTFGYMDPELMRTGKA 524
V+HRDIK ++LL D KL DFG A++ +P+ LVGT +M PE++
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQI--SKDVPKRKSLVGTPYWMAPEVISRSLY 218
Query: 525 STSTDVYAFGVFMLEVASGRRP 546
+T D+++ G+ ++E+ G P
Sbjct: 219 ATEVDIWSLGIMVIEMVDGEPP 240
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-30
Identities = 60/211 (28%), Positives = 93/211 (44%), Gaps = 17/211 (8%)
Query: 350 KDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVA-ELVSMGRLRHRNLVKL- 406
K+ +G GGFG V R + + Q+A+K+ + +E E+ M +L H N+V
Sbjct: 19 KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 407 -----RGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPC-LNWYQRFRIIRGVASGLLYLH 460
LL +Y G L K L+ C L ++ ++S L YLH
Sbjct: 79 EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 138
Query: 461 EDWEQVVLHRDIKPANVLLDADLNG---KLGDFGLARLYDHDTIPQTTKLVGTFGYMDPE 517
E ++HRD+KP N++L K+ D G A+ D + VGT Y+ PE
Sbjct: 139 E---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE--FVGTLQYLAPE 193
Query: 518 LMRTGKASTSTDVYAFGVFMLEVASGRRPVE 548
L+ K + + D ++FG E +G RP
Sbjct: 194 LLEQKKYTVTVDYWSFGTLAFECITGFRPFL 224
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 23/221 (10%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSK-QGIKEFVAEL-VSMGRLRHRNL 403
KD IGRG +G V + V S +AVK++ + K+ + +L V M +
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYI 83
Query: 404 VKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRF------RIIRGVASGLL 457
V+ G R+G+ + + M + S DK +I L
Sbjct: 84 VQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLD---DVIPEEILGKITLATVKALN 139
Query: 458 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGL-ARLYDHDTIPQTTKLVGTFGYMDP 516
+L E ++HRDIKP+N+LLD N KL DFG+ +L D+I +T G YM P
Sbjct: 140 HLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL--VDSIAKTRD-AGCRPYMAP 194
Query: 517 ELMRTGKA----STSTDVYAFGVFMLEVASGRRPVEQQGSM 553
E + + +DV++ G+ + E+A+GR P + S+
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV 235
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 60/301 (19%), Positives = 108/301 (35%), Gaps = 67/301 (22%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKV------SHDSKQGIKEFVAELVSMGRLR 399
F + + IG G FG V++ V A+K+ S D + ++E V +G+
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALRE-VYAHAVLGQ-- 69
Query: 400 HRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRF------RIIRGVA 453
H ++V+ L+ +Y GSL I F ++ V
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADA----ISENYRIMSYFKEAELKDLLLQVG 125
Query: 454 SGLLYLHEDWEQVVLHRDIKPANVLLDAD-------------------LNGKLGDFGLAR 494
GL Y+H ++H DIKP+N+ + + K+GD G
Sbjct: 126 RGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182
Query: 495 LYDHDTIPQTTKLVGTFGYMDPELMRTGKA-STSTDVYAFGVFMLEVASGRRPVEQQGSM 553
PQ G ++ E+++ D++A + ++ A P+ + G
Sbjct: 183 RISS---PQV--EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA-EPLPRNGDQ 236
Query: 554 ETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVM 613
W + IR R+ + ++ EL+ HP PE RP+ ++
Sbjct: 237 ------------WHE--IRQGRLPRIPQVLSQEFTELLKV----MIHPDPERRPSAMALV 278
Query: 614 Q 614
+
Sbjct: 279 K 279
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 3e-30
Identities = 55/202 (27%), Positives = 99/202 (49%), Gaps = 9/202 (4%)
Query: 347 FKDKDVIGRGGFGKVYRGVL-ASNVQIAVKKVSHDSKQG-IKEFVAELVSMGRLRHRNLV 404
F+ +G G G V++ S + +A K + + K + + EL + +V
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 405 KLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWE 464
G GE + ++M GSLD++L + ++ V GL YL E +
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLRE--K 150
Query: 465 QVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKA 524
++HRD+KP+N+L+++ KL DFG++ D++ + VGT YM PE ++
Sbjct: 151 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANS--FVGTRSYMSPERLQGTHY 207
Query: 525 STSTDVYAFGVFMLEVASGRRP 546
S +D+++ G+ ++E+A GR P
Sbjct: 208 SVQSDIWSMGLSLVEMAVGRYP 229
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 53/217 (24%), Positives = 94/217 (43%), Gaps = 22/217 (10%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLV 404
+ D++G+G V+RG + A+K ++ S + + + E + +L H+N+V
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 405 KLRGY--CRRKGEFLLVYDYMPNGSL-DKILHTNIKPCLNWYQRFRIIRGVASGLLYLHE 461
KL +L+ ++ P GSL + + L + ++R V G+ +L E
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 462 DWEQVVLHRDIKPANVLL----DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPE 517
++HR+IKP N++ D KL DFG AR + D + L GT Y+ P+
Sbjct: 131 ---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLHPD 185
Query: 518 LMRTGKASTST--------DVYAFGVFMLEVASGRRP 546
+ D+++ GV A+G P
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 57/202 (28%), Positives = 100/202 (49%), Gaps = 9/202 (4%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQG-IKEFVAELVSMGRLRHRNLV 404
F + IG+G FG+V++G+ + +A+K + + + I++ E+ + + +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 405 KLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWE 464
K G + + ++ +Y+ GS +L L+ Q I+R + GL YLH
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHS--- 137
Query: 465 QVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKA 524
+ +HRDIK ANVLL KL DFG+A DT + VGT +M PE+++
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT-DTQIKRNTFVGTPFWMAPEVIKQSAY 196
Query: 525 STSTDVYAFGVFMLEVASGRRP 546
+ D+++ G+ +E+A G P
Sbjct: 197 DSKADIWSLGITAIELARGEPP 218
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 6e-30
Identities = 69/270 (25%), Positives = 119/270 (44%), Gaps = 34/270 (12%)
Query: 353 IGRGGFGKVYRGV-LASNVQIAVKKVSHDS--KQGIKEFVA-ELVSMGRLRHRNLVKLRG 408
+G+G F VYR + + +++A+K + + K G+ + V E+ +L+H ++++L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 409 YCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVL 468
Y LV + NG +++ L +KP R + + +G+LYLH +L
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR-HFMHQIITGMLYLHS---HGIL 134
Query: 469 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKA-STS 527
HRD+ +N+LL ++N K+ DFGLA T L GT Y+ PE + T A
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPE-IATRSAHGLE 192
Query: 528 TDVYAFGVFMLEVASGRRPVEQQGSMET---VNLVDWVCDCWKKGAIRDASDSRLEGICE 584
+DV++ G + GR P + T V L D+ + +D
Sbjct: 193 SDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKD----------- 241
Query: 585 EKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
L+ +L L P R ++ V+
Sbjct: 242 -----LIHQL-L---RRNPADRLSLSSVLD 262
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 6e-30
Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQ-GIKEFVAELVSMGRLRHRNLV 404
++ ++VIG G V ++A+K+++ + Q + E + E+ +M + H N+V
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 405 KLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFR------IIRGVASGLLY 458
K E LV + GS+ I+ + + I+R V GL Y
Sbjct: 77 SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136
Query: 459 LHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGL-ARLYDHDTIPQTTK---LVGTFGYM 514
LH+ +HRD+K N+LL D + ++ DFG+ A L I + VGT +M
Sbjct: 137 LHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193
Query: 515 DPELMRTGKA-STSTDVYAFGVFMLEVASGRRP 546
PE+M + D+++FG+ +E+A+G P
Sbjct: 194 APEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-30
Identities = 54/289 (18%), Positives = 101/289 (34%), Gaps = 48/289 (16%)
Query: 352 VIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLR-HRNLVKLRGY 409
V+ GGF VY + S + A+K++ + ++ + + E+ M +L H N+V+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 410 C--------RRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHE 461
+ EFLL+ + ++ + + L+ +I + ++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153
Query: 462 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL-----------VGT 510
+ ++HRD+K N+LL KL DFG A H + T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 511 FGYMDPEL---MRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWK 567
Y PE+ D++A G + + + P E + VN
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN---------- 263
Query: 568 KGAIRDASDSRLEGICEE--KQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
G + + M L+ PE R ++ +V+
Sbjct: 264 -GKYSIPPHDTQYTVFHSLIRAM---LQ-------VNPEERLSIAEVVH 301
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 9e-30
Identities = 48/206 (23%), Positives = 100/206 (48%), Gaps = 11/206 (5%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVK 405
++ +G G FGKVY+ + A K + S++ +++++ E+ + H +VK
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 406 LRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQ 465
L G G+ ++ ++ P G++D I+ + L Q + R + L +LH +
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQVVCRQMLEALNFLHS---K 136
Query: 466 VVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKAS 525
++HRD+K NVL+ + + +L DFG++ + + +GT +M PE++
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-FIGTPYWMAPEVVMCETMK 195
Query: 526 TST-----DVYAFGVFMLEVASGRRP 546
+ D+++ G+ ++E+A P
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 57/213 (26%), Positives = 98/213 (46%), Gaps = 22/213 (10%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSK-QGIKEFVAEL-VSMGRLRHRNL 403
+ +GRG +G V + + S +AVK++ Q K + +L +SM +
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68
Query: 404 VKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRF------RIIRGVASGLL 457
V G R+G+ + + M + SLDK K ++ Q +I + L
Sbjct: 69 VTFYGALFREGDVWICMELM-DTSLDKFY----KQVIDKGQTIPEDILGKIAVSIVKALE 123
Query: 458 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPE 517
+LH + V+HRD+KP+NVL++A K+ DFG++ D + + G YM PE
Sbjct: 124 HLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV-DDVAKDI-DAGCKPYMAPE 179
Query: 518 LMRTGKA----STSTDVYAFGVFMLEVASGRRP 546
+ S +D+++ G+ M+E+A R P
Sbjct: 180 RINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 55/202 (27%), Positives = 104/202 (51%), Gaps = 10/202 (4%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVK 405
F + +G G +G VY+ + + +A+K+V + ++E + E+ M + ++VK
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPHVVK 88
Query: 406 LRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQ 465
G + + +V +Y GS+ I+ K L + I++ GL YLH
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT-LTEDEIATILQSTLKGLEYLHF---M 144
Query: 466 VVLHRDIKPANVLLDADLNGKLGDFGL-ARLYDHDTIPQTTKLVGTFGYMDPELMRTGKA 524
+HRDIK N+LL+ + + KL DFG+ +L DT+ + ++GT +M PE+++
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQL--TDTMAKRNTVIGTPFWMAPEVIQEIGY 202
Query: 525 STSTDVYAFGVFMLEVASGRRP 546
+ D+++ G+ +E+A G+ P
Sbjct: 203 NCVADIWSLGITAIEMAEGKPP 224
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 120 bits (301), Expect = 2e-29
Identities = 31/253 (12%), Positives = 69/253 (27%), Gaps = 43/253 (16%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVK---KVSHDSKQGIKEFVAELVSMGRLRH-R 401
V+G+ + V IK+ E++ + LR +
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 402 NLVKLRGYCRRKGEFLLV-----------------------YDYMP--NGSLDKIL---- 432
N + + + R F LV + P +L
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 433 -HTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFG 491
H++ L + R ++ V L LH ++H ++P +++LD L F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFE 256
Query: 492 LARLYDHDTIPQTTKLVGTFGYMDPELMR-----TGKASTSTDVYAFGVFMLEVASGRRP 546
+ + ++ + + D + G+ + + P
Sbjct: 257 HLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
Query: 547 VEQQGSMETVNLV 559
++ +
Sbjct: 317 NTDDAALGGSEWI 329
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 24/231 (10%)
Query: 315 RNKRYEEVYEDWEREYGPQRFTYKDLYKATKGFKDK----DVIGRGGFGKVYRGV-LASN 369
+ Y++ YED ++Y PQ K D + +G G FG V+R V A+
Sbjct: 22 KINDYDKFYEDIWKKYVPQPVEVK-----QGSVYDYYDILEELGSGAFGVVHRCVEKATG 76
Query: 370 VQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSL- 428
K ++ E+ M +L H L+ L K E +L+ +++ G L
Sbjct: 77 RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELF 136
Query: 429 DKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL----DADLN 484
D+I + K ++ + +R GL ++H E ++H DIKP N++ + +
Sbjct: 137 DRIAAEDYK--MSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSV- 190
Query: 485 GKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGV 535
K+ DFGLA + D I + T + PE++ TD++A GV
Sbjct: 191 -KIIDFGLATKLNPDEIVKV--TTATAEFAAPEIVDREPVGFYTDMWAIGV 238
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-29
Identities = 53/214 (24%), Positives = 93/214 (43%), Gaps = 22/214 (10%)
Query: 350 KDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLR 407
D++G+G V+RG + A+K ++ S + + + E + +L H+N+VKL
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 408 GY--CRRKGEFLLVYDYMPNGSL-DKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWE 464
+L+ ++ P GSL + + L + ++R V G+ +L E
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE--- 130
Query: 465 QVVLHRDIKPANVLL----DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMR 520
++HR+IKP N++ D KL DFG AR + D + L GT Y+ P++
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLHPDMYE 188
Query: 521 TGKASTST--------DVYAFGVFMLEVASGRRP 546
D+++ GV A+G P
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 32/310 (10%), Positives = 78/310 (25%), Gaps = 53/310 (17%)
Query: 342 KATKGFKDKDVIGRGGFGKVYRGV-LASNVQIAVK---KVSHDSKQGIKEFVAELVSMGR 397
+ + K + + G V+ + A+K + +S+ ++ + R
Sbjct: 59 QGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAAR 118
Query: 398 LRHRNLVKLRGYCR--------------------------RKGEFLLVYDYMPNGSLDKI 431
L + + R R +LL+ + L+ +
Sbjct: 119 LLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELL 177
Query: 432 L-----HTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGK 486
+ + + L ++H P N+ + D
Sbjct: 178 FSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLM 234
Query: 487 LGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKA--STSTDVYAFGVFMLEVASGR 544
LGD + Y E + A + + + + G+ + V
Sbjct: 235 LGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
Query: 545 RPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPE 604
P + W + + + + + L+ + L +
Sbjct: 291 LPFG---LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVK-TLIGRF-L---NFDRR 342
Query: 605 ARPNMRQVMQ 614
R + M+
Sbjct: 343 RRLLPLEAME 352
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 50/209 (23%), Positives = 91/209 (43%), Gaps = 16/209 (7%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSK-QGIKEFVAEL-VSMGRLRHRNL 403
++ +G G G+V++ + IAVK++ + K + +L V + +
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI 86
Query: 404 VKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDW 463
V+ G + + + M +K+ P + ++ + L YL E
Sbjct: 87 VQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGP-IPERILGKMTVAIVKALYYLKE-- 142
Query: 464 EQVVLHRDIKPANVLLDADLNGKLGDFGL-ARLYDHDTIPQTTKLVGTFGYMDPELMRTG 522
+ V+HRD+KP+N+LLD KL DFG+ RL D + G YM PE +
Sbjct: 143 KHGVIHRDVKPSNILLDERGQIKLCDFGISGRL--VDDKAKDR-SAGCAAYMAPERIDPP 199
Query: 523 KASTST-----DVYAFGVFMLEVASGRRP 546
+ DV++ G+ ++E+A+G+ P
Sbjct: 200 DPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-29
Identities = 42/205 (20%), Positives = 79/205 (38%), Gaps = 24/205 (11%)
Query: 351 DVIGRGGFGKVYRGV--LASNVQIAVK--KVSHDSKQGIKEFVAELVSMGRLRHRNLVKL 406
I GG G +Y + + + +K S D+ + +AE + + H ++V++
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDA-EAQAMAMAERQFLAEVVHPSIVQI 144
Query: 407 RGYCRRKGEFL-----LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHE 461
+ +V +Y+ SL + L + + + L YLH
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILPALSYLHS 200
Query: 462 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRT 521
+++ D+KP N++L + KL D G I L GT G+ PE++R
Sbjct: 201 ---IGLVYNDLKPENIMLTEE-QLKLIDLGAVS-----RINSFGYLYGTPGFQAPEIVR- 250
Query: 522 GKASTSTDVYAFGVFMLEVASGRRP 546
+ +TD+Y G + +
Sbjct: 251 TGPTVATDIYTVGRTLAALTLDLPT 275
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 6e-29
Identities = 69/302 (22%), Positives = 117/302 (38%), Gaps = 73/302 (24%)
Query: 350 KDVIGRGGFGKVYRGVL------ASNVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRN 402
IG G FG+V++ +AVK + + S +F E M + N
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 403 LVKLRGYCRRKGEFLLVYDYMPNGSLDKIL----------------------HTNIKPCL 440
+VKL G C L+++YM G L++ L + P L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 441 NWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHD 499
+ ++ I R VA+G+ YL E+ +HRD+ N L+ ++ K+ DFGL+R +Y D
Sbjct: 172 SCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228
Query: 500 TIPQTTKLVGTFGY-----MDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRP------- 546
M PE + + +T +DV+A+GV + E+ S G +P
Sbjct: 229 YYKADGN-----DAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 283
Query: 547 -----VEQQGSME-----TVNLVDWVCDCWKKGAIRDASD--------SRLEGICEEKQM 588
V + + L + + CW + +D L+ +CE +
Sbjct: 284 EVIYYVRDGNILACPENCPLELYNLMRLCWS----KLPADRPSFCSIHRILQRMCERAEG 339
Query: 589 EL 590
+
Sbjct: 340 TV 341
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-29
Identities = 43/213 (20%), Positives = 83/213 (38%), Gaps = 16/213 (7%)
Query: 347 FKDKDVIGRG--GFGKVYRGV-LASNVQIAVKKVS--HDSKQGIKEFVAELVSMGRLRHR 401
++ VIG+G V + + V++++ S + + EL H
Sbjct: 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 402 NLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHE 461
N+V R E +V +M GS ++ T+ +N I++GV L Y+H
Sbjct: 87 NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH 146
Query: 462 DWEQVVLHRDIKPANVLLDADLNGKLGDFG-LARLYDHDTIPQTTKL-----VGTFGYMD 515
+HR +K +++L+ D L + H + V ++
Sbjct: 147 ---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203
Query: 516 PELMRTGKA--STSTDVYAFGVFMLEVASGRRP 546
PE+++ +D+Y+ G+ E+A+G P
Sbjct: 204 PEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 9e-29
Identities = 58/256 (22%), Positives = 98/256 (38%), Gaps = 47/256 (18%)
Query: 320 EEVYEDWEREYGPQRFTYKDLYKATKGFKDKDVIGRGGFGKVYRGVL------ASNVQIA 373
++ D + E+ R ++ +G G FGKV + + +A
Sbjct: 10 TQLPYDHKWEFPRNRLSFGK------------TLGAGAFGKVVEATAYGLIKSDAAMTVA 57
Query: 374 VK--KVSHDSKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDK 430
VK K S + + ++EL + L H N+V L G C G L++ +Y G L
Sbjct: 58 VKMLKPSAHLTE-REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLN 116
Query: 431 ILHTNIKPCLNWYQRFRIIRG----------------VASGLLYLHEDWEQVVLHRDIKP 474
L + I+ VA G+ +L + +HRD+
Sbjct: 117 FLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAA 173
Query: 475 ANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTF--GYMDPELMRTGKASTSTDVY 531
N+LL K+ DFGLAR + + +M PE + + +DV+
Sbjct: 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGN--ARLPVKWMAPESIFNCVYTFESDVW 231
Query: 532 AFGVFMLEVAS-GRRP 546
++G+F+ E+ S G P
Sbjct: 232 SYGIFLWELFSLGSSP 247
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 56/213 (26%), Positives = 88/213 (41%), Gaps = 22/213 (10%)
Query: 353 IGRGGFGKVYRGV-LASNVQIAVKKVSHDS--KQGIKE-FVAELVSMGRLRHRNLVKLRG 408
+G+GGF K + + A K V K +E E+ L H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 409 YCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRF------RIIRGVASGLLYLHED 462
+ +V + SL ++ + +R + G YLH
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELHKRR--------KALTEPEARYYLRQIVLGCQYLHR- 133
Query: 463 WEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTG 522
V+HRD+K N+ L+ DL K+GDFGLA ++D + L GT Y+ PE++
Sbjct: 134 --NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKK 190
Query: 523 KASTSTDVYAFGVFMLEVASGRRPVEQQGSMET 555
S DV++ G M + G+ P E ET
Sbjct: 191 GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET 223
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 53/207 (25%), Positives = 91/207 (43%), Gaps = 17/207 (8%)
Query: 351 DVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVA----ELVSMGRLRHRNLVK 405
+++G GG +V+ L + +AVK V F E + L H +V
Sbjct: 18 EILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 406 LRGYCRRKGEFL----LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHE 461
+ + +V +Y+ +L I+HT + + +I L + H+
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQ 134
Query: 462 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD--TIPQTTKLVGTFGYMDPELM 519
++HRD+KPAN+++ A K+ DFG+AR ++ QT ++GT Y+ PE
Sbjct: 135 ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 520 RTGKASTSTDVYAFGVFMLEVASGRRP 546
R +DVY+ G + EV +G P
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 58/262 (22%), Positives = 109/262 (41%), Gaps = 56/262 (21%)
Query: 321 EVYEDWEREYGPQRFTYKDLYKATKGFKDKDVIGRGGFGKVYRGVL------ASNVQIAV 374
++ ED + E+ + +G G FGKV + A +AV
Sbjct: 11 KILEDPKWEFPRKNLVLGK------------TLGEGEFGKVVKATAFHLKGRAGYTTVAV 58
Query: 375 KKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILH 433
K + + S +++ ++E + ++ H +++KL G C + G LL+ +Y GSL L
Sbjct: 59 KMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLR 118
Query: 434 TNIKPCLNWYQRFRIIRG----------------------VASGLLYLHEDWEQVVLHRD 471
+ K + ++ G+ YL E ++HRD
Sbjct: 119 ESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRD 175
Query: 472 IKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFG-----YMDPELMRTGKAS 525
+ N+L+ K+ DFGL+R +Y+ D+ + ++ G +M E + +
Sbjct: 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQ-----GRIPVKWMAIESLFDHIYT 230
Query: 526 TSTDVYAFGVFMLEVAS-GRRP 546
T +DV++FGV + E+ + G P
Sbjct: 231 TQSDVWSFGVLLWEIVTLGGNP 252
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 56/213 (26%), Positives = 88/213 (41%), Gaps = 22/213 (10%)
Query: 353 IGRGGFGKVYRGV-LASNVQIAVKKVSHDS--KQGIKE-FVAELVSMGRLRHRNLVKLRG 408
+G+GGF K + + A K V K +E E+ L H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 409 YCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRF------RIIRGVASGLLYLHED 462
+ +V + SL ++ + +R + G YLH
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRR--------KALTEPEARYYLRQIVLGCQYLHR- 159
Query: 463 WEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTG 522
V+HRD+K N+ L+ DL K+GDFGLA ++D + L GT Y+ PE++
Sbjct: 160 --NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKK 216
Query: 523 KASTSTDVYAFGVFMLEVASGRRPVEQQGSMET 555
S DV++ G M + G+ P E ET
Sbjct: 217 GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET 249
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 56/228 (24%), Positives = 100/228 (43%), Gaps = 39/228 (17%)
Query: 350 KDVIGRGGFGKVYRGVL--------ASNVQIAVKKVSHD-SKQGIKEFVAELVSMGRL-R 399
+G G FG+V V +AVK + D +++ + + V+E+ M + +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 400 HRNLVKLRGYCRRKGEFLLVYDYMPNGSL--------------DKILHTNIKPCLNWYQR 445
H+N++ L G C + G ++ +Y G+L ++ + + +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 446 FRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQT 504
+A G+ YL Q +HRD+ NVL+ + K+ DFGLAR + + D +T
Sbjct: 160 VSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 505 TKLVGTFG-----YMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRP 546
T G +M PE + + +DV++FGV M E+ + G P
Sbjct: 217 TN-----GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-28
Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 39/228 (17%)
Query: 350 KDVIGRGGFGKVYRGVL--------ASNVQIAVKKVSHD-SKQGIKEFVAELVSMGRL-R 399
+G G FG+V ++AVK + D +++ + + ++E+ M + +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 400 HRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRG-------- 451
H+N++ L G C + G ++ +Y G+L + L P L +
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 452 ------VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQT 504
VA G+ YL + +HRD+ NVL+ D K+ DFGLAR ++ D +T
Sbjct: 194 VSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 505 TKLVGTFG-----YMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRP 546
T G +M PE + + +DV++FGV + E+ + G P
Sbjct: 251 TN-----GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 8e-28
Identities = 62/247 (25%), Positives = 100/247 (40%), Gaps = 25/247 (10%)
Query: 313 IVRNKRYEEVYEDWEREYGPQRFTYKDLYKATKGFKDK----DVIGRGGFGKVYRGV-LA 367
IVR K D +++ + + D + +G G FG V+R A
Sbjct: 121 IVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERA 180
Query: 368 SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGS 427
+ A K V + + E+ +M LRH LV L E +++Y++M G
Sbjct: 181 TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE 240
Query: 428 L-DKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL----DAD 482
L +K+ + K ++ + +R V GL ++H E +H D+KP N++ +
Sbjct: 241 LFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNE 295
Query: 483 LNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGV---FMLE 539
L KL DFGL D GT + PE+ TD+++ GV +L
Sbjct: 296 L--KLIDFGLTAHLDPKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILL- 350
Query: 540 VASGRRP 546
SG P
Sbjct: 351 --SGLSP 355
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 18/213 (8%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVAELVSMGRL-RHRNLV 404
F+ +++G G +G+VY+G + + A+K + +E E+ + + HRN+
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIA 84
Query: 405 K-----LRGYCRRKGEFL-LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLY 458
++ + L LV ++ GS+ ++ L I R + GL +
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 144
Query: 459 LHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPEL 518
LH+ V+HRDIK NVLL + KL DFG++ D T+ + +GT +M PE+
Sbjct: 145 LHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD-RTVGRRNTFIGTPYWMAPEV 200
Query: 519 MRTGKASTST-----DVYAFGVFMLEVASGRRP 546
+ + +T D+++ G+ +E+A G P
Sbjct: 201 IACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 57/234 (24%), Positives = 107/234 (45%), Gaps = 23/234 (9%)
Query: 314 VRNKRYEEVYEDWEREYGPQRFTYKDLYKATKGFKD------KDVIGRGGFGKVYRGV-L 366
V++KR + D P F ++ + +++G G FG+V++
Sbjct: 54 VKSKRTSALAVDIPAPPAP--FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEET 111
Query: 367 ASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNG 426
A+ +++A K + + +E E+ M +L H NL++L K + +LV +Y+ G
Sbjct: 112 ATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171
Query: 427 SL-DKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL----DA 481
L D+I+ + L ++ + G+ ++H + +LH D+KP N+L
Sbjct: 172 ELFDRIIDESYN--LTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAK 226
Query: 482 DLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGV 535
+ K+ DFGLAR Y + GT ++ PE++ S TD+++ GV
Sbjct: 227 QI--KIIDFGLARRYKPREKLKV--NFGTPEFLAPEVVNYDFVSFPTDMWSVGV 276
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 58/228 (25%), Positives = 101/228 (44%), Gaps = 39/228 (17%)
Query: 350 KDVIGRGGFGKVYRGVL--------ASNVQIAVKKVSHD-SKQGIKEFVAELVSMGRL-R 399
+G G FG+V V +AVK + D +++ + + V+E+ M + +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 400 HRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRG-------- 451
H+N++ L G C + G ++ +Y G+L + L P + + +
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 452 ------VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQT 504
+A G+ YL Q +HRD+ NVL+ + K+ DFGLAR + + D +T
Sbjct: 206 VSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262
Query: 505 TKLVGTFG-----YMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRP 546
T G +M PE + + +DV++FGV M E+ + G P
Sbjct: 263 TN-----GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 52/224 (23%), Positives = 92/224 (41%), Gaps = 32/224 (14%)
Query: 350 KDVIGRGGFGKVYRGVL------ASNVQIAVKKV-SHDSKQGIKEFVAELVSMGRL-RHR 401
+GRG FG+V A+ +AVK + + + ++EL + + H
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 402 NLVKLRGYCRRKGE-FLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRG--------- 451
N+V L G C + G +++ ++ G+L L + + + +
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 452 -----VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTT 505
VA G+ +L + +HRD+ N+LL K+ DFGLAR +Y +
Sbjct: 152 CYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208
Query: 506 KLVGTF--GYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRP 546
+M PE + + +DV++FGV + E+ S G P
Sbjct: 209 D--ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 3e-27
Identities = 51/283 (18%), Positives = 106/283 (37%), Gaps = 40/283 (14%)
Query: 347 FKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRL-RHRNLVK 405
F KDV+G G G + + N +AVK++ + E+ + H N+++
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI---LPECFSFADREVQLLRESDEHPNVIR 82
Query: 406 LRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQ 465
+ + + + +L + + L +++ SGL +LH
Sbjct: 83 YFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPI-TLLQQTTSGLAHLH---SL 137
Query: 466 VVLHRDIKPANVLL-----DADLNGKLGDFGLARLYDHD--TIPQTTKLVGTFGYMDPEL 518
++HRD+KP N+L+ + + DFGL + + + + + GT G++ PE+
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197
Query: 519 MR---TGKASTSTDVYAFGVFMLEVASGRRP----VEQQGSMETVNLVDWVCDCWKKGAI 571
+ + + D+++ G V S Q+ + + C +K
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHED 257
Query: 572 RDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
A + L+ K P+ RP+ + V++
Sbjct: 258 VIARE-------------LIEK----MIAMDPQKRPSAKHVLK 283
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 58/234 (24%), Positives = 93/234 (39%), Gaps = 46/234 (19%)
Query: 350 KDVIGRGGFGKVYRGVL------ASNVQIAVK--KVSHDSKQGIKEFVAELVSMGRL-RH 400
V+G G FGKV ++Q+AVK K DS + + ++EL M +L H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE-REALMSELKMMTQLGSH 108
Query: 401 RNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRG--------- 451
N+V L G C G L+++Y G L L + + + +
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 452 ------------VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDH 498
VA G+ +L + +HRD+ NVL+ K+ DFGLAR +
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225
Query: 499 DTIPQTTKLVGTFG-----YMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRP 546
+M PE + G + +DV+++G+ + E+ S G P
Sbjct: 226 SNYVVRGN-----ARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-27
Identities = 67/261 (25%), Positives = 122/261 (46%), Gaps = 21/261 (8%)
Query: 320 EEVYEDWEREYGPQRFTYKDLYKATKGFKDKDVIGRGGFGKVYRGV-LASNVQIAVKKV- 377
E +Y + + P F ++ ++ +G G +G+V ++V+ A+K +
Sbjct: 12 ENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIR 71
Query: 378 -SHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSL-DKILHTN 435
+ S + + E+ + L H N++KL + K + LV + G L D+I+H
Sbjct: 72 KTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH-- 129
Query: 436 IKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL---DADLNGKLGDFGL 492
+ N II+ V SG+ YLH + ++HRD+KP N+LL + D K+ DFGL
Sbjct: 130 -RMKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGL 185
Query: 493 ARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGS 552
+ ++++ + + +GT Y+ PE++R K DV++ GV + + +G P Q
Sbjct: 186 SAVFENQ--KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD 242
Query: 553 METVNLV-----DWVCDCWKK 568
E + V + WK
Sbjct: 243 QEILRKVEKGKYTFDSPEWKN 263
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-27
Identities = 54/220 (24%), Positives = 89/220 (40%), Gaps = 27/220 (12%)
Query: 350 KDVIGRGGFGKVYRGVL------ASNVQIAVK--KVSHDSKQGIKEFVAELVSMGRL-RH 400
+G G FGKV + +++AVK K + + + + ++EL M L +H
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADE-KEALMSELKIMSHLGQH 109
Query: 401 RNLVKLRGYCRRKGEFLLVYDYMPNGSL------------DKILHTNIKPCLNWYQRFRI 448
N+V L G C G L++ +Y G L +
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 449 IRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKL 507
VA G+ +L + +HRD+ NVLL K+GDFGLAR + +
Sbjct: 170 SSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 508 VGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRP 546
+M PE + + +DV+++G+ + E+ S G P
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 8e-27
Identities = 60/214 (28%), Positives = 95/214 (44%), Gaps = 24/214 (11%)
Query: 352 VIGRGGFGKVYRGV-LASNVQIAVKKV--SHDSKQGIKEFV-AELVSMGRLRHRNLVKLR 407
+G+G FG VY S +A+K + + K G++ + E+ LRH N+++L
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 408 GYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRF------RIIRGVASGLLYLHE 461
GY L+ +Y P G++ + L +F I +A+ L Y H
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYRELQKL--------SKFDEQRTATYITELANALSYCHS 127
Query: 462 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRT 521
+ V+HRDIKP N+LL + K+ DFG + +T L GT Y+ PE++
Sbjct: 128 ---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--RTD-LCGTLDYLPPEMIEG 181
Query: 522 GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMET 555
D+++ GV E G+ P E ET
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 215
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 17/207 (8%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQG---IKEFVAELVSMGRLRHRN 402
F D IG G FG VY + ++ +A+KK+S+ KQ ++ + E+ + +LRH N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 403 LVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHED 462
++ RG R+ LV +Y + D +L + KP L + + G GL YLH
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASD-LLEVHKKP-LQEVEIAAVTHGALQGLAYLHS- 172
Query: 463 WEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTG 522
++HRD+K N+LL KLGDFG A + VGT +M PE++
Sbjct: 173 --HNMIHRDVKAGNILLSEPGLVKLGDFGSA-----SIMAPANSFVGTPYWMAPEVILAM 225
Query: 523 KAST---STDVYAFGVFMLEVASGRRP 546
DV++ G+ +E+A + P
Sbjct: 226 DEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 47/197 (23%), Positives = 86/197 (43%), Gaps = 26/197 (13%)
Query: 350 KDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRG 408
+V+G G F +V+ + A+K + E+ + +++H N+V L
Sbjct: 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 409 YCRRKGEFLLVYDYMPNGSL-DKILHTNIKPCLNWYQRF------RIIRGVASGLLYLHE 461
+ LV + G L D+IL + +I+ V S + YLH
Sbjct: 74 IYESTTHYYLVMQLVSGGELFDRILE---------RGVYTEKDASLVIQQVLSAVKYLH- 123
Query: 462 DWEQVVLHRDIKPANVLL---DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPEL 518
E ++HRD+KP N+L + + + DFGL+++ + + + GT GY+ PE+
Sbjct: 124 --ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM---STACGTPGYVAPEV 178
Query: 519 MRTGKASTSTDVYAFGV 535
+ S + D ++ GV
Sbjct: 179 LAQKPYSKAVDCWSIGV 195
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-26
Identities = 65/223 (29%), Positives = 107/223 (47%), Gaps = 17/223 (7%)
Query: 332 PQRFTYKDLYKATKGFKDKDVIGRGGFGKVYRGV-LASNVQIAVK---KVSHDSKQGIKE 387
P F + +K + V+G+G FG+V + + AVK K K +
Sbjct: 13 PGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES 72
Query: 388 FVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSL-DKILHTNIKPCLNWYQRF 446
+ E+ + +L H N++KL + KG F LV + G L D+I+ + +
Sbjct: 73 LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS---RKRFSEVDAA 129
Query: 447 RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL---DADLNGKLGDFGLARLYDHDTIPQ 503
RIIR V SG+ Y+H + ++HRD+KP N+LL D N ++ DFGL+ ++ +
Sbjct: 130 RIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS--KK 184
Query: 504 TTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRP 546
+GT Y+ PE++ G DV++ GV + + SG P
Sbjct: 185 MKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPP 226
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 54/262 (20%), Positives = 91/262 (34%), Gaps = 58/262 (22%)
Query: 340 LYKATKGFKDK----DVIGRGGFGKVYRGV-LASNVQIAVK-----KVSHDSKQGIKEFV 389
+ + K IG+G +G V + + A+K K+ + + ++
Sbjct: 17 QGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIK 76
Query: 390 AELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSL-DKILHTNIKPCLNWYQRF-- 446
E+ M +L H N+ +L + LV + G L DK+
Sbjct: 77 TEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVK 136
Query: 447 -----------------------------------RIIRGVASGLLYLHEDWEQVVLHRD 471
I+R + S L YLH Q + HRD
Sbjct: 137 TQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRD 193
Query: 472 IKPANVLLDADLNG--KLGDFGLARLYDHDTIPQTTKL---VGTFGYMDPELMRTGKAS- 525
IKP N L + + KL DFGL++ + + + GT ++ PE++ T S
Sbjct: 194 IKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY 253
Query: 526 -TSTDVYAFGVFMLEVASGRRP 546
D ++ GV + + G P
Sbjct: 254 GPKCDAWSAGVLLHLLLMGAVP 275
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 7e-26
Identities = 62/336 (18%), Positives = 110/336 (32%), Gaps = 86/336 (25%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVA-ELVSMGRLRHRNLV 404
F+ +GRGGFG V+ + A+K++ +++ +E V E+ ++ +L H +V
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 405 KLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVAS---------- 454
+ + D+ + IR +
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 455 ------GLLYLH---------EDW------------------------------EQVVLH 469
LY+ +DW + ++H
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMH 187
Query: 470 RDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT-----------TKLVGTFGYMDPEL 518
RD+KP+N+ D K+GDFGL D D QT T VGT YM PE
Sbjct: 188 RDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQ 247
Query: 519 MRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSR 578
+ S D+++ G+ + E+ ME V ++ V + +
Sbjct: 248 IHGNNYSHKVDIFSLGLILFELLYSFST-----QMERVRIITDV----RNLKFPLLFTQK 298
Query: 579 LEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
++ +V + L P P RP +++
Sbjct: 299 Y-----PQEHMMVQDM-L---SPSPTERPEATDIIE 325
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 54/223 (24%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 338 KDLYKATKGFKDK----DVIGRGGFGKVYRGV-LASNVQIAVKKVS-HDSKQGIKEFVAE 391
++LY D +G G FG V+ +S ++ +K ++ S+ +++ AE
Sbjct: 12 ENLYF-QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAE 70
Query: 392 LVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSL-DKILHTNIKP-CLNWYQRFRII 449
+ + L H N++K+ +V + G L ++I+ + L+ ++
Sbjct: 71 IEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELM 130
Query: 450 RGVASGLLYLHEDWEQVVLHRDIKPANVLL---DADLNGKLGDFGLARLYDHDTIPQTTK 506
+ + + L Y H Q V+H+D+KP N+L K+ DFGLA L+ D
Sbjct: 131 KQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN-- 185
Query: 507 LVGTFGYMDPELMRTGKASTSTDVYAFGV---FMLEVASGRRP 546
GT YM PE+ + + D+++ GV F+L +G P
Sbjct: 186 AAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLL---TGCLP 224
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 48/231 (20%), Positives = 87/231 (37%), Gaps = 35/231 (15%)
Query: 352 VIGRGGFGKVYRGVLA--SNVQIAVKKVSHDSKQGIKEFVA-----------------EL 392
+ +G F K+ L N A+KK + ++F EL
Sbjct: 38 TLNQGKFNKII---LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94
Query: 393 VSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRF------ 446
+ +++ + G E ++Y+YM N S+ K N+
Sbjct: 95 QIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154
Query: 447 RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTK 506
II+ V + Y+H E+ + HRD+KP+N+L+D + KL DFG +
Sbjct: 155 CIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK---IKG 209
Query: 507 LVGTFGYMDPELM--RTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMET 555
GT+ +M PE + D+++ G+ + + P + S+
Sbjct: 210 SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 35/262 (13%), Positives = 75/262 (28%), Gaps = 54/262 (20%)
Query: 344 TKGFKDKDVIGRGGFGKVYRGV-LASNVQIAVK---KVSHDSKQGIKEFVAELVSMGRLR 399
+ V+G+ + V IK+ E++ + LR
Sbjct: 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 131
Query: 400 -------------------------HRNLVKLRGYCRRKGEFLLVYDYM-PNGSLDKIL- 432
+ ++++R R + Y +L
Sbjct: 132 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 191
Query: 433 ----HTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLG 488
H++ L + R ++ V L LH ++H ++P +++LD L
Sbjct: 192 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLT 248
Query: 489 DFGLARLYDHDTIPQTTKLVGTFGYMDPELM-----------RTGKASTSTDVYAFGVFM 537
F + + G+ PEL R + S D +A G+ +
Sbjct: 249 GFEHLVRDGARVVS-----SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303
Query: 538 LEVASGRRPVEQQGSMETVNLV 559
+ P+ + ++ +
Sbjct: 304 YWIWCADLPITKDAALGGSEWI 325
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 56/214 (26%), Positives = 92/214 (42%), Gaps = 24/214 (11%)
Query: 352 VIGRGGFGKVYRGV-LASNVQIAVKKV--SHDSKQGIKEFVA-ELVSMGRLRHRNLVKLR 407
+G+G FG VY + +A+K + S K+G++ + E+ LRH N++++
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 408 GYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRF------RIIRGVASGLLYLHE 461
Y + L+ ++ P G L K L + RF + +A L Y HE
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKH--------GRFDEQRSATFMEELADALHYCHE 132
Query: 462 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRT 521
+ V+HRDIKP N+L+ K+ DFG + + + GT Y+ PE++
Sbjct: 133 ---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL---RRRTMCGTLDYLPPEMIEG 186
Query: 522 GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMET 555
D++ GV E G P + ET
Sbjct: 187 KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET 220
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 50/208 (24%), Positives = 92/208 (44%), Gaps = 26/208 (12%)
Query: 350 KDVIGRGGFGKVYRGV-LASNVQIAVK--KVSHDSKQGIKEFVAELVSMGRLRHRNLVKL 406
+ +GRG FG V+R V +S K KV + +K+ E+ + RHRN++ L
Sbjct: 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKK---EISILNIARHRNILHL 66
Query: 407 RGYCRRKGEFLLVYDYMPNGSL-DKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQ 465
E +++++++ + ++I + + LN + + V L +LH
Sbjct: 67 HESFESMEELVMIFEFISGLDIFERINTSAFE--LNEREIVSYVHQVCEALQFLH---SH 121
Query: 466 VVLHRDIKPANVLL----DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRT 521
+ H DI+P N++ + + K+ +FG AR + L Y PE+ +
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTI--KIIEFGQARQLKPGDNFRL--LFTAPEYYAPEVHQH 177
Query: 522 GKASTSTDVYAFGV---FMLEVASGRRP 546
ST+TD+++ G +L SG P
Sbjct: 178 DVVSTATDMWSLGTLVYVLL---SGINP 202
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 39/250 (15%), Positives = 73/250 (29%), Gaps = 34/250 (13%)
Query: 347 FKDKDVIGRGGFGKVYRGV------LASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRH 400
++G G F +VY + + +K + + +
Sbjct: 67 VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQ 126
Query: 401 RNLVKLRGYCRRKGEFLLVYDYMPNGSL-DKILHTNIKP--CLNWYQRFRIIRGVASGLL 457
+K + +LV + G+L + I P + + +
Sbjct: 127 HMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIE 186
Query: 458 YLHEDWEQVVLHRDIKPANVLL-----------DADLNGKLGDFGLARLYDHDTIPQTTK 506
+H + ++H DIKP N +L D L D G + D P+ T
Sbjct: 187 QVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI--DMKLFPKGTI 241
Query: 507 LV---GTFGYMDPELMRTGKAST-STDVYAFGVFMLEVASGRRP-VEQQGSMETVNLV-- 559
T G+ E M + K D + + + G V+ +G +
Sbjct: 242 FTAKCETSGFQCVE-MLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFR 300
Query: 560 -DWVCDCWKK 568
D W +
Sbjct: 301 RLPHLDMWNE 310
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 14/202 (6%)
Query: 350 KDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRG 408
++ IGRG +G+V V + ++ A KK+ + + F E+ M L H N+++L
Sbjct: 14 ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE 73
Query: 409 YCRRKGEFLLVYDYMPNGSL-DKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVV 467
+ LV + G L ++++H K RI++ V S + Y H + V
Sbjct: 74 TFEDNTDIYLVMELCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCH---KLNV 127
Query: 468 LHRDIKPANVLL---DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKA 524
HRD+KP N L D KL DFGLA + + +T VGT Y+ P+++ G
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK--VGTPYYVSPQVLE-GLY 184
Query: 525 STSTDVYAFGVFMLEVASGRRP 546
D ++ GV M + G P
Sbjct: 185 GPECDEWSAGVMMYVLLCGYPP 206
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 53/222 (23%), Positives = 93/222 (41%), Gaps = 42/222 (18%)
Query: 342 KATKGFKDK----DVIGRGGFGKVYRGV-LASNVQIAVK-----KVSHDSKQGIKEFVAE 391
+T GF + +++GRG V R + + + AVK S + ++E
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 392 LVS----MGRL-RHRNLVKLRGYCRRKGEFLLVYDYMPNGSL-DKILHTNIKPCLNWYQR 445
+ + ++ H N+++L+ F LV+D M G L D +
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK---------VT 120
Query: 446 F------RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD 499
+I+R + + LH+ ++HRD+KP N+LLD D+N KL DFG + D
Sbjct: 121 LSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG 177
Query: 500 TIPQTTKLVGTFGYMDPELMRTGKASTST------DVYAFGV 535
+ + GT Y+ PE++ D+++ GV
Sbjct: 178 EKLRE--VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 217
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-25
Identities = 59/233 (25%), Positives = 107/233 (45%), Gaps = 27/233 (11%)
Query: 332 PQRFTYKDLYKATKGFKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVS------------ 378
P + K K + + +G G +G+V + + A+K +
Sbjct: 23 PGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDD 82
Query: 379 -HDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSL-DKILHTNI 436
+ ++ +E E+ + L H N++KL K F LV ++ G L ++I++
Sbjct: 83 NKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN--- 139
Query: 437 KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL---DADLNGKLGDFGLA 493
+ + I++ + SG+ YLH+ ++HRDIKP N+LL ++ LN K+ DFGL+
Sbjct: 140 RHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLS 196
Query: 494 RLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRP 546
+ D +GT Y+ PE+++ K + DV++ GV M + G P
Sbjct: 197 SFFSKDYKL--RDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 43/200 (21%), Positives = 88/200 (44%), Gaps = 24/200 (12%)
Query: 350 KDVIGRGGFGKVYRGV-LASNVQIAVK-----KVSHDSKQGIKEFVAELVS-MGRLRHRN 402
+ +G G F V + + + A K ++S + +E + V+ + +RH N
Sbjct: 10 GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN 69
Query: 403 LVKLRGYCRRKGEFLLVYDYMPNGSL-DKILHTNIKPCLNWYQRFRIIRGVASGLLYLHE 461
++ L K + +L+ + + G L D + K L + + ++ + G+ YLH
Sbjct: 70 IITLHDIFENKTDVVLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLH- 125
Query: 462 DWEQVVLHRDIKPANVLL------DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMD 515
+ + H D+KP N++L + + KL DFG+A + + + GT ++
Sbjct: 126 --SKRIAHFDLKPENIMLLDKNVPNPRI--KLIDFGIAHKIEAGNEFKN--IFGTPEFVA 179
Query: 516 PELMRTGKASTSTDVYAFGV 535
PE++ D+++ GV
Sbjct: 180 PEIVNYEPLGLEADMWSIGV 199
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 25/206 (12%)
Query: 344 TKGFKDK----DVIGRGGFGKVYRGV-LASNVQIAVK-----KVSHDSKQGIKEFVAELV 393
+ F D + +G+G F V R V + ++ A K K+S Q ++ E
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER---EAR 57
Query: 394 SMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSL-DKILHTNIKPCLNWYQRFRIIRGV 452
+L+H N+V+L + + LV+D + G L + I+ + + I+ +
Sbjct: 58 ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA---REFYSEADASHCIQQI 114
Query: 453 ASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG---KLGDFGLARLYDHDTIPQTTKLVG 509
+ Y H ++HR++KP N+LL + G KL DFGLA + G
Sbjct: 115 LESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--AWHGFAG 169
Query: 510 TFGYMDPELMRTGKASTSTDVYAFGV 535
T GY+ PE+++ S D++A GV
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGV 195
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 53/213 (24%), Positives = 88/213 (41%), Gaps = 35/213 (16%)
Query: 340 LYKATKGFKDK----DVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVAELVS 394
D +GRG VYR + A+K + K E+
Sbjct: 44 DGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVL--KKTVDKKIVRTEIGV 101
Query: 395 MGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSL-DKILHTNIKPCLNWYQRF------R 447
+ RL H N++KL+ E LV + + G L D+I+ +
Sbjct: 102 LLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVE---------KGYYSERDAAD 152
Query: 448 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLL-----DADLNGKLGDFGLARLYDHDTIP 502
++ + + YLHE ++HRD+KP N+L DA L K+ DFGL+++ +H +
Sbjct: 153 AVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPL--KIADFGLSKIVEHQVL- 206
Query: 503 QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGV 535
+ GT GY PE++R D+++ G+
Sbjct: 207 -MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGI 238
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-25
Identities = 68/216 (31%), Positives = 99/216 (45%), Gaps = 35/216 (16%)
Query: 347 FKDKDVIGRGGFGKVYRGVL-ASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVK 405
+ D VIG G FG VY+ L S +A+KKV D + +E L M +L H N+V+
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVR 111
Query: 406 LRGYCRRKGE-----FL-LVYDYMPNGSLDKILHTNIKP---------CLNWYQRFRIIR 450
LR + GE +L LV DY+P ++ ++ + L YQ FR
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR--- 167
Query: 451 GVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVG 509
L Y+H + HRDIKP N+LLD D KL DFG A+ +
Sbjct: 168 ----SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYIC 218
Query: 510 TFGYMDPELM-RTGKASTSTDVYAFGVFMLEVASGR 544
+ Y PEL+ ++S DV++ G + E+ G+
Sbjct: 219 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-25
Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 34/215 (15%)
Query: 347 FKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKL 406
+ + VIG G FG V++ L + ++A+KKV D + + EL M ++H N+V L
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----ELQIMRIVKHPNVVDL 97
Query: 407 RGYCRRKGE-----FL-LVYDYMPNGSLDKILHTNIKP---------CLNWYQRFRIIRG 451
+ + G+ FL LV +Y+P ++ + K L YQ R
Sbjct: 98 KAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLR---- 152
Query: 452 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGT 510
L Y+H + HRDIKP N+LLD KL DFG A++ + +
Sbjct: 153 ---SLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG--EPNVSYICS 204
Query: 511 FGYMDPELMRTGKA-STSTDVYAFGVFMLEVASGR 544
Y PEL+ +T+ D+++ G M E+ G+
Sbjct: 205 RYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 42/200 (21%), Positives = 86/200 (43%), Gaps = 24/200 (12%)
Query: 350 KDVIGRGGFGKVYRGV-LASNVQIAVK-----KVSHDSKQGIKEFVA-ELVSMGRLRHRN 402
+ +G G F V + ++ ++ A K + + +E + E+ + ++ H N
Sbjct: 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 403 LVKLRGYCRRKGEFLLVYDYMPNGSL-DKILHTNIKPCLNWYQRFRIIRGVASGLLYLHE 461
++ L + + +L+ + + G L D + K L+ + I+ + G+ YLH
Sbjct: 77 VITLHDVYENRTDVVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLH- 132
Query: 462 DWEQVVLHRDIKPANVLL------DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMD 515
+ + H D+KP N++L + KL DFGLA + + GT ++
Sbjct: 133 --TKKIAHFDLKPENIMLLDKNIPIPHI--KLIDFGLAHEIEDGVE--FKNIFGTPEFVA 186
Query: 516 PELMRTGKASTSTDVYAFGV 535
PE++ D+++ GV
Sbjct: 187 PEIVNYEPLGLEADMWSIGV 206
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 57/226 (25%), Positives = 94/226 (41%), Gaps = 25/226 (11%)
Query: 339 DLYKATKGFKDK----DVIGRGGFGKVYRGV-LASNVQIAVK-----KVSHDSKQGIKEF 388
D+ F+D +VIG+G F V R + + Q AVK K + ++
Sbjct: 14 DMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDL 73
Query: 389 VAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSL-DKIL-HTNIKPCLNWYQRF 446
E L+H ++V+L G +V+++M L +I+ + +
Sbjct: 74 KREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVAS 133
Query: 447 RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL---DADLNGKLGDFGLARLYDHDTIPQ 503
+R + L Y H + ++HRD+KP VLL + KLG FG+A +
Sbjct: 134 HYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA 190
Query: 504 TTKLVGTFGYMDPELMRTGKASTSTDVYAFGV---FMLEVASGRRP 546
+ VGT +M PE+++ DV+ GV +L SG P
Sbjct: 191 GGR-VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILL---SGCLP 232
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-25
Identities = 56/228 (24%), Positives = 96/228 (42%), Gaps = 46/228 (20%)
Query: 344 TKGFKDK----DVIGRGGFGKVYRGV-LASNVQIAVK-----KVSHDSKQGIKEFVAELV 393
F ++ + +G+G F V R V + + + A K+S Q ++ E
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLER---EAR 62
Query: 394 SMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSL-DKILHTNIKPCLNWYQRF------ 446
L+H N+V+L +G L++D + G L + I+ + +
Sbjct: 63 ICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVA---------REYYSEADAS 113
Query: 447 RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL-----DADLNGKLGDFGLARLYDHDTI 501
I+ + +L+ H+ V+HR++KP N+LL A + KL DFGLA + +
Sbjct: 114 HCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAV--KLADFGLAIEVEGEQ- 167
Query: 502 PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGV---FMLEVASGRRP 546
GT GY+ PE++R D++A GV +L G P
Sbjct: 168 QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILL---VGYPP 212
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 26/208 (12%)
Query: 350 KDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLR-HRNLVKLR 407
+G G F + V SN AVK +S + ++ E+ ++ H N+VKL
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLH 72
Query: 408 GYCRRKGEFLLVYDYMPNGSL-DKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQV 466
+ LV + + G L ++I K + + I+R + S + ++H+
Sbjct: 73 EVFHDQLHTFLVMELLNGGELFERIKK---KKHFSETEASYIMRKLVSAVSHMHD---VG 126
Query: 467 VLHRDIKPANVLL-----DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRT 521
V+HRD+KP N+L + ++ K+ DFG ARL D P T T Y PEL+
Sbjct: 127 VVHRDLKPENLLFTDENDNLEI--KIIDFGFARLKPPDNQPLKTP-CFTLHYAAPELLNQ 183
Query: 522 GKASTSTDVYAFGV---FMLEVASGRRP 546
S D+++ GV ML SG+ P
Sbjct: 184 NGYDESCDLWSLGVILYTML---SGQVP 208
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 58/214 (27%), Positives = 106/214 (49%), Gaps = 20/214 (9%)
Query: 344 TKGFKDK----DVIGRGGFGKVYRGV-LASNVQIAVKKVSHD--SKQGIKEFVAELVSMG 396
F ++ ++G+G FG+V + + + AVK ++ + + E+ +
Sbjct: 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76
Query: 397 RLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSL-DKILHTNIKPCLNWYQRFRIIRGVASG 455
+L H N++KL F +V + G L D+I+ + + + RII+ V SG
Sbjct: 77 KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSG 133
Query: 456 LLYLHEDWEQVVLHRDIKPANVLL---DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFG 512
+ Y+H+ ++HRD+KP N+LL + D + K+ DFGL+ + +T + +GT
Sbjct: 134 ITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAY 188
Query: 513 YMDPELMRTGKASTSTDVYAFGVFMLEVASGRRP 546
Y+ PE++R G DV++ GV + + SG P
Sbjct: 189 YIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPP 221
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 25/210 (11%)
Query: 340 LYKATKGFKDK----DVIGRGGFGKVYRGV-LASNVQIAVK-----KVSHDSKQGIKEFV 389
+ A+ F D + +G+G F V R V + ++ A K K+S Q ++
Sbjct: 20 MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER-- 77
Query: 390 AELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSL-DKILHTNIKPCLNWYQRFRI 448
E +L+H N+V+L + + LV+D + G L + I+ + +
Sbjct: 78 -EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA---REFYSEADASHC 133
Query: 449 IRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG---KLGDFGLARLYDHDTIPQTT 505
I+ + + Y H ++HR++KP N+LL + G KL DFGLA +
Sbjct: 134 IQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--AWH 188
Query: 506 KLVGTFGYMDPELMRTGKASTSTDVYAFGV 535
GT GY+ PE+++ S D++A GV
Sbjct: 189 GFAGTPGYLSPEVLKKDPYSKPVDIWACGV 218
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 32/209 (15%)
Query: 351 DVIGRGGFGKVYRGV-LASNVQIAVKKVSHDS-KQGIKEFVA--ELVSMGRLRHRNLVKL 406
++G G +G V + + +A+KK + +K +A E+ + +LRH NLV L
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVK-KIAMREIKLLKQLRHENLVNL 89
Query: 407 RGYCRRKGEFLLVYDYMPNGSLDKILHT--------NIKPCLNWYQRFRIIRGVASGLLY 458
C++K + LV++++ + ++ L ++ L +Q II G+ +
Sbjct: 90 LEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYL--FQ---IINGIG----F 139
Query: 459 LHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT--TKLVGTFGYMDP 516
H ++HRDIKP N+L+ KL DFG AR P V T Y P
Sbjct: 140 CHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTL---AAPGEVYDDEVATRWYRAP 193
Query: 517 E-LMRTGKASTSTDVYAFGVFMLEVASGR 544
E L+ K + DV+A G + E+ G
Sbjct: 194 ELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 42/200 (21%), Positives = 86/200 (43%), Gaps = 24/200 (12%)
Query: 350 KDVIGRGGFGKVYRGV-LASNVQIAVK-----KVSHDSKQGIKEFV-AELVSMGRLRHRN 402
+ +G G F V + ++ ++ A K + + +E + E+ + ++ H N
Sbjct: 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPN 76
Query: 403 LVKLRGYCRRKGEFLLVYDYMPNGSL-DKILHTNIKPCLNWYQRFRIIRGVASGLLYLHE 461
++ L + + +L+ + + G L D + K L+ + I+ + G+ YLH
Sbjct: 77 IITLHDVYENRTDVVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLH- 132
Query: 462 DWEQVVLHRDIKPANVLL------DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMD 515
+ + H D+KP N++L + KL DFGLA + + GT ++
Sbjct: 133 --TKKIAHFDLKPENIMLLDKNIPIPHI--KLIDFGLAHEIEDGVE--FKNIFGTPEFVA 186
Query: 516 PELMRTGKASTSTDVYAFGV 535
PE++ D+++ GV
Sbjct: 187 PEIVNYEPLGLEADMWSIGV 206
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 61/236 (25%), Positives = 100/236 (42%), Gaps = 47/236 (19%)
Query: 341 YKATKGFKDK----DVIGRGGFGKVYRGV-LASNVQIAVK-------KVSHDSKQGIKEF 388
+ A K F K DVIGRG V R V A+ + AVK ++S + + ++E
Sbjct: 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREA 145
Query: 389 VA-ELVSMGRLR-HRNLVKLRGYCRRKGEFLLVYDYMPNGSL-DKILHTNIKPCLNWYQR 445
E + ++ H +++ L LV+D M G L D +
Sbjct: 146 TRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK---------VA 196
Query: 446 F------RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD 499
I+R + + +LH ++HRD+KP N+LLD ++ +L DFG + +
Sbjct: 197 LSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG 253
Query: 500 TIPQTTKLVGTFGYMDPELMRTGKASTST------DVYAFGV---FMLEVASGRRP 546
+ L GT GY+ PE+++ T D++A GV +L +G P
Sbjct: 254 EKLRE--LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLL---AGSPP 304
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 56/213 (26%), Positives = 92/213 (43%), Gaps = 22/213 (10%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVS-HDSKQGIKEF-------VAELVSMGR 397
++ IG G +G VY+ S +A+K V + G VA L +
Sbjct: 11 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA 70
Query: 398 LRHRNLVKLR-----GYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGV 452
H N+V+L R+ + LV++++ L L P L ++R
Sbjct: 71 FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQF 129
Query: 453 ASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT-TKLVGTF 511
GL +LH + ++HRD+KP N+L+ + KL DFGLAR+Y T +V T
Sbjct: 130 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS---YQMALTPVVVTL 183
Query: 512 GYMDPELMRTGKASTSTDVYAFGVFMLEVASGR 544
Y PE++ +T D+++ G E+ +
Sbjct: 184 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 59/209 (28%), Positives = 89/209 (42%), Gaps = 32/209 (15%)
Query: 351 DVIGRGGFGKVYRGV-LASNVQIAVKKVSHDS-KQGIKEFVA--ELVSMGRLRHRNLVKL 406
IG G +G V++ + +A+KK IK +A E+ + +L+H NLV L
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIK-KIALREIRMLKQLKHPNLVNL 67
Query: 407 RGYCRRKGEFLLVYDYMPNGSLDKIL--------HTNIKPCLNWYQRFRIIRGVASGLLY 458
RRK LV++Y + ++ L +K +Q ++ V +
Sbjct: 68 LEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSIT--WQ---TLQAVN----F 117
Query: 459 LHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT--TKLVGTFGYMDP 516
H+ +HRD+KP N+L+ KL DFG ARL T P V T Y P
Sbjct: 118 CHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLL---TGPSDYYDDEVATRWYRSP 171
Query: 517 E-LMRTGKASTSTDVYAFGVFMLEVASGR 544
E L+ + DV+A G E+ SG
Sbjct: 172 ELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-24
Identities = 59/304 (19%), Positives = 112/304 (36%), Gaps = 61/304 (20%)
Query: 347 FKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRL-RHRNLVK 405
+ ++G G G V +AVK++ + E+ + H N+++
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRM---LIDFCDIALMEIKLLTESDDHPNVIR 73
Query: 406 LRGYCRRKGEFLLVYDYMPNGSL-DKI----LHTNIKPCLNWYQRFRIIRGVASGLLYLH 460
+ + N +L D + + Y ++R +ASG+ +LH
Sbjct: 74 YYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 461 EDWEQVVLHRDIKPANVLLD-------------ADLNGKLGDFGLARLYDHDTIPQTTKL 507
++HRD+KP N+L+ +L + DFGL + D T L
Sbjct: 133 ---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 508 ---VGTFGYMDPELMR-------TGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMET- 555
GT G+ PEL+ + + S D+++ G + S G+ P + S E+
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 249
Query: 556 -----VNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMR 610
+L + C + I +A+D L+ ++ + P RP
Sbjct: 250 IIRGIFSLDEMKCLHDRS-LIAEATD-------------LISQM-I---DHDPLKRPTAM 291
Query: 611 QVMQ 614
+V++
Sbjct: 292 KVLR 295
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 5e-24
Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 32/209 (15%)
Query: 353 IGRGGFGKVYRGV-LASNVQIAVKKVSHDS-KQGIKEFVA--ELVSMGRLRHRNLVKLRG 408
IG G +G V++ ++ +A+K+V D +G+ A E+ + L+H+N+V+L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV-PSSALREICLLKELKHKNIVRLHD 68
Query: 409 YCRRKGEFLLVYDYMPNGSLDKILHT--------NIKPCLNWYQRFRIIRGVASGLLYLH 460
+ LV+++ L K + +K L +Q +++G+ + H
Sbjct: 69 VLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFL--FQ---LLKGLG----FCH 118
Query: 461 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT--TKLVGTFGYMDPE- 517
VLHRD+KP N+L++ + KL +FGLAR + IP + V T Y P+
Sbjct: 119 SRN---VLHRDLKPQNLLINRNGELKLANFGLARAF---GIPVRCYSAEVVTLWYRPPDV 172
Query: 518 LMRTGKASTSTDVYAFGVFMLEVASGRRP 546
L STS D+++ G E+A+ RP
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 52/211 (24%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 338 KDLYKATKGFKD----KDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVAEL 392
+ L++ + F D K+ IG G + R + A+N++ AVK + SK+ E E+
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID-KSKRDPTE---EI 66
Query: 393 VSMGRL-RHRNLVKLRGYCRRKGEFLLVYDYMPNGSL-DKILHTNIKPCLNWYQRFRIIR 450
+ R +H N++ L+ +V + M G L DKIL + + + ++
Sbjct: 67 EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILR---QKFFSEREASAVLF 123
Query: 451 GVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG----KLGDFGLARLYDHDTIPQTTK 506
+ + YLH Q V+HRD+KP+N+L + ++ DFG A+ + T
Sbjct: 124 TITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT- 179
Query: 507 LVGTFGYMDPELMRTGKASTSTDVYAFGVFM 537
T ++ PE++ + D+++ GV +
Sbjct: 180 PCYTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 43/200 (21%), Positives = 85/200 (42%), Gaps = 24/200 (12%)
Query: 350 KDVIGRGGFGKVYRGV-LASNVQIAVK-----KVSHDSKQGIKEFVA-ELVSMGRLRHRN 402
+ +G G F V + ++ +Q A K + + +E + E+ + ++H N
Sbjct: 16 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 403 LVKLRGYCRRKGEFLLVYDYMPNGSL-DKILHTNIKPCLNWYQRFRIIRGVASGLLYLHE 461
++ L K + +L+ + + G L D + K L + ++ + +G+ YLH
Sbjct: 76 VITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLH- 131
Query: 462 DWEQVVLHRDIKPANVLL------DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMD 515
+ H D+KP N++L + K+ DFGLA D + GT ++
Sbjct: 132 --SLQIAHFDLKPENIMLLDRNVPKPRI--KIIDFGLAHKIDFGNE--FKNIFGTPEFVA 185
Query: 516 PELMRTGKASTSTDVYAFGV 535
PE++ D+++ GV
Sbjct: 186 PEIVNYEPLGLEADMWSIGV 205
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 55/231 (23%), Positives = 101/231 (43%), Gaps = 38/231 (16%)
Query: 338 KDLYKATKGFKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVAELVSMG 396
+D+Y+ + DV+G G +V + L ++ + AVK + E+ +
Sbjct: 11 EDVYQLQE-----DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLY 65
Query: 397 RLR-HRNLVKLRGYCRRKGEFLLVYDYMPNGSL-DKILHTNIKPCLNWYQRFRIIRGVAS 454
+ + HRN+++L + + F LV++ M GS+ I + N + +++ VAS
Sbjct: 66 QCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK---RRHFNELEASVVVQDVAS 122
Query: 455 GLLYLHEDWEQVVLHRDIKPANVLL-----DADLNGKLGDFGLARLYDHD------TIPQ 503
L +LH + + HRD+KP N+L + + K+ DF L + + P+
Sbjct: 123 ALDFLHN---KGIAHRDLKPENILCEHPNQVSPV--KICDFDLGSGIKLNGDCSPISTPE 177
Query: 504 TTKLVGTFGYMDPELMRTGKASTST-----DVYAFGV---FMLEVASGRRP 546
G+ YM PE++ S D+++ GV +L SG P
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILL---SGYPP 225
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-24
Identities = 57/204 (27%), Positives = 103/204 (50%), Gaps = 16/204 (7%)
Query: 350 KDVIGRGGFGKVYRGV-LASNVQIAVKKV--SHDSKQGIKEFVAELVSMGRLRHRNLVKL 406
++G+G FG+V + + + AVK + + + + E+ + +L H N++KL
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 407 RGYCRRKGEFLLVYDYMPNGSL-DKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQ 465
F +V + G L D+I+ + + + RII+ V SG+ Y+H+
Sbjct: 87 FEILEDSSSFYIVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHK---H 140
Query: 466 VVLHRDIKPANVLL---DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTG 522
++HRD+KP N+LL + D + K+ DFGL+ + +T + +GT Y+ PE++R G
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAYYIAPEVLR-G 197
Query: 523 KASTSTDVYAFGVFMLEVASGRRP 546
DV++ GV + + SG P
Sbjct: 198 TYDEKCDVWSAGVILYILLSGTPP 221
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-24
Identities = 64/252 (25%), Positives = 104/252 (41%), Gaps = 37/252 (14%)
Query: 319 YEEVYEDWEREYGPQRFTYKDLYKATKGFKDKDVIGRGGFGKVYRGVLASNVQI-AVKKV 377
+ W+ T D F +IGRGGFG+VY A ++ A+K +
Sbjct: 170 KFTRFCQWKNVELNIHLTMND-------FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL 222
Query: 378 SHD---SKQGIKEFVAE---LVSMGRLRHRNLVKLRGYCRRKGEFL-LVYDYMPNGSLDK 430
KQG + E L + +V + Y + L + D M G L
Sbjct: 223 DKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDL-- 279
Query: 431 ILHTNIKPCLNWYQRFRIIRG------VASGLLYLHEDWEQVVLHRDIKPANVLLDADLN 484
H L+ + F + GL ++H + V++RD+KPAN+LLD +
Sbjct: 280 HYH------LSQHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGH 330
Query: 485 GKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKA-STSTDVYAFGVFMLEVASG 543
++ D GLA + + VGT GYM PE+++ G A +S D ++ G + ++ G
Sbjct: 331 VRISDLGLACDFSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387
Query: 544 RRPVEQQGSMET 555
P Q + +
Sbjct: 388 HSPFRQHKTKDK 399
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 64/216 (29%), Positives = 98/216 (45%), Gaps = 39/216 (18%)
Query: 347 FKDKDVIGRGGFGKVYRGVLASNVQI-AVKKVSHDSKQG-----IKEFVAELVS-MGRLR 399
+ D +G G + VY+G + A+K++ + ++G I+E VS + L+
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIRE-----VSLLKDLK 58
Query: 400 HRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHT--------NIKPCLNWYQRFRIIRG 451
H N+V L + LV++Y+ L + L N+K L +Q R
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFL--FQLLR---- 111
Query: 452 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT--TKLVG 509
GL Y H VLHRD+KP N+L++ KL DFGLAR +IP V
Sbjct: 112 ---GLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAK---SIPTKTYDNEVV 162
Query: 510 TFGYMDPE-LMRTGKASTSTDVYAFGVFMLEVASGR 544
T Y P+ L+ + ST D++ G E+A+GR
Sbjct: 163 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 44/201 (21%), Positives = 86/201 (42%), Gaps = 26/201 (12%)
Query: 349 DKDVIGRGGFGKVYRGV-LASNVQIAVK--KVSHDSKQGIKEFVAELVSMGRLRHR-NLV 404
+GRG F V + + ++ + A K K + E + E+ + + ++
Sbjct: 33 TSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVI 92
Query: 405 KLRGYCRRKGEFLLVYDYMPNGSL-DKILHTNIKPCLNWYQRF------RIIRGVASGLL 457
L E +L+ +Y G + L + R+I+ + G+
Sbjct: 93 NLHEVYENTSEIILILEYAAGGEIFSLCLPEL-------AEMVSENDVIRLIKQILEGVY 145
Query: 458 YLHEDWEQVVLHRDIKPANVLL---DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYM 514
YLH+ ++H D+KP N+LL + K+ DFG++R H + ++GT Y+
Sbjct: 146 YLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE--IMGTPEYL 200
Query: 515 DPELMRTGKASTSTDVYAFGV 535
PE++ +T+TD++ G+
Sbjct: 201 APEILNYDPITTATDMWNIGI 221
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 57/251 (22%), Positives = 104/251 (41%), Gaps = 38/251 (15%)
Query: 313 IVRNKRYEEVYEDWEREYGPQR---FTYKDLY-----KATKGFKDK----DVIGRGGFGK 360
+ + KR E R F + DL K +D+ +G G G+
Sbjct: 92 VGKGKRRPLNNNS-EIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGE 150
Query: 361 VYRGV-LASNVQIAVKKVS--------HDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCR 411
V + ++A++ +S E+ + +L H ++K++ +
Sbjct: 151 VKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210
Query: 412 RKGEFLLVYDYMPNGSL-DKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHR 470
+ ++ +V + M G L DK++ L + + YLHE ++HR
Sbjct: 211 AE-DYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHE---NGIIHR 263
Query: 471 DIKPANVLL---DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPE-LMRTGKA-- 524
D+KP NVLL + D K+ DFG +++ ++ +T L GT Y+ PE L+ G A
Sbjct: 264 DLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT--LCGTPTYLAPEVLVSVGTAGY 321
Query: 525 STSTDVYAFGV 535
+ + D ++ GV
Sbjct: 322 NRAVDCWSLGV 332
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 56/212 (26%), Positives = 99/212 (46%), Gaps = 22/212 (10%)
Query: 347 FKDKDVIGRGGFGKVYRG--VLASNVQIAVKKVSHDS-KQG-----IKEFVAELVSMGRL 398
++ IG G +GKV++ + +A+K+V + ++G I+E VA L +
Sbjct: 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE-VAVLRHLETF 71
Query: 399 RHRNLVKLR-----GYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVA 453
H N+V+L R+ + LV++++ L L +P + ++ +
Sbjct: 72 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLL 130
Query: 454 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT-TKLVGTFG 512
GL +LH V+HRD+KP N+L+ + KL DFGLAR+Y T +V T
Sbjct: 131 RGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVVVTLW 184
Query: 513 YMDPELMRTGKASTSTDVYAFGVFMLEVASGR 544
Y PE++ +T D+++ G E+ +
Sbjct: 185 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 65/212 (30%), Positives = 109/212 (51%), Gaps = 26/212 (12%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQG-----IKEFVAELVS-MGRLR 399
FK + +G G + VY+G+ + V +A+K+V DS++G I+E +S M L+
Sbjct: 7 FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIRE-----ISLMKELK 61
Query: 400 HRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVA----SG 455
H N+V+L + + LV+++M N L K + + +++ G
Sbjct: 62 HENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 456 LLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT--TKLVGTFGY 513
L + HE+ +LHRD+KP N+L++ KLGDFGLAR + IP + V T Y
Sbjct: 121 LAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAF---GIPVNTFSSEVVTLWY 174
Query: 514 MDPE-LMRTGKASTSTDVYAFGVFMLEVASGR 544
P+ LM + STS D+++ G + E+ +G+
Sbjct: 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 55/233 (23%), Positives = 93/233 (39%), Gaps = 43/233 (18%)
Query: 332 PQRFTYKDLYKATKGFKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVA 390
P+++ D Y+ K V+G G GKV + + A+K + DS + +E
Sbjct: 21 PKKYAVTDDYQL-----SKQVLGLGVNGKVLECFHRRTGQKCALKLLY-DSPKARQEVDH 74
Query: 391 ELVSMGRLRHRNLVKLRGYC----RRKGEFLLVYDYMPNGSL-DKILHTNIKPCLNWYQR 445
+ G ++V + K L++ + M G L +I Q
Sbjct: 75 HWQASG---GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERG-------DQA 124
Query: 446 F------RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL---DADLNGKLGDFGLARLY 496
F I+R + + + +LH + HRD+KP N+L + D KL DFG A+
Sbjct: 125 FTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181
Query: 497 DHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGV---FMLEVASGRRP 546
+ + T Y+ PE++ K S D+++ GV +L G P
Sbjct: 182 TQNAL---QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL---CGFPP 228
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 56/224 (25%), Positives = 96/224 (42%), Gaps = 33/224 (14%)
Query: 341 YKATKGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLR 399
K F+ + + G+G FG V G + + +A+KKV D + +E + + + L
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLH 77
Query: 400 HRNLVKLRGYCRRKGE-------FLLVYDYMPNGSLDKILHTNIKP---------CLNWY 443
H N+V+L+ Y GE +V +Y+P+ +L + + + +
Sbjct: 78 HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLF 136
Query: 444 QRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG--KLGDFGLARLYDHDTI 501
Q R + LH V HRDIKP NVL++ +G KL DFG A+
Sbjct: 137 QLIR-------SIGCLHLPSVNV-CHRDIKPHNVLVNEA-DGTLKLCDFGSAKKLSPSE- 186
Query: 502 PQTTKLVGTFGYMDPELMRTGKA-STSTDVYAFGVFMLEVASGR 544
+ + Y PEL+ + +T+ D+++ G E+ G
Sbjct: 187 -PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 67/212 (31%), Positives = 107/212 (50%), Gaps = 31/212 (14%)
Query: 347 FKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDS-KQGIKEFVA--ELVSMGRLRHRNL 403
++ + +G G +G VY+ + +A+K++ D+ +GI A E+ + L H N+
Sbjct: 23 YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGI-PSTAIREISLLKELHHPNI 81
Query: 404 VKLRGYCRRKGEFLLVYDYMPNGSLDKILHT--------NIKPCLNWYQRFRIIRGVASG 455
V L + LV+++M L K+L IK L YQ ++RGVA
Sbjct: 82 VSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYL--YQ---LLRGVA-- 133
Query: 456 LLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT--TKLVGTFGY 513
+ H+ +LHRD+KP N+L+++D KL DFGLAR + IP T V T Y
Sbjct: 134 --HCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAF---GIPVRSYTHEVVTLWY 185
Query: 514 MDPE-LMRTGKASTSTDVYAFGVFMLEVASGR 544
P+ LM + K STS D+++ G E+ +G+
Sbjct: 186 RAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 59/240 (24%), Positives = 105/240 (43%), Gaps = 32/240 (13%)
Query: 325 DWEREYGPQRFTYKDLYKATKGFKDKDVIGRGGFGKVYRGV---LASNVQIAVKKVSHDS 381
D++ + +R +DL++ + +GRG +G VY+ + A+K++
Sbjct: 6 DFKVKLSSERERVEDLFE-----YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT- 59
Query: 382 KQGI-KEFVAELVSMGRLRHRNLVKLRGYCRRKGE--FLLVYDYMPNGSLDKILHTNIKP 438
GI E+ + L+H N++ L+ + L++DY + L I+ +
Sbjct: 60 --GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRAS 116
Query: 439 CLNWYQRFRIIRGVAS-------GLLYLHEDWEQVVLHRDIKPANVLLDADLNG----KL 487
N V S G+ YLH +W VLHRD+KPAN+L+ + K+
Sbjct: 117 KANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173
Query: 488 GDFGLARLYD--HDTIPQTTKLVGTFGYMDPELMRTGKA-STSTDVYAFGVFMLEVASGR 544
D G ARL++ + +V TF Y PEL+ + + + D++A G E+ +
Sbjct: 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 1e-22
Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 31/206 (15%)
Query: 353 IGRGGFGKVYRGVLASNVQIAVKKVSHDS-KQGIKEFVA--ELVSMGRLRHRNLVKLRGY 409
IG G +G VY+ A+KK+ + +GI E+ + L+H N+VKL
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGI-PSTTIREISILKELKHSNIVKLYDV 68
Query: 410 CRRKGEFLLVYDYMPNGSLDKILHT--------NIKPCLNWYQRFRIIRGVASGLLYLHE 461
K +LV++++ L K+L K L Q ++ G+A Y H+
Sbjct: 69 IHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFL--LQ---LLNGIA----YCHD 118
Query: 462 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT--TKLVGTFGYMDPE-L 518
VLHRD+KP N+L++ + K+ DFGLAR + IP T + T Y P+ L
Sbjct: 119 RR---VLHRDLKPQNLLINREGELKIADFGLARAF---GIPVRKYTHEIVTLWYRAPDVL 172
Query: 519 MRTGKASTSTDVYAFGVFMLEVASGR 544
M + K ST+ D+++ G E+ +G
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 1e-22
Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 20/211 (9%)
Query: 347 FKDKDVIGRGGFGKVYRGVLASNVQI-AVKKVSHD---SKQGIKEFVAELVSMGRLRHRN 402
F D V+GRGGFG+V+ + + ++ A KK++ ++G + + E + ++ R
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 403 LVKLRGYCRRKGEFL-LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRG------VASG 455
+V L Y L LV M G + +I F+ R + SG
Sbjct: 247 IVSLA-YAFETKTDLCLVMTIMNGGDI----RYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 456 LLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMD 515
L +LH+ + +++RD+KP NVLLD D N ++ D GLA +T GT G+M
Sbjct: 302 LEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ-TKTKGYAGTPGFMA 357
Query: 516 PELMRTGKASTSTDVYAFGVFMLEVASGRRP 546
PEL+ + S D +A GV + E+ + R P
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 64/215 (29%), Positives = 97/215 (45%), Gaps = 36/215 (16%)
Query: 353 IGRGGFGKVYRGV-LASNVQIAVKKVSHDS-KQGIKEFVA--ELVSMGRLRHRNLVKLRG 408
IG+G FG+V++ + ++A+KKV ++ K+G A E+ + L+H N+V L
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP-ITALREIKILQLLKHENVVNLIE 83
Query: 409 --------YCRRKGEFLLVYDYMPN---GSLD----KILHTNIKPCLNWYQRFRIIRGVA 453
Y R KG LV+D+ + G L K + IK +
Sbjct: 84 ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK-RV-MQMLLN------ 135
Query: 454 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYD---HDTIPQTTKLVGT 510
GL Y+H + +LHRD+K ANVL+ D KL DFGLAR + + + T V T
Sbjct: 136 -GLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 191
Query: 511 FGYMDPE-LMRTGKASTSTDVYAFGVFMLEVASGR 544
Y PE L+ D++ G M E+ +
Sbjct: 192 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 21/203 (10%)
Query: 353 IGRGGFGKVYRGV-LASNVQIAVK-----KVSHDSKQGIKEFVAELVSMGRLRHRNLVKL 406
IG+G F KV + + ++A+K +++ S Q + E+ M L H N+VKL
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF---REVRIMKILNHPNIVKL 79
Query: 407 RGYCRRKGEFLLVYDYMPNGSL-DKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQ 465
+ L+ +Y G + D ++ + + R + S + Y H+ +
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQ---K 133
Query: 466 VVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGK-- 523
++HRD+K N+LLDAD+N K+ DFG + + G Y PEL + GK
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF--CGAPPYAAPELFQ-GKKY 190
Query: 524 ASTSTDVYAFGVFMLEVASGRRP 546
DV++ GV + + SG P
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLP 213
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 6e-22
Identities = 52/226 (23%), Positives = 94/226 (41%), Gaps = 45/226 (19%)
Query: 332 PQRFTYKDLYKATKGFKDKDVIGRGGFGKVYRGV-LASNVQIAVK--------KVSHDSK 382
P+ +D Y +K +G G G+V + ++A+K S
Sbjct: 5 PKAL--RDEYIMSK------TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREA 56
Query: 383 QGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSL-DKILHTNIKPCLN 441
E+ + +L H ++K++ + + ++ +V + M G L DK++
Sbjct: 57 DPALNVETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGN------- 108
Query: 442 WYQRF------RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL---DADLNGKLGDFGL 492
+R + + YLHE ++HRD+KP NVLL + D K+ DFG
Sbjct: 109 --KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163
Query: 493 ARLYDHDTIPQTTKLVGTFGYMDPE-LMRTGKASTST--DVYAFGV 535
+++ ++ L GT Y+ PE L+ G A + D ++ GV
Sbjct: 164 SKILGETSL--MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 207
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 7e-22
Identities = 54/211 (25%), Positives = 90/211 (42%), Gaps = 22/211 (10%)
Query: 347 FKDKDVIGRGGFGKVYRGVLASNVQI-AVK---KVSHDSKQGIKEFVAELVSMGRLRHRN 402
FK ++G G F V + + A+K K + + E M RL H
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 403 LVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRG------VASGL 456
VKL + + Y NG L + + + F + S L
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNGEL--LKY------IRKIGSFDETCTRFYTAEIVSAL 143
Query: 457 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTK-LVGTFGYMD 515
YLH + ++HRD+KP N+LL+ D++ ++ DFG A++ ++ VGT Y+
Sbjct: 144 EYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 200
Query: 516 PELMRTGKASTSTDVYAFGVFMLEVASGRRP 546
PEL+ A S+D++A G + ++ +G P
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 1e-21
Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 33/211 (15%)
Query: 351 DVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVA-----ELVSMGRLRHRNLV 404
D +G G F VY+ +N +A+KK+ + K+ + E+ + L H N++
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 405 KLRGYCRRKGEFLLVYDYMPNGSLDKILHT--------NIKPCLNWYQRFRIIRGVASGL 456
L K LV+D+M L+ I+ +IK + ++G+
Sbjct: 76 GLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYM--LM---TLQGLE--- 126
Query: 457 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT--TKLVGTFGYM 514
YLH+ W +LHRD+KP N+LLD + KL DFGLA+ + P T V T Y
Sbjct: 127 -YLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF---GSPNRAYTHQVVTRWYR 179
Query: 515 DPELMRTGKA-STSTDVYAFGVFMLEVASGR 544
PEL+ + D++A G + E+
Sbjct: 180 APELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 54/210 (25%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDS-KQGIKEFVA--ELVSMGRLRHRN 402
++ +G G +G+VY+ + +N +A+K++ + ++G+ A E+ + L+HRN
Sbjct: 36 YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGV-PGTAIREVSLLKELQHRN 94
Query: 403 LVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHED 462
+++L+ L+++Y N L K + N ++ + + +G+ + H
Sbjct: 95 IIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPD--VSMRVIKSFLYQLINGVNFCHSR 151
Query: 463 WEQVVLHRDIKPANVLLDADLNG-----KLGDFGLARLYDHDTIPQT--TKLVGTFGYMD 515
LHRD+KP N+LL K+GDFGLAR + IP T + T Y
Sbjct: 152 R---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF---GIPIRQFTHEIITLWYRP 205
Query: 516 PE-LMRTGKASTSTDVYAFGVFMLEVASGR 544
PE L+ + STS D+++ E+
Sbjct: 206 PEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 2e-21
Identities = 53/219 (24%), Positives = 87/219 (39%), Gaps = 43/219 (19%)
Query: 349 DKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVAELVSMGRL-RHRNLVKL 406
V+G G GKV + + + A+K + D + +E EL R + ++V++
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARRE--VEL--HWRASQCPHIVRI 120
Query: 407 RGYC----RRKGEFLLVYDYMPNGSL-DKILHTNIKPCLNWYQRF------RIIRGVASG 455
+ L+V + + G L +I Q F I++ +
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRG-------DQAFTEREASEIMKSIGEA 173
Query: 456 LLYLHEDWEQVVLHRDIKPANVLL-----DADLNGKLGDFGLARLYDHDTIPQTTKLVGT 510
+ YLH + HRD+KP N+L +A L KL DFG A+ T T
Sbjct: 174 IQYLHS---INIAHRDVKPENLLYTSKRPNAIL--KLTDFGFAKETTSHNSLTTP--CYT 226
Query: 511 FGYMDPELMRTGKASTSTDVYAFGV---FMLEVASGRRP 546
Y+ PE++ K S D+++ GV +L G P
Sbjct: 227 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILL---CGYPP 262
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 3e-21
Identities = 52/231 (22%), Positives = 87/231 (37%), Gaps = 36/231 (15%)
Query: 337 YKDLYKATKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVA------ 390
+L+ + + I G +G V GV + + +A+K+V + G +
Sbjct: 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 391 -----ELVSMGRLRHRNLVKLR-----GYCRRKGEFLLVYDYMPNGSLDKILHTNIKP-- 438
E+ + H N++ LR + LV + M L +++H
Sbjct: 74 KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVIS 132
Query: 439 ----CLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR 494
Y GL LHE V+HRD+ P N+LL + + + DF LAR
Sbjct: 133 PQHIQYFMYHILL-------GLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAR 182
Query: 495 LYDHDTIPQTTKLVGTFGYMDPELMRTGKA-STSTDVYAFGVFMLEVASGR 544
D T V Y PEL+ K + D+++ G M E+ + +
Sbjct: 183 EDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-21
Identities = 64/212 (30%), Positives = 92/212 (43%), Gaps = 34/212 (16%)
Query: 352 VIGRGGFGKVYRGVLASNVQI-AVKKVSHDSKQGIKEF------VAELVSMGRLRHRNLV 404
IG+G FGKV ++ A+K ++ KQ E EL M L H LV
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMN---KQKCVERNEVRNVFKELQIMQGLEHPFLV 78
Query: 405 KLRGYCRRKGEFL-LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRG------VASGLL 457
L Y + E + +V D + G L H L F+ + L
Sbjct: 79 NLW-YSFQDEEDMFMVVDLLLGGDL--RYH------LQQNVHFKEETVKLFICELVMALD 129
Query: 458 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPE 517
YL Q ++HRD+KP N+LLD + + DF +A + +T Q T + GT YM PE
Sbjct: 130 YLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET--QITTMAGTKPYMAPE 184
Query: 518 LMRTGKA---STSTDVYAFGVFMLEVASGRRP 546
+ + K S + D ++ GV E+ GRRP
Sbjct: 185 MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 6e-21
Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 15/202 (7%)
Query: 352 VIGRGGFGKVYRGVLASNVQI-AVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKLR 407
V+G+GGFG+V + + ++ A KK+ ++G + E + ++ R +V L
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250
Query: 408 GYC-RRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQ-RFRIIRGVASGLLYLHEDWEQ 465
Y K LV M G L ++ + + F + GL LH +
Sbjct: 251 -YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDLHR---E 305
Query: 466 VVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMDPELMRTGKA 524
+++RD+KP N+LLD + ++ D GLA + + T VGT GYM PE+++ +
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERY 362
Query: 525 STSTDVYAFGVFMLEVASGRRP 546
+ S D +A G + E+ +G+ P
Sbjct: 363 TFSPDWWALGCLLYEMIAGQSP 384
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 6e-21
Identities = 50/210 (23%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 344 TKGFKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSH--DSKQGIKEFVAELVSMGRLRH 400
K +++ IG G G V + +A+KK+S ++ K ELV M + H
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 401 RNLVKLR------GYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVAS 454
+N++ L + LV + M +L +++ + Y ++++ G
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCG--- 176
Query: 455 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYM 514
+ +LH ++HRD+KP+N+++ +D K+ DFGLAR T V T Y
Sbjct: 177 -IKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYR 230
Query: 515 DPELMRTGKASTSTDVYAFGVFMLEVASGR 544
PE++ + D+++ G M E+ +
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 7e-21
Identities = 49/196 (25%), Positives = 82/196 (41%), Gaps = 22/196 (11%)
Query: 353 IGRGGFGKVYRGV-LASNVQIAVK--------KVSHDSKQGIKEFVAELVSMGRLRHRNL 403
+G G FG V+ V N ++ VK + + + E+ + R+ H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 404 VKLRGYCRRKGEFLLVYDYMPNGS--LDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHE 461
+K+ +G F LV + +G I P L+ I R + S + YL
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRL 148
Query: 462 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRT 521
+ ++HRDIK N+++ D KL DFG A + + T GT Y PE++
Sbjct: 149 ---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF--CGTIEYCAPEVLM- 202
Query: 522 GK--ASTSTDVYAFGV 535
G ++++ GV
Sbjct: 203 GNPYRGPELEMWSLGV 218
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 8e-21
Identities = 30/213 (14%), Positives = 68/213 (31%), Gaps = 39/213 (18%)
Query: 351 DVIGRGGFGKVYRGV-LASNVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKL 406
G + ++ + A + Q+A+ V ++E ++ + + R+ + ++
Sbjct: 37 IFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 407 RGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQV 466
+ L+V +++ GSL ++ T+ P R ++ +A+ H
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVADTSPSP----VGAIRAMQSLAAAADAAHR---AG 149
Query: 467 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKAST 526
V P+ V + D G L M A+
Sbjct: 150 VALSIDHPSRVRVSID--------GDVVL-------------AYPATMPD-------ANP 181
Query: 527 STDVYAFGVFMLEVASGRRPVEQQGSMETVNLV 559
D+ G + + R P+ + G +
Sbjct: 182 QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA 214
|
| >1qmo_A Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 Length = 113 | Back alignment and structure |
|---|
Score = 86.9 bits (215), Expect = 8e-21
Identities = 28/112 (25%), Positives = 46/112 (41%), Gaps = 20/112 (17%)
Query: 30 FIYHGFNEDAQ-LQRDGLASVHSNGLLQLTNTVS-----PQQEGHAFYRLPIKFNTSSSE 83
F + F+ + + L G A+ +N +LQ+T S G Y P++ S+
Sbjct: 6 FSFTKFDPNQEDLIFQGHATS-TNNVLQVTKLDSAGNPVSSSAGRVLYSAPLRLWEDSAV 64
Query: 84 SLSFSSNFVFAI----------GMAFVISPSKDLGKAEASPSEYLGLFNASN 125
SF + F I G+AF I+P + + +LGLF +N
Sbjct: 65 LTSFDTIINFEISTPYTSRIADGLAFFIAPPDSVI---SYHGGFLGLFPNAN 113
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-20
Identities = 63/255 (24%), Positives = 101/255 (39%), Gaps = 32/255 (12%)
Query: 318 RYEEVYEDWEREYGPQRFTYKDLYKATKGFKDKDVIGRGGFGKVYRGVLASNVQI-AVKK 376
R + +++ Y +DL + ++ VIGRG FG+V S ++ A+K
Sbjct: 42 RKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL 101
Query: 377 VSHD---SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFL-LVYDYMPNGSLDKIL 432
+S + F E M +V+L Y + +L +V +YMP G L
Sbjct: 102 LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDL---- 156
Query: 433 HTNIKPCLNWYQRFRIIRGVA--------SGLLYLHEDWEQVVLHRDIKPANVLLDADLN 484
+N + + A L +H +HRD+KP N+LLD +
Sbjct: 157 -------VNLMSNYDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGH 206
Query: 485 GKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPE-LMRTGKAST---STDVYAFGVFMLEV 540
KL DFG + + + + VGT Y+ PE L G D ++ GVF+ E+
Sbjct: 207 LKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 266
Query: 541 ASGRRPVEQQGSMET 555
G P + T
Sbjct: 267 LVGDTPFYADSLVGT 281
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 54/200 (27%), Positives = 87/200 (43%), Gaps = 28/200 (14%)
Query: 352 VIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVA---------ELVSMGRLRHR 401
++G GGFG VY G+ ++ N+ +A+K V K I ++ E+V + ++
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVE---KDRISDWGELPNGTRVPMEVVLLKKVSSG 106
Query: 402 --NLVKLRGYCRRKGEFLLVYDY-MPNGSL-DKILHTNIKPCLNWYQRFRIIRGVASGLL 457
+++L + R F+L+ + P L D I + L V +
Sbjct: 107 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVR 163
Query: 458 YLHEDWEQVVLHRDIKPANVLLDAD-LNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDP 516
+ H VLHRDIK N+L+D + KL DFG L DT+ GT Y P
Sbjct: 164 HCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDF--DGTRVYSPP 217
Query: 517 ELMRTGK-ASTSTDVYAFGV 535
E +R + S V++ G+
Sbjct: 218 EWIRYHRYHGRSAAVWSLGI 237
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 49/207 (23%), Positives = 91/207 (43%), Gaps = 19/207 (9%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSH--DSKQGIKEFVAELVSMGRLRHRNL 403
+++ IG G G V +A+KK+S ++ K ELV M + H+N+
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 404 VKLR------GYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLL 457
+ L + +V + M +L +++ + Y ++++ G +
Sbjct: 87 IGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLCG----IK 141
Query: 458 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPE 517
+LH ++HRD+KP+N+++ +D K+ DFGLAR T V T Y PE
Sbjct: 142 HLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPE 196
Query: 518 LMRTGKASTSTDVYAFGVFMLEVASGR 544
++ + D+++ G M E+ G
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 47/202 (23%), Positives = 82/202 (40%), Gaps = 30/202 (14%)
Query: 352 VIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVA---------ELVSMGRLR-- 399
++G+GGFG V+ G L +Q+A+K + + + + E+ + ++
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIP---RNRVLGWSPLSDSVTCPLEVALLWKVGAG 94
Query: 400 --HRNLVKLRGYCRRKGEFLLVYDYMPNGS--LDKILHTNIKPCLNWYQRFRIIRGVASG 455
H +++L + + F+LV + D I K L V +
Sbjct: 95 GGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAA 151
Query: 456 LLYLHEDWEQVVLHRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYM 514
+ + H + V+HRDIK N+L+D KL DFG L HD GT Y
Sbjct: 152 IQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALL-HDEPYTDF--DGTRVYS 205
Query: 515 DPELMRTGK-ASTSTDVYAFGV 535
PE + + + V++ G+
Sbjct: 206 PPEWISRHQYHALPATVWSLGI 227
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 28/214 (13%)
Query: 344 TKGFKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSH--DSKQGIKEFVAELVSMGRLRH 400
K + +G G +G V + S ++A+KK+S S+ K EL+ + ++H
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 401 RNLVKLR------GYCRRKGEFLLVYDYMPNGSLDKILHTNIKP---CLNWYQRFRIIRG 451
N++ L R +F LV +M L KI+ YQ +
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQMLK---- 137
Query: 452 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 511
GL Y+H V+HRD+KP N+ ++ D K+ DFGLAR D + T V T
Sbjct: 138 ---GLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHAD----AEMTGYVVTR 187
Query: 512 GYMDPELMRT-GKASTSTDVYAFGVFMLEVASGR 544
Y PE++ + + + D+++ G M E+ +G+
Sbjct: 188 WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 4e-20
Identities = 54/190 (28%), Positives = 94/190 (49%), Gaps = 16/190 (8%)
Query: 353 IGRGGFGKVYRGV-LASNVQIAVKKVSHDS--KQGIKEFVA-ELVSMGRLRHRNLVKLRG 408
+G G FGKV G + ++AVK ++ + + E+ ++ RH +++KL
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 409 YCRRKGEFLLVYDYMPNGSL-DKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVV 467
+F +V +Y+ G L D I + + R+ + + S + Y H +V
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHR---HMV 132
Query: 468 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGK--AS 525
+HRD+KP NVLLDA +N K+ DFGL+ + +T+ G+ Y PE++ G+ A
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEVIS-GRLYAG 189
Query: 526 TSTDVYAFGV 535
D+++ GV
Sbjct: 190 PEVDIWSCGV 199
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 8e-20
Identities = 62/221 (28%), Positives = 99/221 (44%), Gaps = 34/221 (15%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVK 405
+ D +G GG G V+ V + ++A+KK+ Q +K + E+ + RL H N+VK
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 406 LR-----------GYCRRKGEFL---LVYDYMPNGSLDKILHTNI----KPCLNWYQRFR 447
+ E +V +YM L +L L YQ R
Sbjct: 73 VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHARLFMYQLLR 131
Query: 448 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA-DLNGKLGDFGLARLYD--HDTIPQT 504
GL Y+H VLHRD+KPAN+ ++ DL K+GDFGLAR+ D +
Sbjct: 132 -------GLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL 181
Query: 505 TKLVGTFGYMDPELMRTGKA-STSTDVYAFGVFMLEVASGR 544
++ + T Y P L+ + + + D++A G E+ +G+
Sbjct: 182 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 8e-20
Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVS-HDSKQGIKEFVAELVSMGRLRHRNLV 404
+ + IG G +G V + V++A+KK+S + + + + E+ + R RH N++
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 405 KLR-----GYCRRKGEFLLVYDYMPNGSLDKILH----TNIKPCLNWYQRFRIIRGVASG 455
+ + + +V D M L K+L +N C YQ R G
Sbjct: 89 GINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILR-------G 140
Query: 456 LLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYD--HDTIPQTTKLVGTFGY 513
L Y+H VLHRD+KP+N+LL+ + K+ DFGLAR+ D HD T+ V T Y
Sbjct: 141 LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 514 MDPELMRTGKA-STSTDVYAFGVFMLEVASGR 544
PE+M K + S D+++ G + E+ S R
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 9e-20
Identities = 69/307 (22%), Positives = 117/307 (38%), Gaps = 37/307 (12%)
Query: 268 SSLPRLPHLPRPRAKANDKPQLKLVISVSLIAILVVLITIGAAVYIVRNKRYEEV---YE 324
S RL L + + + +L+ IL+ L + R K E +
Sbjct: 1 SGEVRLRQLEQFILDGPAQTNGQCFSVETLLDILICLYDECNNSPLRREKNILEYLEWAK 60
Query: 325 DWEREYGPQRFTYKDLYKATKGFKDKDVIGRGGFGKVYRGVLASNVQI-AVKKVSHD--- 380
+ + R +D F+ VIGRG FG+V L + ++ A+K ++
Sbjct: 61 PFTSKVKQMRLHRED-------FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML 113
Query: 381 SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFL-LVYDYMPNGSLDKILHTNIKPC 439
+ F E + + + L Y + L LV DY G L +L
Sbjct: 114 KRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLS------ 166
Query: 440 LNWYQRFRIIRG------VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLA 493
+ R + + +H+ +HRDIKP N+L+D + + +L DFG
Sbjct: 167 -KFEDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSC 222
Query: 494 RLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTST-----DVYAFGVFMLEVASGRRPVE 548
D Q++ VGT Y+ PE+++ + D ++ GV M E+ G P
Sbjct: 223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY 282
Query: 549 QQGSMET 555
+ +ET
Sbjct: 283 AESLVET 289
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 1e-19
Identities = 58/251 (23%), Positives = 97/251 (38%), Gaps = 67/251 (26%)
Query: 344 TKGFKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRN 402
+K + +G G FG V + S + A+KKV D + +E L M L H N
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE----LDIMKVLDHVN 61
Query: 403 LVKLRGYCRRKGEFL--------------------------------------LVYDYMP 424
++KL Y G+ ++ +Y+P
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 425 NGSLDKILHTNIKP---------CLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPA 475
+ +L K+L + I+ + YQ FR + ++H + HRDIKP
Sbjct: 122 D-TLHKVLKSFIRSGRSIPMNLISIYIYQLFR-------AVGFIHS---LGICHRDIKPQ 170
Query: 476 NVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKA-STSTDVYAF 533
N+L+++ N KL DFG A+ + + + Y PELM + S D+++
Sbjct: 171 NLLVNSKDNTLKLCDFGSAKKLIPS--EPSVAYICSRFYRAPELMLGATEYTPSIDLWSI 228
Query: 534 GVFMLEVASGR 544
G E+ G+
Sbjct: 229 GCVFGELILGK 239
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 2e-19
Identities = 54/218 (24%), Positives = 88/218 (40%), Gaps = 29/218 (13%)
Query: 347 FKDKDVIGRGGFGKVYRGVLASNVQI-AVKKVSHD---SKQGIKEFVAELVSMGRLRHRN 402
F+ VIGRG F +V + Q+ A+K ++ + + F E + R
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 403 LVKLRGYCRRKGEFL-LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRG------VASG 455
+ +L + + +L LV +Y G L +L + +R +
Sbjct: 123 ITQLH-FAFQDENYLYLVMEYYVGGDLLTLLS-------KFGERIPAEMARFYLAEIVMA 174
Query: 456 LLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMD 515
+ +H +HRDIKP N+LLD + +L DFG D ++ VGT Y+
Sbjct: 175 IDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLS 231
Query: 516 PELMRTGKASTSTDVY-------AFGVFMLEVASGRRP 546
PE+++ T Y A GVF E+ G+ P
Sbjct: 232 PEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 59/206 (28%), Positives = 91/206 (44%), Gaps = 15/206 (7%)
Query: 353 IGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVA-ELVSMGRLRHRNLVKLRGYC 410
+G G +G+V V + +AVK V E + E+ L H N+VK G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 411 RRKGEFLLVYDYMPNGSL-DKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLH 469
R L +Y G L D+I + R + +G++YLH + H
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHG---IGITH 128
Query: 470 RDIKPANVLLDADLNGKLGDFGLARLYDHDTIP---QTTKLVGTFGYMDPE-LMRTGKAS 525
RDIKP N+LLD N K+ DFGLA ++ ++ GT Y+ PE L R +
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--CGTLPYVAPELLKRREFHA 186
Query: 526 TSTDVYAFGVFMLEVASGRRPVEQQG 551
DV++ G+ + + +G P +Q
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPS 212
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 4e-19
Identities = 56/221 (25%), Positives = 93/221 (42%), Gaps = 45/221 (20%)
Query: 350 KDVIGRGGFGKVYRGV-LASNVQIAVKKVS-------------------------HDSKQ 383
KD IG+G +G V N A+K +S +
Sbjct: 18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77
Query: 384 GIKEFVA-ELVSMGRLRHRNLVKLRGY----CRRKGEFLLVYDYMPNGSLDKILHTNIKP 438
G E V E+ + +L H N+VKL + +V++ + G + ++
Sbjct: 78 GPIEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEVPT---LK 132
Query: 439 CLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY-D 497
L+ Q + + G+ YLH Q ++HRDIKP+N+L+ D + K+ DFG++ +
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189
Query: 498 HDTIPQTTKLVGTFGYMDPELMRTGKAS---TSTDVYAFGV 535
D + T VGT +M PE + + + DV+A GV
Sbjct: 190 SDALLSNT--VGTPAFMAPESLSETRKIFSGKALDVWAMGV 228
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 5e-19
Identities = 53/195 (27%), Positives = 84/195 (43%), Gaps = 28/195 (14%)
Query: 353 IGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVA-ELVSMGRLRHRNLVKLRGYC 410
IG G FG + +AVK + + I E V E+++ LRH N+V+ +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYI--ERGAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 411 RRKGEFLLVYDYMPNGSL-DKILHTNIKPCLNWYQRF------RIIRGVASGLLYLHEDW 463
++ +Y G L ++I + RF + + SG+ Y H
Sbjct: 86 LTPTHLAIIMEYASGGELYERICN---------AGRFSEDEARFFFQQLLSGVSYCHS-- 134
Query: 464 EQVVLHRDIKPANVLLDADLNG--KLGDFGLARLYDHDTIPQTTKLVGTFGYMDPE-LMR 520
+ HRD+K N LLD K+ DFG ++ + P++T VGT Y+ PE L+R
Sbjct: 135 -MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLR 191
Query: 521 TGKASTSTDVYAFGV 535
DV++ GV
Sbjct: 192 QEYDGKIADVWSCGV 206
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 5e-19
Identities = 52/212 (24%), Positives = 89/212 (41%), Gaps = 26/212 (12%)
Query: 351 DVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVA----ELVSMGRLRHRNLVK 405
D++G G +GKV + + + AVK + + I A E+ + RLRH+N+++
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 406 LRG--YCRRKGEFLLVYDYMPNGS---LDKILHTNIKPCLNWYQR--FR-IIRGVASGLL 457
L Y K + +V +Y G LD + F +I G+
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPV---CQAHGYFCQLIDGLE---- 123
Query: 458 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLV-GTFGYMDP 516
YLH Q ++H+DIKP N+LL K+ G+A T + G+ + P
Sbjct: 124 YLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180
Query: 517 ELMRTGK--ASTSTDVYAFGVFMLEVASGRRP 546
E+ + D+++ GV + + +G P
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 5e-19
Identities = 52/244 (21%), Positives = 104/244 (42%), Gaps = 27/244 (11%)
Query: 309 AAVYIVRNKRYEEVYEDWEREYGPQRFTYKDLYKATKGFKDKDVIGRGGFGKVYRGV-LA 367
A VY N Y D+E ++ + ++ +GRG + +V+ + +
Sbjct: 8 ARVYTDVNTHRPREYWDYE--------SHVVEWGNQDDYQLVRKLGRGKYSEVFEAINIT 59
Query: 368 SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLR-HRNLVKLRGYCRRKGEF--LLVYDYMP 424
+N ++ VK + K+ IK E+ + LR N++ L + LV++++
Sbjct: 60 NNEKVVVKILKPVKKKKIKR---EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVN 116
Query: 425 NGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLN 484
N ++ T + + + I++ L Y H ++HRD+KP NV++D +
Sbjct: 117 NTDFKQLYQT-LTDYDIRFYMYEILKA----LDYCHSMG---IMHRDVKPHNVMIDHEHR 168
Query: 485 G-KLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKA-STSTDVYAFGVFMLEVAS 542
+L D+GLA Y + V + + PEL+ + S D+++ G + +
Sbjct: 169 KLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 226
Query: 543 GRRP 546
+ P
Sbjct: 227 RKEP 230
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 7e-19
Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 33/217 (15%)
Query: 344 TKGFKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSH--DSKQGIKEFVAELVSMGRLRH 400
++D +G G +G V V + ++A+KK+ S+ K EL + +RH
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 401 RNLVKLR------GYCRRKGEFLLVYDYMPNGSLDKILHTN------IKPCLNWYQRFRI 448
N++ L +F LV +M L K++ I+ + YQ +
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFLV--YQMLK- 139
Query: 449 IRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLV 508
GL Y+H ++HRD+KP N+ ++ D K+ DFGLAR D + T V
Sbjct: 140 ------GLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQAD----SEMTGYV 186
Query: 509 GTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGR 544
T Y PE++ + + + D+++ G M E+ +G+
Sbjct: 187 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 55/217 (25%), Positives = 95/217 (43%), Gaps = 33/217 (15%)
Query: 344 TKGFKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSH--DSKQGIKEFVAELVSMGRLRH 400
+ +++ +G G +G V + +++AVKK+S S K EL + ++H
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 401 RNLVKLR------GYCRRKGEFLLVYDYMPNGSLDKILHTN------IKPCLNWYQRFRI 448
N++ L + LV M L+ I+ ++ + YQ R
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLI--YQILR- 143
Query: 449 IRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLV 508
GL Y+H ++HRD+KP+N+ ++ D K+ DFGLAR + T V
Sbjct: 144 ------GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTA----DEMTGYV 190
Query: 509 GTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGR 544
T Y PE+M + + D+++ G M E+ +GR
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 2e-18
Identities = 58/193 (30%), Positives = 96/193 (49%), Gaps = 22/193 (11%)
Query: 353 IGRGGFGKVYRGV-LASNVQIAVKKV------SHDSKQGIKEFVAELVSMGRLRHRNLVK 405
+G G FGKV G + ++AVK + S D I+ E+ ++ RH +++K
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR---EIQNLKLFRHPHIIK 80
Query: 406 LRGYCRRKGEFLLVYDYMPNGSL-DKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWE 464
L + +V +Y+ G L D I L+ + R+ + + SG+ Y H
Sbjct: 81 LYQVISTPSDIFMVMEYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHR--- 134
Query: 465 QVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGK- 523
+V+HRD+KP NVLLDA +N K+ DFGL+ + +T+ G+ Y PE++ G+
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEVIS-GRL 191
Query: 524 -ASTSTDVYAFGV 535
A D+++ GV
Sbjct: 192 YAGPEVDIWSSGV 204
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 56/190 (29%), Positives = 85/190 (44%), Gaps = 15/190 (7%)
Query: 353 IGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVA-ELVSMGRLRHRNLVKLRGYC 410
+G G +G+V V + +AVK V E + E+ L H N+VK G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 411 RRKGEFLLVYDYMPNGSL-DKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLH 469
R L +Y G L D+I + R + +G++YLH + H
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHG---IGITH 128
Query: 470 RDIKPANVLLDADLNGKLGDFGLARLYDH---DTIPQTTKLVGTFGYMDPE-LMRTGKAS 525
RDIKP N+LLD N K+ DFGLA ++ + + + GT Y+ PE L R +
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--CGTLPYVAPELLKRREFHA 186
Query: 526 TSTDVYAFGV 535
DV++ G+
Sbjct: 187 EPVDVWSCGI 196
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 52/224 (23%), Positives = 95/224 (42%), Gaps = 36/224 (16%)
Query: 344 TKGFKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVS-HDSKQGIKEFVAELVSMGRLRHR 401
+ F+ K ++G G +G V + +A+KK+ D + E+ + +H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 402 NLVKLR-----GYCRRKGEFLLVYDYMPNGSLDKILHTN------IKPCLNWYQRFRIIR 450
N++ + E ++ + M L +++ T I+ + YQ R
Sbjct: 70 NIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFI--YQTLR--- 123
Query: 451 GVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYD---------HDTI 501
+ LH V+HRD+KP+N+L++++ + K+ DFGLAR+ D
Sbjct: 124 ----AVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 502 PQTTKLVGTFGYMDPELMRTGKA-STSTDVYAFGVFMLEVASGR 544
+ V T Y PE+M T S + DV++ G + E+ R
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 1e-17
Identities = 41/163 (25%), Positives = 74/163 (45%), Gaps = 18/163 (11%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGI--KEFVAELVSMGRLRHRNL 403
++ + +IG G +G V +A+KK+ + I K + E+ + RL H ++
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHV 114
Query: 404 VKLR-----GYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRF--RIIRGVASGL 456
VK+ + E +V + + K+ T + + ++ G +
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVG----V 169
Query: 457 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD 499
Y+H +LHRD+KPAN L++ D + K+ DFGLAR D+
Sbjct: 170 KYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 1e-17
Identities = 49/198 (24%), Positives = 82/198 (41%), Gaps = 28/198 (14%)
Query: 344 TKGFKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSH--DSKQGIKEFVAELVSMGRLRH 400
+ K +IGRG +G VY + +A+KKV+ + K + E+ + RL+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS 84
Query: 401 RNLVKLR-----GYCRRKGEFLLVYDYMPNGSLDKILHTN-------IKPCLNWYQRFRI 448
+++L + E +V + + L K+ T IK L Y +
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTIL--YN---L 138
Query: 449 IRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLV 508
+ G ++HE ++HRD+KPAN LL+ D + K+ DFGLAR + + +
Sbjct: 139 LLG----ENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191
Query: 509 GTFGYMDPELMRTGKAST 526
P K T
Sbjct: 192 EENEEPGPHNKNLKKQLT 209
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 54/190 (28%), Positives = 92/190 (48%), Gaps = 17/190 (8%)
Query: 353 IGRGGFGKVYRGV-LASNVQIAVKKVSHD--SKQGIKEFVA-ELVSMGRLRHRNLVKLRG 408
+G G FGKV + ++A+K +S K + V E+ + LRH +++KL
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 409 YCRRKGEFLLVYDYMPNGSL-DKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVV 467
+ ++V +Y G L D I+ K + + R + + + Y H +
Sbjct: 77 VITTPTDIVMVIEYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHR---HKI 129
Query: 468 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGK--AS 525
+HRD+KP N+LLD +LN K+ DFGL+ + +T+ G+ Y PE++ GK A
Sbjct: 130 VHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEVIN-GKLYAG 186
Query: 526 TSTDVYAFGV 535
DV++ G+
Sbjct: 187 PEVDVWSCGI 196
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 5e-17
Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 27/208 (12%)
Query: 352 VIGRGGFGKVYRGVLASNVQI-AVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKLR 407
++G+G FGKV + + A+K + + +K + + E + RH L L+
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 408 GYCRRKGEFL-LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRG------VASGLLYLH 460
Y + + L V +Y G L H L+ + F R + S L YLH
Sbjct: 215 -YSFQTHDRLCFVMEYANGGEL--FFH------LSRERVFSEDRARFYGAEIVSALDYLH 265
Query: 461 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVGTFGYMDPEL 518
E+ V++RD+K N++LD D + K+ DFGL + + D T GT Y+ PE+
Sbjct: 266 S--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFCGTPEYLAPEV 320
Query: 519 MRTGKASTSTDVYAFGVFMLEVASGRRP 546
+ + D + GV M E+ GR P
Sbjct: 321 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 352 VIGRGGFGKVYRGVLASNVQI-AVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKLR 407
++G+G FGKV + + A+K + + +K + V E + RH L L+
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 408 GYCRRKGEFL-LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRG------VASGLLYLH 460
Y + + L V +Y G L H L+ + F R + S L YLH
Sbjct: 72 -YAFQTHDRLCFVMEYANGGEL--FFH------LSRERVFTEERARFYGAEIVSALEYLH 122
Query: 461 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVGTFGYMDPEL 518
+ V++RDIK N++LD D + K+ DFGL + + D T GT Y+ PE+
Sbjct: 123 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTPEYLAPEV 176
Query: 519 MRTGKASTSTDVYAFGVFMLEVASGRRP 546
+ + D + GV M E+ GR P
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 49/213 (23%), Positives = 85/213 (39%), Gaps = 31/213 (14%)
Query: 347 FKDKDVIGRGGFGKVYRGVLASNVQI-AVKKVSHDSKQGIKEF------VAELVSMGRLR 399
F +G G FG+V + A+K + KQ + + + E + +
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD---KQKVVKLKQIEHTLNEKRILQAVN 99
Query: 400 HRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRG------VA 453
LVKL + +V +Y+ G + L RF +
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--------GRFSEPHARFYAAQIV 151
Query: 454 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 513
YLH +++RD+KP N+L+D ++ DFG A+ +T L GT
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWTLCGTPEA 204
Query: 514 MDPELMRTGKASTSTDVYAFGVFMLEVASGRRP 546
+ PE++ + + + D +A GV + E+A+G P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 43/188 (22%), Positives = 81/188 (43%), Gaps = 25/188 (13%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSH--DSKQGIKEFVAELVSMGRLR-HRN 402
++ +G+G +G V++ + + +AVKK+ + + E++ + L H N
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70
Query: 403 LVKLRGYCRRKG--EFLLVYDYMPNGSLDKILHTN------IKPCLNWYQRFRIIRGVAS 454
+V L R + LV+DYM L ++ N + + YQ +
Sbjct: 71 IVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQYVV--YQLIK------- 120
Query: 455 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYM 514
+ YLH +LHRD+KP+N+LL+A+ + K+ DFGL+R + + +
Sbjct: 121 VIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 515 DPELMRTG 522
+
Sbjct: 178 ENFDDDQP 185
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 36/159 (22%), Positives = 62/159 (38%), Gaps = 29/159 (18%)
Query: 350 KDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRG 408
V+G G GKV + + + A+K + D + +E V + ++V++
Sbjct: 23 SQVLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARRE-VELHWRA--SQCPHIVRIVD 78
Query: 409 YC----RRKGEFLLVYDYMPNGSL-DKILHTNIKPCLNWYQRF------RIIRGVASGLL 457
+ L+V + + G L +I Q F I++ + +
Sbjct: 79 VYENLYAGRKCLLIVMECLDGGELFSRIQDRG-------DQAFTEREASEIMKSIGEAIQ 131
Query: 458 YLHEDWEQVVLHRDIKPANVLL---DADLNGKLGDFGLA 493
YLH + HRD+KP N+L + KL DFG A
Sbjct: 132 YLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 2e-15
Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 38/215 (17%)
Query: 352 VIGRGGFGKVY---RGVLASNVQI-AVKKVSHDSKQGIKEFVAELVSM-------GRLRH 400
V+G+GG+GKV+ + A+ +I A+K + K I + ++H
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLK---KAMIVRNAKDTAHTKAERNILEEVKH 80
Query: 401 RNLVKLRGYCRRKGEFL-LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRG------VA 453
+V L Y + G L L+ +Y+ G L + L F ++
Sbjct: 81 PFIVDLI-YAFQTGGKLYLILEYLSGGEL--FMQ------LEREGIFMEDTACFYLAEIS 131
Query: 454 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVGTF 511
L +LH+ + +++RD+KP N++L+ + KL DFGL + ++D T GT
Sbjct: 132 MALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV---THTFCGTI 185
Query: 512 GYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRP 546
YM PE++ + + D ++ G M ++ +G P
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 3e-15
Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 36/213 (16%)
Query: 352 VIGRGGFGKVY---RGVLASNVQI-AVKKVSHDSKQGIK-----EFVAELVSMGRLRHRN 402
V+G+G FGKV+ + + Q+ A+K + K +K E + + H
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLK---KATLKVRDRVRTKMERDILVEVNHPF 87
Query: 403 LVKLRGYCRRKGEFL-LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRG------VASG 455
+VKL Y + L L+ D++ G L L+ F +A
Sbjct: 88 IVKLH-YAFQTEGKLYLILDFLRGGDL--FTR------LSKEVMFTEEDVKFYLAELALA 138
Query: 456 LLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVGTFGY 513
L +LH +++RD+KP N+LLD + + KL DFGL++ + GT Y
Sbjct: 139 LDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK---AYSFCGTVEY 192
Query: 514 MDPELMRTGKASTSTDVYAFGVFMLEVASGRRP 546
M PE++ + S D ++FGV M E+ +G P
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 7e-15
Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 29/209 (13%)
Query: 352 VIGRGGFGKVYRGVLASNVQI-AVKKVSHD---SKQGIKEFVAE-LVSMGRLRHRNLVKL 406
VIG+G FGKV + AVK + K+ K ++E V + ++H LV L
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 407 RGYCRRKGEFL-LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRG------VASGLLYL 459
+ + + L V DY+ G L H L + F R +AS L YL
Sbjct: 105 H-FSFQTADKLYFVLDYINGGEL--FYH------LQRERCFLEPRARFYAAEIASALGYL 155
Query: 460 HEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVGTFGYMDPE 517
H +++RD+KP N+LLD+ + L DFGL + + + T T+ GT Y+ PE
Sbjct: 156 HS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST---TSTFCGTPEYLAPE 209
Query: 518 LMRTGKASTSTDVYAFGVFMLEVASGRRP 546
++ + D + G + E+ G P
Sbjct: 210 VLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 9e-15
Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 31/213 (14%)
Query: 347 FKDKDVIGRGGFGKVYRGVLASNVQI-AVKKVSHDSKQGIKEF------VAELVSMGRLR 399
F+ +G G FG+V+ N + A+K + K+ + E + + +
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLK---KEIVVRLKQVEHTNDERLMLSIVT 64
Query: 400 HRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRG------VA 453
H ++++ G + + ++ DY+ G L L QRF V
Sbjct: 65 HPFIIRMWGTFQDAQQIFMIMDYIEGGEL--FSL------LRKSQRFPNPVAKFYAAEVC 116
Query: 454 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 513
L YLH + +++RD+KP N+LLD + + K+ DFG A+ Y D T L GT Y
Sbjct: 117 LALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK-YVPDV---TYTLCGTPDY 169
Query: 514 MDPELMRTGKASTSTDVYAFGVFMLEVASGRRP 546
+ PE++ T + S D ++FG+ + E+ +G P
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 43/216 (19%)
Query: 352 VIGRGGFGKVYRGVLASNVQI-AVKKVSHDSKQGIKE-----------FVAELVSMGRLR 399
V+G+G FGKV ++ AVK + K + + V L +
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILK---KDVVIQDDDVECTMVEKRVLALPG----K 79
Query: 400 HRNLVKLRGYCRRKGEFL-LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRG------V 452
L +L C + + L V +Y+ G L + H + RF+ +
Sbjct: 80 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDL--MYH------IQQVGRFKEPHAVFYAAEI 130
Query: 453 ASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVGT 510
A GL +L + +++RD+K NV+LD++ + K+ DFG+ + ++D T T GT
Sbjct: 131 AIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGT 184
Query: 511 FGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRP 546
Y+ PE++ S D +AFGV + E+ +G+ P
Sbjct: 185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 64/216 (29%), Positives = 97/216 (44%), Gaps = 43/216 (19%)
Query: 352 VIGRGGFGKVYRGVLASNVQI-AVKKVSHDSKQGIKE-----------FVAELVSMGRLR 399
VIGRG + KV L +I A+K V K+ + + V E S
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVK---KELVNDDEDIDWVQTEKHVFEQAS----N 68
Query: 400 HRNLVKLRGYCRRKGEFL-LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRG------V 452
H LV L C + L V +Y+ G L + H + ++ +
Sbjct: 69 HPFLVGLH-SCFQTESRLFFVIEYVNGGDL--MFH------MQRQRKLPEEHARFYSAEI 119
Query: 453 ASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVGT 510
+ L YLHE + +++RD+K NVLLD++ + KL D+G+ + L DT T+ GT
Sbjct: 120 SLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGT 173
Query: 511 FGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRP 546
Y+ PE++R S D +A GV M E+ +GR P
Sbjct: 174 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 75.8 bits (186), Expect = 2e-14
Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 43/216 (19%)
Query: 352 VIGRGGFGKVYRGVLASNVQI-AVKKVSHDSKQGIKE-----------FVAELVSMGRLR 399
V+G+G FGKV ++ AVK + K + + V L +
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILK---KDVVIQDDDVECTMVEKRVLALPG----K 400
Query: 400 HRNLVKLRGYCRRKGEFL-LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRG------V 452
L +L C + + L V +Y+ G L + H + RF+ +
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDL--MYH------IQQVGRFKEPHAVFYAAEI 451
Query: 453 ASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVGT 510
A GL +L + +++RD+K NV+LD++ + K+ DFG+ + ++D T T GT
Sbjct: 452 AIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGT 505
Query: 511 FGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRP 546
Y+ PE++ S D +AFGV + E+ +G+ P
Sbjct: 506 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 53/216 (24%), Positives = 90/216 (41%), Gaps = 43/216 (19%)
Query: 352 VIGRGGFGKVYRGVLASNVQI-AVKKVSHDSKQGIKE-----------FVAELVSMGRLR 399
++G+G FGKV+ Q A+K + K + V L
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKALK---KDVVLMDDDVECTMVEKRVLSLAW----E 76
Query: 400 HRNLVKLRGYCRRKGEFL-LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRG------V 452
H L + + E L V +Y+ G L + + +F + R +
Sbjct: 77 HPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSC--------HKFDLSRATFYAAEI 127
Query: 453 ASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVGT 510
GL +LH + +++RD+K N+LLD D + K+ DFG+ + + T GT
Sbjct: 128 ILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCGT 181
Query: 511 FGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRP 546
Y+ PE++ K + S D ++FGV + E+ G+ P
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 38/217 (17%)
Query: 352 VIGRGGFGKVY---RGVLASNVQI-AVKKVSHDSKQGIKEFVA---------ELVSMGRL 398
V+G G +GKV+ + ++ A+K + + + E +
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR---- 116
Query: 399 RHRNLVKLRGYCRRKGEFL-LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRG------ 451
+ LV L Y + L L+ DY+ G L H L+ +RF
Sbjct: 117 QSPFLVTLH-YAFQTETKLHLILDYINGGEL--FTH------LSQRERFTEHEVQIYVGE 167
Query: 452 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 511
+ L +LH+ +++RDIK N+LLD++ + L DFGL++ + D + GT
Sbjct: 168 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 224
Query: 512 GYMDPELMRTGKA--STSTDVYAFGVFMLEVASGRRP 546
YM P+++R G + + D ++ GV M E+ +G P
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 43/216 (19%)
Query: 352 VIGRGGFGKVYRGVLASNVQI-AVKKVSHDSKQGIKE-----------FVAELVSMGRLR 399
V+G+G FGKV + + AVK + K I + + L
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLK---KDVILQDDDVECTMTEKRILSLAR----N 82
Query: 400 HRNLVKLRGYCRRKGEFL-LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRG------V 452
H L +L C + + L V +++ G L + H + +RF R +
Sbjct: 83 HPFLTQLF-CCFQTPDRLFFVMEFVNGGDL--MFH------IQKSRRFDEARARFYAAEI 133
Query: 453 ASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLA--RLYDHDTIPQTTKLVGT 510
S L++LH+ + +++RD+K NVLLD + + KL DFG+ + + T T GT
Sbjct: 134 ISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFCGT 187
Query: 511 FGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRP 546
Y+ PE+++ + D +A GV + E+ G P
Sbjct: 188 PDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 43/216 (19%)
Query: 352 VIGRGGFGKVYRGVLASNVQI-AVKKVSHDSKQGIKE-----------FVAELVSMGRLR 399
VIGRG + KV L +I A++ V K+ + + V E S
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVK---KELVNDDEDIDWVQTEKHVFEQAS----N 111
Query: 400 HRNLVKLRGYCRRKGEFL-LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRG------V 452
H LV L C + L V +Y+ G L + H + ++ +
Sbjct: 112 HPFLVGLH-SCFQTESRLFFVIEYVNGGDL--MFH------MQRQRKLPEEHARFYSAEI 162
Query: 453 ASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVGT 510
+ L YLHE + +++RD+K NVLLD++ + KL D+G+ + L DT T+ GT
Sbjct: 163 SLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGT 216
Query: 511 FGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRP 546
Y+ PE++R S D +A GV M E+ +GR P
Sbjct: 217 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 69.1 bits (168), Expect = 7e-13
Identities = 43/264 (16%), Positives = 81/264 (30%), Gaps = 69/264 (26%)
Query: 328 REYGPQRFTYKDLYKATKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSK----- 382
+ GP F++ T+ + + IG G FG+V++ + A + +A+K ++ +
Sbjct: 6 SQKGPVPFSH---CLPTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNG 61
Query: 383 ---QGIKEFVAELVSMGRL---------RHRNLVKLRGYCRRKG----EFLLVYDY---- 422
+ +E + E++ L R + L +G L +D+
Sbjct: 62 SHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNST 121
Query: 423 ---------------------MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHE 461
G +D L + I+ + + L
Sbjct: 122 KGSANDRPDFFKDDQLFIVLEFEFGGID--LEQMRTKLSSLATAKSILHQLTASLAVAEA 179
Query: 462 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT--------------IPQTTKL 507
HRD+ NVLL KL + + + + +
Sbjct: 180 SLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIV 237
Query: 508 VGTFGYMDPELMRTGKASTSTDVY 531
V MD +L TG D+Y
Sbjct: 238 VFCDVSMDEDLF-TGDGDYQFDIY 260
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 30/97 (30%), Positives = 47/97 (48%), Gaps = 5/97 (5%)
Query: 452 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGT 510
VA G+ +L + +HRD+ N+LL K+ DFGLAR +Y +
Sbjct: 202 VAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 511 FGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRP 546
+M PE + + +DV++FGV + E+ S G P
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 6e-10
Identities = 24/122 (19%), Positives = 49/122 (40%), Gaps = 9/122 (7%)
Query: 350 KDVIGRGGFGKVYRGVL------ASNVQIAVKKV-SHDSKQGIKEFVAELVSMGRL-RHR 401
+GRG FG+V A+ +AVK + + + ++EL + + H
Sbjct: 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86
Query: 402 NLVKLRGYC-RRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLH 460
N+V L G C + G +++ ++ G+L L + + + + R + +
Sbjct: 87 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 146
Query: 461 ED 462
D
Sbjct: 147 VD 148
|
| >2ltn_B PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1hkd_B 1rin_B* 1ofs_B* 1bqp_B* 1loe_B 1loa_B* 1loc_B* 1lod_B* 1lob_B 1lof_B* 1log_B* 1lof_D* 1les_B* 2b7y_B* 1lgc_B* 1lgb_B* 1len_B 1lem_B 2lal_B Length = 52 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 1e-11
Identities = 17/47 (36%), Positives = 28/47 (59%)
Query: 216 TKPLLSRAINLSHILLETMYVGFSASTGSLKSSHYVLGWSFNRSGPA 262
T LS ++L ++ E + +GFSA+TG+ ++H VL WSF+
Sbjct: 2 TSYTLSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVLSWSFHSELSG 48
|
| >1gv9_A P58/ergic-53; lectin, carbohydrate binding; 1.46A {Rattus norvegicus} SCOP: b.29.1.13 PDB: 1r1z_A 3a4u_A 3lcp_A Length = 260 | Back alignment and structure |
|---|
Score = 61.8 bits (149), Expect = 9e-11
Identities = 33/251 (13%), Positives = 72/251 (28%), Gaps = 46/251 (18%)
Query: 17 SFIFSALAQDVNQFIYHGFNEDAQLQRDGLASVHSNGLLQLTNTVSPQQEGHAFYRLPIK 76
SF L Q + +A S +++ + Q G + +
Sbjct: 35 SFKGPHLVQSDGTVPFWAHAGNAIP---------SADQIRIAPS-LKSQRGSVWTKTKAA 84
Query: 77 FNTSSSESLSFSSNFVFAI---------GMAFVISPSKDLGKAEASPSEYLGLFNASNNG 127
F ++ F + G+A + + +F +++
Sbjct: 85 FE-------NWEVEVTFRVTGRGRIGADGLAIWYTEN---------QGLDGPVFGSADMW 128
Query: 128 QSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELI-I 186
+ I D+ N + V + + + + + +
Sbjct: 129 NG----VGIFFDSFDNDGKKNNPAIVVVGNNGQI---NYDHQNDGATQALASCQRDFRNK 181
Query: 187 GDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLK 246
P++ I+Y +K L V + P + + ++ + G SA+TG L
Sbjct: 182 PYPVRAKITYY--QKTLTVMINNGFTPDKNDYEFCAKVE-NMVIPTQGHFGISAATGGLA 238
Query: 247 SSHYVLGWSFN 257
H VL +
Sbjct: 239 DDHDVLSFLTF 249
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 46/202 (22%), Positives = 72/202 (35%), Gaps = 56/202 (27%)
Query: 353 IGRGGFGKVYRGV------LASNVQIAVKKVSHDSKQ-----------GIKEFVAELVSM 395
IG+GGFG +Y + S+ VK D+ E + + +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 396 GRLRHRNLVKLRGY---CRRKGEF-LLVYDYMPNG-SLDKILHTNIKPCLNWYQRF---- 446
+L++ + K G + + ++ D G L KI N +RF
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEAN-------AKRFSRKT 153
Query: 447 ------RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGK--LGDFGLARLY-- 496
RI+ L Y+HE +H DIK +N+LL+ + L D+GLA Y
Sbjct: 154 VLQLSLRIL----DILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCP 206
Query: 497 --DHDTIPQTTK--LVGTFGYM 514
H K GT +
Sbjct: 207 EGVHKAYAADPKRCHDGTIEFT 228
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 9e-09
Identities = 27/191 (14%), Positives = 59/191 (30%), Gaps = 34/191 (17%)
Query: 353 IGRGGFGKVYRGV---------LASNVQIAVKKVSHDSK----------QGIKEFVAELV 393
R G +Y + ++K + D + V +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 394 SMGRLRHRNLVKLRGYCRRKGEF-LLVYDYMPNG-SLDKILHTNIKPCLNWYQRFRIIRG 451
+ + G+ + ++ LV + G SL L + K L+ ++
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 452 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGK--LGDFGLARLY--DHDTIP----Q 503
+ L +LHE +H ++ N+ +D + + L +G A Y +
Sbjct: 168 LLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGS 224
Query: 504 TTKLVGTFGYM 514
+ G ++
Sbjct: 225 RSPHEGDLEFI 235
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 5e-08
Identities = 39/201 (19%), Positives = 67/201 (33%), Gaps = 57/201 (28%)
Query: 353 IGRGGFGKVYRGV-LASNVQIAVKKVSHDSK---------------QGIKEFVAELVSMG 396
IG GGFG +Y + A V + + K+ + + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAK-KDCIKKWIERK 103
Query: 397 RLRHRNLVKLRGY---CRRKGEF-LLVYDYMPNG-SLDKILHTNIKPCLNWYQRF----- 446
+L + + G + + +V + + G L KI F
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKIS--------GQNGTFKKSTV 153
Query: 447 -----RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGK--LGDFGLARLY--- 496
R++ L Y+HE +H DIK AN+LL + L D+GL+ Y
Sbjct: 154 LQLGIRML----DVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPN 206
Query: 497 -DHDTIPQTTK--LVGTFGYM 514
+H + + GT +
Sbjct: 207 GNHKQYQENPRKGHNGTIEFT 227
|
| >2dur_A VIP36;, vesicular integral-membrane protein VIP36; beta sandwich, carbohydrate binding protein, cargo receptor, transport; HET: MAN; 1.65A {Canis lupus familiaris} PDB: 2dup_A 2duq_A* 2duo_A* 2e6v_A* Length = 253 | Back alignment and structure |
|---|
Score = 53.4 bits (127), Expect = 5e-08
Identities = 32/219 (14%), Positives = 63/219 (28%), Gaps = 40/219 (18%)
Query: 51 SNGLLQLTNTVSPQQEGHAFYRLPIKFNTSSSESLSFSSNFVFAI-----------GMAF 99
++ ++LT ++ G + P + + F + G+A
Sbjct: 36 TSQYVRLTPDERSKE-GSIWNHQPCFLK-------DWEMHVHFKVHGTGKKNLHGDGIAL 87
Query: 100 VISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVN 159
+ + + + H LAI LDT N + + ++ + VN
Sbjct: 88 WYTRDR-------------LVPGPVFGSKDNFHGLAIFLDTYPNDETTERVFPYISVMVN 134
Query: 160 SLISHESAPAAYFSDREGMNKTLELI-IGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKP 218
+ S + E T + + + Y L V +
Sbjct: 135 N-GSLSYDHSKDGRWTELAGCTADFRNRDHDTFLAVRYS--RGRLTVMTDLEDKNEWKNC 191
Query: 219 LLSRAINLSHILLETMYVGFSASTGSLKSSHYVLGWSFN 257
+ + L Y G SA TG L +H ++
Sbjct: 192 IDITGVRLP----TGYYFGASAGTGDLSDNHDIISMKLF 226
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 43/187 (22%), Positives = 72/187 (38%), Gaps = 32/187 (17%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVK 405
F+ IG G FG++ G L +N +A+K S+ + +
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQ-LGSGDGIPQ 69
Query: 406 LRGYCRRKGEFLLVYDYMPNG-SLDKILHTNIKPCLNWYQRF------RIIRGVASGLLY 458
+ + +V + + G SL+ + C + F I + S + Y
Sbjct: 70 VYYFGPCGKYNAMVLELL--GPSLEDLF----DLC---DRTFSLKTVLMIAIQLISRMEY 120
Query: 459 LHEDWEQVVLHRDIKPANVLLDADLNGK-----LGDFGLARLY-DHDT---IPQTTK--L 507
+H + +++RD+KP N L+ N + DF LA+ Y D +T IP L
Sbjct: 121 VHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSL 177
Query: 508 VGTFGYM 514
GT YM
Sbjct: 178 TGTARYM 184
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 46/188 (24%), Positives = 77/188 (40%), Gaps = 34/188 (18%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRH-RNLV 404
+K IG G FG ++ G L +N Q+A+K S E + L +
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD--EYRTYKLLAGCTGIP 69
Query: 405 KLRGYCRRKGEFLLVYDYMPNG-SLDKILHTNIKPCLNWYQRF------RIIRGVASGLL 457
+ + + +LV D + G SL+ +L + +F + + + +
Sbjct: 70 NVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGR-------KFSVKTVAMAAKQMLARVQ 120
Query: 458 YLHEDWEQVVLHRDIKPANVLLDADLNGK-----LGDFGLARLY-DHDT---IPQTTK-- 506
+HE + +++RDIKP N L+ + + DFG+ + Y D T IP K
Sbjct: 121 SIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN 177
Query: 507 LVGTFGYM 514
L GT YM
Sbjct: 178 LSGTARYM 185
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 51/261 (19%), Positives = 96/261 (36%), Gaps = 50/261 (19%)
Query: 317 KRYEEVYEDWEREYGPQRFTYKDLYKATKGFKDKD-------------------VIGRGG 357
Y E+Y ++ G+ D VIG+G
Sbjct: 53 FSYPEIYFL---GLNAKKRQGMTGGPNNGGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGS 109
Query: 358 FGKVYRGV-LASNVQIAVK---KVSHDSKQGIKE--FVAELVSMGRLRHRNLVKLRGYCR 411
FG+V + + +A+K +Q +E + L + N++ +
Sbjct: 110 FGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT 169
Query: 412 RKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRF------RIIRGVASGLLYLHEDWEQ 465
+ + ++ L L+ IK N +Q F + + L LH+
Sbjct: 170 FRNHICMTFE-----LLSMNLYELIK--KNKFQGFSLPLVRKFAHSILQCLDALHK---N 219
Query: 466 VVLHRDIKPANVLL-DADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGK 523
++H D+KP N+LL +G K+ DFG + Y+H + T + F Y PE++ +
Sbjct: 220 RIIHCDLKPENILLKQQGRSGIKVIDFGSS-CYEHQRV--YTYIQSRF-YRAPEVILGAR 275
Query: 524 ASTSTDVYAFGVFMLEVASGR 544
D+++ G + E+ +G
Sbjct: 276 YGMPIDMWSLGCILAELLTGY 296
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 6e-07
Identities = 42/186 (22%), Positives = 74/186 (39%), Gaps = 32/186 (17%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRH-RNLV 404
++ IG G FG +Y G +A+ ++A+K +K E ++ +
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKMMQGGVGIP 68
Query: 405 KLRGYCRRKGEFLLVYDYMPNG-SLDKILHTNIKPCLNWYQRF------RIIRGVASGLL 457
+R ++V + + G SL+ + + ++F + + S +
Sbjct: 69 TIRWCGAEGDYNVMVMELL--GPSLEDLFNFC-------SRKFSLKTVLLLADQMISRIE 119
Query: 458 YLHEDWEQVVLHRDIKPANVLLDADLNGK---LGDFGLARLY----DHDTIPQTTK--LV 508
Y+H + +HRD+KP N L+ G + DFGLA+ Y H IP L
Sbjct: 120 YIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 176
Query: 509 GTFGYM 514
GT Y
Sbjct: 177 GTARYA 182
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 44/180 (24%), Positives = 75/180 (41%), Gaps = 32/180 (17%)
Query: 353 IGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLV-KLRGYC 410
IG G FG++Y G + +N ++A+K + +K + E L+ + +R +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRILQGGTGIPNVRWFG 72
Query: 411 RRKGEFLLVYDYMPNG-SLDKILHTNIKPCLNWYQRF------RIIRGVASGLLYLHEDW 463
+LV D + G SL+ + + ++ + + + + ++H
Sbjct: 73 VEGDYNVLVMDLL--GPSLEDLFNFC-------SRKLSLKTVLMLADQMINRVEFVHS-- 121
Query: 464 EQVVLHRDIKPANVLLDADLNGK---LGDFGLARLY-DHDT---IPQTTK--LVGTFGYM 514
+ LHRDIKP N L+ + DFGLA+ Y D T IP L GT Y
Sbjct: 122 -KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 7e-07
Identities = 39/221 (17%), Positives = 84/221 (38%), Gaps = 40/221 (18%)
Query: 351 DVIGRGGFGKVYRGV-LASNVQIAVK---KVSHDSKQGIKEF-------VAELVSMGRLR 399
+G G F V+ + +N +A+K ++ E A+ +
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 400 HRNLVKLRG---YCRRKGEFL-LVYDYMPNGSLDKILHTNIKPCLNWYQRF------RII 449
+++KL + G + +V++ + +L ++ ++ +I
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYE------HRGIPLIYVKQIS 137
Query: 450 RGVASGLLYLHEDWEQVVLHRDIKPANVLLD------ADLNGKLGDFGLARLYDHDTIPQ 503
+ + GL Y+H ++H DIKP NVL++ + K+ D G A + +
Sbjct: 138 KQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC-WYDEHY-- 192
Query: 504 TTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGR 544
T + T Y PE++ D+++ + E+ +G
Sbjct: 193 -TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 41/212 (19%), Positives = 85/212 (40%), Gaps = 26/212 (12%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKV-SHDS--KQGIKE--FVAELVSMGRLRH 400
++ +IG+G FG+V + +A+K + + + Q E + +
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 401 RNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRI--IRGVA----S 454
+V L+ + + LV++ L L+ ++ ++ + R A +
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFE-----MLSYNLYDLLR--NTNFRGVSLNLTRKFAQQMCT 168
Query: 455 GLLYLHEDWEQVVLHRDIKPANVLLDADLNG--KLGDFGLARLYDHDTIPQTTKLVGTFG 512
LL+L ++ H D+KP N+LL K+ DFG + I + F
Sbjct: 169 ALLFLATPELSII-HCDLKPENILLCNPKRSAIKIVDFGSS-CQLGQRI--YQYIQSRF- 223
Query: 513 YMDPELMRTGKASTSTDVYAFGVFMLEVASGR 544
Y PE++ + D+++ G ++E+ +G
Sbjct: 224 YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 3e-05
Identities = 59/498 (11%), Positives = 148/498 (29%), Gaps = 157/498 (31%)
Query: 121 FNASNNGQSTNHILAIELDT-VQNLDFDDIDDNHVGI----DVNSLI--SHESAPAAYFS 173
F + IL++ D V N D D+ D I +++ +I +
Sbjct: 9 FETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLF 68
Query: 174 D--REGMNKTLELIIGDPIQI---WI----------------SY-DGAEKLLNVT--LAP 209
+ ++ + + ++I ++ Y + ++L N A
Sbjct: 69 WTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAK 128
Query: 210 MSIPKPTKPL--LSRAI-NLSH---ILLETMYVGF--SASTGSLKSSHYVLG-------W 254
++ + +P L +A+ L +L++ + +G + + S+ V W
Sbjct: 129 YNVSRL-QPYLKLRQALLELRPAKNVLIDGV-LGSGKTWVALDVCLSYKVQCKMDFKIFW 186
Query: 255 -SF-NRSGPAL----------NLDISSLPRLPHLPRPRAKAND-KPQLKLVISV-----S 296
+ N + P +D + R H + + + + +L+ ++
Sbjct: 187 LNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENC 246
Query: 297 LIAIL--V--------------VLITIGAAVYIVRNKRYEEVYEDWEREYGPQRFTYKDL 340
L+ +L V +L+T R+++V + T+ L
Sbjct: 247 LL-VLLNVQNAKAWNAFNLSCKILLT----------TRFKQVTDF----LSAATTTHISL 291
Query: 341 YKATKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQG-------IKEFVAELV 393
+ +V + +L + + + + I E + + +
Sbjct: 292 DHHSMTLTPDEV----------KSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGL 341
Query: 394 SM-GRLRHRNLVKLRGYCRRKGEFLLVYDY---------MPNGSLDKILHTNIKP---CL 440
+ +H N KL L +Y P +I L
Sbjct: 342 ATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPP-------SAHIPTILLSL 394
Query: 441 NWYQ---------------RFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG 485
W+ + + + + ++ ++K + + L+
Sbjct: 395 IWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPS------IYLELK-VKLENEYALHR 447
Query: 486 KLGD-FGLARLYDHDTIP 502
+ D + + + +D D +
Sbjct: 448 SIVDHYNIPKTFDSDDLI 465
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 32/161 (19%), Positives = 50/161 (31%), Gaps = 61/161 (37%)
Query: 441 NWYQRF------RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDAD------------ 482
+ YQ +II+ V GL YLH ++H DIKP N+LL +
Sbjct: 138 SNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEAT 195
Query: 483 -------------------------------------LNGKLGDFGLARLYDHDTIPQTT 505
L K+ D G A T
Sbjct: 196 EWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK----HFT 251
Query: 506 KLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRP 546
+ + T Y E++ +T D+++ E+A+G
Sbjct: 252 EDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYL 292
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 614 | |||
| 3ujo_A | 281 | Legume lectin; carbohydrate-binding, galactose, ad | 100.0 | |
| 3ipv_A | 251 | Lectin alpha chain; galactose binding, SEED lectin | 100.0 | |
| 3zyr_A | 261 | Lectin; sugar binding protein, N-glycan; HET: NAG | 100.0 | |
| 1dbn_A | 239 | MAL, protein (leukoagglutinin); plant lectin, carb | 100.0 | |
| 1hql_A | 257 | Lectin; xenograft antigen, sugar BI protein; HET: | 100.0 | |
| 1fny_A | 237 | BARK lectin, BARK agglutinin I,polypeptide A; legu | 100.0 | |
| 1fx5_A | 242 | UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HO | 100.0 | |
| 1v6i_A | 232 | Agglutinin, PNA, galactose-binding lectin; open qu | 100.0 | |
| 1gzc_A | 239 | Erythrina crista-galli lectin; carbohydrate, sugar | 100.0 | |
| 1qnw_A | 242 | Chitin binding lectin, UEA-II; carbohydrate bindin | 100.0 | |
| 2eig_A | 234 | Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG bin | 100.0 | |
| 1sbf_A | 253 | Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {G | 100.0 | |
| 1g7y_A | 253 | Stem/LEAF lectin DB58; jelly roll fold, sugar bind | 100.0 | |
| 2fmd_A | 240 | Lectin, agglutinin, BMA; legume lectin, beta sandw | 100.0 | |
| 1n47_A | 233 | Isolectin B4; cancer antigen, vicia villosa lectin | 100.0 | |
| 1fat_A | 252 | Phytohemagglutinin-L; glycoprotein, plant defense | 100.0 | |
| 1gsl_A | 243 | Griffonia simplicifolia lectin 4; glycoprotein, ma | 100.0 | |
| 2bqp_A | 234 | Protein (PEA lectin); D-glucopyranose complex, sug | 100.0 | |
| 1wbf_A | 242 | Protein (agglutinin); lectin (agglutinin), legume | 100.0 | |
| 1f9k_A | 238 | Acidic lectin; legume lectin, glycosylated protein | 100.0 | |
| 1avb_A | 226 | Arcelin-1; lectin-like glycoprotein, plant defense | 100.0 | |
| 1ioa_A | 240 | Arcelin-5A, ARC5A; lectin-like proteins, plant def | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 1dhk_B | 223 | Bean lectin-like inhibitor, porcine pancreatic alp | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2ltn_A | 181 | PEA lectin, alpha chain; 1.70A {Pisum sativum} SCO | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1qmo_E | 133 | Mannose binding lectin, FRIL; crosslink, hematopoi | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1nls_A | 237 | Concanavalin A; lectin, agglutinin; 0.94A {Canaval | 100.0 | |
| 2dur_A | 253 | VIP36;, vesicular integral-membrane protein VIP36; | 100.0 | |
| 1gv9_A | 260 | P58/ergic-53; lectin, carbohydrate binding; 1.46A | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1qmo_A | 113 | Mannose binding lectin, FRIL; crosslink, hematopoi | 99.92 | |
| 2a6y_A | 256 | EMP47P (FORM1); beta sandwich, carbohydrate bindin | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 1nls_A | 237 | Concanavalin A; lectin, agglutinin; 0.94A {Canaval | 99.86 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.77 | |
| 2a6z_A | 222 | EMP47P (FORM2); beta sandwich, carbohydrate bindin | 99.62 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.61 | |
| 2ltn_B | 52 | PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP | 99.42 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 2a6v_A | 226 | EMP46P; beta sandwich, carbohydrate binding protei | 99.14 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.04 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.89 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.83 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.48 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.39 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.29 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.22 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.12 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.09 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.7 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.56 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.36 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.2 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.98 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.77 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.75 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.67 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.54 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.51 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.16 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.03 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.89 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.72 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.53 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.13 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 92.69 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 89.83 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.18 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 81.77 |
| >3ujo_A Legume lectin; carbohydrate-binding, galactose, adenine binding protein; HET: ADE GAL; 2.00A {Dolichos lablab} PDB: 3ujq_A* 3uk9_A* 3ul2_A* 1fat_A* 1g8w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-61 Score=479.13 Aligned_cols=217 Identities=32% Similarity=0.529 Sum_probs=194.3
Q ss_pred hccCCcceEEeCCCCCCCCceEecceeEcCCCcEEecCCCCC-----CceeeEeeCCceeecCCC-CCceeeeeeeEEee
Q 044561 22 ALAQDVNQFIYHGFNEDAQLQRDGLASVHSNGLLQLTNTVSP-----QQEGHAFYRLPIKFNTSS-SESLSFSSNFVFAI 95 (614)
Q Consensus 22 ~~~~~~~~f~~~~f~~~~~~~~~g~a~~~~~g~l~Lt~~~~~-----~~~G~~~y~~pv~l~~~~-~~~~sF~t~F~f~i 95 (614)
+.++...+|+|++|+. .+|+++|+|.+. +|.||||++..+ .++|||+|++||+|||++ |+++||+|+|+|.|
T Consensus 21 ~~sa~~~sF~f~~F~~-~nL~l~GdA~i~-~g~L~LT~~~~~~~p~~~s~Gra~Y~~Pi~l~d~~tg~vaSFsTsFsF~I 98 (281)
T 3ujo_A 21 AASANLISFTFKKFNE-TNLILQRDATVS-SGKLRITKAAENGVPTAGSLGRAFYSTPIQIWDNTTGTVASWATSFTFNL 98 (281)
T ss_dssp ---CEEEEEEESSCCS-TTEEECSSCCCB-TTBEECSCCCSSCCCCSSCEEEEEESSCEECBCSSSCCBEEEEEEEEEEC
T ss_pred cCcCCcceEEcCCCCc-cCEEEecceEEe-CCEEEeCCCCCCCcccCCceEEEEECCCEEcccCCCCCceeEEEEEEEEE
Confidence 3456678999999985 899999999998 999999997641 389999999999999987 88999999999999
Q ss_pred ----------eeEEEEcCCCCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeeEecCCCcccc
Q 044561 96 ----------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHE 165 (614)
Q Consensus 96 ----------G~aF~l~p~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~ 165 (614)
||||||+|.+..| +++||||||+|.+++ ++.||+|||||||++|.+| ||++|||||||||+.|.+
T Consensus 99 ~~~~~~~~gdGlAF~laP~~~~p---~~~gg~LGL~n~~~~-~~~n~~vAVEFDT~~N~e~-Dp~~nHVGIDvNSi~S~~ 173 (281)
T 3ujo_A 99 QAPNAASPADGLAFALVPVGSQP---KDKGGFLGLFDSKNY-ASSNQTVAVEFDTFYNGGW-DPTERHIGIDVNSIKSIK 173 (281)
T ss_dssp CCSSTTSCCEEEEEEEEETTCCC---CCCGGGTTTCSCSSC-CTTSCCEEEEECCSCCCSS-CCSSSEEEEEESSSCCSC
T ss_pred ecCCCCCCCCceEEEEecCCCCC---CCCcceeeeccccCC-CccCcEEEEEEeccccccC-CCCCCeEEEEcCCCCccc
Confidence 9999999987553 468999999998876 7789999999999999888 999999999999999999
Q ss_pred cccCccccCccCCCccccccCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcccccccccccccccCCC-
Q 044561 166 SAPAAYFSDREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGS- 244 (614)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastg~- 244 (614)
+++|. +.+|+.++|||+||+.+|+|+|++++.+. |++|+|++.|||+++|||+||||||||||.
T Consensus 174 t~~~~-------------l~~G~~~~vwI~Yd~~tk~L~V~l~~~~~--~~~~~lS~~vDL~~~L~e~v~VGFSAsTG~~ 238 (281)
T 3ujo_A 174 TTSWD-------------FANGENAEVLITYDSSTNLLVASLVHPSQ--KTSFIVSERVDLTSVLPEWVSVGFSATTGLS 238 (281)
T ss_dssp EEECC-------------CCSSCCEEEEEEECTTTCEEEEEEECTTT--CCCEEEEEECCSTTTSCSEEEEEEEEEECSS
T ss_pred ccccc-------------ccCCCEEEEEEEEeCCCCEEEEEEecCCC--CCCceEEEEechHHhccCcEEEEEEeecCCC
Confidence 98763 46899999999999999999999998654 557899999999999999999999999996
Q ss_pred --ccceeeEeccccccCC
Q 044561 245 --LKSSHYVLGWSFNRSG 260 (614)
Q Consensus 245 --~~~~h~i~sWsf~~~~ 260 (614)
..|.|+|++|+|+++.
T Consensus 239 ~~~~e~H~IlsWSFss~l 256 (281)
T 3ujo_A 239 KGYVETNEVLSWSFASKL 256 (281)
T ss_dssp TTSCCCCEEEEEEEEEEE
T ss_pred CcccceeEEEEEEEEEEc
Confidence 5899999999999763
|
| >3ipv_A Lectin alpha chain; galactose binding, SEED lectin, hemagglutinin, legume lectin fungal, sugar binding protein; 2.04A {Spatholobus parviflorus} PDB: 3ipv_B 3usu_B* 3usu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-61 Score=471.24 Aligned_cols=216 Identities=35% Similarity=0.521 Sum_probs=195.3
Q ss_pred CcceEEeCCCCC-CCCceEecceeEcCCCcEEecCCCCC-----CceeeEeeCCceeecCCC-CCceeeeeeeEEee---
Q 044561 26 DVNQFIYHGFNE-DAQLQRDGLASVHSNGLLQLTNTVSP-----QQEGHAFYRLPIKFNTSS-SESLSFSSNFVFAI--- 95 (614)
Q Consensus 26 ~~~~f~~~~f~~-~~~~~~~g~a~~~~~g~l~Lt~~~~~-----~~~G~~~y~~pv~l~~~~-~~~~sF~t~F~f~i--- 95 (614)
..++|+|++|.+ ..+|+|+|+|.+.++|.|+||++..+ .++|||+|++||+|||++ ++++||+|+|+|.|
T Consensus 2 ~~~sF~f~~F~~~~~nl~l~GdA~v~~~g~L~LT~~~~~~~~~~~s~Gra~Y~~Pi~l~d~~tg~vaSFsT~F~F~I~~~ 81 (251)
T 3ipv_A 2 EETSFVFSKFKPLEPNLILQGDALVTVAGVLQLTNVDKNGVPEPSSLGRATYSAPINIWDSATGLVASFATSFRFTIYAP 81 (251)
T ss_dssp EEEEEEESSCCSSCTTEEEEETCEECTTSCEESSCBCTTSCBCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCS
T ss_pred cceEEEeCCCCCCCCCeEEeccEEecCCCeEEcCCCCCCCcccCCcEEEEEECCCEEeecCCCCceeeEEEEEEEEEeCC
Confidence 357899999985 47899999999977999999997641 389999999999999988 88999999999999
Q ss_pred -------eeEEEEcCCCCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeeEecCCCccccccc
Q 044561 96 -------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAP 168 (614)
Q Consensus 96 -------G~aF~l~p~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~ 168 (614)
||||||+|.+..+ +..||||||+|.+++ ++.||+|||||||++|.+|+||++|||||||||+.|.++++
T Consensus 82 ~~~~~gdGlAF~lap~~~~~---~~~gg~LGL~n~~~~-~~~n~~vAVEFDT~~n~~~~Dp~~nHVGIdvNsi~S~~t~~ 157 (251)
T 3ipv_A 82 NIATIADGLAFFLAPVASAP---DSGGGFLGLFDSAVS-GSTYQTVAVEFDTYENTVFTDPPYTHIGFDVNSISSIKTVK 157 (251)
T ss_dssp STTSCCEEEEEEEEETTCCC---CCCGGGTTTCSSSSC-CTTSCCEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEE
T ss_pred CCCCCCCceEEEEecCCCCC---CCCCceeeeccccCC-CccCcEEEEEEecccccccCCCCCCeEEEEcCCCcccccce
Confidence 9999999987654 357999999998876 77899999999999999899999999999999999999887
Q ss_pred CccccCccCCCccccccCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcccccccccccccccCCCc---
Q 044561 169 AAYFSDREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSL--- 245 (614)
Q Consensus 169 ~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastg~~--- 245 (614)
| ++.+|+.++|||+||+.+|+|+|+|++.+. |..|+|++.|||+++|||+||||||||||..
T Consensus 158 ~-------------~l~~G~~~~v~I~Yd~~tk~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~ 222 (251)
T 3ipv_A 158 W-------------SLANGEAAKVLITYNSAVKLLVASLVYPSS--KTSFILADIVDLSSVLPEWVRVGFSAATGASGGK 222 (251)
T ss_dssp C-------------CCCTTCEEEEEEEEETTTTEEEEEEECTTT--CCEEEEEEECCHHHHSCSEEEEEEEEEECSSTTC
T ss_pred e-------------EecCCCEEEEEEEEeCCCCEEEEEEecCCC--CccceEEEEechHHhCCCcEEEEEEEecCCCccc
Confidence 5 367899999999999999999999997653 5678999999999999999999999999998
Q ss_pred cceeeEeccccccCC
Q 044561 246 KSSHYVLGWSFNRSG 260 (614)
Q Consensus 246 ~~~h~i~sWsf~~~~ 260 (614)
.|.|+|++|+|+++.
T Consensus 223 ~e~h~IlsWsF~s~l 237 (251)
T 3ipv_A 223 IETHDVFSWSFASKL 237 (251)
T ss_dssp CCCCEEEEEEEEEEE
T ss_pred cceeEEEEEEEEEEC
Confidence 899999999999763
|
| >3zyr_A Lectin; sugar binding protein, N-glycan; HET: NAG BMA MAN GOL; 1.65A {Platypodium elegans} SCOP: b.29.1.1 PDB: 3zvx_A* 1ukg_A* 1q8o_A* 1q8q_A* 1q8s_A* 1q8v_A* 1q8p_A* 2auy_A* 2gme_A 2gmm_A* 2gmp_A* 2gn3_A* 2gn7_A* 2gnb_A* 2gnd_A* 2gnm_A* 2gnt_A 2phf_A* 2phr_A* 2pht_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-60 Score=467.74 Aligned_cols=220 Identities=29% Similarity=0.448 Sum_probs=196.8
Q ss_pred hccCCcceEEeCCCCC-CCCceEecceeEcCCCcEEecCCCC-----CCceeeEeeCCceeecCCC-CCceeeeeeeEEe
Q 044561 22 ALAQDVNQFIYHGFNE-DAQLQRDGLASVHSNGLLQLTNTVS-----PQQEGHAFYRLPIKFNTSS-SESLSFSSNFVFA 94 (614)
Q Consensus 22 ~~~~~~~~f~~~~f~~-~~~~~~~g~a~~~~~g~l~Lt~~~~-----~~~~G~~~y~~pv~l~~~~-~~~~sF~t~F~f~ 94 (614)
+.++...+|+|++|++ ..+|+++|+|.+.++|.|+||++.. ..++|||+|++||+|||++ ++++||+|+|+|.
T Consensus 6 ~~sa~~~sF~f~~F~~~~~~l~l~GdA~i~~~g~L~LT~~~~~~~~~~~s~Gra~Y~~Pv~l~d~~tg~vaSFsT~F~F~ 85 (261)
T 3zyr_A 6 ANSTDSLSFSFINFDRDERNLIFQGDAHTSRNNILQLTRTDSNGAPVRSTVGRILHSAQVRLWEKSTNRVANLQTQFSFF 85 (261)
T ss_dssp --CCEEEEEEESSCCSCCTTEEEEETCEECTTSCEECSCBCTTSCBCSSEEEEEEESSCEECBCTTTCCBEEEEEEEEEE
T ss_pred cCcCcccEEEcCCCCCCCCCeEEeccEEecCCCeEEeCCCCCCCccccCCEEEEEECCCEEeecCCCCCceeEEEEEEEE
Confidence 3466788999999985 4789999999997799999998753 2689999999999999987 8899999999999
Q ss_pred e---------eeEEEEcCCCCC-CCCCCCCCCcccccccCCCCC-CCCcEEEEEeecc---CCCCCCCCCCCeeeEecCC
Q 044561 95 I---------GMAFVISPSKDL-GKAEASPSEYLGLFNASNNGQ-STNHILAIELDTV---QNLDFDDIDDNHVGIDVNS 160 (614)
Q Consensus 95 i---------G~aF~l~p~~~~-~~~~~~~g~~lGl~~~~~~~~-~~~~~vaVEFDt~---~n~~~~d~~~~Hvgid~ns 160 (614)
| ||||||+|.+.. | .+++||||||+|.+++++ +.||+|||||||+ +|.+| ||++|||||||||
T Consensus 86 I~~~~~~~gdGlAF~lap~~~~~p--~~~~g~~LGL~n~~~~g~~~~n~~vAVEFDT~~~~~n~~~-Dp~~nHVGIdvNs 162 (261)
T 3zyr_A 86 LSSPLSNPADGIAFFIAPPDTTIP--SGSAGGLLGLFNPRTALNESANQVLAVEFDTFFAQNSNTW-DPNYQHIGIDVNS 162 (261)
T ss_dssp EECSSSSCCCEEEEEEECTTCCCC--TTCCGGGTTTCCTTTTTCGGGCCCEEEEEECCCCTTTCTT-SCSSCEEEEEESS
T ss_pred EecCCCCCCccEEEEEccCCCCCC--CCCCCceeeeecccccCCCccCcEEEEEEeccccccCcCC-CCCCCeEEEEcCC
Confidence 9 999999998753 4 678999999999988754 5689999999999 99888 9999999999999
Q ss_pred CcccccccCccccCccCCCccccccCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcccccccccccccc
Q 044561 161 LISHESAPAAYFSDREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSA 240 (614)
Q Consensus 161 ~~s~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsa 240 (614)
+.|.++++|. +.+|+.++|||+||+.+++|+|++++.+ +.+|+|++.|||+++|||+|||||||
T Consensus 163 i~S~~s~~~~-------------l~~G~~~~v~I~Yd~~~~~L~V~l~~~~---~~~~~ls~~vdL~~~l~e~v~VGFSA 226 (261)
T 3zyr_A 163 IRSSKVVRWE-------------RREGKTLNVLVTYNPSTRTIDVVATYPD---GQRYQLSHVVDLTTILPEWVRVGFSA 226 (261)
T ss_dssp SSCSEEEECC-------------CCTTCCEEEEEEEETTTTEEEEEEECTT---CCEEEEEEECCGGGTSCSEEEEEEEE
T ss_pred CCcccccccc-------------ccCCceEEEEEEEcCCCCEEEEEEEcCC---CCCeEEEEEechHHhCcCcEEEEEEe
Confidence 9999998763 5689999999999999999999999764 23789999999999999999999999
Q ss_pred cCCCccceeeEeccccccCC
Q 044561 241 STGSLKSSHYVLGWSFNRSG 260 (614)
Q Consensus 241 stg~~~~~h~i~sWsf~~~~ 260 (614)
|||...|.|+|++|+|+++.
T Consensus 227 sTG~~~e~h~IlsWsF~s~l 246 (261)
T 3zyr_A 227 ASGEQFQTHNLESWSFTSTL 246 (261)
T ss_dssp EESSSCCEEEEEEEEEEEEE
T ss_pred cCCCccceEEEEEEEEEEEc
Confidence 99999999999999999763
|
| >1dbn_A MAL, protein (leukoagglutinin); plant lectin, carbohydrate binding, sialyllactose, sugar BIN protein; HET: NAG SIA GAL BGC; 2.75A {Maackia amurensis} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-59 Score=454.69 Aligned_cols=215 Identities=37% Similarity=0.511 Sum_probs=193.4
Q ss_pred CcceEEeCCCCC-CCCceEecceeEcCCCcEEecCCC----CCCceeeEeeCCceeecCCC-CCceeeeeeeEEee----
Q 044561 26 DVNQFIYHGFNE-DAQLQRDGLASVHSNGLLQLTNTV----SPQQEGHAFYRLPIKFNTSS-SESLSFSSNFVFAI---- 95 (614)
Q Consensus 26 ~~~~f~~~~f~~-~~~~~~~g~a~~~~~g~l~Lt~~~----~~~~~G~~~y~~pv~l~~~~-~~~~sF~t~F~f~i---- 95 (614)
...+|+|++|.+ ..+|.++|+|.+.++|.|+||++. ...++|||+|++||+||+++ ++++||+|+|+|.|
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pi~l~~~~tg~vaSFsT~F~F~I~~~~ 81 (239)
T 1dbn_A 2 DELSFTINNFVPNEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIWGNTTGSVASFSTSFTFVVKAPN 81 (239)
T ss_dssp CEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSS
T ss_pred cceEEEcCCCCCCCCCeEEcccEEecCCCcEEeCCCCCCCcccCceEEEEeCCCEecccCCCCCccceEEEEEEEEeCCC
Confidence 457899999985 479999999999879999999875 12799999999999999987 88999999999999
Q ss_pred ------eeEEEEcCCCC-CCCCCCCCCCcccccccCCCCCCCCcEEEEEeeccCC---CCCCCCCCCeeeEecCCCcccc
Q 044561 96 ------GMAFVISPSKD-LGKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQN---LDFDDIDDNHVGIDVNSLISHE 165 (614)
Q Consensus 96 ------G~aF~l~p~~~-~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n---~~~~d~~~~Hvgid~ns~~s~~ 165 (614)
||||||+|.+. .| .++.||||||+|.++ +++.+|+|||||||++| .+ +||++||||||+||+.|.+
T Consensus 82 ~~~~gdGlAF~l~p~~~~~p--~~~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~n~~~~~-~Dp~~nHVGIdvNs~~S~~ 157 (239)
T 1dbn_A 82 PDITSDGLAFYLAPPDSQIP--SGSVSKYLGLFNNSN-SDSSNQIVAVEFDTYFAHSYDP-WDPNYRHIGIDVNGIESIK 157 (239)
T ss_dssp TTSCCEEEEEEEECTTCCCC--SSSCGGGTTSCSSSC-CCTTSCCEEEEEECCCCTTTCT-TSCSSCEEEEEESSSSCSE
T ss_pred CCCCCCCEEEEEecCCCCCC--cCCCCCcccccccCC-CCccccEEEEEEeccccCcccc-cCCCCCcEEEecCCccccc
Confidence 99999999865 34 678999999999764 46789999999999999 77 5999999999999999998
Q ss_pred cccCccccCccCCCccccccCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcccccccccccccccCCCc
Q 044561 166 SAPAAYFSDREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSL 245 (614)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastg~~ 245 (614)
+++| +|.+|+.++|||+||+.+|+|+|+|++.+. |.+|+|++.|||+++|||+||||||||||..
T Consensus 158 ~~~~-------------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~ 222 (239)
T 1dbn_A 158 TVQW-------------DWINGGVAFATITYLAPNKTLIASLVYPSN--QTTFSVAASVDLKEILPEWVRVGFSAATGYP 222 (239)
T ss_dssp EEEC-------------CCCTTCCEEEEEEEEGGGTEEEEEEEETTT--TEEEEEEEECCHHHHSCSEEEEEEEEEECSG
T ss_pred eEcc-------------cccCCCEEEEEEEEeCCCcEEEEEEccCCC--CCcceEEEEechHHhCCccEEEEEEeccCCC
Confidence 8875 367899999999999999999999988653 5578999999999999999999999999998
Q ss_pred --cceeeEeccccccC
Q 044561 246 --KSSHYVLGWSFNRS 259 (614)
Q Consensus 246 --~~~h~i~sWsf~~~ 259 (614)
.|.|+|++|+|+++
T Consensus 223 ~~~~~h~IlsWsF~s~ 238 (239)
T 1dbn_A 223 TEVETHDVLSWSFTST 238 (239)
T ss_dssp GGCCCCEEEEEEEEEE
T ss_pred ccceeeEEEEEEeEec
Confidence 99999999999863
|
| >1hql_A Lectin; xenograft antigen, sugar BI protein; HET: GLA MBG NAG; 2.20A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1gnz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-58 Score=456.08 Aligned_cols=233 Identities=30% Similarity=0.495 Sum_probs=195.2
Q ss_pred CcceEEeCCCC-C-CCCceEecceeEcCCCcEEecCCCC-----CCceeeEeeCCceeecCCC-CCceeeeeeeEEee--
Q 044561 26 DVNQFIYHGFN-E-DAQLQRDGLASVHSNGLLQLTNTVS-----PQQEGHAFYRLPIKFNTSS-SESLSFSSNFVFAI-- 95 (614)
Q Consensus 26 ~~~~f~~~~f~-~-~~~~~~~g~a~~~~~g~l~Lt~~~~-----~~~~G~~~y~~pv~l~~~~-~~~~sF~t~F~f~i-- 95 (614)
...+|+|++|. + ..+|.++|+|.+. +|.|+||++.. ..+.|||||++||+||+++ ++++||+|+|+|.|
T Consensus 3 ~~~~F~f~~F~~~~~~~l~l~GdA~v~-~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg~vasFsT~F~F~I~~ 81 (257)
T 1hql_A 3 DSVSFTFPNFWSDVEDSIIFQGDANTT-AGTLQLCKTNQYGTPLQWSAGRALYSDPVQLWDNKTESVASFYTEFTFFLKI 81 (257)
T ss_dssp -CCEEEESCSCSCGGGTEEEEETCEEE-TTEEECSCBCTTSCBCSSCEEEEEESSCEECCCSTTCCCCEEEEEEEEEEEE
T ss_pred cceEEEcCCCCCCCCCCEEEccceEec-CCcEEecCCccCCcccCCCeEEEEECCCEecccCCCCCeeceEEEEEEEEec
Confidence 45789999998 3 4799999999998 99999998751 3789999999999999987 88999999999999
Q ss_pred -------eeEEEEcCCCCCCCCCCCCCCcccccccCC-CCCCCCcEEEEEeeccCCCCCCCCCCCeeeEecCCCcccccc
Q 044561 96 -------GMAFVISPSKDLGKAEASPSEYLGLFNASN-NGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESA 167 (614)
Q Consensus 96 -------G~aF~l~p~~~~~~~~~~~g~~lGl~~~~~-~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~ 167 (614)
||||||+|.... +++.||||||+|.++ ++++.||+|||||||++|.+|+||++||||||+||+.|.+++
T Consensus 82 ~~~~~gdGlAF~l~p~~~~---~~~~g~~LGl~n~~~~~~~~~n~~vAVEFDT~~N~~~~Dp~~nHVGIdvNs~~S~~s~ 158 (257)
T 1hql_A 82 TGNGPADGLAFFLAPPDSD---VKDAGEYLGLFNKSTATQPSKNQVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVATK 158 (257)
T ss_dssp CSSCCCCEEEEEEECTTCC---CCCCGGGTTTSCTTTTTCGGGCCCEEEEEECSCCSSSCCCSSCEEEEEESSSSCSEEE
T ss_pred CCCCCCCcEEEEEecCCCC---CCCCCccccccccccccCCccCceEEEEecccccccccCCCCCceeeeeCCcccccee
Confidence 999999998654 458899999999876 367789999999999999999999999999999999999988
Q ss_pred cCccccCccCCCccccccCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcccccccccccccccCC-Ccc
Q 044561 168 PAAYFSDREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTG-SLK 246 (614)
Q Consensus 168 ~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastg-~~~ 246 (614)
+|.. .+|.+|+.++|||+||+.+|+|+|+|.+.+. ..|+|++.+||+.+|||+|||||||||| ...
T Consensus 159 ~~~~----------~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~---~~~~ls~~vdL~~~l~e~~~vGFSAsTG~~~~ 225 (257)
T 1hql_A 159 RWED----------SDIFSGKIATARISYDGSAEILTVVLSYPDG---SDYILSHSVDMRQNLPESVRVGISASTGNNQF 225 (257)
T ss_dssp ECCH----------HHHTSCSCEEEEEEEETTTTEEEEEEEETTT---EEEEEEEECCGGGTSCSEEEEEEEEECCSCCC
T ss_pred ccCc----------ccccCCceEEEEEEEeCCCCEEEEEEecCCC---CceeeEEeechHHhcCCceEEEEEeccCCCcc
Confidence 8631 1356799999999999999999999987654 4689999999999999999999999999 899
Q ss_pred ceeeEeccccccCCCCcccCCCCCCCCCC
Q 044561 247 SSHYVLGWSFNRSGPALNLDISSLPRLPH 275 (614)
Q Consensus 247 ~~h~i~sWsf~~~~~~~~~~~s~~p~~~~ 275 (614)
|.|+|++|+|+++++.+..+.+.+|.+|.
T Consensus 226 ~~H~IlsWsF~s~~~~~~~~~~~~p~~~~ 254 (257)
T 1hql_A 226 LTVYILSWRFSSNLQSTSVKAAMEPEITR 254 (257)
T ss_dssp EEEEEEEEEEEEEC---------------
T ss_pred ceeEEEEEEeEecCCCCCcccccCCCCCc
Confidence 99999999999998888888887776654
|
| >1fny_A BARK lectin, BARK agglutinin I,polypeptide A; legume lectin, jelly roll, sugar binding protein; 1.81A {Robinia pseudoacacia} SCOP: b.29.1.1 PDB: 1fnz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-58 Score=452.10 Aligned_cols=213 Identities=33% Similarity=0.522 Sum_probs=190.2
Q ss_pred cceEEeCCCCC-CCCceEecceeEcCCCcEEecCCC----CCCceeeEeeCCceeecCCC-CCceeeeeeeEEee-----
Q 044561 27 VNQFIYHGFNE-DAQLQRDGLASVHSNGLLQLTNTV----SPQQEGHAFYRLPIKFNTSS-SESLSFSSNFVFAI----- 95 (614)
Q Consensus 27 ~~~f~~~~f~~-~~~~~~~g~a~~~~~g~l~Lt~~~----~~~~~G~~~y~~pv~l~~~~-~~~~sF~t~F~f~i----- 95 (614)
..+|+|++|++ ..+|.++|+|.+.++|.|+||++. ...++|||||++||+||+++ ++++||+|+|+|.|
T Consensus 3 ~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pi~l~d~~tg~vaSFsT~F~F~I~~~~~ 82 (237)
T 1fny_A 3 SLSFSFPKFAPNQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWDSTTGNVASFVTSFTFIIQAPNP 82 (237)
T ss_dssp EEEEEESSCCTTCTTEEEEETCEECTTSCEECSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSST
T ss_pred ceEEEcCCCCCCCCCeEEcccEEeccCCeEEecCCcCCCcccCceEEEEeCCCEecccCCCCCccceEEEEEEEEeCCCC
Confidence 46899999985 479999999999879999999875 12799999999999999987 88999999999999
Q ss_pred -----eeEEEEcCCCCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeeEecCCCcccccccCc
Q 044561 96 -----GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAA 170 (614)
Q Consensus 96 -----G~aF~l~p~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~ 170 (614)
||||||+|.... +++.||||||+|.++ +++.+|+|||||||++|.+| ||++||||||+||+.|.++++|
T Consensus 83 ~~~gdGlAF~l~p~~~~---~~~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~n~~~-Dp~~nHVGIdvNsi~S~~~~~~- 156 (237)
T 1fny_A 83 ATTADGLAFFLAPVDTQ---PLDLGGMLGIFKDGY-FNKSNQIVAVEFDTFSNGDW-DPKGRHLGINVNSIESIKTVPW- 156 (237)
T ss_dssp TSCCEEEEEEEEETTCC---CCCCGGGTTTCC----CCTTSCCEEEEEECSCCTTT-CCSSSEEEEEESSSSCSEEEEC-
T ss_pred CCCCCCEEEEeccCCCC---CCCCCCcccccccCC-CCccccEEEEEeecccCccc-CCCCCceEEecCCccccccccc-
Confidence 999999998654 358899999999764 47789999999999999884 9999999999999999988875
Q ss_pred cccCccCCCccccccCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcccccccccccccccCCCc---cc
Q 044561 171 YFSDREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSL---KS 247 (614)
Q Consensus 171 ~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastg~~---~~ 247 (614)
+|.+|+.++|||+||+.+++|+|+|++.+. |..|+|++.|||+++|||+||||||||||.. .|
T Consensus 157 ------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~~ 222 (237)
T 1fny_A 157 ------------NWTNGEVANVFISYEASTKSLTASLVYPSL--ETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQ 222 (237)
T ss_dssp ------------CCCTTCCEEEEEEEEGGGTEEEEEEEETTT--TEEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCCC
T ss_pred ------------cccCCCEEEEEEEEeCCCcEEEEEEecCCC--CCcceEEEEechHHhCCCcEEEEEEEeeCCCCcccc
Confidence 367899999999999999999999987653 5678999999999999999999999999998 99
Q ss_pred eeeEeccccccC
Q 044561 248 SHYVLGWSFNRS 259 (614)
Q Consensus 248 ~h~i~sWsf~~~ 259 (614)
.|+|++|+|+++
T Consensus 223 ~h~IlsWsF~s~ 234 (237)
T 1fny_A 223 TNDVLSWSFESN 234 (237)
T ss_dssp CCEEEEEEEEEE
T ss_pred eeEEEEEEEEEe
Confidence 999999999865
|
| >1fx5_A UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HOMO-dimer, fucose specific lectin, SUG binding protein; HET: NAG FUC BMA MAN; 2.20A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1jxn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-58 Score=447.87 Aligned_cols=215 Identities=32% Similarity=0.451 Sum_probs=193.3
Q ss_pred CcceEEeCCCCC-CCCceEecceeEcCCCcEEecCCC--CCCceee-EeeCCceeecCCC-CCceeeeeeeEEee-----
Q 044561 26 DVNQFIYHGFNE-DAQLQRDGLASVHSNGLLQLTNTV--SPQQEGH-AFYRLPIKFNTSS-SESLSFSSNFVFAI----- 95 (614)
Q Consensus 26 ~~~~f~~~~f~~-~~~~~~~g~a~~~~~g~l~Lt~~~--~~~~~G~-~~y~~pv~l~~~~-~~~~sF~t~F~f~i----- 95 (614)
...+|+|++|.+ ..+|.++|+|.+.++|.|+||++. ...++|| |+|++||+||++. ++++||+|+|+|.|
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~Gr~a~y~~Pv~l~~~~tg~vaSFsT~F~F~I~~~~~ 81 (242)
T 1fx5_A 2 DDLSFKFKNFSQNGKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIWNCNTGELASFITSFSFFMETSAN 81 (242)
T ss_dssp CEEEEEESSCCTTCSSEEEEETCEECTTSCEESCCCSSSSCSEEEEEEEESSCEECEETTTTEECEEEEEEEEEEEESSC
T ss_pred cceEEEcCCCCCCCCCeEEcccEEeccCCcEEecCCCCcccCCccCEEEeCCCEEeecCCCCCccceEEEEEEEEecCCC
Confidence 457899999985 479999999999879999999875 1279999 9999999999987 88999999999998
Q ss_pred ------eeEEEEcCCCCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeeccCCCCC-CCCCCCeeeEecCCCccccccc
Q 044561 96 ------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDF-DDIDDNHVGIDVNSLISHESAP 168 (614)
Q Consensus 96 ------G~aF~l~p~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~-~d~~~~Hvgid~ns~~s~~~~~ 168 (614)
||||||+|.... +++.||||||+|.++ +++.||+|||||||++|.++ +||++||||||+||+.|.++++
T Consensus 82 ~~~~gdGlAF~l~p~~~~---~~~~g~~LGl~n~~~-~~~~n~~vAVEFDT~~N~~~~~Dp~~nHVGIdvNs~~S~~~~~ 157 (242)
T 1fx5_A 82 PKAATDGLTFFLAPPDSP---LRRAGGYFGLFNDTK-CDSSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAER 157 (242)
T ss_dssp GGGCCCEEEEEEECTTCC---CCBCGGGTTTBSSSC-CCGGGCCEEEEEECCCTTTSTTSCSSCEEEEEESSSSCSEEEE
T ss_pred CCCCCCcEEEEEecCCCC---CCCCCCcccccccCC-CCccCcEEEEEeccccCcccccCCCCCeEEEecCCccccceec
Confidence 999999998654 357899999999765 47789999999999999986 7999999999999999998887
Q ss_pred CccccCccCCCccccccCC--ccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcccccccccccccccC--CC
Q 044561 169 AAYFSDREGMNKTLELIIG--DPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSAST--GS 244 (614)
Q Consensus 169 ~~~~~~~~~~~~~~~l~~g--~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsast--g~ 244 (614)
| +|.+| +.++|||+||+.+|+|+|+|++.+. |.+|+|++.+||+++|||+|||||||+| |.
T Consensus 158 ~-------------~l~~G~~~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~VGFSAsT~~G~ 222 (242)
T 1fx5_A 158 W-------------NKRYGLNNVANVEIIYEASSKTLTASLTYPSD--QTSISVTSIVDLKEILPEWVSVGFSGSTYIGR 222 (242)
T ss_dssp C-------------CCCCSGGGCEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCGGGTSCSEEEEEEEEEEETTS
T ss_pred c-------------cccCCCceeEEEEEEEeCCCCEEEEEEecCCC--CccceeeEEechHHhCCccEEEEEEecccCCC
Confidence 5 36789 9999999999999999999998653 5578999999999999999999999999 98
Q ss_pred ccceeeEeccccccCC
Q 044561 245 LKSSHYVLGWSFNRSG 260 (614)
Q Consensus 245 ~~~~h~i~sWsf~~~~ 260 (614)
. |.|+|++|+|+++.
T Consensus 223 ~-~~h~IlsWsF~s~l 237 (242)
T 1fx5_A 223 Q-ATHEVLNWYFTSTF 237 (242)
T ss_dssp C-EEEEEEEEEEEEES
T ss_pred c-ceeEEEEEEeEeec
Confidence 8 99999999998764
|
| >1v6i_A Agglutinin, PNA, galactose-binding lectin; open quaternary association, orthorhombic, carbohydrate specificity, protein crystallography; HET: GAL GLC; 2.15A {Arachis hypogaea} SCOP: b.29.1.1 PDB: 1bzw_A* 1v6j_A* 1v6k_A* 1v6l_A* 1v6m_A 1v6n_A 1v6o_A 2dva_A* 1cq9_A 1ciw_A* 1qf3_A* 1rir_A* 1rit_A* 2dh1_A 1cr7_A* 2dv9_A* 2dvb_A* 2dvd_A* 2dvf_A 2dvg_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-58 Score=447.08 Aligned_cols=209 Identities=29% Similarity=0.539 Sum_probs=190.7
Q ss_pred cceEEeCCCCC-CCCceEecceeEcCCCcEEecCC-CCCCceeeEeeCCceeecCCC-CCceeeeeeeEEee--------
Q 044561 27 VNQFIYHGFNE-DAQLQRDGLASVHSNGLLQLTNT-VSPQQEGHAFYRLPIKFNTSS-SESLSFSSNFVFAI-------- 95 (614)
Q Consensus 27 ~~~f~~~~f~~-~~~~~~~g~a~~~~~g~l~Lt~~-~~~~~~G~~~y~~pv~l~~~~-~~~~sF~t~F~f~i-------- 95 (614)
..+|+|++|++ ..+|.++|+|.+.++|.|+||++ .. .++|||||++||+||+++ ++++||+|+|+|.|
T Consensus 3 ~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~-~~~Gra~y~~Pi~l~~~~tg~vaSFsT~F~F~I~~~~~~~~ 81 (232)
T 1v6i_A 3 TVSFNFNSFSEGNPAINFQGDVTVLSNGNIQLTNLNKV-NSVGRVLYAMPVRIWSSATGNVASFLTSFSFEMKDIKDYDP 81 (232)
T ss_dssp EEEEEESSCCTTCTTEEEEESCEECTTSCEECSCTTST-TCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECCSSSBC
T ss_pred ceEEEcCCCCCCCCCeEEcccEEEccCCcEEeCCCCCC-CceEEEEeCCCEEeecCCCCCccceEEEEEEEEecCCCCCC
Confidence 56899999985 47999999999987999999987 55 899999999999999987 88999999999999
Q ss_pred --eeEEEEcCCCC-CCCCCCC-CCCcccccccCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeeEecCCCcccccccCcc
Q 044561 96 --GMAFVISPSKD-LGKAEAS-PSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAY 171 (614)
Q Consensus 96 --G~aF~l~p~~~-~~~~~~~-~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~ 171 (614)
||||||+|... .| .++ .||||||+|. ++.+|+|||||||++|.+++||++||||||+||+.|.++++|
T Consensus 82 gdGlAF~l~p~~~~~p--~~~~~g~~LGl~n~----~~~~~~vAVEFDT~~n~~~~Dp~~nHVGIdvns~~S~~~~~~-- 153 (232)
T 1v6i_A 82 ADGIIFFIAPEDTQIP--AGSIGGGTLGVSDT----KGAGHFVGVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVPW-- 153 (232)
T ss_dssp CCEEEEEEEETTCCCC--TTCCCGGGTTTSCT----TSEEEEEEEEEECSCCGGGTCCSSCEEEEEEEESSCSEEEEC--
T ss_pred CCCEEEEEecCCCCCC--CCcCCCcccccccC----CCcccEEEEEeecccccccCCCCCCeEEEEcCCccccccccc--
Confidence 99999999864 34 567 8999999986 567899999999999999889999999999999999988875
Q ss_pred ccCccCCCccccccCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcccccccccccccccCCC--cccee
Q 044561 172 FSDREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGS--LKSSH 249 (614)
Q Consensus 172 ~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastg~--~~~~h 249 (614)
+|.+|+.++|||+||+.+|+|+|+|++ + +|..|+|++.|||+++|||+|||||| |||. ..|.|
T Consensus 154 -----------~l~~G~~~~v~I~Yd~~~~~L~V~l~~-~--~~~~~~ls~~vdL~~~l~e~v~VGFS-sTG~~~~~~~h 218 (232)
T 1v6i_A 154 -----------NSVSGAVVKVTVIYDSSTKTLSVAVTN-D--NGDITTIAQVVDLKAKLPERVKFGFS-ASGSLGGRQIH 218 (232)
T ss_dssp -----------CCCTTCEEEEEEEEETTTTEEEEEEEC-T--TSCEEEEEEECCHHHHSCSEEEEEEE-EECCSSBCCEE
T ss_pred -----------cccCCCEEEEEEEEeCCCcEEEEEEec-C--CCCcceEEEEechHHhCCccEEEEEE-ecCCCccccEE
Confidence 367899999999999999999999997 4 46689999999999999999999999 9998 58999
Q ss_pred eEeccccccC
Q 044561 250 YVLGWSFNRS 259 (614)
Q Consensus 250 ~i~sWsf~~~ 259 (614)
+|++|+|+++
T Consensus 219 ~IlsWsF~s~ 228 (232)
T 1v6i_A 219 LIRSWSFTST 228 (232)
T ss_dssp EEEEEEEEEE
T ss_pred EEEEEEEEee
Confidence 9999999875
|
| >1gzc_A Erythrina crista-galli lectin; carbohydrate, sugar binding protein, saccharide, protein-carbohydrate interactions, lactose, glycoprotein; HET: LAT; 1.58A {Erythrina crista-galli} SCOP: b.29.1.1 PDB: 1gz9_A* 1fyu_A* 1ax0_A* 1ax1_A* 1ax2_A* 1axy_A* 1axz_A* 1lte_A* 1sfy_A* 1v00_A* 1uzz_A 1uzy_A* 3n35_A* 3n36_A* 3n3h_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-57 Score=446.10 Aligned_cols=213 Identities=32% Similarity=0.524 Sum_probs=191.3
Q ss_pred cceEEeCCCCC-CCCceEecceeEcCCCcEEecCCCC-----CCceeeEeeCCceeecCCC-CCceeeeeeeEEee----
Q 044561 27 VNQFIYHGFNE-DAQLQRDGLASVHSNGLLQLTNTVS-----PQQEGHAFYRLPIKFNTSS-SESLSFSSNFVFAI---- 95 (614)
Q Consensus 27 ~~~f~~~~f~~-~~~~~~~g~a~~~~~g~l~Lt~~~~-----~~~~G~~~y~~pv~l~~~~-~~~~sF~t~F~f~i---- 95 (614)
..+|+|++|.+ ..+|.++|+|.+.++|.|+||++.. ..++|||+|++||+||++. ++++||+|+|+|.|
T Consensus 3 ~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pi~l~~~~tg~vaSFsT~F~F~I~~~~ 82 (239)
T 1gzc_A 3 TISFSFSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMWDSTTGTVASFETRFSFSIEQPY 82 (239)
T ss_dssp EEEEEESSCCTTCTTEEEEETCEECTTSCEESSCBCTTSCBCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCCC
T ss_pred eEEEEeCCCCCCCCCeEEcccEEEcCCCcEEeCCCCcCCcccCCceEEEEeCCCEecccCCCCCccceEEEEEEEEeCCC
Confidence 46899999985 4799999999998799999998752 3789999999999999987 88999999999988
Q ss_pred -------eeEEEEcCCCCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeeEecCCCccccccc
Q 044561 96 -------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAP 168 (614)
Q Consensus 96 -------G~aF~l~p~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~ 168 (614)
||||||+|.... +++.||||||+|.++ +++.+|+|||||||++|. |+||++||||||+||+.|.++++
T Consensus 83 ~~~~~gdGlAF~l~p~~~~---~~~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~n~-~dDp~~nHVGIdvns~~S~~~~~ 157 (239)
T 1gzc_A 83 TRPLPADGLVFFMGPTKSK---PAQGYGYLGVFNNSK-QDNSYQTLAVEFDTFSNP-WDPPQVPHIGIDVNSIRSIKTQP 157 (239)
T ss_dssp SSSCCCEEEEEEEECSSCC---CCCCGGGTTTCSSSS-CCGGGCCEEEEEECSCCT-TSCSSSSEEEEEESSSSCSEEEE
T ss_pred CCCCCCCcEEEEEecCCCC---CCCCCCcccccccCC-CCccccEEEEEEeccccc-CCCCCCCeEEEecCCcccccccc
Confidence 999999998654 358899999999764 477899999999999998 88899999999999999998877
Q ss_pred CccccCccCCCccccccCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcccccccccccccccCCC---c
Q 044561 169 AAYFSDREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGS---L 245 (614)
Q Consensus 169 ~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastg~---~ 245 (614)
| +|.+|+.++|||+||+.+++|+|+|++.+. |..|+|++.+||+++|||+||||||||||. .
T Consensus 158 ~-------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~ 222 (239)
T 1gzc_A 158 F-------------QLDNGQVANVVIKYDAPSKILHVVLVYPSS--GAIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDA 222 (239)
T ss_dssp C-------------CCCTTCEEEEEEEEETTTTEEEEEEECTTT--CCEEEEEEECCHHHHSCSEEEEEEEEEECSSTTC
T ss_pred c-------------cccCCCEEEEEEEEeCCCcEEEEEEecCCC--CccceEEEEechHHhCCCceEEEEEeccCCCccc
Confidence 5 367899999999999999999999987643 567899999999999999999999999997 4
Q ss_pred cceeeEeccccccC
Q 044561 246 KSSHYVLGWSFNRS 259 (614)
Q Consensus 246 ~~~h~i~sWsf~~~ 259 (614)
.|.|+|++|+|+++
T Consensus 223 ~~~h~IlsWsF~s~ 236 (239)
T 1gzc_A 223 AETHDVYSWSFQAS 236 (239)
T ss_dssp CCCCEEEEEEEEEE
T ss_pred cceEEEEEEEeEEe
Confidence 89999999999865
|
| >1qnw_A Chitin binding lectin, UEA-II; carbohydrate binding; HET: NAG; 2.35A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1dzq_A* 1qoo_A* 1qos_A* 1qot_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-57 Score=443.88 Aligned_cols=216 Identities=33% Similarity=0.512 Sum_probs=194.4
Q ss_pred CCcceEEeCCCCC-CCCceEecceeEcCCCcEEecCCC--CCCceeeEeeCCceeecCCC-CCceeeeeeeEEee-----
Q 044561 25 QDVNQFIYHGFNE-DAQLQRDGLASVHSNGLLQLTNTV--SPQQEGHAFYRLPIKFNTSS-SESLSFSSNFVFAI----- 95 (614)
Q Consensus 25 ~~~~~f~~~~f~~-~~~~~~~g~a~~~~~g~l~Lt~~~--~~~~~G~~~y~~pv~l~~~~-~~~~sF~t~F~f~i----- 95 (614)
+...+|+|++|++ ..+|.++|+|.+.++|.|+||++. ...++|||||++||+||++. ++++||+|+|+|.|
T Consensus 3 ~~~~~F~f~~F~~~~~~l~l~G~A~i~~~g~l~LT~~~~~~~~~~Gra~y~~Pv~l~~~~tg~vasFsT~F~F~I~~~~~ 82 (242)
T 1qnw_A 3 SDDLSFNFDKFVPNQKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIWDSITGKVASFATSFSFVVKADKS 82 (242)
T ss_dssp CCSEEEEESSCCTTCTTEEEEETCEECTTSCEESSCCC--CCCEEEEEEESSCEECBCTTTCCBCEEEEEEEEECCBSSS
T ss_pred ccceEEEcCCCCCCCCCeEEccceEEccCCcEEecCCCCcccCCeEEEEeCCCEeeecCCCCCcccEEEEEEEEEecCCC
Confidence 4568999999985 479999999999879999999876 12799999999999999987 88999999999999
Q ss_pred ----eeEEEEcCCCC-CCCCCCCCCCcccccccCCCCCCCCcEEEEEeecc----CCCCCCCCCCCeeeEecCCCccccc
Q 044561 96 ----GMAFVISPSKD-LGKAEASPSEYLGLFNASNNGQSTNHILAIELDTV----QNLDFDDIDDNHVGIDVNSLISHES 166 (614)
Q Consensus 96 ----G~aF~l~p~~~-~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~----~n~~~~d~~~~Hvgid~ns~~s~~~ 166 (614)
||||||+|.+. .| .++.||||||+|.++ +++.+|+|||||||+ +|. +||++||||||+||+.|.++
T Consensus 83 ~~gdGlAF~l~p~~~~~p--~~~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~~~~~N~--~Dp~~nHVGIdvNs~~S~~~ 157 (242)
T 1qnw_A 83 DGVDGLAFFLAPANSQIP--SGSSAGMFGLFSSSD-SKSSNQIIAVEFDTYFGKAYNP--WDPDFKHIGIDVNSIKSIKT 157 (242)
T ss_dssp CCCCEEEEEEEETTCCCC--TTCCGGGTTTCSSSS-CCTTSCCEEEEEECCCCTTTCT--TSCSSCEEEEEESSSSCSEE
T ss_pred CCCCCEEEEEecCCCCCC--cCCCCCcccccccCC-CCccccEEEEEeecccccccCC--CCCCCCcEEEecCCccccce
Confidence 99999999874 34 678999999999765 477899999999999 997 59999999999999999988
Q ss_pred ccCccccCccCCCccccccCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcccccccccccccccCCCc-
Q 044561 167 APAAYFSDREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSL- 245 (614)
Q Consensus 167 ~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastg~~- 245 (614)
++| +|.+|+.++|||+||+.+|+|+|+|.+.+ .|..|+|++.+||+.+|||+|||||||+||..
T Consensus 158 ~~~-------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~ 222 (242)
T 1qnw_A 158 VKW-------------DWRNGEVADVVITYRAPTKSLTVCLSYPS--DGTSNIITASVDLKAILPEWVSVGFSGGVGNAA 222 (242)
T ss_dssp EEC-------------CCCTTCCEEEEEEEEGGGTEEEEEEECTT--TCCEEEEEEECCHHHHSCSEEEEEEEEEESCGG
T ss_pred ecc-------------cccCCCEEEEEEEEeCCCcEEEEEEecCC--CCcceeEEEeechHHhcCCceEEEEEeccCCCc
Confidence 775 36789999999999999999999998764 35678999999999999999999999999999
Q ss_pred -cceeeEeccccccCC
Q 044561 246 -KSSHYVLGWSFNRSG 260 (614)
Q Consensus 246 -~~~h~i~sWsf~~~~ 260 (614)
.|.|+|++|+|+++.
T Consensus 223 ~~~~h~IlsWsF~s~l 238 (242)
T 1qnw_A 223 EFETHDVLSWYFTSNL 238 (242)
T ss_dssp GCBCCEEEEEEEEEEC
T ss_pred cceEEEEEEEEeEeec
Confidence 999999999998764
|
| >2eig_A Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG binding protein; HET: NAG; 2.00A {Lotus tetragonolobus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-57 Score=439.88 Aligned_cols=208 Identities=31% Similarity=0.516 Sum_probs=188.7
Q ss_pred ceEEeCCCCCCCCceEecceeEcCCCcEEecCC--CCCCceeeEeeCCceeecCCC-CCceeeeeeeEEee---------
Q 044561 28 NQFIYHGFNEDAQLQRDGLASVHSNGLLQLTNT--VSPQQEGHAFYRLPIKFNTSS-SESLSFSSNFVFAI--------- 95 (614)
Q Consensus 28 ~~f~~~~f~~~~~~~~~g~a~~~~~g~l~Lt~~--~~~~~~G~~~y~~pv~l~~~~-~~~~sF~t~F~f~i--------- 95 (614)
++|+|++|....+|.++|+|.+.++|.|+||++ .. .++|||||++||+||+++ ++++||+|+|+|.|
T Consensus 1 ~sF~f~~F~~~~~l~l~G~A~v~~~g~l~LT~~~~~~-~~~Gra~y~~Pv~l~~~~tg~vaSFsT~F~F~I~~~~~~~~g 79 (234)
T 2eig_A 1 VSFNYTRFKDDGSLIFQGDAKIWTDGRLAMPTDPLVN-RTTSHALYATPVPIWDSATGNVASFITSFSFIVSNVQRYPPT 79 (234)
T ss_dssp CEEEESSCCSSSSEEEEETCEEEGGGEEESSSCGGGS-SEEEEEEESSCEECBCTTTCCBCEEEEEEEEEEEECTTSCCC
T ss_pred CeEEcCCCCCCCCeEEcccEEEcCCCCeeeCCCCCcc-CceEEEEeCCCEEeecCCCCCccceEEEEEEEEeCCCCCCCC
Confidence 479999998337999999999987999999987 44 799999999999999987 88999999999999
Q ss_pred -eeEEEEcCCCC-CCCCCCCCCCcccccccCCCCCCCCcEEEEEeeccCCCCCCCCCC---CeeeEecCCCcccccccCc
Q 044561 96 -GMAFVISPSKD-LGKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDD---NHVGIDVNSLISHESAPAA 170 (614)
Q Consensus 96 -G~aF~l~p~~~-~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~---~Hvgid~ns~~s~~~~~~~ 170 (614)
||||||+|... .| .++.||||||+|.+ ++.+|+|||||||++|. +||++ ||||||+||+.|.++++|
T Consensus 80 dGlAF~l~p~~~~~p--~~~~g~~LGl~n~~---~~~~~~vAVEFDT~~N~--~Dp~~~~~nHVGIdvNsi~S~~~~~~- 151 (234)
T 2eig_A 80 DGVVFFLAPWGTEIP--PNSQGGYLGITDSS---NSQNQFVAVEFDSHPNV--WDPKSLRSSHIGIDVNSIMSLKAVNW- 151 (234)
T ss_dssp CEEEEEEEETTCCCC--TTCCGGGTTTCCTT---CSCCCCEEEEEECSCCT--TSCTTTCSSEEEEEESSSSCSEEEEC-
T ss_pred CcEEEEEecCCCCCC--cCCCCCccccccCC---CccccEEEEEeccccCc--cCCCCCCCCceEEecCCccccceecc-
Confidence 99999999874 44 67889999999876 66789999999999998 59999 999999999999988875
Q ss_pred cccCccCCCccccccCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcccccccccccccccC--CCccce
Q 044561 171 YFSDREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSAST--GSLKSS 248 (614)
Q Consensus 171 ~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsast--g~~~~~ 248 (614)
+|.+|+.++|||+||+.+|+|+|+|++ + .|..|+|++.+||+++|||+|||||||+| |.. |.
T Consensus 152 ------------~l~~g~~~~v~I~Yd~~~~~L~V~l~~-~--~~~~~~ls~~vdL~~~l~e~v~VGFSAsT~~G~~-~~ 215 (234)
T 2eig_A 152 ------------NRVSGSLEKATIIYDSDTKILTVVMTH-Q--NGQITTISQEIDLKTVLPEKVSVGFSATTWNPER-ER 215 (234)
T ss_dssp ------------CCCTTCCEEEEEEEETTTTEEEEEEEE-T--TSCEEEEEEECCHHHHSCSEEEEEEEEEECSSCC-EE
T ss_pred ------------cccCCCEEEEEEEEeCCCcEEEEEEec-C--CCCcceEeEeechHHhcCCceEEEEEeeecCCCc-ce
Confidence 367899999999999999999999998 4 46679999999999999999999999999 988 99
Q ss_pred eeEeccccccCC
Q 044561 249 HYVLGWSFNRSG 260 (614)
Q Consensus 249 h~i~sWsf~~~~ 260 (614)
|+|++|+|+++.
T Consensus 216 h~IlsWsF~s~l 227 (234)
T 2eig_A 216 HDIYSWSFTSTL 227 (234)
T ss_dssp EEEEEEEEEEEC
T ss_pred eEEEEEEEEecC
Confidence 999999999764
|
| >1sbf_A Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {Glycine max} SCOP: b.29.1.1 PDB: 1sbd_A* 1sbe_A* 1g9f_A* 2sba_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-57 Score=442.27 Aligned_cols=211 Identities=34% Similarity=0.512 Sum_probs=190.5
Q ss_pred cceEEeCCCCC-CCCceEecceeEcCCCcEEecCCCC-----CCceeeEeeCCceeecCCC-CCceeeeeeeEEee----
Q 044561 27 VNQFIYHGFNE-DAQLQRDGLASVHSNGLLQLTNTVS-----PQQEGHAFYRLPIKFNTSS-SESLSFSSNFVFAI---- 95 (614)
Q Consensus 27 ~~~f~~~~f~~-~~~~~~~g~a~~~~~g~l~Lt~~~~-----~~~~G~~~y~~pv~l~~~~-~~~~sF~t~F~f~i---- 95 (614)
..+|+|++|++ ..+|.++|+|.+.++|.|+||++.. ..++|||||++||+||+++ ++++||+|+|+|.|
T Consensus 3 ~~~F~f~~F~~~~~~l~l~GdA~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg~vaSFsT~F~F~I~~~~ 82 (253)
T 1sbf_A 3 TVSFSWNKFVPKQPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIWDKETGSVASFAASFNFTFYAPD 82 (253)
T ss_dssp EEEEEESSCCTTCTTEEEEETCEECTTSCEECSCBCTTSCBCTTCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECSS
T ss_pred ceEEEcCCCCCCCCCeEEcccEEEcCCCeEEeCCCccCCcccCCCeEEEEECCCEecccCCCCcccceEEEEEEEEeCCC
Confidence 56899999985 4799999999998799999998752 3689999999999999987 88999999999999
Q ss_pred ------eeEEEEcCCCCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeeEecCCCcccccccC
Q 044561 96 ------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPA 169 (614)
Q Consensus 96 ------G~aF~l~p~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~ 169 (614)
||||||+|.... +++.||||||+|.+ ++.+|+|||||||++|. +||++||||||+||+.|.++++|
T Consensus 83 ~~~~gdGlAF~l~p~~~~---~~~~g~~LGL~n~~---~~~n~~vAVEFDT~~N~--~Dp~~nHVGIdvNs~~S~~t~~~ 154 (253)
T 1sbf_A 83 TKRLADGLAFFLAPIDTK---PQTHAGYLGLFNEN---ESGDQVVAVEFDTFRNS--WDPPNPHIGINVNSIRSIKTTSW 154 (253)
T ss_dssp TTSCCEEEEEEEEETTCC---CCCCGGGTTTCCTT---SCCCSCEEEEEECSCCT--TCCSSSEEEEEESSSSCSEEEEC
T ss_pred CCCCCCcEEEEEecCCCC---CCCCCCccccccCC---CcccceEEEEeccccCC--CCCCCCcEEEEcCCccccceecc
Confidence 999999998654 35889999999876 66899999999999997 59999999999999999988875
Q ss_pred ccccCccCCCccccccCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcccccccccccccccCCCc--cc
Q 044561 170 AYFSDREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSL--KS 247 (614)
Q Consensus 170 ~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastg~~--~~ 247 (614)
+|.+|+.++|||+||+.+++|+|+|++.+. |..|+|+..+||+.+|||+||||||||||.. .|
T Consensus 155 -------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~~~ 219 (253)
T 1sbf_A 155 -------------DLANNKVAKVLITYDASTSLLVASLVYPSQ--RTSNILSDVVDLKTSLPEWVRIGFSAATGLDIPGE 219 (253)
T ss_dssp -------------CCCTTCCEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCHHHHSCSEEEEEEEEEECSSSCCC
T ss_pred -------------cccCCCeeEEEEEEeCCCcEEEEEEecCCC--CCcceEEEEechHHhCCCceEEEEEeccCCCccce
Confidence 367899999999999999999999987653 5578999999999999999999999999998 99
Q ss_pred eeeEeccccccCC
Q 044561 248 SHYVLGWSFNRSG 260 (614)
Q Consensus 248 ~h~i~sWsf~~~~ 260 (614)
.|+|++|+|+++.
T Consensus 220 ~H~IlsWsF~s~l 232 (253)
T 1sbf_A 220 SHDVLSWSFASNL 232 (253)
T ss_dssp EEEEEEEEEEEEE
T ss_pred eeEEEEEEeEeec
Confidence 9999999998763
|
| >1g7y_A Stem/LEAF lectin DB58; jelly roll fold, sugar binding protein; HET: NAG FUC FUL; 2.50A {Vigna unguiculata subsp} SCOP: b.29.1.1 PDB: 1lul_A 1lu1_A* 1bjq_A* 1lu2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-57 Score=442.84 Aligned_cols=213 Identities=33% Similarity=0.508 Sum_probs=191.9
Q ss_pred CcceEEeCCCCCCCCceEecceeEcCCCcEEecCCCC-----CCceeeEeeCCceeecCCC-CCceeeeeeeEEee----
Q 044561 26 DVNQFIYHGFNEDAQLQRDGLASVHSNGLLQLTNTVS-----PQQEGHAFYRLPIKFNTSS-SESLSFSSNFVFAI---- 95 (614)
Q Consensus 26 ~~~~f~~~~f~~~~~~~~~g~a~~~~~g~l~Lt~~~~-----~~~~G~~~y~~pv~l~~~~-~~~~sF~t~F~f~i---- 95 (614)
...+|+|++|.. .+|.++|+|.+. +|.|+||++.. ..++|||||++||+||+++ ++++||+|+|+|.|
T Consensus 2 ~~~~F~f~~F~~-~~l~l~GdA~v~-~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg~vaSFsT~F~F~I~~~~ 79 (253)
T 1g7y_A 2 DIQSFSFKNFNS-SSFILQGDATVS-SSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIYDKSTGAVASWATSFTANIFAPN 79 (253)
T ss_dssp EEEEEEESSCCS-SCEEEEETCEEE-TTEEECSCBCTTSCBCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSS
T ss_pred cceEEEcCCCCc-CCEEEecceEEe-CCEEEeCCCCCCCccccCCeEEEEECCCEEeecCCCCCccceEEEEEEEEecCC
Confidence 356899999985 799999999998 99999998751 3689999999999999987 88999999999999
Q ss_pred ------eeEEEEcCCCCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeeEecCCCcccccccC
Q 044561 96 ------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPA 169 (614)
Q Consensus 96 ------G~aF~l~p~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~ 169 (614)
||||||+|.+.. +++.||||||+|.++ +++.+|+|||||||++|.+ +||++||||||+||+.|.++++|
T Consensus 80 ~~~~gdGlAF~l~p~~~~---~~~~g~~LGl~n~~~-~~~~n~~vAVEFDT~~N~~-~Dp~~nHVGIdvns~~S~~t~~~ 154 (253)
T 1g7y_A 80 KSSSADGIAFALVPVGSE---PKSNSGFLGVFDSDV-YDNSAQTVAVEFDTFSNTD-WDPTSRHIGIDVNSIKSIRTASW 154 (253)
T ss_dssp GGGCCCEEEEEEEETTCC---CCCCGGGTTTCSCSS-CCGGGCCEEEEEECSCCTT-TCCSSCEEEEEESSSSCSEEEEC
T ss_pred CCCCCCcEEEEEecCCCC---CCCCCCcccccccCC-CCccCceEEEEecceeccC-cCCCCCcEeeccCCccccceecc
Confidence 999999998654 358899999999764 4678999999999999988 59999999999999999988875
Q ss_pred ccccCccCCCccccccCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcccccccccccccccCCCc---c
Q 044561 170 AYFSDREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSL---K 246 (614)
Q Consensus 170 ~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastg~~---~ 246 (614)
+|.+|+.++|||+||+.+++|+|++.+.+. |.+|+|+..+||+.+|||+||||||||||.. .
T Consensus 155 -------------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~~~ 219 (253)
T 1g7y_A 155 -------------GLANGQNAEILITYNAATSLLVASLVHPSR--RTSYIVSERVDITNELPEYVSIGFSATTGLSEGYT 219 (253)
T ss_dssp -------------CCCTTSEEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCHHHHSCSEEEEEEEEECCSSSSCC
T ss_pred -------------ccCCCCeEEEEEEEeCCCCEEEEEEecCCC--CCcceEEEEechHHhCCCceEEEEEeCcCCCCccc
Confidence 367899999999999999999999987653 5578999999999999999999999999998 9
Q ss_pred ceeeEeccccccCC
Q 044561 247 SSHYVLGWSFNRSG 260 (614)
Q Consensus 247 ~~h~i~sWsf~~~~ 260 (614)
|.|+|++|+|+++.
T Consensus 220 ~~H~IlsWsF~s~l 233 (253)
T 1g7y_A 220 ETHDVLSWSFASKL 233 (253)
T ss_dssp CCCEEEEEEEEEEE
T ss_pred ceeEEEEEEEEeeC
Confidence 99999999998763
|
| >2fmd_A Lectin, agglutinin, BMA; legume lectin, beta sandwich, protein-carbohydrate complex, sugar binding protein; HET: MAN; 1.90A {Bowringia mildbraedii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-56 Score=437.67 Aligned_cols=216 Identities=35% Similarity=0.488 Sum_probs=191.9
Q ss_pred CcceEEeCCCCC-CCCceEecceeEcCCCcEEecCCCC-----CCceeeEeeCCceeecCCCCCceeeeeeeEEee----
Q 044561 26 DVNQFIYHGFNE-DAQLQRDGLASVHSNGLLQLTNTVS-----PQQEGHAFYRLPIKFNTSSSESLSFSSNFVFAI---- 95 (614)
Q Consensus 26 ~~~~f~~~~f~~-~~~~~~~g~a~~~~~g~l~Lt~~~~-----~~~~G~~~y~~pv~l~~~~~~~~sF~t~F~f~i---- 95 (614)
...+|+|++|++ ..+|.++|+|.+.++|.|+||++.. ..+.|||||++||+||+++++++||+|+|+|.|
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~G~a~y~~Pv~l~~~~g~~~sFst~F~F~I~~~~ 81 (240)
T 2fmd_A 2 NSVCFTFTDFESGQQDLIFQGDASVGSNKALQLTKVDSKGNPQGGSVGRALYTAPIRLWQSSSLVASFETTFTFSISQGS 81 (240)
T ss_dssp CEEEEEESSCCTTCTTEEEEETCEECTTSCEECSCBCTTSCBCSSCEEEEEESSCEECCCTTCSEEEEEEEEEEECCBSS
T ss_pred cceEEEcCCCCCCCCCeEEccceEEcCCCCEEeCCCCcCCcccCCCeEEEEECCCEEeeCCCCCcCcEEEEEEEEEecCC
Confidence 457899999985 4799999999998789999998753 268999999999999998777899999999999
Q ss_pred -----eeEEEEcCCCCCCCCCC-CCCCcccccccCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeeEecCCCcccccccC
Q 044561 96 -----GMAFVISPSKDLGKAEA-SPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPA 169 (614)
Q Consensus 96 -----G~aF~l~p~~~~~~~~~-~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~ 169 (614)
||||+|+|....| .+ +.||||||+|.+++++..+|+|||||||++|.+++||++||||||+||+.|.++++|
T Consensus 82 ~~~gdGlAF~l~p~~~~p--~~g~~g~~LGl~n~~~~~~~~n~~vAVEfDT~~N~~~~Dp~~nHvgIdvns~~S~~s~~~ 159 (240)
T 2fmd_A 82 STPADALTFFIASPDTKI--PSGSGGRLLGLFGSSNNAGSDNGVVSVEFDTYPNTDIGDPNYRHIGIDVNSIRSKAASKW 159 (240)
T ss_dssp SSCCCEEEEEEECTTCCC--CTTCCGGGTTTCSCCC----CCCEEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEEC
T ss_pred CCCCCcEEEEEecCCCCC--CccCCCCcccccccCcCCCCcCcEEEEEeccccccccCCCCCCceeeccccccccceeEE
Confidence 9999999987654 43 889999999988777789999999999999998779999999999999999988775
Q ss_pred ccccCccCCCccccccCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcccccccccccccccCCCcccee
Q 044561 170 AYFSDREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLKSSH 249 (614)
Q Consensus 170 ~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastg~~~~~h 249 (614)
++.+|+.++|||+||+.+++|+|++++.+. ..|+|+..+||+.+||++|||||||+||...+.|
T Consensus 160 -------------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~---~~~~ls~~vdL~~~l~~~~yvGFSAsTG~~~~~H 223 (240)
T 2fmd_A 160 -------------DWQNGKTATAHISYNSASKRLSVVSSYPNS---SPVVVSFDVELNNVBPBWVRVGFSATTGQYTQTN 223 (240)
T ss_dssp -------------CCCSSCEEEEEEEEETTTTEEEEEEECTTS---CCEEEEEECCGGGTSCSEEEEEEEEECCSSCBCC
T ss_pred -------------EeeCCCEEEEEEEEeCCCCEEEEEEecCCC---CceEEEEEechHHhCCCceEEEEEeccCCccccE
Confidence 356899999999999999999999987653 4789999999999999999999999999999999
Q ss_pred eEeccccccC
Q 044561 250 YVLGWSFNRS 259 (614)
Q Consensus 250 ~i~sWsf~~~ 259 (614)
+|++|+|+++
T Consensus 224 ~IlsWsF~s~ 233 (240)
T 2fmd_A 224 NILAWSFRSS 233 (240)
T ss_dssp EEEEEEEEEE
T ss_pred EEEEEEeEec
Confidence 9999999876
|
| >1n47_A Isolectin B4; cancer antigen, vicia villosa lectin, glycoprotein TN-bindin protein, carbohydrate recognition, sugar binding protein; HET: NAG FUC TNR; 2.70A {Vicia villosa} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-56 Score=436.88 Aligned_cols=212 Identities=32% Similarity=0.533 Sum_probs=190.0
Q ss_pred CcceEEeCCCCC-CCCceEecceeEcCCCcEEecCCCC----CCceeeEeeCCceeecCCCCCceeeeeeeEEee-----
Q 044561 26 DVNQFIYHGFNE-DAQLQRDGLASVHSNGLLQLTNTVS----PQQEGHAFYRLPIKFNTSSSESLSFSSNFVFAI----- 95 (614)
Q Consensus 26 ~~~~f~~~~f~~-~~~~~~~g~a~~~~~g~l~Lt~~~~----~~~~G~~~y~~pv~l~~~~~~~~sF~t~F~f~i----- 95 (614)
...+|+|++|++ ..+|.++|+|.+.++|.|+||++.. ..++|||||++||+||++++ ++||+|+|+|.|
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pi~l~d~~~-~~sFsT~F~F~I~~~~~ 80 (233)
T 1n47_A 2 ESTSFSFTNFNPNQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIHDNTT-LASFTTSFSFVMAAPAA 80 (233)
T ss_dssp EEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCBSSSSBCTTCEEEEEESSCEECBCSSC-BCEEEEEEEEECCCSST
T ss_pred cceEEEcCCCCCCCCCeEEccceEEccCCcEEeccCcCCCccCCCeEEEEECCCEeccCCCC-cCCEEEEEEEEEeCCCC
Confidence 356899999985 4799999999998799999998752 26999999999999999877 889999999999
Q ss_pred -----eeEEEEcCCCCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeeEecCCCcccccccCc
Q 044561 96 -----GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAA 170 (614)
Q Consensus 96 -----G~aF~l~p~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~ 170 (614)
||||||+|....| ++.||||||+|.++ +++.||+|||||||++|. +||++||||||+||+.|.++++|
T Consensus 81 ~~~gdGlAF~l~p~~~~p---~~~g~~LGl~n~~~-~~~~n~~vAVEFDT~~N~--~Dp~~nHvGIdvns~~S~~~~~~- 153 (233)
T 1n47_A 81 AAVADGLAFFLAPPDTQP---QARGGFLGLFADRA-HDASYQTVAVEFDTYSNA--WDPNYTHIGIDTNGIESKKTTPF- 153 (233)
T ss_dssp TSCCEEEEEEEECTTCCC---CCCGGGTTTCSSSS-CCGGGCCEEEEEECSCCT--TSCSSCEEEEEESSSSCSEEEEC-
T ss_pred CCCCCcEEEEEecCCCCC---CCCCCcccccccCC-CCccCceEEEEeccccCC--CCCCCCcEEEccCCccccccccc-
Confidence 9999999987654 37899999999774 577899999999999998 59999999999999999988775
Q ss_pred cccCccCCCccccccCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcccccccccccccccCCCc---cc
Q 044561 171 YFSDREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSL---KS 247 (614)
Q Consensus 171 ~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastg~~---~~ 247 (614)
++.+|+.++|||+||+.+++|+|+|.+.+. +..|+|++.+||+.+|||+||||||||||.. .|
T Consensus 154 ------------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~~~~~vGFSAsTG~~~~~~~ 219 (233)
T 1n47_A 154 ------------DMVYGEKANIVITYQASTKALAASLVFPVS--QTSYAVSARVDLRDILPEYVRVGFSATTGLNAGVVE 219 (233)
T ss_dssp ------------CCCTTSCEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCGGGTSCSEEEEEEEEEECSSTTCCC
T ss_pred ------------cccCCCEEEEEEEEeCCCCEEEEEEecCCC--CCcceEEEEechHHhCCCceEEEEEeccCCCccccc
Confidence 367899999999999999999999987653 3478999999999999999999999999998 99
Q ss_pred eeeEeccccccC
Q 044561 248 SHYVLGWSFNRS 259 (614)
Q Consensus 248 ~h~i~sWsf~~~ 259 (614)
.|+|++|+|+++
T Consensus 220 ~h~IlsWsF~s~ 231 (233)
T 1n47_A 220 THDIVSWSFAVS 231 (233)
T ss_dssp CCEEEEEEEEEE
T ss_pred eeEEEEEEEEee
Confidence 999999999864
|
| >1fat_A Phytohemagglutinin-L; glycoprotein, plant defense protein, lectin; HET: NAG; 2.80A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1g8w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-56 Score=442.30 Aligned_cols=212 Identities=36% Similarity=0.533 Sum_probs=191.2
Q ss_pred CcceEEeCCCCCCCCceEecceeEcCCCcEEecCCCC-----CCceeeEeeCCceeecCCC-CCceeeeeeeEEee----
Q 044561 26 DVNQFIYHGFNEDAQLQRDGLASVHSNGLLQLTNTVS-----PQQEGHAFYRLPIKFNTSS-SESLSFSSNFVFAI---- 95 (614)
Q Consensus 26 ~~~~f~~~~f~~~~~~~~~g~a~~~~~g~l~Lt~~~~-----~~~~G~~~y~~pv~l~~~~-~~~~sF~t~F~f~i---- 95 (614)
...+|+|++|.. .+|.++|+|.+.++|.|+||++.. ..++|||||++||+||++. ++++||+|+|+|.|
T Consensus 2 ~~~~F~f~~F~~-~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg~vaSFsT~F~F~I~~~~ 80 (252)
T 1fat_A 2 NDIYFNFQRFNE-TNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWDNTTGTVASFATSFTFNIQVPN 80 (252)
T ss_dssp CCEEEEESSCCG-GGEEEEETCEECTTSCEECSCCC-CCCCCTTCEEEEEEEEEEECEETTTTEEEEEEEEEEEECCCCS
T ss_pred cceEEEcCCCCc-CCEEEeccEEECCCCEEEeCCCCCCCccccCCEEEEEECCCEecccCCCCcccceEEEEEEEEeCCC
Confidence 457899999985 799999999998799999998751 3799999999999999987 88999999999999
Q ss_pred ------eeEEEEcCCCCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeeEecCCCcccccccC
Q 044561 96 ------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPA 169 (614)
Q Consensus 96 ------G~aF~l~p~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~ 169 (614)
||||||+|.+.. +++.||||||+|.+ ++.+|+|||||||++|.+ +||++||||||+||+.|.++++|
T Consensus 81 ~~~~gdGlAF~l~p~~~~---~~~~g~~LGl~n~~---~~~~~~vAVEFDT~~N~~-~Dp~~nHVGIdvNs~~S~~~~~~ 153 (252)
T 1fat_A 81 NAGPADGLAFALVPVGSQ---PKDKGGFLGLFDGS---NSNFHTVAVEFDTLYNKD-WDPTERHIGIDVNSIRSIKTTRW 153 (252)
T ss_dssp SCBCCEEEEEEEEETTCC---CCCSGGGTTTCCSS---CCCCCCEEEEEECSCCTT-TCCSSCEEEEEESSSSCSEEEEC
T ss_pred CCCCCCcEEEEEccCCCC---CCCCCccccccccC---CccCcEEEEEeecccCCC-CCCCCCeEEEecCCccccceecc
Confidence 999999998654 35889999999876 668999999999999988 59999999999999999988775
Q ss_pred ccccCccCCCccccccCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcccccccccccccccCCCc---c
Q 044561 170 AYFSDREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSL---K 246 (614)
Q Consensus 170 ~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastg~~---~ 246 (614)
+|.+|+.++|||+||+.+++|+|++.+.+. |.+|+|+..+||+.+|||+||||||||||.. .
T Consensus 154 -------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~~~ 218 (252)
T 1fat_A 154 -------------DFVNGENAEVLITYDSSTNLLVASLVYPSQ--KTSFIVSDTVDLKSVLPEWVSVGFSATTGINKGNV 218 (252)
T ss_dssp -------------CCCTTCEEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCHHHHSCSEEEEEEEEEECSSTTBC
T ss_pred -------------cccCCCEEEEEEEEeCCCCEEEEEEecCCC--CCcceEEEEechHHhCCCceEEEEEeccCCCCccc
Confidence 367899999999999999999999987653 5578999999999999999999999999998 9
Q ss_pred ceeeEeccccccCC
Q 044561 247 SSHYVLGWSFNRSG 260 (614)
Q Consensus 247 ~~h~i~sWsf~~~~ 260 (614)
|.|+|++|+|+++.
T Consensus 219 ~~H~IlsWsF~s~l 232 (252)
T 1fat_A 219 ETNDVLSWSFASKL 232 (252)
T ss_dssp CCCEEEEEEEEEEE
T ss_pred ceEEEEEEEEEeeC
Confidence 99999999998763
|
| >1gsl_A Griffonia simplicifolia lectin 4; glycoprotein, manganese; HET: FUC GAL MAG NAG BMA; 2.00A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1lec_A* 1led_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-56 Score=439.23 Aligned_cols=213 Identities=31% Similarity=0.473 Sum_probs=191.3
Q ss_pred CcceEEeCCC----CC-CCCceEecceeEcCCCcEEecCCCC-----CCceeeEeeCCceeecCCC-CCceeeeeeeEEe
Q 044561 26 DVNQFIYHGF----NE-DAQLQRDGLASVHSNGLLQLTNTVS-----PQQEGHAFYRLPIKFNTSS-SESLSFSSNFVFA 94 (614)
Q Consensus 26 ~~~~f~~~~f----~~-~~~~~~~g~a~~~~~g~l~Lt~~~~-----~~~~G~~~y~~pv~l~~~~-~~~~sF~t~F~f~ 94 (614)
...+|+|++| .+ ..+|.++|+|.+. +|.|+||++.. ..++|||||++||+||+ + ++++||+|+|+|.
T Consensus 2 ~~~~F~f~~F~~~~~~~~~~l~l~GdA~i~-~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~~-~tg~vasFsT~F~F~ 79 (243)
T 1gsl_A 2 NTVNFTYPDFWSYSLKNGTEITFLGDATRI-PGALQLTKTDANGNPVRSSAGQASYSEPVFLWD-STGKAASFYTSFTFL 79 (243)
T ss_dssp CCCEEEESCCCCTTCCTTSSEEEEETCEEE-TTEEECSCBCTTSCBCSSEEEEEEESSCEECBC-TTSCBCEEEEEEEEE
T ss_pred cceEEEcCCCccccCCCCCCEEEccceEec-CCcEEecCCccCCcccCCCeEEEEECCCEEccC-CCCCcCceEEEEEEE
Confidence 3578999999 54 4799999999998 99999998752 37999999999999999 6 8899999999999
Q ss_pred e---------eeEEEEcCCCCCCCCCCCCCCcccccccCCC-CCCCCcEEEEEeeccCCCCCCCCCCCeeeEecCCCccc
Q 044561 95 I---------GMAFVISPSKDLGKAEASPSEYLGLFNASNN-GQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISH 164 (614)
Q Consensus 95 i---------G~aF~l~p~~~~~~~~~~~g~~lGl~~~~~~-~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~ 164 (614)
| ||||||+|.... +++.||||||+|.+++ +++.||+|||||||++|.+|+||++||||||+||+.|.
T Consensus 80 I~~~~~~~gdGlAF~l~p~~~~---~~~~g~~LGl~n~~~~~~~~~n~~vAVEFDT~~N~~~~Dp~~nHvGIdvns~~S~ 156 (243)
T 1gsl_A 80 LKNYGAPTADGLAFFLAPVDSS---VKDYGGFLGLFRHETAADPSKNQVVAVEFDTWINKDWNDPPYPHIGIDVNSIVSV 156 (243)
T ss_dssp EEESSSSCBCEEEEEEEETTCC---CCCCGGGTTTSCTTTTTCGGGCCCEEEEEECSCCGGGTCCSSCEEEEEESSSSCS
T ss_pred EecCCCCCCCCEEEEEecCCCC---CCCCCCcccccccccccCCccCcEEEEEeccccccccCCCCCCceeeccCCcccc
Confidence 9 999999998654 3588999999998764 77789999999999999999999999999999999999
Q ss_pred ccccCccccCccCCCccccccC---CccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCccccccccccccccc
Q 044561 165 ESAPAAYFSDREGMNKTLELII---GDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSAS 241 (614)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~l~~---g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsas 241 (614)
++++|. |.+ |+.++|||+||+.+++|+|+|.+.+. ..|+|++.+||+.+||++||||||||
T Consensus 157 ~~~~~~-------------l~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~~---~~~~ls~~vdL~~~l~~~~~vGFSAs 220 (243)
T 1gsl_A 157 ATTRWE-------------NDDAYGSSIATAHITYDARSKILTVLLSYEHG---RDYILSHVVDLAKVLPQKVRIGFSAG 220 (243)
T ss_dssp EEEECC-------------HHHHTSCCEEEEEEEEETTTTEEEEEEEETTS---CEEEEEEECCHHHHSCSEEEEEEEEE
T ss_pred ceeeeE-------------EeccCCCcEEEEEEEEeCCCCEEEEEEecCCC---CceeEEEEechHHhCCCceEEEEEec
Confidence 888752 456 99999999999999999999988654 46899999999999999999999999
Q ss_pred CCCccceeeEeccccccCC
Q 044561 242 TGSLKSSHYVLGWSFNRSG 260 (614)
Q Consensus 242 tg~~~~~h~i~sWsf~~~~ 260 (614)
|| ..|.|+|++|+|+++.
T Consensus 221 TG-~~~~h~IlsWsF~s~l 238 (243)
T 1gsl_A 221 VG-YDEVTYILSWHFFSTL 238 (243)
T ss_dssp EC-BSEEEEEEEEEEEEEC
T ss_pred cC-CcceeEEEEEEEEeec
Confidence 99 9999999999998764
|
| >2bqp_A Protein (PEA lectin); D-glucopyranose complex, sugar binding protein; HET: GLC; 1.90A {Pisum sativum} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-56 Score=436.46 Aligned_cols=214 Identities=31% Similarity=0.499 Sum_probs=192.0
Q ss_pred CcceEEeCCCCC-CCCceEecceeEcCCCcEEecCCCCCCceeeEeeCCceeecCCC-CCceeeeeeeEEee--------
Q 044561 26 DVNQFIYHGFNE-DAQLQRDGLASVHSNGLLQLTNTVSPQQEGHAFYRLPIKFNTSS-SESLSFSSNFVFAI-------- 95 (614)
Q Consensus 26 ~~~~f~~~~f~~-~~~~~~~g~a~~~~~g~l~Lt~~~~~~~~G~~~y~~pv~l~~~~-~~~~sF~t~F~f~i-------- 95 (614)
...+|+|++|++ ..+|.++|+|. .++|.|+||++.. .+.|||||++||+||++. ++++||+|+|+|.|
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~-~~~g~l~LT~~~~-~~~G~a~y~~Pv~l~~~~~~~~~sFst~F~F~I~~~~~~~~ 79 (234)
T 2bqp_A 2 ETTSFLITKFSPDQQNLIFQGDGY-TTKEKLTLTKAVK-NTVGRALYSSPIHIWDRETGNVANFVTSFTFVINAPNSYNV 79 (234)
T ss_dssp EEEEEEESSBCTTCTTEEEEETCE-EETBEEEEECSCT-TCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECSSTTSC
T ss_pred cceEEEcCCCCCCCCCEEEeecee-cCCCEEEeCCCCC-CCEEEEEECCCEEcccCCCCceeeEEEEEEEEEeCCCCCCC
Confidence 356899999985 47999999999 5699999999877 899999999999999987 88999999999999
Q ss_pred --eeEEEEcCCCCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeeccCCCCCCCCC--CCeeeEecCCCcccccccCcc
Q 044561 96 --GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDID--DNHVGIDVNSLISHESAPAAY 171 (614)
Q Consensus 96 --G~aF~l~p~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~--~~Hvgid~ns~~s~~~~~~~~ 171 (614)
||||+|+|....| . +.||||||+|.++ ++..+|+|||||||++|.+ +||+ +||||||+||+.|.++++|
T Consensus 80 gdGlAF~l~p~~~~p--~-~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~N~~-~Dp~~~~nHVgIdvns~~S~~s~~~-- 152 (234)
T 2bqp_A 80 ADGFTFFIAPVDTKP--Q-TGGGYLGVFNSAE-YDKTTQTVAVEFDTFYNAA-WDPSNRDRHIGIDVNSIKSVNTKSW-- 152 (234)
T ss_dssp CCEEEEEEEETTCCC--C-CCGGGTTTCSCSS-CCGGGCCEEEEEECSCCTT-TSCTTCCCEEEEEESSSSCSEEEEC--
T ss_pred CCcEEEEEecCCCCC--C-CCCCccccccccC-CCCCCcEEEEEEecccCcc-cCCCCCCCceeEeeCCccccceEee--
Confidence 9999999987654 4 7899999999874 4678999999999999988 4999 9999999999999988775
Q ss_pred ccCccCCCccccccCCccEEEEEEEeCCCcEEEEEEeeCCCC---CCCCCceeeeccCcccccccccccccccCCCccce
Q 044561 172 FSDREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIP---KPTKPLLSRAINLSHILLETMYVGFSASTGSLKSS 248 (614)
Q Consensus 172 ~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~---~~~~~~ls~~~dl~~~l~~~~~vGFsastg~~~~~ 248 (614)
++.+|+.++|||+||+.+++|+|++.+.+.+ +|..|+|+..+||+.+||++||||||||||...+.
T Consensus 153 -----------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~p~~~~ls~~vdL~~~l~~~~yvGFSAsTG~~~~~ 221 (234)
T 2bqp_A 153 -----------KLQNGEEANVVIAFNAATNVLTVSLTYPNNSLEEEVTSYTLSDVVSLKDVVPEWVRIGFSATTGAEYAA 221 (234)
T ss_dssp -----------CCCTTCEEEEEEEEETTTTEEEEEEEECC------CEEEEEEEECCGGGTSCSEEEEEEEEECSSSCCE
T ss_pred -----------EEcCCCEEEEEEEEeCCCCEEEEEEecCCCCcccCCCcceEEEEechHHhCCCceEEEEEeccCCCccc
Confidence 3568999999999999999999999987665 56789999999999999999999999999999999
Q ss_pred eeEeccccccC
Q 044561 249 HYVLGWSFNRS 259 (614)
Q Consensus 249 h~i~sWsf~~~ 259 (614)
|+|++|+|+++
T Consensus 222 H~IlsWsF~s~ 232 (234)
T 2bqp_A 222 HEVLSWSFHSE 232 (234)
T ss_dssp EEEEEEEEEEE
T ss_pred EEEEEEEEEee
Confidence 99999999864
|
| >1wbf_A Protein (agglutinin); lectin (agglutinin), legume lectin, protein crystallography, group specificity, saccharide free form; HET: NAG; 2.30A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 2d3s_A* 2dtw_A* 1wbl_A* 2dty_A* 2du0_A* 2du1_A* 2e51_A* 2e53_A* 2zmk_A* 2zml_A* 2zmn_A* 2e7t_A* 2e7q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-56 Score=435.12 Aligned_cols=211 Identities=34% Similarity=0.549 Sum_probs=189.1
Q ss_pred CcceEEeCCCCC-CCCceEecceeEcCCCcEEecCCCC----CCceeeEeeCCceeecCCC-CCceeeeeeeEEee----
Q 044561 26 DVNQFIYHGFNE-DAQLQRDGLASVHSNGLLQLTNTVS----PQQEGHAFYRLPIKFNTSS-SESLSFSSNFVFAI---- 95 (614)
Q Consensus 26 ~~~~f~~~~f~~-~~~~~~~g~a~~~~~g~l~Lt~~~~----~~~~G~~~y~~pv~l~~~~-~~~~sF~t~F~f~i---- 95 (614)
...+|+|++|++ ..+|+++|+|.+.++|.|+||++.. ..++|||||++||+||++. ++++||+|+|+|.|
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg~vaSFsT~F~F~I~~~~ 81 (242)
T 1wbf_A 2 KTISFNFNQFHQNEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDSTTGNVASFETRFSFSIRQPF 81 (242)
T ss_dssp CEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSC
T ss_pred cceEEEcCCCCCCCCCeEEccceEEccCCcEEecCcccCCcccCCeEEEEECCCEecccCCCCCeeeEEEEEEEEEeCCC
Confidence 356899999985 4799999999998799999998751 2799999999999999987 88999999999988
Q ss_pred -------eeEEEEcCCCCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeeEecCCCccccccc
Q 044561 96 -------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAP 168 (614)
Q Consensus 96 -------G~aF~l~p~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~ 168 (614)
||||||+|.... +++.||||||+|.+ +.+|+|||||||++|. +||++||||||+||+.|.++++
T Consensus 82 ~~~~~gdGlAF~l~p~~~~---~~~~g~~LGl~n~~----~~~~~vAVEFDT~~N~--~Dp~~nHVGIdvNs~~S~~~~~ 152 (242)
T 1wbf_A 82 PRPHPADGLVFFIAPPNTQ---TGEGGGYFGIYNPL----SPYPFVAVEFDTFRNT--WDPQIPHIGIDVNSVISTKTVP 152 (242)
T ss_dssp CSSCCCEEEEEEEECSSCC---CCCCGGGTTTCCTT----SCCCCEEEEEECSCCT--TCCSSSEEEEEESSSSCSEEEE
T ss_pred CCCCCCCcEEEEEecCCCC---CCCCCCccccccCC----CcCcEEEEEeccccCC--CCCCCCeEEEECCCccccceee
Confidence 999999998654 35889999999875 5789999999999997 5999999999999999998877
Q ss_pred CccccCccCCCccccccCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcccccccccccccccC----CC
Q 044561 169 AAYFSDREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSAST----GS 244 (614)
Q Consensus 169 ~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsast----g~ 244 (614)
| +|.+|+.++|||+||+.+++|+|+|.+.+. |..|+|+..|||+.+|||+||||||||| |.
T Consensus 153 ~-------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~VGFSAsTg~~~G~ 217 (242)
T 1wbf_A 153 F-------------TLDNGGIANVVIKYDASTKILHVVLVFPSL--GTIYTIADIVDLKQVLPESVNVGFSAATGDPSGK 217 (242)
T ss_dssp C-------------CCCTTSCEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCHHHHSCSEEEEEEEEEECCGGGC
T ss_pred e-------------EecCCCEEEEEEEEeCCCCEEEEEEccCCC--CCcceEEEEechHHhcCCceEEEEEEeecCcCCc
Confidence 5 367899999999999999999999988653 5578999999999999999999999999 88
Q ss_pred c---cceeeEeccccccCC
Q 044561 245 L---KSSHYVLGWSFNRSG 260 (614)
Q Consensus 245 ~---~~~h~i~sWsf~~~~ 260 (614)
. .|.|+|++|+|+++.
T Consensus 218 ~~~~~~~h~IlsWsF~s~l 236 (242)
T 1wbf_A 218 QRNATETHDILSWSFSASL 236 (242)
T ss_dssp CTTCCCCCEEEEEEEEEEC
T ss_pred cccccceEEEEEEEeEecC
Confidence 7 899999999998764
|
| >1f9k_A Acidic lectin; legume lectin, glycosylated protein, H-antigenic specificity agglutinin, sugar binding protein; HET: NAG MAN AMG; 3.00A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 1fay_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-55 Score=432.38 Aligned_cols=210 Identities=34% Similarity=0.526 Sum_probs=189.0
Q ss_pred cceEEeCCCCC-CCCceEecceeEcCCCcEEecCCCC-----CCceeeEeeCCceeecCCC-CCceeeeeeeEEee----
Q 044561 27 VNQFIYHGFNE-DAQLQRDGLASVHSNGLLQLTNTVS-----PQQEGHAFYRLPIKFNTSS-SESLSFSSNFVFAI---- 95 (614)
Q Consensus 27 ~~~f~~~~f~~-~~~~~~~g~a~~~~~g~l~Lt~~~~-----~~~~G~~~y~~pv~l~~~~-~~~~sF~t~F~f~i---- 95 (614)
.++|+|++|.+ ..+|.++|+|.+.++|.|+||++.. ..++|||||++||+|||+. ++++||+|+|+|.|
T Consensus 2 ~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~~g~vasFsT~F~F~I~~~~ 81 (238)
T 1f9k_A 2 TQSFNFDHFEENSKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWDSTTGNVASFETRFSFNITQPY 81 (238)
T ss_dssp EEEEEESSCCSSCTTEEEEETCEECTTSCEECSCSEETTEECCSCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECCC
T ss_pred CeEEEcCCCCCCCCCeEEccceEECcCCcEEecCccccCccccCCEEEEEECCCEEeecCCCCCeeeEEEEEEEEEecCC
Confidence 46899999985 4799999999998789999998751 2789999999999999987 88999999999998
Q ss_pred -------eeEEEEcCCCCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeeEecCCCccccccc
Q 044561 96 -------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAP 168 (614)
Q Consensus 96 -------G~aF~l~p~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~ 168 (614)
||||||+|.... +++.||||||+|.+ ++ +|+|||||||++|. +||++||||||+||+.|.++++
T Consensus 82 ~~~~~gdGlAF~l~p~~~~---~~~~g~~LGl~n~~---~~-~~~vAVEFDT~~N~--~Dp~~nHVgIdvns~~S~~s~~ 152 (238)
T 1f9k_A 82 AYPEPADGLTFFMVPPNSP---QGEDGGNLGVFKPP---EG-DNAFAVEFDTFQNT--WDPQVPHIGIDVNSIVSSKTLH 152 (238)
T ss_dssp SSSCCCEEEEEEEECTTCC---CCCSGGGTTTCCSS---CC-SCCEEEEEECSCCT--TCCSSSEEEEEESSSSCSEEEE
T ss_pred CCCCCCCcEEEEEccCCCC---CCCCCCcccccccC---CC-CcEEEEEEecccCC--CCCCCCeEEEecCCccccceEe
Confidence 999999998654 35889999999876 55 89999999999997 5999999999999999998876
Q ss_pred CccccCccCCCccccccCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcccccc--cccccccccCCCc-
Q 044561 169 AAYFSDREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLE--TMYVGFSASTGSL- 245 (614)
Q Consensus 169 ~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~--~~~vGFsastg~~- 245 (614)
| +|.+|+.++|||+||+.+++|+|++++.+. |..|+|+..|||+.+||| +||||||||||..
T Consensus 153 ~-------------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~~~~~~~vGFSAsTG~~~ 217 (238)
T 1f9k_A 153 F-------------QLENGGVANVVIKYDSPTKILNVVLAFHSV--GTVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQK 217 (238)
T ss_dssp C-------------CCCTTCCEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCHHHHSTTCSEEEEEEEEEECSST
T ss_pred e-------------cccCCCEEEEEEEEeCCCCEEEEEEecCCC--CCceeEEEEechHHhCCCCceEEEEEEeCcCCCC
Confidence 5 367899999999999999999999987653 557899999999999999 9999999999998
Q ss_pred --cceeeEeccccccCC
Q 044561 246 --KSSHYVLGWSFNRSG 260 (614)
Q Consensus 246 --~~~h~i~sWsf~~~~ 260 (614)
.|.|+|++|+|+++.
T Consensus 218 ~~~~~h~IlsWsF~s~~ 234 (238)
T 1f9k_A 218 NAVETHEIISWSFTSSL 234 (238)
T ss_dssp TCCCEEEEEEEEEEEEC
T ss_pred cccceEEEEEeEeEeec
Confidence 999999999998763
|
| >1avb_A Arcelin-1; lectin-like glycoprotein, plant defense, insecticidal activi lectin; HET: NAG; 1.90A {Phaseolus vulgaris} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-55 Score=428.75 Aligned_cols=205 Identities=36% Similarity=0.530 Sum_probs=184.8
Q ss_pred cceEEeCCCCCCCCceEecceeEcCCCcEEecCC---CCCCceeeEeeCCceeecCCC-CCceeeeeeeEEee-------
Q 044561 27 VNQFIYHGFNEDAQLQRDGLASVHSNGLLQLTNT---VSPQQEGHAFYRLPIKFNTSS-SESLSFSSNFVFAI------- 95 (614)
Q Consensus 27 ~~~f~~~~f~~~~~~~~~g~a~~~~~g~l~Lt~~---~~~~~~G~~~y~~pv~l~~~~-~~~~sF~t~F~f~i------- 95 (614)
..+|+|++|+. .+|.++|+|.+.++|.|+||++ .. .++|||||++||+||+++ ++++||+|+|+|.|
T Consensus 3 ~~~F~f~~F~~-~~l~l~G~A~v~~~g~l~LT~~~~~~~-~~~Gra~y~~Pv~l~~~~~g~vaSFsT~F~F~I~~~~~~~ 80 (226)
T 1avb_A 3 DASFNVETFNK-TNLILQGDATVSSEGHLLLTNVKGNEE-DSMGRAFYSAPIQINDRTIDNLASFSTNFTFRINAKNIEN 80 (226)
T ss_dssp EEEEEESSCCG-GGEEEEETCEECTTSCEECSCSSSCCT-TCEEEEEESSCEECEEGGGTEEEEEEEEEEEEEEESSTTS
T ss_pred ceEEEcCCCCc-cCEEEeccEEECCCCEEEeCCCCCCcc-CCeEEEEeCCCEEeecCCCCCcccEEEEEEEEEeCCCCCC
Confidence 46899999985 7999999999977999999987 44 799999999999999987 88999999999999
Q ss_pred ---eeEEEEcCCCCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeeEecCCCcccccccCccc
Q 044561 96 ---GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYF 172 (614)
Q Consensus 96 ---G~aF~l~p~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~ 172 (614)
||||||+|.+..| . +.||||||+|.+ ++++.||+|||||||+ +||||||+||+.|.++++|.
T Consensus 81 ~gdGlAF~l~p~~~~p--~-~~g~~LGl~n~~-~~~~~~~~vAVEFDT~---------~nHVGIdvNs~~S~~t~~~~-- 145 (226)
T 1avb_A 81 SAYGLAFALVPVGSRP--K-LKGRYLGLFNTT-NYDRDAHTVAVVFDTV---------SNRIEIDVNSIRPIATESCN-- 145 (226)
T ss_dssp CCEEEEEEEEETTCCC--C-CCGGGTTTCSCS-SCCGGGCCEEEEEETT---------TTEEEEEESSSSCSEEEECC--
T ss_pred CCCcEEEEEecCCCCC--C-CCCCcccccccC-CCCCcccEEEEEecCc---------CCccceeecCcccCccccCC--
Confidence 9999999987654 4 789999999976 4467899999999998 68999999999999998763
Q ss_pred cCccCCCccccccCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcccccccccccccccCCCc---ccee
Q 044561 173 SDREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSL---KSSH 249 (614)
Q Consensus 173 ~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastg~~---~~~h 249 (614)
..|.+|+.++|||+||+.+++|+|++++.+. +++|+|++.+||+++|||+|||||||+||.. .|.|
T Consensus 146 ---------~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~~~~~h 214 (226)
T 1avb_A 146 ---------FGHNNGEKAEVRITYDSPKNDLRVSLLYPSS--EEKCHVSATVPLEKEVEDWVSVGFSATSGSKKETTETH 214 (226)
T ss_dssp ---------SGGGTTCEEEEEEEEEGGGTEEEEEEEETTT--TEEEEEEEECCHHHHSCSEEEEEEEEEECSSGGGCEEE
T ss_pred ---------ccccCCCeEEEEEEEeCCCcEEEEEEeecCC--CccceEEEEechHHhCCCceEEEEEeccCCCCccccee
Confidence 4677999999999999999999999987654 3378999999999999999999999999998 9999
Q ss_pred eEeccccccC
Q 044561 250 YVLGWSFNRS 259 (614)
Q Consensus 250 ~i~sWsf~~~ 259 (614)
+|++|+|+++
T Consensus 215 ~IlsWsF~s~ 224 (226)
T 1avb_A 215 NVLSWSFSSN 224 (226)
T ss_dssp EEEEEEEEEE
T ss_pred EEEEEEEEee
Confidence 9999999864
|
| >1ioa_A Arcelin-5A, ARC5A; lectin-like proteins, plant defense proteins, lectin; HET: NAG FUC; 2.70A {Phaseolus vulgaris} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-55 Score=425.98 Aligned_cols=207 Identities=30% Similarity=0.467 Sum_probs=185.3
Q ss_pred CcceEEeCCCCCCCC-ceEecceeEcCCCcEEecCCCC-----CCceeeEeeCCceeecCCCCCceeeeeeeEEee----
Q 044561 26 DVNQFIYHGFNEDAQ-LQRDGLASVHSNGLLQLTNTVS-----PQQEGHAFYRLPIKFNTSSSESLSFSSNFVFAI---- 95 (614)
Q Consensus 26 ~~~~f~~~~f~~~~~-~~~~g~a~~~~~g~l~Lt~~~~-----~~~~G~~~y~~pv~l~~~~~~~~sF~t~F~f~i---- 95 (614)
...+|+|++|.. .+ |.++|+|.+.++|.|+||++.. ..++|||||++||+|||++ +++||+|+|+|.|
T Consensus 2 ~~~~F~f~~F~~-~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~s~Gra~y~~Pi~l~d~~-~vaSFsT~F~F~I~~~~ 79 (240)
T 1ioa_A 2 TETSFNFPNFHT-DDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIKDSN-NVASFNTNFTFIIRAKN 79 (240)
T ss_dssp CCCEEEESSCCT-TSSEEEEETCEECTTSCEETTCBCTTSSBCSSCBEEEEESSCEECBCSS-CBEEEEEEEEEECCBSC
T ss_pred cceEEEcCCCCC-CCcEEEccceEECCCCeEEeCCCCCCCccccCceEEEEECCCEEccCCC-ccccEEEEEEEEEeCCC
Confidence 457899999986 68 9999999998799999998753 1689999999999999987 8899999999999
Q ss_pred ------eeEEEEcCCCCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeeEecCCCcccccccC
Q 044561 96 ------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPA 169 (614)
Q Consensus 96 ------G~aF~l~p~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~ 169 (614)
||||||+|.+..| . +.||||||+|.+ ++++.+|+|||||||+ +||||||+||+.|.++++|
T Consensus 80 ~~~~gdGlAF~l~p~~~~p--~-~~g~~LGL~n~~-~~~~~~~~vAVEFDT~---------~nHVGIdvNs~~S~~t~~~ 146 (240)
T 1ioa_A 80 QSISAYGLAFALVPVNSPP--Q-KKQEFLGIFNTN-NPEPNARTVAVVFNTF---------KNRIDFDKNFIKPYVNENC 146 (240)
T ss_dssp TTSCCEEEEEEEEETTCCC--C-CCGGGTTTCCCS-SCCGGGCCEEEEEETT---------TTEEEEEESSSSCSEEEEC
T ss_pred CCCCCCcEEEEEecCCCCC--C-CCCCcccccccC-CCCCcCcEEEEEecCc---------CCceeeeeCCccccccccC
Confidence 9999999987654 4 889999999976 4467899999999998 6899999999999998876
Q ss_pred ccccCccCCCccccccCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcccccccccccccccCCCc---c
Q 044561 170 AYFSDREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSL---K 246 (614)
Q Consensus 170 ~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastg~~---~ 246 (614)
. ..|.+|+.++|||+||+.+|+|+|++++.+. +++|+|+..|||+++|||+||||||||||.. .
T Consensus 147 ~-----------~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~ 213 (240)
T 1ioa_A 147 D-----------FHKYNGEKTDVQITYDSSNNDLRVFLHFTVS--QVKCSVSATVHLEKEVDEWVSVGFSPTSGLTEDTT 213 (240)
T ss_dssp C-----------HHHHCSSCEEEEEEEETTTTEEEEEEEETTT--CCEEEEEEECCGGGTSCSEEEEEEEEEECSSTTTC
T ss_pred C-----------ccccCCCEEEEEEEEeCCCcEEEEEEecCCC--CccceeEEEechHHhCCCceEEEEEeccCCCCccc
Confidence 3 4677999999999999999999999998653 4478999999999999999999999999998 9
Q ss_pred ceeeEeccccccCC
Q 044561 247 SSHYVLGWSFNRSG 260 (614)
Q Consensus 247 ~~h~i~sWsf~~~~ 260 (614)
|.|+|++|+|++++
T Consensus 214 ~~H~IlsWsF~s~~ 227 (240)
T 1ioa_A 214 ETHDVLSWSFSSKF 227 (240)
T ss_dssp BCCEEEEEEEEEEE
T ss_pred ceeEEEEEEEEeeC
Confidence 99999999999764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-53 Score=439.57 Aligned_cols=251 Identities=27% Similarity=0.451 Sum_probs=202.1
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe------cCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA------SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLL 418 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 418 (614)
++|...+.||+|+||+||+|+++ ++..||||++...+....++|.+|+++|++++|||||+++|+|.+.+.++|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 34666789999999999999874 367899999988888888899999999999999999999999999999999
Q ss_pred EEEecCCCCcchhcccCC-------------CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCE
Q 044561 419 VYDYMPNGSLDKILHTNI-------------KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG 485 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~ 485 (614)
|||||++|+|.++|+... ...++|.+++.|+.|||+||.|||+ ++||||||||+|||+++++++
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcE
Confidence 999999999999997532 2459999999999999999999995 899999999999999999999
Q ss_pred EEeeeccccccCCCC-CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHH
Q 044561 486 KLGDFGLARLYDHDT-IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVC 563 (614)
Q Consensus 486 kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~ 563 (614)
||+|||+++...... .......+||+.|||||++.+..++.++|||||||++|||+| |+.||......+.. ..+
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~---~~i- 273 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI---DCI- 273 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHH---HHH-
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHH---HHH-
Confidence 999999998764432 223345689999999999999999999999999999999999 89999876543322 222
Q ss_pred HhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 564 DCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 564 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.++... .....++ ..+.+|+.+||+.||++||||.||++
T Consensus 274 ---~~g~~~-----~~p~~~~----~~~~~li~~cl~~dP~~RPs~~ei~~ 312 (329)
T 4aoj_A 274 ---TQGREL-----ERPRACP----PEVYAIMRGCWQREPQQRHSIKDVHA 312 (329)
T ss_dssp ---HHTCCC-----CCCTTCC----HHHHHHHHHHCCSSTTTSCCHHHHHH
T ss_pred ---HcCCCC-----CCccccc----HHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 222211 1122233 45778888999999999999999863
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-54 Score=438.28 Aligned_cols=250 Identities=28% Similarity=0.493 Sum_probs=207.5
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe------cCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA------SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLL 418 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 418 (614)
++|...+.||+|+||+||+|++. ++..||||++...+.+..++|.+|++++++++|||||+++|+|.+++.++|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 45677889999999999999874 367899999988888888899999999999999999999999999999999
Q ss_pred EEEecCCCCcchhcccCC-----------CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEE
Q 044561 419 VYDYMPNGSLDKILHTNI-----------KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKL 487 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl 487 (614)
|||||++|+|.++|+... ...++|.+++.|+.|||+||.|||+ ++||||||||+|||+++++++||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEE
Confidence 999999999999997532 3469999999999999999999995 89999999999999999999999
Q ss_pred eeeccccccCCCCC-CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHh
Q 044561 488 GDFGLARLYDHDTI-PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDC 565 (614)
Q Consensus 488 ~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~ 565 (614)
+|||+|+....... .......||+.|||||++.++.++.++|||||||++|||+| |+.||......+.. . .
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~---~----~ 242 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI---E----C 242 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH---H----H
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH---H----H
Confidence 99999986644322 22334579999999999999999999999999999999998 89999876543322 2 2
Q ss_pred hhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHh
Q 044561 566 WKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVM 613 (614)
Q Consensus 566 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 613 (614)
..++.... ....+ .+.+.+|+.+||+.||++||||.||+
T Consensus 243 i~~~~~~~-----~p~~~----~~~~~~li~~cl~~dP~~RPs~~~i~ 281 (299)
T 4asz_A 243 ITQGRVLQ-----RPRTC----PQEVYELMLGCWQREPHMRKNIKGIH 281 (299)
T ss_dssp HHHTCCCC-----CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHcCCCCC-----CCccc----hHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 22232211 11223 34577888899999999999999985
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-53 Score=435.94 Aligned_cols=250 Identities=26% Similarity=0.429 Sum_probs=204.9
Q ss_pred CCCCcceeeeeCcEEEEEEEEe------cCcEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEE
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLA------SNVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLL 418 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 418 (614)
+++..+.||+|+||+||+|++. +++.||||++.... ....++|.+|+.++++++|||||+++|+|.+.+.++|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 3456788999999999999973 35789999997543 3345789999999999999999999999999999999
Q ss_pred EEEecCCCCcchhcccCC--------------CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCC
Q 044561 419 VYDYMPNGSLDKILHTNI--------------KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLN 484 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~ 484 (614)
|||||++|+|.++|.... ...++|.++++|+.|||+||.|||+ ++||||||||+||||+++++
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCCC
Confidence 999999999999996432 2459999999999999999999995 89999999999999999999
Q ss_pred EEEeeeccccccCCCC-CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHH
Q 044561 485 GKLGDFGLARLYDHDT-IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWV 562 (614)
Q Consensus 485 ~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v 562 (614)
+||+|||+++...... ....+..+||+.|||||++.++.++.++|||||||++|||+| |+.||.+....+. ...
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~---~~~- 259 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV---VEM- 259 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH---HHH-
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH---HHH-
Confidence 9999999998654332 223445689999999999999999999999999999999998 8999987654332 222
Q ss_pred HHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 563 CDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 563 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
...+.... .+.++...+.+|+.+||+.||++||||.||++
T Consensus 260 ---i~~~~~~~---------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~ 299 (308)
T 4gt4_A 260 ---IRNRQVLP---------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHS 299 (308)
T ss_dssp ---HHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---HHcCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 22222211 12223345778889999999999999999873
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=429.64 Aligned_cols=251 Identities=27% Similarity=0.452 Sum_probs=197.3
Q ss_pred cCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
++++..+.||+|+||+||+|++++ .||||.++.. ..+..++|.+|+.++++++|||||+++|+|.+ +.++|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 467778899999999999998754 5899988643 45567889999999999999999999999865 568999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC-C
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT-I 501 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~-~ 501 (614)
|++|+|.++|+... ..++|.++..|+.|||+||.|||+ ++||||||||+||||++++++||+|||+|+...... .
T Consensus 113 ~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 113 CEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp CSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred CCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 99999999997643 459999999999999999999995 899999999999999999999999999998765432 2
Q ss_pred CcccccccCCCccchhhhcC---CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccc
Q 044561 502 PQTTKLVGTFGYMDPELMRT---GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSR 578 (614)
Q Consensus 502 ~~~~~~~gt~~y~aPE~~~~---~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~ 578 (614)
......+||+.|||||++.. +.++.++|||||||++|||+||+.||......+.. ......+.. .+.
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~------~~~~~~~~~----~p~ 258 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI------IFMVGRGYA----SPD 258 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH------HHHHHTTCC----CCC
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHH------HHHHhcCCC----CCC
Confidence 23455689999999999863 46899999999999999999999999765443221 111122111 111
Q ss_pred ccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHh
Q 044561 579 LEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVM 613 (614)
Q Consensus 579 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 613 (614)
+. ..+....+.+.+|+.+||+.||++||||.||+
T Consensus 259 ~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~ 292 (307)
T 3omv_A 259 LS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQIL 292 (307)
T ss_dssp ST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHH
T ss_pred cc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 11 11222334677888899999999999999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=428.65 Aligned_cols=249 Identities=25% Similarity=0.347 Sum_probs=208.3
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
+.|+..+.||+|+||+||+|+.+. ++.||||++........+.+.+|+.+|++++|||||++++++.+++.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 457888999999999999999875 8899999997665555567889999999999999999999999999999999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCc
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 503 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 503 (614)
++|+|.+++... .+++.++..++.||+.||.|||+ ++|+||||||+||||+.++++||+|||+|+...... ..
T Consensus 154 ~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~ 226 (346)
T 4fih_A 154 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PR 226 (346)
T ss_dssp TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CC
T ss_pred CCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCC-Cc
Confidence 999999999753 49999999999999999999995 899999999999999999999999999998775443 23
Q ss_pred ccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcC
Q 044561 504 TTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGIC 583 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 583 (614)
.+..+||+.|||||++....|+.++|||||||++|||++|+.||......+... .+. .+.. +.+. .
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~---~i~----~~~~-----~~~~--~ 292 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK---MIR----DNLP-----PRLK--N 292 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---HHH----HSSC-----CCCS--C
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH---HHH----cCCC-----CCCC--c
Confidence 455789999999999999999999999999999999999999998654433221 111 1111 1111 0
Q ss_pred cHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 584 EEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 584 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.......+.+|+.+||+.||++|||+.|+++
T Consensus 293 ~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 293 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1112235677888899999999999999985
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=427.36 Aligned_cols=250 Identities=23% Similarity=0.346 Sum_probs=204.1
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 421 (614)
++|+..+.||+|+||+||+|+.+. ++.||||++... .....+.+.+|+.++++++|||||++++++.+.+.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 578899999999999999999864 899999999754 34456789999999999999999999999999999999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCC
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI 501 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~ 501 (614)
||++|+|.++|.......+++.++..++.||+.||.|||+ ++||||||||+||||+.++++||+|||+|+......
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV- 179 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence 9999999999987655668999999999999999999995 899999999999999999999999999998764321
Q ss_pred CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccC
Q 044561 502 PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEG 581 (614)
Q Consensus 502 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~ 581 (614)
...+..+||+.|||||++.+..|+.++|||||||++|||++|+.||...+..+.. .. ...+... .+..
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~---~~----i~~~~~~-----~~~~ 247 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLV---LK----IISGSFP-----PVSL 247 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HH----HHHTCCC-----CCCT
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH---HH----HHcCCCC-----CCCc
Confidence 1234568999999999999999999999999999999999999999865433222 11 1122221 1112
Q ss_pred cCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 582 ICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 582 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.++ ..+.+|+.+||+.||++|||+.|+++
T Consensus 248 ~~s----~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 248 HYS----YDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp TSC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 223 35677888899999999999999975
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-51 Score=413.33 Aligned_cols=246 Identities=26% Similarity=0.404 Sum_probs=197.9
Q ss_pred CCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEee----cCeEEEEE
Q 044561 348 KDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRR----KGEFLLVY 420 (614)
Q Consensus 348 ~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 420 (614)
+..+.||+|+||+||+|.... +..||+|++... .....+.|.+|+.++++++|||||++++++.. ++.+||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 456789999999999999875 889999999654 44556789999999999999999999999865 35689999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcC-CCCEEEeeeccccccCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA-DLNGKLGDFGLARLYDHD 499 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~-~~~~kl~DfGla~~~~~~ 499 (614)
|||++|+|.+++... ..+++.++..++.||+.||.|||+. ..+|+||||||+|||++. ++.+||+|||+|+.....
T Consensus 109 Ey~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~ 185 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185 (290)
T ss_dssp ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred eCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC
Confidence 999999999999764 4599999999999999999999962 123999999999999985 799999999999865432
Q ss_pred CCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccc
Q 044561 500 TIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRL 579 (614)
Q Consensus 500 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 579 (614)
.....+||+.|||||++.+ +++.++|||||||++|||+||+.||........ +......+.... .+
T Consensus 186 ---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~------~~~~i~~~~~~~----~~ 251 (290)
T 3fpq_A 186 ---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------IYRRVTSGVKPA----SF 251 (290)
T ss_dssp ---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH------HHHHHTTTCCCG----GG
T ss_pred ---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH------HHHHHHcCCCCC----CC
Confidence 2445689999999998864 699999999999999999999999975433221 112222222111 12
Q ss_pred cCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 580 EGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 580 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
....+ ..+.+|+.+||+.||++|||+.|+++
T Consensus 252 ~~~~~----~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 252 DKVAI----PEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GGCCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CccCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22222 24677888999999999999999985
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=430.07 Aligned_cols=249 Identities=24% Similarity=0.335 Sum_probs=209.1
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
+.|+..+.||+|+||.||+|+.+. ++.||||++........+.+.+|+.+|++++|||||++++++.+.+.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 568889999999999999999875 8999999998766555667899999999999999999999999999999999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCc
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 503 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 503 (614)
++|+|.+++... .+++.++..++.||+.||.|||+ ++||||||||+||||+.++++||+|||+|+...... ..
T Consensus 231 ~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-~~ 303 (423)
T 4fie_A 231 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PR 303 (423)
T ss_dssp TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-CC
T ss_pred CCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCC-cc
Confidence 999999999753 49999999999999999999995 899999999999999999999999999998775443 23
Q ss_pred ccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcC
Q 044561 504 TTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGIC 583 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 583 (614)
....+||+.|||||++....|+.++|||||||++|||++|+.||......+.... + ..+...... ....+
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~---i----~~~~~~~~~---~~~~~ 373 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM---I----RDNLPPRLK---NLHKV 373 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH---H----HHSCCCCCS---CTTSS
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH---H----HcCCCCCCc---ccccC
Confidence 4557899999999999999999999999999999999999999986544332221 1 111111110 01112
Q ss_pred cHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 584 EEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 584 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+ ..+.+|+.+||+.||++|||+.|+++
T Consensus 374 s----~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 374 S----PSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp C----HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C----HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2 35677888899999999999999985
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-51 Score=416.86 Aligned_cols=247 Identities=23% Similarity=0.307 Sum_probs=207.1
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC---ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
++|+..+.||+|+||+||+|+.+. ++.||+|++.+. .....+.+.+|++++++++|||||++++++.+++.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 358889999999999999999865 889999999754 2234577899999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
|||++|+|.+++... ..+++.++..++.||+.||.|||+ ++|+||||||+|||++.++++||+|||+|+......
T Consensus 112 Ey~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 999999999999764 459999999999999999999995 899999999999999999999999999999775432
Q ss_pred -CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccc
Q 044561 501 -IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRL 579 (614)
Q Consensus 501 -~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 579 (614)
.......+||+.|||||++.+..|+.++||||+||++|||++|+.||...+..+.. ..+ .++.. .+
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~---~~i----~~~~~------~~ 253 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIF---AKI----IKLEY------DF 253 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHH----HHTCC------CC
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHH----HcCCC------CC
Confidence 23445679999999999999999999999999999999999999999865433222 111 12211 11
Q ss_pred cCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHh
Q 044561 580 EGICEEKQMELVLKLGLFCSHPKPEARPNMRQVM 613 (614)
Q Consensus 580 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 613 (614)
...++ ..+.+|+.+||+.||++|||+.|++
T Consensus 254 p~~~s----~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 254 PEKFF----PKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CTTCC----HHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CcccC----HHHHHHHHHHccCCHhHCcChHHHc
Confidence 12223 3467788889999999999999863
|
| >1dhk_B Bean lectin-like inhibitor, porcine pancreatic alpha-amylase; CO (hydrolase-inhibitor), complex (hydrolase-inhibitor) comple; HET: NAG; 1.85A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1viw_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=389.33 Aligned_cols=189 Identities=31% Similarity=0.499 Sum_probs=167.2
Q ss_pred CcceEEeCCCCCCCCceEecceeEcCCCcEEecCCCCCCceeeEeeCCceeecCCC-CCceeeeeeeEEee---------
Q 044561 26 DVNQFIYHGFNEDAQLQRDGLASVHSNGLLQLTNTVSPQQEGHAFYRLPIKFNTSS-SESLSFSSNFVFAI--------- 95 (614)
Q Consensus 26 ~~~~f~~~~f~~~~~~~~~g~a~~~~~g~l~Lt~~~~~~~~G~~~y~~pv~l~~~~-~~~~sF~t~F~f~i--------- 95 (614)
...+|+|++|.. .+|.++|+|.+.++|.|+||+... .+.|||||++||+||++. ++++||+|+|+|.|
T Consensus 2 ~~~~F~f~~F~~-~~l~l~G~A~v~~~g~l~LT~~~~-~~~Gra~y~~Pi~l~~~~~g~vaSFsT~F~F~I~~~~~~~~g 79 (223)
T 1dhk_B 2 TETSFIIDAFNK-TNLILQGDATVSSNGNLQLSYNSY-DSMSRAFYSAPIQIRDSTTGNVASFDTNFTMNIRTHRQANSA 79 (223)
T ss_dssp CCCEEEESSCCG-GGEEEESSEEECTTSCEEESSSCS-SEEEEEEESSCEESEETTTTEECEEEEEEEEEEECCC---CC
T ss_pred cceEEEcCCCCc-CCEEEeccEEECCCCEEEcCCCCC-CCEEEEEECCCEEeecCCCCCccceEEEEEEEEeCCCCCCCC
Confidence 457899999985 799999999997799999998766 899999999999999987 88999999999999
Q ss_pred -eeEEEEcCCCCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeeEecCCCcccccccCccccC
Q 044561 96 -GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSD 174 (614)
Q Consensus 96 -G~aF~l~p~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~ 174 (614)
||||||+|....| . +++|||||||+ +||||||+||+ |.++++|.
T Consensus 80 dGlAF~l~p~~~~p--~-------------------~~~vAVEFDT~---------~nHVGIdvNsi-S~~~~~~~---- 124 (223)
T 1dhk_B 80 VGLDFVLVPVQPES--K-------------------GDTVTVEFDTF---------LSRISIDVNNN-DIKSVPWD---- 124 (223)
T ss_dssp SEEEEEEEEC---------------------------CCEEEEEETT---------TTEEEEEETTE-EEEEEECC----
T ss_pred CceEEEEecCCCCC--C-------------------ccEEEEEecCC---------CCcccccCCcc-ccccccCC----
Confidence 9999999975432 1 35899999998 68999999999 99888763
Q ss_pred ccCCCccccccCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcccccccccccccccCCCc---cceeeE
Q 044561 175 REGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSL---KSSHYV 251 (614)
Q Consensus 175 ~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastg~~---~~~h~i 251 (614)
..|.+|+.++|||+||+.+++|+|++++.+. +++|+|+..+||+++|||+|||||||+||.. .|.|+|
T Consensus 125 -------~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdLs~~l~e~~~VGFSAsTG~~~~~~~~H~I 195 (223)
T 1dhk_B 125 -------VHDYDGQNAEVRITYNSSTKVFSVSLSNPST--GKSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDV 195 (223)
T ss_dssp -------GGGTTTSCEEEEEEEETTTTEEEEEEECTTT--CCEEEEEEECCCCSGGGSEEEEEEEEEECSGGGSCCEEEE
T ss_pred -------ccccCCCEEEEEEEEeCCCCEEEEEEecCCC--CccceEEEEechHHhCCCceEEEEEeccCCCccccceEEE
Confidence 4677999999999999999999999987653 3478999999999999999999999999998 999999
Q ss_pred eccccccCC
Q 044561 252 LGWSFNRSG 260 (614)
Q Consensus 252 ~sWsf~~~~ 260 (614)
++|+|++++
T Consensus 196 lsWsF~s~~ 204 (223)
T 1dhk_B 196 LSWSFSSKF 204 (223)
T ss_dssp EEEEEEEEC
T ss_pred EEEEEEecc
Confidence 999999764
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=419.28 Aligned_cols=246 Identities=25% Similarity=0.304 Sum_probs=199.9
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
+.|+..++||+|+||+||+|+.+. ++.||||++..+.. ..+|+.++++++|||||++++++.+++.+|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 456777889999999999999865 88999999976532 247999999999999999999999999999999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCC-CEEEeeeccccccCCCCCC
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADL-NGKLGDFGLARLYDHDTIP 502 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~-~~kl~DfGla~~~~~~~~~ 502 (614)
++|+|.++|+.. ..+++.++..++.||+.||.|||+ ++||||||||+||||+.++ ++||+|||+|+....+...
T Consensus 133 ~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 133 EGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp TTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred CCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 999999999764 459999999999999999999994 8999999999999999988 6999999999877543321
Q ss_pred ----cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccc
Q 044561 503 ----QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSR 578 (614)
Q Consensus 503 ----~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~ 578 (614)
.....+||+.|||||++.+..++.++|||||||++|||++|+.||......+....+ .. +... ...
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i---~~----~~~~---~~~ 277 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI---AS----EPPP---IRE 277 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHH---HH----SCCG---GGG
T ss_pred cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH---Hc----CCCC---chh
Confidence 123358999999999999999999999999999999999999999876554433221 11 1100 011
Q ss_pred ccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 579 LEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 579 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+...+ ...+.+++.+||+.||++|||+.|+++
T Consensus 278 ~~~~~----s~~~~~li~~~L~~dP~~R~sa~el~~ 309 (336)
T 4g3f_A 278 IPPSC----APLTAQAIQEGLRKEPVHRASAMELRR 309 (336)
T ss_dssp SCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCccC----CHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 22223 345677888899999999999999863
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=414.53 Aligned_cols=261 Identities=24% Similarity=0.304 Sum_probs=198.5
Q ss_pred cCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecC----eEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKG----EFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~lV~ 420 (614)
+++...+.||+|+||+||+|++ .|+.||||++...... ...+.+|+..+.+++|||||+++|+|.+.+ .++|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 3466778999999999999998 5789999999755432 233456777888999999999999998764 689999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccC-----CCceEecCcCCCCeEEcCCCCEEEeeeccccc
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDW-----EQVVLHRDIKPANVLLDADLNGKLGDFGLARL 495 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDikp~NIll~~~~~~kl~DfGla~~ 495 (614)
|||++|+|.++|+.. .++|.++.+++.|+++||+|||+.+ +++||||||||+|||++.++++||+|||+++.
T Consensus 81 Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 999999999999764 4999999999999999999999642 34999999999999999999999999999987
Q ss_pred cCCCCCC---cccccccCCCccchhhhcCC------CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccc--------cH
Q 044561 496 YDHDTIP---QTTKLVGTFGYMDPELMRTG------KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETV--------NL 558 (614)
Q Consensus 496 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~--------~l 558 (614)
....... .....+||+.|||||++.+. .++.++|||||||++|||+||+.|+......+.. ..
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 6544321 22345899999999999754 3678999999999999999998877543221100 01
Q ss_pred HHHHHHhhhcCCccccccccccCc-CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 559 VDWVCDCWKKGAIRDASDSRLEGI-CEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 559 ~~~v~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
...+.+...++. .++.+... .+.+..+.+.+|+.+||+.||++||||.||++
T Consensus 238 ~~~~~~~~~~~~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 238 VEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp HHHHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhccc----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 122222222211 22222211 23356678899999999999999999999874
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=420.65 Aligned_cols=253 Identities=25% Similarity=0.389 Sum_probs=206.1
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec------CcEEEEEEeecCC-hhhHHHHHHHHHHhcccCC-CceeEEeeEEeec-C
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS------NVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRH-RNLVKLRGYCRRK-G 414 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~-~ 414 (614)
.++|+..+.||+|+||+||+|.+.+ ++.||||++.... ....++|.+|+.+|++++| ||||+++|+|.+. +
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~ 142 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 142 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence 4678889999999999999999764 2579999997653 3456789999999999965 8999999999765 5
Q ss_pred eEEEEEEecCCCCcchhcccCC--------------CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEc
Q 044561 415 EFLLVYDYMPNGSLDKILHTNI--------------KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD 480 (614)
Q Consensus 415 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~ 480 (614)
.++||||||++|+|.++|+... +..++|.++..++.|||+||.|||+ ++||||||||+|||++
T Consensus 143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NILl~ 219 (353)
T 4ase_A 143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLS 219 (353)
T ss_dssp CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCccceeeC
Confidence 7899999999999999997532 2458999999999999999999995 8999999999999999
Q ss_pred CCCCEEEeeeccccccCCCCC-CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccH
Q 044561 481 ADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNL 558 (614)
Q Consensus 481 ~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l 558 (614)
+++.+||+|||+|+....+.. ......+||+.|||||++.++.++.++|||||||++|||+| |+.||......+.
T Consensus 220 ~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~--- 296 (353)
T 4ase_A 220 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--- 296 (353)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH---
T ss_pred CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH---
Confidence 999999999999987654432 23445689999999999999999999999999999999998 9999986543322
Q ss_pred HHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 559 VDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 559 ~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+.....++.... ....++ ..+.+++.+||+.||++|||+.||++
T Consensus 297 ---~~~~i~~g~~~~-----~p~~~~----~~~~~li~~c~~~dP~~RPt~~eil~ 340 (353)
T 4ase_A 297 ---FCRRLKEGTRMR-----APDYTT----PEMYQTMLDCWHGEPSQRPTFSELVE 340 (353)
T ss_dssp ---HHHHHHHTCCCC-----CCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---HHHHHHcCCCCC-----CCccCC----HHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 222222322111 112233 45777888999999999999999974
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-50 Score=403.05 Aligned_cols=245 Identities=23% Similarity=0.355 Sum_probs=190.2
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
.+|+..+.||+|+||+||+|+.+. ++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 579999999999999999999764 8999999997542 234567899999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
||| +|+|.+++..+ ..+++.++..++.||+.||.|||+ ++|+||||||+|||+++++++||+|||+|+......
T Consensus 93 Ey~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp ECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred eCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 999 68999998764 359999999999999999999995 899999999999999999999999999998765433
Q ss_pred CCcccccccCCCccchhhhcCCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMRTGKA-STSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRL 579 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~~~-t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 579 (614)
.....+||+.|||||++.+..+ +.++||||+||++|||++|+.||......+.. +....+.. .+
T Consensus 167 --~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~-------~~i~~~~~------~~ 231 (275)
T 3hyh_A 167 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLF-------KNISNGVY------TL 231 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHTCC------CC
T ss_pred --ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHH-------HHHHcCCC------CC
Confidence 2345689999999999988776 58999999999999999999999765432211 11122221 11
Q ss_pred cCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 580 EGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 580 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
...++ ..+.+|+.+||+.||++|||+.|+++
T Consensus 232 p~~~s----~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 232 PKFLS----PGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CTTSC----HHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCC----HHHHHHHHHHccCChhHCcCHHHHHc
Confidence 12233 34667888899999999999999974
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-50 Score=408.10 Aligned_cols=247 Identities=24% Similarity=0.347 Sum_probs=196.2
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe----cCcEEEEEEeecCC--hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA----SNVQIAVKKVSHDS--KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLL 418 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 418 (614)
++|+..+.||+|+||+||+|+.. .++.||+|.+.... .....++.+|+.++++++|||||++++++.+++.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46889999999999999999863 36789999986542 2223467889999999999999999999999999999
Q ss_pred EEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCC
Q 044561 419 VYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 498 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~ 498 (614)
|||||++|+|.+++... ..+++.++..++.||+.||.|||+ ++|+||||||+|||++.++++||+|||+|+....
T Consensus 104 vmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 99999999999999764 359999999999999999999995 8999999999999999999999999999986543
Q ss_pred CCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccc
Q 044561 499 DTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSR 578 (614)
Q Consensus 499 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~ 578 (614)
.. ......+||+.|||||++.+..++.++||||+||++|||++|+.||...+..+.... + .++.. .
T Consensus 179 ~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~---i----~~~~~------~ 244 (304)
T 3ubd_A 179 HE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTM---I----LKAKL------G 244 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---H----HHCCC------C
T ss_pred CC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHH---H----HcCCC------C
Confidence 32 223456899999999999999999999999999999999999999987554332221 1 11111 1
Q ss_pred ccCcCcHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHhC
Q 044561 579 LEGICEEKQMELVLKLGLFCSHPKPEARPN-----MRQVMQ 614 (614)
Q Consensus 579 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 614 (614)
+...++ ..+.+|+.+||+.||++||| +.|+++
T Consensus 245 ~p~~~s----~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 245 MPQFLS----PEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp CCTTSC----HHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred CCCcCC----HHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 112233 34677888899999999998 467764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=393.50 Aligned_cols=249 Identities=22% Similarity=0.374 Sum_probs=187.8
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeecC--------
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKG-------- 414 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-------- 414 (614)
++|+..+.||+|+||+||+|+.+. ++.||||++.... ....+.+.+|+.++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 357888999999999999999864 8899999997654 344577999999999999999999999987544
Q ss_pred ----eEEEEEEecCCCCcchhcccCCC-CCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEee
Q 044561 415 ----EFLLVYDYMPNGSLDKILHTNIK-PCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGD 489 (614)
Q Consensus 415 ----~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~D 489 (614)
.+|+|||||++|+|.+++..... ...++..+..++.||++||.|||+ ++|+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEcc
Confidence 37999999999999999976432 234566788999999999999995 8999999999999999999999999
Q ss_pred eccccccCCCCCC-----------cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccH
Q 044561 490 FGLARLYDHDTIP-----------QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNL 558 (614)
Q Consensus 490 fGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l 558 (614)
||+|+........ ..+..+||+.|||||++.+..|+.++|||||||++|||++ ||... .+....
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~ 236 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ--MERVRT 236 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHH
Confidence 9999876543211 1234589999999999999999999999999999999996 77532 111111
Q ss_pred HHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 559 VDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 559 ~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
. ........+.. .......+..|+.+||++||++|||+.|+++
T Consensus 237 ~----~~~~~~~~p~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 237 L----TDVRNLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp H----HHHHTTCCCHH---------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H----HHHhcCCCCCC---------CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1 11112111110 1122234567888999999999999999985
|
| >2ltn_A PEA lectin, alpha chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1bqp_A* 1hkd_A 1ofs_A* 1rin_A* 1lof_C* 1len_A 1lem_A 1les_A* 2lal_A 1loe_A 1loa_A* 1loc_A* 1lod_A* 1lob_A 1lof_A* 1log_A* 1lgc_A* 1lgb_A* 2b7y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=353.32 Aligned_cols=165 Identities=30% Similarity=0.487 Sum_probs=148.6
Q ss_pred CcceEEeCCCCC-CCCceEecceeEcCCCcEEecCCCCCCceeeEeeCCceeecCCC-CCceeeeeeeEEee--------
Q 044561 26 DVNQFIYHGFNE-DAQLQRDGLASVHSNGLLQLTNTVSPQQEGHAFYRLPIKFNTSS-SESLSFSSNFVFAI-------- 95 (614)
Q Consensus 26 ~~~~f~~~~f~~-~~~~~~~g~a~~~~~g~l~Lt~~~~~~~~G~~~y~~pv~l~~~~-~~~~sF~t~F~f~i-------- 95 (614)
...+|+|++|.+ ..+|+|+|+|. .++|.|+||++.. .++|||||++||+||++. ++++||+|+|+|.|
T Consensus 2 ~~~sF~f~~F~~~~~~l~l~G~A~-~~~g~l~LT~~~~-~~~Gra~y~~Pv~l~d~~tg~vaSFsT~F~F~I~~~~~~~~ 79 (181)
T 2ltn_A 2 ETTSFLITKFSPDQQNLIFQGDGY-TTKEKLTLTKAVK-NTVGRALYSSPIHIWDRETGNVANFVTSFTFVINAPNSYNV 79 (181)
T ss_dssp EEEEEEESSCCSSCTTEEEEETCE-ECSSSEEEECSCS-SCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECSSTTSC
T ss_pred cceEEEcCCCCCCCCCEEEecccc-CCCCCeEcCCCCC-CCEEEEEECCCEEeecCCCCCccceEEEEEEEEecCCCCCC
Confidence 356899999985 47999999999 6799999999876 899999999999999987 88999999999999
Q ss_pred --eeEEEEcCCCCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeeccCCCCCCCCC--CCeeeEecCCCcccccccCcc
Q 044561 96 --GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDID--DNHVGIDVNSLISHESAPAAY 171 (614)
Q Consensus 96 --G~aF~l~p~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~--~~Hvgid~ns~~s~~~~~~~~ 171 (614)
||||||+|....| . +.||||||+|.+ ++++.+|+|||||||++|.+ +||+ +|||||||||+.|.++++|
T Consensus 80 gdGlAF~l~p~~~~p--~-~~g~~LGL~n~~-~~~~~n~~vAVEFDT~~n~~-~Dp~~~~nHVGIdvNs~~S~~t~~~-- 152 (181)
T 2ltn_A 80 ADGFTFFIAPVDTKP--Q-TGGGYLGVFNSA-EYDKTTQTVAVEFDTFYNAA-WDPSNRDRHIGIDVNSIKSVNTKSW-- 152 (181)
T ss_dssp CCEEEEEEEETTCCC--C-CCGGGTTTCSCS-SCCTTSCCEEEEEECSCCTT-TSCTTCCCEEEEEESSSSCSEEEEC--
T ss_pred CCceEEEEecCCCCC--C-CCCccccccccC-CCCccccEEEEEeccccccc-cCCCCCCCEEEEEcCCccccceecc--
Confidence 9999999987554 4 889999999977 45778999999999999988 5999 9999999999999998875
Q ss_pred ccCccCCCccccccCCccEEEEEEEeCCCcEEEEEEeeC
Q 044561 172 FSDREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPM 210 (614)
Q Consensus 172 ~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~ 210 (614)
+|.+|+.++|||+||+.+|+|+|+|++.
T Consensus 153 -----------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~ 180 (181)
T 2ltn_A 153 -----------KLQNGEEANVVIAFNAATNVLTVSLTYP 180 (181)
T ss_dssp -----------CCCTTCCEEEEEEEETTTTEEEEEEEEC
T ss_pred -----------ccCCCCEEEEEEEEECCCCEEEEEEecC
Confidence 3578999999999999999999999864
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=386.39 Aligned_cols=279 Identities=35% Similarity=0.635 Sum_probs=245.6
Q ss_pred cccCHHHHHHHhcCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEee
Q 044561 333 QRFTYKDLYKATKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRR 412 (614)
Q Consensus 333 ~~~~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 412 (614)
.++++.++..++++|+..+.||+|+||.||+|+.+++..||+|++........+.+.+|+.++++++||||++++++|..
T Consensus 27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred eeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 34555666678899999999999999999999988899999999987777777889999999999999999999999999
Q ss_pred cCeEEEEEEecCCCCcchhcccCC--CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeee
Q 044561 413 KGEFLLVYDYMPNGSLDKILHTNI--KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDF 490 (614)
Q Consensus 413 ~~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~Df 490 (614)
.+..++||||+++|+|.+++.... ...+++.+++.++.|+++||.|||+ ++|+||||||+||+++.++.+||+||
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Df 183 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDF 183 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCC
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeec
Confidence 999999999999999999997643 2358999999999999999999995 89999999999999999999999999
Q ss_pred ccccccCCCC-CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcC
Q 044561 491 GLARLYDHDT-IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKG 569 (614)
Q Consensus 491 Gla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~ 569 (614)
|+++...... ........||+.|+|||++.++.++.++||||||+++|||++|+.||......+......|.......+
T Consensus 184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 263 (321)
T 2qkw_B 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263 (321)
T ss_dssp TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT
T ss_pred ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc
Confidence 9998654322 222344568999999999998899999999999999999999999998877777777888887777788
Q ss_pred CccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 570 AIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 570 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+....++.+......+..+.+.+++.+||+.||++|||+.||++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 308 (321)
T 2qkw_B 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLW 308 (321)
T ss_dssp CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 888888888877788888999999999999999999999999974
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=399.02 Aligned_cols=264 Identities=23% Similarity=0.327 Sum_probs=202.8
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEee------cCe
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRR------KGE 415 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~------~~~ 415 (614)
++|+..+.||+|+||+||+|+.+. ++.||||++... .....+.+.+|+.+|+.++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 468889999999999999999864 899999999654 34456778999999999999999999998754 367
Q ss_pred EEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccc
Q 044561 416 FLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARL 495 (614)
Q Consensus 416 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~ 495 (614)
+|||||||+ |+|.+++..+ ..+++.++..++.||+.||.|||+ ++||||||||+|||++.++.+||+|||+|+.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceeee
Confidence 999999995 7899998764 459999999999999999999995 8999999999999999999999999999987
Q ss_pred cCCCC---CCcccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCc
Q 044561 496 YDHDT---IPQTTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAI 571 (614)
Q Consensus 496 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~ 571 (614)
..... .......+||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+..+.+..+............
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~ 287 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI 287 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGT
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 64322 2234457999999999998765 5699999999999999999999999876655444333221111000000
Q ss_pred cccccc-------cccC--cCc-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 572 RDASDS-------RLEG--ICE-----EKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 572 ~~~~d~-------~l~~--~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
...... .+.. ..+ ......+.+|+.+||..||++|||+.|+|+
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000 0000 000 011235677888999999999999999985
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=384.76 Aligned_cols=283 Identities=39% Similarity=0.737 Sum_probs=246.5
Q ss_pred CcccCHHHHHHHhcCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChh-hHHHHHHHHHHhcccCCCceeEEeeEE
Q 044561 332 PQRFTYKDLYKATKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQ-GIKEFVAELVSMGRLRHRNLVKLRGYC 410 (614)
Q Consensus 332 ~~~~~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~ 410 (614)
..+++++++..+.++|+..+.||+|+||.||+|..+++..||+|++...... ....+.+|+.++++++||||++++++|
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 4678999999999999999999999999999999888899999998765322 233688999999999999999999999
Q ss_pred eecCeEEEEEEecCCCCcchhcccCC--CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEe
Q 044561 411 RRKGEFLLVYDYMPNGSLDKILHTNI--KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLG 488 (614)
Q Consensus 411 ~~~~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~ 488 (614)
...+..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+.+..+|+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999997643 3459999999999999999999997333499999999999999999999999
Q ss_pred eeccccccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCC--CccccccHHHHHHHhh
Q 044561 489 DFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQ--GSMETVNLVDWVCDCW 566 (614)
Q Consensus 489 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~--~~~~~~~l~~~v~~~~ 566 (614)
|||+++..............||+.|+|||++.+..++.++||||||+++|||++|+.||+.. .........+|+....
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 99999877655544455567999999999998888999999999999999999999999632 2233445677888888
Q ss_pred hcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 567 KKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 567 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
....+....+..+......+..+.+.+++.+||+.||++|||+.||++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 304 (326)
T 3uim_A 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 304 (326)
T ss_dssp SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHH
T ss_pred hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHH
Confidence 888888888888888888999999999999999999999999999974
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=380.94 Aligned_cols=199 Identities=27% Similarity=0.421 Sum_probs=170.5
Q ss_pred HhcCCCCcceeeeeCcEEEEEEEEe----cCcEEEEEEeecCChhhHHHHHHHHHHhccc-CCCceeEEeeEEeecCeEE
Q 044561 343 ATKGFKDKDVIGRGGFGKVYRGVLA----SNVQIAVKKVSHDSKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGEFL 417 (614)
Q Consensus 343 ~~~~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 417 (614)
..+.|+..+.||+|+||+||+|+.+ .++.||+|++..... ..++.+|+++++.+ +||||+++++++.+.+++|
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 3567999999999999999999864 257899999866543 35678999999988 6999999999999999999
Q ss_pred EEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCC-CCEEEeeecccccc
Q 044561 418 LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDAD-LNGKLGDFGLARLY 496 (614)
Q Consensus 418 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~-~~~kl~DfGla~~~ 496 (614)
+|||||++|+|.+++.. +++.++..++.||+.||.|||+ ++|+||||||+|||++.+ +.+||+|||+|+..
T Consensus 97 lvmE~~~g~~L~~~~~~-----l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 97 IAMPYLEHESFLDILNS-----LSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp EEEECCCCCCHHHHHTT-----CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEeCCCcccHHHHHcC-----CCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 99999999999999842 8999999999999999999995 899999999999999887 79999999999865
Q ss_pred CCCCC---------------------------CcccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCC
Q 044561 497 DHDTI---------------------------PQTTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVE 548 (614)
Q Consensus 497 ~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~ 548 (614)
..... ...+..+||+.|+|||++.+. .++.++||||+||++|||++|+.||.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 43221 112345799999999998765 58999999999999999999999996
Q ss_pred CCC
Q 044561 549 QQG 551 (614)
Q Consensus 549 ~~~ 551 (614)
...
T Consensus 249 ~~~ 251 (361)
T 4f9c_A 249 KAS 251 (361)
T ss_dssp CCS
T ss_pred CCC
Confidence 543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=405.71 Aligned_cols=251 Identities=24% Similarity=0.321 Sum_probs=210.4
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
++|+..+.||+|+||.||+|+.+. ++.||+|++........+.+.+|+.+|+.++|||||++++++.+.+.+|||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 578999999999999999999875 8899999998877777788999999999999999999999999999999999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCC--CCEEEeeeccccccCCCCC
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDAD--LNGKLGDFGLARLYDHDTI 501 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~--~~~kl~DfGla~~~~~~~~ 501 (614)
++|+|.++|... ...+++.++..++.||+.||.|||+ ++|+||||||+|||++.+ +.+||+|||+++......
T Consensus 237 ~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~- 311 (573)
T 3uto_A 237 SGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ- 311 (573)
T ss_dssp CCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-
T ss_pred CCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC-
Confidence 999999998653 3459999999999999999999995 899999999999999854 899999999999876543
Q ss_pred CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccC
Q 044561 502 PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEG 581 (614)
Q Consensus 502 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~ 581 (614)
.....+||+.|||||++.+..|+.++||||+||++|||++|+.||......+....+ ..+... .+.....
T Consensus 312 -~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i-------~~~~~~--~~~~~~~ 381 (573)
T 3uto_A 312 -SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV-------KSCDWN--MDDSAFS 381 (573)
T ss_dssp -EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH-------HTTCCC--CCSGGGT
T ss_pred -ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH-------HhCCCC--CCccccc
Confidence 344568999999999999999999999999999999999999999876544332211 111110 1111112
Q ss_pred cCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 582 ICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 582 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.++ +.+.+|+.+||+.||++|||+.|+++
T Consensus 382 ~~s----~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 382 GIS----EDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp TSC----HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 222 34667888999999999999999974
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=398.55 Aligned_cols=248 Identities=23% Similarity=0.291 Sum_probs=200.2
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC------hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS------KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFL 417 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 417 (614)
++|+..++||+|+||+||+|+.+. +..||+|++.+.. .....+...++.+++.++|||||++++++.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 568899999999999999999875 8899999996531 122233345577888899999999999999999999
Q ss_pred EEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccC
Q 044561 418 LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYD 497 (614)
Q Consensus 418 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~ 497 (614)
||||||+||+|.++|... ..+++..+..++.||+.||.||| .++||||||||+||||+.+|++||+|||+|+...
T Consensus 269 lVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 999999999999999864 45999999999999999999999 4899999999999999999999999999998765
Q ss_pred CCCCCcccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccc
Q 044561 498 HDTIPQTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASD 576 (614)
Q Consensus 498 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 576 (614)
... ....+||+.|||||++.. ..|+.++||||+||++|||++|+.||......+...+.... ....
T Consensus 344 ~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i----~~~~------ 410 (689)
T 3v5w_A 344 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT----LTMA------ 410 (689)
T ss_dssp SCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH----HHCC------
T ss_pred CCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh----cCCC------
Confidence 443 345689999999999975 47899999999999999999999999764433322222111 1111
Q ss_pred ccccCcCcHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHhC
Q 044561 577 SRLEGICEEKQMELVLKLGLFCSHPKPEARPN-----MRQVMQ 614 (614)
Q Consensus 577 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 614 (614)
..+...++ ..+..|+.+||+.||++|++ +.||++
T Consensus 411 ~~~p~~~S----~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 411 VELPDSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp CCCCTTSC----HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred CCCCccCC----HHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 11122233 34677888899999999998 677763
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=359.42 Aligned_cols=250 Identities=23% Similarity=0.409 Sum_probs=208.1
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
.++|+..+.||+|+||.||+|... ++..||+|++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 357899999999999999999975 4889999999776655567889999999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 502 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 502 (614)
+++|+|.+++... .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 171 (297)
T 3fxz_A 99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (297)
T ss_dssp CTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-
Confidence 9999999999764 48999999999999999999995 8999999999999999999999999999987654432
Q ss_pred cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCc
Q 044561 503 QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGI 582 (614)
Q Consensus 503 ~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 582 (614)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... ....+. ....
T Consensus 172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~------~~~~~~-~~~~------- 237 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL------IATNGT-PELQ------- 237 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH------HHHHCS-CCCS-------
T ss_pred ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HHhCCC-CCCC-------
Confidence 23445799999999999999999999999999999999999999976543222111 111111 0100
Q ss_pred CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 583 CEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 583 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+......+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 238 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 11122345778888999999999999999985
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=358.96 Aligned_cols=262 Identities=24% Similarity=0.345 Sum_probs=214.4
Q ss_pred CcccCHHHHHHHhcC----------CCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCChhhHHHHHHHHHHhcccCC
Q 044561 332 PQRFTYKDLYKATKG----------FKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRH 400 (614)
Q Consensus 332 ~~~~~~~el~~~~~~----------f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H 400 (614)
+..++++++..+++. |+..+.||+|+||.||+|+.. +++.||||++........+.+.+|+.++++++|
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence 345788888877764 566779999999999999987 589999999987766667789999999999999
Q ss_pred CceeEEeeEEeecCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEc
Q 044561 401 RNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD 480 (614)
Q Consensus 401 ~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~ 480 (614)
|||+++++++...+..++||||+++++|.+++... .+++.++..++.|++.||.|||+ .+|+||||||+||+++
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLT 175 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEC
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEC
Confidence 99999999999999999999999999999998753 49999999999999999999995 8999999999999999
Q ss_pred CCCCEEEeeeccccccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHH
Q 044561 481 ADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVD 560 (614)
Q Consensus 481 ~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~ 560 (614)
.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ..
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~---~~ 251 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA---MK 251 (321)
T ss_dssp TTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HH
T ss_pred CCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HH
Confidence 999999999999987654322 23446799999999999998999999999999999999999999976543221 11
Q ss_pred HHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 561 WVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 561 ~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+ ....... +.. .......+.+++.+||+.||++|||+.|+++
T Consensus 252 ~~----~~~~~~~-----~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 252 RL----RDSPPPK-----LKN--SHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp HH----HHSSCCC-----CTT--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HH----hcCCCCC-----cCc--cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11 1111111 110 1112235677888899999999999999985
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=358.42 Aligned_cols=252 Identities=23% Similarity=0.407 Sum_probs=205.5
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
++|...+.||+|+||.||+|.... +..+|+|++........+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 467788999999999999999865 8889999998777778889999999999999999999999999999999999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCc
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 503 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 503 (614)
++|+|.+++... ...+++.++..++.|+++||.|||+ .+|+||||||+||+++.++.+||+|||+++.........
T Consensus 90 ~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 90 KGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp TTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred CCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 999999999864 3459999999999999999999995 899999999999999999999999999998764432111
Q ss_pred -------------ccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCC
Q 044561 504 -------------TTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGA 570 (614)
Q Consensus 504 -------------~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~ 570 (614)
.....||+.|+|||++.+..++.++||||||+++|||++|..|+............. ...
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~-~~~------ 238 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-VRG------ 238 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC-HHH------
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh-hhc------
Confidence 124579999999999999999999999999999999999999987543322110000 000
Q ss_pred ccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 571 IRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 571 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+......+ ...+.+++.+||+.||++|||+.|+++
T Consensus 239 ---~~~~~~~~~~----~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 239 ---FLDRYCPPNC----PPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp ---HHHHTCCTTC----CTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---cccccCCCCC----CHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0011111112 234777888999999999999999863
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=359.68 Aligned_cols=247 Identities=25% Similarity=0.376 Sum_probs=205.8
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
..+|+..+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 357888999999999999999985 5889999999754 4455678899999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
||+++|+|.+++... ..+++.++..++.|+++||.|||+ .+|+||||||+|||++.++++||+|||++.......
T Consensus 94 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp CCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred ECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 999999999999764 349999999999999999999995 899999999999999999999999999998765443
Q ss_pred CCcccccccCCCccchhhhcCCCCC-cchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMRTGKAS-TSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRL 579 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~~~t-~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 579 (614)
.....+||+.|+|||++.+..+. .++||||+||++|||++|+.||......+.. +....+.. .+
T Consensus 169 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-------~~i~~~~~------~~ 233 (328)
T 3fe3_A 169 --KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR-------ERVLRGKY------RI 233 (328)
T ss_dssp --GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCCC------CC
T ss_pred --ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhCCC------CC
Confidence 34456899999999999887764 8999999999999999999999865433221 11112211 11
Q ss_pred cCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 580 EGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 580 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.... ...+.+|+.+||+.||++|||+.|+++
T Consensus 234 p~~~----s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 234 PFYM----STDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp CTTS----CHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred CCCC----CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1112 234667788899999999999999985
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=347.43 Aligned_cols=275 Identities=34% Similarity=0.612 Sum_probs=224.7
Q ss_pred CcccCHHHHHHHhcCCCCc------ceeeeeCcEEEEEEEEecCcEEEEEEeecC----ChhhHHHHHHHHHHhcccCCC
Q 044561 332 PQRFTYKDLYKATKGFKDK------DVIGRGGFGKVYRGVLASNVQIAVKKVSHD----SKQGIKEFVAELVSMGRLRHR 401 (614)
Q Consensus 332 ~~~~~~~el~~~~~~f~~~------~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~Ei~~l~~l~H~ 401 (614)
...|++.++..++++|... +.||+|+||.||+|.. ++..+|+|++... .....+.+.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4679999999999999888 8999999999999987 5778999998653 234567889999999999999
Q ss_pred ceeEEeeEEeecCeEEEEEEecCCCCcchhcccCC-CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEc
Q 044561 402 NLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNI-KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD 480 (614)
Q Consensus 402 niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~ 480 (614)
||+++++++...+..++||||+++++|.+++.... ...+++..+..++.|++.||.|||+ .+|+||||||+||+++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEEc
Confidence 99999999999999999999999999999987432 3459999999999999999999995 8999999999999999
Q ss_pred CCCCEEEeeeccccccCCCCCC-cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHH
Q 044561 481 ADLNGKLGDFGLARLYDHDTIP-QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLV 559 (614)
Q Consensus 481 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~ 559 (614)
.++.+||+|||++......... ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||......+....+
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 246 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHH
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHH
Confidence 9999999999999876543221 2334578999999998864 5889999999999999999999999865544332221
Q ss_pred HHHHHhh-hcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 560 DWVCDCW-KKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 560 ~~v~~~~-~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..... ....+.+..+..+ ...+....+.+.+++.+||+.||++|||+.||++
T Consensus 247 --~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~ 299 (307)
T 2nru_A 247 --KEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299 (307)
T ss_dssp --HHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --HHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 11111 1222333344433 2345667788999999999999999999999874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=358.80 Aligned_cols=260 Identities=28% Similarity=0.387 Sum_probs=203.7
Q ss_pred HhcCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecC----eEEE
Q 044561 343 ATKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKG----EFLL 418 (614)
Q Consensus 343 ~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~l 418 (614)
..++|+..+.||+|+||.||+|+.. ++.||||++...... ...+..|+.++++++||||+++++++.... .+++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQ-SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchH-HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 3467888999999999999999875 788999999765433 345567999999999999999999998754 4799
Q ss_pred EEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCC----------ceEecCcCCCCeEEcCCCCEEEe
Q 044561 419 VYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQ----------VVLHRDIKPANVLLDADLNGKLG 488 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~----------~ivHrDikp~NIll~~~~~~kl~ 488 (614)
||||+++|+|.+++... .+++.++..++.|+++||.|||+ . +|+||||||+|||++.++.+||+
T Consensus 100 v~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred EEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 99999999999999764 39999999999999999999995 6 99999999999999999999999
Q ss_pred eeccccccCCCCC-CcccccccCCCccchhhhcCC-----CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHH--
Q 044561 489 DFGLARLYDHDTI-PQTTKLVGTFGYMDPELMRTG-----KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVD-- 560 (614)
Q Consensus 489 DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-----~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~-- 560 (614)
|||+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.............
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 9999987654332 223345799999999999763 45678999999999999999999998654433222111
Q ss_pred -------HHHHhhhcCCccccccccccCc-CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 561 -------WVCDCWKKGAIRDASDSRLEGI-CEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 561 -------~v~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
........... .+.+... ........+.+++.+||+.||++|||+.||++
T Consensus 254 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 254 GQHPSLEDMQEVVVHKKK----RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp CSSCCHHHHHHHHTTSCC----CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCCchhhhhhhhhcccC----CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11111111111 1111111 12345567899999999999999999999974
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=371.08 Aligned_cols=264 Identities=22% Similarity=0.249 Sum_probs=211.2
Q ss_pred cCHHHHHHHhcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCCh---hhHHHHHHHHHHhcccCCCceeEEeeEE
Q 044561 335 FTYKDLYKATKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSK---QGIKEFVAELVSMGRLRHRNLVKLRGYC 410 (614)
Q Consensus 335 ~~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~ 410 (614)
+.++++....++|+..++||+|+||+||+|+.+. ++.||+|++..... ...+.+.+|..++..++||||++++++|
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 4456666677899999999999999999999876 78899999975322 1223478899999999999999999999
Q ss_pred eecCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeee
Q 044561 411 RRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDF 490 (614)
Q Consensus 411 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~Df 490 (614)
.+.+.+++|||||++|+|.+++... ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++++||+||
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcch
Confidence 9999999999999999999999763 2459999999999999999999995 89999999999999999999999999
Q ss_pred ccccccCCCCCCcccccccCCCccchhhhc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHh
Q 044561 491 GLARLYDHDTIPQTTKLVGTFGYMDPELMR-----TGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDC 565 (614)
Q Consensus 491 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~ 565 (614)
|+++.............+||+.|+|||++. .+.++.++|||||||++|||++|+.||......+....+ ...
T Consensus 220 Gla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i---~~~ 296 (437)
T 4aw2_A 220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI---MNH 296 (437)
T ss_dssp TTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH---HTH
T ss_pred hhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhh---hhc
Confidence 999876554443445568999999999987 567899999999999999999999999875543332221 111
Q ss_pred hhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCC--CCCHHHHhC
Q 044561 566 WKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEA--RPNMRQVMQ 614 (614)
Q Consensus 566 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~ 614 (614)
...-.++ ......+ ..+.+|+.+|+..+|++ ||++.|+++
T Consensus 297 ~~~~~~p-----~~~~~~s----~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 297 KERFQFP-----TQVTDVS----ENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHHCCCC-----SSCCCSC----HHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred cccccCC-----cccccCC----HHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 1111111 1111122 34666777788888888 999999875
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=357.81 Aligned_cols=251 Identities=20% Similarity=0.297 Sum_probs=206.3
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChh------hHHHHHHHHHHhcccCCCceeEEeeEEeecCeE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQ------GIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEF 416 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 416 (614)
.+.|+..+.||+|+||.||++..+. +..||+|.+...... ..+.+.+|+.++++++||||+++++++.+.+.+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 3568889999999999999999875 889999999765322 356789999999999999999999999999999
Q ss_pred EEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCC----CEEEeeecc
Q 044561 417 LLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADL----NGKLGDFGL 492 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~----~~kl~DfGl 492 (614)
++||||+++|+|.+++... ..+++.++..++.||+.||.|||+ .+|+||||||+|||++.++ .+||+|||+
T Consensus 91 ~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 9999999999999999763 459999999999999999999995 8999999999999998877 799999999
Q ss_pred ccccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcc
Q 044561 493 ARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIR 572 (614)
Q Consensus 493 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~ 572 (614)
+....... .....+||+.|+|||++....++.++|||||||++|||++|+.||......+.... ...+...
T Consensus 166 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~-------i~~~~~~ 236 (361)
T 2yab_A 166 AHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-------ITAVSYD 236 (361)
T ss_dssp CEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH-------HHTTCCC
T ss_pred ceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------HHhcCCC
Confidence 98765533 23446799999999999988999999999999999999999999976543322211 1111110
Q ss_pred ccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 573 DASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 573 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.++...... .+.+.+++.+||+.||++|||+.|+++
T Consensus 237 --~~~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 237 --FDEEFFSQT----SELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp --CCHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --CCchhccCC----CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111111122 235677888899999999999999985
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=350.43 Aligned_cols=252 Identities=21% Similarity=0.409 Sum_probs=198.9
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC---ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
++|+..+.||+|+||.||++.... +..||+|++... .....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 568889999999999999999764 889999998543 3445678999999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
||+++++|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 91 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 91 EYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp ECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred eCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 999999999999764 359999999999999999999995 899999999999999999999999999998766544
Q ss_pred CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
........||+.|+|||.+.+..++.++||||||+++|||++|+.||......+. ..+.... ..... .....
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~-~~~~~-~~~~~ 237 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI------AIKHIQD-SVPNV-TTDVR 237 (294)
T ss_dssp ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH------HHHHHSS-CCCCH-HHHSC
T ss_pred ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhhc-cCCCc-chhcc
Confidence 4444556799999999999999999999999999999999999999976543221 1111111 11111 11111
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCC-CHHHHh
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARP-NMRQVM 613 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl 613 (614)
. ...+.+.+++.+|++.||++|| ++.++.
T Consensus 238 ~----~~~~~l~~li~~~l~~dp~~R~~~~~~l~ 267 (294)
T 4eqm_A 238 K----DIPQSLSNVILRATEKDKANRYKTIQEMK 267 (294)
T ss_dssp T----TSCHHHHHHHHHHSCSSGGGSCSSHHHHH
T ss_pred c----CCCHHHHHHHHHHhcCCHhHccccHHHHH
Confidence 2 2234577888889999999999 666654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=351.27 Aligned_cols=265 Identities=23% Similarity=0.304 Sum_probs=203.7
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCC--hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDS--KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 421 (614)
.++|+..+.||+|+||.||+|+..++..||+|++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 36788899999999999999999889999999987543 2335678899999999999999999999999999999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCC
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI 501 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~ 501 (614)
|++ ++|.+++... ...+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 100 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 174 (311)
T 3niz_A 100 FME-KDLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR 174 (311)
T ss_dssp CCS-EEHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred CCC-CCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence 997 5788877654 3459999999999999999999995 8999999999999999999999999999987654322
Q ss_pred CcccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccc----
Q 044561 502 PQTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASD---- 576 (614)
Q Consensus 502 ~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d---- 576 (614)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+...........+....+
T Consensus 175 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 253 (311)
T 3niz_A 175 -SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW 253 (311)
T ss_dssp ----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred -cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchh
Confidence 2344578999999999876 5689999999999999999999999987665544332221111111111111000
Q ss_pred ---------ccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 577 ---------SRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 577 ---------~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
............+.+.+|+.+||+.||++|||+.|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000001112245778889999999999999999985
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=355.81 Aligned_cols=253 Identities=29% Similarity=0.456 Sum_probs=197.2
Q ss_pred HHhcCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCC--hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEE
Q 044561 342 KATKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDS--KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLV 419 (614)
Q Consensus 342 ~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 419 (614)
....+|+..+.||+|+||.||+|+. .+..||+|++.... ....+++.+|+.++++++||||+++++++...+..++|
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 3456788899999999999999987 57889999987553 44567899999999999999999999999999999999
Q ss_pred EEecCCCCcchhcccCC-CCCcChhHHHHHHHHhHhhchhhhccCCCc--eEecCcCCCCeEEcCCCCEEEeeecccccc
Q 044561 420 YDYMPNGSLDKILHTNI-KPCLNWYQRFRIIRGVASGLLYLHEDWEQV--VLHRDIKPANVLLDADLNGKLGDFGLARLY 496 (614)
Q Consensus 420 ~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDikp~NIll~~~~~~kl~DfGla~~~ 496 (614)
|||+++|+|.+++.... ...+++.+++.++.|++.||.|||+ .+ |+||||||+|||++.++.+||+|||+++..
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 99999999999997643 2348999999999999999999995 67 999999999999999999999999999865
Q ss_pred CCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccc
Q 044561 497 DHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASD 576 (614)
Q Consensus 497 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 576 (614)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... +.. ... .
T Consensus 190 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~---~~~---~~~-----~ 257 (309)
T 3p86_A 190 ASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAA---VGF---KCK-----R 257 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH---HHH---SCC-----C
T ss_pred cccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHh---cCC-----C
Confidence 4332 123345799999999999999999999999999999999999999976543322111 111 110 0
Q ss_pred ccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 577 SRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 577 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+...++ ..+.+++.+||+.||++|||+.|+++
T Consensus 258 ~~~~~~~~----~~l~~li~~~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 258 LEIPRNLN----PQVAAIIEGCWTNEPWKRPSFATIMD 291 (309)
T ss_dssp CCCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCccCC----HHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11112222 35778888999999999999999874
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=361.90 Aligned_cols=251 Identities=25% Similarity=0.425 Sum_probs=205.0
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe--------cCcEEEEEEeecC-ChhhHHHHHHHHHHhccc-CCCceeEEeeEEeecC
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA--------SNVQIAVKKVSHD-SKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKG 414 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 414 (614)
++|+..+.||+|+||.||+|... ++..||+|++... .....+++.+|+.+++++ +||||++++++|...+
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 160 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence 56788899999999999999863 2456999999765 344567899999999999 8999999999999999
Q ss_pred eEEEEEEecCCCCcchhcccCC--------------CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEc
Q 044561 415 EFLLVYDYMPNGSLDKILHTNI--------------KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD 480 (614)
Q Consensus 415 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~ 480 (614)
.+++||||+++|+|.+++.... ...+++.+++.++.||+.||.|||+ ++|+||||||+|||++
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVT 237 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEC
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEEC
Confidence 9999999999999999997643 1348999999999999999999995 8999999999999999
Q ss_pred CCCCEEEeeeccccccCCCCC-CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccH
Q 044561 481 ADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNL 558 (614)
Q Consensus 481 ~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l 558 (614)
.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+...
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~- 316 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK- 316 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-
T ss_pred CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-
Confidence 999999999999986654322 22334567889999999999999999999999999999999 999998654433221
Q ss_pred HHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 559 VDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 559 ~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
. ...+... .. +......+.+++.+||+.||++|||+.|+++
T Consensus 317 --~----~~~~~~~-----~~----~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 357 (370)
T 2psq_A 317 --L----LKEGHRM-----DK----PANCTNELYMMMRDCWHAVPSQRPTFKQLVE 357 (370)
T ss_dssp --H----HHTTCCC-----CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --H----HhcCCCC-----CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1 1122111 11 1122345778888999999999999999874
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=354.92 Aligned_cols=250 Identities=30% Similarity=0.488 Sum_probs=201.6
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe----cCcEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA----SNVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLV 419 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 419 (614)
++|+..+.||+|+||.||+|.+. .+..||||++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 45677899999999999999985 3456999999765 445567899999999999999999999999999999999
Q ss_pred EEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCC
Q 044561 420 YDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD 499 (614)
Q Consensus 420 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~ 499 (614)
|||+++|+|.+++... ...+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 129 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 129 TEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp EECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred eeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 9999999999999754 2459999999999999999999995 89999999999999999999999999999876543
Q ss_pred CCC--cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCcccccc
Q 044561 500 TIP--QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASD 576 (614)
Q Consensus 500 ~~~--~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 576 (614)
... ......+|+.|+|||++....++.++||||||+++|||++ |+.||......+... ....+...
T Consensus 205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~-------~~~~~~~~---- 273 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVIS-------SVEEGYRL---- 273 (325)
T ss_dssp --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHH-------HHHTTCCC----
T ss_pred ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHH-------HHHcCCCC----
Confidence 321 1222356778999999998899999999999999999999 999997654433221 11111110
Q ss_pred ccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 577 SRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 577 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
. .+......+.+++.+||+.||++|||+.||++
T Consensus 274 -~----~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 274 -P----APMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp -C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -C----CCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1 11122345778888999999999999999874
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=346.21 Aligned_cols=249 Identities=27% Similarity=0.454 Sum_probs=205.0
Q ss_pred cCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecC
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMP 424 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 424 (614)
++|+..+.||+|+||.||+|...++..||+|++..... ..+++.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 46788899999999999999998888999999976543 33678999999999999999999999999999999999999
Q ss_pred CCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcc
Q 044561 425 NGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT 504 (614)
Q Consensus 425 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 504 (614)
+++|.+++... ...+++.++..++.|+++||.|||+ .+|+||||||+||+++.++.+||+|||++...........
T Consensus 89 ~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (269)
T 4hcu_A 89 HGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 164 (269)
T ss_dssp TCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence 99999999764 3458999999999999999999995 8999999999999999999999999999987654332223
Q ss_pred cccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcC
Q 044561 505 TKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGIC 583 (614)
Q Consensus 505 ~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 583 (614)
....+|+.|+|||.+....++.++||||+|++++||++ |+.||......+... ....+. ........
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~-------~~~~~~-----~~~~~~~~ 232 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE-------DISTGF-----RLYKPRLA 232 (269)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH-------HHHTTC-----CCCCCTTS
T ss_pred cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHH-------HHhcCc-----cCCCCCcC
Confidence 34456788999999998999999999999999999999 999997654432211 111111 01111112
Q ss_pred cHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 584 EEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 584 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
...+.+++.+||+.||++|||+.|+++
T Consensus 233 ----~~~~~~li~~~l~~~p~~Rps~~~ll~ 259 (269)
T 4hcu_A 233 ----STHVYQIMNHCWRERPEDRPAFSRLLR 259 (269)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----CHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 245777888899999999999999874
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=347.39 Aligned_cols=265 Identities=24% Similarity=0.320 Sum_probs=210.0
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeecC--eEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKG--EFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV~ 420 (614)
++|+..+.||+|+||.||+|.... ++.||+|++.... ....+.+.+|+.++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 467888999999999999999875 8899999997543 334567889999999999999999999988765 789999
Q ss_pred EecCCCCcchhcccCCC-CCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEE----cCCCCEEEeeeccccc
Q 044561 421 DYMPNGSLDKILHTNIK-PCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL----DADLNGKLGDFGLARL 495 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll----~~~~~~kl~DfGla~~ 495 (614)
||+++++|.+++..... ..+++.++..++.|+++||.|||+ .+|+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 99999999999986432 339999999999999999999995 899999999999999 8888899999999987
Q ss_pred cCCCCCCcccccccCCCccchhhhc--------CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccc-cHHHHHHHhh
Q 044561 496 YDHDTIPQTTKLVGTFGYMDPELMR--------TGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETV-NLVDWVCDCW 566 (614)
Q Consensus 496 ~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~-~l~~~v~~~~ 566 (614)
..... ......||+.|+|||++. ...++.++|||||||++|||++|+.||......... .....+....
T Consensus 166 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (319)
T 4euu_A 166 LEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (319)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred cCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence 65543 233457999999999986 567899999999999999999999999754433222 2222222211
Q ss_pred hcCCccccc-----------cccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 567 KKGAIRDAS-----------DSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 567 ~~~~~~~~~-----------d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
....+.... +..............+..++.+||+.||++|||+.|+++
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~ 302 (319)
T 4euu_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (319)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhh
Confidence 111111110 001112345677788999999999999999999999974
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=374.76 Aligned_cols=249 Identities=25% Similarity=0.460 Sum_probs=204.3
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
.++|+..+.||+|+||.||+|.++++..||||++.... ...++|.+|+.++++++||||+++++++. .+..++|||||
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~ 264 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM 264 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence 35677889999999999999999888899999997654 34678999999999999999999999986 66789999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCc
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 503 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 503 (614)
++|+|.+++.......+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.........
T Consensus 265 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 341 (454)
T 1qcf_A 265 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 341 (454)
T ss_dssp TTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHT
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceec
Confidence 99999999986544458899999999999999999995 899999999999999999999999999998765432222
Q ss_pred ccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCc
Q 044561 504 TTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGI 582 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 582 (614)
.....+|..|+|||++..+.++.++|||||||++|||++ |+.||......+... .+ ..+....
T Consensus 342 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~---~i----~~~~~~~--------- 405 (454)
T 1qcf_A 342 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR---AL----ERGYRMP--------- 405 (454)
T ss_dssp TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH---HH----HHTCCCC---------
T ss_pred cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHH---HH----HcCCCCC---------
Confidence 223356788999999998999999999999999999999 999998655433221 11 1111100
Q ss_pred CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHh
Q 044561 583 CEEKQMELVLKLGLFCSHPKPEARPNMRQVM 613 (614)
Q Consensus 583 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 613 (614)
.+....+.+.+++.+||+.||++|||+.+|+
T Consensus 406 ~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~ 436 (454)
T 1qcf_A 406 RPENCPEELYNIMMRCWKNRPEERPTFEYIQ 436 (454)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 1112234577888899999999999999986
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=352.60 Aligned_cols=250 Identities=21% Similarity=0.316 Sum_probs=204.4
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChh------hHHHHHHHHHHhcccCCCceeEEeeEEeecCeEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQ------GIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFL 417 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 417 (614)
+.|+..+.||+|+||.||++.... +..||+|.+...... ..+.+.+|+.++++++||||+++++++...+..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 457888999999999999999875 889999998764321 3577899999999999999999999999999999
Q ss_pred EEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCC----CEEEeeeccc
Q 044561 418 LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADL----NGKLGDFGLA 493 (614)
Q Consensus 418 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~----~~kl~DfGla 493 (614)
+||||+++++|.+++... ..+++.++..++.||+.||.|||+ .+|+||||||+|||++.++ .+||+|||++
T Consensus 91 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp EEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 999999999999999763 459999999999999999999995 8999999999999999887 8999999999
Q ss_pred cccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccc
Q 044561 494 RLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRD 573 (614)
Q Consensus 494 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~ 573 (614)
....... ......||+.|+|||++....++.++|||||||++|||++|+.||......+.... +. .....
T Consensus 166 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---~~----~~~~~- 235 (326)
T 2y0a_A 166 HKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN---VS----AVNYE- 235 (326)
T ss_dssp EECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH---HH----HTCCC-
T ss_pred eECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHH---HH----hcCCC-
Confidence 8765433 23345799999999999988999999999999999999999999976543322211 11 11100
Q ss_pred cccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 574 ASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 574 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
......... ...+.+++.+||+.||++|||+.|+++
T Consensus 236 -~~~~~~~~~----~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 236 -FEDEYFSNT----SALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp -CCHHHHTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -cCccccccC----CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 001111112 245678888999999999999999974
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=343.34 Aligned_cols=250 Identities=28% Similarity=0.431 Sum_probs=205.5
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
.++|+..+.||+|+||.||+|..+++..||+|++..... ..+++.+|+.++++++||||+++++++...+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 356788899999999999999998888899999976543 3467899999999999999999999999999999999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCc
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 503 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 503 (614)
++++|.+++... ...+++.++..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++..........
T Consensus 86 ~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 161 (268)
T 3sxs_A 86 SNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS 161 (268)
T ss_dssp TTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE
T ss_pred CCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhhhc
Confidence 999999999764 2358999999999999999999995 899999999999999999999999999998766544333
Q ss_pred ccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCc
Q 044561 504 TTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGI 582 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 582 (614)
.....+|+.|+|||.+....++.++||||||++++||++ |+.||......+... ....+... .....
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-------~~~~~~~~-----~~~~~ 229 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL-------KVSQGHRL-----YRPHL 229 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-------HHHTTCCC-----CCCTT
T ss_pred ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHH-------HHHcCCCC-----CCCCc
Confidence 334456778999999998889999999999999999999 999997654332211 11111100 00111
Q ss_pred CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 583 CEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 583 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
. ...+.+++.+||+.||++|||+.|+++
T Consensus 230 ~----~~~l~~li~~~l~~~p~~Rps~~~ll~ 257 (268)
T 3sxs_A 230 A----SDTIYQIMYSCWHELPEKRPTFQQLLS 257 (268)
T ss_dssp S----CHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred C----hHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 2 235778888999999999999999974
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=353.55 Aligned_cols=247 Identities=25% Similarity=0.309 Sum_probs=204.0
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC---ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
++|+..+.||+|+||.||+++.+. ++.||+|.+... .....+.+.+|+.+++.++||||+++++++...+.+++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 568889999999999999999874 889999999754 2234567889999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
||+++|+|..++... ..+++.++..++.||+.||.|||+ ++|+||||||+|||++.++++||+|||+++......
T Consensus 85 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 85 EYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp ECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 999999999998763 358999999999999999999995 899999999999999999999999999998643322
Q ss_pred CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+... ....+.. .+.
T Consensus 160 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~-------~i~~~~~------~~p 225 (337)
T 1o6l_A 160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE-------LILMEEI------RFP 225 (337)
T ss_dssp -CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------HHHHCCC------CCC
T ss_pred -CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHH-------HHHcCCC------CCC
Confidence 22345689999999999999899999999999999999999999997654322211 1111111 111
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHhC
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARP-----NMRQVMQ 614 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 614 (614)
..++ ..+.+++.+||+.||++|| ++.||++
T Consensus 226 ~~~s----~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 226 RTLS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp TTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCC----HHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 2222 3567778889999999999 8999874
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=361.29 Aligned_cols=250 Identities=27% Similarity=0.496 Sum_probs=192.8
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe----cCcEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA----SNVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLV 419 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 419 (614)
++|+..+.||+|+||.||+|+.+ .+..||+|++... .....++|.+|+.++++++||||++++++|.+.+..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 46888999999999999999976 4677999999765 445567899999999999999999999999999999999
Q ss_pred EEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCC
Q 044561 420 YDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD 499 (614)
Q Consensus 420 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~ 499 (614)
|||+++|+|.+++... ...+++.+++.++.||++||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 125 ~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 125 TEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp EECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 9999999999999764 3459999999999999999999995 89999999999999999999999999999876543
Q ss_pred CCCc--ccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCcccccc
Q 044561 500 TIPQ--TTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASD 576 (614)
Q Consensus 500 ~~~~--~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 576 (614)
.... .....+++.|+|||++....++.++||||||+++|||++ |+.||......+.. . ....+..
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~---~----~i~~~~~----- 268 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI---K----AVDEGYR----- 268 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHH---H----HHHTTEE-----
T ss_pred CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH---H----HHHcCCC-----
Confidence 2211 122245778999999999999999999999999999998 99999765433221 1 1111110
Q ss_pred ccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 577 SRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 577 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
...+......+.+++.+||+.||++||++.||++
T Consensus 269 ----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 269 ----LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp ----CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 0011122345788889999999999999999873
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=350.74 Aligned_cols=251 Identities=25% Similarity=0.364 Sum_probs=200.6
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCCh-hhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSK-QGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
++|+..+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 57888999999999999999987 488899999865432 2346688999999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC-C
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT-I 501 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~-~ 501 (614)
+++|+|.+++... ..+++.++..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++....... .
T Consensus 87 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 87 CSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp CTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred CCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 9999999999764 349999999999999999999995 899999999999999999999999999998654322 1
Q ss_pred CcccccccCCCccchhhhcCCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 502 PQTTKLVGTFGYMDPELMRTGKA-STSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 502 ~~~~~~~gt~~y~aPE~~~~~~~-t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
.......||+.|+|||++....+ +.++|||||||++|||++|+.||......... ...+. ...... .+ .
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~-----~~~~~~--~~--~ 231 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWK-----EKKTYL--NP--W 231 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHHHH-----TTCTTS--TT--G
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHHh-----cccccC--Cc--c
Confidence 22345689999999999987765 78999999999999999999999765432211 11111 110000 00 0
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+ ...+.+|+.+||+.||++|||+.|+++
T Consensus 232 ~~~----~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 232 KKI----DSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp GGS----CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccC----CHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 112 234667888899999999999999985
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=344.12 Aligned_cols=264 Identities=22% Similarity=0.328 Sum_probs=200.2
Q ss_pred cCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCCh--hhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSK--QGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
++|+..+.||+|+||.||+|+...+..+|+|++..... ...+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 46788899999999999999997789999999965532 2346788999999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 502 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 502 (614)
+++ +|.+++.... ..+++.++..++.|+++||.|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR- 155 (288)
T ss_dssp CSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred cCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-
Confidence 975 8988887542 458999999999999999999995 8999999999999999999999999999987653321
Q ss_pred cccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccc-----cc
Q 044561 503 QTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDA-----SD 576 (614)
Q Consensus 503 ~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~-----~d 576 (614)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+............... .+
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence 2234578999999999875 45899999999999999999999999865543322211111100000000000 01
Q ss_pred cccc-------CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 577 SRLE-------GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 577 ~~l~-------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+.+. ........+.+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1100 0011112345678888999999999999999985
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=356.67 Aligned_cols=252 Identities=21% Similarity=0.290 Sum_probs=207.6
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
.++|+..+.||+|+||.||+|..+. +..+|+|.+..........+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 3578899999999999999999874 788999999877666667899999999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcC--CCCEEEeeeccccccCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA--DLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~--~~~~kl~DfGla~~~~~~~ 500 (614)
+++|+|.+++... ...+++.++..++.||+.||.|||+ .+|+||||||+|||++. ++.+||+|||+++......
T Consensus 130 ~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 130 LSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp CCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 9999999998764 2359999999999999999999995 89999999999999974 5779999999998765443
Q ss_pred CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
......||+.|+|||++....++.++|||||||++|||++|+.||......+.. ..+. ..... .+....
T Consensus 206 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~---~~i~----~~~~~--~~~~~~ 274 (387)
T 1kob_A 206 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL---QNVK----RCDWE--FDEDAF 274 (387)
T ss_dssp --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---HHHH----HCCCC--CCSSTT
T ss_pred --ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHH---HHHH----hCCCC--CCcccc
Confidence 233457999999999999889999999999999999999999999765432221 1111 11110 111111
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+ ...+.+++.+||+.||++|||+.|+++
T Consensus 275 ~~~----s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 275 SSV----SPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp TTS----CHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccC----CHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 122 235778888999999999999999985
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=354.01 Aligned_cols=244 Identities=23% Similarity=0.311 Sum_probs=193.8
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecC--ChhhHHHHHHHHHHhccc-CCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHD--SKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 420 (614)
++|+..++||+|+||+||+|+.. +++.||||++... ......++..|+..+.++ +||||++++++|.+.+..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57888999999999999999987 5889999998654 333444566666666555 8999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
||+ +++|.+++.... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++++||+|||++.......
T Consensus 137 e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp ECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred ecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 999 779988887643 459999999999999999999995 799999999999999999999999999998765433
Q ss_pred CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
......||+.|+|||++.+ .++.++|||||||++|||++|+.|+..... +.....+... +.+.
T Consensus 212 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----------~~~~~~~~~~----~~~~ 274 (311)
T 3p1a_A 212 --AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----------WQQLRQGYLP----PEFT 274 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----------HHHHTTTCCC----HHHH
T ss_pred --CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----------HHHHhccCCC----cccc
Confidence 2344579999999998875 789999999999999999999877643211 1111222111 1111
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.. ..+.+.+++.+||++||++|||+.|+++
T Consensus 275 ~~----~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 275 AG----LSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp TT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cC----CCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 12 2345778888999999999999999985
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=352.16 Aligned_cols=251 Identities=20% Similarity=0.260 Sum_probs=205.4
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
.++|+..+.||+|+||.||+|.... +..+|+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 3578889999999999999999875 7889999887543 3446788999999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcC--CCCEEEeeeccccccCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA--DLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~--~~~~kl~DfGla~~~~~~~ 500 (614)
|++|+|.+++.... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++. ++.+||+|||++.......
T Consensus 83 ~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 83 ISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 99999999997642 358999999999999999999995 89999999999999987 7899999999998775443
Q ss_pred CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .+ ..+... .+....
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---~i----~~~~~~--~~~~~~ 227 (321)
T 1tki_A 159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIE---NI----MNAEYT--FDEEAF 227 (321)
T ss_dssp --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH---HH----HHTCCC--CCHHHH
T ss_pred --ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHH---HH----HcCCCC--CChhhh
Confidence 2344679999999999998888999999999999999999999997654332211 11 111110 011111
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
... ...+.+++.+|++.||++|||+.|+++
T Consensus 228 ~~~----s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 228 KEI----SIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp TTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccC----CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 112 245778888999999999999999974
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=358.53 Aligned_cols=274 Identities=22% Similarity=0.256 Sum_probs=213.3
Q ss_pred CcccCHHHHHHHhcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccC-----CCceeE
Q 044561 332 PQRFTYKDLYKATKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLR-----HRNLVK 405 (614)
Q Consensus 332 ~~~~~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----H~niv~ 405 (614)
...+++++.....++|+..+.||+|+||.||+|+... +..||+|++... ....+.+..|+.+++.++ ||||++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 3456666666677899999999999999999999864 788999998643 344566778999988886 999999
Q ss_pred EeeEEeecCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcC----
Q 044561 406 LRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA---- 481 (614)
Q Consensus 406 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~---- 481 (614)
+++++...+..++||||+ +++|.+++.......+++.++..++.||+.||.|||+ .+|+||||||+|||++.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCC
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEcccccc
Confidence 999999999999999999 9999999987665669999999999999999999995 89999999999999975
Q ss_pred ---------------------CCCEEEeeeccccccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHH
Q 044561 482 ---------------------DLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEV 540 (614)
Q Consensus 482 ---------------------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el 540 (614)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 252 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence 789999999999865432 2345789999999999999999999999999999999
Q ss_pred HcCCCCCCCCCccccccHHHHHHHh--------hhcCCccccc-cccc----cCc----------------CcHHHHHHH
Q 044561 541 ASGRRPVEQQGSMETVNLVDWVCDC--------WKKGAIRDAS-DSRL----EGI----------------CEEKQMELV 591 (614)
Q Consensus 541 ~tg~~p~~~~~~~~~~~l~~~v~~~--------~~~~~~~~~~-d~~l----~~~----------------~~~~~~~~l 591 (614)
++|+.||......+....+...... .......... ...+ ... .+....+.+
T Consensus 253 l~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 332 (360)
T 3llt_A 253 YTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELF 332 (360)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHH
T ss_pred HHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHH
Confidence 9999999876544333222111000 0000000000 0000 000 000011557
Q ss_pred HHHHHHcCCCCCCCCCCHHHHhC
Q 044561 592 LKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 592 ~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+|+.+||+.||++|||+.|+++
T Consensus 333 ~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 333 CDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHhcCChhhCCCHHHHhc
Confidence 78999999999999999999985
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=354.30 Aligned_cols=251 Identities=23% Similarity=0.340 Sum_probs=204.9
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
.++|+..+.||+|+||.||+|..+. +..||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4568889999999999999999864 889999999754 3445677899999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCC---CEEEeeeccccccC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADL---NGKLGDFGLARLYD 497 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~---~~kl~DfGla~~~~ 497 (614)
||+++|+|.+++... ..+++.++..++.||+.||.|||+ .+|+||||||+|||++.++ .+||+|||++....
T Consensus 108 e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 108 DLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp CCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 999999999988764 458999999999999999999995 8999999999999998654 59999999998765
Q ss_pred CCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccc
Q 044561 498 HDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDS 577 (614)
Q Consensus 498 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~ 577 (614)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. .....+.... ..+
T Consensus 183 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-------~~i~~~~~~~-~~~ 252 (362)
T 2bdw_A 183 DSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY-------AQIKAGAYDY-PSP 252 (362)
T ss_dssp TCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHTCCCC-CTT
T ss_pred CCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH-------HHHHhCCCCC-Ccc
Confidence 433 233468999999999999889999999999999999999999999765432211 1112221110 001
Q ss_pred cccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 578 RLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 578 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
....+ ...+.+++.+||+.||++|||+.|+++
T Consensus 253 -~~~~~----~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 253 -EWDTV----TPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp -GGGGS----CHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -cccCC----CHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11112 235677888899999999999999985
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=342.67 Aligned_cols=262 Identities=22% Similarity=0.311 Sum_probs=200.2
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 421 (614)
++|+..+.||+|+||+||+|.... ++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 468889999999999999999875 888999999754 33345778899999999999999999999999999999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCC
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI 501 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~ 501 (614)
|+++ +|.+.+... ...+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV- 155 (292)
T ss_dssp CCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-
T ss_pred cCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-
Confidence 9975 555555443 2459999999999999999999995 899999999999999999999999999998765432
Q ss_pred CcccccccCCCccchhhhcCCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhc---CCcccccc-
Q 044561 502 PQTTKLVGTFGYMDPELMRTGK-ASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKK---GAIRDASD- 576 (614)
Q Consensus 502 ~~~~~~~gt~~y~aPE~~~~~~-~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~---~~~~~~~d- 576 (614)
.......||+.|+|||++.+.. ++.++|||||||+++||++|+.|+......+ .....+.+.... ..+.....
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~ 233 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHHhCCCChhhhhhhccc
Confidence 2234457899999999997765 7999999999999999999888864432221 112222221111 11000000
Q ss_pred -----------ccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 577 -----------SRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 577 -----------~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..............+.+++.+|++.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00000111123345678888999999999999999985
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=376.48 Aligned_cols=250 Identities=28% Similarity=0.444 Sum_probs=207.9
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
++|+..+.||+|+||.||+|.++. +..||||.+..... ..++|.+|+.++++++||||++++++|...+.+++|||||
T Consensus 220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~ 298 (495)
T 1opk_A 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 298 (495)
T ss_dssp GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence 457778999999999999999886 88899999976543 3578999999999999999999999999999999999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCc
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 503 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 503 (614)
++|+|.+++.......+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.........
T Consensus 299 ~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 375 (495)
T 1opk_A 299 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 375 (495)
T ss_dssp TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEEC
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCCceee
Confidence 99999999987655679999999999999999999995 899999999999999999999999999998765443222
Q ss_pred ccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCc
Q 044561 504 TTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGI 582 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 582 (614)
.....++..|+|||++....++.++|||||||++|||++ |+.||......+.. ..+ ..+... .
T Consensus 376 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~---~~~----~~~~~~---------~ 439 (495)
T 1opk_A 376 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY---ELL----EKDYRM---------E 439 (495)
T ss_dssp CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH---HHH----HTTCCC---------C
T ss_pred cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH---HHH----HcCCCC---------C
Confidence 333456789999999998899999999999999999999 99999876543322 111 111100 1
Q ss_pred CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 583 CEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 583 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+......+.+|+.+||+.||++|||+.||++
T Consensus 440 ~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 440 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 11222345778888999999999999999874
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=344.36 Aligned_cols=248 Identities=25% Similarity=0.345 Sum_probs=195.7
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCCh--------------------------hhHHHHHHHHHHhcc
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSK--------------------------QGIKEFVAELVSMGR 397 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--------------------------~~~~~~~~Ei~~l~~ 397 (614)
++|+..+.||+|+||.||+|+... ++.||+|++..... ...+.+.+|+.++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 578889999999999999999764 78899999875431 123568899999999
Q ss_pred cCCCceeEEeeEEee--cCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCC
Q 044561 398 LRHRNLVKLRGYCRR--KGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPA 475 (614)
Q Consensus 398 l~H~niv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~ 475 (614)
++||||+++++++.. .+..++||||+++++|.+++.. ..+++.++..++.||++||.|||+ .+|+||||||+
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~ 166 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPS 166 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGG
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHH
Confidence 999999999999986 5689999999999999987654 359999999999999999999995 89999999999
Q ss_pred CeEEcCCCCEEEeeeccccccCCCCCCcccccccCCCccchhhhcCCC---CCcchhHHHHHHHHHHHHcCCCCCCCCCc
Q 044561 476 NVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGK---ASTSTDVYAFGVFMLEVASGRRPVEQQGS 552 (614)
Q Consensus 476 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~~~Dv~S~Gvll~el~tg~~p~~~~~~ 552 (614)
|||++.++++||+|||+++....... ......||+.|+|||.+.... ++.++|||||||++|||++|+.||.....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 99999999999999999987654322 233457999999999987655 37889999999999999999999975432
Q ss_pred cccccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 553 METVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 553 ~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+ . ......+.... + ....+ .+.+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~---~----~~~~~~~~~~~---~-~~~~~----~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 246 MC---L----HSKIKSQALEF---P-DQPDI----AEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HH---H----HHHHHHCCCCC---C-SSSCC----CHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HH---H----HHHHhcccCCC---C-Ccccc----CHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 11 1 11111111110 0 01112 235778888899999999999999985
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=363.20 Aligned_cols=250 Identities=26% Similarity=0.436 Sum_probs=203.0
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
++|...+.||+|+||.||+|.++ ++..||+|.+.... ....++|.+|+.++++++||||++++++|...+..++||||
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 193 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL 193 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence 46778899999999999999987 58899999987553 34456789999999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 502 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 502 (614)
+++|+|.+++... ...+++.++..++.|+++||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 194 VQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp CTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred CCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 9999999999754 2348999999999999999999995 89999999999999999999999999999865432211
Q ss_pred c-ccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 503 Q-TTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 503 ~-~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
. .....++..|+|||.+..+.++.++|||||||++|||++ |+.||......+.. +....+.... ..
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~-------~~~~~~~~~~-----~~ 337 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR-------EFVEKGGRLP-----CP 337 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHH-------HHHHTTCCCC-----CC
T ss_pred ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCCCCC-----CC
Confidence 1 112245778999999998899999999999999999998 99999765443221 1122221111 11
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+ ...+.+++.+||+.||++|||+.+|++
T Consensus 338 ~~~----~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 338 ELC----PDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCC----CHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 122 345778888999999999999999873
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=347.85 Aligned_cols=266 Identities=24% Similarity=0.376 Sum_probs=191.6
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCCh-hhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSK-QGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 421 (614)
.++|+..+.||+|+||.||+|..+. +..||+|++..... ...+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 4578889999999999999999764 88999999976533 234678899999999999999999999999999999999
Q ss_pred ecCCCCcchhcccCC----CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccC
Q 044561 422 YMPNGSLDKILHTNI----KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYD 497 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~ 497 (614)
|++ |+|.+++.... ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 69998886431 2358999999999999999999995 899999999999999999999999999998765
Q ss_pred CCCCCcccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccc-
Q 044561 498 HDTIPQTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDAS- 575 (614)
Q Consensus 498 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~- 575 (614)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+...........+....
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 3321 2234578999999999876 468999999999999999999999998765443332221111100000000000
Q ss_pred ----cccc------------cCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 576 ----DSRL------------EGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 576 ----d~~l------------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+.+ ...........+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0000 00001112245788888999999999999999985
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=353.34 Aligned_cols=257 Identities=23% Similarity=0.391 Sum_probs=200.5
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-----cCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeec--CeEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-----SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRK--GEFL 417 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~ 417 (614)
++|+..+.||+|+||.||+|++. ++..||+|++........+.+.+|+.++++++||||++++++|... ..++
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 56788899999999999999852 4788999999888877788999999999999999999999998654 5689
Q ss_pred EEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccC
Q 044561 418 LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYD 497 (614)
Q Consensus 418 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~ 497 (614)
+||||+++|+|.+++.... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++++||+|||+++...
T Consensus 90 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp EEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred EEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 9999999999999997653 348999999999999999999995 899999999999999999999999999998765
Q ss_pred CCCC--CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcc---------ccccHHHHHHHhh
Q 044561 498 HDTI--PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSM---------ETVNLVDWVCDCW 566 (614)
Q Consensus 498 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~---------~~~~l~~~v~~~~ 566 (614)
.... .......++..|+|||.+.+..++.++||||||+++|||++|..|+...... ..........+..
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHH
Confidence 4321 1223345777899999999999999999999999999999999998642110 0000111112222
Q ss_pred hcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 567 KKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 567 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.++... ..+......+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 246 KNNGRL---------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HTTCCC---------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hccCcC---------CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 111111 112222346778888999999999999999873
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=354.73 Aligned_cols=261 Identities=19% Similarity=0.283 Sum_probs=205.1
Q ss_pred hcCCCCcceeeee--CcEEEEEEEEec-CcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEE
Q 044561 344 TKGFKDKDVIGRG--GFGKVYRGVLAS-NVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLL 418 (614)
Q Consensus 344 ~~~f~~~~~lG~G--~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 418 (614)
.++|+..+.||+| +||.||+|+.+. +..||+|++... .....+.+.+|+.++++++||||+++++++...+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3578889999999 999999999874 889999999754 34456778899999999999999999999999999999
Q ss_pred EEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCC
Q 044561 419 VYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 498 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~ 498 (614)
|||||++|+|.+++.......+++.++..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 9999999999999987655669999999999999999999995 8999999999999999999999999999865422
Q ss_pred CC------CCcccccccCCCccchhhhcC--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCC
Q 044561 499 DT------IPQTTKLVGTFGYMDPELMRT--GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGA 570 (614)
Q Consensus 499 ~~------~~~~~~~~gt~~y~aPE~~~~--~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~ 570 (614)
.. ........||+.|+|||++.. ..++.++|||||||++|||++|+.||......+..... . .+.
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~--~-----~~~ 253 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK--L-----NGT 253 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--h-----cCC
Confidence 11 111223478999999999987 57899999999999999999999999765443322110 0 000
Q ss_pred cccccccc-----------------------c-------------cCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 571 IRDASDSR-----------------------L-------------EGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 571 ~~~~~d~~-----------------------l-------------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.....+.. + ...........+.+|+.+||+.||++|||+.|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 254 VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp ----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 00000000 0 00011222345888999999999999999999985
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=345.16 Aligned_cols=250 Identities=28% Similarity=0.435 Sum_probs=202.3
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
.++|+..+.||+|+||.||++..+++..||+|++..... ..+++.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 356788899999999999999998888999999976543 2467899999999999999999999999999999999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCc
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 503 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 503 (614)
++++|.+++... ...+++.++..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++..........
T Consensus 102 ~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (283)
T 3gen_A 102 ANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 177 (283)
T ss_dssp TTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHS
T ss_pred CCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEcccccccccccccccc
Confidence 999999999763 2359999999999999999999995 899999999999999999999999999998765433222
Q ss_pred ccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCc
Q 044561 504 TTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGI 582 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 582 (614)
.....+|+.|+|||.+....++.++||||||+++|||++ |+.||......+.... ...+. .......
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~-------~~~~~-----~~~~~~~ 245 (283)
T 3gen_A 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH-------IAQGL-----RLYRPHL 245 (283)
T ss_dssp TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-------HHTTC-----CCCCCTT
T ss_pred ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHH-------Hhccc-----CCCCCCc
Confidence 233456788999999998899999999999999999998 9999976544322211 11111 0111111
Q ss_pred CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 583 CEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 583 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
. .+.+.+++.+||+.||++|||+.|+++
T Consensus 246 ~----~~~l~~li~~~l~~~p~~Rps~~~ll~ 273 (283)
T 3gen_A 246 A----SEKVYTIMYSCWHEKADERPTFKILLS 273 (283)
T ss_dssp C----CHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred C----CHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 2 245778888999999999999999874
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=345.20 Aligned_cols=266 Identities=24% Similarity=0.306 Sum_probs=201.5
Q ss_pred HhcCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCC-----hhhHHHHHHHHHHhccc---CCCceeEEeeEEeec
Q 044561 343 ATKGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDS-----KQGIKEFVAELVSMGRL---RHRNLVKLRGYCRRK 413 (614)
Q Consensus 343 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~ 413 (614)
..++|+..+.||+|+||+||+|+.. +++.||+|++.... ......+.+|+.+++++ +||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 3578999999999999999999975 48899999986432 11123456677666665 499999999999875
Q ss_pred C-----eEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEe
Q 044561 414 G-----EFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLG 488 (614)
Q Consensus 414 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~ 488 (614)
. ..++||||++ ++|.+++.......+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEEe
Confidence 5 5899999996 699999987666669999999999999999999995 899999999999999999999999
Q ss_pred eeccccccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhc
Q 044561 489 DFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKK 568 (614)
Q Consensus 489 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~ 568 (614)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.........
T Consensus 163 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (308)
T 3g33_A 163 DFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 240 (308)
T ss_dssp SCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 999998765433 234568999999999999999999999999999999999999999876544333222111111111
Q ss_pred CCccccc---ccccc-------CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 569 GAIRDAS---DSRLE-------GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 569 ~~~~~~~---d~~l~-------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+.... ...+. .....+..+.+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 1111000 00000 0001112346778888999999999999999985
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=356.19 Aligned_cols=248 Identities=21% Similarity=0.307 Sum_probs=199.7
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC---ChhhHHHHHHHHHHhccc-CCCceeEEeeEEeecCeEEE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD---SKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGEFLL 418 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 418 (614)
.++|+..+.||+|+||.||+|+.+. +..||+|++... .....+.+.+|..+++.+ +||||+++++++.+.+.+|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 4679999999999999999999875 889999999764 233456678899999988 69999999999999999999
Q ss_pred EEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCC
Q 044561 419 VYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 498 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~ 498 (614)
|||||++|+|.+++... ..+++.++..++.||+.||.|||+ .+|+||||||+|||++.++++||+|||+++....
T Consensus 102 v~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 99999999999999764 349999999999999999999995 8999999999999999999999999999985433
Q ss_pred CCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccc
Q 044561 499 DTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSR 578 (614)
Q Consensus 499 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~ 578 (614)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... ...+.. .
T Consensus 177 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~-------i~~~~~------~ 242 (353)
T 3txo_A 177 NG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA-------ILNDEV------V 242 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-------HHHCCC------C
T ss_pred CC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHH-------HHcCCC------C
Confidence 22 233456899999999999988899999999999999999999999986554332211 111111 1
Q ss_pred ccCcCcHHHHHHHHHHHHHcCCCCCCCCCCH------HHHhC
Q 044561 579 LEGICEEKQMELVLKLGLFCSHPKPEARPNM------RQVMQ 614 (614)
Q Consensus 579 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~------~evl~ 614 (614)
..... ...+..++.+||+.||++||++ .|+++
T Consensus 243 ~p~~~----~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 243 YPTWL----HEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp CCTTS----CHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CCCCC----CHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 11112 2346778888999999999998 67763
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=340.80 Aligned_cols=258 Identities=24% Similarity=0.361 Sum_probs=197.2
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcc--cCCCceeEEeeEEee----cCeEE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGR--LRHRNLVKLRGYCRR----KGEFL 417 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~----~~~~~ 417 (614)
.++|+..+.||+|+||.||+|+. ++..||||++..... +.+..|.+++.. ++||||+++++++.. ....+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGGH---HHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccccc---hhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 35788999999999999999987 588899999865432 444555555554 899999999998754 35689
Q ss_pred EEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccC-----CCceEecCcCCCCeEEcCCCCEEEeeecc
Q 044561 418 LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDW-----EQVVLHRDIKPANVLLDADLNGKLGDFGL 492 (614)
Q Consensus 418 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDikp~NIll~~~~~~kl~DfGl 492 (614)
+||||+++|+|.++++.. .+++.+++.++.|+++||.|||+.. +++|+||||||+|||++.++.+||+|||+
T Consensus 83 lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 159 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL 159 (301)
T ss_dssp EEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCC
Confidence 999999999999999643 4999999999999999999999321 38999999999999999999999999999
Q ss_pred ccccCCCCCCc---ccccccCCCccchhhhcCC------CCCcchhHHHHHHHHHHHHcC----------CCCCCCCCcc
Q 044561 493 ARLYDHDTIPQ---TTKLVGTFGYMDPELMRTG------KASTSTDVYAFGVFMLEVASG----------RRPVEQQGSM 553 (614)
Q Consensus 493 a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~t~~~Dv~S~Gvll~el~tg----------~~p~~~~~~~ 553 (614)
++......... .....||+.|+|||++... .++.++|||||||++|||++| +.||......
T Consensus 160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~ 239 (301)
T 3q4u_A 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239 (301)
T ss_dssp CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred eeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC
Confidence 98665433221 2334799999999999876 445799999999999999999 8888654332
Q ss_pred ccccHHHHHHHhhhcCCccccccccc-cCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 554 ETVNLVDWVCDCWKKGAIRDASDSRL-EGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 554 ~~~~l~~~v~~~~~~~~~~~~~d~~l-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+... ............ .+.+ ....+......+.+++.+||+.||++|||+.||++
T Consensus 240 ~~~~--~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 240 DPSF--EDMRKVVCVDQQ----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp SCCH--HHHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred Ccch--hhhhHHHhccCC----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 2211 111111111111 1111 11233456778999999999999999999999974
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=355.85 Aligned_cols=247 Identities=23% Similarity=0.319 Sum_probs=198.3
Q ss_pred CcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecCCCC
Q 044561 349 DKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGS 427 (614)
Q Consensus 349 ~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 427 (614)
..+.||+|+||.||+|.... +..||+|++........+++.+|+.++++++||||+++++++...+..++||||+++++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 35689999999999999864 88999999988777777889999999999999999999999999999999999999999
Q ss_pred cchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEE--cCCCCEEEeeeccccccCCCCCCccc
Q 044561 428 LDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL--DADLNGKLGDFGLARLYDHDTIPQTT 505 (614)
Q Consensus 428 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll--~~~~~~kl~DfGla~~~~~~~~~~~~ 505 (614)
|.+++... ...+++.++..++.||++||.|||+ .+|+||||||+|||+ +.++.+||+|||+++...... ...
T Consensus 173 L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~~ 246 (373)
T 2x4f_A 173 LFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KLK 246 (373)
T ss_dssp EHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--BCC
T ss_pred HHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--ccc
Confidence 99988754 2358999999999999999999995 899999999999999 567899999999998765443 233
Q ss_pred ccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcH
Q 044561 506 KLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEE 585 (614)
Q Consensus 506 ~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~ 585 (614)
...||+.|+|||++....++.++|||||||++|||++|+.||......+... .+.. .... . .......+
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~---~i~~----~~~~-~-~~~~~~~~-- 315 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLN---NILA----CRWD-L-EDEEFQDI-- 315 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH---HHHH----TCCC-S-CSGGGTTS--
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHh----ccCC-C-ChhhhccC--
Confidence 4579999999999998889999999999999999999999997654432221 1111 1110 0 01111122
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 586 KQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 586 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+.+.+++.+||+.||++|||+.|+++
T Consensus 316 --~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 316 --SEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp --CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --CHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 245778888999999999999999974
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=364.28 Aligned_cols=244 Identities=30% Similarity=0.426 Sum_probs=200.7
Q ss_pred cCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecC-eEEEEEEec
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKG-EFLLVYDYM 423 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~lV~E~~ 423 (614)
++|+..+.||+|+||.||+|.++ +..||||++.... ..+.|.+|+.++++++||||++++++|...+ .+++|||||
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred HHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 45777899999999999999885 6789999997654 4568999999999999999999999987665 799999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCc
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 503 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 503 (614)
++|+|.+++.......+++.+++.++.||++||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 270 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 343 (450)
T 1k9a_A 270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 343 (450)
T ss_dssp TTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc---
Confidence 99999999987655558999999999999999999995 899999999999999999999999999998544321
Q ss_pred ccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCc
Q 044561 504 TTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGI 582 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 582 (614)
....++..|+|||.+....++.++|||||||++|||++ |+.||......+... .+ .++... .
T Consensus 344 -~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~---~i----~~~~~~-----~---- 406 (450)
T 1k9a_A 344 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP---RV----EKGYKM-----D---- 406 (450)
T ss_dssp ----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHH---HH----HTTCCC-----C----
T ss_pred -cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HH----HcCCCC-----C----
Confidence 22357889999999999999999999999999999998 999998765443221 11 222111 1
Q ss_pred CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 583 CEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 583 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+......+.+++.+||+.||++|||+.|+++
T Consensus 407 ~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 407 APDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 11122345778888999999999999999863
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=370.10 Aligned_cols=249 Identities=27% Similarity=0.453 Sum_probs=198.6
Q ss_pred cCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecC
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMP 424 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 424 (614)
++|+..+.||+|+||.||+|.++++..||||++..... ..++|.+|+.++++++||||+++++++.+ +..++|||||+
T Consensus 184 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~ 261 (452)
T 1fmk_A 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 261 (452)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence 45677889999999999999998888899999976543 34679999999999999999999999876 67899999999
Q ss_pred CCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcc
Q 044561 425 NGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT 504 (614)
Q Consensus 425 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 504 (614)
+|+|.+++.......+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..........
T Consensus 262 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 338 (452)
T 1fmk_A 262 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 338 (452)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCceecc
Confidence 9999999976444568999999999999999999995 8999999999999999999999999999987654432233
Q ss_pred cccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcC
Q 044561 505 TKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGIC 583 (614)
Q Consensus 505 ~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 583 (614)
....++..|+|||.+..+.++.++||||||+++|||++ |+.||......+... ....+... . .
T Consensus 339 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~-------~i~~~~~~-----~----~ 402 (452)
T 1fmk_A 339 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD-------QVERGYRM-----P----C 402 (452)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH-------HHHTTCCC-----C----C
T ss_pred cCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHH-------HHHcCCCC-----C----C
Confidence 33457889999999998999999999999999999999 999998655433221 11222111 1 1
Q ss_pred cHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 584 EEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 584 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+....+.+.+++.+||+.||++|||+.+|++
T Consensus 403 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 403 PPECPESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1223346778888999999999999999863
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=351.76 Aligned_cols=245 Identities=21% Similarity=0.331 Sum_probs=200.6
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
.+|...+.||+|+||.||+|... .+..||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 56888999999999999999985 48899999986542 122357889999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
||+ +|+|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++++||+|||++.......
T Consensus 89 E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 89 EYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp CCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred ECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 999 78898888663 349999999999999999999995 799999999999999999999999999998765433
Q ss_pred CCcccccccCCCccchhhhcCCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMRTGKA-STSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRL 579 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~~~-t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 579 (614)
.....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||......+....+ ..+ ...+
T Consensus 163 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i-------~~~------~~~~ 227 (336)
T 3h4j_B 163 --FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV-------NSC------VYVM 227 (336)
T ss_dssp --TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC-------CSS------CCCC
T ss_pred --ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH-------HcC------CCCC
Confidence 2344579999999999987765 78999999999999999999999765433222110 000 0111
Q ss_pred cCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 580 EGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 580 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.... ...+.+++.+||+.||++|||+.|+++
T Consensus 228 p~~~----s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 228 PDFL----SPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CTTS----CHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred cccC----CHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1122 345677888999999999999999975
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=361.32 Aligned_cols=252 Identities=22% Similarity=0.298 Sum_probs=203.7
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC--hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS--KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
.++|+..+.||+|+||.||+|.... +..+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 4568889999999999999999764 8889999987653 334567899999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEc---CCCCEEEeeeccccccC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD---ADLNGKLGDFGLARLYD 497 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~---~~~~~kl~DfGla~~~~ 497 (614)
|||++|+|.+.+... ..+++.++..++.||+.||.|||+ ++|+||||||+|||++ .++.+||+|||++....
T Consensus 90 E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 90 DLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp CCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 999999999998764 359999999999999999999995 8999999999999998 46789999999998765
Q ss_pred CCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccc
Q 044561 498 HDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDS 577 (614)
Q Consensus 498 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~ 577 (614)
.... ......||+.|+|||++....++.++||||+||++|||++|+.||......+... ....+.... ..+
T Consensus 165 ~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~-------~i~~~~~~~-~~~ 235 (444)
T 3soa_A 165 GEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQ-------QIKAGAYDF-PSP 235 (444)
T ss_dssp TTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-------HHHHTCCCC-CTT
T ss_pred CCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHH-------HHHhCCCCC-Ccc
Confidence 4432 2344689999999999998899999999999999999999999997654332221 112221111 111
Q ss_pred cccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 578 RLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 578 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
. ...+ ...+.+++.+||+.||++|||+.|+++
T Consensus 236 ~-~~~~----s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 236 E-WDTV----TPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp T-TTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred c-cccC----CHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1 1122 234677888899999999999999974
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=355.86 Aligned_cols=251 Identities=26% Similarity=0.436 Sum_probs=205.1
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec--------CcEEEEEEeecC-ChhhHHHHHHHHHHhccc-CCCceeEEeeEEeecC
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS--------NVQIAVKKVSHD-SKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKG 414 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 414 (614)
++|...+.||+|+||.||+|+... +..||+|++... .....+++.+|+.+++++ +||||++++++|...+
T Consensus 69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 148 (382)
T 3tt0_A 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 148 (382)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence 567788999999999999999642 356999999765 344567899999999999 8999999999999999
Q ss_pred eEEEEEEecCCCCcchhcccCC--------------CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEc
Q 044561 415 EFLLVYDYMPNGSLDKILHTNI--------------KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD 480 (614)
Q Consensus 415 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~ 480 (614)
..++||||+++|+|.+++.... ...+++.+++.++.||+.||.|||+ .+|+||||||+|||++
T Consensus 149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~ 225 (382)
T 3tt0_A 149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 225 (382)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEC
T ss_pred ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEEEc
Confidence 9999999999999999997643 2359999999999999999999995 8999999999999999
Q ss_pred CCCCEEEeeeccccccCCCCC-CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccH
Q 044561 481 ADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNL 558 (614)
Q Consensus 481 ~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l 558 (614)
.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+.
T Consensus 226 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~--- 302 (382)
T 3tt0_A 226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL--- 302 (382)
T ss_dssp TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---
T ss_pred CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---
Confidence 999999999999987654322 22344567889999999999999999999999999999999 9999976543321
Q ss_pred HHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 559 VDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 559 ~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+...++.... ....+ ...+.+++.+||+.||++|||+.||++
T Consensus 303 ----~~~~~~~~~~~-----~~~~~----~~~l~~li~~~l~~dP~~Rps~~ell~ 345 (382)
T 3tt0_A 303 ----FKLLKEGHRMD-----KPSNC----TNELYMMMRDCWHAVPSQRPTFKQLVE 345 (382)
T ss_dssp ----HHHHHTTCCCC-----CCSSC----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----HHHHHcCCCCC-----CCccC----CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 12222221111 11122 345778888999999999999999974
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=346.96 Aligned_cols=254 Identities=26% Similarity=0.339 Sum_probs=203.1
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC---ChhhHHHHHHHHHHhccc-CCCceeEEeeEEeecCeEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD---SKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGEFLLV 419 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 419 (614)
++|+..+.||+|+||.||+++.+. ++.||+|++... .....+.+.+|..++.++ +||||+++++++.+.+.+++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 468888999999999999999875 788999999754 344566788999999887 899999999999999999999
Q ss_pred EEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCC
Q 044561 420 YDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD 499 (614)
Q Consensus 420 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~ 499 (614)
|||+++|+|.+++... ..+++.++..++.||+.||.|||+ .+|+||||||+|||++.++++||+|||+++.....
T Consensus 89 ~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 9999999999999764 359999999999999999999995 89999999999999999999999999999864322
Q ss_pred CCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccc--cHHHHHHHhhhcCCccccccc
Q 044561 500 TIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETV--NLVDWVCDCWKKGAIRDASDS 577 (614)
Q Consensus 500 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~--~l~~~v~~~~~~~~~~~~~d~ 577 (614)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. .......+....+..
T Consensus 164 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~------ 236 (345)
T 3a8x_A 164 G-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------ 236 (345)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC------
T ss_pred C-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC------
Confidence 2 2334568999999999999989999999999999999999999999753322111 111222222222211
Q ss_pred cccCcCcHHHHHHHHHHHHHcCCCCCCCCCCH------HHHhC
Q 044561 578 RLEGICEEKQMELVLKLGLFCSHPKPEARPNM------RQVMQ 614 (614)
Q Consensus 578 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~------~evl~ 614 (614)
.+.... ...+..++.+||+.||++||++ .|+++
T Consensus 237 ~~p~~~----s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 237 RIPRSL----SVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp CCCTTS----CHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred CCCCCC----CHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 111222 2356778888999999999995 67653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=346.55 Aligned_cols=250 Identities=24% Similarity=0.294 Sum_probs=181.5
Q ss_pred cceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccC-CCceeEEeeEEeecCeEEEEEEecCCCC
Q 044561 350 KDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLR-HRNLVKLRGYCRRKGEFLLVYDYMPNGS 427 (614)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gs 427 (614)
.+.||+|+||.||+|..+. ++.||+|++... ....+.+|+.+++.++ ||||+++++++.+.+..++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 4789999999999999875 889999999654 3456778999999997 9999999999999999999999999999
Q ss_pred cchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCC---CEEEeeeccccccCCCCCCcc
Q 044561 428 LDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADL---NGKLGDFGLARLYDHDTIPQT 504 (614)
Q Consensus 428 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~---~~kl~DfGla~~~~~~~~~~~ 504 (614)
|.+++... ..+++.++..++.|++.||.|||+ ++|+||||||+|||++.++ .+||+|||+++....... ..
T Consensus 93 L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~~ 166 (325)
T 3kn6_A 93 LFERIKKK--KHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PL 166 (325)
T ss_dssp HHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-cc
Confidence 99999874 459999999999999999999995 8999999999999997765 899999999986654332 23
Q ss_pred cccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCc
Q 044561 505 TKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICE 584 (614)
Q Consensus 505 ~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 584 (614)
...+||+.|+|||++....++.++|||||||++|||++|+.||................+....+.... .....
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~------~~~~~ 240 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF------EGEAW 240 (325)
T ss_dssp -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC------CSHHH
T ss_pred cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC------Ccccc
Confidence 445789999999999999999999999999999999999999986544322222223333333332211 11111
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 585 EKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 585 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
....+.+.+|+.+||+.||++|||+.|+++
T Consensus 241 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 241 KNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred cCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 122345778888999999999999999874
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=344.76 Aligned_cols=244 Identities=23% Similarity=0.344 Sum_probs=202.8
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
++|+..+.||+|+||.||+++.+. ++.||+|.+.... ....+.+.+|..+++.++||||+++++++.+.+.+++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 568889999999999999999864 8899999997542 233567789999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
||+++|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~- 159 (318)
T 1fot_A 86 DYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 159 (318)
T ss_dssp CCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence 999999999999864 34899999999999999999999 489999999999999999999999999999875432
Q ss_pred CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ..+ ..+.. .+.
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~~i----~~~~~------~~p 223 (318)
T 1fot_A 160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY---EKI----LNAEL------RFP 223 (318)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---HHH----HHCCC------CCC
T ss_pred ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH---HHH----HhCCC------CCC
Confidence 33468999999999999989999999999999999999999999765432211 111 11111 111
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHhC
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARP-----NMRQVMQ 614 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 614 (614)
..++ ..+.+++.+|++.||++|| ++.|+++
T Consensus 224 ~~~~----~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 224 PFFN----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp TTSC----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCC----HHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 2222 3567778889999999999 8888874
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=356.00 Aligned_cols=262 Identities=24% Similarity=0.377 Sum_probs=207.6
Q ss_pred cCHHHHHHHhcCCCCcceeeeeCcEEEEEEEEe------cCcEEEEEEeecC-ChhhHHHHHHHHHHhccc-CCCceeEE
Q 044561 335 FTYKDLYKATKGFKDKDVIGRGGFGKVYRGVLA------SNVQIAVKKVSHD-SKQGIKEFVAELVSMGRL-RHRNLVKL 406 (614)
Q Consensus 335 ~~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l 406 (614)
+...+.....++|+..+.||+|+||.||+|.+. ++..||||++... .....+.+.+|+.++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 344444556678999999999999999999853 2478999999764 344557899999999999 79999999
Q ss_pred eeEEeecC-eEEEEEEecCCCCcchhcccCCC------------------------------------------------
Q 044561 407 RGYCRRKG-EFLLVYDYMPNGSLDKILHTNIK------------------------------------------------ 437 (614)
Q Consensus 407 ~g~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------ 437 (614)
+++|.+.+ ..++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99998765 48999999999999999976432
Q ss_pred ----------------CCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC-
Q 044561 438 ----------------PCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT- 500 (614)
Q Consensus 438 ----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~- 500 (614)
..+++.+++.++.|+++||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 128999999999999999999995 899999999999999999999999999998664332
Q ss_pred CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRL 579 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 579 (614)
........||+.|+|||++.+..++.++|||||||++|||++ |+.||......+.. ......+.... .
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~------~~~~~~~~~~~-----~ 317 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF------CRRLKEGTRMR-----A 317 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH------HHHHHHTCCCC-----C
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH------HHHHHcCCCCC-----C
Confidence 223344578999999999999999999999999999999998 99999765443221 11112211111 1
Q ss_pred cCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 580 EGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 580 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
...++ ..+.+++.+||+.||++|||+.||++
T Consensus 318 ~~~~~----~~l~~li~~~l~~dP~~Rps~~ell~ 348 (359)
T 3vhe_A 318 PDYTT----PEMYQTMLDCWHGEPSQRPTFSELVE 348 (359)
T ss_dssp CTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCC----HHHHHHHHHHccCChhhCCCHHHHHH
Confidence 11222 35777888899999999999999874
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=336.30 Aligned_cols=245 Identities=20% Similarity=0.334 Sum_probs=199.9
Q ss_pred cCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeec--CeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRK--GEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 420 (614)
++|+..+.||+|+||.||+|+.+ +..+|+|++... .....+.+.+|+.++++++||||+++++++... +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 46888899999999999999985 788999998764 345567899999999999999999999999877 7889999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCc--eEecCcCCCCeEEcCCCCEEEeeeccccccCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQV--VLHRDIKPANVLLDADLNGKLGDFGLARLYDH 498 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDikp~NIll~~~~~~kl~DfGla~~~~~ 498 (614)
||+++|+|.+++.......+++.++..++.|+++||.|||+ .+ |+||||||+||+++.++.++|+|||++.....
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 99999999999987655569999999999999999999995 67 99999999999999999999999998764332
Q ss_pred CCCCcccccccCCCccchhhhcCCCCCc---chhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccc
Q 044561 499 DTIPQTTKLVGTFGYMDPELMRTGKAST---STDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDAS 575 (614)
Q Consensus 499 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~---~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~ 575 (614)
....||+.|+|||.+.+..++. ++||||||+++|||++|+.||......+.. ......+..
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~~~~~~~---- 229 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG------MKVALEGLR---- 229 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH------HHHHHSCCC----
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH------HHHHhcCCC----
Confidence 2346899999999998765444 899999999999999999999765432221 111111111
Q ss_pred cccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 576 DSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 576 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+.+...+ ...+.+++.+||+.||++|||+.|+++
T Consensus 230 -~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 230 -PTIPPGI----SPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp -CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CCCCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1111222 335778888899999999999999874
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=361.27 Aligned_cols=259 Identities=23% Similarity=0.270 Sum_probs=207.9
Q ss_pred HHHHHHHhcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCCh---hhHHHHHHHHHHhcccCCCceeEEeeEEee
Q 044561 337 YKDLYKATKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSK---QGIKEFVAELVSMGRLRHRNLVKLRGYCRR 412 (614)
Q Consensus 337 ~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 412 (614)
++++....++|+..+.||+|+||+||+|+.+. +..||+|++..... ...+.+.+|+.+++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 34555567789999999999999999999875 78899999865321 122457889999999999999999999999
Q ss_pred cCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecc
Q 044561 413 KGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGL 492 (614)
Q Consensus 413 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGl 492 (614)
.+.+|+|||||++|+|.+++... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++++||+|||+
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccce
Confidence 99999999999999999999753 38999999999999999999995 8999999999999999999999999999
Q ss_pred ccccCCCCCCcccccccCCCccchhhhcCCC----CCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhc
Q 044561 493 ARLYDHDTIPQTTKLVGTFGYMDPELMRTGK----ASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKK 568 (614)
Q Consensus 493 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~ 568 (614)
++.............+||+.|+|||++.... ++.++|||||||++|||++|+.||...+..+.... +......
T Consensus 215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~---i~~~~~~ 291 (410)
T 3v8s_A 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK---IMNHKNS 291 (410)
T ss_dssp CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH---HHTHHHH
T ss_pred eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHH---HHhcccc
Confidence 9877654433444678999999999997655 78999999999999999999999986544332221 1111000
Q ss_pred CCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCC--CCCHHHHhC
Q 044561 569 GAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEA--RPNMRQVMQ 614 (614)
Q Consensus 569 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~ 614 (614)
-.... ...++ ..+..|+.+||+.+|++ ||++.||++
T Consensus 292 ~~~p~------~~~~s----~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 292 LTFPD------DNDIS----KEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp CCCCT------TCCCC----HHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred ccCCC------ccccc----HHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 00000 01122 34667778899999988 999999975
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=354.06 Aligned_cols=248 Identities=27% Similarity=0.371 Sum_probs=203.2
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
++|+..+.||+|+||.||++..+. +..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 568889999999999999999875 7889999986542 234567889999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
||+++|+|..++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 95 e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169 (384)
T ss_dssp CCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred ecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence 999999999999864 359999999999999999999995 899999999999999999999999999998765433
Q ss_pred CCcccccccCCCccchhhhcC---CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMRT---GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDS 577 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~---~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~ 577 (614)
.....+||+.|+|||++.. ..++.++|||||||++|||++|+.||................ ... .
T Consensus 170 --~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~----~~~------~ 237 (384)
T 4fr4_A 170 --QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE----TTV------V 237 (384)
T ss_dssp --CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH----HCC------C
T ss_pred --ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh----hcc------c
Confidence 3445689999999999864 458999999999999999999999997654433222221111 111 1
Q ss_pred cccCcCcHHHHHHHHHHHHHcCCCCCCCCCC-HHHHh
Q 044561 578 RLEGICEEKQMELVLKLGLFCSHPKPEARPN-MRQVM 613 (614)
Q Consensus 578 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~evl 613 (614)
.....+ ...+..++.+||+.||++||+ +.+++
T Consensus 238 ~~p~~~----s~~~~~li~~lL~~dP~~R~s~~~~l~ 270 (384)
T 4fr4_A 238 TYPSAW----SQEMVSLLKKLLEPNPDQRFSQLSDVQ 270 (384)
T ss_dssp CCCTTS----CHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred CCCCcC----CHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence 111122 345777888899999999999 77765
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=337.11 Aligned_cols=250 Identities=24% Similarity=0.307 Sum_probs=204.8
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
.++|+..+.||+|+||.||+|..+. +..+|+|++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 3568889999999999999999876 678999999876556678899999999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEE---cCCCCEEEeeeccccccCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL---DADLNGKLGDFGLARLYDHD 499 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll---~~~~~~kl~DfGla~~~~~~ 499 (614)
+++++|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+||++ +.++.+||+|||++......
T Consensus 88 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 88 CTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp CCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 9999999988764 348999999999999999999995 899999999999999 88899999999999876544
Q ss_pred CCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccc
Q 044561 500 TIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRL 579 (614)
Q Consensus 500 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 579 (614)
. ......||+.|+|||.+.+ .++.++||||||++++||++|+.||......+.. ....++.... ....
T Consensus 163 ~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~~--~~~~ 230 (277)
T 3f3z_A 163 K--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVM-------LKIREGTFTF--PEKD 230 (277)
T ss_dssp S--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCCCCC--CHHH
T ss_pred c--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHH-------HHHHhCCCCC--Cchh
Confidence 3 2334579999999999865 4899999999999999999999999765433221 1111111110 0000
Q ss_pred cCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 580 EGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 580 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
... ....+.+++.+|++.||++|||+.|+++
T Consensus 231 ~~~----~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 231 WLN----VSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HTT----SCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011 1345778888999999999999999985
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=343.65 Aligned_cols=264 Identities=23% Similarity=0.293 Sum_probs=200.7
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC--hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS--KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 421 (614)
++|+..+.||+|+||.||+|.... +..||+|++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 578889999999999999999875 8899999986543 3345678899999999999999999999999999999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCC
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI 501 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~ 501 (614)
|+++++|.+++... ..+++..+..++.|+++||.|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 83 ~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 83 YCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp CCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred eCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence 99999999988653 348999999999999999999995 8999999999999999999999999999987653322
Q ss_pred CcccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHH--------HhhhcCCcc
Q 044561 502 PQTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVC--------DCWKKGAIR 572 (614)
Q Consensus 502 ~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~--------~~~~~~~~~ 572 (614)
......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+.... ..+......
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 158 -YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred -ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence 2234578999999999876 578999999999999999999999998765544333222111 001000000
Q ss_pred ccc-cccccCcCc-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 573 DAS-DSRLEGICE-----EKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 573 ~~~-d~~l~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
... .+....... ......+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000 000000000 112345778899999999999999999985
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=352.31 Aligned_cols=252 Identities=24% Similarity=0.315 Sum_probs=202.0
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC-----hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS-----KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLL 418 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 418 (614)
+.|+..+.||+|+||.||+|..+. ++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+.+++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 457888999999999999999864 8899999986432 1235778999999999999999999999999999999
Q ss_pred EEEecCCCCcchhcccCC--CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCC---EEEeeeccc
Q 044561 419 VYDYMPNGSLDKILHTNI--KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLN---GKLGDFGLA 493 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~---~kl~DfGla 493 (614)
|||||++++|.+.+.... ...+++..+..++.||++||.|||+ .+|+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 999999999988876432 2358999999999999999999995 89999999999999987655 999999999
Q ss_pred cccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccc
Q 044561 494 RLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRD 573 (614)
Q Consensus 494 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~ 573 (614)
........ .....+||+.|+|||++....++.++|||||||++|||++|+.||..... .+. .....+...
T Consensus 181 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~----~~i~~~~~~- 250 (351)
T 3c0i_A 181 IQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLF----EGIIKGKYK- 250 (351)
T ss_dssp EECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHH----HHHHHTCCC-
T ss_pred eEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHH----HHHHcCCCC-
Confidence 87654332 23345799999999999988999999999999999999999999976321 111 111111111
Q ss_pred cccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 574 ASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 574 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.++.....+ .+.+.+++.+||+.||++|||+.|+++
T Consensus 251 -~~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 251 -MNPRQWSHI----SESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp -CCHHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -CCccccccC----CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 011111112 245778888999999999999999985
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=352.14 Aligned_cols=249 Identities=23% Similarity=0.345 Sum_probs=203.3
Q ss_pred HHhcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhccc-CCCceeEEeeEEeecCeE
Q 044561 342 KATKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGEF 416 (614)
Q Consensus 342 ~~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 416 (614)
...++|+..+.||+|+||.||+|+.+. ++.||+|++.... ....+.+..|..++..+ +||||+++++++.+.+.+
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 345789999999999999999999875 8889999997642 23346678899998877 899999999999999999
Q ss_pred EEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecccccc
Q 044561 417 LLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 496 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~ 496 (614)
++||||+++|+|.+++... ..+++.++..++.||+.||.|||+ ++|+||||||+|||++.++++||+|||+++..
T Consensus 94 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 9999999999999999763 348999999999999999999995 89999999999999999999999999999864
Q ss_pred CCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccc
Q 044561 497 DHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASD 576 (614)
Q Consensus 497 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 576 (614)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... ...+.
T Consensus 169 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~-------i~~~~------ 234 (345)
T 1xjd_A 169 MLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS-------IRMDN------ 234 (345)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-------HHHCC------
T ss_pred ccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHH-------HHhCC------
Confidence 3322 224456899999999999998999999999999999999999999976543322211 11111
Q ss_pred ccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHH-HHh
Q 044561 577 SRLEGICEEKQMELVLKLGLFCSHPKPEARPNMR-QVM 613 (614)
Q Consensus 577 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl 613 (614)
..+...++ ..+..++.+||+.||++||++. ||+
T Consensus 235 ~~~p~~~s----~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 PFYPRWLE----KEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp CCCCTTSC----HHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CCCCcccC----HHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 11112222 3567778889999999999997 665
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=354.92 Aligned_cols=249 Identities=26% Similarity=0.341 Sum_probs=198.5
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhccc-CCCceeEEeeEEeecCeEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGEFLLV 419 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 419 (614)
++|+..+.||+|+||+||+++.+. ++.+|+|++.... ....+.+.+|..++.++ +||||+++++++.+.+.+++|
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 568889999999999999999875 7789999997642 23345578899999887 899999999999999999999
Q ss_pred EEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCC
Q 044561 420 YDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD 499 (614)
Q Consensus 420 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~ 499 (614)
|||+++|+|..++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++++||+|||+++.....
T Consensus 132 ~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 9999999999999764 359999999999999999999995 89999999999999999999999999999853322
Q ss_pred CCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcccc--ccHHHHHHHhhhcCCccccccc
Q 044561 500 TIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMET--VNLVDWVCDCWKKGAIRDASDS 577 (614)
Q Consensus 500 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~--~~l~~~v~~~~~~~~~~~~~d~ 577 (614)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ....+.+.+....+..
T Consensus 207 ~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------ 279 (396)
T 4dc2_A 207 G-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------ 279 (396)
T ss_dssp T-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC------
T ss_pred C-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc------
Confidence 2 234456899999999999999999999999999999999999999975432211 1111222222222211
Q ss_pred cccCcCcHHHHHHHHHHHHHcCCCCCCCCCCH
Q 044561 578 RLEGICEEKQMELVLKLGLFCSHPKPEARPNM 609 (614)
Q Consensus 578 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 609 (614)
.+...+ ...+..|+.+||+.||++||++
T Consensus 280 ~~p~~~----s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 RIPRSL----SVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp CCCTTS----CHHHHHHHHHHTCSCTTTSTTC
T ss_pred CCCCcC----CHHHHHHHHHHhcCCHhHcCCC
Confidence 111222 2356778888999999999995
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=343.17 Aligned_cols=252 Identities=28% Similarity=0.462 Sum_probs=210.2
Q ss_pred HhcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEE
Q 044561 343 ATKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 343 ~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 421 (614)
..++|+..+.||+|+||.||+|..+. +..||+|.+..... ..+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST-HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 34678888999999999999999876 78899999876543 45788999999999999999999999999999999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCC
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI 501 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~ 501 (614)
|+++++|.+++.......+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence 9999999999987666679999999999999999999995 8999999999999999999999999999987765544
Q ss_pred CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 502 PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 502 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
.......+|+.|+|||.+....++.++||||||+++|||++ |+.||......+.... + ..+. .....
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~---~----~~~~-----~~~~~ 234 (288)
T 3kfa_A 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL---L----EKDY-----RMERP 234 (288)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH---H----HTTC-----CCCCC
T ss_pred ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---H----hccC-----CCCCC
Confidence 44444567889999999998899999999999999999999 9999976554332211 1 1110 01111
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+ .+.+.+++.+|++.||++|||+.|+++
T Consensus 235 ~~~----~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 235 EGC----PEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCC----CHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 122 345778888999999999999999874
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=334.95 Aligned_cols=251 Identities=23% Similarity=0.346 Sum_probs=204.8
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
.++|+..+.||+|+||.||+|..+. +..||+|++... .....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4678889999999999999999865 889999998654 3445677889999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCC---EEEeeeccccccC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLN---GKLGDFGLARLYD 497 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~---~kl~DfGla~~~~ 497 (614)
||+++++|.+.+... ..+++.++..++.|++.||.|||+ .+|+||||||+||+++.++. +||+|||++....
T Consensus 85 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 999999998888764 358999999999999999999995 89999999999999987665 9999999998765
Q ss_pred CCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccc
Q 044561 498 HDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDS 577 (614)
Q Consensus 498 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~ 577 (614)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.... ...+.... ..+
T Consensus 160 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~-------~~~~~~~~-~~~ 229 (284)
T 3kk8_A 160 DSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ-------IKAGAYDY-PSP 229 (284)
T ss_dssp SSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-------HHHTCCCC-CTT
T ss_pred cCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHH-------HHhccccC-Cch
Confidence 433 23345799999999999999999999999999999999999999976543322111 11111110 011
Q ss_pred cccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 578 RLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 578 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
. ...+ ...+.+++.+|+++||++|||+.|+++
T Consensus 230 ~-~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 230 E-WDTV----TPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp T-TTTS----CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred h-hccc----CHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0 1112 234677888899999999999999985
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=360.23 Aligned_cols=264 Identities=22% Similarity=0.246 Sum_probs=209.9
Q ss_pred ccCHHHHHHHhcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeE
Q 044561 334 RFTYKDLYKATKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGY 409 (614)
Q Consensus 334 ~~~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~ 409 (614)
.+.+++.....++|+..+.||+|+||.||+++.+. ++.||+|++.+.. ....+.+.+|..++.+++||||++++++
T Consensus 50 ~~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~ 129 (412)
T 2vd5_A 50 VVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFA 129 (412)
T ss_dssp HHHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred hhhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence 34556666677899999999999999999999864 8899999997532 2223457889999999999999999999
Q ss_pred EeecCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEee
Q 044561 410 CRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGD 489 (614)
Q Consensus 410 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~D 489 (614)
+.+.+.+|+|||||++|+|.+++.... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++++||+|
T Consensus 130 ~~~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 130 FQDENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECC
T ss_pred EeeCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEee
Confidence 999999999999999999999997632 359999999999999999999995 8999999999999999999999999
Q ss_pred eccccccCCCCCCcccccccCCCccchhhhc-------CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHH
Q 044561 490 FGLARLYDHDTIPQTTKLVGTFGYMDPELMR-------TGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWV 562 (614)
Q Consensus 490 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v 562 (614)
||+++.............+||+.|+|||++. ...++.++|||||||++|||++|+.||......+....+
T Consensus 206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i--- 282 (412)
T 2vd5_A 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKI--- 282 (412)
T ss_dssp CTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH---
T ss_pred chhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHH---
Confidence 9999877654433344568999999999987 356899999999999999999999999875543322211
Q ss_pred HHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCC---CCHHHHhC
Q 044561 563 CDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEAR---PNMRQVMQ 614 (614)
Q Consensus 563 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~R---Ps~~evl~ 614 (614)
......-.+ +.....+ ...+.+++.+||. +|++| |++.|+++
T Consensus 283 ~~~~~~~~~-----p~~~~~~----s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 283 VHYKEHLSL-----PLVDEGV----PEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HTHHHHCCC-----C----CC----CHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HhcccCcCC-----CccccCC----CHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 111000001 1111122 2356777888999 99998 69999874
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=349.30 Aligned_cols=252 Identities=27% Similarity=0.436 Sum_probs=204.6
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec------CcEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS------NVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEF 416 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 416 (614)
.++|+..+.||+|+||.||+|+..+ +..||+|.+... .....+.+.+|+.++++++||||++++++|...+..
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 125 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 125 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCce
Confidence 4678889999999999999999863 378999999765 344567899999999999999999999999999999
Q ss_pred EEEEEecCCCCcchhcccCC----------------------CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCC
Q 044561 417 LLVYDYMPNGSLDKILHTNI----------------------KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKP 474 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp 474 (614)
++||||+++|+|.+++.... ...+++.+++.++.||++||.|||+ .+|+||||||
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp 202 (343)
T 1luf_A 126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLAT 202 (343)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSG
T ss_pred EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCc
Confidence 99999999999999997632 1469999999999999999999995 8999999999
Q ss_pred CCeEEcCCCCEEEeeeccccccCCCC-CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 044561 475 ANVLLDADLNGKLGDFGLARLYDHDT-IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGS 552 (614)
Q Consensus 475 ~NIll~~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~ 552 (614)
+|||++.++.+||+|||+++...... ........+|+.|+|||.+....++.++||||||+++|||++ |+.||.....
T Consensus 203 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 282 (343)
T 1luf_A 203 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 282 (343)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred ceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh
Confidence 99999999999999999998654322 122334568899999999998899999999999999999999 9999976543
Q ss_pred cccccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 553 METVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 553 ~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+.. .....+.... ....+ ...+.+++.+||+.||++|||+.|+++
T Consensus 283 ~~~~-------~~~~~~~~~~-----~~~~~----~~~l~~li~~~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 283 EEVI-------YYVRDGNILA-----CPENC----PLELYNLMRLCWSKLPADRPSFCSIHR 328 (343)
T ss_dssp HHHH-------HHHHTTCCCC-----CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHH-------HHHhCCCcCC-----CCCCC----CHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 2211 1222222211 11122 345778888999999999999999863
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=338.00 Aligned_cols=248 Identities=28% Similarity=0.505 Sum_probs=189.1
Q ss_pred cCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCCh----hhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSK----QGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
++|+..+.||+|+||.||+|... +..+|+|++..... ...+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 56888899999999999999975 78899999865432 23567889999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcC--------CCCEEEeeecc
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA--------DLNGKLGDFGL 492 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~--------~~~~kl~DfGl 492 (614)
||+++++|.+++.. ..+++.++..++.|+++||.|||+....+|+||||||+||+++. ++.+||+|||+
T Consensus 86 e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 86 EFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp ECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred EcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 99999999999864 35899999999999999999999621122999999999999986 77899999999
Q ss_pred ccccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcc
Q 044561 493 ARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIR 572 (614)
Q Consensus 493 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~ 572 (614)
+....... .....||+.|+|||.+.+..++.++||||||++++||++|+.||......+.. .... .+...
T Consensus 163 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------~~~~-~~~~~ 232 (271)
T 3dtc_A 163 AREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA------YGVA-MNKLA 232 (271)
T ss_dssp ----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH------HHHH-TSCCC
T ss_pred cccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------Hhhh-cCCCC
Confidence 98655432 22357899999999999989999999999999999999999999765432211 1111 11111
Q ss_pred ccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 573 DASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 573 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
... +....+.+.+++.+||+.||++|||+.|+++
T Consensus 233 ----~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 266 (271)
T 3dtc_A 233 ----LPI----PSTCPEPFAKLMEDCWNPDPHSRPSFTNILD 266 (271)
T ss_dssp ----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----CCC----CcccCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 111 1122345778888999999999999999974
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=339.14 Aligned_cols=249 Identities=27% Similarity=0.477 Sum_probs=203.4
Q ss_pred cCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecC
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMP 424 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 424 (614)
++|+..+.||+|+||.||+|..+++..||+|++..... ..+.+.+|++++++++||||+++++++. .+..++||||++
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 90 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME 90 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCC
Confidence 56888899999999999999988888999999876543 3567899999999999999999999986 456899999999
Q ss_pred CCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcc
Q 044561 425 NGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT 504 (614)
Q Consensus 425 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 504 (614)
+++|.+++.......+++.++..++.|++.||.|||+ .+|+||||||+||++++++.+||+|||++...........
T Consensus 91 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 167 (279)
T 1qpc_A 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167 (279)
T ss_dssp TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccc
Confidence 9999999976433359999999999999999999995 8999999999999999999999999999987765443333
Q ss_pred cccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcC
Q 044561 505 TKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGIC 583 (614)
Q Consensus 505 ~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 583 (614)
....++..|+|||.+..+.++.++||||||++++||++ |+.||......+.. . ...++.. ......+
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~----~~~~~~~-----~~~~~~~ 235 (279)
T 1qpc_A 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI---Q----NLERGYR-----MVRPDNC 235 (279)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH---H----HHHTTCC-----CCCCTTC
T ss_pred cCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHH---H----HHhcccC-----CCCcccc
Confidence 34467889999999988889999999999999999999 99999765433221 1 1111111 1111122
Q ss_pred cHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 584 EEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 584 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+.+.+++.+|++.||++|||+.++++
T Consensus 236 ----~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 236 ----PEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----cHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 345778888899999999999999863
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=349.34 Aligned_cols=260 Identities=23% Similarity=0.308 Sum_probs=201.0
Q ss_pred HHHHHhcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC-----ChhhHHHHHHHHHHhcccCCCceeEEeeEEee
Q 044561 339 DLYKATKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD-----SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRR 412 (614)
Q Consensus 339 el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 412 (614)
++....++|+..+.||+|+||.||+|..+. +..+|+|.+... .....+.+.+|+.++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 345566789999999999999999999865 788999998654 23456789999999999999999999999999
Q ss_pred cCeEEEEEEecCCCCcchhcccCC--------------------------------------CCCcChhHHHHHHHHhHh
Q 044561 413 KGEFLLVYDYMPNGSLDKILHTNI--------------------------------------KPCLNWYQRFRIIRGVAS 454 (614)
Q Consensus 413 ~~~~~lV~E~~~~gsL~~~l~~~~--------------------------------------~~~l~~~~~~~i~~~ia~ 454 (614)
.+..++||||+++|+|.+++.... ...+++..+..++.||++
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 999999999999999999985210 112467788899999999
Q ss_pred hchhhhccCCCceEecCcCCCCeEEcCCC--CEEEeeeccccccCCCC---CCcccccccCCCccchhhhcC--CCCCcc
Q 044561 455 GLLYLHEDWEQVVLHRDIKPANVLLDADL--NGKLGDFGLARLYDHDT---IPQTTKLVGTFGYMDPELMRT--GKASTS 527 (614)
Q Consensus 455 gL~yLH~~~~~~ivHrDikp~NIll~~~~--~~kl~DfGla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~t~~ 527 (614)
||.|||+ .+|+||||||+||+++.++ .+||+|||++....... ........||+.|+|||++.. ..++.+
T Consensus 180 ~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 9999995 7999999999999998776 89999999998654321 112345679999999999865 678999
Q ss_pred hhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCC
Q 044561 528 TDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARP 607 (614)
Q Consensus 528 ~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP 607 (614)
+|||||||++|||++|+.||......+... ........ ...+.. ..+ ...+.+++.+||+.||++||
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~~~~------~~~~~~~~--~~~~~~-~~~----~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDADTIS------QVLNKKLC--FENPNY-NVL----SPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHHCCCC--TTSGGG-GGS----CHHHHHHHHHHSCSCTTTSC
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHHHHH------HHHhcccc--cCCccc-ccC----CHHHHHHHHHHcCCChhHCC
Confidence 999999999999999999997654432221 11111110 001111 112 24577788889999999999
Q ss_pred CHHHHhC
Q 044561 608 NMRQVMQ 614 (614)
Q Consensus 608 s~~evl~ 614 (614)
|+.|+++
T Consensus 324 s~~~~l~ 330 (345)
T 3hko_A 324 DAMRALQ 330 (345)
T ss_dssp CHHHHHH
T ss_pred CHHHHhc
Confidence 9999974
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=347.71 Aligned_cols=249 Identities=24% Similarity=0.389 Sum_probs=195.2
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-Cc----EEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NV----QIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLL 418 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 418 (614)
++|+..+.||+|+||.||+|++.. +. +||+|.+... .....+++.+|+.++++++||||++++++|...+ .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 467888999999999999999753 33 3688887543 3345678999999999999999999999998754 789
Q ss_pred EEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCC
Q 044561 419 VYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 498 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~ 498 (614)
|+||+++|+|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++++||+|||+++....
T Consensus 94 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 999999999999997643 459999999999999999999995 8999999999999999999999999999987654
Q ss_pred CCCC-cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCcccccc
Q 044561 499 DTIP-QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASD 576 (614)
Q Consensus 499 ~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 576 (614)
.... ......+|..|+|||++.+..++.++|||||||++|||++ |+.||......+....+ ..+....
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~-------~~~~~~~--- 239 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-------EKGERLP--- 239 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-------HTTCCCC---
T ss_pred CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHH-------HcCCCCC---
Confidence 3322 2233456889999999999999999999999999999999 99999865543322111 1111100
Q ss_pred ccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 577 SRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 577 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+......+..++.+||+.||++|||+.|+++
T Consensus 240 ------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 271 (327)
T 3poz_A 240 ------QPPICTIDVYMIMVKCWMIDADSRPKFRELII 271 (327)
T ss_dssp ------CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHH
T ss_pred ------CCccCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 11112335778888999999999999999873
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=357.10 Aligned_cols=251 Identities=28% Similarity=0.458 Sum_probs=202.2
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe------cCcEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA------SNVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFL 417 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 417 (614)
++|+..+.||+|+||.||+|++. .+..||||++... ......++.+|+.++++++||||+++++++...+..+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 46778899999999999999953 3567999999654 4555668899999999999999999999999999999
Q ss_pred EEEEecCCCCcchhcccCC-----CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCC---CEEEee
Q 044561 418 LVYDYMPNGSLDKILHTNI-----KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADL---NGKLGD 489 (614)
Q Consensus 418 lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~---~~kl~D 489 (614)
+||||+++|+|.+++.... ...+++.+++.++.||++||.|||+ ++|+||||||+|||++.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEECC
Confidence 9999999999999997532 2458999999999999999999995 8999999999999999555 599999
Q ss_pred eccccccCCC-CCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhh
Q 044561 490 FGLARLYDHD-TIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWK 567 (614)
Q Consensus 490 fGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~ 567 (614)
||+++..... .........||+.|+|||++.+..++.++|||||||++|||++ |+.||......+.. . ...
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~---~----~i~ 300 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL---E----FVT 300 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH---H----HHH
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---H----HHH
Confidence 9999754322 1122334578999999999999999999999999999999998 99999765433221 1 111
Q ss_pred cCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 568 KGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 568 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+.... ....+ ...+.+++.+||+.||++|||+.||++
T Consensus 301 ~~~~~~-----~~~~~----~~~l~~li~~~l~~dP~~Rps~~eil~ 338 (367)
T 3l9p_A 301 SGGRMD-----PPKNC----PGPVYRIMTQCWQHQPEDRPNFAIILE 338 (367)
T ss_dssp TTCCCC-----CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCCCC-----CCccC----CHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 211111 11122 235778888999999999999999974
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=350.10 Aligned_cols=250 Identities=23% Similarity=0.298 Sum_probs=188.1
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
.++|+..+.||+|+||.||+|+... ++.||+|++.... ..+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 4578889999999999999999875 7889999997653 335678999999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcC---CCCEEEeeeccccccCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA---DLNGKLGDFGLARLYDHD 499 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~---~~~~kl~DfGla~~~~~~ 499 (614)
+++|+|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++. ++.+||+|||+++.....
T Consensus 130 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 130 VTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp CCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 9999999998764 348999999999999999999995 89999999999999975 899999999999876543
Q ss_pred CCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccc
Q 044561 500 TIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRL 579 (614)
Q Consensus 500 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 579 (614)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. . ......+... .. ...
T Consensus 205 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~----~~~i~~~~~~-~~-~~~ 274 (349)
T 2w4o_A 205 V--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--M----FRRILNCEYY-FI-SPW 274 (349)
T ss_dssp ----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--H----HHHHHTTCCC-CC-TTT
T ss_pred c--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--H----HHHHHhCCCc-cC-Cch
Confidence 2 23345799999999999998999999999999999999999999975443221 1 1111111111 00 111
Q ss_pred cCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 580 EGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 580 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
... ....+.+++.+||+.||++|||+.|+++
T Consensus 275 ~~~----~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 275 WDE----VSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp TTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhh----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111 2345778888999999999999999974
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=339.62 Aligned_cols=250 Identities=25% Similarity=0.418 Sum_probs=190.9
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec----CcEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS----NVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLL 418 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 418 (614)
.++|+..+.||+|+||.||+|.... +..||+|++... .....+.+.+|+.++++++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 3567888999999999999999753 456899998754 3445678999999999999999999999984 567899
Q ss_pred EEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCC
Q 044561 419 VYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 498 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~ 498 (614)
||||+++++|.+++... ...+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 93 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp EEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccccCc
Confidence 99999999999999764 3458999999999999999999995 8999999999999999999999999999987655
Q ss_pred CCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccc
Q 044561 499 DTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDS 577 (614)
Q Consensus 499 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~ 577 (614)
..........+|+.|+|||.+....++.++||||||+++|||++ |+.||......+.. ..+ ..+...
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~---~~i----~~~~~~----- 236 (281)
T 1mp8_A 169 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GRI----ENGERL----- 236 (281)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---HHH----HTTCCC-----
T ss_pred ccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHH---HHH----HcCCCC-----
Confidence 44333344567889999999998899999999999999999996 99999865543322 111 111111
Q ss_pred cccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 578 RLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 578 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+...+ ...+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~ 269 (281)
T 1mp8_A 237 PMPPNC----PPTLYSLMTKCWAYDPSRRPRFTELKA 269 (281)
T ss_dssp CCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCC----CHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 111222 345777888999999999999999873
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=337.83 Aligned_cols=246 Identities=26% Similarity=0.410 Sum_probs=199.7
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLV 419 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 419 (614)
.++|+..+.||+|+||.||+|.... +..||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 3568889999999999999999875 6789999986542 22346788999999999999999999999999999999
Q ss_pred EEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCC
Q 044561 420 YDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD 499 (614)
Q Consensus 420 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~ 499 (614)
|||+++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 88 ~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp ECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 9999999999998764 34899999999999999999999 489999999999999999999999999998654433
Q ss_pred CCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccc
Q 044561 500 TIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRL 579 (614)
Q Consensus 500 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 579 (614)
. .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....+ .... ...
T Consensus 163 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-------~~~~------~~~ 226 (279)
T 3fdn_A 163 R---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-------SRVE------FTF 226 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-------HHTC------CCC
T ss_pred c---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHH-------HhCC------CCC
Confidence 2 23457899999999999989999999999999999999999999765433222111 1111 111
Q ss_pred cCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 580 EGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 580 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.... ...+.+++.+||+.||++|||+.|+++
T Consensus 227 ~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 227 PDFV----TEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp CTTS----CHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCcC----CHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1112 235667888899999999999999974
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=343.80 Aligned_cols=252 Identities=25% Similarity=0.429 Sum_probs=205.1
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEe------cCcEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLA------SNVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEF 416 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 416 (614)
.++|...+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 456888899999999999999863 2478999998764 345567899999999999999999999999999999
Q ss_pred EEEEEecCCCCcchhcccCCC----------------------CCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCC
Q 044561 417 LLVYDYMPNGSLDKILHTNIK----------------------PCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKP 474 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp 474 (614)
++||||+++++|.+++..... ..+++.+++.++.||++||.|||+ .+|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccch
Confidence 999999999999999976432 348999999999999999999995 8999999999
Q ss_pred CCeEEcCCCCEEEeeeccccccCCCCC-CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 044561 475 ANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGS 552 (614)
Q Consensus 475 ~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~ 552 (614)
+||+++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987654322 12233467889999999998889999999999999999999 9999976554
Q ss_pred cccccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 553 METVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 553 ~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+... ....+... .....+ .+.+.+++.+||+.||++|||+.|+++
T Consensus 259 ~~~~~-------~~~~~~~~-----~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~l~~ 304 (314)
T 2ivs_A 259 ERLFN-------LLKTGHRM-----ERPDNC----SEEMYRLMLQCWKQEPDKRPVFADISK 304 (314)
T ss_dssp GGHHH-------HHHTTCCC-----CCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHH-------HhhcCCcC-----CCCccC----CHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 33221 11121111 111122 345778888999999999999999873
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=348.77 Aligned_cols=244 Identities=20% Similarity=0.264 Sum_probs=203.9
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
++|+..+.||+|+||.||+++.+. +..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 578889999999999999999874 8899999986542 234567889999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
||+++|+|.+++... ..+++.++..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 999999999999764 348999999999999999999995 89999999999999999999999999999876542
Q ss_pred CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. +....+.. .+.
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-------~~i~~~~~------~~p 258 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY-------EKIVSGKV------RFP 258 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCCC------CCC
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHH-------HHHHcCCC------CCC
Confidence 23458999999999999989999999999999999999999999765432221 11112211 111
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHhC
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARPN-----MRQVMQ 614 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 614 (614)
..+ ...+..++.+||+.||++||+ +.||++
T Consensus 259 ~~~----~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 259 SHF----SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp TTC----CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCC----CHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 222 235677888899999999998 888864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=356.29 Aligned_cols=265 Identities=24% Similarity=0.377 Sum_probs=193.6
Q ss_pred HhcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC--ChhhHHHHHHHHHHhcccC-CCceeEEeeEEeecC--eE
Q 044561 343 ATKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD--SKQGIKEFVAELVSMGRLR-HRNLVKLRGYCRRKG--EF 416 (614)
Q Consensus 343 ~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~--~~ 416 (614)
..++|+..+.||+|+||.||+|.... +..||+|++... .....+.+.+|+.+++++. ||||+++++++...+ .+
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 45688999999999999999999764 889999998643 4455677889999999997 999999999997544 79
Q ss_pred EEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecccccc
Q 044561 417 LLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 496 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~ 496 (614)
|+|||||+ ++|.+++..+ .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 87 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 99999997 6899988763 48999999999999999999995 89999999999999999999999999999865
Q ss_pred CCCC--------------------CCcccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcccc
Q 044561 497 DHDT--------------------IPQTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMET 555 (614)
Q Consensus 497 ~~~~--------------------~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~ 555 (614)
.... ....+..+||+.|+|||++.+ ..++.++||||+||+++||++|+.||.+.+..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 239 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 3211 112344689999999999876 6789999999999999999999999987655443
Q ss_pred ccHHHHHHHhhhcCCccccc------------------cccccCcCc------------HHHHHHHHHHHHHcCCCCCCC
Q 044561 556 VNLVDWVCDCWKKGAIRDAS------------------DSRLEGICE------------EKQMELVLKLGLFCSHPKPEA 605 (614)
Q Consensus 556 ~~l~~~v~~~~~~~~~~~~~------------------d~~l~~~~~------------~~~~~~l~~l~~~cl~~dP~~ 605 (614)
...+...........+.... .......++ ......+.+|+.+||+.||++
T Consensus 240 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~ 319 (388)
T 3oz6_A 240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK 319 (388)
T ss_dssp HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCccc
Confidence 33221111000000000000 000000000 011245778889999999999
Q ss_pred CCCHHHHhC
Q 044561 606 RPNMRQVMQ 614 (614)
Q Consensus 606 RPs~~evl~ 614 (614)
|||+.|+++
T Consensus 320 R~t~~e~l~ 328 (388)
T 3oz6_A 320 RISANDALK 328 (388)
T ss_dssp SCCHHHHTT
T ss_pred CCCHHHHhC
Confidence 999999985
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=342.41 Aligned_cols=249 Identities=20% Similarity=0.337 Sum_probs=196.6
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeecC--------
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKG-------- 414 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-------- 414 (614)
++|+..+.||+|+||.||+|+.+ ++..||+|++.... ....+.+.+|+.++++++||||++++++|.+.+
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 56888899999999999999987 58899999997543 345678999999999999999999999986543
Q ss_pred -------------------------------------------------eEEEEEEecCCCCcchhcccCCC-CCcChhH
Q 044561 415 -------------------------------------------------EFLLVYDYMPNGSLDKILHTNIK-PCLNWYQ 444 (614)
Q Consensus 415 -------------------------------------------------~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~ 444 (614)
..++|||||++++|.+++..... ...++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 38999999999999999986432 3356677
Q ss_pred HHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCC-----------CcccccccCCCc
Q 044561 445 RFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-----------PQTTKLVGTFGY 513 (614)
Q Consensus 445 ~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~-----------~~~~~~~gt~~y 513 (614)
++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++....... .......||+.|
T Consensus 166 ~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 89999999999999995 8999999999999999999999999999987665421 122345799999
Q ss_pred cchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHH
Q 044561 514 MDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLK 593 (614)
Q Consensus 514 ~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 593 (614)
+|||++.+..++.++|||||||++|||++|..|+.. ... ............ ........+.+
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~----~~~~~~~~~~~~---------~~~~~~~~~~~ 304 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVR----IITDVRNLKFPL---------LFTQKYPQEHM 304 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHH----HHHHHHTTCCCH---------HHHHHCHHHHH
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHH----HHHHhhccCCCc---------ccccCChhHHH
Confidence 999999999999999999999999999998776421 111 111111111111 11223345678
Q ss_pred HHHHcCCCCCCCCCCHHHHhC
Q 044561 594 LGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 594 l~~~cl~~dP~~RPs~~evl~ 614 (614)
++.+||++||++|||+.|+++
T Consensus 305 li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 305 MVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHccCCCCcCCCHHHHhh
Confidence 889999999999999999974
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=337.21 Aligned_cols=249 Identities=27% Similarity=0.444 Sum_probs=204.1
Q ss_pred cCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecC
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMP 424 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 424 (614)
++|+..+.||+|+||.||++...++..||+|++..... ..+++.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 46778899999999999999998888999999976543 23678999999999999999999999999999999999999
Q ss_pred CCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcc
Q 044561 425 NGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT 504 (614)
Q Consensus 425 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 504 (614)
+++|.+++... ...+++.++..++.|+++||.|||+ .+++||||||+||+++.++.+||+|||++...........
T Consensus 87 ~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (267)
T 3t9t_A 87 HGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 162 (267)
T ss_dssp TCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence 99999999764 3458999999999999999999995 8999999999999999999999999999987644322222
Q ss_pred cccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcC
Q 044561 505 TKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGIC 583 (614)
Q Consensus 505 ~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 583 (614)
....++..|+|||.+....++.++||||||+++|||++ |+.||......+.. . ....+.. .......
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~----~i~~~~~-----~~~~~~~ 230 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV---E----DISTGFR-----LYKPRLA 230 (267)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---H----HHHTTCC-----CCCCTTS
T ss_pred ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHH---H----HHhcCCc-----CCCCccC
Confidence 33457788999999998899999999999999999999 89999765432211 1 1111110 0111112
Q ss_pred cHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 584 EEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 584 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
...+.+++.+||+.||++|||+.|+++
T Consensus 231 ----~~~l~~li~~~l~~~p~~Rps~~~ll~ 257 (267)
T 3t9t_A 231 ----STHVYQIMNHCWRERPEDRPAFSRLLR 257 (267)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----cHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 345777888999999999999999874
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=342.96 Aligned_cols=250 Identities=20% Similarity=0.304 Sum_probs=204.9
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChh------hHHHHHHHHHHhcccCCCceeEEeeEEeecCeEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQ------GIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFL 417 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 417 (614)
++|+..+.||+|+||.||+|.... +..||+|.+...... ..+++.+|+.++++++||||+++++++...+..+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 468889999999999999999874 889999998764321 3577899999999999999999999999999999
Q ss_pred EEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCC----CEEEeeeccc
Q 044561 418 LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADL----NGKLGDFGLA 493 (614)
Q Consensus 418 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~----~~kl~DfGla 493 (614)
+||||+++++|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+||+++.++ .+||+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp EEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred EEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 999999999999999764 458999999999999999999995 8999999999999999888 7999999999
Q ss_pred cccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccc
Q 044561 494 RLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRD 573 (614)
Q Consensus 494 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~ 573 (614)
....... ......||+.|+|||++....++.++||||||+++|||++|+.||......+... .......
T Consensus 167 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-------~i~~~~~-- 235 (321)
T 2a2a_A 167 HEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA-------NITSVSY-- 235 (321)
T ss_dssp EECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH-------HHHTTCC--
T ss_pred eecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHH-------HHHhccc--
Confidence 8765433 2334579999999999998899999999999999999999999997654332211 1111110
Q ss_pred cccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 574 ASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 574 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..++...... ...+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 236 DFDEEFFSHT----SELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CCCHHHHTTC----CHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred ccChhhhccc----CHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0111111112 245778888999999999999999974
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=348.12 Aligned_cols=248 Identities=22% Similarity=0.313 Sum_probs=202.9
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhccc-CCCceeEEeeEEeecCeEEE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGEFLL 418 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 418 (614)
.++|+..+.||+|+||.||+|+.+. ++.||+|++.... ....+.+..|..++..+ +||||+++++++...+.+|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 4678999999999999999999875 7889999997642 23456778999999988 79999999999999999999
Q ss_pred EEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCC
Q 044561 419 VYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 498 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~ 498 (614)
||||+++|+|.+++... ..+++.++..++.||+.||.|||+ .+|+||||||+|||++.++++||+|||+++....
T Consensus 99 v~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 99999999999999763 349999999999999999999995 8999999999999999999999999999986433
Q ss_pred CCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccc
Q 044561 499 DTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSR 578 (614)
Q Consensus 499 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~ 578 (614)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ..+ ..+.. .
T Consensus 174 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~---~~i----~~~~~------~ 239 (353)
T 2i0e_A 174 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF---QSI----MEHNV------A 239 (353)
T ss_dssp TT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHH----HHCCC------C
T ss_pred CC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHH---HHH----HhCCC------C
Confidence 22 2334568999999999999999999999999999999999999999765433221 111 11111 1
Q ss_pred ccCcCcHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHhC
Q 044561 579 LEGICEEKQMELVLKLGLFCSHPKPEARPN-----MRQVMQ 614 (614)
Q Consensus 579 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 614 (614)
+.... ...+..++.+||+.||++||+ +.||++
T Consensus 240 ~p~~~----s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 240 YPKSM----SKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp CCTTS----CHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred CCCCC----CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 11122 345677888899999999995 577653
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=337.66 Aligned_cols=255 Identities=20% Similarity=0.235 Sum_probs=204.7
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCChhhHHHHHHHHHHhccc-CCCceeEEeeEEeecCeEEEEEE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 421 (614)
.++|+..+.||+|+||.||+|... ++..||+|++..... .+.+.+|+.+++.+ +|+|++++++++......++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 356888999999999999999974 588999999865432 24577899999999 79999999999999999999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCC-----EEEeeecccccc
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLN-----GKLGDFGLARLY 496 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~-----~kl~DfGla~~~ 496 (614)
|+ +++|.+++.... ..+++.++..++.||+.||.||| +.+|+||||||+||+++.++. +||+|||+++..
T Consensus 87 ~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 87 LL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 99 999999998643 35999999999999999999999 489999999999999987776 999999999876
Q ss_pred CCCCC------CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCC
Q 044561 497 DHDTI------PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGA 570 (614)
Q Consensus 497 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~ 570 (614)
..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..............+........
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 241 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence 54432 123446799999999999999999999999999999999999999987554433333222222211111
Q ss_pred ccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 571 IRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 571 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.. .+...+ .+.+.+++.+||+.||++||++.+|++
T Consensus 242 ~~-----~~~~~~----~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 242 LR-----ELCAGF----PEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HH-----HHTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HH-----HHHhhC----cHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 11 111112 345778888899999999999999863
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=361.58 Aligned_cols=248 Identities=25% Similarity=0.314 Sum_probs=194.6
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC---ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
++|+..+.||+|+||.||+|.... +..||+|++... .......+.+|+.+++.++||||++++++|...+.+++||
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 227 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence 468888999999999999999865 889999999753 3344567789999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
|||++|+|.+++... ..+++.++..++.||+.||.|||+ +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 228 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 303 (446)
T 4ejn_A 228 EYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 303 (446)
T ss_dssp CCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred eeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence 999999999998764 358999999999999999999995 3789999999999999999999999999998643322
Q ss_pred CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... + ..+. ..+.
T Consensus 304 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~---i----~~~~------~~~p 369 (446)
T 4ejn_A 304 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL---I----LMEE------IRFP 369 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---H----HHCC------CCCC
T ss_pred -cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHH---H----HhCC------CCCC
Confidence 223446899999999999999999999999999999999999999976543322211 1 1111 1111
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHhC
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARP-----NMRQVMQ 614 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 614 (614)
..++ ..+.+++.+||+.||++|| ++.|+++
T Consensus 370 ~~~~----~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 370 RTLG----PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp TTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ccCC----HHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 2222 3567788889999999999 9999975
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=346.29 Aligned_cols=252 Identities=23% Similarity=0.336 Sum_probs=194.9
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecC---ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecC----e
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKG----E 415 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~ 415 (614)
.++|+..+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 357888999999999999999975 4888999999764 3344567899999999999999999999987654 3
Q ss_pred EEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccc
Q 044561 416 FLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARL 495 (614)
Q Consensus 416 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~ 495 (614)
.++||||+++++|.+++... ..+++.++..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred cEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 59999999999999999764 359999999999999999999995 8999999999999999999999999999987
Q ss_pred cCCCCC--CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccc
Q 044561 496 YDHDTI--PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRD 573 (614)
Q Consensus 496 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~ 573 (614)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ............
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~~~~~~ 239 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDPIPP 239 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCCCCCH
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhcCCCCCc
Confidence 654321 223345799999999999999999999999999999999999999976543221 111111111110
Q ss_pred cccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHh
Q 044561 574 ASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVM 613 (614)
Q Consensus 574 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 613 (614)
...... ....+.+++.+||+.||++||++.+++
T Consensus 240 ---~~~~~~----~~~~l~~li~~~l~~dP~~R~~~~~~l 272 (311)
T 3ork_A 240 ---SARHEG----LSADLDAVVLKALAKNPENRYQTAAEM 272 (311)
T ss_dssp ---HHHSTT----CCHHHHHHHHHHTCSSGGGSCSSHHHH
T ss_pred ---ccccCC----CCHHHHHHHHHHHhcCHhhChhhHHHH
Confidence 000111 234577888899999999999988876
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=346.27 Aligned_cols=255 Identities=26% Similarity=0.403 Sum_probs=189.4
Q ss_pred HHHhcCCCCcceeeeeCcEEEEEEEEecC----cEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecC
Q 044561 341 YKATKGFKDKDVIGRGGFGKVYRGVLASN----VQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKG 414 (614)
Q Consensus 341 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~----~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 414 (614)
....++|+..+.||+|+||.||+|..... ..||+|.+... .....+++.+|+.++++++||||+++++++...+
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 34456799999999999999999997653 27999998764 3445678999999999999999999999998776
Q ss_pred eE------EEEEEecCCCCcchhcccCC----CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCC
Q 044561 415 EF------LLVYDYMPNGSLDKILHTNI----KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLN 484 (614)
Q Consensus 415 ~~------~lV~E~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~ 484 (614)
.. ++||||+++|+|.+++.... ...+++.++..++.|+++||.|||+ ++|+||||||+|||++.++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCC
Confidence 55 99999999999999986422 2258999999999999999999995 89999999999999999999
Q ss_pred EEEeeeccccccCCCCC-CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHH
Q 044561 485 GKLGDFGLARLYDHDTI-PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWV 562 (614)
Q Consensus 485 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v 562 (614)
+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+... .+
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~---~~ 252 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN---YL 252 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH---HH
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHH---HH
Confidence 99999999987644332 12233456788999999999999999999999999999999 999998755443221 11
Q ss_pred HHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 563 CDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 563 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
. .+... .. +......+.+++.+||+.||++|||+.|+++
T Consensus 253 ~----~~~~~-----~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 291 (323)
T 3qup_A 253 I----GGNRL-----KQ----PPECMEEVYDLMYQCWSADPKQRPSFTCLRM 291 (323)
T ss_dssp H----TTCCC-----CC----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred h----cCCCC-----CC----CCccCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1 11111 11 1122345778888999999999999888763
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=348.97 Aligned_cols=249 Identities=22% Similarity=0.362 Sum_probs=195.1
Q ss_pred cCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecC--ChhhHHHHHHHHHHhcccCC--CceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRH--RNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~lV~ 420 (614)
+.|+..+.||+|+||.||++...++..||+|++... ..+..+.+.+|+.++++++| |||+++++++...+..++||
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 88 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 88 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence 568889999999999999999888899999998754 44556789999999999986 99999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
| +.+++|.+++... ..+++.++..++.||+.||.|||+ .+|+||||||+|||++ ++.+||+|||+++......
T Consensus 89 e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 89 E-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp C-CCSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred e-CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 9 5688999999874 458999999999999999999995 8999999999999997 6789999999998765433
Q ss_pred CC-cccccccCCCccchhhhcC-----------CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhc
Q 044561 501 IP-QTTKLVGTFGYMDPELMRT-----------GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKK 568 (614)
Q Consensus 501 ~~-~~~~~~gt~~y~aPE~~~~-----------~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~ 568 (614)
.. ......||+.|+|||++.. ..++.++|||||||++|||++|+.||...... ..........
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~~~~~~ 236 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAIIDP 236 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHCT
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-----HHHHHHHhcC
Confidence 21 2334579999999999864 67899999999999999999999999753221 1111111111
Q ss_pred CCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 569 GAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 569 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.. ........ ...+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~-----~~~~~~~~----~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 237 NH-----EIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp TS-----CCCCCCCS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred Cc-----ccCCcccC----CHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 10 01111112 235677888899999999999999985
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=344.97 Aligned_cols=246 Identities=23% Similarity=0.339 Sum_probs=192.2
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe----cCcEEEEEEeecCC----hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA----SNVQIAVKKVSHDS----KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEF 416 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 416 (614)
++|+..+.||+|+||.||+++.. .+..+|+|++.... ......+.+|+.++++++||||+++++++...+.+
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 56888999999999999999973 58899999997642 23345678899999999999999999999999999
Q ss_pred EEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecccccc
Q 044561 417 LLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 496 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~ 496 (614)
++||||+++++|.+++... ..+++.++..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 97 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 97 YLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp EEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred EEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 9999999999999999763 348999999999999999999995 89999999999999999999999999999764
Q ss_pred CCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccc
Q 044561 497 DHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASD 576 (614)
Q Consensus 497 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 576 (614)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ..+.. +..
T Consensus 172 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~~----~~~----- 238 (327)
T 3a62_A 172 IHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI---DKILK----CKL----- 238 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHH----TCC-----
T ss_pred ccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHH---HHHHh----CCC-----
Confidence 3322 1233457999999999999889999999999999999999999999765433221 11111 111
Q ss_pred ccccCcCcHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHh
Q 044561 577 SRLEGICEEKQMELVLKLGLFCSHPKPEARP-----NMRQVM 613 (614)
Q Consensus 577 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl 613 (614)
.+...+ ...+.+++.+||+.||++|| ++.|++
T Consensus 239 -~~p~~~----~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l 275 (327)
T 3a62_A 239 -NLPPYL----TQEARDLLKKLLKRNAASRLGAGPGDAGEVQ 275 (327)
T ss_dssp -CCCTTS----CHHHHHHHHHHSCSCGGGSTTSSTTTHHHHH
T ss_pred -CCCCCC----CHHHHHHHHHHHhcCHhhccCCCCCCHHHHH
Confidence 111122 24567788889999999999 777876
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=347.43 Aligned_cols=245 Identities=29% Similarity=0.449 Sum_probs=198.4
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
+.|+..+.||+|+||.||+|+.. ++..||+|++.... ....+++.+|+.++++++||||+++++++...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 34777889999999999999975 58889999997542 334567899999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
||++ |+|.+++... ...+++.++..++.|+++||.|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 134 e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 207 (348)
T ss_dssp ECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred ecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-
Confidence 9997 6888877543 3459999999999999999999995 79999999999999999999999999999865432
Q ss_pred CCcccccccCCCccchhhhc---CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMR---TGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDS 577 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~---~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~ 577 (614)
....||+.|+|||++. .+.++.++|||||||++|||++|+.||......+.. ..... +......
T Consensus 208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~------~~~~~-~~~~~~~-- 274 (348)
T 1u5q_A 208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQ-NESPALQ-- 274 (348)
T ss_dssp ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHH-SCCCCCC--
T ss_pred ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHHh-cCCCCCC--
Confidence 3357999999999984 567899999999999999999999999765432211 11111 1111111
Q ss_pred cccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 578 RLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 578 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
...+ .+.+.+++.+||+.||++|||+.|+++
T Consensus 275 --~~~~----~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 275 --SGHW----SEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp --CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --CCCC----CHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 1122 234677888899999999999999985
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=356.95 Aligned_cols=261 Identities=22% Similarity=0.262 Sum_probs=197.3
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeec------C
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRK------G 414 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~ 414 (614)
.++|+..+.||+|+||.||+|.... ++.||+|++... .....+++.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 4678899999999999999999765 888999999764 445567889999999999999999999998654 4
Q ss_pred eEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecccc
Q 044561 415 EFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR 494 (614)
Q Consensus 415 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~ 494 (614)
..|+|||||+++ |.+.+.. .+++.++..++.||+.||.|||+ .+|+||||||+|||++.++++||+|||+++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred eEEEEEeCCCCC-HHHHHhh----cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 689999999754 6565543 38999999999999999999995 899999999999999999999999999998
Q ss_pred ccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHH-----------
Q 044561 495 LYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVC----------- 563 (614)
Q Consensus 495 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~----------- 563 (614)
...... ..+..+||+.|+|||++.+..++.++||||+||+++||++|+.||.+.+..+....+....
T Consensus 213 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 213 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp ----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred ecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence 765432 2345689999999999999999999999999999999999999998765433322221110
Q ss_pred -----HhhhcC------Ccccccccccc---CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 564 -----DCWKKG------AIRDASDSRLE---GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 564 -----~~~~~~------~~~~~~d~~l~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
...... .+.......+. ..........+.+|+.+||+.||++|||+.|+++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 00000000000 0011122456889999999999999999999985
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=350.59 Aligned_cols=252 Identities=20% Similarity=0.244 Sum_probs=191.6
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
.++|+..+.||+|+||.||+++.. .++.||+|++..... ..+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 357888999999999999999987 488899999976533 235678999999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCC--EEEeeeccccccCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLN--GKLGDFGLARLYDHDT 500 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~--~kl~DfGla~~~~~~~ 500 (614)
+++|+|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++. +||+|||+++......
T Consensus 98 ~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~ 172 (361)
T 3uc3_A 98 ASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172 (361)
T ss_dssp CCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence 9999999998763 349999999999999999999995 89999999999999987765 9999999997543322
Q ss_pred CCcccccccCCCccchhhhcCCCCCcc-hhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMRTGKASTS-TDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRL 579 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~~~t~~-~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 579 (614)
......||+.|+|||++.+..++.+ +|||||||++|||++|+.||......+.... .+.... ........+
T Consensus 173 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~--~~~~~~-~~~~~~~~~--- 244 (361)
T 3uc3_A 173 --QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRK--TIQRIL-SVKYSIPDD--- 244 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHH--HHHHHH-TTCCCCCTT---
T ss_pred --CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHH--HHHHHh-cCCCCCCCc---
Confidence 2334579999999999988777655 8999999999999999999986544332211 111111 111100000
Q ss_pred cCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 580 EGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 580 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+ ...+.+|+.+||+.||++|||+.|+++
T Consensus 245 -~~~----s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 245 -IRI----SPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp -SCC----CHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred -CCC----CHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 011 235677888899999999999999985
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=336.49 Aligned_cols=267 Identities=23% Similarity=0.320 Sum_probs=198.1
Q ss_pred CHHHHHHHhcCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHh--cccCCCceeEEeeEEeec
Q 044561 336 TYKDLYKATKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSM--GRLRHRNLVKLRGYCRRK 413 (614)
Q Consensus 336 ~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l--~~l~H~niv~l~g~~~~~ 413 (614)
....-....++|+..+.||+|+||.||+|+.+ +..||+|++..... ..+..|.+++ ..++||||+++++++...
T Consensus 28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 103 (337)
T 3mdy_A 28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAADIKG 103 (337)
T ss_dssp CHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred CcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence 33333445578999999999999999999875 88899999865433 2334444444 445999999999999877
Q ss_pred ----CeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccC-----CCceEecCcCCCCeEEcCCCC
Q 044561 414 ----GEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDW-----EQVVLHRDIKPANVLLDADLN 484 (614)
Q Consensus 414 ----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDikp~NIll~~~~~ 484 (614)
...++||||+++|+|.+++... .+++.+++.++.|++.||.|||+.. +.+|+||||||+|||++.++.
T Consensus 104 ~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 104 TGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp CGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred CCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC
Confidence 7899999999999999999754 4999999999999999999999521 129999999999999999999
Q ss_pred EEEeeeccccccCCCCCC---cccccccCCCccchhhhcCCCCCcc------hhHHHHHHHHHHHHcC----------CC
Q 044561 485 GKLGDFGLARLYDHDTIP---QTTKLVGTFGYMDPELMRTGKASTS------TDVYAFGVFMLEVASG----------RR 545 (614)
Q Consensus 485 ~kl~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~t~~------~Dv~S~Gvll~el~tg----------~~ 545 (614)
+||+|||++......... ......||+.|+|||++.....+.+ +|||||||++|||++| +.
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~ 260 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260 (337)
T ss_dssp EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence 999999999766443221 1224579999999999987766654 9999999999999999 66
Q ss_pred CCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 546 PVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 546 p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
||......+.. ................... ........+.+.+++.+||+.||++|||+.||++
T Consensus 261 p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (337)
T 3mdy_A 261 PYHDLVPSDPS--YEDMREIVCIKKLRPSFPN---RWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324 (337)
T ss_dssp TTTTTSCSSCC--HHHHHHHHTTSCCCCCCCG---GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cHhhhcCCCCc--hhhhHHHHhhhccCccccc---cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHH
Confidence 66543322211 1111111111111111111 1122356778999999999999999999999874
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=341.15 Aligned_cols=252 Identities=25% Similarity=0.360 Sum_probs=204.4
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe------cCcEEEEEEeecCC-hhhHHHHHHHHHHhccc-CCCceeEEeeEEeecCeE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA------SNVQIAVKKVSHDS-KQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGEF 416 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 416 (614)
++|+..+.||+|+||.||+|... .+..||+|++.... ....+.+.+|+.+++++ +||||+++++++...+..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 102 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence 56888899999999999999852 35789999997654 34457889999999999 999999999999999999
Q ss_pred EEEEEecCCCCcchhcccCCC----------------CCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEc
Q 044561 417 LLVYDYMPNGSLDKILHTNIK----------------PCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD 480 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~ 480 (614)
++||||+++|+|.+++..... ..+++.+++.++.|+++||.|||+ .+|+||||||+||+++
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~ 179 (313)
T 1t46_A 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLT 179 (313)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEE
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEc
Confidence 999999999999999976432 248999999999999999999995 8999999999999999
Q ss_pred CCCCEEEeeeccccccCCCCCC-cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccH
Q 044561 481 ADLNGKLGDFGLARLYDHDTIP-QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNL 558 (614)
Q Consensus 481 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l 558 (614)
.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+..
T Consensus 180 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-- 257 (313)
T 1t46_A 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF-- 257 (313)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH--
T ss_pred CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH--
Confidence 9999999999999876554322 2233467889999999999999999999999999999999 99999765433221
Q ss_pred HHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 559 VDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 559 ~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
......+.. ..... .....+.+++.+||+.||++|||+.|+++
T Consensus 258 ----~~~~~~~~~-----~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~ 300 (313)
T 1t46_A 258 ----YKMIKEGFR-----MLSPE----HAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (313)
T ss_dssp ----HHHHHHTCC-----CCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----HHHhccCCC-----CCCcc----cCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 111111110 11111 12345778888999999999999999874
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=344.00 Aligned_cols=253 Identities=18% Similarity=0.195 Sum_probs=203.7
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCChhhHHHHHHHHHHhccc-CCCceeEEeeEEeecCeEEEEEEe
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
++|+..+.||+|+||.||+|+.. +++.||+|.+..... .+.+.+|+.+++++ +||||+++++++...+..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 57888999999999999999975 488999999875533 24578999999999 999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCC-----EEEeeeccccccC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLN-----GKLGDFGLARLYD 497 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~-----~kl~DfGla~~~~ 497 (614)
+ +++|.+++... ...+++.++..++.|++.||.|||+ .+|+||||||+|||++.++. +||+|||+++...
T Consensus 87 ~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 87 L-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp C-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred C-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 9 99999999864 3459999999999999999999995 89999999999999999887 9999999998764
Q ss_pred CCCCC------cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCc
Q 044561 498 HDTIP------QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAI 571 (614)
Q Consensus 498 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~ 571 (614)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.......+........
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~- 240 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP- 240 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC-
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC-
Confidence 43211 12456899999999999999999999999999999999999999987654443333322221111100
Q ss_pred cccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 572 RDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 572 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
...+...++ .+.+++..||+.||++||++.+|++
T Consensus 241 ----~~~~~~~~p-----~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 241 ----IEVLCENFP-----EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp ----HHHHTTTCH-----HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ----HHHHhccCh-----HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 001111111 6778888999999999999999863
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=373.22 Aligned_cols=250 Identities=26% Similarity=0.451 Sum_probs=204.2
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
.++|+..+.||+|+||.||+|.++++..||||++..... ..++|.+|+.++++++||||++++++|.+ +..++|||||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 456778899999999999999998888899999976543 34689999999999999999999999876 6789999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCc
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 503 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 503 (614)
++|+|.+++.......+++.+++.++.||++||.|||+ ++|+||||||+|||++.++.+||+|||+++.........
T Consensus 344 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 420 (535)
T 2h8h_A 344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 420 (535)
T ss_dssp TTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHT
T ss_pred cCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceec
Confidence 99999999976444558999999999999999999995 899999999999999999999999999998765322112
Q ss_pred ccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCc
Q 044561 504 TTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGI 582 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 582 (614)
.....++..|+|||++..+.++.++|||||||++|||++ |+.||......+... ....+....
T Consensus 421 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~-------~i~~~~~~~--------- 484 (535)
T 2h8h_A 421 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD-------QVERGYRMP--------- 484 (535)
T ss_dssp TCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHH-------HHHTTCCCC---------
T ss_pred ccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-------HHHcCCCCC---------
Confidence 223356788999999998999999999999999999999 999997654433221 112221111
Q ss_pred CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 583 CEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 583 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+....+.+.+|+.+||+.||++|||+.+|++
T Consensus 485 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 485 CPPECPESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 11122345778888999999999999999863
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=347.13 Aligned_cols=253 Identities=25% Similarity=0.362 Sum_probs=201.8
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEe------cCcEEEEEEeecCC-hhhHHHHHHHHHHhccc-CCCceeEEeeEEeecCe
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLA------SNVQIAVKKVSHDS-KQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGE 415 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 415 (614)
.++|+..+.||+|+||.||+|... .+..||+|.+.... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 467888999999999999999962 25679999997542 33456789999999999 89999999999999999
Q ss_pred EEEEEEecCCCCcchhcccCCC---------------------CCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCC
Q 044561 416 FLLVYDYMPNGSLDKILHTNIK---------------------PCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKP 474 (614)
Q Consensus 416 ~~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp 474 (614)
.++||||+++|+|.+++..... ..+++.+++.++.||+.||.|||+ .+|+||||||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp 200 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAA 200 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCh
Confidence 9999999999999999976432 238999999999999999999995 8999999999
Q ss_pred CCeEEcCCCCEEEeeeccccccCCCCC-CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 044561 475 ANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGS 552 (614)
Q Consensus 475 ~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~ 552 (614)
+|||++.++.+||+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 999999999999999999986654332 12334567889999999998999999999999999999998 9999976543
Q ss_pred cccccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 553 METVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 553 ~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+.. ......+.. ...... ....+..++.+||+.||++|||+.|+++
T Consensus 281 ~~~~------~~~~~~~~~-----~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~ 327 (344)
T 1rjb_A 281 DANF------YKLIQNGFK-----MDQPFY----ATEEIYIIMQSCWAFDSRKRPSFPNLTS 327 (344)
T ss_dssp SHHH------HHHHHTTCC-----CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHH------HHHHhcCCC-----CCCCCC----CCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 3221 111111111 111111 2345777888999999999999999873
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=341.96 Aligned_cols=257 Identities=20% Similarity=0.334 Sum_probs=202.9
Q ss_pred HHHHhcCCCCc-ceeeeeCcEEEEEEEEec-CcEEEEEEeecCC--hhhHHHHHHHHHHhcccC-CCceeEEeeEEeecC
Q 044561 340 LYKATKGFKDK-DVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS--KQGIKEFVAELVSMGRLR-HRNLVKLRGYCRRKG 414 (614)
Q Consensus 340 l~~~~~~f~~~-~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~ 414 (614)
.....+.|... +.||+|+||.||+|.... +..||+|++.... .....++.+|+.++++++ ||||+++++++...+
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~ 102 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence 33444556665 889999999999999875 8899999987542 334578899999999995 699999999999999
Q ss_pred eEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcC---CCCEEEeeec
Q 044561 415 EFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA---DLNGKLGDFG 491 (614)
Q Consensus 415 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~---~~~~kl~DfG 491 (614)
..++||||+++|+|.+++.......+++.++..++.|++.||.|||+ .+|+||||||+|||++. ++.+||+|||
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL~Dfg 179 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFG 179 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEEeeCc
Confidence 99999999999999999976655679999999999999999999995 89999999999999988 7899999999
Q ss_pred cccccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCc
Q 044561 492 LARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAI 571 (614)
Q Consensus 492 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~ 571 (614)
+++...... ......||+.|+|||++....++.++||||||+++|||++|+.||......+....+ ... ....
T Consensus 180 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i---~~~--~~~~ 252 (327)
T 3lm5_A 180 MSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI---SQV--NVDY 252 (327)
T ss_dssp GCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHT--CCCC
T ss_pred cccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHH---Hhc--cccc
Confidence 998765433 233457999999999999999999999999999999999999999765443322111 110 0000
Q ss_pred cccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 572 RDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 572 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.... .......+.+++.+||+.||++|||+.|+++
T Consensus 253 ----~~~~----~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 253 ----SEET----FSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp ----CTTT----TTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ----Cchh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 0111 1112345777888999999999999999985
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=345.66 Aligned_cols=266 Identities=21% Similarity=0.311 Sum_probs=195.3
Q ss_pred HHhcCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCCh--hhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEE
Q 044561 342 KATKGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSK--QGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLL 418 (614)
Q Consensus 342 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 418 (614)
...++|+..+.||+|+||.||+|... ++..||+|++..... ...+.+.+|+.++++++||||+++++++...+..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 34467889999999999999999976 488899999975532 234567899999999999999999999999999999
Q ss_pred EEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEc-----CCCCEEEeeeccc
Q 044561 419 VYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD-----ADLNGKLGDFGLA 493 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~-----~~~~~kl~DfGla 493 (614)
||||++ |+|.+++.... .+++.++..++.||+.||.|||+ .+|+||||||+|||++ .++.+||+|||++
T Consensus 111 v~e~~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EEECCS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EEecCC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 999997 59999987643 48999999999999999999995 8999999999999994 5556999999999
Q ss_pred cccCCCCCCcccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCc-
Q 044561 494 RLYDHDTIPQTTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAI- 571 (614)
Q Consensus 494 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~- 571 (614)
+....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+....+............
T Consensus 185 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (329)
T 3gbz_A 185 RAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP 263 (329)
T ss_dssp HHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred cccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhh
Confidence 87654321 23445789999999999874 4899999999999999999999999875543332222111111000000
Q ss_pred ------------cccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 572 ------------RDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 572 ------------~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+.....+...........+.+|+.+||+.||++|||+.|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000111110011112345778889999999999999999985
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=351.66 Aligned_cols=249 Identities=22% Similarity=0.352 Sum_probs=196.1
Q ss_pred cCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecC--ChhhHHHHHHHHHHhcccC--CCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHD--SKQGIKEFVAELVSMGRLR--HRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~lV~ 420 (614)
+.|+..+.||+|+||.||++...++..||||++... .....+.+.+|+.++++++ ||||+++++++...+.+++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 358889999999999999999888899999998754 4456678999999999996 599999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
| +.+++|.+++.... .+++.++..++.||+.||.|||+ .+|+||||||+|||++ ++.+||+|||+++......
T Consensus 136 E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp E-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred e-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 9 56899999998743 58999999999999999999994 8999999999999995 5899999999998765433
Q ss_pred C-CcccccccCCCccchhhhcC-----------CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhc
Q 044561 501 I-PQTTKLVGTFGYMDPELMRT-----------GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKK 568 (614)
Q Consensus 501 ~-~~~~~~~gt~~y~aPE~~~~-----------~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~ 568 (614)
. ......+||+.|+|||++.. ..++.++|||||||++|||++|+.||...... ..........
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~~~~~~~~~ 283 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAIIDP 283 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----HHHHHHHHCT
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----HHHHHHHhCc
Confidence 2 12344679999999999865 46899999999999999999999999754321 1111111111
Q ss_pred CCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 569 GAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 569 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.. ........ ...+.+++.+||+.||++|||+.|+++
T Consensus 284 ~~-----~~~~~~~~----~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 284 NH-----EIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp TS-----CCCCCCCS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cc-----cCCCCccc----hHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 11 01111112 235677888899999999999999985
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=356.96 Aligned_cols=246 Identities=24% Similarity=0.400 Sum_probs=203.8
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCCh---hhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSK---QGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
.+|...+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56888899999999999999987 488999999975422 23567889999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
||+++|+|.+++..+ ..+++.++..++.||+.||.||| ..+|+||||||+|||++.++++||+|||++.......
T Consensus 96 E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 96 EYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp ECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 999999999999764 45999999999999999999999 4899999999999999999999999999998765433
Q ss_pred CCcccccccCCCccchhhhcCCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMRTGKA-STSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRL 579 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~~~-t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 579 (614)
.....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||......+. .. ....+... .
T Consensus 171 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~---~~----~i~~~~~~------~ 235 (476)
T 2y94_A 171 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL---FK----KICDGIFY------T 235 (476)
T ss_dssp --CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH---HH----HHHTTCCC------C
T ss_pred --cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH---HH----HHhcCCcC------C
Confidence 2344589999999999987765 7899999999999999999999976543221 11 11122111 1
Q ss_pred cCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 580 EGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 580 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
...++ ..+.+|+.+||+.||++|||+.|+++
T Consensus 236 p~~~s----~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 236 PQYLN----PSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp CTTCC----HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CccCC----HHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 11122 34677888899999999999999975
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=333.52 Aligned_cols=248 Identities=24% Similarity=0.417 Sum_probs=182.5
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCCh---hhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSK---QGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
++|+..+.||+|+||.||+|+.. ++..||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 46888899999999999999985 588999999965422 23467899999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
||+++++|.+++... ...+++.++..++.|+++||.|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 91 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 91 EMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp ECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred ecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 999999999999764 2458999999999999999999995 899999999999999999999999999998765332
Q ss_pred CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
. ......||+.|+|||.+....++.++||||||+++|||++|+.||......+..... .. .+....
T Consensus 167 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-------~~------~~~~~~ 232 (278)
T 3cok_A 167 E-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV-------VL------ADYEMP 232 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C-------CS------SCCCCC
T ss_pred C-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH-------hh------cccCCc
Confidence 1 223357899999999998888999999999999999999999999765433221100 00 011111
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+ ...+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 233 SFL----SIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp TTS----CHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccc----CHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 222 235677888899999999999999985
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=336.75 Aligned_cols=250 Identities=24% Similarity=0.344 Sum_probs=196.2
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
++|...+.||+|+||.||++.... +..+|+|++.... ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 467888999999999999999864 8889999987653 33467889999999999999999999999999999999999
Q ss_pred cCCCCcchhcccC--CCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEE---cCCCCEEEeeeccccccC
Q 044561 423 MPNGSLDKILHTN--IKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL---DADLNGKLGDFGLARLYD 497 (614)
Q Consensus 423 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll---~~~~~~kl~DfGla~~~~ 497 (614)
+++|+|.+++... ....+++..+..++.|+++||.|||+ .+|+||||||+||++ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999988642 13459999999999999999999995 899999999999999 456889999999998765
Q ss_pred CCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccc
Q 044561 498 HDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDS 577 (614)
Q Consensus 498 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~ 577 (614)
... ......||+.|+|||.+. +.++.++||||||+++|||++|+.||......+..... . ........
T Consensus 179 ~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~---~--~~~~~~~~---- 246 (285)
T 3is5_A 179 SDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA---T--YKEPNYAV---- 246 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---H--HCCCCCCC----
T ss_pred Ccc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhh---c--cCCccccc----
Confidence 433 234457899999999985 57899999999999999999999999765432211111 0 00100000
Q ss_pred cccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 578 RLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 578 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
. .... ...+.+++.+||+.||++|||+.|+++
T Consensus 247 ~-~~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 247 E-CRPL----TPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ---CCC----CHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred c-cCcC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0111 234667888899999999999999985
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=345.60 Aligned_cols=264 Identities=23% Similarity=0.309 Sum_probs=196.7
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCChhh-HHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSKQG-IKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
++|+..+.||+|+||.||+|+.. ++..||+|++....... ...+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46888899999999999999987 48889999987543322 22456799999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 502 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 502 (614)
++ |+|.+++.... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~- 155 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 155 (324)
T ss_dssp CS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred cc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-
Confidence 97 68888887643 458999999999999999999995 8999999999999999999999999999986543321
Q ss_pred cccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccc---
Q 044561 503 QTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSR--- 578 (614)
Q Consensus 503 ~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~--- 578 (614)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+...........+.......
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence 2234578999999999876 568999999999999999999999998765544333322221111111111111100
Q ss_pred ------ccCc----CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 579 ------LEGI----CEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 579 ------l~~~----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.... ........+.+|+.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000 00112245678888999999999999999985
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=363.19 Aligned_cols=253 Identities=24% Similarity=0.322 Sum_probs=207.4
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLV 419 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 419 (614)
.++|+..+.||+|+||.||+|+.+. +..||+|++.... ......+.+|+.++++++||||+++++++.+.+.+++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 3568889999999999999999864 8899999996542 23356688999999999999999999999999999999
Q ss_pred EEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCC
Q 044561 420 YDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD 499 (614)
Q Consensus 420 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~ 499 (614)
|||+++|+|.+++.......+++..+..++.||+.||.|||+ ++|+||||||+|||++.++++||+|||+++.....
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 999999999999987655569999999999999999999995 89999999999999999999999999999876543
Q ss_pred CCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccc
Q 044561 500 TIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRL 579 (614)
Q Consensus 500 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 579 (614)
. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ ........ ..+
T Consensus 340 ~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i---~~~i~~~~------~~~ 408 (576)
T 2acx_A 340 Q--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV---ERLVKEVP------EEY 408 (576)
T ss_dssp C--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHH---HHHHHHCC------CCC
T ss_pred c--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHH---HHHhhccc------ccC
Confidence 3 233458999999999999888999999999999999999999999865432221111 11111111 111
Q ss_pred cCcCcHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHhC
Q 044561 580 EGICEEKQMELVLKLGLFCSHPKPEARP-----NMRQVMQ 614 (614)
Q Consensus 580 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 614 (614)
...+ ...+..|+.+||+.||++|| ++.||++
T Consensus 409 p~~~----s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 409 SERF----SPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp CTTS----CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred CccC----CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 1122 24567788889999999999 7888874
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=339.00 Aligned_cols=244 Identities=22% Similarity=0.369 Sum_probs=197.6
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-C-------cEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-N-------VQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEF 416 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 416 (614)
++|+..+.||+|+||.||+|.... + ..||+|.+........+.+.+|+.++++++||||+++++++...+..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 467888999999999999999765 3 46999999877777778899999999999999999999999999999
Q ss_pred EEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCC--------EEEe
Q 044561 417 LLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLN--------GKLG 488 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~--------~kl~ 488 (614)
++||||+++|+|.+++.... ..+++.++..++.|+++||.|||+ ++|+||||||+|||++.++. +||+
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred EEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccceeeec
Confidence 99999999999999998653 348999999999999999999995 89999999999999999887 9999
Q ss_pred eeccccccCCCCCCcccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhh
Q 044561 489 DFGLARLYDHDTIPQTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWK 567 (614)
Q Consensus 489 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~ 567 (614)
|||++..... .....||+.|+|||++.+ ..++.++||||||+++|||++|..|+........ ... ....
T Consensus 164 Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~--~~~---~~~~ 233 (289)
T 4fvq_A 164 DPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR--KLQ---FYED 233 (289)
T ss_dssp CCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHH---HHHT
T ss_pred cCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH--HHH---Hhhc
Confidence 9999875432 233468899999999987 6789999999999999999996555433222111 111 0111
Q ss_pred cCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 568 KGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 568 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
...... .. ...+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~--------~~----~~~l~~li~~~l~~dp~~Rps~~~ll~ 268 (289)
T 4fvq_A 234 RHQLPA--------PK----AAELANLINNCMDYEPDHRPSFRAIIR 268 (289)
T ss_dssp TCCCCC--------CS----SCTTHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cCCCCC--------CC----CHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 111111 11 123667888899999999999999974
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=334.18 Aligned_cols=247 Identities=26% Similarity=0.386 Sum_probs=204.3
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC---ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
++|...+.||+|+||.||++...+ +..+|+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 567888999999999999999875 778999998654 3445677899999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
||+++++|.+++... ..+++.++..++.|+++||.|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 95 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 95 ELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp ECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 999999999988763 358999999999999999999995 899999999999999999999999999998765332
Q ss_pred CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+... ....+.. .+.
T Consensus 170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-------~~~~~~~------~~~ 235 (294)
T 2rku_A 170 E-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL-------RIKKNEY------SIP 235 (294)
T ss_dssp C-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-------HHHTTCC------CCC
T ss_pred c-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHhhccC------CCc
Confidence 2 2334578999999999998889999999999999999999999997654322111 1111111 111
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
...+ ..+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~----~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 236 KHIN----PVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp TTSC----HHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccC----HHHHHHHHHHcccChhhCcCHHHHhh
Confidence 1222 35677888899999999999999974
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=344.98 Aligned_cols=249 Identities=26% Similarity=0.439 Sum_probs=196.1
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcE----EEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQ----IAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLL 418 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~----vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 418 (614)
++|+..+.||+|+||.||+|.+.. +.. |++|.+.... ....+.+.+|+.++++++||||++++++|. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 467888999999999999999754 333 7888775432 333456778999999999999999999986 567899
Q ss_pred EEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCC
Q 044561 419 VYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 498 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~ 498 (614)
||||+++|+|.+++... +..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++++||+|||+++....
T Consensus 92 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 99999999999999764 3459999999999999999999995 8999999999999999999999999999987754
Q ss_pred CCCC-cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCcccccc
Q 044561 499 DTIP-QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASD 576 (614)
Q Consensus 499 ~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 576 (614)
.... ......+|..|+|||++..+.++.++|||||||++|||++ |+.||......+.... ...+.....
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-------~~~~~~~~~-- 238 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL-------LEKGERLAQ-- 238 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHH-------HHTTCBCCC--
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHH-------HHcCCCCCC--
Confidence 4322 2344568889999999998999999999999999999999 9999987554332211 111111110
Q ss_pred ccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 577 SRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 577 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
...+ ...+..++.+||+.||++|||+.|+++
T Consensus 239 ---~~~~----~~~~~~li~~~l~~dp~~Rps~~el~~ 269 (325)
T 3kex_A 239 ---PQIC----TIDVYMVMVKCWMIDENIRPTFKELAN 269 (325)
T ss_dssp ---CTTB----CTTTTHHHHHHTCSCTTTSCCHHHHHH
T ss_pred ---CCcC----cHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0111 123566788899999999999999873
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=348.88 Aligned_cols=250 Identities=21% Similarity=0.273 Sum_probs=189.5
Q ss_pred cCCCCc-ceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhc-ccCCCceeEEeeEEee----cCeEE
Q 044561 345 KGFKDK-DVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMG-RLRHRNLVKLRGYCRR----KGEFL 417 (614)
Q Consensus 345 ~~f~~~-~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~-~l~H~niv~l~g~~~~----~~~~~ 417 (614)
++|... +.||+|+||+||++..+. +..||+|++... ..+.+|+.++. ..+||||+++++++.. .+.++
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 345554 689999999999999875 888999998643 34567887764 4589999999999875 66799
Q ss_pred EEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcC---CCCEEEeeecccc
Q 044561 418 LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA---DLNGKLGDFGLAR 494 (614)
Q Consensus 418 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~---~~~~kl~DfGla~ 494 (614)
+|||||++|+|.+++.......+++.++..++.||+.||.|||+ .+|+||||||+|||++. ++.+||+|||+++
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 99999999999999987655569999999999999999999995 89999999999999998 7899999999998
Q ss_pred ccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcccccc-HHHHHHHhhhcCCccc
Q 044561 495 LYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVN-LVDWVCDCWKKGAIRD 573 (614)
Q Consensus 495 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~-l~~~v~~~~~~~~~~~ 573 (614)
...... .....+||+.|+|||++....++.++|||||||++|||++|+.||......+... ....+ ..+...
T Consensus 213 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i----~~~~~~- 285 (400)
T 1nxk_A 213 ETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----RMGQYE- 285 (400)
T ss_dssp ECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH----HHTCCC-
T ss_pred ccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH----HcCccc-
Confidence 655332 2345688999999999998999999999999999999999999997654332211 11111 111111
Q ss_pred cccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 574 ASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 574 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
...+. ...+ ...+.+|+.+||+.||++|||+.|+++
T Consensus 286 ~~~~~-~~~~----s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 286 FPNPE-WSEV----SEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp CCTTT-TTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCcc-cccC----CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00000 1112 245778888999999999999999973
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=334.10 Aligned_cols=250 Identities=21% Similarity=0.309 Sum_probs=200.8
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCCh------hhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSK------QGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFL 417 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 417 (614)
++|+..+.||+|+||.||++.... +..+|+|.+..... ...+.+.+|+.++++++||||+++++++...+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 457888999999999999999874 88999999875422 13578899999999999999999999999999999
Q ss_pred EEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCC----CEEEeeeccc
Q 044561 418 LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADL----NGKLGDFGLA 493 (614)
Q Consensus 418 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~----~~kl~DfGla 493 (614)
+||||+++++|.+++... ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++ .+||+|||++
T Consensus 85 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 999999999999999763 358999999999999999999995 8999999999999998877 8999999999
Q ss_pred cccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccc
Q 044561 494 RLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRD 573 (614)
Q Consensus 494 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~ 573 (614)
....... ......||+.|+|||++....++.++||||||+++|||++|+.||......+... ........
T Consensus 160 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------~~~~~~~~- 229 (283)
T 3bhy_A 160 HKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLT-------NISAVNYD- 229 (283)
T ss_dssp EECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-------HHHTTCCC-
T ss_pred eeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHH-------HhHhcccC-
Confidence 8765432 2234578999999999998899999999999999999999999997654322111 11111100
Q ss_pred cccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 574 ASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 574 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+...... ..+.+.+++.+|++.||++|||+.|+++
T Consensus 230 -~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 230 -FDEEYFSN----TSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp -CCHHHHTT----CCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -Ccchhccc----CCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 01111111 2345778888999999999999999874
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=331.27 Aligned_cols=246 Identities=26% Similarity=0.411 Sum_probs=198.0
Q ss_pred CCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEee----cCeEEE
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRR----KGEFLL 418 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~l 418 (614)
.|+..+.||+|+||.||+|.... +..||+|.+... .....+.+.+|+.++++++||||+++++++.. ...+++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 36677789999999999999865 778999998754 45556789999999999999999999998865 456899
Q ss_pred EEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCc--eEecCcCCCCeEEc-CCCCEEEeeeccccc
Q 044561 419 VYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQV--VLHRDIKPANVLLD-ADLNGKLGDFGLARL 495 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDikp~NIll~-~~~~~kl~DfGla~~ 495 (614)
||||+++++|.+++... ..+++..+..++.|++.||.|||+ .+ |+||||||+||+++ .++.+||+|||++..
T Consensus 107 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 99999999999999763 348999999999999999999995 66 99999999999998 789999999999976
Q ss_pred cCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccc
Q 044561 496 YDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDAS 575 (614)
Q Consensus 496 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~ 575 (614)
..... .....||+.|+|||++. +.++.++||||||+++|||++|+.||........ .......+....
T Consensus 182 ~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------~~~~~~~~~~~~-- 249 (290)
T 1t4h_A 182 KRASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------IYRRVTSGVKPA-- 249 (290)
T ss_dssp CCTTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH------HHHHHTTTCCCG--
T ss_pred ccccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH------HHHHHhccCCcc--
Confidence 54432 33457999999999886 4689999999999999999999999976433221 111112221111
Q ss_pred cccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 576 DSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 576 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
...... ...+.+++.+||+.||++|||+.|+++
T Consensus 250 --~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 250 --SFDKVA----IPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --GGGGCC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --ccCCCC----CHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 111112 235778888999999999999999985
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=344.19 Aligned_cols=264 Identities=24% Similarity=0.386 Sum_probs=200.8
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC--hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS--KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 421 (614)
++|+..+.||+|+||.||+|.... +..||+|++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 568888999999999999999875 8899999986543 3345678899999999999999999999999999999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCC
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI 501 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~ 501 (614)
|+++++|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 105 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 105 FVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp CCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred cCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 99999998887653 349999999999999999999995 8999999999999999999999999999986554321
Q ss_pred CcccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHH--------HHhhhcCC-c
Q 044561 502 PQTTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWV--------CDCWKKGA-I 571 (614)
Q Consensus 502 ~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v--------~~~~~~~~-~ 571 (614)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+....+... ...+.... .
T Consensus 180 -~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 180 -VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred -ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 22345789999999999775 7899999999999999999999999876543332211110 11111110 0
Q ss_pred cccccccccCcCc-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 572 RDASDSRLEGICE-----EKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 572 ~~~~d~~l~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.....+.+....+ ....+.+.+++.+||+.||++|||+.|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0111111111111 122456888899999999999999999985
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=340.78 Aligned_cols=247 Identities=26% Similarity=0.386 Sum_probs=204.0
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC---ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
++|...+.||+|+||.||++...+ +..+|+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 457778999999999999999875 778999998654 3445677899999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
||+++++|.+++... ..+++.++..++.|+++||.|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 121 e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 121 ELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp CCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred ecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 999999999988763 358999999999999999999995 899999999999999999999999999998765332
Q ss_pred CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+... ....+.. .+.
T Consensus 196 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-------~~~~~~~------~~~ 261 (335)
T 2owb_A 196 E-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL-------RIKKNEY------SIP 261 (335)
T ss_dssp C-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-------HHHHTCC------CCC
T ss_pred c-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHH-------HHhcCCC------CCC
Confidence 2 2334579999999999998889999999999999999999999997654322111 1111111 111
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..++ ..+.+++.+||+.||++|||+.|+++
T Consensus 262 ~~~~----~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 262 KHIN----PVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp TTSC----HHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1222 34667888899999999999999974
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=347.96 Aligned_cols=201 Identities=26% Similarity=0.424 Sum_probs=176.5
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
++|+..+.||+|+||.||++.... +..||+|++... .....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 568888999999999999999874 888999998765 344567899999999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 502 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 502 (614)
+++++|.+++... ..+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++++||+|||++.......
T Consensus 113 ~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 186 (360)
T 3eqc_A 113 MDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 186 (360)
T ss_dssp CTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC--
T ss_pred CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--hCCEEcCCccHHHEEECCCCCEEEEECCCCccccccc--
Confidence 9999999999764 348999999999999999999995 2389999999999999999999999999997553221
Q ss_pred cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCc
Q 044561 503 QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGS 552 (614)
Q Consensus 503 ~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~ 552 (614)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 187 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 235 (360)
T 3eqc_A 187 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235 (360)
T ss_dssp -----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCH
T ss_pred -ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 2335789999999999999999999999999999999999999976543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=333.41 Aligned_cols=250 Identities=26% Similarity=0.435 Sum_probs=198.5
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec----CcEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS----NVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLL 418 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 418 (614)
.++|+..+.||+|+||.||+|.... +..||+|.+... .....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4578888999999999999999754 235999998765 34456789999999999999999999999865 45689
Q ss_pred EEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCC
Q 044561 419 VYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 498 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~ 498 (614)
||||+++++|.+++... ...+++.++..++.|+++||.|||+ .+|+||||||+||+++.++.+||+|||++.....
T Consensus 90 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 90 IMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 99999999999999764 2458999999999999999999995 8999999999999999999999999999987655
Q ss_pred CCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccc
Q 044561 499 DTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDS 577 (614)
Q Consensus 499 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~ 577 (614)
..........+|+.|+|||.+....++.++||||||+++|||++ |+.||......+.. ..+. .+....
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~---~~~~----~~~~~~---- 234 (281)
T 3cc6_A 166 EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI---GVLE----KGDRLP---- 234 (281)
T ss_dssp -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH---HHHH----HTCCCC----
T ss_pred ccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHH---HHHh----cCCCCC----
Confidence 44333344567889999999998899999999999999999998 99999765443322 1111 111110
Q ss_pred cccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 578 RLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 578 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
....+ .+.+.+++.+||+.||++|||+.|+++
T Consensus 235 -~~~~~----~~~l~~li~~~l~~~p~~Rps~~ell~ 266 (281)
T 3cc6_A 235 -KPDLC----PPVLYTLMTRCWDYDPSDRPRFTELVC 266 (281)
T ss_dssp -CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CCCCC----CHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 11112 245778888999999999999999873
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=331.40 Aligned_cols=251 Identities=26% Similarity=0.429 Sum_probs=198.7
Q ss_pred CCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecC
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMP 424 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 424 (614)
++.....||+|+||.||+|.... +..||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 45566799999999999999754 78899999987766667889999999999999999999999999999999999999
Q ss_pred CCCcchhcccCC-CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcC-CCCEEEeeeccccccCCCCCC
Q 044561 425 NGSLDKILHTNI-KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA-DLNGKLGDFGLARLYDHDTIP 502 (614)
Q Consensus 425 ~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~-~~~~kl~DfGla~~~~~~~~~ 502 (614)
+++|.+++.... ...+++..+..++.|++.||.|||+ .+|+||||||+||+++. ++.+||+|||++....... .
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-~ 178 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-P 178 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCC-C
Confidence 999999997643 2346788999999999999999995 89999999999999988 8999999999998765432 1
Q ss_pred cccccccCCCccchhhhcCCC--CCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 503 QTTKLVGTFGYMDPELMRTGK--ASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 503 ~~~~~~gt~~y~aPE~~~~~~--~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
......||+.|+|||++.... ++.++||||||+++|||++|+.||......+.. .... ... ...+.+.
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~-~~~-------~~~~~~~ 248 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA--MFKV-GMF-------KVHPEIP 248 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH--HHHH-HHH-------CCCCCCC
T ss_pred cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH--HHhh-ccc-------ccccccc
Confidence 233457899999999987643 789999999999999999999999654322211 0000 000 0111122
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+ ...+.+++.+||+.||++|||+.|+++
T Consensus 249 ~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 249 ESM----SAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp TTS----CHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ccC----CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 222 345677888899999999999999985
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=353.40 Aligned_cols=241 Identities=16% Similarity=0.154 Sum_probs=188.9
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecC---ChhhHHHHHHHH---HHhcccCCCceeEEe-------eE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHD---SKQGIKEFVAEL---VSMGRLRHRNLVKLR-------GY 409 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei---~~l~~l~H~niv~l~-------g~ 409 (614)
.++|+..+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+ .++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 356788899999999999999975 4889999999743 344567889999 566666899999998 55
Q ss_pred EeecC-----------------eEEEEEEecCCCCcchhcccCC-----CCCcChhHHHHHHHHhHhhchhhhccCCCce
Q 044561 410 CRRKG-----------------EFLLVYDYMPNGSLDKILHTNI-----KPCLNWYQRFRIIRGVASGLLYLHEDWEQVV 467 (614)
Q Consensus 410 ~~~~~-----------------~~~lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 467 (614)
+...+ ..++||||+ +|+|.+++.... ...+++..++.|+.||+.||.|||+ .+|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 55443 289999999 689999997532 1234568899999999999999995 899
Q ss_pred EecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcccccccCCCccchhhhcCC-----------CCCcchhHHHHHHH
Q 044561 468 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTG-----------KASTSTDVYAFGVF 536 (614)
Q Consensus 468 vHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~t~~~Dv~S~Gvl 536 (614)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++... .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999986433 2344577 999999999877 89999999999999
Q ss_pred HHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 537 MLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 537 l~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+|||++|+.||......+....+ .. . ...++ ..+.+++.+||+.||++|||+.|+++
T Consensus 303 l~elltg~~Pf~~~~~~~~~~~~---------------~~-~-~~~~~----~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGSEWI---------------FR-S-CKNIP----QPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHSSCCC------CCSGGG---------------GS-S-CCCCC----HHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHCCCCCcccccccchhhh---------------hh-h-ccCCC----HHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999765433322111 00 0 01222 35677888899999999999999985
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=334.23 Aligned_cols=247 Identities=25% Similarity=0.525 Sum_probs=196.8
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCChhh-------HHHHHHHHHHhcccCCCceeEEeeEEeecCeE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSKQG-------IKEFVAELVSMGRLRHRNLVKLRGYCRRKGEF 416 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 416 (614)
++|+..+.||+|+||.||+|+.. ++..||+|++....... .+.+.+|+.++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 57888899999999999999986 48889999986543211 167899999999999999999999987665
Q ss_pred EEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCc--eEecCcCCCCeEEcCCCC-----EEEee
Q 044561 417 LLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQV--VLHRDIKPANVLLDADLN-----GKLGD 489 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDikp~NIll~~~~~-----~kl~D 489 (614)
++||||+++|+|.+++... ...+++..+..++.|++.||.|||+ .+ |+||||||+||+++.++. +||+|
T Consensus 97 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 6999999999999888664 3459999999999999999999995 67 999999999999988776 99999
Q ss_pred eccccccCCCCCCcccccccCCCccchhhhc--CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhh
Q 044561 490 FGLARLYDHDTIPQTTKLVGTFGYMDPELMR--TGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWK 567 (614)
Q Consensus 490 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~ 567 (614)
||+++.... ......||+.|+|||.+. ...++.++|||||||++|||++|+.||......+.. ...... .
T Consensus 173 fg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~---~ 244 (287)
T 4f0f_A 173 FGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK-FINMIR---E 244 (287)
T ss_dssp CTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH-HHHHHH---H
T ss_pred CCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH-HHHHHh---c
Confidence 999985433 234457999999999983 456789999999999999999999999765443221 111111 1
Q ss_pred cCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 568 KGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 568 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+ . .+.+...+ ...+.+++.+||+.||++|||+.|+++
T Consensus 245 ~~-~----~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 245 EG-L----RPTIPEDC----PPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp SC-C----CCCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cC-C----CCCCCccc----CHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 11 1 11111222 345778888899999999999999974
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=331.99 Aligned_cols=247 Identities=26% Similarity=0.469 Sum_probs=204.7
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
+.|+..+.||+|+||.||+|.... +..||+|.+.... ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 457888999999999999999764 8889999997553 34567899999999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 502 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 502 (614)
+++++|.+++.. ..+++.++..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 102 ~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 174 (303)
T 3a7i_A 102 LGGGSALDLLEP---GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 174 (303)
T ss_dssp CTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-
T ss_pred CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCcccc-
Confidence 999999999865 348999999999999999999995 8999999999999999999999999999987654332
Q ss_pred cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCc
Q 044561 503 QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGI 582 (614)
Q Consensus 503 ~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 582 (614)
......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.. ..+ .++. .+.+...
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~----~~~~-----~~~~~~~ 242 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL---FLI----PKNN-----PPTLEGN 242 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HHH----HHSC-----CCCCCSS
T ss_pred ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHH---HHh----hcCC-----CCCCccc
Confidence 223457899999999999989999999999999999999999999764432211 111 1111 1112222
Q ss_pred CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 583 CEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 583 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
++ ..+.+++.+||+.||++|||+.|+++
T Consensus 243 ~~----~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 243 YS----KPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp CC----HHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cC----HHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 33 34777888899999999999999985
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=342.58 Aligned_cols=259 Identities=22% Similarity=0.301 Sum_probs=197.2
Q ss_pred cCCCC-cceeeeeCcEEEEEEEEe-cCcEEEEEEeecCChhhHHHHHHHHHHhccc-CCCceeEEeeEEeecCeEEEEEE
Q 044561 345 KGFKD-KDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 345 ~~f~~-~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 421 (614)
+.|+. .+.||+|+||.||+|... ++..||+|++........+.+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 45665 378999999999999975 4889999999877666677889999999885 79999999999999999999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCC---EEEeeeccccccCC
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLN---GKLGDFGLARLYDH 498 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~---~kl~DfGla~~~~~ 498 (614)
|+++|+|.+++... ..+++.++..++.||+.||.|||+ .+|+||||||+|||++.++. +||+|||++.....
T Consensus 92 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 92 KMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp CCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred cCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 99999999999764 358999999999999999999995 89999999999999998776 99999999976542
Q ss_pred CC------CCcccccccCCCccchhhhcC-----CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccH--------H
Q 044561 499 DT------IPQTTKLVGTFGYMDPELMRT-----GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNL--------V 559 (614)
Q Consensus 499 ~~------~~~~~~~~gt~~y~aPE~~~~-----~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l--------~ 559 (614)
.. ........||+.|+|||++.. ..++.++|||||||++|||++|+.||......+.... .
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 21 112233569999999999875 4578999999999999999999999976543221100 0
Q ss_pred HHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 560 DWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 560 ~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
....+...++... ..+. .... ....+.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~i~~~~~~-~~~~-~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 247 NMLFESIQEGKYE-FPDK-DWAH----ISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHCCCC-CCHH-HHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHhccCcc-cCch-hccc----CCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 1111122222110 0000 0011 1245778888999999999999999974
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=342.49 Aligned_cols=251 Identities=20% Similarity=0.306 Sum_probs=199.0
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhccc-CCCceeEEeeEEeecCeEEEEEE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 421 (614)
.++|+..+.||+|+||.||++..+. +..||+|.+...... ..+|++++.++ +||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 4568888999999999999999875 888999999765432 34678888777 79999999999999999999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCC----CCEEEeeeccccccC
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDAD----LNGKLGDFGLARLYD 497 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~----~~~kl~DfGla~~~~ 497 (614)
||++|+|.+++... ..+++.++..++.||+.||.|||+ .+|+||||||+|||+..+ +.+||+|||+++...
T Consensus 97 ~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 97 LMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp CCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 99999999998764 359999999999999999999995 899999999999998543 359999999998765
Q ss_pred CCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccc
Q 044561 498 HDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDS 577 (614)
Q Consensus 498 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~ 577 (614)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..........+. .....+.... ..
T Consensus 172 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~----~~i~~~~~~~--~~ 244 (342)
T 2qr7_A 172 AENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL----ARIGSGKFSL--SG 244 (342)
T ss_dssp CTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHH----HHHHHCCCCC--CS
T ss_pred CCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHH----HHHccCCccc--Cc
Confidence 4332 234458999999999998877899999999999999999999999764322222222 2222222211 11
Q ss_pred cccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 578 RLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 578 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..... ....+.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~~~----~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 245 GYWNS----VSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp TTTTT----SCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ccccc----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11111 2345677888899999999999999975
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=338.42 Aligned_cols=247 Identities=29% Similarity=0.482 Sum_probs=191.8
Q ss_pred cCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecC
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMP 424 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 424 (614)
++|+..+.||+|+||.||+|+.. +..||+|++.... ..+.+.+|+.++++++||||+++++++.+ ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 46778899999999999999875 6789999986543 45788999999999999999999998873 4799999999
Q ss_pred CCCcchhcccCCC-CCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCC-EEEeeeccccccCCCCCC
Q 044561 425 NGSLDKILHTNIK-PCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLN-GKLGDFGLARLYDHDTIP 502 (614)
Q Consensus 425 ~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~-~kl~DfGla~~~~~~~~~ 502 (614)
+|+|.+++..... ..+++.+++.++.|+++||.|||+...++|+||||||+||+++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999986532 34788999999999999999999643378999999999999998887 799999999765432
Q ss_pred cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCc
Q 044561 503 QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGI 582 (614)
Q Consensus 503 ~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 582 (614)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||........ ...+.. ..+.. +.....
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~~~~~-~~~~~-----~~~~~~ 228 (307)
T 2eva_A 160 -MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF----RIMWAV-HNGTR-----PPLIKN 228 (307)
T ss_dssp ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH----HHHHHH-HTTCC-----CCCBTT
T ss_pred -cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH----HHHHHH-hcCCC-----CCcccc
Confidence 2334689999999999998999999999999999999999999975433211 111111 11111 111122
Q ss_pred CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 583 CEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 583 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
++ ..+.+++.+||+.||++|||+.|+++
T Consensus 229 ~~----~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 229 LP----KPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp CC----HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cC----HHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 22 35677888999999999999999873
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=342.03 Aligned_cols=252 Identities=26% Similarity=0.437 Sum_probs=203.5
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEe--------cCcEEEEEEeecC-ChhhHHHHHHHHHHhccc-CCCceeEEeeEEeec
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLA--------SNVQIAVKKVSHD-SKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRK 413 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 413 (614)
.++|+..+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.+++++ +||||++++++|...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 357888899999999999999873 3677999999765 344567899999999999 899999999999999
Q ss_pred CeEEEEEEecCCCCcchhcccCCC--------------CCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEE
Q 044561 414 GEFLLVYDYMPNGSLDKILHTNIK--------------PCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL 479 (614)
Q Consensus 414 ~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll 479 (614)
+..++||||+++|+|.+++..... ..+++.+++.++.||++||.|||+ .+|+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEE
Confidence 999999999999999999976432 248999999999999999999995 899999999999999
Q ss_pred cCCCCEEEeeeccccccCCCCC-CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcccccc
Q 044561 480 DADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVN 557 (614)
Q Consensus 480 ~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~ 557 (614)
+.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+..
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~- 269 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF- 269 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH-
Confidence 9999999999999987654322 12233457889999999988889999999999999999999 99999765433221
Q ss_pred HHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 558 LVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 558 l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.....+... .....+ ...+.+++.+||+.||++|||+.|+++
T Consensus 270 ------~~~~~~~~~-----~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~ 311 (334)
T 2pvf_A 270 ------KLLKEGHRM-----DKPANC----TNELYMMMRDCWHAVPSQRPTFKQLVE 311 (334)
T ss_dssp ------HHHHHTCCC-----CCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------HHHhcCCCC-----CCCccC----CHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 111121111 111122 245777888899999999999999874
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=328.44 Aligned_cols=252 Identities=25% Similarity=0.365 Sum_probs=202.9
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 421 (614)
.++|+..+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 356888899999999999999987 48899999986543 3445778999999999999999999999999999999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC-
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT- 500 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~- 500 (614)
|+++++|.+++... ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 86 YCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp CCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred ecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 99999999999764 358999999999999999999995 899999999999999999999999999998654322
Q ss_pred CCcccccccCCCccchhhhcCCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMRTGKA-STSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRL 579 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~~~-t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 579 (614)
........||+.|+|||.+....+ +.++||||||+++|||++|+.||........ ....+ ....... ..
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~-----~~~~~~~----~~ 230 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDW-----KEKKTYL----NP 230 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHH-----HTTCTTS----TT
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHh-----hhccccc----Cc
Confidence 112344578999999999987665 7899999999999999999999976543221 11111 1111000 00
Q ss_pred cCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 580 EGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 580 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.... ...+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~----~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 231 WKKI----DSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp GGGS----CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhc----CHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 1112 234677888899999999999999985
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=331.74 Aligned_cols=245 Identities=23% Similarity=0.361 Sum_probs=202.5
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
++|+..+.||+|+||.||+|.... +..||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 468888999999999999999875 7789999986542 223467889999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
||+++++|.+++... ..+++.++..++.|+++||.||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 94 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (284)
T 2vgo_A 94 EFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR 168 (284)
T ss_dssp CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred EeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence 999999999999764 34899999999999999999999 4899999999999999999999999999997654322
Q ss_pred CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
.....|++.|+|||++.+..++.++||||||+++|||++|+.||......+... ...... ..+.
T Consensus 169 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-------~~~~~~------~~~~ 232 (284)
T 2vgo_A 169 ---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHR-------RIVNVD------LKFP 232 (284)
T ss_dssp ---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-------HHHTTC------CCCC
T ss_pred ---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHH-------HHhccc------cCCC
Confidence 234578999999999999899999999999999999999999997654322111 111111 1111
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
...+ ..+.+++.+|++.||++|||+.|+++
T Consensus 233 ~~~~----~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 233 PFLS----DGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp TTSC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CcCC----HHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 2222 35677888899999999999999985
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=346.38 Aligned_cols=257 Identities=23% Similarity=0.349 Sum_probs=205.2
Q ss_pred cCCCCcceeeeeCcEEEEEEEE-----ecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEe--ecCeEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVL-----ASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCR--RKGEFL 417 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~--~~~~~~ 417 (614)
++|+..+.||+|+||.||++++ ..+..||+|++........+.+.+|+.++++++||||+++++++. ..+..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5678889999999999999984 247889999998887777788999999999999999999999886 456799
Q ss_pred EEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccC
Q 044561 418 LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYD 497 (614)
Q Consensus 418 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~ 497 (614)
+||||+++++|.+++.... ..+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++....
T Consensus 103 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred EEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 9999999999999997632 348999999999999999999995 899999999999999999999999999998765
Q ss_pred CCCCC--cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccc--------cccHHHHHHHhhh
Q 044561 498 HDTIP--QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSME--------TVNLVDWVCDCWK 567 (614)
Q Consensus 498 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~--------~~~l~~~v~~~~~ 567 (614)
..... ......||..|+|||++.+..++.++||||||+++|||++|+.||....... .......+.+...
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE 258 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHH
T ss_pred cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhh
Confidence 43321 2233467888999999998889999999999999999999999986432110 0011111112111
Q ss_pred cCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 568 KGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 568 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+.. ...+....+.+.+++.+||++||++|||+.|+++
T Consensus 259 ~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 296 (327)
T 3lxl_A 259 EGQR---------LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGP 296 (327)
T ss_dssp TTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccC---------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1111 1112223345778888999999999999999963
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=332.12 Aligned_cols=249 Identities=27% Similarity=0.391 Sum_probs=200.7
Q ss_pred cCCCCcc-eeeeeCcEEEEEEEEe---cCcEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEE
Q 044561 345 KGFKDKD-VIGRGGFGKVYRGVLA---SNVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLV 419 (614)
Q Consensus 345 ~~f~~~~-~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 419 (614)
++|...+ .||+|+||.||+|... .+..||+|.+... .....+++.+|+.++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 3444555 8999999999999864 4778999999765 445667899999999999999999999999 56679999
Q ss_pred EEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCC
Q 044561 420 YDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD 499 (614)
Q Consensus 420 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~ 499 (614)
|||+++++|.+++... ...+++.++..++.|+++||.|||+ .+|+||||||+||+++.++.+||+|||++......
T Consensus 88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 9999999999999753 3459999999999999999999995 89999999999999999999999999999876543
Q ss_pred CCC--cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCcccccc
Q 044561 500 TIP--QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASD 576 (614)
Q Consensus 500 ~~~--~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 576 (614)
... ......+|+.|+|||++....++.++||||||+++|||++ |+.||......+.. . ....+...
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~----~i~~~~~~---- 232 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM---A----FIEQGKRM---- 232 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH---H----HHHTTCCC----
T ss_pred cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH---H----HHhcCCcC----
Confidence 321 1223456889999999988889999999999999999998 99999765543322 1 11122111
Q ss_pred ccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 577 SRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 577 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.. +......+.+++.+||+.||++||++.|+++
T Consensus 233 -~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 265 (287)
T 1u59_A 233 -EC----PPECPPELYALMSDCWIYKWEDRPDFLTVEQ 265 (287)
T ss_dssp -CC----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred -CC----CCCcCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11 1122346778888999999999999999874
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=348.32 Aligned_cols=264 Identities=24% Similarity=0.322 Sum_probs=207.1
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeecC--eEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKG--EFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV~ 420 (614)
++|+..+.||+|+||.||+|.... +..||+|++.... ....+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 467888999999999999999875 8899999997543 234567889999999999999999999998765 789999
Q ss_pred EecCCCCcchhcccCCC-CCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEE----cCCCCEEEeeeccccc
Q 044561 421 DYMPNGSLDKILHTNIK-PCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL----DADLNGKLGDFGLARL 495 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll----~~~~~~kl~DfGla~~ 495 (614)
||+++|+|.+++..... ..+++.+++.++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 99999999999976432 339999999999999999999995 899999999999999 7888899999999987
Q ss_pred cCCCCCCcccccccCCCccchhhhcC--------CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcccc-ccHHHHHHHhh
Q 044561 496 YDHDTIPQTTKLVGTFGYMDPELMRT--------GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMET-VNLVDWVCDCW 566 (614)
Q Consensus 496 ~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~-~~l~~~v~~~~ 566 (614)
..... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||........ ......+....
T Consensus 166 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 243 (396)
T 4eut_A 166 LEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (396)
T ss_dssp CCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSC
T ss_pred ccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCC
Confidence 65433 2334579999999999864 4678899999999999999999999975443222 11221121111
Q ss_pred hcCCccccc-----------cccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHh
Q 044561 567 KKGAIRDAS-----------DSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVM 613 (614)
Q Consensus 567 ~~~~~~~~~-----------d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 613 (614)
....+.... +..............+..++.+||+.||++||++.|++
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l 301 (396)
T 4eut_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF 301 (396)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHH
T ss_pred CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHH
Confidence 111111000 00111234567778899999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=341.65 Aligned_cols=264 Identities=25% Similarity=0.318 Sum_probs=198.2
Q ss_pred HHhcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChh-----hHHHHHHHHHHhcccCCCceeEEeeEEeecCe
Q 044561 342 KATKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQ-----GIKEFVAELVSMGRLRHRNLVKLRGYCRRKGE 415 (614)
Q Consensus 342 ~~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 415 (614)
...++|+..+.||+|+||.||+|.... +..||+|++...... ..+.+.+|+.++++++||||+++++++...+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 345689999999999999999999865 889999998653221 12467899999999999999999999999999
Q ss_pred EEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccc
Q 044561 416 FLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARL 495 (614)
Q Consensus 416 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~ 495 (614)
.++||||+++ +|.+++... ...+++.++..++.|+++||.|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred eEEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 9999999975 888888654 3458999999999999999999995 8999999999999999999999999999987
Q ss_pred cCCCCCCcccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhc---CCc
Q 044561 496 YDHDTIPQTTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKK---GAI 571 (614)
Q Consensus 496 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~---~~~ 571 (614)
..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+... .+.+.... ..+
T Consensus 162 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~---~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 162 FGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT---RIFETLGTPTEEQW 237 (346)
T ss_dssp TTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHHHCCCCTTTS
T ss_pred ccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHH---HHHHHcCCCChhhh
Confidence 65432 223445789999999998754 58999999999999999999999997655433222 22221111 111
Q ss_pred cccc---cc---cccCcCc-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 572 RDAS---DS---RLEGICE-----EKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 572 ~~~~---d~---~l~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+.. +. ......+ ......+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 1100 00 0000001 112356788889999999999999999985
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=347.29 Aligned_cols=264 Identities=23% Similarity=0.293 Sum_probs=198.1
Q ss_pred HHHhcCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeec------
Q 044561 341 YKATKGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRK------ 413 (614)
Q Consensus 341 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------ 413 (614)
....++|+..+.||+|+||.||+|... ++..||+|++..+... ..+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 345678999999999999999999975 4889999999765432 24799999999999999999998443
Q ss_pred --------------------------------CeEEEEEEecCCCCcchhccc--CCCCCcChhHHHHHHHHhHhhchhh
Q 044561 414 --------------------------------GEFLLVYDYMPNGSLDKILHT--NIKPCLNWYQRFRIIRGVASGLLYL 459 (614)
Q Consensus 414 --------------------------------~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yL 459 (614)
..+++||||++ |+|.+.+.. .....+++..+..++.||++||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34899999997 587777653 2235699999999999999999999
Q ss_pred hccCCCceEecCcCCCCeEEc-CCCCEEEeeeccccccCCCCCCcccccccCCCccchhhhcCC-CCCcchhHHHHHHHH
Q 044561 460 HEDWEQVVLHRDIKPANVLLD-ADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFM 537 (614)
Q Consensus 460 H~~~~~~ivHrDikp~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll 537 (614)
| ..+|+||||||+|||++ .++.+||+|||+++...... ......||+.|+|||++.+. .++.++||||+||++
T Consensus 158 H---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 158 H---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp H---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred H---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 9 48999999999999998 68899999999998765433 23345789999999998765 489999999999999
Q ss_pred HHHHcCCCCCCCCCccccccHHHHHHHh------------hhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCC
Q 044561 538 LEVASGRRPVEQQGSMETVNLVDWVCDC------------WKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEA 605 (614)
Q Consensus 538 ~el~tg~~p~~~~~~~~~~~l~~~v~~~------------~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~ 605 (614)
|||++|+.||......+....+...... +.+-.+...........++......+.+|+.+||+.||++
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 9999999999876544433222111000 0000111111111111122223455788889999999999
Q ss_pred CCCHHHHhC
Q 044561 606 RPNMRQVMQ 614 (614)
Q Consensus 606 RPs~~evl~ 614 (614)
|||+.|+++
T Consensus 313 R~t~~e~l~ 321 (383)
T 3eb0_A 313 RINPYEAMA 321 (383)
T ss_dssp SCCHHHHHT
T ss_pred CCCHHHHhc
Confidence 999999985
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=346.26 Aligned_cols=268 Identities=21% Similarity=0.288 Sum_probs=201.1
Q ss_pred CHHHHHHHhcCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCC-----------hhhHHHHHHHHHHhcccCCCcee
Q 044561 336 TYKDLYKATKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDS-----------KQGIKEFVAELVSMGRLRHRNLV 404 (614)
Q Consensus 336 ~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~Ei~~l~~l~H~niv 404 (614)
..+++....++|+..+.||+|+||.||+|...++..||+|++.... ....+.+.+|+.++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 4567788889999999999999999999998889999999985432 22347889999999999999999
Q ss_pred EEeeEEee-----cCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEE
Q 044561 405 KLRGYCRR-----KGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL 479 (614)
Q Consensus 405 ~l~g~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll 479 (614)
++++++.. ...+++||||++ |+|.+++... ...+++.++..++.||+.||.|||+ .+|+||||||+|||+
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILL 167 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEEE
Confidence 99999844 346899999997 6888887754 3459999999999999999999995 899999999999999
Q ss_pred cCCCCEEEeeeccccccCCCCCCcccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccH
Q 044561 480 DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNL 558 (614)
Q Consensus 480 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l 558 (614)
+.++.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 245 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK 245 (362)
T ss_dssp CTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred cCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 999999999999998544332 2344578999999999876 6789999999999999999999999987554332222
Q ss_pred HHHHHHhhhcC-------------------CccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 559 VDWVCDCWKKG-------------------AIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 559 ~~~v~~~~~~~-------------------~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+ .+..... .......... ..........+.+|+.+||+.||++|||+.|+++
T Consensus 246 i---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 246 I---VEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAW-TAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp H---HHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCH-HHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H---HHHcCCCChHHhhhccchhhhHHHHhhcccCChhhH-HhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 1 1111100 0000000000 0011112345778889999999999999999985
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=339.56 Aligned_cols=250 Identities=28% Similarity=0.517 Sum_probs=195.1
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-----CcEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-----NVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLL 418 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 418 (614)
++|+..+.||+|+||.||+|..+. +..||+|.+... .......+.+|+.++++++||||+++++++...+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 355667899999999999999764 235999999765 34455678999999999999999999999999999999
Q ss_pred EEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCC
Q 044561 419 VYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 498 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~ 498 (614)
||||+++|+|.+++... ...+++.+++.++.|+++||.|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 124 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 124 ITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 99999999999999764 3459999999999999999999995 8999999999999999999999999999987654
Q ss_pred CCCC--cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccc
Q 044561 499 DTIP--QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDAS 575 (614)
Q Consensus 499 ~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~ 575 (614)
.... ......+|+.|+|||.+....++.++||||||+++|||++ |+.||......+.. ....++....
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~-------~~~~~~~~~~-- 270 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM-------KAINDGFRLP-- 270 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-------HHHHTTCCCC--
T ss_pred ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHH-------HHHHCCCcCC--
Confidence 3211 1222346788999999999999999999999999999999 99999765432211 1112221110
Q ss_pred cccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 576 DSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 576 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
... .....+.+++.+||+.||++||++.|+++
T Consensus 271 ---~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 302 (333)
T 1mqb_A 271 ---TPM----DCPSAIYQLMMQCWQQERARRPKFADIVS 302 (333)
T ss_dssp ---CCT----TCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ---Ccc----cCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 111 12345778888999999999999999863
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=334.93 Aligned_cols=268 Identities=24% Similarity=0.323 Sum_probs=205.9
Q ss_pred cCHHHHHHHhcCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcc--cCCCceeEEeeEEee
Q 044561 335 FTYKDLYKATKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGR--LRHRNLVKLRGYCRR 412 (614)
Q Consensus 335 ~~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~ 412 (614)
....--....++|+..+.||+|+||.||+|+. .++.||+|++.... .+.+.+|.+++.. ++||||+++++++..
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 34444445567899999999999999999998 48899999986543 3566778888776 789999999999987
Q ss_pred cC----eEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccC-----CCceEecCcCCCCeEEcCCC
Q 044561 413 KG----EFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDW-----EQVVLHRDIKPANVLLDADL 483 (614)
Q Consensus 413 ~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDikp~NIll~~~~ 483 (614)
.+ ..++||||+++|+|.+++... .+++.+++.++.|++.||.|||+.. +.+|+||||||+|||++.++
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~ 184 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 184 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS
T ss_pred cCCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC
Confidence 76 899999999999999999763 4899999999999999999999321 37999999999999999999
Q ss_pred CEEEeeeccccccCCCCCC---cccccccCCCccchhhhcCCC------CCcchhHHHHHHHHHHHHcC----------C
Q 044561 484 NGKLGDFGLARLYDHDTIP---QTTKLVGTFGYMDPELMRTGK------ASTSTDVYAFGVFMLEVASG----------R 544 (614)
Q Consensus 484 ~~kl~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~t~~~Dv~S~Gvll~el~tg----------~ 544 (614)
++||+|||++......... ......||+.|+|||++.... ++.++|||||||++|||++| +
T Consensus 185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 264 (342)
T 1b6c_B 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264 (342)
T ss_dssp CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence 9999999999876544321 223457999999999997652 33689999999999999999 7
Q ss_pred CCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 545 RPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 545 ~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.||......+.. . ....+.............+ ....+....+.+++.+||+.||++|||+.||++
T Consensus 265 ~p~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~ 329 (342)
T 1b6c_B 265 LPYYDLVPSDPS-V-EEMRKVVCEQKLRPNIPNR---WQSCEALRVMAKIMRECWYANGAARLTALRIKK 329 (342)
T ss_dssp CTTTTTSCSSCC-H-HHHHHHHTTSCCCCCCCGG---GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cCccccCcCccc-H-HHHHHHHHHHHhCCCCccc---ccchhHHHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 787654332211 1 1112222121111111111 123456778999999999999999999999874
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=345.21 Aligned_cols=260 Identities=20% Similarity=0.222 Sum_probs=199.7
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec------CcEEEEEEeecCChhhH-----------HHHHHHHHHhcccCCCceeEE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS------NVQIAVKKVSHDSKQGI-----------KEFVAELVSMGRLRHRNLVKL 406 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~Ei~~l~~l~H~niv~l 406 (614)
.++|+..+.||+|+||.||+|.++. +..||+|.+........ ..+..|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4578899999999999999999865 36799999877653221 124456677888999999999
Q ss_pred eeEEeec----CeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEc--
Q 044561 407 RGYCRRK----GEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD-- 480 (614)
Q Consensus 407 ~g~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~-- 480 (614)
++++... ...++||||+ +++|.+++... ...+++.+++.++.||+.||.|||+ .+|+||||||+|||++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEESS
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEecC
Confidence 9998765 4589999999 99999999764 3459999999999999999999995 8999999999999999
Q ss_pred CCCCEEEeeeccccccCCCCC------CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccc
Q 044561 481 ADLNGKLGDFGLARLYDHDTI------PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSME 554 (614)
Q Consensus 481 ~~~~~kl~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~ 554 (614)
.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 889999999999986543221 11233569999999999999899999999999999999999999998543322
Q ss_pred cccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 555 TVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 555 ~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
. ......... ...+....+..+.. ......+.+++..||+.||++||++.+|++
T Consensus 269 ~--~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 269 K--YVRDSKIRY-RENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp H--HHHHHHHHH-HHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred H--HHHHHHHHh-hhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 1 111111111 11223333333321 112345777888899999999999999863
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=335.72 Aligned_cols=257 Identities=25% Similarity=0.394 Sum_probs=199.4
Q ss_pred cCCCCcceeeeeCcEEEEEEEE-----ecCcEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeec--CeE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVL-----ASNVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRK--GEF 416 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 416 (614)
+.|+..+.||+|+||.||+|++ ..+..||+|++.... ....+.+.+|+.++++++||||+++++++... +..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 3477889999999999999984 347889999997543 33457889999999999999999999999876 678
Q ss_pred EEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecccccc
Q 044561 417 LLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 496 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~ 496 (614)
++||||+++|+|.+++.... ..+++.+++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcccccccc
Confidence 99999999999999996542 459999999999999999999995 89999999999999999999999999999876
Q ss_pred CCCCC--CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCc--------cccccHHHHHHHhh
Q 044561 497 DHDTI--PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGS--------METVNLVDWVCDCW 566 (614)
Q Consensus 497 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~--------~~~~~l~~~v~~~~ 566 (614)
..... .......||..|+|||.+.+..++.++||||||+++|||++|+.|+..... ..............
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence 55432 122345688889999999988899999999999999999999998643210 00001111111111
Q ss_pred hcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 567 KKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 567 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+... ..+....+.+.+++.+||+.||++|||+.|+++
T Consensus 257 ~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 257 KEGKRL---------PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HTTCCC---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred hccCCC---------CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 111111 111222346778888999999999999999874
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=336.02 Aligned_cols=250 Identities=22% Similarity=0.331 Sum_probs=201.8
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
.++|...+.||+|+||.||+++.. +++.||+|.+........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 356888999999999999999986 4889999999876555556788999999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEE---cCCCCEEEeeeccccccCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL---DADLNGKLGDFGLARLYDHD 499 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll---~~~~~~kl~DfGla~~~~~~ 499 (614)
+++++|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+||++ +.++.+||+|||++......
T Consensus 88 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 88 VSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp CCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred CCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 9999999998763 348999999999999999999995 899999999999999 78899999999999764432
Q ss_pred CCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccc
Q 044561 500 TIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRL 579 (614)
Q Consensus 500 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 579 (614)
......||+.|+|||++.+..++.++||||||+++|||++|+.||......+. . +...++... .....
T Consensus 163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~----~~i~~~~~~--~~~~~ 230 (304)
T 2jam_A 163 ---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL---F----EKIKEGYYE--FESPF 230 (304)
T ss_dssp ---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---H----HHHHHCCCC--CCTTT
T ss_pred ---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH---H----HHHHcCCCC--CCccc
Confidence 22345789999999999988999999999999999999999999976543221 1 111222111 01111
Q ss_pred cCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 580 EGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 580 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
... ....+.+++.+|++.||++|||+.|+++
T Consensus 231 ~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 231 WDD----ISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp TTT----SCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccc----CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 112 2345778888899999999999999975
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=334.21 Aligned_cols=253 Identities=27% Similarity=0.474 Sum_probs=190.9
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 421 (614)
.++|+..+.||+|+||.||+|+.++ .+|+|++... .....+.+.+|+.++++++||||+++++++ ..+..++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 3578889999999999999998654 5899988654 455567899999999999999999999966 4566899999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC-
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT- 500 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~- 500 (614)
|+++++|.+++... ...+++.+++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 100 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 100 WCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp CCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred ecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence 99999999999754 3459999999999999999999995 899999999999999999999999999998654322
Q ss_pred CCcccccccCCCccchhhhc---CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMR---TGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDS 577 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~---~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~ 577 (614)
........||+.|+|||.+. ...++.++||||||+++|||++|+.||......+. +.+....+...... .
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~-~ 248 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIEMVGRGSLSPDL-S 248 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH------HHHHHHHTSCCCCT-T
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH------HHHHhcccccCcch-h
Confidence 22234457999999999986 56788999999999999999999999976544322 11222222221111 1
Q ss_pred cccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 578 RLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 578 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+... ....+.+++.+||+.||++|||+.|+++
T Consensus 249 ~~~~~----~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 249 KVRSN----CPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp SSCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hcccc----CCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 11122 2346778888999999999999999874
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=345.89 Aligned_cols=243 Identities=25% Similarity=0.329 Sum_probs=190.6
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHH-hcccCCCceeEEeeEEeecCeEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVS-MGRLRHRNLVKLRGYCRRKGEFLLV 419 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~-l~~l~H~niv~l~g~~~~~~~~~lV 419 (614)
++|+..+.||+|+||.||+++.+. +..||+|++.... ....+.+.+|..+ ++.++||||+++++++.+.+.+|+|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 467888999999999999999875 7889999997643 2334556777776 5778999999999999999999999
Q ss_pred EEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCC
Q 044561 420 YDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD 499 (614)
Q Consensus 420 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~ 499 (614)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++++||+|||+++.....
T Consensus 118 ~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 118 LDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 9999999999999763 348899999999999999999995 89999999999999999999999999999864332
Q ss_pred CCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccc
Q 044561 500 TIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRL 579 (614)
Q Consensus 500 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 579 (614)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+... ....+.. .+
T Consensus 193 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~-------~i~~~~~------~~ 258 (373)
T 2r5t_A 193 N-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD-------NILNKPL------QL 258 (373)
T ss_dssp C-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHH-------HHHHSCC------CC
T ss_pred C-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHH-------HHHhccc------CC
Confidence 2 23445689999999999999999999999999999999999999997654332211 1111111 11
Q ss_pred cCcCcHHHHHHHHHHHHHcCCCCCCCCCCHH
Q 044561 580 EGICEEKQMELVLKLGLFCSHPKPEARPNMR 610 (614)
Q Consensus 580 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 610 (614)
...++ ..+..++.+||+.||++||++.
T Consensus 259 ~~~~~----~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 259 KPNIT----NSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp CSSSC----HHHHHHHHHHTCSSGGGSTTTT
T ss_pred CCCCC----HHHHHHHHHHcccCHHhCCCCC
Confidence 12222 3467778889999999999974
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=342.74 Aligned_cols=259 Identities=24% Similarity=0.433 Sum_probs=207.2
Q ss_pred HHHHHHHhcCCCCcceeeeeCcEEEEEEEEe------cCcEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeE
Q 044561 337 YKDLYKATKGFKDKDVIGRGGFGKVYRGVLA------SNVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGY 409 (614)
Q Consensus 337 ~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~ 409 (614)
.++.....++|+..+.||+|+||.||+|+.. .+..||+|.+... ......++.+|+.++++++||||++++++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 3344455678899999999999999999875 2677999998754 33455678999999999999999999999
Q ss_pred EeecCeEEEEEEecCCCCcchhcccCC--------CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcC
Q 044561 410 CRRKGEFLLVYDYMPNGSLDKILHTNI--------KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA 481 (614)
Q Consensus 410 ~~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~ 481 (614)
+.+.+..++||||+++|+|.+++.... ...+++.+++.++.|++.||.|||+ .+|+||||||+||+++.
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~ 173 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAE 173 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECT
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcC
Confidence 999999999999999999999987521 1347899999999999999999995 89999999999999999
Q ss_pred CCCEEEeeeccccccCCCCC-CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHH
Q 044561 482 DLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLV 559 (614)
Q Consensus 482 ~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~ 559 (614)
++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+..
T Consensus 174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~--- 250 (322)
T 1p4o_A 174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL--- 250 (322)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH---
T ss_pred CCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHH---
Confidence 99999999999986543221 12233467889999999998899999999999999999999 89998765432211
Q ss_pred HHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 560 DWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 560 ~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
....++.... ....+ ...+.+++.+||+.||++|||+.|+++
T Consensus 251 ----~~~~~~~~~~-----~~~~~----~~~l~~li~~~l~~dp~~Rps~~e~l~ 292 (322)
T 1p4o_A 251 ----RFVMEGGLLD-----KPDNC----PDMLFELMRMCWQYNPKMRPSFLEIIS 292 (322)
T ss_dssp ----HHHHTTCCCC-----CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----HHHHcCCcCC-----CCCCC----CHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1112222111 11122 345777888899999999999999874
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=342.29 Aligned_cols=253 Identities=26% Similarity=0.367 Sum_probs=199.8
Q ss_pred CCCcceeeeeCcEEEEEEEEe-----cCcEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEee--cCeEEE
Q 044561 347 FKDKDVIGRGGFGKVYRGVLA-----SNVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRR--KGEFLL 418 (614)
Q Consensus 347 f~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~l 418 (614)
|+..+.||+|+||.||++.++ +++.||+|++.... ....+.+.+|+.++++++||||+++++++.. ...+++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 478899999999999998753 47889999997653 4456789999999999999999999999987 467899
Q ss_pred EEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCC
Q 044561 419 VYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 498 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~ 498 (614)
||||+++|+|.+++... .+++.+++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++.....
T Consensus 113 v~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 99999999999999764 38999999999999999999995 8999999999999999999999999999987755
Q ss_pred CCC--CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccc--------cccHHHHHHHhhhc
Q 044561 499 DTI--PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSME--------TVNLVDWVCDCWKK 568 (614)
Q Consensus 499 ~~~--~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~--------~~~l~~~v~~~~~~ 568 (614)
... .......+|..|+|||.+.+..++.++||||||+++|||++|+.||....... .......+.+....
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER 266 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHT
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhc
Confidence 432 12233467888999999998889999999999999999999999986432110 00000111111111
Q ss_pred CCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 569 GAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 569 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+. ....+......+.+++.+||+.||++|||+.|+++
T Consensus 267 ~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 267 GE---------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp TC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cc---------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 11 11112223356788888999999999999999874
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=351.86 Aligned_cols=252 Identities=21% Similarity=0.325 Sum_probs=191.4
Q ss_pred HhcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC--------hhhHHHHHHHHHHhcccCCCceeEEeeEEeec
Q 044561 343 ATKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS--------KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRK 413 (614)
Q Consensus 343 ~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 413 (614)
..++|...+.||+|+||.||+|.... +..||+|++.... ......+.+|+.++++++||||+++++++. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 35688999999999999999999865 7899999987532 122235789999999999999999999975 4
Q ss_pred CeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCC---CEEEeee
Q 044561 414 GEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADL---NGKLGDF 490 (614)
Q Consensus 414 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~---~~kl~Df 490 (614)
+..++|||||++|+|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++ .+||+||
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~DF 286 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDF 286 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred CceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEeec
Confidence 5689999999999999998764 359999999999999999999995 8999999999999997544 5999999
Q ss_pred ccccccCCCCCCcccccccCCCccchhhhcC---CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhh
Q 044561 491 GLARLYDHDTIPQTTKLVGTFGYMDPELMRT---GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWK 567 (614)
Q Consensus 491 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~ 567 (614)
|+++...... .....+||+.|+|||++.. ..++.++|||||||++|||++|+.||........ +...+ .
T Consensus 287 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~~i----~ 358 (419)
T 3i6u_A 287 GHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQI----T 358 (419)
T ss_dssp STTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHHHH----H
T ss_pred ccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHHHH----h
Confidence 9998765432 2345689999999999853 5778999999999999999999999975433221 11111 1
Q ss_pred cCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 568 KGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 568 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+.... .+..... ..+.+.+++.+||+.||++|||+.|+++
T Consensus 359 ~~~~~~--~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 359 SGKYNF--IPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp TTCCCC--CHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cCCCCC--Cchhhcc----cCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 111110 0111111 2345778888999999999999999974
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=366.21 Aligned_cols=242 Identities=27% Similarity=0.420 Sum_probs=194.2
Q ss_pred eeeeeCcEEEEEEEEe---cCcEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecCCCC
Q 044561 352 VIGRGGFGKVYRGVLA---SNVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGS 427 (614)
Q Consensus 352 ~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 427 (614)
.||+|+||.||+|.++ ++..||||++.... ....+++.+|+.++++++||||++++++|.. +.+++|||||++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999875 35679999997653 3456889999999999999999999999976 56999999999999
Q ss_pred cchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCC--ccc
Q 044561 428 LDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP--QTT 505 (614)
Q Consensus 428 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~--~~~ 505 (614)
|.+++... ...+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++........ ...
T Consensus 422 L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 497 (613)
T 2ozo_A 422 LHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 497 (613)
T ss_dssp HHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------
T ss_pred HHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeecc
Confidence 99999754 3459999999999999999999995 89999999999999999999999999999876543221 112
Q ss_pred ccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCc
Q 044561 506 KLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICE 584 (614)
Q Consensus 506 ~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 584 (614)
...+|+.|+|||++..+.++.++|||||||++|||++ |+.||......+.. .....+.... .+
T Consensus 498 ~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~-------~~i~~~~~~~---------~p 561 (613)
T 2ozo_A 498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-------AFIEQGKRME---------CP 561 (613)
T ss_dssp ----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHH-------HHHHTTCCCC---------CC
T ss_pred CCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-------HHHHcCCCCC---------CC
Confidence 2345689999999998999999999999999999998 99999876554322 1222222111 11
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 585 EKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 585 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
......+.+++.+||+.||++||++.+|++
T Consensus 562 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 562 PECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp TTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred CcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 223346778888999999999999999863
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=337.29 Aligned_cols=262 Identities=24% Similarity=0.390 Sum_probs=186.3
Q ss_pred HhcCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 343 ATKGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 343 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
..++|+..+.||+|+||.||+|... ++..||+|++.... ....+++.+|+.++++++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 3468999999999999999999975 47889999886543 334567889999999999999999999999999999999
Q ss_pred EecCCCCcchhccc------CCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecccc
Q 044561 421 DYMPNGSLDKILHT------NIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR 494 (614)
Q Consensus 421 E~~~~gsL~~~l~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~ 494 (614)
||+++++|.+++.. .....+++.++..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 99999999999864 123458999999999999999999995 899999999999999999999999999997
Q ss_pred ccCCCC----CCcccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcC
Q 044561 495 LYDHDT----IPQTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKG 569 (614)
Q Consensus 495 ~~~~~~----~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~ 569 (614)
...... ........||+.|+|||++.. ..++.++||||||+++|||++|+.||......+.. ..........
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~ 246 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL---MLTLQNDPPS 246 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH---HHHHTSSCCC
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH---HHHhccCCCc
Confidence 654322 111234578999999999875 56899999999999999999999999765443221 1111110000
Q ss_pred CccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 570 AIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 570 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
......+......++ ..+.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 247 LETGVQDKEMLKKYG----KSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TTC-----CCCCCCC----HHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cccccccchhhhhhh----HHHHHHHHHHccCChhhCcCHHHHhh
Confidence 001111122222222 35677888899999999999999985
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=333.18 Aligned_cols=250 Identities=26% Similarity=0.402 Sum_probs=200.7
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEee--cCeEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRR--KGEFLLV 419 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV 419 (614)
++|+..+.||+|+||.||++.... ++.||+|++... .....+.+.+|+.++++++||||+++++++.. .+..++|
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 85 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence 568888999999999999999874 888999999754 34456788999999999999999999998754 5789999
Q ss_pred EEecCCCCcchhcccCC--CCCcChhHHHHHHHHhHhhchhhhccCCCc-----eEecCcCCCCeEEcCCCCEEEeeecc
Q 044561 420 YDYMPNGSLDKILHTNI--KPCLNWYQRFRIIRGVASGLLYLHEDWEQV-----VLHRDIKPANVLLDADLNGKLGDFGL 492 (614)
Q Consensus 420 ~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-----ivHrDikp~NIll~~~~~~kl~DfGl 492 (614)
|||+++++|.+++.... ...+++.+++.++.|++.||.|||+ .+ |+||||||+||+++.++.+||+|||+
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 99999999999987532 3458999999999999999999996 55 99999999999999999999999999
Q ss_pred ccccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcc
Q 044561 493 ARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIR 572 (614)
Q Consensus 493 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~ 572 (614)
++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ .. +...++...
T Consensus 163 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~----~~i~~~~~~ 234 (279)
T 2w5a_A 163 ARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LA----GKIREGKFR 234 (279)
T ss_dssp HHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH----HHHHHTCCC
T ss_pred heeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH---HH----HHHhhcccc
Confidence 987654321 1233578999999999998899999999999999999999999997654322 11 122222221
Q ss_pred ccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 573 DASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 573 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
. +...+ ...+.+++.+||+.||++|||+.||++
T Consensus 235 ~-----~~~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~ 267 (279)
T 2w5a_A 235 R-----IPYRY----SDELNEIITRMLNLKDYHRPSVEEILE 267 (279)
T ss_dssp C-----CCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred c-----CCccc----CHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 1 11122 345778888899999999999999985
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=342.19 Aligned_cols=255 Identities=24% Similarity=0.375 Sum_probs=204.2
Q ss_pred HHhcCCCCcceeeeeCcEEEEEEEEec-C-----cEEEEEEeecCC-hhhHHHHHHHHHHhccc-CCCceeEEeeEEeec
Q 044561 342 KATKGFKDKDVIGRGGFGKVYRGVLAS-N-----VQIAVKKVSHDS-KQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRK 413 (614)
Q Consensus 342 ~~~~~f~~~~~lG~G~fg~Vy~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 413 (614)
...++|+..+.||+|+||.||+|.... + ..||+|.+.... ....+.+.+|+.+++++ +||||++++++|...
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 345678889999999999999999753 2 479999997653 34567789999999999 899999999999999
Q ss_pred CeEEEEEEecCCCCcchhcccCC------------CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcC
Q 044561 414 GEFLLVYDYMPNGSLDKILHTNI------------KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA 481 (614)
Q Consensus 414 ~~~~lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~ 481 (614)
+..++||||+++|+|.+++.... ...+++.+++.++.|++.||.|||+ .+|+||||||+|||++.
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTN 199 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEG
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECC
Confidence 99999999999999999987532 2358999999999999999999995 89999999999999999
Q ss_pred CCCEEEeeeccccccCCCCC-CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHH
Q 044561 482 DLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLV 559 (614)
Q Consensus 482 ~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~ 559 (614)
++.+||+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+..
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~--- 276 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF--- 276 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH---
T ss_pred CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH---
Confidence 99999999999986544322 12233467889999999998899999999999999999998 99999765433221
Q ss_pred HHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 560 DWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 560 ~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
......+.. ....... ...+.+++.+||+.||++|||+.||++
T Consensus 277 ---~~~~~~~~~-----~~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 277 ---YKLVKDGYQ-----MAQPAFA----PKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp ---HHHHHHTCC-----CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---HHHHhcCCC-----CCCCCCC----CHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 111111110 0011112 245778888999999999999999873
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=342.32 Aligned_cols=265 Identities=25% Similarity=0.366 Sum_probs=202.3
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCC--hhhHHHHHHHHHHhcccCCCceeEEeeEEee--------c
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDS--KQGIKEFVAELVSMGRLRHRNLVKLRGYCRR--------K 413 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--------~ 413 (614)
.+|+..+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.++++++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 56888999999999999999985 48899999986543 2234577899999999999999999999877 4
Q ss_pred CeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccc
Q 044561 414 GEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLA 493 (614)
Q Consensus 414 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla 493 (614)
+..++||||+++ +|.+.+.... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 578999999974 7777765542 359999999999999999999995 89999999999999999999999999999
Q ss_pred cccCCCC---CCcccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcC
Q 044561 494 RLYDHDT---IPQTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKG 569 (614)
Q Consensus 494 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~ 569 (614)
+...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+..........
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 251 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 251 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 8765322 122344578999999999876 457999999999999999999999998765544443333222222111
Q ss_pred Ccccccccccc--------Cc-CcHHH------HHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 570 AIRDASDSRLE--------GI-CEEKQ------MELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 570 ~~~~~~d~~l~--------~~-~~~~~------~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
........... .. ...+. ...+.+|+.+||+.||++|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 11111110000 00 00111 234778999999999999999999985
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=338.67 Aligned_cols=263 Identities=26% Similarity=0.378 Sum_probs=191.3
Q ss_pred cCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEee-----cCeEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRR-----KGEFLLV 419 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-----~~~~~lV 419 (614)
++|+..+.||+|+||.||+|+. ++..||+|++....... .....|+..+..++||||+++++.+.. ...+++|
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~-~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv 90 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQN-FINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLV 90 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEE
T ss_pred HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchhh-HHHHHHHHHHHhccCcchhhheecccccccCCCceEEEE
Confidence 5788899999999999999976 57889999997654332 122345555667899999999986542 3467999
Q ss_pred EEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccC------CCceEecCcCCCCeEEcCCCCEEEeeeccc
Q 044561 420 YDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDW------EQVVLHRDIKPANVLLDADLNGKLGDFGLA 493 (614)
Q Consensus 420 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~ivHrDikp~NIll~~~~~~kl~DfGla 493 (614)
|||+++|+|.+++.... .++..+..++.||++||.|||+.. +.+|+||||||+|||++.++.+||+|||++
T Consensus 91 ~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a 167 (336)
T 3g2f_A 91 MEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167 (336)
T ss_dssp ECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTC
T ss_pred EecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccce
Confidence 99999999999997643 689999999999999999999521 119999999999999999999999999999
Q ss_pred cccCCCCC-------CcccccccCCCccchhhhcC-------CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccc-cH
Q 044561 494 RLYDHDTI-------PQTTKLVGTFGYMDPELMRT-------GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETV-NL 558 (614)
Q Consensus 494 ~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~-~l 558 (614)
+....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.|+......... ..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~ 247 (336)
T 3g2f_A 168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA 247 (336)
T ss_dssp EECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCT
T ss_pred eecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHh
Confidence 87653221 12234579999999999976 35667899999999999999998776443221111 11
Q ss_pred H----------HHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 559 V----------DWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 559 ~----------~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
. ..................... ........+.+++.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 248 FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWK--ENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp THHHHCSSCCHHHHHHHHTTSCCCCCCCTTCC--CCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhcccCCCchHHHHHhhhcccccCCCCCcccc--cccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence 0 001111111111111111111 12235567899999999999999999999974
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=337.21 Aligned_cols=251 Identities=23% Similarity=0.295 Sum_probs=192.3
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecC---ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLV 419 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 419 (614)
.++|+..+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 367889999999999999999986 4788999998654 233457889999999999999999999999999999999
Q ss_pred EEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCC
Q 044561 420 YDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD 499 (614)
Q Consensus 420 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~ 499 (614)
|||+++++|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++......
T Consensus 113 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 9999999999999764 358999999999999999999995 89999999999999999999999999999876554
Q ss_pred CCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccc
Q 044561 500 TIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRL 579 (614)
Q Consensus 500 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 579 (614)
.........|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .......... .. ....
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~-~~--~~~~ 257 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAI-PR--PSTV 257 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCC-CC--GGGT
T ss_pred ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCC-CC--cccc
Confidence 433344567999999999999889999999999999999999999999764321 1111111111 00 0011
Q ss_pred cCcCcHHHHHHHHHHHHHcCCCCCCCCC-CHHHHh
Q 044561 580 EGICEEKQMELVLKLGLFCSHPKPEARP-NMRQVM 613 (614)
Q Consensus 580 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl 613 (614)
...+ ...+.+++.+||+.||++|| ++.+++
T Consensus 258 ~~~~----~~~l~~li~~~l~~dP~~Rp~s~~~l~ 288 (309)
T 2h34_A 258 RPGI----PVAFDAVIARGMAKNPEDRYVTCGDLS 288 (309)
T ss_dssp STTC----CTHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred CCCC----CHHHHHHHHHhccCCHHHHHHhHHHHH
Confidence 1122 23577788889999999999 898876
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=350.99 Aligned_cols=202 Identities=18% Similarity=0.300 Sum_probs=175.2
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhccc------CCCceeEEeeEEeecCeEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRL------RHRNLVKLRGYCRRKGEFL 417 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l------~H~niv~l~g~~~~~~~~~ 417 (614)
.+|+..+.||+|+||.||+|.... +..||||++... ....+++.+|+.+++.+ +|+||+++++++...+..+
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 468888999999999999999865 788999999754 33445677787777766 5779999999999999999
Q ss_pred EEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCC--EEEeeeccccc
Q 044561 418 LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLN--GKLGDFGLARL 495 (614)
Q Consensus 418 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~--~kl~DfGla~~ 495 (614)
+||||++ ++|.+++.......+++..+..++.||+.||.|||+ .+|+||||||+|||++.++. +||+|||++..
T Consensus 176 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~ 251 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY 251 (429)
T ss_dssp EEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence 9999995 699999887665669999999999999999999995 79999999999999999987 99999999976
Q ss_pred cCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcccc
Q 044561 496 YDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMET 555 (614)
Q Consensus 496 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~ 555 (614)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.
T Consensus 252 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~ 307 (429)
T 3kvw_A 252 EHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQ 307 (429)
T ss_dssp TTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred cCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 5432 2345789999999999999999999999999999999999999987655443
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=345.86 Aligned_cols=241 Identities=23% Similarity=0.370 Sum_probs=199.4
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCCh--------hhHHHHHHHHHHhcccCCCceeEEeeEEeecC
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSK--------QGIKEFVAELVSMGRLRHRNLVKLRGYCRRKG 414 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 414 (614)
.++|+..+.||+|+||.||+|.... +..||+|++..... ...+.+.+|+.++++++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 4578899999999999999999764 88899999976531 13345778999999999999999999999999
Q ss_pred eEEEEEEecCCC-CcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccc
Q 044561 415 EFLLVYDYMPNG-SLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLA 493 (614)
Q Consensus 415 ~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla 493 (614)
..++||||+.+| +|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence 999999999777 999998764 349999999999999999999995 89999999999999999999999999999
Q ss_pred cccCCCCCCcccccccCCCccchhhhcCCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcc
Q 044561 494 RLYDHDTIPQTTKLVGTFGYMDPELMRTGKA-STSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIR 572 (614)
Q Consensus 494 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~ 572 (614)
....... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... . ...
T Consensus 178 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~-----------~~~-- 240 (335)
T 3dls_A 178 AYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--V-----------EAA-- 240 (335)
T ss_dssp EECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--T-----------TTC--
T ss_pred eECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--H-----------hhc--
Confidence 8765543 2334579999999999988776 88999999999999999999999642110 0 000
Q ss_pred ccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 573 DASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 573 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
. .....+ ...+.+++.+||++||++|||+.|+++
T Consensus 241 --~--~~~~~~----~~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 241 --I--HPPYLV----SKELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp --C--CCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --c--CCCccc----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 001112 234777888899999999999999974
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=342.35 Aligned_cols=262 Identities=20% Similarity=0.250 Sum_probs=203.9
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccC--------CCceeEEeeEEe---
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLR--------HRNLVKLRGYCR--- 411 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~--------H~niv~l~g~~~--- 411 (614)
.++|+..+.||+|+||.||+|+... ++.||+|++... ....+.+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 3678999999999999999999764 788999998754 345577889999999885 788999999987
Q ss_pred -ecCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCC-ceEecCcCCCCeEEcCCC------
Q 044561 412 -RKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQ-VVLHRDIKPANVLLDADL------ 483 (614)
Q Consensus 412 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDikp~NIll~~~~------ 483 (614)
.....++||||+ +++|.+.+.......+++.++..++.||+.||.|||+ + +|+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhhhhh
Confidence 556899999999 5666666655444569999999999999999999995 6 999999999999998775
Q ss_pred -------------------------------------------CEEEeeeccccccCCCCCCcccccccCCCccchhhhc
Q 044561 484 -------------------------------------------NGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMR 520 (614)
Q Consensus 484 -------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 520 (614)
.+||+|||++...... .....||+.|+|||++.
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~ 266 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLI 266 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHH
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhc
Confidence 8999999999876543 23457899999999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccH---HHHHHHhhhc--------C-----------Ccccccccc
Q 044561 521 TGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNL---VDWVCDCWKK--------G-----------AIRDASDSR 578 (614)
Q Consensus 521 ~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l---~~~v~~~~~~--------~-----------~~~~~~d~~ 578 (614)
+..++.++|||||||++|||++|+.||......+.... ...+.+.... + .+....+..
T Consensus 267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (397)
T 1wak_A 267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK 346 (397)
T ss_dssp TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence 99999999999999999999999999986554332211 1111111100 0 000000000
Q ss_pred c---------cCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 579 L---------EGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 579 l---------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
. ....+......+.+|+.+||+.||++|||+.|+++
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0 01234566778999999999999999999999985
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=330.91 Aligned_cols=256 Identities=18% Similarity=0.246 Sum_probs=199.3
Q ss_pred HhcCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEE-eecCeEEEEE
Q 044561 343 ATKGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYC-RRKGEFLLVY 420 (614)
Q Consensus 343 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~-~~~~~~~lV~ 420 (614)
..++|+..+.||+|+||.||+|+.. ++..||+|.+...... +++.+|+.+++.++|++++..++++ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 4568999999999999999999975 4888999987654332 3578899999999988877776665 5667889999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEE---cCCCCEEEeeeccccccC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL---DADLNGKLGDFGLARLYD 497 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll---~~~~~~kl~DfGla~~~~ 497 (614)
||+ +++|.+++.... ..+++.++..++.|++.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++...
T Consensus 85 e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp ECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred Ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 999 999999997532 349999999999999999999995 899999999999999 889999999999998765
Q ss_pred CCCC------CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCc
Q 044561 498 HDTI------PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAI 571 (614)
Q Consensus 498 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~ 571 (614)
.... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.......+.........
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence 4432 1223467999999999999999999999999999999999999999876554444333332222111110
Q ss_pred cccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 572 RDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 572 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+.+...+ ...+.+++.+||+.||++|||+.||++
T Consensus 240 -----~~~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 240 -----EVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp -----HHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred -----hhhhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 0011112 245778888999999999999999874
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=330.92 Aligned_cols=244 Identities=20% Similarity=0.356 Sum_probs=198.3
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecC--ChhhHHHHHHHHHHhccc-CCCceeEEeeEEeecCeEEEE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHD--SKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGEFLLV 419 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 419 (614)
.++|+..+.||+|+||.||+|... ++..||+|++... ......++.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 356888999999999999999987 5889999998764 334567788999999999 999999999999999999999
Q ss_pred EEecCCCCcchhcccCC--CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcC----------------
Q 044561 420 YDYMPNGSLDKILHTNI--KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA---------------- 481 (614)
Q Consensus 420 ~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~---------------- 481 (614)
|||+++++|.+++.... ...+++.++..++.||++||.|||+ ++|+||||||+||+++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999997642 2458999999999999999999995 89999999999999984
Q ss_pred ---CCCEEEeeeccccccCCCCCCcccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcccccc
Q 044561 482 ---DLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVN 557 (614)
Q Consensus 482 ---~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~ 557 (614)
...+||+|||++....... ...||+.|+|||.+.+. .++.++|||||||+++||++|+.|+.....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~----- 236 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ----- 236 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH-----
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH-----
Confidence 4479999999998765432 23589999999999765 567899999999999999999987643211
Q ss_pred HHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 558 LVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 558 l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+....++... .+...++ ..+.+++.+||+.||++|||+.|+++
T Consensus 237 -----~~~~~~~~~~-----~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 237 -----WHEIRQGRLP-----RIPQVLS----QEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp -----HHHHHTTCCC-----CCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----HHHHHcCCCC-----CCCcccC----HHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 1111222221 1222223 35677888899999999999999985
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=353.46 Aligned_cols=192 Identities=28% Similarity=0.412 Sum_probs=155.0
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEee-----cCeE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRR-----KGEF 416 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-----~~~~ 416 (614)
++|+..+.||+|+||.||+|.... +..||+|++... .....+++.+|+.++++++||||+++++++.. .+.+
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 578889999999999999999764 889999999653 44456789999999999999999999999843 3579
Q ss_pred EEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecccccc
Q 044561 417 LLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 496 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~ 496 (614)
|+||||+ +++|.+++... ..+++.++..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 133 ~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp EEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred EEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence 9999998 57899988764 459999999999999999999995 89999999999999999999999999999876
Q ss_pred CCCCC--------------------------CcccccccCCCccchhhh-cCCCCCcchhHHHHHHHHHHHHc
Q 044561 497 DHDTI--------------------------PQTTKLVGTFGYMDPELM-RTGKASTSTDVYAFGVFMLEVAS 542 (614)
Q Consensus 497 ~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~t~~~Dv~S~Gvll~el~t 542 (614)
..... ...+..+||+.|+|||++ ....++.++|||||||++|||++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 43221 123445789999999986 45679999999999999999999
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=345.36 Aligned_cols=252 Identities=22% Similarity=0.319 Sum_probs=200.5
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe----cCcEEEEEEeecCC----hhhHHHHHHHHHHhccc-CCCceeEEeeEEeecCe
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA----SNVQIAVKKVSHDS----KQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGE 415 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 415 (614)
++|+..+.||+|+||.||+++.. .+..||+|++.... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 56888999999999999999973 57899999986432 22335567899999999 69999999999999999
Q ss_pred EEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccc
Q 044561 416 FLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARL 495 (614)
Q Consensus 416 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~ 495 (614)
.++||||+++|+|.+++... ..+++.++..++.||+.||.|||+ .+|+||||||+|||++.++++||+|||+++.
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred EEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 99999999999999999764 358999999999999999999995 8999999999999999999999999999987
Q ss_pred cCCCCCCcccccccCCCccchhhhcC--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccc
Q 044561 496 YDHDTIPQTTKLVGTFGYMDPELMRT--GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRD 573 (614)
Q Consensus 496 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~ 573 (614)
............+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+ ...... .
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~--~~~~~~-~---- 281 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SRRILK-S---- 281 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH--HHHHHH-C----
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHH--HHHHhc-c----
Confidence 65443333445689999999999985 34789999999999999999999999765433222111 111111 0
Q ss_pred cccccccCcCcHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHhC
Q 044561 574 ASDSRLEGICEEKQMELVLKLGLFCSHPKPEARP-----NMRQVMQ 614 (614)
Q Consensus 574 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 614 (614)
.+.... .....+.+++.+||+.||++|| ++.|+++
T Consensus 282 --~~~~~~----~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~ 321 (355)
T 1vzo_A 282 --EPPYPQ----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 321 (355)
T ss_dssp --CCCCCT----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred --CCCCCc----ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence 111111 2234567788899999999999 9999875
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=338.64 Aligned_cols=262 Identities=24% Similarity=0.378 Sum_probs=207.4
Q ss_pred cCHHHHHHHhcCCCCcceeeeeCcEEEEEEEEe------cCcEEEEEEeecCC-hhhHHHHHHHHHHhccc-CCCceeEE
Q 044561 335 FTYKDLYKATKGFKDKDVIGRGGFGKVYRGVLA------SNVQIAVKKVSHDS-KQGIKEFVAELVSMGRL-RHRNLVKL 406 (614)
Q Consensus 335 ~~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l 406 (614)
+...+.....++|+..+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.+++++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 334444445678999999999999999999853 35789999997653 34556789999999999 79999999
Q ss_pred eeEEeecC-eEEEEEEecCCCCcchhcccCCC--------------CCcChhHHHHHHHHhHhhchhhhccCCCceEecC
Q 044561 407 RGYCRRKG-EFLLVYDYMPNGSLDKILHTNIK--------------PCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 471 (614)
Q Consensus 407 ~g~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrD 471 (614)
++++...+ ..++||||+++|+|.+++..... ..+++.++..++.|+++||.|||+ .+|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCccccc
Confidence 99987754 58999999999999999976432 228999999999999999999995 8999999
Q ss_pred cCCCCeEEcCCCCEEEeeeccccccCCCCC-CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCC
Q 044561 472 IKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQ 549 (614)
Q Consensus 472 ikp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~ 549 (614)
|||+||+++.++.+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999987654332 22334567899999999999999999999999999999998 9999976
Q ss_pred CCccccccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 550 QGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 550 ~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
....+.. ......+... ...... ...+.+++.+||+.||++|||+.|+++
T Consensus 254 ~~~~~~~------~~~~~~~~~~-----~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~ 303 (316)
T 2xir_A 254 VKIDEEF------CRRLKEGTRM-----RAPDYT----TPEMYQTMLDCWHGEPSQRPTFSELVE 303 (316)
T ss_dssp CCCSHHH------HHHHHHTCCC-----CCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cchhHHH------HHHhccCccC-----CCCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 5433211 1111222111 111112 235777888899999999999999874
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=345.39 Aligned_cols=248 Identities=29% Similarity=0.482 Sum_probs=188.3
Q ss_pred CCCcceeeeeCcEEEEEEEEec----CcEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEee-cCeEEEEE
Q 044561 347 FKDKDVIGRGGFGKVYRGVLAS----NVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRR-KGEFLLVY 420 (614)
Q Consensus 347 f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV~ 420 (614)
|+..+.||+|+||.||+|.+.+ ...+|+|.+... .....+++.+|+.++++++||||++++++|.. ++..++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 5566889999999999999753 235899988654 34556789999999999999999999998754 56789999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
||+++|+|.+++... ...+++.++..++.||++||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 171 e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp ECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred ECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 999999999999764 3458999999999999999999995 899999999999999999999999999998654332
Q ss_pred CC---cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCcccccc
Q 044561 501 IP---QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASD 576 (614)
Q Consensus 501 ~~---~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 576 (614)
.. ......+|+.|+|||.+.+..++.++|||||||++|||++ |..||......+.. ..+. .+...
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~---~~~~----~~~~~---- 315 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT---VYLL----QGRRL---- 315 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHH---HHHH----TTCCC----
T ss_pred cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHH---HHHH----cCCCC----
Confidence 11 1233467889999999999999999999999999999999 67777655443322 1111 11111
Q ss_pred ccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 577 SRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 577 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.....+ ...+.+++.+||+.||++|||+.|+++
T Consensus 316 -~~p~~~----~~~l~~li~~cl~~dp~~RPs~~ell~ 348 (373)
T 3c1x_A 316 -LQPEYC----PDPLYEVMLKCWHPKAEMRPSFSELVS 348 (373)
T ss_dssp -CCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CCCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011122 245778888999999999999999874
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=350.67 Aligned_cols=198 Identities=28% Similarity=0.409 Sum_probs=167.5
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeec-----Ce
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRK-----GE 415 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~ 415 (614)
.++|+..+.||+|+||.||+|.... +..||+|++... .....+.+.+|+.++++++||||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 4678899999999999999999865 788999999754 444567899999999999999999999998766 57
Q ss_pred EEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccc
Q 044561 416 FLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARL 495 (614)
Q Consensus 416 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~ 495 (614)
.|+||||++ ++|.+++... ..+++.++..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 999999996 6999999764 459999999999999999999995 8999999999999999999999999999987
Q ss_pred cCCCCC---------------------CcccccccCCCccchhhh-cCCCCCcchhHHHHHHHHHHHHcCCCCC
Q 044561 496 YDHDTI---------------------PQTTKLVGTFGYMDPELM-RTGKASTSTDVYAFGVFMLEVASGRRPV 547 (614)
Q Consensus 496 ~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~t~~~Dv~S~Gvll~el~tg~~p~ 547 (614)
...... ...+..+||+.|+|||++ ....++.++||||+||++|||++|..|+
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 654321 123556899999999986 5567999999999999999999865544
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=329.18 Aligned_cols=255 Identities=18% Similarity=0.239 Sum_probs=201.9
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEE-eecCeEEEEEE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYC-RRKGEFLLVYD 421 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~-~~~~~~~lV~E 421 (614)
.++|+..+.||+|+||.||+|+.. +++.||+|++...... +++.+|+.+++.++|++++..+.++ ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 467889999999999999999974 5889999998765432 4678999999999988877666665 56678899999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEE---cCCCCEEEeeeccccccCC
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL---DADLNGKLGDFGLARLYDH 498 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll---~~~~~~kl~DfGla~~~~~ 498 (614)
|+ +++|.+++.... ..+++.++..++.|++.||.|||+ .+|+||||||+|||+ +.++.+||+|||++.....
T Consensus 86 ~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred ec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 99 999999997532 459999999999999999999995 899999999999999 5889999999999987654
Q ss_pred CCC------CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcc
Q 044561 499 DTI------PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIR 572 (614)
Q Consensus 499 ~~~------~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~ 572 (614)
... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.......+........
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-- 238 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-- 238 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC--
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc--
Confidence 432 123446799999999999999999999999999999999999999987554443333332222111111
Q ss_pred ccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 573 DASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 573 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+.+...++ ..+.+++.+||+.||++|||+.||++
T Consensus 239 ---~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 239 ---IEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp ---HHHHTTTSC----HHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred ---hHHHHhhCC----HHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 011111222 45778888999999999999999874
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=355.60 Aligned_cols=249 Identities=26% Similarity=0.376 Sum_probs=197.8
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC--hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS--KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 421 (614)
++|+..+.||+|+||.||+|+.+. +..+|+|++.... ......+.+|+.+++.++||||++++++|...+..++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 457888999999999999999874 7889999987643 3335678999999999999999999999999999999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCC---CCEEEeeeccccccCC
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDAD---LNGKLGDFGLARLYDH 498 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~---~~~kl~DfGla~~~~~ 498 (614)
||++|+|.+++... ..+++.++..++.||+.||.|||+ .+|+||||||+|||++.. +.+||+|||++.....
T Consensus 117 ~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 117 CYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp CCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred cCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 99999999888764 348999999999999999999995 899999999999999764 4599999999987654
Q ss_pred CCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccc
Q 044561 499 DTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSR 578 (614)
Q Consensus 499 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~ 578 (614)
.. .....+||+.|+|||++. +.++.++||||+||++|||++|+.||......+... ....+.... +..
T Consensus 192 ~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-------~i~~~~~~~--~~~ 259 (494)
T 3lij_A 192 QK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILR-------KVEKGKYTF--DSP 259 (494)
T ss_dssp TB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------HHHHTCCCC--CSG
T ss_pred Cc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHHhCCCCC--Cch
Confidence 33 234457999999999986 568999999999999999999999998755433221 112221111 111
Q ss_pred ccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 579 LEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 579 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.....+ ..+.+++.+||+.||++|||+.|+++
T Consensus 260 ~~~~~s----~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 260 EWKNVS----EGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp GGTTSC----HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccCC----HHHHHHHHHHCCCChhhCccHHHHhc
Confidence 111222 34677888899999999999999985
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=328.33 Aligned_cols=241 Identities=24% Similarity=0.447 Sum_probs=198.9
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEee----------
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRR---------- 412 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~---------- 412 (614)
..+|+..+.||+|+||.||+|... +++.||+|++..... .+.+|+.++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSG----GGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccH----HHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 356888999999999999999987 588999999976543 45689999999999999999998854
Q ss_pred ------cCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEE
Q 044561 413 ------KGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGK 486 (614)
Q Consensus 413 ------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~k 486 (614)
...+++||||+++++|.+++.......+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+|
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCCEE
Confidence 4568999999999999999976555669999999999999999999995 8999999999999999999999
Q ss_pred EeeeccccccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhh
Q 044561 487 LGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCW 566 (614)
Q Consensus 487 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~ 566 (614)
|+|||++....... ......||+.|+|||.+.+..++.++||||||+++|||++|..|+... .......
T Consensus 163 l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---------~~~~~~~ 231 (284)
T 2a19_B 163 IGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---------SKFFTDL 231 (284)
T ss_dssp ECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---------HHHHHHH
T ss_pred ECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---------HHHHHHh
Confidence 99999998765543 233457999999999999989999999999999999999999886421 1111112
Q ss_pred hcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 567 KKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 567 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+.+ ...++ ..+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~--------~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~ 267 (284)
T 2a19_B 232 RDGII--------SDIFD----KKEKTLLQKLLSKKPEDRPNTSEILR 267 (284)
T ss_dssp HTTCC--------CTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hcccc--------cccCC----HHHHHHHHHHccCChhhCcCHHHHHH
Confidence 22221 12233 24667788899999999999999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=333.70 Aligned_cols=261 Identities=20% Similarity=0.278 Sum_probs=205.5
Q ss_pred cCCCCcceeeeeCcEEEEEEEE-e-cCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCc------eeEEeeEEeecCeE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVL-A-SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRN------LVKLRGYCRRKGEF 416 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n------iv~l~g~~~~~~~~ 416 (614)
++|+..+.||+|+||.||+|.. . ++..||+|++... ....+.+.+|+.+++.++|+| ++++++++...+..
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 5788899999999999999997 3 4788999998654 344567889999999887665 99999999999999
Q ss_pred EEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcC---------------
Q 044561 417 LLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA--------------- 481 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~--------------- 481 (614)
++||||+ +++|.+++.......+++.++..++.|+++||.|||+ .+|+||||||+|||++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred EEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCcccccc
Confidence 9999999 8999999987655568999999999999999999995 89999999999999987
Q ss_pred ----CCCEEEeeeccccccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcccccc
Q 044561 482 ----DLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVN 557 (614)
Q Consensus 482 ----~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~ 557 (614)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+...
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 244 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA 244 (339)
T ss_dssp EEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHH
T ss_pred ccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 678999999999865432 234578999999999998899999999999999999999999998765444332
Q ss_pred HHHHHHH--------hhhcCCccc------------------cccccc-cCcCcHHHHHHHHHHHHHcCCCCCCCCCCHH
Q 044561 558 LVDWVCD--------CWKKGAIRD------------------ASDSRL-EGICEEKQMELVLKLGLFCSHPKPEARPNMR 610 (614)
Q Consensus 558 l~~~v~~--------~~~~~~~~~------------------~~d~~l-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 610 (614)
.+..... ......... ...+.. .........+.+.+++.+||+.||++|||+.
T Consensus 245 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ 324 (339)
T 1z57_A 245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLR 324 (339)
T ss_dssp HHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHH
Confidence 2221111 000000000 000000 0011234456788999999999999999999
Q ss_pred HHhC
Q 044561 611 QVMQ 614 (614)
Q Consensus 611 evl~ 614 (614)
|+++
T Consensus 325 ell~ 328 (339)
T 1z57_A 325 EALK 328 (339)
T ss_dssp HHTT
T ss_pred HHhc
Confidence 9985
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=342.58 Aligned_cols=258 Identities=19% Similarity=0.197 Sum_probs=193.1
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe----cCcEEEEEEeecCChhh-----------HHHHHHHHHHhcccCCCceeEEeeE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA----SNVQIAVKKVSHDSKQG-----------IKEFVAELVSMGRLRHRNLVKLRGY 409 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~-----------~~~~~~Ei~~l~~l~H~niv~l~g~ 409 (614)
++|+..+.||+|+||.||+|... .+..+|+|+........ .+.+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 56888899999999999999986 46779999987654221 1236678889999999999999999
Q ss_pred Eee----cCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCC--
Q 044561 410 CRR----KGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADL-- 483 (614)
Q Consensus 410 ~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~-- 483 (614)
+.. ....++||||+ +++|.+++.... .+++.+++.++.||+.||.|||+ .+|+||||||+|||++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSSTT
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCCCC
Confidence 988 67899999999 999999998643 59999999999999999999995 8999999999999999887
Q ss_pred CEEEeeeccccccCCCC------CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcccccc
Q 044561 484 NGKLGDFGLARLYDHDT------IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVN 557 (614)
Q Consensus 484 ~~kl~DfGla~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~ 557 (614)
.+||+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~-- 268 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV-- 268 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH--
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH--
Confidence 99999999998764321 1122445799999999999998999999999999999999999999964322211
Q ss_pred HHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 558 LVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 558 l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
........... .+......... .....+.+.+++.+||+.||++|||+.+|++
T Consensus 269 ~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 269 AVQTAKTNLLD-ELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHHHHHH-TTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHhhcc-cccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 11111111111 11111111000 0012345778888899999999999999874
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=337.94 Aligned_cols=207 Identities=19% Similarity=0.312 Sum_probs=176.5
Q ss_pred HHHhcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccC-CC-----ceeEEeeEEeec
Q 044561 341 YKATKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLR-HR-----NLVKLRGYCRRK 413 (614)
Q Consensus 341 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~-----niv~l~g~~~~~ 413 (614)
....++|+..+.||+|+||.||+|.... ++.||+|++... ....+++..|+.+++.++ |+ +++++++++...
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 3446789999999999999999999874 788999999754 334566778888887774 44 599999999999
Q ss_pred CeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEc--CCCCEEEeeec
Q 044561 414 GEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD--ADLNGKLGDFG 491 (614)
Q Consensus 414 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~--~~~~~kl~DfG 491 (614)
+..++||||++ ++|.+++.......+++..+..++.|++.||.|||+. +.+|+||||||+|||++ .++.+||+|||
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred CceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 99999999995 5999999876555699999999999999999999953 47899999999999994 57889999999
Q ss_pred cccccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccc
Q 044561 492 LARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSME 554 (614)
Q Consensus 492 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~ 554 (614)
+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+
T Consensus 207 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~ 265 (382)
T 2vx3_A 207 SSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVD 265 (382)
T ss_dssp TCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred Cceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99876542 234578999999999999999999999999999999999999998765443
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=339.40 Aligned_cols=260 Identities=23% Similarity=0.354 Sum_probs=200.0
Q ss_pred cCHHHHHHHhcCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCChhhHHHHHHHHHHhccc-CCCceeEEeeEEee
Q 044561 335 FTYKDLYKATKGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRR 412 (614)
Q Consensus 335 ~~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~ 412 (614)
+++.++....++|+..+.||+|+||.||+|... ++..||+|.+..... ..+.+.+|+.+++++ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 444455556788999999999999999999985 488999999875433 346788999999999 79999999999976
Q ss_pred ------cCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEE
Q 044561 413 ------KGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGK 486 (614)
Q Consensus 413 ------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~k 486 (614)
.+..++||||+++|+|.+++.......+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+|
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEE
Confidence 4689999999999999999987555569999999999999999999995 8999999999999999999999
Q ss_pred EeeeccccccCCCCCCcccccccCCCccchhhhc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHH
Q 044561 487 LGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMR-----TGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDW 561 (614)
Q Consensus 487 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~ 561 (614)
|+|||++........ ......||+.|+|||++. ...++.++|||||||++|||++|+.||......+...
T Consensus 170 l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---- 244 (326)
T 2x7f_A 170 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF---- 244 (326)
T ss_dssp ECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH----
T ss_pred EeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH----
Confidence 999999986653321 223457899999999986 5678999999999999999999999997644322111
Q ss_pred HHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 562 VCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 562 v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
. ...+...... ...+ ...+.+++.+||+.||++||++.|+++
T Consensus 245 --~-~~~~~~~~~~----~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 245 --L-IPRNPAPRLK----SKKW----SKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp --H-HHHSCCCCCS----CSCS----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --H-hhcCccccCC----cccc----CHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1 1111111111 1112 235777888899999999999999985
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=328.25 Aligned_cols=252 Identities=24% Similarity=0.364 Sum_probs=203.7
Q ss_pred HhcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---------hhhHHHHHHHHHHhcccC-CCceeEEeeEEe
Q 044561 343 ATKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---------KQGIKEFVAELVSMGRLR-HRNLVKLRGYCR 411 (614)
Q Consensus 343 ~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---------~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~ 411 (614)
..++|+..+.||+|+||.||+|..+. ++.||+|.+.... ....+.+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 34678899999999999999999875 7889999997543 223467889999999996 999999999999
Q ss_pred ecCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeec
Q 044561 412 RKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFG 491 (614)
Q Consensus 412 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfG 491 (614)
..+..++||||+++++|.+++... ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEeccc
Confidence 999999999999999999999763 358999999999999999999995 899999999999999999999999999
Q ss_pred cccccCCCCCCcccccccCCCccchhhhc------CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHh
Q 044561 492 LARLYDHDTIPQTTKLVGTFGYMDPELMR------TGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDC 565 (614)
Q Consensus 492 la~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~ 565 (614)
++....... ......|++.|+|||++. ...++.++||||||++++||++|+.||......+.. . .
T Consensus 170 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---~----~ 240 (298)
T 1phk_A 170 FSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML---R----M 240 (298)
T ss_dssp TCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H----H
T ss_pred chhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHH---H----H
Confidence 998765433 233457899999999985 456889999999999999999999999764432211 1 1
Q ss_pred hhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 566 WKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 566 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
...+.... ..+. .......+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~-~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 241 IMSGNYQF-GSPE-----WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHTCCCC-CTTT-----GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HhcCCccc-Cccc-----ccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 11111110 0010 1112345778888999999999999999985
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=355.08 Aligned_cols=249 Identities=27% Similarity=0.399 Sum_probs=203.9
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
++|+..+.||+|+||.||+|... .+..||+|++.... ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 46888899999999999999987 48899999986542 335678899999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEE---cCCCCEEEeeeccccccC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL---DADLNGKLGDFGLARLYD 497 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll---~~~~~~kl~DfGla~~~~ 497 (614)
||+++|+|.+++... ..+++.++..++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||++....
T Consensus 106 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 106 EVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp CCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 999999999988764 359999999999999999999995 899999999999999 567899999999998765
Q ss_pred CCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccc
Q 044561 498 HDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDS 577 (614)
Q Consensus 498 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~ 577 (614)
... ......||+.|+|||++.+ .++.++||||+||++|||++|+.||......+.. . ....+..... .+
T Consensus 181 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~----~i~~~~~~~~-~~ 249 (484)
T 3nyv_A 181 ASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDIL---K----KVEKGKYTFE-LP 249 (484)
T ss_dssp CCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H----HHHHCCCCCC-SG
T ss_pred ccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHH---H----HHHcCCCCCC-Cc
Confidence 543 2344579999999999875 6899999999999999999999999865443222 1 1122221110 01
Q ss_pred cccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 578 RLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 578 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
. ...+ .+.+.+++.+||+.||++|||+.|+++
T Consensus 250 ~-~~~~----s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 250 Q-WKKV----SESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp G-GGGS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred c-cccC----CHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 0 1112 345678888899999999999999985
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=337.96 Aligned_cols=249 Identities=24% Similarity=0.406 Sum_probs=193.1
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-Cc----EEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NV----QIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLL 418 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 418 (614)
++|+..+.||+|+||.||+|.... +. +|++|.+... .....+++.+|+.++++++||||++++++|.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 568889999999999999999754 33 3577777543 3445678999999999999999999999998765 889
Q ss_pred EEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCC
Q 044561 419 VYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 498 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~ 498 (614)
|+||+++|+|.+++.... ..+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 94 v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred EEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 999999999999997643 459999999999999999999995 8999999999999999999999999999987654
Q ss_pred CCC-CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCcccccc
Q 044561 499 DTI-PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASD 576 (614)
Q Consensus 499 ~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 576 (614)
... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......+.... + ..+....
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~---~----~~~~~~~--- 239 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---L----EKGERLP--- 239 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH---H----HTTCCCC---
T ss_pred ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH---H----HcCCCCC---
Confidence 321 12223456788999999999999999999999999999999 9999987654432211 1 1111110
Q ss_pred ccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 577 SRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 577 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
....+ ...+.+++.+||+.||++|||+.|+++
T Consensus 240 --~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 240 --QPPIC----TIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp --CCTTB----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --CCccC----CHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 11112 235777888999999999999999874
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=331.30 Aligned_cols=251 Identities=24% Similarity=0.312 Sum_probs=184.9
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCC-hh-hHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDS-KQ-GIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
.++|+..+.||+|+||.||++... +++.||+|++.... .. ..+.+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 357888999999999999999985 48889999997642 22 2334445556688899999999999999999999999
Q ss_pred EecCCCCcchhccc--CCCCCcChhHHHHHHHHhHhhchhhhccCCC-ceEecCcCCCCeEEcCCCCEEEeeeccccccC
Q 044561 421 DYMPNGSLDKILHT--NIKPCLNWYQRFRIIRGVASGLLYLHEDWEQ-VVLHRDIKPANVLLDADLNGKLGDFGLARLYD 497 (614)
Q Consensus 421 E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDikp~NIll~~~~~~kl~DfGla~~~~ 497 (614)
||++ |+|.+++.. .....+++.++..++.|++.||.|||+ + +|+||||||+||+++.++.+||+|||++....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9997 588777754 123469999999999999999999996 5 99999999999999999999999999998765
Q ss_pred CCCCCcccccccCCCccchhhh----cCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccc
Q 044561 498 HDTIPQTTKLVGTFGYMDPELM----RTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRD 573 (614)
Q Consensus 498 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~ 573 (614)
... ......||+.|+|||++ ....++.++||||||+++|||++|+.||....... ........... ..
T Consensus 162 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~-~~ 233 (290)
T 3fme_A 162 DDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF-----QQLKQVVEEPS-PQ 233 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH-----HHHHHHHHSCC-CC
T ss_pred ccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH-----HHHHHHhccCC-CC
Confidence 433 22334799999999996 45678999999999999999999999997533221 11111111111 11
Q ss_pred cccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 574 ASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 574 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.. ...+ ...+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~----~~~~----~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 234 LP----ADKF----SAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CC----TTTS----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cc----cccC----CHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 11 0112 235778888899999999999999985
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=354.79 Aligned_cols=248 Identities=26% Similarity=0.355 Sum_probs=201.8
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
++|...+.||+|+||.||+++.+. ++.||+|++.... ....+.+.+|+.++++++||||+++++++...+.+|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 568888999999999999999864 8899999997542 233567889999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCC--CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCC
Q 044561 421 DYMPNGSLDKILHTNI--KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 498 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~ 498 (614)
||+++|+|.+++.... ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++++||+|||+++....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 9999999999987643 3469999999999999999999995 8999999999999999999999999999987654
Q ss_pred CCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccc
Q 044561 499 DTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSR 578 (614)
Q Consensus 499 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~ 578 (614)
... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .+.+....+.. .
T Consensus 342 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~---~~~~~i~~~~~------~ 411 (543)
T 3c4z_A 342 GQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK---ELKQRVLEQAV------T 411 (543)
T ss_dssp TCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHH---HHHHHHHHCCC------C
T ss_pred CCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHH---HHHHHHhhccc------C
Confidence 432 2334589999999999999899999999999999999999999997654322111 11111111111 1
Q ss_pred ccCcCcHHHHHHHHHHHHHcCCCCCCCCCCH
Q 044561 579 LEGICEEKQMELVLKLGLFCSHPKPEARPNM 609 (614)
Q Consensus 579 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 609 (614)
....+ ...+..++.+||+.||++||++
T Consensus 412 ~p~~~----s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 412 YPDKF----SPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp CCTTS----CHHHHHHHHHHSCSSGGGSCCC
T ss_pred CCccc----CHHHHHHHHHhccCCHhHCCCC
Confidence 11122 3456777888999999999975
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=330.83 Aligned_cols=250 Identities=26% Similarity=0.385 Sum_probs=196.5
Q ss_pred CCCCcceeeeeCcEEEEEEEEec-C---cEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeE-EEE
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS-N---VQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEF-LLV 419 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~-~lV 419 (614)
.|+..+.||+|+||.||+|.+.+ + ..+|+|.+... .....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 34556899999999999999754 2 26899998754 345567899999999999999999999999876655 999
Q ss_pred EEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCC
Q 044561 420 YDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD 499 (614)
Q Consensus 420 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~ 499 (614)
|||+.+|+|.+++... ...+++.++..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 102 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp ECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 9999999999999764 3458999999999999999999995 89999999999999999999999999999865432
Q ss_pred C---CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccc
Q 044561 500 T---IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASD 576 (614)
Q Consensus 500 ~---~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 576 (614)
. ........+|+.|+|||.+.+..++.++||||||+++|||++|..|+....... .....+.. +...
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~~----~~~~---- 247 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF--DLTHFLAQ----GRRL---- 247 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG--GHHHHHHT----TCCC----
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH--HHHHHhhc----CCCC----
Confidence 1 122334567899999999999999999999999999999999666554332221 12221111 1110
Q ss_pred ccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 577 SRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 577 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.....+ ...+.+++.+||+.||++|||+.|+++
T Consensus 248 -~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 248 -PQPEYC----PDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp -CCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CCCccc----hHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 011112 245778888999999999999999873
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=354.41 Aligned_cols=250 Identities=24% Similarity=0.346 Sum_probs=200.9
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCCh-------------hhHHHHHHHHHHhcccCCCceeEEeeE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSK-------------QGIKEFVAELVSMGRLRHRNLVKLRGY 409 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-------------~~~~~~~~Ei~~l~~l~H~niv~l~g~ 409 (614)
.++|+..+.||+|+||+||+|..+. +..+|+|.+..... ...+.+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 4678889999999999999999875 78899999875421 235678999999999999999999999
Q ss_pred EeecCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCC---CEE
Q 044561 410 CRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADL---NGK 486 (614)
Q Consensus 410 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~---~~k 486 (614)
+.+.+..++|||||++|+|.+++... ..+++.++..++.||+.||.|||+ .+|+||||||+|||++.++ .+|
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSEE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccEE
Confidence 99999999999999999999988764 349999999999999999999995 8999999999999998776 699
Q ss_pred EeeeccccccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhh
Q 044561 487 LGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCW 566 (614)
Q Consensus 487 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~ 566 (614)
|+|||++....... ......||+.|+|||++. +.++.++||||+||++|||++|+.||......+... ..
T Consensus 190 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-------~i 259 (504)
T 3q5i_A 190 IVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIK-------KV 259 (504)
T ss_dssp ECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------HH
T ss_pred EEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HH
Confidence 99999998765543 234457999999999986 568999999999999999999999998755433221 11
Q ss_pred hcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 567 KKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 567 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+.... +....... ...+.+++.+||++||++|||+.|+++
T Consensus 260 ~~~~~~~--~~~~~~~~----s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 260 EKGKYYF--DFNDWKNI----SDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHCCCCC--CHHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HcCCCCC--CccccCCC----CHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 2221110 00001112 245778888899999999999999985
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=338.11 Aligned_cols=249 Identities=28% Similarity=0.462 Sum_probs=197.6
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcE--EEEEEeecC-ChhhHHHHHHHHHHhccc-CCCceeEEeeEEeecCeEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQ--IAVKKVSHD-SKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGEFLLV 419 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~--vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 419 (614)
++|+..+.||+|+||.||+|.... +.. +++|++... .....+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 568889999999999999999865 554 489988754 334456789999999999 899999999999999999999
Q ss_pred EEecCCCCcchhcccCC--------------CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCE
Q 044561 420 YDYMPNGSLDKILHTNI--------------KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG 485 (614)
Q Consensus 420 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~ 485 (614)
|||+++|+|.+++.... ...+++.+++.++.||++||.|||+ .+|+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeE
Confidence 99999999999997642 2469999999999999999999995 899999999999999999999
Q ss_pred EEeeeccccccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHH
Q 044561 486 KLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCD 564 (614)
Q Consensus 486 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~ 564 (614)
||+|||+++...... ......+++.|+|||.+....++.++||||||+++|||++ |+.||......+. .+
T Consensus 182 kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~-------~~ 252 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-------YE 252 (327)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-------HH
T ss_pred EEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH-------HH
Confidence 999999997433221 2233457889999999988889999999999999999998 9999976543221 11
Q ss_pred hhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 565 CWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 565 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
....+.. ......+ ...+.+++.+||+.||++|||+.|+++
T Consensus 253 ~~~~~~~-----~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~ 293 (327)
T 1fvr_A 253 KLPQGYR-----LEKPLNC----DDEVYDLMRQCWREKPYERPSFAQILV 293 (327)
T ss_dssp HGGGTCC-----CCCCTTB----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhhcCCC-----CCCCCCC----CHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1222211 1111122 245778888999999999999999874
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=345.58 Aligned_cols=261 Identities=23% Similarity=0.325 Sum_probs=195.9
Q ss_pred cCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecC------eEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKG------EFLL 418 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------~~~l 418 (614)
.+|+..+.||+|+||.||+|+...+..+|+|++...... ..+|+.+++.++||||+++++++...+ .+++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 357888999999999999999988777999998765332 236999999999999999999986544 3889
Q ss_pred EEEecCCCCcchhcc-cCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEc-CCCCEEEeeecccccc
Q 044561 419 VYDYMPNGSLDKILH-TNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD-ADLNGKLGDFGLARLY 496 (614)
Q Consensus 419 V~E~~~~gsL~~~l~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~-~~~~~kl~DfGla~~~ 496 (614)
||||++++.+..... ......+++..+..++.||++||.|||+ .+|+||||||+|||++ .++.+||+|||+++..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 999998754443332 1123459999999999999999999995 8999999999999999 7999999999999876
Q ss_pred CCCCCCcccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHH------------
Q 044561 497 DHDTIPQTTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVC------------ 563 (614)
Q Consensus 497 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~------------ 563 (614)
.... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+....+....
T Consensus 193 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 270 (394)
T 4e7w_A 193 IAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN 270 (394)
T ss_dssp CTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred cCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 5443 23345789999999998764 58999999999999999999999998765443332221110
Q ss_pred HhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 564 DCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 564 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+.+..+.......+...+.......+.+|+.+||+.||++|||+.|+++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 001111111111111111112223346788889999999999999999975
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=343.76 Aligned_cols=259 Identities=23% Similarity=0.343 Sum_probs=196.0
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeec------C
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRK------G 414 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~ 414 (614)
.++|+..+.||+|+||.||+|.... +..||+|++... .....+++.+|+.+++.++||||+++++++... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 3578889999999999999999864 889999998653 344567889999999999999999999998765 3
Q ss_pred eEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecccc
Q 044561 415 EFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR 494 (614)
Q Consensus 415 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~ 494 (614)
.+|+||||+ +++|.+++... .+++.++..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 569999999 88999998763 48999999999999999999995 899999999999999999999999999998
Q ss_pred ccCCCCCCcccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHH--------h
Q 044561 495 LYDHDTIPQTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCD--------C 565 (614)
Q Consensus 495 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~--------~ 565 (614)
..... ....++|+.|+|||++.+ ..++.++||||+||+++||++|+.||.+....+....+..... .
T Consensus 177 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 252 (367)
T 1cm8_A 177 QADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 252 (367)
T ss_dssp ECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred ccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 76532 334578999999999877 6789999999999999999999999987654333222211100 0
Q ss_pred hhcC-------CccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 566 WKKG-------AIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 566 ~~~~-------~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+... .+.......+.. ........+.+|+.+||+.||++|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 253 LQSDEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhhHHHHHHHHhCCCCCCCCHHH-HCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 0000 000000111110 11112345778888999999999999999874
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=340.23 Aligned_cols=254 Identities=25% Similarity=0.367 Sum_probs=203.7
Q ss_pred HHHhcCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCC--------hhhHHHHHHHHHHhccc-CCCceeEEeeEE
Q 044561 341 YKATKGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDS--------KQGIKEFVAELVSMGRL-RHRNLVKLRGYC 410 (614)
Q Consensus 341 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~ 410 (614)
....++|+..+.||+|+||.||+|+.. ++..||||++.... ....+.+.+|+.+++++ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 334567888999999999999999986 58999999987543 12245678999999999 799999999999
Q ss_pred eecCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeee
Q 044561 411 RRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDF 490 (614)
Q Consensus 411 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~Df 490 (614)
...+..++||||+++++|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+||
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~Df 244 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDF 244 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCC
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEec
Confidence 9999999999999999999999763 359999999999999999999995 89999999999999999999999999
Q ss_pred ccccccCCCCCCcccccccCCCccchhhhcC------CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHH
Q 044561 491 GLARLYDHDTIPQTTKLVGTFGYMDPELMRT------GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCD 564 (614)
Q Consensus 491 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~ 564 (614)
|++....... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||......+.. ..+
T Consensus 245 G~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~---~~i-- 317 (365)
T 2y7j_A 245 GFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILML---RMI-- 317 (365)
T ss_dssp TTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHH--
T ss_pred CcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHH---HHH--
Confidence 9998765433 2344689999999999863 35789999999999999999999999764332211 111
Q ss_pred hhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 565 CWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 565 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+.... ..+. .... ...+.+++.+||+.||++|||+.|+++
T Consensus 318 --~~~~~~~-~~~~-~~~~----~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 318 --MEGQYQF-SSPE-WDDR----SSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp --HHTCCCC-CHHH-HSSS----CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --HhCCCCC-CCcc-cccC----CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111110 0000 0111 235778888999999999999999974
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=339.35 Aligned_cols=259 Identities=21% Similarity=0.319 Sum_probs=205.4
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChh-----------------hHHHHHHHHHHhcccCCCceeEE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQ-----------------GIKEFVAELVSMGRLRHRNLVKL 406 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~Ei~~l~~l~H~niv~l 406 (614)
.++|+..+.||+|+||.||+|.. ++..||+|++...... ..+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 35788999999999999999999 8899999998754221 12788999999999999999999
Q ss_pred eeEEeecCeEEEEEEecCCCCcchh------cccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEc
Q 044561 407 RGYCRRKGEFLLVYDYMPNGSLDKI------LHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD 480 (614)
Q Consensus 407 ~g~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~ 480 (614)
++++.+.+..++||||+++|+|.++ +.......+++..+..++.|++.||.|||+ +.+|+||||||+||+++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMD 186 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEEC
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEc
Confidence 9999999999999999999999999 665445679999999999999999999995 38999999999999999
Q ss_pred CCCCEEEeeeccccccCCCCCCcccccccCCCccchhhhcCC-CCCc-chhHHHHHHHHHHHHcCCCCCCCCCccccccH
Q 044561 481 ADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTG-KAST-STDVYAFGVFMLEVASGRRPVEQQGSMETVNL 558 (614)
Q Consensus 481 ~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~-~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l 558 (614)
.++.+||+|||++...... ......||..|+|||.+.+. .++. ++||||||+++|||++|+.||....... ..
T Consensus 187 ~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~ 261 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV--EL 261 (348)
T ss_dssp TTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH--HH
T ss_pred CCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HH
Confidence 9999999999999876543 23445789999999999877 5655 9999999999999999999998654421 11
Q ss_pred HHHHHHhhhcCCcccccc--ccc-------cCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 559 VDWVCDCWKKGAIRDASD--SRL-------EGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 559 ~~~v~~~~~~~~~~~~~d--~~l-------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.. ....+......+ ... ...........+.+++.+||+.||++|||+.|+++
T Consensus 262 ~~----~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 262 FN----NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HH----HHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HH----HHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11 112221111000 000 00001222346778888999999999999999985
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=333.01 Aligned_cols=249 Identities=27% Similarity=0.384 Sum_probs=197.9
Q ss_pred hcCCCCcc-eeeeeCcEEEEEEEEe---cCcEEEEEEeecCC--hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEE
Q 044561 344 TKGFKDKD-VIGRGGFGKVYRGVLA---SNVQIAVKKVSHDS--KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFL 417 (614)
Q Consensus 344 ~~~f~~~~-~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 417 (614)
.++|...+ .||+|+||.||+|.+. .+..||+|++.... ....+++.+|+.++++++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 35666677 8999999999999753 25789999987543 33467899999999999999999999999 667889
Q ss_pred EEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccC
Q 044561 418 LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYD 497 (614)
Q Consensus 418 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~ 497 (614)
+||||+++++|.+++... ..+++.++..++.|+++||.|||+ .+|+||||||+||+++.++.+||+|||++....
T Consensus 94 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 999999999999999874 348999999999999999999995 899999999999999999999999999998765
Q ss_pred CCCCC--cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCcccc
Q 044561 498 HDTIP--QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDA 574 (614)
Q Consensus 498 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~ 574 (614)
..... ......+++.|+|||.+....++.++||||||+++|||++ |+.||......+. ......+...
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-------~~~~~~~~~~-- 239 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-------TAMLEKGERM-- 239 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-------HHHHHTTCCC--
T ss_pred cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-------HHHHHcCCCC--
Confidence 44321 1222356788999999988889999999999999999999 9999976543321 1111222111
Q ss_pred ccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 575 SDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 575 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.. +......+.+++.+||+.||++|||+.|+++
T Consensus 240 ---~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 240 ---GC----PAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp ---CC----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ---CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11 1122345778888999999999999999874
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=331.87 Aligned_cols=245 Identities=30% Similarity=0.434 Sum_probs=192.8
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeec-CeEEEEEEe
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRK-GEFLLVYDY 422 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~lV~E~ 422 (614)
.++|+..+.||+|+||.||++..+ +..||+|.+.... ..+.+.+|+.++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 356888999999999999999874 7889999987553 456789999999999999999999997554 578999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 502 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 502 (614)
+++++|.+++.......+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 171 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 171 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence 999999999976544448899999999999999999995 899999999999999999999999999998654322
Q ss_pred cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccccC
Q 044561 503 QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEG 581 (614)
Q Consensus 503 ~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~ 581 (614)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.. . ....+.. .....
T Consensus 172 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~---~----~~~~~~~-----~~~~~ 237 (278)
T 1byg_A 172 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---P----RVEKGYK-----MDAPD 237 (278)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH---H----HHTTTCC-----CCCCT
T ss_pred --cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH---H----HHhcCCC-----CCCcc
Confidence 23367889999999998899999999999999999998 99999765433221 1 1111111 11112
Q ss_pred cCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 582 ICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 582 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+ ...+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~----~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 238 GC----PPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp TC----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cC----CHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 22 345777888899999999999999873
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=330.66 Aligned_cols=250 Identities=28% Similarity=0.464 Sum_probs=195.4
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec----CcEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEe-ecCeEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS----NVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCR-RKGEFLL 418 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~-~~~~~~l 418 (614)
.+|+..+.||+|+||.||+|...+ ...+|+|.+... .....+.+.+|+.++++++||||++++++|. .++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 357778999999999999999643 235899988754 3445678999999999999999999999865 4567899
Q ss_pred EEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCC
Q 044561 419 VYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 498 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~ 498 (614)
||||+++|+|.+++... ...+++.++..++.|+++||.|||+ ++|+||||||+||+++.++.+||+|||+++....
T Consensus 105 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccccccc
Confidence 99999999999999764 3458999999999999999999995 8999999999999999999999999999986644
Q ss_pred CCC---CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCcccc
Q 044561 499 DTI---PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDA 574 (614)
Q Consensus 499 ~~~---~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~ 574 (614)
... .......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||......+. ..... .+...
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~---~~~~~----~~~~~-- 251 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVYLL----QGRRL-- 251 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH---HHHHH----TTCCC--
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH---HHHHh----cCCCC--
Confidence 321 12233467889999999999999999999999999999999 5556654433222 11111 11100
Q ss_pred ccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 575 SDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 575 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.....+ ...+.+++.+||++||++|||+.|+++
T Consensus 252 ---~~~~~~----~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 252 ---LQPEYC----PDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp ---CCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---CCCccC----CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 001112 235778888999999999999999874
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=329.88 Aligned_cols=250 Identities=24% Similarity=0.350 Sum_probs=198.3
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC----hhhHHHHHHHHHHhcccCCCceeEEeeEE--eecCeE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS----KQGIKEFVAELVSMGRLRHRNLVKLRGYC--RRKGEF 416 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~--~~~~~~ 416 (614)
.++|+..+.||+|+||.||++.... +..+|+|.+.... ....+.+.+|+.++++++||||+++++++ .+.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 4679999999999999999999864 7889999987542 23457889999999999999999999998 455689
Q ss_pred EEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecccccc
Q 044561 417 LLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 496 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~ 496 (614)
++||||++++ |.+++.......+++.++..++.|+++||.|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999876 7777766555669999999999999999999995 89999999999999999999999999999876
Q ss_pred CCCC-CCcccccccCCCccchhhhcCCC--CCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccc
Q 044561 497 DHDT-IPQTTKLVGTFGYMDPELMRTGK--ASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRD 573 (614)
Q Consensus 497 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~ 573 (614)
.... ........||+.|+|||++.+.. ++.++||||||+++|||++|+.||......+. .+....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~i~~~~~-- 230 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL-------FENIGKGSY-- 230 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-------HHHHHHCCC--
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH-------HHHHhcCCC--
Confidence 5322 12233457899999999987644 37899999999999999999999976433221 111122211
Q ss_pred cccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 574 ASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 574 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+...++ ..+.+++.+||+.||++|||+.|+++
T Consensus 231 ----~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 231 ----AIPGDCG----PPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp ----CCCSSSC----HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----CCCCccC----HHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1112222 35677888899999999999999974
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=342.53 Aligned_cols=252 Identities=12% Similarity=0.067 Sum_probs=181.6
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCCh---hhHHHHHHHH---HHhcccCCCceeEEe-------eEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSK---QGIKEFVAEL---VSMGRLRHRNLVKLR-------GYC 410 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei---~~l~~l~H~niv~l~-------g~~ 410 (614)
.+|+..+.||+|+||.||+|... ++..||+|++..... ...+.+.+|+ ..++. +||||++++ +++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence 45888899999999999999986 488999999987542 3455677775 45555 699988855 344
Q ss_pred eec-----------------CeEEEEEEecCCCCcchhcccCCCCCcChhHH------HHHHHHhHhhchhhhccCCCce
Q 044561 411 RRK-----------------GEFLLVYDYMPNGSLDKILHTNIKPCLNWYQR------FRIIRGVASGLLYLHEDWEQVV 467 (614)
Q Consensus 411 ~~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~i 467 (614)
... ..+++|||||+ |+|.+++.... ..+++..+ ..++.||++||.|||+ ++|
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~i 215 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQS---KGL 215 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHH---CCC
Confidence 332 34899999998 89999998642 23567777 8888999999999995 899
Q ss_pred EecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcccccccCCCccchhhhcC--CCCCcchhHHHHHHHHHHHHcCCC
Q 044561 468 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRT--GKASTSTDVYAFGVFMLEVASGRR 545 (614)
Q Consensus 468 vHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~~~Dv~S~Gvll~el~tg~~ 545 (614)
+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999866432 224467799999999987 678999999999999999999999
Q ss_pred CCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 546 PVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 546 p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
||.......... +..............-.........+.+++.+||+.||++|||+.|+++
T Consensus 292 Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 292 PFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp STTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 998654321110 0000000000111110001122345778888999999999999999985
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=340.34 Aligned_cols=254 Identities=17% Similarity=0.166 Sum_probs=198.4
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec---------CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeE----------
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS---------NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVK---------- 405 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~---------- 405 (614)
++|+..+.||+|+||.||+|+... +..||+|.+... +.+.+|+.++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 578889999999999999999864 678999998755 35788999999999999988
Q ss_pred -----EeeEEee-cCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEE
Q 044561 406 -----LRGYCRR-KGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL 479 (614)
Q Consensus 406 -----l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll 479 (614)
+++++.. .+..++||||+ +++|.+++.......+++.+++.++.||+.||.|||+ .+|+||||||+|||+
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFV 192 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGEEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEE
Confidence 6677766 67899999999 9999999987644669999999999999999999995 899999999999999
Q ss_pred cCCC--CEEEeeeccccccCCCCC------CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Q 044561 480 DADL--NGKLGDFGLARLYDHDTI------PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQG 551 (614)
Q Consensus 480 ~~~~--~~kl~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~ 551 (614)
+.++ .+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9998 999999999986543221 11233579999999999999899999999999999999999999997654
Q ss_pred ccccccHHHHHHHhhhcCCcccccccccc-CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 552 SMETVNLVDWVCDCWKKGAIRDASDSRLE-GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 552 ~~~~~~l~~~v~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.... .... ....+.. ......+.... ..+ ...+.+++.+||+.||++|||+.||++
T Consensus 273 ~~~~-~~~~-~~~~~~~-~~~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 273 PNTE-DIMK-QKQKFVD-KPGPFVGPCGHWIRP----SETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp TCHH-HHHH-HHHHHHH-SCCCEECTTSCEECC----CHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cCHH-HHHH-HHHhccC-ChhhhhhhccccCCC----cHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 2211 1111 1111111 11111111110 112 245777888899999999999999863
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=334.76 Aligned_cols=252 Identities=22% Similarity=0.374 Sum_probs=197.8
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
.++|+..+.||+|+||.||+|.... +..+|+|.+........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 4578889999999999999999875 888999999877666678899999999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 502 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 502 (614)
+++++|.+++... ...+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++....... .
T Consensus 98 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 172 (302)
T 2j7t_A 98 CPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-Q 172 (302)
T ss_dssp CTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-H
T ss_pred CCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCccccccc-c
Confidence 9999999988753 2349999999999999999999995 899999999999999999999999999976432111 0
Q ss_pred cccccccCCCccchhhh-----cCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccc
Q 044561 503 QTTKLVGTFGYMDPELM-----RTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDS 577 (614)
Q Consensus 503 ~~~~~~gt~~y~aPE~~-----~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~ 577 (614)
......||+.|+|||++ ....++.++||||||+++|||++|+.||......+. ..... .+......
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~-~~~~~~~~-- 243 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKIA-KSDPPTLL-- 243 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHH-HSCCCCCS--
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH------HHHHh-ccCCcccC--
Confidence 12234689999999998 356789999999999999999999999976543221 11111 11111110
Q ss_pred cccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 578 RLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 578 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+......+.+++.+||+.||++|||+.|+++
T Consensus 244 -----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 244 -----TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -----SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -----CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 11112245778888899999999999999975
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=335.01 Aligned_cols=257 Identities=24% Similarity=0.393 Sum_probs=194.1
Q ss_pred HHHHHhcCCCCcceeeeeCcEEEEEEEEec----CcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEee
Q 044561 339 DLYKATKGFKDKDVIGRGGFGKVYRGVLAS----NVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRR 412 (614)
Q Consensus 339 el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 412 (614)
++....++|...+.||+|+||.||+|.... +..||+|++... .....+.+.+|+.++++++||||+++++++..
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 333445678888999999999999998753 347999998754 44556789999999999999999999999977
Q ss_pred cC-----eEEEEEEecCCCCcchhcccC----CCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCC
Q 044561 413 KG-----EFLLVYDYMPNGSLDKILHTN----IKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADL 483 (614)
Q Consensus 413 ~~-----~~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~ 483 (614)
.+ ..++||||+++|+|.+++... ....+++.+++.++.|+++||.|||+ .+|+||||||+||+++.++
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTS
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCC
Confidence 55 359999999999999998432 23569999999999999999999994 8999999999999999999
Q ss_pred CEEEeeeccccccCCCCC-CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHH
Q 044561 484 NGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDW 561 (614)
Q Consensus 484 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~ 561 (614)
.+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.. ..
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~~ 261 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY---DY 261 (313)
T ss_dssp CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH---HH
T ss_pred cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH---HH
Confidence 999999999986644321 12233467889999999999999999999999999999999 88999765543322 11
Q ss_pred HHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 562 VCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 562 v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+. .+... ..... ....+.+++.+||+.||++|||+.++++
T Consensus 262 ~~----~~~~~-----~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~ 301 (313)
T 3brb_A 262 LL----HGHRL-----KQPED----CLDELYEIMYSCWRTDPLDRPTFSVLRL 301 (313)
T ss_dssp HH----TTCCC-----CCBTT----CCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HH----cCCCC-----CCCcc----ccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11 11111 11112 2345778888999999999999999873
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=329.03 Aligned_cols=257 Identities=20% Similarity=0.288 Sum_probs=198.1
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCChhhHHHHHHHHHHhcccC-CCceeEEeeEEee--cCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLR-HRNLVKLRGYCRR--KGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~--~~~~~lV~ 420 (614)
++|+..+.||+|+||.||+|+.. +++.||+|++.... .+.+.+|+.++++++ ||||+++++++.. ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 56888999999999999999975 48899999987544 356889999999997 9999999999987 67899999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCC-CEEEeeeccccccCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADL-NGKLGDFGLARLYDHD 499 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~-~~kl~DfGla~~~~~~ 499 (614)
||+++++|.+++.. +++.++..++.|++.||.|||+ .+|+||||||+|||++.++ .+||+|||+++.....
T Consensus 113 e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 113 EHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp ECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred eccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 99999999998853 8899999999999999999995 8999999999999999776 8999999999876544
Q ss_pred CCCcccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcc-ccccHHH------HHHHhhhcCCc
Q 044561 500 TIPQTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSM-ETVNLVD------WVCDCWKKGAI 571 (614)
Q Consensus 500 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~-~~~~l~~------~v~~~~~~~~~ 571 (614)
. ......||..|+|||++.+ ..++.++|||||||++|||++|+.||...... +...... ...+...+...
T Consensus 185 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T 3nsz_A 185 Q--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262 (330)
T ss_dssp C--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred C--ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence 3 2334578999999999877 67899999999999999999999999643321 1111000 00000000000
Q ss_pred --------------cccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 572 --------------RDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 572 --------------~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
...................+.+++.+||+.||++|||+.|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000011111112356788889999999999999999985
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=334.64 Aligned_cols=263 Identities=24% Similarity=0.350 Sum_probs=201.2
Q ss_pred HHhcCCCCcceeeeeCcEEEEEEEEe--cCcEEEEEEeecCCh--hhHHHHHHHHHHhccc---CCCceeEEeeEEe---
Q 044561 342 KATKGFKDKDVIGRGGFGKVYRGVLA--SNVQIAVKKVSHDSK--QGIKEFVAELVSMGRL---RHRNLVKLRGYCR--- 411 (614)
Q Consensus 342 ~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~--- 411 (614)
.+.++|+..+.||+|+||.||+|... ++..||+|++..... .....+.+|+.+++.+ +||||++++++|.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 34578999999999999999999984 478899998864321 1123455676666655 8999999999987
Q ss_pred --ecCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEee
Q 044561 412 --RKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGD 489 (614)
Q Consensus 412 --~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~D 489 (614)
.....++||||++ |+|.+++.......+++.++..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEec
Confidence 5678999999997 699999987655669999999999999999999995 8999999999999999999999999
Q ss_pred eccccccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhc-
Q 044561 490 FGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKK- 568 (614)
Q Consensus 490 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~- 568 (614)
||++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+... .+.+....
T Consensus 164 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~i~~~~~~~ 238 (326)
T 1blx_A 164 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG---KILDVIGLP 238 (326)
T ss_dssp CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCC
T ss_pred CcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH---HHHHHcCCC
Confidence 99998654322 2334578999999999999899999999999999999999999998655433222 22211110
Q ss_pred --CCcccc-----------ccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 569 --GAIRDA-----------SDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 569 --~~~~~~-----------~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+... ....+ ..........+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 239 GEEDWPRDVALPRQAFHSKSAQPI-EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCG-GGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CcccCccccccchhhhcccCcchh-hhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 00000 0111122345778888999999999999999984
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=331.61 Aligned_cols=253 Identities=28% Similarity=0.435 Sum_probs=191.8
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecC---ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
.+|+..+.||+|+||.||+|... ++..||+|++... .....+++.+|+.++++++||||+++++++...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 46888899999999999999975 5889999999753 3455678899999999999999999999999999999999
Q ss_pred EecCCCCcchhcccC--CCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCC
Q 044561 421 DYMPNGSLDKILHTN--IKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 498 (614)
Q Consensus 421 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~ 498 (614)
||+++++|.+++... ....+++.+++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 999999999998642 23458999999999999999999995 8999999999999999999999999999986654
Q ss_pred CCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccc
Q 044561 499 DTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSR 578 (614)
Q Consensus 499 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~ 578 (614)
... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .... ......+......
T Consensus 189 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~----~~~~~~~~~~~~~--- 259 (310)
T 2wqm_A 189 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSL----CKKIEQCDYPPLP--- 259 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC-HHHH----HHHHHTTCSCCCC---
T ss_pred CCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh-HHHH----HHHhhcccCCCCc---
Confidence 321 223457899999999999999999999999999999999999999754321 1111 1122222221111
Q ss_pred ccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 579 LEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 579 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
...+ ...+.+++.+||+.||++|||+.||++
T Consensus 260 -~~~~----~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 260 -SDHY----SEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp -TTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -cccc----CHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1112 235777888899999999999999874
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=365.33 Aligned_cols=242 Identities=28% Similarity=0.415 Sum_probs=193.5
Q ss_pred ceeeeeCcEEEEEEEEe---cCcEEEEEEeecCC--hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecCC
Q 044561 351 DVIGRGGFGKVYRGVLA---SNVQIAVKKVSHDS--KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPN 425 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 425 (614)
+.||+|+||.||+|.+. .+..||||++.... ....+++.+|+.++++++||||++++++|.. +..++|||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999764 25789999997643 3446789999999999999999999999964 568999999999
Q ss_pred CCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCC--Cc
Q 044561 426 GSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI--PQ 503 (614)
Q Consensus 426 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~--~~ 503 (614)
|+|.+++... ..+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 454 g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 454 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence 9999999764 359999999999999999999995 8999999999999999999999999999987654331 12
Q ss_pred ccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCc
Q 044561 504 TTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGI 582 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 582 (614)
.....+|+.|+|||++....++.++|||||||++|||++ |+.||......+.. .....+....
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~-------~~i~~~~~~~--------- 592 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-------AMLEKGERMG--------- 592 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-------HHHHTTCCCC---------
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCCCCC---------
Confidence 233456789999999999999999999999999999998 99999876543322 1222222111
Q ss_pred CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 583 CEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 583 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+......+.+++.+||+.||++||++.+|++
T Consensus 593 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 593 CPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 11222346778888999999999999999863
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=327.90 Aligned_cols=246 Identities=23% Similarity=0.403 Sum_probs=194.1
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
++|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 57888999999999999999987 58899999986542 223567889999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
||+++++|.+++... ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 91 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 91 EYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp ECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred eccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 999999999999764 348999999999999999999995 899999999999999999999999999998765432
Q ss_pred CCcccccccCCCccchhhhcCCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMRTGKA-STSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRL 579 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~~~-t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 579 (614)
......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||......+. .+....+.. .+
T Consensus 166 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------~~~~~~~~~------~~ 230 (276)
T 2h6d_A 166 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL-------FKKIRGGVF------YI 230 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCC------CC
T ss_pred --ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH-------HHHhhcCcc------cC
Confidence 2234578999999999987665 6899999999999999999999976433221 111111111 01
Q ss_pred cCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 580 EGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 580 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
...+ ...+.+++.+|++.||++|||+.|+++
T Consensus 231 ~~~~----~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 231 PEYL----NRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chhc----CHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 1122 234677888899999999999999974
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=337.99 Aligned_cols=261 Identities=22% Similarity=0.259 Sum_probs=192.8
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecC------
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKG------ 414 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 414 (614)
.++|+..+.||+|+||.||+|.... +..||+|++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 3678899999999999999999764 888999999754 3445677899999999999999999999987654
Q ss_pred eEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecccc
Q 044561 415 EFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR 494 (614)
Q Consensus 415 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~ 494 (614)
..++||||++ ++|.+.+.. .+++.++..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred ceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 7899999996 578887753 38899999999999999999995 899999999999999999999999999998
Q ss_pred ccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHH--------------
Q 044561 495 LYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVD-------------- 560 (614)
Q Consensus 495 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~-------------- 560 (614)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.
T Consensus 176 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 176 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred cccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 665432 2334579999999999999899999999999999999999999998754332211110
Q ss_pred --HHHHhhhcC-Cc-----cccccccc-c--CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 561 --WVCDCWKKG-AI-----RDASDSRL-E--GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 561 --~v~~~~~~~-~~-----~~~~d~~l-~--~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+....... .. ........ . ..........+.+|+.+||+.||++|||+.|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 000000000 00 00000000 0 0011223567889999999999999999999974
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=337.34 Aligned_cols=244 Identities=14% Similarity=0.121 Sum_probs=191.2
Q ss_pred HHhcCCCCcceeeeeCcEEEEEEE------EecCcEEEEEEeecCChhhHHHHHHHHHHhcccC---CCceeEEeeEEee
Q 044561 342 KATKGFKDKDVIGRGGFGKVYRGV------LASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLR---HRNLVKLRGYCRR 412 (614)
Q Consensus 342 ~~~~~f~~~~~lG~G~fg~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~ 412 (614)
...++|...+.||+|+||.||+|. ...+..||+|++...... ++..|+.+++.++ |+||+++++++..
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW---EFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHH---HHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChh---HHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 344678889999999999999994 345788999999766544 4555665555554 9999999999999
Q ss_pred cCeEEEEEEecCCCCcchhcccC---CCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcC--------
Q 044561 413 KGEFLLVYDYMPNGSLDKILHTN---IKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA-------- 481 (614)
Q Consensus 413 ~~~~~lV~E~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~-------- 481 (614)
.+..++|||||++|+|.+++... ....+++.++..++.||+.||.|||+ .+|+||||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCcccc
Confidence 99999999999999999999742 23469999999999999999999994 89999999999999998
Q ss_pred ---CCCEEEeeeccccccCC-CCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcccccc
Q 044561 482 ---DLNGKLGDFGLARLYDH-DTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVN 557 (614)
Q Consensus 482 ---~~~~kl~DfGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~ 557 (614)
++.+||+|||+++.... .........+||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-- 293 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC-- 293 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE--
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce--
Confidence 89999999999976542 222234556899999999999998999999999999999999999999854322110
Q ss_pred HHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCC-CHHHH
Q 044561 558 LVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARP-NMRQV 612 (614)
Q Consensus 558 l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~ev 612 (614)
.....+..... .+.+.+++..|++.+|.+|+ +++++
T Consensus 294 ----------------~~~~~~~~~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l 330 (365)
T 3e7e_A 294 ----------------KPEGLFRRLPH---LDMWNEFFHVMLNIPDCHHLPSLDLL 330 (365)
T ss_dssp ----------------EECSCCTTCSS---HHHHHHHHHHHHCCCCTTCCCCHHHH
T ss_pred ----------------eechhccccCc---HHHHHHHHHHHcCCCCCCcchHHHHH
Confidence 01111111122 23455666779999999984 55544
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=347.86 Aligned_cols=259 Identities=25% Similarity=0.332 Sum_probs=193.1
Q ss_pred CCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeec------CeEEE
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRK------GEFLL 418 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~~~l 418 (614)
+|+..+.||+|+||.||+|+... ++.||||++...... ..+|++++++++||||+++++++... ..+++
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh----HHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 57778999999999999999865 889999999765322 34799999999999999999988542 24779
Q ss_pred EEEecCCCCcchhccc--CCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCC-CCEEEeeeccccc
Q 044561 419 VYDYMPNGSLDKILHT--NIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDAD-LNGKLGDFGLARL 495 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~-~~~kl~DfGla~~ 495 (614)
||||+++ +|.+.+.. .....+++..+..++.||++||.||| ..+|+||||||+|||++.+ +.+||+|||+++.
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 9999975 56555542 22356999999999999999999999 4899999999999999965 5689999999987
Q ss_pred cCCCCCCcccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHH-----hhh--
Q 044561 496 YDHDTIPQTTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCD-----CWK-- 567 (614)
Q Consensus 496 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~-----~~~-- 567 (614)
..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+.+..+..... .+.
T Consensus 207 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~ 284 (420)
T 1j1b_A 207 LVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 284 (420)
T ss_dssp CCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred cccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 65433 23345789999999998764 789999999999999999999999987654333222211100 000
Q ss_pred cCCcccccccccc-----CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 568 KGAIRDASDSRLE-----GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 568 ~~~~~~~~d~~l~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.....+...+.+. ..+.......+.+|+.+||+.||++|||+.|+++
T Consensus 285 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 0011111111111 0111222356788888999999999999999974
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=330.01 Aligned_cols=251 Identities=24% Similarity=0.406 Sum_probs=199.4
Q ss_pred HhcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEE
Q 044561 343 ATKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 343 ~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 421 (614)
..++|+..+.||+|+||.||+|.... +..||+|.+.... ..+++.+|+.++++++||||+++++++...+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 34678889999999999999999875 8899999997654 34678899999999999999999999999999999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCC
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI 501 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~ 501 (614)
|+++++|.+++... ...+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 105 ~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 105 YCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp CCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred cCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 99999999998643 2458999999999999999999995 8999999999999999999999999999987654321
Q ss_pred CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccC
Q 044561 502 PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEG 581 (614)
Q Consensus 502 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~ 581 (614)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.. .. ...+.......
T Consensus 181 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~-~~~~~~~~~~~----- 247 (314)
T 3com_A 181 -KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI------FM-IPTNPPPTFRK----- 247 (314)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HH-HHHSCCCCCSS-----
T ss_pred -ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH------HH-HhcCCCcccCC-----
Confidence 233457899999999999889999999999999999999999999764432211 11 11111111100
Q ss_pred cCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 582 ICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 582 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+......+.+++.+||+.||++|||+.|+++
T Consensus 248 --~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 248 --PELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp --GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 1112245778888999999999999999985
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=333.67 Aligned_cols=251 Identities=22% Similarity=0.334 Sum_probs=196.1
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC--------hhhHHHHHHHHHHhcccCCCceeEEeeEEeecC
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS--------KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKG 414 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 414 (614)
.++|+..+.||+|+||.||+|.... +..||+|.+.... ......+.+|+.++++++||||+++++++...+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 3568889999999999999999865 7889999986532 122345789999999999999999999987655
Q ss_pred eEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCC---EEEeeec
Q 044561 415 EFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLN---GKLGDFG 491 (614)
Q Consensus 415 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~---~kl~DfG 491 (614)
.++||||+++++|.+++... ..+++.++..++.||+.||.|||+ .+|+||||||+|||++.++. +||+|||
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred -eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 89999999999999988754 358999999999999999999995 89999999999999987665 9999999
Q ss_pred cccccCCCCCCcccccccCCCccchhhhc---CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhc
Q 044561 492 LARLYDHDTIPQTTKLVGTFGYMDPELMR---TGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKK 568 (614)
Q Consensus 492 la~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~ 568 (614)
++....... ......||+.|+|||++. ...++.++|||||||++|||++|+.||........ +...+ ..
T Consensus 163 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~----~~ 234 (322)
T 2ycf_A 163 HSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQI----TS 234 (322)
T ss_dssp TCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHH----HH
T ss_pred cceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHH----Hh
Confidence 998765432 223457899999999974 46789999999999999999999999976543322 11111 11
Q ss_pred CCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 569 GAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 569 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+.... .+..... ..+.+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~--~~~~~~~----~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 235 GKYNF--IPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp TCCCC--CHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred Ccccc--Cchhhhh----cCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 11110 0111111 2345778888999999999999999985
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=340.21 Aligned_cols=265 Identities=25% Similarity=0.320 Sum_probs=202.2
Q ss_pred HhcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEeec-----Ce
Q 044561 343 ATKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRK-----GE 415 (614)
Q Consensus 343 ~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~ 415 (614)
...+|+..+.||+|+||.||+|.... +..||+|++... .....+.+.+|+.++++++||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 34678999999999999999999764 788999999754 344457889999999999999999999998655 47
Q ss_pred EEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccc
Q 044561 416 FLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARL 495 (614)
Q Consensus 416 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~ 495 (614)
.++||||++ |+|.+++... .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++..
T Consensus 105 ~~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 899999996 6899988753 49999999999999999999995 8999999999999999999999999999987
Q ss_pred cCCCCC--CcccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcc
Q 044561 496 YDHDTI--PQTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIR 572 (614)
Q Consensus 496 ~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~ 572 (614)
...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+...........+.
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 257 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 653321 11244589999999998754 458999999999999999999999998766544333221110000000000
Q ss_pred ccc------------cc-cc-cCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 573 DAS------------DS-RL-EGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 573 ~~~------------d~-~l-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
... .. .. ...........+.+|+.+||+.||++|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 00 00 00000111245778888999999999999999985
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=344.45 Aligned_cols=259 Identities=23% Similarity=0.332 Sum_probs=184.1
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeec------C
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRK------G 414 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~ 414 (614)
.++|+..+.||+|+||.||+|.... +..||+|++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 3678889999999999999999754 889999998653 344567889999999999999999999998654 5
Q ss_pred eEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecccc
Q 044561 415 EFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR 494 (614)
Q Consensus 415 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~ 494 (614)
..++|+||+ +++|.+++.. ..+++.++..++.||++||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred eEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 689999999 7899998875 349999999999999999999995 899999999999999999999999999998
Q ss_pred ccCCCCCCcccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccc
Q 044561 495 LYDHDTIPQTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRD 573 (614)
Q Consensus 495 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~ 573 (614)
..... .....||+.|+|||++.+ ..++.++|||||||+++||++|+.||.+....+....+...........+..
T Consensus 181 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 256 (367)
T 2fst_X 181 HTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred ccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 65432 334579999999999876 6789999999999999999999999987654433322211110000000000
Q ss_pred c---------------ccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 574 A---------------SDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 574 ~---------------~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
. ....+...+ ......+.+|+.+||+.||++|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 257 ISSESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHT-TTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhHHHHHHHhccCCCCCCCHHHHC-CCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 0 000000000 011245778888999999999999999985
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=342.93 Aligned_cols=257 Identities=23% Similarity=0.400 Sum_probs=202.1
Q ss_pred cCCCCcceeeeeCcEEEEEEEE-----ecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecC--eEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVL-----ASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKG--EFL 417 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~ 417 (614)
++|+..+.||+|+||.||++++ .++..||+|++........+.+.+|+.++++++||||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 4577889999999999999984 247889999998877777788999999999999999999999987654 789
Q ss_pred EEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccC
Q 044561 418 LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYD 497 (614)
Q Consensus 418 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~ 497 (614)
+||||+++++|.+++.... ..+++.+++.++.|+++||.|||+ .+|+||||||+||+++.++.+||+|||++....
T Consensus 121 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp EEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 9999999999999998653 458999999999999999999995 899999999999999999999999999998765
Q ss_pred CCCCC--cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCc---------cccccHHHHHHHhh
Q 044561 498 HDTIP--QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGS---------METVNLVDWVCDCW 566 (614)
Q Consensus 498 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~---------~~~~~l~~~v~~~~ 566 (614)
..... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+..... .........+.+..
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHh
Confidence 44321 12234567789999999988899999999999999999999999753210 00000111111111
Q ss_pred hcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 567 KKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 567 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+... . .+......+.+++.+||+.||++|||+.||++
T Consensus 277 ~~~~~~-----~----~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 277 KNNGRL-----P----RPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HTTCCC-----C----CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hcCCCC-----C----CCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 111111 0 11122345778888999999999999999873
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=352.99 Aligned_cols=250 Identities=24% Similarity=0.366 Sum_probs=200.6
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCC--hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDS--KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
.++|+..+.||+|+||+||+|... ++..||+|++.... ......+.+|+.++++++||||+++++++...+.+++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 356888999999999999999986 48899999986432 234567899999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEc---CCCCEEEeeeccccccC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD---ADLNGKLGDFGLARLYD 497 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~---~~~~~kl~DfGla~~~~ 497 (614)
|||++|+|.+.+... ..+++.++..++.||+.||.|||+ .+|+||||||+|||++ .++.+||+|||+++...
T Consensus 101 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 999999999988764 359999999999999999999995 8999999999999995 45679999999998765
Q ss_pred CCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccc
Q 044561 498 HDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDS 577 (614)
Q Consensus 498 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~ 577 (614)
... .....+||+.|+|||++.+ .++.++||||+||++|||++|+.||......+... ....+..... .+
T Consensus 176 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-------~i~~~~~~~~-~~ 244 (486)
T 3mwu_A 176 QNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK-------RVETGKYAFD-LP 244 (486)
T ss_dssp CC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------HHHHTCCCSC-SG
T ss_pred CCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHHhCCCCCC-Cc
Confidence 433 2344579999999999875 58999999999999999999999997654432221 1112211110 01
Q ss_pred cccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 578 RLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 578 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
. ...+ ...+.+++.+||+.||++|||+.|+++
T Consensus 245 ~-~~~~----s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 245 Q-WRTI----SDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp G-GGGS----CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred c-cCCC----CHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1 1112 235678888899999999999999974
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=336.80 Aligned_cols=248 Identities=23% Similarity=0.325 Sum_probs=182.2
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCChhhHHHHHHHHHHhcccC-CCceeEEeeEEe--------ec
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLR-HRNLVKLRGYCR--------RK 413 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~--------~~ 413 (614)
..+|+..+.||+|+||.||+|+.. ++..||+|++........+.+.+|+.+++++. ||||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 346888999999999999999986 48899999998777777788999999999996 999999999983 34
Q ss_pred CeEEEEEEecCCCCcchhccc-CCCCCcChhHHHHHHHHhHhhchhhhccCCCc--eEecCcCCCCeEEcCCCCEEEeee
Q 044561 414 GEFLLVYDYMPNGSLDKILHT-NIKPCLNWYQRFRIIRGVASGLLYLHEDWEQV--VLHRDIKPANVLLDADLNGKLGDF 490 (614)
Q Consensus 414 ~~~~lV~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDikp~NIll~~~~~~kl~Df 490 (614)
..+++||||++ |+|.+++.. .....+++.+++.++.||+.||.|||+ .+ |+||||||+|||++.++.+||+||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEecC
Confidence 56899999995 799888864 223459999999999999999999995 66 999999999999999999999999
Q ss_pred ccccccCCCCCC-----------cccccccCCCccchhhh---cCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccc
Q 044561 491 GLARLYDHDTIP-----------QTTKLVGTFGYMDPELM---RTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETV 556 (614)
Q Consensus 491 Gla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~ 556 (614)
|++......... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||......+..
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~ 262 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV 262 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhh
Confidence 999876543211 11234689999999998 5667899999999999999999999999754322111
Q ss_pred cHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 557 NLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 557 ~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+..... ..... ...+.+++.+||+.||++|||+.|+++
T Consensus 263 -----------~~~~~~~----~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~ 301 (337)
T 3ll6_A 263 -----------NGKYSIP----PHDTQ----YTVFHSLIRAMLQVNPEERLSIAEVVH 301 (337)
T ss_dssp --------------CCCC----TTCCS----SGGGHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -----------cCcccCC----ccccc----chHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0000000 00111 123667888999999999999999874
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=336.16 Aligned_cols=252 Identities=28% Similarity=0.464 Sum_probs=199.0
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEe------cCcEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLA------SNVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEF 416 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 416 (614)
.++|+..+.||+|+||.||+|++. .+..||+|++... ......++.+|+.++++++||||+++++++...+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 357888999999999999999842 3678999999754 445567899999999999999999999999999999
Q ss_pred EEEEEecCCCCcchhcccCCC-----CCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcC---CCCEEEe
Q 044561 417 LLVYDYMPNGSLDKILHTNIK-----PCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA---DLNGKLG 488 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~---~~~~kl~ 488 (614)
++||||+++++|.+++..... ..+++.+++.++.|++.||.|||+ .+|+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999976432 458999999999999999999995 89999999999999984 4569999
Q ss_pred eeccccccCCCC-CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhh
Q 044561 489 DFGLARLYDHDT-IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCW 566 (614)
Q Consensus 489 DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~ 566 (614)
|||++....... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+. .. ..
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~----~~ 258 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV---LE----FV 258 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---HH----HH
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHH---HH----HH
Confidence 999997654332 122334568899999999998899999999999999999998 9999976543221 11 11
Q ss_pred hcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 567 KKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 567 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+.... ....+ ...+.+++.+||+.||++|||+.|+++
T Consensus 259 ~~~~~~~-----~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~ 297 (327)
T 2yfx_A 259 TSGGRMD-----PPKNC----PGPVYRIMTQCWQHQPEDRPNFAIILE 297 (327)
T ss_dssp HTTCCCC-----CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hcCCCCC-----CCCCC----CHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1211111 11122 245778888999999999999999874
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=333.90 Aligned_cols=260 Identities=24% Similarity=0.336 Sum_probs=195.1
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEe------------
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCR------------ 411 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~------------ 411 (614)
++|+..+.||+|+||.||+|.... ++.||+|++........+++.+|+.++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 578889999999999999999876 8899999998877777889999999999999999999999873
Q ss_pred --ecCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEc-CCCCEEEe
Q 044561 412 --RKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD-ADLNGKLG 488 (614)
Q Consensus 412 --~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~-~~~~~kl~ 488 (614)
+.+..++||||++ |+|.+++.. ..+++.++..++.|++.||.|||+ .+|+||||||+||+++ +++.+||+
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred ccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEEc
Confidence 4468899999997 699999865 348999999999999999999995 8999999999999997 56799999
Q ss_pred eeccccccCCCCC--CcccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHh
Q 044561 489 DFGLARLYDHDTI--PQTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDC 565 (614)
Q Consensus 489 DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~ 565 (614)
|||+++....... .......+|..|+|||.+.. ..++.++||||||+++|||++|+.||......+....+ .+.
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~---~~~ 240 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI---LES 240 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHH
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHh
Confidence 9999987643221 12234467999999998865 67899999999999999999999999875543322111 110
Q ss_pred hhc----------CCcccccccccc-C-----cCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 566 WKK----------GAIRDASDSRLE-G-----ICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 566 ~~~----------~~~~~~~d~~l~-~-----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
... ..+......... . .........+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 000 000000000000 0 000112345788899999999999999999985
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=334.28 Aligned_cols=254 Identities=21% Similarity=0.244 Sum_probs=198.0
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEe----ecCeEEE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCR----RKGEFLL 418 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~----~~~~~~l 418 (614)
.++|+..+.||+|+||.||++... +++.||+|++........+.+.+|+.++++++||||+++++++. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 357888999999999999999985 58899999998777777888999999999999999999999987 3457899
Q ss_pred EEEecCCCCcchhcccC--CCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecccccc
Q 044561 419 VYDYMPNGSLDKILHTN--IKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 496 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~ 496 (614)
||||+++|+|.+++... ....+++.+++.++.|+++||.|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999998752 23569999999999999999999995 89999999999999999999999999998764
Q ss_pred CCCCCC--------cccccccCCCccchhhhcCCC---CCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHh
Q 044561 497 DHDTIP--------QTTKLVGTFGYMDPELMRTGK---ASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDC 565 (614)
Q Consensus 497 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~ 565 (614)
...... ......||+.|+|||++.... ++.++||||||+++|||++|+.||........ ......
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~--- 260 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVALAV--- 260 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHHHH---
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhHHh---
Confidence 321100 112345799999999987543 68999999999999999999999953211110 111111
Q ss_pred hhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 566 WKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 566 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.. .... + ....+ ...+.+++.+||+.||++|||+.|+++
T Consensus 261 -~~-~~~~---~-~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~ 299 (317)
T 2buj_A 261 -QN-QLSI---P-QSPRH----SSALWQLLNSMMTVDPHQRPHIPLLLS 299 (317)
T ss_dssp -HC-C--C---C-CCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -hc-cCCC---C-ccccC----CHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 00 0000 0 01112 245778888999999999999999874
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=337.18 Aligned_cols=272 Identities=23% Similarity=0.271 Sum_probs=191.5
Q ss_pred HHHHHHhcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCe-
Q 044561 338 KDLYKATKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGE- 415 (614)
Q Consensus 338 ~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~- 415 (614)
.+.....++|+..+.||+|+||.||+|+... +..||+|++...... ...+.+|+..++.++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-RNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC-CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc-cHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 4455667889999999999999999999864 889999998665332 3456778888899999999999999876443
Q ss_pred ------EEEEEEecCCCCcchhccc--CCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcC-CCCEE
Q 044561 416 ------FLLVYDYMPNGSLDKILHT--NIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA-DLNGK 486 (614)
Q Consensus 416 ------~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~-~~~~k 486 (614)
.++||||+++ +|...+.. .....+++..+..++.|++.||.|||.. ..+|+||||||+|||++. ++.+|
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTEEE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCcEE
Confidence 8999999976 44443332 2244589999999999999999999922 389999999999999997 89999
Q ss_pred EeeeccccccCCCCCCcccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHH---
Q 044561 487 LGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWV--- 562 (614)
Q Consensus 487 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v--- 562 (614)
|+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+....+...
T Consensus 173 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 250 (360)
T 3e3p_A 173 LCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC 250 (360)
T ss_dssp ECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred EeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCC
Confidence 99999998765433 23345789999999998654 4899999999999999999999999876544333222111
Q ss_pred -----HHhhhcC-Cccccccc------cccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 563 -----CDCWKKG-AIRDASDS------RLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 563 -----~~~~~~~-~~~~~~d~------~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+...... ......+. .............+.+|+.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp CCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000000 00000000 0001111123457888999999999999999999985
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=334.89 Aligned_cols=263 Identities=22% Similarity=0.296 Sum_probs=199.5
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEeec-----CeE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRK-----GEF 416 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~ 416 (614)
.++|+..+.||+|+||.||+|.... +..||+|++... .......+.+|+.++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 4678899999999999999999874 888999999654 344456788999999999999999999988764 679
Q ss_pred EEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecccccc
Q 044561 417 LLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 496 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~ 496 (614)
++||||++ ++|.+++... .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++...
T Consensus 90 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 99999996 6899988763 48999999999999999999995 89999999999999999999999999999876
Q ss_pred CCCCCC---------cccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhh
Q 044561 497 DHDTIP---------QTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCW 566 (614)
Q Consensus 497 ~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~ 566 (614)
...... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||......+....+.......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 532211 1223578999999998765 678999999999999999999999998765433222111111000
Q ss_pred h-cCCccccc---------------cccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 567 K-KGAIRDAS---------------DSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 567 ~-~~~~~~~~---------------d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
. ........ ...+.. ........+.+++.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEK-MFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHH-HSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred chhccccccccchhhHHhhcccCCCCcchhh-hcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0 00000000 000000 00112345678888999999999999999985
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=362.90 Aligned_cols=249 Identities=22% Similarity=0.309 Sum_probs=204.2
Q ss_pred HhcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC---ChhhHHHHHHHHHHhccc-CCCceeEEeeEEeecCeEE
Q 044561 343 ATKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD---SKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGEFL 417 (614)
Q Consensus 343 ~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 417 (614)
..++|+..+.||+|+||.||+|+.+. ++.||+|++... .....+.+..|..++..+ +||||+++++++.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 34678899999999999999999875 788999999754 223346678899999887 7999999999999999999
Q ss_pred EEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccC
Q 044561 418 LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYD 497 (614)
Q Consensus 418 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~ 497 (614)
|||||+++|+|.+++... ..+++.++..++.||+.||.|||+ ++|+||||||+|||++.++++||+|||+++...
T Consensus 419 lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 999999999999999864 349999999999999999999995 899999999999999999999999999998643
Q ss_pred CCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccc
Q 044561 498 HDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDS 577 (614)
Q Consensus 498 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~ 577 (614)
... ......+||+.|+|||++....++.++|||||||++|||++|+.||...+..+.... ..++..
T Consensus 494 ~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~-------i~~~~~------ 559 (674)
T 3pfq_A 494 WDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS-------IMEHNV------ 559 (674)
T ss_dssp CTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-------HHSSCC------
T ss_pred cCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHH-------HHhCCC------
Confidence 332 234456899999999999999999999999999999999999999987544322211 111111
Q ss_pred cccCcCcHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHhC
Q 044561 578 RLEGICEEKQMELVLKLGLFCSHPKPEARPNM-----RQVMQ 614 (614)
Q Consensus 578 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~evl~ 614 (614)
.+... ....+.+|+.+||+.||++||++ .||++
T Consensus 560 ~~p~~----~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 560 AYPKS----MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp CCCTT----SCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred CCCcc----CCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 11112 23456778888999999999997 77753
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=329.97 Aligned_cols=262 Identities=17% Similarity=0.237 Sum_probs=202.7
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-C-cEEEEEEeecCChhhHHHHHHHHHHhcccCCCc------eeEEeeEEeecCe
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-N-VQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRN------LVKLRGYCRRKGE 415 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~-~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n------iv~l~g~~~~~~~ 415 (614)
.++|+..+.||+|+||.||+|.... + ..||+|++... ....+.+.+|+.++++++|++ ++.+.+++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 3678899999999999999999754 3 68999998654 344567888999999998766 9999999999999
Q ss_pred EEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEE----------------
Q 044561 416 FLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL---------------- 479 (614)
Q Consensus 416 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll---------------- 479 (614)
.++||||+ +++|.+++.......+++.++..++.||+.||.|||+ .+|+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeccccccccccccccc
Confidence 99999999 6677777766554569999999999999999999994 899999999999999
Q ss_pred ---cCCCCEEEeeeccccccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccc
Q 044561 480 ---DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETV 556 (614)
Q Consensus 480 ---~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~ 556 (614)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+..
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 248 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 248 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 67889999999999865432 23457999999999999999999999999999999999999999876544333
Q ss_pred cHHHHHHHh--------hhcCCcccc------------------ccc-cccCcCcHHHHHHHHHHHHHcCCCCCCCCCCH
Q 044561 557 NLVDWVCDC--------WKKGAIRDA------------------SDS-RLEGICEEKQMELVLKLGLFCSHPKPEARPNM 609 (614)
Q Consensus 557 ~l~~~v~~~--------~~~~~~~~~------------------~d~-~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 609 (614)
..+...... ......... ..+ .............+.+|+.+||+.||++|||+
T Consensus 249 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 328 (355)
T 2eu9_A 249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL 328 (355)
T ss_dssp HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCH
Confidence 222211100 000000000 000 00001122334578899999999999999999
Q ss_pred HHHhC
Q 044561 610 RQVMQ 614 (614)
Q Consensus 610 ~evl~ 614 (614)
.|+++
T Consensus 329 ~e~l~ 333 (355)
T 2eu9_A 329 AEALL 333 (355)
T ss_dssp HHHTT
T ss_pred HHHhc
Confidence 99985
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=326.14 Aligned_cols=251 Identities=25% Similarity=0.472 Sum_probs=192.1
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEee----------
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRR---------- 412 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~---------- 412 (614)
.++|+..+.||+|+||.||+|+.. ++..||+|++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 456888999999999999999986 5889999998653 3456788999999999999999999998865
Q ss_pred ---cCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEee
Q 044561 413 ---KGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGD 489 (614)
Q Consensus 413 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~D 489 (614)
.+..++||||+++|+|.+++... ...+++.+++.++.|+++||.|||+ .+|+||||||+||+++.++.+||+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECC
T ss_pred cccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEee
Confidence 46789999999999999999764 2457889999999999999999995 8999999999999999999999999
Q ss_pred eccccccCCCC-------------CCcccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcccc
Q 044561 490 FGLARLYDHDT-------------IPQTTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSMET 555 (614)
Q Consensus 490 fGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~ 555 (614)
||++....... ........||+.|+|||++.+. .++.++|||||||++|||++ |+.... +.
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~--~~ 234 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM--ER 234 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--HH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--hH
Confidence 99998654321 1122345789999999999754 78999999999999999998 553211 11
Q ss_pred ccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 556 VNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 556 ~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.... ....... ..+...++......+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~----~~~~~~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 235 VNIL----KKLRSVS------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHH----HHHHSTT------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHH----Hhccccc------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 1111 1111111 11112223333455778888999999999999999974
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=338.64 Aligned_cols=258 Identities=22% Similarity=0.304 Sum_probs=196.3
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeE----
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEF---- 416 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~---- 416 (614)
.++|...+.||+|+||.||+|.... +..||+|++... .....+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 3578888999999999999999864 889999999764 344567889999999999999999999999877654
Q ss_pred --EEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecccc
Q 044561 417 --LLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR 494 (614)
Q Consensus 417 --~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~ 494 (614)
++||||++ ++|.+++.. .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred eEEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 99999996 688887743 38999999999999999999995 899999999999999999999999999998
Q ss_pred ccCCCCCCcccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcC---C
Q 044561 495 LYDHDTIPQTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKG---A 570 (614)
Q Consensus 495 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~---~ 570 (614)
..... .....||+.|+|||++.+ ..++.++|||||||+++||++|+.||......+....+.......... .
T Consensus 193 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 268 (371)
T 4exu_A 193 HADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 268 (371)
T ss_dssp -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred ccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHH
Confidence 65432 234578999999999887 678999999999999999999999998755433322211100000000 0
Q ss_pred ------------ccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 571 ------------IRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 571 ------------~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+.......+. .........+.+|+.+||+.||++|||+.|+++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 269 LNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp CSCHHHHHHHHHSCCCCCCCHH-HHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhhhhhhhhccCCCcchhHH-HhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 0000000000 000112346788889999999999999999985
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=331.79 Aligned_cols=261 Identities=20% Similarity=0.297 Sum_probs=200.4
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCChhhHHHHHHHHHHhcccC-----------CCceeEEeeEEee
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLR-----------HRNLVKLRGYCRR 412 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----------H~niv~l~g~~~~ 412 (614)
.+|+..+.||+|+||.||+|+.. +++.||+|++... ....+.+.+|+.++++++ ||||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 57888999999999999999975 4888999998754 334567788999988886 8999999999886
Q ss_pred cC----eEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCC-ceEecCcCCCCeEEc------C
Q 044561 413 KG----EFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQ-VVLHRDIKPANVLLD------A 481 (614)
Q Consensus 413 ~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDikp~NIll~------~ 481 (614)
.+ .+++||||+ +++|.+++.......+++..+..++.||+.||.|||+ + +|+||||||+|||++ .
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETTTT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCCcC
Confidence 54 789999999 8999999987655669999999999999999999995 6 999999999999994 4
Q ss_pred CCCEEEeeeccccccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcccccc---H
Q 044561 482 DLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVN---L 558 (614)
Q Consensus 482 ~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~---l 558 (614)
.+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .
T Consensus 174 ~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 249 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249 (373)
T ss_dssp EEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence 457999999999876542 234578999999999999999999999999999999999999998654222111 1
Q ss_pred HHHHHHhhhc-------------------CCccccccccc---------cCcCcHHHHHHHHHHHHHcCCCCCCCCCCHH
Q 044561 559 VDWVCDCWKK-------------------GAIRDASDSRL---------EGICEEKQMELVLKLGLFCSHPKPEARPNMR 610 (614)
Q Consensus 559 ~~~v~~~~~~-------------------~~~~~~~d~~l---------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 610 (614)
...+.+.... +.+........ ...++......+.+|+.+||+.||++|||+.
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 329 (373)
T 1q8y_A 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329 (373)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence 1111111000 00000000000 1124456678899999999999999999999
Q ss_pred HHhC
Q 044561 611 QVMQ 614 (614)
Q Consensus 611 evl~ 614 (614)
|+++
T Consensus 330 ell~ 333 (373)
T 1q8y_A 330 GLVN 333 (373)
T ss_dssp HHHT
T ss_pred HHhh
Confidence 9985
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=328.62 Aligned_cols=253 Identities=26% Similarity=0.377 Sum_probs=177.7
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCC-hhhHHHHHHHHH-HhcccCCCceeEEeeEEeecCeEEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDS-KQGIKEFVAELV-SMGRLRHRNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~E 421 (614)
++|+..+.||+|+||.||+|..+ +++.||+|++.... .....++..|+. +++.++||||+++++++...+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 57888899999999999999986 48889999997653 334456666666 7788899999999999999999999999
Q ss_pred ecCCCCcchhccc---CCCCCcChhHHHHHHHHhHhhchhhhccCCC-ceEecCcCCCCeEEcCCCCEEEeeeccccccC
Q 044561 422 YMPNGSLDKILHT---NIKPCLNWYQRFRIIRGVASGLLYLHEDWEQ-VVLHRDIKPANVLLDADLNGKLGDFGLARLYD 497 (614)
Q Consensus 422 ~~~~gsL~~~l~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDikp~NIll~~~~~~kl~DfGla~~~~ 497 (614)
|+++ +|.+++.. .....+++..+..++.|++.||.|||+ . +|+||||||+||+++.++.+||+|||+++...
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 9974 77777652 224568999999999999999999995 5 99999999999999999999999999998765
Q ss_pred CCCCCcccccccCCCccchhhh----cCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccc
Q 044561 498 HDTIPQTTKLVGTFGYMDPELM----RTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRD 573 (614)
Q Consensus 498 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~ 573 (614)
... ......||+.|+|||++ ....++.++||||||+++|||++|+.||........ .. .....+..
T Consensus 178 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~-~~~~~~~~-- 247 (327)
T 3aln_A 178 DSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QL-TQVVKGDP-- 247 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCCSCC--
T ss_pred ccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HH-HHHhcCCC--
Confidence 432 22334789999999998 456789999999999999999999999975432110 00 00011111
Q ss_pred cccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 574 ASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 574 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+.+...........+.+++.+||+.||++|||+.|+++
T Consensus 248 ---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 248 ---PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp ---CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 11111111112345778888899999999999999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=331.80 Aligned_cols=259 Identities=21% Similarity=0.343 Sum_probs=198.4
Q ss_pred cCHHHHHHHhcCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecC--ChhhHHHHHHHHHHhcccC--CCceeEEeeEE
Q 044561 335 FTYKDLYKATKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHD--SKQGIKEFVAELVSMGRLR--HRNLVKLRGYC 410 (614)
Q Consensus 335 ~~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~ 410 (614)
+.++.+....++|+..+.||+|+||.||++...++..||+|++... .....+.+.+|+.++++++ |+||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 3344444455678999999999999999999888899999998754 4456678999999999997 59999999999
Q ss_pred eecCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeee
Q 044561 411 RRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDF 490 (614)
Q Consensus 411 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~Df 490 (614)
...+..++||| +.+++|.+++... ..+++.++..++.|+++||.|||+ .+|+||||||+||++++ +.+||+||
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Df 170 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDF 170 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCC
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeec
Confidence 99999999999 5689999999864 358999999999999999999995 89999999999999964 89999999
Q ss_pred ccccccCCCCC-CcccccccCCCccchhhhcC-----------CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccH
Q 044561 491 GLARLYDHDTI-PQTTKLVGTFGYMDPELMRT-----------GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNL 558 (614)
Q Consensus 491 Gla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-----------~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l 558 (614)
|++........ .......||+.|+|||.+.. ..++.++||||||+++|||++|+.||......
T Consensus 171 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~----- 245 (313)
T 3cek_A 171 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----- 245 (313)
T ss_dssp SSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----
T ss_pred cccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-----
Confidence 99987654321 12234578999999999865 46889999999999999999999999754321
Q ss_pred HHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 559 VDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 559 ~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
............ ........ ...+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~~~~~~~~~~~-----~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 246 ISKLHAIIDPNH-----EIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp HHHHHHHHCTTS-----CCCCCCCS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHhccc-----ccCCcccc----hHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 111111111111 01111112 235677888899999999999999985
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=340.64 Aligned_cols=259 Identities=23% Similarity=0.317 Sum_probs=179.3
Q ss_pred cceeeeeCcEEEEEEEEe---cCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEee--cCeEEEEEEecC
Q 044561 350 KDVIGRGGFGKVYRGVLA---SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRR--KGEFLLVYDYMP 424 (614)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~ 424 (614)
.++||+|+||.||+|+.+ .+..||+|++..... ...+.+|+.++++++||||+++++++.. ....++||||++
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~ 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence 457999999999999976 367899999975432 2467899999999999999999999954 678999999996
Q ss_pred CCCcchhcccC-------CCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEE----cCCCCEEEeeeccc
Q 044561 425 NGSLDKILHTN-------IKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL----DADLNGKLGDFGLA 493 (614)
Q Consensus 425 ~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll----~~~~~~kl~DfGla 493 (614)
++|.+++... ....+++..+..++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||++
T Consensus 104 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 179 (405)
T 3rgf_A 104 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 179 (405)
T ss_dssp -EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred -CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence 5787776521 12348999999999999999999995 899999999999999 77899999999999
Q ss_pred cccCCCCC--CcccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCccc------cccHHHHHHH
Q 044561 494 RLYDHDTI--PQTTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSME------TVNLVDWVCD 564 (614)
Q Consensus 494 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~------~~~l~~~v~~ 564 (614)
+....... ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .......+.+
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~ 259 (405)
T 3rgf_A 180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 259 (405)
T ss_dssp C----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHH
T ss_pred eecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHH
Confidence 87654321 223446899999999999874 58999999999999999999999997544311 0111121211
Q ss_pred hhhc---CCcccccc------------ccccCcCcH---------HHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 565 CWKK---GAIRDASD------------SRLEGICEE---------KQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 565 ~~~~---~~~~~~~d------------~~l~~~~~~---------~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.... ..+..... ......+.. .....+.+|+.+||+.||++|||+.|+++
T Consensus 260 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 260 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1110 00000000 000000000 00235678899999999999999999985
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=328.28 Aligned_cols=250 Identities=27% Similarity=0.389 Sum_probs=190.8
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec--C--cEEEEEEeecC---ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS--N--VQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFL 417 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~--~--~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 417 (614)
++|+..+.||+|+||.||+|++.. + ..||+|++... .....+.+.+|+.++++++||||+++++++...+ .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 568888999999999999998643 2 25899988654 3345678999999999999999999999998765 88
Q ss_pred EEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccC
Q 044561 418 LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYD 497 (614)
Q Consensus 418 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~ 497 (614)
+||||+++++|.+++... ...+++.++..++.|+++||.|||+ .+++||||||+||+++.++.+||+|||++....
T Consensus 97 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp EEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 999999999999999764 2458999999999999999999995 899999999999999999999999999998765
Q ss_pred CCCCC--cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCcccc
Q 044561 498 HDTIP--QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDA 574 (614)
Q Consensus 498 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~ 574 (614)
..... ......+|..|+|||++....++.++||||||+++|||++ |+.||......+.. . .....+...
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~---~~~~~~~~~-- 244 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL---H---KIDKEGERL-- 244 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---H---HHHTSCCCC--
T ss_pred ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHH---H---HHHccCCCC--
Confidence 43321 1233467888999999988889999999999999999999 99999765433211 1 111111100
Q ss_pred ccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 575 SDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 575 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..... ..+.+.+++.+||+.||++|||+.++++
T Consensus 245 ---~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 245 ---PRPED----CPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp ---CCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---CCCcC----cCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 01112 2345778888999999999999999873
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=341.90 Aligned_cols=255 Identities=20% Similarity=0.267 Sum_probs=201.9
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCChhhHHHHHHHHHHhcccCC-CceeEEeeEEeecCeEEEEEE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRH-RNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~E 421 (614)
.++|+..+.||+|+||.||+|+.. ++..||||++...... .++..|+++++.++| +++..+..++...+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 357889999999999999999975 4889999988655432 357889999999987 556666667778889999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEE---cCCCCEEEeeeccccccCC
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL---DADLNGKLGDFGLARLYDH 498 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll---~~~~~~kl~DfGla~~~~~ 498 (614)
|+ +++|.+++.... ..+++.+++.|+.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++....
T Consensus 84 ~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred CC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 99 999999997532 359999999999999999999995 899999999999999 6899999999999987654
Q ss_pred CCC------CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcc
Q 044561 499 DTI------PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIR 572 (614)
Q Consensus 499 ~~~------~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~ 572 (614)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+........+.
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE 238 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence 332 12235689999999999999999999999999999999999999998765544333333322221111111
Q ss_pred ccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 573 DASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 573 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+...+ ...+.+++..||+.||++||++.+|++
T Consensus 239 -----~l~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 239 -----ALCRGY----PTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp -----HHHTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred -----HHhcCC----cHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 111112 245778888999999999999999863
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=331.22 Aligned_cols=258 Identities=22% Similarity=0.320 Sum_probs=196.3
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCe-----
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGE----- 415 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~----- 415 (614)
.++|...+.||+|+||.||+|.... +..||+|++... .....+.+.+|+.++++++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 3578889999999999999999864 889999999654 34446788999999999999999999999987653
Q ss_pred -EEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecccc
Q 044561 416 -FLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR 494 (614)
Q Consensus 416 -~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~ 494 (614)
.++||||++ ++|.+++.. .+++.++..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred eEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeeccccc
Confidence 599999997 688888743 38999999999999999999995 899999999999999999999999999998
Q ss_pred ccCCCCCCcccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHh--------
Q 044561 495 LYDHDTIPQTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDC-------- 565 (614)
Q Consensus 495 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~-------- 565 (614)
..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+......
T Consensus 175 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 175 HADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp C------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred CCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 65432 234578999999999876 67899999999999999999999999875543322211110000
Q ss_pred hhc-------CCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 566 WKK-------GAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 566 ~~~-------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
... ..+.......+. .........+.+++.+|++.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000 000000000110 011123456778888999999999999999985
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=320.63 Aligned_cols=250 Identities=24% Similarity=0.359 Sum_probs=201.0
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCC--hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDS--KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
.++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 467889999999999999999987 48899999986542 334678899999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCC---CCEEEeeeccccccC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDAD---LNGKLGDFGLARLYD 497 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~---~~~kl~DfGla~~~~ 497 (614)
||+++++|.+++... ..+++.++..++.|++.||.|||+ .+++||||||+||+++.+ +.+||+|||++....
T Consensus 101 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 101 ELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 999999999888753 348999999999999999999995 899999999999999764 469999999998765
Q ss_pred CCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccc
Q 044561 498 HDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDS 577 (614)
Q Consensus 498 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~ 577 (614)
... ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||......+. . +....+..... .
T Consensus 176 ~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~----~~~~~~~~~~~--~ 243 (287)
T 2wei_A 176 QNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI---L----KRVETGKYAFD--L 243 (287)
T ss_dssp CCS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H----HHHHHCCCCCC--S
T ss_pred CCC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH---H----HHHHcCCCCCC--c
Confidence 433 2233468999999999865 589999999999999999999999976543221 1 11222221110 0
Q ss_pred cccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 578 RLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 578 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.....+ ...+.+++.+|+++||++|||+.|+++
T Consensus 244 ~~~~~~----~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 244 PQWRTI----SDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp GGGTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhhhc----CHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 001112 235778888899999999999999974
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=336.50 Aligned_cols=249 Identities=20% Similarity=0.335 Sum_probs=187.1
Q ss_pred CCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhccc-CCCceeEEeeEEeecCeEEEEEEecCC
Q 044561 347 FKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGEFLLVYDYMPN 425 (614)
Q Consensus 347 f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 425 (614)
|...+.||+|+||+||.+...+++.||||++..+. .+.+.+|+.+++++ +||||+++++++.+.+..++|||||+
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~- 92 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN- 92 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-
Confidence 44567899999999987666678999999987543 34678899999876 89999999999999999999999995
Q ss_pred CCcchhcccCCCC-----CcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCC-------------CCEEE
Q 044561 426 GSLDKILHTNIKP-----CLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDAD-------------LNGKL 487 (614)
Q Consensus 426 gsL~~~l~~~~~~-----~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~-------------~~~kl 487 (614)
|+|.+++...... ..++..++.++.||+.||.|||+ .+|+||||||+|||++.+ +.+||
T Consensus 93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 7999999764321 12445678899999999999995 899999999999999754 48999
Q ss_pred eeeccccccCCCCCC---cccccccCCCccchhhhcC-------CCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccc
Q 044561 488 GDFGLARLYDHDTIP---QTTKLVGTFGYMDPELMRT-------GKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETV 556 (614)
Q Consensus 488 ~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~ 556 (614)
+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||......+
T Consensus 170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-- 247 (434)
T 2rio_A 170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-- 247 (434)
T ss_dssp CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--
T ss_pred cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--
Confidence 999999877654321 1234579999999999965 578999999999999999999 999997543321
Q ss_pred cHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 557 NLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 557 ~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
......... . +......+......+.+++.+||+.||++|||+.||++
T Consensus 248 --~~i~~~~~~---~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 --SNIIRGIFS---L-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp --HHHHHTCCC---C-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HHHhcCCCC---c-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 111111110 0 11111223455677889999999999999999999985
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=357.44 Aligned_cols=250 Identities=25% Similarity=0.416 Sum_probs=198.5
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec----CcEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS----NVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLL 418 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 418 (614)
.++|+..+.||+|+||.||+|.+.. +..||+|++... .....+.+.+|+.++++++||||+++++++. .+..++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence 4567888999999999999999753 456899998754 3445578999999999999999999999985 466899
Q ss_pred EEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCC
Q 044561 419 VYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 498 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~ 498 (614)
||||+++|+|.+++... ...+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 468 v~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp EEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred EEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 99999999999999764 3358999999999999999999995 8999999999999999999999999999987755
Q ss_pred CCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccc
Q 044561 499 DTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDS 577 (614)
Q Consensus 499 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~ 577 (614)
..........+|+.|+|||++....++.++|||||||++|||++ |+.||......+.. ..+ ..+...
T Consensus 544 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~---~~i----~~~~~~----- 611 (656)
T 2j0j_A 544 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GRI----ENGERL----- 611 (656)
T ss_dssp ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HHH----HHTCCC-----
T ss_pred CcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHH----HcCCCC-----
Confidence 44333344567889999999998899999999999999999997 99999765443221 111 111111
Q ss_pred cccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 578 RLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 578 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.....+ ...+.+++.+||+.||++|||+.|+++
T Consensus 612 ~~~~~~----~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 612 PMPPNC----PPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp CCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCccc----cHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 111222 345778888999999999999999873
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=328.96 Aligned_cols=252 Identities=21% Similarity=0.258 Sum_probs=170.8
Q ss_pred hcCCCCc-ceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEee----cCeEE
Q 044561 344 TKGFKDK-DVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRR----KGEFL 417 (614)
Q Consensus 344 ~~~f~~~-~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~ 417 (614)
.++|... +.||+|+||.||+|..+. ++.||+|++..... ..++ ....++.++||||+++++++.. +...+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~e---~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-ARQE---VDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH-HHHH---HHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH-HHHH---HHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 4567774 569999999999999874 88999999875422 2222 2233556789999999999876 45689
Q ss_pred EEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcC---CCCEEEeeecccc
Q 044561 418 LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA---DLNGKLGDFGLAR 494 (614)
Q Consensus 418 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~---~~~~kl~DfGla~ 494 (614)
+||||+++|+|.+++.......+++.++..++.|++.||.|||+ .+|+||||||+||+++. ++.+||+|||+++
T Consensus 103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 99999999999999987655679999999999999999999995 89999999999999976 4559999999998
Q ss_pred ccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccc
Q 044561 495 LYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDA 574 (614)
Q Consensus 495 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~ 574 (614)
...... .....||+.|+|||++....++.++||||||+++|||++|+.||............ ......+..
T Consensus 180 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~~--- 250 (336)
T 3fhr_A 180 ETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM---KRRIRLGQY--- 250 (336)
T ss_dssp EC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------------
T ss_pred eccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH---HHhhhcccc---
Confidence 655332 23457899999999998888999999999999999999999999765432211100 000000000
Q ss_pred ccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 575 SDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 575 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.............+.+++.+||+.||++|||+.|+++
T Consensus 251 ---~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 251 ---GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp ---CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000001112345777888899999999999999974
|
| >1qmo_E Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=274.85 Aligned_cols=113 Identities=38% Similarity=0.462 Sum_probs=104.9
Q ss_pred CcEEEEEeeccCCCCCCCCCCCeeeEecCCCcccccccCccccCccCCCccccccCCccEEEEEEEeCCCcEEEEEEeeC
Q 044561 131 NHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPM 210 (614)
Q Consensus 131 ~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~ 210 (614)
||+|||||||++|.+++||++||||||+||+.|.++++| ++.+|+.++|||+||+.+++|+|++++.
T Consensus 1 n~~vAVEFDT~~N~e~~Dp~~nHVGIdvNsi~S~~s~~~-------------~l~sG~~~~v~I~Yd~~~~~L~V~l~~~ 67 (133)
T 1qmo_E 1 SNVVAVEFDTYLNPDYGDPNYIHIGIDVNSIRSKVTAKW-------------DWQNGKIATAHISYNSVSKRLSVTSYYA 67 (133)
T ss_dssp CCCEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEEC-------------CCCTTSCEEEEEEEETTTTEEEEEEECS
T ss_pred CCEEEEEEeCCcCccccCCCCCeeEEecccccccceeee-------------EEcCCCEEEEEEEEeCCCcEEEEEEccC
Confidence 589999999999999889999999999999999998875 3579999999999999999999999876
Q ss_pred CCCCCCCCceeeeccCcccccccccccccccCCCccceeeEeccccccC
Q 044561 211 SIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLKSSHYVLGWSFNRS 259 (614)
Q Consensus 211 ~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastg~~~~~h~i~sWsf~~~ 259 (614)
+. .+|+|+..+||+++|||+||||||||||...|.|+|++|+|+++
T Consensus 68 ~~---~~p~ls~~vdLs~~l~e~v~VGFSAsTG~~~~~h~IlsWsF~s~ 113 (133)
T 1qmo_E 68 GS---KPATLSYDIELHTVLPEWVRVGLSASTGQDKERNTVHSWSFTSS 113 (133)
T ss_dssp SS---CCEEEEEECCGGGTSCSEEEEEEEEECSSSCCEEEEEEEEEEEE
T ss_pred CC---ccceEEEeechHHhccccEEEEEEeccCCCcceeEEEEEEEEee
Confidence 53 27899999999999999999999999999999999999999876
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=325.49 Aligned_cols=250 Identities=23% Similarity=0.384 Sum_probs=193.9
Q ss_pred HhcCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCC--hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 343 ATKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDS--KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 343 ~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
..++|+..+.||+|+||.||+|..++ .+++|++.... ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 34678889999999999999998754 48899886532 233456778999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
||+++++|.+++... ...+++.++..++.|++.||.|||+ .+|+||||||+||+++ ++.+||+|||++.......
T Consensus 109 e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp BCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred ecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 999999999999764 3459999999999999999999995 8999999999999998 6799999999987653211
Q ss_pred ----CCcccccccCCCccchhhhcC---------CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhh
Q 044561 501 ----IPQTTKLVGTFGYMDPELMRT---------GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWK 567 (614)
Q Consensus 501 ----~~~~~~~~gt~~y~aPE~~~~---------~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~ 567 (614)
........||+.|+|||++.. ..++.++||||||+++|||++|+.||......+.. ....
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-------~~~~ 256 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII-------WQMG 256 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH-------HHHH
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHhc
Confidence 112233468999999999864 35789999999999999999999999765432211 1111
Q ss_pred cCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 568 KGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 568 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+........ .++ ..+.+++.+||+.||++|||+.|+++
T Consensus 257 ~~~~~~~~~~----~~~----~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 257 TGMKPNLSQI----GMG----KEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp TTCCCCCCCS----SCC----TTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred cCCCCCCCcC----CCC----HHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 2211111111 111 24677888899999999999999874
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=325.38 Aligned_cols=241 Identities=22% Similarity=0.385 Sum_probs=188.9
Q ss_pred HhcCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCChh------hHHHHHHHHHHhccc----CCCceeEEeeEEe
Q 044561 343 ATKGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSKQ------GIKEFVAELVSMGRL----RHRNLVKLRGYCR 411 (614)
Q Consensus 343 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l----~H~niv~l~g~~~ 411 (614)
..++|+..+.||+|+||.||+|... ++..||+|++...... ....+.+|+.+++++ +||||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 3467999999999999999999875 4789999999654321 223456788888888 8999999999999
Q ss_pred ecCeEEEEEEe-cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEc-CCCCEEEee
Q 044561 412 RKGEFLLVYDY-MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD-ADLNGKLGD 489 (614)
Q Consensus 412 ~~~~~~lV~E~-~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~-~~~~~kl~D 489 (614)
..+..++|+|| +++++|.+++... ..+++.++..++.||++||.|||+ .+|+||||||+||+++ .++.+||+|
T Consensus 109 ~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~d 183 (312)
T 2iwi_A 109 TQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLID 183 (312)
T ss_dssp ----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEEECC
T ss_pred cCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEEEEE
Confidence 99999999999 7899999999763 348999999999999999999995 7999999999999999 889999999
Q ss_pred eccccccCCCCCCcccccccCCCccchhhhcCCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhc
Q 044561 490 FGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKA-STSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKK 568 (614)
Q Consensus 490 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~ 568 (614)
||++....... .....||..|+|||++....+ +.++||||||+++|||++|+.||..... ...
T Consensus 184 fg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------~~~---- 247 (312)
T 2iwi_A 184 FGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE---------ILE---- 247 (312)
T ss_dssp CSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------HHH----
T ss_pred cchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH---------Hhh----
Confidence 99998765432 334578999999999877665 4589999999999999999999964210 000
Q ss_pred CCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 569 GAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 569 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.. ..+...+ ...+.+++.+||+.||++|||+.|+++
T Consensus 248 ~~------~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 248 AE------LHFPAHV----SPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp TC------CCCCTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hc------cCCcccC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 0111122 235677888999999999999999974
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=315.61 Aligned_cols=251 Identities=19% Similarity=0.291 Sum_probs=177.1
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCCh-hhH-HHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSK-QGI-KEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~-~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 421 (614)
++|+..+.||+|+||.||+|... ++..||+|++..... ... +.+.++..+++.++||||+++++++...+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 56778899999999999999986 488999999976532 222 334445567788899999999999999999999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCC
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI 501 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~ 501 (614)
|+ ++.+..+... ....+++..+..++.|+++||.|||+ +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 105 ~~-~~~~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~- 179 (318)
T 2dyl_A 105 LM-GTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK- 179 (318)
T ss_dssp CC-SEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHH--HHCCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred cc-CCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHh--hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc-
Confidence 99 4455554433 23458999999999999999999995 1389999999999999999999999999997665432
Q ss_pred CcccccccCCCccchhhhc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccc
Q 044561 502 PQTTKLVGTFGYMDPELMR-----TGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASD 576 (614)
Q Consensus 502 ~~~~~~~gt~~y~aPE~~~-----~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 576 (614)
......||+.|+|||++. ...++.++||||||+++|||++|+.||....... .... .... +.......
T Consensus 180 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~---~~~~-~~~~~~~~ 252 (318)
T 2dyl_A 180 -AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF--EVLT---KVLQ-EEPPLLPG 252 (318)
T ss_dssp --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH--HHHH---HHHH-SCCCCCCS
T ss_pred -cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH--HHHH---HHhc-cCCCCCCc
Confidence 223457899999999984 4568899999999999999999999997543221 1111 1111 11111000
Q ss_pred ccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 577 SRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 577 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
...++ ..+.+++.+||+.||++||++.|+++
T Consensus 253 ---~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 253 ---HMGFS----GDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp ---SSCCC----HHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---cCCCC----HHHHHHHHHHccCChhHCcCHHHHhh
Confidence 01122 34677888899999999999999985
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=327.46 Aligned_cols=241 Identities=24% Similarity=0.402 Sum_probs=196.3
Q ss_pred HhcCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCChh------hHHHHHHHHHHhcccC--CCceeEEeeEEeec
Q 044561 343 ATKGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSKQ------GIKEFVAELVSMGRLR--HRNLVKLRGYCRRK 413 (614)
Q Consensus 343 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~ 413 (614)
..++|+..+.||+|+||.||+|+.. +++.||+|++...... ..+.+.+|+.++++++ |+||+++++++...
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 3467888999999999999999975 4888999998754321 2245678999999996 59999999999999
Q ss_pred CeEEEEEEecCC-CCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEc-CCCCEEEeeec
Q 044561 414 GEFLLVYDYMPN-GSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD-ADLNGKLGDFG 491 (614)
Q Consensus 414 ~~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~-~~~~~kl~DfG 491 (614)
+..++|+|++.+ ++|.+++... ..+++.++..++.||++||.|||+ .+|+||||||+|||++ +++.+||+|||
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred CcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 999999999976 8999998763 358999999999999999999995 8999999999999999 78999999999
Q ss_pred cccccCCCCCCcccccccCCCccchhhhcCCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCC
Q 044561 492 LARLYDHDTIPQTTKLVGTFGYMDPELMRTGKA-STSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGA 570 (614)
Q Consensus 492 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~ 570 (614)
+++...... .....||+.|+|||++....+ +.++||||||+++|||++|+.||..... . ..+.
T Consensus 196 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---------~----~~~~ 259 (320)
T 3a99_A 196 SGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---------I----IRGQ 259 (320)
T ss_dssp TCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------H----HHCC
T ss_pred ccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh---------h----hccc
Confidence 998765432 334579999999999887665 6889999999999999999999964210 0 0011
Q ss_pred ccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 571 IRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 571 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
. .....++ ..+.+++.+||+.||++|||+.||++
T Consensus 260 ~------~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 260 V------FFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp C------CCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred c------cccccCC----HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0111222 35677888899999999999999985
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=331.36 Aligned_cols=248 Identities=20% Similarity=0.314 Sum_probs=186.2
Q ss_pred cCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhccc-CCCceeEEeeEEeecCeEEEEEEec
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
.+|+..+.||+|+||+||.....+++.||||++...... .+.+|+.+++++ +||||+++++++.+.+..++|||||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 457888999999999966555557889999999754332 346799999999 7999999999999999999999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcC-----CCCEEEeeeccccccCC
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA-----DLNGKLGDFGLARLYDH 498 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~-----~~~~kl~DfGla~~~~~ 498 (614)
+ |+|.+++.... ..+.+.++..++.||++||.|||+ .+|+||||||+|||++. ...+||+|||+++....
T Consensus 101 ~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 101 A-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp S-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred C-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 6 69999987653 335666778999999999999995 89999999999999943 34688999999987654
Q ss_pred CCC--CcccccccCCCccchhhhc---CCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCcc
Q 044561 499 DTI--PQTTKLVGTFGYMDPELMR---TGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIR 572 (614)
Q Consensus 499 ~~~--~~~~~~~gt~~y~aPE~~~---~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~ 572 (614)
... .......||+.|+|||++. ...++.++|||||||++|||++ |+.||........ . ........
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~----~---~~~~~~~~- 247 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA----N---ILLGACSL- 247 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH----H---HHTTCCCC-
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH----H---HHhccCCc-
Confidence 321 2234467999999999997 4567889999999999999999 8999854322111 0 11111111
Q ss_pred ccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 573 DASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 573 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.... ........+.+|+.+||+.||++|||+.||++
T Consensus 248 ~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 248 DCLH------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TTSC------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccC------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0000 11223445678889999999999999999985
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=344.41 Aligned_cols=260 Identities=26% Similarity=0.354 Sum_probs=200.8
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEee------cCeE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRR------KGEF 416 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~------~~~~ 416 (614)
.+|+..+.||+|+||.||+|.... +..||+|++... .....+.+.+|+.++++++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 679999999999999999999864 888999998764 44556789999999999999999999998765 6778
Q ss_pred EEEEEecCCCCcchhcccCC-CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCC---EEEeeecc
Q 044561 417 LLVYDYMPNGSLDKILHTNI-KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLN---GKLGDFGL 492 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~---~kl~DfGl 492 (614)
++|||||++|+|.+++.... ...+++..+..++.|++.||.|||+ .+|+||||||+||+++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999998643 2359999999999999999999995 89999999999999997765 99999999
Q ss_pred ccccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhh-----
Q 044561 493 ARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWK----- 567 (614)
Q Consensus 493 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~----- 567 (614)
+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... .|......
T Consensus 171 a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~-----~~~~~i~~~~~~~ 243 (676)
T 3qa8_A 171 AKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV-----QWHGKVREKSNEH 243 (676)
T ss_dssp CCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH-----HSSTTCC------
T ss_pred cccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh-----hhhhhhhcccchh
Confidence 98765543 2344579999999999999999999999999999999999999997542211 11000000
Q ss_pred -------cCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 568 -------KGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 568 -------~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+.....................+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~ 297 (676)
T 3qa8_A 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPN 297 (676)
T ss_dssp CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCC
T ss_pred hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhc
Confidence 00000000001112233445677889999999999999999988763
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-36 Score=340.17 Aligned_cols=232 Identities=22% Similarity=0.296 Sum_probs=188.8
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe--cCcEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCe-----E
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA--SNVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGE-----F 416 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-----~ 416 (614)
++|+..+.||+|+||.||+|.+. +++.||||++... .....+.+.+|+.++++++||||+++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 67889999999999999999986 4788999998654 34456678999999999999999999999987765 7
Q ss_pred EEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecccccc
Q 044561 417 LLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 496 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~ 496 (614)
||||||+++++|.+++.. .+++.++..++.||++||.|||+ .+|+||||||+|||++.+ .+||+|||+++..
T Consensus 160 ~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp EEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred EEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence 999999999999988754 49999999999999999999995 899999999999999986 9999999999876
Q ss_pred CCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccc
Q 044561 497 DHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASD 576 (614)
Q Consensus 497 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 576 (614)
... ....||+.|+|||++.++. +.++|||||||+++||++|..|+....... +.
T Consensus 232 ~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------------~~---- 285 (681)
T 2pzi_A 232 NSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG----------------LP---- 285 (681)
T ss_dssp TCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS----------------CC----
T ss_pred ccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc----------------cc----
Confidence 543 3457999999999987654 899999999999999999998876421110 00
Q ss_pred ccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHh
Q 044561 577 SRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVM 613 (614)
Q Consensus 577 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 613 (614)
...........+.+++.+||++||++||+..+.+
T Consensus 286 ---~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l 319 (681)
T 2pzi_A 286 ---EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEM 319 (681)
T ss_dssp ---TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHH
T ss_pred ---ccccccccCHHHHHHHhhhccCChhhCCCHHHHH
Confidence 0001112234577889999999999999766544
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=324.93 Aligned_cols=240 Identities=17% Similarity=0.142 Sum_probs=181.9
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCCh---hhHHHHHHHHHHhcccCC-Cce---------------e
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSK---QGIKEFVAELVSMGRLRH-RNL---------------V 404 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~H-~ni---------------v 404 (614)
.+|+..+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|+.+++.++| +|. +
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 45677889999999999999976 488999999874432 235778999999999977 221 1
Q ss_pred EEe------eEEee-----cCeEEEEEEecCCCCcchhcc-----cCCCCCcChhHHHHHHHHhHhhchhhhccCCCceE
Q 044561 405 KLR------GYCRR-----KGEFLLVYDYMPNGSLDKILH-----TNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVL 468 (614)
Q Consensus 405 ~l~------g~~~~-----~~~~~lV~E~~~~gsL~~~l~-----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv 468 (614)
.+. .++.. ....+++|+++ +++|.+++. ......+++..++.++.|+++||.|||+ ++|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcc
Confidence 111 11111 22467778776 689999884 2234458899999999999999999995 8999
Q ss_pred ecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcccccccCCCccchhhh----------cCCCCCcchhHHHHHHHHH
Q 044561 469 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELM----------RTGKASTSTDVYAFGVFML 538 (614)
Q Consensus 469 HrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~t~~~Dv~S~Gvll~ 538 (614)
||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++ ....++.++|||||||++|
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 9999999999999999999999998865432 344577 999999999 5556889999999999999
Q ss_pred HHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 539 EVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 539 el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
||++|+.||......+....+ ... ...++ +.+.+|+.+||+.||++||++.|+++
T Consensus 309 elltg~~Pf~~~~~~~~~~~~---------------~~~--~~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGGSEWI---------------FRS--CKNIP----QPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHSSCCCCTTGGGSCSGGG---------------GSS--CCCCC----HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHCCCCCCCcchhhhHHHH---------------Hhh--cccCC----HHHHHHHHHHccCChhhCcCHHHHHh
Confidence 999999999765433322111 000 01122 45778888999999999999999875
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=303.79 Aligned_cols=226 Identities=21% Similarity=0.271 Sum_probs=176.5
Q ss_pred cCCCCc-ceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHh-cccCCCceeEEeeEEee----cCeEE
Q 044561 345 KGFKDK-DVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSM-GRLRHRNLVKLRGYCRR----KGEFL 417 (614)
Q Consensus 345 ~~f~~~-~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l-~~l~H~niv~l~g~~~~----~~~~~ 417 (614)
++|... +.||+|+||.||++.... +..||+|++... ..+.+|+.++ +.++||||+++++++.. .+..+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 455555 779999999999999854 889999998653 3456788877 55689999999999887 67899
Q ss_pred EEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcC---CCCEEEeeecccc
Q 044561 418 LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA---DLNGKLGDFGLAR 494 (614)
Q Consensus 418 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~---~~~~kl~DfGla~ 494 (614)
+||||+++|+|.+++.......+++.++..++.|++.||.|||+ .+|+||||||+||+++. ++.+||+|||++.
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 99999999999999987655679999999999999999999995 89999999999999998 7899999999987
Q ss_pred ccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccc
Q 044561 495 LYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDA 574 (614)
Q Consensus 495 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~ 574 (614)
.... ..++.++|||||||++|||++|+.||......+... ......
T Consensus 169 ~~~~-----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-----------~~~~~~ 214 (299)
T 3m2w_A 169 ETTG-----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-----------GMKTRI 214 (299)
T ss_dssp ECTT-----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C-----------CSCCSS
T ss_pred cccc-----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH-----------HHHHHH
Confidence 4331 346789999999999999999999997543321110 000000
Q ss_pred ccccccCcCc----HHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 575 SDSRLEGICE----EKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 575 ~d~~l~~~~~----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..... ..+ ......+.+++.+||+.||++|||+.|+++
T Consensus 215 ~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 215 RMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp CTTCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00000 011 112345778888999999999999999985
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=300.41 Aligned_cols=224 Identities=13% Similarity=0.139 Sum_probs=177.5
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
.+|+..+.||+|+||.||+|.... ++.||+|.+.... ....+.+.+|+..+++++||||+++++++...+..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 468888999999999999999875 8899999997652 445578999999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
||+++++|.+++..+ ....++.+++.|++.||.|||+ ++|+||||||+|||++.++.+||++++
T Consensus 111 e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~--------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA--------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred EecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc---------
Confidence 999999999999642 3455788999999999999995 899999999999999999999997433
Q ss_pred CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
|++| ++.++|||||||++|||++|+.||......+...... .. ..+... ....+.
T Consensus 175 ------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~---~~-~~~~~~--~~~~~~ 229 (286)
T 3uqc_A 175 ------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE---RD-TAGQPI--EPADID 229 (286)
T ss_dssp ------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC---BC-TTSCBC--CHHHHC
T ss_pred ------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH---HH-hccCCC--Chhhcc
Confidence 3333 6899999999999999999999998765433221000 00 000000 000111
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+ ...+.+++.+||+.||++| |+.|+++
T Consensus 230 ~~~----~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 230 RDI----PFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp TTS----CHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred cCC----CHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 122 3457788889999999999 9999874
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=307.28 Aligned_cols=240 Identities=15% Similarity=0.196 Sum_probs=181.7
Q ss_pred cCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCC--------hhhHHHHHHHHHHhcccC---------CCceeEEe
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDS--------KQGIKEFVAELVSMGRLR---------HRNLVKLR 407 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~---------H~niv~l~ 407 (614)
++|+..+.||+|+||+||+|+. +++.||+|++.... ....+.+.+|+.++++++ ||||+++.
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 4577889999999999999998 67899999997653 223467888888888875 77777666
Q ss_pred eEE-----------------ee-------------cCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhch
Q 044561 408 GYC-----------------RR-------------KGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLL 457 (614)
Q Consensus 408 g~~-----------------~~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~ 457 (614)
+.+ .. .+..++|||||++|++.+.+.. ..+++.++..++.||+.||.
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHHH
Confidence 653 22 6789999999999987766643 34899999999999999999
Q ss_pred hhh-ccCCCceEecCcCCCCeEEcCCC--------------------CEEEeeeccccccCCCCCCcccccccCCCccch
Q 044561 458 YLH-EDWEQVVLHRDIKPANVLLDADL--------------------NGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDP 516 (614)
Q Consensus 458 yLH-~~~~~~ivHrDikp~NIll~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aP 516 (614)
||| + .+|+||||||+|||++.++ .+||+|||+++..... ..+||+.|+||
T Consensus 176 ~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aP 246 (336)
T 2vuw_A 176 VAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDE 246 (336)
T ss_dssp HHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCS
T ss_pred HHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccCh
Confidence 999 6 7999999999999999887 8999999999876542 34799999999
Q ss_pred hhhcCCCCCcchhHHHHHHH-HHHHHcCCCCCCCCCccccccHHHHHHHhhh-cCCccccccccccCcCcHHHHHHHHHH
Q 044561 517 ELMRTGKASTSTDVYAFGVF-MLEVASGRRPVEQQGSMETVNLVDWVCDCWK-KGAIRDASDSRLEGICEEKQMELVLKL 594 (614)
Q Consensus 517 E~~~~~~~t~~~Dv~S~Gvl-l~el~tg~~p~~~~~~~~~~~l~~~v~~~~~-~~~~~~~~d~~l~~~~~~~~~~~l~~l 594 (614)
|++.+.. +.++||||++++ .+++++|..||.... ......+... ..... ..............+.+|
T Consensus 247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~------~~~~~~~~~~~~~~~~----~~~~~~~~~~~s~~~~dl 315 (336)
T 2vuw_A 247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL------WLHYLTDKMLKQMTFK----TKCNTPAMKQIKRKIQEF 315 (336)
T ss_dssp GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH------HHHHHHHHHHHTCCCS----SCCCSHHHHHHHHHHHHH
T ss_pred hhhcCCC-ccceehhhhhCCCCcccccccCCCcchh------hhhHHHHhhhhhhccC----cccchhhhhhcCHHHHHH
Confidence 9998655 899999998777 777888999974210 0000111111 10111 111111234456778999
Q ss_pred HHHcCCCCCCCCCCHHHHh
Q 044561 595 GLFCSHPKPEARPNMRQVM 613 (614)
Q Consensus 595 ~~~cl~~dP~~RPs~~evl 613 (614)
+.+||+.| |+.|++
T Consensus 316 i~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 316 HRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHGGGSS-----SHHHHH
T ss_pred HHHHhccC-----CHHHHH
Confidence 99999976 999987
|
| >1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=278.42 Aligned_cols=115 Identities=32% Similarity=0.461 Sum_probs=106.4
Q ss_pred CCcEEEEEeeccCCCCCCCCCCCeeeEecCCCcccccccCccccCccCCCccccccCCccEEEEEEEeCCCcEEEEEEee
Q 044561 130 TNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAP 209 (614)
Q Consensus 130 ~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~ 209 (614)
.||+|||||||++|.+|+||++|||||||||+.|.++++| ++.+|+.++|||+||+.+++|+|++++
T Consensus 1 ~n~~vAVEFDT~~n~~~~Dp~~nHVGIdvNs~~S~~~~~~-------------~l~~g~~~~v~I~Yd~~~~~L~V~l~~ 67 (237)
T 1nls_A 1 ADTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAKW-------------NMQNGKVGTAHIIYNSVDKRLSAVVSY 67 (237)
T ss_dssp CCCEEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEEC-------------CCCTTCEEEEEEEEETTTTEEEEEEEC
T ss_pred CCCEEEEEEeCCCCcccCCCCCCeeeEecCCccccccccc-------------cccCCCEEEEEEEEeCCCCEEEEEEec
Confidence 3799999999999999999999999999999999998875 357999999999999999999999987
Q ss_pred CCCCCCCCCceeeeccCcccccccccccccccCCCccceeeEeccccccCC
Q 044561 210 MSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLKSSHYVLGWSFNRSG 260 (614)
Q Consensus 210 ~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastg~~~~~h~i~sWsf~~~~ 260 (614)
.+. .+|+|++.|||+++|+|+||||||||||...|.|+|++|+|+++.
T Consensus 68 ~~~---~~~~ls~~vdLs~~l~e~~~VGFSAsTG~~~~~h~IlsWsF~s~~ 115 (237)
T 1nls_A 68 PNA---DSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSKL 115 (237)
T ss_dssp TTS---CCEEEEEECCGGGTSCSEEEEEEEEECSSSCCCCEEEEEEEEEEE
T ss_pred CCC---CcceEEEeeChHHhCccccEEEEEeccCCcceeeeeEEEEEEecc
Confidence 643 578999999999999999999999999999999999999998764
|
| >2dur_A VIP36;, vesicular integral-membrane protein VIP36; beta sandwich, carbohydrate binding protein, cargo receptor, transport; HET: MAN; 1.65A {Canis lupus familiaris} PDB: 2dup_A 2duq_A* 2duo_A* 2e6v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=272.34 Aligned_cols=187 Identities=20% Similarity=0.214 Sum_probs=141.1
Q ss_pred CCceEecceeEcCCCcEEecCCCCCCceeeEeeCCceeecCCCCCceeeeeeeEEee-----------eeEEEEcCCCCC
Q 044561 39 AQLQRDGLASVHSNGLLQLTNTVSPQQEGHAFYRLPIKFNTSSSESLSFSSNFVFAI-----------GMAFVISPSKDL 107 (614)
Q Consensus 39 ~~~~~~g~a~~~~~g~l~Lt~~~~~~~~G~~~y~~pv~l~~~~~~~~sF~t~F~f~i-----------G~aF~l~p~~~~ 107 (614)
+++.++|+|.+. +|.|+||++.. .+.|||||+.|+++ +||+|+|+|.| ||||+|+|...
T Consensus 25 ~~~~l~G~a~i~-~g~l~LT~~~~-~~~G~~w~~~pi~~-------~sF~t~F~F~I~~~~~~~~~gdGlAF~l~~~~~- 94 (253)
T 2dur_A 25 PLWDFQGSTILT-SQYVRLTPDER-SKEGSIWNHQPCFL-------KDWEMHVHFKVHGTGKKNLHGDGIALWYTRDRL- 94 (253)
T ss_dssp CSEEEEETCEEC-SSCEEEECSSS-SEEEEEEESSCBCC-------SSEEEEEEEEEECCCCTTCCCCEEEEEEESCCS-
T ss_pred CCEEEccceEEE-CCEEEECCCCC-CCEEEEEeCCCCcc-------CcEEEEEEEEEecCCCCCcCCCcEEEEEECCCC-
Confidence 689999999995 99999999876 79999999999997 46999999999 99999999653
Q ss_pred CCCCCCCCCcccccccCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeeEecCCCcccccccCccccCccC---CCc--cc
Q 044561 108 GKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREG---MNK--TL 182 (614)
Q Consensus 108 ~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~~~~---~~~--~~ 182 (614)
..|++||+.+ .++.|||||||++|.++.| |+++|||++.+..+..+.. +.++ ... ..
T Consensus 95 -----~~G~~lG~~~-------~~~gvAVefDT~~n~~~~~----~~~~~I~~~~n~gs~~~d~--~~dg~~~~~~~c~~ 156 (253)
T 2dur_A 95 -----VPGPVFGSKD-------NFHGLAIFLDTYPNDETTE----RVFPYISVMVNNGSLSYDH--SKDGRWTELAGCTA 156 (253)
T ss_dssp -----CEETBTEECS-------SCEEEEEEEECSCCCTTCC----SCSSEEEEEEEESCCCCCG--GGTTGGGCCEEEEC
T ss_pred -----CCCcccCcCC-------CCCEEEEEEECCCCCCCCC----CCCcEEEEEecCCceeeec--cCCCcccccccccH
Confidence 2478999633 3578999999999975433 6666666666555543211 1111 000 11
Q ss_pred cc-cCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcccccccccccccccCCCccceeeEeccccccC
Q 044561 183 EL-IIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLKSSHYVLGWSFNRS 259 (614)
Q Consensus 183 ~l-~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastg~~~~~h~i~sWsf~~~ 259 (614)
++ ..|++++|||+||+. +|+|++++.+.. +.+ +...++ ...||++|||||||+||...+.|+|++|+|..-
T Consensus 157 ~~~n~g~~~~v~I~Y~~~--~L~V~l~~~~~~-~~~--~~~~~~-~v~Lp~~~yvGfSAaTG~~~~~h~Ilswsf~sl 228 (253)
T 2dur_A 157 DFRNRDHDTFLAVRYSRG--RLTVMTDLEDKN-EWK--NCIDIT-GVRLPTGYYFGASAGTGDLSDNHDIISMKLFQL 228 (253)
T ss_dssp CCBTCSSCEEEEEEEETT--EEEEEEECSSSS-CCE--EEEEEC-CEECCSSBEEEEEEEESSSCCEEEEEEEEEEEC
T ss_pred hhccCCCCeEEEEEEECC--EEEEEEeCCCCC-Cce--EEEEeC-CcccCCCcEEEEEeccCCCcceEEEEEEEEEec
Confidence 23 348899999999965 899999875432 323 334445 446999999999999999999999999999753
|
| >1gv9_A P58/ergic-53; lectin, carbohydrate binding; 1.46A {Rattus norvegicus} SCOP: b.29.1.13 PDB: 1r1z_A 3a4u_A 3lcp_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=273.34 Aligned_cols=195 Identities=16% Similarity=0.196 Sum_probs=148.0
Q ss_pred ceEEeCCCCC----CCCceEecceeEcCCCcEEecCCCCCCceeeEeeCCceeecCCCCCceeeeeeeEEee--------
Q 044561 28 NQFIYHGFNE----DAQLQRDGLASVHSNGLLQLTNTVSPQQEGHAFYRLPIKFNTSSSESLSFSSNFVFAI-------- 95 (614)
Q Consensus 28 ~~f~~~~f~~----~~~~~~~g~a~~~~~g~l~Lt~~~~~~~~G~~~y~~pv~l~~~~~~~~sF~t~F~f~i-------- 95 (614)
.||..|.... .+++.++|+|.+ ++|.|+||++.. .+.||+||+.|+++ +||+|+|+|.|
T Consensus 34 ~Sf~~P~~~~~~~~i~~w~~~G~a~i-~~~~IrLT~~~~-~~~G~~w~~~p~~~-------~sF~t~F~F~I~~~~~~~g 104 (260)
T 1gv9_A 34 YSFKGPHLVQSDGTVPFWAHAGNAIP-SADQIRIAPSLK-SQRGSVWTKTKAAF-------ENWEVEVTFRVTGRGRIGA 104 (260)
T ss_dssp GCEECSSCSCTTSCBTTEEEEETCEE-CSSCEEEECSST-TCEEEEEESSCBCC-------SSEEEEEEEEEECSSSCCC
T ss_pred eeEcCccccCCCCccCCeEEcccEEe-eCCEEEeCCCCC-CCEEEEEECCCccc-------cCEEEEEEEEEecCCCCCC
Confidence 4555554432 268999999999 589999999876 79999999999965 57999999999
Q ss_pred -eeEEEEcCCCCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeeccCCCCCC-CC------CCCeeeEecCC-Cccccc
Q 044561 96 -GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFD-DI------DDNHVGIDVNS-LISHES 166 (614)
Q Consensus 96 -G~aF~l~p~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~-d~------~~~Hvgid~ns-~~s~~~ 166 (614)
||||+|+|... ..|++||+. ..++.|||||||+.|.++. +| +++|+|||+|+ +.|...
T Consensus 105 dGlAF~l~~~~~------~~g~~~G~~-------~~~~gvaVefDT~~N~~~~~~p~I~~~indg~~~~d~~~d~~s~~~ 171 (260)
T 1gv9_A 105 DGLAIWYTENQG------LDGPVFGSA-------DMWNGVGIFFDSFDNDGKKNNPAIVVVGNNGQINYDHQNDGATQAL 171 (260)
T ss_dssp CEEEEEEESSCC------CEEEETTEC-------SCCEEEEEEEECCCC-----CCEEEEEEEESCCCCCHHHHHHHHCS
T ss_pred CeEEEEEecCCC------CCCCccCCC-------CCCCEEEEEEECCCCCCCCCCCceEEEeCCCceEeecCCCccccee
Confidence 99999999643 257888983 2357799999999997431 23 46788888875 544433
Q ss_pred ccCccccCccCCCccccc-cCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcccccccccccccccCCCc
Q 044561 167 APAAYFSDREGMNKTLEL-IIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSL 245 (614)
Q Consensus 167 ~~~~~~~~~~~~~~~~~l-~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastg~~ 245 (614)
+.+. .++ .+|++++|||+|++. +|+|.+.+...+......++..+| ..+||+++||||||+||..
T Consensus 172 ~~c~-----------~~~~n~g~~~~~~I~Y~~~--~L~V~l~~~~~~~~~~~~~~~~vd-~~~LP~~~~vGfSAaTG~~ 237 (260)
T 1gv9_A 172 ASCQ-----------RDFRNKPYPVRAKITYYQK--TLTVMINNGFTPDKNDYEFCAKVE-NMVIPTQGHFGISAATGGL 237 (260)
T ss_dssp EEEC-----------CCCBSCSSCEEEEEEEETT--EEEEEEECSSCCCTTCCEEEEEET-TCCCCSSBEEEEEEECCSS
T ss_pred eccC-----------hhhccCCCcEEEEEEEECC--EEEEEEeeccCCCCCcceEEEEEc-ccccCCCcEEEEEEeCCCC
Confidence 3221 112 258899999999986 899999864212222346888899 6789999999999999999
Q ss_pred cceeeEecccccc
Q 044561 246 KSSHYVLGWSFNR 258 (614)
Q Consensus 246 ~~~h~i~sWsf~~ 258 (614)
.+.|+|++|+|..
T Consensus 238 ~e~hdIlsw~~~~ 250 (260)
T 1gv9_A 238 ADDHDVLSFLTFQ 250 (260)
T ss_dssp CCEEEEEEEEEEE
T ss_pred cceEEEEEEEEEE
Confidence 9999999999974
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.3e-29 Score=275.90 Aligned_cols=183 Identities=20% Similarity=0.127 Sum_probs=129.3
Q ss_pred eeeeCcEEEEEEEEe-cCcEEEEEEeecC----------ChhhHHHHHHHHHHhccc-CCCceeEEeeEEeecCeEEEEE
Q 044561 353 IGRGGFGKVYRGVLA-SNVQIAVKKVSHD----------SKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 353 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~----------~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 420 (614)
.+.|++|.+..++.. -|..+++|.+... .....++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 566677766655433 2778999998654 133456799999999999 7999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
||++|++|.++|.... .++.. +|+.||++||.|||+ ++||||||||+|||+++++++||+|||+|+......
T Consensus 322 Eyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp ECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred ecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 9999999999998743 35543 589999999999995 899999999999999999999999999998765443
Q ss_pred CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCC
Q 044561 501 IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRR 545 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~ 545 (614)
. .....+||+.|||||++.+ .+..++|+||+|++++++.++..
T Consensus 394 ~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 394 S-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp C-CSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred c-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 2 3345689999999999864 56788999999999877765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-26 Score=255.72 Aligned_cols=185 Identities=13% Similarity=0.166 Sum_probs=145.7
Q ss_pred CCcceeeeeCcEEEEEEEEecCcEEEEEEeecCC--------hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEE
Q 044561 348 KDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDS--------KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLV 419 (614)
Q Consensus 348 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 419 (614)
...+.||+|+||.||+|.. .+..+++|+..... ....+++.+|++++++++||||+++..++...+..+||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999954 46778888764421 11245689999999999999999777777778888999
Q ss_pred EEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCC
Q 044561 420 YDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD 499 (614)
Q Consensus 420 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~ 499 (614)
|||+++++|.+++.. +..++.|+++||.|||+ ++|+||||||+|||++. ++||+|||+++.....
T Consensus 418 mE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 418 MSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred EECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 999999999999875 45899999999999995 89999999999999999 9999999999977553
Q ss_pred CCCc------ccccccCCCccchhhhcC--CCCCcchhHHHHHHHHHHHHcCCCCCC
Q 044561 500 TIPQ------TTKLVGTFGYMDPELMRT--GKASTSTDVYAFGVFMLEVASGRRPVE 548 (614)
Q Consensus 500 ~~~~------~~~~~gt~~y~aPE~~~~--~~~t~~~Dv~S~Gvll~el~tg~~p~~ 548 (614)
.... .....||+.|+|||++.. ..|+..+|+|+..+-.++-+.++.+|.
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 2111 135689999999999976 567888999999998888888777763
|
| >1qmo_A Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=99.92 E-value=5.1e-25 Score=188.59 Aligned_cols=94 Identities=28% Similarity=0.476 Sum_probs=82.7
Q ss_pred cceEEeCCCCC-CCCceEecceeEcCCCcEEecCCCC-----CCceeeEeeCCceeecCCCCCceeeeeeeEEee-----
Q 044561 27 VNQFIYHGFNE-DAQLQRDGLASVHSNGLLQLTNTVS-----PQQEGHAFYRLPIKFNTSSSESLSFSSNFVFAI----- 95 (614)
Q Consensus 27 ~~~f~~~~f~~-~~~~~~~g~a~~~~~g~l~Lt~~~~-----~~~~G~~~y~~pv~l~~~~~~~~sF~t~F~f~i----- 95 (614)
..+|+|++|.+ ..+|+++|+|.+.+ |.|+||++.. ..++|||+|++||+|||++++++||+|+|+|+|
T Consensus 3 ~~~F~f~~F~~~~~nl~l~G~A~v~~-g~l~LT~~~~~g~~~~~s~Gra~Y~~Pv~l~d~tg~vaSFsT~F~F~I~~~~~ 81 (113)
T 1qmo_A 3 SLSFSFTKFDPNQEDLIFQGHATSTN-NVLQVTKLDSAGNPVSSSAGRVLYSAPLRLWEDSAVLTSFDTIINFEISTPYT 81 (113)
T ss_dssp EEEEEESSCCSSCTTEEEEETCEEET-TEEECSCBCTTSCBCSSCEEEEEESSCEECCCTTEEEEEEEEEEEEEEECSSS
T ss_pred ceEEEcCCCCCCCCCeEEecceEcCC-CceEeCCCCCCCcccCCcEEEEEeCCCEEeeCCCCCEEeeEEEEEEEEecCCC
Confidence 56899999985 47999999999985 9999998753 268999999999999998667899999999999
Q ss_pred -----eeEEEEcCCCCCCCCCCCCCCcccccccC
Q 044561 96 -----GMAFVISPSKDLGKAEASPSEYLGLFNAS 124 (614)
Q Consensus 96 -----G~aF~l~p~~~~~~~~~~~g~~lGl~~~~ 124 (614)
||||||+|....| . +.||||||+|.+
T Consensus 82 ~~~gdGlAF~lap~~~~p--~-s~g~~LGL~n~~ 112 (113)
T 1qmo_A 82 SRIADGLAFFIAPPDSVI--S-YHGGFLGLFPNA 112 (113)
T ss_dssp SCCCCEEEEEEECTTCCC--C-CCGGGTTTCSSC
T ss_pred CCCCCeEEEEecCCCCCC--C-CCccccccccCC
Confidence 9999999987654 5 899999999874
|
| >2a6y_A EMP47P (FORM1); beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.42A {Saccharomyces cerevisiae} SCOP: b.29.1.13 | Back alignment and structure |
|---|
Probab=99.89 E-value=5.5e-23 Score=203.29 Aligned_cols=178 Identities=17% Similarity=0.249 Sum_probs=136.5
Q ss_pred CCCceEecceeEcCCCcEEecCCCCCCceeeEeeCCceeecCCCCCceeeeeeeEEee---------eeEEEEcCCCCCC
Q 044561 38 DAQLQRDGLASVHSNGLLQLTNTVSPQQEGHAFYRLPIKFNTSSSESLSFSSNFVFAI---------GMAFVISPSKDLG 108 (614)
Q Consensus 38 ~~~~~~~g~a~~~~~g~l~Lt~~~~~~~~G~~~y~~pv~l~~~~~~~~sF~t~F~f~i---------G~aF~l~p~~~~~ 108 (614)
.+++.++|+|.+. ++.|+||++ . .+.|++|.+.|+++.+ +|+++|+|.| ||||+++|....+
T Consensus 30 i~~w~~~G~a~v~-~~~IrLTp~-~-~s~G~iW~~~p~~~~~------~f~~~f~FrI~g~~~~~gdGlAfwlt~~~~~~ 100 (256)
T 2a6y_A 30 PNNWQTGEQASLE-EGRIVLTSN-Q-NSKGSLWLKQGFDLKD------SFTMEWTFRSVGYSGQTDGGISFWFVQDSNIP 100 (256)
T ss_dssp CTTEEEEETCEEE-TBEEECCCS-T-TCEEEEEESSCEEESS------CEEEEEEEEEESCCSCCSCEEEEEEEECSSSC
T ss_pred cCCeEEccceEEe-CCEEEECCC-C-CceEEEeeCCCCcccC------CEEEEEEEEEecCCCCCCCeEEEEEeCCCCcc
Confidence 3689999999994 999999988 4 6799999999998643 4999999999 9999999965421
Q ss_pred CCCCCCCCcccccccCCCCCCCCcEEEEEeeccCCCCCCCCC------CCeeeEecCCCcccccccCccccCccCCCccc
Q 044561 109 KAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDID------DNHVGIDVNSLISHESAPAAYFSDREGMNKTL 182 (614)
Q Consensus 109 ~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~------~~Hvgid~ns~~s~~~~~~~~~~~~~~~~~~~ 182 (614)
..|+.+|.++. -+-+||||||+.|. .|. +.|+++|.+++.+...+.+.+ .+
T Consensus 101 ----~~g~~~G~~~~-------f~GlaV~fDT~~n~---~p~i~~~~Ndg~~~~d~~~~~~~~~~~c~~---------~~ 157 (256)
T 2a6y_A 101 ----RDKQLYNGPVN-------YDGLQLLVDNNGPL---GPTLRGQLNDGQKPVDKTKIYDQSFASCLM---------GY 157 (256)
T ss_dssp ----CCCTBTTBCTT-------CEEEEEEEESCSTT---CSEEEEEEEESSSCCCGGGHHHHCSEEEEC---------CC
T ss_pred ----cCCcccCcCCC-------CCEEEEEEECCCCC---CceEEEEECCCceecccCCCcccceeccee---------ec
Confidence 56788888642 23489999999873 343 678888887644443333211 00
Q ss_pred cccCCccEEEEEEEe-CCCcEEEEEEeeCCCCCCCCCceeeeccCccc-ccccc-cccccccCC---CccceeeEecccc
Q 044561 183 ELIIGDPIQIWISYD-GAEKLLNVTLAPMSIPKPTKPLLSRAINLSHI-LLETM-YVGFSASTG---SLKSSHYVLGWSF 256 (614)
Q Consensus 183 ~l~~g~~~~~~I~Y~-~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~-l~~~~-~vGFsastg---~~~~~h~i~sWsf 256 (614)
..+|.+.++||+|+ +..+.|+|.+.+ ..-+++..+ ||+++ |+||||+|| ...+.|.|++|+|
T Consensus 158 -rn~~~~~~v~I~Y~~~~~~~L~V~i~~-----------~~c~~~~~v~LP~~~~~~GfSAaTG~~~~~~d~hdIls~~~ 225 (256)
T 2a6y_A 158 -QDSSVPSTIRVTYDLEDDNLLKVQVDN-----------KVCFQTRKVRFPSGSYRIGVTAQNGAVNNNAESFEIFKMQF 225 (256)
T ss_dssp -TTCSSCEEEEEEEEGGGTSEEEEEETT-----------EEEEEESCEECCSEEEEEEEEEECCSGGGCCCEEEEEEEEE
T ss_pred -ccCCCcEEEEEEEecCCCcEEEEEEcC-----------EEEEEECcEEeCCCCeEEEEEEeCCCCCCCcceEEEEEEEE
Confidence 13788999999999 888999999953 112344444 88887 699999999 7889999999999
Q ss_pred ccC
Q 044561 257 NRS 259 (614)
Q Consensus 257 ~~~ 259 (614)
...
T Consensus 226 ~~~ 228 (256)
T 2a6y_A 226 FNG 228 (256)
T ss_dssp EES
T ss_pred Eec
Confidence 863
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=8.6e-23 Score=207.21 Aligned_cols=150 Identities=13% Similarity=0.082 Sum_probs=120.1
Q ss_pred HHHHhcCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCCh------------------hhHHHHHHHHHHhcccCCC
Q 044561 340 LYKATKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSK------------------QGIKEFVAELVSMGRLRHR 401 (614)
Q Consensus 340 l~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~Ei~~l~~l~H~ 401 (614)
+......|+..+.||+|+||.||+|...++..||+|.+..... .....+.+|+.++++++
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-- 162 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-- 162 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence 3344455666799999999999999996689999999864321 13467899999999999
Q ss_pred ceeEEeeEEeecCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcC
Q 044561 402 NLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA 481 (614)
Q Consensus 402 niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~ 481 (614)
| +++.+++.. +..++||||+++++|.+ +.. .+...++.|+++||.|||+ .+|+||||||+|||++
T Consensus 163 ~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~- 227 (282)
T 1zar_A 163 G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS- 227 (282)
T ss_dssp T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-
T ss_pred C-CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-
Confidence 5 666665543 56699999999999998 422 2345799999999999995 8999999999999999
Q ss_pred CCCEEEeeeccccccCCCCCCcccccccCCCccchhhhc
Q 044561 482 DLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMR 520 (614)
Q Consensus 482 ~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 520 (614)
++.+||+|||+++. +..++|||++.
T Consensus 228 ~~~vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 228 EEGIWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence 99999999999873 33478999874
|
| >1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... | Back alignment and structure |
|---|
Probab=99.86 E-value=3.9e-22 Score=193.63 Aligned_cols=97 Identities=31% Similarity=0.519 Sum_probs=85.5
Q ss_pred CcceEEeCCCCC-CCCceEecceeEcCCCcEEecCCCC-----CCceeeEeeCCceeecCCCCCceeeeeeeEEee----
Q 044561 26 DVNQFIYHGFNE-DAQLQRDGLASVHSNGLLQLTNTVS-----PQQEGHAFYRLPIKFNTSSSESLSFSSNFVFAI---- 95 (614)
Q Consensus 26 ~~~~f~~~~f~~-~~~~~~~g~a~~~~~g~l~Lt~~~~-----~~~~G~~~y~~pv~l~~~~~~~~sF~t~F~f~i---- 95 (614)
...+|.|++|.+ ..+|+++|+|.+.++|.|+||++.. ..++|||+|++||+||+++++++||+|+|+|.|
T Consensus 124 ~~~~F~~~~F~~~~~nl~l~G~A~v~~~g~l~LT~~~~n~~~~~~~~Gra~Y~~Pv~lwd~~~~vaSFsT~F~F~I~~~~ 203 (237)
T 1nls_A 124 NALHFMFNQFSKDQKDLILQGDATTGTDGNLELTRVSSNGSPQGSSVGRALFYAPVHIWESSAVVASFEATFTFLIKSPD 203 (237)
T ss_dssp EEEEEEESCCCTTCTTEEEEETCEEEETTEEESSCBCTTSCBCSSCEEEEEESSCEECCCTTEEEEEEEEEEEEECCCSS
T ss_pred ccchhhhccccccCCCeEEccceEecCCCceEecCCccCCccccCceEEEEeCCCEEeecCCCCEeeeEEEEEEEEecCC
Confidence 446999999986 4699999999998799999998753 268999999999999997778899999999999
Q ss_pred -----eeEEEEcCCCC-CCCCCCCCCCcccccccC
Q 044561 96 -----GMAFVISPSKD-LGKAEASPSEYLGLFNAS 124 (614)
Q Consensus 96 -----G~aF~l~p~~~-~~~~~~~~g~~lGl~~~~ 124 (614)
||||||+|... .| .+++||||||||.+
T Consensus 204 ~~~g~GlAF~lap~~~~~p--~~~~g~~LGL~n~~ 236 (237)
T 1nls_A 204 SHPADGIAFFISNIDSSIP--SGSTGRLLGLFPDA 236 (237)
T ss_dssp SSCCCEEEEEEECTTCCCC--TTCCGGGTTTCSSC
T ss_pred CCCCccEEEEECCCCCCCC--CCCCcCeeccccCC
Confidence 99999999873 44 78899999999975
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=4.9e-19 Score=177.14 Aligned_cols=138 Identities=17% Similarity=0.144 Sum_probs=106.2
Q ss_pred CCCcceeeeeCcEEEEEEEE-ecCcE--EEEEEeecCCh------------------------hhHHHHHHHHHHhcccC
Q 044561 347 FKDKDVIGRGGFGKVYRGVL-ASNVQ--IAVKKVSHDSK------------------------QGIKEFVAELVSMGRLR 399 (614)
Q Consensus 347 f~~~~~lG~G~fg~Vy~~~~-~~~~~--vavK~~~~~~~------------------------~~~~~~~~Ei~~l~~l~ 399 (614)
|+..+.||+|+||.||+|.. .++.. ||||.+..... .....+.+|+..+.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 45678999999999999998 56888 99998754311 11236788999999998
Q ss_pred CCce--eEEeeEEeecCeEEEEEEecCC-C----CcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCc
Q 044561 400 HRNL--VKLRGYCRRKGEFLLVYDYMPN-G----SLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 472 (614)
Q Consensus 400 H~ni--v~l~g~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDi 472 (614)
|+++ ..++.+ +..+|||||+.+ | +|.++... .++.++..++.|++.+|.|||. ..+|+||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~--~~givHrDl 197 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQ--EAELVHADL 197 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCC
Confidence 8764 334432 356899999942 4 45544322 3466788999999999999993 279999999
Q ss_pred CCCCeEEcCCCCEEEeeeccccccC
Q 044561 473 KPANVLLDADLNGKLGDFGLARLYD 497 (614)
Q Consensus 473 kp~NIll~~~~~~kl~DfGla~~~~ 497 (614)
||+|||++. .++|+|||++....
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEETT
T ss_pred CHHHEEEcC--cEEEEECcccccCC
Confidence 999999998 99999999997653
|
| >2a6z_A EMP47P (FORM2); beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.00A {Saccharomyces cerevisiae} SCOP: b.29.1.13 PDB: 2a70_A 2a71_A | Back alignment and structure |
|---|
Probab=99.62 E-value=1.8e-15 Score=146.16 Aligned_cols=171 Identities=18% Similarity=0.260 Sum_probs=118.7
Q ss_pred CCceEecceeEcCCCcEEecCCCCCCceeeEeeCCceeecCCCCCceeeeeeeEEee---------eeEEEEcCCCCCCC
Q 044561 39 AQLQRDGLASVHSNGLLQLTNTVSPQQEGHAFYRLPIKFNTSSSESLSFSSNFVFAI---------GMAFVISPSKDLGK 109 (614)
Q Consensus 39 ~~~~~~g~a~~~~~g~l~Lt~~~~~~~~G~~~y~~pv~l~~~~~~~~sF~t~F~f~i---------G~aF~l~p~~~~~~ 109 (614)
+...+.|+|.+. ++.|+||++ . .+.|.+|.+.|+++.+. |+++|+|.| ||||.+++....+
T Consensus 24 ~~W~~~G~a~i~-~~~IrLTp~-~-~~~G~iWs~~p~~~~~~------weie~~Fri~g~~~~~gdGlA~W~t~~~~~~- 93 (222)
T 2a6z_A 24 NNWQTGEQASLE-EGRIVLTSN-Q-NSKGSLWLKQGFDLKDS------FTMEWTFRSVGYSGQTDGGISFWFVQDSNIP- 93 (222)
T ss_dssp TTEEEEETCEEE-TTEEESCCS-T-TCEEEEEESSCEECCSC------EEEEEEEEEESCCSCCSCEEEEEEEECSSSC-
T ss_pred CCcEEcccEEEc-CCEEEECCC-C-CCeEEEEeCCCCCCCCC------EEEEEEEEEeCCCCCCCCEEEEEEECCCccc-
Confidence 578999999996 899999998 4 57899999999987554 999999999 9999999864311
Q ss_pred CCCCCCCcccccccCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeeEecCC-Ccc----------cccccCccccCccCC
Q 044561 110 AEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNS-LIS----------HESAPAAYFSDREGM 178 (614)
Q Consensus 110 ~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns-~~s----------~~~~~~~~~~~~~~~ 178 (614)
..|..+|..+.- .=+||+|||+.|. .++|.+.+|- -.+ .....+.|
T Consensus 94 ---~~g~~~G~~~~f-------~GL~I~~Dt~~n~------~p~i~~~~ndG~~~yd~~~~~~~~~~~C~~~~------- 150 (222)
T 2a6z_A 94 ---RDKQLYNGPVNY-------DGLQLLVDNNGPL------GPTLRGQLNDGQKPVDKTKIYDQSFASCLMGY------- 150 (222)
T ss_dssp ---CCCTBTTBCTTC-------EEEEEEEESCSTT------SSEEEEEEEESSSCCCGGGHHHHCSEEEECCC-------
T ss_pred ---CCCcccCCCCCC-------CEEEEEEECCCCC------CceEEEEECCCCeeeccCCCccccccccceec-------
Confidence 234444542211 1179999999873 3456555532 111 11111111
Q ss_pred CccccccCCccEEEEEEEe-CCCcEEEEEEeeCCCCCCCCCceeeeccCccccccc-ccccccccCC---CccceeeEec
Q 044561 179 NKTLELIIGDPIQIWISYD-GAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLET-MYVGFSASTG---SLKSSHYVLG 253 (614)
Q Consensus 179 ~~~~~l~~g~~~~~~I~Y~-~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~-~~vGFsastg---~~~~~h~i~s 253 (614)
...+.+.+++|+|+ ...+.|+|.+.. ....-...|+ ||+. .|+||||+|| ...+.|.|++
T Consensus 151 -----rn~~~~~~~rI~Y~~~~~~~l~v~id~------~~C~~~~~v~----LP~~~~y~G~SA~TG~l~~~~d~hdil~ 215 (222)
T 2a6z_A 151 -----QDSSVPSTIRVTYDLEDDNLLKVQVDN------KVCFQTRKVR----FPSGSYRIGVTAQNGAVNNNAESFEIFK 215 (222)
T ss_dssp -----TTEEEEEEEEEEEEGGGTSEEEEEETT------EEEEEESCCC----CCSSEEEEEEEEECCSGGGCCCEEEEEE
T ss_pred -----cCCCCcEEEEEEEEcCCCcEEEEEEcC------eEEEEeCCee----cCCCCcEEEEEEcCCCCCCCCccEEEEE
Confidence 13567899999999 678889999852 1111112233 4554 4799999999 7889999999
Q ss_pred cccc
Q 044561 254 WSFN 257 (614)
Q Consensus 254 Wsf~ 257 (614)
|++.
T Consensus 216 ~~~~ 219 (222)
T 2a6z_A 216 MQFF 219 (222)
T ss_dssp EEEE
T ss_pred EEEE
Confidence 9875
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.61 E-value=4.3e-16 Score=162.71 Aligned_cols=140 Identities=13% Similarity=0.112 Sum_probs=99.0
Q ss_pred CCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCCh--------------hhHHH--------HHHHHHHhcccCCCcee
Q 044561 347 FKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSK--------------QGIKE--------FVAELVSMGRLRHRNLV 404 (614)
Q Consensus 347 f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~--------~~~Ei~~l~~l~H~niv 404 (614)
|+..+.||+|+||.||+|...+|+.||||.++.... ..... ..+|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 788899999999999999998899999998753210 00111 12345555555443322
Q ss_pred EEeeEEeecCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCC-
Q 044561 405 KLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADL- 483 (614)
Q Consensus 405 ~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~- 483 (614)
-..-+.. ...+|||||+++++|.++... .....++.|++.+|.|||. .+||||||||.|||+++++
T Consensus 177 vp~p~~~--~~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 177 VPEPIAQ--SRHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAK---HGLIHGDFNEFNILIREEKD 243 (397)
T ss_dssp CCCEEEE--ETTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEEEEC
T ss_pred CCeeeec--cCceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeCCCC
Confidence 1111111 123699999999888765432 2345688999999999994 8999999999999998877
Q ss_pred ---------CEEEeeeccccccCCC
Q 044561 484 ---------NGKLGDFGLARLYDHD 499 (614)
Q Consensus 484 ---------~~kl~DfGla~~~~~~ 499 (614)
.+.|+||+-+...+++
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~~~hp 268 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVSMDHP 268 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEETTST
T ss_pred cccccccccceEEEEeCCcccCCCC
Confidence 3899999988765543
|
| >2ltn_B PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1hkd_B 1rin_B* 1ofs_B* 1bqp_B* 1loe_B 1loa_B* 1loc_B* 1lod_B* 1lob_B 1lof_B* 1log_B* 1lof_D* 1les_B* 2b7y_B* 1lgc_B* 1lgb_B* 1len_B 1lem_B 2lal_B | Back alignment and structure |
|---|
Probab=99.42 E-value=1.3e-14 Score=104.67 Aligned_cols=44 Identities=36% Similarity=0.564 Sum_probs=41.4
Q ss_pred CCceeeeccCcccccccccccccccCCCccceeeEeccccccCC
Q 044561 217 KPLLSRAINLSHILLETMYVGFSASTGSLKSSHYVLGWSFNRSG 260 (614)
Q Consensus 217 ~~~ls~~~dl~~~l~~~~~vGFsastg~~~~~h~i~sWsf~~~~ 260 (614)
+|+|+..+||+++|+|+|||||||+||...+.|+|++|+|++++
T Consensus 3 ~p~ls~~vdLs~~l~e~v~VGFSAsTG~~~~~h~IlsWsF~s~~ 46 (52)
T 2ltn_B 3 SYTLSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVLSWSFHSEL 46 (52)
T ss_dssp EEEEEEECCHHHHSCSEEEEEEEEECCSSCCEEEEEEEEEEEEE
T ss_pred eeeEEEEEcHHHhcCceEEEEEEeccCCcceeEEEEEeEEEeec
Confidence 47899999999999999999999999999999999999998764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=2.7e-11 Score=120.71 Aligned_cols=146 Identities=18% Similarity=0.077 Sum_probs=112.5
Q ss_pred HHHhcCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccC-CCceeEEeeEEeecCeEEEE
Q 044561 341 YKATKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLR-HRNLVKLRGYCRRKGEFLLV 419 (614)
Q Consensus 341 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV 419 (614)
.....+|.....++.|+.+.||+.... +..+++|............+.+|+.+++.+. +.++.++++++...+..|+|
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 334457777788888889999998754 6789999986532122235778888888884 67788999999988999999
Q ss_pred EEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhcc-------------------------------------
Q 044561 420 YDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHED------------------------------------- 462 (614)
Q Consensus 420 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------- 462 (614)
|||++|.+|.+.+. +..+...++.+++++|..||+.
T Consensus 89 ~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 89 MSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 99999999887642 1233457888999999999971
Q ss_pred -------------------CCCceEecCcCCCCeEEcCCCCEEEeeecccc
Q 044561 463 -------------------WEQVVLHRDIKPANVLLDADLNGKLGDFGLAR 494 (614)
Q Consensus 463 -------------------~~~~ivHrDikp~NIll~~~~~~kl~DfGla~ 494 (614)
....++|+|++|.|||++++..+.|+||+.+.
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01569999999999999876566799998765
|
| >2a6v_A EMP46P; beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.52A {Saccharomyces cerevisiae} SCOP: b.29.1.13 PDB: 2a6w_A 2a6x_A | Back alignment and structure |
|---|
Probab=99.14 E-value=5.1e-10 Score=107.56 Aligned_cols=176 Identities=18% Similarity=0.206 Sum_probs=110.8
Q ss_pred CCceEecceeEcCCCcEEecCCCCCCceeeEeeCCceeecCCCCCceeeeeeeEEee---------eeEEEEcCCCCCCC
Q 044561 39 AQLQRDGLASVHSNGLLQLTNTVSPQQEGHAFYRLPIKFNTSSSESLSFSSNFVFAI---------GMAFVISPSKDLGK 109 (614)
Q Consensus 39 ~~~~~~g~a~~~~~g~l~Lt~~~~~~~~G~~~y~~pv~l~~~~~~~~sF~t~F~f~i---------G~aF~l~p~~~~~~ 109 (614)
+...+.|+|.+. ++.|+||++ + ++.|.+|-+.|+.+-+ +|+.+|.|.| ||||.++.....
T Consensus 27 ~~W~~~G~t~v~-~~~IrLTp~-~-s~~G~lWs~~p~~~~~------~weiev~Fri~G~~~~~gdGlA~Wyt~~~~~-- 95 (226)
T 2a6v_A 27 SQWTLGDKVKLE-EGRFVLTPG-K-NTKGSLWLKPEYSIKD------AMTIEWTFRSFGFRGSTKGGLAFWLKQGNEG-- 95 (226)
T ss_dssp TTEEEEETCEEE-TTEEESCCS-T-TCEEEEEESSCBCCSS------CEEEEEEEEEESCCSCCSCEEEEEEECSCCC--
T ss_pred CCcEEcCCeEEe-CCEEEECCC-C-CceEEEeeCCCCCCCC------CeEEEEEEEEecCCCCCCCEEEEEEECCCCC--
Confidence 468889999997 778999999 6 8999999999998623 3999999999 999999965321
Q ss_pred CCCCCCCcccccccCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeeEecC-CCcccc---cccCccccCccCCCcccccc
Q 044561 110 AEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVN-SLISHE---SAPAAYFSDREGMNKTLELI 185 (614)
Q Consensus 110 ~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~n-s~~s~~---~~~~~~~~~~~~~~~~~~l~ 185 (614)
..|...|-....-+| +||.|||+.|. .+.|-+-+| +..+-. ....+.-. .. -..
T Consensus 96 ---~~g~vfGg~~d~f~G------lgI~~Dt~~n~------~p~i~~~~NDGt~~yd~~~~~~~g~C~------~~-~rn 153 (226)
T 2a6v_A 96 ---DSTELFGGSSKKFNG------LMILLRLDDKL------GESVTAYLNDGTKDLDIESSPYFASCL------FQ-YQD 153 (226)
T ss_dssp ---CCCTBTTTBCSSCEE------EEEEEEEETTT------EEEEEEEEEESSSCCCTTTSCCSEEEE------CC-CSS
T ss_pred ---CCcccccccCCCccE------EEEEEECCCCC------CceEEEEECCCCcccCCCCCcccceEe------Ee-ccC
Confidence 122222210101111 79999999872 122222222 211100 01110000 00 123
Q ss_pred CCccEEEEEEEe-CCCcEEEEEEeeCCCCCCCCCceeeeccCccccccc--ccccccccCCCccceeeEeccccc
Q 044561 186 IGDPIQIWISYD-GAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLET--MYVGFSASTGSLKSSHYVLGWSFN 257 (614)
Q Consensus 186 ~g~~~~~~I~Y~-~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~--~~vGFsastg~~~~~h~i~sWsf~ 257 (614)
.+.+.+++|.|. ...+.|+|.+.. + .-..++ .-.||.. +|+||||+||...+.|.|++-.+.
T Consensus 154 ~~~~t~~ri~Y~~~~~~~l~v~id~-------~--~Cf~~~-~v~LP~g~~~yfGiSAaTg~~~D~hdils~~~~ 218 (226)
T 2a6v_A 154 SMVPSTLRLTYNPLDNHLLKLQMDN-------R--VCFQTR-KVKFMGSSPFRIGTSAINDASKESFEILKMKLY 218 (226)
T ss_dssp CSSCEEEEEEEEGGGTSEEEEEETT-------E--EEEEES-CCCGGGTSCBEEEEEEECCTTCCEEEEEEEEEE
T ss_pred CCCCEEEEEEEEccCCCEEEEEEcC-------C--eeEEEC-CeecCCCCccEEEEEEcCCCCcccEEEEEEEEE
Confidence 567899999997 467889998852 1 111111 1134543 499999999999999999986543
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.04 E-value=1.3e-10 Score=115.04 Aligned_cols=136 Identities=17% Similarity=0.118 Sum_probs=97.5
Q ss_pred CCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCc--eeEEeeEEeecCeEEEEEEec
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRN--LVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~~~~~~~~~lV~E~~ 423 (614)
++....+.+.|..+.||+....++..+++|..... ....+.+|+.+++.+.+.+ +.+++++....+..++||||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 34333333355569999998766778999987654 2245678888888886544 456888888888899999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccC----------------------------------------
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDW---------------------------------------- 463 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------- 463 (614)
++.+|. ... . ....++.++++.|..||+..
T Consensus 98 ~G~~l~--~~~-----~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
T 1nd4_A 98 PGQDLL--SSH-----L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP 167 (264)
T ss_dssp SSEETT--TSC-----C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred CCcccC--cCc-----C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccH
Confidence 998884 211 1 12356667777777777521
Q ss_pred ---------------CCceEecCcCCCCeEEcCCCCEEEeeecccc
Q 044561 464 ---------------EQVVLHRDIKPANVLLDADLNGKLGDFGLAR 494 (614)
Q Consensus 464 ---------------~~~ivHrDikp~NIll~~~~~~kl~DfGla~ 494 (614)
...++|+|++|.||+++++..+.|+||+.+.
T Consensus 168 ~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 168 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1239999999999999887667799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.89 E-value=2.1e-09 Score=112.17 Aligned_cols=142 Identities=13% Similarity=0.176 Sum_probs=106.2
Q ss_pred CcceeeeeCcEEEEEEEEecCcEEEEEEee--cCC-hhhHHHHHHHHHHhcccC--CCceeEEeeEEeec---CeEEEEE
Q 044561 349 DKDVIGRGGFGKVYRGVLASNVQIAVKKVS--HDS-KQGIKEFVAELVSMGRLR--HRNLVKLRGYCRRK---GEFLLVY 420 (614)
Q Consensus 349 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~---~~~~lV~ 420 (614)
..+.|+.|.++.||+....+ ..+++|+.. ... ......+.+|..+++.+. +..+.+++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 35678999999999988754 567888765 322 122346778998888886 45688899988776 4589999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccC-------------------------------------
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDW------------------------------------- 463 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------- 463 (614)
||+++..+.+... ..++..++..++.++++.|..||+..
T Consensus 121 e~v~G~~l~~~~~----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 121 EFVSGRVLWDQSL----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp ECCCCBCCCCTTC----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EecCCeecCCCcc----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 9999988854221 23678888999999999999999620
Q ss_pred ------------------CCceEecCcCCCCeEEcCCCC--EEEeeeccccc
Q 044561 464 ------------------EQVVLHRDIKPANVLLDADLN--GKLGDFGLARL 495 (614)
Q Consensus 464 ------------------~~~ivHrDikp~NIll~~~~~--~kl~DfGla~~ 495 (614)
...++|+|+++.|||++.++. +.|.||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999997753 68999998874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.83 E-value=1.9e-09 Score=109.79 Aligned_cols=183 Identities=15% Similarity=0.167 Sum_probs=120.6
Q ss_pred cceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccC-CCc--eeEEeeEEeecC---eEEEEEEec
Q 044561 350 KDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLR-HRN--LVKLRGYCRRKG---EFLLVYDYM 423 (614)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~n--iv~l~g~~~~~~---~~~lV~E~~ 423 (614)
.+.++.|....||+.. ..+++|+.... .....+.+|...++.+. +.. +.+++..+...+ ..|+|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4569999999999853 45788875432 34567888999988773 322 344555543333 348899999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhcc-----------------------------------------
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHED----------------------------------------- 462 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------------------------------------- 462 (614)
+|.+|...... .++..++..++.++++.|..||+.
T Consensus 99 ~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 99 KGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 99988754321 256677777788888888777751
Q ss_pred --------------CCCceEecCcCCCCeEEcC--CCCEEEeeeccccccCCCCCCcccccccCCCc---cchhhhcC--
Q 044561 463 --------------WEQVVLHRDIKPANVLLDA--DLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY---MDPELMRT-- 521 (614)
Q Consensus 463 --------------~~~~ivHrDikp~NIll~~--~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y---~aPE~~~~-- 521 (614)
....++|+|++|.||++++ ...+.|+||+.+..-+... . ....... ..|+....
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~--D---l~~~~~~~~~~~~~~~~~~l 249 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN--D---FISLMEDDEEYGMEFVSKIL 249 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH--H---HHTTCCTTTSCCHHHHHHHH
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH--H---HHHHHhhccccCHHHHHHHH
Confidence 1246899999999999998 4567899999887543211 0 0001111 23332110
Q ss_pred ---CC---------CCcchhHHHHHHHHHHHHcCCCCC
Q 044561 522 ---GK---------ASTSTDVYAFGVFMLEVASGRRPV 547 (614)
Q Consensus 522 ---~~---------~t~~~Dv~S~Gvll~el~tg~~p~ 547 (614)
+. .....+.|+++.++|++.+|+.++
T Consensus 250 ~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 250 NHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11 112368999999999999998775
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=4.5e-06 Score=84.84 Aligned_cols=138 Identities=18% Similarity=0.135 Sum_probs=92.6
Q ss_pred CcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCC---ceeEEeeEEe-ecCeEEEEEEecC
Q 044561 349 DKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHR---NLVKLRGYCR-RKGEFLLVYDYMP 424 (614)
Q Consensus 349 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~---niv~l~g~~~-~~~~~~lV~E~~~ 424 (614)
..+.++.|....||+. +..+++|+.. .......+.+|..+++.+.+. .+.+.+.++. ..+..++|||+++
T Consensus 23 ~v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 23 SVESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp CEEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 3466889999999987 5667888742 233456788999999988652 3556666664 4556789999999
Q ss_pred CCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhcc------------------------------------------
Q 044561 425 NGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHED------------------------------------------ 462 (614)
Q Consensus 425 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------ 462 (614)
|.+|...... .++..++..++.++++.|..||+.
T Consensus 97 G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 97 GQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp SEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred CeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 9888763211 123333344444444444444421
Q ss_pred ---------------CCCceEecCcCCCCeEEcC---CCC-EEEeeecccccc
Q 044561 463 ---------------WEQVVLHRDIKPANVLLDA---DLN-GKLGDFGLARLY 496 (614)
Q Consensus 463 ---------------~~~~ivHrDikp~NIll~~---~~~-~kl~DfGla~~~ 496 (614)
....++|+|+++.||+++. ++. +.|+||+.+..-
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 1346799999999999987 455 489999987643
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=5.2e-06 Score=82.44 Aligned_cols=136 Identities=19% Similarity=0.173 Sum_probs=92.7
Q ss_pred ceeeeeCcE-EEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccC-CCceeEEeeEEeecCeEEEEEEecCCCC
Q 044561 351 DVIGRGGFG-KVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLR-HRNLVKLRGYCRRKGEFLLVYDYMPNGS 427 (614)
Q Consensus 351 ~~lG~G~fg-~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gs 427 (614)
+.+..|..| .||+..... +..+++|+-... ...++.+|...|+.+. +-.+.++++++.+.+..++|||++++.+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 345556655 689877654 567888876543 3456778888887774 3346788899999999999999999988
Q ss_pred cchhcccCCCCCcChhHHHHHHHHhHhhchhhhcc---------------------------------------------
Q 044561 428 LDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHED--------------------------------------------- 462 (614)
Q Consensus 428 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~--------------------------------------------- 462 (614)
+.+..... ......+..+++..|..||+.
T Consensus 107 ~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 107 AFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 76654221 112223444444444444421
Q ss_pred ----------CCCceEecCcCCCCeEEcCCCCEEEeeeccccc
Q 044561 463 ----------WEQVVLHRDIKPANVLLDADLNGKLGDFGLARL 495 (614)
Q Consensus 463 ----------~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~ 495 (614)
....++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 123589999999999999877777999998763
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.09 E-value=4.1e-06 Score=86.93 Aligned_cols=81 Identities=6% Similarity=0.006 Sum_probs=54.8
Q ss_pred ccee-eeeCcEEEEEEEEe-------cCcEEEEEEeecCC---hhhHHHHHHHHHHhcccCC---CceeEEeeEEeec--
Q 044561 350 KDVI-GRGGFGKVYRGVLA-------SNVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRH---RNLVKLRGYCRRK-- 413 (614)
Q Consensus 350 ~~~l-G~G~fg~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H---~niv~l~g~~~~~-- 413 (614)
.+.| +.|....+|+.... ++..+++|...... ......+.+|..+++.+.. -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 78889999998765 25667887754322 0011345678887777742 3466788877665
Q ss_pred -CeEEEEEEecCCCCcch
Q 044561 414 -GEFLLVYDYMPNGSLDK 430 (614)
Q Consensus 414 -~~~~lV~E~~~~gsL~~ 430 (614)
+..++||||+++..+.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 45789999999888764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00019 Score=73.40 Aligned_cols=139 Identities=17% Similarity=0.246 Sum_probs=78.1
Q ss_pred ceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccC-----CCceeEEe-e--EEeecCeEEEEEEe
Q 044561 351 DVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLR-----HRNLVKLR-G--YCRRKGEFLLVYDY 422 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----H~niv~l~-g--~~~~~~~~~lV~E~ 422 (614)
+.|+.|..+.||+....++ .+++|+.... . .+...|..+++.+. .|.++... | +....+..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4466667889999876544 5888888653 2 22233444444332 34443311 1 12346678999999
Q ss_pred cCCCCcch--------------hcccC---C--C-------CCcChhHHH------------------------------
Q 044561 423 MPNGSLDK--------------ILHTN---I--K-------PCLNWYQRF------------------------------ 446 (614)
Q Consensus 423 ~~~gsL~~--------------~l~~~---~--~-------~~l~~~~~~------------------------------ 446 (614)
++|..+.. .+|.. . . ..-.|...+
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 99876541 11110 0 0 011232111
Q ss_pred -HHHHHhHhhchhhhc----------cCCCceEecCcCCCCeEEcCCCCEEEeeecccc
Q 044561 447 -RIIRGVASGLLYLHE----------DWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR 494 (614)
Q Consensus 447 -~i~~~ia~gL~yLH~----------~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~ 494 (614)
.+...+..++.+|+. .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111123345556652 125789999999999999888899999999875
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.56 E-value=9.7e-05 Score=77.73 Aligned_cols=75 Identities=13% Similarity=0.072 Sum_probs=47.7
Q ss_pred cceeeeeCcEEEEEEEEe-cCcEEEEEEeecCCh-------hhHHHHHHHHHHhcccCC--Cc-eeEEeeEEeecCeEEE
Q 044561 350 KDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSK-------QGIKEFVAELVSMGRLRH--RN-LVKLRGYCRRKGEFLL 418 (614)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~Ei~~l~~l~H--~n-iv~l~g~~~~~~~~~l 418 (614)
.+.||.|..+.||++... ++..+++|......+ .....+..|..+++.+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457999999999999765 367899997643221 122345678888776632 33 4455544 3345689
Q ss_pred EEEecCCC
Q 044561 419 VYDYMPNG 426 (614)
Q Consensus 419 V~E~~~~g 426 (614)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00041 Score=69.43 Aligned_cols=80 Identities=18% Similarity=0.186 Sum_probs=56.3
Q ss_pred CCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCC---CceeEEeeEEeecCeEEEEEEe
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRH---RNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H---~niv~l~g~~~~~~~~~lV~E~ 422 (614)
.....+.+|.|..+.||+....+|+.+.+|+...........|..|...|+.|.- -.+.+++++. .-++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 3445677999999999999999999999998765443333457788888877732 2244455442 23789999
Q ss_pred cCCCCcc
Q 044561 423 MPNGSLD 429 (614)
Q Consensus 423 ~~~gsL~ 429 (614)
++.+...
T Consensus 92 l~~~~~~ 98 (288)
T 3f7w_A 92 VDERPPT 98 (288)
T ss_dssp CCCCCCC
T ss_pred ecccCCC
Confidence 9877653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0026 Score=64.48 Aligned_cols=139 Identities=17% Similarity=0.132 Sum_probs=91.8
Q ss_pred CCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccC---CCceeEEeeEEeecCeEEEEEEecC
Q 044561 348 KDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLR---HRNLVKLRGYCRRKGEFLLVYDYMP 424 (614)
Q Consensus 348 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV~E~~~ 424 (614)
...+.|+.|....+|+... ++..+++|..... ....+..|...|+.|. ...+.+++.++...+..++||||++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 3456799999999999875 4667888887643 2456788888888774 3568888888888889999999999
Q ss_pred CCCcch-----------hcccCCC-C-------------------CcChhHHH---HHHH--H--------------hHh
Q 044561 425 NGSLDK-----------ILHTNIK-P-------------------CLNWYQRF---RIIR--G--------------VAS 454 (614)
Q Consensus 425 ~gsL~~-----------~l~~~~~-~-------------------~l~~~~~~---~i~~--~--------------ia~ 454 (614)
+..+.. .|+.... . .-+|...+ ++.. + +..
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 887632 1222111 0 11343321 1111 1 111
Q ss_pred hc-hhhhc-cCCCceEecCcCCCCeEEcCCCCEEEeeec
Q 044561 455 GL-LYLHE-DWEQVVLHRDIKPANVLLDADLNGKLGDFG 491 (614)
Q Consensus 455 gL-~yLH~-~~~~~ivHrDikp~NIll~~~~~~kl~DfG 491 (614)
-+ ..|.. .....++|+|+.+.|++++.++ +.|.|+.
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 11 12321 2257899999999999999887 8899974
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0009 Score=70.90 Aligned_cols=77 Identities=10% Similarity=0.093 Sum_probs=47.3
Q ss_pred CCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCccccccc--CCCccchhhhcCC---CCCcchhHHHHHHHHH
Q 044561 464 EQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVG--TFGYMDPELMRTG---KASTSTDVYAFGVFML 538 (614)
Q Consensus 464 ~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~t~~~Dv~S~Gvll~ 538 (614)
...++|+|+++.|||++.++ +++.||+.+..-+... ....... ...|.+|+..... ......++......+|
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~--Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF--DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH--HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH--HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 57899999999999998876 9999999887432110 0000010 1235566554311 1122355567777788
Q ss_pred HHHcC
Q 044561 539 EVASG 543 (614)
Q Consensus 539 el~tg 543 (614)
+.+++
T Consensus 308 ~~y~~ 312 (420)
T 2pyw_A 308 NLFNK 312 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0035 Score=63.94 Aligned_cols=33 Identities=30% Similarity=0.363 Sum_probs=28.4
Q ss_pred CCceEecCcCCCCeEEcCC----CCEEEeeecccccc
Q 044561 464 EQVVLHRDIKPANVLLDAD----LNGKLGDFGLARLY 496 (614)
Q Consensus 464 ~~~ivHrDikp~NIll~~~----~~~kl~DfGla~~~ 496 (614)
...++|||+.+.|||++.+ ..+.|.||+.+..-
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 4689999999999999875 67899999988743
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.75 E-value=0.0026 Score=67.62 Aligned_cols=74 Identities=22% Similarity=0.227 Sum_probs=49.0
Q ss_pred cceeeeeCcEEEEEEEEec--------CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCce-eEEeeEEeecCeEEEEE
Q 044561 350 KDVIGRGGFGKVYRGVLAS--------NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNL-VKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~ 420 (614)
.+.|+.|....+|+....+ +..+++|+...... ...+..|..+++.+...++ .++++.+.. .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 3568888889999998753 46788887743211 1345578888887753344 456665542 2899
Q ss_pred EecCCCCcc
Q 044561 421 DYMPNGSLD 429 (614)
Q Consensus 421 E~~~~gsL~ 429 (614)
||+++.+|.
T Consensus 152 e~l~G~~l~ 160 (429)
T 1nw1_A 152 EYIPSRPLS 160 (429)
T ss_dssp CCCCEEECC
T ss_pred EEeCCcccC
Confidence 999875653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.67 E-value=0.012 Score=59.34 Aligned_cols=157 Identities=16% Similarity=0.102 Sum_probs=83.4
Q ss_pred cCHHHHHHHhcCCCC-----cceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCc--eeEEe
Q 044561 335 FTYKDLYKATKGFKD-----KDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRN--LVKLR 407 (614)
Q Consensus 335 ~~~~el~~~~~~f~~-----~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~ 407 (614)
++.+++......|.. .+.|+.|....+|+....++ .+++|...... ...++..|+.+++.+...+ +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 344555555454543 23466788889999887655 67888876521 1123445666665553212 22333
Q ss_pred eE------EeecCeEEEEEEecCCCCcchh--------------cccCC---C-C------CcChhHHHHHH--------
Q 044561 408 GY------CRRKGEFLLVYDYMPNGSLDKI--------------LHTNI---K-P------CLNWYQRFRII-------- 449 (614)
Q Consensus 408 g~------~~~~~~~~lV~E~~~~gsL~~~--------------l~~~~---~-~------~l~~~~~~~i~-------- 449 (614)
.. ....+..+++++|++|..+... ++... . . ...|...+.-.
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21 1234667999999998765321 11100 0 0 01232211110
Q ss_pred ----HHhHhhchhhhc----cCCCceEecCcCCCCeEEcCCCCEEEeeecccc
Q 044561 450 ----RGVASGLLYLHE----DWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR 494 (614)
Q Consensus 450 ----~~ia~gL~yLH~----~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~ 494 (614)
..+...+..++. .....++|+|+.+.|||++.+..+.|+||+.+.
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 012223333332 124679999999999999987666899998775
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.54 E-value=0.013 Score=59.46 Aligned_cols=141 Identities=15% Similarity=0.196 Sum_probs=78.8
Q ss_pred ceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCc--eeEEeeE-----EeecCeEEEEEEec
Q 044561 351 DVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRN--LVKLRGY-----CRRKGEFLLVYDYM 423 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~-----~~~~~~~~lV~E~~ 423 (614)
..++ |....||+....++..+++|...... .....+..|...++.+.... +.+++.. ....+..+++||++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 88889998877667678999886331 12234556666666653212 3334332 22355678999999
Q ss_pred CCCCcch----h----------ccc---C----CCCCcChhHH----HHH------------------HHHhHhhchhh-
Q 044561 424 PNGSLDK----I----------LHT---N----IKPCLNWYQR----FRI------------------IRGVASGLLYL- 459 (614)
Q Consensus 424 ~~gsL~~----~----------l~~---~----~~~~l~~~~~----~~i------------------~~~ia~gL~yL- 459 (614)
++..+.. . ++. . .....++... ..+ +..++..+.-+
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 8866531 0 111 0 0111222111 011 11111111111
Q ss_pred hccCCCceEecCcCCCCeEEcCCCCEEEeeeccccc
Q 044561 460 HEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARL 495 (614)
Q Consensus 460 H~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~ 495 (614)
.......++|+|+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 101246789999999999999 4 899999988753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.51 E-value=0.0018 Score=65.06 Aligned_cols=137 Identities=12% Similarity=0.020 Sum_probs=73.8
Q ss_pred cceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCce-eEEeeEEeecCeEEEEEEec-CCCC
Q 044561 350 KDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNL-VKLRGYCRRKGEFLLVYDYM-PNGS 427 (614)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~-~~gs 427 (614)
.+.|+.|....+|+. ..+++|+........ ....+|...++.+...++ .++++.+. +.-++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecCCCcc
Confidence 678999999999998 457788775432211 112456666666542222 35555443 2346899999 6655
Q ss_pred cchh------------------cccCCC---CCcC-hhHHHHHHHHh--------------Hhhch----hhh-ccCCCc
Q 044561 428 LDKI------------------LHTNIK---PCLN-WYQRFRIIRGV--------------ASGLL----YLH-EDWEQV 466 (614)
Q Consensus 428 L~~~------------------l~~~~~---~~l~-~~~~~~i~~~i--------------a~gL~----yLH-~~~~~~ 466 (614)
|... +|.... ...+ +.....+...+ ...+. .|. ......
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 5421 111110 0011 11111111111 00011 110 112466
Q ss_pred eEecCcCCCCeEEcCCCCEEEeeeccccc
Q 044561 467 VLHRDIKPANVLLDADLNGKLGDFGLARL 495 (614)
Q Consensus 467 ivHrDikp~NIll~~~~~~kl~DfGla~~ 495 (614)
++|+|+.+.||+ ..++.+.++||..+..
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 999999999999 6667889999998764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.16 E-value=0.013 Score=61.08 Aligned_cols=140 Identities=20% Similarity=0.187 Sum_probs=81.9
Q ss_pred ceeeeeCcEEEEEEEEec--------CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCc-eeEEeeEEeecCeEEEEEE
Q 044561 351 DVIGRGGFGKVYRGVLAS--------NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRN-LVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~lV~E 421 (614)
+.|..|-...+|+....+ +..+++|+.... ........+|..+++.+.-.+ -.++++.+.. .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 457778888899988742 467888775332 223445568888887774222 2556666543 28999
Q ss_pred ecCCCCcchh-----------------cccCC---CCCc--ChhHHHHHHHHhHhh-------------------chhhh
Q 044561 422 YMPNGSLDKI-----------------LHTNI---KPCL--NWYQRFRIIRGVASG-------------------LLYLH 460 (614)
Q Consensus 422 ~~~~gsL~~~-----------------l~~~~---~~~l--~~~~~~~i~~~ia~g-------------------L~yLH 460 (614)
|+++.+|..- |+... .... -|.++.++..++... +..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998776421 11110 1111 245555555444321 12221
Q ss_pred ----c-cCCCceEecCcCCCCeEEcCC----CCEEEeeeccccc
Q 044561 461 ----E-DWEQVVLHRDIKPANVLLDAD----LNGKLGDFGLARL 495 (614)
Q Consensus 461 ----~-~~~~~ivHrDikp~NIll~~~----~~~kl~DfGla~~ 495 (614)
. .....++|+|+.+.|||++.+ +.+.++||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 1 124679999999999999876 7899999998763
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.03 E-value=0.0079 Score=62.27 Aligned_cols=73 Identities=10% Similarity=0.152 Sum_probs=41.6
Q ss_pred ceeeeeCcEEEEEEEEecC---------cEEEEEEeecCChhhHHHHHHHHHHhcccCCCce-eEEeeEEeecCeEEEEE
Q 044561 351 DVIGRGGFGKVYRGVLASN---------VQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNL-VKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~~---------~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~ 420 (614)
+.|+.|....+|+....++ ..+++|........ ......|..+++.+...++ .++++.. .+ ++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--CC--cEEE
Confidence 4577788889999887542 56777766543221 1123467777776643333 3555443 22 6899
Q ss_pred EecCCCCc
Q 044561 421 DYMPNGSL 428 (614)
Q Consensus 421 E~~~~gsL 428 (614)
||+++..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987655
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.89 E-value=0.017 Score=61.61 Aligned_cols=75 Identities=13% Similarity=0.072 Sum_probs=46.5
Q ss_pred cceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCce-eEEeeEEeecCeEEEEEEecCCCC
Q 044561 350 KDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNL-VKLRGYCRRKGEFLLVYDYMPNGS 427 (614)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~~~gs 427 (614)
.+.|+.|-...+|+....+ +..+++|+......... .-.+|..+++.|...++ .++++.+. + .+||||+++.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 4568888889999998765 46777877643221111 11467877877764444 46676663 2 25999998866
Q ss_pred cc
Q 044561 428 LD 429 (614)
Q Consensus 428 L~ 429 (614)
|.
T Consensus 188 l~ 189 (458)
T 2qg7_A 188 LS 189 (458)
T ss_dssp CC
T ss_pred CC
Confidence 64
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.72 E-value=0.01 Score=56.10 Aligned_cols=103 Identities=15% Similarity=0.069 Sum_probs=65.8
Q ss_pred CCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcc
Q 044561 425 NGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT 504 (614)
Q Consensus 425 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 504 (614)
.-||.++|... ..+++++++|.++.|.+..|.-+-. +..-..+=+.|..|++..+|++...+ ..+.
T Consensus 32 ~vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 32 ALSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred cccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc----------
Confidence 34788888765 3569999999999999998876621 01111233456899999999988764 1111
Q ss_pred cccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCC
Q 044561 505 TKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRR 545 (614)
Q Consensus 505 ~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~ 545 (614)
.....+.+||... ...+.+.=|||+|+++|.-+-=..
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence 1122456788753 345788899999999999875333
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.53 E-value=0.058 Score=55.05 Aligned_cols=33 Identities=27% Similarity=0.309 Sum_probs=28.9
Q ss_pred CCceEecCcCCCCeEEcCCCCEEEeeecccccc
Q 044561 464 EQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 496 (614)
Q Consensus 464 ~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~ 496 (614)
...++|+|+.+.||+++.++.+.|.||+.+..-
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 467999999999999998888999999877643
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=92.69 E-value=0.28 Score=51.62 Aligned_cols=140 Identities=14% Similarity=0.118 Sum_probs=80.3
Q ss_pred cceeeeeCcEEEEEEEEec--------CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCc-eeEEeeEEeecCeEEEEE
Q 044561 350 KDVIGRGGFGKVYRGVLAS--------NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRN-LVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~lV~ 420 (614)
.+.+..|-...+|+....+ +..+++++........ -.-.+|..+++.+.-.+ ..++++.+ .+ ++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~-idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF-YDSKVELDVFRYLSNINIAPNIIADF--PE--GRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC-CCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh-cCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEE
Confidence 3457778888999988753 4677777764432211 12246777776664322 33455433 22 6899
Q ss_pred EecCCCCcchh-c----------------cc--------C---CCCCcChhHHHHHHHHhH-------------------
Q 044561 421 DYMPNGSLDKI-L----------------HT--------N---IKPCLNWYQRFRIIRGVA------------------- 453 (614)
Q Consensus 421 E~~~~gsL~~~-l----------------~~--------~---~~~~l~~~~~~~i~~~ia------------------- 453 (614)
||+++..|..- + |. . .+.+.-|.++.++..++-
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 99998765321 0 10 0 111112444333332221
Q ss_pred hhchhhh---------------------ccCCCceEecCcCCCCeEEcCCCCEEEeeeccccc
Q 044561 454 SGLLYLH---------------------EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARL 495 (614)
Q Consensus 454 ~gL~yLH---------------------~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~ 495 (614)
..+..|. ......++|+|+.+.||+ +.++.+.++||..+..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 1122221 112467999999999999 8888999999998764
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=89.83 E-value=3 Score=39.13 Aligned_cols=116 Identities=10% Similarity=0.125 Sum_probs=80.3
Q ss_pred CCCceeEEeeEEeecCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeE
Q 044561 399 RHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVL 478 (614)
Q Consensus 399 ~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIl 478 (614)
.||++++. ..-.+.+.+.+.|+.-+++-=..-+.. ++...+++++..|+....++++ -+|--+.|+||+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik~-----~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~ 111 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIKS-----FTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELF 111 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGGG-----SCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHHh-----cCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEE
Confidence 58888866 455666777777776543322222332 7889999999999998877763 367789999999
Q ss_pred EcCCCCEEEeeeccccccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCC
Q 044561 479 LDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVE 548 (614)
Q Consensus 479 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~ 548 (614)
++.++.+++.=.|+-..+ +|. ..++..=.-.+=+++..+++++..|+
T Consensus 112 f~~~~~p~i~~RGik~~l------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 112 FTRDGLPIAKTRGLQNVV------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp ECTTSCEEESCCEETTTB------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EcCCCCEEEEEccCccCC------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999877764322 121 11222224457788899999988875
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=88.18 E-value=1.1 Score=46.51 Aligned_cols=31 Identities=29% Similarity=0.351 Sum_probs=25.7
Q ss_pred CceEecCcCCCCeEE------cCCCCEEEeeeccccc
Q 044561 465 QVVLHRDIKPANVLL------DADLNGKLGDFGLARL 495 (614)
Q Consensus 465 ~~ivHrDikp~NIll------~~~~~~kl~DfGla~~ 495 (614)
..++|+|+.+.|||+ +++..++++||..|..
T Consensus 244 ~vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 244 VVFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 346799999999999 4567799999988764
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=81.77 E-value=3.3 Score=38.99 Aligned_cols=115 Identities=12% Similarity=0.067 Sum_probs=77.3
Q ss_pred CCCceeEEeeEEeecCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhch-hhhccCCCceEecCcCCCCe
Q 044561 399 RHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLL-YLHEDWEQVVLHRDIKPANV 477 (614)
Q Consensus 399 ~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~-yLH~~~~~~ivHrDikp~NI 477 (614)
.||++ -...-.+++.+.+.|+.-+++-=...++. ++...+++++..|+.-.. ++++ -+|--+.|+||
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~-----~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL 115 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK-----TTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENL 115 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT-----SCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh-----cCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceE
Confidence 57777 33444677788887877644433333332 788999999999998877 6663 46778899999
Q ss_pred EEcCCCCEEEeeeccccccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCC
Q 044561 478 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVE 548 (614)
Q Consensus 478 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~ 548 (614)
++|.++.+++.-.|+-..+ +|.- .++.-=.-++=|++..++.++..|+
T Consensus 116 ~f~~~~~p~i~hRGi~~~l------------------pP~e-----~~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 116 MFNRALEPFFLHVGVKESL------------------PPDE-----WDDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp EECTTCCEEESCCEETTTB------------------SSCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EEeCCCcEEEEEcCCcccC------------------CCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999887764322 2211 1111123356777888888877764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 614 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-69 | |
| d1gzca_ | 239 | b.29.1.1 (A:) Legume lectin {Cockspur coral tree ( | 1e-65 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-65 | |
| d1hqla_ | 236 | b.29.1.1 (A:) Legume lectin {Griffonia simplicifol | 5e-64 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-63 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-62 | |
| d1f9ka_ | 234 | b.29.1.1 (A:) Legume lectin {Winged bean (Psophoca | 7e-62 | |
| d1qnwa_ | 237 | b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus | 1e-61 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-61 | |
| d1leda_ | 243 | b.29.1.1 (A:) Legume lectin {West-central african | 5e-61 | |
| d1fx5a_ | 240 | b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus | 1e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-60 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-60 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-60 | |
| d1g9fa_ | 251 | b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) | 1e-59 | |
| d1g8wa_ | 233 | b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar | 1e-59 | |
| d1g7ya_ | 253 | b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos | 5e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-59 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-59 | |
| d2d3sa1 | 237 | b.29.1.1 (A:1-237) Legume lectin {Winged bean (Pso | 8e-59 | |
| d1v6ia_ | 232 | b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypog | 2e-58 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-58 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-58 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-57 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-57 | |
| d1avba_ | 226 | b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar | 2e-56 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-56 | |
| g1qmo.1 | 230 | b.29.1.1 (A:,E:) Legume lectin {Field bean (Dolich | 5e-56 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-55 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-55 | |
| d1fnya_ | 237 | b.29.1.1 (A:) Legume lectin {Black locust (Robinia | 1e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-55 | |
| d1n47a_ | 233 | b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia vi | 4e-55 | |
| d1dbna_ | 239 | b.29.1.1 (A:) Legume lectin {Maackia amurensis, le | 5e-55 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-55 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-55 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 9e-55 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-54 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-53 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-53 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-53 | |
| d1ukga_ | 241 | b.29.1.1 (A:) Legume lectin {Bloodwood tree (Ptero | 2e-53 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-53 | |
| d1ioaa_ | 228 | b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar | 1e-52 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-52 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-52 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-51 | |
| g2ltn.1 | 229 | b.29.1.1 (A:,B:) Legume lectin {Garden pea (Pisum | 1e-51 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-51 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-51 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-49 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-48 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-48 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 9e-47 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 9e-46 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-45 | |
| d1dhkb_ | 204 | b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also ar | 7e-45 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 9e-44 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 9e-44 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-43 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-42 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-41 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-41 | |
| d1nlsa_ | 237 | b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia | 1e-40 | |
| d1nlsa_ | 237 | b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia | 3e-21 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-40 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-39 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-38 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-33 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-26 | |
| d1gv9a_ | 228 | b.29.1.13 (A:) Carbohydrate-recognition domain of | 4e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-24 | |
| d2a6va1 | 218 | b.29.1.13 (A:9-226) Emp46p N-terminal domain {Bake | 6e-08 | |
| d2a6za1 | 221 | b.29.1.13 (A:7-227) Emp47p N-terminal domain {Bake | 4e-05 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (568), Expect = 7e-69
Identities = 71/272 (26%), Positives = 121/272 (44%), Gaps = 20/272 (7%)
Query: 347 FKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKL 406
IG G FG VY+G +V + + V+ + Q ++ F E+ + + RH N++
Sbjct: 10 ITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 407 RGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQV 466
GY + +V + SL LH I+ + I R A G+ YLH +
Sbjct: 70 MGYS-TAPQLAIVTQWCEGSSLYHHLH-IIETKFEMIKLIDIARQTAQGMDYLH---AKS 124
Query: 467 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP-QTTKLVGTFGYMDPELMRT---G 522
++HRD+K N+ L DL K+GDFGLA + + Q +L G+ +M PE++R
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 523 KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGI 582
S +DVYAFG+ + E+ +G+ P + + + + S++
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM-------VGRGYLSPDLSKVRSN 237
Query: 583 CEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
C + L+ + C K + RP Q++
Sbjct: 238 CPKAMKRLMAE----CLKKKRDERPLFPQILA 265
|
| >d1gzca_ b.29.1.1 (A:) Legume lectin {Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]} Length = 239 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]
Score = 212 bits (542), Expect = 1e-65
Identities = 69/253 (27%), Positives = 108/253 (42%), Gaps = 41/253 (16%)
Query: 30 FIYHGFNED-AQLQRDGLASVHSNGLLQLTNTV-----SPQQEGHAFYRLPIKFNTSSSE 83
F + F L G A + +G+LQLT + G Y P+ S++
Sbjct: 6 FSFSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMWDSTTG 65
Query: 84 SL-SFSSNFVFAI-----------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTN 131
++ SF + F F+I G+ F + P+K A YLG+FN S ++
Sbjct: 66 TVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKP---AQGYGYLGVFNNSKQD-NSY 121
Query: 132 HILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGDPIQ 191
LA+E DT N +D H+GIDVNS+ S ++ P +L G
Sbjct: 122 QTLAVEFDTFSN-PWDPPQVPHIGIDVNSIRSIKTQPF-------------QLDNGQVAN 167
Query: 192 IWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGS---LKSS 248
+ I YD K+L+V L S ++ +++ +L + + VG S +TG+ +
Sbjct: 168 VVIKYDAPSKILHVVLVYPS--SGAIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDAAET 225
Query: 249 HYVLGWSFNRSGP 261
H V WSF S P
Sbjct: 226 HDVYSWSFQASLP 238
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 9e-65
Identities = 65/268 (24%), Positives = 114/268 (42%), Gaps = 20/268 (7%)
Query: 347 FKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKL 406
K + +G G FG+V+ G + ++AVK + S F+AE M +L+H+ LV+L
Sbjct: 15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRL 73
Query: 407 RGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQV 466
+ ++ +YM NGSL L T L + + +A G+ ++ E
Sbjct: 74 YAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--- 129
Query: 467 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKAST 526
+HRD++ AN+L+ L+ K+ DFGLARL + + + PE + G +
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 527 STDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEK 586
+DV++FG+ + E+ + R + V + C E+
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ-----------NLERGYRMVRPDNCPEE 238
Query: 587 QMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+L+ C +PE RP +
Sbjct: 239 LYQLMRL----CWKERPEDRPTFDYLRS 262
|
| >d1hqla_ b.29.1.1 (A:) Legume lectin {Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]} Length = 236 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]
Score = 208 bits (531), Expect = 5e-64
Identities = 71/249 (28%), Positives = 116/249 (46%), Gaps = 36/249 (14%)
Query: 30 FIYHGFNEDAQ--LQRDGLASVHSNGLLQLTNTVS-----PQQEGHAFYRLPIKF-NTSS 81
F + F D + + G A+ + G LQL T G A Y P++ + +
Sbjct: 4 FTFPNFWSDVEDSIIFQGDANT-TAGTLQLCKTNQYGTPLQWSAGRALYSDPVQLWDNKT 62
Query: 82 SESLSFSSNFVFAI---------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQ-STN 131
SF + F F + G+AF ++P EYLGLFN S Q S N
Sbjct: 63 ESVASFYTEFTFFLKITGNGPADGLAFFLAPPDSDV---KDAGEYLGLFNKSTATQPSKN 119
Query: 132 HILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGDPIQ 191
++A+E DT N +F + H+GI+VNS++S + + ++ G
Sbjct: 120 QVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVATKR----------WEDSDIFSGKIAT 169
Query: 192 IWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLKS-SHY 250
ISYDG+ ++L V L+ P + +LS ++++ L E++ VG SASTG+ + + Y
Sbjct: 170 ARISYDGSAEILTVVLSY---PDGSDYILSHSVDMRQNLPESVRVGISASTGNNQFLTVY 226
Query: 251 VLGWSFNRS 259
+L W F+ +
Sbjct: 227 ILSWRFSSN 235
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 208 bits (530), Expect = 4e-63
Identities = 76/299 (25%), Positives = 140/299 (46%), Gaps = 39/299 (13%)
Query: 335 FTYKDLYKATKGF---------KDKDVIGRGGFGKVYRGVLASN----VQIAVKKVSHD- 380
FT++D +A + F K + VIG G FG+V G L + +A+K +
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 381 SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCL 440
+++ ++F++E MG+ H N++ L G + +++ ++M NGSLD L N
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 441 NWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500
Q ++RG+A+G+ YL + +HRD+ N+L++++L K+ DFGL+R + DT
Sbjct: 126 TVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 501 IPQTTK----LVGTFGYMDPELMRTGKASTSTDVYAFGVFMLE-VASGRRPVEQQGSMET 555
T + PE ++ K ++++DV+++G+ M E ++ G RP + +
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV 242
Query: 556 VNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+N ++ D RL + +L L C RP Q++
Sbjct: 243 INAIE--------------QDYRLP--PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 3e-62
Identities = 65/268 (24%), Positives = 112/268 (41%), Gaps = 20/268 (7%)
Query: 347 FKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKL 406
IG G FG V+ G + ++A+K + + ++F+ E M +L H LV+L
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQL 65
Query: 407 RGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQV 466
G C + LV+++M +G L L T + V G+ E
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF-AAETLLGMCLDVCEGM---AYLEEAC 121
Query: 467 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKAST 526
V+HRD+ N L+ + K+ DFG+ R D +T + PE+ + S+
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 527 STDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEK 586
+DV++FGV M EV S + + S +V+ + ++ R AS
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDISTGFRLYKPRLASTH--------- 230
Query: 587 QMELVLKLGLFCSHPKPEARPNMRQVMQ 614
V ++ C +PE RP ++++
Sbjct: 231 ----VYQIMNHCWKERPEDRPAFSRLLR 254
|
| >d1f9ka_ b.29.1.1 (A:) Legume lectin {Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]} Length = 234 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]
Score = 203 bits (516), Expect = 7e-62
Identities = 74/257 (28%), Positives = 107/257 (41%), Gaps = 47/257 (18%)
Query: 26 DVNQFIYHGFNED-AQLQRDGLASVHSNGLLQLTNTV-----SPQQEGHAFYRLPIKFNT 79
+ F + F E+ +L AS+ SNG+L+LT + G A Y PIK
Sbjct: 1 ETQSFNFDHFEENSKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWD 60
Query: 80 SSSESL-SFSSNFVFAI-----------GMAFVISPSKDLGKAEASPSEYLGLFNASNNG 127
S++ ++ SF + F F I G+ F + P SP G
Sbjct: 61 STTGNVASFETRFSFNITQPYAYPEPADGLTFFMVPPN-------SPQGEDGGNLGVFKP 113
Query: 128 QSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIG 187
++ A+E DT QN D H+GIDVNS++S ++ +L G
Sbjct: 114 PEGDNAFAVEFDTFQN--TWDPQVPHIGIDVNSIVSSKTLH-------------FQLENG 158
Query: 188 DPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILL--ETMYVGFSASTGSL 245
+ I YD K+LNV LA S T LS ++L E + VG SA+TG
Sbjct: 159 GVANVVIKYDSPTKILNVVLAFHS--VGTVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQ 216
Query: 246 K---SSHYVLGWSFNRS 259
K +H ++ WSF S
Sbjct: 217 KNAVETHEIISWSFTSS 233
|
| >d1qnwa_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-II [TaxId: 3902]} Length = 237 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Furze (Ulex europaeus), UEA-II [TaxId: 3902]
Score = 202 bits (514), Expect = 1e-61
Identities = 67/246 (27%), Positives = 115/246 (46%), Gaps = 34/246 (13%)
Query: 29 QFIYHGFNEDAQ-LQRDGLASVHSNGLLQLTNTVSP--QQEGHAFYRLPIKFNTSSSESL 85
F + F + + + G ASV + G+LQ+T P G A Y PI+ S + +
Sbjct: 5 SFNFDKFVPNQKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIWDSITGKV 64
Query: 86 -SFSSNFVFAI---------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILA 135
SF+++F F + G+AF ++P+ + S + +S++ +S+N I+A
Sbjct: 65 ASFATSFSFVVKADKSDGVDGLAFFLAPANSQIPS--GSSAGMFGLFSSSDSKSSNQIIA 122
Query: 136 IELDTVQNLDFD--DIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGDPIQIW 193
+E DT ++ D D H+GIDVNS+ S ++ + + G+ +
Sbjct: 123 VEFDTYFGKAYNPWDPDFKHIGIDVNSIKSIKTVKWDWRN-------------GEVADVV 169
Query: 194 ISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLK--SSHYV 251
I+Y K L V L+ S T +++ +++L IL E + VGFS G+ +H V
Sbjct: 170 ITYRAPTKSLTVCLSYPS--DGTSNIITASVDLKAILPEWVSVGFSGGVGNAAEFETHDV 227
Query: 252 LGWSFN 257
L W F
Sbjct: 228 LSWYFT 233
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 2e-61
Identities = 68/269 (25%), Positives = 105/269 (39%), Gaps = 22/269 (8%)
Query: 347 FKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKL 406
+G G FG V G +A+K + S EF+ E M L H LV+L
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 407 RGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQV 466
G C ++ ++ +YM NG L L Q + + V + YL
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQ--- 120
Query: 467 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKAST 526
LHRD+ N L++ K+ DFGL+R D + + PE++ K S+
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 527 STDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEE 585
+D++AFGV M E+ S G+ P E+ + ET + L
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI----------------AQGLRLYRPH 224
Query: 586 KQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
E V + C H K + RP + ++
Sbjct: 225 LASEKVYTIMYSCWHEKADERPTFKILLS 253
|
| >d1leda_ b.29.1.1 (A:) Legume lectin {West-central african legume (Griffonia simplicifolia) [TaxId: 3850]} Length = 243 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: West-central african legume (Griffonia simplicifolia) [TaxId: 3850]
Score = 201 bits (511), Expect = 5e-61
Identities = 66/251 (26%), Positives = 103/251 (41%), Gaps = 38/251 (15%)
Query: 29 QFIYHGFNED-----AQLQRDGLASVHSNGLLQLTNTVS-----PQQEGHAFYRLPIKFN 78
F Y F ++ G A+ G LQLT T + G A Y P+
Sbjct: 5 NFTYPDFWSYSLKNGTEITFLGDATR-IPGALQLTKTDANGNPVRSSAGQASYSEPVFLW 63
Query: 79 TSSSESLSFSSNFVF---------AIGMAFVISPSKDLGKAEASPSEYLGLFNASNNG-Q 128
S+ ++ SF ++F F A G+AF ++P + +LGLF
Sbjct: 64 DSTGKAASFYTSFTFLLKNYGAPTADGLAFFLAPV---DSSVKDYGGFLGLFRHETAADP 120
Query: 129 STNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGD 188
S N ++A+E DT N D++D H+GIDVNS++S +
Sbjct: 121 SKNQVVAVEFDTWINKDWNDPPYPHIGIDVNSIVSVATTRWENDD----------AYGSS 170
Query: 189 PIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLKSS 248
I+YD K+L V L+ +LS ++L+ +L + + +GFSA G
Sbjct: 171 IATAHITYDARSKILTVLLSY---EHGRDYILSHVVDLAKVLPQKVRIGFSAGVG-YDEV 226
Query: 249 HYVLGWSFNRS 259
Y+L W F +
Sbjct: 227 TYILSWHFFST 237
|
| >d1fx5a_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-I [TaxId: 3902]} Length = 240 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Furze (Ulex europaeus), UEA-I [TaxId: 3902]
Score = 199 bits (507), Expect = 1e-60
Identities = 66/249 (26%), Positives = 106/249 (42%), Gaps = 35/249 (14%)
Query: 29 QFIYHGFNED-AQLQRDGLASVHSNGLLQLTNT---VSPQQEGHAFYRLPIKF-NTSSSE 83
F + F+++ L G ASV G+LQL + + G A Y PI N ++ E
Sbjct: 5 SFKFKNFSQNGKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIWNCNTGE 64
Query: 84 SLSFSSNFVFAI-----------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNH 132
SF ++F F + G+ F ++P Y GLFN S+
Sbjct: 65 LASFITSFSFFMETSANPKAATDGLTFFLAPPDSPL---RRAGGYFGLFN-DTKCDSSYQ 120
Query: 133 ILAIELDTVQN-LDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGDPIQ 191
+A+E DT+ + ++F D H+GIDVN + S + + +
Sbjct: 121 TVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAERWNK-----------RYGLNNVAN 169
Query: 192 IWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTG-SLKSSHY 250
+ I Y+ + K L +L S T ++ ++L IL E + VGFS ST +++H
Sbjct: 170 VEIIYEASSKTLTASLTYPS--DQTSISVTSIVDLKEILPEWVSVGFSGSTYIGRQATHE 227
Query: 251 VLGWSFNRS 259
VL W F +
Sbjct: 228 VLNWYFTST 236
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 2e-60
Identities = 63/268 (23%), Positives = 108/268 (40%), Gaps = 20/268 (7%)
Query: 347 FKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKL 406
+ + +G+G FG+V+ G ++A+K + + F+ E M +LRH LV+L
Sbjct: 19 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL 77
Query: 407 RGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQV 466
+V +YM GSL L L Q + +ASG+ Y+
Sbjct: 78 YAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--- 133
Query: 467 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKAST 526
+HRD++ AN+L+ +L K+ DFGLARL + + + PE G+ +
Sbjct: 134 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 193
Query: 527 STDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEK 586
+DV++FG+ + E+ + R + D + C +
Sbjct: 194 KSDVWSFGILLTELTTKGRVPYPGMVNR---------------EVLDQVERGYRMPCPPE 238
Query: 587 QMELVLKLGLFCSHPKPEARPNMRQVMQ 614
E + L C +PE RP +
Sbjct: 239 CPESLHDLMCQCWRKEPEERPTFEYLQA 266
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 3e-60
Identities = 63/288 (21%), Positives = 115/288 (39%), Gaps = 28/288 (9%)
Query: 350 KDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGY 409
++ IG+G FG+V+RG ++AVK S ++ AE+ LRH N++
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAA 65
Query: 410 CRRKG----EFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHED--- 462
+ + LV DY +GSL L+ + + ++ ASGL +LH +
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 463 --WEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD---TIPQTTKLVGTFGYMDPE 517
+ + HRD+K N+L+ + + D GLA +D VGT YM PE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 518 LMRT------GKASTSTDVYAFGVFMLEVASGRRP----VEQQGSMETVNLVDWVCDCWK 567
++ ++ D+YA G+ E+A + Q + D + +
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 568 KGAIRDASDSRLEGICEEKQ-MELVLKLGLFCSHPKPEARPNMRQVMQ 614
K + + + + ++ K+ C + AR ++ +
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 7e-60
Identities = 56/210 (26%), Positives = 100/210 (47%), Gaps = 9/210 (4%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGI-KEFVAELVSMGRLRHRNLV 404
F+ +G G G V++ S + +A K + + K I + + EL + +V
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 405 KLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWE 464
G GE + ++M GSLD++L + + ++ V GL YL E +
Sbjct: 68 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLRE--K 123
Query: 465 QVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKA 524
++HRD+KP+N+L+++ KL DFG++ VGT YM PE ++
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHY 180
Query: 525 STSTDVYAFGVFMLEVASGRRPVEQQGSME 554
S +D+++ G+ ++E+A GR P+ + E
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210
|
| >d1g9fa_ b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) [TaxId: 3847]} Length = 251 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Soybean (Glycine max) [TaxId: 3847]
Score = 197 bits (502), Expect = 1e-59
Identities = 75/266 (28%), Positives = 118/266 (44%), Gaps = 43/266 (16%)
Query: 24 AQDVNQFIYHGFNED-AQLQRDGLASVHSNGLLQLTN-----TVSPQQEGHAFYRLPIKF 77
A+ V+ F ++ F + G A V S+G LQL T P G A Y PI
Sbjct: 1 AETVS-FSWNKFVPKQPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHI 59
Query: 78 NTSSSESL-SFSSNFVFAI----------GMAFVISPSKDLGKAEASPSEYLGLFNASNN 126
+ S+ SF+++F F G+AF ++P P + G N
Sbjct: 60 WDKETGSVASFAASFNFTFYAPDTKRLADGLAFFLAPID------TKPQTHAGYLGLFNE 113
Query: 127 GQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELII 186
+S + ++A+E DT +N D + H+GI+VNS+ S ++ +L
Sbjct: 114 NESGDQVVAVEFDTFRN--SWDPPNPHIGINVNSIRSIKTTS-------------WDLAN 158
Query: 187 GDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSL- 245
++ I+YD + LL +L S + T +LS ++L L E + +GFSA+TG
Sbjct: 159 NKVAKVLITYDASTSLLVASLVYPS--QRTSNILSDVVDLKTSLPEWVRIGFSAATGLDI 216
Query: 246 -KSSHYVLGWSFNRSGPALNLDISSL 270
SH VL WSF + P + +I L
Sbjct: 217 PGESHDVLSWSFASNLPHASSNIDPL 242
|
| >d1g8wa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 233 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 196 bits (500), Expect = 1e-59
Identities = 79/253 (31%), Positives = 122/253 (48%), Gaps = 43/253 (16%)
Query: 24 AQDVNQFIYHGFNEDAQLQRDGLASVHSNGLLQLTNT-----VSPQQEGHAFYRLPIKF- 77
+ D+ F + FNE L ASV S+G L+LTN G AFY PI+
Sbjct: 1 SNDI-YFNFQRFNE-TNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIW 58
Query: 78 NTSSSESLSFSSNFVFAI----------GMAFVISPSKDLGKAEASPSEYLGLFNASNNG 127
+ ++ SF+++F F I G+AF + P +LGLF+ SN
Sbjct: 59 DNTTGTVASFATSFTFNIQVPNNAGPADGLAFALVPVGSQP---KDKGGFLGLFDGSN-- 113
Query: 128 QSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIG 187
S H +A+E DT+ N D+D + H+GIDVNS+ S ++ + + G
Sbjct: 114 -SNFHTVAVEFDTLYNKDWDP-TERHIGIDVNSIRSIKTTRWDFVN-------------G 158
Query: 188 DPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLK- 246
+ ++ I+YD + LL +L S + T ++S ++L +L E + VGFSA+TG K
Sbjct: 159 ENAEVLITYDSSTNLLVASLVYPS--QKTSFIVSDTVDLKSVLPEWVSVGFSATTGINKG 216
Query: 247 --SSHYVLGWSFN 257
++ VL WSF
Sbjct: 217 NVETNDVLSWSFA 229
|
| >d1g7ya_ b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]} Length = 253 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]
Score = 196 bits (498), Expect = 5e-59
Identities = 77/268 (28%), Positives = 122/268 (45%), Gaps = 45/268 (16%)
Query: 26 DVNQFIYHGFNEDAQLQRDGLASVHSNGLLQLTNTV-----SPQQEGHAFYRLPIKF-NT 79
D+ F + FN + G A+V S+ L+LT + G AFY PI+ +
Sbjct: 2 DIQSFSFKNFNS-SSFILQGDATV-SSSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIYDK 59
Query: 80 SSSESLSFSSNFVFAI----------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQS 129
S+ S++++F I G+AF + P K S S +LG+F++ +
Sbjct: 60 STGAVASWATSFTANIFAPNKSSSADGIAFALVPVGSEPK---SNSGFLGVFDSDVYD-N 115
Query: 130 TNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGDP 189
+ +A+E DT N D+D H+GIDVNS+ S +A L G
Sbjct: 116 SAQTVAVEFDTFSNTDWDP-TSRHIGIDVNSIKSIRTASW-------------GLANGQN 161
Query: 190 IQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTG---SLK 246
+I I+Y+ A LL +L S + T ++S +++++ L E + +GFSA+TG
Sbjct: 162 AEILITYNAATSLLVASLVHPS--RRTSYIVSERVDITNELPEYVSIGFSATTGLSEGYT 219
Query: 247 SSHYVLGWSFN----RSGPALNLDISSL 270
+H VL WSF LDI+S
Sbjct: 220 ETHDVLSWSFASKLPDDSTTEPLDIASY 247
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 5e-59
Identities = 68/277 (24%), Positives = 119/277 (42%), Gaps = 26/277 (9%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDS--KQGIKEFVAELVSMGRLRHRNL 403
++ IG G +G+ + + + K++ + S + + V+E+ + L+H N+
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 404 VKLRGYC--RRKGEFLLVYDYMPNGSLDKILHTNIK--PCLNWYQRFRIIRGVASGLLYL 459
V+ R +V +Y G L ++ K L+ R++ + L
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 460 HE--DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPE 517
H D VLHRD+KPANV LD N KLGDFGLAR+ +HDT VGT YM PE
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT-SFAKAFVGTPYYMSPE 184
Query: 518 LMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDS 577
M + +D+++ G + E+ + P E IR+
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG------------KIREGKFR 232
Query: 578 RLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
R+ ++ E++ + + K RP++ ++++
Sbjct: 233 RIPYRYSDELNEIITR----MLNLKDYHRPSVEEILE 265
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 196 bits (499), Expect = 8e-59
Identities = 69/284 (24%), Positives = 120/284 (42%), Gaps = 20/284 (7%)
Query: 332 PQRFTYKDLYKATKGFKDKDVIGRGGFGKVYRGVL-ASNVQIAVKKVSHDSKQGIKEFVA 390
P Y K +G G +G+VY GV ++ +AVK + D+ + ++EF+
Sbjct: 4 PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLK 62
Query: 391 ELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIR 450
E M ++H NLV+L G C R+ F ++ ++M G+L L + ++ +
Sbjct: 63 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 122
Query: 451 GVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT 510
++S + YL ++ +HRD+ N L+ + K+ DFGL+RL DT
Sbjct: 123 QISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 179
Query: 511 FGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGA 570
+ PE + K S +DV+AFGV + E+A+ +
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------------- 224
Query: 571 IRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+ + + E E V +L C P RP+ ++ Q
Sbjct: 225 VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268
|
| >d2d3sa1 b.29.1.1 (A:1-237) Legume lectin {Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]} Length = 237 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]
Score = 194 bits (495), Expect = 8e-59
Identities = 71/256 (27%), Positives = 114/256 (44%), Gaps = 48/256 (18%)
Query: 30 FIYHGFNED-AQLQRDGLASVHSNGLLQLTNTV----SPQQEGHAFYRLPIKF-NTSSSE 83
F ++ F+++ QL+ A + SN +L+LT V + G A Y P++ ++++
Sbjct: 5 FNFNQFHQNEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDSTTGN 64
Query: 84 SLSFSSNFVFAI-----------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNH 132
SF + F F+I G+ F I+P G + N S
Sbjct: 65 VASFETRFSFSIRQPFPRPHPADGLVFFIAPPNTQTGE-------GGGYFGIYNPLSPYP 117
Query: 133 ILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGDPIQI 192
+A+E DT +N D H+GIDVNS+IS ++ P L G +
Sbjct: 118 FVAVEFDTFRN--TWDPQIPHIGIDVNSVISTKTVP-------------FTLDNGGIANV 162
Query: 193 WISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLK------ 246
I YD + K+L+V L S T ++ ++L +L E++ VGFSA+TG
Sbjct: 163 VIKYDASTKILHVVLVFPS--LGTIYTIADIVDLKQVLPESVNVGFSAATGDPSGKQRNA 220
Query: 247 -SSHYVLGWSFNRSGP 261
+H +L WSF+ S P
Sbjct: 221 TETHDILSWSFSASLP 236
|
| >d1v6ia_ b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3818]} Length = 232 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Peanut (Arachis hypogaea) [TaxId: 3818]
Score = 193 bits (491), Expect = 2e-58
Identities = 62/247 (25%), Positives = 110/247 (44%), Gaps = 34/247 (13%)
Query: 24 AQDVNQFIYHGFNE-DAQLQRDGLASVHSNGLLQLTNTVSPQQEGHAFYRLPIKF-NTSS 81
A+ V+ F ++ F+E + + G +V SNG +QLTN G Y +P++ ++++
Sbjct: 1 AETVS-FNFNSFSEGNPAINFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIWSSAT 59
Query: 82 SESLSFSSNFVF----------AIGMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTN 131
SF ++F F A G+ F I+P + G ++ +
Sbjct: 60 GNVASFLTSFSFEMKDIKDYDPADGIIFFIAPEDT----QIPAGSIGGGTLGVSDTKGAG 115
Query: 132 HILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGDPIQ 191
H + +E DT N +++D +HVGIDVNS+ S ++ P S G ++
Sbjct: 116 HFVGVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVPWNSVS-------------GAVVK 162
Query: 192 IWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSL-KSSHY 250
+ + YD + K L+V + +++ ++L L E + GFSAS + H
Sbjct: 163 VTVIYDSSTKTLSVAVTND---NGDITTIAQVVDLKAKLPERVKFGFSASGSLGGRQIHL 219
Query: 251 VLGWSFN 257
+ WSF
Sbjct: 220 IRSWSFT 226
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 195 bits (498), Expect = 3e-58
Identities = 73/278 (26%), Positives = 119/278 (42%), Gaps = 32/278 (11%)
Query: 344 TKGFKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQG---IKEFVAELVSMGRLR 399
K F D IG G FG VY + ++ +A+KK+S+ KQ ++ + E+ + +LR
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 400 HRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYL 459
H N ++ RG R+ LV +Y + D + K L + + G GL YL
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYL 131
Query: 460 HEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPEL- 518
H ++HRD+K N+LL KLGDFG A + VGT +M PE+
Sbjct: 132 H---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANSFVGTPYWMAPEVI 183
Query: 519 --MRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASD 576
M G+ DV++ G+ +E+A + P+ +M + + ++ S
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-----------AQNESP 232
Query: 577 SRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+ G E V C P+ RP +++
Sbjct: 233 ALQSGHWSEYFRNFVDS----CLQKIPQDRPTSEVLLK 266
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 4e-58
Identities = 75/269 (27%), Positives = 114/269 (42%), Gaps = 26/269 (9%)
Query: 347 FKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKL 406
K IG+G FG V G ++AVK + +D+ + F+AE M +LRH NLV+L
Sbjct: 9 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQL 65
Query: 407 RGYC-RRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQ 465
G KG +V +YM GSL L + + L + V + YL +
Sbjct: 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN-- 123
Query: 466 VVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKAS 525
+HRD+ NVL+ D K+ DFGL + + PE +R K S
Sbjct: 124 -FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALREKKFS 178
Query: 526 TSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEE 585
T +DV++FG+ + E+ S R + ++ V +KG DA D C
Sbjct: 179 TKSDVWSFGILLWEIYSFGRVPYPRIPLK------DVVPRVEKGYKMDAPDG-----CPP 227
Query: 586 KQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
E++ C H RP+ Q+ +
Sbjct: 228 AVYEVMKN----CWHLDAAMRPSFLQLRE 252
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 3e-57
Identities = 65/276 (23%), Positives = 112/276 (40%), Gaps = 29/276 (10%)
Query: 347 FKDKDVIGRGGFGKVYRGVL-ASNVQIAVKKVS--HDSKQGIKEFVAELVSMGRLRHRNL 403
K IGRG F VY+G+ + V++A ++ +K + F E + L+H N+
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 404 VKLRGYC----RRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYL 459
V+ + K +LV + M +G+L L + R + GL +L
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFL 128
Query: 460 HEDWEQVVLHRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMDPEL 518
H ++ HRD+K N+ + K+GD GLA L ++GT +M PE+
Sbjct: 129 HTRTPPII-HRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---FAKAVIGTPEFMAPEM 184
Query: 519 MRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSR 578
K S DVYAFG+ MLE+A+ P + V K + +
Sbjct: 185 YE-EKYDESVDVYAFGMCMLEMATSEYPYS--ECQNAAQIYRRVTSGVKPASFDKVAIPE 241
Query: 579 LEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
++ E++ C + R +++ ++
Sbjct: 242 VK--------EIIEG----CIRQNKDERYSIKDLLN 265
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 6e-57
Identities = 67/285 (23%), Positives = 121/285 (42%), Gaps = 29/285 (10%)
Query: 338 KDLYKATKGFKDKDV-IGRGGFGKVYRGVLA---SNVQIAVKKVSHDSKQG-IKEFVAEL 392
K L+ D+ +G G FG V +GV + +A+K + +++ +E + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 393 VSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGV 452
M +L + +V+L G C+ + +LV + G L K L + + ++ V
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQV 118
Query: 453 ASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY--DHDTIPQTTKLVGT 510
+ G+ YL E + +HRD+ NVLL K+ DFGL++ D +
Sbjct: 119 SMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175
Query: 511 FGYMDPELMRTGKASTSTDVYAFGVFMLEV-ASGRRPVEQQGSMETVNLVDWVCDCWKKG 569
+ PE + K S+ +DV+++GV M E + G++P ++ E + + ++G
Sbjct: 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-------EQG 228
Query: 570 AIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+ C + L+ C K E RP+ V Q
Sbjct: 229 KRMECPPE-----CPPELYALMSD----CWIYKWEDRPDFLTVEQ 264
|
| >d1avba_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 226 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 188 bits (478), Expect = 2e-56
Identities = 71/252 (28%), Positives = 106/252 (42%), Gaps = 44/252 (17%)
Query: 24 AQDVNQFIYHGFNEDAQLQRDGLASVHSNGLLQLTNTVSPQQE--GHAFYRLPIKF-NTS 80
+ D F FN+ L G A+V S G L LTN +++ G AFY PI+ + +
Sbjct: 1 SNDA-SFNVETFNK-TNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQINDRT 58
Query: 81 SSESLSFSSNFVFAI----------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQST 130
SFS+NF F I G+AF + P YLGLFN +N
Sbjct: 59 IDNLASFSTNFTFRINAKNIENSAYGLAFALVPVGSRP---KLKGRYLGLFNTTNY---- 111
Query: 131 NHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGDPI 190
+ D D N + IDVNS+ + + + G+
Sbjct: 112 ------DRDAHTVAVVFDTVSNRIEIDVNSIRPIATESCNFGHNN-----------GEKA 154
Query: 191 QIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLK---S 247
++ I+YD + L V+L S K +S + L + + + VGFSA++GS K
Sbjct: 155 EVRITYDSPKNDLRVSLLYPS--SEEKCHVSATVPLEKEVEDWVSVGFSATSGSKKETTE 212
Query: 248 SHYVLGWSFNRS 259
+H VL WSF+ +
Sbjct: 213 THNVLSWSFSSN 224
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 3e-56
Identities = 64/298 (21%), Positives = 124/298 (41%), Gaps = 36/298 (12%)
Query: 323 YEDWEREYGPQRFTYKDLYKATKGFKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDS 381
YE R+ P+ D ++ +G G FGKVY+ ++V A K + S
Sbjct: 1 YEHVTRDLNPE-----DFWEIIG------ELGDGAFGKVYKAQNKETSVLAAAKVIDTKS 49
Query: 382 KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLN 441
++ +++++ E+ + H N+VKL + ++ ++ G++D ++ +P L
Sbjct: 50 EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP-LT 108
Query: 442 WYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI 501
Q + + L YLH + ++HRD+K N+L D + KL DFG++ TI
Sbjct: 109 ESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT-RTI 164
Query: 502 PQTTKLVGTFGYMDPELMRTGKA-----STSTDVYAFGVFMLEVASGRRPVEQQGSMETV 556
+ +GT +M PE++ + DV++ G+ ++E+A P + M +
Sbjct: 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL 224
Query: 557 NLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+ A + + + K C +AR Q++Q
Sbjct: 225 LKI----------AKSEPPTLAQPSRWSSNFKDFLKK----CLEKNVDARWTTSQLLQ 268
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 1e-55
Identities = 72/274 (26%), Positives = 119/274 (43%), Gaps = 28/274 (10%)
Query: 350 KDVIGRGGFGKVYRGVLASN----VQIAVKKVSHDSKQG-IKEFVAELVSMGRLRHRNLV 404
+VIGRG FG VY G L N + AVK ++ + G + +F+ E + M H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 405 KLRGYC-RRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDW 463
L G C R +G L+V YM +G L + VA G+
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGM---KFLA 147
Query: 464 EQVVLHRDIKPANVLLDADLNGKLGDFGLARLY---DHDTIPQTTKLVGTFGYMDPELMR 520
+ +HRD+ N +LD K+ DFGLAR + D++ T +M E ++
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 521 TGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580
T K +T +DV++FGV + E+ + P + T ++ ++ + D
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAPPY--PDVNTFDITVYLLQGRRLLQPEYCPDP--- 262
Query: 581 GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+ ++ L C HPK E RP+ +++
Sbjct: 263 ----------LYEVMLKCWHPKAEMRPSFSELVS 286
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 1e-55
Identities = 67/272 (24%), Positives = 111/272 (40%), Gaps = 29/272 (10%)
Query: 347 FKDKDVIGRGGFGKVYRGVL-ASNVQIAVKKVS---HDSKQGIKEFVAELVSMGRLRHRN 402
F+ +G+G FG VY S +A+K + + + E+ LRH N
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 403 LVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHED 462
+++L GY L+ +Y P G++ + L K + + I +A+ L Y H
Sbjct: 68 ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHS- 124
Query: 463 WEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTG 522
+ V+HRDIKP N+LL + K+ DFG + + T L GT Y+ PE++
Sbjct: 125 --KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTTLCGTLDYLPPEMIEGR 179
Query: 523 KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGI 582
D+++ GV E G+ P E ET + V +
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-------------EFTFPDF 226
Query: 583 CEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
E +L+ + P RP +R+V++
Sbjct: 227 VTEGARDLISR----LLKHNPSQRPMLREVLE 254
|
| >d1fnya_ b.29.1.1 (A:) Legume lectin {Black locust (Robinia pseudoacacia) [TaxId: 35938]} Length = 237 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Black locust (Robinia pseudoacacia) [TaxId: 35938]
Score = 186 bits (472), Expect = 1e-55
Identities = 73/251 (29%), Positives = 115/251 (45%), Gaps = 39/251 (15%)
Query: 30 FIYHGFNED-AQLQRDGLASVHSNGLLQLTNTV----SPQQEGHAFYRLPIKFNTSSSES 84
F + F + L G A V S G+LQLTN V S + G A Y P + S++ +
Sbjct: 6 FSFPKFAPNQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWDSTTGN 65
Query: 85 L-SFSSNFVFAI----------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHI 133
+ SF ++F F I G+AF ++P LG+F +N I
Sbjct: 66 VASFVTSFTFIIQAPNPATTADGLAFFLAPVDTQP---LDLGGMLGIFK-DGYFNKSNQI 121
Query: 134 LAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGDPIQIW 193
+A+E DT N D+D H+GI+VNS+ S ++ P + + G+ ++
Sbjct: 122 VAVEFDTFSNGDWDP-KGRHLGINVNSIESIKTVPWNWTN-------------GEVANVF 167
Query: 194 ISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLKSS---HY 250
ISY+ + K L +L S T ++ +++ +L E + GFSA+TG K +
Sbjct: 168 ISYEASTKSLTASLVYPS--LETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQTND 225
Query: 251 VLGWSFNRSGP 261
VL WSF + P
Sbjct: 226 VLSWSFESNLP 236
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 3e-55
Identities = 59/272 (21%), Positives = 120/272 (44%), Gaps = 22/272 (8%)
Query: 344 TKGFKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRN 402
K + + IG+G G VY + +A+ ++A+++++ + + + E++ M ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 403 LVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHED 462
+V E +V +Y+ GSL ++ + C++ Q + R L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLH-- 133
Query: 463 WEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTG 522
V+HRDIK N+LL D + KL DFG + + + +VGT +M PE++
Sbjct: 134 -SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTMVGTPYWMAPEVVTRK 191
Query: 523 KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGI 582
D+++ G+ +E+ G P + + + L+ G + +L I
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI------ATNGTPELQNPEKLSAI 245
Query: 583 CEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+ + + C E R + ++++Q
Sbjct: 246 FR----DFLNR----CLDMDVEKRGSAKELLQ 269
|
| >d1n47a_ b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]} Length = 233 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]
Score = 184 bits (469), Expect = 4e-55
Identities = 67/249 (26%), Positives = 110/249 (44%), Gaps = 40/249 (16%)
Query: 29 QFIYHGFNED-AQLQRDGLASVHSNGLLQLTNTVS----PQQEGHAFYRLPIKFNTSSSE 83
F + FN + L A V+S G L+LT + P G A Y PI ++
Sbjct: 5 SFSFTNFNPNQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHI-HDNTT 63
Query: 84 SLSFSSNFVFAI----------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHI 133
SF+++F F + G+AF ++P + + +LGLF + ++
Sbjct: 64 LASFTTSFSFVMAAPAAAAVADGLAFFLAPPDTQPQ---ARGGFLGLFADRAHD-ASYQT 119
Query: 134 LAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGDPIQIW 193
+A+E DT N D + H+GID N + S ++ P +++ G+ I
Sbjct: 120 VAVEFDTYSN--AWDPNYTHIGIDTNGIESKKTTP-------------FDMVYGEKANIV 164
Query: 194 ISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGS---LKSSHY 250
I+Y + K L +L T +S ++L IL E + VGFSA+TG + +H
Sbjct: 165 ITYQASTKALAASLVFPV--SQTSYAVSARVDLRDILPEYVRVGFSATTGLNAGVVETHD 222
Query: 251 VLGWSFNRS 259
++ WSF S
Sbjct: 223 IVSWSFAVS 231
|
| >d1dbna_ b.29.1.1 (A:) Legume lectin {Maackia amurensis, leukoagglutinin [TaxId: 37501]} Length = 239 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Maackia amurensis, leukoagglutinin [TaxId: 37501]
Score = 184 bits (469), Expect = 5e-55
Identities = 73/251 (29%), Positives = 111/251 (44%), Gaps = 37/251 (14%)
Query: 29 QFIYHGFNED-AQLQRDGLASVHSNGLLQLTNTV----SPQQEGHAFYRLPIKF-NTSSS 82
F + F + A L G ASV S G+LQLT G A Y P++ ++
Sbjct: 5 SFTINNFVPNEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIWGNTTG 64
Query: 83 ESLSFSSNFVFAI----------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNH 132
SFS++F F + G+AF ++P + S S+YLGLFN ++N S+N
Sbjct: 65 SVASFSTSFTFVVKAPNPDITSDGLAFYLAPPDSQIPSG-SVSKYLGLFN-NSNSDSSNQ 122
Query: 133 ILAIELDTVQNLDFDDIDDN--HVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGDPI 190
I+A+E DT +D D N H+GIDVN + S ++ + + L +
Sbjct: 123 IVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIESIKTVQWDWINGGVAFATITYLAPNKTL 182
Query: 191 QIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLK--SS 248
+ Y T ++ +++L IL E + VGFSA+TG +
Sbjct: 183 IASLVYP---------------SNQTTFSVAASVDLKEILPEWVRVGFSAATGYPTEVET 227
Query: 249 HYVLGWSFNRS 259
H VL WSF +
Sbjct: 228 HDVLSWSFTST 238
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 188 bits (478), Expect = 6e-55
Identities = 72/299 (24%), Positives = 120/299 (40%), Gaps = 23/299 (7%)
Query: 319 YEEVYEDWEREYGPQRFTYKDLYKATKGFKDKDVIGRGGFGKVYRGV-LASNVQIAVKKV 377
Y+ D ++Y PQ K + + + +G G FG V+R A+ A K V
Sbjct: 1 YDNYVFDIWKQYYPQPVEIKHDHVLDH-YDIHEELGTGAFGVVHRVTERATGNNFAAKFV 59
Query: 378 SHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIK 437
+ + E+ +M LRH LV L E +++Y++M G L + +
Sbjct: 60 MTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN 119
Query: 438 PCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG--KLGDFGLARL 495
++ + +R V GL ++H E +H D+KP N++ + KL DFGL
Sbjct: 120 K-MSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175
Query: 496 YDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMET 555
D + T GT + PE+ TD+++ GV + SG P + ET
Sbjct: 176 LDPKQSVKVT--TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET 233
Query: 556 VNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+ V K + DS GI E+ + + + K P R + Q ++
Sbjct: 234 LRNV--------KSCDWNMDDSAFSGISEDGK-DFIRK----LLLADPNTRMTIHQALE 279
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 7e-55
Identities = 68/287 (23%), Positives = 120/287 (41%), Gaps = 39/287 (13%)
Query: 347 FKDKDVIGRGGFGKVYRGVLASN---VQIAVKKVS-HDSKQGIKEFVAELVSMGRL-RHR 401
K +DVIG G FG+V + + + + A+K++ + SK ++F EL + +L H
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 402 NLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPC--------------LNWYQRFR 447
N++ L G C +G L +Y P+G+L L + L+ Q
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 448 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 507
VA G+ YL ++ +HRD+ N+L+ + K+ DFGL+R + + T
Sbjct: 132 FAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV--KKTMG 186
Query: 508 VGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWK 567
+M E + +T++DV+++GV + E+ S M L + + ++
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC--GMTCAELYEKLPQGYR 244
Query: 568 KGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+ D V L C KP RP+ Q++
Sbjct: 245 LEKPLNCDDE-------------VYDLMRQCWREKPYERPSFAQILV 278
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 9e-55
Identities = 65/276 (23%), Positives = 124/276 (44%), Gaps = 27/276 (9%)
Query: 347 FKDKDVIGRGGFGKVYRGVLASN-----VQIAVKKVSHDSKQG-IKEFVAELVSMGRLRH 400
+ VIG G FG+VY+G+L ++ V +A+K + + +F+ E MG+ H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 401 RNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLH 460
N+++L G + +++ +YM NG+LDK + Q ++RG+A+G+ YL
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGALDKF-LREKDGEFSVLQLVGMLRGIAAGMKYLA 127
Query: 461 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY--DHDTIPQTTKLVGTFGYMDPEL 518
+HRD+ N+L++++L K+ DFGL+R+ D + T+ + PE
Sbjct: 128 NMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184
Query: 519 MRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSR 578
+ K ++++DV++FG+ M EV + + S + A +
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---------------EVMKAINDG 229
Query: 579 LEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+ +L + C + RP ++
Sbjct: 230 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 1e-54
Identities = 65/272 (23%), Positives = 109/272 (40%), Gaps = 23/272 (8%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKE-FVAELVSMGRLRHRNLV 404
+ +G G +G+V V + +AVK V E E+ L H N+V
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 405 KLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWE 464
K G+ R L +Y G L + +I + R + +G++YLH
Sbjct: 67 KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH---G 121
Query: 465 QVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ-TTKLVGTFGYMDPELMRTGK 523
+ HRDIKP N+LLD N K+ DFGLA ++ ++ + K+ GT Y+ PEL++ +
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 524 -ASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGI 582
+ DV++ G+ + + +G Q S DW + +
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAG-ELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA----- 235
Query: 583 CEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+ L+ K P AR + + +
Sbjct: 236 ----PLALLHK----ILVENPSARITIPDIKK 259
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 184 bits (469), Expect = 1e-53
Identities = 66/299 (22%), Positives = 118/299 (39%), Gaps = 23/299 (7%)
Query: 319 YEEVYEDWEREYGPQRFTYKDLYKATKGFKDKDVIGRGGFGKVYRGV-LASNVQIAVKKV 377
Y++ YED ++Y PQ K + + +G G FG V+R V A+ K +
Sbjct: 4 YDKFYEDIWKKYVPQPVEVKQ-GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFI 62
Query: 378 SHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIK 437
+ E+ M +L H L+ L K E +L+ +++ G L +
Sbjct: 63 NTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY 122
Query: 438 PCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG--KLGDFGLARL 495
++ + +R GL ++HE ++H DIKP N++ + K+ DFGLA
Sbjct: 123 K-MSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATK 178
Query: 496 YDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMET 555
+ D I + T T + PE++ TD++A GV + SG P + +ET
Sbjct: 179 LNPDEIVKVT--TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET 236
Query: 556 VNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+ V + + A S + + + +P R + ++
Sbjct: 237 LQNVKRCDWEFDEDAFSSVS---------PEAKDFIKN----LLQKEPRKRLTVHDALE 282
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 2e-53
Identities = 58/293 (19%), Positives = 99/293 (33%), Gaps = 42/293 (14%)
Query: 347 FKDKDVIGRGGFGKVYRGVLA------SNVQIAVKKVSHDSKQG-IKEFVAELVSMGRL- 398
+G G FGKV + + +AVK + + + ++EL + L
Sbjct: 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84
Query: 399 RHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILH----------------TNIKPCLNW 442
H N+V L G C G L++ +Y G L L + + L+
Sbjct: 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 443 YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTI 501
VA G+ +L +HRD+ N+LL K+ DFGLAR + +
Sbjct: 145 EDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 502 PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDW 561
+M PE + + +DV+++G+F+ E+ S
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS--------------P 247
Query: 562 VCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+ E + + C P RP +Q++Q
Sbjct: 248 YPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 2e-53
Identities = 67/276 (24%), Positives = 111/276 (40%), Gaps = 31/276 (11%)
Query: 347 FKDKDVIGRGGFGKVYRGVLA---SNVQIAVKKVSHDSKQG--IKEFVAELVSMGRLRHR 401
+DK +G G FG V +G +AVK + +++ E +AE M +L +
Sbjct: 10 LEDK-ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNP 68
Query: 402 NLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHE 461
+V++ G C + ++LV + G L+K L N + ++ V+ G+ YL E
Sbjct: 69 YIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEE 125
Query: 462 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY--DHDTIPQTTKLVGTFGYMDPELM 519
+HRD+ NVLL K+ DFGL++ D + T + PE +
Sbjct: 126 SN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 520 RTGKASTSTDVYAFGVFMLE-VASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSR 578
K S+ +DV++FGV M E + G++P E +++ +
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-----------KGERMGC 231
Query: 579 LEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
G E + L C E RP V
Sbjct: 232 PAGCPRE-----MYDLMNLCWTYDVENRPGFAAVEL 262
|
| >d1ukga_ b.29.1.1 (A:) Legume lectin {Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]} Length = 241 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]
Score = 180 bits (457), Expect = 2e-53
Identities = 63/247 (25%), Positives = 101/247 (40%), Gaps = 37/247 (14%)
Query: 30 FIYHGFNED-AQLQRDGLASVHSNGLLQLTNTV-----SPQQEGHAFYRLPIKF-NTSSS 82
F + F D L G A + N +QLT T G + + SSS
Sbjct: 6 FGFPTFPSDQKNLIFQGDAQI-KNNAVQLTKTDSNGNPVASTVGRILFSAQVHLWEKSSS 64
Query: 83 ESLSFSSNFVFAI---------GMAFVISPSKDLGKAEASPSEYLGLFNASNNG-QSTNH 132
+F S F F++ G+AF I+P D S LGLF S N
Sbjct: 65 RVANFQSQFSFSLKSPLSNGADGIAFFIAPP-DTTIPSGSGGGLLGLFAPGTAQNTSANQ 123
Query: 133 ILAIELDTVQNLDFDDID--DNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGDPI 190
++A+E DT D + D H+GIDVNS+ S ++ G +
Sbjct: 124 VIAVEFDTFYAQDSNTWDPNYPHIGIDVNSIRSVKTVKWDRRD-------------GQSL 170
Query: 191 QIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLKSSHY 250
+ ++++ + + L+V T+ +S +++ +L E + VGFSA++G +H
Sbjct: 171 NVLVTFNPSTRNLDVVATY---SDGTRYEVSYEVDVRSVLPEWVRVGFSAASGEQYQTHT 227
Query: 251 VLGWSFN 257
+ WSF
Sbjct: 228 LESWSFT 234
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 182 bits (462), Expect = 3e-53
Identities = 70/298 (23%), Positives = 114/298 (38%), Gaps = 48/298 (16%)
Query: 347 FKDKDVIGRGGFGKVYRGVL------ASNVQIAVKKVSHD-SKQGIKEFVAELVSMGRLR 399
+ IG G FG+V++ +AVK + + S +F E M
Sbjct: 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD 74
Query: 400 HRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTN----------------------IK 437
+ N+VKL G C L+++YM G L++ L +
Sbjct: 75 NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 134
Query: 438 PCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LY 496
P L+ ++ I R VA+G+ YL E +HRD+ N L+ ++ K+ DFGL+R +Y
Sbjct: 135 PPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 497 DHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETV 556
D +M PE + + +T +DV+A+GV + E+ S + E
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE-- 249
Query: 557 NLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
V + G I C E + L C P RP+ + +
Sbjct: 250 ----EVIYYVRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1ioaa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]} Length = 228 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]
Score = 178 bits (451), Expect = 1e-52
Identities = 68/252 (26%), Positives = 105/252 (41%), Gaps = 46/252 (18%)
Query: 24 AQDVNQFIYHGFNEDAQLQRDGLASVHSNGLLQLTNTVS-----PQQEGHAFYRLPIKFN 78
A + F + F+ D +L G A++ S G LQLT S G AFY PI+
Sbjct: 1 ATET-SFNFPNFHTDDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIK 59
Query: 79 TSSSESLSFSSNFVFAI----------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQ 128
S++ + SF++NF F I G+AF + P E+LG+FN +NN +
Sbjct: 60 DSNNVA-SFNTNFTFIIRAKNQSISAYGLAFALVPVNSPP---QKKQEFLGIFN-TNNPE 114
Query: 129 STNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGD 188
+A+ +T +N D D N + VN G+
Sbjct: 115 PNARTVAVVFNTFKN--RIDFDKNFIKPYVNENCDFH------------------KYNGE 154
Query: 189 PIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLK-- 246
+ I+YD + L V L K +S ++L + E + VGFS ++G +
Sbjct: 155 KTDVQITYDSSNNDLRVFLHFTV--SQVKCSVSATVHLEKEVDEWVSVGFSPTSGLTEDT 212
Query: 247 -SSHYVLGWSFN 257
+H VL WSF+
Sbjct: 213 TETHDVLSWSFS 224
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 1e-52
Identities = 71/280 (25%), Positives = 110/280 (39%), Gaps = 30/280 (10%)
Query: 345 KGFKDKDVIGRGGFGKVYRGVL----ASNVQIAVKKVSHD---SKQGIKEFVAELVSMGR 397
K + + +G G FG V RG V +AVK + D + + +F+ E+ +M
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 398 LRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLL 457
L HRNL++L G +V + P GSL L + R VA G+
Sbjct: 68 LDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMG 125
Query: 458 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARL--YDHDTIPQTTKLVGTFGYMD 515
YL +HRD+ N+LL K+GDFGL R + D F +
Sbjct: 126 YLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 516 PELMRTGKASTSTDVYAFGVFMLE-VASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDA 574
PE ++T S ++D + FGV + E G+ P + ++ + D
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI-------------DK 229
Query: 575 SDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
RL E + + + + C KPE RP +
Sbjct: 230 EGERLP--RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 4e-52
Identities = 70/305 (22%), Positives = 128/305 (41%), Gaps = 40/305 (13%)
Query: 332 PQRFTYKDLYKATK------GFKDKDVIGRGGFGKVYRGVL------ASNVQIAVKKVSH 379
P+ F+ D+Y + +G+G FG VY GV ++A+K V+
Sbjct: 1 PEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE 60
Query: 380 D-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTN--- 435
S + EF+ E M ++V+L G + L++ + M G L L +
Sbjct: 61 AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPA 120
Query: 436 -----IKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDF 490
+ + + ++ +A G+ YL +HRD+ N ++ D K+GDF
Sbjct: 121 MANNPVLAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDF 177
Query: 491 GLAR-LYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQ 549
G+ R +Y+ D + K + +M PE ++ G +T +DV++FGV + E+A+ Q
Sbjct: 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 237
Query: 550 QGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNM 609
S E V +G + D D +++ +L C P+ RP+
Sbjct: 238 GLSNE------QVLRFVMEGGLLDKPD---------NCPDMLFELMRMCWQYNPKMRPSF 282
Query: 610 RQVMQ 614
+++
Sbjct: 283 LEIIS 287
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 1e-51
Identities = 65/327 (19%), Positives = 114/327 (34%), Gaps = 56/327 (17%)
Query: 320 EEVYEDWEREYGPQRFTYKDLYKATKG-FKDKDVIGRGGFGKVYRGVL------ASNVQI 372
E Y D + + Y ++ + + V+G G FGKV ++Q+
Sbjct: 17 EYFYVD------FREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQV 70
Query: 373 AVKKVSHDSKQG-IKEFVAELVSMGRL-RHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDK 430
AVK + + + ++EL M +L H N+V L G C G L+++Y G L
Sbjct: 71 AVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLN 130
Query: 431 ILHTNIKP---------------------CLNWYQRFRIIRGVASGLLYLHEDWEQVVLH 469
L + + L + VA G+ +L + +H
Sbjct: 131 YLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVH 187
Query: 470 RDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMDPELMRTGKASTST 528
RD+ NVL+ K+ DFGLAR + +M PE + G + +
Sbjct: 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKS 247
Query: 529 DVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQ 587
DV+++G+ + E+ S G P + I++ E+
Sbjct: 248 DVWSYGILLWEIFSLGVNPYPGIPVDANFYKL-----------IQNGFKMDQPFYATEEI 296
Query: 588 MELVLKLGLFCSHPKPEARPNMRQVMQ 614
++ C RP+ +
Sbjct: 297 YIIMQS----CWAFDSRKRPSFPNLTS 319
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 2e-51
Identities = 63/274 (22%), Positives = 116/274 (42%), Gaps = 27/274 (9%)
Query: 347 FKDKDVIGRGGFGKVYRGVLASN----VQIAVKKVSHDSKQGIKE-FVAELVSMGRLRHR 401
+ IG G FG V++G+ S + +A+K + + ++E F+ E ++M + H
Sbjct: 9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68
Query: 402 NLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHE 461
++VKL G + ++ + G L L L+ +++ L YL
Sbjct: 69 HIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLES 126
Query: 462 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRT 521
+ +HRDI NVL+ ++ KLGDFGL+R + T + +K +M PE +
Sbjct: 127 ---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183
Query: 522 GKASTSTDVYAFGVFMLEV-ASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580
+ ++++DV+ FGV M E+ G +P + + + + I + +
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG------------RIENGERLPMP 231
Query: 581 GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
C L+ K C P RP ++
Sbjct: 232 PNCPPTLYSLMTK----CWAYDPSRRPRFTELKA 261
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 5e-51
Identities = 60/276 (21%), Positives = 114/276 (41%), Gaps = 29/276 (10%)
Query: 347 FKDKDVIGRGGFGKVYRGVLASN-----VQIAVKKVSH-DSKQGIKEFVAELVSMGRLRH 400
FK V+G G FG VY+G+ + +A+K++ S + KE + E M + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 401 RNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLH 460
++ +L G C L+ MP G L + + K + +A G+ YL
Sbjct: 71 PHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYL- 127
Query: 461 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMDPELM 519
++ ++HRD+ NVL+ + K+ DFGLA+ L + +M E +
Sbjct: 128 --EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 520 RTGKASTSTDVYAFGVFMLE-VASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSR 578
+ +DV+++GV + E + G +P + + E ++++ R
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE--------------KGER 231
Query: 579 LEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
L V + + C ++RP R+++
Sbjct: 232 LP--QPPICTIDVYMIMVKCWMIDADSRPKFRELII 265
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 1e-49
Identities = 61/273 (22%), Positives = 102/273 (37%), Gaps = 27/273 (9%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRN 402
FK ++G G F V LA++ + A+K + + + E M RL H
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 403 LVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHED 462
VKL + + Y NG L K + + + S L YLH
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGK 127
Query: 463 WEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD-TIPQTTKLVGTFGYMDPELMRT 521
++HRD+KP N+LL+ D++ ++ DFG A++ + + VGT Y+ PEL+
Sbjct: 128 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 522 GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEG 581
A S+D++A G + ++ +G P I E
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ------------KIIKLEYDFPEK 232
Query: 582 ICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+ + +LV K R ++
Sbjct: 233 FFPKAR-DLVEK----LLVLDATKRLGCEEMEG 260
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 169 bits (430), Expect = 1e-48
Identities = 62/283 (21%), Positives = 112/283 (39%), Gaps = 29/283 (10%)
Query: 341 YKATKGFKDK----DVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKE-FVAELVS 394
+K + +D DV+G G F +V + +A+K ++ + +G + E+
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 395 MGRLRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVAS 454
+ +++H N+V L G L+ + G L + K R+I V
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE--KGFYTERDASRLIFQVLD 118
Query: 455 GLLYLHEDWEQVVLHRDIKPANVLL---DADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 511
+ YLH+ ++HRD+KP N+L D D + DFGL+++ D ++ + GT
Sbjct: 119 AVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV--LSTACGTP 173
Query: 512 GYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAI 571
GY+ PE++ S + D ++ GV + G P + + + +
Sbjct: 174 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW 233
Query: 572 RDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
D SDS + + PE R Q +Q
Sbjct: 234 DDISDS---------AKDFIRH----LMEKDPEKRFTCEQALQ 263
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 5e-48
Identities = 54/279 (19%), Positives = 114/279 (40%), Gaps = 24/279 (8%)
Query: 338 KDLYKATKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGR 397
K+LY+ + + +GRG FG V+R V S+ + + K E+ +
Sbjct: 1 KELYEK---YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNI 57
Query: 398 LRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLL 457
RHRN++ L E +++++++ + + ++T+ LN + + V L
Sbjct: 58 ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQ 116
Query: 458 YLHEDWEQVVLHRDIKPANVLLDADLNG--KLGDFGLARLYDHDTIPQTTKLVGTFGYMD 515
+LH + H DI+P N++ + K+ +FG AR + Y
Sbjct: 117 FLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYA 171
Query: 516 PELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDAS 575
PE+ + ST+TD+++ G + + SG P + + + + + + + A ++ S
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEIS 231
Query: 576 DSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
M+ V + + ++R + +Q
Sbjct: 232 IE---------AMDFVDR----LLVKERKSRMTASEALQ 257
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 9e-47
Identities = 64/293 (21%), Positives = 116/293 (39%), Gaps = 43/293 (14%)
Query: 347 FKDKDVIGRGGFGKVYRGVL--------ASNVQIAVKKVSHD-SKQGIKEFVAELVSMGR 397
+G G FG+V ++AVK + D +++ + + ++E+ M
Sbjct: 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74
Query: 398 L-RHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPC--------------LNW 442
+ +H+N++ L G C + G ++ +Y G+L + L P L+
Sbjct: 75 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 134
Query: 443 YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 502
VA G+ YL + +HRD+ NVL+ D K+ DFGLAR H
Sbjct: 135 KDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 503 QTTKL-VGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDW 561
+ T +M PE + + +DV++FGV + E+ + +E
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE------E 245
Query: 562 VCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+ K+G D + C + ++ C H P RP +Q+++
Sbjct: 246 LFKLLKEGHRMDKPSN-----CTNELYMMMRD----CWHAVPSQRPTFKQLVE 289
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 9e-46
Identities = 65/292 (22%), Positives = 112/292 (38%), Gaps = 41/292 (14%)
Query: 347 FKDKDVIGRGGFGKVYRGV------LASNVQIAVKKVSHDSKQG-IKEFVAELVSMGR-L 398
K +GRG FG+V A+ +AVK + + + ++EL +
Sbjct: 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74
Query: 399 RHRNLVKLRGYCRRKGE-FLLVYDYMPNGSLDKILHTN--------------IKPCLNWY 443
H N+V L G C + G +++ ++ G+L L + K L
Sbjct: 75 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 134
Query: 444 QRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIP 502
VA G+ +L + +HRD+ N+LL K+ DFGLAR +Y
Sbjct: 135 HLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191
Query: 503 QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWV 562
+ +M PE + + +DV++FGV + E+ S V + +
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEF 246
Query: 563 CDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
C K+G A D + + +L C H +P RP ++++
Sbjct: 247 CRRLKEGTRMRAPDY-----TTPEMYQTMLD----CWHGEPSQRPTFSELVE 289
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 161 bits (407), Expect = 1e-45
Identities = 62/285 (21%), Positives = 122/285 (42%), Gaps = 37/285 (12%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVS---------HDSKQGIKEFVAELVSMG 396
++ K+++GRG V R + + + AVK + + ++ + + E+ +
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 397 RLR-HRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASG 455
++ H N+++L+ F LV+D M G L L + L+ + +I+R +
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEV 122
Query: 456 LLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMD 515
+ LH+ ++HRD+KP N+LLD D+N KL DFG + D + ++ GT Y+
Sbjct: 123 ICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE--KLREVCGTPSYLA 177
Query: 516 PELMRTGKA------STSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKG 569
PE++ D+++ GV M + +G P + M + ++ +
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237
Query: 570 AIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
D SD+ +LV + +P+ R + +
Sbjct: 238 EWDDYSDT---------VKDLVSR----FLVVQPQKRYTAEEALA 269
|
| >d1dhkb_ b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 204 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 156 bits (395), Expect = 7e-45
Identities = 56/234 (23%), Positives = 96/234 (41%), Gaps = 40/234 (17%)
Query: 28 NQFIYHGFNEDAQLQRDGLASVHSNGLLQLTNTVSPQQEGHAFYRLPIKFNTSSSESL-S 86
FI FN+ L G A+V SNG LQL+ S AFY PI+ S++ ++ S
Sbjct: 4 TSFIIDAFNK-TNLILQGDATVSSNGNLQLSYN-SYDSMSRAFYSAPIQIRDSTTGNVAS 61
Query: 87 FSSNFVFAIGMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDF 146
F +NF I +A+ + L +S + +E DT +
Sbjct: 62 FDTNFTMNI-----------RTHRQANSAVGLDFVLVPVQPESKGDTVTVEFDTFLSRIS 110
Query: 147 DDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGDPIQIWISYDGAEKLLNVT 206
D+++N + + G ++ I+Y+ + K+ +V+
Sbjct: 111 IDVNNNDIKSVPWDV---------------------HDYDGQNAEVRITYNSSTKVFSVS 149
Query: 207 LAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLKSS---HYVLGWSFN 257
L+ S +S + L + + + VGFSA++G+ + S H VL WSF+
Sbjct: 150 LSNPS--TGKSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDVLSWSFS 201
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 155 bits (393), Expect = 9e-44
Identities = 62/271 (22%), Positives = 111/271 (40%), Gaps = 28/271 (10%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRN 402
++ +++G GG +V+ L + +AVK + D F E + L H
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68
Query: 403 LVKLRGYCRRKGE----FLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLY 458
+V + + +V +Y+ +L I+HT + + +I L +
Sbjct: 69 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNF 126
Query: 459 LHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY--DHDTIPQTTKLVGTFGYMDP 516
+ ++HRD+KPAN+++ A K+ DFG+AR +++ QT ++GT Y+ P
Sbjct: 127 S---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 517 ELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASD 576
E R +DVY+ G + EV +G P + ++ I
Sbjct: 184 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH------VREDPIPP--S 235
Query: 577 SRLEGICEEKQMELVLKLGLFCSHPKPEARP 607
+R EG+ + +VLK PE R
Sbjct: 236 ARHEGLSADLD-AVVLK----ALAKNPENRY 261
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 9e-44
Identities = 70/295 (23%), Positives = 119/295 (40%), Gaps = 23/295 (7%)
Query: 340 LYKATKGFKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQG-IKEFVAELVSMGR 397
++ + + IG G +G V + V++A+KK+S Q + + E+ + R
Sbjct: 3 VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLR 62
Query: 398 LRHRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKP-CLNWYQRFRIIRGVASGL 456
RH N++ + R + Y+ + L+ +K L+ + + GL
Sbjct: 63 FRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGL 122
Query: 457 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY--DHDTIPQTTKLVGTFGYM 514
Y+H VLHRD+KP+N+LL+ + K+ DFGLAR+ DHD T+ V T Y
Sbjct: 123 KYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 179
Query: 515 DPELMRTGKAST-STDVYAFGVFMLEVASGRRPVEQQGSMETVNLV----------DWVC 563
PE+M K T S D+++ G + E+ S R + ++ +N + D C
Sbjct: 180 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239
Query: 564 DCWKKGAIRDASDSRLEGICEEKQM----ELVLKLGLFCSHPKPEARPNMRQVMQ 614
K S + + L L P R + Q +
Sbjct: 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 7e-43
Identities = 60/270 (22%), Positives = 110/270 (40%), Gaps = 28/270 (10%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHD---SKQGIKEFVAELVSMGR-LRHR 401
F ++G+G FGKV+ +N A+K + D ++ + E + H
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 402 NLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHE 461
L + + K V +Y+ G L + + K + + + GL +L
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFL-- 119
Query: 462 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRT 521
+ +++RD+K N+LLD D + K+ DFG+ + T GT Y+ PE++
Sbjct: 120 -HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEILLG 177
Query: 522 GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEG 581
K + S D ++FGV + E+ G+ P Q E + + + + ++A D
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD----- 232
Query: 582 ICEEKQMELVLKLGLFCSHPKPEARPNMRQ 611
L++K +PE R +R
Sbjct: 233 --------LLVK----LFVREPEKRLGVRG 250
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 152 bits (384), Expect = 2e-42
Identities = 56/286 (19%), Positives = 112/286 (39%), Gaps = 27/286 (9%)
Query: 347 FKDKDVIGRGGFGKVYRGVLASNVQIAVKKV--SHDSKQGIKEFVAELVSMGRLRHRNLV 404
+ + IG G +G VY+ A+KK+ + + + E+ + L+H N+V
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 405 KLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWE 464
KL K +LV++++ + + L + + +G+ Y H+
Sbjct: 64 KLYDVIHTKKRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR- 120
Query: 465 QVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKA 524
VLHRD+KP N+L++ + K+ DFGLAR + T ++V + LM + K
Sbjct: 121 --VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 525 STSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASD-------- 576
ST+ D+++ G E+ +G + + + + + ++
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 577 --------SRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+E ++L+ K P R +Q ++
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSK----MLKLDPNQRITAKQALE 280
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 5e-42
Identities = 54/279 (19%), Positives = 107/279 (38%), Gaps = 31/279 (11%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKV------SHDSKQGIKEFVAELVSMGRLR 399
+ + +G G F V + ++ +Q A K + S ++ E+ + ++
Sbjct: 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 400 HRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYL 459
H N++ L K + +L+ + + G L L K L + ++ + +G+ YL
Sbjct: 72 HPNVITLHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYL 129
Query: 460 HEDWEQVVLHRDIKPANVLLDAD----LNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMD 515
H + H D+KP N++L K+ DFGLA D + + GT ++
Sbjct: 130 HSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVA 184
Query: 516 PELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDAS 575
PE++ D+++ GV + SG P ET+ V V ++ + S
Sbjct: 185 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 244
Query: 576 DSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+ + + P+ R ++ +Q
Sbjct: 245 AL---------AKDFIRR----LLVKDPKKRMTIQDSLQ 270
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 6e-42
Identities = 58/283 (20%), Positives = 111/283 (39%), Gaps = 19/283 (6%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNL 403
F+ + IG G +G VY+ + +A+KK+ D ++ + E+ + L H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 404 VKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDW 463
VKL + + LV++++ + L K + + + + + GL +
Sbjct: 64 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC---H 119
Query: 464 EQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGK 523
VLHRD+KP N+L++ + KL DFGLAR + T ++V + L+
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 524 ASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLV--------DWVCDCWKKGAIRDAS 575
ST+ D+++ G E+ + R ++ + + + V S
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 576 DSRLEGICEEKQM----ELVLKLGLFCSHPKPEARPNMRQVMQ 614
+ K + E L H P R + + +
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 9e-42
Identities = 71/290 (24%), Positives = 111/290 (38%), Gaps = 31/290 (10%)
Query: 347 FKDKDVIGRGGFGKVYRGVL-ASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVK 405
+ D VIG G FG VY+ L S +A+KKV D + EL M +L H N+V+
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVR 77
Query: 406 LRGYCRRKGE------FLLVYDYMPNGSLDKILH-TNIKPCLNWYQRFRIIRGVASGLLY 458
LR + GE LV DY+P H + K L + + L Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 459 LHEDWEQVVLHRDIKPANVLLDAD-LNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDP- 516
+H + HRDIKP N+LLD D KL DFG A+ + + + Y P
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY--ICSRYYRAPE 192
Query: 517 ELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASD 576
+ ++S DV++ G + E+ G+ ++ + + V + IR+ +
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252
Query: 577 SRLEG------------ICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+ E + + + L P AR +
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 2e-41
Identities = 63/297 (21%), Positives = 116/297 (39%), Gaps = 28/297 (9%)
Query: 340 LYKATKGFKDKDVIGRGGFGKVYRG--VLASNVQIAVKKVSHDSKQG-----IKEFVAEL 392
L +A + ++ IG G +GKV++ + +A+K+V + + VA L
Sbjct: 2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61
Query: 393 VSMGRLRHRNLVKLRGYC-----RRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFR 447
+ H N+V+L C R+ + LV++++ + +P +
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP-EPGVPTETIKD 120
Query: 448 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 507
++ + GL +LH V+HRD+KP N+L+ + KL DFGLAR+Y +
Sbjct: 121 MMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV-- 175
Query: 508 VGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLV-------- 559
V T Y PE++ +T D+++ G E+ + ++ + +
Sbjct: 176 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235
Query: 560 --DWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
DW D + ++ EL L L C P R + +
Sbjct: 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 2e-41
Identities = 51/273 (18%), Positives = 98/273 (35%), Gaps = 26/273 (9%)
Query: 350 KDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRG 408
V+G G GKV + + + A+K + D + +E + + ++V++
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKML-QDCPKARREVELHWRA---SQCPHIVRIVD 72
Query: 409 YCR----RKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWE 464
+ L+V + + G L + + I++ + + YLH
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---S 129
Query: 465 QVVLHRDIKPANVLLDADLNG---KLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRT 521
+ HRD+KP N+L + KL DFG A+ T T Y+ PE++
Sbjct: 130 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC--YTPYYVAPEVLGP 187
Query: 522 GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEG 581
K S D+++ GV M + G P + + + + +
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM----KTRIRMGQYEFPNPEWSE 243
Query: 582 ICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+ EE + L+ +P R + + M
Sbjct: 244 VSEEVK-MLIRN----LLKTEPTQRMTITEFMN 271
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 3e-41
Identities = 62/282 (21%), Positives = 103/282 (36%), Gaps = 24/282 (8%)
Query: 351 DVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKE-----FVAELVSMGRLRHRNLV 404
D +G G F VY+ +N +A+KK+ + K+ + E+ + L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 405 KLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWE 464
L K LV+D+M I L + GL YLH+ W
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHW- 120
Query: 465 QVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKA 524
+LHRD+KP N+LLD + KL DFGLA+ + T + V T Y PEL+ +
Sbjct: 121 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ-VVTRWYRAPELLFGARM 177
Query: 525 -STSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGIC 583
D++A G + E+ + ++ + + + D
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 584 EEKQMELVLKLGLFCS-----------HPKPEARPNMRQVMQ 614
+ + + P AR Q ++
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 151 bits (381), Expect = 4e-41
Identities = 55/227 (24%), Positives = 94/227 (41%), Gaps = 16/227 (7%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHD---SKQGIKEFVAELVSMGRLR--- 399
F +IGRGGFG+VY + A+K + KQG + E + + +
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 400 HRNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYL 459
+V + + + D M G L L + + GL ++
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS--EADMRFYAAEIILGLEHM 123
Query: 460 HEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELM 519
H + V++RD+KPAN+LLD + ++ D GLA + + VGT GYM PE++
Sbjct: 124 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTHGYMAPEVL 177
Query: 520 RTGKA-STSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDC 565
+ G A +S D ++ G + ++ G P Q + + +
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 224
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 149 bits (376), Expect = 6e-41
Identities = 51/217 (23%), Positives = 100/217 (46%), Gaps = 13/217 (5%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRN 402
F+ +G G FG+V+ + A+K + + + ++ E + + + H
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 403 LVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHED 462
++++ G + + ++ DY+ G L +L + + V L YLH
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP--NPVAKFYAAEVCLALEYLHS- 122
Query: 463 WEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTG 522
+ +++RD+KP N+LLD + + K+ DFG A+ T L GT Y+ PE++ T
Sbjct: 123 --KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYTLCGTPDYIAPEVVSTK 176
Query: 523 KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLV 559
+ S D ++FG+ + E+ +G P +M+T +
Sbjct: 177 PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI 213
|
| >d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} Length = 237 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Concanavalin A species: Jack bean (Canavalia ensiformis) [TaxId: 3823]
Score = 145 bits (367), Expect = 1e-40
Identities = 38/127 (29%), Positives = 61/127 (48%), Gaps = 16/127 (12%)
Query: 131 NHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGDPI 190
+ I+A+ELDT N D D H+GID+ S+ S ++A + G
Sbjct: 2 DTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAK-------------WNMQNGKVG 48
Query: 191 QIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLKSSHY 250
I Y+ +K L+ ++ P +S ++L ++L E + VG SASTG K ++
Sbjct: 49 TAHIIYNSVDKRLSAVVSY---PNADSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNT 105
Query: 251 VLGWSFN 257
+L WSF
Sbjct: 106 ILSWSFT 112
|
| >d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} Length = 237 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Concanavalin A species: Jack bean (Canavalia ensiformis) [TaxId: 3823]
Score = 90.8 bits (225), Expect = 3e-21
Identities = 33/112 (29%), Positives = 48/112 (42%), Gaps = 16/112 (14%)
Query: 29 QFIYHGFNEDA-QLQRDGLASVHSNGLLQLTNTVS-----PQQEGHAFYRLPIKFNTSSS 82
F+++ F++D L G A+ ++G L+LT S G A + P+ SS+
Sbjct: 127 HFMFNQFSKDQKDLILQGDATTGTDGNLELTRVSSNGSPQGSSVGRALFYAPVHIWESSA 186
Query: 83 ESLSFSSNFVFAI---------GMAFVISPSKDLGKAEASPSEYLGLFNASN 125
SF + F F I G+AF IS D S LGLF +N
Sbjct: 187 VVASFEATFTFLIKSPDSHPADGIAFFISNI-DSSIPSGSTGRLLGLFPDAN 237
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 146 bits (368), Expect = 5e-40
Identities = 50/278 (17%), Positives = 101/278 (36%), Gaps = 25/278 (8%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVK 405
++ IG G FG +Y G +A+ ++A+K +K + E ++ +
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIP 66
Query: 406 LRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQ 465
+C +G++ ++ + SL+ + + + + + + S + Y+H +
Sbjct: 67 TIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK-FSLKTVLLLADQMISRIEYIHS---K 122
Query: 466 VVLHRDIKPANVLLDADLNGKL---GDFGLARLYDHDTIPQ------TTKLVGTFGYMDP 516
+HRD+KP N L+ G L DFGLA+ Y Q L GT Y
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 517 ELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASD 576
+ S D+ + G ++ G P + + + + + +
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER----ISEKKMSTPIE 238
Query: 577 SRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
+G E FC + + +P+ + Q
Sbjct: 239 VLCKGYPSE-----FATYLNFCRSLRFDDKPDYSYLRQ 271
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 1e-39
Identities = 66/298 (22%), Positives = 127/298 (42%), Gaps = 35/298 (11%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQG--IKEFVAELVSMGRLRHRNL 403
++ IG+G FG+V++ + ++A+KKV ++++ + E+ + L+H N+
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 404 VKLRGYC--------RRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASG 455
V L C R KG LV+D+ + L +N+ + R+++ + +G
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 456 LLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYD---HDTIPQTTKLVGTFG 512
L Y+H + +LHRD+K ANVL+ D KL DFGLAR + + + T V T
Sbjct: 130 LYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 513 YMDPELMRTGKA-STSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAI 571
Y PEL+ + D++ G M E+ + ++ + L+ +C
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 572 RDASDSRLEG---ICEEKQMELVLKLGLFCSHPK------------PEARPNMRQVMQ 614
+ + L + + ++ ++ +L + P P R + +
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 5e-39
Identities = 57/275 (20%), Positives = 100/275 (36%), Gaps = 41/275 (14%)
Query: 351 DVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKE------FVAELVSMGRLR--HR 401
++G GGFG VY G+ ++ N+ +A+K V D E E+V + ++
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 402 NLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHE 461
+++L + R F+L+ + T + L V + +
Sbjct: 70 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHC-- 126
Query: 462 DWEQVVLHRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMR 520
VLHRDIK N+L+D + KL DFG L T GT Y PE +R
Sbjct: 127 -HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIR 182
Query: 521 TGKA-STSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRL 579
+ S V++ G+ + ++ G P E + + +++ +
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF------FRQRVSSECQH--- 233
Query: 580 EGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
L+ C +P RP ++
Sbjct: 234 ----------LIRW----CLALRPSDRPTFEEIQN 254
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 141 bits (357), Expect = 1e-38
Identities = 52/281 (18%), Positives = 98/281 (34%), Gaps = 29/281 (10%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRN-LV 404
+K IG G FG ++ G L +N Q+A+K S + E + L +
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIP 64
Query: 405 KLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWE 464
+ + + +LV D + D L + + + + + +HE
Sbjct: 65 NVYYFGQEGLHNVLVIDLLGPSLED--LLDLCGRKFSVKTVAMAAKQMLARVQSIHE--- 119
Query: 465 QVVLHRDIKPANVLLDADLNG-----KLGDFGLARLYD------HDTIPQTTKLVGTFGY 513
+ +++RDIKP N L+ + + DFG+ + Y H + L GT Y
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179
Query: 514 MDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRD 573
M + S D+ A G + G P + + + + + + +R+
Sbjct: 180 MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE 239
Query: 574 ASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614
G EE K + + +A P+ +
Sbjct: 240 ----LCAGFPEE-----FYKYMHYARNLAFDATPDYDYLQG 271
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 4e-38
Identities = 52/284 (18%), Positives = 105/284 (36%), Gaps = 21/284 (7%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKV--SHDSKQGIKEFVAELVSMGRLRHRNL 403
++ + IG G +G V++ ++ +A+K+V D + + E+ + L+H+N+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 404 VKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDW 463
V+L + LV+++ N + F + L L
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF-----LFQLLKGLGFCH 118
Query: 464 EQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGK 523
+ VLHRD+KP N+L++ + KL +FGLAR + + ++V + L
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 524 ASTSTDVYAFGVFMLEVASGRRPVEQQGS-METVNLVDWVCDCWKKGAIRDASDSRLEGI 582
STS D+++ G E+A+ RP+ + + + + + +
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 583 CEEKQMELVLKLGLF------------CSHPKPEARPNMRQVMQ 614
L + P R + + +Q
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 2e-37
Identities = 54/217 (24%), Positives = 84/217 (38%), Gaps = 10/217 (4%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRN 402
F ++G+G FGKV A+ A+K + + +K + V E + RH
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 403 LVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHED 462
L L+ + V +Y G L L + + S L
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSAL---EYL 121
Query: 463 WEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTG 522
+ V++RDIK N++LD D + K+ DFGL + D GT Y+ PE++
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLEDN 180
Query: 523 KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLV 559
+ D + GV M E+ GR P Q L+
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 3e-37
Identities = 57/307 (18%), Positives = 117/307 (38%), Gaps = 37/307 (12%)
Query: 335 FTYKDLYKATKGFKDK----DVIGRGGFGKVYRGV-LASNVQIAVKKV--SHDSKQGIKE 387
F +++ K + +G G +G V V + ++A+KK+ S+ K
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 388 FVAELVSMGRLRHRNLVKLRGYCRRKG------EFLLVYDYMPNGSLDKILHTNIKPCLN 441
EL + +RH N++ L +F LV +M + H L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH----EKLG 119
Query: 442 WYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI 501
+ ++ + GL Y+H HRD+KP N+ ++ D K+ DFGLAR D +
Sbjct: 120 EDRIQFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADSEM- 175
Query: 502 PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDW 561
T +V + ++ + + + D+++ G M E+ +G+ + ++ + +
Sbjct: 176 --TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 233
Query: 562 VC----DCWKKGAIRDASDSRLEGICEEKQMELVLKLGLF----------CSHPKPEARP 607
V + + D + + ++G+ E ++ + L E R
Sbjct: 234 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 293
Query: 608 NMRQVMQ 614
+ +
Sbjct: 294 TAGEALA 300
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 131 bits (331), Expect = 2e-34
Identities = 49/234 (20%), Positives = 90/234 (38%), Gaps = 13/234 (5%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRN 402
F +G G FG+V S A+K + + I+ + E + +
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 403 LVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHED 462
LVKL + +V +Y+ G + L + + + YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHS- 159
Query: 463 WEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTG 522
+++RD+KP N+L+D ++ DFG A+ +T L GT + PE++ +
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWTLCGTPEALAPEIILSK 213
Query: 523 KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASD 576
+ + D +A GV + E+A+G P ++ + + D D
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKD 267
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 131 bits (329), Expect = 2e-34
Identities = 62/323 (19%), Positives = 119/323 (36%), Gaps = 43/323 (13%)
Query: 322 VYEDWEREYGPQRFTYKDLYKATKG---FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKV 377
VY D + + Y+ ++ +GRG + +V+ + + +N ++ VK +
Sbjct: 9 VYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL 68
Query: 378 SHDSKQGIKEFVAELVSMGRLR-HRNLVKLRGYCRRKGE--FLLVYDYMPNGSLDKILHT 434
K K+ E+ + LR N++ L + LV++++ N ++ T
Sbjct: 69 KPVKK---KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT 125
Query: 435 NIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDAD-LNGKLGDFGLA 493
L Y + + L Y H ++HRD+KP NV++D + +L D+GLA
Sbjct: 126 -----LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 177
Query: 494 RLYDHDTIPQTTKLVGTFGYMDPELMRTGKA-STSTDVYAFGVFMLEVASGRRP------ 546
Y + V + + PEL+ + S D+++ G + + + P
Sbjct: 178 EFYHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 235
Query: 547 -VEQQGSMETVNLVDWVCDCWKKGAIRDASD----------SRLEGICEEKQMELVLKLG 595
+Q + V + + D K I R E + LV
Sbjct: 236 NYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEA 295
Query: 596 L----FCSHPKPEARPNMRQVMQ 614
L ++R R+ M+
Sbjct: 296 LDFLDKLLRYDHQSRLTAREAME 318
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 2e-33
Identities = 51/222 (22%), Positives = 94/222 (42%), Gaps = 19/222 (8%)
Query: 347 FKDKDVIGRGGFGKVYRGV-LASNVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNL 403
+++ IG G G V + +A+KK+S ++ K ELV M + H+N+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 404 VKLRGYCRRKG------EFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLL 457
+ L + + LV + M I L+ + ++ + G+
Sbjct: 79 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM-----ELDHERMSYLLYQMLCGIK 133
Query: 458 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPE 517
+LH ++HRD+KP+N+++ +D K+ DFGLAR T V T Y PE
Sbjct: 134 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPE 188
Query: 518 LMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLV 559
++ + D+++ G M E+ + + ++ N V
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 230
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (313), Expect = 4e-32
Identities = 55/306 (17%), Positives = 110/306 (35%), Gaps = 35/306 (11%)
Query: 335 FTYKDLYKATKGFKDK----DVIGRGGFGKVYRGV-LASNVQIAVKKVS--HDSKQGIKE 387
F ++L K ++ +G G +G V + +++AVKK+S S K
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63
Query: 388 FVAELVSMGRLRHRNLVKLRGYCRRKGEF-----LLVYDYMPNGSLDKILHTNIKPCLNW 442
EL + ++H N++ L + + ++ L+ I+ L
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTD 120
Query: 443 YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 502
+I + GL Y+H ++HRD+KP+N+ ++ D K+ DFGLAR D
Sbjct: 121 DHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD---E 174
Query: 503 QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWV 562
T + + ++ + + D+++ G M E+ +GR ++ + L+ +
Sbjct: 175 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 234
Query: 563 CDCWKKGAIRDASDSRLEGICEEKQM--------------ELVLKLGLFCSHPKPEARPN 608
++ S + L + L + R
Sbjct: 235 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 294
Query: 609 MRQVMQ 614
Q +
Sbjct: 295 AAQALA 300
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 5e-31
Identities = 54/224 (24%), Positives = 96/224 (42%), Gaps = 16/224 (7%)
Query: 347 FKDKDVIGRGGFGKVYRGVLASNVQ----IAVKKVSH----DSKQGIKEFVAELVSMGRL 398
F+ V+G G +GKV+ S A+K + + + E + +
Sbjct: 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85
Query: 399 RHR-NLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLL 457
R LV L + + + L+ DY+ G L L + + Q + V +L
Sbjct: 86 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY-----VGEIVL 140
Query: 458 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPE 517
L + +++RDIK N+LLD++ + L DFGL++ + D + GT YM P+
Sbjct: 141 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200
Query: 518 LMRTGKA--STSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLV 559
++R G + + D ++ GV M E+ +G P G + +
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI 244
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 108 bits (270), Expect = 3e-26
Identities = 41/234 (17%), Positives = 82/234 (35%), Gaps = 20/234 (8%)
Query: 351 DVIGRGGFGKVYRGV-LASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRG- 408
+G G F V+ + +N +A+K V D K + E+ + R+ + K
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 409 -------------YCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASG 455
+ G +++ + +L ++ + +I + + G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 456 LLYLHEDWEQVVLHRDIKPANVLLDA-DLNGKLGDFGLARLYDHDTIPQTTKLV-GTFGY 513
L Y+H ++H DIKP NVL++ D L +A L + + T Y
Sbjct: 138 LDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195
Query: 514 MDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWK 567
PE++ D+++ + E+ +G E D + +
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249
|
| >d1gv9a_ b.29.1.13 (A:) Carbohydrate-recognition domain of P58/ERGIC-53 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 228 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Carbohydrate-recognition domain of P58/ERGIC-53 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 101 bits (253), Expect = 4e-25
Identities = 34/242 (14%), Positives = 68/242 (28%), Gaps = 30/242 (12%)
Query: 17 SFIFSALAQDVNQFIYHGFNEDAQLQRDGLASVHSNGLLQLTNTVSPQQEGHAFYRLPIK 76
SF L Q + +A S +++ + Q G + +
Sbjct: 10 SFKGPHLVQSDGTVPFWAHAGNAIP---------SADQIRIAPS-LKSQRGSVWTKTKAA 59
Query: 77 FN--TSSSESLSFSSNFVFAIGMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHIL 134
F + A G+A + ++ G + +
Sbjct: 60 FENWEVEVTFRVTGRGRIGADGLAIWYTENQ------GLDGPVFG-------SADMWNGV 106
Query: 135 AIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGDPIQIWI 194
I D+ N ++ + + N+ + + + P++ I
Sbjct: 107 GIFFDSFDN--DGKKNNPAIVVVGNNGQINYDHQNDGATQALASCQRDFRNKPYPVRAKI 164
Query: 195 SYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLKSSHYVLGW 254
+Y K L V + P A + ++ + G SA+TG L H VL +
Sbjct: 165 TYYQ--KTLTVMINNGFTPDKN-DYEFCAKVENMVIPTQGHFGISAATGGLADDHDVLSF 221
Query: 255 SF 256
Sbjct: 222 LT 223
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 97.2 bits (241), Expect = 8e-24
Identities = 27/158 (17%), Positives = 50/158 (31%), Gaps = 19/158 (12%)
Query: 351 DVIGRGGFGKVYRGVLASNVQIAVK----------KVSHDSKQGIKEFVAELVSMGRLRH 400
++G G V+ + VK KV G F + R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 401 RNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLH 460
R L KL+G K VY + N L +++ + ++ + + +
Sbjct: 66 RALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 461 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 498
++H D+ NVL+ + + DF +
Sbjct: 121 HRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGE 154
|
| >d2a6va1 b.29.1.13 (A:9-226) Emp46p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 218 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Emp46p N-terminal domain species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 51.5 bits (123), Expect = 6e-08
Identities = 29/213 (13%), Positives = 54/213 (25%), Gaps = 40/213 (18%)
Query: 51 SNGLLQLTNTVSPQQEGHAFYRLPIKFNTSSSESLSF---SSNFVFAIGMAFVISPSKDL 107
G LT +G + + + + +F G+AF +
Sbjct: 33 EEGRFVLTP--GKNTKGSLWLKPEYSIKDAMTIEWTFRSFGFRGSTKGGLAFWLKQGN-- 88
Query: 108 GKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDF---DDIDDNHVGIDVNSLISH 164
+S L I L L ++D +D+ S
Sbjct: 89 -----EGDSTELFGGSSKKFNG----LMILLRLDDKLGESVTAYLNDGTKDLDIESSPYF 139
Query: 165 ESAPAAYFSDREGMNKTLELIIGDPIQIWISYDGAE-KLLNVTLAPMSIPKPTKPLLSRA 223
S Y P + ++Y+ + LL + + + K
Sbjct: 140 ASCLFQYQDS------------MVPSTLRLTYNPLDNHLLKLQMDNRVCFQTRKVKF--- 184
Query: 224 INLSHILLETMYVGFSASTGSLKSSHYVLGWSF 256
+ +G SA + K S +L
Sbjct: 185 -----MGSSPFRIGTSAINDASKESFEILKMKL 212
|
| >d2a6za1 b.29.1.13 (A:7-227) Emp47p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 221 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Emp47p N-terminal domain species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 43.1 bits (101), Expect = 4e-05
Identities = 28/211 (13%), Positives = 63/211 (29%), Gaps = 49/211 (23%)
Query: 51 SNGLLQLTNTVSPQQEGHAFYRLPIKFNTSSSESLSFSSNFVFAI---------GMAFVI 101
G + LT+ + +G + + S F+ + F G++F
Sbjct: 34 EEGRIVLTS--NQNSKGSLWLKQGFDLKDS------FTMEWTFRSVGYSGQTDGGISFWF 85
Query: 102 SPSKDLGKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVG-IDVNS 160
++ + NG L + +D L + G V+
Sbjct: 86 VQDSNIPR-----------DKQLYNGPVNYDGLQLLVDNNGPLGPTLRGQLNDGQKPVDK 134
Query: 161 LISHESAPAAY-FSDREGMNKTLELIIGDPIQIWISYDGAEK-LLNVTLAPMSIPKPTKP 218
++ + A+ ++ P I ++YD + LL V + + K
Sbjct: 135 TKIYDQSFASCLMGYQD---------SSVPSTIRVTYDLEDDNLLKVQVDNKVCFQTRKV 185
Query: 219 LLSRAINLSHILLETMYVGFSASTGSLKSSH 249
+ +G +A G++ ++
Sbjct: 186 RFPS---------GSYRIGVTAQNGAVNNNA 207
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 614 | |||
| d1hqla_ | 236 | Legume lectin {Griffonia simplicifolia, lectin I-b | 100.0 | |
| d1leda_ | 243 | Legume lectin {West-central african legume (Griffo | 100.0 | |
| d1fx5a_ | 240 | Legume lectin {Furze (Ulex europaeus), UEA-I [TaxI | 100.0 | |
| d1gzca_ | 239 | Legume lectin {Cockspur coral tree (Erythrina cris | 100.0 | |
| d1qnwa_ | 237 | Legume lectin {Furze (Ulex europaeus), UEA-II [Tax | 100.0 | |
| d2d3sa1 | 237 | Legume lectin {Winged bean (Psophocarpus tetragono | 100.0 | |
| d1f9ka_ | 234 | Legume lectin {Winged bean (Psophocarpus tetragono | 100.0 | |
| d1g9fa_ | 251 | Legume lectin {Soybean (Glycine max) [TaxId: 3847] | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1g7ya_ | 253 | Legume lectin {Horse gram (Dolichos biflorus), dif | 100.0 | |
| d1g8wa_ | 233 | Phytohemagglutinin-L, PHA-L, also arcelin {Kidney | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1dbna_ | 239 | Legume lectin {Maackia amurensis, leukoagglutinin | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1v6ia_ | 232 | Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3 | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1n47a_ | 233 | Legume lectin {Hairy vetch (Vicia villosa), isolec | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fnya_ | 237 | Legume lectin {Black locust (Robinia pseudoacacia) | 100.0 | |
| g1qmo.1 | 230 | Legume lectin {Field bean (Dolichos lablab), Fril | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1ukga_ | 241 | Legume lectin {Bloodwood tree (Pterocarpus angolen | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| g2ltn.1 | 229 | Legume lectin {Garden pea (Pisum sativum) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1ioaa_ | 228 | Phytohemagglutinin-L, PHA-L, also arcelin {Kidney | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1avba_ | 226 | Phytohemagglutinin-L, PHA-L, also arcelin {Kidney | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1dhkb_ | 204 | Phytohemagglutinin-L, PHA-L, also arcelin {Kidney | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1nlsa_ | 237 | Concanavalin A {Jack bean (Canavalia ensiformis) [ | 99.97 | |
| d1gv9a_ | 228 | Carbohydrate-recognition domain of P58/ERGIC-53 {R | 99.92 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1nlsa_ | 237 | Concanavalin A {Jack bean (Canavalia ensiformis) [ | 99.86 | |
| d2a6za1 | 221 | Emp47p N-terminal domain {Baker's yeast (Saccharom | 99.76 | |
| d2a6va1 | 218 | Emp46p N-terminal domain {Baker's yeast (Saccharom | 99.75 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.39 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.83 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.84 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.15 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.65 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.33 |
| >d1hqla_ b.29.1.1 (A:) Legume lectin {Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]
Probab=100.00 E-value=9.4e-55 Score=424.29 Aligned_cols=216 Identities=31% Similarity=0.518 Sum_probs=191.5
Q ss_pred cceEEeCCCCC--CCCceEecceeEcCCCcEEecCCCC-----CCceeeEeeCCceeecCCC-CCceeeeeeeEEee---
Q 044561 27 VNQFIYHGFNE--DAQLQRDGLASVHSNGLLQLTNTVS-----PQQEGHAFYRLPIKFNTSS-SESLSFSSNFVFAI--- 95 (614)
Q Consensus 27 ~~~f~~~~f~~--~~~~~~~g~a~~~~~g~l~Lt~~~~-----~~~~G~~~y~~pv~l~~~~-~~~~sF~t~F~f~i--- 95 (614)
.++|+|++|.. ..+|.|+|+|.+. +|.|+||++.. ..++|||+|++||+||+.. +.++||+|+|+|.|
T Consensus 1 ~~sF~f~~F~~~~~~~l~l~G~A~~~-~~~l~LT~~~~~~~~~~~s~Gra~y~~Pv~l~~~~t~~~asFsT~F~F~i~~~ 79 (236)
T d1hqla_ 1 SVSFTFPNFWSDVEDSIIFQGDANTT-AGTLQLCKTNQYGTPLQWSAGRALYSDPVQLWDNKTESVASFYTEFTFFLKIT 79 (236)
T ss_dssp CCEEEESCSCSCGGGTEEEEETCEEE-TTEEECSCBCTTSCBCSSCEEEEEESSCEECCCSTTCCCCEEEEEEEEEEEEC
T ss_pred CEEEEeCCCCCCCcCCEEEeccEEec-CCEEEEecCCCCCcccccceEEEEECCCEEeecCCCCceeEEEEEEEEEEeCC
Confidence 36899999975 3679999999986 89999998642 3589999999999999988 88999999999999
Q ss_pred ------eeEEEEcCCCCCCCCCCCCCCcccccccCCCC-CCCCcEEEEEeeccCCCCCCCCCCCeeeEecCCCccccccc
Q 044561 96 ------GMAFVISPSKDLGKAEASPSEYLGLFNASNNG-QSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAP 168 (614)
Q Consensus 96 ------G~aF~l~p~~~~~~~~~~~g~~lGl~~~~~~~-~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~ 168 (614)
||||+|+|.... .+..|++||+++..+.+ .+.+++|||||||++|.+++||++||||||+||+.|.++.+
T Consensus 80 ~~~~gDGlAFvl~p~~~~---~~~~G~~lGl~~~~~~~~~~~~~~vAVEFDT~~n~~~~D~~~nHIgIdvns~~s~~~~~ 156 (236)
T d1hqla_ 80 GNGPADGLAFFLAPPDSD---VKDAGEYLGLFNKSTATQPSKNQVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVATKR 156 (236)
T ss_dssp SSCCCCEEEEEEECTTCC---CCCCGGGTTTSCTTTTTCGGGCCCEEEEEECSCCSSSCCCSSCEEEEEESSSSCSEEEE
T ss_pred CCCCCceEEEEEeCCCCC---CCCCccccccccccccCCcccCceEEEEeeCccCCCCCCCCCCEEEEEcCCcccccccc
Confidence 999999997643 46789999999987654 35789999999999999999999999999999999988876
Q ss_pred CccccCccCCCccccccCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcccccccccccccccCCCc-cc
Q 044561 169 AAYFSDREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSL-KS 247 (614)
Q Consensus 169 ~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastg~~-~~ 247 (614)
+. ..++.+|+.++|||+||+.+|+|+|+|++. ++..|+|++.|||+++|+++||||||||||.. .+
T Consensus 157 ~~----------~~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~---~~~~~~ls~~vdL~~~l~~~v~vGFSasTG~~~~~ 223 (236)
T d1hqla_ 157 WE----------DSDIFSGKIATARISYDGSAEILTVVLSYP---DGSDYILSHSVDMRQNLPESVRVGISASTGNNQFL 223 (236)
T ss_dssp CC----------HHHHTSCSCEEEEEEEETTTTEEEEEEEET---TTEEEEEEEECCGGGTSCSEEEEEEEEECCSCCCE
T ss_pred cc----------cccccCCCEEEEEEEEeCCCcEEEEEEecC---CCCCeeEEEEeCHHHhCCCcEEEEEEeECCCCCce
Confidence 53 357889999999999999999999999864 46678999999999999999999999999974 67
Q ss_pred eeeEeccccccC
Q 044561 248 SHYVLGWSFNRS 259 (614)
Q Consensus 248 ~h~i~sWsf~~~ 259 (614)
.|+|++|+|+++
T Consensus 224 ~h~I~sWsF~s~ 235 (236)
T d1hqla_ 224 TVYILSWRFSSN 235 (236)
T ss_dssp EEEEEEEEEEEE
T ss_pred EEEEEEeEeEec
Confidence 899999999864
|
| >d1leda_ b.29.1.1 (A:) Legume lectin {West-central african legume (Griffonia simplicifolia) [TaxId: 3850]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: West-central african legume (Griffonia simplicifolia) [TaxId: 3850]
Probab=100.00 E-value=3.1e-54 Score=422.01 Aligned_cols=217 Identities=30% Similarity=0.471 Sum_probs=192.8
Q ss_pred CcceEEeCCCCC-----CCCceEecceeEcCCCcEEecCCCC-----CCceeeEeeCCceeecCCCCCceeeeeeeEEee
Q 044561 26 DVNQFIYHGFNE-----DAQLQRDGLASVHSNGLLQLTNTVS-----PQQEGHAFYRLPIKFNTSSSESLSFSSNFVFAI 95 (614)
Q Consensus 26 ~~~~f~~~~f~~-----~~~~~~~g~a~~~~~g~l~Lt~~~~-----~~~~G~~~y~~pv~l~~~~~~~~sF~t~F~f~i 95 (614)
+.++|+|++|.. ..+|+|+|+|.+. +|.|+||+... ..++|||+|++||+||++++.++||+|+|+|.|
T Consensus 2 ~s~sF~f~~F~~~~~~~~~~l~l~G~A~~~-~g~l~LT~~~~~~~~~~~s~Gra~y~~Pv~l~~~t~~~asFsT~F~f~i 80 (243)
T d1leda_ 2 NTVNFTYPDFWSYSLKNGTEITFLGDATRI-PGALQLTKTDANGNPVRSSAGQASYSEPVFLWDSTGKAASFYTSFTFLL 80 (243)
T ss_dssp CCCEEEESCBCCTTSCTTTSEEEEETCEEE-TBEEECSCBCTTSCBCSSEEEEEEESSCEECBCTTSCBCEEEEEEEEEE
T ss_pred CceEEEcCCCCCCCCCCCCcEEEeeeeEEc-CCEEEeccCCCCCCccccceEEEEeCCCeEecCCCCcEeeEEEEEEEEc
Confidence 468999999974 3679999999997 89999997543 258999999999999998788999999999988
Q ss_pred ---------eeEEEEcCCCCCCCCCCCCCCcccccccCCCCC-CCCcEEEEEeeccCCCCCCCCCCCeeeEecCCCcccc
Q 044561 96 ---------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQ-STNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHE 165 (614)
Q Consensus 96 ---------G~aF~l~p~~~~~~~~~~~g~~lGl~~~~~~~~-~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~ 165 (614)
||||+|+|.+.. .+..||+||+++..+.++ +.+++|||||||++|.+++||++||||||+|++.|..
T Consensus 81 ~~~~~~~gdGlAF~l~p~~~~---~~~~g~~lGl~~~~~~~~~~~~~~vAVEFDT~~n~~~~d~~~nHVgIdvns~~s~~ 157 (243)
T d1leda_ 81 KNYGAPTADGLAFFLAPVDSS---VKDYGGFLGLFRHETAADPSKNQVVAVEFDTWINKDWNDPPYPHIGIDVNSIVSVA 157 (243)
T ss_dssp EESSSSCBCEEEEEEEETTCC---CCCCGGGTTTCCTTTTTCGGGCCCEEEEEECSCCGGGTCCSSCEEEEEESSSSCSE
T ss_pred CCCCCCCCCceEEEEcCCCCC---CCCCccccccccccccCCCccCcEEEEEEeCccccccCCCCCCceEEEecCccccc
Confidence 999999997643 467899999998887654 4789999999999999999999999999999999988
Q ss_pred cccCccccCccCCCccccccCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcccccccccccccccCCCc
Q 044561 166 SAPAAYFSDREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSL 245 (614)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastg~~ 245 (614)
+.++.. .++.+|+.++|||+||+.+++|+|++++. ++..|+|++.|||+++|+++||||||||||.
T Consensus 158 ~~~~~~----------~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~---~~~~p~ls~~idL~~~l~~~vyvGFSAsTG~- 223 (243)
T d1leda_ 158 TTRWEN----------DDAYGSSIATAHITYDARSKILTVLLSYE---HGRDYILSHVVDLAKVLPQKVRIGFSAGVGY- 223 (243)
T ss_dssp EEECCH----------HHHTSCCEEEEEEEEETTTTEEEEEEEET---TSCEEEEEEECCHHHHSCSEEEEEEEEEECB-
T ss_pred cccccc----------CCcccCceeEEEEEEECCCCEEEEEEeeC---CCCCceEEEecCHHHhcCCcEEEEEEcccCC-
Confidence 887642 46789999999999999999999999864 5678899999999999999999999999995
Q ss_pred cceeeEeccccccCC
Q 044561 246 KSSHYVLGWSFNRSG 260 (614)
Q Consensus 246 ~~~h~i~sWsf~~~~ 260 (614)
.|.|+|++|+|+++.
T Consensus 224 ~~~h~I~sWsF~s~l 238 (243)
T d1leda_ 224 DEVTYILSWHFFSTL 238 (243)
T ss_dssp SEEEEEEEEEEEEEC
T ss_pred cceeeEEEEEEEeeC
Confidence 699999999999764
|
| >d1fx5a_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-I [TaxId: 3902]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Furze (Ulex europaeus), UEA-I [TaxId: 3902]
Probab=100.00 E-value=6e-53 Score=414.03 Aligned_cols=217 Identities=30% Similarity=0.448 Sum_probs=191.7
Q ss_pred CcceEEeCCCCC-CCCceEecceeEcCCCcEEecCCCC---CCceeeEeeCCceeecCCC-CCceeeeeeeEEee-----
Q 044561 26 DVNQFIYHGFNE-DAQLQRDGLASVHSNGLLQLTNTVS---PQQEGHAFYRLPIKFNTSS-SESLSFSSNFVFAI----- 95 (614)
Q Consensus 26 ~~~~f~~~~f~~-~~~~~~~g~a~~~~~g~l~Lt~~~~---~~~~G~~~y~~pv~l~~~~-~~~~sF~t~F~f~i----- 95 (614)
..++|+|++|+. .++|+|+|+|.+.++|.||||+... ..++|||+|++||+||+.. +.++||+|+|+|.|
T Consensus 2 ~~~sF~f~~F~~~~~~l~l~G~A~~~~~g~l~LT~~~~~~~~~~~G~a~y~~Pv~l~~~~t~~~~sF~t~F~f~i~~~~~ 81 (240)
T d1fx5a_ 2 DDLSFKFKNFSQNGKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIWNCNTGELASFITSFSFFMETSAN 81 (240)
T ss_dssp CEEEEEESSCCTTCSSEEEEETCEECTTSCEESCCCSSSSCSEEEEEEEESSCEECEETTTTEECEEEEEEEEEEEESSC
T ss_pred CceEEECCCCCCCCCCEEEeeeeEecCCCEEEccCCCCCCccceeEEEecCCCceeecCCCCceeeeEEEEEEEEeCCCC
Confidence 467999999986 4789999999998899999998653 3588999999999999988 88999999999998
Q ss_pred ------eeEEEEcCCCCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeeccCCC-CCCCCCCCeeeEecCCCccccccc
Q 044561 96 ------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNL-DFDDIDDNHVGIDVNSLISHESAP 168 (614)
Q Consensus 96 ------G~aF~l~p~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~-~~~d~~~~Hvgid~ns~~s~~~~~ 168 (614)
||||+|+|.+. + .+..|++|||++.++ +++.+++|||||||++|. +++||++||||||+||+.|..+.+
T Consensus 82 ~~~ggdG~AFvl~p~~~-~--~~~~g~~lGl~~~~~-~~~~~~~vAVEFDT~~n~~~~~D~~~nHIgid~ns~~s~~~~~ 157 (240)
T d1fx5a_ 82 PKAATDGLTFFLAPPDS-P--LRRAGGYFGLFNDTK-CDSSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAER 157 (240)
T ss_dssp GGGCCCEEEEEEECTTC-C--CCBCGGGTTTBSSSC-CCGGGCCEEEEEECCCTTTSTTSCSSCEEEEEESSSSCSEEEE
T ss_pred CCCCCCcEEEEECCCCC-C--CCCCCccccccccCC-CCccCceEEEEeeccccccccCCCCCCceEEccCCcccccccc
Confidence 99999999753 3 678999999998754 456789999999999985 678999999999999999988776
Q ss_pred CccccCccCCCccccccCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcccccccccccccccCCC-ccc
Q 044561 169 AAYFSDREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGS-LKS 247 (614)
Q Consensus 169 ~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastg~-~~~ 247 (614)
+. ..+.+|+.++|||+||+.+|+|+|++.+.+ +|..|.++..|||+.+|+++||||||||||. ..|
T Consensus 158 ~~-----------~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~ls~~vdLs~~l~~~v~vGFSasTG~~~~~ 224 (240)
T d1fx5a_ 158 WN-----------KRYGLNNVANVEIIYEASSKTLTASLTYPS--DQTSISVTSIVDLKEILPEWVSVGFSGSTYIGRQA 224 (240)
T ss_dssp CC-----------CCCSGGGCEEEEEEEETTTTEEEEEEEETT--TTEEEEEEEECCGGGTSCSEEEEEEEEEEETTSCE
T ss_pred cc-----------cccCCCCeEEEEEEEcCCCCEEEEEEecCC--CceeeEEeEEEchHHhCCCcEEEEEEeECCCCCCc
Confidence 54 356789999999999999999999998754 6778899999999999999999999999995 668
Q ss_pred eeeEeccccccC
Q 044561 248 SHYVLGWSFNRS 259 (614)
Q Consensus 248 ~h~i~sWsf~~~ 259 (614)
.|+|++|+|+++
T Consensus 225 ~H~I~sWsFsst 236 (240)
T d1fx5a_ 225 THEVLNWYFTST 236 (240)
T ss_dssp EEEEEEEEEEEE
T ss_pred eEEEEEEEeEEe
Confidence 999999999875
|
| >d1gzca_ b.29.1.1 (A:) Legume lectin {Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]
Probab=100.00 E-value=1.5e-52 Score=411.00 Aligned_cols=215 Identities=32% Similarity=0.524 Sum_probs=190.2
Q ss_pred CcceEEeCCCCC-CCCceEecceeEcCCCcEEecCCCC-----CCceeeEeeCCceeecCCC-CCceeeeeeeEEee---
Q 044561 26 DVNQFIYHGFNE-DAQLQRDGLASVHSNGLLQLTNTVS-----PQQEGHAFYRLPIKFNTSS-SESLSFSSNFVFAI--- 95 (614)
Q Consensus 26 ~~~~f~~~~f~~-~~~~~~~g~a~~~~~g~l~Lt~~~~-----~~~~G~~~y~~pv~l~~~~-~~~~sF~t~F~f~i--- 95 (614)
++++|+|++|+. .++|+|+|+|.+.++|.||||+... ..++|||+|++||+||++. ++++||+|+|+|.|
T Consensus 2 ~~~sF~f~~F~~~~~nl~l~G~A~i~~~g~l~LT~~~~~~~~~~~~~Gr~~y~~Pv~l~~~~~~~~~sFst~F~f~i~~~ 81 (239)
T d1gzca_ 2 ETISFSFSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMWDSTTGTVASFETRFSFSIEQP 81 (239)
T ss_dssp EEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCBCTTSCBCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCC
T ss_pred eeEEEEeCCCCCCCCCeEEeeeeEECCCCeEEccCCCCCCcccccceEEEEeCCCeEecCCCCCceeeEEEEEEEEEecC
Confidence 357999999986 5789999999998899999998653 2588999999999999988 88999999999998
Q ss_pred --------eeEEEEcCCCCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeeEecCCCcccccc
Q 044561 96 --------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESA 167 (614)
Q Consensus 96 --------G~aF~l~p~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~ 167 (614)
||||+|+|.+.. .+..+|+||+++..+. .+.++.|||||||++| +++||+++|||||+|++.|.++.
T Consensus 82 ~~~~~g~dG~aF~l~p~~~~---~~~~~g~lg~~~~~~~-~~~~~~vaVEFDT~~n-~~~d~~~~HvgI~vn~~~s~~t~ 156 (239)
T d1gzca_ 82 YTRPLPADGLVFFMGPTKSK---PAQGYGYLGVFNNSKQ-DNSYQTLAVEFDTFSN-PWDPPQVPHIGIDVNSIRSIKTQ 156 (239)
T ss_dssp CSSSCCCEEEEEEEECSSCC---CCCCGGGTTTCSSSSC-CGGGCCEEEEEECSCC-TTSCSSSSEEEEEESSSSCSEEE
T ss_pred CCCCCCCCeEEEEECCCCCC---CCCCcccccccccCCC-CCccceEEEEEEcccc-CCCCCCCCEEEEEECCccccccC
Confidence 999999998754 4568899999877654 3467889999999999 47899999999999999998877
Q ss_pred cCccccCccCCCccccccCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcccccccccccccccCCC---
Q 044561 168 PAAYFSDREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGS--- 244 (614)
Q Consensus 168 ~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastg~--- 244 (614)
++ ++.+|+.++|||+||+.+++|+|++++.. +|..|.|++.|||+++|+++|||||||+||.
T Consensus 157 ~~-------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~ 221 (239)
T d1gzca_ 157 PF-------------QLDNGQVANVVIKYDAPSKILHVVLVYPS--SGAIYTIAEIVDVKQVLPDWVDVGLSGATGAQRD 221 (239)
T ss_dssp EC-------------CCCTTCEEEEEEEEETTTTEEEEEEECTT--TCCEEEEEEECCHHHHSCSEEEEEEEEEECSSTT
T ss_pred Cc-------------cccCCCEEEEEEEEeCCCcEEEEEEecCC--CCcceeeeeEechHHhcCCcEEEEEEEEcCCCCC
Confidence 63 57899999999999999999999998643 6888999999999999999999999999994
Q ss_pred ccceeeEeccccccCC
Q 044561 245 LKSSHYVLGWSFNRSG 260 (614)
Q Consensus 245 ~~~~h~i~sWsf~~~~ 260 (614)
..|.|+|++|+|+++.
T Consensus 222 ~~~~H~V~sWsF~s~l 237 (239)
T d1gzca_ 222 AAETHDVYSWSFQASL 237 (239)
T ss_dssp CCCCCEEEEEEEEEEE
T ss_pred CceeeEEEEEEeEeeC
Confidence 5689999999999764
|
| >d1qnwa_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-II [TaxId: 3902]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Furze (Ulex europaeus), UEA-II [TaxId: 3902]
Probab=100.00 E-value=1.3e-51 Score=403.96 Aligned_cols=217 Identities=32% Similarity=0.520 Sum_probs=190.2
Q ss_pred CcceEEeCCCCC-CCCceEecceeEcCCCcEEecCCCC--CCceeeEeeCCceeecCCC-CCceeeeeeeEEee------
Q 044561 26 DVNQFIYHGFNE-DAQLQRDGLASVHSNGLLQLTNTVS--PQQEGHAFYRLPIKFNTSS-SESLSFSSNFVFAI------ 95 (614)
Q Consensus 26 ~~~~f~~~~f~~-~~~~~~~g~a~~~~~g~l~Lt~~~~--~~~~G~~~y~~pv~l~~~~-~~~~sF~t~F~f~i------ 95 (614)
+.++|+|++|.+ ..+|.|+|+|.+.++|.|+||+... ..++|||||++||+||++. +.++||+|+|+|.|
T Consensus 2 ~~lsF~f~~F~~~~~~l~l~GdA~i~~~g~l~LT~~~~~~~~~~G~a~y~~Pi~l~~~~~~~~~sF~t~F~f~i~~~~~~ 81 (237)
T d1qnwa_ 2 DDLSFNFDKFVPNQKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIWDSITGKVASFATSFSFVVKADKSD 81 (237)
T ss_dssp CSEEEEESSCCTTCTTEEEEETCEECTTSCEESSCCC--CCCEEEEEEESSCEECBCTTTCCBCEEEEEEEEECCBSSSC
T ss_pred CcEEEEcCCCCCCCCCEEEeeceEEcCCCeEEeccCCCCccccEEEEEECCCEEecCCCCcceeeEEEEEEEEEecCCCC
Confidence 468999999976 5789999999998899999998653 3689999999999999988 88999999999999
Q ss_pred ---eeEEEEcCCCCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeeccCCCCCC--CCCCCeeeEecCCCcccccccCc
Q 044561 96 ---GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFD--DIDDNHVGIDVNSLISHESAPAA 170 (614)
Q Consensus 96 ---G~aF~l~p~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~--d~~~~Hvgid~ns~~s~~~~~~~ 170 (614)
||||+|+|..... +.++.|+++|+++.. ++.+.+++|||||||++|.+++ ||+++|||||+|++.|.+++++
T Consensus 82 ggdG~aF~l~p~~~~~-~~~~~~~~~g~~~~~-~~~~~~~~vAVEFDT~~n~~~~~~d~~~nHvgid~ns~~s~~~~~~- 158 (237)
T d1qnwa_ 82 GVDGLAFFLAPANSQI-PSGSSAGMFGLFSSS-DSKSSNQIIAVEFDTYFGKAYNPWDPDFKHIGIDVNSIKSIKTVKW- 158 (237)
T ss_dssp CCCEEEEEEEETTCCC-CTTCCGGGTTTCSSS-SCCTTSCCEEEEEECCCCTTTCTTSCSSCEEEEEESSSSCSEEEEC-
T ss_pred CcceeEEEEeCCCCCC-CCCCccccccccCCC-CCCCcccEEEEEeeceecCCcCCCCCCCCeEEEECCCCCccccccc-
Confidence 9999999987542 267788888888754 3467899999999999998765 5899999999999998877654
Q ss_pred cccCccCCCccccccCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcccccccccccccccCCCcc--ce
Q 044561 171 YFSDREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLK--SS 248 (614)
Q Consensus 171 ~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastg~~~--~~ 248 (614)
++.+|+.++|||+||+.+|+|+|++++.+ +|..|+|++.|||+++|+++||||||||||... |.
T Consensus 159 ------------~~~~G~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~p~ls~~vDLs~~l~~~vyvGFSasTG~~~~~q~ 224 (237)
T d1qnwa_ 159 ------------DWRNGEVADVVITYRAPTKSLTVCLSYPS--DGTSNIITASVDLKAILPEWVSVGFSGGVGNAAEFET 224 (237)
T ss_dssp ------------CCCTTCCEEEEEEEEGGGTEEEEEEECTT--TCCEEEEEEECCHHHHSCSEEEEEEEEEESCGGGCBC
T ss_pred ------------ccCCCcEEEEEEEEcCCCcEEEEEEecCC--CCccceEEEEEChHHhCCCcEEEEEEeECCCCCCccE
Confidence 45789999999999999999999998643 788899999999999999999999999999754 89
Q ss_pred eeEeccccccC
Q 044561 249 HYVLGWSFNRS 259 (614)
Q Consensus 249 h~i~sWsf~~~ 259 (614)
|+|++|+|+++
T Consensus 225 h~I~sWsF~s~ 235 (237)
T d1qnwa_ 225 HDVLSWYFTSN 235 (237)
T ss_dssp CEEEEEEEEEE
T ss_pred eEEEEeEeEEe
Confidence 99999999865
|
| >d2d3sa1 b.29.1.1 (A:1-237) Legume lectin {Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]
Probab=100.00 E-value=1.1e-51 Score=403.95 Aligned_cols=210 Identities=34% Similarity=0.544 Sum_probs=186.0
Q ss_pred cceEEeCCCCC-CCCceEecceeEcCCCcEEecCCCC----CCceeeEeeCCceeecCCC-CCceeeeeeeEEee-----
Q 044561 27 VNQFIYHGFNE-DAQLQRDGLASVHSNGLLQLTNTVS----PQQEGHAFYRLPIKFNTSS-SESLSFSSNFVFAI----- 95 (614)
Q Consensus 27 ~~~f~~~~f~~-~~~~~~~g~a~~~~~g~l~Lt~~~~----~~~~G~~~y~~pv~l~~~~-~~~~sF~t~F~f~i----- 95 (614)
+++|+|++|++ +++|.|+|+|.+.++|.|+||++.. .+++|||||++||+||+++ ++++||+|+|+|.|
T Consensus 2 t~sF~f~~F~~~~~~l~l~G~A~i~~~g~l~LT~~~~~~~~~~~~G~a~y~~pi~l~~~~~~~~~sF~t~F~f~i~~~~~ 81 (237)
T d2d3sa1 2 TISFNFNQFHQNEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDSTTGNVASFETRFSFSIRQPFP 81 (237)
T ss_dssp EEEEEESSCCSSCTTEEEEETCEECTTSCEECSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSCC
T ss_pred eEEEEeCCCCCCCCCEEEeeeeEeCCCCeEEcCCCCCCCcccccEEEEEeCCCEEeecCCCCceeeEEEEEEEEeecCCC
Confidence 57899999975 5789999999998789999998532 3689999999999999988 88999999999999
Q ss_pred ------eeEEEEcCCCCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeeEecCCCcccccccC
Q 044561 96 ------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPA 169 (614)
Q Consensus 96 ------G~aF~l~p~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~ 169 (614)
||||+|+|.... .+..||+||+++.. ..+++|||||||++|. +||++||||||+|++.|.++.++
T Consensus 82 ~~~g~dGlaFvl~p~~~~---~~~~gg~lG~~~~~----~~~~~vaVEFDT~~n~--~d~~~nHvgI~vns~~s~~~~~~ 152 (237)
T d2d3sa1 82 RPHPADGLVFFIAPPNTQ---TGEGGGYFGIYNPL----SPYPFVAVEFDTFRNT--WDPQIPHIGIDVNSVISTKTVPF 152 (237)
T ss_dssp SSCCCEEEEEEEECSSCC---CCBCGGGTTTBCTT----SCCCCEEEEEECSCCT--TCCSSSEEEEEESSSSCSEEEEC
T ss_pred CCCCCCeEEEEeCCCCcc---CCccccccccccCC----CcCceEEEEEEeecCC--CCCCCCcEEEEcCCCccccccce
Confidence 999999997643 56789999998764 3578999999999997 59999999999999998776553
Q ss_pred ccccCccCCCccccccCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcccccccccccccccCCC-----
Q 044561 170 AYFSDREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGS----- 244 (614)
Q Consensus 170 ~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastg~----- 244 (614)
++.+|+.++|||+||+.+|+|+|++.+.+ +|..|+++..|||+.+|+++||||||||||.
T Consensus 153 -------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~ls~~vdL~~~l~~~vyvGFSasTG~~~~~~ 217 (237)
T d2d3sa1 153 -------------TLDNGGIANVVIKYDASTKILHVVLVFPS--LGTIYTIADIVDLKQVLPESVNVGFSAATGDPSGKQ 217 (237)
T ss_dssp -------------CCCTTCEEEEEEEEETTTTEEEEEEEETT--TTEEEEEEEECCHHHHSCSEEEEEEEEEECCGGGCC
T ss_pred -------------eecCCCEEEEEEEEECCCCEEEEEEEcCC--CCcccceeeEechHHhCCCcEEEEEEeECCCCccCc
Confidence 57899999999999999999999998755 5677899999999999999999999999995
Q ss_pred --ccceeeEeccccccCC
Q 044561 245 --LKSSHYVLGWSFNRSG 260 (614)
Q Consensus 245 --~~~~h~i~sWsf~~~~ 260 (614)
..|.|+|++|+|+++.
T Consensus 218 ~~~~e~h~I~sWsFss~l 235 (237)
T d2d3sa1 218 RNATETHDILSWSFSASL 235 (237)
T ss_dssp TTCCCCCEEEEEEEEEEC
T ss_pred cccceeeEEEEeEeEeeC
Confidence 4689999999999764
|
| >d1f9ka_ b.29.1.1 (A:) Legume lectin {Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]
Probab=100.00 E-value=1e-50 Score=396.60 Aligned_cols=209 Identities=35% Similarity=0.528 Sum_probs=183.9
Q ss_pred cceEEeCCCCC-CCCceEecceeEcCCCcEEecCCCC-----CCceeeEeeCCceeecCCC-CCceeeeeeeEEee----
Q 044561 27 VNQFIYHGFNE-DAQLQRDGLASVHSNGLLQLTNTVS-----PQQEGHAFYRLPIKFNTSS-SESLSFSSNFVFAI---- 95 (614)
Q Consensus 27 ~~~f~~~~f~~-~~~~~~~g~a~~~~~g~l~Lt~~~~-----~~~~G~~~y~~pv~l~~~~-~~~~sF~t~F~f~i---- 95 (614)
+.||+|++|.. .++|+|+|+|.+.++|.|+||+... ..++|||+|++||+||++. +..+||+|+|+|.|
T Consensus 2 ~~SF~f~~F~~~~~~l~l~G~A~~~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~~~~~~~~~sFsT~F~f~i~~~~ 81 (234)
T d1f9ka_ 2 TQSFNFDHFEENSKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWDSTTGNVASFETRFSFNITQPY 81 (234)
T ss_dssp EEEEEESSCCSSCTTEEEEETCEECTTSCEECSCSEETTEECCSCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECCC
T ss_pred ceEEEeCCCCCCCCCEEEeeeEEEcCCCEEEeecCCCCCCcccceeEEEEeCCCEEeeCCCCCcCcceEEEEEEEEECCC
Confidence 57999999975 5789999999998899999998742 2589999999999999987 88999999999999
Q ss_pred -------eeEEEEcCCCCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeeEecCCCccccccc
Q 044561 96 -------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAP 168 (614)
Q Consensus 96 -------G~aF~l~p~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~ 168 (614)
||||+|+|.... .+..|+++|+++.. ..++.|||||||++|. +||++||||||+|++.|.++.+
T Consensus 82 ~~~~g~dG~aF~i~p~~~~---~~~~g~~~g~~~~~----~~~~~vaVEFDT~~n~--~Dp~~nHvgi~~ns~~s~~~~~ 152 (234)
T d1f9ka_ 82 AYPEPADGLTFFMVPPNSP---QGEDGGNLGVFKPP----EGDNAFAVEFDTFQNT--WDPQVPHIGIDVNSIVSSKTLH 152 (234)
T ss_dssp SSSCCCEEEEEEEECTTCC---CCCSGGGTTTCCSS----CCSCCEEEEEECSCCT--TCCSSSEEEEEESSSSCSEEEE
T ss_pred CCCCccceEEEEECCCCCC---cccccccccccCCC----CccceEEEEEeccccC--CCCCCCcEeEecCCcccccccc
Confidence 999999997643 56788999987764 3567899999999997 6999999999999999877655
Q ss_pred CccccCccCCCccccccCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCccccc--ccccccccccCCC--
Q 044561 169 AAYFSDREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILL--ETMYVGFSASTGS-- 244 (614)
Q Consensus 169 ~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~--~~~~vGFsastg~-- 244 (614)
+ ++.+|+.++|||+||+.+++|+|++++.. ++..|.|++.|||+.+|+ ++||||||||||.
T Consensus 153 ~-------------~l~~G~~~~v~I~Yd~~~~~l~V~l~~~~--~~~~~~ls~~idL~~~l~~~~~v~vGFSasTG~~~ 217 (234)
T d1f9ka_ 153 F-------------QLENGGVANVVIKYDSPTKILNVVLAFHS--VGTVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQK 217 (234)
T ss_dssp C-------------CCCTTCCEEEEEEEETTTTEEEEEEEETT--TTEEEEEEEECCHHHHSTTCSEEEEEEEEEECSST
T ss_pred c-------------cccCCCEEEEEEEEcCCCcEEEEEEEeCC--CCccceEEEEEcHHHhcCCCCEEEEEEEeecCCCC
Confidence 3 67899999999999999999999998754 566789999999999997 5799999999994
Q ss_pred -ccceeeEeccccccC
Q 044561 245 -LKSSHYVLGWSFNRS 259 (614)
Q Consensus 245 -~~~~h~i~sWsf~~~ 259 (614)
..|.|+|++|+|+++
T Consensus 218 ~~~~~h~I~sWsF~s~ 233 (234)
T d1f9ka_ 218 NAVETHEIISWSFTSS 233 (234)
T ss_dssp TCCCEEEEEEEEEEEE
T ss_pred CceeeeEEEEEEeEEe
Confidence 568999999999864
|
| >d1g9fa_ b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Soybean (Glycine max) [TaxId: 3847]
Probab=100.00 E-value=2e-50 Score=398.64 Aligned_cols=215 Identities=33% Similarity=0.519 Sum_probs=184.2
Q ss_pred CcceEEeCCCCC-CCCceEecceeEcCCCcEEecCCCC-----CCceeeEeeCCceeecCCC-CCceeeeeeeEEee---
Q 044561 26 DVNQFIYHGFNE-DAQLQRDGLASVHSNGLLQLTNTVS-----PQQEGHAFYRLPIKFNTSS-SESLSFSSNFVFAI--- 95 (614)
Q Consensus 26 ~~~~f~~~~f~~-~~~~~~~g~a~~~~~g~l~Lt~~~~-----~~~~G~~~y~~pv~l~~~~-~~~~sF~t~F~f~i--- 95 (614)
..++|+|++|.+ ..+++|+|+|.+.++|.|+||++.. ..++|||+|++||+||++. +..+||+|+|+|.|
T Consensus 2 ~~~sF~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~~~~~~~~~sf~t~f~F~i~~~ 81 (251)
T d1g9fa_ 2 ETVSFSWNKFVPKQPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIWDKETGSVASFAASFNFTFYAP 81 (251)
T ss_dssp EEEEEEESSCCC-CTTEEEEETCBCCTTC-CBCSCBC---CBCTTCEEEEEESSCEECBCC-CCCBCEEEEEEEEEEECS
T ss_pred ceEEEEeCCCCCCCCCEEEeeeEEECCCCEEEecCCcCCCcccCceEEEEEeCCCEEccCCCCccceeeEEEEEEEEecC
Confidence 468999999986 4689999999998899999998642 3689999999999999988 88899999999999
Q ss_pred -------eeEEEEcCCCCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeeEecCCCccccccc
Q 044561 96 -------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAP 168 (614)
Q Consensus 96 -------G~aF~l~p~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~ 168 (614)
||||+|+|.+.. .+..||+||+++.. ...++.|||||||++|. +||+++|||||+|++.|..+..
T Consensus 82 ~~~~~gDGlAFvl~p~~~~---~~~~~g~lG~~~~~---~~~~~~vaVEFDT~~n~--~D~~~~Hvgi~~n~~~s~~~~~ 153 (251)
T d1g9fa_ 82 DTKRLADGLAFFLAPIDTK---PQTHAGYLGLFNEN---ESGDQVVAVEFDTFRNS--WDPPNPHIGINVNSIRSIKTTS 153 (251)
T ss_dssp CC--CCEEEEEEEEETTCC---CCCCGGGTTTCCTT---SCCCSCEEEEEECC-CT--TSCSSSEEEEEESSSSCSEEEE
T ss_pred CCCCCCCceEEEEecCCCC---CCCccCccCccccc---CCCcceEEEEEecccCC--CCCCCCcEeEEecCcccccccc
Confidence 999999997654 46788999998764 34578999999999997 5999999999999999877765
Q ss_pred CccccCccCCCccccccCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcccccccccccccccCCCcc--
Q 044561 169 AAYFSDREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLK-- 246 (614)
Q Consensus 169 ~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastg~~~-- 246 (614)
+ ++.+|+.++|||+||+.+++|+|++.... +|..|+++..|||+.+|+++||||||||||...
T Consensus 154 ~-------------~l~~g~~~~v~I~Yd~~~~~L~v~l~~~~--~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~~~~ 218 (251)
T d1g9fa_ 154 W-------------DLANNKVAKVLITYDASTSLLVASLVYPS--QRTSNILSDVVDLKTSLPEWVRIGFSAATGLDIPG 218 (251)
T ss_dssp C-------------CCCTTCCEEEEEEEETTTTEEEEEEEEGG--GTEEEEEEEECCC-CCSCSEEEEEEEEEECSSSCC
T ss_pred e-------------EecCCCEEEEEEEEECCccEEEEEEecCC--CCcceeEEEEecchhhCCCcEEEEEEeecCCCCCC
Confidence 3 57799999999999999999999998643 677889999999999999999999999999754
Q ss_pred ceeeEeccccccCCCCc
Q 044561 247 SSHYVLGWSFNRSGPAL 263 (614)
Q Consensus 247 ~~h~i~sWsf~~~~~~~ 263 (614)
|.|+|++|+|+++.+++
T Consensus 219 ~~h~I~sWsF~s~~~~~ 235 (251)
T d1g9fa_ 219 ESHDVLSWSFASNLPHA 235 (251)
T ss_dssp CEEEEEEEEEEEEECC-
T ss_pred ceeEEEEeEeECCCCCC
Confidence 88999999999875443
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.1e-51 Score=414.97 Aligned_cols=260 Identities=28% Similarity=0.496 Sum_probs=198.5
Q ss_pred cCHHHHHHHhcC---------CCCcceeeeeCcEEEEEEEEec-C---cEEEEEEeecC-ChhhHHHHHHHHHHhcccCC
Q 044561 335 FTYKDLYKATKG---------FKDKDVIGRGGFGKVYRGVLAS-N---VQIAVKKVSHD-SKQGIKEFVAELVSMGRLRH 400 (614)
Q Consensus 335 ~~~~el~~~~~~---------f~~~~~lG~G~fg~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H 400 (614)
++++++..++++ |+..+.||+|+||+||+|+++. + ..||||++... .....++|.+|+.++++++|
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence 455555555544 4456799999999999999853 2 35889988654 45566789999999999999
Q ss_pred CceeEEeeEEeecCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEc
Q 044561 401 RNLVKLRGYCRRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD 480 (614)
Q Consensus 401 ~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~ 480 (614)
||||+++|+|.+.+.+++|||||++|+|.+++... ...++|.+++.++.|||+||.|||+ ++|+||||||+|||++
T Consensus 87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~ 162 (299)
T d1jpaa_ 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVN 162 (299)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEC
T ss_pred CCCccEEEEEeeCCEEEEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEEC
Confidence 99999999999999999999999999999988764 3459999999999999999999995 8999999999999999
Q ss_pred CCCCEEEeeeccccccCCCCCCc----ccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcccc
Q 044561 481 ADLNGKLGDFGLARLYDHDTIPQ----TTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMET 555 (614)
Q Consensus 481 ~~~~~kl~DfGla~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~ 555 (614)
.++++||+|||+++......... .....||+.|+|||.+.++.++.++|||||||++|||+| |+.||......+.
T Consensus 163 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~ 242 (299)
T d1jpaa_ 163 SNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV 242 (299)
T ss_dssp TTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred CCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999998765433211 122467899999999999999999999999999999998 8999976554332
Q ss_pred ccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 556 VNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 556 ~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
. ..+ .++.... .+.+..+.+.+|+.+||+.||++||||.||++
T Consensus 243 ~---~~i----~~~~~~~---------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~ 285 (299)
T d1jpaa_ 243 I---NAI----EQDYRLP---------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285 (299)
T ss_dssp H---HHH----HTTCCCC---------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred H---HHH----HcCCCCC---------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 2 222 1211111 11223345778889999999999999999874
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-51 Score=409.39 Aligned_cols=249 Identities=27% Similarity=0.448 Sum_probs=194.2
Q ss_pred cCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecC
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMP 424 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 424 (614)
++|+..+.||+|+||+||+|.+.++..||||++..... ..++|.+|++++++++||||++++|+|...+..++|||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC-cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 46778899999999999999998888999999976443 34789999999999999999999999999999999999999
Q ss_pred CCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcc
Q 044561 425 NGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT 504 (614)
Q Consensus 425 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 504 (614)
+|+|.+++... ...+++.+++.++.|||+||.|||+ ++|+||||||+|||+++++++||+|||+++..........
T Consensus 84 ~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 159 (263)
T d1sm2a_ 84 HGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 159 (263)
T ss_dssp TCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence 99999998764 3458999999999999999999995 8999999999999999999999999999987765543344
Q ss_pred cccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcC-CCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcC
Q 044561 505 TKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASG-RRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGIC 583 (614)
Q Consensus 505 ~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg-~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 583 (614)
....||+.|+|||++.++.++.++|||||||++|||+|+ ++|+......+. ...+. .+.. ......+
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~---~~~i~----~~~~-----~~~p~~~ 227 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV---VEDIS----TGFR-----LYKPRLA 227 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHH---HHHHH----HTCC-----CCCCTTS
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHH---HHHHH----hcCC-----CCCcccc
Confidence 456799999999999999999999999999999999995 555544332221 22221 1111 1111122
Q ss_pred cHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 584 EEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 584 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+.+.+++.+||+.||++||||+||++
T Consensus 228 ----~~~l~~li~~cl~~~p~~Rps~~~il~ 254 (263)
T d1sm2a_ 228 ----STHVYQIMNHCWKERPEDRPAFSRLLR 254 (263)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----CHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 245778889999999999999999974
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-50 Score=404.84 Aligned_cols=251 Identities=25% Similarity=0.345 Sum_probs=201.9
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
++|+..+.||+|+||+||+|+.+. ++.||+|++.... .+..+++.+|+.++++++||||+++++++.+++.+|+||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 468888999999999999999864 8899999997653 33456789999999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC-C
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT-I 501 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~-~ 501 (614)
|++|+|.+++..+ ..+++.++..++.||++||.|||+ ++|+||||||+|||+++++++||+|||+|+...... .
T Consensus 85 ~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 85 CSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp CTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 9999999999764 459999999999999999999995 899999999999999999999999999998765432 2
Q ss_pred CcccccccCCCccchhhhcCCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 502 PQTTKLVGTFGYMDPELMRTGKA-STSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 502 ~~~~~~~gt~~y~aPE~~~~~~~-t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
...+..+||+.|+|||++.+..+ +.++||||+||++|||++|+.||.......... . .. ....... ...
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~-~----~~-~~~~~~~----~~~ 229 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-S----DW-KEKKTYL----NPW 229 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH-H----HH-HTTCTTS----TTG
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH-H----HH-hcCCCCC----Ccc
Confidence 23445689999999999988775 678999999999999999999997654322111 1 11 1111100 001
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..++ ..+.+|+.+||+.||++|||+.|+++
T Consensus 230 ~~~s----~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 230 KKID----SAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp GGSC----HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCC----HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1122 34667788899999999999999985
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-51 Score=410.40 Aligned_cols=250 Identities=26% Similarity=0.448 Sum_probs=203.9
Q ss_pred cCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecC
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMP 424 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 424 (614)
++|+..+.||+|+||.||+|.++++..||||++..... ..++|.+|+.++++++|||||+++|+|.+ +.+++|||||+
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~ 90 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence 46778899999999999999998888999999976543 35689999999999999999999998865 56799999999
Q ss_pred CCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcc
Q 044561 425 NGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT 504 (614)
Q Consensus 425 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 504 (614)
+|+|.+++.......++|.++++|+.||++||.|||+ ++|+||||||+|||+++++.+||+|||+|+..........
T Consensus 91 ~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~ 167 (272)
T d1qpca_ 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167 (272)
T ss_dssp TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCccccc
Confidence 9999998876555569999999999999999999995 8999999999999999999999999999998765554444
Q ss_pred cccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCc
Q 044561 505 TKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICE 584 (614)
Q Consensus 505 ~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 584 (614)
....||+.|+|||++.++.++.++|||||||++|||+||..|+....... .... ....+.. ......++
T Consensus 168 ~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~--~~~~----~i~~~~~-----~~~p~~~~ 236 (272)
T d1qpca_ 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQ----NLERGYR-----MVRPDNCP 236 (272)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHH----HHHTTCC-----CCCCTTCC
T ss_pred cccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH--HHHH----HHHhcCC-----CCCcccCh
Confidence 55679999999999999999999999999999999999665544322211 1111 1122211 11112233
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 585 EKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 585 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+.+.+|+.+||+.||++||||.||++
T Consensus 237 ----~~l~~li~~cl~~~P~~Rpt~~ei~~ 262 (272)
T d1qpca_ 237 ----EELYQLMRLCWKERPEDRPTFDYLRS 262 (272)
T ss_dssp ----HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----HHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 35778888999999999999999863
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-50 Score=407.70 Aligned_cols=249 Identities=22% Similarity=0.387 Sum_probs=208.0
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
++|+..+.||+|+||+||+|+... ++.||+|++........+.+.+|+.++++++||||+++++++.+.+.+|+|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 468999999999999999999754 8899999998665555678999999999999999999999999999999999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCc
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 503 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 503 (614)
++|+|.+++..+ .+++.++..++.||+.||.|||+ ++|+||||||+|||++.++++||+|||+++....... .
T Consensus 100 ~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~ 172 (293)
T d1yhwa1 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (293)
T ss_dssp TTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred CCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeeccccc-c
Confidence 999999988653 49999999999999999999995 8999999999999999999999999999987654432 3
Q ss_pred ccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcC
Q 044561 504 TTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGIC 583 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 583 (614)
....+||+.|+|||++.++.++.++|||||||++|||++|+.||......+... .....+. ... .....+
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~------~~~~~~~-~~~---~~~~~~ 242 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------LIATNGT-PEL---QNPEKL 242 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHHCS-CCC---SSGGGS
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHH------HHHhCCC-CCC---CCcccC
Confidence 345689999999999999999999999999999999999999997654332211 1111111 111 111122
Q ss_pred cHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 584 EEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 584 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
...+.+|+.+||++||++|||+.|+++
T Consensus 243 ----s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 243 ----SAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp ----CHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 345677888899999999999999985
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=403.89 Aligned_cols=245 Identities=26% Similarity=0.412 Sum_probs=205.7
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
++|+..+.||+|+||+||+|+.+. ++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++.+++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 358888999999999999999875 8899999986532 234567899999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
|||++|+|.+++... ..+++.++..++.||++||.|||+ ++|+||||||+|||++.++++||+|||+++......
T Consensus 86 Ey~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 86 EYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp ECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred eecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence 999999999999764 359999999999999999999995 899999999999999999999999999998665432
Q ss_pred CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+... ...++.. .+.
T Consensus 161 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~-------~i~~~~~------~~p 224 (263)
T d2j4za1 161 ---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK-------RISRVEF------TFP 224 (263)
T ss_dssp ---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-------HHHTTCC------CCC
T ss_pred ---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHH-------HHHcCCC------CCC
Confidence 345689999999999999999999999999999999999999997654332221 1112111 112
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..++ +.+.+|+.+||++||++|||+.|+++
T Consensus 225 ~~~s----~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 225 DFVT----EGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp TTSC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ccCC----HHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 2223 35667888899999999999999985
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=406.21 Aligned_cols=252 Identities=29% Similarity=0.481 Sum_probs=197.8
Q ss_pred cCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
++|+..+.||+|+||+||+|++++ .||||++... ..+..+.|.+|+.++++++||||+++++++.+ +.+++||||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey 84 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW 84 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred ccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence 568889999999999999998753 5999998643 45567889999999999999999999998854 568999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC-C
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT-I 501 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~-~ 501 (614)
|++|+|.+++.... ..+++.++..++.|||+||+|||+ ++||||||||+|||++.++++||+|||+++...... .
T Consensus 85 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 85 CEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp CCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred CCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 99999999997643 459999999999999999999995 899999999999999999999999999998765432 2
Q ss_pred CcccccccCCCccchhhhcC---CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccc
Q 044561 502 PQTTKLVGTFGYMDPELMRT---GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSR 578 (614)
Q Consensus 502 ~~~~~~~gt~~y~aPE~~~~---~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~ 578 (614)
.......||+.|||||++.. +.++.++|||||||++|||+||+.||......+.. .....++...... ..
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~------~~~~~~~~~~p~~-~~ 233 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI------IFMVGRGYLSPDL-SK 233 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH------HHHHHHTSCCCCG-GG
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH------HHHHhcCCCCCcc-hh
Confidence 23445689999999999864 35899999999999999999999999865443221 1111222111100 11
Q ss_pred ccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 579 LEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 579 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
....+ .+.+.+|+.+||+.||++||||.||++
T Consensus 234 ~~~~~----~~~l~~li~~cl~~dp~~RPt~~~il~ 265 (276)
T d1uwha_ 234 VRSNC----PKAMKRLMAECLKKKRDERPLFPQILA 265 (276)
T ss_dssp SCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccccc----hHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 12223 346778888999999999999999873
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.1e-51 Score=414.66 Aligned_cols=251 Identities=27% Similarity=0.434 Sum_probs=208.7
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
++|+..+.||+|+||+||+|++++ ++.||||++..+.. ..++|.+|+.++++++|||||+++++|.+.+.+++|||||
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 95 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 95 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence 567888999999999999999875 88899999876543 4578999999999999999999999999999999999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCc
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 503 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 503 (614)
++|+|.+++.......+++..+..++.||++||.|||+ ++|+||||||+|||+++++++||+|||+++.........
T Consensus 96 ~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~ 172 (287)
T d1opja_ 96 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 172 (287)
T ss_dssp TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEE
T ss_pred cCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCCCcee
Confidence 99999999987666779999999999999999999995 899999999999999999999999999999876655444
Q ss_pred ccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcC
Q 044561 504 TTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGIC 583 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 583 (614)
.....||+.|+|||++.++.++.++|||||||++|||++|..|+........ +.+....+.. ......+
T Consensus 173 ~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~------~~~~i~~~~~-----~~~~~~~ 241 (287)
T d1opja_ 173 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYELLEKDYR-----MERPEGC 241 (287)
T ss_dssp ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HHHHHHTTCC-----CCCCTTC
T ss_pred eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH------HHHHHhcCCC-----CCCCccc
Confidence 4455789999999999999999999999999999999997777654332211 1122222211 1111222
Q ss_pred cHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 584 EEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 584 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+.+.+|+.+||+.||++||||.||++
T Consensus 242 ----~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 242 ----PEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----hHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 345778888999999999999999863
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-50 Score=398.42 Aligned_cols=249 Identities=28% Similarity=0.429 Sum_probs=210.1
Q ss_pred cCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecC
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMP 424 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 424 (614)
++|+..+.||+|+||+||+|+++++..||||++..... ..++|.+|+.++++++||||++++|+|.+++.+++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 57889999999999999999998888999999986544 34689999999999999999999999999999999999999
Q ss_pred CCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcc
Q 044561 425 NGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT 504 (614)
Q Consensus 425 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 504 (614)
+|+|..++.... ..+++..+.+++.|+++||.|||+ .+|+||||||+|||+++++.+||+|||+++..........
T Consensus 83 ~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 83 NGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp TEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred CCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence 999999976643 458999999999999999999995 8999999999999999999999999999987665544444
Q ss_pred cccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcC
Q 044561 505 TKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGIC 583 (614)
Q Consensus 505 ~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 583 (614)
....||+.|+|||++.++.++.++|||||||++|||+| |+.||......+... ...++.... . ...+
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~-------~i~~~~~~~--~---p~~~ 226 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE-------HIAQGLRLY--R---PHLA 226 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHH-------HHHTTCCCC--C---CTTC
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHH-------HHHhCCCCC--C---cccc
Confidence 45679999999999999999999999999999999998 899998765443222 122221111 1 1122
Q ss_pred cHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 584 EEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 584 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+.+.+|+.+||+.||++|||+.||++
T Consensus 227 ----~~~l~~li~~cl~~dP~~RPt~~eil~ 253 (258)
T d1k2pa_ 227 ----SEKVYTIMYSCWHEKADERPTFKILLS 253 (258)
T ss_dssp ----CHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred ----cHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 246778889999999999999999873
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-50 Score=405.11 Aligned_cols=251 Identities=22% Similarity=0.350 Sum_probs=206.2
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
+.|+..+.||+|+||+||+|+... +..||+|++........+.+.+|++++++++||||+++++++.+.+.+++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 357788999999999999999865 8889999998777777788999999999999999999999999999999999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCc
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 503 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 503 (614)
++|+|.+++... ...+++.++..++.||++||.|||+ ++|+||||||+|||++.++++||+|||+|+...... ..
T Consensus 92 ~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~ 166 (288)
T d2jfla1 92 AGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 166 (288)
T ss_dssp TTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HH
T ss_pred CCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCc-cc
Confidence 999999987653 2459999999999999999999995 899999999999999999999999999997543221 12
Q ss_pred ccccccCCCccchhhhc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccc
Q 044561 504 TTKLVGTFGYMDPELMR-----TGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSR 578 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~-----~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~ 578 (614)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||......+... .+. .+.......
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~---~i~----~~~~~~~~~-- 237 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL---KIA----KSEPPTLAQ-- 237 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH---HHH----HSCCCCCSS--
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHH---HHH----cCCCCCCCc--
Confidence 23468999999999984 4568999999999999999999999998765443321 111 111111111
Q ss_pred ccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 579 LEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 579 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+......+.+|+.+||++||++|||+.|+++
T Consensus 238 -----~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 238 -----PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112345677888899999999999999985
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-50 Score=402.21 Aligned_cols=253 Identities=25% Similarity=0.385 Sum_probs=194.7
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEee--cCeEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRR--KGEFLLV 419 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV 419 (614)
++|+..+.||+|+||+||+|+.+. ++.||+|++... .+...+.+.+|++++++++||||+++++++.+ .+.+|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 568889999999999999999864 889999998654 34456778999999999999999999999864 4568999
Q ss_pred EEecCCCCcchhcccC--CCCCcChhHHHHHHHHhHhhchhhhccC--CCceEecCcCCCCeEEcCCCCEEEeeeccccc
Q 044561 420 YDYMPNGSLDKILHTN--IKPCLNWYQRFRIIRGVASGLLYLHEDW--EQVVLHRDIKPANVLLDADLNGKLGDFGLARL 495 (614)
Q Consensus 420 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDikp~NIll~~~~~~kl~DfGla~~ 495 (614)
||||++|+|.+++... ....+++.+++.++.||++||.|||+.. ..+|+||||||+|||++.++++||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998642 2356999999999999999999999631 13599999999999999999999999999988
Q ss_pred cCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccc
Q 044561 496 YDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDAS 575 (614)
Q Consensus 496 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~ 575 (614)
...+.. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+. .....++....
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~-------~~~i~~~~~~~-- 233 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL-------AGKIREGKFRR-- 233 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-------HHHHHHTCCCC--
T ss_pred cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH-------HHHHHcCCCCC--
Confidence 765432 23446899999999999999999999999999999999999999976543321 11222222221
Q ss_pred cccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 576 DSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 576 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+...++ +.+.+|+.+||++||++|||+.|+++
T Consensus 234 ---~~~~~s----~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 ---IPYRYS----DELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ---CCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CCcccC----HHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 112233 35777888999999999999999985
|
| >d1g7ya_ b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]
Probab=100.00 E-value=4.4e-49 Score=390.43 Aligned_cols=213 Identities=33% Similarity=0.544 Sum_probs=187.7
Q ss_pred CCcceEEeCCCCCCCCceEecceeEcCCCcEEecCCCC-----CCceeeEeeCCceeecCCC-CCceeeeeeeEEee---
Q 044561 25 QDVNQFIYHGFNEDAQLQRDGLASVHSNGLLQLTNTVS-----PQQEGHAFYRLPIKFNTSS-SESLSFSSNFVFAI--- 95 (614)
Q Consensus 25 ~~~~~f~~~~f~~~~~~~~~g~a~~~~~g~l~Lt~~~~-----~~~~G~~~y~~pv~l~~~~-~~~~sF~t~F~f~i--- 95 (614)
++..+|+|++|+. .+|+++|||.+. ++.|+||++.. ..++|||+|++||+||++. +..+||+|+|+|.|
T Consensus 1 a~~~sF~f~~F~~-~~l~l~GdA~~~-~~~l~LT~~~~~~~~~~~~~G~a~y~~pv~l~~~~~~~~~sF~t~F~F~i~~~ 78 (253)
T d1g7ya_ 1 ADIQSFSFKNFNS-SSFILQGDATVS-SSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIYDKSTGAVASWATSFTANIFAP 78 (253)
T ss_dssp CEEEEEEESSCCS-SCEEEEETCEEE-TTEEECSCBCTTSCBCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCS
T ss_pred CcccEEecCCCCc-ccEEEEeeeEEc-CCEEEeCCCCCCCCcccceeEEEEeCCCeEeecCCCCceeeEEEEEEEEEecC
Confidence 3467999999987 789999999996 78899998643 2589999999999999988 88999999999999
Q ss_pred -------eeEEEEcCCCCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeeEecCCCccccccc
Q 044561 96 -------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAP 168 (614)
Q Consensus 96 -------G~aF~l~p~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~ 168 (614)
||||+|+|.+.. .+..||+||+++..+. ...++.+||||||++|.++ ||+++|||||+|++.|..+++
T Consensus 79 ~~~~ggDGlAF~l~~~~~~---~~~~~g~lgl~~~~~~-~~~~~~vaVEFDT~~n~~~-d~~~~Hvgi~~ns~~s~~~~~ 153 (253)
T d1g7ya_ 79 NKSSSADGIAFALVPVGSE---PKSNSGFLGVFDSDVY-DNSAQTVAVEFDTFSNTDW-DPTSRHIGIDVNSIKSIRTAS 153 (253)
T ss_dssp SGGGCCCEEEEEEEETTCC---CCCCGGGTTTCSCSSC-CGGGCCEEEEEECSCCTTT-CCSSCEEEEEESSSSCSEEEE
T ss_pred CCCCCCCceEEEEeCCCCC---CCCCcccccccccCCC-CCcCceEEEEEeceecCCC-CCCCCcEEEeeCCcccccccC
Confidence 999999997754 3567899999987544 3467889999999999875 999999999999999987765
Q ss_pred CccccCccCCCccccccCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcccccccccccccccCC---Cc
Q 044561 169 AAYFSDREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTG---SL 245 (614)
Q Consensus 169 ~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastg---~~ 245 (614)
+ .+.+|+.++|||+||+.+++|+|++.+. .+|..|++++.+||+.+||++|||||||+|| +.
T Consensus 154 ~-------------~~~~g~~~~v~I~Yd~~~~~L~v~l~~~--~~~~~~~ls~~vdL~~~l~~~~yvGFSAsTG~~~~~ 218 (253)
T d1g7ya_ 154 W-------------GLANGQNAEILITYNAATSLLVASLVHP--SRRTSYIVSERVDITNELPEYVSIGFSATTGLSEGY 218 (253)
T ss_dssp C-------------CCCTTSEEEEEEEEETTTTEEEEEEEET--TTTEEEEEEEECCHHHHSCSEEEEEEEEECCSSSSC
T ss_pred C-------------CccCCCEEEEEEEEeCCcEEEEEEEecC--CCCCceEEEEEechhhcCCCcEEEEEEeEcCCCCCc
Confidence 4 4678999999999999999999999864 3678889999999999999999999999999 46
Q ss_pred cceeeEeccccccC
Q 044561 246 KSSHYVLGWSFNRS 259 (614)
Q Consensus 246 ~~~h~i~sWsf~~~ 259 (614)
.+.|+|++|+|+++
T Consensus 219 ~~~H~IlsWsF~s~ 232 (253)
T d1g7ya_ 219 TETHDVLSWSFASK 232 (253)
T ss_dssp CCCCEEEEEEEEEE
T ss_pred ccccEEEEEEeEEe
Confidence 79999999999864
|
| >d1g8wa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=5.1e-49 Score=384.56 Aligned_cols=211 Identities=36% Similarity=0.561 Sum_probs=186.6
Q ss_pred CcceEEeCCCCCCCCceEecceeEcCCCcEEecCCCC-----CCceeeEeeCCceeecCCC-CCceeeeeeeEEee----
Q 044561 26 DVNQFIYHGFNEDAQLQRDGLASVHSNGLLQLTNTVS-----PQQEGHAFYRLPIKFNTSS-SESLSFSSNFVFAI---- 95 (614)
Q Consensus 26 ~~~~f~~~~f~~~~~~~~~g~a~~~~~g~l~Lt~~~~-----~~~~G~~~y~~pv~l~~~~-~~~~sF~t~F~f~i---- 95 (614)
.+++|+|++|+. .+++|+|||.+.++|.||||+... ..++|||+|++||+||++. +.++||+|+|+|.|
T Consensus 2 ~~~sF~f~~F~~-~nl~l~GdA~i~~~g~l~LT~~~~~~~~~~~~~G~~~y~~Pi~l~~~~~~~~~sF~t~f~f~i~~~~ 80 (233)
T d1g8wa_ 2 NDIYFNFQRFNE-TNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWDNTTGTVASFATSFTFNIQVPN 80 (233)
T ss_dssp EEEEEEESSCCG-GGEEEEETCEECTTSCEECSCCCSTTCCCTTCEEEEEESSCEECBCTTTCCBEEEEEEEEEECCCCS
T ss_pred CceEEECCCCCc-CcEEEeccEEECCCCEEEecCCCCCCCcccceeEEEEcCCCeEeecCCCCceeeEEEEEEEEEecCC
Confidence 468999999987 789999999998899999998642 2589999999999999988 88899999999999
Q ss_pred ------eeEEEEcCCCCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeeEecCCCcccccccC
Q 044561 96 ------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPA 169 (614)
Q Consensus 96 ------G~aF~l~p~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~ 169 (614)
||||+|+|.... .+..|++||+++.. +..++.|||||||++|.++ ||+++||||++|++.|..+.++
T Consensus 81 ~~~~gDGlAF~l~~~~~~---~g~~g~~lG~~~g~---~~~~~~vaVEFDT~~N~~~-d~~~~Hvgi~~n~~~s~~~~~~ 153 (233)
T d1g8wa_ 81 NAGPADGLAFALVPVGSQ---PKDKGGFLGLFDGS---NSNFHTVAVEFDTLYNKDW-DPTERHIGIDVNSIRSIKTTRW 153 (233)
T ss_dssp SCBCCEEEEEEEEETTCC---CCCCGGGTTTCCSS---CCCCCCEEEEEECSCCTTT-CCSSCEEEEEESSSSCSEEEEC
T ss_pred CCCCCCeEEEEEecCCCC---CCcccccCCccccC---CCcccEEEEEeecccCCCC-CCCCCeEEEECCCcceeeeccc
Confidence 999999997653 46789999998764 3457889999999999875 9999999999999998776653
Q ss_pred ccccCccCCCccccccCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcccccccccccccccCCC---cc
Q 044561 170 AYFSDREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGS---LK 246 (614)
Q Consensus 170 ~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastg~---~~ 246 (614)
++.+|+.++|||+||+.+++|.|++.+.+ +|..|+++..+||+.+||++|||||||+||. ..
T Consensus 154 -------------~~~~g~~~~~~I~yd~~~~~l~v~l~~~~--~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~~~~~ 218 (233)
T d1g8wa_ 154 -------------DFVNGENAEVLITYDSSTNLLVASLVYPS--QKTSFIVSDTVDLKSVLPEWVSVGFSATTGINKGNV 218 (233)
T ss_dssp -------------CCCTTCCEEEEEEEETTTTEEEEEEEETT--TTEEEEEEEECCHHHHSCSEEEEEEEEEECSSTTBC
T ss_pred -------------cccCCcEEEEEEEEeCCCcEEEEEEEeCC--CCCcEEEEEEechhHcCCCcEEEEEEEEcCCCCCCc
Confidence 46789999999999999999999998754 6777899999999999999999999999994 55
Q ss_pred ceeeEeccccccC
Q 044561 247 SSHYVLGWSFNRS 259 (614)
Q Consensus 247 ~~h~i~sWsf~~~ 259 (614)
|.|+|++|+|+++
T Consensus 219 ~~h~I~sWsFss~ 231 (233)
T d1g8wa_ 219 ETNDVLSWSFASK 231 (233)
T ss_dssp CCCEEEEEEEEEE
T ss_pred eeeEEEEEEEEEE
Confidence 7899999999874
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-49 Score=394.66 Aligned_cols=244 Identities=26% Similarity=0.414 Sum_probs=197.2
Q ss_pred CCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEee----cCeEEEEE
Q 044561 348 KDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRR----KGEFLLVY 420 (614)
Q Consensus 348 ~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 420 (614)
+..+.||+|+||+||+|.... +..||+|++... .....+.+.+|++++++++||||+++++++.. ...+++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 455689999999999999875 788999998654 44556789999999999999999999999865 35689999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCc--eEecCcCCCCeEEc-CCCCEEEeeeccccccC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQV--VLHRDIKPANVLLD-ADLNGKLGDFGLARLYD 497 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDikp~NIll~-~~~~~kl~DfGla~~~~ 497 (614)
|||++|+|.+++... ..+++.++..++.||++||.|||+ ++ |+||||||+|||++ +++.+||+|||+++...
T Consensus 92 E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 999999999999764 359999999999999999999995 55 99999999999996 57899999999998654
Q ss_pred CCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccc
Q 044561 498 HDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDS 577 (614)
Q Consensus 498 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~ 577 (614)
.. .....+||+.|+|||++.+ +++.++|||||||++|||++|+.||......+. +.+....+... .
T Consensus 167 ~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~------~~~~i~~~~~~----~ 232 (270)
T d1t4ha_ 167 AS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------IYRRVTSGVKP----A 232 (270)
T ss_dssp TT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH------HHHHHTTTCCC----G
T ss_pred CC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH------HHHHHHcCCCC----c
Confidence 33 2345689999999999865 699999999999999999999999975433221 11222222211 1
Q ss_pred cccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 578 RLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 578 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+....+ ..+.+|+.+||++||++|||+.|+++
T Consensus 233 ~~~~~~~----~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 233 SFDKVAI----PEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GGGGCCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCccCC----HHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1222222 34677888999999999999999985
|
| >d1dbna_ b.29.1.1 (A:) Legume lectin {Maackia amurensis, leukoagglutinin [TaxId: 37501]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Maackia amurensis, leukoagglutinin [TaxId: 37501]
Probab=100.00 E-value=6.8e-49 Score=386.71 Aligned_cols=218 Identities=37% Similarity=0.524 Sum_probs=189.4
Q ss_pred CCcceEEeCCCCC-CCCceEecceeEcCCCcEEecCCCC----CCceeeEeeCCceeecCCC-CCceeeeeeeEEee---
Q 044561 25 QDVNQFIYHGFNE-DAQLQRDGLASVHSNGLLQLTNTVS----PQQEGHAFYRLPIKFNTSS-SESLSFSSNFVFAI--- 95 (614)
Q Consensus 25 ~~~~~f~~~~f~~-~~~~~~~g~a~~~~~g~l~Lt~~~~----~~~~G~~~y~~pv~l~~~~-~~~~sF~t~F~f~i--- 95 (614)
++.++|+|++|.+ ..+|.|+|+|.+.++|.||||++.. ..++|||||++||+||++. +.++||+|+|+|.|
T Consensus 1 ~~~~sF~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~G~a~y~~pi~l~~~~~~~~~sFst~F~F~i~~~ 80 (239)
T d1dbna_ 1 SDELSFTINNFVPNEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIWGNTTGSVASFSTSFTFVVKAP 80 (239)
T ss_dssp CCEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCS
T ss_pred CCceEEEeCCCCCCCCCEEEeeeeEECCCCEEEccCCCCCCcccceeEEEeecCCEEccCCCCccceEEEEEEEEEEECC
Confidence 3578999999976 5789999999998899999998642 2679999999999999987 88999999999999
Q ss_pred -------eeEEEEcCCCCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeeccCCCCCC--CCCCCeeeEecCCCccccc
Q 044561 96 -------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFD--DIDDNHVGIDVNSLISHES 166 (614)
Q Consensus 96 -------G~aF~l~p~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~--d~~~~Hvgid~ns~~s~~~ 166 (614)
||||+|+|.+... +.++.|++||+++..+ +++.++.+||||||++|.+++ ||+.+|||||+|++.|..+
T Consensus 81 ~~~~~gdG~AF~l~~~~~~~-~~~~~g~~lGl~~~~~-~~~~~~~~aVEfDT~~n~~~~~~d~~~~hvgid~n~~~s~~~ 158 (239)
T d1dbna_ 81 NPDITSDGLAFYLAPPDSQI-PSGSVSKYLGLFNNSN-SDSSNQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIESIKT 158 (239)
T ss_dssp STTSCCEEEEEEEECTTCCC-CSSSCGGGTTSCSSSC-CCTTSCCEEEEEECCCCTTTCTTSCSSCEEEEEESSSSCSEE
T ss_pred CCCCCCCCEEEEEeCCCccC-CcccCccccccccccC-CCcccCeeeeEEeeeecCCCCCCCCCCceeeEEcCCcccccc
Confidence 9999999977432 2567899999998654 456789999999999997764 7899999999999998777
Q ss_pred ccCccccCccCCCccccccCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcccccccccccccccCCCc-
Q 044561 167 APAAYFSDREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSL- 245 (614)
Q Consensus 167 ~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastg~~- 245 (614)
.+.. +.+|+.++|||+|++.+++|.|++.+.. +|..|.++..+||+.+|+++||||||||||..
T Consensus 159 ~~~~-------------~~~g~~~~~~i~y~~~~~~l~v~l~~~~--~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~ 223 (239)
T d1dbna_ 159 VQWD-------------WINGGVAFATITYLAPNKTLIASLVYPS--NQTTFSVAASVDLKEILPEWVRVGFSAATGYPT 223 (239)
T ss_dssp EECC-------------CCTTCCEEEEEEEEGGGTEEEEEEEETT--TTEEEEEEEECCHHHHSCSEEEEEEEEEECSGG
T ss_pred ccce-------------EeCCceeEEEEEEcCCCCEEEEEEEecC--CCccEEEEEecchHHhcCCcEEEEEEEeCCCCC
Confidence 6543 4579999999999999999999998753 66778999999999999999999999999964
Q ss_pred -cceeeEeccccccC
Q 044561 246 -KSSHYVLGWSFNRS 259 (614)
Q Consensus 246 -~~~h~i~sWsf~~~ 259 (614)
.|.|+|++|||+++
T Consensus 224 ~~~~H~I~sWsFss~ 238 (239)
T d1dbna_ 224 EVETHDVLSWSFTST 238 (239)
T ss_dssp GCCCCEEEEEEEEEE
T ss_pred CcceeEEEEEEeEEe
Confidence 57899999999864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=409.46 Aligned_cols=202 Identities=26% Similarity=0.419 Sum_probs=178.7
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 421 (614)
.++|+..+.||+|+||+||+|+... ++.||+|++.... ....+++.+|+.++++++|||||+++++|.+.+++++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 4578889999999999999999864 8889999997653 3445678999999999999999999999999999999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCC
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI 501 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~ 501 (614)
||++|+|.+++.+. ..+++..+..++.|+++||.|||+ +.+|+||||||+|||++.++++||+|||+|+......
T Consensus 85 y~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~- 159 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 159 (322)
T ss_dssp CCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT-
T ss_pred cCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc-
Confidence 99999999999764 349999999999999999999996 2489999999999999999999999999998664322
Q ss_pred CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCc
Q 044561 502 PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGS 552 (614)
Q Consensus 502 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~ 552 (614)
.+..+||+.|+|||++.+..++.++||||+||++|||++|+.||.....
T Consensus 160 --~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~ 208 (322)
T d1s9ja_ 160 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208 (322)
T ss_dssp --C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred --cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 3346899999999999999999999999999999999999999976543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-49 Score=399.01 Aligned_cols=249 Identities=27% Similarity=0.417 Sum_probs=201.7
Q ss_pred cCCCCcce-eeeeCcEEEEEEEEec---CcEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEE
Q 044561 345 KGFKDKDV-IGRGGFGKVYRGVLAS---NVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLV 419 (614)
Q Consensus 345 ~~f~~~~~-lG~G~fg~Vy~~~~~~---~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 419 (614)
+++...+. ||+|+||+||+|.++. +..||||++... .....++|.+|++++++++|||||+++|+|.. +.+++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 34555564 9999999999998753 457999999765 44556889999999999999999999999865 568999
Q ss_pred EEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCC
Q 044561 420 YDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD 499 (614)
Q Consensus 420 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~ 499 (614)
||||++|+|.+++... +..+++.++.+++.|||+||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 87 mE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence 9999999999987653 3459999999999999999999995 89999999999999999999999999999877543
Q ss_pred CC--CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCcccccc
Q 044561 500 TI--PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASD 576 (614)
Q Consensus 500 ~~--~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 576 (614)
.. .......||+.|+|||++..+.++.++|||||||++|||+| |+.||......+.. ....++....
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~-------~~i~~~~~~~--- 232 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-------AFIEQGKRME--- 232 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH-------HHHHTTCCCC---
T ss_pred ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCCCCC---
Confidence 32 12234568999999999999999999999999999999998 99999876543322 1222332221
Q ss_pred ccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 577 SRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 577 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
....++ ..+.+|+.+||+.||++||||.+|++
T Consensus 233 --~p~~~~----~~l~~li~~cl~~~p~~RPs~~~i~~ 264 (285)
T d1u59a_ 233 --CPPECP----PELYALMSDCWIYKWEDRPDFLTVEQ 264 (285)
T ss_dssp --CCTTCC----HHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred --CCCcCC----HHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 122233 45778888999999999999999863
|
| >d1v6ia_ b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3818]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Peanut (Arachis hypogaea) [TaxId: 3818]
Probab=100.00 E-value=1.3e-48 Score=382.37 Aligned_cols=214 Identities=28% Similarity=0.475 Sum_probs=182.2
Q ss_pred CcceEEeCCCCC-CCCceEecceeEcCCCcEEecCCCCCCceeeEeeCCceeecCCC-CCceeeeeeeEEee--------
Q 044561 26 DVNQFIYHGFNE-DAQLQRDGLASVHSNGLLQLTNTVSPQQEGHAFYRLPIKFNTSS-SESLSFSSNFVFAI-------- 95 (614)
Q Consensus 26 ~~~~f~~~~f~~-~~~~~~~g~a~~~~~g~l~Lt~~~~~~~~G~~~y~~pv~l~~~~-~~~~sF~t~F~f~i-------- 95 (614)
.+++|+|++|.+ +.++.|+|||.+.++|.||||++....++|||+|++||+||++. +..+||+|+|+|.|
T Consensus 2 ~~~sF~~~~F~~~~~~l~l~GdA~i~~~g~l~LT~~~~~~~~G~a~y~~Pi~l~~~~~~~~~sf~t~f~f~i~~~~~~~~ 81 (232)
T d1v6ia_ 2 ETVSFNFNSFSEGNPAINFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIWSSATGNVASFLTSFSFEMKDIKDYDP 81 (232)
T ss_dssp EEEEEEESSCCTTCTTEEEEESCEECTTSCEECSCTTSTTCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECCSSSBC
T ss_pred ccEEEECCCCCCCCCCEEEeeeeEEcCCCEEEeCCCCCCCceEEEEcCCCEEccCCCCCccceeEEEEEEEeccCCCCCC
Confidence 468999999987 46799999999988999999986544799999999999999988 88999999999999
Q ss_pred --eeEEEEcCCCCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeeEecCCCcccccccCcccc
Q 044561 96 --GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFS 173 (614)
Q Consensus 96 --G~aF~l~p~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~ 173 (614)
||||+|+|..... . .++..|++....+.++.++.|||||||++|.+++||+++|||||+|++.|.....
T Consensus 82 gDG~AF~l~~~~~~~--~--~~~~~g~~~~~~~~~~~~~~~aVEfDT~~n~~~~d~~~~Higid~n~~~s~~~~~----- 152 (232)
T d1v6ia_ 82 ADGIIFFIAPEDTQI--P--AGSIGGGTLGVSDTKGAGHFVGVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVP----- 152 (232)
T ss_dssp CCEEEEEEEETTCCC--C--TTCCCGGGTTTSCTTSEEEEEEEEEECSCCGGGTCCSSCEEEEEEEESSCSEEEE-----
T ss_pred CCeEEEEEECCCCCC--C--CCccCCcccccccCCCCCceEEEEEEeEecCCCCCCCCccEeEeeCCcccccccc-----
Confidence 9999999977543 1 1222233333333456779999999999999889999999999999998876654
Q ss_pred CccCCCccccccCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcccccccccccccccCCCc-cceeeEe
Q 044561 174 DREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSL-KSSHYVL 252 (614)
Q Consensus 174 ~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastg~~-~~~h~i~ 252 (614)
.++.+|+.++|||+||+.+++|+|++.+. ++..|.++..|||+.+||++||||||||||.. .|.|+|+
T Consensus 153 --------~~~~~g~~~~v~I~Yd~~~~~L~V~~~~~---~~~~~~l~~~vdL~~~l~~~vyvGFSAsTG~~~~~~H~I~ 221 (232)
T d1v6ia_ 153 --------WNSVSGAVVKVTVIYDSSTKTLSVAVTND---NGDITTIAQVVDLKAKLPERVKFGFSASGSLGGRQIHLIR 221 (232)
T ss_dssp --------CCCCTTCEEEEEEEEETTTTEEEEEEECT---TSCEEEEEEECCHHHHSCSEEEEEEEEECCSSBCCEEEEE
T ss_pred --------cccCCCCEEEEEEEEeCCceEEEEEEecC---CCCcceEEEEEchhhccCCcEEEEEEEECCCCCCcccEEE
Confidence 25678999999999999999999999853 56678899999999999999999999999974 5899999
Q ss_pred ccccccC
Q 044561 253 GWSFNRS 259 (614)
Q Consensus 253 sWsf~~~ 259 (614)
+|+|+++
T Consensus 222 sWsFss~ 228 (232)
T d1v6ia_ 222 SWSFTST 228 (232)
T ss_dssp EEEEEEE
T ss_pred EeEeEEe
Confidence 9999975
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-49 Score=397.48 Aligned_cols=251 Identities=26% Similarity=0.474 Sum_probs=195.2
Q ss_pred cCCCCcceeeeeCcEEEEEEEEecC-----cEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLASN-----VQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLL 418 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 418 (614)
+.|+..++||+|+||.||+|.++.. ..||||++... .....++|.+|+.++++++|||||+++|+|.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4577789999999999999998652 46999999654 34455679999999999999999999999999999999
Q ss_pred EEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCC
Q 044561 419 VYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 498 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~ 498 (614)
|||||.+++|.+++... ...++|.++.+++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 87 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 87 ITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 99999999999887764 3459999999999999999999995 8999999999999999999999999999987654
Q ss_pred CCC--CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccc
Q 044561 499 DTI--PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASD 576 (614)
Q Consensus 499 ~~~--~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 576 (614)
... .......||+.|+|||++.++.++.++|||||||++|||++|..|+....... ... +...++...
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~--~~~----~~i~~~~~~---- 232 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EVM----KAINDGFRL---- 232 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHH----HHHHTTCCC----
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH--HHH----HHHhccCCC----
Confidence 321 12233568999999999999999999999999999999999766654332221 111 222222111
Q ss_pred ccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 577 SRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 577 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
. .+......+.+|+.+||+.||++||||.||++
T Consensus 233 -~----~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 233 -P----TPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp -C----CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -C----CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 1 11223345788899999999999999999873
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-49 Score=396.06 Aligned_cols=241 Identities=28% Similarity=0.414 Sum_probs=194.2
Q ss_pred ceeeeeCcEEEEEEEEec---CcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecCC
Q 044561 351 DVIGRGGFGKVYRGVLAS---NVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMPN 425 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 425 (614)
++||+|+||+||+|.+++ ++.||||++... +....++|.+|+.++++++|||||+++|+|.. +..+||||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998754 457999998654 23345789999999999999999999999965 567899999999
Q ss_pred CCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCC--c
Q 044561 426 GSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP--Q 503 (614)
Q Consensus 426 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~--~ 503 (614)
|+|.+++... ..+++.++..++.||++||.|||+ ++|+||||||+|||++.++.+||+|||+++........ .
T Consensus 92 g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 92 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 9999999864 359999999999999999999995 89999999999999999999999999999876544322 2
Q ss_pred ccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCc
Q 044561 504 TTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGI 582 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 582 (614)
.....||+.|+|||.+.++.++.++|||||||++|||+| |+.||......+.. ....++.... ....
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~-------~~i~~~~~~~-----~p~~ 234 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-------AMLEKGERMG-----CPAG 234 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-------HHHHTTCCCC-----CCTT
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHH-------HHHHcCCCCC-----CCcc
Confidence 234578999999999999999999999999999999998 89999865443221 1222222111 1122
Q ss_pred CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHh
Q 044561 583 CEEKQMELVLKLGLFCSHPKPEARPNMRQVM 613 (614)
Q Consensus 583 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 613 (614)
++ ..+.+|+.+||+.||++|||+.||+
T Consensus 235 ~~----~~~~~li~~cl~~dp~~RPs~~~i~ 261 (277)
T d1xbba_ 235 CP----REMYDLMNLCWTYDVENRPGFAAVE 261 (277)
T ss_dssp CC----HHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred cC----HHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 33 4577888899999999999999985
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-49 Score=399.49 Aligned_cols=247 Identities=23% Similarity=0.307 Sum_probs=202.5
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
++|+..+.||+|+||+||+|+.+ +++.||||++.... ....+.+.+|++++++++||||+++++++.+++.+|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 45888999999999999999986 48899999987532 234567899999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
|||++|+|.+++... ..+++.++..++.|++.||.|||+ ++|+||||||+|||+++++.+||+|||+|+......
T Consensus 88 Ey~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 999999999998764 359999999999999999999995 899999999999999999999999999998775433
Q ss_pred -CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccc
Q 044561 501 -IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRL 579 (614)
Q Consensus 501 -~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 579 (614)
.......+||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+.. ....++.. .+
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~-------~~i~~~~~------~~ 229 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF-------QKIIKLEY------DF 229 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHTTCC------CC
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHH-------HHHHcCCC------CC
Confidence 22344568999999999999999999999999999999999999999865433221 11112211 11
Q ss_pred cCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHh
Q 044561 580 EGICEEKQMELVLKLGLFCSHPKPEARPNMRQVM 613 (614)
Q Consensus 580 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 613 (614)
...++ ..+.+|+.+||+.||++|||+.|++
T Consensus 230 p~~~s----~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 230 PEKFF----PKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp CTTCC----HHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred CccCC----HHHHHHHHHHccCCHhHCcCHHHHc
Confidence 12222 3567888899999999999999874
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=401.14 Aligned_cols=249 Identities=26% Similarity=0.437 Sum_probs=197.2
Q ss_pred cCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEecC
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYMP 424 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 424 (614)
++|+..+.||+|+||+||+|+++++..||||++.... ...+.|.+|+.++++++|||||+++|+|.+ +..++|||||+
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 4688899999999999999999888889999986543 345789999999999999999999999854 56899999999
Q ss_pred CCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCcc
Q 044561 425 NGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT 504 (614)
Q Consensus 425 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 504 (614)
+|+|..++.......++|.+++.++.||+.||+|||+ ++|+||||||+|||++.++++||+|||+++..........
T Consensus 95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 171 (285)
T d1fmka3 95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 171 (285)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCceee
Confidence 9999999876555569999999999999999999995 8999999999999999999999999999987765544444
Q ss_pred cccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCcCc
Q 044561 505 TKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGICE 584 (614)
Q Consensus 505 ~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 584 (614)
....||+.|+|||++..+.++.++|||||||++|||++|..|+....... .....+ ..+. .......++
T Consensus 172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~--~~~~~i----~~~~-----~~~~~~~~~ 240 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLDQV----ERGY-----RMPCPPECP 240 (285)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHH----HTTC-----CCCCCTTSC
T ss_pred ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH--HHHHHH----HhcC-----CCCCCcccC
Confidence 55679999999999999999999999999999999999766654433221 112222 1111 111222233
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHh
Q 044561 585 EKQMELVLKLGLFCSHPKPEARPNMRQVM 613 (614)
Q Consensus 585 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl 613 (614)
+.+.+++.+||+.||++||||.+|+
T Consensus 241 ----~~l~~li~~cl~~dP~~Rps~~~i~ 265 (285)
T d1fmka3 241 ----ESLHDLMCQCWRKEPEERPTFEYLQ 265 (285)
T ss_dssp ----HHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ----HHHHHHHHHHcccCHhHCcCHHHHH
Confidence 4577888899999999999999986
|
| >d1n47a_ b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]
Probab=100.00 E-value=5.3e-48 Score=378.13 Aligned_cols=212 Identities=32% Similarity=0.551 Sum_probs=185.4
Q ss_pred CcceEEeCCCCC-CCCceEecceeEcCCCcEEecCCCC----CCceeeEeeCCceeecCCCCCceeeeeeeEEee-----
Q 044561 26 DVNQFIYHGFNE-DAQLQRDGLASVHSNGLLQLTNTVS----PQQEGHAFYRLPIKFNTSSSESLSFSSNFVFAI----- 95 (614)
Q Consensus 26 ~~~~f~~~~f~~-~~~~~~~g~a~~~~~g~l~Lt~~~~----~~~~G~~~y~~pv~l~~~~~~~~sF~t~F~f~i----- 95 (614)
++++|+|++|++ .++++|+|+|.+.++|.||||++.. +.++|||||++||+||+. +..+||+|+|+|.|
T Consensus 2 ~~~sF~f~~F~~~~~~l~l~G~A~i~~~g~i~LT~~~~~~~~~~~~G~~~y~~Pv~l~~~-~~~~sF~t~f~f~i~~~~~ 80 (233)
T d1n47a_ 2 ESTSFSFTNFNPNQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIHDN-TTLASFTTSFSFVMAAPAA 80 (233)
T ss_dssp EEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCBSSSSBCTTCEEEEEESSCEECBCS-SCBCEEEEEEEEECCCSST
T ss_pred CceEEEeCCCCCCCCCeEEecceEECCCCEEEecCCCCCCcCCCceEEEEeCCCEEccCC-CeeeeEEEEEEEEEeCCCC
Confidence 468999999976 4789999999998889999998643 258999999999999986 45789999999999
Q ss_pred -----eeEEEEcCCCCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeeEecCCCcccccccCc
Q 044561 96 -----GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAA 170 (614)
Q Consensus 96 -----G~aF~l~p~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~ 170 (614)
||||+|+|.+.. .+..||+||+++..+. ++.++.|||||||++|. +||++||||||+|++.|..+.++
T Consensus 81 ~~~gDGlAF~l~~~~~~---~~~~gg~lGl~~~~~~-~~~~~~~aVefDT~~n~--~d~~~~higi~~n~~~s~~~~~~- 153 (233)
T d1n47a_ 81 AAVADGLAFFLAPPDTQ---PQARGGFLGLFADRAH-DASYQTVAVEFDTYSNA--WDPNYTHIGIDTNGIESKKTTPF- 153 (233)
T ss_dssp TSCCEEEEEEEECTTCC---CCCCGGGTTTCSSSSC-CGGGCCEEEEEECSCCT--TSCSSCEEEEEESSSSCSEEEEC-
T ss_pred CCCCCceEEEECCCCCC---CCCCCCccccccccCC-CCcCceEEEEEEeeecC--CCCCCCceeEccCCccccccccc-
Confidence 999999997654 4667899999976544 45678899999999997 59999999999999998777653
Q ss_pred cccCccCCCccccccCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcccccccccccccccCC---Cccc
Q 044561 171 YFSDREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTG---SLKS 247 (614)
Q Consensus 171 ~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastg---~~~~ 247 (614)
.+.+|+.++|||+||+.+++|.|++.+.. ++..|.++..+||+.+||++|||||||+|| +..|
T Consensus 154 ------------~l~~g~~~~v~I~Y~~~~~~l~v~l~~~~--~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~~~ 219 (233)
T d1n47a_ 154 ------------DMVYGEKANIVITYQASTKALAASLVFPV--SQTSYAVSARVDLRDILPEYVRVGFSATTGLNAGVVE 219 (233)
T ss_dssp ------------CCCTTSCEEEEEEEETTTTEEEEEEEETT--TTEEEEEEEECCGGGTSCSEEEEEEEEEECSSTTCCC
T ss_pred ------------eecCCCEEEEEEEEcCCCeEEEEEEEeCC--CCccEEEEEEechHHhcCCcEEEEEEEecCCCCCccc
Confidence 56789999999999999999999998653 677889999999999999999999999999 4568
Q ss_pred eeeEeccccccC
Q 044561 248 SHYVLGWSFNRS 259 (614)
Q Consensus 248 ~h~i~sWsf~~~ 259 (614)
.|+|++|+|+++
T Consensus 220 ~H~I~sWsFss~ 231 (233)
T d1n47a_ 220 THDIVSWSFAVS 231 (233)
T ss_dssp CCEEEEEEEEEE
T ss_pred ccEEEEEEeEEE
Confidence 999999999875
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-48 Score=399.17 Aligned_cols=244 Identities=27% Similarity=0.426 Sum_probs=200.8
Q ss_pred CCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEE
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 421 (614)
.|+..+.||+|+||+||+|+... +..||||++.... ....+++.+|+.++++++|||||++++++.+.+.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 47888999999999999999764 7889999997653 3445679999999999999999999999999999999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCC
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI 501 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~ 501 (614)
||++|+|..++..+ ..+++.++..++.||++||.|||+ ++|+||||||+|||++.++++||+|||+++....
T Consensus 96 ~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~--- 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--- 167 (309)
T ss_dssp CCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---
T ss_pred ecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCC---
Confidence 99999998776553 459999999999999999999995 8999999999999999999999999999986543
Q ss_pred CcccccccCCCccchhhhcC---CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccc
Q 044561 502 PQTTKLVGTFGYMDPELMRT---GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSR 578 (614)
Q Consensus 502 ~~~~~~~gt~~y~aPE~~~~---~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~ 578 (614)
.....||+.|+|||++.+ +.++.++|||||||++|||++|+.||......+.. ..+ ..+......+
T Consensus 168 --~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~---~~i----~~~~~~~~~~-- 236 (309)
T d1u5ra_ 168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---YHI----AQNESPALQS-- 236 (309)
T ss_dssp --BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HHH----HHSCCCCCSC--
T ss_pred --CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHH---HHH----HhCCCCCCCC--
Confidence 234579999999999863 46899999999999999999999999765432221 111 1111111111
Q ss_pred ccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 579 LEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 579 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+ .+.+.+|+.+||+.||++|||+.|+++
T Consensus 237 --~~~----s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 237 --GHW----SEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp --TTS----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --CCC----CHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 112 245777888999999999999999975
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.2e-48 Score=403.70 Aligned_cols=252 Identities=24% Similarity=0.318 Sum_probs=209.3
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
.++|+..+.||+|+||.||+|+.+. +..||||++........+.+.+|+.++++++||||+++++++.+++.+|+||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 3579999999999999999999864 889999999887777778899999999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcC--CCCEEEeeeccccccCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA--DLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~--~~~~kl~DfGla~~~~~~~ 500 (614)
|++|+|.+++... ...+++.++..++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+++......
T Consensus 105 ~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 105 MSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 9999999998654 3459999999999999999999995 89999999999999954 6789999999998776543
Q ss_pred CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... + ..+... .+....
T Consensus 181 --~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~---i----~~~~~~--~~~~~~ 249 (350)
T d1koaa2 181 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRN---V----KSCDWN--MDDSAF 249 (350)
T ss_dssp --CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---H----HHTCCC--SCCGGG
T ss_pred --ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHH---H----HhCCCC--CCcccc
Confidence 33456899999999999999999999999999999999999999976544332211 1 111110 111111
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..++ +.+.+|+.+||+.||++|||+.|+++
T Consensus 250 ~~~s----~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 250 SGIS----EDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp GGCC----HHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cCCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1222 35677888899999999999999974
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=404.23 Aligned_cols=252 Identities=25% Similarity=0.358 Sum_probs=201.9
Q ss_pred cCCCCcceeeeeCcEEEEEEEEecC------cEEEEEEeecC-ChhhHHHHHHHHHHhccc-CCCceeEEeeEEeecCeE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLASN------VQIAVKKVSHD-SKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGEF 416 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~~------~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 416 (614)
++|+..+.||+|+||+||+|++... ..||+|++... .......+.+|+.++.++ +|||||+++++|.+.+.+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 5678889999999999999997642 36899988654 333456789999999998 899999999999999999
Q ss_pred EEEEEecCCCCcchhcccCCC---------------------CCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCC
Q 044561 417 LLVYDYMPNGSLDKILHTNIK---------------------PCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPA 475 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~ 475 (614)
++|||||++|+|.++|+.... ..+++.+++.++.||++||.|||+ ++|+||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCchh
Confidence 999999999999999975421 358999999999999999999995 89999999999
Q ss_pred CeEEcCCCCEEEeeeccccccCCCCCC-cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcc
Q 044561 476 NVLLDADLNGKLGDFGLARLYDHDTIP-QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSM 553 (614)
Q Consensus 476 NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~ 553 (614)
|||++.++++||+|||+|+........ ......||+.|+|||++.++.++.++|||||||++|||+| |+.||.+....
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999999876543322 2334578999999999999999999999999999999997 89999865543
Q ss_pred ccccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 554 ETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 554 ~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+... +....+.- ......+ .+.+.+|+.+||+.||++|||+.||++
T Consensus 274 ~~~~------~~~~~~~~-----~~~p~~~----~~~l~~li~~cl~~dP~~RPt~~ei~~ 319 (325)
T d1rjba_ 274 ANFY------KLIQNGFK-----MDQPFYA----TEEIYIIMQSCWAFDSRKRPSFPNLTS 319 (325)
T ss_dssp HHHH------HHHHTTCC-----CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHH------HHHhcCCC-----CCCCCcC----CHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 3221 11112111 1111222 345778888999999999999999974
|
| >d1fnya_ b.29.1.1 (A:) Legume lectin {Black locust (Robinia pseudoacacia) [TaxId: 35938]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Black locust (Robinia pseudoacacia) [TaxId: 35938]
Probab=100.00 E-value=5.9e-48 Score=379.67 Aligned_cols=215 Identities=33% Similarity=0.511 Sum_probs=187.3
Q ss_pred CcceEEeCCCCC-CCCceEecceeEcCCCcEEecCCCC----CCceeeEeeCCceeecCCC-CCceeeeeeeEEee----
Q 044561 26 DVNQFIYHGFNE-DAQLQRDGLASVHSNGLLQLTNTVS----PQQEGHAFYRLPIKFNTSS-SESLSFSSNFVFAI---- 95 (614)
Q Consensus 26 ~~~~f~~~~f~~-~~~~~~~g~a~~~~~g~l~Lt~~~~----~~~~G~~~y~~pv~l~~~~-~~~~sF~t~F~f~i---- 95 (614)
.++||+|++|.. .+++.|+|||.+.++|.||||++.. ..++|||||++||+||++. +.++||+|+|+|.|
T Consensus 2 ~~~sF~f~~F~~~~~~l~l~G~A~v~~~g~i~LT~~~~~~~~~~~~G~~~y~~Pi~l~~~~~~~~~sF~t~F~F~i~~~~ 81 (237)
T d1fnya_ 2 GSLSFSFPKFAPNQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWDSTTGNVASFVTSFTFIIQAPN 81 (237)
T ss_dssp EEEEEEESSCCTTCTTEEEEETCEECTTSCEECSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSS
T ss_pred ceEEEEeCCCCCCCCCeEEcccEEEcCCCEEECCCCCCCCcccccEEEEEeCCCeEcccCCCCcceeeEEEEEEEEecCC
Confidence 367999999986 4789999999998899999998632 2689999999999999988 88999999999999
Q ss_pred ------eeEEEEcCCCCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeeEecCCCcccccccC
Q 044561 96 ------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPA 169 (614)
Q Consensus 96 ------G~aF~l~p~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~ 169 (614)
||||+|+|.+.. .+..||+||+++... .+..++.+||||||++|.++ ||+++|||||+|++.|..+.+.
T Consensus 82 ~~~~gDG~AF~l~~~~~~---~~~~gg~lg~~~~~~-~~~~~~~~aVefDT~~n~~~-d~~~~Higi~~n~~~s~~~~~~ 156 (237)
T d1fnya_ 82 PATTADGLAFFLAPVDTQ---PLDLGGMLGIFKDGY-FNKSNQIVAVEFDTFSNGDW-DPKGRHLGINVNSIESIKTVPW 156 (237)
T ss_dssp TTSCCEEEEEEEEETTCC---CCCCGGGTTTCC----CCTTSCCEEEEEECSCCTTT-CCSSSEEEEEESSSSCSEEEEC
T ss_pred CCCCCCeeEEEEcCCCCC---cccccCcccccCCCC-ccCccceEEEEeccccccCC-CCCCceEEEecCCCcccccccc
Confidence 999999997654 466789999987543 34678899999999999876 9999999999999998777653
Q ss_pred ccccCccCCCccccccCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcccccccccccccccCC---Ccc
Q 044561 170 AYFSDREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTG---SLK 246 (614)
Q Consensus 170 ~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastg---~~~ 246 (614)
++.+|+.++|||+||+.+++|.|++.+.+ ++..|+++..+||+.++|++|||||||+|| +..
T Consensus 157 -------------~~~~g~~~~v~I~Y~~~~~~l~v~l~~~~--~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~s~~~ 221 (237)
T d1fnya_ 157 -------------NWTNGEVANVFISYEASTKSLTASLVYPS--LETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYV 221 (237)
T ss_dssp -------------CCCTTCCEEEEEEEEGGGTEEEEEEEETT--TTEEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCC
T ss_pred -------------cccCCcEEEEEEEEeCCccEEEEEEEeCC--CCcceeEEEEechhhcCCCcEEEEEEEECCCCCCcc
Confidence 45689999999999999999999998754 567789999999999999999999999999 456
Q ss_pred ceeeEeccccccCC
Q 044561 247 SSHYVLGWSFNRSG 260 (614)
Q Consensus 247 ~~h~i~sWsf~~~~ 260 (614)
|.|+|++|+|+++.
T Consensus 222 e~H~I~sWsF~s~l 235 (237)
T d1fnya_ 222 QTNDVLSWSFESNL 235 (237)
T ss_dssp CCCEEEEEEEEEEE
T ss_pred cccEEEEeEeEEeC
Confidence 89999999999864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1e-47 Score=400.18 Aligned_cols=251 Identities=22% Similarity=0.300 Sum_probs=209.1
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
++|+..+.||+|+||+||+|+.. +++.||||++........+.+.+|+.++++++||||+++++++.+++.+|+|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 56889999999999999999986 48899999998877666778899999999999999999999999999999999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEc--CCCCEEEeeeccccccCCCCC
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD--ADLNGKLGDFGLARLYDHDTI 501 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~--~~~~~kl~DfGla~~~~~~~~ 501 (614)
++|+|.+++... ...+++.++..|+.||+.||.|||+ .+|+||||||+|||++ .++++||+|||+|+......
T Consensus 109 ~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~- 183 (352)
T d1koba_ 109 SGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 183 (352)
T ss_dssp CCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred CCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCCC-
Confidence 999998887654 3359999999999999999999995 8999999999999998 57899999999999876543
Q ss_pred CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccC
Q 044561 502 PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEG 581 (614)
Q Consensus 502 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~ 581 (614)
......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+... .+ ..+... .......
T Consensus 184 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~---~i----~~~~~~--~~~~~~~ 253 (352)
T d1koba_ 184 -IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ---NV----KRCDWE--FDEDAFS 253 (352)
T ss_dssp -CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH---HH----HHCCCC--CCSSTTT
T ss_pred -ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH---HH----HhCCCC--CCccccc
Confidence 3345689999999999999999999999999999999999999997654433221 11 111111 1111111
Q ss_pred cCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 582 ICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 582 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+ ...+.+|+.+||+.||++|||+.|+++
T Consensus 254 ~~----s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 254 SV----SPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp TS----CHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22 235678888999999999999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.9e-49 Score=402.29 Aligned_cols=251 Identities=22% Similarity=0.333 Sum_probs=189.3
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCCh-hhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSK-QGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 421 (614)
.+.|+..+.||+|+||+||+|+.+. ++.||||++..... ...+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 3568889999999999999999864 88899999976532 234567899999999999999999999999999999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEc---CCCCEEEeeeccccccCC
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD---ADLNGKLGDFGLARLYDH 498 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~---~~~~~kl~DfGla~~~~~ 498 (614)
||++|+|.+++... ..+++.++..++.||+.||.|||+ ++|+||||||+|||+. +++.+||+|||+++....
T Consensus 88 ~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 88 LVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp CCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred ccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 99999999999764 459999999999999999999995 8999999999999994 578999999999987654
Q ss_pred CCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccc
Q 044561 499 DTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSR 578 (614)
Q Consensus 499 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~ 578 (614)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...+. .+... .+..
T Consensus 163 ~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~---~~~i~----~~~~~--~~~~ 231 (307)
T d1a06a_ 163 GS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL---FEQIL----KAEYE--FDSP 231 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHH----TTCCC--CCTT
T ss_pred CC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH---HHHHh----ccCCC--CCCc
Confidence 43 23446899999999999999999999999999999999999999976543322 11111 11111 1111
Q ss_pred ccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 579 LEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 579 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
....+ .+.+.+|+.+||+.||++|||+.|+++
T Consensus 232 ~~~~~----s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 232 YWDDI----SDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp TTTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cccCC----CHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 11122 245777888899999999999999974
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-48 Score=391.81 Aligned_cols=250 Identities=20% Similarity=0.303 Sum_probs=205.4
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC------hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS------KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFL 417 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 417 (614)
+.|+..+.||+|+||+||+|+.+. ++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+.+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 568889999999999999999864 8899999986532 123578999999999999999999999999999999
Q ss_pred EEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCC----CEEEeeeccc
Q 044561 418 LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADL----NGKLGDFGLA 493 (614)
Q Consensus 418 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~----~~kl~DfGla 493 (614)
+|||||++|+|.+++... ..+++.++..++.|++.||.|||+ ++|+||||||+|||++.++ .+||+|||++
T Consensus 90 iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhhh
Confidence 999999999999999764 359999999999999999999995 8999999999999998776 5999999999
Q ss_pred cccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccc
Q 044561 494 RLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRD 573 (614)
Q Consensus 494 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~ 573 (614)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+.... ...+...
T Consensus 165 ~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~-------i~~~~~~- 234 (293)
T d1jksa_ 165 HKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-------VSAVNYE- 234 (293)
T ss_dssp EECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-------HHTTCCC-
T ss_pred hhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHH-------HHhcCCC-
Confidence 8775543 23445799999999999998999999999999999999999999986544332211 1111110
Q ss_pred cccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 574 ASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 574 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
........ ....+.+|+.+||++||++|||+.|+++
T Consensus 235 -~~~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 235 -FEDEYFSN----TSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp -CCHHHHTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -CCchhcCC----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00111111 2245677888999999999999999973
|
| >d1ukga_ b.29.1.1 (A:) Legume lectin {Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]
Probab=100.00 E-value=8.7e-47 Score=372.24 Aligned_cols=216 Identities=29% Similarity=0.451 Sum_probs=187.5
Q ss_pred CcceEEeCCCCC-CCCceEecceeEcCCCcEEecCCCC-----CCceeeEeeCCceeecCCC-CCceeeeeeeEEee---
Q 044561 26 DVNQFIYHGFNE-DAQLQRDGLASVHSNGLLQLTNTVS-----PQQEGHAFYRLPIKFNTSS-SESLSFSSNFVFAI--- 95 (614)
Q Consensus 26 ~~~~f~~~~f~~-~~~~~~~g~a~~~~~g~l~Lt~~~~-----~~~~G~~~y~~pv~l~~~~-~~~~sF~t~F~f~i--- 95 (614)
++++|+|++|++ .++|+|+|+|.+. ++.|+||++.. ..++|||||++||+||++. +.++||+|+|+|.|
T Consensus 2 ~~~sF~f~~F~~~~~~l~l~G~A~i~-~~~i~LT~~~~~~~~~~~~~G~~~y~~Pi~l~~~~~~~~~sF~t~F~f~i~~~ 80 (241)
T d1ukga_ 2 DSLSFGFPTFPSDQKNLIFQGDAQIK-NNAVQLTKTDSNGNPVASTVGRILFSAQVHLWEKSSSRVANFQSQFSFSLKSP 80 (241)
T ss_dssp CEEEEEESSCCSCCSSEEEEETCEEE-TTEEECSCBCTTSCBCSSEEEEEEESSCEECEETTTTEEEEEEEEEEEEEECS
T ss_pred ccEEEEeCCCCCCCCCEEEeeeEEEe-CCEEEeCCCCCCCCccccceEEEEeCCCeecccCCCCceeeeEEEEEEEEecC
Confidence 467999999975 4789999999997 78999998643 3689999999999999988 78899999999999
Q ss_pred ------eeEEEEcCCCCCCCCCCCCCCcccccccCCC-CCCCCcEEEEEeeccCCCCCC--CCCCCeeeEecCCCccccc
Q 044561 96 ------GMAFVISPSKDLGKAEASPSEYLGLFNASNN-GQSTNHILAIELDTVQNLDFD--DIDDNHVGIDVNSLISHES 166 (614)
Q Consensus 96 ------G~aF~l~p~~~~~~~~~~~g~~lGl~~~~~~-~~~~~~~vaVEFDt~~n~~~~--d~~~~Hvgid~ns~~s~~~ 166 (614)
|+||+++|..... +.+.+|+++|+++.... +.+.|+.+||||||++|.+.+ ||+++|||||+|++.|.++
T Consensus 81 ~~~~~~g~~f~~~~~~~~~-~~~~~g~~~~~~~~~~~~~~~~n~~vaVEfDt~~n~~~~~~~~~~~Higid~n~~~s~~~ 159 (241)
T d1ukga_ 81 LSNGADGIAFFIAPPDTTI-PSGSGGGLLGLFAPGTAQNTSANQVIAVEFDTFYAQDSNTWDPNYPHIGIDVNSIRSVKT 159 (241)
T ss_dssp SSSCCCEEEEEEECTTCCC-CTTCCGGGTTTSCGGGTTCGGGCCCEEEEEECCCCTTTCTTSCSSCEEEEEESSSSCSEE
T ss_pred CCCCCCceEEEEeCCCCCc-ccccCcccccccccccccCCccCcccceeccCEecCccCCCCCCCccEeeecCCcccccc
Confidence 9999999866332 26678888898877553 456789999999999987654 5889999999999998776
Q ss_pred ccCccccCccCCCccccccCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcccccccccccccccCCCcc
Q 044561 167 APAAYFSDREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLK 246 (614)
Q Consensus 167 ~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastg~~~ 246 (614)
.++ ++.+|+.++|||+||+.+++|+|++.+. ++..|.+++.|||+.+++++||||||||||...
T Consensus 160 ~~~-------------~~~~g~~~~v~I~Yd~~~~~L~v~~~~~---~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~~ 223 (241)
T d1ukga_ 160 VKW-------------DRRDGQSLNVLVTFNPSTRNLDVVATYS---DGTRYEVSYEVDVRSVLPEWVRVGFSAASGEQY 223 (241)
T ss_dssp EEC-------------CCCTTCCEEEEEEEETTTTEEEEEEEET---TCCEEEEEEECCGGGTSCSEEEEEEEEEESSSC
T ss_pred ccc-------------ccCCCcEEEEEEEEeCCCcEEEEEEccC---CCCceEEEEEEehHHhCCCcEEEEEEEecCCCC
Confidence 543 5678999999999999999999999864 567789999999999999999999999999999
Q ss_pred ceeeEeccccccC
Q 044561 247 SSHYVLGWSFNRS 259 (614)
Q Consensus 247 ~~h~i~sWsf~~~ 259 (614)
|.|+|++|+|+++
T Consensus 224 ~~H~IlsWsFss~ 236 (241)
T d1ukga_ 224 QTHTLESWSFTST 236 (241)
T ss_dssp CEEEEEEEEEEEE
T ss_pred ceeEEEEeEEEEE
Confidence 9999999999875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-48 Score=385.89 Aligned_cols=244 Identities=31% Similarity=0.453 Sum_probs=192.9
Q ss_pred cCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEee-cCeEEEEEEec
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRR-KGEFLLVYDYM 423 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV~E~~ 423 (614)
++|+..+.||+|+||.||+|.++ +..||||+++.+. ..++|.+|++++++++||||++++|+|.+ .+.+++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 45677889999999999999985 6789999997543 34679999999999999999999999865 46789999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCc
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 503 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 503 (614)
++|+|.++|.......++|..+++++.||+.||.|||+ .+|+||||||+|||++.++++||+|||+++.....
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---- 156 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 156 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCC----
Confidence 99999999976544568999999999999999999995 89999999999999999999999999999865432
Q ss_pred ccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCccccccccccCc
Q 044561 504 TTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEGI 582 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 582 (614)
.....+|..|+|||++.++.++.++|||||||++|||+| |+.|+......+ ...++ .++... .+...
T Consensus 157 ~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~i----~~~~~~-----~~~~~ 224 (262)
T d1byga_ 157 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRV----EKGYKM-----DAPDG 224 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHH----TTTCCC-----CCCTT
T ss_pred CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHHH----HcCCCC-----CCCcc
Confidence 233468899999999999999999999999999999998 688876654333 22222 122111 12222
Q ss_pred CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 583 CEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 583 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
++ ..+.+|+.+||+.||++||||.||++
T Consensus 225 ~~----~~~~~li~~cl~~dP~~Rps~~~l~~ 252 (262)
T d1byga_ 225 CP----PAVYEVMKNCWHLDAAMRPSFLQLRE 252 (262)
T ss_dssp CC----HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CC----HHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 22 45778888999999999999999874
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=385.29 Aligned_cols=249 Identities=25% Similarity=0.422 Sum_probs=192.3
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec----CcEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS----NVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLV 419 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 419 (614)
++|+..+.||+|+||.||+|++.. +..||||++... .....+.|.+|+.++++++||||++++++|. .+.+++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 467888999999999999998753 356889988654 4445678999999999999999999999996 4678999
Q ss_pred EEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCC
Q 044561 420 YDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD 499 (614)
Q Consensus 420 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~ 499 (614)
||||++|+|.+++... ...+++.+++.++.||++||.|||+ ++|+||||||+||++++++.+||+|||+++.....
T Consensus 86 ~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp EECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence 9999999999987654 3459999999999999999999995 89999999999999999999999999999877655
Q ss_pred CCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCcccccccc
Q 044561 500 TIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSR 578 (614)
Q Consensus 500 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~ 578 (614)
.........||+.|+|||++..+.++.++|||||||++|||++ |+.||......+.. ..+ .++... .
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~---~~i----~~~~~~-----~ 229 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GRI----ENGERL-----P 229 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---HHH----HTTCCC-----C
T ss_pred cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHH---HHH----HcCCCC-----C
Confidence 4444556678999999999999999999999999999999998 89999776554322 222 222211 1
Q ss_pred ccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 579 LEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 579 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
....++ +.+.+|+.+||+.||++|||+.||++
T Consensus 230 ~~~~~~----~~~~~li~~cl~~dp~~Rps~~ei~~ 261 (273)
T d1mp8a_ 230 MPPNCP----PTLYSLMTKCWAYDPSRRPRFTELKA 261 (273)
T ss_dssp CCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCC----HHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 122233 45778888999999999999999873
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-47 Score=391.85 Aligned_cols=254 Identities=26% Similarity=0.422 Sum_probs=205.3
Q ss_pred HHhcCCCCcceeeeeCcEEEEEEEEec------CcEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeecC
Q 044561 342 KATKGFKDKDVIGRGGFGKVYRGVLAS------NVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKG 414 (614)
Q Consensus 342 ~~~~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 414 (614)
...++|+..+.||+|+||+||+|++++ +..||||++.... .+..++|.+|+.++++++||||++++++|...+
T Consensus 10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 89 (301)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence 345679999999999999999999753 4679999997653 445678999999999999999999999999999
Q ss_pred eEEEEEEecCCCCcchhcccCC----------------------CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCc
Q 044561 415 EFLLVYDYMPNGSLDKILHTNI----------------------KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 472 (614)
Q Consensus 415 ~~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDi 472 (614)
..+++|||+++|+|.++++... ...+++.+++.|+.|++.||+|||+ ++||||||
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDl 166 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDL 166 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCC
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEeeEE
Confidence 9999999999999999986421 1348999999999999999999995 89999999
Q ss_pred CCCCeEEcCCCCEEEeeeccccccCCCC-CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCC-CCCCCC
Q 044561 473 KPANVLLDADLNGKLGDFGLARLYDHDT-IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGR-RPVEQQ 550 (614)
Q Consensus 473 kp~NIll~~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~-~p~~~~ 550 (614)
||+|||++.++++||+|||+++...... ....+...||+.|+|||++....++.++|||||||++|||++|. .||...
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~ 246 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred cccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC
Confidence 9999999999999999999998654332 22334567899999999999999999999999999999999986 567655
Q ss_pred CccccccHHHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 551 GSMETVNLVDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 551 ~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
...+.. .. ..++.... ....+ ...+.+|+.+||+.||++||||.||++
T Consensus 247 ~~~e~~---~~----v~~~~~~~-----~p~~~----~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 247 AHEEVI---YY----VRDGNILA-----CPENC----PLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp CHHHHH---HH----HHTTCCCC-----CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHH---HH----HHcCCCCC-----CCccc----hHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 443322 21 22333221 11222 345778899999999999999999964
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-46 Score=387.04 Aligned_cols=244 Identities=23% Similarity=0.333 Sum_probs=203.9
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
++|+..+.||+|+||+||+|+.+. ++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 468889999999999999999864 8899999997542 234577899999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
|||++|+|..++.... .+++.++..++.||+.||.||| +++|+||||||+|||++.++++||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp CCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred eecCCccccccccccc--cccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence 9999999999987743 4888999999999999999999 489999999999999999999999999999876543
Q ss_pred CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
....+||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+... ....+.. .+.
T Consensus 158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-------~i~~~~~------~~p 221 (316)
T d1fota_ 158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE-------KILNAEL------RFP 221 (316)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-------HHHHCCC------CCC
T ss_pred ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHH-------HHHcCCC------CCC
Confidence 345689999999999999899999999999999999999999998654432221 1111111 111
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHhC
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARP-----NMRQVMQ 614 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 614 (614)
..++ +.+.+++.+||+.||++|| |+.|+++
T Consensus 222 ~~~s----~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 222 PFFN----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp TTSC----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCC----HHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 2233 3466778889999999996 8998874
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-47 Score=389.54 Aligned_cols=249 Identities=24% Similarity=0.397 Sum_probs=197.7
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-Cc----EEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NV----QIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLL 418 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 418 (614)
.+|+..++||+|+||+||+|.+.. ++ .||+|++... +.+..++|.+|+.++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 358889999999999999999754 33 5899988653 444578899999999999999999999999765 5678
Q ss_pred EEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCC
Q 044561 419 VYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 498 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~ 498 (614)
++||+.+|+|.+++... ...+++.++++++.|||+||.|||+ ++|+||||||+|||++.++++||+|||+++....
T Consensus 88 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 89999999999988765 3459999999999999999999995 8999999999999999999999999999997755
Q ss_pred CCCC-cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCcccccc
Q 044561 499 DTIP-QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASD 576 (614)
Q Consensus 499 ~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 576 (614)
.... ......||+.|+|||++.++.++.++|||||||++|||+| |+.||......+....+ ..+...
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i-------~~~~~~---- 232 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-------EKGERL---- 232 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH-------HHTCCC----
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH-------HcCCCC----
Confidence 4322 2334568999999999999999999999999999999998 78898766544322211 122111
Q ss_pred ccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 577 SRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 577 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
. .+......+.+|+.+||+.||++|||+.||++
T Consensus 233 -~----~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~ 265 (317)
T d1xkka_ 233 -P----QPPICTIDVYMIMVKCWMIDADSRPKFRELII 265 (317)
T ss_dssp -C----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -C----CCcccCHHHHHHHHHhCCCChhhCcCHHHHHH
Confidence 1 11122345778888999999999999999873
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=388.97 Aligned_cols=247 Identities=25% Similarity=0.308 Sum_probs=205.8
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC---ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
++|+..+.||+|+||.||+|+.+. ++.||+|++.+. .....+.+.+|+.++++++||||+++++++.+.+.+|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 468889999999999999999864 899999999754 2334577899999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
|||++|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 85 ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 85 EYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp ECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred eccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 999999999998874 348999999999999999999995 899999999999999999999999999998655432
Q ss_pred CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
. .....+||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+.. +....+.. .+.
T Consensus 160 ~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-------~~i~~~~~------~~p 225 (337)
T d1o6la_ 160 A-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF-------ELILMEEI------RFP 225 (337)
T ss_dssp C-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCCC------CCC
T ss_pred c-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHH-------HHHhcCCC------CCC
Confidence 2 334568999999999999999999999999999999999999999876543222 11122211 112
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHhC
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARPN-----MRQVMQ 614 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 614 (614)
..++ ..+.+|+.+||++||++||+ +.|+++
T Consensus 226 ~~~s----~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 226 RTLS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp TTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ccCC----HHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 2233 34667888899999999995 777764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.2e-46 Score=376.29 Aligned_cols=250 Identities=24% Similarity=0.367 Sum_probs=204.0
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCC---------hhhHHHHHHHHHHhcccC-CCceeEEeeEEeec
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDS---------KQGIKEFVAELVSMGRLR-HRNLVKLRGYCRRK 413 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~ 413 (614)
++|+..+.||+|+||+||+|+.. +++.||||++.... +...+.+.+|+.++++++ ||||+++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 57888999999999999999975 48899999987642 122346889999999997 99999999999999
Q ss_pred CeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccc
Q 044561 414 GEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLA 493 (614)
Q Consensus 414 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla 493 (614)
+.+|||||||++|+|.+++..+ ..+++.++..++.||++||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchhe
Confidence 9999999999999999999764 459999999999999999999995 89999999999999999999999999999
Q ss_pred cccCCCCCCcccccccCCCccchhhhcC------CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhh
Q 044561 494 RLYDHDTIPQTTKLVGTFGYMDPELMRT------GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWK 567 (614)
Q Consensus 494 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~ 567 (614)
+...... ..+...||+.|+|||.+.. ..++.++||||+||+++||++|+.||......+.. +...
T Consensus 158 ~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~-------~~i~ 228 (277)
T d1phka_ 158 CQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML-------RMIM 228 (277)
T ss_dssp EECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHH
T ss_pred eEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHH-------HHHH
Confidence 8876543 2344689999999999853 35688999999999999999999999865433221 1111
Q ss_pred cCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 568 KGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 568 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
++... ...+ ....++ +.+.+|+.+||++||++|||+.||++
T Consensus 229 ~~~~~-~~~~-~~~~~s----~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 229 SGNYQ-FGSP-EWDDYS----DTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HTCCC-CCTT-TGGGSC----HHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred hCCCC-CCCc-ccccCC----HHHHHHHHHHccCChhHCcCHHHHHc
Confidence 22111 0011 111222 45777888899999999999999985
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-46 Score=380.35 Aligned_cols=261 Identities=24% Similarity=0.306 Sum_probs=198.1
Q ss_pred cCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecC----eEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKG----EFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~lV~ 420 (614)
++|...+.||+|+||.||+|++ ++..||||++...... ......|+..+++++||||++++++|.+.+ .+++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 3466678899999999999997 5789999998654332 223345677778899999999999998654 689999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccC-----CCceEecCcCCCCeEEcCCCCEEEeeeccccc
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDW-----EQVVLHRDIKPANVLLDADLNGKLGDFGLARL 495 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDikp~NIll~~~~~~kl~DfGla~~ 495 (614)
|||++|+|.++|++. .++|.++++++.|+|.||.|||+.. +++|+||||||+|||++.++++||+|||+++.
T Consensus 81 Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 999999999999864 4999999999999999999999631 47999999999999999999999999999987
Q ss_pred cCCCCCC---cccccccCCCccchhhhcCCC------CCcchhHHHHHHHHHHHHcCCCCCCCCCccccc--------cH
Q 044561 496 YDHDTIP---QTTKLVGTFGYMDPELMRTGK------ASTSTDVYAFGVFMLEVASGRRPVEQQGSMETV--------NL 558 (614)
Q Consensus 496 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~--------~l 558 (614)
....... ......||+.|+|||++.... ++.++|||||||++|||+||+.|+......+.. ..
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 6543321 234468999999999987542 577899999999999999999887543221110 11
Q ss_pred HHHHHHhhhcCCccccccccccCc-CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 559 VDWVCDCWKKGAIRDASDSRLEGI-CEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 559 ~~~v~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.....+....+.+ ++.+... .+.+..+.+.+|+.+||+.||++|||+.||++
T Consensus 238 ~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 238 VEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp HHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 1222222222221 2222111 23345677899999999999999999999864
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-47 Score=382.73 Aligned_cols=250 Identities=28% Similarity=0.406 Sum_probs=192.5
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec----CcEEEEEEeecC---ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS----NVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFL 417 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 417 (614)
++|+..+.||+|+||.||+|+++. ...||||++... ..+..++|.+|+.++++++||||++++|+|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 457888999999999999999753 246899988654 34456789999999999999999999999965 4678
Q ss_pred EEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccC
Q 044561 418 LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYD 497 (614)
Q Consensus 418 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~ 497 (614)
+|||||++|+|.+++.... ..+++..+..++.|||+||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 87 lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 9999999999998877643 459999999999999999999995 899999999999999999999999999999775
Q ss_pred CCCCC--cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccHHHHHHHhhhcCCcccc
Q 044561 498 HDTIP--QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNLVDWVCDCWKKGAIRDA 574 (614)
Q Consensus 498 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~ 574 (614)
..... ......||..|+|||++.+..++.++|||||||++|||+| |+.||......+.. .++ ...+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~---~~i---~~~~~~~-- 234 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL---HKI---DKEGERL-- 234 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HHH---HTSCCCC--
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHH---HHH---HhCCCCC--
Confidence 44321 2234567889999999999999999999999999999998 89999865544322 222 1221111
Q ss_pred ccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 575 SDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 575 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.....++ ..+.+|+.+||+.||++||||.||++
T Consensus 235 ---~~~~~~~----~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 235 ---PRPEDCP----QDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp ---CCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---CCccccc----HHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1112223 35778888999999999999999863
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-46 Score=380.93 Aligned_cols=246 Identities=29% Similarity=0.470 Sum_probs=197.0
Q ss_pred cceeeeeCcEEEEEEEEecC----cEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEee-cCeEEEEEEec
Q 044561 350 KDVIGRGGFGKVYRGVLASN----VQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRR-KGEFLLVYDYM 423 (614)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV~E~~ 423 (614)
.++||+|+||+||+|++.++ ..||||++... .....++|.+|++++++++||||++++|+|.+ ++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999997542 35899999753 55567889999999999999999999999875 56899999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCC-
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP- 502 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~- 502 (614)
++|+|.+++... ...+++..+++++.|+++||.|||+ .+|+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 112 KHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp TTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred ecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 999999998764 3458899999999999999999995 89999999999999999999999999999876543321
Q ss_pred --cccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 503 --QTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 503 --~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
......||+.|+|||.+.++.++.++||||||+++|||+||+.|+....... ....++. .+.... ..
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~i~----~g~~~~-----~p 256 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLL----QGRRLL-----QP 256 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHH----TTCCCC-----CC
T ss_pred ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHHHH----cCCCCC-----Cc
Confidence 2234578999999999999999999999999999999999888876533221 2222222 222111 11
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+ .+.+.+|+.+||+.||++||||.||++
T Consensus 257 ~~~----~~~l~~li~~cl~~dP~~RPs~~ei~~ 286 (311)
T d1r0pa_ 257 EYC----PDPLYEVMLKCWHPKAEMRPSFSELVS 286 (311)
T ss_dssp TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccC----cHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 122 245778889999999999999999974
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=385.05 Aligned_cols=249 Identities=27% Similarity=0.429 Sum_probs=197.7
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-Cc--EEEEEEeecC-ChhhHHHHHHHHHHhccc-CCCceeEEeeEEeecCeEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NV--QIAVKKVSHD-SKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGEFLLV 419 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 419 (614)
++|+..+.||+|+||+||+|++++ +. .||||++... .....++|.+|+++++++ +||||++++|+|.+++.+++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 567888999999999999999875 33 4788888644 444567899999999998 799999999999999999999
Q ss_pred EEecCCCCcchhcccC--------------CCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCE
Q 044561 420 YDYMPNGSLDKILHTN--------------IKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG 485 (614)
Q Consensus 420 ~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~ 485 (614)
|||+++|+|.++|+.+ ....+++.++.+++.|||.||.|||+ ++|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCce
Confidence 9999999999999754 23569999999999999999999995 899999999999999999999
Q ss_pred EEeeeccccccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCC-CCCCCCccccccHHHHHHH
Q 044561 486 KLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRR-PVEQQGSMETVNLVDWVCD 564 (614)
Q Consensus 486 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~-p~~~~~~~~~~~l~~~v~~ 564 (614)
||+|||+++...... ......||..|+|||.+..+.++.++|||||||++|||++|.. ||......+. . +
T Consensus 167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~---~----~ 237 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---Y----E 237 (309)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---H----H
T ss_pred EEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHH---H----H
Confidence 999999998654332 2233468999999999999999999999999999999999765 5655433221 1 1
Q ss_pred hhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 565 CWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 565 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
...++.. +..... ..+.+.+|+.+||+.||++||||.||++
T Consensus 238 ~i~~~~~-----~~~~~~----~~~~~~~li~~cl~~dP~~RPs~~eil~ 278 (309)
T d1fvra_ 238 KLPQGYR-----LEKPLN----CDDEVYDLMRQCWREKPYERPSFAQILV 278 (309)
T ss_dssp HGGGTCC-----CCCCTT----BCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhcCC-----CCCCcc----CCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1222211 111112 2346778888999999999999999974
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-46 Score=380.20 Aligned_cols=259 Identities=24% Similarity=0.255 Sum_probs=197.3
Q ss_pred cceeeeeCcEEEEEEEEec-CcEEEEEEeecCChh-----hHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 350 KDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQ-----GIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
.++||+|+||+||+|+.+. ++.||||++...... ..+.+.+|+.++++++||||+++++++..++.+|+|||||
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 4789999999999999865 889999998654322 1346889999999999999999999999999999999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCCc
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 503 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 503 (614)
+++++..+... ...+++.++..++.||++||.|||+ ++|+||||||+|||+++++.+||+|||+++....... .
T Consensus 83 ~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-~ 156 (299)
T d1ua2a_ 83 ETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-A 156 (299)
T ss_dssp SEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-C
T ss_pred cchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCcc-c
Confidence 98887776654 3459999999999999999999995 8999999999999999999999999999987654432 2
Q ss_pred ccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccc------
Q 044561 504 TTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASD------ 576 (614)
Q Consensus 504 ~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d------ 576 (614)
....+||+.|+|||++... .++.++|||||||++|||++|+.||......+....+.................
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhh
Confidence 3345799999999998754 579999999999999999999999987655443333222111111111100000
Q ss_pred ccccCcCc-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 577 SRLEGICE-----EKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 577 ~~l~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.......+ ....+.+.+|+.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00000011 112245788889999999999999999985
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.3e-45 Score=386.18 Aligned_cols=248 Identities=23% Similarity=0.304 Sum_probs=199.5
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhh---HHHHHHHHHHhcccCCCceeEEeeEEeecCeEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQG---IKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFL 417 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 417 (614)
++|+..+.||+|+||.||+|+... ++.||+|++.... ... ..+...|+.+++.++||||+++++++.+.+.+|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 578889999999999999999865 8899999986432 111 223345578888889999999999999999999
Q ss_pred EEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccC
Q 044561 418 LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYD 497 (614)
Q Consensus 418 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~ 497 (614)
+|||||++|+|.+++... ..+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+...
T Consensus 84 ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 999999999999999764 358899999999999999999995 899999999999999999999999999998765
Q ss_pred CCCCCcccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccc
Q 044561 498 HDTIPQTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASD 576 (614)
Q Consensus 498 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 576 (614)
... ....+||+.|+|||++.. ..++.++|||||||++|||++|+.||......+...+ ....... .
T Consensus 159 ~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~----~~~~~~~------~ 225 (364)
T d1omwa3 159 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLTM------A 225 (364)
T ss_dssp SSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH----HHHSSSC------C
T ss_pred CCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHhcccC------C
Confidence 443 344689999999999975 4689999999999999999999999986554332211 1111111 1
Q ss_pred ccccCcCcHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHhC
Q 044561 577 SRLEGICEEKQMELVLKLGLFCSHPKPEARPN-----MRQVMQ 614 (614)
Q Consensus 577 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 614 (614)
..+...++ ..+.+|+.+||+.||++||| +.|+++
T Consensus 226 ~~~~~~~s----~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 226 VELPDSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CCCCSSSC----HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCCCCCC----HHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 11122233 34677888899999999999 588764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.4e-46 Score=375.35 Aligned_cols=251 Identities=23% Similarity=0.340 Sum_probs=195.7
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecC---ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecC----eE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHD---SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKG----EF 416 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~ 416 (614)
++|+..+.||+|+||+||+|+.. +++.||+|++... +....+.+.+|+.++++++||||+++++++...+ .+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 56888999999999999999975 4889999999754 3344567999999999999999999999987654 48
Q ss_pred EEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecccccc
Q 044561 417 LLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 496 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~ 496 (614)
|+|||||++++|.+++... ..+++.++..++.||++||.|||+ ++|+||||||+|||++.++..+|+|||.+...
T Consensus 87 ~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred EEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhhh
Confidence 9999999999999988764 359999999999999999999995 89999999999999999999999999998765
Q ss_pred CCCC--CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccc
Q 044561 497 DHDT--IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDA 574 (614)
Q Consensus 497 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~ 574 (614)
.... .......+||+.|+|||++.+..++.++|||||||++|||+||+.||......+. .......+....
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~~~~~~~~~~- 234 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDPIPP- 234 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCCCCCG-
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH------HHHHHhcCCCCC-
Confidence 4332 2234456899999999999999999999999999999999999999976543322 122222221111
Q ss_pred ccccccCcCcHHHHHHHHHHHHHcCCCCCCCCC-CHHHHh
Q 044561 575 SDSRLEGICEEKQMELVLKLGLFCSHPKPEARP-NMRQVM 613 (614)
Q Consensus 575 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl 613 (614)
......++ +.+.+++.+|+++||++|| |+.+++
T Consensus 235 --~~~~~~~s----~~l~~li~~~L~~dp~~R~~sa~~l~ 268 (277)
T d1o6ya_ 235 --SARHEGLS----ADLDAVVLKALAKNPENRYQTAAEMR 268 (277)
T ss_dssp --GGTSSSCC----HHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred --chhccCCC----HHHHHHHHHHccCCHhHCHhHHHHHH
Confidence 11112222 4567788889999999999 788775
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9e-46 Score=385.34 Aligned_cols=244 Identities=21% Similarity=0.269 Sum_probs=203.9
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCC---hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDS---KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 420 (614)
++|+..+.||+|+||.||+|+.+ +++.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 47899999999999999999986 48999999986532 234567899999999999999999999999999999999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 500 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~ 500 (614)
||+.+|+|..++... ..+++.++..++.||+.||.|||+ ++||||||||+|||++.++++||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred ccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 999999999998764 359999999999999999999995 89999999999999999999999999999876543
Q ss_pred CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccccccccc
Q 044561 501 IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLE 580 (614)
Q Consensus 501 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 580 (614)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. . ....+.. ...
T Consensus 195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~----~i~~~~~------~~p 258 (350)
T d1rdqe_ 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY---E----KIVSGKV------RFP 258 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H----HHHHCCC------CCC
T ss_pred ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHH---H----HHhcCCC------CCC
Confidence 33468999999999999999999999999999999999999999765432211 1 1111111 111
Q ss_pred CcCcHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHhC
Q 044561 581 GICEEKQMELVLKLGLFCSHPKPEARP-----NMRQVMQ 614 (614)
Q Consensus 581 ~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 614 (614)
..++ ..+.+++.+||+.||++|+ |+.|+++
T Consensus 259 ~~~s----~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 259 SHFS----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp TTCC----HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ccCC----HHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 2222 3467788889999999994 8999875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-46 Score=379.56 Aligned_cols=252 Identities=25% Similarity=0.382 Sum_probs=192.8
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec------CcEEEEEEeecC-ChhhHHHHHHHHHHhccc-CCCceeEEeeEEeec-Ce
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS------NVQIAVKKVSHD-SKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRK-GE 415 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~-~~ 415 (614)
++|+..+.||+|+||.||+|.+.. ++.||||++... .....+++.+|...+.++ +|+||+++++++.+. +.
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 568888999999999999999753 357999998754 344566788888888777 689999999998765 56
Q ss_pred EEEEEEecCCCCcchhcccCC--------------CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcC
Q 044561 416 FLLVYDYMPNGSLDKILHTNI--------------KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA 481 (614)
Q Consensus 416 ~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~ 481 (614)
+++|||||++|+|.++++... ...+++.++..++.||++||.|||+ ++|+||||||+|||+++
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeECC
Confidence 899999999999999996532 2358999999999999999999995 89999999999999999
Q ss_pred CCCEEEeeeccccccCCCC-CCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCC-CCCCCCCccccccHH
Q 044561 482 DLNGKLGDFGLARLYDHDT-IPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGR-RPVEQQGSMETVNLV 559 (614)
Q Consensus 482 ~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~-~p~~~~~~~~~~~l~ 559 (614)
++++||+|||+|+...... ........||+.|+|||++.++.++.++|||||||++|||++|. .||......+.
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~---- 245 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---- 245 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH----
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH----
Confidence 9999999999998765433 22344568999999999999999999999999999999999875 57765443322
Q ss_pred HHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 560 DWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 560 ~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+.....++.... ....+ ...+.+++.+||+.||++|||+.||++
T Consensus 246 --~~~~~~~~~~~~-----~~~~~----~~~l~~li~~cl~~dP~~Rpt~~eil~ 289 (299)
T d1ywna1 246 --FCRRLKEGTRMR-----APDYT----TPEMYQTMLDCWHGEPSQRPTFSELVE 289 (299)
T ss_dssp --HHHHHHHTCCCC-----CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --HHHHHhcCCCCC-----CCccC----CHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 122222222221 11222 235778888999999999999999974
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-46 Score=382.97 Aligned_cols=251 Identities=21% Similarity=0.261 Sum_probs=197.1
Q ss_pred cCCCCc-ceeeeeCcEEEEEEEEe-cCcEEEEEEeecCChhhHHHHHHHHHHhccc-CCCceeEEeeEEee----cCeEE
Q 044561 345 KGFKDK-DVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSKQGIKEFVAELVSMGRL-RHRNLVKLRGYCRR----KGEFL 417 (614)
Q Consensus 345 ~~f~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~----~~~~~ 417 (614)
++|+.. +.||+|+||+||+|+.. +++.||||++... +.+.+|+.++.++ +||||+++++++.+ +..+|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 467765 46999999999999985 4889999998643 3466899886554 89999999999865 46789
Q ss_pred EEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcC---CCCEEEeeecccc
Q 044561 418 LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA---DLNGKLGDFGLAR 494 (614)
Q Consensus 418 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~---~~~~kl~DfGla~ 494 (614)
+|||||++|+|.++|.......+++.++..++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+++
T Consensus 86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccceee
Confidence 99999999999999987555579999999999999999999995 89999999999999985 5679999999998
Q ss_pred ccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcccc
Q 044561 495 LYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDA 574 (614)
Q Consensus 495 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~ 574 (614)
...... .....+||+.|+|||++.+..++.++|||||||++|||+||+.||......+.... +......+.
T Consensus 163 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~---~~~~i~~~~---- 233 (335)
T d2ozaa1 163 ETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRIRMGQ---- 233 (335)
T ss_dssp ECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCS----
T ss_pred eccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH---HHHHHhcCC----
Confidence 765543 23456899999999999988999999999999999999999999976543332211 111111111
Q ss_pred ccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 575 SDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 575 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+.........+.+.+|+.+||+.||++|||+.|+++
T Consensus 234 --~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 234 --YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp --SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 01111111223456788889999999999999999873
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-46 Score=381.77 Aligned_cols=246 Identities=24% Similarity=0.358 Sum_probs=202.1
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCC---hhhHHHHHHHHHHhc-ccCCCceeEEeeEEeecCeEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS---KQGIKEFVAELVSMG-RLRHRNLVKLRGYCRRKGEFLLV 419 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~-~l~H~niv~l~g~~~~~~~~~lV 419 (614)
++|+..+.||+|+||+||+|+.+. ++.||||++.... ....+.+..|..++. .++||||+++++++.+++.+|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 468889999999999999999875 8899999997542 233456677777665 68999999999999999999999
Q ss_pred EEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCC
Q 044561 420 YDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD 499 (614)
Q Consensus 420 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~ 499 (614)
||||++|+|.+++... ..+++.++..++.||+.||.|||+ ++|+||||||+|||+++++++||+|||+++.....
T Consensus 82 mEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 9999999999999764 348999999999999999999995 89999999999999999999999999999866543
Q ss_pred CCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccc
Q 044561 500 TIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRL 579 (614)
Q Consensus 500 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 579 (614)
. ...+...||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+..+.. .....+. +.+
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~-------~~i~~~~------~~~ 222 (320)
T d1xjda_ 157 D-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF-------HSIRMDN------PFY 222 (320)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCC------CCC
T ss_pred c-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHH-------HHHHcCC------CCC
Confidence 3 2334468999999999999999999999999999999999999999865443322 1111211 112
Q ss_pred cCcCcHHHHHHHHHHHHHcCCCCCCCCCCHH-HHh
Q 044561 580 EGICEEKQMELVLKLGLFCSHPKPEARPNMR-QVM 613 (614)
Q Consensus 580 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl 613 (614)
...++ ..+.+|+.+||+.||++|||+. |++
T Consensus 223 p~~~s----~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 223 PRWLE----KEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp CTTSC----HHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CccCC----HHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 22233 3467888889999999999995 665
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=380.33 Aligned_cols=250 Identities=20% Similarity=0.265 Sum_probs=204.5
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEec
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDYM 423 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 423 (614)
++|+..+.||+|+||+||+|..+. ++.||+|.+...... ...+.+|+++|+.++||||+++++++.+.+.+|+|||||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 568889999999999999999875 788999999765443 356889999999999999999999999999999999999
Q ss_pred CCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCC--CCEEEeeeccccccCCCCC
Q 044561 424 PNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDAD--LNGKLGDFGLARLYDHDTI 501 (614)
Q Consensus 424 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~--~~~kl~DfGla~~~~~~~~ 501 (614)
++|+|.+++.... ..+++.++..++.||++||.|||+ .+|+||||||+|||++.+ .++||+|||+++......
T Consensus 84 ~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~- 158 (321)
T d1tkia_ 84 SGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp CCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccCC-
Confidence 9999999997642 359999999999999999999995 899999999999999854 589999999998765433
Q ss_pred CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccccccccC
Q 044561 502 PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDASDSRLEG 581 (614)
Q Consensus 502 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~ 581 (614)
......+|+.|+|||.+.+..++.++||||+||++|||++|+.||......+.... + ..+... .+.....
T Consensus 159 -~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~---i----~~~~~~--~~~~~~~ 228 (321)
T d1tkia_ 159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIEN---I----MNAEYT--FDEEAFK 228 (321)
T ss_dssp -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH---H----HHTCCC--CCHHHHT
T ss_pred -cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHH---H----HhCCCC--CChhhcc
Confidence 23445789999999999999999999999999999999999999987554332211 1 111110 1111111
Q ss_pred cCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 582 ICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 582 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+ ...+.+|+.+||+.||++|||+.|+++
T Consensus 229 ~~----s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 229 EI----SIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp TS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 12 234677888999999999999999873
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-46 Score=378.26 Aligned_cols=251 Identities=26% Similarity=0.439 Sum_probs=200.8
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec--------CcEEEEEEeecCC-hhhHHHHHHHHHHhccc-CCCceeEEeeEEeecC
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS--------NVQIAVKKVSHDS-KQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKG 414 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 414 (614)
++|...+.||+|+||.||+|+... +..||||++..+. .....++.+|...+.++ +||||++++++|.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 467778999999999999998643 2469999997654 34567889999999888 8999999999999999
Q ss_pred eEEEEEEecCCCCcchhcccCC--------------CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEc
Q 044561 415 EFLLVYDYMPNGSLDKILHTNI--------------KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD 480 (614)
Q Consensus 415 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~ 480 (614)
..++|||||++|+|.+++.... ...+++.++++++.||+.||.|||+ .+||||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceeec
Confidence 9999999999999999997543 2458999999999999999999995 8999999999999999
Q ss_pred CCCCEEEeeeccccccCCCCC-CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCccccccH
Q 044561 481 ADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPVEQQGSMETVNL 558 (614)
Q Consensus 481 ~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~t-g~~p~~~~~~~~~~~l 558 (614)
.++.+||+|||+++....... .......||+.|+|||.+.++.++.++|||||||++|||++ |+.||......+
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~---- 245 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---- 245 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH----
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH----
Confidence 999999999999987654432 23445678999999999999999999999999999999998 688887544322
Q ss_pred HHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 559 VDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 559 ~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+.+.+..+.... ....+ .+.+.+|+.+||+.||++|||+.||++
T Consensus 246 ---~~~~i~~~~~~~-----~p~~~----~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 246 ---LFKLLKEGHRMD-----KPSNC----TNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp ---HHHHHHTTCCCC-----CCSSC----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---HHHHHHcCCCCC-----CCccc----hHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 222223322221 11222 345788899999999999999999974
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-45 Score=373.83 Aligned_cols=265 Identities=23% Similarity=0.318 Sum_probs=200.2
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCC--hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDS--KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 421 (614)
++|+..+.||+|+||+||+|+.. +++.||+|++.... ....+++.+|++++++++||||+++++++.+.+.+|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 57888999999999999999985 48899999996543 2335678999999999999999999999999999999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCC
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI 501 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~ 501 (614)
|+.+ ++.+++.......+++.++..++.||+.||.|||+ ++||||||||+|||++.++++||+|||+++.......
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence 9965 45555544445669999999999999999999995 8999999999999999999999999999987654332
Q ss_pred CcccccccCCCccchhhhcCCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccc---c-
Q 044561 502 PQTTKLVGTFGYMDPELMRTGK-ASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDAS---D- 576 (614)
Q Consensus 502 ~~~~~~~gt~~y~aPE~~~~~~-~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~---d- 576 (614)
......||+.|+|||.+.... ++.++||||+||++|||++|+.||......+....+........+....... +
T Consensus 158 -~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 158 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp -CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred -cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence 334458999999999877655 5889999999999999999999998654433222111110000000000000 0
Q ss_pred -cc---cc-CcC---cHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 577 -SR---LE-GIC---EEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 577 -~~---l~-~~~---~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.. .. ... .....+.+.+|+.+|+++||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 00 00 000 0011245677888999999999999999985
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=378.66 Aligned_cols=252 Identities=25% Similarity=0.363 Sum_probs=203.1
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe------cCcEEEEEEeecCC-hhhHHHHHHHHHHhccc-CCCceeEEeeEEeecCeE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA------SNVQIAVKKVSHDS-KQGIKEFVAELVSMGRL-RHRNLVKLRGYCRRKGEF 416 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 416 (614)
++|+..+.||+|+||.||+|++. .+..||||++.... .....+|.+|+.+++++ +|||||+++++|.+.+..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 56778899999999999999863 24679999997653 34556789999999999 699999999999999999
Q ss_pred EEEEEecCCCCcchhcccCC----------------CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEc
Q 044561 417 LLVYDYMPNGSLDKILHTNI----------------KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD 480 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~ 480 (614)
++|||||++|+|.++++... ...+++.++..++.||++||.|||+ ++++||||||+||+++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccccccccccc
Confidence 99999999999999987532 2358999999999999999999995 8999999999999999
Q ss_pred CCCCEEEeeeccccccCCCCC-CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcC-CCCCCCCCccccccH
Q 044561 481 ADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASG-RRPVEQQGSMETVNL 558 (614)
Q Consensus 481 ~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg-~~p~~~~~~~~~~~l 558 (614)
.++.+||+|||+++....... .......||+.|+|||.+.++.++.++|||||||++|||+|+ ++|+......+..
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~-- 257 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF-- 257 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH--
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH--
Confidence 999999999999987654432 233456889999999999999999999999999999999995 5555444332221
Q ss_pred HHHHHHhhhcCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 559 VDWVCDCWKKGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 559 ~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+....+... ..+......+.+|+.+||++||++||||.||++
T Consensus 258 ----~~~i~~~~~~---------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 258 ----YKMIKEGFRM---------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp ----HHHHHHTCCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----HHHHhcCCCC---------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1111222111 111122345788889999999999999999874
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=377.26 Aligned_cols=251 Identities=24% Similarity=0.445 Sum_probs=203.8
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe------cCcEEEEEEeecC-ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA------SNVQIAVKKVSHD-SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFL 417 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 417 (614)
++|+..+.||+|+||+||+|.++ ++..||||++... ..+....|.+|+.++++++||||++++++|..++..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 56778899999999999999874 2568999999754 4445567999999999999999999999999999999
Q ss_pred EEEEecCCCCcchhcccCC--------CCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEee
Q 044561 418 LVYDYMPNGSLDKILHTNI--------KPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGD 489 (614)
Q Consensus 418 lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~D 489 (614)
+|||||++|+|.+++.... ...+++.++.+++.|+|+||.|||+ ++|+||||||+|||+++++++||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEee
Confidence 9999999999999986421 2347899999999999999999995 8999999999999999999999999
Q ss_pred eccccccCCCCC-CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCC-CCCCCCCccccccHHHHHHHhhh
Q 044561 490 FGLARLYDHDTI-PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGR-RPVEQQGSMETVNLVDWVCDCWK 567 (614)
Q Consensus 490 fGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~-~p~~~~~~~~~~~l~~~v~~~~~ 567 (614)
||+++....... .......||+.|+|||.+.++.++.++||||||+++|||++|+ .||......+... ...
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~-------~i~ 249 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR-------FVM 249 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH-------HHH
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHH-------HHH
Confidence 999986644322 2234457899999999999999999999999999999999985 6676544333221 112
Q ss_pred cCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 568 KGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 568 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
++..... ...+ ...+.+++.+||+.||++||||.||++
T Consensus 250 ~~~~~~~-----p~~~----~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 250 EGGLLDK-----PDNC----PDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp TTCCCCC-----CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hCCCCCC-----cccc----hHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 2222111 1122 246888889999999999999999974
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.1e-45 Score=369.35 Aligned_cols=264 Identities=21% Similarity=0.293 Sum_probs=202.0
Q ss_pred cCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCC--hhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEEe
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDS--KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 422 (614)
++|+..+.||+|+||+||+|+.++++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 4788899999999999999999889999999997653 22357889999999999999999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 502 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 502 (614)
+.++.+..+.... ..+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~- 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR- 155 (286)
T ss_dssp CSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCcc-
Confidence 9887777666543 459999999999999999999995 8999999999999999999999999999987654432
Q ss_pred cccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccccc------
Q 044561 503 QTTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRDAS------ 575 (614)
Q Consensus 503 ~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~------ 575 (614)
......+++.|+|||.+... .++.++||||+||+++||++|+.||......+....+................
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence 23334689999999998754 56899999999999999999999998665443332221111110000000000
Q ss_pred ------cccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 576 ------DSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 576 ------d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.+.............+.+++.+||++||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000001111112345778888999999999999999985
|
| >d1ioaa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]
Probab=100.00 E-value=3.1e-45 Score=357.80 Aligned_cols=208 Identities=32% Similarity=0.494 Sum_probs=178.6
Q ss_pred CCcceEEeCCCCCCCCceEecceeEcCCCcEEecCCCC-----CCceeeEeeCCceeecCCCCCceeeeeeeEEee----
Q 044561 25 QDVNQFIYHGFNEDAQLQRDGLASVHSNGLLQLTNTVS-----PQQEGHAFYRLPIKFNTSSSESLSFSSNFVFAI---- 95 (614)
Q Consensus 25 ~~~~~f~~~~f~~~~~~~~~g~a~~~~~g~l~Lt~~~~-----~~~~G~~~y~~pv~l~~~~~~~~sF~t~F~f~i---- 95 (614)
+...+|+|++|+...+|.|+|||.+.++|.||||++.. ..++|||+|++||+||+. ++++||+|+|+|.|
T Consensus 1 a~~~sF~f~~F~~~~~l~l~GdA~i~~~g~l~LT~~~~~~~~~~~s~G~a~y~~Pv~l~~~-~~~~sFst~F~f~i~~~~ 79 (228)
T d1ioaa_ 1 ATETSFNFPNFHTDDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIKDS-NNVASFNTNFTFIIRAKN 79 (228)
T ss_dssp CCCCEEEESSCCTTSSEEEEETCEECTTSCEETTCBCTTSSBCSSCBEEEEESSCEECBCS-SCBEEEEEEEEEECCBSC
T ss_pred CccceEEcCCCCCCCcEEEeeeeEEcCCCEEEecCCCCCCccccceeEEEEECCceEecCC-CceeeEEEEEEEEEecCC
Confidence 35689999999886679999999998889999998653 257899999999999985 67899999999999
Q ss_pred ------eeEEEEcCCCCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeeEecCCCcccccccC
Q 044561 96 ------GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPA 169 (614)
Q Consensus 96 ------G~aF~l~p~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~ 169 (614)
||||+|+|.+.. .+..||+||+++.+. ++..++.|||||||++|. .|++.+|||+++++..+
T Consensus 80 ~~~~gDGlAF~l~~~~~~---~~~~g~~lgl~~~~~-~~~~~~~vave~dt~~n~--~~~~~~~~~~~~~~~~~------ 147 (228)
T d1ioaa_ 80 QSISAYGLAFALVPVNSP---PQKKQEFLGIFNTNN-PEPNARTVAVVFNTFKNR--IDFDKNFIKPYVNENCD------ 147 (228)
T ss_dssp TTSCCEEEEEEEEETTCC---CCCCGGGTTTCCCSS-CCGGGCCEEEEEETTTTE--EEEEESSSSCSEEEECC------
T ss_pred CCCCCCEEEEEEeCCCCC---CCCCccccccccccC-CCCcceeEEEEecCcccc--ccCCCCccceecccccc------
Confidence 999999997654 467889999988643 455788999999999985 47888888888765321
Q ss_pred ccccCccCCCccccccCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcccccccccccccccCC---Ccc
Q 044561 170 AYFSDREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTG---SLK 246 (614)
Q Consensus 170 ~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastg---~~~ 246 (614)
.++.+|+.++|||+||+.+++|+|++.+.. +|..|.++..+||+++|+++|||||||||| +..
T Consensus 148 ------------~~~~~g~~~~v~I~Yd~~~~~l~V~l~~~~--~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~~ 213 (228)
T d1ioaa_ 148 ------------FHKYNGEKTDVQITYDSSNNDLRVFLHFTV--SQVKCSVSATVHLEKEVDEWVSVGFSPTSGLTEDTT 213 (228)
T ss_dssp ------------HHHHCSSCEEEEEEEETTTTEEEEEEEETT--TCCEEEEEEECCGGGTSCSEEEEEEEEEECSSTTTC
T ss_pred ------------cccccCcEEEEEEEEcCCCCEEEEEEEeCC--CCceeeEEEEEchHHcCCCcEEEEEEeecCCCCCCc
Confidence 356789999999999999999999998753 677899999999999999999999999999 556
Q ss_pred ceeeEeccccccC
Q 044561 247 SSHYVLGWSFNRS 259 (614)
Q Consensus 247 ~~h~i~sWsf~~~ 259 (614)
|.|+|++|+|+++
T Consensus 214 ~~h~I~sWsFss~ 226 (228)
T d1ioaa_ 214 ETHDVLSWSFSSK 226 (228)
T ss_dssp BCCEEEEEEEEEE
T ss_pred eEEEEEEEEeEEe
Confidence 8999999999864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=369.39 Aligned_cols=265 Identities=22% Similarity=0.304 Sum_probs=196.9
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEe-c-CcEEEEEEeecCC--hhhHHHHHHHHHHhccc---CCCceeEEeeEEee----
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLA-S-NVQIAVKKVSHDS--KQGIKEFVAELVSMGRL---RHRNLVKLRGYCRR---- 412 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~-~-~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~---- 412 (614)
.++|+..+.||+|+||+||+|+.. . ++.||||++.... ......+.+|+.+++.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 367899999999999999999974 3 5678999986532 22223455677666655 79999999999853
Q ss_pred -cCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeec
Q 044561 413 -KGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFG 491 (614)
Q Consensus 413 -~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfG 491 (614)
...++++|||++++++...... ....+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchh
Confidence 3578999999988776554433 34568999999999999999999995 899999999999999999999999999
Q ss_pred cccccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCc
Q 044561 492 LARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAI 571 (614)
Q Consensus 492 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~ 571 (614)
+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+........+..+
T Consensus 162 ~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 162 LARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp SCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 988654332 344568999999999999999999999999999999999999999876554433332222111100000
Q ss_pred ccc------c----cccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 572 RDA------S----DSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 572 ~~~------~----d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
... . .............+.+.+|+.+||++||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 0 000000111112345677888899999999999999985
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-45 Score=368.59 Aligned_cols=239 Identities=24% Similarity=0.405 Sum_probs=193.8
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCCh------hhHHHHHHHHHHhcccC--CCceeEEeeEEeecCe
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSK------QGIKEFVAELVSMGRLR--HRNLVKLRGYCRRKGE 415 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~ 415 (614)
++|+..+.||+|+||+||+|+.. +++.||||++..... ...+++.+|+.++++++ ||||+++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 46888999999999999999986 488999999875321 12234678999999986 8999999999999999
Q ss_pred EEEEEEecCC-CCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCC-CCEEEeeeccc
Q 044561 416 FLLVYDYMPN-GSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDAD-LNGKLGDFGLA 493 (614)
Q Consensus 416 ~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~-~~~kl~DfGla 493 (614)
.++||||+.+ +++.+++..+ ..+++.++..++.||++||.|||+ ++|+||||||+|||++.+ +.+||+|||++
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccccc
Confidence 9999999976 5677777653 459999999999999999999995 899999999999999854 79999999999
Q ss_pred cccCCCCCCcccccccCCCccchhhhcCCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCcc
Q 044561 494 RLYDHDTIPQTTKLVGTFGYMDPELMRTGKA-STSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIR 572 (614)
Q Consensus 494 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~ 572 (614)
+...... .+...||+.|+|||++.+..+ +.++||||+||++|||++|+.||..... +. ++.
T Consensus 159 ~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---------i~----~~~-- 220 (273)
T d1xwsa_ 159 ALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---------II----RGQ-- 220 (273)
T ss_dssp EECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------HH----HCC--
T ss_pred eeccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH---------Hh----hcc--
Confidence 8755432 345689999999999987665 6779999999999999999999964210 10 111
Q ss_pred ccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 573 DASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 573 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..+...++ ..+.+++.+||+.||++|||+.|+++
T Consensus 221 ----~~~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 221 ----VFFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ----CCCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----cCCCCCCC----HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 01112233 34677888899999999999999975
|
| >d1avba_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=1.1e-44 Score=353.66 Aligned_cols=207 Identities=33% Similarity=0.478 Sum_probs=182.0
Q ss_pred CcceEEeCCCCCCCCceEecceeEcCCCcEEecCCC--CCCceeeEeeCCceeecCCC-CCceeeeeeeEEee-------
Q 044561 26 DVNQFIYHGFNEDAQLQRDGLASVHSNGLLQLTNTV--SPQQEGHAFYRLPIKFNTSS-SESLSFSSNFVFAI------- 95 (614)
Q Consensus 26 ~~~~f~~~~f~~~~~~~~~g~a~~~~~g~l~Lt~~~--~~~~~G~~~y~~pv~l~~~~-~~~~sF~t~F~f~i------- 95 (614)
...+|+|++|+. .|++|+|||.+.++|.||||+.. ...++|||||++||+||++. +.++||+|+|+|.|
T Consensus 2 ~~~sf~f~~F~~-~nl~l~GdA~v~~~g~i~LT~~~~~~~~~~G~~~y~~Pv~l~~~~~~~~~sF~t~f~f~i~~~~~~~ 80 (226)
T d1avba_ 2 NDASFNVETFNK-TNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQINDRTIDNLASFSTNFTFRINAKNIEN 80 (226)
T ss_dssp EEEEEEESSCCG-GGEEEEETCEECTTSCEECSCSSSCCTTCEEEEEESSCEECEEGGGTEEEEEEEEEEEEEEESSTTS
T ss_pred CceEEECCCCCc-cceeEecceEECCCCeEEccCCCCCCccceEEEEeCCCeEcccCCCCcccceEEEEEEEEecCCCCC
Confidence 467999999987 79999999999888999999753 23789999999999999987 88899999999999
Q ss_pred ---eeEEEEcCCCCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeeEecCCCcccccccCccc
Q 044561 96 ---GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYF 172 (614)
Q Consensus 96 ---G~aF~l~p~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~ 172 (614)
||||+|+|.... .+..||++|+++. ++|||||+.|...+|+..||||||+|+..+..+.+..
T Consensus 81 ~gDG~aF~i~~~~~~---~g~~gg~~gl~~~----------~~v~fdt~~~~~~~d~~~nhi~i~~n~~~s~~~~~~~-- 145 (226)
T d1avba_ 81 SAYGLAFALVPVGSR---PKLKGRYLGLFNT----------TNYDRDAHTVAVVFDTVSNRIEIDVNSIRPIATESCN-- 145 (226)
T ss_dssp CCEEEEEEEEETTCC---CCCCGGGTTTCSC----------SSCCGGGCCEEEEEETTTTEEEEEESSSSCSEEEECC--
T ss_pred CCceEEEEEccCCCC---CCCccccCCcccc----------ccccccceeccccccCCCCEEEEeCCCCccccccccc--
Confidence 999999997754 4667899999764 4789999998766699999999999999988777654
Q ss_pred cCccCCCccccccCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcccccccccccccccCCC---cccee
Q 044561 173 SDREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGS---LKSSH 249 (614)
Q Consensus 173 ~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastg~---~~~~h 249 (614)
..+.+|+.++|||+||+.+++|+|++.+.+ ++..|.++..+||+.+||++|||||||+||. ..|.|
T Consensus 146 ---------~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~~~~~vdL~~~l~~~~y~GFSAaTG~~s~~~~~H 214 (226)
T d1avba_ 146 ---------FGHNNGEKAEVRITYDSPKNDLRVSLLYPS--SEEKCHVSATVPLEKEVEDWVSVGFSATSGSKKETTETH 214 (226)
T ss_dssp ---------SGGGTTCEEEEEEEEEGGGTEEEEEEEETT--TTEEEEEEEECCHHHHSCSEEEEEEEEEECSSGGGCEEE
T ss_pred ---------cccCCCeEEEEEEEEcCCCcEEEEEEEeCC--CCccEEEEEEecHHHccCCcEEEEEEEEcCCCCCCeeee
Confidence 356799999999999999999999998764 6777889999999999999999999999995 56789
Q ss_pred eEeccccccC
Q 044561 250 YVLGWSFNRS 259 (614)
Q Consensus 250 ~i~sWsf~~~ 259 (614)
+|++|+|+++
T Consensus 215 ~IlsWsF~s~ 224 (226)
T d1avba_ 215 NVLSWSFSSN 224 (226)
T ss_dssp EEEEEEEEEE
T ss_pred EEEEEEeEEe
Confidence 9999999864
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-43 Score=367.16 Aligned_cols=260 Identities=26% Similarity=0.307 Sum_probs=194.6
Q ss_pred CCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEEeeEEeec------CeEEE
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRK------GEFLL 418 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~~~l 418 (614)
+|+..++||+|+||+||+|+... ++.||||++..+... ..+|+.++++++||||+++++++... ..++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 46777899999999999999875 889999999765432 24799999999999999999998543 35899
Q ss_pred EEEecCCCCcchhccc-CCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCC-CEEEeeecccccc
Q 044561 419 VYDYMPNGSLDKILHT-NIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADL-NGKLGDFGLARLY 496 (614)
Q Consensus 419 V~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~-~~kl~DfGla~~~ 496 (614)
|||||+++.+..+... .....+++.++..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987654444321 224469999999999999999999994 8999999999999999775 8999999999876
Q ss_pred CCCCCCcccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHH--------HHhhh
Q 044561 497 DHDTIPQTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWV--------CDCWK 567 (614)
Q Consensus 497 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v--------~~~~~ 567 (614)
.... ......||..|+|||.+.. ..++.++||||+||++|||++|+.||......+....+... +....
T Consensus 174 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 174 VRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp CTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred cCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence 5543 2334579999999998765 46899999999999999999999999876544433222111 11110
Q ss_pred ----cCCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 568 ----KGAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 568 ----~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.......................+.+|+.+||+.||++|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01111111111111111122345777888999999999999999985
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-43 Score=362.33 Aligned_cols=265 Identities=24% Similarity=0.352 Sum_probs=197.8
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEee--------c
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRR--------K 413 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--------~ 413 (614)
++|+..+.||+|+||+||+|+.+ +++.||||++... .+...+++.+|++++++++|||++++++++.. +
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 67888999999999999999986 5889999998644 33345678899999999999999999998855 3
Q ss_pred CeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccc
Q 044561 414 GEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLA 493 (614)
Q Consensus 414 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla 493 (614)
+.+++|||||+++.+...... ...++..++..++.||++||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeeccee
Confidence 568999999988877665544 3458899999999999999999995 89999999999999999999999999999
Q ss_pred cccCCCCC---CcccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcC
Q 044561 494 RLYDHDTI---PQTTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKG 569 (614)
Q Consensus 494 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~ 569 (614)
+....... ......+||+.|+|||++... .++.++||||+||++|||++|+.||.+....+....+..........
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 244 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence 86653321 122335799999999998755 68999999999999999999999998765444333332222111111
Q ss_pred Cccccccccc--------cCcCc-HH------HHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 570 AIRDASDSRL--------EGICE-EK------QMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 570 ~~~~~~d~~l--------~~~~~-~~------~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.......... ..... .+ ....+.+|+.+||++||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 1111100000 00000 00 1234567899999999999999999974
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-42 Score=348.52 Aligned_cols=262 Identities=22% Similarity=0.289 Sum_probs=203.4
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecCeEEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 421 (614)
++|+..+.||+|+||+||+|+.. +++.||||+++.. .....+++.+|+.+++.++||||+++++++......++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 46888999999999999999986 4788999998654 33456789999999999999999999999999999999999
Q ss_pred ecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccCCCCC
Q 044561 422 YMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI 501 (614)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~~~~~ 501 (614)
++.+++|..++... ..+++..+..++.|+++||+|||+ ++|+||||||+|||++.++++||+|||.++.......
T Consensus 82 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 82 FCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred eccccccccccccc--cccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 99999998887653 458999999999999999999995 8999999999999999999999999999987654432
Q ss_pred CcccccccCCCccchhhhcCCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcC---Ccc-----
Q 044561 502 PQTTKLVGTFGYMDPELMRTGK-ASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKG---AIR----- 572 (614)
Q Consensus 502 ~~~~~~~gt~~y~aPE~~~~~~-~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~---~~~----- 572 (614)
......++..|+|||.+.... ++.++||||+||+++||++|+.||....... .....+....... ...
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred -cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH--HHHHHHHhhcCCCChhhhhhhhhc
Confidence 223346788999999987654 6899999999999999999999975433222 1122222211110 000
Q ss_pred -cccc------ccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 573 -DASD------SRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 573 -~~~d------~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
+..+ ..-.........+.+.+|+.+|+++||++|||+.||++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 00000111222345677888999999999999999985
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-43 Score=363.16 Aligned_cols=259 Identities=23% Similarity=0.339 Sum_probs=193.7
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeecC------
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKG------ 414 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 414 (614)
.++|+..+.||+|+||+||+|..+. ++.||||++... .+...+.+.+|+.+|++++||||++++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 3578889999999999999999865 889999999753 4445678899999999999999999999997654
Q ss_pred eEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeecccc
Q 044561 415 EFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR 494 (614)
Q Consensus 415 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~ 494 (614)
++++||||| +.+|..+++. ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhccccccccccccccee
Confidence 579999999 5677777654 349999999999999999999995 899999999999999999999999999998
Q ss_pred ccCCCCCCcccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHh--------
Q 044561 495 LYDHDTIPQTTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDC-------- 565 (614)
Q Consensus 495 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~-------- 565 (614)
..+.. .+...||+.|+|||++.+. .++.++||||+||+++||++|+.||...+..+...........
T Consensus 170 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (346)
T d1cm8a_ 170 QADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245 (346)
T ss_dssp ECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred ccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence 76543 3456899999999998764 5689999999999999999999999876543332222111100
Q ss_pred hhc-------CCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 566 WKK-------GAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 566 ~~~-------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
... ..+.+.....+. .........+.+|+.+||+.||++|||+.|+|+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 246 LQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 000000000010 011112234667888999999999999999974
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-43 Score=362.70 Aligned_cols=261 Identities=25% Similarity=0.327 Sum_probs=195.6
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCC-hhhHHHHHHHHHHhcccCCCceeEEeeEEeecC----eEE
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDS-KQGIKEFVAELVSMGRLRHRNLVKLRGYCRRKG----EFL 417 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~ 417 (614)
+.+|+..+.||+|+||+||+|+.+ +++.||||++.... ....+.+.+|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 356888999999999999999975 58999999997543 445678899999999999999999999987643 234
Q ss_pred EEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccccC
Q 044561 418 LVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYD 497 (614)
Q Consensus 418 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~~~ 497 (614)
++++|+.+|+|.+++..+ .+++.++..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 87 ~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 445566799999999754 49999999999999999999995 899999999999999999999999999998654
Q ss_pred CCCC--CcccccccCCCccchhhhcC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCC----
Q 044561 498 HDTI--PQTTKLVGTFGYMDPELMRT-GKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGA---- 570 (614)
Q Consensus 498 ~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~---- 570 (614)
.... ......+||+.|+|||++.. ..++.++||||+||+++||++|+.||......+................
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence 3321 22345679999999999854 4678999999999999999999999976654333222211111000000
Q ss_pred -----------cccccc---ccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 571 -----------IRDASD---SRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 571 -----------~~~~~d---~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
...... ..+.... ...+..|+.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNRLFPNA----DSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhcccccCCccCCCCHHHhCCCC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 0000111 134678889999999999999999985
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.7e-41 Score=349.21 Aligned_cols=257 Identities=20% Similarity=0.272 Sum_probs=195.3
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccC-CCceeEEeeEEee--cCeEEEEE
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLR-HRNLVKLRGYCRR--KGEFLLVY 420 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~--~~~~~lV~ 420 (614)
++|+..++||+|+||+||+|+... ++.||+|++.... .+++.+|+.+|++++ ||||+++++++.. ...+++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 478899999999999999999864 8889999987544 356789999999995 9999999999874 45699999
Q ss_pred EecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCC-CEEEeeeccccccCCC
Q 044561 421 DYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADL-NGKLGDFGLARLYDHD 499 (614)
Q Consensus 421 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~-~~kl~DfGla~~~~~~ 499 (614)
|||++++|..+.+ .+++.++..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||+++.....
T Consensus 112 e~~~~~~L~~~~~-----~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 112 EHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp ECCCSCBGGGTTT-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eecCCCcHHHHhc-----CCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 9999999987643 38999999999999999999995 8999999999999998765 5899999999876654
Q ss_pred CCCcccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcccc-ccHHHHH------HHhhhcCCc
Q 044561 500 TIPQTTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSMET-VNLVDWV------CDCWKKGAI 571 (614)
Q Consensus 500 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~-~~l~~~v------~~~~~~~~~ 571 (614)
. ......+|+.|+|||.+.+. .++.++||||+||+++||++|+.||........ ...+... .........
T Consensus 184 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 184 Q--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp C--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred C--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 3 23455789999999998765 479999999999999999999999976543211 1111000 000000000
Q ss_pred ---cc---cc-------ccc-ccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 572 ---RD---AS-------DSR-LEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 572 ---~~---~~-------d~~-l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
.. .. ... ............+.+|+.+||+.||++|||++|+|+
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00 000 000011112235677888999999999999999985
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-42 Score=355.16 Aligned_cols=252 Identities=23% Similarity=0.321 Sum_probs=201.9
Q ss_pred cCCCCcceeeeeCcEEEEEEEEe----cCcEEEEEEeecC----ChhhHHHHHHHHHHhcccCC-CceeEEeeEEeecCe
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLA----SNVQIAVKKVSHD----SKQGIKEFVAELVSMGRLRH-RNLVKLRGYCRRKGE 415 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~ 415 (614)
++|+..+.||+|+||+||+|+.. +++.||+|.+... .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56899999999999999999863 3788999998543 22234567899999999977 899999999999999
Q ss_pred EEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccc
Q 044561 416 FLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARL 495 (614)
Q Consensus 416 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~ 495 (614)
++++||||.+|+|.+++.... .++......++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 999999999999999997643 47788999999999999999995 8999999999999999999999999999987
Q ss_pred cCCCCCCcccccccCCCccchhhhcCC--CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccc
Q 044561 496 YDHDTIPQTTKLVGTFGYMDPELMRTG--KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRD 573 (614)
Q Consensus 496 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~ 573 (614)
.............|++.|+|||.+... .++.++|||||||+||||++|+.||......+....+ ........
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i---~~~~~~~~--- 252 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI---SRRILKSE--- 252 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH---HHHHHHCC---
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHhcccCC---
Confidence 655444444556899999999998754 4688999999999999999999999876554433222 11111111
Q ss_pred cccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHhC
Q 044561 574 ASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPN-----MRQVMQ 614 (614)
Q Consensus 574 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 614 (614)
..+.. .....+.+++.+||++||++||| ++|+++
T Consensus 253 ---~~~~~----~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 ---PPYPQ----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ---CCCCT----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ---CCCcc----cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 11111 22346777888899999999995 788874
|
| >d1dhkb_ b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=1.2e-41 Score=326.41 Aligned_cols=189 Identities=31% Similarity=0.501 Sum_probs=158.0
Q ss_pred CCcceEEeCCCCCCCCceEecceeEcCCCcEEecCCCCCCceeeEeeCCceeecCCC-CCceeeeeeeEEee--------
Q 044561 25 QDVNQFIYHGFNEDAQLQRDGLASVHSNGLLQLTNTVSPQQEGHAFYRLPIKFNTSS-SESLSFSSNFVFAI-------- 95 (614)
Q Consensus 25 ~~~~~f~~~~f~~~~~~~~~g~a~~~~~g~l~Lt~~~~~~~~G~~~y~~pv~l~~~~-~~~~sF~t~F~f~i-------- 95 (614)
+..++|+|++|+. ++|+|+|||.+.++|.||||++.+ +++|||||++||+||++. +.++||+|+|+|.|
T Consensus 1 a~~~sF~~~~F~~-~~l~l~GdA~v~~~g~i~LT~~~~-~~~G~~~y~~Pi~l~~~~~~~~~sF~t~F~f~i~~~~~~~~ 78 (204)
T d1dhkb_ 1 ATETSFIIDAFNK-TNLILQGDATVSSNGNLQLSYNSY-DSMSRAFYSAPIQIRDSTTGNVASFDTNFTMNIRTHRQANS 78 (204)
T ss_dssp CCCCEEEESSCCG-GGEEEESSEEECTTSCEEESSSCS-SEEEEEEESSCEESEETTTTEECEEEEEEEEEEECCC---C
T ss_pred CccceEECCCCCc-cCeeEecceEEcCCCeEEeCCCCC-CCEEEEEeCCCEeccCCCCcccccEEEEEEEEEecCCCCCC
Confidence 3568999999987 789999999998899999999877 899999999999999987 78899999999999
Q ss_pred --eeEEEEcCCCCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeeEecCCCcccccccCcccc
Q 044561 96 --GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFS 173 (614)
Q Consensus 96 --G~aF~l~p~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~ 173 (614)
||||+++|.... ..++.+||||||++| |+++|+|+...... .+
T Consensus 79 gdGlaf~~~~~~~~---------------------~~~~~~~vefDt~~n---------~~~~d~~~~~~~~~-~~---- 123 (204)
T d1dhkb_ 79 AVGLDFVLVPVQPE---------------------SKGDTVTVEFDTFLS---------RISIDVNNNDIKSV-PW---- 123 (204)
T ss_dssp CSEEEEEEEEC---------------------------CCEEEEEETTTT---------EEEEEETTEEEEEE-EC----
T ss_pred CceEEEEecCCCCC---------------------CCCcEeeEeeEcccc---------cccCcccccccccc-cc----
Confidence 999999985421 224679999999875 66666666432211 11
Q ss_pred CccCCCccccccCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcccccccccccccccCCCc---cceee
Q 044561 174 DREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSL---KSSHY 250 (614)
Q Consensus 174 ~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastg~~---~~~h~ 250 (614)
...+.+|+.++|||+||+.+++|+|++++.+ +|..|.++..+||+.+||++||||||||||.. .|.|+
T Consensus 124 -------~~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~l~~~vdL~~~l~~~~yvGFSAaTG~~~~~~e~H~ 194 (204)
T d1dhkb_ 124 -------DVHDYDGQNAEVRITYNSSTKVFSVSLSNPS--TGKSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHD 194 (204)
T ss_dssp -------CGGGTTTSCEEEEEEEETTTTEEEEEEECTT--TCCEEEEEEECCCCSGGGSEEEEEEEEEECSGGGSCCEEE
T ss_pred -------ccEecCCCEEEEEEEEcCCCEEEEEEEecCC--CCCceeEEEEecchhccCCcEEEEEEeecCCCCCCceeeE
Confidence 2466799999999999999999999998765 56678899999999999999999999999963 57899
Q ss_pred EeccccccC
Q 044561 251 VLGWSFNRS 259 (614)
Q Consensus 251 i~sWsf~~~ 259 (614)
|++|+|+++
T Consensus 195 IlsWsFss~ 203 (204)
T d1dhkb_ 195 VLSWSFSSK 203 (204)
T ss_dssp EEEEEEEEE
T ss_pred EEEEEEEec
Confidence 999999863
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=355.05 Aligned_cols=260 Identities=22% Similarity=0.245 Sum_probs=190.9
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEee------cCe
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRR------KGE 415 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~------~~~ 415 (614)
++|+..++||+|+||+||+|+... ++.||||++... +....+++.+|+.++++++||||+++++++.. .+.
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 578899999999999999999874 899999999754 34556678999999999999999999999864 368
Q ss_pred EEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccc
Q 044561 416 FLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARL 495 (614)
Q Consensus 416 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~ 495 (614)
+|+|||||.++.+. .+. ..+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+|++|||+++.
T Consensus 97 ~~iv~Ey~~~~l~~-~~~----~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VIQ----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSEEHHH-HHT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eEEEEeccchHHHH-hhh----cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhhc
Confidence 99999999765554 443 238999999999999999999995 8999999999999999999999999999886
Q ss_pred cCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHH-------------
Q 044561 496 YDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWV------------- 562 (614)
Q Consensus 496 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v------------- 562 (614)
..... ..+...+|+.|+|||++.+..++.++||||+||+++||++|+.||...+.......+...
T Consensus 169 ~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 169 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred ccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 65433 334557999999999999999999999999999999999999999765433222111100
Q ss_pred ---HHhhhc-CCc-----ccccccccc---CcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 563 ---CDCWKK-GAI-----RDASDSRLE---GICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 563 ---~~~~~~-~~~-----~~~~d~~l~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
...... ... ......... ..........+.+|+.+|+++||++|||+.|||+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000 000 000001110 1112234556888999999999999999999985
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-41 Score=345.68 Aligned_cols=253 Identities=17% Similarity=0.223 Sum_probs=190.7
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCCCceeEE-eeEEeecCeEEEEEEe
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNLVKL-RGYCRRKGEFLLVYDY 422 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l-~g~~~~~~~~~lV~E~ 422 (614)
++|+..+.||+|+||+||+|+... ++.||||.+...... +++..|+++++.++|+|++.. .++..+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 468889999999999999999864 889999988765432 457889999999987765554 5555777889999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEc---CCCCEEEeeeccccccCCC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD---ADLNGKLGDFGLARLYDHD 499 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~---~~~~~kl~DfGla~~~~~~ 499 (614)
+ +++|...+... ...+++..+..++.|++.||+|||+ ++|+||||||+|||++ .+..+||+|||+|+.....
T Consensus 85 ~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 85 L-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp C-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred c-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 9 55666665543 3459999999999999999999995 8999999999999985 4567999999999876543
Q ss_pred CC------CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCccc
Q 044561 500 TI------PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAIRD 573 (614)
Q Consensus 500 ~~------~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~ 573 (614)
.. .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+................
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~--- 236 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--- 236 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC---
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC---
Confidence 21 223456899999999999999999999999999999999999999987654443332221111111100
Q ss_pred cccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHh
Q 044561 574 ASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVM 613 (614)
Q Consensus 574 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 613 (614)
.+.+...++ ..+.+++..||+.||++||++.++.
T Consensus 237 --~~~~~~~~p----~~~~~li~~cl~~~p~~RP~~~~i~ 270 (299)
T d1ckia_ 237 --IEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLR 270 (299)
T ss_dssp --HHHHTTTSC----HHHHHHHHHHHHSCTTCCCCHHHHH
T ss_pred --hhHhccCCC----HHHHHHHHHHccCChhHCcCHHHHH
Confidence 111112222 3567788889999999999998764
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3e-41 Score=343.07 Aligned_cols=253 Identities=19% Similarity=0.230 Sum_probs=198.9
Q ss_pred cCCCCcceeeeeCcEEEEEEEEec-CcEEEEEEeecCChhhHHHHHHHHHHhcccCC-CceeEEeeEEeecCeEEEEEEe
Q 044561 345 KGFKDKDVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDSKQGIKEFVAELVSMGRLRH-RNLVKLRGYCRRKGEFLLVYDY 422 (614)
Q Consensus 345 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~E~ 422 (614)
++|+..+.||+|+||+||+|+... ++.||||.+...... +++.+|++.++.++| +|++++++++......++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS--CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc--HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 578889999999999999999764 889999988654322 346678888888865 8999999999999999999999
Q ss_pred cCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcC-----CCCEEEeeeccccccC
Q 044561 423 MPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA-----DLNGKLGDFGLARLYD 497 (614)
Q Consensus 423 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~-----~~~~kl~DfGla~~~~ 497 (614)
+ +++|.+++.... ..+++.++..++.|++.||.||| +++|+||||||+|||++. ++.+||+|||+++...
T Consensus 83 ~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 83 L-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp C-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred c-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 9 789999887643 45999999999999999999999 589999999999999964 5789999999998765
Q ss_pred CCCC------CcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhcCCc
Q 044561 498 HDTI------PQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKKGAI 571 (614)
Q Consensus 498 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~~~~ 571 (614)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..............+.........
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence 3321 1234468999999999999999999999999999999999999999866544333222222221111111
Q ss_pred cccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHh
Q 044561 572 RDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVM 613 (614)
Q Consensus 572 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 613 (614)
+.+...++ +.+.+++..|++.+|++||++..+.
T Consensus 238 -----~~l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 238 -----RELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp -----HHHTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred -----HHhcCCCC----HHHHHHHHHHhcCCcccCcCHHHHH
Confidence 11122233 3466777889999999999987653
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-41 Score=352.76 Aligned_cols=260 Identities=22% Similarity=0.306 Sum_probs=194.5
Q ss_pred hcCCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecC--ChhhHHHHHHHHHHhcccCCCceeEEeeEEeec-----Ce
Q 044561 344 TKGFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHD--SKQGIKEFVAELVSMGRLRHRNLVKLRGYCRRK-----GE 415 (614)
Q Consensus 344 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~ 415 (614)
.++|+..+.||+|+||+||+|+.. +++.||||++... +....+++.+|+.++++++|||++++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 457888999999999999999975 4899999999754 344556789999999999999999999998633 34
Q ss_pred EEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeeeccccc
Q 044561 416 FLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARL 495 (614)
Q Consensus 416 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~~ 495 (614)
.+++++|+.+|+|.+++..+ .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+|++|||++..
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred eEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhcc
Confidence 46667788899999998653 49999999999999999999995 8999999999999999999999999999975
Q ss_pred cCCCCCCcccccccCCCccchhhhcCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHHHhhhc------
Q 044561 496 YDHDTIPQTTKLVGTFGYMDPELMRTG-KASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVCDCWKK------ 568 (614)
Q Consensus 496 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~~~~~~------ 568 (614)
... ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||.+.+.......+.........
T Consensus 171 ~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (348)
T d2gfsa1 171 TDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246 (348)
T ss_dssp CTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred cCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhc
Confidence 543 23445789999999987665 4689999999999999999999999876543332222111000000
Q ss_pred ---------CCccccccccccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHhC
Q 044561 569 ---------GAIRDASDSRLEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVMQ 614 (614)
Q Consensus 569 ---------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 614 (614)
..........+... .......+.+|+.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 247 SSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp CCHHHHHHHTTSCCCCCCCHHHH-STTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cchhhhhhhhhcccCCCcchhhh-cCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 00000000000000 0011234677888999999999999999985
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.6e-36 Score=314.61 Aligned_cols=262 Identities=19% Similarity=0.247 Sum_probs=190.1
Q ss_pred CCCCcceeeeeCcEEEEEEEEe-cCcEEEEEEeecCChhhHHHHHHHHHHhcccC-----------CCceeEEeeEEeec
Q 044561 346 GFKDKDVIGRGGFGKVYRGVLA-SNVQIAVKKVSHDSKQGIKEFVAELVSMGRLR-----------HRNLVKLRGYCRRK 413 (614)
Q Consensus 346 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----------H~niv~l~g~~~~~ 413 (614)
+|+..+.||+|+||+||+|+.. +++.||||++..+.. ..+.+.+|+.++++++ |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 4888999999999999999986 488999999976533 3456778888887775 57899999988654
Q ss_pred --CeEEEEEEecCCCCc-chhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCC------
Q 044561 414 --GEFLLVYDYMPNGSL-DKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLN------ 484 (614)
Q Consensus 414 --~~~~lV~E~~~~gsL-~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~------ 484 (614)
...+++++++..+.. ...........+++..+..++.||++||.|||+ ..+|+||||||+|||++.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccce
Confidence 466777777655543 333333444568999999999999999999996 489999999999999987654
Q ss_pred EEEeeeccccccCCCCCCcccccccCCCccchhhhcCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCccccccHHHHHH-
Q 044561 485 GKLGDFGLARLYDHDTIPQTTKLVGTFGYMDPELMRTGKASTSTDVYAFGVFMLEVASGRRPVEQQGSMETVNLVDWVC- 563 (614)
Q Consensus 485 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~S~Gvll~el~tg~~p~~~~~~~~~~~l~~~v~- 563 (614)
+|++|||.+...... ....+||+.|+|||++....++.++||||+||+++||++|+.||............+...
T Consensus 171 ~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 171 IKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 899999999765432 234579999999999999999999999999999999999999997543221111111110
Q ss_pred --Hhh--------hcC----------Cc-ccccccc---------ccCcCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHh
Q 044561 564 --DCW--------KKG----------AI-RDASDSR---------LEGICEEKQMELVLKLGLFCSHPKPEARPNMRQVM 613 (614)
Q Consensus 564 --~~~--------~~~----------~~-~~~~d~~---------l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 613 (614)
... ..+ .. ....... ............+.+|+.+|++.||++|||++|+|
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 000 000 00 0000000 01123455677889999999999999999999998
Q ss_pred C
Q 044561 614 Q 614 (614)
Q Consensus 614 ~ 614 (614)
+
T Consensus 327 ~ 327 (362)
T d1q8ya_ 327 N 327 (362)
T ss_dssp T
T ss_pred c
Confidence 6
|
| >d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Concanavalin A species: Jack bean (Canavalia ensiformis) [TaxId: 3823]
Probab=99.97 E-value=1.3e-31 Score=257.53 Aligned_cols=114 Identities=32% Similarity=0.481 Sum_probs=105.3
Q ss_pred CCcEEEEEeeccCCCCCCCCCCCeeeEecCCCcccccccCccccCccCCCccccccCCccEEEEEEEeCCCcEEEEEEee
Q 044561 130 TNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAP 209 (614)
Q Consensus 130 ~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~ 209 (614)
.|++|||||||++|.+++||++||||||+||+.|.++.++ ++.+|+.++|||+||+.+++|+|++.+
T Consensus 1 an~ivAVEFDT~~N~~~~Dp~~nHIgIdvns~~S~~~~~~-------------~l~~G~~~~v~I~Yd~~~~~L~V~~~~ 67 (237)
T d1nlsa_ 1 ADTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAKW-------------NMQNGKVGTAHIIYNSVDKRLSAVVSY 67 (237)
T ss_dssp CCCEEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEEC-------------CCCTTCEEEEEEEEETTTTEEEEEEEC
T ss_pred CCCEEEEEEECCcCCCCCCCCCCEEEEEeCCCCccceecc-------------cccCCCEEEEEEEEecCCcEEEEEEec
Confidence 3799999999999998899999999999999999877654 578999999999999999999999974
Q ss_pred CCCCCCCCCceeeeccCcccccccccccccccCCCccceeeEeccccccC
Q 044561 210 MSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLKSSHYVLGWSFNRS 259 (614)
Q Consensus 210 ~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastg~~~~~h~i~sWsf~~~ 259 (614)
. ++..|++++.|||+++|+++||||||||||...|.|+|++|+|+++
T Consensus 68 ~---~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~h~I~sWsFsS~ 114 (237)
T d1nlsa_ 68 P---NADSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSK 114 (237)
T ss_dssp T---TSCCEEEEEECCGGGTSCSEEEEEEEEECSSSCCCCEEEEEEEEEE
T ss_pred C---CCCCeEEEEEEChHHhCCCcEEEEEEeecCCCccceEEEEEEEEee
Confidence 3 5677899999999999999999999999999999999999999875
|
| >d1gv9a_ b.29.1.13 (A:) Carbohydrate-recognition domain of P58/ERGIC-53 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Carbohydrate-recognition domain of P58/ERGIC-53 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.92 E-value=3.3e-25 Score=215.59 Aligned_cols=201 Identities=15% Similarity=0.156 Sum_probs=132.9
Q ss_pred eEEeCCCCC----CCCceEecceeEcCCCcEEecCCCCCCceeeEeeCCceeecCCCCCceeeeeeeEEee---------
Q 044561 29 QFIYHGFNE----DAQLQRDGLASVHSNGLLQLTNTVSPQQEGHAFYRLPIKFNTSSSESLSFSSNFVFAI--------- 95 (614)
Q Consensus 29 ~f~~~~f~~----~~~~~~~g~a~~~~~g~l~Lt~~~~~~~~G~~~y~~pv~l~~~~~~~~sF~t~F~f~i--------- 95 (614)
||..|.+.. .....+.|+|.+. ++.||||++.. .++|++||++|+++. +|+|+|+|.+
T Consensus 10 sf~~P~~~~~~~~~~~w~~~G~a~i~-~~~i~LT~~~~-~~~G~v~~~~p~~~~-------~F~~~f~f~~~~~~~~ggd 80 (228)
T d1gv9a_ 10 SFKGPHLVQSDGTVPFWAHAGNAIPS-ADQIRIAPSLK-SQRGSVWTKTKAAFE-------NWEVEVTFRVTGRGRIGAD 80 (228)
T ss_dssp CEECSSCSCTTSCBTTEEEEETCEEC-SSCEEEECSST-TCEEEEEESSCBCCS-------SEEEEEEEEEECSSSCCCC
T ss_pred ccCCCcccCCCCCccceEEeeeEEEE-CCEEEECCCCC-CCEEEEEeCCCcccc-------CcEEEEEEeccCCCCCCCC
Confidence 455554433 2356899999986 88999999877 899999999999884 3999999998
Q ss_pred eeEEEEcCCCCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeeEecCCCccccccc-CccccC
Q 044561 96 GMAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAP-AAYFSD 174 (614)
Q Consensus 96 G~aF~l~p~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~-~~~~~~ 174 (614)
||||+|+|... ..|+.+|.. +..+-+||||||+.|. ++++.+|+.++.|......... -.+...
T Consensus 81 G~aF~i~~~~~------~~g~~~G~~-------~~~~glaVefDt~~n~--~~~~~~~~~~~~n~~~~~~~~~~~~~~~~ 145 (228)
T d1gv9a_ 81 GLAIWYTENQG------LDGPVFGSA-------DMWNGVGIFFDSFDND--GKKNNPAIVVVGNNGQINYDHQNDGATQA 145 (228)
T ss_dssp EEEEEEESSCC------CEEEETTEC-------SCCEEEEEEEECCCC-------CCEEEEEEEESCCCCCHHHHHHHHC
T ss_pred EEEEEEecCCC------CCCCccCcC-------CCCceEEEEEEccccc--CCCCCCcEEEEecCCcceeeecCCCcccc
Confidence 99999998642 345566652 2345699999999996 5788888888876432111100 000000
Q ss_pred ccCCCccccccCCccEEEEEEEeCCCcEEEEEEeeCCCCCCCCCceeeeccCcccccccccccccccCCCccceeeEecc
Q 044561 175 REGMNKTLELIIGDPIQIWISYDGAEKLLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLKSSHYVLGW 254 (614)
Q Consensus 175 ~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastg~~~~~h~i~sW 254 (614)
....... ...++..+++||+|+ .+.|+|++..........+.....++ ...+++++|||||||||...+.|.|++|
T Consensus 146 ~~~~~~~-~~~~~~~~~i~~~~~--~~~l~v~i~~~~~~~~~~~~~~~~~~-~~~l~~~~y~GFTAsTG~~~~~H~I~s~ 221 (228)
T d1gv9a_ 146 LASCQRD-FRNKPYPVRAKITYY--QKTLTVMINNGFTPDKNDYEFCAKVE-NMVIPTQGHFGISAATGGLADDHDVLSF 221 (228)
T ss_dssp SEEECCC-CBSCSSCEEEEEEEE--TTEEEEEEECSSCCCTTCCEEEEEET-TCCCCSSBEEEEEEECCSSCCEEEEEEE
T ss_pred ccceeee-ecCCceEEEEEEEec--CCEEEEEEeccccCCCcceeEEEEec-ccccCCCEEEEEEEeCCCCcCeEEEEEE
Confidence 0000000 112344555555555 78899999765443333333333333 5678999999999999999999999999
Q ss_pred ccc
Q 044561 255 SFN 257 (614)
Q Consensus 255 sf~ 257 (614)
.+.
T Consensus 222 ~~~ 224 (228)
T d1gv9a_ 222 LTF 224 (228)
T ss_dssp EEE
T ss_pred EEE
Confidence 764
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=1.2e-22 Score=191.67 Aligned_cols=162 Identities=12% Similarity=0.099 Sum_probs=120.3
Q ss_pred CcceeeeeCcEEEEEEEEecCcEEEEEEeecCC------------------hhhHHHHHHHHHHhcccCCCceeEEeeEE
Q 044561 349 DKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDS------------------KQGIKEFVAELVSMGRLRHRNLVKLRGYC 410 (614)
Q Consensus 349 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~------------------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~ 410 (614)
..++||+|+||+||+|+..++..||||.+.... .........|...+.++.|.++++.+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 467899999999999998889999999864321 01123345688889999999999887653
Q ss_pred eecCeEEEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhccCCCceEecCcCCCCeEEcCCCCEEEeee
Q 044561 411 RRKGEFLLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDF 490 (614)
Q Consensus 411 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~Df 490 (614)
. .+++|||+++..+.+ ++......++.|++++|.|||+ .+|+||||||+|||++++ .++|+||
T Consensus 84 ~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 84 G----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp T----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEECCC
T ss_pred C----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEEEEC
Confidence 2 279999998765433 4455667899999999999995 899999999999999865 5899999
Q ss_pred ccccccCCCCCCcccccccCCCccch------hhhcCCCCCcchhHHHHHHHH
Q 044561 491 GLARLYDHDTIPQTTKLVGTFGYMDP------ELMRTGKASTSTDVYAFGVFM 537 (614)
Q Consensus 491 Gla~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~t~~~Dv~S~Gvll 537 (614)
|+|....++... .|+.. |.+ .++|..++|+||..--+
T Consensus 147 G~a~~~~~~~~~---------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGWR---------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTHH---------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred CCcccCCCCCcH---------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 999866543211 11111 111 35678899999975443
|
| >d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Concanavalin A species: Jack bean (Canavalia ensiformis) [TaxId: 3823]
Probab=99.86 E-value=1.6e-22 Score=193.83 Aligned_cols=98 Identities=31% Similarity=0.513 Sum_probs=86.2
Q ss_pred CCcceEEeCCCCC-CCCceEecceeEcCCCcEEecCCCC-----CCceeeEeeCCceeecCCCCCceeeeeeeEEee---
Q 044561 25 QDVNQFIYHGFNE-DAQLQRDGLASVHSNGLLQLTNTVS-----PQQEGHAFYRLPIKFNTSSSESLSFSSNFVFAI--- 95 (614)
Q Consensus 25 ~~~~~f~~~~f~~-~~~~~~~g~a~~~~~g~l~Lt~~~~-----~~~~G~~~y~~pv~l~~~~~~~~sF~t~F~f~i--- 95 (614)
+...+|+|++|.+ ..+|.|+|+|.+.++|.||||+... ..++|||+|++||||||++++++||+|+|+|.|
T Consensus 123 sn~~~F~f~~F~~~~~nl~l~G~A~i~~~G~l~LT~~~~~~~~~~~s~Gra~y~~Pv~l~d~t~~~~SFsT~F~F~I~~~ 202 (237)
T d1nlsa_ 123 TNALHFMFNQFSKDQKDLILQGDATTGTDGNLELTRVSSNGSPQGSSVGRALFYAPVHIWESSAVVASFEATFTFLIKSP 202 (237)
T ss_dssp EEEEEEEESCCCTTCTTEEEEETCEEEETTEEESSCBCTTSCBCSSCEEEEEESSCEECCCTTEEEEEEEEEEEEECCCS
T ss_pred cccceEEeeecCCCCCCEEEeeeeEecCCCcEEecCCCCCCcccCcceEEEEeCCCEEEECCCCcEeeEEEEEEEEEecC
Confidence 3467999999986 5799999999998899999998542 368999999999999998788999999999999
Q ss_pred ------eeEEEEcCCCC-CCCCCCCCCCcccccccC
Q 044561 96 ------GMAFVISPSKD-LGKAEASPSEYLGLFNAS 124 (614)
Q Consensus 96 ------G~aF~l~p~~~-~~~~~~~~g~~lGl~~~~ 124 (614)
||||||+|.+. .| .++.||||||||.+
T Consensus 203 ~~~~gdG~aF~iap~~~~~p--~~~~g~~LGL~n~~ 236 (237)
T d1nlsa_ 203 DSHPADGIAFFISNIDSSIP--SGSTGRLLGLFPDA 236 (237)
T ss_dssp SSSCCCEEEEEEECTTCCCC--TTCCGGGTTTCSSC
T ss_pred CCCCCCCEEEEEeCCCCCCC--CCCCCCeeeeccCC
Confidence 99999999653 34 68899999999886
|
| >d2a6za1 b.29.1.13 (A:7-227) Emp47p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Emp47p N-terminal domain species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.76 E-value=3.5e-18 Score=163.98 Aligned_cols=185 Identities=14% Similarity=0.144 Sum_probs=120.9
Q ss_pred EEeCCCCC----CCCceEecceeEcCCCcEEecCCCCCCceeeEeeCCceeecCCCCCceeeeeeeEEee---------e
Q 044561 30 FIYHGFNE----DAQLQRDGLASVHSNGLLQLTNTVSPQQEGHAFYRLPIKFNTSSSESLSFSSNFVFAI---------G 96 (614)
Q Consensus 30 f~~~~f~~----~~~~~~~g~a~~~~~g~l~Lt~~~~~~~~G~~~y~~pv~l~~~~~~~~sF~t~F~f~i---------G 96 (614)
|++|.+.. ..+..+.|+|.+. +|.|+||++ . .+.|.+|+..|+++++. |+++|.|.| |
T Consensus 10 ~s~p~~~~~~~~~~~W~~~g~a~~~-~~~i~LTp~-~-~~~G~~w~~~~i~~~~~------f~~~~~F~i~g~~~~ggdG 80 (221)
T d2a6za1 10 YSLPDLINTRKVPNNWQTGEQASLE-EGRIVLTSN-Q-NSKGSLWLKQGFDLKDS------FTMEWTFRSVGYSGQTDGG 80 (221)
T ss_dssp GCBCCCTTCCSCCTTEEEEETCEEE-TTEEESCCS-T-TCEEEEEESSCEECCSC------EEEEEEEEEESCCSCCSCE
T ss_pred ccCCCccccccCCCccEEcceeEEE-CCEEEECCC-C-CCceEEEECCccccCCC------eEEEEEEEEeCCCCCCCCc
Confidence 66665532 3579999999997 899999986 4 68899999999999876 999999999 9
Q ss_pred eEEEEcCCCCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeeEecCCCcccccc----cCccc
Q 044561 97 MAFVISPSKDLGKAEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESA----PAAYF 172 (614)
Q Consensus 97 ~aF~l~p~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~----~~~~~ 172 (614)
|||++++.... +..|+++|..+. ..-+||||||+.|. ....|+.++-++..-..+. ..+..
T Consensus 81 ~af~~~~~~~~----~~~g~~~G~~~~-------~~GlaV~fDt~~n~----~~~~~~~~ndgt~~~~~~~~~~~~~~~~ 145 (221)
T d2a6za1 81 ISFWFVQDSNI----PRDKQLYNGPVN-------YDGLQLLVDNNGPL----GPTLRGQLNDGQKPVDKTKIYDQSFASC 145 (221)
T ss_dssp EEEEEEECSSS----CCCCTBTTBCTT-------CEEEEEEEESCSTT----SSEEEEEEEESSSCCCGGGHHHHCSEEE
T ss_pred EEEEEEcCCCc----cccccccccCCC-------CceEEEEEECCCCC----CCceEEEecCCCccccccCCccccccee
Confidence 99999975422 234555554222 24489999999883 2233444443333211111 11100
Q ss_pred cCccCCCccccccCCccEEEEEEEeCCCcE-EEEEEeeCCCCCCCCCceeeeccCcccccccccccccccCCCccceeeE
Q 044561 173 SDREGMNKTLELIIGDPIQIWISYDGAEKL-LNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLKSSHYV 251 (614)
Q Consensus 173 ~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~-l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastg~~~~~h~i 251 (614)
. . -...++...+++|+|++.++. |.|.+... +-..++--.+-++.+|+||||+||...+.|.+
T Consensus 146 ~------~-~~~~~~~~~~~~I~y~~~~~~~l~v~id~~---------~c~~~~~v~lp~~~~~fG~SA~TG~~~~~hd~ 209 (221)
T d2a6za1 146 L------M-GYQDSSVPSTIRVTYDLEDDNLLKVQVDNK---------VCFQTRKVRFPSGSYRIGVTAQNGAVNNNAES 209 (221)
T ss_dssp E------C-CCTTEEEEEEEEEEEEGGGTSEEEEEETTE---------EEEEESCCCCCSSEEEEEEEEECCSGGGCCCE
T ss_pred e------e-cccCCCCCEEEEEEEecCccceEEEEecCc---------EeEEECCeecCCCCEEEEEEEccCCccCCCce
Confidence 0 0 013467788999999976654 78877411 11112222222467899999999998888886
Q ss_pred ecc
Q 044561 252 LGW 254 (614)
Q Consensus 252 ~sW 254 (614)
+.+
T Consensus 210 ~~i 212 (221)
T d2a6za1 210 FEI 212 (221)
T ss_dssp EEE
T ss_pred EEE
Confidence 543
|
| >d2a6va1 b.29.1.13 (A:9-226) Emp46p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Emp46p N-terminal domain species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.75 E-value=5.1e-18 Score=162.20 Aligned_cols=180 Identities=16% Similarity=0.163 Sum_probs=121.1
Q ss_pred CCceEecceeEcCCCcEEecCCCCCCceeeEeeCCceeecCCCCCceeeeeeeEEee---------eeEEEEcCCCCCCC
Q 044561 39 AQLQRDGLASVHSNGLLQLTNTVSPQQEGHAFYRLPIKFNTSSSESLSFSSNFVFAI---------GMAFVISPSKDLGK 109 (614)
Q Consensus 39 ~~~~~~g~a~~~~~g~l~Lt~~~~~~~~G~~~y~~pv~l~~~~~~~~sF~t~F~f~i---------G~aF~l~p~~~~~~ 109 (614)
.+..+.|+|.+. +|.|+||++ . .+.|++|+..|+++++. |+++|+|.| ||||++++.....
T Consensus 22 ~~W~~~G~~~~~-~~~i~LTp~-~-~~~G~~w~~~~i~~~~~------f~i~~~F~i~g~~~~~~dG~afw~~~~~~~~- 91 (218)
T d2a6va1 22 SQWTLGDKVKLE-EGRFVLTPG-K-NTKGSLWLKPEYSIKDA------MTIEWTFRSFGFRGSTKGGLAFWLKQGNEGD- 91 (218)
T ss_dssp TTEEEEETCEEE-TTEEESCCS-T-TCEEEEEESSCBCCSSC------EEEEEEEEEESCCSCCSCEEEEEEECSCCCC-
T ss_pred CccEECCCEEEE-CCEEEECCC-C-CCeeEEEeCCccccccc------ceEEEEEEEeCCCCCCCCcEEEEEEcCCccc-
Confidence 678999999997 899999987 4 57899999999999876 999999999 9999999754321
Q ss_pred CCCCCCCcccccccCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeeEecCCCcccccccCccccCccCCCccc---cccC
Q 044561 110 AEASPSEYLGLFNASNNGQSTNHILAIELDTVQNLDFDDIDDNHVGIDVNSLISHESAPAAYFSDREGMNKTL---ELII 186 (614)
Q Consensus 110 ~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~~~~~~~~~---~l~~ 186 (614)
..+..+|..+.++ =+||||||+.|. .+||.+.+|.=. .+..... +..+... ...+
T Consensus 92 ~~~~~~G~~~~f~----------GlaV~fDt~~n~------~~~i~~~~ndGs----~~~~~~~--d~~~g~c~~~~~~~ 149 (218)
T d2a6va1 92 STELFGGSSKKFN----------GLMILLRLDDKL------GESVTAYLNDGT----KDLDIES--SPYFASCLFQYQDS 149 (218)
T ss_dssp CCTBTTTBCSSCE----------EEEEEEEEETTT------EEEEEEEEEESS----SCCCTTT--SCCSEEEECCCSSC
T ss_pred CCCcccccCCCcc----------eEEEEEECCCCC------CCeEEEEeCCCC----ccccccC--CcccceEEecccCC
Confidence 0111223233222 189999999884 368887765211 1100000 0011111 1346
Q ss_pred CccEEEEEEEeCCCc-EEEEEEeeCCCCCCCCCceeeeccCcccccccccccccccCCCccceeeEecccccc
Q 044561 187 GDPIQIWISYDGAEK-LLNVTLAPMSIPKPTKPLLSRAINLSHILLETMYVGFSASTGSLKSSHYVLGWSFNR 258 (614)
Q Consensus 187 g~~~~~~I~Y~~~~~-~l~v~~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastg~~~~~h~i~sWsf~~ 258 (614)
+.+.+++|.|+..+. .|+|.+.. ..-+-...|+| ..++++|+||||+||...+.|.|++|++..
T Consensus 150 ~~~~~~~i~Y~~~~~~~l~v~id~------~~c~~t~~i~l--p~~~~~yfG~SA~Tg~~~d~~dIls~~~~~ 214 (218)
T d2a6va1 150 MVPSTLRLTYNPLDNHLLKLQMDN------RVCFQTRKVKF--MGSSPFRIGTSAINDASKESFEILKMKLYD 214 (218)
T ss_dssp SSCEEEEEEEEGGGTSEEEEEETT------EEEEEESCCCG--GGTSCBEEEEEEECCTTCCEEEEEEEEEES
T ss_pred CCcEEEEEEEECcccceEEEEeCC------cEEEEECCeec--CCCCcEEEEEEECCCCCcCcEEEEEEEEEe
Confidence 778999999997664 46777631 11111222333 345679999999999999999999999864
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.39 E-value=3.7e-07 Score=87.99 Aligned_cols=149 Identities=18% Similarity=0.097 Sum_probs=96.2
Q ss_pred HHHHHHhcCCCCcceeeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccC-CCceeEEeeEEeecCeE
Q 044561 338 KDLYKATKGFKDKDVIGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLR-HRNLVKLRGYCRRKGEF 416 (614)
Q Consensus 338 ~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~ 416 (614)
.|+....+.|+..+..+-+..+.||+... ++..+++|+...........+.+|...+..+. +--+.+++.++...+..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 34555556666555544444568998764 45667888886654444445667777776653 43356778888888999
Q ss_pred EEEEEecCCCCcchhcccCCCCCcChhHHHHHHHHhHhhchhhhcc----------------------------------
Q 044561 417 LLVYDYMPNGSLDKILHTNIKPCLNWYQRFRIIRGVASGLLYLHED---------------------------------- 462 (614)
Q Consensus 417 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------------------------------- 462 (614)
++||+++++.++.+..... .+...++.++++.+..||+.
T Consensus 86 ~lv~~~l~G~~~~~~~~~~-------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC-------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEEeccccccccccccc-------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 9999999988875543211 11122233333333333310
Q ss_pred ----------------------CCCceEecCcCCCCeEEcCCCCEEEeeecccc
Q 044561 463 ----------------------WEQVVLHRDIKPANVLLDADLNGKLGDFGLAR 494 (614)
Q Consensus 463 ----------------------~~~~ivHrDikp~NIll~~~~~~kl~DfGla~ 494 (614)
....++|+|+.|.|||+++++.+-|.||+.+.
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 02348999999999999987666799999775
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.83 E-value=2.6e-05 Score=74.15 Aligned_cols=76 Identities=16% Similarity=0.082 Sum_probs=52.6
Q ss_pred eeeeeCc-EEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccC--CCceeEEeeEEeecCeEEEEEEecCCCCc
Q 044561 352 VIGRGGF-GKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLR--HRNLVKLRGYCRRKGEFLLVYDYMPNGSL 428 (614)
Q Consensus 352 ~lG~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~lV~E~~~~gsL 428 (614)
.+..|.. +.||+...+++..+++|........ .+..|...++.+. .-.+.+++.++.+.+..++||+++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3444543 6789998877777888876554332 3455666666553 23366778888888899999999988776
Q ss_pred ch
Q 044561 429 DK 430 (614)
Q Consensus 429 ~~ 430 (614)
.+
T Consensus 94 ~~ 95 (255)
T d1nd4a_ 94 LS 95 (255)
T ss_dssp TT
T ss_pred cc
Confidence 54
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.84 E-value=0.00095 Score=67.57 Aligned_cols=76 Identities=12% Similarity=0.050 Sum_probs=45.9
Q ss_pred ceeeeeCcEEEEEEEEec-CcEEEEEEeecCC-------hhhHHHHHHHHHHhcccC---CCceeEEeeEEeecCeEEEE
Q 044561 351 DVIGRGGFGKVYRGVLAS-NVQIAVKKVSHDS-------KQGIKEFVAELVSMGRLR---HRNLVKLRGYCRRKGEFLLV 419 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-------~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV 419 (614)
+.||.|....||+....+ +..+++|.-.... .....+...|...++.+. ...+.+++.+. ....++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEEE
Confidence 468999999999998765 6678888643211 111223445666666552 23455666554 4455789
Q ss_pred EEecCCCCc
Q 044561 420 YDYMPNGSL 428 (614)
Q Consensus 420 ~E~~~~gsL 428 (614)
||++++..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999976553
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.15 E-value=0.006 Score=59.65 Aligned_cols=135 Identities=16% Similarity=0.192 Sum_probs=76.6
Q ss_pred cEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCCCc-----eeEEe--eEEeecCeEEEEEEecCCCCcch
Q 044561 358 FGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRN-----LVKLR--GYCRRKGEFLLVYDYMPNGSLDK 430 (614)
Q Consensus 358 fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n-----iv~l~--g~~~~~~~~~lV~E~~~~gsL~~ 430 (614)
--.||+....+|..+++|..... ....+++..|...+..|...+ .+..- ......+..+.++++++|..+..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 34899999988998999887543 223455667777776664222 11111 12345667899999998765432
Q ss_pred h----c----------cc-------CCCCCcCh-------------------hHH---HHHHHHhHhhchh-hhccCCCc
Q 044561 431 I----L----------HT-------NIKPCLNW-------------------YQR---FRIIRGVASGLLY-LHEDWEQV 466 (614)
Q Consensus 431 ~----l----------~~-------~~~~~l~~-------------------~~~---~~i~~~ia~gL~y-LH~~~~~~ 466 (614)
. + +. ..+..+++ ..+ ...+..+...+.- +.+....+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 1 0 00 00111111 111 1122222222221 12223567
Q ss_pred eEecCcCCCCeEEcCCCCEEEeeeccccc
Q 044561 467 VLHRDIKPANVLLDADLNGKLGDFGLARL 495 (614)
Q Consensus 467 ivHrDikp~NIll~~~~~~kl~DfGla~~ 495 (614)
+||+|+.+.|||++++ ..+.||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 9999999999999753 45899998763
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.65 E-value=0.0088 Score=60.10 Aligned_cols=73 Identities=22% Similarity=0.248 Sum_probs=47.0
Q ss_pred ceeeeeCcEEEEEEEEecC--------cEEEEEEeecCChhhHHHHHHHHHHhcccCCCce-eEEeeEEeecCeEEEEEE
Q 044561 351 DVIGRGGFGKVYRGVLASN--------VQIAVKKVSHDSKQGIKEFVAELVSMGRLRHRNL-VKLRGYCRRKGEFLLVYD 421 (614)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E 421 (614)
+.|+-|-.-.+|+....++ ..+.++... .... .....+|..+++.+.-.++ .++++++.. .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPET-ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccch-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 5688888899999887542 345555444 3222 2344578888887753344 467777643 57999
Q ss_pred ecCCCCcc
Q 044561 422 YMPNGSLD 429 (614)
Q Consensus 422 ~~~~gsL~ 429 (614)
|+++.+|.
T Consensus 122 fi~g~~l~ 129 (395)
T d1nw1a_ 122 YIPSRPLS 129 (395)
T ss_dssp CCCEEECC
T ss_pred EeccccCC
Confidence 99876554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.33 E-value=0.088 Score=50.40 Aligned_cols=157 Identities=16% Similarity=0.051 Sum_probs=81.9
Q ss_pred cCHHHHHHHhcCCCCcce-----eeeeCcEEEEEEEEecCcEEEEEEeecCChhhHHHHHHHHHHhcccCC-----Ccee
Q 044561 335 FTYKDLYKATKGFKDKDV-----IGRGGFGKVYRGVLASNVQIAVKKVSHDSKQGIKEFVAELVSMGRLRH-----RNLV 404 (614)
Q Consensus 335 ~~~~el~~~~~~f~~~~~-----lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H-----~niv 404 (614)
.+.+|+....++|...+. |..|---+.|+.+.+++ .+++|+...... .++...|+..+..|.. |..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccc
Confidence 456777777778866544 33555577899887655 488888754321 1233445555555532 2222
Q ss_pred EEe-e--EEeecCeEEEEEEecCCCCcchhcc--------------c---CC-----CC-C----------------cCh
Q 044561 405 KLR-G--YCRRKGEFLLVYDYMPNGSLDKILH--------------T---NI-----KP-C----------------LNW 442 (614)
Q Consensus 405 ~l~-g--~~~~~~~~~lV~E~~~~gsL~~~l~--------------~---~~-----~~-~----------------l~~ 442 (614)
... | +....+....++.+..+......-. . .. .. . ...
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 211 1 1223456677777776654432110 0 00 00 0 000
Q ss_pred hHHHHHHHHhHhhchhhh-ccCCCceEecCcCCCCeEEcCCCCEEEeeecccc
Q 044561 443 YQRFRIIRGVASGLLYLH-EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR 494 (614)
Q Consensus 443 ~~~~~i~~~ia~gL~yLH-~~~~~~ivHrDikp~NIll~~~~~~kl~DfGla~ 494 (614)
......+..+...+.-.+ .....++||+|+.+.||+++.+...-|.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 111112222222222211 1235789999999999999988777899999876
|